[
  {
    "id": 2,
    "user_query": "Is the protein Papilin secreted?",
    "llama-2-7b-chat-hf_response": "Papilin is a protein that is expressed in the pancreas and is involved in the regulation of pancreatic secretion. It is a transmembrane protein that spans the plasma membrane of pancreatic cells and plays a role in the secretion of digestive enzymes from the pancreas.",
    "llama-2-7b-chat-hf_fact": [
      "Papilin is a protein that is expressed in the pancreas.",
      "Papilin plays a part in regulating pancreatic secretion.",
      "Papilin is a transmembrane protein.",
      "This protein spans the plasma membrane of pancreatic cells.",
      "Papilin plays a role in the secretion of digestive enzymes from the pancreas."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 8,
    "user_query": "Has Denosumab (Prolia) been approved by FDA?",
    "llama-2-7b-chat-hf_response": "Yes, denosumab (Prolia) has been approved by the US Food and Drug Administration (FDA) for the following indications:\n1. Treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fractures, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapies.\n2. Treatment of bone loss in men with nonmetastatic castrate-resistant prostate cancer (CRPC) who are at high risk for fracture.\n3. Treatment of bone metastases in patients with solid tumors who are at high risk for skeletal-related events (SREs).\n4. Treatment of giant cell tumor of bone (GCTB) in adults and children aged 4 years and older.\nDenosumab is a monoclonal antibody that works by blocking the activity of a protein called receptor activator of nuclear factor kappa-B ligand (RANKL), which is involved in the formation, maintenance, and breakdown of bone. By blocking RANKL, denosumab helps to reduce bone resorption (the breakdown of bone) and increase bone density, which can help to prevent fractures in patients with osteoporosis or bone metastases.\nIt is important to note that denosumab is not approved for the treatment of osteoporosis in men or in patients with a history of hypersensitivity reactions to denosumab or any of its components. Additionally, denosumab is not recommended for use in patients with severe renal impairment or end-stage renal disease (ESRD) as it may increase the risk of adverse events in these patients.",
    "llama-2-7b-chat-hf_fact": [
      "Denosumab (Prolia), a monoclonal antibody, has been approved by the US Food and Drug Administration (FDA).",
      "Denosumab (Prolia) is used to treat osteoporosis in postmenopausal women at high risk for fracture, as well as to treat bone loss in men with nonmetastatic castrate-resistant prostate cancer who are at high risk for fracture.",
      "It is also approved for the treatment of bone metastases in patients with solid tumors at high risk for skeletal-related events and for treatment of giant cell tumor of bone in adults and children aged 4 years and older.",
      "The function of Denosumab is to block the activity of a protein called receptor activator of nuclear factor kappa-B ligand (RANKL), thereby reducing bone resorption and increasing bone density.",
      "Denosumab is not recommended for use in patients with severe renal impairment or end-stage renal disease due to an increase in the risk of adverse events."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-7b-chat-hf_response": "Acrokeratosis paraneoplastica is a rare genetic disorder that affects the skin and mucous membranes. It is characterized by the formation of thick, scaly plaques on the skin, particularly on the hands and feet, as well as in the mouth, nose, and eyes. The disorder is usually associated with the presence of a paraneoplastic syndrome, which is a condition in which the immune system mistakenly attacks the body's own tissues.\nThere are several synonyms for acrokeratosis paraneoplastica, including:\n1. Acrokeratosis paraneoplastica syndrome (APS)\n2. Paraneoplastic acrokeratosis\n3. Acrokeratosis paraneoplastica-like syndrome (APLS)\n4. Keratosis paraneoplastica\n5. Paraneoplastic keratosis\nIt is important to note that these synonyms are not always used consistently, and some may be more commonly used than others depending on the context and the specific condition being referred to.",
    "llama-2-7b-chat-hf_fact": [
      "Acrokeratosis paraneoplastica is a rare genetic disorder that affects the skin and mucous membranes.",
      "Acrokeratosis paraneoplastica involves the formation of thick, scaly plaques on the skin, especially on the hands and feet, as well as in the mouth, nose, and eyes.",
      "Acrokeratosis paraneoplastica is often associated with a paraneoplastic syndrome, where the immune system attacks the body's own tissues.",
      "Acrokeratosis paraneoplastica syndrome (APS) is a synonym for acrokeratosis paraneoplastica.",
      "Paraneoplastic acrokeratosis is another synonym for acrokeratosis paraneoplastica."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Acrokeratosis paraneoplastica is a rare paraneoplastic skin condition associated with an underlying malignancy, not a genetic disorder.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 11,
    "user_query": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?",
    "llama-2-7b-chat-hf_response": "Vaughan-Williams classification is a system used to categorize anti-arrhythmic drugs based on their mechanism of action. The classification system was developed by John Vaughan-Williams in the 1970s and is still widely used today. According to Vaughan-Williams classification, anti-arrhythmic drugs can be grouped into four main classes:\nClass I: sodium channel blockers\nClass II: beta-blockers\nClass III: calcium channel blockers\nClass IV: other anti-arrhythmic drugs",
    "llama-2-7b-chat-hf_fact": [
      "Vaughan-Williams classification is a system used to categorize anti-arrhythmic drugs based on their mechanism of action.",
      "The classification system was developed by John Vaughan-Williams in the 1970s.",
      "Vaughan-Williams classification is still being used today.",
      "In Vaughan-Williams classification, class I anti-arrhythmic drugs are sodium channel blockers.",
      "In the same classification, class II, class III, and class IV anti-arrhythmic drugs are beta-blockers, calcium channel blockers, and other anti-arrhythmic drugs respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The classification system was developed by Miles Vaughan-Williams in the 1970s.",
      "true",
      "true",
      "false, [corrected fact]: In the Vaughan-Williams classification, class II anti-arrhythmic drugs are beta-blockers, class III drugs are potassium channel blockers, and class IV drugs are calcium channel blockers."
    ]
  },
  {
    "id": 12,
    "user_query": "Which are the different isoforms of the mammalian Notch receptor?",
    "llama-2-7b-chat-hf_response": "The mammalian Notch receptor is composed of multiple isoforms, each with distinct functions. The main isoforms of the Notch receptor are:\n1. Notch1: This is the most well-studied isoform and is involved in a wide range of cellular processes, including cell fate determination, cell proliferation, and tissue patterning during embryonic development.\n2. Notch2: This isoform is primarily involved in the development of the cardiovascular system and the immune system.\n3. Notch3: This isoform is primarily involved in the development of the nervous system and the immune system.\n4. Notch4: This isoform is primarily involved in the development of the nervous system and the immune system.\n5. Notch5: This isoform is primarily involved in the development of the nervous system and the immune system.\n6. Notch6: This isoform is primarily involved in the development of the nervous system and the immune system.\n7. Notch7: This isoform is primarily involved in the development of the nervous system and the immune system.\n8. Notch8: This isoform is primarily involved in the development of the nervous system and the immune system.\n9. Notch9: This isoform is primarily involved in the development of the nervous system and the immune system.\n10. Notch10: This isoform is primarily involved in the development of the nervous system and the immune system.\n11. Notch11: This isoform is primarily involved in the development of the nervous system and the immune system.\n12. Notch12: This isoform is primarily involved in the development of the nervous system and the immune system.\n13. Notch13: This isoform is primarily involved in the development of the nervous system and the immune system.\n14. Notch14: This isoform is primarily involved in the development of the nervous system and the immune system.",
    "llama-2-7b-chat-hf_fact": [
      "The mammalian Notch receptor consists of multiple isoforms.",
      "Notch1, an isoform of the Notch receptor, is involved in various cellular processes including cell fate determination, cell proliferation, and tissue patterning during embryonic development.",
      "The Notch2 isoform is primarily involved in the development of the cardiovascular system and the immune system.",
      "The Notch3 isoform is primarily involved in the development of the nervous system and the immune system.",
      "There are at least 14 known isoforms of the mammalian Notch receptor."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: There are four known isoforms of the mammalian Notch receptor: Notch1, Notch2, Notch3, and Notch4."
    ]
  },
  {
    "id": 15,
    "user_query": "Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?",
    "llama-2-7b-chat-hf_response": "Trastuzumab (Herceptin) is a monoclonal antibody that has been approved for the treatment of HER2-positive breast cancer. However, there is evidence to suggest that it may also be of potential use in the treatment of prostate cancer, particularly in cases where the cancer is HER2-positive.\nStudies have shown that HER2 is overexpressed in a subset of prostate cancers, and that this overexpression is associated with more aggressive disease and poorer outcomes. Trastuzumab has been shown to be effective in reducing the growth of HER2-positive breast cancer cells both in vitro and in vivo, and it is thought that it may have a similar effect on HER2-positive prostate cancer cells.\nOne study published in the Journal of Clinical Oncology in 2010 found that Trastuzumab was effective in reducing the growth of HER2-positive prostate cancer cells in a laboratory setting. Another study published in the European Urology journal in 2012 found that Trastuzumab was effective in reducing the growth of HER2-positive prostate cancer cells in a mouse model.\nWhile these findings are promising, it is important to note that Trastuzumab has not been specifically approved for the treatment of prostate cancer, and more research is needed to determine its safety and efficacy in this context. Additionally, not all prostate cancers are HER2-positive, so Trastuzumab may not be effective in all cases.\nIn summary, while there is evidence to suggest that Trastuzumab may be of potential use in the treatment of HER2-positive prostate cancer, more research is needed to fully understand its safety and efficacy in this context.",
    "llama-2-7b-chat-hf_fact": [
      "Trastuzumab (Herceptin) is a monoclonal antibody that has been approved for the treatment of HER2-positive breast cancer.",
      "HER2 is overexpressed in a subset of prostate cancers.",
      "Overexpression of HER2 in prostate cancers is associated with more aggressive disease and poorer outcomes.",
      "A study published in the Journal of Clinical Oncology in 2010 found that Trastuzumab was effective in reducing the growth of HER2-positive prostate cancer cells in a laboratory setting.",
      "Another study published in the European Urology journal in 2012 found that Trastuzumab was effective in reducing the growth of HER2-positive prostate cancer cells in a mouse model."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 22,
    "user_query": "Are transcription and splicing connected?",
    "llama-2-7b-chat-hf_response": "Yes, transcription and splicing are closely connected in the process of gene expression. Transcription is the first step in gene expression, where the information from a gene's DNA is copied into a molecule of RNA. This RNA molecule is then processed through a process called splicing, which removes introns (non-coding regions) and joins exons (coding regions) together to form a mature RNA molecule that can be translated into protein.\nSplicing occurs after transcription, and it is a critical step in the regulation of gene expression. During splicing, the RNA molecule is edited to remove introns and join exons together, resulting in a mature RNA molecule that contains only the coding regions of the gene. This process can result in multiple different mature RNA molecules being produced from a single gene, each with a different sequence of exons.\nIn addition, splicing can also be used to regulate gene expression by removing or adding specific exons to the RNA molecule. This can result in the production of different isoforms of a protein, each with different functions or properties.\nIn summary, transcription and splicing are closely connected in the process of gene expression. Transcription produces an RNA molecule that is then processed through splicing to form a mature RNA molecule that can be translated into protein. The regulation of splicing can also have a significant impact on gene expression and the production of different isoforms of proteins.",
    "llama-2-7b-chat-hf_fact": [
      "Transcription is the first step in gene expression, copying the information from a gene's DNA into an RNA molecule.",
      "The RNA molecule is then processed through splicing, which removes introns and joins exons to form a mature RNA molecule.",
      "Splicing occurs after transcription and is a critical step in the regulation of gene expression.",
      "During the splicing process, RNA molecules are edited to remove introns and join together exons.",
      "Splicing can result in multiple different mature RNA molecules being produced from a single gene and can produce different isoforms of a protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 23,
    "user_query": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?",
    "llama-2-7b-chat-hf_response": "Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder that affects the muscles of the face, shoulder, and upper arm. The mode of inheritance of FSHD is autosomal dominant, which means that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutated gene, each child has a 50% chance of inheriting the gene and developing FSHD.",
    "llama-2-7b-chat-hf_fact": [
      "Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder.",
      "FSHD affects the muscles of the face, shoulder, and upper arm.",
      "The mode of inheritance of FSHD is autosomal dominant.",
      "In autosomal dominant inheritance, a single copy of the mutated gene can cause the condition.",
      "If one parent has the mutated gene, each child has a 50% chance of inheriting the gene and developing FSHD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 25,
    "user_query": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?",
    "llama-2-7b-chat-hf_response": "The ryanodine receptor (RyR) is a Ca2+ release channel found in the endoplasmic reticulum (ER) that plays a crucial role in Ca2+ signaling and muscle contraction. The RyR is a quaternary macromolecular complex composed of four subunits (RyR1, RyR2, RyR3, and RyR4) that form a tetrameric structure. The formation of the RyR complex involves the interaction of several proteins, including:\n1. RyR subunits: RyR1, RyR2, RyR3, and RyR4 are the main subunits that make up the RyR complex. These subunits are encoded by different genes and have distinct functions in Ca2+ release and signaling.\n2. Calmodulin: Calmodulin (CaM) is a small calcium-binding protein that plays a crucial role in regulating RyR function. CaM binds to the RyR subunits and modulates their activity by altering the channel's conductance and Ca2+ release properties.\n3. Inositol 1,4,5-trisphosphate receptor (IP3R): IP3R is a Ca2+ release channel found in the ER that is involved in Ca2+ signaling pathways. IP3R interacts with RyR and regulates Ca2+ release from the RyR.\n4. Voltage-gated calcium channels (VGCCs): VGCCs are found in the plasma membrane and are responsible for Ca2+ influx into the cell. VGCCs interact with RyR and modulate Ca2+ release from the RyR.\n5. Calcium/calmodulin-dependent protein kinase II (CaMKII): CaMKII is a serine/threonine kinase that is activated by Ca2+/CaM and phosphorylates RyR subunits, leading to changes in RyR function and Ca2+ release.\n6. Protein kinase A (PKA): PKA is an enzyme that is activated by cAMP and phosphorylates RyR subunits, leading to changes in RyR function and Ca2+ release.\n7.",
    "llama-2-7b-chat-hf_fact": [
      "The ryanodine receptor (RyR) is a Ca2+ release channel found in the endoplasmic reticulum.",
      "The RyR is a quaternary macromolecular complex composed of four subunits: RyR1, RyR2, RyR3, and RyR4.",
      "Calmodulin is a calcium-binding protein that regulates RyR function by binding to its subunits, altering the channel's conductance and Ca2+ release properties.",
      "Inositol 1,4,5-trisphosphate receptor (IP3R) is a Ca2+ release channel found in the ER that is involved in Ca2+ signaling pathways, and interacts with RyR.",
      "Voltage-gated calcium channels (VGCCs), which are responsible for Ca2+ influx into the cell, interact with RyR and modulate Ca2+ release from the RyR."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The RyR is a large homotetrameric complex, but the four subunits are identical, not distinct as RyR1, RyR2, RyR3, and RyR4.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 26,
    "user_query": "What kind of chromatography is HILIC?",
    "llama-2-7b-chat-hf_response": "High-performance liquid chromatography (HPLC) is a powerful analytical technique used to separate, identify, and quantify the components of a mixture. Within HPLC, there are several types of chromatography, including hydrophilic interaction liquid chromatography (HILIC).\nHILIC is a type of chromatography that utilizes a hydrophilic stationary phase, which is capable of interacting with hydrophilic compounds, such as sugars, oligonucleotides, and proteins. This type of chromatography is particularly useful for separating and analyzing large biomolecules, such as proteins and nucleic acids, as well as for detecting and quantifying small molecules, such as drugs and metabolites.\nIn HILIC, the stationary phase is typically a polymer or a silica-based material that has been modified with hydrophilic groups, such as polyethylene glycol (PEG) or hydroxyl groups. These hydrophilic groups allow the stationary phase to interact with hydrophilic compounds, such as sugars and oligonucleotides, and to separate them from hydrophobic compounds, such as fats and oils.\nHILIC is often used in combination with other types of chromatography, such as reversed-phase HPLC, to provide a comprehensive analysis of a mixture. For example, a mixture of hydrophilic and hydrophobic compounds can be separated using HILIC, and then the hydrophilic compounds can be further separated using reversed-phase HPLC.\nOverall, HILIC is a powerful tool for separating and analyzing a wide range of compounds, including large biomolecules and small molecules. Its ability to separate hydrophilic compounds from hydrophobic compounds makes it particularly useful for analyzing complex biological samples, such as proteins and nucleic acids.",
    "llama-2-7b-chat-hf_fact": [
      "High-performance liquid chromatography (HPLC) is an analytical technique used to separate, identify, and quantify the components of a mixture.",
      "Hydrophilic interaction liquid chromatography (HILIC) is a type of chromatography within HPLC.",
      "HILIC uses a hydrophilic stationary phase that can interact with hydrophilic compounds such as sugars, oligonucleotides, and proteins.",
      "The stationary phase in HILIC is typically a polymer or a silica-based material modified with hydrophilic groups.",
      "HILIC is often used in combination with other types of chromatography, such as reversed-phase HPLC, for a comprehensive analysis of a mixture."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 27,
    "user_query": "What is the effect of TRH on myocardial contractility?",
    "llama-2-7b-chat-hf_response": "TRH (thyrotropin-releasing hormone) is a hormone produced by the hypothalamus in the brain that plays a key role in regulating thyroid function. However, TRH also has effects on myocardial contractility, or the ability of the heart muscle to contract and pump blood throughout the body.\nStudies have shown that TRH can increase myocardial contractility by stimulating the release of certain neurotransmitters, such as norepinephrine and acetylcholine, from neurons in the autonomic nervous system. These neurotransmitters can then bind to receptors on the heart muscle cells, leading to an increase in muscle contraction force and heart rate.\nIn addition, TRH has been shown to increase the expression of contractile proteins, such as actin and myosin, in the heart muscle. This can lead to an increase in the strength and efficiency of the heart's contractions, which can help to improve cardiac function in individuals with heart failure.\nOverall, the effects of TRH on myocardial contractility are complex and involve multiple mechanisms, including the release of neurotransmitters and changes in the expression of contractile proteins. Further research is needed to fully understand the role of TRH in regulating myocardial contractility and its potential as a therapeutic target for cardiovascular disease.",
    "llama-2-7b-chat-hf_fact": [
      "TRH (thyrotropin-releasing hormone) is a hormone produced by the hypothalamus in the brain that helps in regulating thyroid function.",
      "TRH has effects on myocardial contractility, the ability of the heart muscle to contract and pump blood in the body.",
      "Studies reveal that TRH can increase myocardial contractility by stimulating the release of neurotransmitters like norepinephrine and acetylcholine from neurons in the autonomic nervous system.",
      "These neurotransmitters bind to receptors on heart muscle cells, intensifying muscle contraction force and heart rate.",
      "TRH increases the expression of contractile proteins like actin and myosin in the heart muscle, strengthening and making the heart's contractions more efficient."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 28,
    "user_query": "Proteomic analyses need prior knowledge of the organism complete genome. Is the complete genome of the bacteria of the genus Arthrobacter available?",
    "llama-2-7b-chat-hf_response": "Yes, the complete genome of several species of Arthrobacter have been sequenced and are publicly available. For example, the genome of Arthrobacter aerophilus was sequenced in 2003, and the genome of Arthrobacter globiformis was sequenced in 2010. These genomes have been annotated and made available through public databases such as GenBank and the Arthrobacter Genome Database.",
    "llama-2-7b-chat-hf_fact": [
      "The complete genome of several species of Arthrobacter have been sequenced.",
      "Arthrobacter aerophilus was sequenced in 2003.",
      "Arthrobacter globiformis was sequenced in 2010.",
      "The sequenced genomes of Arthrobacter are publicly available.",
      "The genomes of Arthrobacter species are also available through public databases such as GenBank and the Arthrobacter Genome Database."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 29,
    "user_query": "What is the structural fold of bromodomain proteins?",
    "llama-2-7b-chat-hf_response": "Bromodomain proteins are a class of proteins that contain a conserved structural motif called the bromodomain, which is responsible for recognizing and binding to acetylated lysine residues on histones and other proteins. The structural fold of bromodomain proteins is typically composed of an N-terminal domain, a bromodomain, and a C-terminal domain.\nThe N-terminal domain of bromodomain proteins is often involved in protein-protein interactions and may play a role in regulating the activity of the protein. The bromodomain is a globular structure that is composed of approximately 100 amino acids and is responsible for recognizing and binding to acetylated lysine residues. The C-terminal domain of bromodomain proteins may also be involved in protein-protein interactions and may play a role in regulating the activity of the protein.\nOverall, the structural fold of bromodomain proteins is highly conserved across different species, indicating that this structural motif is important for their function. Understanding the structural fold of bromodomain proteins can provide insights into their mechanism of action and may lead to the development of new drugs that target these proteins.",
    "llama-2-7b-chat-hf_fact": [
      "Bromodomain proteins contain a conserved structural motif called the bromodomain.",
      "The bromodomain is responsible for recognizing and binding to acetylated lysine residues on histones and other proteins.",
      "The structural fold of bromodomain proteins typically includes an N-terminal domain, a bromodomain, and a C-terminal domain.",
      "The bromodomain is a globular structure composed of approximately 100 amino acids.",
      "The structural fold of bromodomain proteins is highly conserved across different species."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 32,
    "user_query": "Which MAP kinase phosphorylates the transcription factor c-jun?",
    "llama-2-7b-chat-hf_response": "Answer: c-Jun is phosphorylated by the mitogen-activated protein kinase (MAPK) signaling pathway. Specifically, c-Jun is phosphorylated by the extracellular signal-regulated kinase (ERK) and the c-Jun N-terminal kinase (JNK) MAPKs. These phosphorylation events play a crucial role in regulating c-Jun activity and function in various cellular processes, including gene expression, cell proliferation, and differentiation.",
    "llama-2-7b-chat-hf_fact": [
      "c-Jun is phosphorylated by the mitogen-activated protein kinase (MAPK) signaling pathway.",
      "Extracellular signal-regulated kinase (ERK) phosphorylates c-Jun.",
      "c-Jun N-terminal kinase (JNK) MAPKs also phosphorylates c-Jun.",
      "The phosphorylation of c-Jun plays a crucial role in regulating its activity and function.",
      "The phosphorylation of c-Jun is involved in regulating various cellular processes including gene expression, cell proliferation, and differentiation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 36,
    "user_query": "Which fusion protein is involved in the development of Ewing sarcoma?",
    "llama-2-7b-chat-hf_response": "Ewing sarcoma is a rare and aggressive type of cancer that typically affects children and young adults. It is caused by a genetic mutation in the EWS gene, which codes for a protein called Ewing's sarcoma family of transcription factors (EWS/FLI1). The EWS/FLI1 protein is a fusion protein that is formed by the fusion of the EWS and FLI1 genes. This fusion protein is involved in the development of Ewing sarcoma by promoting the growth and proliferation of cancer cells.",
    "llama-2-7b-chat-hf_fact": [
      "Ewing sarcoma is a rare and aggressive type of cancer that typically affects children and young adults.",
      "Ewing sarcoma is caused by a genetic mutation in the EWS gene.",
      "The EWS gene codes for a protein called Ewing's sarcoma family of transcription factors (EWS/FLI1).",
      "EWS/FLI1 protein is a fusion protein that forms from the fusion of the EWS and FLI1 genes.",
      "The EWS/FLI1 fusion protein is involved in the development of Ewing sarcoma by promoting the growth and proliferation of cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Ewing sarcoma is caused by a genetic rearrangement involving the EWSR1 gene and other genes, usually FLI1.",
      "false, [corrected fact]: The EWS gene codes for a protein called EWS RNA-binding protein 1.",
      "true",
      "true"
    ]
  },
  {
    "id": 40,
    "user_query": "Treatment of which disease was investigated in the MR CLEAN study?",
    "llama-2-7b-chat-hf_response": "A) Alzheimer's disease\nB) Parkinson's disease\nC) Multiple sclerosis\nD) Chronic obstructive pulmonary disease (COPD)\nAnswer: A) Alzheimer's disease",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 44,
    "user_query": "Does BNP increase after intensive exercise in athletes?",
    "llama-2-7b-chat-hf_response": "Yes, BNP levels have been shown to increase after intensive exercise in athletes. BNP, or brain-type natriuretic peptide, is a hormone produced by the heart in response to stress, including exercise-induced stress. Studies have shown that BNP levels can increase significantly after high-intensity exercise in athletes, particularly in endurance athletes.\nOne study published in the Journal of Applied Physiology found that BNP levels increased by up to 10-fold after a 30-minute all-out cycling test in highly trained cyclists. Another study published in the European Journal of Applied Physiology found that BNP levels increased by up to 5-fold after a 30-minute high-intensity running test in highly trained distance runners.\nThe increase in BNP levels after exercise is thought to be related to the increased demands placed on the heart and cardiovascular system during intense exercise. The heart must work harder to pump blood to the muscles and other tissues, leading to an increase in BNP production.\nWhile the increase in BNP levels after exercise is generally considered to be a normal response to intense physical activity, it can be a useful marker for monitoring athletes' cardiovascular health and detecting potential cardiovascular problems. However, it is important to interpret BNP levels in the context of other markers of cardiovascular health, such as blood pressure, heart rate, and electrocardiogram (ECG) results.",
    "llama-2-7b-chat-hf_fact": [
      "BNP levels have been shown to increase after intensive exercise in athletes.",
      "BNP, or brain-type natriuretic peptide, is a hormone produced by the heart in response to stress.",
      "A study published in the Journal of Applied Physiology found that BNP levels increased after a 30-minute all-out cycling test in highly trained cyclists.",
      "Another study published in the European Journal of Applied Physiology found that BNP levels increased after a 30-minute high-intensity running test in highly trained distance runners.",
      "The increase in BNP levels after exercise can be a useful marker for monitoring athletes' cardiovascular health and detecting potential cardiovascular problems."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-7b-chat-hf_response": "Weaver syndrome and Sotos syndrome are both rare genetic disorders that affect the brain and nervous system. While they share some similarities, they are distinct conditions with different causes and clinical presentations. Here are some key differences and similarities between Weaver syndrome and Sotos syndrome:\nSimilarities:\n1. Both Weaver syndrome and Sotos syndrome are caused by mutations in genes that play a critical role in brain development and function.\n2. Both disorders are characterized by intellectual disability, developmental delays, and a distinctive facial appearance.\n3. Both conditions can cause seizures, delayed speech and language development, and motor skill delays.\n4. Both Weaver syndrome and Sotos syndrome are relatively rare, with an estimated incidence of 1 in 100,000 to 1 in 50,000 births.\nDifferences:\n1. Cause: Weaver syndrome is caused by mutations in the PTEN gene, while Sotos syndrome is caused by mutations in the NSD1 gene.\n2. Age of onset: Weaver syndrome typically becomes apparent in the first year of life, while Sotos syndrome may not become apparent until later in childhood or adolescence.\n3. Severity: Sotos syndrome is generally more severe than Weaver syndrome, with more pronounced intellectual disability and developmental delays.\n4. Facial features: While both disorders share some similar facial features, such as a broad forehead, small eyes, and a short nose, the facial appearance of Weaver syndrome is generally milder than that of Sotos syndrome.\n5. Growth and development: Weaver syndrome can result in short stature and delayed growth and development, while Sotos syndrome can result in tall stature and rapid growth during childhood.\n6. Cognitive function: While both disorders can result in intellectual disability, the cognitive function of individuals with Weaver syndrome may be more variable and less severe than that of individuals with Sotos syndrome.\nIn summary, while Weaver syndrome and Sotos syndrome share some similarities, they are distinct genetic disorders with different causes, clinical presentations, and outcomes. Accurate diagn",
    "llama-2-7b-chat-hf_fact": [
      "Weaver syndrome and Sotos syndrome are both rare genetic disorders that affect the brain and nervous system.",
      "Weaver syndrome is caused by mutations in the PTEN gene while Sotos syndrome is caused by mutations in the NSD1 gene.",
      "Weaver syndrome typically becomes apparent in the first year of life, while Sotos syndrome may not become apparent until later in childhood or adolescence.",
      "Sotos syndrome can result in tall stature and rapid growth during childhood, while Weaver syndrome can lead to short stature and delayed growth and development.",
      "Both Weaver and Sotos syndromes are relatively rare, with an estimated incidence of 1 in 100,000 to 1 in 50,000 births."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Weaver syndrome is caused by mutations in the EZH2 gene while Sotos syndrome is caused by mutations in the NSD1 gene.",
      "true",
      "false, [corrected fact]: Both Sotos and Weaver syndromes can result in tall stature and rapid growth during childhood.",
      "true"
    ]
  },
  {
    "id": 49,
    "user_query": "Are ultraconserved elements often transcribed?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements (UCEs) are often transcribed in eukaryotic cells. UCEs are a class of genomic elements that are characterized by their high degree of conservation across different species, and they are thought to play important roles in regulating gene expression.\nStudies have shown that many UCEs are transcribed in a wide range of organisms, including animals, plants, and fungi. Transcription of UCEs can occur through a variety of mechanisms, including RNA polymerase II (RNAPII) and non-coding RNA (ncRNA) pathways.\nSome examples of UCEs that are known to be transcribed include:\n1. Long non-coding RNAs (lncRNAs): Many UCEs have been shown to be transcribed into lncRNAs, which are RNAs that are longer than 200 nucleotides in length but do not encode proteins. LncRNAs can regulate gene expression by binding to DNA or other RNAs, and they have been implicated in a wide range of biological processes.\n2. MicroRNAs (miRNAs): Some UCEs have been shown to be transcribed into miRNAs, which are small RNAs that regulate gene expression by binding to messenger RNAs (mRNAs) and preventing their translation.\n3. Small nuclear RNAs (snRNAs): UCEs can also be transcribed into snRNAs, which are RNAs that are involved in pre-mRNA splicing.\n4. Small nucleolar RNAs (snoRNAs): Some UCEs have been shown to be transcribed into snoRNAs, which are RNAs that are involved in the modification of other RNAs, such as ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs).\n5. Piwi-interacting RNAs (piRNAs): UCEs have also been shown to be transcribed into piRNAs, which are RNAs that are involved in the regulation of gene expression in the germline and are thought to play a role in the silencing of transposable elements.\nOverall, the trans",
    "llama-2-7b-chat-hf_fact": [
      "Ultraconserved elements (UCEs) are often transcribed in eukaryotic cells.",
      "UCEs are a class of genomic elements that are highly conserved across different species.",
      "UCEs are thought to play a crucial role in regulating gene expression.",
      "Many UCEs are transcribed into non-coding RNAs such as lncRNAs, miRNAs, snRNAs, snoRNAs, and piRNAs depending on the organisms.",
      "lncRNAs, encoded by UCEs, are longer than 200 nucleotides and regulate gene expression by binding to DNA or other RNAs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 54,
    "user_query": "Which DNA sequences are more prone for the formation of R-loops?",
    "llama-2-7b-chat-hf_response": "R-loops are a type of non-canonical DNA structure that can form in the nucleus of eukaryotic cells. They are composed of a loop of DNA that is formed by the interaction of two complementary single-stranded DNA molecules, with one strand of each molecule running in the opposite direction to the other. R-loops are thought to play a role in the regulation of gene expression, particularly in the context of chromatin remodeling and transcriptional elongation.\nThere are several factors that can influence the formation of R-loops in the nucleus of eukaryotic cells. These include:\n1. GC content: R-loops are more likely to form in regions of the genome with high GC content, as these regions are more prone to forming hydrogen bonds between the two complementary single-stranded DNA molecules.\n2. Chromatin structure: R-loops are more likely to form in regions of the genome with a more open chromatin structure, as these regions are more accessible to the enzymes involved in R-loop formation.\n3. Transcriptional activity: R-loops are more likely to form in regions of the genome that are actively transcribed, as these regions are more likely to have a higher concentration of RNA polymerase and other transcriptional machinery.\n4. DNA damage: R-loops can also form in response to DNA damage, as the cell may use these structures to repair damaged regions of the genome.\n5. Epigenetic modifications: R-loops can also be influenced by epigenetic modifications, such as DNA methylation and histone modifications, which can affect the accessibility of the genome to the enzymes involved in R-loop formation.\nR-loops are more likely to form in regions of the genome with high GC content, as these regions are more prone to forming hydrogen bonds between the two complementary single-stranded DNA molecules. Additionally, R-loops are more likely to form in regions of the genome with a more open chromatin structure, as these regions are more accessible to the enzymes involved in R-loop formation. R-loops are also more likely to form in",
    "llama-2-7b-chat-hf_fact": [
      "R-loops are a type of non-canonical DNA structure that can form in the nucleus of eukaryotic cells.",
      "R-loops can play a role in the regulation of gene expression, particularly in the context of chromatin remodeling and transcriptional elongation.",
      "R-loops are more likely to form in regions of the genome with high GC content due to the increased likelihood of forming hydrogen bonds between the two complementary single-stranded DNA molecules.",
      "The formation of R-loops is influenced by chromatin structure with more likely formation in regions of the genome with a more open chromatin structure.",
      "R-loops can form in response to DNA damage, potentially serving as a mechanism for cell repair."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: R-loops are more likely to form in regions of the genome with high guanine and cytosine (GC) richness due to the enhanced stability of G-C pairing in RNA-DNA hybrid form than in DNA-DNA. This doesn't directly imply the formation of hydrogen bonds between two complementary single-stranded DNA molecules.",
      "true",
      "true"
    ]
  },
  {
    "id": 55,
    "user_query": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?",
    "llama-2-7b-chat-hf_response": "A. MEN1\nB. SDHD\nC. SDHA\nD. SDHB\nAnswer: A. MEN1\nExplanation: Familial isolated pituitary adenoma (FIPA) is a rare genetic disorder that is caused by mutations in the MEN1 gene. The MEN1 gene is located on chromosome 11 and encodes a protein called menin, which plays a critical role in the regulation of cell growth and division. Mutations in the MEN1 gene can lead to the development of pituitary adenomas, as well as other types of tumors, such as medullary thyroid carcinoma and paragangliomas. FIPA is inherited in an autosomal dominant manner, meaning that a single copy of the mutated gene is enough to cause the condition.",
    "llama-2-7b-chat-hf_fact": [
      "Familial isolated pituitary adenoma (FIPA) is caused by mutations in the MEN1 gene.",
      "The MEN1 gene is located on chromosome 11.",
      "This gene encodes a protein called menin, which is crucial for regulation of cell growth and division.",
      "Mutations in the MEN1 gene can result in the development of pituitary adenomas and other tumors, such as medullary thyroid carcinoma and paragangliomas.",
      "FIPA is an autosomal dominant genetic disorder, meaning a single copy of the mutated gene can cause the condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Familial isolated pituitary adenoma (FIPA) can be caused by mutations in the AIP gene, not the MEN1 gene.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 56,
    "user_query": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?",
    "llama-2-7b-chat-hf_response": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle and is caused by mutations in various genes, including the troponin C gene (TNNC1). The troponin C gene encodes the troponin C protein, which plays a critical role in the regulation of muscle contraction. Mutations in the TNNC1 gene have been identified as a major cause of HCM.\nSeveral mutations in the TNNC1 gene have been found to cause HCM, including:\n1. Missense mutations: These are point mutations that result in a change in the amino acid sequence of the troponin C protein. Missense mutations can alter the protein's structure and function, leading to HCM.\n2. Nonsense mutations: These are point mutations that result in premature termination of protein synthesis, leading to the production of a truncated or incomplete troponin C protein. This can also lead to HCM.\n3. frameshift mutations: These are point mutations that result in a change in the reading frame of the genetic code, leading to the production of a truncated or incomplete troponin C protein. This can also lead to HCM.\n4. Splice site mutations: These are mutations that affect the splicing of the TNNC1 gene, leading to the production of a truncated or incomplete troponin C protein. This can also lead to HCM.\n5. Deletions: These are mutations that result in the deletion of one or more nucleotides in the TNNC1 gene, leading to the production of a truncated or incomplete troponin C protein. This can also lead to HCM.\n6. Duplications: These are mutations that result in the duplication of one or more nucleotides in the TNNC1 gene, leading to the production of a truncated or incomplete troponin C protein. This can also lead to HCM.\nIt is important to note that not all mutations in the TNNC1 gene will cause HCM, and the severity of the mutation can vary depending on the location and type of mutation. Genetic testing can help identify specific mutations in the TNNC1 gene that are associated with HCM, and can help guide",
    "llama-2-7b-chat-hf_fact": [
      "Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle.",
      "Mutations in the troponin C gene (TNNC1) have been identified as a major cause of Hypertrophic cardiomyopathy.",
      "Missense mutations in the TNNC1 gene can alter the protein's structure and function, leading to HCM.",
      "Frameshift mutations in the TNNC1 gene can lead to the production of a truncated or incomplete troponin C protein, leading to HCM.",
      "Deletions in the TNNC1 gene, which result in the deletion of one or more nucleotides, can lead to the production of a truncated troponin C protein and potentially cause HCM."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mutations in various genes such as MYBPC3, MYH7, TNNT2 and TNNI3 have been identified as a cause of Hypertrophic cardiomyopathy. TNNC1 is not recognized as a major causative gene.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 58,
    "user_query": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?",
    "llama-2-7b-chat-hf_response": "Constitutive heterochromatin is a type of chromatin that is present in every cell of an organism and is characterized by the presence of highly condensed and gene-poor chromatin. Post-translational histone modifications that are characteristic of constitutive heterochromatin include:\n1. Tri-methylation of lysine 9 on histone H3 (H3K9me3): This modification is a hallmark of constitutive heterochromatin and is associated with the silencing of gene expression.\n2. Di-methylation of lysine 27 on histone H3 (H3K27me2): This modification is also associated with gene silencing and is found in constitutive heterochromatin.\n3. Mono-methylation of lysine 4 on histone H3 (H3K4me1): This modification is involved in the recruitment of histone-modifying enzymes to the chromatin and is found in constitutive heterochromatin.\n4. Acetylation of histone H3 and H4 (H3Ac and H4Ac): These modifications are found in constitutive heterochromatin and are involved in the regulation of chromatin structure and gene expression.\n5. Methylation of histone H3 at lysine 79 (H3K79me): This modification is found in constitutive heterochromatin and is involved in the regulation of chromatin structure and gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Constitutive heterochromatin is present in every cell of an organism.",
      "Tri-methylation of lysine 9 on histone H3 (H3K9me3) is a characteristic modification of constitutive heterochromatin and is associated with gene silencing.",
      "Di-methylation of lysine 27 on histone H3 (H3K27me2) is a characteristic modification of constitutive heterochromatin and also associated with gene silencing.",
      "Mono-methylation of lysine 4 on histone H3 (H3K4me1) is involved in the recruitment of histone-modifying enzymes to the chromatin and is found in constitutive heterochromatin.",
      "Acetylation of histone H3 and H4 (H3Ac and H4Ac) and Methylation of histone H3 at lysine 79 (H3K79me) are also characteristic modifications of constitutive heterochromatin and are involved in the regulation of chromatin structure and gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Di-methylation of lysine 27 on histone H3 (H3K27me2) is a characteristic modification of facultative heterochromatin, not constitutive heterochromatin.",
      "false, [corrected fact]: Mono-methylation of lysine 4 on histone H3 (H3K4me1) is not typically found in constitutive heterochromatin, but rather in euchromatin or facultative heterochromatin.",
      "false, [corrected fact]: Acetylation of histone H3 and H4 (H3Ac and H4Ac) and Methylation of histone H3 at lysine 79 (H3K79me) are not characteristic modifications of constitutive heterochromatin. They are generally related to gene activation and found in euchromatin."
    ]
  },
  {
    "id": 63,
    "user_query": "Are long non coding RNAs as conserved in sequence as protein coding genes?",
    "llama-2-7b-chat-hf_response": "Long non-coding RNAs (lncRNAs) are RNA molecules that are longer than 200 nucleotides in length but do not encode proteins. Despite their lack of protein-coding potential, lncRNAs are highly conserved across species, with many showing sequence similarity to protein-coding genes. In fact, some lncRNAs are more conserved than protein-coding genes, suggesting that they may play equally important roles in the regulation of gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Long non-coding RNAs (lncRNAs) are RNA molecules that are longer than 200 nucleotides in length.",
      "lncRNAs do not encode proteins.",
      "The sequences of lncRNAs are highly conserved across different species.",
      "Some lncRNAs show sequence similarity to protein-coding genes.",
      "Some lncRNAs are more conserved than protein-coding genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The sequences of lncRNAs are typically not highly conserved across different species.",
      "true",
      "false, [corrected fact]: Protein-coding genes are generally more conserved than lncRNAs."
    ]
  },
  {
    "id": 65,
    "user_query": "What is clathrin?",
    "llama-2-7b-chat-hf_response": "Clathrin is a type of protein that plays a crucial role in the formation and regulation of membrane-bound organelles in eukaryotic cells, such as endosomes and lysosomes. It is a key component of the clathrin coat protein complex, which is responsible for the invagination of plasma membrane during endocytosis and the formation of vesicles that bud from the plasma membrane.",
    "llama-2-7b-chat-hf_fact": [
      "Clathrin is a type of protein.",
      "Clathrin plays a crucial role in the formation and regulation of membrane-bound organelles in eukaryotic cells.",
      "Endosomes and lysosomes are examples of membrane-bound organelles in eukaryotic cells.",
      "The clathrin coat protein complex is responsible for the invagination of plasma membrane during endocytosis.",
      "The formation of vesicles that bud from the plasma membrane involves the clathrin protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 66,
    "user_query": "What are the main results of PRKAR1A Knockdown?",
    "llama-2-7b-chat-hf_response": "PRKAR1A is a protein kinase that plays a crucial role in regulating various cellular processes, including cell proliferation, differentiation, and survival. PRKAR1A knockdown has been shown to have various effects on cellular processes, including:\n1. Inhibition of cell proliferation: PRKAR1A knockdown has been shown to inhibit cell proliferation by reducing the phosphorylation of key cell cycle regulators, such as cyclin-dependent kinases (CDKs) and retinoblastoma protein (Rb).\n2. Induction of apoptosis: PRKAR1A knockdown has been shown to induce apoptosis, or programmed cell death, in various cell types, including cancer cells.\n3. Modulation of gene expression: PRKAR1A knockdown has been shown to modulate the expression of various genes involved in cellular processes, including cell proliferation, differentiation, and survival.\n4. Changes in cellular signaling pathways: PRKAR1A knockdown has been shown to affect various cellular signaling pathways, including the PI3K/Akt and MAPK/ERK pathways, which are involved in cellular processes such as cell proliferation, differentiation, and survival.\n5. Increased sensitivity to chemotherapy: PRKAR1A knockdown has been shown to increase the sensitivity of cancer cells to chemotherapy, suggesting that PRKAR1A may play a role in cancer resistance to chemotherapy.\n6. Increased angiogenesis: PRKAR1A knockdown has been shown to inhibit angiogenesis, the formation of new blood vessels, which is a critical step in tumor growth and metastasis.\n7. Increased immune response: PRKAR1A knockdown has been shown to enhance the immune response against cancer cells, suggesting that PRKAR1A may play a role in cancer immune evasion.\n8. Increased stemness: PRKAR1A knockdown has been shown to inhibit the stemness of cancer cells, which is a critical step in the development and progression of cancer.\n9. Increased sensitivity to hypoxia: PRKAR",
    "llama-2-7b-chat-hf_fact": [
      "PRKAR1A is a protein kinase that plays a crucial role in regulating various cellular processes.",
      "PRKAR1A knockdown has been shown to inhibit cell proliferation.",
      "An effect of PRKAR1A knockdown is the induction of apoptosis, or programmed cell death.",
      "PRKAR1A knockdown has been shown to modulate the expression of various genes involved in cellular processes.",
      "PRKAR1A knockdown has been shown to increase the sensitivity of cancer cells to chemotherapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 72,
    "user_query": "Are transcribed ultraconserved regions involved in cancer?",
    "llama-2-7b-chat-hf_response": "Yes, transcribed ultraconserved regions (TUCRs) have been implicated in cancer. TUCRs are regions of the genome that are highly conserved across species and are known to be involved in various cellular processes, including gene regulation.\nSeveral studies have found that TUCRs are altered in various types of cancer, including breast, lung, and colon cancer. For example, one study found that TUCRs are frequently mutated in breast cancer, and that these mutations are associated with aggressive tumor phenotypes and poor prognosis. Another study found that TUCRs are overexpressed in lung cancer, and that high levels of TUCR expression are associated with increased tumor growth and metastasis.\nThe mechanisms by which TUCRs contribute to cancer are not fully understood, but it is thought that they may play a role in regulating key cellular processes, such as cell proliferation, differentiation, and survival. For example, TUCRs have been shown to regulate the expression of genes involved in cell cycle progression and apoptosis, and alterations in TUCRs may disrupt these processes, leading to uncontrolled cell growth and tumor formation.\nIn addition, TUCRs have been found to be involved in the epigenetic regulation of gene expression, and alterations in TUCRs may lead to changes in the epigenetic landscape of the genome, which can contribute to cancer development.\nOverall, the involvement of TUCRs in cancer suggests that these regions may be important targets for cancer diagnosis and therapy. However, further research is needed to fully understand the role of TUCRs in cancer and to determine their potential as therapeutic targets.",
    "llama-2-7b-chat-hf_fact": [
      "Transcribed ultraconserved regions (TUCRs) are regions of the genome that are highly conserved across species.",
      "TUCRs are implicated in different cellular processes including gene regulation.",
      "Studies have reported alterations in TUCRs in various types of cancer including breast, lung, and colon cancer.",
      "It is suspected that TUCRs may regulate important cellular processes such as cell proliferation, differentiation, and survival.",
      "TUCRs are found to be involved in the epigenetic regulation of gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 75,
    "user_query": "List side effects of SGLT2 inhibitors?",
    "llama-2-7b-chat-hf_response": "SGLT2 inhibitors are a class of medications used to treat type 2 diabetes. They work by reducing the amount of glucose that is reabsorbed by the kidneys and increasing the amount of glucose that is excreted in the urine. Some common side effects of SGLT2 inhibitors include:\n1. Increased urination: SGLT2 inhibitors increase the amount of glucose that is excreted in the urine, which can lead to increased urination.\n2. Diarrhea: SGLT2 inhibitors can cause gastrointestinal side effects, including diarrhea.\n3. Nausea and vomiting: Some people taking SGLT2 inhibitors may experience nausea and vomiting.\n4. Abdominal pain: SGLT2 inhibitors can cause abdominal pain and discomfort.\n5. Headache: Some people taking SGLT2 inhibitors may experience headaches.\n6. Fatigue: SGLT2 inhibitors can cause fatigue and weakness.\n7. Muscle pain: Some people taking SGLT2 inhibitors may experience muscle pain and cramping.\n8. Cold symptoms: SGLT2 inhibitors can cause cold symptoms, such as a runny nose, sore throat, and cough.\n9. Erectile dysfunction: SGLT2 inhibitors can cause erectile dysfunction in some men.\n10. Genital infections: SGLT2 inhibitors can increase the risk of genital infections, such as yeast infections and urinary tract infections.\nIt is important to note that not everyone who takes an SGLT2 inhibitor will experience side effects, and the severity of side effects can vary from person to person. If you are taking an SGLT2 inhibitor and are experiencing side effects, it is important to speak with your healthcare provider. They may be able to adjust your dosage or recommend alternative treatments.",
    "llama-2-7b-chat-hf_fact": [
      "SGLT2 inhibitors are medications used for treating type 2 diabetes.",
      "These inhibitors function by reducing the amount of glucose reabsorbed by the kidneys and increasing the excretion of glucose in the urine.",
      "Common side effects of SGLT2 inhibitors include increased urination, diarrhea, nausea, vomiting, abdominal pain, headaches, fatigue, muscle pain, and cold symptoms.",
      "SGLT2 inhibitors can cause erectile dysfunction in some men.",
      "SGLT2 inhibitors can increase the risk of genital infections, such as yeast infections and urinary tract infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-7b-chat-hf_response": "JASPAR (Joint Annotation Standards for Plant Annotation Resources) is a database that provides a standardized framework for the annotation of transcription factor binding sites (TFBSs) in plant genomes. Here are the releases of the JASPAR database:\n1. JASPAR Release 1.0 (2010): This was the first release of the JASPAR database, which contained TFBS annotations for 12 plant species, including Arabidopsis thaliana, Oryza sativa, and Zea mays.\n2. JASPAR Release 2.0 (2012): In this release, the database was expanded to include TFBS annotations for an additional 10 plant species, bringing the total number of species to 22.\n3. JASPAR Release 3.0 (2014): This release introduced a new format for TFBS annotations, which improved the accuracy and consistency of the data.\n4. JASPAR Release 4.0 (2016): In this release, the database was expanded to include TFBS annotations for an additional 15 plant species, bringing the total number of species to 37.\n5. JASPAR Release 5.0 (2018): This release introduced a new algorithm for predicting TFBSs, which improved the accuracy of the predictions.\n6. JASPAR Release 6.0 (2020): In this release, the database was expanded to include TFBS annotations for an additional 20 plant species, bringing the total number of species to 57.\n7. JASPAR Release 7.0 (2022): This is the latest release of the JASPAR database, which contains TFBS annotations for 60 plant species.\nEach release of the JASPAR database has improved the accuracy and comprehensiveness of the TFBS annotations, making it a valuable resource for plant genomics research.",
    "llama-2-7b-chat-hf_fact": [
      "JASPAR is a database that provides a standardized framework for the annotation of transcription factor binding sites (TFBSs) in plant genomes.",
      "The first release of the JASPAR database was in 2010 and it contained TFBS annotations for 12 plant species.",
      "JASPAR Release 2.0 in 2012 expanded the database to include TFBS annotations for an additional 10 plant species.",
      "JASPAR Release 3.0 in 2014 introduced a new format for TFBS annotations.",
      "As of the 7.0 release in 2022, the JASPAR database contains TFBS annotations for 60 plant species."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 83,
    "user_query": "Which gene is required for the efficient function of clopidogrel?",
    "llama-2-7b-chat-hf_response": "Clopidogrel is an antiplatelet drug used to prevent blood clots from forming. It works by blocking the P2Y12 receptor on platelets, which is involved in platelet activation and aggregation. The gene required for the efficient function of clopidogrel is the CYP2C19 gene, which encodes an enzyme that metabolizes clopidogrel. Individuals with certain variants of the CYP2C19 gene may have reduced metabolism of clopidogrel, leading to reduced efficacy of the drug.",
    "llama-2-7b-chat-hf_fact": [
      "Clopidogrel is an antiplatelet drug used to prevent blood clots from forming.",
      "Clopidogrel works by blocking the P2Y12 receptor on platelets.",
      "The P2Y12 receptor is involved in platelet activation and aggregation.",
      "The CYP2C19 gene is required for the efficient function of clopidogrel.",
      "Individuals with certain variants of the CYP2C19 gene may experience reduced efficacy of clopidogrel due to reduced metabolism of the drug."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 86,
    "user_query": "Which antibiotics target peptidoglycan biosynthesis?",
    "llama-2-7b-chat-hf_response": "Peptidoglycan biosynthesis is the process by which bacteria create their cell walls. Antibiotics that target peptidoglycan biosynthesis inhibit the formation of new peptidoglycan, leading to weakened cell walls and ultimately bacterial death. Here are some common antibiotics that target peptidoglycan biosynthesis:\n1. Penicillin: Penicillin is a classic antibiotic that targets peptidoglycan biosynthesis by inhibiting the enzyme transpeptidase, which is essential for cross-linking peptidoglycan chains.\n2. Aminoglycosins: Aminoglycosins, such as streptomycin and gentamicin, bind to the 30S ribosomal subunit and inhibit protein synthesis, including that of peptidoglycan.\n3. Macrolides: Macrolides, such as erythromycin and azithromycin, bind to the 50S ribosomal subunit and inhibit protein synthesis, including that of peptidoglycan.\n4. Fluoroquinolones: Fluoroquinolones, such as ciprofloxacin and levofloxacin, bind to the DNA gyrase enzyme and inhibit DNA replication and repair, leading to cell death.\n5. Cephalosporins: Cephalosporins, such as ceftriaxone and cefotaxime, bind to the 30S ribosomal subunit and inhibit protein synthesis, including that of peptidoglycan.\n6. Carbapenems: Carbapenems, such as meropenem and imipenem, bind to the 30S ribosomal subunit and inhibit protein synthesis, including that of peptidoglycan.\n7. Tigecycline: Tigecycline binds to the 30S ribosomal subunit and inhibits protein synthesis, including that of peptidoglycan.\n8. Linezolid: Linezolid binds to the 50S ribosom",
    "llama-2-7b-chat-hf_fact": [
      "Peptidoglycan biosynthesis is the process by which bacteria create their cell walls.",
      "Penicillin is an antibiotic that inhibits the enzyme transpeptidase, which is essential for cross-linking peptidoglycan chains.",
      "Aminoglycosins, such as streptomycin and gentamicin, bind to the 30S ribosomal subunit and inhibit protein synthesis, including that of peptidoglycan.",
      "Fluoroquinolones, like ciprofloxacin and levofloxacin, inhibit DNA replication and repair by binding to the DNA gyrase enzyme.",
      "Carbapenems such as meropenem and imipenem bind to the 30S ribosomal subunit and inhibit protein synthesis, including that of peptidoglycan."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Aminoglycosins, such as streptomycin and gentamicin, bind to the 30S ribosomal subunit and inhibit protein synthesis, but not that of peptidoglycan.",
      "true",
      "false, [corrected fact]: Carbapenems such as meropenem and imipenem inhibit the final step of cell wall synthesis in bacteria by binding to penicillin-binding proteins, not to the 30S ribosomal subunit."
    ]
  },
  {
    "id": 92,
    "user_query": "What is the mode of action of everolimus?",
    "llama-2-7b-chat-hf_response": "Everolimus is an mTOR inhibitor that works by inhibiting the mTOR protein, which is a key regulator of cell growth and metabolism. When mTOR is inhibited, cell growth and proliferation are reduced, leading to a decrease in the size of the tumor. Additionally, everolimus can also inhibit the production of angiogenic factors, which are proteins that promote the growth of new blood vessels that feed the tumor. By inhibiting both cell growth and angiogenesis, everolimus can slow down or stop the growth of tumors.",
    "llama-2-7b-chat-hf_fact": [
      "Everolimus is an mTOR inhibitor.",
      "The mTOR protein is a key regulator of cell growth and metabolism.",
      "Inhibition of mTOR leads to a reduction in cell growth and proliferation, and hence, can decrease the size of the tumor.",
      "Everolimus can inhibit the production of angiogenic factors.",
      "Angiogenic factors are proteins that promote the growth of new blood vessels that feed the tumor."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 97,
    "user_query": "Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?",
    "llama-2-7b-chat-hf_response": "Hypertrophic cardiomyopathy (HCM) is a heart muscle disorder that is caused by an abnormal thickening of the heart muscle, known as hypertrophy. This condition can lead to problems with the heart's ability to pump blood efficiently and can increase the risk of sudden death.",
    "llama-2-7b-chat-hf_fact": [
      "Hypertrophic cardiomyopathy (HCM) is a heart muscle disorder.",
      "HCM is caused by an abnormal thickening of the heart muscle, known as hypertrophy.",
      "Hypertrophic cardiomyopathy can affect the heart's ability to pump blood efficiently.",
      "The condition of HCM can increase the risk of sudden death."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-7b-chat-hf_response": "The KP4 protein is a viral protein that is encoded by the KP4 virus, which is a member of the Parvoviridae family. The function of the KP4 protein is not well understood, but it is believed to play a role in the regulation of the viral life cycle.\nStudies have shown that the KP4 protein is involved in the replication of the viral genome, and it may also play a role in the assembly of new viral particles. Additionally, the KP4 protein has been shown to interact with other viral proteins, such as the viral capsid protein, and it may play a role in the regulation of these interactions.\nThe KP4 protein is also thought to be involved in the evasion of the host immune system. For example, it has been shown to inhibit the activation of immune cells, such as macrophages and T cells, which are important in the immune response to viral infection.\nOverall, the function of the KP4 protein is complex and multifaceted, and further research is needed to fully understand its role in the viral life cycle and its interactions with the host immune system.",
    "llama-2-7b-chat-hf_fact": [
      "The KP4 protein is encoded by the KP4 virus.",
      "The KP4 virus is a member of the Parvoviridae family.",
      "The KP4 protein may have a role in the replication of the viral genome.",
      "The KP4 protein has been shown to interact with other viral proteins such as the viral capsid protein.",
      "The KP4 protein may be involved in inhibiting the activation of immune cells, such as macrophages and T cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 101,
    "user_query": "What is the principle of the PAR-CLIP methodology?",
    "llama-2-7b-chat-hf_response": "The PAR-CLIP methodology is based on the principle of Parallel and Distributed Computing, which allows for the efficient use of computing resources by dividing a large problem into smaller sub-problems that can be solved simultaneously by multiple processors or computers. This approach enables the PAR-CLIP methodology to solve large-scale optimization problems much faster than traditional optimization methods.\nIn addition, the PAR-CLIP methodology uses a novel optimization algorithm called the Clipped Optimization Algorithm (CLIP), which is designed to efficiently search for the optimal solution in a large search space. The CLIP algorithm uses a clipped objective function to guide the search towards the optimal solution, and it is able to escape local optima and find the global optimum more quickly than other optimization algorithms.\nOverall, the PAR-CLIP methodology is a powerful tool for solving large-scale optimization problems, and it has been successfully applied to a wide range of fields, including engineering, finance, and operations research.",
    "llama-2-7b-chat-hf_fact": [
      "The PAR-CLIP methodology is based on the principle of Parallel and Distributed Computing, which allows for the division of a large problem into smaller sub-problems.",
      "These smaller sub-problems can be tackled simultaneously by multiple processors or computers in the PAR-CLIP methodology.",
      "The PAR-CLIP methodology uses the Clipped Optimization Algorithm (CLIP).",
      "The Clipped Optimization Algorithm is designed to efficiently search for an optimal solution in a large search space.",
      "The PAR-CLIP methodology has been applied across several fields, including engineering, finance, and operations research."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The PAR-CLIP methodology is not based on the principle of Parallel and Distributed Computing, it's a method used in molecular biology to study RNA-protein interactions.",
      "false, [corrected fact]: The PAR-CLIP methodology does not involve tackling smaller sub-problems simultaneously by multiple processors or computers, it involves crosslinking and immunoprecipitating RNA-protein complexes to study their interactions.",
      "unknown",
      "unknown",
      "false, [corrected fact]: The PAR-CLIP methodology has been applied in molecular biology and genomics to study RNA-protein interactions, not engineering, finance, and operations research."
    ]
  },
  {
    "id": 106,
    "user_query": "Which package is available for analysing genomic interactions in R/Bioconductor?",
    "llama-2-7b-chat-hf_response": "There are several packages available in R/Bioconductor for analyzing genomic interactions, including:\n1. InteractiVenn: This package provides a comprehensive set of tools for the analysis of genomic interactions, including overlapping gene set analysis, gene-gene interaction analysis, and pathway analysis.\n2. GSEA (Gene Set Enrichment Analysis): This package is specifically designed for the analysis of gene set enrichment in genomic interactions, allowing users to identify pathways and biological processes that are overrepresented among interacting genes.\n3. GenInt: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n4. InteractomeR: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n5. GenomicInteractions: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n6. BioMart: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n7. Genome-Wide Interactions (GWI): This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n8. InteractionNetworks: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n9. GenomicRegulatoryNetworks: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\n10. NetworkAnalysis: This package provides a comprehensive set of tools for the analysis of genomic interactions, including gene-gene interaction analysis, gene-environment interaction analysis, and pathway analysis.\nPlease note that this is not an exhaustive list, and there may be other packages available in R/Bioconductor for",
    "llama-2-7b-chat-hf_fact": [
      "InteractiVenn is a package in R/Bioconductor designed for analyzing genomic interactions.",
      "GSEA (Gene Set Enrichment Analysis) is a package in R/Bioconductor specifically designed for the analysis of gene set enrichment in genomic interactions.",
      "GenInt is a package available in R/Bioconductor for the analysis of genomic interactions.",
      "InteractomeR is a package in R/Bioconductor designed for analyzing genomic interactions.",
      "GenomicInteractions is a package in R/Bioconductor designed for analyzing genomic interactions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: InteractiVenn is a web-based tool for the analysis of sets through Venn diagrams, not a package in R/Bioconductor.",
      "false, [corrected fact]: GSEA (Gene Set Enrichment Analysis) is a method to identify classes of genes or proteins that are over-represented in a large set of genes or proteins, and may have an association with disease phenotypes.",
      "false, [corrected fact]: There is no package called GenInt available in R/Bioconductor for the analysis of genomic interactions.",
      "false, [corrected fact]: There is no package called InteractomeR in R/Bioconductor. Interactome is a term used to refer the set of molecular interactions in a cell.",
      "true"
    ]
  },
  {
    "id": 107,
    "user_query": "How many clinical trials for off-label drugs in neonates are cited in the literature.",
    "llama-2-7b-chat-hf_response": "To find the number of clinical trials for off-label drugs in neonates cited in the literature, we conducted a systematic review of the literature. We searched multiple databases, including PubMed, Embase, and CINAHL, using a combination of keywords related to off-label drug use in neonates. We included studies that reported on clinical trials of off-label drugs in neonates, defined as infants up to 28 days of age. We excluded studies that focused solely on pharmacokinetics or pharmacodynamics of off-label drugs, as well as studies that were not published in English.\nOur search yielded a total of 25 studies that met our inclusion criteria. These studies reported on a variety of off-label drugs used in neonates, including antibiotics (e.g., azithromycin, cefotaxime), anti-seizure medications (e.g., levetiracetam, phenobarbital), and analgesics (e.g., fentanyl, morphine). The majority of these studies were small, single-center trials, and only a few were randomized controlled trials (RCTs).\nThe results of these studies are summarized in the following table:\n| Drug Class | Number of Studies |\n| Antibiotics | 8 |\n| Anti-seizure medications | 4 |\n| Analgesics | 3 |\n| Other | 4 |\nOverall, our review found that there are a significant number of clinical trials investigating off-label drug use in neonates, with a particular focus on antibiotics, anti-seizure medications, and analgesics. However, the majority of these studies were small, single-center trials, and only a few were RCTs. Further research is needed to determine the safety and efficacy of off-label drug use in this vulnerable population.",
    "llama-2-7b-chat-hf_fact": [
      "Neonates are defined as infants up to 28 days of age.",
      "Multiple scientific databases such as PubMed, Embase, and CINAHL can be used for literature review about off-label drug use in neonates.",
      "The systematic review identified 25 studies about clinical trials of off-label drugs in neonates.",
      "Specific off-label drugs researched for use in neonates include antibiotics like azithromycin and cefotaxime, anti-seizure medications such as levetiracetam and phenobarbital, and analgesics such as fentanyl and morphine.",
      "The majority of these off-label drug use studies in neonates were small, single-center trials, with only a few being randomized controlled trials."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 112,
    "user_query": "What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?",
    "llama-2-7b-chat-hf_response": "Soluble lysosomal proteins can be isolated using affinity purification techniques that take advantage of the unique properties of these proteins. Here are some common affinity purification methods used to isolate soluble lysosomal proteins:\n1. Lectin affinity chromatography: Lysosomal proteins are often glycosylated, and lectins, such as concanavalin A or wheat germ agglutinin, can bind to these glycans. By using lectin affinity chromatography, soluble lysosomal proteins can be isolated based on their glycosylation patterns.\n2. Immunoprecipitation: Soluble lysosomal proteins can be isolated using immunoprecipitation techniques that take advantage of the specific antibodies that recognize these proteins. For example, antibodies against lysosomal proteins such as cathepsins or lysosomal-associated membrane proteins (LAMPs) can be used to immunoprecipitate these proteins from cell lysates.\n3. Nickel affinity chromatography: Soluble lysosomal proteins can also be isolated using nickel affinity chromatography, which takes advantage of the high affinity of nickel ions for cysteine-rich proteins. Many lysosomal proteins contain cysteine residues, which can bind to nickel ions, allowing for their isolation.\n4. Gel filtration: Soluble lysosomal proteins can also be isolated using gel filtration chromatography, which separates proteins based on their size. Soluble lysosomal proteins tend to be larger than other cytosolic proteins, so they can be separated from other proteins using gel filtration.\n5. Ion exchange chromatography: Soluble lysosomal proteins can also be isolated using ion exchange chromatography, which separates proteins based on their charge. Lysosomal proteins tend to have a higher negative charge than other cytosolic proteins, so they can be separated from other proteins using ion exchange resins.\n6. Hydrophobic interaction chromatography",
    "llama-2-7b-chat-hf_fact": [
      "Affinity purification techniques can be used to isolate soluble lysosomal proteins.",
      "Lectin affinity chromatography is a technique used to isolate soluble lysosomal proteins based on their glycosylation patterns.",
      "Immunoprecipitation can isolate soluble lysosomal proteins using specific antibodies that recognize these proteins.",
      "Nickel affinity chromatography isolates soluble lysosomal proteins based on the high affinity of nickel ions for cysteine-rich proteins.",
      "Gel filtration chromatography and ion exchange chromatography can also be used to isolate soluble lysosomal proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Nickel affinity chromatography isolates proteins that have a histidine tag, not cysteine-rich proteins.",
      "true"
    ]
  },
  {
    "id": 113,
    "user_query": "Which are the genes thought to be regulated by EWS/FLI?",
    "llama-2-7b-chat-hf_response": "EWS/FLI is a transcription factor that is known to regulate the expression of a wide range of genes involved in various cellular processes, including cell growth, differentiation, and survival. Some of the genes that are thought to be regulated by EWS/FLI include:\n1. Myc (v-myc avian myelocytomatosis viral oncogene homolog) - EWS/FLI has been shown to bind to the Myc promoter and enhance its transcription, leading to increased Myc protein expression. Myc is a transcription factor that regulates cell growth, proliferation, and differentiation.\n2. Fos (v-fos avian myelocytomatosis viral oncogene homolog) - EWS/FLI has been shown to bind to the Fos promoter and enhance its transcription, leading to increased Fos protein expression. Fos is a transcription factor that regulates cell growth, proliferation, and differentiation.\n3. Egr-1 (v-egr-1 avian myelocytomatosis viral oncogene homolog) - EWS/FLI has been shown to bind to the Egr-1 promoter and enhance its transcription, leading to increased Egr-1 protein expression. Egr-1 is a transcription factor that regulates cell growth, proliferation, and differentiation.\n4. c-Jun (v-jun avian myelocytomatosis viral oncogene homolog) - EWS/FLI has been shown to bind to the c-Jun promoter and enhance its transcription, leading to increased c-Jun protein expression. c-Jun is a transcription factor that regulates cell growth, proliferation, and differentiation.\n5. c-Fos (v-fos avian myelocytomatosis viral oncogene homolog) - EWS/FLI has been shown to bind to the c-Fos promoter and enhance its transcription, leading to increased c-Fos protein expression. c-Fos is a transcription factor that regulates cell growth, proliferation, and differentiation.\n6. Cyclin D1 (CCND1) - EWS",
    "llama-2-7b-chat-hf_fact": [
      "EWS/FLI is a transcription factor that regulates the expression of a range of genes.",
      "Myc, a gene thought to be regulated by EWS/FLI, is a transcription factor that regulates cell growth, proliferation, and differentiation.",
      "Fos is another gene that EWS/FLI regulates, it is a transcription factor that manages cell growth, proliferation and differentiation.",
      "Egr-1 is a gene considered to be regulated by EWS/FLI and it also plays a role in regulating cell growth, proliferation, and differentiation.",
      "c-Jun is a gene that EWS/FLI has been shown to regulate, it is a transcription factor that impacts cell growth, proliferation, and differentiation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 115,
    "user_query": "Which pathological conditions are caused by mutations in the CYLD gene?",
    "llama-2-7b-chat-hf_response": "The CYLD gene provides instructions for making a protein called cylin-D-like 1 (CYLD1). This protein is involved in the regulation of cell growth and division, and it also plays a role in the development and maintenance of tissues. Mutations in the CYLD gene have been associated with several rare genetic disorders, including:\n1. Nephronophthisis (NPHP): This is a group of rare genetic disorders that affect the kidneys and can lead to kidney failure. Mutations in the CYLD gene are found in some cases of NPHP.\n2. Meckel-Gruber syndrome: This is a rare genetic disorder that affects the brain and spinal cord, as well as other organs. Mutations in the CYLD gene have been found in some cases of Meckel-Gruber syndrome.\n3. Jeune's syndrome: This is a rare genetic disorder that affects the brain and spinal cord, as well as other organs. Mutations in the CYLD gene have been found in some cases of Jeune's syndrome.\n4. Polycystic kidney disease (PKD): This is a genetic disorder that causes cysts to grow on the kidneys, which can lead to kidney failure. Mutations in the CYLD gene have been found in some cases of PKD.\n5. Birt-Hogg-Dub syndrome: This is a rare genetic disorder that affects the kidneys, lungs, and skin. Mutations in the CYLD gene have been found in some cases of Birt-Hogg-Dub syndrome.\nIt's important to note that having a mutation in the CYLD gene does not guarantee that an individual will develop one of these conditions, and not everyone with these conditions has a mutation in the CYLD gene.",
    "llama-2-7b-chat-hf_fact": [
      "The CYLD gene provides instructions for making a protein called cylin-D-like 1 (CYLD1).",
      "This protein is involved in the regulation of cell growth and division.",
      "Mutations in the CYLD gene can cause Nephronophthisis, a group of rare genetic disorders that affect the kidneys.",
      "Meckel-Gruber syndrome and Jeune's syndrome, which are genetic disorders affecting the brain, spinal cord, and other organs could be caused by the CYLD gene mutations in some cases.",
      "CYLD gene mutations can lead to Polycystic kidney disease (PKD) and Birt-Hogg-Dub syndrome in some cases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The CYLD gene provides instructions for making a tumor suppressor protein that regulates cell growth and division.",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 121,
    "user_query": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A).",
    "llama-2-7b-chat-hf_response": "Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common form of Charcot-Marie-Tooth disease, accounting for approximately 70% of all cases. It is an autosomal dominant disorder caused by mutations in the PMP22 gene, which codes for the peripheral myelin protein 22 (PMP22). PMP22 is a critical component of the myelin sheath that surrounds nerve fibers, providing insulation and facilitating the transmission of nerve impulses. Mutations in the PMP22 gene lead to a decrease in the amount and/or function of PMP22 protein, resulting in demyelination and axonal degeneration of the peripheral nervous system.",
    "llama-2-7b-chat-hf_fact": [
      "Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common form of Charcot-Marie-Tooth disease.",
      "CMT1A accounts for approximately 70% of all Charcot-Marie-Tooth disease cases.",
      "CMT1A is an autosomal dominant disorder caused by mutations in the PMP22 gene.",
      "The PMP22 gene codes for the peripheral myelin protein 22 (PMP22), which is a critical component of the myelin sheath that surrounds nerve fibers.",
      "Mutations in the PMP22 gene lead to a decrease in the amount and/or function of PMP22 protein, resulting in demyelination and axonal degeneration of the peripheral nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 123,
    "user_query": "Which genes have been associated with Cerebral Cavernous Malformation?",
    "llama-2-7b-chat-hf_response": "Cerebral cavernous malformations (CCMs) are congenital vascular abnormalities that are caused by mutations in several genes. Here are some of the genes that have been associated with CCMs:\n1. ARVCF gene: The ARVCF gene, also known as the caveolin-1 gene, is the most commonly mutated gene in CCMs. Mutations in this gene can lead to the formation of cavernous malformations in the brain.\n2. CCM1 gene: The CCM1 gene encodes for a protein called cavernin-1, which is involved in the formation and maintenance of the blood-brain barrier. Mutations in this gene have been linked to CCMs.\n3. CCM2 gene: The CCM2 gene encodes for a protein called cavernin-2, which is also involved in the formation and maintenance of the blood-brain barrier. Mutations in this gene have been associated with CCMs.\n4. KCNQ2 gene: The KCNQ2 gene encodes for a potassium channel subunit that is involved in the regulation of electrical activity in neurons. Mutations in this gene have been linked to CCMs.\n5. KCNQ3 gene: The KCNQ3 gene encodes for another potassium channel subunit that is involved in the regulation of electrical activity in neurons. Mutations in this gene have been associated with CCMs.\n6. SCN1A gene: The SCN1A gene encodes for a sodium channel subunit that is involved in the regulation of electrical activity in neurons. Mutations in this gene have been linked to CCMs.\n7. SCN1B gene: The SCN1B gene encodes for another sodium channel subunit that is involved in the regulation of electrical activity in neurons. Mutations in this gene have been associated with CCMs.\n8. CAV1 gene: The CAV1 gene encodes for a protein called caveolin-1, which is involved in the formation and maintenance of the blood-brain barrier. Mutations in this gene have been linked to CCMs.\n9. CAV2 gene: The CAV2 gene encodes for another protein called caveolin-2, which is",
    "llama-2-7b-chat-hf_fact": [
      "Cerebral cavernous malformations (CCMs) are congenital vascular abnormalities caused by mutations in several genes.",
      "The ARVCF gene or the caveolin-1 gene, when mutated, can lead to the formation of cavernous malformations in the brain.",
      "Mutations in the CCM1 gene, which encodes for a protein involved in the formation and maintenance of the blood-brain barrier, have been linked to CCMs.",
      "The CCM2 gene encodes for a protein involved in the formation and maintenance of the blood-brain barrier, and its mutations have been associated with CCMs.",
      "The KCNQ2 gene encodes for a potassium channel subunit involved in the regulation of electrical activity in neurons and its mutations have been linked to CCMs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Currently, there are no known links between mutations in the ARVCF gene or the caveolin-1 gene and the formation of cavernous malformations in the brain.",
      "true",
      "true",
      "false, [corrected fact]: The KCNQ2 gene encodes for a potassium channel subunit involved in the regulation of electrical activity in neurons, but its mutations have NOT been linked to CCMs. Instead, they are often associated with a form of epilepsy."
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-7b-chat-hf_response": "?\nYes, DITPA (1,1-diethyl-3,3-dinitro-5,5-pentanedione) is a thyroid hormone analog that has been utilized in both experimental and clinical studies. DITPA is a synthetic compound that mimics the structure of the thyroid hormone thyroxine (T4) and has been shown to have similar effects on the body as T4.\nIn experimental studies, DITPA has been used to investigate the mechanisms of thyroid hormone action, to study the effects of thyroid hormone deficiency, and to test the efficacy of thyroid hormone replacement therapy. For example, DITPA has been used to study the effects of thyroid hormone deficiency on growth and development in animal models, and to investigate the role of thyroid hormone in regulating metabolism and energy expenditure.\nIn clinical studies, DITPA has been used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormones. DITPA has been shown to be effective in restoring normal thyroid hormone levels in patients with hypothyroidism, and it has been used as an alternative to levothyroxine, the most commonly used thyroid hormone replacement medication.\nHowever, it is important to note that DITPA has some limitations as a thyroid hormone analog. For example, it has a shorter half-life than levothyroxine, which means that it may need to be taken more frequently to maintain normal thyroid hormone levels. Additionally, DITPA may have different effects on the body than levothyroxine, and it may not be suitable for all patients with hypothyroidism. Therefore, DITPA should only be used under the close supervision of a healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "DITPA is a thyroid hormone analog utilized in both experimental and clinical studies.",
      "DITPA, a synthetic compound that mimics the structure of thyroxine, has similar effects on the body as thyroxine.",
      "In experimental studies, DITPA has been used to study the mechanisms of thyroid hormone action and the effects of thyroid hormone deficiency, among other investigations.",
      "Clinical studies have used DITPA to treat hypothyroidism as an alternative to levothyroxine, a commonly used thyroid hormone replacement medication.",
      "DITPA has a shorter half-life than levothyroxine and its effects on the body can differ from levothyroxine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 130,
    "user_query": "What is needed for MMP proteins to be functional?",
    "llama-2-7b-chat-hf_response": "MMP proteins are a family of enzymes that play a crucial role in the breakdown of the extracellular matrix (ECM) and are involved in various physiological processes such as tissue development, repair, and remodeling. For MMP proteins to be functional, several factors are required:\n1. Active site: MMP proteins have a specific active site that is responsible for catalyzing the degradation of the ECM. This active site is made up of a conserved sequence of amino acids that forms a cleft or pocket where the substrate binds.\n2. Substrate binding: MMP proteins require a specific substrate to bind to in order to be functional. The substrate can be a component of the ECM, such as collagen, or other molecules that are involved in the degradation process.\n3. Cofactors: MMP proteins often require cofactors or accessory proteins to facilitate their activity. These cofactors can help to stabilize the active site of the MMP protein or provide additional binding sites for the substrate.\n4. pH and temperature: MMP proteins are optimally active at specific pH and temperature ranges. For example, some MMP proteins are more active at acidic pH, while others are more active at neutral or basic pH. Similarly, some MMP proteins are more active at higher temperatures, while others are more active at lower temperatures.\n5. Cellular localization: MMP proteins are primarily localized to the extracellular space, but some can also be found in the cytosol or nucleus. The localization of MMP proteins can affect their activity and the specific substrates they degrade.\n6. Regulation: MMP proteins are regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational. This regulation can affect the expression and activity of MMP proteins, and is important for maintaining tissue homeostasis and preventing excessive degradation of the ECM.\n7. Inhibitors: MMP proteins can be inhibited by various molecules, including other proteins, lipids, and small molecules. These inhibitors can bind to the active site of the MMP protein or to other sites on",
    "llama-2-7b-chat-hf_fact": [
      "MMP proteins are a family of enzymes involved in the breakdown of the extracellular matrix (ECM).",
      "The functionality of MMP proteins depends on the availability of a specific active site which is responsible for catalyzing the ECM degradation.",
      "MMP proteins require a specific substrate to bind to in order to be functional.",
      "MMP proteins often require cofactors or accessory proteins to facilitate their activity.",
      "The activity of MMP proteins can be affected by pH, temperature, and their cellular localization."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 133,
    "user_query": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?",
    "llama-2-7b-chat-hf_response": "Botulism, also known as botul poisoning, is a serious and potentially life-threatening illness caused by the ingestion of the toxin produced by the bacterium Clostridium botulinum. The bacterium is anaerobic, meaning it does not require oxygen to grow, and can be found in a variety of environments, including soil, water, and the intestines of animals.\nClostridium botulinum is the most common bacterium responsible for botulism, and it can produce seven different types of botulinum toxin. These toxins can cause a range of symptoms, including muscle weakness, paralysis, and difficulty breathing. In severe cases, botulism can lead to respiratory failure and death.\nPrevention of botulism involves proper food handling and storage practices, such as cooking and refrigerating foods properly, and avoiding home canning of low-acid foods. Treatment of botulism typically involves administration of antitoxin, which can help neutralize the effects of the toxin. In severe cases, hospitalization and supportive care, such as mechanical ventilation, may be necessary.",
    "llama-2-7b-chat-hf_fact": [
      "Botulism is a potentially life-threatening illness caused by the toxin produced by the bacterium Clostridium botulinum.",
      "Clostridium botulinum is anaerobic and can grow without oxygen.",
      "The bacterium Clostridium botulinum can typically be found in soil, water, and the intestines of animals.",
      "Clostridium botulinum can produce seven different types of botulinum toxin.",
      "Treatment for botulism can involve administration of antitoxin and, in severe cases, hospitalization and mechanical ventilation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 138,
    "user_query": "Which are the plant DNA (cytosine-5) methyltransferase families?",
    "llama-2-7b-chat-hf_response": "There are three plant DNA (cytosine-5) methyltransferase families:\n1. Methyltransferase (MT) family: This family includes the most well-studied DNA methyltransferases in plants, which are involved in the methylation of cytosine residues in CpG dinucleotides. Members of this family are often referred to as \"CpG methyltransferases\" or \"DNA methyltransferases 1\" (DNMT1s).\n2. Methyltransferase-like (MTL) family: This family includes enzymes that are similar in structure and function to the MT family, but are not as well-studied. Members of this family are also involved in the methylation of cytosine residues in CpG dinucleotides, but they may have different substrate specificities or tissue-specific expressions compared to the MT family.\n3. Plant-specific (PS) family: This family includes enzymes that are unique to plants and are involved in the methylation of cytosine residues in non-CpG dinucleotides. Members of this family are often referred to as \"non-CpG DNA methyltransferases\" or \"DNA methyltransferases 2\" (DNMT2s).",
    "llama-2-7b-chat-hf_fact": [
      "There are three plant DNA (cytosine-5) methyltransferase families: Methyltransferase (MT) family, Methyltransferase-like (MTL) family, and Plant-specific (PS) family.",
      "The MT family includes the most well-studied DNA methyltransferases in plants, which are involved in the methylation of cytosine residues in CpG dinucleotides.",
      "Members of the MT family are often referred to as \"CpG methyltransferases\" or \"DNA methyltransferases 1\" (DNMT1s).",
      "The MTL family, similar in structure and function to the MT family, also involves in the methylation of cytosine residues in CpG dinucleotides.",
      "The PS family includes enzymes unique to plants and are involved in the methylation of cytosine residues in non-CpG dinucleotides, often referred to as \"non-CpG DNA methyltransferases\" or \"DNA methyltransferases 2\" (DNMT2s)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 139,
    "user_query": "Where is the histone variant CENPA preferentially localized?",
    "llama-2-7b-chat-hf_response": "Histone variant CENPA is preferentially localized to the centromere region of chromosomes.",
    "llama-2-7b-chat-hf_fact": [
      "Histone variant CENPA is localized to the centromere region of chromosomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 140,
    "user_query": "In which proteins is the chromodomain present?",
    "llama-2-7b-chat-hf_response": "The chromodomain is a protein domain that is involved in the regulation of chromatin structure and gene expression. It is found in a variety of proteins, including:\n1. Histone-modifying enzymes: Chromodomains are often found in proteins that modify histones, such as histone acetyltransferases (HATs) and histone deacetylases (HDACs). These proteins use the chromodomain to recognize and bind to acetylated histones, which are associated with active gene expression.\n2. Transcription factors: Chromodomains are also found in some transcription factors, which are proteins that regulate gene expression by binding to specific DNA sequences. These proteins use the chromodomain to recognize and bind to chromatin structures that are associated with active gene expression.\n3. Chromatin remodelers: Chromodomains are also found in proteins that remodel chromatin structure, such as SWI/SNF complexes. These proteins use the chromodomain to recognize and bind to chromatin structures that are associated with active gene expression.\n4. Nuclear receptors: Chromodomains are also found in some nuclear receptors, which are proteins that regulate gene expression in response to hormones or other signaling molecules. These proteins use the chromodomain to recognize and bind to chromatin structures that are associated with active gene expression.\n5. Other proteins: Chromodomains are also found in other proteins that are involved in various cellular processes, such as DNA repair, cell cycle regulation, and apoptosis.\nIn summary, the chromodomain is a protein domain that is involved in the regulation of chromatin structure and gene expression, and it is found in a variety of proteins, including histone-modifying enzymes, transcription factors, chromatin remodelers, nuclear receptors, and other proteins.",
    "llama-2-7b-chat-hf_fact": [
      "The chromodomain is a protein domain that regulates chromatin structure and gene expression.",
      "Chromodomains are often found in proteins that modify histones, such as histone acetyltransferases (HATs) and histone deacetylases (HDACs).",
      "Some transcription factors, which regulate gene expression by binding to specific DNA sequences, also contain chromodomains.",
      "Proteins that remodel chromatin structure, such as SWI/SNF complexes, often contain chromodomains.",
      "Chromodomains are also found in some nuclear receptors, proteins that regulate gene expression in response to hormones or other signaling molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 142,
    "user_query": "Is amiodarone a class I anti-arrhythmic drug?",
    "llama-2-7b-chat-hf_response": "Amiodarone is a class III anti-arrhythmic drug, not a class I drug. Class I anti-arrhythmic drugs are those that slow the heart rate and decrease the excitability of the heart muscle. Examples of class I anti-arrhythmic drugs include quinidine, procainamide, and lidocaine. Amiodarone, on the other hand, is a class III drug, which means it has a slower onset of action and a longer duration of action compared to class I drugs. Class III drugs, such as amiodarone, are used to treat life-threatening arrhythmias, such as ventricular fibrillation and pulseless ventricular tachycardia.",
    "llama-2-7b-chat-hf_fact": [
      "Amiodarone is a class III anti-arrhythmic drug.",
      "Class I anti-arrhythmic drugs slow the heart rate and decrease the excitability of the heart muscle.",
      "Examples of class I anti-arrhythmic drugs include quinidine, procainamide, and lidocaine.",
      "Class III anti-arrhythmic drugs have a slower onset of action and a longer duration of action compared to class I drugs.",
      "Class III drugs, like amiodarone, are used to treat life-threatening arrhythmias such as ventricular fibrillation and pulseless ventricular tachycardia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Class I anti-arrhythmic drugs block the sodium channels and decrease the excitability of the heart muscle.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-7b-chat-hf_response": "The COUGER tool is a software tool designed to help organizations measure and manage their cybersecurity risk. Developed by the Center for Internet Security (CIS), the COUGER tool provides a comprehensive framework for identifying, assessing, and mitigating cybersecurity threats.",
    "llama-2-7b-chat-hf_fact": [
      "The COUGER tool is a software tool intended to assist in measuring and managing cybersecurity risk.",
      "The COUGER tool was developed by the Center for Internet Security (CIS).",
      "The tool provides a comprehensive framework for identifying, assessing, and mitigating cybersecurity threats."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-7b-chat-hf_response": "There are no specific drugs for treating tick-borne encephalitis (TBE), but antiviral medications may be prescribed to help manage symptoms and reduce the severity of the infection. The choice of antiviral medication will depend on the severity of the infection and the patient's overall health.\nSome of the antiviral medications that may be used to treat TBE include:\n1. Ribavirin: This medication is commonly used to treat viral infections, including TBE. It works by reducing the replication of the virus in the body.\n2. Oseltamivir (Tamiflu): This medication is commonly used to treat influenza, but it has also been shown to be effective in treating TBE. It works by reducing the replication of the virus in the body.\n3. Zanamivir (Relenza): This medication is also commonly used to treat influenza, and it has been shown to be effective in treating TBE as well. It works by reducing the replication of the virus in the body.\n4. Valaciclovir (Valtrex): This medication is commonly used to treat herpes viruses, but it has also been shown to be effective in treating TBE. It works by reducing the replication of the virus in the body.\n5. Aztreonam (Azithromycin): This medication is an antibiotic that is commonly used to treat bacterial infections, but it has also been shown to be effective in treating TBE. It works by reducing the replication of the virus in the body.\nIt's important to note that antiviral medications are most effective when started early in the course of the infection, and they may not be effective in all cases. In addition, antiviral medications may have side effects, so it's important to discuss the potential benefits and risks with a healthcare provider.\nIn addition to antiviral medications, other treatments may be recommended to help manage symptoms and reduce the severity of TBE. These may include:\n1. Pain relief medications: Over-the-counter pain relievers, such as acetaminophen or ibuprofen, may be recommended to help manage headaches, muscle aches, and",
    "llama-2-7b-chat-hf_fact": [
      "There are no specific drugs for treating tick-borne encephalitis (TBE), but antiviral medications can help manage symptoms and reduce the severity of the infection.",
      "Ribavirin, Oseltamivir (Tamiflu), Zanamivir (Relenza), Valaciclovir (Valtrex), and Aztreonam (Azithromycin) are antiviral medications that may be used to treat TBE.",
      "Ribavirin, Oseltamivir, Zanamivir, Valaciclovir, and Aztreonam work by reducing the replication of the virus in the body.",
      "Antiviral medications for TBE are most effective when started early in the course of the infection.",
      "Over-the-counter pain relievers, such as acetaminophen or ibuprofen, may be recommended to help manage symptoms of TBE."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: While Ribavirin, Oseltamivir (Tamiflu), Zanamivir (Relenza), and Valaciclovir (Valtrex) are antiviral medications, they may not specifically treat TBE. Furthermore, Aztreonam is an antibacterial drug, not an antiviral.",
      "true",
      "false, [corrected fact]: Antiviral medications for TBE are not typically used as there are no specific antiviral drugs for this disease. Supportive treatment is provided to manage symptoms.",
      "true"
    ]
  },
  {
    "id": 146,
    "user_query": "Is SLC22A3 expressed in the brain?",
    "llama-2-7b-chat-hf_response": "Yes, SLC22A3 is expressed in the brain. SLC22A3 is a member of the solute carrier family 22 (SLC22A) of membrane transport proteins, which are involved in the transport of various compounds across cell membranes. In the brain, SLC22A3 is expressed in various regions, including the cerebral cortex, hippocampus, and cerebellum.\nStudies have shown that SLC22A3 is involved in the transport of the neurotransmitter glutamate, which is the most abundant excitatory neurotransmitter in the brain. Glutamate plays a critical role in various brain functions, including learning and memory, and dysregulation of glutamate transport has been implicated in various neurological disorders, such as epilepsy and stroke.\nIn addition to its role in glutamate transport, SLC22A3 has also been implicated in the transport of other neurotransmitters, such as GABA and dopamine. Dysregulation of SLC22A3 has been linked to various neurological disorders, including epilepsy, schizophrenia, and Parkinson's disease.\nOverall, the expression of SLC22A3 in the brain highlights its importance in regulating the transport of neurotransmitters and maintaining proper brain function.",
    "llama-2-7b-chat-hf_fact": [
      "SLC22A3 is expressed in the brain.",
      "SLC22A3 is a member of the solute carrier family 22.",
      "SLC22A3 is involved in the transport of the neurotransmitter glutamate.",
      "Dysregulation of SLC22A3 has been linked to neurological disorders, including epilepsy and stroke.",
      "SLC22A3 also assists in the transport of other neurotransmitters such as GABA and dopamine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: SLC22A3 is involved in the transport of the neurotransmitter, organic cations.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-7b-chat-hf_response": "There are several genome browsers available that provide DNA shape annotations, including:\n1. UCSC Genome Browser: The UCSC Genome Browser is a popular genome browser that provides DNA shape annotations for a variety of organisms, including humans.\n2. Ensembl Genome Browser: Ensembl is another widely-used genome browser that provides DNA shape annotations for a variety of organisms, including humans.\n3. Genome Browser by the Broad Institute: The Broad Institute's Genome Browser provides DNA shape annotations for a variety of organisms, including humans.\n4. HUGO Gene Nomenclature Committee: The HUGO Gene Nomenclature Committee provides DNA shape annotations for a variety of organisms, including humans.\n5. Mouse Genome Informatics: Mouse Genome Informatics provides DNA shape annotations for the mouse genome.\n6. WormBase: WormBase provides DNA shape annotations for the nematode worm Caenorhabditis elegans.\n7. Zebrafish Genome Annotation: Zebrafish Genome Annotation provides DNA shape annotations for the zebrafish genome.\n8. Plant Genome Annotation: Plant Genome Annotation provides DNA shape annotations for a variety of plant genomes.\n9. Fungal Genome Annotation: Fungal Genome Annotation provides DNA shape annotations for a variety of fungal genomes.\n10. Bacterial Genome Annotation: Bacterial Genome Annotation provides DNA shape annotations for a variety of bacterial genomes.\nPlease note that this is not an exhaustive list and there may be other genome browsers available that provide DNA shape annotations.",
    "llama-2-7b-chat-hf_fact": [
      "The UCSC Genome Browser is a genome browser which provides DNA shape annotations for a variety of organisms.",
      "Ensembl Genome Browser provides DNA shape annotations for a variety of organisms, including humans.",
      "The Broad Institute's Genome Browser also offers DNA shape annotations for different organisms.",
      "Mouse Genome Informatics provides DNA shape annotations specifically for the mouse genome.",
      "WormBase offers DNA shape annotations for the nematode worm Caenorhabditis elegans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 153,
    "user_query": "What is the relationship between TailorX and Oncotype?",
    "llama-2-7b-chat-hf_response": "TailorX and Oncotype are both companies that provide genomic testing and analysis services for cancer patients. While they share some similarities, there are also some key differences between the two companies. Here are some of the main similarities and differences:\nSimilarities:\n1. Focus on personalized cancer treatment: Both TailorX and Oncotype are focused on providing personalized cancer treatment options based on the unique genetic characteristics of each patient's cancer.\n2. Use of genomic testing: Both companies use genomic testing to identify specific genetic mutations in a patient's cancer cells. This information is then used to develop targeted therapies that are more effective and less toxic than traditional chemotherapy.\n3. Data-driven approach: Both TailorX and Oncotype use advanced data analytics and machine learning algorithms to analyze large amounts of genomic data and identify patterns that can inform treatment decisions.\n4. Collaboration with oncologists: Both companies work closely with oncologists and other healthcare professionals to ensure that their testing and analysis services are integrated into clinical practice.\nDifferences:\n1. Testing platform: TailorX uses a next-generation sequencing (NGS) platform to analyze a patient's entire genome, while Oncotype uses a targeted sequencing approach that focuses on specific genes known to be associated with cancer.\n2. Testing scope: TailorX offers a broader range of testing options, including whole-genome sequencing, exome sequencing, and transcriptome analysis. Oncotype, on the other hand, focuses primarily on testing for specific genes that are known to be associated with cancer.\n3. Data analysis: TailorX uses advanced data analytics and machine learning algorithms to analyze large amounts of genomic data and identify patterns that can inform treatment decisions. Oncotype, on the other hand, uses a more traditional statistical analysis approach to interpret the genomic data.\n4. Clinical trials: TailorX has been involved in several clinical trials to validate its testing platform and algorithms, while Oncotype has also conducted clinical trials but has a more established track record in this area.\nIn summary, while TailorX and Oncotype share some similarities",
    "llama-2-7b-chat-hf_fact": [
      "TailorX and Oncotype are companies that provide genomic testing and analysis services for cancer patients.",
      "Both companies focus on personalized cancer treatment options based on the unique genetic characteristics of each patient's cancer.",
      "Both TailorX and Oncotype utilize genomic testing to identify specific genetic mutations in a patient's cancer cells, which inform the development of targeted therapies.",
      "TailorX uses a next-generation sequencing (NGS) platform to analyze a patient's entire genome while Oncotype uses a targeted sequencing approach that focuses on specific genes known to be associated with cancer.",
      "TailorX has participated in several clinical trials to validate its testing platform and algorithms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: TailorX is a trial name, not a company. Oncotype DX is a commercial product for genomic testing in cancer patients provided by Genomic Health.",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 154,
    "user_query": "Does strenuous physical activity affect thyroid hormone metabolism?",
    "llama-2-7b-chat-hf_response": "Yes, strenuous physical activity can affect thyroid hormone metabolism. Thyroid hormones play a crucial role in regulating metabolism, and strenuous physical activity can impact the production and metabolism of these hormones. Here are some ways in which strenuous physical activity can affect thyroid hormone metabolism:\n1. Increased thyroid hormone production: During strenuous physical activity, the body releases stress hormones such as cortisol and adrenaline. These hormones can stimulate the thyroid gland to produce more thyroid hormones, leading to increased metabolism and energy expenditure.\n2. Changes in thyroid hormone sensitivity: Strenuous physical activity can also affect the sensitivity of thyroid hormones to insulin and glucose. This can lead to changes in glucose metabolism and insulin resistance, which can impact thyroid hormone production and metabolism.\n3. Inflammation: Strenuous physical activity can cause inflammation in the body, which can affect the production and metabolism of thyroid hormones. Inflammation can lead to changes in the expression of genes involved in thyroid hormone production and metabolism, leading to changes in thyroid hormone levels.\n4. Hormonal imbalance: Strenuous physical activity can also lead to hormonal imbalances, which can affect thyroid hormone production and metabolism. For example, high levels of cortisol and adrenaline can suppress the production of thyroid hormones, leading to hypothyroidism.\n5. Nutrient deficiencies: Strenuous physical activity can also lead to nutrient deficiencies, which can affect thyroid hormone production and metabolism. For example, low levels of iodine, selenium, and zinc can affect the production of thyroid hormones.\nIn summary, strenuous physical activity can affect thyroid hormone metabolism by increasing thyroid hormone production, changing thyroid hormone sensitivity, causing inflammation, leading to hormonal imbalances, and causing nutrient deficiencies. It is important to monitor thyroid hormone levels",
    "llama-2-7b-chat-hf_fact": [
      "Strenuous physical activity can impact the production and metabolism of thyroid hormones.",
      "Stress hormones, such as cortisol and adrenaline, released during strenuous physical activity can stimulate the thyroid gland to produce more thyroid hormones.",
      "Strenuous physical activity can influence the sensitivity of thyroid hormones to insulin and glucose, leading to changes in glucose metabolism and insulin resistance.",
      "Strenuous physical activity can cause inflammation, affecting the production and metabolism of thyroid hormones.",
      "High levels of cortisol and adrenaline, often associated with strenuous physical activity, can suppress the production of thyroid hormones."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 155,
    "user_query": "Which is the main function of \"RNA sponges\"?",
    "llama-2-7b-chat-hf_response": "RNA sponges are RNA molecules that can bind to and sequester other RNA molecules, preventing them from carrying out their normal functions. They are found in many organisms, including bacteria, archaea, and eukaryotes. The main function of RNA sponges is to regulate gene expression by controlling the levels of specific RNA molecules in the cell.\nRNA sponges can bind to and sequester a wide range of RNA molecules, including messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). They can also bind to non-coding RNA molecules, such as microRNAs and long non-coding RNAs. By sequestering these RNA molecules, RNA sponges can prevent them from being translated into proteins or from interacting with other RNA molecules.\nRNA sponges can also act as decoys for RNA-binding proteins, which can bind to the sponge instead of the target RNA. This can prevent the RNA-binding protein from interacting with its normal target, leading to changes in gene expression.\nOverall, the main function of RNA sponges is to regulate gene expression by controlling the levels of specific RNA molecules in the cell. They do this by binding to and sequestering these RNA molecules, preventing them from carrying out their normal functions.",
    "llama-2-7b-chat-hf_fact": [
      "RNA sponges are RNA molecules that bind to and sequester other RNA molecules.",
      "RNA sponges are found in many organisms, including bacteria, archaea, and eukaryotes.",
      "The main function of RNA sponges is to regulate gene expression.",
      "RNA sponges can bind to a wide range of RNA molecules, including mRNA, tRNA, and rRNA.",
      "RNA sponges can act as decoys for RNA-binding proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 157,
    "user_query": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?",
    "llama-2-7b-chat-hf_response": "Phospholamban (PLN) is a protein that plays a crucial role in the regulation of cardiac contractility and energy metabolism. Mutations in the PLN gene have been associated with various forms of cardiomyopathy, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM). Here are some of the mutations of phospholamban that have been found in patients with cardiomyopathy:\n1. R145G mutation: This mutation is the most common mutation found in HCM patients and is associated with an increased thickness of the left ventricular wall.\n2. R145H mutation: This mutation is also found in HCM patients and is associated with an increased risk of sudden cardiac death.\n3. R145W mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n4. R145Q mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n5. R145S mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n6. R145C mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n7. R145F mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n8. R145L mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n9. R145M mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of cardiac arrhythmias.\n10. R145T mutation: This mutation is found in both HCM and DCM patients and is associated with an increased risk of card",
    "llama-2-7b-chat-hf_fact": [
      "Phospholamban is a protein that plays a crucial role in the regulation of cardiac contractility and energy metabolism.",
      "Mutations in the Phospholamban gene have been linked to hypertrophic cardiomyopathy, dilated cardiomyopathy, and restrictive cardiomyopathy.",
      "The R145G mutation in the Phospholamban gene is commonly found in patients with hypertrophic cardiomyopathy and is associated with an increased thickness of the left ventricular wall.",
      "The R145H mutation in the Phospholamban gene is found in hypertrophic cardiomyopathy patients and carries an increased risk of sudden cardiac death.",
      "The R145W mutation in the Phospholamban gene is found in both hypertrophic cardiomyopathy and dilated cardiomyopathy patients and is associated with an increased risk of cardiac arrhythmias."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 160,
    "user_query": "Is there any software for automated analysis of FISH images?",
    "llama-2-7b-chat-hf_response": "Fluorescence in situ hybridization (FISH) is a powerful tool for detecting and visualizing specific DNA or RNA sequences in cells and tissues. However, the analysis of FISH images can be time-consuming and challenging, especially when dealing with large datasets. To address this challenge, several software tools have been developed for automated analysis of FISH images. Here are some of the commonly used software tools:\n1. ImageJ: ImageJ is a free, open-source image processing software developed by the National Institutes of Health (NIH). It has a variety of plugins available for FISH image analysis, including the Fiji FISH plugin, which provides tools for image segmentation, feature detection, and quantification.\n2. CellProfiler: CellProfiler is a high-throughput image analysis software that can be used for FISH image analysis. It provides a range of tools for image processing, feature detection, and quantification, and can handle large datasets.\n3. HoechstImager: HoechstImager is a software tool specifically designed for the analysis of fluorescence in situ hybridization (FISH) images. It provides tools for image segmentation, feature detection, and quantification, and can handle both 2D and 3D FISH images.\n4. FISH Explorer: FISH Explorer is a software tool for the automated analysis of FISH images. It provides tools for image segmentation, feature detection, and quantification, and can handle both 2D and 3D FISH images.\n5. MetaFISH: MetaFISH is a software tool for the automated analysis of FISH images. It provides tools for image segmentation, feature detection, and quantification, and can handle both 2D and 3D FISH images.\n6. FISH-Viewer: FISH-Viewer is a software tool for the visualization and analysis of FISH images. It provides tools for image segmentation, feature detection, and quantification, and can handle both 2D and 3D FISH images.\n7. FISH-Analyst: FISH-Analyst is a software tool for the automated analysis of FISH images. It provides tools for image segmentation, feature detection, and",
    "llama-2-7b-chat-hf_fact": [
      "Fluorescence in situ hybridization (FISH) is a tool for detecting and visualizing specific DNA or RNA sequences in cells and tissues.",
      "There are several software tools developed for automated analysis of FISH images.",
      "ImageJ is a free, open-source image processing software developed by the National Institutes of Health and can be used for FISH image analysis.",
      "CellProfiler is a high-throughput image analysis software useful for FISH image analysis.",
      "HoechstImager, FISH Explorer, MetaFISH, FISH-Viewer, and FISH-Analyst are software tools specifically designed for the analysis of FISH images."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 165,
    "user_query": "List markers for autophagy.",
    "llama-2-7b-chat-hf_response": "Autophagy is a catabolic process that involves the degradation of cellular components, such as proteins and organelles, by the lysosome. Autophagy is a crucial mechanism for maintaining cellular homeostasis and responding to stress, and it has been implicated in a wide range of diseases, including cancer, neurodegeneration, and metabolic disorders.\nHere are some key markers for autophagy:\n1. LC3 (Light Chain 3): LC3 is a protein that is involved in the formation of autophagosomes, the membranous structures that engulf cellular components for degradation. LC3 is cleaved into two forms, LC3-I and LC3-II, during the process of autophagy.\n2. Atg7 (Autophagy-Related Gene 7): Atg7 is a protein that is involved in the formation of autophagosomes and the degradation of cellular components. Atg7 is a key regulator of autophagy and is required for the proper formation of autophagosomes.\n3. Atg5 (Autophagy-Related Gene 5): Atg5 is a protein that is involved in the formation of autophagosomes and the degradation of cellular components. Atg5 is a key regulator of autophagy and is required for the proper formation of autophagosomes.\n4. Atg12 (Autophagy-Related Gene 12): Atg12 is a protein that is involved in the formation of autophagosomes and the degradation of cellular components. Atg12 is a key regulator of autophagy and is required for the proper formation of autophagosomes.\n5. Atg16L1 (Autophagy-Related Gene 16-Like 1): Atg16L1 is a protein that is involved in the formation of autophagosomes and the degradation of cellular components. Atg16L1 is a key regulator of autophagy and is required for the proper formation of autophagosomes.\n6. P62 (Protein 62): P62 is a protein that is involved",
    "llama-2-7b-chat-hf_fact": [
      "Autophagy is a catabolic process that involves the degradation of cellular components by the lysosome.",
      "LC3 (Light Chain 3) is a protein involved in the formation of autophagosomes.",
      "Atg7 (Autophagy-Related Gene 7) is a protein involved in the formation of autophagosomes and the degradation of cellular components.",
      "Atg5 (Autophagy-Related Gene 5) is a protein that is also involved in the formation of autophagosomes.",
      "Atg12 (Autophagy-Related Gene 12) is another protein involved in the formation of autophagosomes related to Autophagy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 169,
    "user_query": "Are there any specific antidotes for rivaroxaban?",
    "llama-2-7b-chat-hf_response": "Rivaroxaban is a blood thinner that is used to prevent blood clots from forming. If you take too much rivaroxaban, you may experience bleeding. In this case, there are several antidotes that can be used to reverse the effects of rivaroxaban and stop the bleeding. Here are some of the specific antidotes for rivaroxaban:\n1. Idarucizumab: This is a specific antidote for rivaroxaban that is given intravenously to reverse the effects of the drug. It works by binding to rivaroxaban and preventing it from inhibiting the activity of the coagulation factor Xa.\n2. Protamine sulfate: This is another antidote for rivaroxaban that is given intravenously. It works by neutralizing the effects of rivaroxaban by binding to it and preventing it from inhibiting the activity of the coagulation factor Xa.\n3. Vitamin K: Vitamin K is a natural antidote for rivaroxaban that can be given orally or intravenously. It works by increasing the activity of the coagulation factor Xa, which can help to reverse the effects of rivaroxaban and promote clotting.\n4. Fresh frozen plasma (FFP): FFP is a blood product that contains clotting factors that can be used to reverse the effects of rivaroxaban. It is given intravenously and works by providing the body with clotting factors that can help to promote clotting and stop bleeding.\n5. Activated prothrombin complex concentrate (aPCC): aPCC is a blood product that contains clotting factors that can be used to reverse the effects of rivaroxaban. It is given intravenously and works by providing the body with clotting factors that can help to promote clotting and stop bleeding.\nIt is important to note that these antidotes should only be used in cases of severe bleeding or overdose, and should be administered by a healthcare professional. If you have taken too much rivaroxaban, it is important to seek medical attention immediately.",
    "llama-2-7b-chat-hf_fact": [
      "Rivaroxaban is a blood thinner that is used to prevent blood clots from forming.",
      "Idarucizumab, given intravenously, can reverse the effects of rivaroxaban by binding to it and inhibiting its activity.",
      "Protamine sulfate is another antidote for rivaroxaban, given intravenously, which neutralizes the drug's effects.",
      "Vitamin K, either given orally or intravenously, can counteract the effects of rivaroxaban by increasing the activity of coagulation factor Xa.",
      "Activated prothrombin complex concentrate (aPCC), a blood product provided intravenously, contains clotting factors that can be used to reverse the effects of rivaroxaban."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Idarucizumab, given intravenously, can reverse the effects of dabigatran, not rivaroxaban, by binding to it and inhibiting its activity.",
      "false, [corrected fact]: Protamine sulfate is an antidote for heparin, not rivaroxaban.",
      "false, [corrected fact]: Vitamin K is used to counteract the effects of warfarin, not rivaroxaban. It cannot increase the activity of coagulation factor Xa inhibited by rivaroxaban.",
      "unknown"
    ]
  },
  {
    "id": 171,
    "user_query": "What is the function of 6SRNA in bacteria?",
    "llama-2-7b-chat-hf_response": "6SRNA (6-sulfate ribosomal RNA) is a type of RNA molecule found in bacteria and other microorganisms. It plays a crucial role in the synthesis of proteins within these organisms. Here are some of the key functions of 6SRNA in bacteria:\n1. Ribosome biogenesis: 6SRNA is an essential component of the ribosome, which is the cellular machine responsible for protein synthesis. It helps to assemble and stabilize the ribosome, allowing it to function properly.\n2. Translation initiation: 6SRNA helps to initiate protein synthesis by binding to the messenger RNA (mRNA) molecule and recruiting the ribosome to the correct location on the mRNA.\n3. Translation elongation: Once the ribosome has been recruited to the mRNA, 6SRNA helps to facilitate the elongation of the protein chain by providing a stable platform for the ribosome to work on.\n4. mRNA splicing: In some bacteria, 6SRNA has been shown to play a role in the splicing of mRNA, which involves the removal of introns (non-coding regions) and the joining of exons (coding regions) to form a mature mRNA molecule.\n5. Regulation of gene expression: 6SRNA has been implicated in the regulation of gene expression in some bacteria, particularly in the regulation of the expression of genes involved in the synthesis of antibiotics and other secondary metabolites.\nOverall, 6SRNA plays a crucial role in the synthesis of proteins in bacteria, and its dysregulation can have significant consequences for the organism.",
    "llama-2-7b-chat-hf_fact": [
      "6SRNA is a type of RNA molecule found in bacteria and other microorganisms.",
      "An essential function of 6SRNA in bacteria is its role in ribosome biogenesis.",
      "6SRNA also helps to initiate protein synthesis by binding to the messenger RNA molecule and recruiting the ribosome to the right location.",
      "In the process of translating elongation, 6SRNA provides a stable platform for the ribosome to work on.",
      "6SRNA has been indicated to play a part in the regulation of gene expression in some bacteria."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: An essential function of 6SRNA in bacteria is not in ribosome biogenesis, but in regulation of transcription.",
      "false, [corrected fact]: 6SRNA does not initiate protein synthesis. It acts as a regulatory RNA molecule in bacteria and changes the activity of the RNA polymerase enzyme.",
      "false, [corrected fact]: 6SRNA does not provide a stable platform for the ribosome to work on during elongation. It plays a role in transcription regulation, not translation.",
      "true"
    ]
  },
  {
    "id": 172,
    "user_query": "Is cytisine superior to nicotine replacement therapy for smoking cessation?",
    "llama-2-7b-chat-hf_response": "Cytisine is a plant alkaloid that has been shown to have nicotine-like effects on the brain, but it does not produce the same addictive effects as nicotine. Some studies have suggested that cytisine may be more effective than nicotine replacement therapy (NRT) for smoking cessation, but more research is needed to confirm these findings.\nOne study published in the Journal of Nicotine & Tobacco Research found that cytisine was more effective than NRT in helping smokers quit smoking. The study found that 30% of participants who received cytisine were able to quit smoking for at least six months, compared to 10% of those who received NRT.\nAnother study published in the International Journal of Clinical Practice found that cytisine was more effective than NRT in reducing withdrawal symptoms and cravings in smokers who were trying to quit. The study found that cytisine was also better tolerated than NRT, with fewer side effects reported.\nHowever, it's important to note that these studies were small and more research is needed to confirm the effectiveness of cytisine for smoking cessation. Additionally, cytisine is not yet approved by the US Food and Drug Administration (FDA) for smoking cessation, so more research is needed to determine its safety and efficacy in larger populations.\nIn summary, while some studies suggest that cytisine may be more effective than NRT for smoking cessation, more research is needed to confirm these findings and to determine the long-term safety and efficacy of cytisine for smoking cessation. If you're considering using cytisine or any other smoking cessation treatment, it's important to talk to your doctor or a healthcare professional to determine the best course of treatment for you.",
    "llama-2-7b-chat-hf_fact": [
      "Cytisine is a plant alkaloid which has nicotine-like effects on the brain without producing the same addictive effects.",
      "Some studies suggest that cytisine may be more effective than nicotine replacement therapy for smoking cessation.",
      "One study published in the Journal of Nicotine & Tobacco Research found that 30% of participants who received cytisine were able to quit smoking for at least six months.",
      "Another study in the International Journal of Clinical Practice found that cytisine was more effective than nicotine replacement therapy in reducing withdrawal symptoms and cravings in those trying to quit smoking.",
      "Cytisine is not yet approved by the US Food and Drug Administration for smoking cessation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 173,
    "user_query": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?",
    "llama-2-7b-chat-hf_response": "Cadasil syndrome is a rare genetic disorder caused by mutations in the NOTCH3 gene. The NOTCH3 gene provides instructions for making a protein called Notch3, which plays a critical role in the development and maintenance of the nervous system. Mutations in the NOTCH3 gene have been identified in approximately 70% of cases of Cadasil syndrome. The majority of these mutations are missense mutations, which means that a single amino acid residue in the Notch3 protein is changed (mutated) from its normal sequence. The specific amino acid residue that is most commonly mutated in Cadasil syndrome is Gly318. This residue is located in the extracellular domain of the Notch3 protein and is important for the proper functioning of the protein.",
    "llama-2-7b-chat-hf_fact": [
      "Cadasil syndrome is a genetic disorder caused by mutations in the NOTCH3 gene.",
      "The NOTCH3 gene provides instructions for making the Notch3 protein, crucial for the development and maintenance of the nervous system.",
      "Approximately 70% of Cadasil syndrome cases are due to mutations in the NOTCH3 gene.",
      "The majority of these mutations are missense, meaning a single amino acid residue in the Notch3 protein is changed.",
      "The specific amino acid residue most commonly mutated in Cadasil syndrome is Gly318."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Almost all cases of Cadasil syndrome are due to mutations in the NOTCH3 gene.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-7b-chat-hf_response": "EZH2 is a gene that encodes for the enzyme enzyme histone methyltransferase 2 (EZH2), which plays a crucial role in regulating gene expression by modifying histone proteins. Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Rubinstein-Taybi syndrome (RTS): This is a rare genetic disorder characterized by intellectual disability, growth retardation, facial dysmorphism, and congenital anomalies. EZH2 mutations are found in approximately 50% of RTS cases.\n2. Noonan syndrome (NS): This is a rare genetic disorder characterized by short stature, congenital heart defects, facial dysmorphism, and other developmental abnormalities. EZH2 mutations have been identified in approximately 10% of NS cases.\n3. Multiple endocrine neoplasia type 1 (MEN1): This is a rare genetic disorder characterized by the development of multiple endocrine tumors, including pituitary, parathyroid, and pancreatic tumors. EZH2 mutations have been identified in approximately 5% of MEN1 cases.\n4. Juvenile myelomonocytic leukemia (JMML): This is a rare and aggressive form of leukemia that typically affects children under the age of 6. EZH2 mutations have been identified in approximately 20% of JMML cases.\n5. Langerhans cell histiocytosis (LCH): This is a rare disorder characterized by the accumulation of abnormal immune cells in various organs, including the bones, lungs, and spleen. EZH2 mutations have been identified in approximately 10% of LCH cases.\nThese syndromes are associated with mutations in the EZH2 gene due to its role in regulating gene expression and modifying histone proteins, which play a crucial role in the development and progression of these disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The EZH2 gene encodes for the enzyme histone methyltransferase 2 (EZH2), which plays a role in regulating gene expression by modifying histone proteins.",
      "Mutations in the EZH2 gene are associated with Rubinstein-Taybi syndrome (RTS), a genetic disorder characterized by intellectual disability, growth retardation, and congenital anomalies.",
      "Mutations in the EZH2 gene are also associated with Noonan syndrome (NS), another genetic disorder characterized by short stature, congenital heart defects, and other developmental abnormalities.",
      "The EZH2 gene also has a role in Multiple endocrine neoplasia type 1 (MEN1), a genetic disorder involving the development of multiple endocrine tumors.",
      "EZH2 gene mutations have been identified in Juvenile myelomonocytic leukemia (JMML) and Langerhans cell histiocytosis (LCH), rare disorders that affect children and are characterized by abnormal immune cell accumulation respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mutations in the CREBBP or EP300 genes, not the EZH2 gene, are associated with Rubinstein-Taybi syndrome (RTS).",
      "false, [corrected fact]: EZH2 mutations are not associated with Noonan syndrome. Mutations in several genes (SOS1, LEOPARD, RAF1 etc.) are linked to this syndrome.",
      "false, [corrected fact]: Mutations in the MEN1 gene, not the EZH2 gene, are associated with Multiple endocrine neoplasia type 1 (MEN1).",
      "true"
    ]
  },
  {
    "id": 175,
    "user_query": "Which databases exist for experimentally determined topologies of -helical transmembrane proteins ?",
    "llama-2-7b-chat-hf_response": "There are several databases that contain experimentally determined topologies of -helical transmembrane proteins. Here are some of the most well-known ones:\n1. Protein Data Bank (PDB): The PDB is a comprehensive database of 3D structures of proteins, including those of -helical transmembrane proteins. The PDB contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n2. TopDB: TopDB is a database of experimentally determined protein-ligand complexes, including those of -helical transmembrane proteins. It contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n3. HelixDB: HelixDB is a database of experimentally determined topological structures of -helical transmembrane proteins. It contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n4. TransTopDB: TransTopDB is a database of experimentally determined topologies of transmembrane proteins, including those of -helical transmembrane proteins. It contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n5. TOPO-DB: TOPO-DB is a database of experimentally determined topologies of membrane proteins, including those of -helical transmembrane proteins. It contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n6. Membrane Protein Topology Database (MPTDB): MPTDB is a database of experimentally determined topologies of membrane proteins, including those of -helical transmembrane proteins. It contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n7. Transmembrane Protein Topology Database (TPTDB): TPTDB is a database of experimentally determined topologies of transmembrane proteins, including those of -helical transmembrane proteins. It contains structures determined by X-ray crystallography, NMR spectroscopy, and other methods.\n8. Protein-Ligand",
    "llama-2-7b-chat-hf_fact": [
      "The Protein Data Bank (PDB) is a database of 3D structures of proteins, determined by methods including X-ray crystallography and NMR spectroscopy.",
      "TopDB is a database of experimentally determined protein-ligand complexes, which includes structures determined by X-ray crystallography, NMR spectroscopy, and other methods.",
      "HelixDB and TransTopDB are databases that contain experimentally determined topological structures of -helical transmembrane proteins, determined by methods such as X-ray crystallography and NMR spectroscopy.",
      "TOPO-DB and Membrane Protein Topology Database (MPTDB) provide experimentally determined topologies of membrane proteins, using methods including X-ray crystallography and NMR spectroscopy.",
      "Transmembrane Protein Topology Database (TPTDB) is a database, which includes the topologies of transmembrane proteins that have been experimentally determined by X-ray crystallography, NMR spectroscopy, and other methods."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: TopDB is a database of experimentally determined topological structures of transmembrane proteins.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 178,
    "user_query": "How is oprozomib administered?",
    "llama-2-7b-chat-hf_response": "Oprozomib is administered orally, in the form of a capsule or tablet, once daily. It is important to take oprozomib at the same time each day to maintain a consistent level of the drug in the body.\nOprozomib can be taken with or without food, but it is recommended to take it with food to help reduce the risk of nausea and vomiting. It is important to follow the dosage instructions provided by your healthcare provider and to not stop taking oprozomib without consulting with them first.\nCommon side effects of oprozomib include nausea, vomiting, diarrhea, and fatigue. These side effects are usually mild to moderate and can be managed with supportive care and medication. In rare cases, oprozomib can cause more serious side effects, such as anemia, infections, and liver problems. It is important to seek medical attention if you experience any of these side effects or if you have any concerns about your treatment.\nOverall, oprozomib is a convenient and easy-to-use medication that can be administered in the comfort of your own home. However, it is important to follow the dosage instructions carefully and to seek medical attention if you experience any side effects or have any concerns about your treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Oprozomib is administered orally, in the form of a capsule or tablet, once daily.",
      "The drug can be taken with or without food.",
      "Common side effects of oprozomib include nausea, vomiting, diarrhea, and fatigue.",
      "In rare cases, oprozomib can cause more serious side effects, such as anemia, infections, and liver problems.",
      "Oprozomib is a medication that can be administered in the comfort of your own home."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 182,
    "user_query": "Does thyroid hormone regulate calcium transient in the myocardium?",
    "llama-2-7b-chat-hf_response": "Yes, thyroid hormone has been shown to regulate calcium transient in the myocardium. Calcium transient is an important mechanism for regulating cardiac contractility and excitability, and thyroid hormone has been shown to modulate this process through various mechanisms.\nOne of the key mechanisms by which thyroid hormone regulates calcium transient is by altering the expression and activity of ion channels and pumps that regulate calcium influx and efflux in the myocardium. For example, thyroid hormone has been shown to increase the expression of the L-type calcium channel subunit (Cav1.1) in the myocardium, leading to increased calcium influx during the diastolic phase of the cardiac cycle. Conversely, thyroid hormone has also been shown to decrease the expression of the ryanodine receptor (RyR2), which is involved in calcium release from the sarcoplasmic reticulum during the systolic phase of the cardiac cycle.\nIn addition to altering the expression and activity of ion channels and pumps, thyroid hormone has also been shown to regulate the activity of enzymes involved in calcium metabolism in the myocardium. For example, thyroid hormone has been shown to increase the activity of the enzyme inositol 1,4,5-trisphosphate receptor (IP3R), which is involved in calcium release from the sarcoplasmic reticulum during the diastolic phase of the cardiac cycle.\nOverall, the regulation of calcium transient by thyroid hormone is complex and involves multiple mechanisms, including alterations in ion channel expression and activity, enzyme activity, and the regulation of calcium release from the sarcoplasmic reticulum. Understanding the mechanisms by which thyroid hormone regulates calcium transient in the myocardium can provide valuable insights into the pathophysiology of thyroid hormone-related cardiac disorders, such as hypothyroidism and hyperthyroidism.",
    "llama-2-7b-chat-hf_fact": [
      "Thyroid hormone regulates calcium transient in the myocardium.",
      "Thyroid hormone can alter the expression and activity of ion channels and pumps that regulate calcium influx and efflux in the myocardium.",
      "One way thyroid hormone does this is by increasing the expression of the L-type calcium channel subunit (Cav1.1) in the myocardium.",
      "Thyroid hormone can decrease the expression of the ryanodine receptor (RyR2) which is involved in calcium release from the sarcoplasmic reticulum.",
      "Thyroid hormone can also regulate the activity of enzymes involved in calcium metabolism in the myocardium, such as enhancing the activity of the enzyme inositol 1,4,5-trisphosphate receptor (IP3R)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 185,
    "user_query": "The protein NONO forms heterodimers. With which proteins?",
    "llama-2-7b-chat-hf_response": "NONO (NAD(P)H oxidase 1) forms heterodimers with other proteins, including:\n1. Cyclic nucleotide-gated channels (CNCs): NONO forms heterodimers with CNCs, which are ion channels that are activated by cyclic nucleotides.\n2. PDE7: NONO forms a heterodimer with PDE7 (phosphodiesterase 7), which is an enzyme that hydrolyzes cyclic nucleotides.\n3. Rho-associated protein kinase (ROCK): NONO forms a heterodimer with ROCK, which is a serine/threonine kinase that regulates the cytoskeleton.\n4. Protein kinase C (PKC): NONO forms a heterodimer with PKC, which is a family of serine/threonine kinases that play a role in signal transduction.\n5. Calcium/calmodulin-dependent protein kinase II (CaMKII): NONO forms a heterodimer with CaMKII, which is a serine/threonine kinase that is activated by calcium/calmodulin.",
    "llama-2-7b-chat-hf_fact": [
      "The protein NONO forms heterodimers with other proteins.",
      "NONO forms heterodimers with cyclic nucleotide-gated channels.",
      "NONO forms a heterodimer with phosphodiesterase 7 (PDE7).",
      "NONO forms a heterodimer with Rho-associated protein kinase (ROCK).",
      "NONO forms a heterodimer with Protein kinase C (PKC) and Calcium/calmodulin-dependent protein kinase II (CaMKII)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 188,
    "user_query": "Is there any link between CTF4 and CTF18 during sister chromatid cohesion?",
    "llama-2-7b-chat-hf_response": "Sister chromatid cohesion is the process by which sister chromatids are held together during DNA replication and cell division. This process is crucial for maintaining the integrity of the genome, as it ensures that the genetic information is accurately transmitted from one generation to the next. There are several proteins that play a critical role in sister chromatid cohesion, including CTF4 and CTF18.\nCTF4 (chromatin remodeling factor 4) is a protein that is involved in the regulation of chromatin structure and gene expression. It is a multi-subunit complex that uses energy from ATP hydrolysis to move nucleosomes along DNA, creating a more accessible chromatin structure. CTF4 has been shown to play a role in sister chromatid cohesion, as it helps to maintain the cohesion between sister chromatids during DNA replication and cell division.\nCTF18 (chromatin remodeling factor 18) is another protein that is involved in the regulation of chromatin structure and gene expression. It is also a multi-subunit complex that uses energy from ATP hydrolysis to move nucleosomes along DNA, creating a more accessible chromatin structure. CTF18 has been shown to play a role in sister chromatid cohesion, as it helps to maintain the cohesion between sister chromatids during DNA replication and cell division.\nStudies have shown that CTF4 and CTF18 work together to regulate sister chromatid cohesion. For example, one study found that CTF4 and CTF18 are required for the proper separation of sister chromatids during cell division, and that they work together to maintain the cohesion between sister chromatids during DNA replication. Another study found that CTF4 and CTF18 are involved in the regulation of the cohesin complex, which is a protein complex that plays a critical role in sister chromatid cohesion.\nIn summary, CTF4 and CTF18 are both involved in the regulation of sister chromatid cohesion, and they work together to maintain the cohesion between sister chromatids during DNA replication and cell division.",
    "llama-2-7b-chat-hf_fact": [
      "Sister chromatid cohesion is the process by which sister chromatids are held together during DNA replication and cell division.",
      "CTF4 (chromatin remodeling factor 4) is a protein that plays a critical role in the regulation of chromatin structure and gene expression.",
      "CTF18 (chromatin remodeling factor 18) is a protein involved in the regulation of chromatin structure and gene expression.",
      "Both CTF4 and CTF18 use energy from ATP hydrolysis to move nucleosomes along DNA.",
      "Studies have shown that CTF4 and CTF18 work together in the regulation of sister chromatid cohesion and the cohesin complex."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: CTF4 (Chromosome transmission fidelity factor 4) is not typically described as a chromatin remodeling factor. It is a protein that is known to interact with DNA polymerase and is involved in sister chromatid cohesion.",
      "false, [corrected fact]: CTF18 is not a chromatin remodeling factor either. It is a protein that forms a complex involved in the processes of DNA replication and repair.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_response": "Here are some examples of human proteins that are known to undergo a dimer-to-tetramer transition:\n1. Hemoglobin: Hemoglobin is a tetrameric protein that consists of four subunits, each of which is a dimer. The dimer-to-tetramer transition is thought to play a role in the regulation of hemoglobin function.\n2. Myoglobin: Myoglobin is another tetrameric protein that undergoes a dimer-to-tetramer transition. The transition is thought to be involved in the regulation of myoglobin function in muscle cells.\n3. Kininogen: Kininogen is a tetrameric protein that undergoes a dimer-to-tetramer transition in response to changes in pH. The transition is thought to play a role in the regulation of kininogen function.\n4. Ceruloplasmin: Ceruloplasmin is a tetrameric protein that undergoes a dimer-to-tetramer transition in response to changes in copper levels. The transition is thought to play a role in the regulation of ceruloplasmin function.\n5. Lactoferrin: Lactoferrin is a tetrameric protein that undergoes a dimer-to-tetramer transition in response to changes in pH. The transition is thought to play a role in the regulation of lactoferrin function.\n6. Transferrin: Transferrin is a tetrameric protein that undergoes a dimer-to-tetramer transition in response to changes in iron levels. The transition is thought to play a role in the regulation of transferrin function.\n7. Retinol-binding protein: Retinol-binding protein is a tetrameric protein that undergoes a dimer-to-tetramer transition in response to changes in retinol levels. The transition is thought to play a role in the regulation of retinol-binding protein function.\n8. Apolipoprotein A-I: Apolipoprotein A-I is a tetrameric protein that undergoes a dimer-to-tetramer transition in response",
    "llama-2-7b-chat-hf_fact": [
      "Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition.",
      "Myoglobin is a tetrameric protein in humans that can transition from dimer to tetramer.",
      "Kininogen is a human protein that undergoes a dimer-to-tetramer transition in response to changes in pH.",
      "Ceruloplasmin is a tetrameric protein that can undergo a dimer-to-tetramer transition in response to changes in copper levels.",
      "Lactoferrin undergoes a dimer-to-tetramer transition, a process believed to regulate its function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Hemoglobin is a human protein that undergoes a tetramer-to-dimer transition.",
      "false, [corrected fact]: Myoglobin is a monomeric protein in humans, not a tetrameric protein.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 197,
    "user_query": "Which gene strand is targeted by transcription-coupled repair (TCR)?",
    "llama-2-7b-chat-hf_response": "A) sense strand\nB) antisense strand\nC) coding strand\nD) non-coding strand\nAnswer: B) antisense strand\nExplanation: Transcription-coupled repair (TCR) is a repair pathway that uses the RNA polymerase enzyme to repair DNA damage. During transcription, the RNA polymerase enzyme reads the DNA template strand and synthesizes an RNA transcript. TCR targets the antisense strand of the DNA template, which is the strand that is complementary to the RNA transcript being synthesized. By repairing DNA damage on the antisense strand, TCR helps to maintain the integrity of the genome.",
    "llama-2-7b-chat-hf_fact": [
      "Transcription-coupled repair (TCR) is a repair pathway that uses the RNA polymerase enzyme to repair DNA damage.",
      "During transcription, the RNA polymerase enzyme reads the DNA template strand and synthesizes an RNA transcript.",
      "TCR targets the antisense strand of the DNA template.",
      "The antisense strand is the strand that is complementary to the RNA transcript being synthesized.",
      "By repairing DNA damage on the antisense strand, TCR helps to maintain the integrity of the genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: TCR targets the transcribed strand of the DNA template, not the antisense strand.",
      "true",
      "true"
    ]
  },
  {
    "id": 199,
    "user_query": "Which is the branch site consensus sequence in U12-dependent introns?",
    "llama-2-7b-chat-hf_response": "In U12-dependent introns, the branch site consensus sequence is GGAGG. This sequence is located upstream of the intron-exon boundary and serves as a recognition site for the RNA splicing factor U12. The U12 protein binds to the branch site sequence and positions the intron for splicing.",
    "llama-2-7b-chat-hf_fact": [
      "In U12-dependent introns, the branch site consensus sequence is GGAGG.",
      "The branch site consensus sequence is located upstream of the intron-exon boundary.",
      "The branch site consensus sequence serves as a recognition site for the RNA splicing factor U12.",
      "The U12 protein binds to the branch site sequence.",
      "U12 protein positions the intron for splicing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The U2AF65 protein, not the U12 protein, binds to the branch site sequence.",
      "false, [corrected fact]: The U2 snRNP, not the U12 protein, positions the intron for splicing."
    ]
  },
  {
    "id": 201,
    "user_query": "What is the suggested therapy for Mycobacterium avium infection?",
    "llama-2-7b-chat-hf_response": "The suggested therapy for Mycobacterium avium infection depends on the severity and location of the infection, as well as the patient's overall health. Here are some common treatment options:\n1. Antibiotics: The primary treatment for Mycobacterium avium infection is antibiotics. The most commonly used antibiotics include macrolides such as erythromycin, azithromycin, and clarithromycin, as well as fluoroquinolones such as ciprofloxacin and moxifloxacin.\n2. Combination therapy: In more severe cases of Mycobacterium avium infection, combination therapy with two or more antibiotics may be necessary. This can help to increase the effectiveness of treatment and reduce the risk of resistance to the antibiotics.\n3. Surgical drainage: In some cases, surgical drainage may be necessary to remove any abscesses or infected tissue.\n4. Corticosteroids: Corticosteroids may be prescribed to reduce inflammation and swelling in the affected area.\n5. Supportive care: Patients with Mycobacterium avium infection may require supportive care, such as oxygen therapy, to help manage respiratory symptoms and improve oxygen levels in the blood.\n6. Pulmonary rehabilitation: Pulmonary rehabilitation may be recommended to help improve lung function and overall health in patients with Mycobacterium avium infection.\n7. Lung transplantation: In severe cases of Mycobacterium avium infection that are resistant to treatment, lung transplantation may be necessary.\nIt's important to note that the treatment of Mycobacterium avium infection can be lengthy and may take several months to a year or more to complete. It's important to work closely with a healthcare provider to develop a personalized treatment plan and to monitor progress throughout treatment.",
    "llama-2-7b-chat-hf_fact": [
      "The primary treatment for Mycobacterium avium infection is antibiotics, including macrolides and fluoroquinolones.",
      "In severe cases of Mycobacterium avium infection, combination therapy with two or more antibiotics may be necessary.",
      "Surgical drainage may be required to remove abscesses or infected tissue in some cases of Mycobacterium avium infection.",
      "Patients with Mycobacterium avium infection may require supportive care, such as oxygen therapy.",
      "In cases of Mycobacterium avium infection that are resistant to treatment, lung transplantation may be necessary."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-7b-chat-hf_response": "Answer: The protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is Bcl-2. Bcl-2 is a member of the Bcl-2 family of proteins, which are involved in regulating programmed cell death (apoptosis). PLN is a protein that inhibits the activity of the pro-apoptotic protein Bax, and Bcl-2 has been shown to interact with PLN and prevent its inhibition of Bax. This suggests that Bcl-2 may play a role in protecting cells against apoptosis by inhibiting the activity of pro-apoptotic proteins such as Bax.",
    "llama-2-7b-chat-hf_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein.",
      "Bcl-2 is a member of the Bcl-2 family of proteins which are involved in regulating programmed cell death (apoptosis).",
      "PLN inhibits the activity of the pro-apoptotic protein Bax.",
      "Bcl-2 prevents the inhibition of Bax by PLN, suggesting that it may play a role in protecting cells against apoptosis by inhibiting the activity of pro-apoptotic proteins such as Bax."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 213,
    "user_query": "Is protein M3/6 a dual specificity phosphatase?",
    "llama-2-7b-chat-hf_response": "Protein M3/6 is a protein that has been identified as a dual specificity phosphatase. This means that it has the ability to dephosphorylate two different substrates, leading to the inactivation of two different signaling pathways.",
    "llama-2-7b-chat-hf_fact": [
      "Protein M3/6 is identified as a dual specificity phosphatase.",
      "A dual specificity phosphatase has the ability to dephosphorylate two different substrates.",
      "Dephosphorylation leads to inactivation of signaling pathways."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-7b-chat-hf_response": "Yes, several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people. Here are some examples:\n1. A 2010 meta-analysis published in the Journal of the American Geriatrics Society found that vitamin D supplementation was associated with a significant reduction in fall risk in older adults (RR=0.77, 95% CI=0.65-0.90).\n2. A 2012 randomized controlled trial published in the Journal of Bone and Mineral Research found that vitamin D supplementation reduced the incidence of falls in older adults with low baseline 25-hydroxyvitamin D levels (RR=0.57, 95% CI=0.39-0.84).\n3. A 2013 randomized controlled trial published in the Journal of the American Geriatrics Society found that vitamin D supplementation reduced the incidence of falls in older adults with a history of falls (RR=0.43, 95% CI=0.24-0.77).\n4. A 2016 meta-analysis published in the Journal of Clinical Endocrinology and Metabolism found that vitamin D supplementation was associated with a significant reduction in fall risk in older adults (RR=0.73, 95% CI=0.63-0.85).\nOverall, these studies suggest that vitamin D supplementation may be effective in reducing the incidence of falls in older people, particularly those with low baseline 25-hydroxyvitamin D levels or a history of falls. However, it's important to note that these findings are based on observational studies and randomized controlled trials, and more research is needed to confirm these results and establish the optimal dosage and duration of vitamin D supplementation for fall prevention.",
    "llama-2-7b-chat-hf_fact": [
      "Several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people.",
      "A 2010 meta-analysis found vitamin D supplementation was associated with a significant reduction in fall risk in older adults.",
      "A 2012 randomized controlled trial concluded that vitamin D supplementation reduced the incidence of falls in older adults with low baseline 25-hydroxyvitamin D levels.",
      "A 2013 randomized controlled trial reported that vitamin D supplementation reduced the incidence of falls in older adults with a history of falls.",
      "A 2016 meta-analysis demonstrated that vitamin D supplementation was associated with a significant reduction in fall risk in older adults."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 221,
    "user_query": "What is the generic name of Gliolan?",
    "llama-2-7b-chat-hf_response": "Gliolan is a brand name, not a generic name. Therefore, it does not have a generic equivalent. Gliolan is a registered trademark of the pharmaceutical company, Novartis, and is used to market the drug fluorescein sodium in various countries.",
    "llama-2-7b-chat-hf_fact": [
      "Gliolan is a brand name per the pharmaceutical terminology.",
      "Gliolan does not have a generic equivalent.",
      "Gliolan is a registered trademark of the pharmaceutical company, Novartis.",
      "Gliolan is used to market the drug fluorescein sodium.",
      "Gliolan is a drug marketed in various countries."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false, [corrected fact]: Gliolan is a registered trademark of the pharmaceutical company, photonamic GmbH & Co. KG, not Novartis.",
      "false, [corrected fact]: Gliolan is used to market the drug Aminolevulinic Acid Hydrochloride, not fluorescein sodium.",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-7b-chat-hf_response": "Jarid2 (Jumonji AT-rich interactive domain 2) is a histone H3 lysine 9 demethylase that has been implicated in the regulation of T cell differentiation and function. miR-155 (microRNA-155) is a small non-coding RNA molecule that has been shown to play a critical role in the regulation of Th17 cell differentiation and function.\nRecent studies have suggested that Jarid2 and miR-155 may be associated in Th17 cells. For example, one study found that Jarid2 is required for the proper expression of miR-155 in Th17 cells, and that miR-155 regulates Jarid2 expression in these cells. Another study found that Jarid2 and miR-155 are co-localized in the nucleus of Th17 cells, suggesting a direct association between the two molecules.\nOverall, these findings suggest that Jarid2 and miR-155 may play a coordinated role in regulating Th17 cell differentiation and function, with Jarid2 promoting the expression of miR-155 and miR-155 in turn regulating Jarid2 expression. Further research is needed to fully understand the mechanisms underlying this association and its implications for T cell biology.",
    "llama-2-7b-chat-hf_fact": [
      "Jarid2 is a histone H3 lysine 9 demethylase that has a role in the regulation of T cell differentiation and function.",
      "miR-155 is a small non-coding RNA molecule that is involved in regulating Th17 cell differentiation and function.",
      "Recent studies suggest an association between Jarid2 and miR-155 in Th17 cells.",
      "Jarid2 is required for the proper expression of miR-155 in Th17 cells and miR-155 regulates Jarid2 expression in these cells.",
      "Jarid2 and miR-155 have been observed to be co-localized in the nucleus of Th17 cells, suggesting a possible interaction between the two molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-7b-chat-hf_response": "The human HoxD cluster contains 6 genes: Hoxd1, Hoxd2, Hoxd3, Hoxd13, Hoxd14, and Hoxd15.",
    "llama-2-7b-chat-hf_fact": [
      "The human HoxD cluster contains 6 genes.",
      "Hoxd1 is a gene in the human HoxD cluster.",
      "Hoxd2 is a gene in the human HoxD cluster.",
      "Hoxd3 is a gene in the human HoxD cluster.",
      "Hoxd13 is a gene in the human HoxD cluster.",
      "Hoxd14 is a gene in the human HoxD cluster.",
      "Hoxd15 is a gene in the human HoxD cluster."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The human HoxD cluster contains 9 genes.",
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Hoxd14 is not a gene in the human HoxD cluster.",
      "false, [corrected fact]: Hoxd15 is not a gene in the human HoxD cluster."
    ]
  },
  {
    "id": 229,
    "user_query": "Which are the human glutamate transporters?",
    "llama-2-7b-chat-hf_response": "Glutamate is the most abundant excitatory neurotransmitter in the central nervous system (CNS), and it plays a crucial role in various physiological processes, including synaptic plasticity, learning, and memory. The transport of glutamate across the synaptic cleft is mediated by several types of glutamate transporters, including:\n1. Excitatory amino acid transporters (EAATs): These transporters are responsible for the uptake of glutamate from the synaptic cleft into the presynaptic neuron. There are three subtypes of EAATs: EAAT1, EAAT2, and EAAT3.\n2. Cystine-glutamate antiporters (xCT): These transporters are responsible for the efflux of glutamate from the presynaptic neuron into the extracellular space. There is only one subtype of xCT.\n3. Solute carrier family 13 (SLC13) transporters: These transporters are responsible for the uptake of glutamate from the extracellular space into the presynaptic neuron. There are two subtypes of SLC13 transporters: SLC13A1 and SLC13A2.\n4. Proton-coupled glutamate transporters (PCTs): These transporters are responsible for the efflux of glutamate from the presynaptic neuron into the extracellular space. There are two subtypes of PCTs: PCT1 and PCT2.\n5. Voltage-gated glutamate transporters (VGATs): These transporters are responsible for the efflux of glutamate from the presynaptic neuron into the extracellular space in response to changes in the membrane potential. There are two subtypes of VGATs: VGAT1 and VGAT2.\nEach of these transporters has a distinct function and expression pattern in the brain, and their dysfunction has been implicated in various neurological disorders, including epilepsy, stroke, and neurodegener",
    "llama-2-7b-chat-hf_fact": [
      "Glutamate is the most abundant excitatory neurotransmitter in the central nervous system.",
      "The transport of glutamate across the synaptic cleft is mediated by different types of transporters.",
      "Excitatory amino acid transporters, EAATs, are responsible for the uptake of glutamate from the synaptic cleft into the presynaptic neuron, with three subtypes: EAAT1, EAAT2, and EAAT3.",
      "Cystine-glutamate antiporters (xCT) are responsible for the efflux of glutamate from the presynaptic neuron into the extracellular space, with only one subtype of xCT.",
      "Dysfunction of glutamate transporters has been implicated in various neurological disorders, including epilepsy, stroke, and neurodegeneration."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Excitatory amino acid transporters, EAATs, are responsible for the uptake of glutamate from the synaptic cleft into the postsynaptic neuron, with five known subtypes: EAAT1, EAAT2, EAAT3, EAAT4, and EAAT5.",
      "true",
      "true"
    ]
  },
  {
    "id": 235,
    "user_query": "What is the causative agent of the \"Panama disease\" affecting bananas?",
    "llama-2-7b-chat-hf_response": "The \"Panama disease\" is a fungal disease that affects banana plants, caused by the fungus Fusarium oxysporum f. sp. cubense. This disease was first identified in Panama in the 1950s and has since spread to many banana-producing countries around the world. The fungus attacks the plant's vascular system, causing yellowing and wilting of the leaves, and eventually killing the plant. The disease is particularly problematic for banana farmers because it is difficult to control and can lead to significant crop losses.",
    "llama-2-7b-chat-hf_fact": [
      "\"Panama disease\" is a fungal disease that affects banana plants.",
      "The cause of Panama disease is the fungus Fusarium oxysporum f. sp. cubense.",
      "Panama disease was first identified in Panama in the 1950s.",
      "The fungus attacks the plant's vascular system, leading to yellowing and wilting of the leaves, and eventually killing the plant.",
      "Panama disease is difficult to control and can lead to significant crop losses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Panama disease was first identified in Panama in the 1890s.",
      "true",
      "true"
    ]
  },
  {
    "id": 237,
    "user_query": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?",
    "llama-2-7b-chat-hf_response": "Mercedes Benz syndrome, also known as craniofacial microsomia, is a rare congenital disorder that affects the development of various cranial structures. The characteristic features of Mercedes Benz syndrome include:\n1. Microcephaly: A small head size is a common feature of Mercedes Benz syndrome, which can range from mild to severe.\n2. Synostosis: The syndrome is characterized by the premature fusion of cranial sutures, which can result in a distinctive skull shape. The most commonly affected sutures are those between the frontal bones (frontal synostosis), the parietal bones (parietal synostosis), and the occipital bone (occipital synostosis).\n3. Cranial neural tube defects: Mercedes Benz syndrome can also involve defects in the development of the cranial neural tube, which can lead to various neurological problems, such as hydrocephalus, microcephaly, and cognitive impairments.\n4. Eye abnormalities: The syndrome can cause various eye abnormalities, including microphthalmia (small eyes), anophthalmia (absence of one eye), coloboma (a hole in the iris), and cataracts.\n5. Ear abnormalities: Mercedes Benz syndrome can also cause ear abnormalities, such as microtia (small ear) or anotia (absence of one ear).\n6. Facial dysmorphism: The syndrome can result in various facial abnormalities, including a small or malformed nose, micrognathia (small jaw), and dental abnormalities.\n7. Neurological problems: Mercedes Benz syndrome can also cause various neurological problems, such as seizures, developmental delays, and cognitive impairments.\nIt is important to note that the severity of the syndrome can vary widely among individuals, and some may have only a few of these characteristic features, while others may have many. A comprehensive diagnostic evaluation, including imaging studies and genetic testing, is necessary to confirm the diagnosis of Mercedes Benz syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Mercedes Benz syndrome, also known as craniofacial microsomia, is a rare congenital disorder that affects the development of various cranial structures.",
      "Mercedes Benz syndrome is characterized by the premature fusion of cranial sutures, most commonly between the frontal bones, the parietal bones, and the occipital bone.",
      "The syndrome can involve defects in the development of the cranial neural tube, leading to various neurological problems such as hydrocephalus, microcephaly, and cognitive impairments.",
      "Mercedes Benz syndrome can cause various eye and ear abnormalities, including smaller than normal size or absence of one eye or ear, a hole in the iris, and cataracts.",
      "Facial abnormalities, such as a small or malformed nose, micrognathia, and dental abnormalities, can result from Mercedes Benz syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Mercedes Benz is an automobile brand and is not associated with any medical syndrome. Craniofacial microsomia, is indeed a rare congenital disorder that affects the development of various cranial structures.",
      "false, [corrected fact]: The disorder characterized by the premature fusion of cranial sutures, most commonly between the frontal bones, the parietal bones, and the occipital bone, is known as craniosynostosis.",
      "false, [corrected fact]: Defects in the development of the cranial neural tube, leading to various neurological problems such as hydrocephalus, microcephaly, and cognitive impairments, are associated with conditions known as neural tube defects, not Mercedes Benz syndrome.",
      "true",
      "true"
    ]
  },
  {
    "id": 242,
    "user_query": "What is a mitochondrial nucleoid?",
    "llama-2-7b-chat-hf_response": "A mitochondrial nucleoid is a region within a mitochondrion where the mitochondrial DNA (mtDNA) is located. Mitochondria are organelles found in the cells of most eukaryotes, and they play a crucial role in generating energy for the cell through the process of cellular respiration. The mtDNA is a small circular genome that contains the genetic information necessary for the mitochondria to function properly. The nucleoid is the site where the mtDNA is organized and replicated, and it is surrounded by a protein matrix that helps to protect the DNA and regulate its interactions with other cellular components.",
    "llama-2-7b-chat-hf_fact": [
      "A mitochondrial nucleoid is a region within a mitochondrion where the mitochondrial DNA (mtDNA) is located.",
      "Mitochondrial nucleoid is crucial in organizing and replicating the mtDNA.",
      "Mitochondria are organelles found in the cells of most eukaryotes that generate energy for the cell through cellular respiration.",
      "The mtDNA is a small circular genome that holds the genetic information needed for mitochondrial functionality.",
      "The nucleoid is surrounded by a protein matrix that protects the DNA and regulates its interactions with other cellular components."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 247,
    "user_query": "What is the effect of ivabradine in heart failure with preserved ejection fraction?",
    "llama-2-7b-chat-hf_response": "Ivabradine is a selective sinus node modulator that has been shown to improve exercise capacity and quality of life in patients with heart failure with reduced ejection fraction (HFrEF). However, its effect in patients with heart failure with preserved ejection fraction (HFpEF) is less clear. Some studies have suggested that ivabradine may have a beneficial effect on exercise capacity and quality of life in patients with HFpEF, while others have found no significant difference compared to placebo. The exact mechanism of ivabradine's effect in HFpEF is not fully understood, but it is thought to involve a reduction in the sympathetic nervous system activity, which can help to improve cardiac function and reduce symptoms.\nIt is important to note that ivabradine is not approved for use in patients with HFpEF by the US Food and Drug Administration (FDA), and its use in this population is considered off-label. Therefore, the use of ivabradine in patients with HFpEF should be carefully evaluated on a case-by-case basis, taking into account the patient's individual circumstances and medical history.\nIn summary, the effect of ivabradine in heart failure with preserved ejection fraction is less clear than in heart failure with reduced ejection fraction, and more research is needed to fully understand its potential benefits and risks in this population.",
    "llama-2-7b-chat-hf_fact": [
      "Ivabradine is a selective sinus node modulator.",
      "Ivabradine has been shown to improve exercise capacity and quality of life in patients with heart failure with reduced ejection fraction (HFrEF).",
      "The relationship between ivabradine and its effects on patients with heart failure with preserved ejection fraction (HFpEF) is not well established.",
      "Ivabradine is not approved for use in patients with HFpEF by the US Food and Drug Administration (FDA).",
      "The use of ivabradine in patients with HFpEF is considered off-label in the context of the FDA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 248,
    "user_query": "Is low T3 syndrome a prognostic marker in patients with renal insufficiency?",
    "llama-2-7b-chat-hf_response": "Low T3 syndrome, also known as hypothyroidism, has been associated with an increased risk of cardiovascular disease and mortality in patients with renal insufficiency. A study published in the Journal of the American Society of Nephrology found that patients with low T3 syndrome had a higher risk of all-cause mortality and cardiovascular events compared to those with normal T3 levels. Another study published in the American Journal of Kidney Diseases found that low T3 syndrome was independently associated with an increased risk of cardiovascular disease in patients with chronic kidney disease. These findings suggest that low T3 syndrome may be a useful prognostic marker in patients with renal insufficiency.",
    "llama-2-7b-chat-hf_fact": [
      "Low T3 syndrome is also known as hypothyroidism.",
      "Low T3 syndrome has been associated with an increased risk of cardiovascular disease and mortality in patients with renal insufficiency.",
      "A study found that patients with low T3 syndrome had a higher risk of mortality and cardiovascular events compared to those with normal T3 levels.",
      "A different study found that low T3 syndrome was independently associated with an increased risk of cardiovascular disease in patients with chronic kidney disease.",
      "Low T3 syndrome may be a useful prognostic marker in renal insufficiency."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Low T3 syndrome is a condition characterized by a decrease in the active thyroid hormone T3, but it's not the same as hypothyroidism. Hypothyroidism is a condition in which you have an underactive thyroid.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 254,
    "user_query": "Which is the relation between sweating and anaerobic threshold?",
    "llama-2-7b-chat-hf_response": "Sweating is a common symptom of anaerobic threshold, which is the point at which the body can no longer sustain aerobic metabolism and begins to rely on anaerobic metabolism to produce energy. At this point, the body starts to produce lactic acid, which can cause muscle fatigue and soreness.\nAnaerobic threshold is the point at which the body can no longer sustain aerobic metabolism and begins to rely on anaerobic metabolism to produce energy. At this point, the body starts to produce lactic acid, which can cause muscle fatigue and soreness.\nSweating is a common symptom of anaerobic threshold, as the body's attempt to cool itself down in response to increased muscle activity and heat production. As the body reaches its anaerobic threshold, it begins to sweat more heavily in order to cool itself down and prevent overheating.\nIn summary, sweating is a symptom of anaerobic threshold, as the body's attempt to cool itself down in response to increased muscle activity and heat production. At this point, the body starts to produce lactic acid, which can cause muscle fatigue and soreness.",
    "llama-2-7b-chat-hf_fact": [
      "Sweating is a common symptom of anaerobic threshold.",
      "Anaerobic threshold is the point at which the body can no longer sustain aerobic metabolism and begins to rely on anaerobic metabolism to produce energy.",
      "When the body reaches its anaerobic threshold, it begins to produce lactic acid.",
      "Lactic acid can cause muscle fatigue and soreness.",
      "As the body reaches its anaerobic threshold, it begins to sweat more heavily in order to prevent overheating."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 256,
    "user_query": "What is the mode of action of bedaquiline?",
    "llama-2-7b-chat-hf_response": "Bedaquiline is an antibiotic that works by inhibiting the activity of the enzyme Fumarate hydratase (FH), which is essential for the survival of Mycobacterium tuberculosis. FH is involved in the degradation of fumarate, a compound that is present in the mycobacterial cell wall. By inhibiting FH, bedaquiline prevents the degradation of fumarate, leading to an accumulation of toxic compounds in the mycobacterial cell. This ultimately results in the death of the bacteria.\nBedaquiline is unique among anti-tubercular drugs in that it acts through a novel mechanism of action, which makes it effective against drug-resistant strains of M. tuberculosis. The drug has been shown to be effective in treating drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB).\nIt is important to note that bedaquiline is not a cure for TB, and it is typically used in combination with other anti-tubercular drugs as part of a comprehensive treatment regimen.",
    "llama-2-7b-chat-hf_fact": [
      "Bedaquiline is an antibiotic that inhibits the activity of the enzyme Fumarate hydratase (FH).",
      "Fumarate hydratase is essential for the survival of Mycobacterium tuberculosis.",
      "Bedaquiline, by inhibiting Fumarate hydratase, leads to an accumulation of toxic compounds in the mycobacterial cell, causing the bacteria's death.",
      "Bedaquiline has been shown to be effective in treating drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB).",
      "Bedaquiline is typically used in combination with other anti-tubercular drugs as part of a comprehensive treatment regimen."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Bedaquiline is an antibiotic that inhibits the activity of the enzyme ATP synthase, not Fumarate hydratase (FH).",
      "true",
      "false, [corrected fact]: Bedaquiline, by inhibiting ATP synthase, impairs the energy production of the mycobacterial cell, causing the bacteria's death, not by accumulation of toxic compounds.",
      "true",
      "true"
    ]
  },
  {
    "id": 259,
    "user_query": "Is oxidative stress affected by FOXO expression?",
    "llama-2-7b-chat-hf_response": "Oxidative stress is a state of imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify these harmful compounds. ROS can damage cellular components, including DNA, proteins, and lipids, leading to various diseases. FOXO (forkhead box O) proteins are transcription factors that play a crucial role in regulating cellular responses to oxidative stress. FOXO proteins are activated in response to oxidative stress and regulate the expression of genes involved in antioxidant defense, DNA repair, and cell survival.\nStudies have shown that FOXO expression is affected by oxidative stress. FOXO proteins are known to be phosphorylated and inactivated by various signaling pathways, including the PI3K/Akt and MAPK/ERK pathways, which are activated in response to oxidative stress. This phosphorylation and inactivation of FOXO proteins can reduce their ability to regulate the expression of genes involved in antioxidant defense and DNA repair, leading to decreased resistance to oxidative stress.\nAdditionally, FOXO proteins have been shown to regulate the expression of genes involved in the production of ROS, such as NADPH oxidase and cytochrome P450 enzymes. FOXO proteins can also regulate the expression of genes involved in the detoxification of ROS, such as glutathione peroxidase and catalase.\nIn summary, FOXO expression is affected by oxidative stress, and FOXO proteins play a crucial role in regulating cellular responses to oxidative stress by modulating the expression of genes involved in antioxidant defense, DNA repair, and ROS production and detoxification.",
    "llama-2-7b-chat-hf_fact": [
      "Oxidative stress involves an imbalance between the production of reactive oxygen species (ROS) and the body's detoxification ability.",
      "FOXO proteins are transcription factors that regulate the response to oxidative stress.",
      "FOXO proteins are activated in response to oxidative stress and regulate the expression of genes involved in antioxidant defense, DNA repair, and cell survival.",
      "FOXO proteins are phosphorylated and inactivated by pathways including the PI3K/Akt and MAPK/ERK, which are activated in response to oxidative stress.",
      "FOXO proteins regulate the expression of genes involved in the production and detoxification of ROS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 260,
    "user_query": "Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.",
    "llama-2-7b-chat-hf_response": "The LINX system is a minimally invasive, endoscopic treatment for gastroesophageal reflux disease (GERD) that involves the placement of a ring of interlocking magnetic beads around the lower esophageal sphincter (LES). The mechanism of action of the LINX system is as follows:",
    "llama-2-7b-chat-hf_fact": [
      "The LINX system is an endoscopic treatment for gastroesophageal reflux disease.",
      "The LINX system is a minimally invasive procedure.",
      "The LINX system involves the placement of a ring of interlocking magnetic beads.",
      "This placement occurs around the lower esophageal sphincter.",
      "The LINX system is used to treat gastroesophageal reflux disease, also known as GERD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 262,
    "user_query": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.",
    "llama-2-7b-chat-hf_response": "The characteristic feature of the Dyke-Davidoff-Masson syndrome is the presence of a distinctive facial appearance, which includes:\n1. Microphthalmia (small eyes)\n2. Proptosis (bulging eyes)\n3. Retrognathia (receding lower jaw)\n4. Microdontia (small teeth)\n5. Cleft lip and/or palate\n6. Hearing loss\n7. Intellectual disability\n8. Distinctive facial features, such as a long, narrow face, a flat nasal bridge, and a small, upturned nose.\nThese features are present from birth and can vary in severity from one individual to another. The syndrome is usually diagnosed in infancy or early childhood and can be identified by a combination of clinical findings and genetic testing.",
    "llama-2-7b-chat-hf_fact": [
      "Dyke-Davidoff-Masson syndrome is characterized by a distinctive facial appearance.",
      "Microphthalmia, proptosis, retrognathia, microdontia, and cleft lip and/or palate are among the features observed in Dyke-Davidoff-Masson syndrome.",
      "The unique features observed in this syndrome are present from birth and can vary in severity from one individual to another.",
      "Hearing loss and intellectual disability are also associated with Dyke-Davidoff-Masson syndrome.",
      "The syndrome is usually diagnosed in infancy or early childhood and can be identified by a combination of clinical findings and genetic testing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Dyke-Davidoff-Masson syndrome is characterized by hemiatrophy of the brain, which leads to seizures, facial asymmetry, and mental retardation.",
      "false, [corrected fact]: Microphthalmia, proptosis, retrognathia, microdontia, and cleft lip and/or palate are not typically features observed in Dyke-Davidoff-Masson syndrome. These features can be associated with other genetic syndromes, not Dyke-Davidoff-Masson syndrome.",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 263,
    "user_query": "Which gene is involved in the development of Barth syndrome?",
    "llama-2-7b-chat-hf_response": "Barth syndrome is a rare genetic disorder that affects males almost exclusively. It is caused by mutations in the TCF4 gene, which is located on the X chromosome. The TCF4 gene provides instructions for making a protein called transcription factor 4 (TCF4), which plays a critical role in regulating the expression of genes involved in cell growth and division. Mutations in the TCF4 gene can lead to the development of Barth syndrome, which is characterized by a range of symptoms including growth delays, muscle weakness, and heart problems.",
    "llama-2-7b-chat-hf_fact": [
      "Barth syndrome is a rare genetic disorder that primarily affects males.",
      "The condition is caused by mutations in the TCF4 gene.",
      "The TCF4 gene is located on the X chromosome.",
      "The TCF4 gene provides instructions for creating a protein called transcription factor 4.",
      "Transcription factor 4 plays a role in regulating genes involved in cell growth and division."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Barth syndrome is caused by mutations in the TAZ gene, not the TCF4 gene.",
      "true",
      "false, [corrected fact]: The TCF4 gene provides instructions for creating a protein associated with a different condition called Pitt-Hopkins syndrome.",
      "true"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-7b-chat-hf_response": "Casein Kinase 1 (CK1) is a serine/threonine protein kinase that plays a crucial role in various cellular processes, including cell signaling, cytoskeleton organization, and gene expression. CK1 has been implicated in various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. Here are some phosphorylation consensus motifs for CK1:\n1. Ser/Thr-Pro-Thr/Ser: This is a common consensus motif for CK1 phosphorylation sites. The Pro residue can be either directly phosphorylated by CK1 or serve as a recognition site for downstream kinases.\n2. Ser/Thr-Gly-Thr/Ser: This motif is similar to the previous one but with a Gly residue instead of Pro.\n3. Ser/Thr-Ala-Thr/Ser: This motif is found in the N-terminal region of some CK1 substrates and is important for their phosphorylation by CK1.\n4. Ser/Thr-Arg-Thr/Ser: This motif is found in the C-terminal region of some CK1 substrates and is important for their phosphorylation by CK1.\n5. Ser-X-Thr/Ser: Where X is any amino acid, this motif is found in the substrate sequences of CK1 and is important for their phosphorylation.\n6. Thr-X-Thr/Ser: Where X is any amino acid, this motif is found in the substrate sequences of CK1 and is important for their phosphorylation.\n7. Ser-Gly-X-Thr/Ser: Where X is any amino acid, this motif is found in the substrate sequences of CK1 and is important for their phosphorylation.\n8. Ser-Pro-X-Thr/Ser: Where X is any amino acid, this motif is found in the substrate sequences of CK1 and is important for their phosphorylation.\n9. Thr-Pro-X-Thr/Ser: Where X is any amino acid, this motif is found in the substrate sequences of CK1",
    "llama-2-7b-chat-hf_fact": [
      "Casein Kinase 1 (CK1) is a serine/threonine protein kinase crucial for cellular processes like cell signaling, cytoskeleton organization, and gene expression.",
      "CK1 plays a role in various diseases, including cancer, neurodegenerative disorders, and metabolic disorders.",
      "The phosphorylation consensus motif Ser/Thr-Pro-Thr/Ser is commonly utilized by CK1.",
      "The Ser/Thr-Gly-Thr/Ser motif is another recognizable phosphorylation sequence targeted by CK1.",
      "CK1 recognizes and phosphorylates substrates containing the Ser-X-Thr/Ser motif, where X can be any amino acid."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The Ser/Thr-Gly-Thr/Ser motif is not a known phosphorylation sequence targeted by CK1.",
      "unknown"
    ]
  },
  {
    "id": 273,
    "user_query": "What is the Barr body?",
    "llama-2-7b-chat-hf_response": "The Barr body is a cytogenetic phenomenon that occurs in female mammals, including humans, in which one of the two X chromosomes is inactivated in most cells of the body. This occurs as a result of a process called X-inactivation, which is necessary to avoid a doubling of gene expression due to the presence of two X chromosomes in female cells.",
    "llama-2-7b-chat-hf_fact": [
      "The Barr body is a cytogenetic phenomenon that occurs in female mammals, including humans.",
      "One of the two X chromosomes is inactivated in most cells of the body in the Barr body.",
      "This phenomenon of X chromosome inactivation in the Barr body is a result of a process called X-inactivation.",
      "X-inactivation is needed to prevent a doubling of gene expression due to the presence of two X chromosomes in female cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 275,
    "user_query": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?",
    "llama-2-7b-chat-hf_response": "Shotgun lipidomics is a lipid analysis technique that involves the direct infusion of a lipid sample into a mass spectrometer without any prior separation or purification of the lipids. This approach is also known as \"raw lipidomics\" or \"unseparated lipidomics.\"\nIn shotgun lipidomics, the lipid sample is dissolved in a solvent, such as methanol or acetonitrile, and then injected directly into the mass spectrometer without any further processing. The mass spectrometer then separates the lipids based on their mass-to-charge ratio, and the resulting mass spectrum is analyzed to identify and quantify the different lipid species present in the sample.\nShotgun lipidomics has several advantages over other lipid analysis techniques, such as liquid chromatography-mass spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS). For example, shotgun lipidomics can be used to analyze complex lipid mixtures without the need for extensive sample preparation, which can save time and resources. Additionally, shotgun lipidomics can provide a more comprehensive view of the lipid composition of a sample, as it does not rely on any prior separation or purification of the lipids.\nHowever, shotgun lipidomics also has some limitations. For example, the direct infusion of a lipid sample into a mass spectrometer can result in the analysis of lipids in a non-specific manner, which can make it difficult to identify and quantify individual lipid species. Additionally, the sensitivity of shotgun lipidomics can be lower than that of other lipid analysis techniques, such as LC-MS or GC-MS, which can make it more difficult to detect and quantify low-abundance lipid species.\nIn summary, shotgun lipidomics is a lipid analysis technique that involves the direct infusion of a lipid sample into a mass spectrometer without any prior separation or purification of the lipids. While it has several advantages, it also has some limitations, and the choice of lipid analysis technique will depend on the specific research question and experimental design.",
    "llama-2-7b-chat-hf_fact": [
      "Shotgun lipidomics is a lipid analysis technique which involves direct infusion of a lipid sample into a mass spectrometer without any prior separation or purification of the lipids.",
      "In shotgun lipidomics, the lipid sample is dissolved in a solvent and then directly injected into the mass spectrometer.",
      "The mass spectrometer in shotgun lipidomics separates the lipids based on their mass-to-charge ratio.",
      "Despite its advantages, shotgun lipidomics can result in non-specific analysis of lipids which can make it difficult to identify and quantify individual lipid species.",
      "The sensitivity of shotgun lipidomics can be lower than other techniques like liquid chromatography-mass spectrometry or gas chromatography-mass spectrometry."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 283,
    "user_query": "List functions that are evaluated with the Full Outline of Unresponsiveness score?",
    "llama-2-7b-chat-hf_response": "1. **Full Outline of Unresponsiveness (FOU)**: This score measures the degree to which a function is unresponsive to changes in the input. A higher FOU score indicates that the function is less sensitive to changes in the input, and is more likely to produce the same output regardless of the input.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 285,
    "user_query": "Is ospemifene effective for treatment of dyspareunia?",
    "llama-2-7b-chat-hf_response": "Yes, ospemifene has been shown to be effective in the treatment of dyspareunia, which is painful sexual intercourse in women. Ospemifene is a selective estrogen receptor modulator (SERM) that has been approved by the FDA for the treatment of moderate to severe dyspareunia in postmenopausal women.\nStudies have shown that ospemifene can improve sexual function and reduce pain during sexual activity in women with dyspareunia. In a phase III clinical trial, ospemifene was shown to significantly improve sexual function and reduce pain during sexual activity compared to placebo in postmenopausal women with dyspareunia.\nThe exact mechanism of action of ospemifene in dyspareunia is not fully understood, but it is thought to work by increasing the levels of estrogen in the vagina, which can help to improve vaginal lubrication and reduce inflammation. Additionally, ospemifene may also have a direct effect on the nerve endings in the vagina, which can help to reduce pain during sexual activity.\nIt is important to note that ospemifene is only approved for the treatment of moderate to severe dyspareunia in postmenopausal women, and it may not be effective for all women with dyspareunia. Additionally, ospemifene can have potential side effects, including hot flashes, breast tenderness, and vaginal discharge, so it is important to discuss the potential benefits and risks with a healthcare provider before starting treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Ospemifene is a selective estrogen receptor modulator (SERM).",
      "The FDA has approved ospemifene for the treatment of moderate to severe dyspareunia in postmenopausal women.",
      "Studies have shown that ospemifene can improve sexual function and reduce pain during sexual activity in women with dyspareunia.",
      "A phase III clinical trial showed that ospemifene significantly improved sexual function and reduced pain during sexual activity compared to placebo in postmenopausal women with dyspareunia.",
      "Potential side effects of ospemifene include hot flashes, breast tenderness, and vaginal discharge."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 287,
    "user_query": "What is the biological role of expansins in fungi?",
    "llama-2-7b-chat-hf_response": "Expansins are a type of glycoprotein found in fungi that play a crucial role in cell wall biosynthesis and cell expansion. They are responsible for the breakdown of the existing cell wall and the synthesis of a new one, which allows the cell to grow and divide. Expansins are also involved in the formation of appressoria, specialized structures that allow fungi to penetrate plant tissues.",
    "llama-2-7b-chat-hf_fact": [
      "Expansins are a type of glycoprotein found in fungi.",
      "Expansins play a crucial role in cell wall biosynthesis and cell expansion.",
      "They are involved in the breakdown and synthesis of the fungal cell wall.",
      "Expansins contribute to the growth and division of fungal cells.",
      "These proteins are also involved in the formation of appressoria, which are structures that allow fungi to penetrate plant tissues."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Expansins are a type of protein primarily found in plants, not fungi.",
      "true",
      "false, [corrected fact]: Expansins do not directly involve in the breakdown and synthesis of cell walls but rather they loosen cell walls to facilitate cell expansion.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 301,
    "user_query": "Which oncogenes are able to induce cellular senescence?",
    "llama-2-7b-chat-hf_response": "Several oncogenes have been shown to be able to induce cellular senescence, including:\n1. Ras oncogenes: The Ras family of oncogenes (H-Ras, K-Ras, and N-Ras) are commonly mutated in various types of cancer and have been shown to induce cellular senescence.\n2. Myc oncogene: The Myc oncogene is a transcription factor that regulates cellular proliferation and differentiation. Overexpression of Myc has been shown to induce cellular senescence.\n3. Src oncogene: The Src family of oncogenes (Src, Fyn, and Lyn) are involved in cellular signaling pathways and have been shown to induce cellular senescence.\n4. EGFR oncogene: The Epidermal Growth Factor Receptor (EGFR) is a transmembrane receptor that is involved in cellular signaling pathways. Mutations in EGFR have been shown to induce cellular senescence.\n5. PI3K oncogene: The Phosphatidylinositol 3-kinase (PI3K) oncogene is involved in cellular signaling pathways and has been shown to induce cellular senescence.\n6. AKT oncogene: The AKT oncogene is involved in cellular signaling pathways and has been shown to induce cellular senescence.\n7. MAPK oncogene: The Mitogen-Activated Protein Kinase (MAPK) oncogene is involved in cellular signaling pathways and has been shown to induce cellular senescence.\n8. STK11 oncogene: The Serine/Threonine Kinase 11 (STK11) oncogene is involved in cellular signaling pathways and has been shown to induce cellular senescence.\n9. TP53 oncogene: The Tumor Protein P53 (TP53) oncogene is a transcription factor that regulates cellular proliferation and differentiation. Mutations in TP53 have been shown to induce cellular senescence.\n10",
    "llama-2-7b-chat-hf_fact": [
      "Ras family of oncogenes, which includes H-Ras, K-Ras, and N-Ras, can induce cellular senescence.",
      "The Myc oncogene, a transcription factor that regulates cellular proliferation and differentiation, is capable of inducing cellular senescence.",
      "The Src family of oncogenes, such as Src, Fyn, and Lyn, are involved in cellular signaling pathways and can induce cellular senescence.",
      "Mutations in the Epidermal Growth Factor Receptor (EGFR) oncogene have been shown to induce cellular senescence.",
      "The AKT oncogene, involved in cellular signaling pathways, has also been shown to induce cellular senescence."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The Src family of oncogenes, such as Src, Fyn, and Lyn, are involved in cellular signaling pathways but typically lead to enhanced cellular proliferation and survival, not cellular senescence.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-7b-chat-hf_response": "The ASPH (aspartate beta-hydroxylase) gene encodes several isoforms of the enzyme aspartate beta-hydroxylase, which is involved in the biosynthesis of the neurotransmitter serotonin. The different isoforms of the ASPH gene in humans are:\n1. ASPH: This is the full-length form of the enzyme, which is primarily expressed in the brain and plays a key role in the biosynthesis of serotonin.\n2. ASPH-B: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the liver.\n3. ASPH-C: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the kidneys.\n4. ASPH-D: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the pancreas.\n5. ASPH-E: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the testes.\n6. ASPH-F: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the ovaries.\n7. ASPH-G: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the adrenal glands.\n8. ASPH-H: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the heart.\n9. ASPH-I: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the skeletal muscles.\n10. ASPH-J: This isoform is produced through alternative splicing of the ASPH gene and is primarily expressed in the brain.\nEach of these isoforms has a distinct tissue distribution and function, and they may play different roles in the biosynthesis of serotonin and other neurotransmitters. Mutations in the ASPH gene have been associated with various neurological disorders, including autism spectrum disorder and bipolar disorder.",
    "llama-2-7b-chat-hf_fact": [
      "The ASPH gene encodes several isoforms of the enzyme aspartate beta-hydroxylase, which contributes to the biosynthesis of serotonin.",
      "Different isoforms of the ASPH gene are produced through alternative splicing and primarily expressed in different parts of the human body including the brain, liver, kidneys, pancreas, testes, ovaries, adrenal glands, heart, and skeletal muscles.",
      "Each isoform of the ASPH gene has a distinct tissue distribution and function.",
      "The ASPH gene and its isoforms contribute to the biosynthesis of not just serotonin, but also other neurotransmitters.",
      "Mutations in the ASPH gene have been associated with various neurological disorders, including autism spectrum disorder and bipolar disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The ASPH gene encodes the enzyme aspartate beta-hydroxylase, which contributes to the biosynthesis of proteins involved in the calcium-dependent signal transduction pathway, not serotonin.",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 310,
    "user_query": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"",
    "llama-2-7b-chat-hf_response": "across different samples?\nThe most common measures of differences between dinucleotide relative abundance \"genomic signatures\" across different samples are:\n1. Hierarchical clustering: This method groups samples based on their similarity in dinucleotide relative abundance profiles. Samples that are more similar in their dinucleotide profiles are grouped together, while samples that are more dissimilar are separated.\n2. Principal component analysis (PCA): This method projects the dinucleotide relative abundance data onto a lower-dimensional space, allowing for visualization of the similarities and differences between samples. The first principal component (PC1) captures the most variation in the data, while subsequent components (PC2, PC3, etc.) capture progressively less variation.\n3. Partial least squares-discriminant analysis (PLS-DA): This method uses a combination of PCA and linear discriminant analysis (LDA) to identify the most informative features (i.e., dinucleotides) that distinguish between samples. PLS-DA can be used to identify both continuous and categorical variables that are associated with specific sample groups.\n4. k-Nearest neighbors (k-NN): This method identifies the k most similar samples to a given sample based on their dinucleotide relative abundance profiles. The similarity between samples is typically measured using a distance metric, such as Euclidean distance or Jaccard similarity.\n5. Receiver operating characteristic (ROC) curve analysis: This method evaluates the ability of a genomic signature to distinguish between different sample groups. The ROC curve plots the true positive rate (sensitivity) against the false positive rate (1 - specificity) for different thresholds of the genomic signature.\n6. Random forest analysis: This method uses a machine learning algorithm to identify the most important features (i.e., dinucleotides) that distinguish between different sample groups. Random forest analysis can be used to identify both continuous and categorical variables that are associated with specific sample groups.\n7. Unsupervised machine learning methods: These methods use unsupervised learning algorithms, such as k-means clustering or hierarchical clustering, to identify patterns in the dinucleotide relative abundance data that are associated with specific sample groups.\n8. Supervised machine learning methods: These methods use supervised",
    "llama-2-7b-chat-hf_fact": [
      "Hierarchical clustering is a method that groups samples based on their similarity in dinucleotide relative abundance profiles.",
      "Principal component analysis (PCA) projects the dinucleotide relative abundance data onto a lower-dimensional space to visualize similarities and differences between samples.",
      "Partial least squares-discriminant analysis (PLS-DA) uses a combination of PCA and linear discriminant analysis (LDA) to identify the most informative features that distinguish between samples.",
      "k-Nearest neighbors (k-NN) identifies the k most similar samples to a given sample based on their dinucleotide relative abundance profiles.",
      "Receiver operating characteristic (ROC) curve analysis evaluates the ability of a genomic signature to distinguish between different sample groups."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 312,
    "user_query": "Why do we use \"N-terminal proteomics\"?",
    "llama-2-7b-chat-hf_response": "N-terminal proteomics is a type of proteomics that focuses on the analysis of the N-terminal region of proteins. The N-terminal region is the portion of a protein that is synthesized first during protein biosynthesis and is often rich in hydrophobic amino acids.\nThere are several reasons why N-terminal proteomics is useful:\n1. Protein identification: The N-terminal region of a protein is often highly conserved and can be used as a tag for protein identification. By analyzing the N-terminal region of proteins in a sample, researchers can identify the proteins present in the sample.\n2. Protein structure prediction: The N-terminal region of a protein can provide information about the protein's structure and function. By analyzing the N-terminal region of proteins, researchers can predict the protein's structure and function.\n3. Protein-protein interactions: The N-terminal region of a protein can interact with other proteins and play a role in protein-protein interactions. By analyzing the N-terminal region of proteins, researchers can understand how proteins interact with each other.\n4. Post-translational modifications: The N-terminal region of a protein can be modified after translation, such as by phosphorylation or glycosylation. By analyzing the N-terminal region of proteins, researchers can identify post-translational modifications and understand their role in protein function.\n5. Cancer research: The N-terminal region of proteins can be altered in cancer cells, leading to changes in protein function. By analyzing the N-terminal region of proteins in cancer cells, researchers can identify potential biomarkers for cancer diagnosis and treatment.\n6. Neurodegenerative diseases: The N-terminal region of proteins can be altered in neurodegenerative diseases such as Alzheimer's and Parkinson's. By analyzing the N-terminal region of proteins in these diseases, researchers can identify potential biomarkers for diagnosis and treatment.\n7. Drug discovery: The N-terminal region of proteins can be targeted by drugs, leading to changes in protein function. By analyzing the N-terminal region",
    "llama-2-7b-chat-hf_fact": [
      "N-terminal proteomics focuses on the analysis of the N-terminal region of proteins, which is synthesized first during protein biosynthesis.",
      "The N-terminal region of a protein is often rich in hydrophobic amino acids.",
      "Protein-protein interactions can involve the N-terminal region of a protein.",
      "The N-terminal region of a protein can be modified after translation by processes like phosphorylation or glycosylation.",
      "The N-terminal region of proteins can be altered in neurodegenerative diseases such as Alzheimer's and Parkinson's."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The N-terminal region of a protein is often not specifically rich in hydrophobic amino acids; its composition can vary greatly depending on the specific protein.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 317,
    "user_query": "Have mutations in the Polycomb group been found in human diseases?",
    "llama-2-7b-chat-hf_response": "A: Yes, mutations in the Polycomb group (PcG) genes have been found to be associated with several human diseases, including cancer, developmental disorders, and neurological disorders. Here are some examples:\n1. Cancer: Mutations in the PcG genes have been found to be associated with various types of cancer, including breast cancer, ovarian cancer, and leukemia. For example, mutations in the PcG gene EZH2 have been found to be associated with breast cancer, and mutations in the PcG gene SUZ12 have been found to be associated with leukemia.\n2. Developmental disorders: Mutations in the PcG genes have been found to be associated with several developmental disorders, including Rett syndrome, which is a neurodevelopmental disorder that affects girls almost exclusively. Mutations in the PcG gene MECP2, which encodes the protein MeCP2, have been found to be associated with Rett syndrome.\n3. Neurological disorders: Mutations in the PcG genes have been found to be associated with several neurological disorders, including neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. For example, mutations in the PcG gene EZH2 have been found to be associated with Alzheimer's disease, and mutations in the PcG gene SUZ12 have been found to be associated with Parkinson's disease.\n4. Autism spectrum disorder: Mutations in the PcG genes have been found to be associated with autism spectrum disorder (ASD). For example, mutations in the PcG gene EZH2 have been found to be associated with ASD, and mutations in the PcG gene SUZ12 have been found to be associated with ASD.\n5. Intellectual disability: Mutations in the PcG genes have been found to be associated with intellectual disability. For example, mutations in the PcG gene MECP2 have been found to be associated with intellectual disability, and mutations in the PcG gene EZH2 have been found to be associated with intellectual disability.\nOverall, these findings suggest that the Polycomb",
    "llama-2-7b-chat-hf_fact": [
      "Mutations in the Polycomb group (PcG) genes have been identified in several human diseases.",
      "PcG gene mutations have been found in certain types of cancer such as breast cancer, ovarian cancer, and leukemia.",
      "Developmental disorders, such as Rett syndrome, have been associated with mutations in the PcG genes.",
      "Certain neurological disorders, including Alzheimer's disease and Parkinson's disease, have been associated with mutations in the PcG genes.",
      "Mutations in the PcG genes have been found to be associated with autism spectrum disorder and intellectual disability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 318,
    "user_query": "Describe the mechanism of action of drisapersen",
    "llama-2-7b-chat-hf_response": ", a drug used to treat Duchenne muscular dystrophy.\nDuchenne muscular dystrophy (DMD) is a genetic disorder caused by mutations in the dystrophin gene. Drisapersen is a drug that has been developed to treat DMD by increasing the production of dystrophin.\nThe mechanism of action of drisapersen involves the inhibition of the mRNA degradation pathway, which leads to an increase in the levels of dystrophin mRNA in muscle cells. Drisapersen works by binding to the 3' untranslated region (UTR) of the dystrophin mRNA and preventing the degradation of the mRNA by the cellular machinery. This leads to an increase in the levels of dystrophin protein in the muscles, which can help to improve muscle function and reduce muscle degeneration.\nDrisapersen is taken up into muscle cells through a process called endocytosis, and once inside the cell, it binds to the dystrophin mRNA and prevents its degradation. This leads to an increase in the levels of dystrophin mRNA, which is then translated into dystrophin protein. The increased levels of dystrophin protein can help to improve muscle function and reduce muscle degeneration by stabilizing the muscle membrane and promoting the proper functioning of the muscle fibers.\nIn addition to increasing dystrophin production, drisapersen has also been shown to reduce the levels of pro-inflammatory cytokines in the muscles of DMD patients. Pro-inflammatory cytokines are molecules that promote inflammation and muscle damage, and their reduction can help to reduce muscle degeneration and improve muscle function.\nOverall, the mechanism of action of drisapersen is to increase the production of dystrophin protein in muscle cells, which can help to improve muscle function and reduce muscle degeneration in patients with DMD.",
    "llama-2-7b-chat-hf_fact": [
      "Duchenne muscular dystrophy (DMD) is a genetic disorder caused by mutations in the dystrophin gene.",
      "Drisapersen is a drug that has been developed to treat DMD by increasing the production of dystrophin.",
      "The mechanism of action of drisapersen involves the inhibition of the mRNA degradation pathway.",
      "Drisapersen works by binding to the 3' untranslated region (UTR) of the dystrophin mRNA and preventing its degradation.",
      "Drisapersen has been shown to reduce the levels of pro-inflammatory cytokines in the muscles of DMD patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The mechanism of action of drisapersen involves modifying the splicing of the messenger RNA (mRNA) during protein synthesis, not the inhibition of the mRNA degradation pathway.",
      "false, [corrected fact]: Drisapersen works by binding to the exon 51 of the dystrophin gene, inducing skipping of this exon during mRNA processing.",
      "unknown"
    ]
  },
  {
    "id": 325,
    "user_query": "How does ranolazine affect calcium handling in the heart",
    "llama-2-7b-chat-hf_response": "?\nRanolazine is a medication used to treat angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart muscle. While its mechanism of action is not fully understood, studies have shown that ranolazine can affect calcium handling in the heart, which may contribute to its therapeutic effects.\nCalcium is an essential ion that plays a critical role in the functioning of the heart. It is involved in the contraction and relaxation of the heart muscle, and abnormalities in calcium handling can lead to various cardiac arrhythmias and diseases. Ranolazine has been shown to increase the amount of calcium available for muscle contraction in the heart, which may help to improve cardiac function in patients with angina pectoris.\nOne study published in the Journal of the American College of Cardiology found that ranolazine increased the amount of calcium available for muscle contraction in the heart by inhibiting the activity of a protein called the ryanodine receptor. This protein is involved in the release of calcium from the sarcoplasmic reticulum, a specialized organelle in the heart muscle that stores calcium. By inhibiting the activity of the ryanodine receptor, ranolazine increases the amount of calcium available for muscle contraction, which may help to improve cardiac function in patients with angina pectoris.\nAnother study published in the European Heart Journal found that ranolazine improved cardiac function in patients with chronic heart failure by increasing the amount of calcium available for muscle contraction. The study found that ranolazine increased the amount of calcium available for muscle contraction by reducing the activity of the ryanodine receptor, which is also involved in the release of calcium from the sarcoplasmic reticulum.\nOverall, these studies suggest that ranolazine may affect calcium handling in the heart by increasing the amount of calcium available for muscle contraction. This may contribute to its therapeutic effects in treating angina pectoris and other cardiac conditions. However, further research is needed to fully understand the mechanisms by which ranolazine affects calcium handling in the heart.",
    "llama-2-7b-chat-hf_fact": [
      "Ranolazine is a medication used for the treatment of angina pectoris.",
      "Calcium plays a critical role in the contraction and relaxation of the heart muscle.",
      "Ranolazine has been shown to increase the amount of calcium available for muscle contraction in the heart.",
      "The Journal of the American College of Cardiology published a study showing that ranolazine inhibited the activity of the ryanodine receptor, increasing the amount of calcium for heart muscle contraction.",
      "The European Heart Journal published a study showcasing that ranolazine improved cardiac function in chronic heart failure patients by increasing the amount of calcium for muscle contraction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Ranolazine has been shown to decrease the amount of calcium available for muscle contraction in the heart.",
      "true",
      "false, [corrected fact]: The European Heart Journal published a study showcasing that ranolazine improved cardiac function in chronic heart failure patients by decreasing the amount of calcium for muscle contraction."
    ]
  },
  {
    "id": 326,
    "user_query": "Which is the primary distinction between the Reverse Warburg effect and the conventional Warburg effect?",
    "llama-2-7b-chat-hf_response": "A) The Reverse Warburg effect involves the uptake of glucose by cancer cells, whereas the conventional Warburg effect involves the breakdown of glucose.\nB) The Reverse Warburg effect occurs in the presence of oxygen, whereas the conventional Warburg effect occurs in the absence of oxygen.\nC) The Reverse Warburg effect involves the production of ATP through oxidative phosphorylation, whereas the conventional Warburg effect involves the production of ATP through glycolysis.\nD) The Reverse Warburg effect occurs in healthy tissues, whereas the conventional Warburg effect occurs in cancer cells.\nE) The Reverse Warburg effect is a more aggressive form of cancer metabolism than the conventional Warburg effect.\nThe correct answer is (A): The Reverse Warburg effect involves the uptake of glucose by cancer cells, whereas the conventional Warburg effect involves the breakdown of glucose.\nThe Reverse Warburg effect is a recently discovered phenomenon in which cancer cells take up glucose from the bloodstream and convert it into fatty acids and other lipids, rather than breaking it down to produce ATP through glycolysis. This is in contrast to the conventional Warburg effect, which is a hallmark of cancer metabolism and involves the breakdown of glucose to produce ATP through glycolysis, even in the presence of oxygen.",
    "llama-2-7b-chat-hf_fact": [
      "The Reverse Warburg effect involves the uptake of glucose by cancer cells.",
      "The conventional Warburg effect involves the breakdown of glucose.",
      "The Reverse Warburg effect results in the conversion of glucose into fatty acids and other lipids.",
      "The Reverse Warburg effect is a recently discovered phenomenon.",
      "The conventional Warburg effect is a hallmark of cancer metabolism and involves the production of ATP through glycolysis, even in the presence of oxygen."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Reverse Warburg effect involves the uptake of glucose by cancer-associated fibroblast cells, not by cancer cells themselves.",
      "true",
      "false, [corrected fact]: The Reverse Warburg effect results in the conversion of glucose into lactate.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 327,
    "user_query": "What is the role of per genes in circadian rhythm control?",
    "llama-2-7b-chat-hf_response": "Per genes are a group of transcription factors that play a crucial role in regulating the expression of clock genes and other genes involved in circadian rhythm control. The per gene family consists of three members: Per1, Per2, and Per3. These genes were first identified in Drosophila melanogaster (the fruit fly) and were later found to be conserved in mammals, including humans.\nThe per genes act as transcriptional regulators, meaning they control the expression of other genes by binding to specific DNA sequences. In the context of circadian rhythm control, the per genes regulate the expression of clock genes, such as Bmal1 and Cry1, which are essential for maintaining the circadian rhythm. The per genes also regulate the expression of other genes involved in circadian rhythm control, including genes involved in the regulation of sleep-wake cycles, hormone secretion, and metabolism.\nThe per genes are expressed in a circadian manner, with high levels of expression observed during the subjective day and low levels during the subjective night. This circadian expression pattern is thought to be mediated by the interaction of the per genes with other clock genes and regulatory elements in the genome.\nMutations in the per genes have been associated with circadian rhythm disorders, such as advanced sleep-wake phase disorder and delayed sleep-wake phase disorder. These disorders are characterized by abnormalities in the timing of sleep and wakefulness, which can have significant impacts on an individual's quality of life and overall health.\nIn summary, the per genes play a critical role in regulating the expression of clock genes and other genes involved in circadian rhythm control. Their circadian expression pattern and regulatory function are essential for maintaining the proper timing of physiological processes and ensuring proper sleep-wake cycles.",
    "llama-2-7b-chat-hf_fact": [
      "Per genes are transcription factors that regulate the expression of clock genes and other genes involved in circadian rhythm control.",
      "The per gene family consists of three members: Per1, Per2, and Per3.",
      "These genes were first identified in Drosophila melanogaster, but are also found in mammals, including humans.",
      "Mutations in the per genes have been linked with circadian rhythm disorders such as advanced sleep-wake phase disorder and delayed sleep-wake phase disorder.",
      "Per genes are expressed in a circadian manner, with high levels observed during the subjective day and low levels during the subjective night."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Per genes are not transcription factors but they are involved in regulation of circadian rhythms.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-7b-chat-hf_response": "Empagliflozin (Jardiance) was approved by the US Food and Drug Administration (FDA) in 2014 for the treatment of type 2 diabetes. It was approved for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "Empagliflozin, also known as Jardiance, was approved by the US Food and Drug Administration in 2014.",
      "The purpose of Empagliflozin approval is for the treatment of type 2 diabetes.",
      "Empagliflozin usage is approved as an adjunct to diet and exercise to improve glycemic control.",
      "Empagliflozin is intended for use in adults with type 2 diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 331,
    "user_query": "Which R/bioconductor package is used for integrative genomics visualizations?",
    "llama-2-7b-chat-hf_response": "There are several R packages that can be used for integrative genomics visualizations, including:\n1. Integrative Genomics Viewer (IGV): IGV is a popular open-source package for visualizing and analyzing large-scale genomic data sets, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n2. Genomic Visualization Toolkit (GVTK): GVTK is an open-source package for visualizing and analyzing large-scale genomic data sets, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n3. Circos: Circos is a package for visualizing genomic data in a circular layout, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n4. UCSC Genome Browser: The UCSC Genome Browser is a web-based tool for visualizing and analyzing genomic data, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n5. Ensembl Genome Browser: The Ensembl Genome Browser is a web-based tool for visualizing and analyzing genomic data, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n6. HISAT2: HISAT2 is a spliced aligner that can be used for integrative genomics visualizations, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n7. STAR: STAR is a spliced aligner that can be used for integrative genomics visualizations, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n8. TopHat: TopHat is a spliced aligner that can be used for integrative genomics visualizations, including mRNA expression, miRNA expression, DNA methylation, and genome-wide association studies.\n9. Cufflinks: Cufflinks is a package for quantifying gene expression from RNA-seq data, and can be used for integrative genomics visualizations, including mRNA",
    "llama-2-7b-chat-hf_fact": [
      "Integrative Genomics Viewer (IGV) is an open-source package used for visualizing and analyzing large-scale genomic data sets.",
      "Genomic Visualization Toolkit (GVTK) is another open-source package for visualizing and analyzing large-scale genomic data sets.",
      "Circos is a package for visualizing genomic data in a circular layout.",
      "UCSC Genome Browser is a web-based tool used for visualizing and analyzing genomic data.",
      "Ensembl Genome Browser is another web-based tool used for visualizing and analyzing genomic data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 333,
    "user_query": "How many genes are imprinted in the human genome?",
    "llama-2-7b-chat-hf_response": "Imprinted genes are genes that have a differentially methylated region (DMR) at their promoter region, which leads to differential expression of the gene depending on the methylation status of the DMR. The number of imprinted genes in the human genome is not well established, but it is estimated to be around 100-200.",
    "llama-2-7b-chat-hf_fact": [
      "Imprinted genes have a differentially methylated region (DMR) at their promoter region.",
      "The expression of imprinted genes depends on the methylation status of the DMR.",
      "The exact number of imprinted genes in the human genome is not well established.",
      "It is estimated that there are around 100-200 imprinted genes in the human genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 336,
    "user_query": "In which cells are A-type lamins expressed?",
    "llama-2-7b-chat-hf_response": "A-type lamins are expressed in the nucleus of eukaryotic cells, specifically in the nuclear lamina, which is a network of filaments that provides structural support to the nucleus. A-type lamins are also expressed in the cytoplasm, but at much lower levels than in the nucleus.",
    "llama-2-7b-chat-hf_fact": [
      "A-type lamins are expressed in eukaryotic cells.",
      "A-type lamins are present in the nucleus of these cells.",
      "They are specifically located in the nuclear lamina.",
      "The nuclear lamina is a network of filaments that provides structural support to the nucleus.",
      "A-type lamins are also found in the cytoplasm, but at lower levels than in the nucleus."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 338,
    "user_query": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?",
    "llama-2-7b-chat-hf_response": "RNA interference (RNAi) is a mechanism of gene silencing that occurs in eukaryotic organisms, including animals, plants, and fungi. In eukaryotic cells, RNAi works by degrading specific messenger RNA (mRNA) molecules, which are responsible for carrying genetic information from DNA to the ribosome for protein synthesis. This leads to a decrease in the levels of the corresponding protein.\nIn prokaryotic organisms, such as bacteria, there is an analogous process called \"RNA interference-like\" (RNAi-like) mechanisms. These mechanisms involve the degradation of specific mRNA molecules through a process that is similar to RNAi in eukaryotic cells. However, the mechanisms underlying RNAi-like processes in prokaryotes are different from those of RNAi in eukaryotes.\nOne of the main differences between RNAi in eukaryotes and RNAi-like mechanisms in prokaryotes is the type of RNA molecule involved. In eukaryotes, RNAi involves the degradation of specific mRNA molecules, while in prokaryotes, RNAi-like mechanisms involve the degradation of small RNA molecules called \"small RNAs\" (sRNAs). These sRNAs are typically 20-30 nucleotides in length and are derived from longer precursor molecules.\nAnother difference between RNAi in eukaryotes and RNAi-like mechanisms in prokaryotes is the location of the RNA degradation. In eukaryotes, RNAi occurs primarily in the cytoplasm, while in prokaryotes, RNAi-like mechanisms occur primarily in the cytoplasm and nucleus.\nOverall, while RNAi and RNAi-like mechanisms share some similarities, they are distinct processes that occur in different cellular compartments and involve different types of RNA molecules.",
    "llama-2-7b-chat-hf_fact": [
      "RNA interference (RNAi) is a mechanism of gene silencing that occurs in eukaryotic organisms.",
      "RNAi works by degrading specific messenger RNA (mRNA) molecules in eukaryotic cells, which carries genetic information from DNA to the ribosome for protein synthesis.",
      "In prokaryotic organisms such as bacteria, a process similar to RNAi is referred to as \"RNA interference-like\" (RNAi-like) mechanisms.",
      "RNAi-like mechanisms in prokaryotes involve degradation of small RNA molecules called \"small RNAs\" (sRNAs), which are typically 20-30 nucleotides in length.",
      "In eukaryotes, RNAi occurs primarily in the cytoplasm, while in prokaryotes, RNAi-like mechanisms occur primarily in the cytoplasm and nucleus."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Prokaryotic organisms such as bacteria do not have a nucleus and, therefore, do not have mechanisms exactly similar to RNA interference.",
      "true",
      "false, [corrected fact]: In prokaryotes, RNAi-like mechanisms can only occur in the cytoplasm because prokaryotic cells lack a nucleus."
    ]
  },
  {
    "id": 339,
    "user_query": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?",
    "llama-2-7b-chat-hf_response": "Mutational biases are introduced due to directional mutation pressure when the mutation rate is higher in one direction than in the other. This can occur due to various factors, including:\n1. Temperature: Higher temperatures can increase the mutation rate, leading to directional mutation pressure. For example, bacteria that live in hot springs or volcanic regions may have a higher mutation rate than those that live in cooler environments.\n2. Radiation: Exposure to ionizing radiation, such as ultraviolet light or X-rays, can increase the mutation rate and lead to directional mutation pressure. This is because ionizing radiation can break DNA molecules, leading to mutations.\n3. Reactive oxygen species (ROS): ROS, such as hydrogen peroxide, can damage DNA and lead to mutations. This can occur in response to environmental stress, such as exposure to pollutants or cigarette smoke.\n4. Methylation: DNA methylation is a process by which methyl groups are added to DNA molecules. Methylation can affect the mutation rate, leading to directional mutation pressure. For example, methylation of certain genes can reduce the mutation rate in those genes, leading to directional mutation pressure in other genes.\n5. Replication timing: The timing of DNA replication can affect the mutation rate, leading to directional mutation pressure. For example, genes that are replicated later in the cell cycle may have a higher mutation rate than those that are replicated earlier, leading to directional mutation pressure.",
    "llama-2-7b-chat-hf_fact": [
      "Higher temperatures can increase the mutation rate, potentially creating mutational bias in organisms such as bacteria living in hot springs or volcanic regions.",
      "Exposure to ionizing radiation like ultraviolet light or X-rays can increase the mutation rate, contributing to directional mutation pressure.",
      "Reactive oxygen species, such as hydrogen peroxide, can damage DNA and lead to mutations, a process that can be influenced by environmental stressors like pollutants or cigarette smoke.",
      "DNA methylation, the addition of methyl groups to DNA molecules, can influence the mutation rate and cause directional mutation pressure.",
      "The timing of DNA replication can impact the mutation rate, potentially leading to directional mutation pressure, with genes replicated later in the cell cycle possibly having a higher mutation rate."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 340,
    "user_query": "Is it feasible to determine the complete proteome of yeast?",
    "llama-2-7b-chat-hf_response": "Yes, it is feasible to determine the complete proteome of yeast. In fact, the complete proteome of Saccharomyces cerevisiae (baker's yeast) has been determined using a combination of proteomics techniques, including mass spectrometry and two-dimensional gel electrophoresis.\nThe complete proteome of yeast consists of approximately 6,000 proteins, including both soluble and membrane-bound proteins. These proteins are involved in a wide range of cellular processes, including metabolism, signaling, transport, and protein synthesis.\nTo determine the complete proteome of yeast, researchers have used a variety of techniques, including:\n1. Mass spectrometry: This technique involves breaking open cells and isolating proteins, which are then digested with enzymes and analyzed using mass spectrometry. This allows researchers to identify and quantify individual proteins based on their mass-to-charge ratio.\n2. Two-dimensional gel electrophoresis: This technique involves separating proteins based on their size and charge using a gel matrix. Proteins are first separated by size in the first dimension, and then separated by charge in the second dimension.\n3. Protein microarrays: This technique involves printing thousands of protein samples onto a glass slide, which is then probed with labeled antibodies to detect specific proteins.\n4. RNA sequencing: This technique involves sequencing the RNA molecules in a cell, which can provide information on the abundance of different mRNAs and the translation of those mRNAs into proteins.\n5. Protein-protein interaction assays: This technique involves studying the interactions between different proteins in a cell, which can provide information on the function of individual proteins and their interactions with other proteins.\n6. Post-translational modification (PTM) analysis: This technique involves studying the modifications that occur to proteins after they are synthesized, such as phosphorylation, glycosylation, and ubiquitination.\n7. Protein structure prediction: This technique involves using computational methods to predict the three-dimensional structure of proteins, which can provide information on their function and interactions with other molecules.\nBy combining these techniques, researchers have been able to determine the complete proteome of yeast and gain",
    "llama-2-7b-chat-hf_fact": [
      "The complete proteome of Saccharomyces cerevisiae (baker's yeast) has been determined.",
      "The proteome of yeast includes approximately 6,000 proteins.",
      "Proteomic techniques used to determine the complete proteome of yeast include mass spectrometry, two-dimensional gel electrophoresis, protein microarrays, RNA sequencing, protein-protein interaction assays, post-translational modification analysis, and protein structure prediction.",
      "Mass spectrometry in proteomics involves breaking open cells and isolating proteins, which are then digested with enzymes and analyzed to identify and quantify individual proteins based on their mass-to-charge ratio.",
      "Two-dimensional gel electrophoresis separates proteins based on their size and charge using a gel matrix."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 346,
    "user_query": "Which is the most common cause of sudden cardiac death in young athletes?",
    "llama-2-7b-chat-hf_response": "A. Hypertrophic cardiomyopathy\nB. Arrhythmogenic right ventricular cardiomyopathy\nC. Coronary artery disease\nD. Congenital heart disease\nE. Marfan syndrome\nThe correct answer is B: Arrhythmogenic right ventricular cardiomyopathy.\nArrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder that affects the heart muscle and can lead to sudden cardiac death in young athletes. It is characterized by abnormal electrical activity in the right ventricle of the heart, which can cause irregular heartbeats and potentially lead to sudden death.\nHypertrophic cardiomyopathy (A) is a common cause of sudden cardiac death in young athletes, but it is not the most common cause. Coronary artery disease (C) is also a potential cause of sudden cardiac death in young athletes, but it is less common than ARVC. Congenital heart disease (D) is a rare cause of sudden cardiac death in young athletes. Marfan syndrome (E) is a genetic disorder that can affect the heart and can increase the risk of sudden cardiac death, but it is not the most common cause.\nIt is important for young athletes to undergo regular cardiac screenings to detect any potential heart problems and prevent sudden cardiac death.",
    "llama-2-7b-chat-hf_fact": [
      "The most common cause of sudden cardiac death in young athletes is Arrhythmogenic right ventricular cardiomyopathy.",
      "Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder that affects the heart muscle.",
      "The disorder is characterized by abnormal electrical activity in the right ventricle of the heart, which can cause irregular heartbeats and potentially lead to sudden death.",
      "Hypertrophic cardiomyopathy is a common cause of sudden cardiac death in young athletes, but not the most common.",
      "Marfan syndrome is a genetic disorder that can affect the heart and increase the risk of sudden cardiac death, but it is not the most common cause."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young athletes, not Arrhythmogenic right ventricular cardiomyopathy.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 347,
    "user_query": "Could the Menzerath-Altmann law be proved mathematically trivial in genomes?",
    "llama-2-7b-chat-hf_response": "The Menzerath-Altmann law is a statistical law that relates the distribution of the number of repeats in a genomic region to the size of the region. It states that the number of repeats follows a power-law distribution with an exponent that decreases as the size of the region increases.\nWhile the Menzerath-Altmann law has been observed in many genomes, it is not clear whether it can be proved mathematically in all genomes. In this answer, I will explain why the Menzerath-Altmann law might be proved mathematically trivial in some genomes.\nFirst, let's define the Menzerath-Altmann law mathematically. Let $n$ be the number of repeats in a genomic region of size $L$. The Menzerath-Altmann law states that the probability distribution of $n$ follows a power law with an exponent that decreases as $L$ increases:\n$$P(n) \\propto n^{-(1+1/L)}$$\nThis means that the distribution of repeats becomes more uniform as the size of the genomic region increases.\nNow, let's consider why the Menzerath-Altmann law might be proved mathematically trivial in some genomes. One reason is that the law is based on the assumption that the repeats are randomly distributed in the genomic region. However, in some genomes, the repeats may not be randomly distributed, but instead, they may be clustered or biased towards certain regions. In such cases, the Menzerath-Altmann law may not hold, and the distribution of repeats may be different from what is predicted by the law.\nAnother reason why the Menzerath-Altmann law might be proved mathematically trivial in some genomes is that it is based on a simplifying assumption that the genomic region is large compared to the repeat length. However, in some genomes, the repeat length may be longer than the size of the genomic region, and in such cases, the Menzerath-Altmann law may not be applicable.\nFinally, it is also possible that the Menzerath-Altmann law may not hold in all genomes because it is a statistical law that is based on the average behavior of repeats in a large number of genomes. However, each genome may have its unique properties that can lead to deviations from the Menzerath-Altmann",
    "llama-2-7b-chat-hf_fact": [
      "The Menzerath-Altmann law is a statistical law that connects the number of repeats in a genomic region to the size of the region.",
      "This law indicates that the number of repeats abides by a power-law distribution, with an exponent that decreases as the size of the region increases.",
      "The Menzerath-Altmann law might be considered mathematically insignificant in some genomes due to the assumption that the repeats are randomly spread in the genomic region.",
      "The law may also lose validity if the repeat length is longer than the size of the genomic region.",
      "The Menzerath-Altmann law is a statistical law based on the average behavior of repeats in a large number of genomes, which means individual genomes can show deviations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Menzerath-Altmann law is a linguistic law that states the larger a linguistic construct, the smaller its constituents.",
      "false, [corrected fact]: This law typically implies a decrease in the size of constituents as the size of the whole increases, rather than a power-law distribution linked to number of repeats.",
      "unknown",
      "unknown",
      "false, [corrected fact]: The Menzerath-Altmann law pertains to language structure, not the behavior of repeats in genomes. Moreover, it does not imply that individual instances cannot deviate from the overall trend."
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-7b-chat-hf_response": "Loss of the protein Lon1 in the plant Arabidopsis has been shown to have several consequences, including:\n1. Increased sensitivity to oxidative stress: Lon1 is involved in the repair of DNA damage caused by reactive oxygen species (ROS), and loss of Lon1 leads to increased sensitivity to oxidative stress.\n2. Altered cell wall structure and function: Lon1 is involved in the biosynthesis of cell wall components, and loss of Lon1 leads to changes in cell wall structure and function.\n3. Impaired plant growth and development: Loss of Lon1 leads to impaired plant growth and development, including reduced stem elongation and leaf size.\n4. Increased susceptibility to pathogens: Lon1 is involved in the immune response, and loss of Lon1 leads to increased susceptibility to pathogens.\n5. Altered hormone signaling: Lon1 is involved in the regulation of hormone signaling, and loss of Lon1 leads to changes in hormone signaling that can affect plant growth and development.\n6. Changes in gene expression: Lon1 is involved in the regulation of gene expression, and loss of Lon1 leads to changes in gene expression that can affect plant growth and development.\n7. Increased ROS production: Lon1 is involved in the regulation of ROS production, and loss of Lon1 leads to increased ROS production, which can damage cellular components and lead to oxidative stress.\n8. Increased DNA damage: Lon1 is involved in the repair of DNA damage, and loss of Lon1 leads to increased DNA damage, which can affect plant growth and development.\n9. Increased apoptosis: Lon1 is involved in the regulation of programmed cell death (apoptosis), and loss of Lon1 leads to increased apoptosis, which can affect plant growth and development.\n10. Changes in the redox state of the cell: Lon1 is involved in the regulation of the redox state of the cell, and loss of Lon1 leads to changes in the redox state of the cell, which can affect plant growth and development.\nOverall, the loss of Lon1 in Arabidopsis has significant",
    "llama-2-7b-chat-hf_fact": [
      "The protein Lon1 in Arabidopsis helps repair DNA damage caused by reactive oxygen species (ROS).",
      "Loss of the protein Lon1 in Arabidopsis increases the plant's sensitivity to oxidative stress.",
      "Lon1 is involved in the biosynthesis of cell wall components in Arabidopsis.",
      "Deprivation of the protein Lon1 can lead to impaired plant growth and development.",
      "Loss of Lon1 in Arabidopsis results in an increased susceptibility to pathogens."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 352,
    "user_query": "Are there studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and cadasil syndrome?",
    "llama-2-7b-chat-hf_response": "Notch is a transmembrane receptor that plays a crucial role in the regulation of cell fate decisions, including cell proliferation, differentiation, and survival. Mutations in the Notch gene have been associated with various neurodegenerative diseases, including Down syndrome, Pick's disease, Prion's disease, and cadasil syndrome. Here are some studies that have investigated the involvement of Notch mutations in these diseases:\n1. Down syndrome:\nDown syndrome is a genetic disorder caused by an extra copy of chromosome 21. Notch mutations have been identified in individuals with Down syndrome, and these mutations have been linked to the development of Alzheimer's disease and other neurodegenerative disorders. For example, a study published in the journal Nature Medicine in 2013 found that individuals with Down syndrome have a higher frequency of Notch1 mutations compared to the general population, and that these mutations are associated with an increased risk of Alzheimer's disease.\n2. Pick's disease:\nPick's disease is a rare neurodegenerative disorder characterized by progressive dementia, cognitive decline, and motor dysfunction. Notch mutations have been identified in individuals with Pick's disease, and these mutations have been linked to the pathogenesis of the disease. For example, a study published in the journal Neurobiology of Aging in 2017 found that individuals with Pick's disease have a higher frequency of Notch3 mutations compared to healthy controls, and that these mutations are associated with an increased risk of cognitive decline.\n3. Prion's disease:\nPrion's disease is a rare and fatal neurodegenerative disorder caused by the misfolding of the prion protein. Notch mutations have been identified in individuals with Prion's disease, and these mutations have been linked to the pathogenesis of the disease. For example, a study published in the journal Science in 2013 found that individuals with Prion's disease have a higher frequency of Notch1 mutations compared to healthy controls, and that these mutations are associated with an increased risk of disease progression.\n4. Cadasil syndrome:\nC",
    "llama-2-7b-chat-hf_fact": [
      "Notch is a transmembrane receptor that regulates cell fate decisions, including cell proliferation, differentiation, and survival.",
      "Mutations in the Notch gene are associated with various neurodegenerative diseases, including Down syndrome, Pick's disease, Prion's disease, and cadasil syndrome.",
      "Down syndrome is a genetic disorder caused by an extra copy of chromosome 21.",
      "Prion's disease is a neurodegenerative disorder caused by the misfolding of the prion protein.",
      "Pick's disease is a neurodegenerative disorder characterized by progressive dementia, cognitive decline, and motor dysfunction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mutations in the Notch gene are associated with certain types of cancer and a genetic disorder known as Alagille syndrome but the other mentioned conditions are not directly associated with Notch gene mutations.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 353,
    "user_query": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog?",
    "llama-2-7b-chat-hf_response": "Mfd (Mitochondrial fission protein 1) and CSB (Cocaine syndrome protein B) are both homologous proteins that play important roles in regulating mitochondrial dynamics. While they share some similarities, there are also some functional differences between the two proteins.\n1. Subcellular localization: Mfd is primarily localized to the mitochondria, while CSB is localized to both the mitochondria and the cytosol.\n2. Function in mitochondrial dynamics: Mfd is primarily involved in mitochondrial fission, while CSB is involved in both mitochondrial fission and fusion.\n3. Interaction with other proteins: Mfd interacts with the Fis1 protein, which is involved in mitochondrial fission, while CSB interacts with the Opa1 protein, which is involved in mitochondrial fusion.\n4. Regulation of mitochondrial morphology: Mfd regulates mitochondrial morphology by promoting fission, while CSB regulates mitochondrial morphology by promoting fusion.\n5. Response to stress: Mfd is involved in the response to oxidative stress, while CSB is involved in the response to endoplasmic reticulum (ER) stress.\n6. Disease association: Mfd has been implicated in a variety of diseases, including neurodegenerative disorders and cancer, while CSB has been implicated in a variety of diseases, including cocaine addiction and neurodegenerative disorders.\nIn summary, while Mfd and CSB share some similarities, there are also some functional differences between the two proteins. Mfd is primarily involved in mitochondrial fission, while CSB is involved in both mitochondrial fission and fusion. Mfd regulates mitochondrial morphology by promoting fission, while CSB regulates mitochondrial morphology by promoting fusion. Additionally, Mfd is involved in the response to oxidative stress, while CSB is involved in the response to ER stress.",
    "llama-2-7b-chat-hf_fact": [
      "Mfd (Mitochondrial fission protein 1) and CSB (Cocaine syndrome protein B) are homologous proteins that play roles in regulating mitochondrial dynamics.",
      "Mfd is primarily localized to the mitochondria, while CSB can be found in both the mitochondria and the cytosol.",
      "Mfd interacts with the Fis1 protein, which is involved in mitochondrial fission, and CSB interacts with the Opa1 protein, which is involved in mitochondrial fusion.",
      "Mfd regulates mitochondrial morphology by promoting fission, while CSB regulates mitochondrial morphology by promoting fusion.",
      "Mfd is involved in the response to oxidative stress, while CSB is involved in responding to endoplasmic reticulum (ER) stress."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 354,
    "user_query": "What is membrane scission?",
    "llama-2-7b-chat-hf_response": "Membrane scission is a process by which a cell membrane is split or broken, leading to the release of cellular contents into the surrounding environment. This process can occur in response to various stimuli, including mechanical stress, changes in temperature, or exposure to chemicals.\nThere are several types of membrane scission, including:\n1. Fatty acid-mediated scission: This type of scission occurs when fatty acids are introduced into the cell membrane and cause it to break apart.\n2. Cholesterol-mediated scission: This type of scission occurs when cholesterol molecules are introduced into the cell membrane and cause it to break apart.\n3. pH-mediated scission: This type of scission occurs when the pH of the surrounding environment changes, causing the cell membrane to break apart.\n4. Temperature-mediated scission: This type of scission occurs when the temperature of the surrounding environment changes, causing the cell membrane to break apart.\n5. Oxidative stress-mediated scission: This type of scission occurs when the cell is exposed to high levels of reactive oxygen species (ROS), which can damage the cell membrane and cause it to break apart.\nMembrane scission can play a role in various cellular processes, including:\n1. Cell signaling: Membrane scission can be involved in the release of signaling molecules, such as hormones or neurotransmitters, which can transmit signals to other cells.\n2. Cell adhesion: Membrane scission can affect the adhesion of cells to each other or to the extracellular matrix, leading to changes in tissue structure and function.\n3. Cell death: Membrane scission can lead to the death of cells, either through direct damage to the cell membrane or through the release of cellular contents that are toxic to surrounding cells.\n4. Inflammation: Membrane scission can contribute to the inflammatory response by releasing pro-inflammatory molecules into the surrounding environment.\n5. Cancer: Membrane scission has been implicated in the development and progression of cancer, as it can contribute to the release of oncogenic molecules and the disruption of cellular adhesion and signaling",
    "llama-2-7b-chat-hf_fact": [
      "Membrane scission is a process by which a cell membrane is split or broken, leading to the release of cellular contents into the surrounding environment.",
      "Fatty acid-mediated scission, cholesterol-mediated scission, pH-mediated scission, temperature-mediated scission, and oxidative stress-mediated scission are types of membrane scission.",
      "Membrane scission can be involved in the release of signaling molecules, such as hormones or neurotransmitters.",
      "Membrane scission can affect the adhesion of cells to each other or to the extracellular matrix.",
      "Membrane scission has been implicated in the development and progression of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Membrane scission is a process by which a vesicle or a part of the cell membrane is pinched off, leading to the formation of separate compartments, not the release of cellular contents into the surrounding environment.",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 356,
    "user_query": "Is the yeast ac1 transcription factor induced upon copper deficiency?",
    "llama-2-7b-chat-hf_response": "Yes, the yeast transcription factor Mac1 is induced upon copper deficiency. Mac1 is a transcriptional regulator that plays a key role in the response of Saccharomyces cerevisiae to copper deficiency. When copper levels are low, Mac1 is activated and regulates the expression of genes involved in copper homeostasis and detoxification.\nMac1 is a member of the basic region leucine zipper (bZIP) family of transcription factors, which are characterized by the presence of a conserved DNA-binding domain called the bZIP domain. Mac1 contains two bZIP domains and is able to bind to specific DNA sequences in the promoter regions of target genes.\nStudies have shown that Mac1 is induced upon copper deficiency in a variety of ways, including:\n1. Reduced copper levels: Copper deficiency leads to reduced levels of copper in the cell, which activates Mac1 and induces the expression of genes involved in copper homeostasis and detoxification.\n2. Oxidative stress: Copper deficiency can also lead to oxidative stress, which can activate Mac1 and induce the expression of genes involved in antioxidant defense.\n3. Signaling pathways: Mac1 can also be induced by signaling pathways that are activated in response to copper deficiency, such as the Hog1 mitogen-activated protein kinase (MAPK) pathway.\nOverall, the induction of Mac1 upon copper deficiency plays a critical role in the response of S. cerevisiae to copper stress and is an important factor in maintaining copper homeostasis in the cell.",
    "llama-2-7b-chat-hf_fact": [
      "The yeast transcription factor Mac1 is typically induced upon copper deficiency.",
      "Saccharomyces cerevisiae uses the transcription factor Mac1 as a response to copper deficiency.",
      "Mac1 is part of the basic region leucine zipper (bZIP) family of transcription factors.",
      "Mac1 is able to bind to specific DNA sequences in the promoter regions of target genes.",
      "The induction of Mac1 upon copper deficiency plays a critical role in the response of S. cerevisiae to copper stress and maintaining copper homeostasis in the cell."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 357,
    "user_query": "What is the mechanism of DNA replication termination in vertebrates?",
    "llama-2-7b-chat-hf_response": "DNA replication termination in vertebrates is a complex process that involves the coordinated action of several enzymes and proteins. Here are the general steps involved in DNA replication termination in vertebrates:\n1. Unwinding of the double helix: The double helix structure of DNA is unwound by an enzyme called helicase, which breaks the hydrogen bonds between the two strands of DNA.\n2. Binding of primers: Short RNA molecules called primers bind to the template strands at specific regions called origins of replication. The primers provide a starting point for DNA synthesis.\n3. Synthesis of new strands: DNA polymerase synthesizes new strands of DNA by adding nucleotides to the template strands. The new strands are complementary to the template strands.\n4. Proofreading and editing: DNA polymerase proofreads and edits the newly synthesized DNA strands to correct any errors that may have occurred during synthesis.\n5. Ligation of Okazaki fragments: In the process of DNA replication, the newly synthesized DNA strands are ligated together by an enzyme called DNA ligase. This forms a continuous strand of DNA.\n6. Removal of RNA primers: The RNA primers are removed from the template strands by an enzyme called RNAse H.\n7. Sealing of the replication fork: The replication fork, where DNA synthesis occurs, is sealed by an enzyme called topoisomerase II. This prevents the replication fork from moving backwards and ensures that the newly synthesized DNA strands are properly sealed.\n8. Completion of DNA replication: Once the replication fork is sealed, the process of DNA replication is complete, and the new DNA molecule is ready to be transcribed and translated.\nIn summary, the mechanism of DNA replication termination in vertebrates involves the coordinated action of several enzymes and proteins, including helicase, primers, DNA polymerase, DNA ligase, RNAse H, and topoisomerase II. These enzymes work together to unwind the double helix, synthesize new strands, proofread and edit the newly synthesized",
    "llama-2-7b-chat-hf_fact": [
      "The double helix structure of DNA is unwound by an enzyme called helicase during DNA replication termination in vertebrates.",
      "DNA replication termination involves short RNA molecules called primers binding to the template strands at specific regions called origins of replication.",
      "DNA polymerase synthesizes new strands of DNA, adds nucleotides to the template strands and proofreads and edits the newly synthesized DNA strands.",
      "The newly synthesized DNA strands are ligated together by an enzyme called DNA ligase during DNA replication termination.",
      "The replication fork, where DNA synthesis occurs, is sealed by an enzyme called topoisomerase II during DNA replication termination in vertebrates."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: DNA replication initiation, not termination, involves short RNA molecules called primers binding to the template strands at specific regions called origins of replication.",
      "true",
      "false, [corrected fact]: The newly synthesized DNA strands are ligated together by an enzyme called DNA ligase during the processes of DNA replication and repair, not specifically during termination.",
      "false, [corrected fact]: The topoisomerase II enzyme is involved in regulating the overwinding or underwinding of DNA, it doesn't specifically seal the replication fork during DNA replication termination."
    ]
  },
  {
    "id": 360,
    "user_query": "Have thyronamines  effects on fat tissue?",
    "llama-2-7b-chat-hf_response": "Thyronamines are a class of thyroid hormones that have been shown to have various effects on different tissues in the body. One of the tissues that thyronamines have been shown to affect is fat tissue. Here are some of the effects of thyronamines on fat tissue:\n1. Increased lipolysis: Thyronamines have been shown to stimulate the breakdown of fat cells (lipolysis) in adipose tissue. This can lead to increased fat burning and weight loss.\n2. Increased glucose uptake: Thyronamines have also been shown to increase glucose uptake in fat cells, which can help to improve insulin sensitivity and reduce the risk of developing type 2 diabetes.\n3. Reduced inflammation: Thyronamines have anti-inflammatory effects, which can help to reduce inflammation in fat tissue. Chronic inflammation is a major contributor to the development of metabolic disorders, such as obesity and insulin resistance.\n4. Improved browning of white adipose tissue: Thyronamines have been shown to promote the browning of white adipose tissue, which can help to improve insulin sensitivity and reduce the risk of developing metabolic disorders.\n5. Increased thermogenesis: Thyronamines have been shown to increase thermogenesis in brown adipose tissue, which can help to increase metabolic rate and promote weight loss.\nOverall, the effects of thyronamines on fat tissue are complex and multifaceted, and more research is needed to fully understand their mechanisms of action. However, it is clear that thyronamines play an important role in regulating fat metabolism and may have potential as a therapeutic agent for the treatment of metabolic disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Thyronamines are a class of thyroid hormones.",
      "Thyronamines have been shown to stimulate the breakdown of fat cells in adipose tissue.",
      "Thyronamines can increase glucose uptake in fat cells, potentially improving insulin sensitivity.",
      "Thyronamines have anti-inflammatory effects and can help reduce inflammation in fat tissue.",
      "Thyronamines can increase thermogenesis in brown adipose tissue, potentially boosting metabolic rate and promoting weight loss."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 361,
    "user_query": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?",
    "llama-2-7b-chat-hf_response": "There are several anti-CD52 monoclonal antibody therapies that have been developed for the treatment of multiple sclerosis (MS). Some of the most commonly used anti-CD52 monoclonal antibodies for MS include:\n1. Rituximab (Rituxan): Rituximab is a chimeric (mouse-human) monoclonal antibody that targets CD20-positive B cells, which are involved in the autoimmune response in MS. Rituximab has been shown to reduce inflammation and slow the progression of disability in patients with relapsing-remitting MS (RRMS).\n2. Ocrelizumab (Ocrevus): Ocrelizumab is a humanized monoclonal antibody that targets CD20-positive B cells. It is approved for the treatment of primary progressive MS (PPMS) and relapsing-remitting MS (RRMS). Ocrelizumab has been shown to reduce inflammation and slow the progression of disability in patients with MS.\n3. Ofatumumab (Kesimpta): Ofatumumab is a chimeric (mouse-human) monoclonal antibody that targets CD20-positive B cells. It is approved for the treatment of relapsing-remitting MS (RRMS) and primary progressive MS (PPMS). Ofatumumab has been shown to reduce inflammation and slow the progression of disability in patients with MS.\n4. Alemtuzumab (Lemtrada): Alemtuzumab is a chimeric (mouse-human) monoclonal antibody that targets CD52-positive B cells. It is approved for the treatment of relapsing-remitting MS (RRMS) and primary progressive MS (PPMS). Alemtuzumab has been shown to reduce inflammation and slow the progression of disability in patients with MS.\n5. Ibritumomab tiuxetan (Zevalin): Ibritumomab tiuxetan is a chimeric (mouse-human) monoclonal antibody that targets CD20-positive B cells. It is approved",
    "llama-2-7b-chat-hf_fact": [
      "Anti-CD52 monoclonal antibody therapies have been developed for the treatment of multiple sclerosis (MS).",
      "Rituximab, known as Rituxan, is a chimeric monoclonal antibody that targets CD20-positive B cells in MS treatment.",
      "Ocrelizumab, branded as Ocrevus, is a humanized monoclonal antibody used in the treatment for both primary progressive and relapsing-remitting multiple sclerosis.",
      "Ofatumumab, sold as Kesimpta, is a chimeric monoclonal antibody used for treating primary progressive and relapsing-remitting multiple sclerosis.",
      "Alemtuzumab, sold under the brand name Lemtrada, is a chimeric monoclonal antibody which targets CD52-positive B cells and is used in the treatment of both primary progressive and relapsing-remitting multiple sclerosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Ofatumumab, sold as Kesimpta, is a human monoclonal antibody used for treating relapsing forms of multiple sclerosis.",
      "false, [corrected fact]: Alemtuzumab, sold under the brand name Lemtrada, is a humanized monoclonal antibody which targets CD52-positive B cells and is used in the treatment of relapsing-remitting multiple sclerosis."
    ]
  },
  {
    "id": 369,
    "user_query": "At which kind of individuals is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?",
    "llama-2-7b-chat-hf_response": "Pharmacological treatment of subclinical hypothyroidism has been shown to be effective in reducing cardiovascular events in certain individuals, including:\n1. Elderly individuals: Subclinical hypothyroidism is more common in older adults, and pharmacological treatment has been shown to reduce the risk of cardiovascular events, such as heart attacks and strokes, in this population.\n2. Individuals with a history of cardiovascular disease: Pharmacological treatment of subclinical hypothyroidism has been shown to reduce the risk of cardiovascular events in individuals who have a history of cardiovascular disease, such as heart failure, coronary artery disease, or peripheral artery disease.\n3. Individuals with high thyroid-stimulating hormone (TSH) levels: TSH is a hormone produced by the pituitary gland that stimulates the thyroid gland to produce thyroid hormones. High levels of TSH in the blood are associated with an increased risk of cardiovascular events in individuals with subclinical hypothyroidism. Pharmacological treatment of subclinical hypothyroidism has been shown to reduce TSH levels and reduce the risk of cardiovascular events in these individuals.\n4. Individuals with a family history of cardiovascular disease: Pharmacological treatment of subclinical hypothyroidism has been shown to reduce the risk of cardiovascular events in individuals who have a family history of cardiovascular disease.\n5. Individuals with other cardiovascular risk factors: Pharmacological treatment of subclinical hypothyroidism has been shown to reduce the risk of cardiovascular events in individuals who have other cardiovascular risk factors, such as high blood pressure, high cholesterol, or smoking.\nIt is important to note that not all individuals with subclinical hypothyroidism will benefit from pharmacological treatment, and the decision to initiate treatment should be made on an individual basis, taking into account the patient's overall health status and medical history.",
    "llama-2-7b-chat-hf_fact": [
      "Pharmacological treatment of subclinical hypothyroidism can reduce cardiovascular events in elderly individuals.",
      "Individuals with a history of cardiovascular disease might benefit from pharmacological treatment of subclinical hypothyroidism.",
      "High levels of thyroid-stimulating hormone (TSH) in the blood are associated with an increased risk of cardiovascular events in individuals with subclinical hypothyroidism.",
      "Subclinical hypothyroidism treatment can potentially decrease cardiovascular events in individuals with a family history of cardiovascular disease.",
      "Individuals with other cardiovascular risk factors, such as high blood pressure, high cholesterol, or smoking, may benefit from subclinical hypothyroidism treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 372,
    "user_query": "What is known about the association between the use of selective serotonin reuptake inhibitors during pregnancy and risk for autism in offspring?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 374,
    "user_query": "Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)?",
    "llama-2-7b-chat-hf_response": "Desmin is an intermediate filament protein that is predominantly expressed in striated muscles, including the heart. Mutations in the desmin gene have been associated with a variety of muscular disorders, including dilated cardiomyopathy (DCM). DCM is a condition characterized by the enlargement of the heart chambers and a decrease in the heart's ability to pump blood effectively.\nDesmin is a key component of the contractile apparatus in the heart, and mutations in the desmin gene have been shown to disrupt the structure and function of the cardiac muscle fibers. These mutations can lead to the development of DCM, which can result in symptoms such as fatigue, shortness of breath, and swelling of the legs and feet.\nIn addition to its role in DCM, desmin has also been implicated in other cardiac disorders, including hypertrophic cardiomyopathy (HCM) and cardiac arrhythmias. Further research is needed to fully understand the role of desmin in these conditions and to identify potential therapeutic targets for the treatment of cardiac diseases.\nIn summary, desmin is an intermediate filament protein that plays a critical role in the structure and function of the cardiac muscle. Mutations in the desmin gene have been associated with a variety of cardiac disorders, including DCM, HCM, and cardiac arrhythmias.",
    "llama-2-7b-chat-hf_fact": [
      "Desmin is an intermediate filament protein that is predominantly expressed in striated muscles, including the heart.",
      "Mutations in the desmin gene have been associated with a variety of muscular disorders, including dilated cardiomyopathy (DCM).",
      "Dilated cardiomyopathy (DCM) is a condition characterized by the enlargement of the heart chambers and a decrease in the heart's ability to pump blood effectively.",
      "Desmin is a key component of the contractile apparatus in the heart.",
      "In addition to its role in DCM, desmin has also been implicated in other cardiac disorders, including hypertrophic cardiomyopathy (HCM) and cardiac arrhythmias."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 376,
    "user_query": "List human diseases involving genomic imprinting.",
    "llama-2-7b-chat-hf_response": "Here are some examples of human diseases that involve genomic imprinting:\n1. Beckwith-Wiedemann syndrome: This is a genetic disorder that affects the growth and development of various organs, including the liver, kidneys, and pancreas. It is caused by mutations in the imprinted gene IGF2, which codes for insulin-like growth factor 2.\n2. Silver-Russell syndrome: This is a rare genetic disorder that affects growth and development, particularly in children. It is caused by mutations in the H19 gene, which is imprinted and located on chromosome 11.\n3. Angelman syndrome: This is a genetic disorder that affects the nervous system and causes developmental delays, intellectual disability, and other symptoms. It is caused by mutations in the UBE3A gene, which is imprinted and located on chromosome 15.\n4. Prader-Willi syndrome: This is a genetic disorder that affects growth and development, particularly in children. It is caused by mutations in the PWS gene, which is imprinted and located on chromosome 15.\n5. Turner syndrome: This is a genetic disorder that affects females and is caused by a missing or partially deleted X chromosome. It can result in growth and developmental delays, as well as other symptoms.\n6. Mowat-Wilson syndrome: This is a rare genetic disorder that affects the nervous system, digestive system, and other organs. It is caused by mutations in several imprinted genes, including the MLF1 gene, which is located on chromosome 7.\n7. Coffin-Lowry syndrome: This is a rare genetic disorder that affects the nervous system, bones, and other organs. It is caused by mutations in the HMGA2 gene, which is imprinted and located on chromosome 7.\n8. Smith-Magenis syndrome: This is a rare genetic disorder that affects the nervous system, growth and development, and other organs. It is caused by mutations in the RAI1 gene, which is imprinted and located on",
    "llama-2-7b-chat-hf_fact": [
      "Beckwith-Wiedemann syndrome is a genetic disorder caused by mutations in the imprinted gene IGF2.",
      "Silver-Russell syndrome is caused by mutations in the H19 gene, which is imprinted and located on chromosome 11.",
      "Angelman syndrome is caused by mutations in the UBE3A gene, which is imprinted and located on chromosome 15.",
      "Prader-Willi syndrome is caused by mutations in the PWS gene, which is imprinted and located on chromosome 15.",
      "Turner syndrome is a genetic disorder affecting females, caused by a missing or partially deleted X chromosome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Prader-Willi syndrome is caused by a loss of function of genes in a particular region of chromosome 15. The specific genes are not fully understood.",
      "true"
    ]
  },
  {
    "id": 378,
    "user_query": "Which deficiency is the cause of restless leg syndrome?",
    "llama-2-7b-chat-hf_response": "A) Iron deficiency\nB) Magnesium deficiency\nC) Potassium deficiency\nD) Vitamin B12 deficiency\nCorrect answer: A) Iron deficiency\nExplanation: Restless Leg Syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, usually due to an uncomfortable or unpleasant sensation in the legs. While the exact cause of RLS is not fully understood, iron deficiency is a common underlying factor. Iron plays a crucial role in the functioning of the nervous system, and iron deficiency can lead to abnormalities in the brain and nervous system, including the development of RLS. Other potential causes of RLS include magnesium deficiency, potassium deficiency, and vitamin B12 deficiency, but iron deficiency is the most commonly associated deficiency.",
    "llama-2-7b-chat-hf_fact": [
      "Iron deficiency is a common underlying factor of Restless Leg Syndrome (RLS).",
      "Restless Leg Syndrome is a neurological disorder characterized by an uncontrollable urge to move the legs.",
      "Iron plays a crucial role in the functioning of the nervous system.",
      "Iron deficiency can lead to abnormalities in the brain and nervous system, including the development of RLS.",
      "Other potential causes of RLS include magnesium deficiency, potassium deficiency, and vitamin B12 deficiency."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 379,
    "user_query": "What histone modification is recognized by the bromodomain?",
    "llama-2-7b-chat-hf_response": "Histones are proteins that make up the chromatin structure of DNA in eukaryotic cells. Histone modifications play a crucial role in regulating chromatin dynamics and gene expression. Bromodomains are protein domains that recognize and bind to acetylated histone residues, which are associated with active gene expression.\nThe most common histone modification recognized by bromodomains is acetylation of lysine residues on histone proteins, particularly histone H3 and histone H4. Acetylation of these residues leads to a more open chromatin structure, allowing for greater accessibility of the DNA to transcription factors and other regulatory proteins.\nOther histone modifications, such as methylation, phosphorylation, and ubiquitination, can also be recognized by bromodomains, but acetylation is the most well-studied and widely recognized. The specific recognition of these modifications by bromodomains is thought to be mediated by the binding of the bromodomain to the acetylated histone residues, which creates a conformational change in the bromodomain that allows it to interact with other proteins and regulate gene expression.\nIn summary, bromodomains recognize and bind to acetylated histone residues, particularly on histone H3 and H4, which are associated with active gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Histones are proteins that constitute the chromatin structure of DNA in eukaryotic cells.",
      "Bromodomains are protein domains that recognize and bind to acetylated histone residues.",
      "Acetylated histone residues are associated with active gene expression.",
      "The most common histone modification recognized by bromodomains is acetylation of lysine residues on histone H3 and H4.",
      "Other histone modifications such as methylation, phosphorylation, and ubiquitination can also be recognized by bromodomains."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Other histone modifications such as methylation, phosphorylation, and ubiquitination are usually recognized by other protein domains, not bromodomains."
    ]
  },
  {
    "id": 387,
    "user_query": "What is the methodological principle of ChIA-PET?",
    "llama-2-7b-chat-hf_response": "ChIA-PET (Chromosome-scale Inference of Ancestral Genomes by Phylogenetic Ensemble Tree) is a computational method that uses a combination of phylogenetic and genomic data to infer the ancestral genomes of extinct species. The methodological principle of ChIA-PET is based on the following steps:\n1. Phylogenetic tree reconstruction: ChIA-PET uses a phylogenetic tree to infer the relationships between the extinct and living species. The tree is constructed using a combination of molecular and morphological data.\n2. Ancestral genome reconstruction: Once the phylogenetic tree is constructed, ChIA-PET uses a genome assembly algorithm to reconstruct the ancestral genomes of the extinct species. The algorithm takes into account the evolutionary relationships between the species and the available genomic data to infer the most likely ancestral genome.\n3. Ancestral gene content analysis: After reconstructing the ancestral genomes, ChIA-PET analyzes the content of the genes in the ancestral genomes. This step involves identifying the presence or absence of genes in the ancestral genomes and comparing them to the corresponding genes in the living species.\n4. Ancestral gene order analysis: ChIA-PET also analyzes the order of the genes in the ancestral genomes. This step involves comparing the gene order in the ancestral genomes to the gene order in the living species to identify any changes or rearrangements that may have occurred during evolution.\n5. Inference of ancestral genomes: Finally, ChIA-PET uses the results of the ancestral genome reconstruction, gene content analysis, and gene order analysis to infer the most likely ancestral genomes of the extinct species. This step involves combining the results of the different analyses to create a comprehensive picture of the ancestral genomes.",
    "llama-2-7b-chat-hf_fact": [
      "ChIA-PET is a computational method that uses phylogenetic and genomic data to infer the ancestral genomes of extinct species.",
      "The method involves reconstructing a phylogenetic tree to infer relationships between extinct and living species.",
      "ChIA-PET uses a genome assembly algorithm to reconstruct the ancestral genomes.",
      "After reconstructing the ancestral genomes, ChIA-PET analyzes both the content of the genes and their order.",
      "ChIA-PET combines the results of the ancestral genome reconstruction, gene content analysis, and gene order analysis to infer the most likely ancestral genomes of the extinct species."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: ChIA-PET is a chromatin interaction analysis method using paired-end tag sequencing, not a computational method to infer ancestral genomes of extinct species.",
      "false, [corrected fact]: The method mentioned is common in ancestral genome reconstructions, but not specific to ChIA-PET. ChIA-PET is used for understanding the 3-dimensional structure of genomes.",
      "false, [corrected fact]: ChIA-PET does not use genome assembly algorithms. It analyzes physical interactions between genomic regions.",
      "false, [corrected fact]: ChIA-PET does not reconstruct ancestral genomes. It closely studies the interaction between DNA regions within a genome.",
      "false, [corrected fact]: ChIA-PET does not infer ancestral genomes but provides information about chromosome conformation and interaction between genomic regions."
    ]
  },
  {
    "id": 390,
    "user_query": "Does PU.1 (SPI1) affect NF-kB binding?",
    "llama-2-7b-chat-hf_response": "Yes, PU.1 (SPI1) has been shown to affect NF-B binding in various cell types. NF-B is a transcription factor that plays a crucial role in regulating inflammation and immune responses, and PU.1 has been shown to modulate NF-B activity through several mechanisms.\nFirstly, PU.1 can directly bind to the NF-B consensus sequence in the promoter region of NF-B target genes and enhance their transcriptional activity. This can lead to increased production of pro-inflammatory cytokines and chemokines, such as TNF- and IL-8.\nSecondly, PU.1 can also regulate NF-B activity by modulating the activity of upstream signaling pathways that activate NF-B. For example, PU.1 can inhibit the activity of the IKK complex, which is a key upstream regulator of NF-B activation.\nFinally, PU.1 can also affect the stability and localization of NF-B proteins. For example, PU.1 has been shown to promote the degradation of p50/p105 NF-B subunits, leading to decreased NF-B activity.\nOverall, PU.1 plays a complex role in regulating NF-B activity, and its effects can vary depending on the specific cellular context and the type of NF-B subunit involved.",
    "llama-2-7b-chat-hf_fact": [
      "PU.1 (SPI1) affects NF-B binding in various cell types.",
      "NF-B is a transcription factor that regulates inflammation and immune responses.",
      "PU.1 can directly bind to the NF-B consensus sequence in the promoter region of NF-B target genes.",
      "PU.1 can regulate NF-B activity by modulating the activity of upstream signaling pathways that activate NF-B.",
      "PU.1 can affect the stability and localization of NF-B proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 391,
    "user_query": "Does the majority of the mitochondrial genomes abide to the second parity rule (PR2)?",
    "llama-2-7b-chat-hf_response": "The second parity rule (PR2) states that the total number of guanine (G) and cytosine (C) bases in a mitochondrial genome must be even. This rule applies to most eukaryotic mitochondrial genomes, including those of animals, plants, and fungi. However, there are some exceptions, such as the mitochondrial genome of the choanoflagellate Monosiga brevicollis, which violates PR2 by having a G-biased genome.",
    "llama-2-7b-chat-hf_fact": [
      "The second parity rule (PR2) states that the total number of guanine (G) and cytosine (C) bases in a mitochondrial genome must be even.",
      "The second parity rule (PR2) applies to most eukaryotic mitochondrial genomes.",
      "Animal, plant, and fungi mitochondrial genomes abide to the second parity rule (PR2).",
      "There are exceptions to the second parity rule (PR2) in some mitochondrial genomes.",
      "The mitochondrial genome of the choanoflagellate Monosiga brevicollis violates the second parity rule (PR2) by having a G-biased genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 396,
    "user_query": "Which hormone abnormalities are common in Williams syndrome ?",
    "llama-2-7b-chat-hf_response": "Williams syndrome is a rare genetic disorder that affects approximately 1 in 10,000 individuals worldwide. It is caused by a deletion of genetic material on chromosome 7, which leads to a range of physical and developmental abnormalities. Some of the common hormone abnormalities associated with Williams syndrome include:\n1. Growth hormone deficiency: Individuals with Williams syndrome often have low levels of growth hormone, which can result in short stature and delayed growth and development.\n2. Adrenal insufficiency: Williams syndrome can cause adrenal insufficiency, which is a condition where the adrenal glands do not produce enough cortisol and aldosterone hormones. This can lead to fatigue, weakness, and electrolyte imbalances.\n3. Hypothyroidism: Some individuals with Williams syndrome may have hypothyroidism, which is a condition where the thyroid gland does not produce enough thyroid hormones. This can lead to fatigue, weight gain, and cold intolerance.\n4. Hyperparathyroidism: Williams syndrome can also cause hyperparathyroidism, which is a condition where the parathyroid glands produce too much parathyroid hormone. This can lead to an imbalance of calcium and phosphorus levels in the body, which can cause a range of symptoms including bone pain, fatigue, and kidney stones.\n5. Menstrual irregularities: Women with Williams syndrome may experience irregular menstrual cycles, which can be caused by hormonal imbalances.\n6. Increased risk of diabetes: Individuals with Williams syndrome have an increased risk of developing type 2 diabetes, which can be caused by insulin resistance and hormonal imbalances.\n7. Sleep apnea: Williams syndrome can also cause sleep apnea, which is a condition where a person's breathing is interrupted during sleep. This can be caused by hormonal imbalances and can lead to fatigue, headaches, and other symptoms.\n8. Cardiovascular disease: Individuals with Williams syndrome have an increased risk of developing cardiovascular disease, which can",
    "llama-2-7b-chat-hf_fact": [
      "Williams syndrome is a rare disorder that occurs in approximately 1 in 10,000 individuals worldwide.",
      "Williams syndrome is caused by a deletion of genetic material on chromosome 7.",
      "Growth hormone deficiency, which can result in short stature and delayed growth, is a common hormonal abnormality in individuals with Williams syndrome.",
      "Williams syndrome can cause adrenal insufficiency, a condition where the adrenal glands do not produce enough cortisol and aldosterone hormones.",
      "Some individuals with Williams syndrome can have hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormones."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Williams syndrome is a rare disorder that occurs in approximately 1 in 7,500 individuals worldwide.",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 398,
    "user_query": "Albumin depletion is a common first step for proteomic analysis of CSF fluid. What is the advantage and disadvantage of this procedure?",
    "llama-2-7b-chat-hf_response": "Albumin depletion is a common first step for proteomic analysis of cerebrospinal fluid (CSF) fluid. Advantages of albumin depletion include:\nAdvantages of albumin depletion:\n1. Removes albumin, which can interfere with protein analysis: Albumin is the most abundant protein in CSF, and its presence can interfere with protein analysis. Depleting albumin removes this interference, allowing for more accurate measurements of other proteins.\n2. Improves protein recovery: Albumin depletion can improve protein recovery by reducing the binding of proteins to the depletion reagent. This can result in higher yields of proteins for analysis.\n3. Enhances protein separation: Albumin depletion can also enhance protein separation by reducing the complexity of the protein mixture. This can improve the resolution of protein separations and make it easier to identify and quantify proteins.\n4. Facilitates protein identification: Depleting albumin can make it easier to identify proteins in the CSF sample. This is because albumin can mask the signals of other proteins, making it more difficult to identify them.\nHowever, there are also some disadvantages of albumin depletion, including:\nDisadvantages of albumin depletion:\n1. Loss of information: Depleting albumin can result in the loss of information about the protein composition of the CSF sample. This can make it more difficult to identify and quantify proteins.\n2. Time-consuming and labor-intensive: Albumin depletion can be a time-consuming and labor-intensive process, requiring multiple steps and reagents.\n3. Costly: The reagents and equipment needed for albumin depletion can be costly, which can increase the overall cost of the proteomic analysis.\n4. Limited applicability: Albumin depletion may not be applicable to all types of CSF samples or protein analyses. For example, it may not be suitable for samples with low protein concentrations or for analyses that require the detection of low-abundance proteins.\nIn summary, albumin depletion is a common first step for proteomic analysis of CSF fluid, which can improve protein recovery, enhance protein separation, facilitate protein identification, and remove albumin",
    "llama-2-7b-chat-hf_fact": [
      "Albumin depletion is typically the first step for proteomic analysis of cerebrospinal fluid, or CSF.",
      "The presence of albumin, an abundant protein in CSF, can interfere with protein analysis.",
      "Albumin depletion can improve protein recovery and enhance protein separation for analysis.",
      "The process of albumin depletion can result in the loss of information about the protein composition of the CSF sample.",
      "Albumin depletion is potentially time-consuming, labor-intensive, and costly due to the need for multiple steps, reagents, and equipment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 401,
    "user_query": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?",
    "llama-2-7b-chat-hf_response": "A) Serine 129\nB) Threonine 115\nC) Serine 130\nD) Threonine 121\nAnswer: B) Threonine 115\nExplanation: Alpha-synuclein is a protein that is implicated in the pathogenesis of Parkinson's disease and dementia with Lewy bodies. Phosphorylation of alpha-synuclein at specific residues has been shown to play a role in its aggregation and toxicity. In Lewy bodies, the residue Threonine 115 of alpha-synuclein has been found to be phosphorylated. This phosphorylation is thought to contribute to the aggregation and toxicity of alpha-synuclein and may play a role in the pathogenesis of Parkinson's disease and dementia with Lewy bodies.",
    "llama-2-7b-chat-hf_fact": [
      "Alpha-synuclein is a protein implicated in the pathogenesis of Parkinson's disease and dementia with Lewy bodies.",
      "Phosphorylation of alpha-synuclein at specific residues plays a role in its aggregation and toxicity.",
      "Phosphorylation of the residue Threonine 115 of alpha-synuclein is found in Lewy bodies.",
      "Aggregation and toxicity of alpha-synuclein potentially contribute to the pathogenesis of Parkinson's disease and dementia with Lewy bodies.",
      "The phosphorylation of alpha-synuclein may play a role in the pathogenesis of Parkinson's disease and dementia with Lewy bodies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 403,
    "user_query": "What is known about thalidomide therapy and survival of glioblastoma patients?",
    "llama-2-7b-chat-hf_response": "Thalidomide is an immunomodulatory drug that has been investigated as a potential treatment for glioblastoma, an aggressive form of brain cancer. Studies have shown that thalidomide can inhibit the growth of glioblastoma cells and increase the expression of tumor suppressor genes, leading to improved survival outcomes for patients.\nOne study published in the Journal of Clinical Oncology found that patients with glioblastoma who received thalidomide as part of their initial treatment had a median overall survival of 14.6 months, compared to 10.2 months for those who did not receive thalidomide. Another study published in the journal Neuro-Oncology found that thalidomide therapy was associated with improved overall survival and progression-free survival in patients with glioblastoma.\nHowever, it is important to note that thalidomide therapy is not a cure for glioblastoma, and the majority of patients will eventually experience disease progression despite treatment. Additionally, thalidomide can have significant side effects, including nausea, fatigue, and skin rash.\nOverall, while thalidomide therapy has shown promise in improving survival outcomes for glioblastoma patients, more research is needed to fully understand its effectiveness and potential side effects.",
    "llama-2-7b-chat-hf_fact": [
      "Thalidomide is an immunomodulatory drug.",
      "Glioblastoma is an aggressive form of brain cancer.",
      "Studies have shown that thalidomide can inhibit the growth of glioblastoma cells and increase the expression of tumor suppressor genes.",
      "A study published in the Journal of Clinical Oncology found that glioblastoma patients who received thalidomide had a median overall survival of 14.6 months, compared to 10.2 months for those who did not receive thalidomide.",
      "Thalidomide therapy can have side effects, which include nausea, fatigue, and skin rash."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 404,
    "user_query": "Is endostatin a proangiogenic factor?",
    "llama-2-7b-chat-hf_response": "Endostatin is a protein that is produced by the endothelium, the inner lining of blood vessels, in response to hypoxia. It is a potent inhibitor of angiogenesis, or the formation of new blood vessels, and has been shown to have anti-tumor effects by inhibiting the growth of tumor vessels. However, recent studies have suggested that endostatin may also have pro-angiogenic effects in certain contexts.\nOne study found that endostatin can promote the formation of new blood vessels in the retina, which could have implications for the treatment of retinal diseases such as age-related macular degeneration. Another study found that endostatin can stimulate the growth of new blood vessels in the skeletal muscle of mice, which could have implications for the treatment of muscle wasting diseases such as muscular dystrophy.\nThe pro-angiogenic effects of endostatin are thought to be mediated by its ability to activate the VEGF receptor, which is a key regulator of angiogenesis. When endostatin binds to the VEGF receptor, it can stimulate the production of VEGF, which in turn can promote the formation of new blood vessels.\nOverall, while endostatin is best known for its anti-angiogenic effects, recent studies have suggested that it may also have pro-angiogenic effects in certain contexts. Further research is needed to fully understand the role of endostatin in angiogenesis and to determine its potential as a therapeutic agent for a variety of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Endostatin is a protein that is produced by the endothelium, the inner lining of blood vessels, in response to hypoxia.",
      "Endostatin is a potent inhibitor of angiogenesis, the formation of new blood vessels.",
      "A study found that endostatin can promote the formation of new blood vessels in the retina, potentially impacting the treatment of retinal diseases like age-related macular degeneration.",
      "Another study found endostatin can stimulate the growth of new blood vessels in the skeletal muscle of mice, potentially affecting the treatment of muscle wasting diseases such as muscular dystrophy.",
      "The pro-angiogenic effects of endostatin are thought to be mediated by its ability to activate the VEGF receptor, a key regulator of angiogenesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Endostatin is not produced by the endothelium; it is a protein derived from the breakdown of collagen XVIII in the basement membranes of blood vessels.",
      "true",
      "false, [corrected fact]: Endostatin is known to inhibit angiogenesis, and therefore it is unlikely to promote the formation of new blood vessels in the retina. It is used in the treatment of diseases like age-related macular degeneration due to its inhibitory effects.",
      "false, [corrected fact]: Endostatin inhibits the formation and growth of new blood vessels rather than promoting it.",
      "false, [corrected fact]: The anti-angiogenic effects of endostatin are thought to be mediated by its ability to inhibit the VEGF receptor, a key regulator of angiogenesis."
    ]
  },
  {
    "id": 407,
    "user_query": "List the off-label use of SSRIs",
    "llama-2-7b-chat-hf_response": "for non-depressive conditions\nSSRIs (selective serotonin reuptake inhibitors) are commonly prescribed for depression, but they have also been used off-label for other conditions. Here are some of the off-label uses of SSRIs for non-depressive conditions:\n1. Anxiety disorders: SSRIs have been used to treat anxiety disorders such as generalized anxiety disorder, panic disorder, and post-traumatic stress disorder (PTSD).\n2. Obsessive-compulsive disorder (OCD): SSRIs have been used to treat OCD, as they can help reduce the frequency and severity of obsessive thoughts and compulsive behaviors.\n3. Eating disorders: SSRIs have been used to treat eating disorders such as bulimia nervosa and binge eating disorder, as they can help reduce bingeing and purging behaviors.\n4. Sleep disorders: SSRIs have been used to treat sleep disorders such as insomnia, as they can help improve sleep quality and duration.\n5. Chronic pain: SSRIs have been used to treat chronic pain, as they can help reduce pain perception and improve mood.\n6. Fibromyalgia: SSRIs have been used to treat fibromyalgia, as they can help reduce pain and improve sleep quality.\n7. Irritable bowel syndrome (IBS): SSRIs have been used to treat IBS, as they can help reduce abdominal pain and improve bowel habits.\n8. Autism spectrum disorder: SSRIs have been used to treat autism spectrum disorder, as they can help improve social interactions and reduce repetitive behaviors.\n9. Attention deficit hyperactivity disorder (ADHD): SSRIs have been used to treat ADHD, as they can help improve attention and impulse control.\n10. Smoking cessation: SSRIs have been used to help people quit smoking, as they can help reduce nicotine cravings and improve mood.\nIt is important to note that while SSRIs have been used off-label for these conditions, they may not be approved by the FDA for these uses, and more research is needed to fully understand",
    "llama-2-7b-chat-hf_fact": [
      "SSRIs are commonly prescribed for depression, but they are also used off-label for other conditions.",
      "SSRIs have been used off-label to treat anxiety disorders such as generalized anxiety disorder, panic disorder, and post-traumatic stress disorder (PTSD).",
      "Off-label use of SSRIs includes the treatment of obsessive-compulsive disorder (OCD) and eating disorders like bulimia nervosa and binge eating disorder.",
      "Chronic pain, fibromyalgia, and sleep disorders like insomnia are some conditions treated with SSRIs off-label.",
      "SSRIs have also been used off-label for treatments of conditions such as irritable bowel syndrome (IBS), autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), and for smoking cessation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: SSRIs are commonly used to treat obsessive-compulsive disorder (OCD) and some eating disorders, such as bulimia nervosa and binge eating disorder. This is not considered off-label use.",
      "true",
      "true"
    ]
  },
  {
    "id": 408,
    "user_query": "Which is the definition of pyknons in DNA?",
    "llama-2-7b-chat-hf_response": "Pyknons are a type of DNA structure that are found in the genomes of many organisms, including bacteria, archaea, and eukaryotes. They are short, repetitive sequences of DNA that are typically 20-40 nucleotides in length and are found in regions of the genome that are rich in guanine and cytosine bases.\nPyknons are thought to play a role in the regulation of gene expression, particularly in the context of DNA replication and repair. They are also involved in the formation of higher-order chromatin structures, such as chromatin loops and topologically associating domains (TADs).\nPyknons were first identified in the genome of the bacterium Escherichia coli, where they were found to be enriched in regions of the genome that are involved in the regulation of gene expression. Since then, pyknons have been found in the genomes of many other organisms, including humans.\nIn summary, pyknons are short, repetitive sequences of DNA that are found in the genomes of many organisms and are thought to play a role in the regulation of gene expression and the formation of higher-order chromatin structures.",
    "llama-2-7b-chat-hf_fact": [
      "Pyknons refer to a type of DNA structure found in many organisms including bacteria, archaea, and eukaryotes.",
      "These structures are short, repetitive DNA sequences typically 20-40 nucleotides in length.",
      "Pyknons generally occur in regions of the genome rich in guanine and cytosine bases.",
      "Pyknons are believed to contribute to the regulation of gene expression and the formation of higher-order chromatin structures.",
      "The existence of pyknons was first identified in the genome of the bacterium Escherichia coli."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Pyknons refer to non-random, over-represented sequences in the human genome.",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-7b-chat-hf_response": "Yes, linker histones are present in the yeast genome. Linker histones are histones that are not part of the nucleosome, but instead are located between the nucleosomes. In yeast, there are two linker histones: H2A.Z and H3.3. These histones are involved in the regulation of chromatin structure and gene expression, and they play a role in the repair of DNA damage.",
    "llama-2-7b-chat-hf_fact": [
      "Linker histones exist in the yeast genome.",
      "Linker histones are histones that are located between the nucleosomes, and not part of the nucleosome.",
      "In yeast, there are two types of linker histones: H2A.Z and H3.3.",
      "Linker histones are involved in the regulation of chromatin structure and gene expression.",
      "Linker histones play a role in the repair of DNA damage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: In yeast, there is no canonical linker histone like H1. H2A.Z and H3.3 are variants of core histones, not linker histones.",
      "true",
      "true"
    ]
  },
  {
    "id": 410,
    "user_query": "What is the role of deadenylases in the cell?",
    "llama-2-7b-chat-hf_response": "Deadenylases are enzymes that play a crucial role in the regulation of gene expression by removing the poly(A) tail from messenger RNA (mRNA). The poly(A) tail is a long sequence of adenine nucleotides that is added to the 3' end of mRNA after transcription. The removal of the poly(A) tail by deadenylases is important for several reasons:\n1. mRNA degradation: The poly(A) tail acts as a protective shield that prevents mRNA from being degraded by exonucleases. Once the poly(A) tail is removed by deadenylases, the mRNA is more susceptible to degradation by exonucleases, leading to a decrease in mRNA levels.\n2. Translation initiation: The presence of a long poly(A) tail on mRNA can inhibit translation initiation by blocking the binding of ribosomes to the mRNA. Once the poly(A) tail is removed by deadenylases, the mRNA becomes more accessible to ribosomes, allowing for translation initiation to occur.\n3. mRNA localization: The poly(A) tail can influence the localization of mRNA within the cell. For example, some mRNAs with long poly(A) tails are localized to the cytoplasm, while others are localized to the nucleus. The removal of the poly(A) tail by deadenylases can alter the localization of mRNA, allowing it to be transported to different cellular compartments.\n4. miRNA function: Deadenylases can also play a role in the function of microRNAs (miRNAs), which are small RNAs that regulate gene expression by binding to mRNA. miRNAs can bind to the 3' untranslated region (UTR) of mRNA, and the presence of a long poly(A) tail can inhibit this binding. Once the poly(A) tail is removed by deadenylases, the 3' UTR becomes more accessible to miRNAs, allowing for more efficient binding and regulation of gene expression.\nIn summary, deadenylases play a crucial role in",
    "llama-2-7b-chat-hf_fact": [
      "Deadenylases are enzymes that regulate gene expression by removing the poly(A) tail from messenger RNA (mRNA).",
      "The poly(A) tail is a sequence of adenine nucleotides that is added to the 3' end of mRNA after transcription.",
      "The removal of the poly(A) tail makes mRNA more susceptible to degradation by exonucleases.",
      "Deadenylases can influence the localization of mRNA within the cell.",
      "Deadenylases can play a role in the function of microRNAs (miRNAs), small RNAs that regulate gene expression by binding to mRNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 412,
    "user_query": "How long, in kb (kilobases),  is a \"Long interspersed nuclear element\"?",
    "llama-2-7b-chat-hf_response": "A Long Interspersed Nuclear Element (LINE) is a type of retrotransposon, which is a mobile genetic element that can insert itself into new locations within a genome. LINEs are typically around 1,000-2,000 base pairs (bp) in length, although some can be as short as 500 bp or as long as 10,000 bp.",
    "llama-2-7b-chat-hf_fact": [
      "A Long Interspersed Nuclear Element (LINE) is a mobile genetic element.",
      "A LINE can insert itself into new locations within a genome.",
      "LINEs are typically around 1,000-2,000 base pairs in length.",
      "Some LINEs can be as short as 500 base pairs.",
      "Some LINEs can be as long as 10,000 base pairs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: LINEs are typically around 6,000-8,000 base pairs in length.",
      "false, [corrected fact]: LINEs are not typically as short as 500 base pairs.",
      "true"
    ]
  },
  {
    "id": 414,
    "user_query": "List receptors of the drug Cilengitide",
    "llama-2-7b-chat-hf_response": "Cilengitide is a drug used in the treatment of glioblastoma, a type of brain cancer. It works by inhibiting the activity of a protein called integrin alpha v beta 3, which is involved in the growth and spread of cancer cells. Here are some of the receptors that cilengitide binds to:\n1. Integrin alpha v beta 3: Cilengitide selectively binds to the integrin alpha v beta 3 receptor, which is overexpressed on the surface of many types of cancer cells, including glioblastoma cells. By binding to this receptor, cilengitide inhibits the activity of the protein and slows the growth and spread of the cancer cells.\n2. Vascular endothelial growth factor (VEGF): Cilengitide also binds to VEGF, a protein that is involved in the formation of new blood vessels in the body. By binding to VEGF, cilengitide inhibits the formation of new blood vessels in the tumor, which can slow the growth and spread of the cancer.\n3. Fibrinogen: Cilengitide also binds to fibrinogen, a protein that is involved in the formation of blood clots. By binding to fibrinogen, cilengitide can help to prevent the formation of blood clots in the tumor, which can reduce the risk of complications such as stroke or pulmonary embolism.\n4. Platelet-derived growth factor (PDGF): Cilengitide also binds to PDGF, a protein that is involved in the growth and spread of cancer cells. By binding to PDGF, cilengitide can inhibit the activity of the protein and slow the growth and spread of the cancer cells.\n5. Epidermal growth factor receptor (EGFR): Cilengitide also binds to EGFR, a protein that is involved in the growth and spread of cancer cells. By binding to EGFR, cilengitide can inhibit the activity of the protein and slow the growth and spread of the cancer cells.\n6. Cadherin-17: Cilengitide also binds to cadherin-17, a protein that is involved in the ad",
    "llama-2-7b-chat-hf_fact": [
      "Cilengitide is a drug used in the treatment of glioblastoma, a type of brain cancer.",
      "Cilengitide works by inhibiting the activity of a protein called integrin alpha v beta 3.",
      "Integrin alpha v beta 3 is involved in the growth and spread of cancer cells.",
      "Cilengitide can bind to various proteins, including vascular endothelial growth factor (VEGF), fibrinogen, platelet-derived growth factor (PDGF), epidermal growth factor receptor (EGFR) and Cadherin-17.",
      "Cilengitide, by binding to these proteins, inhibits their activities, which are all involved in either the growth and spread of cancer cells, the formation of new blood vessels in tumors, the formation of blood clots in tumors, or in cell adhesion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Cilengitide is an inhibitor of integrins, not all the proteins mentioned. It specifically targets the integrins alpha v beta 3 and alpha v beta 5.",
      "false, [corrected fact]: Cilengitide binds to integrins alpha v beta 3 and alpha v beta 5, inhibiting their activities which are involved in the growth and spread of cancer cells, and the formation of new blood vessels in tumors. It does not bind to or inhibit the activities of VEGF, fibrinogen, PDGF, EGFR, or Cadherin-17."
    ]
  },
  {
    "id": 415,
    "user_query": "Can protein coding exons originate from ALU sequences?",
    "llama-2-7b-chat-hf_response": "Protein-coding exons are regions of DNA that are spliced together to form mature RNA molecules that encode proteins. These exons are typically found in the coding regions of genes, but can they also originate from non-coding regions like ALU (Alu) sequences?\nALU (Alu) sequences are short, repetitive DNA elements that are found throughout the human genome. They are thought to be remnants of ancient retrotransposons, which are mobile genetic elements that can insert themselves into new locations within the genome. While ALU sequences are not typically considered to be part of the protein-coding regions of genes, recent studies have suggested that they may play a role in the evolution of protein-coding genes.\nOne study published in the journal Nature Communications in 2019 found that a significant proportion of protein-coding exons in the human genome appear to have originated from ALU sequences. The researchers used a computational approach to identify exons that were likely to have arisen from ALU sequences, based on their location and sequence characteristics. They found that approximately 10% of protein-coding exons in the human genome could be traced back to ALU sequences.\nThe study suggests that ALU sequences may have played a role in the evolution of protein-coding genes by providing a source of new genetic material that could be incorporated into the protein-coding regions of genes. This could have occurred through a process known as retrotransposition, in which mobile genetic elements like ALU sequences are inserted into new locations within the genome. Over time, these insertions could have accumulated and led to the creation of new protein-coding exons.\nWhile the study suggests that protein-coding exons can originate from ALU sequences, it's important to note that this is not a common occurrence. Most protein-coding exons are thought to arise from the coding regions of genes themselves, rather than from non-coding regions like ALU sequences.\nIn summary, while protein-coding exons can originate from ALU sequences, this is a relatively rare occurrence. Most protein-coding exons are thought to arise from the coding regions of genes themselves, rather than from non-coding regions like ALU sequences. However, the study suggests that ALU",
    "llama-2-7b-chat-hf_fact": [
      "Protein-coding exons are regions of DNA that are spliced together to form mature RNA molecules that encode proteins.",
      "ALU sequences are short, repetitive DNA elements found throughout the human genome and are thought to be remnants of ancient retrotransposons.",
      "A study published in Nature Communications in 2019 found that about 10% of protein-coding exons in the human genome originated from ALU sequences.",
      "The study suggests that ALU sequences might have contributed to the evolution of protein-coding genes through retrotransposition, a process of inserting mobile genetic elements into new genome locations.",
      "Most protein-coding exons are thought to arise from the coding regions of genes themselves, rather than from non-coding regions like ALU sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-7b-chat-hf_response": "There is some evidence to suggest that drinking tomato juice may help lower cholesterol levels, although the evidence is not yet conclusive.\nSome studies have found that drinking tomato juice can help reduce levels of low-density lipoprotein (LDL) cholesterol, also known as \"bad\" cholesterol, and increase levels of high-density lipoprotein (HDL) cholesterol, also known as \"good\" cholesterol.\nFor example, a 2013 study published in the Journal of Functional Foods found that drinking tomato juice for 12 weeks resulted in significant reductions in LDL cholesterol and increases in HDL cholesterol in healthy adults.\nAnother study published in 2016 in the Journal of Nutrition and Metabolism found that drinking tomato juice for 8 weeks resulted in significant reductions in LDL cholesterol and increases in HDL cholesterol in people with high cholesterol levels.\nIt's thought that the lycopene and other antioxidants in tomato juice may contribute to these cholesterol-lowering effects. Lycopene is a powerful antioxidant that has been shown to have a number of health benefits, including reducing the risk of certain types of cancer and heart disease.\nHowever, it's important to note that the evidence for the cholesterol-lowering effects of tomato juice is still emerging and more research is needed to confirm these findings. Additionally, while tomato juice may help lower cholesterol levels, it's unlikely to have a significant impact on overall cholesterol levels without other lifestyle changes, such as a healthy diet and regular exercise.\nIn summary, while there is some evidence to suggest that tomato juice may help lower cholesterol levels, more research is needed to confirm these findings and to determine the optimal dosage and duration of tomato juice consumption for cholesterol-lowering effects.",
    "llama-2-7b-chat-hf_fact": [
      "Some studies suggest that drinking tomato juice can potentially reduce LDL cholesterol and increase HDL cholesterol.",
      "A 2013 study published in the Journal of Functional Foods reported that drinking tomato juice for 12 weeks led to significant reductions in LDL cholesterol and increases in HDL cholesterol in healthy adults.",
      "A 2016 study published in the Journal of Nutrition and Metabolism reported that drinking tomato juice for 8 weeks led to significant reductions in LDL cholesterol and increases in HDL cholesterol in people with high cholesterol levels.",
      "Lycopene, an antioxidant found in tomatoes, may contribute to this cholesterol-lowering effect.",
      "Lycopene has been shown to reduce the risk of certain types of cancer and heart disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: THERE IS NO EVIDENCE OF SUCH A STUDY PUBLISHED IN THE JOURNAL OF FUNCTIONAL FOODS IN 2013",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 423,
    "user_query": "What is the mode of inheritance of nemaline myopathy?",
    "llama-2-7b-chat-hf_response": "Nemaline myopathy is a rare genetic disorder that affects the muscles and is characterized by muscle weakness, muscle wasting, and muscle cramps. The mode of inheritance of nemaline myopathy is X-linked recessive, which means that the mutated gene responsible for the disorder is located on the X chromosome and is more common in males, who have only one X chromosome. Females, who have two X chromosomes, are less likely to be affected but can be carriers of the mutated gene.",
    "llama-2-7b-chat-hf_fact": [
      "Nemaline myopathy is a rare genetic disorder.",
      "Nemaline myopathy affects the muscles and can lead to muscle weakness, muscle wasting, and muscle cramps.",
      "The mode of inheritance of nemaline myopathy is X-linked recessive.",
      "The mutated gene responsible for nemaline myopathy is located on the X chromosome.",
      "Males, who have only one X chromosome, are more likely to be affected by nemaline myopathy, while females can be carriers of the mutated gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The mode of inheritance of nemaline myopathy is generally autosomal dominant or autosomal recessive, not X-linked recessive.",
      "false, [corrected fact]: The mutated genes responsible for nemaline myopathy are not located on the X chromosome but on various autosomes.",
      "false, [corrected fact]: Both males and females are affected by nemaline myopathy equally because it is not an X-linked disorder."
    ]
  },
  {
    "id": 432,
    "user_query": "Is it possible to detect survivin protein expression in normal human adult tissues?",
    "llama-2-7b-chat-hf_response": "Yes, survivin protein expression can be detected in normal human adult tissues. Survivin is a member of the inhibitor of apoptosis (IAP) protein family and is known to play a role in the regulation of apoptosis, or programmed cell death, in various types of cells. While survivin is often overexpressed in cancer cells, it is also expressed at lower levels in normal adult tissues, including the brain, heart, liver, and pancreas.\nStudies have shown that survivin protein expression can be detected in various normal adult tissues, including:\n1. Brain: Survivin protein expression has been detected in the brain, particularly in the cerebral cortex, hippocampus, and cerebellum.\n2. Heart: Survivin protein expression has been detected in the heart, particularly in the myocardium and endocardium.\n3. Liver: Survivin protein expression has been detected in the liver, particularly in the hepatocytes and bile ducts.\n4. Pancreas: Survivin protein expression has been detected in the pancreas, particularly in the islets of Langerhans.\n5. Lungs: Survivin protein expression has been detected in the lungs, particularly in the alveolar type II cells.\n6. Skin: Survivin protein expression has been detected in the skin, particularly in the keratinocytes.\n7. Muscle: Survivin protein expression has been detected in skeletal muscle, particularly in the muscle fibers.\n8. Bone marrow: Survivin protein expression has been detected in the bone marrow, particularly in the hematopoietic cells.\n9. Kidneys: Survivin protein expression has been detected in the kidneys, particularly in the proximal tubular cells.\n10. Adipose tissue: Survivin protein expression has been detected in adipose tissue, particularly in the white adipocytes.\nIt is important to note that while survivin protein expression can be detected in normal adult tissues, the levels of expression may be lower compared to cancer cells. Additionally, the expression of survivin in normal tissues may be regulated by various factors, such as developmental stage, tissue type, and",
    "llama-2-7b-chat-hf_fact": [
      "Survivin protein expression can be detected in normal human adult tissues.",
      "Survivin is a member of the inhibitor of apoptosis (IAP) protein family and plays a role in the regulation of programmed cell death.",
      "Survivin protein expression is present in the brain, heart, liver, and pancreas.",
      "Studies indicate that survivin protein expression can also be found in the lungs, skin, skeletal muscle, bone marrow, kidneys, and adipose tissue.",
      "The levels of survivin protein expression in normal tissues may be lower compared to that in cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 433,
    "user_query": "List symptoms of Meigs' Syndrome.",
    "llama-2-7b-chat-hf_response": "Meigs' Syndrome is a rare medical condition that affects the small intestine and can cause a range of symptoms, including:\n1. Abdominal pain: Pain in the abdomen is the most common symptom of Meigs' Syndrome. The pain can be constant or intermittent and may be located in the upper or lower abdomen.\n2. Diarrhea: Patients with Meigs' Syndrome may experience diarrhea, which can be severe and persistent.\n3. Weight loss: Loss of weight can occur due to malabsorption of nutrients in the small intestine.\n4. Fatigue: Fatigue is another common symptom of Meigs' Syndrome, which can make it difficult to carry out daily activities.\n5. Nausea and vomiting: Patients with Meigs' Syndrome may experience nausea and vomiting, which can lead to dehydration and electrolyte imbalances.\n6. Abdominal bloating: Some patients with Meigs' Syndrome may experience abdominal bloating, which can be uncomfortable and painful.\n7. Rectal bleeding: In some cases, Meigs' Syndrome can cause rectal bleeding, which can be a sign of inflammation in the small intestine.\n8. Anemia: Malabsorption of nutrients in the small intestine can lead to anemia, which can cause fatigue, weakness, and shortness of breath.\n9. Vitamin deficiencies: Meigs' Syndrome can cause deficiencies in vitamins such as vitamin B12 and iron, which can lead to a range of symptoms including fatigue, weakness, and pale skin.\n10. Intestinal obstruction: In rare cases, Meigs' Syndrome can cause intestinal obstruction, which can lead to abdominal pain, nausea, vomiting, and constipation.\nIt is important to note that the symptoms of Meigs' Syndrome can vary in severity and frequency, and some patients may experience only a few of these symptoms. If you are experiencing any of these symptoms, it is important to consult with a healthcare provider for proper diagnosis and",
    "llama-2-7b-chat-hf_fact": [
      "Meigs' Syndrome is a medical condition that affects the small intestine.",
      "Common symptoms of Meigs' Syndrome include abdominal pain, diarrhea, weight loss, and fatigue.",
      "Meigs' Syndrome can cause nausea, vomiting, and abdominal bloating.",
      "More severe symptoms of Meigs' Syndrome may include rectal bleeding, anemia, vitamin deficiencies, and intestinal obstruction.",
      "Severity and frequency of Meigs' Syndrome symptoms can vary among patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Meigs' Syndrome is a medical condition that primarily affects the ovaries, not the small intestine.",
      "false, [corrected fact]: Common symptoms of Meigs' Syndrome include pleural effusion, ascites, and a benign ovarian tumor.",
      "false, [corrected fact]: These symptoms are not associated with Meigs' Syndrome but rather could be indications of gastrointestinal disorders.",
      "false, [corrected fact]: These severe symptoms are not associated with Meigs' Syndrome but could indicate a gastrointestinal disorder.",
      "true"
    ]
  },
  {
    "id": 435,
    "user_query": "What is the molecular function of psoralen photobinding on DNA?",
    "llama-2-7b-chat-hf_response": "Psoralen is a naturally occurring compound that has been shown to bind to DNA and undergo photochemical reactions upon exposure to ultraviolet (UV) light. The molecular function of psoralen photobinding on DNA is not fully understood, but several studies have suggested that it may play a role in the regulation of gene expression.\nOne study found that psoralen binds to the minor groove of double-stranded DNA and inhibits the activity of the DNA-dependent protein kinase, which is involved in the repair of DNA damage. This suggests that psoralen may interfere with the repair of DNA damage, leading to the accumulation of mutations and potentially contributing to the development of cancer.\nAnother study found that psoralen can induce the formation of DNA adducts, which are stable complexes between DNA and psoralen. These adducts can lead to the formation of mutagenic hotspots and may contribute to the development of cancer.\nOverall, the molecular function of psoralen photobinding on DNA is complex and multifaceted, and further research is needed to fully understand its mechanisms of action. However, it is clear that psoralen has the potential to play a role in the regulation of gene expression and the development of cancer, and further studies are needed to explore its therapeutic potential in these areas.",
    "llama-2-7b-chat-hf_fact": [
      "Psoralen is a naturally occurring compound that binds to DNA.",
      "Upon exposure to ultraviolet (UV) light, psoralen undergoes photochemical reactions.",
      "Psoralen has been found to inhibit the activity of the DNA-dependent protein kinase.",
      "Psoralen can induce the formation of DNA adducts, which are stable complexes between DNA and psoralen.",
      "DNA adducts can lead to the formation of mutagenic hotspots and may contribute to the development of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 440,
    "user_query": "Which are the main causes of fetal echogenic bowel?",
    "llama-2-7b-chat-hf_response": "Fetal echogenic bowel is a condition where the bowel is more echogenic (brighter) than the surrounding tissues on an ultrasound image. This can be caused by a variety of factors, including:\n1. Genetic disorders: Some genetic disorders, such as Down syndrome, can cause fetal echogenic bowel.\n2. Intrauterine infections: Infections that occur in the uterus during pregnancy can cause fetal echogenic bowel.\n3. Placental insufficiency: When the placenta is not functioning properly, it can cause fetal echogenic bowel.\n4. Fetal growth restriction: When the fetus is not growing at a normal rate, it can cause fetal echogenic bowel.\n5. Multiple gestations: Fetal echogenic bowel is more common in multiple gestations, such as twins or triplets.\n6. Maternal hypertension: High blood pressure in the mother during pregnancy can cause fetal echogenic bowel.\n7. Maternal diabetes: Diabetes in the mother during pregnancy can cause fetal echogenic bowel.\n8. Fetal anomalies: Fetal echogenic bowel can be a sign of certain fetal anomalies, such as gastroschisis or omphalocele.\n9. Umbilical cord abnormalities: Abnormalities in the umbilical cord, such as knots or kinking, can cause fetal echogenic bowel.\n10. Unknown causes: In some cases, the cause of fetal echogenic bowel may not be identified.\nIt is important to note that fetal echogenic bowel is not always a sign of a serious condition, and in some cases, it may resolve on its own without any complications. However, it is important to discuss any concerns with a healthcare provider to rule out any potential problems.",
    "llama-2-7b-chat-hf_fact": [
      "Fetal echogenic bowel is a condition where the bowel is brighter than the surrounding tissues on an ultrasound image.",
      "Some genetic disorders, like Down syndrome, can cause fetal echogenic bowel.",
      "Fetal echogenic bowel can result from intrauterine infections during pregnancy.",
      "Fetal echogenic bowel can be caused when the placenta isn't functioning properly.",
      "Fetal echogenic bowel is more common in multiple gestations, like twins or triplets."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 442,
    "user_query": "Which is the enzymatic activity of the myotubularin family of proteins?",
    "llama-2-7b-chat-hf_response": "Myotubularin proteins are a family of enzymes that play a crucial role in the regulation of lipid metabolism, particularly in the muscle tissue. They are involved in the hydrolysis of phosphatidylinositol 3,4,5-trisphosphate (PIP3) to phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2). This enzymatic activity is important for the regulation of various cellular processes, including cell signaling, membrane trafficking, and protein kinase activity.\nThe myotubularin family of proteins consists of three members: myotubularin-related protein 1 (MTMR1), myotubularin-related protein 2 (MTMR2), and myotubularin-related protein 3 (MTMR3). These proteins are ubiquitously expressed in various tissues, including muscle, brain, and liver.\nThe enzymatic activity of the myotubularin family of proteins is as follows:\n* Myotubularin-related protein 1 (MTMR1) hydrolyzes PIP3 to PI4P and PI(3,4)P2.\n* Myotubularin-related protein 2 (MTMR2) hydrolyzes PIP3 to PI4P and PI(3,4)P2.\n* Myotubularin-related protein 3 (MTMR3) hydrolyzes PIP3 to PI4P and PI(3,4)P2.\nIn summary, the myotubularin family of proteins is involved in the hydrolysis of PIP3 to PI4P and PI(3,4)P2, which plays a crucial role in the regulation of various cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Myotubularin proteins play a role in the regulation of lipid metabolism, especially in muscle tissue.",
      "These proteins are involved in the hydrolysis of phosphatidylinositol 3,4,5-trisphosphate (PIP3) to phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2).",
      "The enzymatic activity of myotubularin proteins is crucial for the regulation of cell signaling, membrane trafficking, and protein kinase activity.",
      "The myotubularin family of proteins includes myotubularin-related protein 1 (MTMR1), myotubularin-related protein 2 (MTMR2), and myotubularin-related protein 3 (MTMR3).",
      "MTMR1, MTMR2, and MTMR3 all hydrolyze PIP3 to PI4P and PI(3,4)P2."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 445,
    "user_query": "Is there any relationship between histone ubiquitylation and splicing?",
    "llama-2-7b-chat-hf_response": "Histone ubiquitination is a post-translational modification that plays a crucial role in various cellular processes, including chromatin remodeling, transcriptional activation, and DNA repair. Recent studies have also implicated histone ubiquitination in the regulation of RNA splicing, a critical process that involves the removal of introns and the joining of exons to form mature RNA molecules.\nOne of the key mechanisms by which histone ubiquitination regulates splicing is through the recruitment of splicing factors to specific genomic regions. Ubiquitinated histones can act as a platform for the assembly of splicing complexes, facilitating the recognition and binding of splicing factors to specific pre-mRNA sequences. This can lead to the activation or repression of specific splicing events, depending on the type of ubiquitination and the splicing factors involved.\nAnother mechanism by which histone ubiquitination regulates splicing is through the modulation of the splicing machinery itself. Ubiquitinated histones can interact with the splicing machinery, such as the spliceosome, and alter its activity or stability. This can result in changes in the splicing patterns of specific pre-mRNAs, leading to the production of different isoforms of proteins or other RNA molecules.\nOverall, the relationship between histone ubiquitination and splicing is complex and multifaceted, and further research is needed to fully understand the mechanisms by which these two processes interact. However, it is clear that histone ubiquitination plays an important role in the regulation of RNA splicing, and that dysregulation of these processes can have significant consequences for cellular function and disease.",
    "llama-2-7b-chat-hf_fact": [
      "Histone ubiquitination is a post-translational modification involved in various cellular processes, including chromatin remodeling, transcriptional activation, and DNA repair.",
      "Recent studies have shown that histone ubiquitination is implicated in the regulation of RNA splicing.",
      "Histone ubiquitination regulates splicing by recruiting splicing factors to specific genomic regions.",
      "Ubiquitinated histones can interact with the splicing machinery and alter its activity or stability, affecting the splicing patterns of specific pre-mRNAs.",
      "Dysregulation of histone ubiquitination and RNA splicing can have significant consequences for cellular function and disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 448,
    "user_query": "What are the advantages of the top down mass spectrometric analysis of histones?",
    "llama-2-7b-chat-hf_response": "Top-down mass spectrometry is a technique used to analyze histones, which are proteins that play a crucial role in the structure and function of chromatin, the complex of DNA and proteins that make up the chromosomes in eukaryotic cells. The advantages of top-down mass spectrometry for analyzing histones include:\n1. High resolution: Top-down mass spectrometry can provide high-resolution mass measurements of histones, allowing for the detection of small differences in mass between different histone variants or post-translational modifications.\n2. Sensitivity: Top-down mass spectrometry is highly sensitive, allowing for the detection of low-abundance histone variants or modifications in complex histone mixtures.\n3. Identification of post-translational modifications: Top-down mass spectrometry can be used to identify and quantify specific post-translational modifications (PTMs) on histones, such as acetylation, methylation, and phosphorylation.\n4. Identification of histone variants: Top-down mass spectrometry can be used to identify and quantify different histone variants in a sample, which can provide information on the epigenetic state of the chromatin.\n5. Ability to analyze histones in complex mixtures: Top-down mass spectrometry can be used to analyze histones in complex mixtures, such as those found in nuclear extracts or chromatin immunoprecipitation (ChIP) samples.\n6. Reduced sample consumption: Top-down mass spectrometry requires less sample material than other mass spectrometry techniques, such as bottom-up analysis, which can be advantageous for analyzing rare or limited sample materials.\n7. Improved accuracy: Top-down mass spectrometry can provide more accurate mass measurements than other techniques, which can be important for identifying and quantifying histone modifications.\n8. Increased throughput: Top-down mass spectrometry can be used to analyze multiple samples in parallel, which can increase the throughput of the analysis.\n9. Reduced contamination: Top-down mass spectrometry can be less prone to contamination than other techniques, which can be important for analyzing histones in complex samples.\n10",
    "llama-2-7b-chat-hf_fact": [
      "Top-down mass spectrometry is a technique used to analyze histones.",
      "Histones play a crucial role in the structure and function of chromatin, which makes up the chromosomes in eukaryotic cells.",
      "Top-down mass spectrometry can provide high-resolution mass measurements of histones.",
      "Top-down mass spectrometry can be used to identify and quantify specific post-translational modifications (PTMs) on histones, such as acetylation, methylation, and phosphorylation.",
      "Top-down mass spectrometry requires less sample material than other mass spectrometry techniques."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 451,
    "user_query": "What is the indication of Daonil (Glibenclamide)?",
    "llama-2-7b-chat-hf_response": "What are the contraindications of Daonil (Glibenclamide)?\nWhat are the side effects of Daonil (Glibenclamide)?\nWhat are the special precautions to be taken while taking Daonil (Glibenclamide)?\nWhat are the drug interactions of Daonil (Glibenclamide)?\nWhat are the missed dose of Daonil (Glibenclamide)?\nWhat are the overdose of Daonil (Glibenclamide)?\nDaonil (Glibenclamide) is an oral hypoglycemic medication used to treat type 2 diabetes mellitus. It works by increasing the amount of glucose released from the liver and decreasing the amount of glucose produced by the liver.\nIndications:\nDaonil (Glibenclamide) is indicated for the management of type 2 diabetes mellitus. It is used in combination with diet and exercise to improve glycemic control in patients with type 2 diabetes.\nContraindications:\nDaonil (Glibenclamide) is contraindicated in patients with:\n1. Known hypersensitivity to glibenclamide or any other sulfonylurea.\n2. Diabetic ketoacidosis or non-ketotic hyperosmolar coma.\n3. Severe renal or hepatic impairment.\n4. Pregnancy and lactation.\n5. Children and adolescents under 18 years of age.\nSide effects:\nCommon side effects of Daonil (Glibenclamide) include:\n1. Hypoglycemia (low blood sugar).\n2. Nausea and vomiting.\n3. Diarrhea.\n4. Abdominal pain.\n5. Headache.\n6. Fatigue.\n7. Dizziness.\n8. Skin rash.\nSpecial precautions:\n1. Daonil (Glibenclamide) should be used with caution in patients with hepatic impairment.\n2. Daonil (Glibenclamide) should be used with caution in patients with renal impairment.\n3. Daonil",
    "llama-2-7b-chat-hf_fact": [
      "Daonil (Glibenclamide) is an oral hypoglycemic medication.",
      "Daonil (Glibenclamide) is used to treat type 2 diabetes mellitus.",
      "Daonil works by increasing the glucose released from the liver and decreasing the glucose produced by the liver.",
      "Consumption of Daonil (Glibenclamide) is contraindicated during pregnancy and lactation, and for patients under 18 years of age.",
      "Common side effects of Daonil (Glibenclamide) include hypoglycemia, nausea, vomiting, diarrhea, abdominal pain, headache, fatigue, dizziness, and skin rash."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Daonil (Glibenclamide) works by stimulating the cells in the pancreas to produce more insulin, thereby decreasing glucose levels in the blood.",
      "true",
      "true"
    ]
  },
  {
    "id": 452,
    "user_query": "Which is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus?",
    "llama-2-7b-chat-hf_response": "The retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is mediated by a variety of peptide sequences. However, one of the most typical peptide sequences responsible for this process is the ER retention sequence (K/R)X(K/R)X(K/R)X, where X is any amino acid except proline.\nThis peptide sequence is recognized by the ER-resident chaperone protein, calreticulin, which binds to the sequence and facilitates the retrieval of the protein from the Golgi apparatus back to the ER lumen. The (K/R)X(K/R)X(K/R)X sequence is found in many ER lumenal proteins and plays a crucial role in their proper folding and targeting to the ER lumen.\nOther peptide sequences that have been identified as important for ER retention include the ER retention sequence (R/K)X(R/K)X(R/K)X, the (R/K)X(R/K)X(R/K)X(R/K)X sequence, and the (R/K)X(R/K)X(R/K)X(R/K)X(R/K)X sequence. However, the (K/R)X(K/R)X(K/R)X sequence is the most well-studied and widely recognized ER retention sequence.\nIn summary, the most typical peptide sequence responsible for retrieval of ER lumenal proteins from the Golgi apparatus is the (K/R)X(K/R)X(K/R)X sequence, which is recognized by the ER-resident chaperone protein, calreticulin.",
    "llama-2-7b-chat-hf_fact": [
      "The retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is mediated by a variety of peptide sequences.",
      "The most typical peptide sequence responsible for this process is the ER retention sequence (K/R)X(K/R)X(K/R)X.",
      "This peptide sequence, (K/R)X(K/R)X(K/R)X, is recognized by the ER-resident chaperone protein, calreticulin.",
      "The ER retention sequence is found in many ER lumenal proteins and plays a role in their proper folding and targeting to the ER lumen.",
      "Other sequences important for ER retention include (R/K)X(R/K)X(R/K)X, (R/K)X(R/K)X(R/K)X(R/K)X, and (R/K)X(R/K)X(R/K)X(R/K)X(R/K)X."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 454,
    "user_query": "List the main proteases used for sample digestion in proteomics.",
    "llama-2-7b-chat-hf_response": "Proteases are enzymes that break peptide bonds in proteins, and they play a crucial role in protein digestion and degradation. In proteomics, proteases are used to break proteins into smaller peptides and proteolytic fragments, which can then be analyzed using mass spectrometry. Here are some of the main proteases used for sample digestion in proteomics:\n1. Trypsin: Trypsin is a serine protease that is commonly used for protein digestion in proteomics. It recognizes and cleaves peptide bonds after the amino acids arginine and lysine.\n2. Chymotrypsin: Chymotrypsin is another serine protease that is often used for protein digestion in proteomics. It recognizes and cleaves peptide bonds after the amino acids tyrosine, tryptophan, and phenylalanine.\n3. Peptidylglutamyl peptide hydrolase (PGPH): PGPH is a cysteine protease that is used to digest proteins in proteomics. It recognizes and cleaves peptide bonds after the amino acid glutamine.\n4. Aspartic protease: Aspartic protease is a cysteine protease that is used for protein digestion in proteomics. It recognizes and cleaves peptide bonds after the amino acids aspartic acid and glutamic acid.\n5. Matrix metalloproteinases (MMPs): MMPs are a family of zinc-dependent proteases that are used for protein digestion in proteomics. They recognize and cleave peptide bonds in proteins, leading to the degradation of the protein into smaller peptides and proteolytic fragments.\n6. Carboxypeptidases: Carboxypeptidases are a family of proteases that are used for protein digestion in proteomics. They recognize and cleave peptide bonds after the amino acid carboxyl group.\n7. Thrombin: Thrombin is a serine protease that is used for protein digestion in proteomics. It recognizes and cleaves peptide bonds after the amino",
    "llama-2-7b-chat-hf_fact": [
      "Proteases are enzymes that break peptide bonds in proteins.",
      "Trypsin, a serine protease, is commonly used for protein digestion in proteomics and recognizes and cleaves peptide bonds after the amino acids arginine and lysine.",
      "Chymotrypsin is a serine protease often used for protein digestion in proteomics, and recognizes and cleaves peptide bonds after the amino acids tyrosine, tryptophan, and phenylalanine.",
      "Peptidylglutamyl peptide hydrolase (PGPH) is a cysteine protease used to digest proteins in proteomics and recognizes and cleaves peptide bonds after the amino acid glutamine.",
      "Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases used for protein digestion in proteomics."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 456,
    "user_query": "What is the association between Generalized anxiety disorder and mortality risk?",
    "llama-2-7b-chat-hf_response": "Generalized anxiety disorder (GAD) is a common mental disorder characterized by excessive, persistent, and intrusive worry about everyday things, lasting for at least 6 months. GAD has been associated with an increased risk of mortality from various causes, including cardiovascular disease, suicide, and all-cause mortality.\nStudies have shown that individuals with GAD have a higher risk of developing cardiovascular disease, which is a leading cause of mortality worldwide. This increased risk is thought to be due to the chronic stress and inflammation associated with GAD, which can lead to the development of atherosclerosis and other cardiovascular risk factors.\nGAD has also been linked to an increased risk of suicide. Studies have shown that individuals with GAD are at a higher risk of suicide compared to the general population, and that the risk increases with the severity of the disorder.\nFinally, GAD has been associated with an increased risk of all-cause mortality. Studies have shown that individuals with GAD have a higher risk of death from any cause compared to the general population, and that the risk increases with the severity of the disorder.\nIt is important to note that these associations are based on observational studies, and more research is needed to confirm these findings and to understand the underlying mechanisms. However, these findings suggest that GAD is a serious mental disorder that can have significant consequences for an individual's physical health and mortality risk.",
    "llama-2-7b-chat-hf_fact": [
      "Generalized anxiety disorder (GAD) is a mental disorder characterized by excessive, persistent, and intrusive worry about everyday things, lasting for at least 6 months.",
      "GAD is associated with an increased risk of mortality from cardiovascular disease, suicide, and all-cause mortality.",
      "Studies have shown that individuals with GAD have a higher risk of developing cardiovascular disease, due to the chronic stress and inflammation associated with the disorder.",
      "Individuals with GAD have been found to be at a higher risk of suicide compared to the general population.",
      "GAD has been associated with an increased risk of death from any cause."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 457,
    "user_query": "Which molecule is targeted by a monoclonal antibody Mepolizumab?",
    "llama-2-7b-chat-hf_response": "Mepolizumab is a monoclonal antibody that targets the protein interleukin-5 (IL-5). IL-5 is a cytokine that is involved in the inflammatory response and is overproduced in certain respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Mepolizumab works by binding to IL-5 and blocking its activity, which can help to reduce inflammation and improve lung function in people with these conditions.",
    "llama-2-7b-chat-hf_fact": [
      "Mepolizumab is a monoclonal antibody that targets the protein interleukin-5 (IL-5).",
      "Interleukin-5 (IL-5) is a cytokine that is involved in the inflammatory response.",
      "IL-5 is overproduced in certain respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD).",
      "Mepolizumab functions by binding to IL-5 and blocking its activity.",
      "The use of Mepolizumab can help to reduce inflammation and improve lung function in people with diseases such as asthma and COPD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 461,
    "user_query": "Which genes are affected in ROMANO-WARD syndrome?",
    "llama-2-7b-chat-hf_response": "ROMANO-WARD syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. It is caused by mutations in the KCNQ2 and KCNQ3 genes, which are responsible for producing potassium channels that regulate the flow of ions across the cell membrane. These mutations disrupt the normal functioning of these channels, leading to abnormal electrical activity in the brain and spinal cord.\nThe KCNQ2 and KCNQ3 genes are located on chromosome 2p16.1, and they are among the most commonly mutated genes in ROMANO-WARD syndrome. The mutations can occur in either the KCNQ2 or KCNQ3 gene, or in both genes simultaneously.\nROMANO-WARD syndrome is characterized by a range of symptoms, including intellectual disability, seizures, ataxia, and problems with vision and hearing. The disorder is usually diagnosed in infancy or early childhood, and it can have a significant impact on an individual's quality of life.\nThere is currently no cure for ROMANO-WARD syndrome, but various treatments can help manage the symptoms. These may include anticonvulsant medications to control seizures, physical therapy to improve mobility and coordination, and speech and language therapy to address communication difficulties.\nIn summary, ROMANO-WARD syndrome is a rare genetic disorder caused by mutations in the KCNQ2 and KCNQ3 genes. These genes are responsible for producing potassium channels that regulate the flow of ions across the cell membrane, and mutations in these genes can lead to abnormal electrical activity in the brain and spinal cord. The disorder is characterized by a range of symptoms, including intellectual disability, seizures, ataxia, and problems with vision and hearing, and it can have a significant impact on an individual's quality of life.",
    "llama-2-7b-chat-hf_fact": [
      "ROMANO-WARD syndrome is a genetic disorder that affects the development of the brain and spinal cord.",
      "The disorder is caused by mutations in the KCNQ2 and KCNQ3 genes, which are responsible for producing potassium channels.",
      "The KCNQ2 and KCNQ3 genes are located on chromosome 2p16.1.",
      "Symptoms of ROMANO-WARD syndrome include intellectual disability, seizures, ataxia, and problems with vision and hearing.",
      "There is currently no cure for ROMANO-WARD syndrome, but symptoms can be managed via various treatments including anticonvulsant medications, physical therapy, and speech and language therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: ROMANO-WARD syndrome is a genetic disorder that affects the heart's electrical system.",
      "true",
      "true",
      "false, [corrected fact]: Symptoms of ROMANO-WARD syndrome include long QT syndrome which can cause arrhythmias.",
      "true"
    ]
  },
  {
    "id": 462,
    "user_query": "Does melanoma  occur in people of African origin ?",
    "llama-2-7b-chat-hf_response": "Yes, melanoma can occur in people of African origin. Melanoma is a type of skin cancer that can affect anyone, regardless of their race or ethnicity. However, there are some factors that may increase the risk of developing melanoma in people of African descent.\nOne of the main risk factors for melanoma is exposure to ultraviolet (UV) radiation from the sun or tanning beds. People of African descent are more likely to have darker skin, which provides some natural protection against UV radiation. However, this does not mean that they are completely immune to the harmful effects of UV radiation, and they can still develop melanoma.\nOther risk factors for melanoma in people of African descent include:\n1. Family history: Having a family history of melanoma or other skin cancers can increase a person's risk of developing the disease.\n2. Age: The risk of developing melanoma increases with age, with most cases occurring in people over the age of 50.\n3. Skin type: People with darker skin are less likely to develop melanoma, but they are still at risk.\n4. Moles: Having a large number of moles, especially if they are irregular in shape and color, can increase the risk of developing melanoma.\n5. Weakened immune system: People with weakened immune systems, such as those with autoimmune disorders or who have undergone organ transplants, are at higher risk of developing melanoma.\n6. Environmental factors: Exposure to certain chemicals, such as pesticides and solvents, has been linked to an increased risk of melanoma.\n7. Genetics: Some people may be born with genetic mutations that increase their risk of developing melanoma.\nIt is important for people of African descent to be aware of these risk factors and to take steps to protect their skin from the sun and to detect melanoma early, when it is most treatable. This includes practicing sun safety, getting regular skin exams, and being aware of the signs and symptoms of melanoma.\nIn summary, melanoma can occur in people of African origin, and it is important for them to be aware of the risk factors and to take steps to protect their skin and detect the disease early.",
    "llama-2-7b-chat-hf_fact": [
      "Melanoma is a type of skin cancer that can affect anyone, regardless of their race or ethnicity.",
      "One of the main risk factors for melanoma is exposure to ultraviolet (UV) radiation from the sun or tanning beds.",
      "People with weakened immune systems, such as those with autoimmune disorders or who have undergone organ transplants, are at higher risk of developing melanoma.",
      "Exposure to certain chemicals, such as pesticides and solvents, has been linked to an increased risk of melanoma.",
      "Some people may be born with genetic mutations that increase their risk of developing melanoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 463,
    "user_query": "What is the effect of resveratrol on mTOR activity?",
    "llama-2-7b-chat-hf_response": "Resveratrol has been shown to have a variety of effects on cellular signaling pathways, including the mTOR (mechanistic target of rapamycin) pathway. mTOR is a key regulator of cell growth and metabolism, and dysregulation of the mTOR pathway has been implicated in a number of diseases, including cancer and metabolic disorders.\nResveratrol has been shown to inhibit the activity of mTOR in a number of ways, including:\n1. Inhibition of mTORC1: Resveratrol has been shown to inhibit the activity of mTORC1, a complex that plays a key role in regulating cell growth and metabolism.\n2. Inhibition of mTORC2: Resveratrol has also been shown to inhibit the activity of mTORC2, a complex that is involved in the regulation of cell growth and metabolism.\n3. Inhibition of the PI3K/Akt/mTOR signaling pathway: Resveratrol has been shown to inhibit the PI3K/Akt/mTOR signaling pathway, which is involved in the regulation of cell growth and metabolism.\n4. Inhibition of the mTORC1/S6K1 signaling pathway: Resveratrol has been shown to inhibit the mTORC1/S6K1 signaling pathway, which is involved in the regulation of protein synthesis and cell growth.\n5. Inhibition of the mTORC2/S6K1 signaling pathway: Resveratrol has been shown to inhibit the mTORC2/S6K1 signaling pathway, which is involved in the regulation of protein synthesis and cell growth.\n6. Inhibition of the mTORC1/4E-BP1 signaling pathway: Resveratrol has been shown to inhibit the mTORC1/4E-BP1 signaling pathway, which is involved in the regulation of protein synthesis and cell growth.\n7. Inhibition of the mTORC2/4E-BP1 signaling pathway: Resveratrol",
    "llama-2-7b-chat-hf_fact": [
      "Resveratrol is known to have various effects on cellular signaling pathways, including the mTOR pathway.",
      "mTOR, a key regulator of cell growth and metabolism, can become dysregulated and contribute to diseases such as cancer and metabolic disorders.",
      "Resveratrol has been shown to inhibit the activity of mTORC1 and mTORC2, both of which play roles in regulating cell growth and metabolism.",
      "The PI3K/Akt/mTOR and mTORC1/S6K1 signaling pathways, involved in cell growth and metabolism, can be inhibited by Resveratrol.",
      "Resveratrol has been shown to inhibit the mTORC2/S6K1 and mTORC1/4E-BP1 signaling pathways, which are involved in the regulation of protein synthesis and cell growth."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 464,
    "user_query": "Are people with blood group O protected against severe Malaria?",
    "llama-2-7b-chat-hf_response": "There is some evidence to suggest that people with blood group O may be protected against severe malaria. This is because the parasite that causes malaria, Plasmodium falciparum, has difficulty infecting red blood cells that have the O blood group antigen.",
    "llama-2-7b-chat-hf_fact": [
      "There is evidence suggesting that people with blood group O might have protection against severe malaria.",
      "The malaria disease is caused by the parasite called Plasmodium falciparum.",
      "According to some research, Plasmodium falciparum has difficulty infecting red blood cells with the O blood group antigen."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 467,
    "user_query": "What is the mechanism of action of solanezumab?",
    "llama-2-7b-chat-hf_response": "Solanezumab is an anti-amyloid monoclonal antibody that is used to treat Alzheimer's disease. The mechanism of action of solanezumab involves the binding of the antibody to beta-amyloid peptides, which are the main component of amyloid plaques in the brain. This binding leads to the removal of beta-amyloid peptides from the brain, which can help to slow down the progression of Alzheimer's disease. Additionally, solanezumab may also help to reduce inflammation and oxidative stress in the brain, which are also thought to contribute to the progression of Alzheimer's disease.",
    "llama-2-7b-chat-hf_fact": [
      "Solanezumab is an anti-amyloid monoclonal antibody used to treat Alzheimer's disease.",
      "The mechanism of action of solanezumab involves the binding of the antibody to beta-amyloid peptides.",
      "Beta-amyloid peptides are the main component of amyloid plaques in the brain.",
      "The binding of solanezumab to beta-amyloid peptides leads to their removal from the brain.",
      "Solanezumab may help to reduce inflammation and oxidative stress in the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Solanezumab is an anti-amyloid monoclonal antibody that was investigated as a potential treatment for Alzheimer's disease, but it has not been approved for this use due to lack of sufficient effectiveness.",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 469,
    "user_query": "What is the treatment of neuropathic pain in children?",
    "llama-2-7b-chat-hf_response": "Neuropathic pain in children can be challenging to diagnose and treat, as it can manifest differently than in adults. However, there are several treatment options available for managing neuropathic pain in children. Here are some of the most common treatment options:\n1. Medications: Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and opioids may be used to manage neuropathic pain in children. However, these medications should be used with caution and under the close supervision of a pediatrician or other healthcare provider, as they can have serious side effects.\n2. Physical therapy: Physical therapy can help children with neuropathic pain improve their mobility and reduce their discomfort. A physical therapist can teach children exercises to stretch and strengthen their muscles, as well as provide other pain management techniques.\n3. Alternative therapies: Alternative therapies such as acupuncture, massage, and music therapy may also be helpful in managing neuropathic pain in children. These therapies can help reduce pain and improve mood and overall well-being.\n4. Psychological interventions: Psychological interventions such as cognitive-behavioral therapy (CBT) and relaxation techniques can help children with neuropathic pain manage their pain and improve their mental health.\n5. Surgery: In some cases, surgery may be necessary to treat the underlying cause of neuropathic pain in children. For example, if the pain is caused by a tumor or other structural abnormality, surgery may be necessary to remove the tumor or correct the abnormality.\n6. Transcutaneous electrical nerve stimulation (TENS): TENS is a non-invasive treatment that involves using a small device to deliver electrical impulses to the nerves. This can help reduce pain and improve mobility.\n7. Spinal cord stimulation: Spinal cord stimulation is a more invasive treatment that involves using a small device to deliver electrical impulses to the spinal cord. This can help reduce pain and improve mobility.\n8. Intradural therapy: Intradural therapy involves delivering medication directly to the",
    "llama-2-7b-chat-hf_fact": [
      "Medications such as NSAIDs, acetaminophen, and opioids can be used to manage neuropathic pain in children.",
      "Physical therapy can be used to help children with neuropathic pain to improve their mobility and reduce discomfort.",
      "Alternative therapies like acupuncture, massage, and music therapy may be used in managing neuropathic pain in children.",
      "Psychological interventions like cognitive-behavioral therapy and relaxation techniques can be used in managing neuropathic pain in children.",
      "Treatments like transcutaneous electrical nerve stimulation and spinal cord stimulation can be used for pain management in children with neuropathic pain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 470,
    "user_query": "Which phenomenon is known as the \"calcium paradox\" in the isolated perfused heart?",
    "llama-2-7b-chat-hf_response": "A) The increase in cardiac output during hypoxia\nB) The decrease in cardiac output during hypoxia\nC) The increase in myocardial contractility during hypoxia\nD) The decrease in myocardial relaxation time during hypoxia\nAnswer: B) The decrease in cardiac output during hypoxia.\nExplanation: The \"calcium paradox\" refers to the observation that during hypoxia, the cardiac output of the isolated perfused heart decreases, despite an increase in myocardial contractility (C) and a decrease in myocardial relaxation time (D). This is thought to be due to a decrease in the amount of calcium available for muscle contraction, which outweighs the increases in contractility and relaxation time.",
    "llama-2-7b-chat-hf_fact": [
      "The \"calcium paradox\" refers to the decrease in cardiac output during hypoxia in the isolated perfused heart.",
      "Despite an increase in myocardial contractility and a decrease in myocardial relaxation time, cardiac output decreases during hypoxia.",
      "This decrease in cardiac output during hypoxia is thought to be due to a reduction in the amount of calcium available for muscle contraction.",
      "An increase in myocardial contractility occurs during hypoxia.",
      "A decrease in myocardial relaxation time happens during hypoxia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-7b-chat-hf_response": "Heat shock proteins (Hsps) are a family of proteins that play a crucial role in protecting cells against various types of stress, including heat stress. Two members of the Hsp family, Hsp70 and Hsp110, have been shown to affect mRNA stability.\nHsp70 is a chaperone protein that helps to fold and stabilize proteins, and it has been shown to play a role in mRNA stability by binding to the 3' untranslated region (UTR) of mRNAs and protecting them from degradation. Hsp110 is another chaperone protein that has been shown to play a role in mRNA stability by binding to the 5' UTR of mRNAs and protecting them from degradation.\nStudies have shown that Hsp70 and Hsp110 can bind to mRNAs and protect them from degradation by the RNA exosome, a complex of enzymes that degrade mRNAs. By binding to mRNAs, Hsp70 and Hsp110 can prevent the RNA exosome from recognizing and degrading the mRNAs, leading to increased mRNA stability.\nIn addition to protecting mRNAs from degradation, Hsp70 and Hsp110 can also affect the translation of mRNAs. Hsp70 has been shown to promote the translation of mRNAs by binding to the 3' UTR of mRNAs and recruiting ribosomes to initiate translation. Hsp110 has been shown to inhibit the translation of mRNAs by binding to the 5' UTR of mRNAs and preventing the recruitment of ribosomes.\nOverall, Hsp70 and Hsp110 play important roles in regulating mRNA stability and translation, and their dysregulation has been implicated in a variety of diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Heat shock proteins (Hsps) are a family of proteins that protect cells against various types of stress.",
      "Hsp70 and Hsp110, members of the Hsp family, have been observed to affect mRNA stability.",
      "Hsp70 can promote the translation of mRNAs by binding to the 3' untranslated region (UTR) of mRNAs and recruiting ribosomes.",
      "Hsp110 can inhibit the translation of mRNAs by binding to the 5' UTR of mRNAs and preventing the recruitment of ribosomes.",
      "Dysregulation of Hsp70 and Hsp110 has been implicated in a variety of diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 477,
    "user_query": "What is FINDbase?",
    "llama-2-7b-chat-hf_response": "FINDbase is a comprehensive database of functional interaction networks (FINs) that integrates information on protein-protein interactions (PPIs), protein-DNA interactions (PDIs), and protein-RNA interactions (PRIs). FINDbase is a valuable resource for researchers studying the complex interactions between proteins, DNA, RNA, and other molecules in various biological processes.",
    "llama-2-7b-chat-hf_fact": [
      "FINDbase is a database of functional interaction networks.",
      "This database integrates information on protein-protein interactions.",
      "It also includes data about protein-DNA interactions.",
      "Information about protein-RNA interactions is included in FINDbase as well.",
      "FINDbase is used by researchers studying complex interactions between proteins, DNA, RNA, and other molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: FINDbase is a worldwide database that records the frequencies of causative genetic variations worldwide.",
      "false, [corrected fact]: This database integrates information on different types of genetic variations across various populations rather than protein-protein interactions.",
      "false, [corrected fact]: FINDbase does not include data about protein-DNA interactions but provides information about allelic variations in human genes that have known clinical implications.",
      "false, [corrected fact]: The database does not contain information about protein-RNA interactions instead it contains data about the impact of specific genetic variations on human health.",
      "true"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-7b-chat-hf_response": "Skeletal muscle contains several types of deiodinases, including:\n1. Type 1 iodothyronine deiodinase (D1): This enzyme is the primary deiodinase in skeletal muscle and is responsible for the conversion of T4 to T3.\n2. Type 2 iodothyronine deiodinase (D2): This enzyme is also present in skeletal muscle and is responsible for the conversion of T4 to reverse T3 (rT3).\n3. Type 3 iodothyronine deiodinase (D3): This enzyme is found in small amounts in skeletal muscle and is responsible for the conversion of T3 to T2 (3,3',5-triiodothyronine).\n4. Type 4 iodothyronine deiodinase (D4): This enzyme is found in small amounts in skeletal muscle and is responsible for the conversion of T3 to T0 (0,0',5-triiodothyronine).\nIt's worth noting that the activity of these deiodinases can be influenced by various factors, such as thyroid hormone levels, nutrient availability, and exercise status.",
    "llama-2-7b-chat-hf_fact": [
      "Skeletal muscle contains several types of deiodinases.",
      "Type 1 iodothyronine deiodinase (D1) is present in skeletal muscle and is responsible for the conversion of T4 to T3.",
      "Type 2 iodothyronine deiodinase (D2) is also present in skeletal muscle and converts T4 to reverse T3 (rT3).",
      "Type 3 iodothyronine deiodinase (D3) is found in skeletal muscle in small amounts and converts T3 to T2.",
      "Type 4 iodothyronine deiodinase (D4) exists in small amounts in skeletal muscle and is responsible for the conversion of T3 to T0."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no type 4 iodothyronine deiodinase (D4) in the existence that converts T3 to T0. The principle deiodinases are only three types: D1, D2, and D3."
    ]
  },
  {
    "id": 483,
    "user_query": "Which is the molecular weight of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a protein that plays a key role in angiogenesis, the formation of new blood vessels. The molecular weight of angiogenin is approximately 30 kDa.",
    "llama-2-7b-chat-hf_fact": [
      "Angiogenin is a protein.",
      "Angiogenin plays a key role in angiogenesis.",
      "Angiogenesis is the formation of new blood vessels.",
      "The molecular weight of angiogenin is approximately 30 kDa."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The molecular weight of angiogenin is approximately 14.7 kDa."
    ]
  },
  {
    "id": 484,
    "user_query": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 486,
    "user_query": "Why does the prodrug amifostine (ethyol) create hypoxia?",
    "llama-2-7b-chat-hf_response": "Amifostine (ethyol) is a prodrug that is converted to the active metabolite, ethylene oxide, in the body. Ethylene oxide is a potent inhibitor of the enzyme aldehyde dehydrogenase (ALDH), which is involved in the detoxification of aldehydes. By inhibiting ALDH, ethylene oxide can accumulate in cells and create a hypoxic environment.\nHypoxia is a condition in which there is a reduction in the amount of oxygen available to cells. This can occur due to a variety of factors, including decreased blood flow to a tissue or organ, increased metabolic demand for oxygen, or exposure to toxins that interfere with oxygen delivery. Hypoxia can have serious consequences, including cell death, tissue damage, and impaired organ function.\nIn the case of amifostine (ethyol), the inhibition of ALDH by ethylene oxide leads to an accumulation of toxic aldehydes in cells, which can create a hypoxic environment. This can occur in a variety of tissues, including the lung, liver, and brain, and can lead to a range of adverse effects, including cytotoxicity, inflammation, and impaired organ function.\nOverall, the creation of hypoxia by amifostine (ethyol) is a complex process that involves the inhibition of ALDH and the accumulation of toxic aldehydes in cells. This can have serious consequences for cellular function and tissue health, and highlights the importance of maintaining adequate oxygen levels in the body.",
    "llama-2-7b-chat-hf_fact": [
      "Amifostine (ethyol) is a prodrug that turns into the active metabolite, ethylene oxide, in the body.",
      "Ethylene oxide inhibits the enzyme aldehyde dehydrogenase (ALDH), which is involved in detoxification of aldehydes.",
      "The inhibition of ALDH by ethylene oxide leads to an accumulation of toxic aldehydes which can create a hypoxic environment in cells.",
      "Hypoxia is a condition where oxygen availability to cells is reduced and it can cause cell death, tissue damage, and impaired organ function.",
      "The process by which amifostine (ethyol) leads to hypoxia can occur in a variety of tissues including the lung, liver and brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Amifostine (ethyol) is a prodrug that turns into the active metabolite, WR-1065, in the body.",
      "false, [corrected fact]: The metabolite of Amifostine, WR-1065, is not known to inhibit aldehyde dehydrogenase (ALDH). Rather, it protects normal tissues from the harmful effects of radiotherapy and chemotherapy.",
      "false, [corrected fact]: Ethylene oxide does not lead to the inhibition of ALDH and does not cause an accumulation of toxic aldehydes in cells.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 493,
    "user_query": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?",
    "llama-2-7b-chat-hf_response": "Goldberg-Shprintzen syndrome is a rare genetic disorder that affects the development of the brain and nervous system. It is characterized by a range of symptoms including intellectual disability, seizures, and distinctive facial features. In some cases, Goldberg-Shprintzen syndrome may also be associated with other genetic disorders, such as:\n* Fragile X syndrome: This is a genetic disorder that affects the brain and nervous system, and is characterized by intellectual disability, behavioral problems, and physical features such as large ears and a long face.\n* Smith-Lemli-Opitz syndrome: This is a genetic disorder that affects the development of the brain and nervous system, and is characterized by intellectual disability, seizures, and distinctive facial features.\nA) Fragile X syndrome\nB) Smith-Lemli-Opitz syndrome\nC) None of the above",
    "llama-2-7b-chat-hf_fact": [
      "Goldberg-Shprintzen syndrome is a rare genetic disorder affecting the development of the brain and nervous system.",
      "The syndrome may present symptoms such as intellectual disability, seizures, and distinctive facial features.",
      "In some cases, Goldberg-Shprintzen syndrome may be associated with other genetic disorders.",
      "Fragile X syndrome is a genetic disorder characterized by intellectual disability, behavioral problems and distinctive physical features.",
      "Smith-Lemli-Opitz syndrome is another genetic disorder associated with Goldberg-Shprintzen syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Smith-Lemli-Opitz syndrome is not associated with Goldberg-Shprintzen syndrome. It is a separate genetic disorder affecting multiple parts of the body."
    ]
  },
  {
    "id": 496,
    "user_query": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?",
    "llama-2-7b-chat-hf_response": "Lewy bodies are abnormal protein clumps that are found in the brains of people with certain neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. The presence of Lewy bodies in the brain is a hallmark of these diseases, and they are thought to play a role in the death of brain cells and the progression of the diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Lewy bodies are abnormal protein clumps found in the brain.",
      "Lewy bodies are found in the brains of people with certain neurodegenerative diseases.",
      "Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy are diseases associated with Lewy bodies.",
      "The presence of Lewy bodies in the brain is a characteristic feature of the named diseases.",
      "Lewy bodies are believed to play a role in the death of brain cells and the progression of these diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 501,
    "user_query": "Is Kanzaki disease associated with deficiency in alpha-N-acetylgalactosaminidase?",
    "llama-2-7b-chat-hf_response": "Kanzaki disease, also known as mucopolysaccharidosis type VII, is a rare genetic disorder caused by a deficiency of the enzyme alpha-N-acetylgalactosaminidase. This enzyme is necessary for the breakdown of certain sugar molecules in the body, and its deficiency leads to the accumulation of these sugars in various tissues and organs, including the brain, spinal cord, and connective tissue.\nThe symptoms of Kanzaki disease can vary in severity and may include:\n* Coarse facial features, such as a large head, prominent forehead, and widely spaced eyes\n* Corneal clouding or opacification\n* Scoliosis or other spinal deformities\n* Joint stiffness and contractures\n* Delayed cognitive and motor development\n* Seizures\n* Vision loss\n* Hearing loss\n* Respiratory problems\nThe diagnosis of Kanzaki disease is based on a combination of clinical findings, laboratory tests, and genetic analysis. Treatment is focused on managing the symptoms and preventing complications, and may include:\n* Enzyme replacement therapy (ERT) with alpha-N-acetylgalactosaminidase\n* Physical therapy and occupational therapy to improve joint mobility and function\n* Speech therapy to improve communication and swallowing difficulties\n* Medications to manage seizures, vision loss, and other complications\nOverall, Kanzaki disease is a rare and complex disorder that can have a significant impact on the quality of life of affected individuals. Early diagnosis and appropriate management can help to improve outcomes and reduce the risk of complications.",
    "llama-2-7b-chat-hf_fact": [
      "Kanzaki disease is also known as mucopolysaccharidosis type VII.",
      "Kanzaki disease is a genetic disorder caused by a deficiency of the enzyme alpha-N-acetylgalactosaminidase.",
      "The enzyme alpha-N-acetylgalactosaminidase is needed for the breakdown of certain sugar molecules in the body.",
      "A deficiency of alpha-N-acetylgalactosaminidase leads to the accumulation of sugars in various tissues and organs in the body.",
      "The diagnosis of Kanzaki disease is based on clinical findings, laboratory tests, and genetic analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Kanzaki disease is also known as alpha-N-acetylgalactosaminidase deficiency.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 512,
    "user_query": "Is vemurafenib effective for hairy-cell leukemia?",
    "llama-2-7b-chat-hf_response": "Vemurafenib is a BRAF inhibitor that has been approved for the treatment of melanoma, but it has also shown promise in the treatment of other cancers, including hairy-cell leukemia. In clinical trials, vemurafenib has been shown to be effective in reducing the size of tumors and improving the symptoms of hairy-cell leukemia. However, it is important to note that vemurafenib is not a cure for hairy-cell leukemia, and more research is needed to determine its long-term effectiveness and safety.",
    "llama-2-7b-chat-hf_fact": [
      "Vemurafenib is a BRAF inhibitor.",
      "Vemurafenib has been approved for the treatment of melanoma.",
      "Vemurafenib has shown promise in the treatment of other cancers, including hairy-cell leukemia.",
      "In clinical trials, Vemurafenib has been shown to reduce the size of tumors and improve the symptoms of hairy-cell leukemia.",
      "Vemurafenib is not a cure for hairy-cell leukemia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 513,
    "user_query": "Which are the inhibitors of histone methyltransferases?",
    "llama-2-7b-chat-hf_response": "Histone methyltransferases (HMTs) are enzymes that catalyze the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to specific residues on histone proteins, leading to changes in chromatin structure and gene expression. Inhibitors of HMTs have been developed as potential therapeutics for various diseases, including cancer and neurological disorders. Here are some of the inhibitors of HMTs:\n1. Histone methyltransferase inhibitors (HMTIs): These are small molecules that specifically inhibit the activity of HMTs, leading to decreased histone methylation and altered chromatin structure. Examples of HMTIs include:\na. 5-Azacytidine: This is a DNA methyltransferase inhibitor that also inhibits HMTs, leading to demethylation of histone H3 lysine 9 (H3K9) and H3K27.\nb. Trichostatin A (TSA): This is a natural product that inhibits histone deacetylases (HDACs) and also inhibits HMTs, leading to increased histone acetylation and altered chromatin structure.\nc. Vorinostat (Zolinza): This is a synthetic compound that inhibits HDACs and also inhibits HMTs, leading to increased histone acetylation and altered chromatin structure.\n2. Histone deacetylase inhibitors (HDACis): These are compounds that inhibit the activity of HDACs, leading to increased histone acetylation and altered chromatin structure. Examples of HDACis include:\na. Trichostatin A (TSA): As mentioned earlier, TSA is a natural product that inhibits HDACs and also inhibits HMTs.\nb. Vorinostat (Zolinza): This is a synthetic compound that inhibits HDACs and also inhibits HMTs, leading to increased histone acetylation and altered chromatin structure.\nc. Romidepsin (Istodax): This is a synthetic",
    "llama-2-7b-chat-hf_fact": [
      "Histone methyltransferases (HMTs) are enzymes that catalyze the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to specific residues on histone proteins.",
      "Inhibitors of histone methyltransferases have been developed as potential therapeutics for various diseases, such as cancer and neurological disorders.",
      "5-Azacytidine is a DNA methyltransferase inhibitor that also inhibits HMTs.",
      "Trichostatin A (TSA) is a natural product that inhibits histone deacetylases (HDACs) and also inhibits HMTs.",
      "Vorinostat (Zolinza) is a synthetic compound that inhibits both histone deacetylases (HDACs) and histone methyltransferases (HMTs)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: 5-Azacytidine is a DNA methyltransferase inhibitor but it does not inhibit histone methyltransferases (HMTs).",
      "false, [corrected fact]: Trichostatin A (TSA) is a natural product that inhibits histone deacetylases (HDACs), not histone methyltransferases (HMTs).",
      "false, [corrected fact]: Vorinostat (Zolinza) is a synthetic compound that inhibits histone deacetylases (HDACs), not histone methyltransferases (HMTs)."
    ]
  },
  {
    "id": 517,
    "user_query": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?",
    "llama-2-7b-chat-hf_response": "Answer: There are several JAK (Janus kinase) inhibitors that are approved for the treatment of rheumatoid arthritis (RA). Some of the most commonly used JAK inhibitors for RA include:\n1. Ruxolitinib (Jakavi): Ruxolitinib is a JAK1/JAK2 inhibitor that is approved for the treatment of moderate-to-severe RA. It works by blocking the activity of JAK1 and JAK2, which are involved in the signaling pathways that promote inflammation and joint damage in RA.\n2. Baricitinib (Olumiant): Baricitinib is a JAK1 inhibitor that is approved for the treatment of moderate-to-severe RA. It works by blocking the activity of JAK1, which is involved in the signaling pathways that promote inflammation and joint damage in RA.\n3. Filgotinib (Gilotrif): Filgotinib is a JAK1 inhibitor that is approved for the treatment of moderate-to-severe RA. It works by blocking the activity of JAK1, which is involved in the signaling pathways that promote inflammation and joint damage in RA.\n4. Abrocitinib (Xeljanz): Abrocitinib is a JAK1 inhibitor that is approved for the treatment of moderate-to-severe RA. It works by blocking the activity of JAK1, which is involved in the signaling pathways that promote inflammation and joint damage in RA.\n5. Upadacitinib (Rinvoq): Upadacitinib is a JAK1/JAK2 inhibitor that is approved for the treatment of moderate-to-severe RA. It works by blocking the activity of JAK1 and JAK2, which are involved in the signaling pathways that promote inflammation and joint damage in RA.",
    "llama-2-7b-chat-hf_fact": [
      "Ruxolitinib is a JAK1/JAK2 inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis.",
      "Baricitinib is a JAK1 inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis.",
      "Filgotinib is a JAK1 inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis.",
      "Abrocitinib is a JAK1 inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis.",
      "Upadacitinib is a JAK1/JAK2 inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Ruxolitinib is a JAK1/JAK2 inhibitor approved for the treatment of myelofibrosis and polycythemia vera, not rheumatoid arthritis.",
      "true",
      "true",
      "false, [corrected fact]: Abrocitinib is a JAK1 inhibitor approved for the treatment of moderate-to-severe atopic dermatitis, not rheumatoid arthritis.",
      "false, [corrected fact]: Upadacitinib is a JAK1 inhibitor, not a JAK1/JAK2 inhibitor, approved for the treatment of moderate-to-severe rheumatoid arthritis."
    ]
  },
  {
    "id": 519,
    "user_query": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?",
    "llama-2-7b-chat-hf_response": "Thalassemia is a genetic disorder that affects the production of hemoglobin, leading to anemia, fatigue, and other complications. Currently, the only available treatments for thalassemia are blood transfusions and iron chelation therapy, which can help manage the symptoms but do not cure the disease. Recently, researchers have identified several new DNA nucleases that could potentially be used to treat thalassemia by editing the genes responsible for the disorder. These nucleases include:\n1. CRISPR-Cas9: This is the most well-known DNA nuclease and has been used to edit genes in a variety of organisms, including humans. CRISPR-Cas9 works by cutting DNA at specific locations, allowing researchers to introduce changes to the genetic code.\n2. TALENs: TALENs (transcription activator-like effector nucleases) are another type of DNA nuclease that can be used to edit genes. TALENs are composed of two proteins that work together to cut DNA at specific locations.\n3. ZFNs (zinc finger nucleases): ZFNs are proteins that are made up of two subunits, each of which recognizes a specific DNA sequence. When the two subunits bind to the target DNA sequence, they cut the DNA, allowing researchers to introduce changes to the genetic code.\n4. Homing endonucleases: Homing endonucleases are enzymes that can cut DNA at specific locations within the genome. They are particularly useful for editing genes that are located in hard-to-reach areas of the genome.\n5. Meganucleases: Meganucleases are large proteins that can cut DNA at specific locations. They are similar to homing endonucleases but are larger and more versatile.\nThese newly identified DNA nucleases have the potential to revolutionize the treatment of thalassemia by allowing researchers to edit the genes responsible for the disorder. By correcting the genetic mutations that cause thalassemia, these nucleases could potentially cure the disease. However, more research is needed to fully understand the safety and efficacy of these nucleases before they can be used in humans.",
    "llama-2-7b-chat-hf_fact": [
      "Thalassemia is a genetic disorder that affects the production of hemoglobin.",
      "The only available treatments for thalassemia currently are blood transfusions and iron chelation therapy.",
      "CRISPR-Cas9, a type of DNA nuclease, is known for its use in gene editing across various organisms.",
      "TALENs (transcription activator-like effector nucleases), ZFNs (zinc finger nucleases), homing endonucleases, and meganucleases are all types of DNA nucleases.",
      "These DNA nucleases can potentially be used to treat thalassemia by editing the genes responsible for the disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The primary treatments for thalassemia include blood transfusions, iron chelation therapy, and in some cases, a bone marrow transplant.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 524,
    "user_query": "Is the protein 1-integrin recycled?",
    "llama-2-7b-chat-hf_response": "Yes, the protein 1-integrin is recycled in cells. 1-integrin is a transmembrane receptor that plays a crucial role in cell adhesion and signaling, and its recycling is an important mechanism for regulating its function.\n1-integrin is internalized from the cell surface through a process called endocytosis, in which the protein is engulfed by the cell membrane and transported to an early endosome. Once in the endosome, 1-integrin is dephosphorylated and undergoes a series of conformational changes that allow it to be recycled back to the cell surface.\nThe recycling of 1-integrin is mediated by a complex of proteins called the endosomal sorting complex required for transport (ESCRT). ESCRT proteins are involved in the sorting and transport of proteins and lipids within endosomes, and they play a key role in the recycling of 1-integrin.\nOnce recycled, 1-integrin can re-enter the cell surface membrane and continue to participate in cell adhesion and signaling events. The recycling of 1-integrin is a dynamic process that is regulated by a variety of intracellular signaling pathways, including the PI3K/Akt and MAPK pathways.\nIn addition to its role in cell adhesion and signaling, the recycling of 1-integrin has been implicated in a variety of cellular processes, including cell migration, differentiation, and survival. Dysregulation of 1-integrin recycling has been implicated in a number of diseases, including cancer and cardiovascular disease.",
    "llama-2-7b-chat-hf_fact": [
      "The protein 1-integrin is recycled in cells.",
      "1-integrin is a transmembrane receptor that plays a crucial role in cell adhesion and signaling.",
      "The recycling of 1-integrin is mediated by a complex of proteins called the endosomal sorting complex required for transport (ESCRT).",
      "Once recycled, 1-integrin can re-enter the cell surface membrane and participate in cell adhesion and signaling events.",
      "Dysregulation of 1-integrin recycling has been implicated in a number of diseases, including cancer and cardiovascular disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 526,
    "user_query": "Which signaling pathway is activating the dishevelled proteins?",
    "llama-2-7b-chat-hf_response": "Dishevelled (Dvl) proteins are activated by various signaling pathways in different cellular contexts. Here are some of the signaling pathways that can activate Dvl proteins:\n1. Planar cell polarity (PCP) pathway: The PCP pathway is primarily involved in regulating cell orientation and polarity during embryonic development. The PCP pathway activates Dvl proteins by phosphorylating and activating their cytoplasmic domain.\n2. Wnt/-catenin pathway: The Wnt/-catenin pathway is involved in regulating cell proliferation, differentiation, and tissue patterning during embryonic development. The Wnt/-catenin pathway can activate Dvl proteins by stabilizing -catenin, which then interacts with Dvl proteins and activates their downstream signaling events.\n3. Notch signaling pathway: The Notch signaling pathway is involved in regulating cell fate determination, cell proliferation, and tissue patterning during embryonic development. The Notch signaling pathway can activate Dvl proteins by phosphorylating and activating their extracellular domain.\n4. Epidermal growth factor receptor (EGFR) signaling pathway: The EGFR signaling pathway is involved in regulating cell proliferation, differentiation, and survival in response to extracellular ligands. The EGFR signaling pathway can activate Dvl proteins by phosphorylating and activating their cytoplasmic domain.\n5. Hedgehog signaling pathway: The Hedgehog signaling pathway is involved in regulating cell proliferation, differentiation, and tissue patterning during embryonic development. The Hedgehog signaling pathway can activate Dvl proteins by phosphorylating and activating their cytoplasmic domain.\nIn summary, Dvl proteins can be activated by various signaling pathways, including the PCP pathway, Wnt/-catenin pathway, Notch signaling pathway, EGFR signaling pathway, and Hedgehog signaling pathway. The specific signaling",
    "llama-2-7b-chat-hf_fact": [
      "Dishevelled (Dvl) proteins can be activated by various signaling pathways.",
      "The Planar cell polarity (PCP) pathway can activate Dvl proteins.",
      "The Wnt/-catenin pathway can also activate Dvl proteins.",
      "The Notch signaling pathway has the capability to activate Dvl proteins.",
      "The Epidermal growth factor receptor (EGFR) signaling pathway and Hedgehog signaling pathway can also activate Dvl proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false, [corrected fact]: The Epidermal growth factor receptor (EGFR) signaling pathway and Hedgehog signaling pathway are not known to activate Dvl proteins."
    ]
  },
  {
    "id": 533,
    "user_query": "Can a peptide aptamer be used as protein inhibitor?",
    "llama-2-7b-chat-hf_response": "A peptide aptamer is a peptide molecule that binds specifically to a target protein, and can be used as a tool for studying protein-protein interactions or as a therapeutic agent. However, can a peptide aptamer also be used as a protein inhibitor?\nThe answer is yes, a peptide aptamer can be used as a protein inhibitor. In fact, peptide aptamers have been shown to be effective in inhibiting the activity of a variety of proteins, including enzymes, receptors, and ion channels.\nThere are several ways in which a peptide aptamer can be used as a protein inhibitor:\n1. Competitive inhibition: In this approach, the peptide aptamer competes with the target protein for binding to a shared ligand, thereby inhibiting the protein's activity.\n2. Non-competitive inhibition: In this approach, the peptide aptamer binds to a site on the target protein that is distinct from the active site, where the ligand binds. This can alter the protein's conformation or interactions with other molecules, leading to inhibition of its activity.\n3. Allosteric inhibition: In this approach, the peptide aptamer binds to a site on the target protein that is distant from the active site, and alters the protein's conformation or interactions with other molecules, leading to inhibition of its activity.\n4. Proteolysis: In this approach, the peptide aptamer can be designed to cleave the target protein, leading to its degradation and inhibition of its activity.\nThe advantages of using peptide aptamers as protein inhibitors include:\n1. High specificity: Peptide aptamers can be designed to bind specifically to a particular target protein, reducing the risk of off-target effects.\n2. High affinity: Peptide aptamers can have high affinity for their target proteins, leading to effective inhibition of protein activity.\n3. Reversibility: The binding of a peptide aptamer to a target protein can be reversible, allowing for dynamic regulation of protein activity.\n4. Drug-like properties: Peptide aptamers can be engineered to have",
    "llama-2-7b-chat-hf_fact": [
      "A peptide aptamer is a peptide molecule that binds specifically to a target protein.",
      "Peptide aptamers can be used to study protein-protein interactions or as a therapeutic agent.",
      "Peptide aptamers can also be used as a protein inhibitor.",
      "Peptide aptamers have been shown to be effective in inhibiting the activity of a variety of proteins, including enzymes, receptors, and ion channels.",
      "The binding of a peptide aptamer to a target protein can be reversible, allowing for dynamic regulation of protein activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-7b-chat-hf_response": "Caspases are a family of enzymes that play a central role in the regulation of inflammation. They are involved in the processing and activation of pro-inflammatory cytokines, the degradation of inflammatory mediators, and the regulation of immune cell function. Here are some examples of inflammatory caspase proteins:\n1. Caspase-1: Also known as interleukin-1 beta (IL-1) converting enzyme (ICE), caspase-1 is involved in the processing and activation of pro-inflammatory cytokines such as IL-1 and tumor necrosis factor-alpha (TNF-).\n2. Caspase-3: This caspase is involved in the degradation of pro-inflammatory cytokines and the regulation of immune cell function.\n3. Caspase-8: Also known as Fas-associated death domain protein (FADD), caspase-8 is involved in the regulation of apoptosis and the activation of pro-inflammatory cytokines.\n4. Caspase-9: This caspase is involved in the regulation of apoptosis and the degradation of pro-inflammatory cytokines.\n5. Caspase-12: This caspase is involved in the regulation of inflammation and the degradation of inflammatory mediators.\n6. Caspase-13: This caspase is involved in the regulation of inflammation and the degradation of inflammatory mediators.\n7. Caspase-14: This caspase is involved in the regulation of inflammation and the degradation of inflammatory mediators.\n8. Caspase-15: This caspase is involved in the regulation of inflammation and the degradation of inflammatory mediators.\n9. Caspase-16: This caspase is involved in the regulation of inflammation and the degradation of inflammatory mediators.\n10. Caspase-17: This caspase is involved in the regulation of inflammation and the degradation of inflammatory mediators",
    "llama-2-7b-chat-hf_fact": [
      "Caspases are a family of enzymes that play a central role in the regulation of inflammation.",
      "Caspase-1, also known as interleukin-1 beta (IL-1) converting enzyme (ICE), is involved in the processing and activation of pro-inflammatory cytokines such as IL-1 and tumor necrosis factor-alpha (TNF-).",
      "Caspase-3 is involved in the degradation of pro-inflammatory cytokines and the regulation of immune cell function.",
      "Caspase-8, also known as Fas-associated death domain protein (FADD), is involved in the regulation of apoptosis and the activation of pro-inflammatory cytokines.",
      "Caspase-9 is involved in the regulation of apoptosis and the degradation of pro-inflammatory cytokines."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Caspase-3 is primarily involved in the execution phase of cell apoptosis and not directly involved in the degradation of pro-inflammatory cytokines and the regulation of immune cell function.",
      "false, [corrected fact]: Caspase-8, although it is involved in the regulation of apoptosis, it's not called Fas-associated death domain protein (FADD). Caspase-8 can be activated by FADD in death receptor signalling to initiate apoptosis.",
      "false, [corrected fact]: Caspase-9 is involved in the activation of apoptosis but not in the degradation of pro-inflammatory cytokines."
    ]
  },
  {
    "id": 538,
    "user_query": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma",
    "llama-2-7b-chat-hf_response": "(SEGA) associated with Neurofibromatosis Type 1 (NF1).\nTwo chemotherapeutic agents that are used for the treatment of Subependymal Giant Cell Astrocytoma (SEGA) associated with Neurofibromatosis Type 1 (NF1) are:\n1. Bevacizumab: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is used to treat SEGA associated with NF1. It works by inhibiting the growth of new blood vessels that supply the tumor, thereby slowing down the growth of the tumor.\n2. Temozolomide: Temozolomide is an oral chemotherapy drug that is used to treat SEGA associated with NF1. It works by inhibiting the activity of an enzyme called O6-methylguanine-DNA methyltransferase (MGMT), which helps to repair DNA damage caused by chemotherapy and radiation therapy. By inhibiting MGMT, temozolomide can increase the sensitivity of the tumor to chemotherapy and radiation therapy.",
    "llama-2-7b-chat-hf_fact": [
      "Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is used to treat Subependymal Giant Cell Astrocytoma (SEGA) associated with Neurofibromatosis Type 1 (NF1).",
      "The functioning of Bevacizumab involves inhibiting the growth of new blood vessels that supply the tumor.",
      "Temozolomide is an oral chemotherapy drug used for the treatment of Subependymal Giant Cell Astrocytoma (SEGA) associated with Neurofibromatosis Type 1 (NF1).",
      "Temozolomide works by inhibiting the activity of an enzyme called O6-methylguanine-DNA methyltransferase (MGMT).",
      "The inhibition of MGMT by temozolomide can increase the sensitivity of the tumor to chemotherapy and radiation therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is used to treat various types of cancers, but it is not specifically used for the treatment of Subependymal Giant Cell Astrocytoma (SEGA) associated with Neurofibromatosis Type 1 (NF1).",
      "true",
      "false, [corrected fact]: Temozolomide is an oral chemotherapy drug used for the treatment of certain types of brain tumors like glioblastoma and anaplastic astrocytoma, not specifically for Subependymal Giant Cell Astrocytoma (SEGA) associated with Neurofibromatosis Type 1 (NF1).",
      "true",
      "true"
    ]
  },
  {
    "id": 541,
    "user_query": "List available databases containing information about conserved noncoding elements.",
    "llama-2-7b-chat-hf_response": "Here are some databases that contain information about conserved noncoding elements:\n1. UCSC Genome Browser: The UCSC Genome Browser provides a comprehensive collection of conserved noncoding elements, including repeats, transposons, and other noncoding regions.\n2. Ensembl: Ensembl is a comprehensive and integrated resource for exploring genomic data, including information about conserved noncoding elements.\n3. Gene Ontology: Gene Ontology is a resource that provides a standardized vocabulary for describing the functions of genes, including information about conserved noncoding elements.\n4. Pfam: Pfam is a database of protein domain families, including information about conserved noncoding elements.\n5. Repbase: Repbase is a database of repetitive DNA elements, including information about conserved noncoding elements.\n6. RepeatMasker: RepeatMasker is a tool for identifying repetitive DNA elements in a genome, including information about conserved noncoding elements.\n7. Rfam: Rfam is a database of RNA family entries, including information about conserved noncoding elements.\n8. The Cancer Genome Atlas (TCGA): TCGA is a collaborative effort to catalogue the genomic changes in various cancer types, including information about conserved noncoding elements.\n9. The ENCODE Project: The ENCODE Project is a large-scale effort to identify all functional elements in the human genome, including information about conserved noncoding elements.\n10. The Roadmap Epigenomics Project: The Roadmap Epigenomics Project is a large-scale effort to map the epigenetic landscape of various organisms, including information about conserved noncoding elements.\nThese databases provide a wealth of information about conserved noncoding elements, including their location, function, and evolutionary conservation.",
    "llama-2-7b-chat-hf_fact": [
      "The UCSC Genome Browser is a comprehensive collection of conserved noncoding elements.",
      "Ensembl is a resource for exploring genomic data, including conserved noncoding elements.",
      "Gene Ontology provides a standardized vocabulary for describing the functions of genes and includes information about conserved noncoding elements.",
      "Pfam is a database that includes information about conserved noncoding elements among its records on protein domain families.",
      "The Cancer Genome Atlas catalogs the genomic changes in various cancer types and includes information about conserved noncoding elements."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The UCSC Genome Browser is a tool for visualizing and exploring genomic data, not a collection of conserved noncoding elements.",
      "true",
      "true",
      "false, [corrected fact]: Pfam is a database that includes information about protein families and domains, but does not specifically include information about conserved noncoding elements.",
      "true"
    ]
  },
  {
    "id": 546,
    "user_query": "What disease in Loxapine prominently used for?",
    "llama-2-7b-chat-hf_response": "Loxapine is a drug that is primarily used to treat schizophrenia. It is an antipsychotic medication that works by blocking the action of dopamine in the brain, which can help to reduce the symptoms of schizophrenia such as hallucinations, delusions, and disorganized thinking. Loxapine is also sometimes used to treat other mental health conditions such as bipolar disorder and major depressive disorder.",
    "llama-2-7b-chat-hf_fact": [
      "Loxapine is primarily used to treat schizophrenia.",
      "Loxapine is an antipsychotic medication.",
      "Loxapine works by blocking the action of dopamine in the brain.",
      "Loxapine can help reduce symptoms of schizophrenia like hallucinations, delusions, and disorganized thinking.",
      "Loxapine is occasionally utilized in the treatment of other mental health conditions such as bipolar disorder and major depressive disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 548,
    "user_query": "Which antibodies cause Riedel thyroiditis?",
    "llama-2-7b-chat-hf_response": "Riedel thyroiditis is a rare autoimmune disorder that affects the thyroid gland. It is characterized by the inflammation of the thyroid gland, which can lead to hypothyroidism, thyrotoxicosis, or both. The exact cause of Riedel thyroiditis is not fully understood, but it is believed to be an autoimmune disorder, meaning that the immune system mistakenly attacks the thyroid gland.\nThere are several antibodies that have been associated with Riedel thyroiditis, including:\n1. Anti-TPO (Thyroid Peroxidase) antibodies: These antibodies are the most common antibodies found in patients with Riedel thyroiditis. They are produced by the immune system and attack the thyroid gland, leading to inflammation and damage to the gland.\n2. Anti-TG (Thyroglobulin) antibodies: These antibodies are also commonly found in patients with Riedel thyroiditis. They are produced by the immune system and attack the thyroglobulin protein, which is an important component of the thyroid gland.\n3. Anti-thyroid peroxidase (TPO) antibodies: These antibodies are produced by the immune system and attack the thyroid peroxidase enzyme, which is important for the production of thyroid hormones.\n4. Anti-thyroid stimulating hormone receptor (TSH-R) antibodies: These antibodies are produced by the immune system and attack the TSH-R protein, which is important for the regulation of thyroid hormone production.\nIt is important to note that not all patients with Riedel thyroiditis will have all of these antibodies, and some may have additional antibodies that are not yet recognized. The presence of these antibodies can help support the diagnosis of Riedel thyroiditis, but a definitive diagnosis can only be made through a combination of clinical evaluation, laboratory tests, and imaging studies.",
    "llama-2-7b-chat-hf_fact": [
      "Riedel thyroiditis is a rare autoimmune disorder that affects the thyroid gland.",
      "Anti-TPO (Thyroid Peroxidase) antibodies are the most common antibodies found in patients with Riedel thyroiditis.",
      "Anti-TG (Thyroglobulin) antibodies are also found in patients with Riedel thyroiditis.",
      "Anti-thyroid peroxidase antibodies are associated with Riedel thyroiditis and attack the thyroid peroxidase enzyme.",
      "Anti-thyroid stimulating hormone receptor antibodies, which attack the TSH-R protein, can be observed in patients with Riedel thyroiditis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 551,
    "user_query": "Which receptors are bound by Tasimelteon?",
    "llama-2-7b-chat-hf_response": "Tasimelteon is a melatonin receptor agonist that selectively binds to the MT1 and MT2 melatonin receptors. It has a high affinity for the MT1 receptor and a lower affinity for the MT2 receptor. The binding of tasimelteon to these receptors leads to the regulation of various physiological processes, including sleep-wake cycles, circadian rhythms, and inflammation.",
    "llama-2-7b-chat-hf_fact": [
      "Tasimelteon is a melatonin receptor agonist.",
      "Tasimelteon selectively binds to the MT1 and MT2 melatonin receptors.",
      "Tasimelteon has a higher affinity for the MT1 receptor compared to the MT2 receptor.",
      "The binding of tasimelteon to these receptors regulates physiological processes.",
      "These physiological processes include sleep-wake cycles, circadian rhythms, and inflammation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false, [corrected fact]: These physiological processes include sleep-wake cycles and circadian rhythms, not inflammation."
    ]
  },
  {
    "id": 552,
    "user_query": "Is zyxin a focal adhesion protein?",
    "llama-2-7b-chat-hf_response": "Yes, zyxin is a focal adhesion protein. Focal adhesion proteins are a class of proteins that play a crucial role in cellular adhesion and signaling. They are involved in the formation and maintenance of adhesion complexes between cells and the extracellular matrix (ECM), and they also participate in intracellular signaling pathways that regulate various cellular processes, including cell migration, differentiation, and survival.\nZyxin is a member of the zyxin family of proteins, which are characterized by the presence of a conserved N-terminal domain called the zyxin domain. This domain is involved in the binding of zyxin to actin filaments and other proteins, and it is thought to play a role in the regulation of actin dynamics and cellular adhesion.\nStudies have shown that zyxin is involved in a variety of cellular processes, including cell migration, cell adhesion, and cell signaling. For example, zyxin has been shown to regulate the formation of focal adhesions, which are clusters of proteins that form at the leading edge of migrating cells and are involved in the adhesion of cells to the ECM. Zyxin has also been shown to participate in intracellular signaling pathways that regulate cell migration and differentiation.\nOverall, zyxin is an important protein that plays a key role in cellular adhesion and signaling, and its dysregulation has been implicated in a variety of diseases, including cancer and cardiovascular disease.",
    "llama-2-7b-chat-hf_fact": [
      "Zyxin is a focal adhesion protein.",
      "Focal adhesion proteins are involved in the formation and maintenance of adhesion complexes between cells and the extracellular matrix (ECM).",
      "Zyxin is a member of the zyxin family of proteins and has a conserved N-terminal domain called the zyxin domain.",
      "Zyxin is involved in a variety of cellular processes, including cell migration, cell adhesion, and cell signaling.",
      "Dysregulation of zyxin has been implicated in a variety of diseases, including cancer and cardiovascular disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 556,
    "user_query": "Which RNA polymerase is used for the replication of viroids?",
    "llama-2-7b-chat-hf_response": "A) RNA polymerase I\nB) RNA polymerase II\nC) RNA polymerase III\nD) RNA polymerase IV\nAnswer: (D) RNA polymerase IV.\nExplanation: Viroids are small, single-stranded RNA molecules that replicate through a process called \"rolling circle replication.\" This process involves the RNA polymerase IV enzyme, which is responsible for synthesizing new RNA strands by adding nucleotides to the existing RNA template in a circular manner. Therefore, the correct answer is (D) RNA polymerase IV.",
    "llama-2-7b-chat-hf_fact": [
      "Viroids are small, single-stranded RNA molecules.",
      "The process by which viroids replicate is known as \"rolling circle replication\".",
      "RNA polymerase IV enzyme plays a role in the replication process of viroids.",
      "The function of RNA polymerase IV is to synthesize new RNA strands by adding nucleotides to the existing RNA template."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 559,
    "user_query": "What is known about Vancomycin dosing in neonates?",
    "llama-2-7b-chat-hf_response": "Vancomycin is an antibiotic that is commonly used to treat neonatal infections, particularly those caused by Gram-positive bacteria. However, the dosing of vancomycin in neonates can be challenging due to their small size and immature kidneys. Here are some key points to know about vancomycin dosing in neonates:\n1. Load dose: The typical load dose of vancomycin for neonates is 30-40 mg/kg, given once or twice daily, depending on the severity of the infection.\n2. Maintenance dose: After the load dose, the maintenance dose of vancomycin for neonates is typically 10-20 mg/kg/day, given once or twice daily.\n3. Dosing in preterm neonates: Preterm neonates may require lower doses of vancomycin due to their immature kidneys. The load dose for preterm neonates is typically 20-30 mg/kg, and the maintenance dose is 5-10 mg/kg/day.\n4. Dosing in term neonates: Term neonates may require higher doses of vancomycin than preterm neonates due to their larger size and more mature kidneys. The load dose for term neonates is typically 30-40 mg/kg, and the maintenance dose is 10-20 mg/kg/day.\n5. Monitoring of trough levels: It is important to monitor the trough levels of vancomycin in neonates to ensure that the drug is at therapeutic levels. Trough levels should be measured 24-48 hours after the last dose.\n6. Dosing in neonates with renal impairment: Neonates with renal impairment may require lower doses of vancomycin due to their decreased ability to clear the drug. The dosing of vancomycin in neonates with renal impairment should be individualized based on the severity of the impairment.\n7. Dosing in neonates with hepatic impairment: Neonates with hepatic",
    "llama-2-7b-chat-hf_fact": [
      "Vancomycin is an antibiotic used to treat neonatal infections.",
      "The typical load dose of vancomycin for neonates is 30-40 mg/kg, given once or twice daily.",
      "After the load dose, the maintenance dose of vancomycin for neonates is typically 10-20 mg/kg/day.",
      "Preterm neonates may require lower doses of vancomycin due to their immature kidneys.",
      "It is important to monitor the trough levels of vancomycin in neonates to ensure the drug is at therapeutic levels."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 562,
    "user_query": "Which antiepileptic drug is most strongly associated with spina bifida?",
    "llama-2-7b-chat-hf_response": "A) Valproate\nB) Lamotrigine\nC) Levetiracetam\nD) Topiramate\nCorrect answer: A) Valproate.\nValproate is the antiepileptic drug most strongly associated with spina bifida, a congenital malformation that affects the spine and spinal cord. Studies have shown that valproate exposure during pregnancy is associated with an increased risk of spina bifida, particularly in the highest doses. Other antiepileptic drugs, such as lamotrigine, levetiracetam, and topiramate, have also been associated with an increased risk of spina bifida, but the evidence is less strong than for valproate. It is important for pregnant women with epilepsy to discuss their medication regimen with their healthcare provider to minimize the risk of adverse outcomes for their baby.",
    "llama-2-7b-chat-hf_fact": [
      "Valproate is an antiepileptic drug that is strongly associated with spina bifida.",
      "Spina bifida is a congenital malformation that affects the spine and spinal cord.",
      "Valproate exposure during pregnancy is associated with increased risk of spina bifida.",
      "Other antiepileptic drugs like lamotrigine, levetiracetam, and topiramate have been associated with increased risk of spina bifida.",
      "Pregnant women with epilepsy are advised to discuss their medication regimen with their healthcare provider to minimize the risk of adverse outcomes for their baby."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Other antiepileptic drugs like lamotrigine, levetiracetam, and topiramate have not been associated with increased risk of spina bifida.",
      "true"
    ]
  },
  {
    "id": 564,
    "user_query": "The drug JTV519 is derivative of which group of chemical compounds?",
    "llama-2-7b-chat-hf_response": "JTV519 is a potent and selective inhibitor of the enzyme bromodomain-containing protein 4 (BRD4). BRD4 is a member of the BET (bromodomain and extraterminal) protein family, which are involved in regulation of gene expression by binding to acetylated histone proteins.\nTherefore, JTV519 is a derivative of the chemical compound group known as BET (bromodomain and extraterminal) inhibitors.",
    "llama-2-7b-chat-hf_fact": [
      "JTV519 is an inhibitor of the enzyme bromodomain-containing protein 4 (BRD4).",
      "BRD4 is a member of the BET (bromodomain and extraterminal) protein family.",
      "The BET protein family is involved in the regulation of gene expression by binding to acetylated histone proteins.",
      "JTV519 is a derivative of the chemical compound group known as BET inhibitors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: JTV519 is not an inhibitor of the enzyme bromodomain-containing protein 4 (BRD4), but it is a synthetic compound with protective effects on the heart muscle.",
      "true",
      "true",
      "false, [corrected fact]: JTV519 is not a derivative of the chemical compound group known as BET inhibitors. It is a synthetic compound used in treatments for heart diseases."
    ]
  },
  {
    "id": 566,
    "user_query": "Oxantel is used for periodontitis treatment. How does it work?",
    "llama-2-7b-chat-hf_response": "Oxantel is an antibiotic that is used to treat periodontitis, a bacterial infection of the gums and supporting tissues of the teeth. It works by killing the bacteria that cause the infection, thereby reducing the inflammation and preventing further damage to the teeth and gums.\nOxantel belongs to a class of antibiotics called macrolides, which are effective against a wide range of bacteria, including those that cause periodontitis. When oxantel is administered, it is absorbed into the bloodstream and reaches the site of the infection, where it acts by inhibiting the synthesis of the bacterial cell wall. This ultimately leads to the death of the bacteria and the resolution of the infection.\nIn addition to its antibacterial effects, oxantel has been shown to have anti-inflammatory properties, which can help to reduce the swelling and pain associated with periodontitis. It may also help to promote the healing of the gums and supporting tissues around the teeth.\nIt is important to note that oxantel is not a cure for periodontitis, and it is typically used in combination with other treatments, such as scaling and root planing, to achieve the best results. Scaling and root planing involves removing the plaque and tartar from the teeth and smoothing the roots of the teeth to prevent further buildup of bacteria.\nOverall, oxantel is an effective treatment for periodontitis that can help to reduce the symptoms of the infection and promote healing of the gums and supporting tissues around the teeth. However, it is important to use it as directed by your dentist or healthcare provider to achieve the best results.",
    "llama-2-7b-chat-hf_fact": [
      "Oxantel is an antibiotic used to treat periodontitis.",
      "Oxantel belongs to a class of antibiotics called macrolides.",
      "Oxantel works by killing the bacteria causing the infection, thereby reducing inflammation and preventing further damage.",
      "Oxantel is absorbed into the bloodstream and reaches the site of infection, where it inhibits the synthesis of the bacterial cell wall.",
      "Oxantel is typically used in combination with other treatments like scaling and root planing for periodontitis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Oxantel is an anthelmintic drug, not an antibiotic, and it is generally used to treat worm infestations, not periodontitis.",
      "false, [corrected fact]: Oxantel is an anthelmintic drug, not a macrolide antibiotic.",
      "true",
      "false, [corrected fact]: Oxantel works inside the intestine after oral administration, and it does not work by inhibiting the synthesis of the bacterial cell wall.",
      "false, [corrected fact]: Oxantel is not typically used in combination with dental treatments such as scaling and root planing for periodontitis; it is used to treat worm infestations."
    ]
  },
  {
    "id": 568,
    "user_query": "What is the function of the protein encoded by the gene PABPC4?",
    "llama-2-7b-chat-hf_response": "The protein encoded by the gene PABPC4 is a subunit of the eukaryotic translation initiation factor 4F (eIF4F). eIF4F is a complex of proteins that plays a central role in the initiation of protein synthesis in eukaryotic cells. The PABPC4 protein is one of the four subunits of the eIF4F complex, which also includes the proteins eIF4A, eIF4B, and eIF4E. The eIF4F complex is responsible for recruiting mRNA to the ribosome and positioning it for translation initiation. The PABPC4 protein is also involved in the regulation of translation initiation and termination, and it has been implicated in various cellular processes, including cell growth and differentiation.",
    "llama-2-7b-chat-hf_fact": [
      "The protein encoded by the gene PABPC4 is a subunit of the eukaryotic translation initiation factor 4F (eIF4F).",
      "eIF4F is a complex of proteins that plays a central role in the initiation of protein synthesis in eukaryotic cells.",
      "PABPC4 protein is one of the four subunits of the eIF4F complex, with other proteins being eIF4A, eIF4B, and eIF4E.",
      "The eIF4F complex is responsible for recruiting mRNA to the ribosome and positioning it for translation initiation.",
      "PABPC4 protein is involved in the regulation of translation initiation and termination."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The protein encoded by the gene PABPC4 is not a subunit of the eukaryotic translation initiation factor 4F (eIF4F). It is a poly(A) binding protein.",
      "true",
      "false, [corrected fact]: PABPC4 protein is not a subunit of the eIF4F complex. The eIF4F complex is made up of three proteins: eIF4A, eIF4E, and eIF4G.",
      "true",
      "true"
    ]
  },
  {
    "id": 570,
    "user_query": "What is the mode of inheritance of Romano Ward long QT syndrome?",
    "llama-2-7b-chat-hf_response": "Romano-Ward long QT syndrome is a rare genetic disorder that affects the heart's electrical activity, leading to irregular heart rhythms (arrhythmias) and an increased risk of sudden death. The disorder is caused by mutations in the KCNQ1 gene, which encodes a potassium channel subunit that plays a critical role in the regulation of the heart's electrical activity.\nThe mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant, which means that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutated gene, each child has a 50% chance of inheriting the mutated gene and developing the disorder.",
    "llama-2-7b-chat-hf_fact": [
      "Romano-Ward long QT syndrome is a rare genetic disorder that affects the heart's electrical activity.",
      "The disorder is caused by mutations in the KCNQ1 gene.",
      "The KCNQ1 gene encodes a potassium channel subunit that plays a critical role in the regulation of the heart's electrical activity.",
      "The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant.",
      "If one parent has the mutated gene, each child has a 50% chance of inheriting the mutated gene and developing the disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 571,
    "user_query": "Which histone modifications have been associated to alternative splicing?",
    "llama-2-7b-chat-hf_response": "Several histone modifications have been implicated in the regulation of alternative splicing. These modifications include:\n1. Histone 3 lysine 4 trimethylation (H3K4me3): H3K4me3 is known to be involved in the regulation of constitutive exons, which are exons that are always included in the final mature mRNA transcript, regardless of the cellular context.\n2. Histone 3 lysine 27 trimethylation (H3K27me3): H3K27me3 is known to be involved in the regulation of cryptic exons, which are exons that are only included in the final mature mRNA transcript under specific cellular conditions.\n3. Histone 2A lysine 119 ubiquitination (H2AK119ub): H2AK119ub is known to be involved in the regulation of alternative splicing in response to cellular stress.\n4. Histone 3 lysine 79 phosphorylation (H3S79ph): H3S79ph is known to be involved in the regulation of alternative splicing in response to growth factors and developmental signals.\n5. Histone 2B lysine 5 acetylation (H2BK5ac): H2BK5ac is known to be involved in the regulation of alternative splicing in response to transcriptional activators.\n6. Histone 3 lysine 9 acetylation (H3K9ac): H3K9ac is known to be involved in the regulation of alternative splicing in response to transcriptional repressors.\n7. Histone 3 lysine 27 acetylation (H3K27ac): H3K27ac is known to be involved in the regulation of alternative splicing in response to transcriptional activators.\n8. Histone 4 lysine 5 trimethylation (H4K5me3): H4K5me3 is known to be involved in the regulation of alternative splicing in response to transcriptional activators.\n9. Histone 3 lysine 14 acetylation (",
    "llama-2-7b-chat-hf_fact": [
      "Histone 3 lysine 4 trimethylation (H3K4me3) has been implicated in the regulation of constitutive exons.",
      "Histone 3 lysine 27 trimethylation (H3K27me3) has been implicated in the regulation of cryptic exons.",
      "Histone 2A lysine 119 ubiquitination (H2AK119ub) can regulate alternative splicing in response to cellular stress.",
      "Histone 3 lysine 79 phosphorylation (H3S79ph) is involved in the regulation of alternative splicing in response to growth factors and developmental signals.",
      "Histone 2B lysine 5 acetylation (H2BK5ac) is involved in the regulation of alternative splicing in response to transcriptional activators."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 575,
    "user_query": "What is the mechanism of action of decitabine?",
    "llama-2-7b-chat-hf_response": "Decitabine is a hypomethylating agent that works by inhibiting the enzyme DNA methyltransferase, which is responsible for adding a methyl group to the cytosine residue of CpG dinucleotides in DNA. By inhibiting this enzyme, decitabine reduces the amount of 5-methylcytosine in the DNA, leading to demethylation of the promoter regions of genes that are silenced by DNA methylation. This results in the reactivation of these genes, leading to the restoration of normal cellular function.\nDecitabine has been shown to be effective in treating various types of cancer, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and chronic lymphocytic leukemia (CLL). It has also been used in combination with other chemotherapeutic agents in the treatment of AML and MDS.\nThe mechanism of action of decitabine is distinct from that of other hypomethylating agents, such as azacitidine and 5-aza-2'-deoxycytidine, which also inhibit DNA methyltransferase but have different chemical structures and mechanisms of action.\nOverall, the mechanism of action of decitabine is a complex process that involves the inhibition of DNA methyltransferase, leading to demethylation of the promoter regions of silenced genes, and the restoration of normal cellular function.",
    "llama-2-7b-chat-hf_fact": [
      "Decitabine is a hypomethylating agent that works by inhibiting the enzyme DNA methyltransferase.",
      "DNA methyltransferase is responsible for adding a methyl group to the cytosine residue of CpG dinucleotides in DNA.",
      "Decitabine is used for treating various types of cancer, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and chronic lymphocytic leukemia (CLL).",
      "It is distinct from other hypomethylating agents, such as azacitidine and 5-aza-2'-deoxycytidine, which also inhibit DNA methyltransferase but have different chemical structures and mechanisms of action.",
      "The mechanism of action of decitabine involves the demethylation of the promoter regions of silenced genes and the restoration of normal cellular function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Decitabine is used for treating myelodysplastic syndromes (MDS) and may be used for acute myeloid leukemia (AML). However, it is not typically used to treat chronic lymphocytic leukemia (CLL).",
      "true",
      "true"
    ]
  },
  {
    "id": 576,
    "user_query": "Which gene is associated with the Mitchell-Riley syndrome?",
    "llama-2-7b-chat-hf_response": "Mitchell-Riley syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. It is caused by mutations in the PHOX2B gene, which is located on chromosome 7. The PHOX2B gene provides instructions for making a protein called PHOX2B, which plays a critical role in the development of the brain and spinal cord during fetal development. Mutations in the PHOX2B gene can lead to abnormalities in the structure and function of the brain and spinal cord, resulting in the characteristic symptoms of Mitchell-Riley syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Mitchell-Riley syndrome is a genetic disorder that affects the development of the brain and spinal cord.",
      "The PHOX2B gene is associated with Mitchell-Riley syndrome.",
      "The PHOX2B gene is located on chromosome 7.",
      "The PHOX2B gene provides instructions for making a protein also called PHOX2B.",
      "Mutations in the PHOX2B gene can lead to abnormalities in the structure and function of the brain and spinal cord."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Mitchell-Riley syndrome is a genetic disorder that affects the function of the pancreas and liver, it is also called Mitchell-Riley Syndrome.",
      "false, [corrected fact]: The RFX6 gene, not the PHOX2B gene, is associated with Mitchell-Riley syndrome.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-7b-chat-hf_response": "Aurora B kinase is a protein that plays a crucial role in the regulation of mitosis, the process by which a cell divides into two daughter cells. It is involved in the proper separation of chromosomes during cell division and helps to ensure that the genetic material is accurately passed on to the daughter cells.\nPolycomb protein Ring1B, on the other hand, is a protein that plays a role in the regulation of gene expression, particularly during embryonic development. It is involved in the modification of histone proteins, which are the building blocks of chromatin, the complex of DNA and proteins that make up the chromosomes. This modification, known as histone modification, can affect the expression of genes by altering the structure of chromatin and making it more or less accessible to the machinery of gene expression.\nWhile Aurora B kinase and Ring1B are distinct proteins with different functions, there is some evidence to suggest that they may be linked in certain contexts. For example, studies have shown that Aurora B kinase can phosphorylate and activate Ring1B, which can then go on to modify histones and regulate gene expression. Additionally, Ring1B has been shown to be involved in the regulation of mitosis, and mutations in the Ring1B gene have been linked to cancer and other diseases.\nIn summary, while Aurora B kinase and Ring1B are distinct proteins with different functions, there is evidence to suggest that they may be linked in certain contexts, particularly in the regulation of mitosis and gene expression. Further research is needed to fully understand the relationship between these two proteins and their roles in cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Aurora B kinase is a protein involved in the regulation of mitosis, ensuring accurate transmission of genetic material during cell division.",
      "Polycomb protein Ring1B is a protein that regulates gene expression, particularly during embryonic development.",
      "Polycomb protein Ring1B modifies histone proteins, which affect gene expression by altering chromatin structure.",
      "Studies have shown that Aurora B kinase can phosphorylate and activate Ring1B, which then modifies histones and regulates gene expression.",
      "Ring1B plays a role in regulating mitosis and mutations in the Ring1B gene have been linked with cancer and other diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Ring1B plays a role in regulating gene expression and mutations in the Ring1B gene have been linked with cancer and other diseases."
    ]
  },
  {
    "id": 582,
    "user_query": "Name five programs for transcript quantification from RNASeq experiments",
    "llama-2-7b-chat-hf_response": "Here are five popular programs for transcript quantification from RNA-seq experiments:\n1. Cufflinks: Cufflinks is a widely used tool for transcript quantification from RNA-seq data. It can handle various types of RNA-seq data, including reads from Illumina, 454, and SOLiD sequencing platforms. Cufflinks can estimate gene expression levels, detect novel transcripts, and quantify alternative splicing events.\n2. STAR: STAR (Spliced Transcripts Alignment to a Reference) is another popular tool for transcript quantification from RNA-seq data. STAR can align RNA-seq reads to a reference genome or transcriptome, and estimate gene expression levels based on the number of aligned reads. STAR can also detect novel transcripts and quantify alternative splicing events.\n3. HISAT2: HISAT2 (Hierarchical Indexing for Spliced Transcript Alignment) is a high-performance tool for transcript quantification from RNA-seq data. HISAT2 can align RNA-seq reads to a reference genome or transcriptome, and estimate gene expression levels based on the number of aligned reads. HISAT2 can also detect novel transcripts and quantify alternative splicing events.\n4. Kallisto: Kallisto is an open-source tool for transcript quantification from RNA-seq data. Kallisto can align RNA-seq reads to a reference genome or transcriptome, and estimate gene expression levels based on the number of aligned reads. Kallisto can also detect novel transcripts and quantify alternative splicing events.\n5. Salmon: Salmon is a high-performance tool for transcript quantification from RNA-seq data. Salmon can align RNA-seq reads to a reference genome or transcriptome, and estimate gene expression levels based on the number of aligned reads. Salmon can also detect novel transcripts and quantify alternative splicing events.",
    "llama-2-7b-chat-hf_fact": [
      "Cufflinks is a program used for transcript quantification from RNA-seq data.",
      "STAR, or Spliced Transcripts Alignment to a Reference, is a tool that can align RNA-seq reads to a reference genome or transcriptome.",
      "HISAT2, short for Hierarchical Indexing for Spliced Transcript Alignment, is a high-performance tool used for transcript quantification in RNA-seq experiments.",
      "Kallisto is an open-source tool that is useful for transcript quantification from RNA-seq data.",
      "Salmon is another high-performance tool for transcript quantification from RNA-seq data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: HISAT2, short for Hierarchical Indexing for Spliced Alignment of Transcripts 2, is a high-performance tool used for aligning RNA-seq reads in RNA-seq experiments.",
      "true",
      "true"
    ]
  },
  {
    "id": 587,
    "user_query": "List variants of the MC1R gene.",
    "llama-2-7b-chat-hf_response": "The melanocortin 1 receptor (MC1R) gene is a gene that plays a crucial role in regulating pigmentation and skin color. There are several variants of the MC1R gene that have been identified, including:\n1. Single nucleotide polymorphisms (SNPs): These are small changes in the DNA sequence of the MC1R gene that can affect the function of the receptor. Examples of SNPs in the MC1R gene include:\n* TaqIB: This SNP is located in the 5' untranslated region of the MC1R gene and is associated with red hair and fair skin.\n* Asp294Gly: This SNP is located in the transmembrane domain of the MC1R gene and is associated with increased risk of melanoma.\n* Ser304Thr: This SNP is located in the intracellular domain of the MC1R gene and is associated with increased risk of melanoma.\n2. Copy number variations: These are changes in the number of copies of the MC1R gene in the genome. Examples of copy number variations in the MC1R gene include:\n* Deletions: These are losses of genetic material in the MC1R gene, which can result in reduced function of the receptor.\n* Duplications: These are gains of genetic material in the MC1R gene, which can result in increased function of the receptor.\n3. Point mutations: These are changes in the DNA sequence of the MC1R gene that can affect the function of the receptor. Examples of point mutations in the MC1R gene include:\n* Cysteine substitutions: These are changes in the amino acid sequence of the MC1R protein that can affect its function.\n* Arginine substitutions: These are changes in the amino acid sequence of the MC1R protein that can affect its function.\n4. Insertions and deletions (indels): These are changes in the DNA sequence of the MC1R gene that involve the insertion or deletion of one or more nucleotides. Examples of indels in the MC1R gene include:\n* 5' insertions: These are insertions of one or more nucleotides in the 5' untranslated region of the MC",
    "llama-2-7b-chat-hf_fact": [
      "The melanocortin 1 receptor (MC1R) gene plays a crucial role in regulating pigmentation and skin color.",
      "Single nucleotide polymorphisms (SNPs) in the MC1R gene are small changes in the DNA sequence that can affect receptor function.",
      "Examples of SNPs include TaqIB, Asp294Gly, and Ser304Thr, which are associated with traits like red hair, fair skin, and risk of melanoma.",
      "Copy number variations in the MC1R gene are changes in the number of copies of the gene and include deletions and duplications.",
      "Point mutations, cysteine substitutions, and arginine substitutions are changes in the DNA or amino acid sequence of the MC1R gene that can affect its function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 589,
    "user_query": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?",
    "llama-2-7b-chat-hf_response": "The BSCL2 gene encodes a protein called basic leucine zipper transcription factor 2 (bZIP2). Heterozygous mutations in the BSCL2 gene have been associated with a variety of phenotypes, including:\n1. Atopic dermatitis: Heterozygous mutations in the BSCL2 gene have been associated with an increased risk of developing atopic dermatitis, a chronic inflammatory skin disorder characterized by itching, redness, and dryness of the skin.\n2. Asthma: Some studies have suggested that heterozygous mutations in the BSCL2 gene may be associated with an increased risk of developing asthma, a chronic respiratory disease characterized by airway inflammation and obstruction.\n3. Autoimmune diseases: Heterozygous mutations in the BSCL2 gene have been associated with an increased risk of developing autoimmune diseases, such as multiple sclerosis, type 1 diabetes, and rheumatoid arthritis.\n4. Cancer: Some studies have suggested that heterozygous mutations in the BSCL2 gene may be associated with an increased risk of developing certain types of cancer, such as breast cancer and ovarian cancer.\n5. Neurological disorders: Heterozygous mutations in the BSCL2 gene have been associated with an increased risk of developing neurological disorders, such as epilepsy and migraine.\n6. Cardiovascular disease: Some studies have suggested that heterozygous mutations in the BSCL2 gene may be associated with an increased risk of developing cardiovascular disease, such as high blood pressure and atherosclerosis.\n7. Metabolic disorders: Heterozygous mutations in the BSCL2 gene have been associated with an increased risk of developing metabolic disorders, such as obesity and insulin resistance.\n8. Immune system disorders: Heterozygous mutations in the BSCL2 gene have been associated with an increased risk of developing immune system disorders, such as lupus and rheumatoid arth",
    "llama-2-7b-chat-hf_fact": [
      "The BSCL2 gene encodes a protein called basic leucine zipper transcription factor 2 (bZIP2).",
      "Heterozygous mutations in the BSCL2 gene have been associated with an increased risk of developing atopic dermatitis.",
      "There's an association between heterozygous mutations in the BSCL2 gene and an increased risk of developing asthma.",
      "Heterozygous mutations in the BSCL2 gene have been linked with an increased risk of developing certain autoimmune diseases.",
      "Some studies have suggested that heterozygous mutations in the BSCL2 gene may be associated with an increased risk of developing certain types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The BSCL2 gene encodes a protein called seipin.",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 592,
    "user_query": "What is the genomic structure of the FAA (FANCA) gene?",
    "llama-2-7b-chat-hf_response": "The FAA (FANCA) gene is located on chromosome 3q26.3 and spans approximately 100 kb in length. It consists of 12 exons, which are interspersed with introns, and encodes a protein of approximately 1,100 amino acids. The FAA gene is a member of the Fanconi anemia (FA) gene family, which is associated with Fanconi anemia, a rare genetic disorder characterized by congenital abnormalities, bone marrow failure, and an increased risk of cancer. The FAA gene is responsible for encoding the FANCA protein, which plays a critical role in the repair of DNA interstrand cross-links (ICLs), a type of DNA damage that can lead to genetic instability and cancer. Mutations in the FAA gene have been identified as the cause of Fanconi anemia in approximately 80% of cases.",
    "llama-2-7b-chat-hf_fact": [
      "The FAA (FANCA) gene is located on chromosome 3q26.3.",
      "The FAA gene spans approximately 100 kb in length and consists of 12 exons.",
      "The FAA gene is a member of the Fanconi anemia (FA) gene family.",
      "The FAA gene encodes the FANCA protein, which plays a role in the repair of DNA interstrand cross-links.",
      "Mutations in the FAA gene have been identified as the cause of Fanconi anemia in approximately 80% of cases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 593,
    "user_query": "What is Snord116?",
    "llama-2-7b-chat-hf_response": "Snord116 is a gene that provides instructions for making a protein called synaptotagmin 116. Synaptotagmin 116 is a member of the synaptotagmin family of proteins, which are involved in the release of neurotransmitters from nerve cells (neurons) in the brain. Neurotransmitters are chemical messengers that transmit signals between neurons and play a critical role in many brain functions, including learning, memory, and mood regulation.\nMutations in the Snord116 gene have been associated with several neurological disorders, including epilepsy, intellectual disability, and autism spectrum disorder. These disorders are often characterized by problems with brain development, communication between neurons, and the regulation of neurotransmitters.\nSnord116 is a non-coding RNA gene, meaning that it does not code for a protein but instead plays a regulatory role in the expression of other genes. Specifically, Snord116 is a long non-coding RNA (lncRNA) that is involved in the regulation of gene expression at the level of messenger RNA (mRNA). mRNA is the intermediate molecule that carries genetic information from DNA to the ribosome, where proteins are made. By regulating the expression of mRNA, lncRNAs like Snord116 can influence the production of proteins and the function of cells.\nOverall, Snord116 is a critical gene involved in the regulation of neurotransmitter release and the function of nerve cells in the brain. Mutations in this gene have been implicated in several neurological disorders, highlighting the importance of this gene in brain function and development.",
    "llama-2-7b-chat-hf_fact": [
      "Snord116 is a gene that provides instructions for making a protein called synaptotagmin 116.",
      "Synaptotagmin 116 is a member of the synaptotagmin family of proteins, which are involved in the release of neurotransmitters from nerve cells in the brain.",
      "Mutations in the Snord116 gene have been associated with several neurological disorders, including epilepsy, intellectual disability, and autism spectrum disorder.",
      "Snord116 is a long non-coding RNA (lncRNA) that is involved in the regulation of gene expression at the level of messenger RNA (mRNA).",
      "Snord116 plays a critical role in the regulation of neurotransmitter release and the function of nerve cells in the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Snord116 is a non-coding RNA, not a gene that provides instructions for making a protein.",
      "false, [corrected fact]: Synaptotagmin 116 does not exist, as Snord116 does not produce a protein.",
      "false, [corrected fact]: No specific disorders have been directly linked to mutations in Snord116; it is most notably associated with Prader-Willi syndrome.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 594,
    "user_query": "What is the functional role of the protein Drp1?",
    "llama-2-7b-chat-hf_response": "Drp1 (Dynamin-related protein 1) is a protein that plays a crucial role in the regulation of mitochondrial dynamics, particularly in the process of mitochondrial fission. Mitochondrial fission is the process by which a mother mitochondrion divides into two or more daughter mitochondria. Drp1 is a key regulator of this process and is essential for the proper maintenance of mitochondrial shape and function.\nDrp1 is a GTPase, meaning that it can bind to and hydrolyze GTP (guanosine triphosphate) to activate its activity. When Drp1 binds to mitochondrial membranes, it recruits and activates other proteins that are involved in the fission process, such as Fis1 (Fission 1) and Mff (Mitochondrial fission factor). These proteins work together to cleave the mitochondrial membrane, leading to the formation of daughter mitochondria.\nIn addition to its role in mitochondrial fission, Drp1 also plays a role in the regulation of mitochondrial transport and the maintenance of mitochondrial DNA (mtDNA) integrity. Drp1 has been implicated in a number of diseases, including neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease, as well as cancer.\nOverall, the functional role of Drp1 is to regulate the dynamics of mitochondria, particularly in the process of mitochondrial fission, and to maintain mitochondrial shape and function.",
    "llama-2-7b-chat-hf_fact": [
      "Drp1 or Dynamin-related protein 1 is a protein that plays a crucial role in the regulation of mitochondrial dynamics.",
      "Drp1 is a key regulator in the process of mitochondrial fission, where a mother mitochondrion divides into two or more daughter mitochondria.",
      "Drp1 is a GTPase, meaning it can bind to and hydrolyze GTP to activate its activity.",
      "Drp1 recruits and activates proteins like Fis1 and Mff that are involved in the fission process and help in the cleavage of the mitochondrial membrane.",
      "Drp1 also plays a role in regulating mitochondrial transport, maintaining mitochondrial DNA (mtDNA) integrity, and has been implicated in diseases such as Parkinson's disease, Alzheimer's disease, and cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 595,
    "user_query": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?",
    "llama-2-7b-chat-hf_response": "Fanconi anemia is a rare genetic disorder characterized by congenital abnormalities, bone marrow failure, and an increased risk of cancer. There are 16 complementation groups (FANCA, FANCB, FANCD1, FANCD2, FANDE, FANDF, FANDS, FANDR, FANED, FANF, FANG, FANH1, FANH2, FANI, FANJ, and FANK) of Fanconi anemia, each caused by mutations in a specific gene. FANCD1 is one of the complementation groups, and it is caused by mutations in the FANCD1 gene.\nThe FANCD1 gene is located on chromosome 3q26.3 and encodes a protein called FANCD1, which is involved in the repair of DNA interstrand cross-links (ICLs). ICLs are a type of DNA damage that can lead to genetic instability and cancer if left unrepaired. The FANCD1 protein plays a critical role in the repair of ICLs through the Fanconi anemia pathway.\nMutations in the FANCD1 gene can lead to the development of Fanconi anemia complementation group D1, which is characterized by congenital abnormalities, bone marrow failure, and an increased risk of cancer. The symptoms of Fanconi anemia complementation group D1 are similar to those of other complementation groups, but the age of onset and the severity of the symptoms can vary depending on the specific mutation and the individual affected.\nIn summary, the genetic cause of Fanconi anemia complementation group D1 is mutations in the FANCD1 gene, which encodes a protein involved in the repair of DNA interstrand cross-links and leads to genetic instability and an increased risk of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Fanconi anemia is a rare genetic disorder characterized by congenital abnormalities, bone marrow failure, and an increased risk of cancer.",
      "The genetic cause of Fanconi anemia complementation group D1 is mutations in the FANCD1 gene.",
      "There are 16 complementation groups of Fanconi anemia, each caused by mutations in a specific gene.",
      "The FANCD1 gene encodes a protein that is involved in the repair of DNA interstrand cross-links.",
      "DNA interstrand cross-links are a type of DNA damage that can lead to genetic instability and cancer if left unrepaired."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There are 22 identified complementation groups of Fanconi anemia, each caused by mutations in a specific gene.",
      "true",
      "true"
    ]
  },
  {
    "id": 596,
    "user_query": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?",
    "llama-2-7b-chat-hf_response": "Calsequestrin 2 (CASQ2) is a protein that plays a crucial role in maintaining the proper functioning of the endoplasmic reticulum (ER). Mutations in the CASQ2 gene have been associated with several diseases, including:\n1. Charcot-Marie-Tooth disease (CMT): CMT is a group of genetic disorders that affect the peripheral nervous system, causing muscle weakness, numbness, and loss of coordination. Mutations in the CASQ2 gene have been identified as a cause of some forms of CMT.\n2. Hereditary spastic paraplegia (HSP): HSP is a group of genetic disorders that cause progressive weakness and stiffness in the legs, leading to difficulty walking and mobility issues. Mutations in the CASQ2 gene have been linked to some forms of HSP.\n3. Retinal degeneration: Mutations in the CASQ2 gene have been associated with retinal degeneration, including retinitis pigmentosa and Leber congenital amaurosis. These conditions can lead to vision loss and blindness.\n4. Neuromyelitis optica (NMO): NMO is a rare autoimmune disease that affects the central nervous system, including the optic nerves and spinal cord. Mutations in the CASQ2 gene have been identified in some cases of NMO.\n5. Amyotrophic lateral sclerosis (ALS): ALS is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, twitching, and wasting. While the link between CASQ2 mutations and ALS is still being studied, some research suggests that CASQ2 may play a role in the development of the disease.\nIt's important to note that not all mutations in the CASQ2 gene will lead to these diseases, and not everyone with a mutation in the gene will develop these conditions. Additionally, other genetic and environmental factors can also contribute to the development of these diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Calsequestrin 2 (CASQ2) is a protein that plays a role in maintaining the proper functioning of the endoplasmic reticulum.",
      "Mutations in the CASQ2 gene have been associated with Charcot-Marie-Tooth disease (CMT), a group of genetic disorders affecting the peripheral nervous system.",
      "Hereditary spastic paraplegia (HSP), a group of genetic disorders causing progressive weakness and stiffness in the legs, has been linked to mutations in the CASQ2 gene.",
      "Some forms of retinal degeneration, including retinitis pigmentosa and Leber congenital amaurosis, have been associated with mutations in the CASQ2 gene.",
      "Mutations in the CASQ2 gene have been identified in some cases of Neuromyelitis optica (NMO), a rare autoimmune disease affecting the central nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Calsequestrin 2 (CASQ2) is a protein that plays a role in maintaining the proper functioning of the sarcoplasmic reticulum.",
      "false, [corrected fact]: Mutations in the CASQ2 gene have been associated with Catecholaminergic polymorphic ventricular tachycardia (CPVT), a condition that can cause life-threatening abnormal heart rhythms.",
      "true",
      "false, [corrected fact]: There is currently no research indicating that mutations in the CASQ2 gene are associated with forms of retinal degeneration such as retinitis pigmentosa and Leber congenital amaurosis.",
      "false, [corrected fact]: There is currently no research indicating that mutations in the CASQ2 gene are associated with Neuromyelitis optica (NMO)."
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-7b-chat-hf_response": "Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates have been identified through various bioinformatic and experimental approaches. Here are some of the most frequent non-canonical sequence motifs found at the donor and acceptor splice sites in vertebrates:\nDonor splice sites:\n1. GU-rich sequences: Non-canonical GU-rich sequences are found in the introns of many vertebrate genes. These sequences are rich in guanine and uracil nucleotides and are often located upstream of the donor splice site.\n2. AG-rich sequences: AG-rich sequences are another type of non-canonical sequence found in the introns of vertebrate genes. These sequences are rich in adenine and guanine nucleotides and are often located downstream of the donor splice site.\n3. GT-rich sequences: GT-rich sequences are found in the introns of some vertebrate genes and are characterized by a high content of guanine and thymine nucleotides. These sequences are often located upstream of the donor splice site.\n4. AU-rich sequences: AU-rich sequences are found in the introns of some vertebrate genes and are characterized by a high content of adenine and uracil nucleotides. These sequences are often located downstream of the donor splice site.\nAcceptor splice sites:\n1. GT-rich sequences: GT-rich sequences are found in the exons of many vertebrate genes and are characterized by a high content of guanine and thymine nucleotides. These sequences are often located upstream of the acceptor splice site.\n2. AG-rich sequences: AG-rich sequences are found in the exons of some vertebrate genes and are characterized by a high content of adenine and guanine nucleotides. These sequences are often located downstream of the acceptor splice site.\n3. GU-rich sequences: GU-rich sequences are found in the exons of some vertebrate genes and are characterized by a high content of guanine and uracil nucleotides. These sequences are often located upstream of the acceptor splice site.",
    "llama-2-7b-chat-hf_fact": [
      "Non-canonical GU-rich sequences are frequently found in introns of vertebrate genes and are often located upstream of the donor splice site.",
      "AG-rich sequences are a common type of non-canonical sequence found downstream of donor splice sites in the introns of vertebrate genes.",
      "GT-rich sequences found upstream of the donor splice site are present in introns of some vertebrate genes.",
      "AU-rich sequences are located downstream of the donor splice site in introns of some vertebrate genes.",
      "At acceptor splice sites, GT-rich sequences are found upstream in exons of many vertebrate genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 602,
    "user_query": "Which are the Atg8 homologs in human?",
    "llama-2-7b-chat-hf_response": "Atg8 homologs in human are:\n1. Autophagy-related protein 8 (ATG8A)\n2. Autophagy-related protein 8B (ATG8B)\n3. Autophagy-related protein 8C (ATG8C)\n4. Autophagy-related protein 8D (ATG8D)\n5. Autophagy-related protein 8E (ATG8E)\n6. Autophagy-related protein 8F (ATG8F)\n7. Autophagy-related protein 8G (ATG8G)\n8. Autophagy-related protein 8H (ATG8H)\n9. Autophagy-related protein 8I (ATG8I)\n10. Autophagy-related protein 8J (ATG8J)\nNote: The above list of Atg8 homologs in human is not exhaustive and is based on the current scientific understanding of the topic.",
    "llama-2-7b-chat-hf_fact": [
      "Autophagy-related protein 8 (ATG8A) is an Atg8 homolog in humans.",
      "Autophagy-related protein 8B (ATG8B) is an Atg8 homolog in humans.",
      "Autophagy-related protein 8C (ATG8C) is an Atg8 homolog in humans.",
      "Autophagy-related protein 8D (ATG8D) is an Atg8 homolog in humans.",
      "Autophagy-related protein 8E (ATG8E) is an Atg8 homolog in humans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Autophagy-related protein 8D (ATG8D) does not exist in humans.",
      "false, [corrected fact]: Autophagy-related protein 8E (ATG8E) does not exist in humans."
    ]
  },
  {
    "id": 606,
    "user_query": "Which is the molecular mechanism underlying K-ras alterations in carcinomas?",
    "llama-2-7b-chat-hf_response": "K-ras mutations are found in approximately 20-30% of all human cancers, and are particularly common in pancreatic, colorectal, and lung cancers. The molecular mechanism underlying K-ras alterations in carcinomas is complex and involves multiple steps, including:\n1. Mutations in the K-ras gene: The K-ras gene is located on chromosome 12q24 and encodes for a GTPase protein that regulates signaling pathways involved in cell growth, differentiation, and survival. Mutations in the K-ras gene can lead to the production of a constitutively active GTP-bound form of the protein, which can promote cell proliferation and survival.\n2. Epigenetic alterations: Epigenetic alterations, such as DNA methylation and histone modifications, can also contribute to K-ras mutations in carcinomas. These alterations can result in the silencing of the K-ras gene, leading to its inactivation.\n3. Chromosomal rearrangements: Chromosomal rearrangements, such as translocations or inversions, can also lead to K-ras alterations in carcinomas. These rearrangements can result in the fusion of the K-ras gene with other genes, leading to the production of chimeric proteins that can promote cell proliferation and survival.\n4. Loss of heterozygosity: Loss of heterozygosity (LOH) at the K-ras locus can also contribute to the development of K-ras alterations in carcinomas. LOH can result in the loss of one of the two copies of the K-ras gene, leading to its inactivation.\n5. Mutations in nearby genes: Mutations in nearby genes, such as the p53 tumor suppressor gene, can also contribute to K-ras alterations in carcinomas. These mutations can disrupt the normal function of these genes, leading to the development of K-ras alterations.\nOverall, the molecular mechanism underlying K-ras alterations in carcinomas is complex and involves multiple steps, including mutations in the K-ras gene, epigenetic alterations, chromosom",
    "llama-2-7b-chat-hf_fact": [
      "K-ras mutations are found in approximately 20-30% of all human cancers and are specifically common in pancreatic, colorectal, and lung cancers.",
      "The K-ras gene, which regulates signaling pathways involved in cell growth, differentiation, and survival, is located on chromosome 12q24.",
      "Epigenetic alterations, such as DNA methylation and histone modifications, can contribute to K-ras mutations in carcinomas.",
      "Chromosomal rearrangements, such as translocations or inversions, can result in the fusion of the K-ras gene with other genes.",
      "Mutations in nearby genes, like the p53 tumor suppressor gene, can contribute to K-ras alterations in carcinomas."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The K-ras gene is located on chromosome 12p12.1.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 607,
    "user_query": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?",
    "llama-2-7b-chat-hf_response": "MicroRNAs (miRNAs) are small non-coding RNAs that play a critical role in regulating gene expression by binding to messenger RNAs (mRNAs) and preventing their translation into proteins. Recent studies have shown that miR-30 is involved in the regulation of post-ischemic cardiac remodeling, which is the process by which the heart adapts to injury or stress after an ischemic event.\nOne study published in the journal Circulation Research found that miR-30 is downregulated in the hearts of mice after myocardial infarction (heart attack). The researchers found that this downregulation leads to an increase in the expression of pro-inflammatory genes, such as tumor necrosis factor-alpha (TNF-alpha), and a decrease in the expression of anti-inflammatory genes, such as interleukin-10 (IL-10).\nAnother study published in the journal American Journal of Physiology-Heart and Circulatory Physiology found that miR-30 regulates the expression of genes involved in cardiac hypertrophy, a common response to ischemic injury. The researchers found that overexpression of miR-30 in mice after myocardial infarction leads to a decrease in the expression of genes involved in cardiac hypertrophy, such as atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP).\nThese studies suggest that miR-30 plays a critical role in regulating the response of the heart to ischemic injury and may be a potential therapeutic target for the treatment of post-ischemic cardiac remodeling.",
    "llama-2-7b-chat-hf_fact": [
      "MicroRNAs (miRNAs) are small non-coding RNAs that play a role in regulating gene expression by preventing messenger RNAs (mRNAs) from translating into proteins.",
      "Studies have shown that miR-30 is involved in the regulation of post-ischemic cardiac remodeling.",
      "A study published in the journal Circulation Research found that miR-30 is downregulated in the hearts of mice after myocardial infarction.",
      "Another study published in the journal American Journal of Physiology-Heart and Circulatory Physiology found that miR-30 regulates the expression of genes involved in cardiac hypertrophy, a common response to ischemic injury.",
      "miR-30's role in regulating the response of the heart to ischemic injury suggests it may be a therapeutic target for the treatment of post-ischemic cardiac remodeling."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 613,
    "user_query": "How is myotonic dystrophy inherited?",
    "llama-2-7b-chat-hf_response": "Myotonic dystrophy is a genetic disorder that affects the muscles and is inherited in an autosomal dominant pattern. This means that a single copy of the mutated gene is enough to cause the condition. The mutated gene responsible for myotonic dystrophy is located on chromosome 19.\nThe inheritance pattern of myotonic dystrophy is as follows:\n* Each parent of an affected individual has a 50% chance of carrying the mutated gene.\n* Affected individuals have a 50% chance of passing the mutated gene to each of their children.\n* Unaffected individuals (carriers) have a 50% chance of passing the mutated gene to each of their children, but they will not express the symptoms of the condition themselves.\nIt's important to note that the inheritance pattern of myotonic dystrophy can vary depending on the specific type of the disorder. There are three types of myotonic dystrophy, each with a slightly different inheritance pattern.\nIf you have been diagnosed with myotonic dystrophy or are concerned that you may be a carrier, it's important to speak with a genetic counselor or other healthcare professional to discuss your options and the potential risks to your children. Genetic testing can help determine whether you are a carrier of the mutated gene and whether your children are at risk of inheriting the condition.",
    "llama-2-7b-chat-hf_fact": [
      "Myotonic dystrophy is a genetic disorder that affects muscles.",
      "Myotonic dystrophy is inherited in an autosomal dominant pattern.",
      "The mutated gene responsible for myotonic dystrophy is located on chromosome 19.",
      "Each parent of an affected individual with myotonic dystrophy has a 50% chance of carrying the mutated gene.",
      "There are three types of myotonic dystrophy, each with a slightly different inheritance pattern."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Each child of an affected individual with myotonic dystrophy has a 50% chance of inheriting the mutated gene.",
      "true"
    ]
  },
  {
    "id": 615,
    "user_query": "Which are the mammalian orthologs of Drosophila Yki?",
    "llama-2-7b-chat-hf_response": "Yki (Yeast Kinase I) is a serine/threonine kinase that plays a key role in regulating cell growth and proliferation in Drosophila. There are several mammalian orthologs of Yki, including:\n1. Ste20-like kinase 1 (STELLA): Stella is a member of the Ste20 family of protein kinases and is highly homologous to Yki. It is involved in the regulation of cell growth and proliferation in mammalian cells.\n2. Mitogen-activated protein kinase kinase kinase (MEKK4): MEKK4 is a member of the MEKK family of protein kinases and is involved in the regulation of cell growth and proliferation. It is highly homologous to Yki and has been shown to play a role in the regulation of cell growth in mammalian cells.\n3. Mitogen-activated protein kinase kinase kinase kinase (MEKK7): MEKK7 is a member of the MEKK family of protein kinases and is involved in the regulation of cell growth and proliferation. It is highly homologous to Yki and has been shown to play a role in the regulation of cell growth in mammalian cells.\n4. Mitogen-activated protein kinase kinase kinase kinase (MEKK6): MEKK6 is a member of the MEKK family of protein kinases and is involved in the regulation of cell growth and proliferation. It is highly homologous to Yki and has been shown to play a role in the regulation of cell growth in mammalian cells.\n5. Mitogen-activated protein kinase kinase kinase kinase (MEKK5): MEKK5 is a member of the MEKK family of protein kinases and is involved in the regulation of cell growth and proliferation. It is highly homologous to Yki and has been shown to play a role in the regulation of cell growth in mammalian cells.\nIt is important to note that while these proteins are highly homologous to Yki, they may have different functions and properties in mammalian cells compared to Yki in Drosophila",
    "llama-2-7b-chat-hf_fact": [
      "Yki (Yeast Kinase I) is a serine/threonine kinase that plays a role in regulating cell growth and proliferation in Drosophila.",
      "The STELLA (Ste20-like kinase 1) protein is a mammalian ortholog of Yki, and is involved in the regulation of cell growth and proliferation in mammalian cells.",
      "MEKK4, a member of the MEKK family of protein kinases, is a mammalian ortholog of Yki and contributes to cell growth regulation in mammalian cells.",
      "MEKK7, another MEKK family protein kinase, is a mammalian ortholog of Yki and has a role in the regulation of cell growth in mammalian cells.",
      "MEKK5 and MEKK6, members of the MEKK family, are mammalian orthologs of Yki, which regulate cell growth in mammalian cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false, [corrected fact]: MEKK4, a member of the MEKK family of protein kinases, is not a mammalian ortholog of Yki.",
      "false, [corrected fact]: MEKK7, another MEKK family protein kinase, is not a mammalian ortholog of Yki.",
      "false, [corrected fact]: MEKK5 and MEKK6, members of the MEKK family, are not mammalian orthologs of Yki."
    ]
  },
  {
    "id": 618,
    "user_query": "Does molindone affect body weight?",
    "llama-2-7b-chat-hf_response": "Molindone is an antipsychotic medication that is used to treat schizophrenia and other psychotic disorders. While it is not specifically approved for weight management, some studies suggest that it may have an effect on body weight.\nOne study published in the Journal of Clinical Psychopharmacology found that molindone was associated with a significant increase in body weight in patients with schizophrenia. The study found that patients who received molindone had a mean increase in body weight of 7.5 kg (16.5 lbs) over a 6-month period, compared to a mean increase of 3.5 kg (7.7 lbs) in patients who received a different antipsychotic medication.\nAnother study published in the Journal of Psychopharmacology found that molindone was associated with a decrease in body fat percentage in patients with schizophrenia. The study found that patients who received molindone had a mean decrease in body fat percentage of 2.5% over a 6-month period, compared to a mean decrease of 0.5% in patients who received a different antipsychotic medication.\nIt is thought that molindone may affect body weight by altering the levels of certain neurotransmitters in the brain, such as dopamine and serotonin, which play a role in appetite and metabolism. However, more research is needed to fully understand the effects of molindone on body weight.\nIt is important to note that weight gain is a common side effect of many antipsychotic medications, including molindone. If you are taking molindone and are concerned about weight gain, it is important to talk to your doctor about your options. Your doctor may be able to adjust your dosage or recommend lifestyle changes to help manage weight.",
    "llama-2-7b-chat-hf_fact": [
      "Molindone is an antipsychotic medication used to treat schizophrenia and other psychotic disorders.",
      "A study in the Journal of Clinical Psychopharmacology indicated that molindone was associated with a significant increase in body weight in patients with schizophrenia.",
      "Based on the same study, patients who received molindone had a mean increase in body weight of 7.5 kg over a 6-month period.",
      "Another study in the Journal of Psychopharmacology found that molindone was associated with a decrease in body fat percentage in patients with schizophrenia.",
      "It is considered that molindone's potential to affect body weight could be due to its altering the levels of certain neurotransmitters in the brain, such as dopamine and serotonin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 622,
    "user_query": "Neurostimulation of which nucleus is used for treatment of dystonia?",
    "llama-2-7b-chat-hf_response": "Dystonia is a movement disorder characterized by involuntary muscle contractions and spasms that can cause twisting, repetitive movements, or abnormal postures. Neurostimulation of the globus pallidus internus (GPi) nucleus has been used as a treatment for dystonia. The GPi is a subcortical nucleus located in the basal ganglia that plays a key role in the regulation of movement. Deep brain stimulation (DBS) of the GPi has been shown to improve symptoms of dystonia in some patients, particularly those with generalized dystonia. Other nuclei that have been targeted for neurostimulation in the treatment of dystonia include the subthalamic nucleus (STN) and the cerebellum.",
    "llama-2-7b-chat-hf_fact": [
      "Dystonia is a movement disorder characterized by involuntary muscle contractions and spasms.",
      "The globus pallidus internus (GPi) nucleus has been used in neurostimulation treatment for dystonia.",
      "The GPi is a subcortical nucleus located in the basal ganglia.",
      "Deep brain stimulation (DBS) of the GPi improves symptoms of dystonia in some patients, particularly those with generalized dystonia.",
      "The subthalamic nucleus (STN) and the cerebellum have also been targeted for neurostimulation in the treatment of dystonia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 625,
    "user_query": "Where is the angiogenin binding element  located?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a protein that plays a crucial role in the regulation of angiogenesis, the formation of new blood vessels. The binding element for angiogenin is located in the 5' untranslated region (5' UTR) of target mRNAs. This element is responsible for the binding of angiogenin to its target mRNAs and plays a crucial role in the regulation of gene expression.\nThe specific sequence of the angiogenin binding element varies depending on the target gene, but it typically contains a conserved AU-rich element (ARE) that is rich in adenine and uridine residues. The ARE is usually located around 50-100 nucleotides upstream of the translational start site of the target mRNA.\nOnce angiogenin binds to its target mRNA, it can stimulate the translation of the mRNA into protein or induce the degradation of the mRNA, leading to changes in gene expression. Angiogenin has been implicated in a variety of biological processes, including embryonic development, wound healing, and cancer, and its dysregulation has been implicated in a number of diseases, including cancer and cardiovascular disease.",
    "llama-2-7b-chat-hf_fact": [
      "Angiogenin is a protein involved in the regulation of angiogenesis, the formation of new blood vessels.",
      "The binding element for angiogenin is located in the 5' untranslated region (5' UTR) of target mRNAs.",
      "The angiogenin binding element usually includes an AU-rich element (ARE).",
      "The ARE is typically located around 50-100 nucleotides upstream of the translational start site of the target mRNA.",
      "Once angiogenin binds to its target mRNA, it can either stimulate the mRNA's translation into protein or induce the mRNA's degradation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 626,
    "user_query": "Which proteins cause cytoplasmic sequestration of NF-kB?",
    "llama-2-7b-chat-hf_response": "NF-B (nuclear factor kappa B) is a transcription factor that plays a crucial role in regulating the expression of genes involved in inflammation, immune response, and cell survival. Cytoplasmic sequestration of NF-B refers to the process by which NF-B is retained in the cytoplasm rather than translocating to the nucleus, where it can bind to DNA and regulate gene expression. Several proteins have been identified that can cause cytoplasmic sequestration of NF-B, including:\n1. IB (inhibitor of B): IB is a protein that binds to and inhibits the activity of NF-B, preventing it from translocating to the nucleus. Overexpression or mutations of IB can lead to the sequestration of NF-B in the cytoplasm.\n2. cIAP1 (cellular inhibitor of apoptosis protein 1): cIAP1 is a protein that binds to and inhibits the activity of NF-B, leading to its sequestration in the cytoplasm.\n3. cIAP2 (cellular inhibitor of apoptosis protein 2): cIAP2 is another protein that binds to and inhibits the activity of NF-B, leading to its sequestration in the cytoplasm.\n4. MAL (myeloid cell leukemia 1): MAL is a protein that binds to and inhibits the activity of NF-B, leading to its sequestration in the cytoplasm.\n5. TRAF6 (tumor necrosis factor receptor-associated factor 6): TRAF6 is a protein that binds to and inhibits the activity of NF-B, leading to its sequestration in the cytoplasm.\nUnderstanding the mechanisms of cytoplasmic sequestration of NF-B can provide valuable insights into the regulation of inflammation and immune response, and may lead to the development of new therapeutic strategies for the treatment of diseases characterized by dysregulated NF",
    "llama-2-7b-chat-hf_fact": [
      "NF-B is a transcription factor that regulates the expression of genes related to inflammation, immune response, and cell survival.",
      "Cytoplasmic sequestration refers to the process where NF-B is retained in the cytoplasm and not translocated to the nucleus to regulate gene expression.",
      "The IB protein can cause cytoplasmic sequestration of NF-B.",
      "The proteins cIAP1 and cIAP2 can also cause cytoplasmic sequestration of NF-B.",
      "Other proteins, namely MAL and TRAF6, have been identified to cause cytoplasmic sequestration of NF-B."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 627,
    "user_query": "What is the mode of inheritance of Marchesani syndrome?",
    "llama-2-7b-chat-hf_response": "Marchesani syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. It is caused by mutations in the TCF4 gene, which codes for a transcription factor that plays a critical role in the regulation of gene expression during brain development. The mode of inheritance of Marchesani syndrome is autosomal dominant, meaning that a single copy of the mutated TCF4 gene is enough to cause the condition. This means that if one parent has the mutated gene, each child has a 50% chance of inheriting the mutation.",
    "llama-2-7b-chat-hf_fact": [
      "Marchesani syndrome is a rare genetic disorder that affects the development of the brain and spinal cord.",
      "Marchesani syndrome is caused by mutations in the TCF4 gene.",
      "The TCF4 gene codes for a transcription factor that plays a critical role in the regulation of gene expression during brain development.",
      "The mode of inheritance of Marchesani syndrome is autosomal dominant.",
      "If one parent has the mutated TCF4 gene, each child has a 50% chance of inheriting the mutation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Marchesani syndrome is a rare genetic disorder that primarily affects the eyes and can influence the body's growth and development.",
      "false, [corrected fact]: Marchesani syndrome is caused by mutations in the ADAMTS10 and ADAMTS17 genes.",
      "false, [corrected fact]: The TCF4 gene codes for a transcription factor that plays a critical role in the development and function of the nervous system, not specifically connected to Marchesani syndrome.",
      "true",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-7b-chat-hf_response": "A) Activation of the PI3K/Akt signaling pathway\nB) Activation of the MAPK/ERK signaling pathway\nC) Activation of the JNK signaling pathway\nD) Activation of the NF-B signaling pathway\nAnswer: A) Activation of the PI3K/Akt signaling pathway\nExplanation:\nS6K1 (p70 S6 kinase 1) is a key regulator of protein synthesis and cell growth, and its activity is regulated by various signaling pathways. One of the key events that results in the acetylation of S6K1 is the activation of the PI3K/Akt signaling pathway.\nWhen the PI3K/Akt pathway is activated, phosphatidylinositol 3,4,5-trisphosphate (PIP3) is generated, which then recruits and activates Akt. Activated Akt then phosphorylates and activates S6K1, leading to its acetylation and increased activity.\nIn contrast, the other options are not directly involved in the acetylation of S6K1:\nB) Activation of the MAPK/ERK signaling pathway does not result in the acetylation of S6K1. While MAPK/ERK signaling can activate other protein kinases, it does not directly regulate S6K1.\nC) Activation of the JNK signaling pathway also does not result in the acetylation of S6K1. JNK signaling can activate other protein kinases, but it does not directly regulate S6K1.\nD) Activation of the NF-B signaling pathway can result in the acetylation of other protein kinases, but it does not directly regulate S6K1.\nTherefore, the correct answer is (A) Activation of the PI3K/Akt signaling pathway.",
    "llama-2-7b-chat-hf_fact": [
      "S6K1 (p70 S6 kinase 1) is a key regulator of protein synthesis and cell growth.",
      "The activation of the PI3K/Akt signaling pathway results in the acetylation of S6K1.",
      "When the PI3K/Akt pathway is activated, phosphatidylinositol 3,4,5-trisphosphate (PIP3) is generated, which triggers the activation of Akt, and subsequently S6K1.",
      "Activated Akt phosphorylates and activates S6K1, leading to its acetylation and increased activity.",
      "The MAPK/ERK, JNK and NF-B signaling pathways do not directly regulate S6K1."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The activation of the PI3K/Akt signaling pathway results in the phosphorylation, not acetylation, of S6K1.",
      "true",
      "false, [corrected fact]: Activated Akt phosphorylates and activates S6K1, but this does not result in its acetylation.",
      "unknown"
    ]
  },
  {
    "id": 630,
    "user_query": "List angiocrine factors",
    "llama-2-7b-chat-hf_response": "Angiocrine factors are factors that are produced by endothelial cells and play a role in the regulation of angiogenesis, the formation of new blood vessels. Here are some examples of angiocrine factors:\n1. Vascular endothelial growth factor (VEGF): VEGF is a potent angiocrine factor that promotes angiogenesis by stimulating the proliferation and migration of endothelial cells.\n2. Platelet-derived growth factor (PDGF): PDGF is a growth factor that is produced by platelets and endothelial cells and promotes angiogenesis by stimulating the proliferation of endothelial cells.\n3. Fibroblast growth factor (FGF): FGF is a family of growth factors that promote angiogenesis by stimulating the proliferation and migration of endothelial cells.\n4. Hypoxia-inducible factor (HIF): HIF is a transcription factor that plays a key role in the response to hypoxia and promotes angiogenesis by activating the expression of genes involved in angiogenesis.\n5. Endothelial nitric oxide synthase (eNOS): eNOS is an enzyme that is produced by endothelial cells and plays a role in the regulation of angiogenesis by producing nitric oxide, a potent vasodilator.\n6. Tie2: Tie2 is a receptor that is produced by endothelial cells and plays a role in the regulation of angiogenesis by mediating the response to VEGF.\n7. Angiopoietin-2 (Ang-2): Ang-2 is a protein that is produced by endothelial cells and plays a role in the regulation of angiogenesis by inhibiting the activity of Tie2.\n8. Endothelial protein C receptor (EPCR): EPCR is a receptor that is produced by endothelial cells and plays a role in the regulation of angiogenesis by mediating the response to protein C.\n9. Protein C: Protein C is a protein that is produced by the liver and plays a role in the regulation of ang",
    "llama-2-7b-chat-hf_fact": [
      "Angiocrine factors are produced by endothelial cells and help regulate angiogenesis.",
      "Vascular endothelial growth factor (VEGF) promotes angiogenesis.",
      "Platelet-derived growth factor (PDGF) is an angiocrine factor produced by platelets and endothelial cells.",
      "Fibroblast growth factor (FGF) is a family of growth factors that stimulate the proliferation and migration of endothelial cells.",
      "Hypoxia-inducible factor (HIF) is a transcription factor that plays a role in the response to hypoxia and promotes angiogenesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Platelet-derived growth factor (PDGF) is a growth factor produced by platelets and endothelial cells, it plays an important role in blood vessel formation, but it's not classified as an angiocrine factor.",
      "true",
      "true"
    ]
  },
  {
    "id": 631,
    "user_query": "What is protein carbamylation?",
    "llama-2-7b-chat-hf_response": "Protein carbamylation is a post-translational modification that involves the covalent attachment of a carbamate group to a protein. This modification is known to play a crucial role in various cellular processes, including protein synthesis, folding, and degradation. Carbamylation can occur in different regions of a protein, including the N-terminal, C-terminal, and internal regions.\nProtein carbamylation is mediated by enzymes called carbamyltransferases, which catalyze the transfer of a carbamate group from a donor molecule to a specific acceptor site on the protein. The donor molecule is typically an amino acid, such as glutamine or asparagine, while the acceptor site is usually a lysine or arginine residue.\nProtein carbamylation has been implicated in various cellular processes, including:\n1. Protein synthesis and folding: Carbamylation can modulate the folding and stability of proteins, particularly in the early stages of protein synthesis.\n2. Protein degradation: Carbamylation can influence the degradation of proteins by modulating the activity of proteases, such as the ubiquitin-proteasome system.\n3. Signal transduction: Carbamylation can participate in signal transduction pathways by modulating the activity of signaling proteins, such as kinases and phosphatases.\n4. Cellular stress responses: Carbamylation can play a role in cellular stress responses, such as the unfolded protein response (UPR), by modulating the activity of chaperone proteins.\nDysregulation of protein carbamylation has been implicated in various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. Therefore, understanding the mechanisms of protein carbamylation and its role in cellular processes is crucial for the development of new therapeutic strategies for these diseases.\nIn summary, protein carbamylation is a post-translational modification that plays a crucial role in various cellular processes, including protein synthesis, folding, and degradation. Dysreg",
    "llama-2-7b-chat-hf_fact": [
      "Protein carbamylation is a post-translational modification that involves the attachment of a carbamate group to a protein.",
      "This modification plays a role in cellular processes like protein synthesis, folding, and degradation.",
      "Carbamylation can occur in different regions of a protein, including the N-terminal, C-terminal, and internal regions.",
      "Enzymes known as carbamyltransferases mediate protein carbamylation.",
      "Dysregulation of protein carbamylation has been linked to various diseases such as cancer, neurodegenerative disorders, and metabolic disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-7b-chat-hf_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that affects the nervous system, particularly the cerebellum, and causes episodes of ataxia (loss of coordination and balance) and other neurological symptoms. The exact cause of EA6 is not fully understood, but it is believed to be due to mutations in the FKBP52 gene. The FKBP52 gene provides instructions for making a protein called FK506-binding protein 52 (FKBP52), which is involved in the regulation of protein folding and degradation in the cell. Mutations in the FKBP52 gene have been found to cause EA6 by disrupting the normal function of the protein, leading to the accumulation of abnormal protein aggregates in the cerebellum and other parts of the brain. These aggregates are thought to contribute to the degeneration of neurons and the development of ataxia and other neurological symptoms in EA6 patients.",
    "llama-2-7b-chat-hf_fact": [
      "Episodic ataxia type 6 (EA6) is a rare genetic disorder that affects the nervous system, particularly the cerebellum.",
      "EA6 is characterized by episodes of ataxia (loss of coordination and balance) and other neurological symptoms.",
      "The FKBP52 gene is associated with EA6 and provides instructions for making FK506-binding protein 52.",
      "FK506-binding protein 52 plays a role in the regulation of protein folding and degradation in the cell.",
      "Mutations in the FKBP52 gene lead to the accumulation of abnormal protein aggregates in the cerebellum and other parts of the brain, contributing to neuron degeneration and progression of EA6 symptoms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "false, [corrected fact]: Mutations in the FKBP52 gene are not associated with EA6 or accumulation of abnormal protein aggregates. The gene associated with EA6 and the aforementioned conditions is not specified in the given statements."
    ]
  },
  {
    "id": 633,
    "user_query": "What is the main role of Ctf4 in dna replication?",
    "llama-2-7b-chat-hf_response": "Ctf4 (cellular factor 4) is a protein that plays a crucial role in DNA replication. Its main role is to help initiate DNA replication by recruiting and activating the Mcm2-7 complex, which is responsible for unwinding double-stranded DNA during replication. Ctf4 also interacts with other proteins, such as the mini-chromosome maintenance (MCM) complex, to facilitate the initiation of DNA replication. Additionally, Ctf4 helps to regulate the activity of other proteins involved in DNA replication, such as the helicase and primase enzymes. Overall, Ctf4 plays a critical role in ensuring the proper initiation and progression of DNA replication.",
    "llama-2-7b-chat-hf_fact": [
      "Ctf4 is a protein that plays a role in DNA replication.",
      "Ctf4 helps initiate DNA replication by recruiting and activating the Mcm2-7 complex.",
      "The Mcm2-7 complex unwinds double-stranded DNA during replication.",
      "Ctf4 interacts with other proteins, such as the mini-chromosome maintenance (MCM) complex.",
      "Ctf4 helps to regulate the activity of other proteins involved in DNA replication, such as the helicase and primase enzymes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 634,
    "user_query": "Could Arimidex (anastrozole) cause hot flashes?",
    "llama-2-7b-chat-hf_response": "Yes, Arimidex (anastrozole) can cause hot flashes as a side effect. Hot flashes are a common symptom of menopause and can also be caused by hormonal changes in the body. Anastrozole, the active ingredient in Arimidex, is a selective estrogen receptor modulator (SERM) that is used to treat hormone-sensitive breast cancer in postmenopausal women. It works by blocking the action of estrogen on cancer cells, which can help slow the growth of the cancer. However, estrogen is also involved in the regulation of body temperature, and blocking its action can lead to hot flashes.\nOther common side effects of Arimidex include:\n* Nausea and vomiting\n* Fatigue\n* Headache\n* Muscle pain\n* Joint pain\n* Changes in mood, such as depression or anxiety\n* Changes in libido\n* Changes in sleep patterns\nIt's important to note that not all women who take Arimidex will experience hot flashes, and the severity of the side effect can vary from person to person. If you are taking Arimidex and are experiencing hot flashes, it's important to talk to your doctor about it. Your doctor may be able to adjust your dosage or recommend other treatments to help manage the side effect.",
    "llama-2-7b-chat-hf_fact": [
      "Arimidex (anastrozole) can cause hot flashes as a side effect.",
      "Anastrozole, the active ingredient in Arimidex, is a selective estrogen receptor modulator used to treat hormone-sensitive breast cancer in postmenopausal women.",
      "Anastrozole works by blocking the action of estrogen on cancer cells.",
      "Other common side effects of Arimidex include nausea and vomiting, fatigue, headache, muscle pain, joint pain, changes in mood, changes in libido, and changes in sleep patterns.",
      "Not all women who take Arimidex will experience hot flashes, and the severity of the side effect can vary from person to person."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Anastrozole, the active ingredient in Arimidex, is an aromatase inhibitor used to treat hormone-sensitive breast cancer in postmenopausal women.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 635,
    "user_query": "What is the role of Inn1 in cytokinesis?",
    "llama-2-7b-chat-hf_response": "Inn1 (inner nuclear envelope protein 1) is a protein that plays a crucial role in the regulation of cytokinesis, the process by which a cell divides into two daughter cells. Inn1 is localized to the inner nuclear envelope, a specialized structure that separates the nucleus from the cytoplasm.\nStudies have shown that Inn1 plays a key role in the formation of the cytokinetic cleavage furrow, the groove that forms between the two daughter cells during cytokinesis. Inn1 helps to regulate the contraction of the actin cytoskeleton, which is essential for the formation of the cleavage furrow. Inn1 also interacts with other proteins, such as the Rho-family GTPase Cdc42, to regulate the localization and activity of these proteins during cytokinesis.\nIn addition to its role in cytokinesis, Inn1 has been implicated in other cellular processes, including cell adhesion, migration, and signaling. Dysregulation of Inn1 has been implicated in various diseases, including cancer and neurodegenerative disorders.\nIn summary, Inn1 plays a crucial role in the regulation of cytokinesis by regulating the contraction of the actin cytoskeleton and interacting with other proteins to form the cytokinetic cleavage furrow.",
    "llama-2-7b-chat-hf_fact": [
      "Inn1 (inner nuclear envelope protein 1) plays a crucial role in the regulation of cytokinesis, the process of cell division into two daughter cells.",
      "Inn1 is localized to the inner nuclear envelope, a structure that separates the nucleus from the cytoplasm.",
      "Inn1 plays a key role in the formation of the cytokinetic cleavage furrow during cytokinesis.",
      "Inn1 helps to regulate the contraction of the actin cytoskeleton, essential for the cleavage furrow formation.",
      "Inn1 has been implicated in other cellular processes, including cell adhesion, migration, and signaling, and dysregulation has been linked to diseases such as cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 636,
    "user_query": "Which hormone deficiency is implicated in the Costello syndrome ?",
    "llama-2-7b-chat-hf_response": "Costello syndrome is a rare genetic disorder that affects approximately 1 in 10,000 people worldwide. It is characterized by a range of symptoms including growth delays, intellectual disability, distinctive facial features, and a higher risk of developing certain cancers.\nOne of the key features of Costello syndrome is a deficiency in the hormone gonadotropin-releasing hormone (GnRH). GnRH is produced by the hypothalamus in the brain and plays a crucial role in the regulation of hormone production in the body. In people with Costello syndrome, the deficiency of GnRH can lead to a range of hormonal imbalances, including low levels of sex hormones such as estrogen and testosterone.\nOther hormone deficiencies that have been implicated in Costello syndrome include:\n* Deficiency of thyroid-stimulating hormone (TSH): People with Costello syndrome may have low levels of TSH, which can lead to hypothyroidism (an underactive thyroid gland).\n* Deficiency of adrenocorticotropic hormone (ACTH): Some people with Costello syndrome may have low levels of ACTH, which can lead to adrenal insufficiency (an underactive adrenal gland).\n* Deficiency of prolactin: Some people with Costello syndrome may have low levels of prolactin, which can lead to infertility and other hormonal imbalances.\n* Deficiency of growth hormone: Some people with Costello syndrome may have low levels of growth hormone, which can lead to growth delays and short stature.\nIt is important to note that each person with Costello syndrome may have a different combination of hormone deficiencies, and the severity of these deficiencies can vary from person to person.",
    "llama-2-7b-chat-hf_fact": [
      "Costello syndrome is a rare genetic disorder that impacts approximately 1 in 10,000 people worldwide.",
      "One of the symptoms of Costello syndrome is a deficiency in the hormone gonadotropin-releasing hormone (GnRH).",
      "Some people with Costello syndrome may have a deficiency of thyroid-stimulating hormone (TSH), leading to an underactive thyroid gland.",
      "Some individuals with Costello syndrome possibly have a deficiency in adrenocorticotropic hormone (ACTH), causing an underactive adrenal gland.",
      "Low levels of growth hormone, causing growth delays and short stature, can also be a condition in some people with Costello syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Costello syndrome is an extremely rare genetic disorder, with approximately 300 reported cases worldwide.",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 640,
    "user_query": "Which is the most common CFTR mutation in Caucasians?",
    "llama-2-7b-chat-hf_response": "CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) mutations are the primary cause of cystic fibrosis (CF), a genetic disorder that affects the respiratory, digestive, and reproductive systems. The most common CFTR mutation in Caucasians is the deletion of three nucleotides (F508), which accounts for approximately 70% of CF cases in this population. Other common CFTR mutations in Caucasians include the R117H and S1251N mutations.",
    "llama-2-7b-chat-hf_fact": [
      "CFTR mutations are the primary cause of cystic fibrosis, a genetic disorder.",
      "Cystic fibrosis affects the respiratory, digestive, and reproductive systems.",
      "The most common CFTR mutation in Caucasians is the deletion of three nucleotides (F508).",
      "The F508 mutation accounts for approximately 70% of CF cases in the Caucasian population.",
      "Other common CFTR mutations in Caucasians include the R117H and S1251N mutations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 641,
    "user_query": "Which CDK targets control cytokinesis?",
    "llama-2-7b-chat-hf_response": "Cytokinesis is the process of cell division where the cytoplasm divides and the cell splits into two daughter cells. There are several CDK (cyclin-dependent kinase) targets that control cytokinesis. CDKs are enzymes that add phosphate groups to proteins, which can activate or inhibit their activity. Here are some of the CDK targets that control cytokinesis:\n1. Polo-like kinase 1 (PLK1): PLK1 is a key regulator of cytokinesis and is required for the proper separation of the daughter cells during cell division. PLK1 is activated by CDKs and phosphorylates and activates other proteins that are involved in the formation of the cleavage furrow.\n2. Cyclin-dependent kinase 5 (Cdk5): Cdk5 is a CDK that is involved in the regulation of cytokinesis. Cdk5 phosphorylates and activates proteins that are involved in the formation of the cleavage furrow, and is also required for the proper separation of the daughter cells.\n3. Polo-like kinase 4 (PLK4): PLK4 is another CDK that is involved in the regulation of cytokinesis. PLK4 is activated by CDKs and phosphorylates and activates proteins that are involved in the formation of the cleavage furrow.\n4. Aurora kinase A (Aurora A): Aurora A is a CDK that is involved in the regulation of cytokinesis. Aurora A phosphorylates and activates proteins that are involved in the formation of the cleavage furrow, and is also required for the proper separation of the daughter cells.\n5. Aurora kinase B (Aurora B): Aurora B is another CDK that is involved in the regulation of cytokinesis. Aurora B phosphorylates and activates proteins that are involved in the formation of the cleavage furrow, and is also required for the proper separation of the daughter cells.\nThese CDK targets play important roles in regulating the progression of cytokinesis and ensuring that the cell divides properly. Dysregulation of these CDK targets can lead",
    "llama-2-7b-chat-hf_fact": [
      "Cytokinesis is the process of cell division where the cell splits into two daughter cells.",
      "CDKs (cyclin-dependent kinases) are enzymes that add phosphate groups to proteins, which can activate or inhibit their activity.",
      "Polo-like kinase 1 (PLK1) is a key regulator of cytokinesis and is required for the proper separation of the daughter cells during cell division.",
      "Cyclin-dependent kinase 5 (Cdk5) and Polo-like kinase 4 (PLK4) are CDK that are involved in the regulation of cytokinesis.",
      "Aurora kinase A (Aurora A) and Aurora kinase B (Aurora B) are CDKs that are involved in the regulation of cytokinesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Cyclin-dependent kinase 1 (CDK1) and Polo-like kinase 1 (PLK1) are CDKs that are involved in the regulation of cytokinesis.",
      "true"
    ]
  },
  {
    "id": 643,
    "user_query": "In what type(s) of plant organelles we can detect prolamellar bodies?",
    "llama-2-7b-chat-hf_response": "Prolamellar bodies are membrane-bound organelles found in the cytoplasm of plant cells that are involved in protein synthesis and degradation. They are particularly abundant in the endoplasmic reticulum (ER) of plant cells, where they play a key role in the synthesis and transport of proteins.\nProlamellar bodies can be detected in various types of plant organelles, including:\n1. Endoplasmic reticulum (ER): Prolamellar bodies are most abundant in the ER of plant cells, where they are involved in protein synthesis and transport.\n2. Golgi apparatus: Prolamellar bodies can also be found in the Golgi apparatus of plant cells, where they are involved in protein processing and modification.\n3. Chloroplasts: Prolamellar bodies have been detected in chloroplasts of plant cells, where they are involved in the synthesis and transport of proteins involved in photosynthesis.\n4. Mitochondria: Prolamellar bodies can also be found in the mitochondria of plant cells, where they are involved in protein synthesis and degradation.\n5. Plastids: Prolamellar bodies have been detected in various types of plastids, including chloroplasts and amyloplasts, where they are involved in protein synthesis and degradation.\nIn summary, prolamellar bodies can be detected in various types of plant organelles, including the endoplasmic reticulum, Golgi apparatus, chloroplasts, mitochondria, and plastids.",
    "llama-2-7b-chat-hf_fact": [
      "Prolamellar bodies are membrane-bound organelles found in the cytoplasm of plant cells that are involved in protein synthesis and degradation.",
      "Prolamellar bodies are particularly abundant in the endoplasmic reticulum (ER) of plant cells, where they play a key role in the synthesis and transport of proteins.",
      "Prolamellar bodies can also be found in the Golgi apparatus of plant cells, where they are involved in protein processing and modification.",
      "Prolamellar bodies have been detected in chloroplasts of plant cells, where they are involved in the synthesis and transport of proteins involved in photosynthesis.",
      "Prolamellar bodies can also be found in the mitochondria and in various types of plastids of plant cells, where they are involved in protein synthesis and degradation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Prolamellar bodies are membrane-bound organelles found in the chloroplasts of plant cells, where they contribute to photosynthesis.",
      "false, [corrected fact]: Prolamellar bodies are abundant in the chloroplasts, not the endoplasmic reticulum (ER), of plant cells.",
      "false, [corrected fact]: Prolamellar bodies are not found in the Golgi apparatus of plant cells, they are located in the chloroplasts.",
      "true",
      "false, [corrected fact]: Prolamellar bodies are not found in the mitochondria or plastids of plant cells, they are present in chloroplasts where they contribute to photosynthesis."
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-7b-chat-hf_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that add a methyl group to the cytosine residue of DNA, resulting in 5-methylcytosine (5-mC). 5-mC is a common epigenetic modification found in many organisms, including animals.\nIn animals, 5-mC is known to play a role in regulating gene expression, particularly in the context of development and cell differentiation. For example, 5-mC is known to be enriched at the promoter regions of genes involved in developmental processes, such as cell fate determination and cell proliferation.\nStudies have shown that 5-mC is present in various animal genomes, including those of mammals, birds, and fish. For example, 5-mC has been detected in the genomes of human, mouse, and rat, as well as in the genomes of zebrafish and chicken.\nIn addition to its role in regulating gene expression, 5-mC has also been implicated in the development and progression of cancer in animals. For example, studies have shown that 5-mC is often lost in cancer cells, leading to the activation of oncogenes and the repression of tumor suppressor genes.\nOverall, the presence of chromomethylases in animal genomes highlights the importance of epigenetic modifications in the regulation of gene expression and cellular development in animals, and suggests that dysregulation of these modifications may play a role in the development and progression of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Chromomethylases are enzymes that add a methyl group to the cytosine residue of DNA, resulting in 5-methylcytosine.",
      "5-methylcytosine is a common epigenetic modification found in many organisms, including animals.",
      "5-mC plays a role in regulating gene expression in the context of development and cell differentiation in animals.",
      "5-methylcytosine has been detected in the genomes of various animals, including mammals, birds, and fish.",
      "It has been found that 5-methylcytosine is often lost in animal cancer cells, leading to activation of oncogenes and repression of tumor suppressor genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 647,
    "user_query": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?",
    "llama-2-7b-chat-hf_response": "Autosomal dominant Charcot-Marie-Tooth (CMT) disease is caused by mutations in various genes encoding proteins involved in the structure and function of peripheral nerves. The most common genes associated with autosomal dominant CMT are:\n1. PMP22 gene: The PMP22 gene is the most commonly mutated gene in CMT, accounting for approximately 70% of all cases. Mutations in this gene lead to a deficiency of the protein peripherin-2, which is essential for the maintenance of the myelin sheath in peripheral nerves.\n2. MPZ gene: The MPZ gene is the second most commonly mutated gene in CMT, accounting for approximately 15% of all cases. Mutations in this gene lead to a deficiency of the protein myelin protein zero (MPZ), which is involved in the formation and maintenance of the myelin sheath.\n3. GluR1 gene: The GluR1 gene encodes a subunit of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, a critical component of the glutamatergic synapse in peripheral nerves. Mutations in this gene have been associated with CMT type 1A.\n4. GDAP1 gene: The GDAP1 gene encodes a protein involved in the formation and maintenance of the myelin sheath. Mutations in this gene have been associated with CMT type 1B.\n5. CAV1 gene: The CAV1 gene encodes a protein involved in the formation and maintenance of the myelin sheath. Mutations in this gene have been associated with CMT type 2.\n6. KCNQ2/3 genes: The KCNQ2 and KCNQ3 genes encode potassium channels involved in the regulation of the resting membrane potential and action potential duration in peripheral nerves. Mutations in these genes have been associated with CMT type 2.\n7. PMP2 gene: The PMP2 gene encodes a protein involved in the formation and maintenance of the myelin sheath. Mutations in this gene have been associated with CMT type",
    "llama-2-7b-chat-hf_fact": [
      "Autosomal dominant Charcot-Marie-Tooth (CMT) disease is caused by mutations in genes encoding proteins involved in the structure and function of peripheral nerves.",
      "The most commonly mutated gene in CMT is the PMP22 gene which is associated with around 70% of all cases.",
      "The MPZ gene is the second most commonly mutated gene in CMT and accounts for approximately 15% of all cases.",
      "The GluR1 gene has associations with CMT type 1A.",
      "Mutations in GDAP1, CAV1, KCNQ2/3, and PMP2 genes have been associated with different types of CMT."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The PMP22 gene, not GluR1, is associated with CMT type 1A.",
      "true"
    ]
  },
  {
    "id": 648,
    "user_query": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?",
    "llama-2-7b-chat-hf_response": "The interferon-beta (IFN-b) enhanceosome is a complex of transcription factors (TFs) that work together to regulate the transcription of IFN-b target genes. The following TFs are known to participate in the formation of the IFN-b enhanceosome:\n1. IRFs (interferon regulatory factors): IRFs are a family of TFs that play a central role in the regulation of IFN-b transcription. IRFs recognize and bind to specific DNA sequences in the IFN-b promoter and enhancer regions, leading to the recruitment of other TFs and the activation of transcription.\n2. STATs (signal transducer and activator of transcription): STATs are a family of TFs that are activated by IFN-b and other cytokines. STATs recognize and bind to specific DNA sequences in the IFN-b promoter and enhancer regions, leading to the recruitment of other TFs and the activation of transcription.\n3. CBP (CREB-binding protein): CBP is a TF that binds to the IFN-b promoter and enhancer regions and plays a role in the recruitment of other TFs and the activation of transcription.\n4. EP300 (p300): EP300 is a TF that binds to the IFN-b promoter and enhancer regions and plays a role in the recruitment of other TFs and the activation of transcription.\n5. BRD4 (bromodomain-containing protein 4): BRD4 is a TF that binds to the IFN-b promoter and enhancer regions and plays a role in the recruitment of other TFs and the activation of transcription.\n6. BHLF1 (basic helix-loop-helix factor 1): BHLF1 is a TF that binds to the IFN-b promoter and enhancer regions and plays a role in the recruitment of other TFs and the activation of transcription.\n7. KAT2A (lysine acetyltransferase 2A): KAT",
    "llama-2-7b-chat-hf_fact": [
      "The interferon-beta (IFN-b) enhanceosome regulates the transcription of IFN-b target genes.",
      "Important transcription factors (TFs) in the formation of the IFN-b enhanceosome include IRFs, STATs, CBP, EP300, BRD4, BHLF1, and KAT2A.",
      "IRFs recognize and bind to specific DNA sequences in the IFN-b promoter and enhancer regions.",
      "STATs are activated by IFN-b and other cytokines, and bind to specific DNA sequences in the IFN-b promoter and enhancer regions.",
      "CBP, EP300, BRD4, BHLF1, and KAT2A bind to the IFN-b promoter and enhancer regions and participate in the recruitment of other TFs and the activation of transcription."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-7b-chat-hf_response": "Here are some popular packages for transcription factor binding site (TFBS) analysis available in R/Bioconductor:\n1. **TFBS**: This package provides a comprehensive set of tools for the analysis of TFBSs, including the prediction of TFBSs from DNA sequences, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D space.\n2. **HISAT2**: This package is a popular tool for ChIP-seq analysis, which can also be used for TFBS analysis. It provides a range of tools for aligning sequencing reads to a reference genome and identifying regions of interest, including TFBSs.\n3. **STAR**: This package is another popular tool for ChIP-seq analysis, which can also be used for TFBS analysis. It provides a range of tools for aligning sequencing reads to a reference genome and identifying regions of interest, including TFBSs.\n4. **DREAM**: This package provides a comprehensive set of tools for the analysis of TFBSs, including the prediction of TFBSs from DNA sequences, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D space.\n5. **DeepSEA**: This package provides a range of tools for the analysis of TFBSs, including the prediction of TFBSs from DNA sequences, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D space.\n6. **TFBSTools**: This package provides a set of tools for the analysis of TFBSs, including the prediction of TFBSs from DNA sequences, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D space.\n7. **ChIPseek**: This package provides a range of tools for the analysis of TFBSs, including the prediction of TFBSs from DNA sequences, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D space.\n8. **PeakAnalyzer**: This package provides a range of tools for the analysis of TFBSs, including the prediction of TFBSs from DNA sequences, the analysis of ChIP-seq",
    "llama-2-7b-chat-hf_fact": [
      "The TFBS package in R/Bioconductor includes tools for the analysis of transcription factor binding sites.",
      "HISAT2 is a package in R/Bioconductor that provides tools for ChIP-seq analysis and transcription factor binding site analysis.",
      "STAR is a package in R/Bioconductor used for ChIP-seq and transcription factor binding site analysis.",
      "DREAM is a package in R/Bioconductor that provides tools for the analysis of transcription factor binding sites.",
      "DeepSEA is a package in R/Bioconductor that provides a range of tools for the analysis of TFBSs, including the prediction from DNA sequences, the analysis of ChIP-seq data, and the visualization in 3D space."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: HISAT2 is not a package in R/Bioconductor. It is a fast and sensitive alignment program to map next-generation sequencing reads.",
      "false, [corrected fact]: STAR is not a package in R/Bioconductor. It is used for RNA-seq data processing.",
      "unknown",
      "false, [corrected fact]: DeepSEA is a deep learning-based algorithmic framework for predicting the chromatin effects of sequence alterations with single nucleotide sensitivity, not a package in R/Bioconductor."
    ]
  },
  {
    "id": 651,
    "user_query": "Simpson grading is used to describe resection of which brain tumor?",
    "llama-2-7b-chat-hf_response": "A) Meningioma\nB) Acoustic neuroma\nC) Pineal gland tumor\nD) Metastatic tumor\nAnswer: A) Meningioma.\nSimpson grading is a system used to evaluate the aggressiveness of meningioma, a type of brain tumor that arises from the meninges, the protective coverings of the brain and spinal cord. The Simpson grading system assigns a score based on the extent of resection (removal) of the tumor, with higher scores indicating a more aggressive tumor. The grading system was developed by Dr. William Simpson in the 1970s and is still widely used today.",
    "llama-2-7b-chat-hf_fact": [
      "Simpson grading is used to evaluate the aggressiveness of meningioma.",
      "Meningioma is a type of brain tumor that arises from the meninges.",
      "The Simpson grading system assigns a score based on the extent of resection of the tumor.",
      "Higher scores on the Simpson grading system indicate a more aggressive tumor.",
      "The Simpson grading system was developed by Dr. William Simpson in the 1970s."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Lower scores on the Simpson grading system indicate a more complete resection of the tumor, not a more aggressive tumor.",
      "false, [corrected fact]: The Simpson grading system was developed by Dr. Donald Simpson in 1957."
    ]
  },
  {
    "id": 653,
    "user_query": "Is delayed enhancement documented in patients with non-ischemic dilated cardiomyopathy?",
    "llama-2-7b-chat-hf_response": "Yes, delayed enhancement is documented in patients with non-ischemic dilated cardiomyopathy. Delayed enhancement on cardiac magnetic resonance imaging (MRI) has been shown to be a useful marker of myocardial fibrosis in patients with non-ischemic dilated cardiomyopathy. Myocardial fibrosis is the accumulation of scar tissue in the heart muscle, which can lead to decreased cardiac function and increased risk of heart failure.\nStudies have shown that patients with non-ischemic dilated cardiomyopathy have higher levels of delayed enhancement on MRI compared to healthy controls. The extent of delayed enhancement has been shown to be associated with the severity of cardiac dysfunction and the risk of adverse outcomes, such as heart failure and death.\nOne study published in the journal Circulation: Cardiovascular Imaging found that patients with non-ischemic dilated cardiomyopathy had higher levels of delayed enhancement in the left ventricle compared to healthy controls. The study also found that the extent of delayed enhancement was associated with the severity of cardiac dysfunction and the risk of adverse outcomes.\nAnother study published in the journal Heart found that patients with non-ischemic dilated cardiomyopathy had higher levels of delayed enhancement in the right ventricle compared to healthy controls. The study also found that the extent of delayed enhancement was associated with the severity of cardiac dysfunction and the risk of adverse outcomes.\nOverall, these studies suggest that delayed enhancement on cardiac MRI is a useful marker of myocardial fibrosis in patients with non-ischemic dilated cardiomyopathy, and may help identify patients at risk of adverse outcomes.",
    "llama-2-7b-chat-hf_fact": [
      "Delayed enhancement is documented in patients with non-ischemic dilated cardiomyopathy.",
      "Delayed enhancement on cardiac magnetic resonance imaging (MRI) is a marker of myocardial fibrosis in patients with non-ischemic dilated cardiomyopathy.",
      "Patients with non-ischemic dilated cardiomyopathy have higher levels of delayed enhancement on MRI compared to healthy individuals.",
      "A study published in the journal Circulation: Cardiovascular Imaging found higher levels of delayed enhancement in the left ventricle of patients with non-ischemic dilated cardiomyopathy.",
      "Another study published in the journal Heart reported higher levels of delayed enhancement in the right ventricle of patients with non-ischemic dilated cardiomyopathy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 654,
    "user_query": "Which enzyme is inhibited by Varespladib?",
    "llama-2-7b-chat-hf_response": "Varespladib is a drug that inhibits the enzyme bromodomain-containing protein 4 (BRD4). BRD4 is a member of the bromodomain and extraterminal (BET) protein family, which are involved in regulating gene expression by binding to acetylated histone proteins. Varespladib binds to the bromodomain of BRD4 and prevents it from interacting with acetylated histones, leading to a decrease in gene expression.\nWhich of the following enzymes is inhibited by Varespladib?\nA) Acetyltransferase\nB) Histone deacetylase\nC) Protein kinase\nD) Bromodomain-containing protein 4 (BRD4)\nE) None of the above",
    "llama-2-7b-chat-hf_fact": [
      "Varespladib inhibits the enzyme bromodomain-containing protein 4 (BRD4).",
      "Bromodomain-containing protein 4 (BRD4) is a member of the bromodomain and extraterminal (BET) protein family.",
      "Bromodomain and extraterminal (BET) protein family are involved in regulating gene expression by binding to acetylated histone proteins.",
      "Varespladib binds to the bromodomain of BRD4 and prevents it from interacting with acetylated histones.",
      "This interaction results in a decrease in gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Varespladib is a plasma lyso-phospholipase A2 (Lp-PLA2) inhibitor, not an inhibitor of bromodomain-containing protein 4 (BRD4).",
      "true",
      "true",
      "false, [corrected fact]: Varespladib does not bind to the bromodomain of BRD4. It is a plasma lyso-phospholipase A2 (Lp-PLA2) inhibitor.",
      "unknown"
    ]
  },
  {
    "id": 660,
    "user_query": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?",
    "llama-2-7b-chat-hf_response": "The KFERQ (Lys-Phe-Glu-Arg-Gly) motif is a specific sequence found in the cytosolic proteins of eukaryotic cells that serves as a recognition signal for the autophagy pathway. The KFERQ motif is recognized by the autophagy-related protein Atg8 (also known as LC3), which is involved in the formation of autophagosomes.\nThere are two main autophagy pathways that are triggered by the KFERQ motif:\n1. Macroautophagy: This pathway is the most well-studied and involves the engulfment of large portions of the cytosol by double-membraned autophagosomes. The autophagosomes then fuse with lysosomes, where the engulfed cytosol is degraded by lysosomal enzymes.\n2. Microautophagy: This pathway is less well-studied but involves the degradation of small portions of the cytosol by single-membraned autophagosomes. The autophagosomes then fuse with lysosomes, where the engulfed cytosol is degraded by lysosomal enzymes.\nBoth of these pathways are important for maintaining cellular homeostasis and responding to cellular stress. Dysregulation of the KFERQ-mediated autophagy pathway has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The KFERQ motif is a specific sequence found in the cytosolic proteins of eukaryotic cells.",
      "The KFERQ motif serves as a recognition signal for the autophagy pathway.",
      "The autophagy-related protein Atg8 recognizes the KFERQ motif.",
      "Both macroautophagy and microautophagy are autophagy pathways that are triggered by the KFERQ motif.",
      "Dysregulation of the KFERQ-mediated autophagy pathway has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 665,
    "user_query": "Has overexpression of sirtuins been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae)?",
    "llama-2-7b-chat-hf_response": "Yes, overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae). Sirtuins are a family of NAD+-dependent deacetylases that play a key role in various cellular processes, including DNA repair, metabolism, and stress resistance.\nStudies have shown that overexpressing certain sirtuins, such as Sirtuin 1 (SIRT1), Sirtuin 2 (SIRT2), and Sirtuin 3 (SIRT3), in budding yeast can lead to increased lifespan. For example, one study found that overexpressing SIRT1 in yeast led to a 30% increase in median lifespan, while another study found that overexpressing SIRT2 led to a 20% increase in median lifespan.\nThe mechanism by which sirtuins increase lifespan in yeast is thought to involve their ability to promote DNA repair and reduce oxidative stress. Sirtuins can deacetylate and activate various transcription factors that regulate DNA repair genes, leading to increased repair activity and reduced genome instability. Additionally, sirtuins can also reduce oxidative stress by deacetylating and activating antioxidant enzymes, such as catalase and superoxide dismutase.\nOverall, the findings in budding yeast suggest that sirtuins may be a promising target for increasing lifespan and improving healthspan in other organisms, including humans.",
    "llama-2-7b-chat-hf_fact": [
      "Overexpression of sirtuins is reported to increase the lifespan in budding yeast (Saccharomyces cerevisiae).",
      "Sirtuins are a family of NAD+-dependent deacetylases involved in various cellular processes.",
      "Overexpression of specific sirtuins, such as SIRT1 and SIRT2, in budding yeast has been observed to significantly increase lifespan.",
      "The mechanism by which sirtuins increase lifespan in yeast is speculated to involve their ability to promote DNA repair and reduce oxidative stress.",
      "Sirtuins can activate various transcription factors that regulate DNA repair genes and antioxidant enzymes, resulting in increased repair activity and reduced oxidative stress."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 669,
    "user_query": "How does phospholamban affect the biological activity of the calcium ATPase SERCA?",
    "llama-2-7b-chat-hf_response": "Phospholamban is a protein that inhibits the activity of the calcium ATPase SERCA (sarcoplasmic/endoplasmic reticulum calcium ATPase). SERCA is responsible for pumping calcium ions (Ca2+) back into the endoplasmic reticulum (ER) after it has been released from the sarcoplasmic reticulum (SR) during muscle contraction. Phospholamban binds to the active site of SERCA and prevents it from hydrolyzing ATP, thereby reducing the amount of Ca2+ that is pumped back into the ER. This can lead to an increase in intracellular Ca2+ levels, which can activate various signaling pathways involved in muscle contraction and relaxation.",
    "llama-2-7b-chat-hf_fact": [
      "Phospholamban is a protein that inhibits the activity of the calcium ATPase SERCA.",
      "The sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pumps calcium ions (Ca2+) back into the endoplasmic reticulum (ER).",
      "The pumping of calcium ions by SERCA occurs after these ions have been released from the sarcoplasmic reticulum (SR) during muscle contraction.",
      "Phospholamban binds to the active site of SERCA, thereby reducing the amount of Ca2+ that is pumped back into the ER.",
      "An increase in intracellular Ca2+ levels can activate various signaling pathways involved in muscle contraction and relaxation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 670,
    "user_query": "List the components of mTOR Complex 2 (mTORC2).",
    "llama-2-7b-chat-hf_response": "mTORC2 is a complex of proteins that plays a key role in regulating cell growth, proliferation, and metabolism. The components of mTORC2 include:\n1. mTOR (mammalian target of rapamycin) - the catalytic core of mTORC2\n2. raptor (rapamycin-insensitive companion of mTOR) - a binding partner of mTOR that helps to recruit and activate mTORC2\n3. PRAS40 (prohibitin 40 kDa) - a negative regulator of mTORC2 that inhibits the activity of mTORC2 when phosphorylated\n4. S6K1 (70 kDa ribosomal protein S6 kinase 1) - a key downstream effector of mTORC2 that phosphorylates and activates ribosomal protein S6\n5. 4E-BP1 (eukaryotic translation initiation factor 4E-binding protein 1) - a key downstream effector of mTORC2 that inhibits the activity of eIF4E (eukaryotic initiation factor 4E), thereby regulating translation initiation\n6. mLST8 (mammalian leucine-rich repeat-containing protein 8) - a binding partner of mTORC2 that helps to recruit and activate mTORC2\n7. DEPTOR (deptor) - a binding partner of mTORC2 that helps to regulate the activity of mTORC2 by inhibiting the activity of mTORC2 when phosphorylated\nNote: The composition of mTORC2 can vary depending on the cellular context and the presence of upstream signaling pathways.",
    "llama-2-7b-chat-hf_fact": [
      "mTORC2 is a complex of proteins that regulates cell growth, proliferation, and metabolism.",
      "mTOR is considered the catalytic core of mTORC2.",
      "raptor functions as a binding partner of mTOR and helps to recruit and activate mTORC2.",
      "PRAS40 acts as a negative regulator of mTORC2 by inhibiting the activity of mTORC2 when phosphorylated.",
      "mLST8 is a binding partner of mTORC2 that aids in recruiting and activating mTORC2."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: raptor functions as a binding partner of mTOR and helps to recruit and activate mTORC1, not mTORC2.",
      "false, [corrected fact]: PRAS40 acts as a negative regulator of mTORC1, not mTORC2, by inhibiting the activity of mTORC1 when phosphorylated.",
      "true"
    ]
  },
  {
    "id": 675,
    "user_query": "Which multiple kinase inhibitors are used in cancer therapy?",
    "llama-2-7b-chat-hf_response": "Multiple kinase inhibitors are commonly used in cancer therapy to target different signaling pathways involved in tumor growth and progression. Here are some of the commonly used multiple kinase inhibitors in cancer therapy:\n1. Imatinib (Gleevec): Imatinib is a tyrosine kinase inhibitor that targets the Bcr-Abl fusion protein in chronic myeloid leukemia (CML) cells.\n2. Dasatinib (Sprycel): Dasatinib is a tyrosine kinase inhibitor that targets the Src-family kinase (SFK) family and is used to treat CML.\n3. Nilotinib (Tasigna): Nilotinib is a tyrosine kinase inhibitor that targets the Bcr-Abl fusion protein and is used to treat CML.\n4. Lapatinib (Tykerb): Lapatinib is a tyrosine kinase inhibitor that targets the HER2/neu receptor and is used to treat breast cancer.\n5. Trametinib (Mekinist): Trametinib is a MEK inhibitor that targets the MAPK signaling pathway and is used to treat melanoma.\n6. Cobimetinib (Cotellic): Cobimetinib is a MEK inhibitor that targets the MAPK signaling pathway and is used to treat melanoma.\n7. Vemurafenib (Zelboraf): Vemurafenib is a BRAF inhibitor that targets the BRAF protein and is used to treat melanoma.\n8. Dabrafenib (Tafinlar): Dabrafenib is a BRAF inhibitor that targets the BRAF protein and is used to treat melanoma.\n9. Ibrutinib (Imbruvica): Ibrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that targets the B-cell receptor signaling pathway and is used to treat various B-cell malignancies, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).\n10. Obinutuzumab (",
    "llama-2-7b-chat-hf_fact": [
      "Imatinib, also known as Gleevec, is a tyrosine kinase inhibitor used in cancer therapy, particularly chronic myeloid leukemia (CML).",
      "Dasatinib, also known as Sprycel, is a tyrosine kinase inhibitor used to treat CML.",
      "Lapatinib, marketed as Tykerb, is a tyrosine kinase inhibitor used to treat breast cancer.",
      "Trametinib, known as Mekinist, is a MEK inhibitor used to treat melanoma.",
      "Ibrutinib, also known as Imbruvica, is a Bruton's tyrosine kinase (BTK) inhibitor used to treat chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 678,
    "user_query": "List types of avoided words in bacterial genomes",
    "llama-2-7b-chat-hf_response": "Avoided words in bacterial genomes refer to the words or phrases that are less frequently used in the DNA sequence of a bacterial genome compared to other words or phrases. The study of avoided words in bacterial genomes can provide insights into the evolutionary history and functional properties of bacteria. Here are some types of avoided words in bacterial genomes:\n1. Redundant words: These are words that are repeated multiple times in a genome, often with slight variations. Examples of redundant words in bacterial genomes include \"gene\" and \"protein\".\n2. Non-coding words: These are words that do not code for proteins or other functional products. Examples of non-coding words in bacterial genomes include \"rRNA\" and \"tRNA\".\n3. Amino acid residues: These are words that represent individual amino acids found in proteins. Examples of amino acid residues in bacterial genomes include \"Ala\" and \"Thr\".\n4. Nucleotides: These are words that represent individual nucleotides found in DNA or RNA. Examples of nucleotides in bacterial genomes include \"ATG\" and \"GCT\".\n5. Genetic elements: These are words that represent specific genetic elements such as promoters, terminators, and regulatory sequences. Examples of genetic elements in bacterial genomes include \"PhoB\" and \" LacI\".\n6. Metabolic pathways: These are words that represent specific metabolic pathways or reactions. Examples of metabolic pathways in bacterial genomes include \"glycolysis\" and \"pentose phosphate pathway\".\n7. Biochemical reactions: These are words that represent specific biochemical reactions or processes. Examples of biochemical reactions in bacterial genomes include \"ATP synthesis\" and \"peptidoglycan synthesis\".\n8. Cellular structures: These are words that represent specific cellular structures such as membranes, organelles, or cell walls. Examples of cellular structures in bacterial genomes include \"membrane\" and \"cell wall\".\n9. Transport systems: These are words that represent specific transport systems such as efflux p",
    "llama-2-7b-chat-hf_fact": [
      "Avoided words in bacterial genomes are less frequently used words or phrases in the DNA sequence of a bacterial genome.",
      "Redundant words, a type of avoided word, are those that are repeated many times in a genome, often with slight variations.",
      "Non-coding words in bacterial genomes, another type of avoided word, do not code for proteins or other functional products.",
      "Amino acid residues represent individual amino acids found in proteins.",
      "Genetic elements represent specific genetic elements such as promoters, terminators, and regulatory sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Redundant words are not a type of avoided word. They are phrases in the DNA sequence that are repeated many times, often with slight variations.",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 681,
    "user_query": "Which is the physiological target for LeuRS translational quality control?",
    "llama-2-7b-chat-hf_response": "LeuRS (leucine-rich repeats-containing serine/threonine protein kinase receptor subunit 1) is a protein that plays a key role in translational quality control, particularly in the regulation of protein synthesis in response to amino acid availability. LeuRS is a receptor for the amino acid leucine, and it is activated when leucine is bound to the receptor. Activation of LeuRS leads to the phosphorylation and inhibition of the translation initiation factor eIF4E, which in turn reduces the rate of protein synthesis.\nThe physiological target for LeuRS translational quality control is the translation initiation factor eIF4E. When LeuRS is activated, it phosphorylates and inhibits eIF4E, leading to a reduction in the rate of protein synthesis. This mechanism allows the cell to regulate protein synthesis in response to changes in amino acid availability, ensuring that proteins are synthesized at the appropriate rate to meet cellular needs.",
    "llama-2-7b-chat-hf_fact": [
      "LeuRS (leucine-rich repeats-containing serine/threonine protein kinase receptor subunit 1) is a protein that plays a key role in translational quality control.",
      "LeuRS is a receptor for the amino acid leucine.",
      "Activation of LeuRS leads to the phosphorylation and inhibition of the translation initiation factor eIF4E.",
      "Inhibition of eIF4E by LeuRS reduces the rate of protein synthesis.",
      "The mechanism of LeuRS allows the cell to regulate protein synthesis in response to changes in amino acid availability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 685,
    "user_query": "Which is the target of the drug Denosumab?",
    "llama-2-7b-chat-hf_response": "A) Bone\nB) Cartilage\nC) Cancer cells\nD) Inflammatory cells\nAnswer: C) Cancer cells.\nDenosumab is a monoclonal antibody drug that targets and inhibits the activity of a protein called receptor activator of nuclear factor kappa-B ligand (RANKL). RANKL is involved in the regulation of bone metabolism and is overexpressed in many types of cancer, including breast, lung, and prostate cancer. By blocking the activity of RANKL, denosumab inhibits the growth and spread of cancer cells, making it a targeted therapy for the treatment of certain types of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Denosumab is a monoclonal antibody drug.",
      "Denosumab targets and inhibits the activity of a protein called receptor activator of nuclear factor kappa-B ligand (RANKL).",
      "RANKL is involved in the regulation of bone metabolism.",
      "RANKL is overexpressed in many types of cancer, including breast, lung, and prostate cancer.",
      "By blocking the activity of RANKL, denosumab inhibits the growth and spread of cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: By blocking the activity of RANKL, denosumab inhibits the formation and activity of osteoclasts, cells that break down bone tissue. It does not directly inhibit the growth and spread of cancer cells."
    ]
  },
  {
    "id": 693,
    "user_query": "Which gene test can be used for the X-linked myotubular myopathy?",
    "llama-2-7b-chat-hf_response": "X-linked myotubular myopathy (XLMTM) is a rare genetic disorder that affects the muscles of the body, particularly those in the legs, hips, and back. It is caused by mutations in the MTM1 gene, which is located on the X chromosome. The MTM1 gene provides instructions for making a protein called myotubularin, which plays a critical role in the development and maintenance of muscle fibers.\nThere are several genetic tests that can be used to diagnose XLMTM, including:\n1. Chromosomal microarray analysis (CMA): This test can identify small changes in the number or structure of the chromosomes, including deletions or duplications of genetic material that may cause XLMTM.\n2. Whole-exome sequencing (WES): This test looks at the DNA sequence of all the genes in a person's genome to identify mutations that may be causing XLMTM.\n3. Whole-genome sequencing (WGS): This test looks at the DNA sequence of all the genes in a person's genome to identify mutations that may be causing XLMTM.\n4. Sanger sequencing: This test uses a technique called polymerase chain reaction (PCR) to amplify specific DNA sequences, and then sequences the amplified DNA to identify mutations that may be causing XLMTM.\n5. Next-generation sequencing (NGS): This test uses high-throughput sequencing technologies to identify mutations in all the genes in a person's genome that may be causing XLMTM.\nIt is important to note that genetic testing for XLMTM is still in its early stages, and not all mutations in the MTM1 gene have been identified. A diagnosis of XLMTM should be made by a multidisciplinary team of healthcare professionals, including geneticists, neurologists, and muscle specialists.",
    "llama-2-7b-chat-hf_fact": [
      "X-linked myotubular myopathy (XLMTM) is a genetic disorder caused by mutations in the MTM1 gene located on the X chromosome.",
      "The MTM1 gene provides instructions for making a protein called myotubularin, which is essential for the development and maintenance of muscle fibers.",
      "Chromosomal microarray analysis, whole-exome sequencing, whole-genome sequencing, Sanger sequencing, and next-generation sequencing are methods that can be used to diagnose XLMTM.",
      "Not all mutations in the MTM1 gene have been identified.",
      "A diagnosis of XLMTM should be made by a multidisciplinary team of healthcare professionals, such as geneticists, neurologists, and muscle specialists."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 695,
    "user_query": "What is the association between adiponectin and migraine?",
    "llama-2-7b-chat-hf_response": "Adiponectin is a protein hormone produced by adipocytes (fat cells) that plays a role in glucose and lipid metabolism, inflammation, and cardiovascular health. Recent studies have suggested that adiponectin may also be involved in the pathophysiology of migraine.\nMigraine is a common neurological disorder characterized by recurrent headaches, often accompanied by other symptoms such as nausea, vomiting, and sensitivity to light and sound. The exact mechanisms underlying migraine are not fully understood, but it is believed to involve complex interactions between genetic, environmental, and hormonal factors.\nStudies have shown that adiponectin levels are altered in migraine patients compared to healthy controls. For example, one study found that migraine patients had lower levels of adiponectin in their blood compared to healthy controls. Another study found that adiponectin levels were positively correlated with the frequency and severity of migraine attacks.\nThe exact mechanisms by which adiponectin is involved in migraine are not clear, but several possibilities have been proposed. For example, adiponectin may play a role in the regulation of inflammation and oxidative stress, which are thought to be involved in the pathophysiology of migraine. Adiponectin may also affect the function of blood vessels in the brain, which can contribute to the development of migraine.\nOverall, the association between adiponectin and migraine is complex and not fully understood. Further research is needed to determine the exact mechanisms by which adiponectin is involved in migraine and to identify potential therapeutic targets for the treatment of migraine.",
    "llama-2-7b-chat-hf_fact": [
      "Adiponectin is a protein hormone produced by adipocytes (fat cells) that is involved in glucose and lipid metabolism, inflammation, and cardiovascular health.",
      "Migraine is a neurological disorder characterized by recurrent headaches, often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound.",
      "Some studies have shown altered adiponectin levels in migraine patients compared to healthy individuals.",
      "There is a suggested link between adiponectin levels and the frequency and severity of migraine attacks.",
      "Potential roles for adiponectin in migraine include regulation of inflammation and oxidative stress, and affecting blood vessels' function in the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 703,
    "user_query": "Is there an association between FGFR3 mutation and plagiocephaly?",
    "llama-2-7b-chat-hf_response": "FGFR3 mutations have been associated with several craniofacial abnormalities, including plagiocephaly. Plagiocephaly is a condition characterized by a flat or misshapen skull, and it can occur alone or in combination with other craniofacial abnormalities.\nFGFR3 is a gene that encodes for a protein called fibroblast growth factor receptor 3, which is involved in the development and growth of various tissues, including the brain and skull. Mutations in the FGFR3 gene can disrupt the normal function of this protein, leading to abnormalities in the development of the skull and face.\nStudies have shown that FGFR3 mutations are present in a significant proportion of individuals with plagiocephaly. For example, a study published in the Journal of Craniofacial Genetics and Developmental Biology found that FGFR3 mutations were present in 60% of individuals with plagiocephaly. Another study published in the American Journal of Medical Genetics found that FGFR3 mutations were present in 40% of individuals with plagiocephaly and other craniofacial abnormalities.\nThe association between FGFR3 mutations and plagiocephaly is thought to be due to the role of FGFR3 in regulating the growth and development of the skull. FGFR3 mutations can disrupt this process, leading to abnormalities in the shape and size of the skull.\nIt's important to note that not all individuals with FGFR3 mutations will develop plagiocephaly, and not all individuals with plagiocephaly have FGFR3 mutations. However, FGFR3 mutations are a common finding in individuals with plagiocephaly, and genetic testing can help identify individuals who are at risk of developing this condition.\nIf you have a family history of plagiocephaly or other craniofacial abnormalities, or if you have been diagnosed with plagiocephaly yourself, you may want to consider genetic testing to determine if you have an FGFR3 mutation. This can help you and your healthcare provider make informed decisions about your care and management.",
    "llama-2-7b-chat-hf_fact": [
      "FGFR3 mutations have been associated with several craniofacial abnormalities, including plagiocephaly.",
      "Plagiocephaly is a condition characterized by a flat or misshapen skull.",
      "FGFR3 is a gene that encodes for a protein called fibroblast growth factor receptor 3, which is involved in the development and growth of various tissues, including the brain and skull.",
      "Studies have found that FGFR3 mutations were present in a significant proportion of individuals with plagiocephaly.",
      "Genetic testing can help identify individuals who may be at risk of developing plagiocephaly due to FGFR3 mutations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 708,
    "user_query": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?",
    "llama-2-7b-chat-hf_response": "The addition of 7-methylguanosine (m7G) to the 3' end of messenger RNA (mRNA) is a post-transcriptional modification that plays a crucial role in the regulation of gene expression. The enzymes involved in the addition of m7G to mRNA are:\n1. MET-binding protein (MBP): MBP is the primary enzyme responsible for the addition of m7G to mRNA. It recognizes the 3' end of the mRNA and catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the 7-position of guanosine.\n2. RNA methyltransferase (RMT): RMT is a family of enzymes that also catalyze the addition of m7G to mRNA. RMTs recognize the 3' end of the mRNA and use SAM as the methyl donor.\n3. Nucleoside methyltransferases (NMTs): NMTs are a broader family of enzymes that can methylate a wide range of nucleosides, including guanosine. NMTs can also catalyze the addition of m7G to mRNA.\n4. Other enzymes: Other enzymes that have been implicated in the addition of m7G to mRNA include the RNA methyltransferase-like 1 (RML1) and the RNA methyltransferase-like 2 (RML2).\nIt is worth noting that the addition of m7G to mRNA is a highly regulated process, and the activity of these enzymes can be modulated by a variety of factors, including the presence of certain transcription factors and the availability of SAM.",
    "llama-2-7b-chat-hf_fact": [
      "The addition of 7-methylguanosine (m7G) to the 3' end of messenger RNA (mRNA) is a post-transcriptional modification.",
      "MET-binding protein (MBP) is the primary enzyme responsible for the addition of m7G to mRNA.",
      "RNA methyltransferase (RMT) is a family of enzymes that catalyze the addition of m7G to mRNA.",
      "Nucleoside methyltransferases (NMTs) are enzymes that can catalyze the addition of m7G to mRNA.",
      "RNA methyltransferase-like 1 (RML1) and RNA methyltransferase-like 2 (RML2) can also participate in the addition of m7G to mRNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The addition of 7-methylguanosine (m7G) to the 5' end of messenger RNA (mRNA) is a post-transcriptional modification.",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 709,
    "user_query": "What is HOCOMOCO?",
    "llama-2-7b-chat-hf_response": "HOCOMOCO is a term used in the context of cryptocurrency and blockchain technology. It stands for \"Hold On for Dear Life, Make it Our Coin,\" which is a play on the phrase \"Hold On for Dear Life.\"\nHOCOMOCO is a community-driven project that aims to create a decentralized cryptocurrency that can be used for everyday transactions. The project is still in its early stages, but it has gained a lot of attention and support from the cryptocurrency community.\nOne of the key features of HOCOMOCO is its use of a proof-of-stake (PoS) consensus algorithm, which is different from the more widely used proof-of-work (PoW) algorithm used by Bitcoin and many other cryptocurrencies. The PoS algorithm allows for faster transaction times and lower energy consumption, making it more environmentally friendly.\nHOCOMOCO also has a unique governance structure that allows holders of the coin to vote on proposals for the development and growth of the project. This allows the community to have a direct say in the direction of the project and ensures that it is truly decentralized.\nOverall, HOCOMOCO is an innovative project that aims to create a more sustainable and community-driven cryptocurrency. While it is still in its early stages, it has already gained a lot of attention and support from the cryptocurrency community and could potentially become a major player in the space.",
    "llama-2-7b-chat-hf_fact": [
      "HOCOMOCO is related to cryptocurrency and blockchain technology.",
      "The aim of HOCOMOCO is to create a decentralized cryptocurrency that can be used for everyday transactions.",
      "HOCOMOCO uses a proof-of-stake consensus algorithm.",
      "HOCOMOCO has a governance structure that allows coin holders to vote on proposals for the development and growth of the project.",
      "The HOCOMOCO project is still in its early stages."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: HOCOMOCO is a platform for buying, constructing and managing houses remotely.",
      "false, [corrected fact]: The aim of HOCOMOCO is to create a user-friendly platform to manage house construction and buying process, not to create a cryptocurrency.",
      "false, [corrected fact]: HOCOMOCO doesn't use a proof-of-stake consensus algorithm, as it is not associated with cryptocurrencies or blockchain technology.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 713,
    "user_query": "What is the typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery?",
    "llama-2-7b-chat-hf_response": "The typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery is an increase in thyroid-stimulating hormone (TSH) levels and a decrease in free thyroxine (FT4) and free triiodothyronine (FT3) levels. These changes are usually seen within the first few days after surgery and can persist for several weeks. The alterations in thyroid metabolism after coronary artery bypass graft surgery are thought to be related to the stress of the surgery and the changes in the body's metabolic state during the postoperative period.",
    "llama-2-7b-chat-hf_fact": [
      "Early after coronary artery bypass graft surgery, there is an increase in thyroid-stimulating hormone (TSH) levels.",
      "There is a decrease in free thyroxine (FT4) and free triiodothyronine (FT3) levels early after coronary artery bypass graft surgery.",
      "The changes in thyroid profile metabolism are seen within the first few days after the surgery.",
      "The alterations in thyroid metabolism can persist for several weeks after coronary artery bypass graft surgery.",
      "These changes in thyroid metabolism post surgery are believed to be related to the stress of the surgery and the resulting changes in the body's metabolic state."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 715,
    "user_query": "What does the SAGA complex acronym stands for?",
    "llama-2-7b-chat-hf_response": "SAGA stands for:\nS - Single-stranded\nA - Adenine\nG - Guanine\nA - Adenine\nExplanation:\nThe SAGA complex is a large protein complex that plays a crucial role in the regulation of gene expression in eukaryotic cells. The acronym SAGA stands for Single-stranded Adenine and Guanine Adenine, which reflects the composition of the complex. The SAGA complex is composed of several subunits that work together to recognize and bind to specific DNA sequences, and to recruit other proteins that are involved in gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "SAGA stands for Single-stranded Adenine Guanine Adenine.",
      "The SAGA complex is a large protein complex.",
      "The SAGA complex plays a crucial role in the regulation of gene expression in eukaryotic cells.",
      "The SAGA complex is composed of several subunits that work together to bind to specific DNA sequences.",
      "The SAGA complex recruits other proteins that are involved in gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: SAGA stands for SptAdaGcn5 acetyltransferase.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 716,
    "user_query": "What is the result of the interaction between TSC1 and PLK1?",
    "llama-2-7b-chat-hf_response": "TSC1 (Tuberous Sclerosis Complex 1) and PLK1 (Protein Kinase Like 1) are two proteins that play important roles in various cellular processes, including cell growth, division, and signaling. The interaction between TSC1 and PLK1 has been studied extensively, and it has been shown to have significant consequences for cellular function. Here are some of the key results of the interaction between TSC1 and PLK1:\n1. Regulation of cell growth and division: TSC1 and PLK1 interact to regulate cell growth and division. TSC1 phosphorylates and inhibits PLK1, which in turn regulates the activity of cyclin-dependent kinases (CDKs) and other key regulators of cell cycle progression.\n2. Modulation of signaling pathways: The interaction between TSC1 and PLK1 also affects the activity of various signaling pathways, including the PI3K/AKT and MAPK pathways. TSC1 has been shown to regulate the activity of these pathways by modulating the activity of upstream kinases, such as PI3K and MAPK.\n3. Regulation of cytoskeleton organization: TSC1 and PLK1 also interact to regulate the organization of the cytoskeleton. TSC1 has been shown to regulate the activity of proteins involved in cytoskeleton organization, such as actin and microtubule-associated proteins.\n4. Modulation of cellular stress responses: The interaction between TSC1 and PLK1 also affects cellular stress responses. TSC1 has been shown to regulate the activity of proteins involved in stress responses, such as heat shock proteins and chaperones.\n5. Regulation of autophagy: TSC1 and PLK1 also interact to regulate autophagy, a process by which cells degrade and recycle damaged or excess cellular components. TSC1 has been shown to regulate the activity of autophagy-related proteins, such as ATG5 and ATG12.\nIn summary, the interaction between TSC1 and PLK1 has significant consequences for cellular function, including the regulation of cell growth and division, signaling pathways, cytoskeleton",
    "llama-2-7b-chat-hf_fact": [
      "TSC1 (Tuberous Sclerosis Complex 1) and PLK1 (Protein Kinase Like 1) are proteins that play crucial roles in cell growth, division, and signaling.",
      "The interaction between TSC1 and PLK1 aids in the regulation of cell growth and division by regulating the activity of cyclin-dependent kinases and other key regulators of cell cycle progression.",
      "The interaction between TSC1 and PLK1 impacts the activity of various signaling pathways, including the PI3K/AKT and MAPK pathways.",
      "TSC1 and PLK1 interact to regulate the organization of the cytoskeleton by controlling the activity of proteins involved in cytoskeleton organization.",
      "The interaction between TSC1 and PLK1 affects cellular stress responses and helps in the regulation of autophagy, a process that enables cells to degrade and recycle damaged or excess cellular components."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 717,
    "user_query": "What are the characteristics of the \"Universal Proteomics Standard 2\" (UPS2)?",
    "llama-2-7b-chat-hf_response": "The \"Universal Proteomics Standard 2\" (UPS2) is a set of guidelines for protein identification and quantification in mass spectrometry-based proteomics. UPS2 was developed to improve the quality and consistency of proteomics research by providing a standardized framework for data acquisition, processing, and analysis. Here are some of the key characteristics of UPS2:\n1. Data Acquisition: UPS2 recommends the use of high-resolution mass spectrometry instruments, such as Orbitrap or ion trap, for protein identification and quantification.\n2. Data Processing: UPS2 provides guidelines for data processing, including peak picking, alignment, and filtering, to ensure that high-quality spectra are used for protein identification and quantification.\n3. Protein Identification: UPS2 recommends the use of database-driven methods, such as MASCOT or SEQUEST, for protein identification. These methods use a database of known protein sequences to match peptide spectra and identify proteins.\n4. Protein Quantification: UPS2 provides guidelines for protein quantification, including the use of isotope-coded affinity tags (ICAT) or label-free quantification methods. These methods allow for the quantification of proteins based on their abundance in the sample.\n5. Data Analysis: UPS2 provides guidelines for data analysis, including the use of statistical methods, such as t-tests or ANOVA, to identify differentially expressed proteins.\n6. Reproducibility: UPS2 emphasizes the importance of reproducibility in proteomics research, including the use of appropriate controls and replicates to ensure that results are reliable.\n7. Standardization: UPS2 encourages the use of standardized protocols and reagents to ensure that results are comparable across different laboratories and experiments.\n8. Data Sharing: UPS2 encourages the sharing of data and reagents to facilitate collaboration and reproducibility in proteomics research.\nBy following these guidelines, researchers can ensure that their proteomics data is of high quality, consistent, and reproducible, and that their results are comparable to those obtained by other researchers.",
    "llama-2-7b-chat-hf_fact": [
      "The \"Universal Proteomics Standard 2\" (UPS2) is a set of guidelines for protein identification and quantification in mass spectrometry-based proteomics.",
      "UPS2 recommends the use of high-resolution mass spectrometry instruments, such as Orbitrap or ion trap, for protein identification and quantification.",
      "UPS2 recommends the use of database-driven methods, like MASCOT or SEQUEST, for protein identification.",
      "UPS2 guidelines for protein quantification include the use of isotope-coded affinity tags (ICAT) or label-free quantification methods.",
      "UPS2 emphasizes the use of standardized protocols and reagents in proteomics research."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The \"Universal Proteomics Standard 2\" (UPS2) is not a set of guidelines, but rather a complex mixture of 48 human proteins that are commonly used as a standard in mass spectrometry-based proteomics.",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 719,
    "user_query": "Which are the smallest known subviral pathogens of plants?",
    "llama-2-7b-chat-hf_response": "Smallest known subviral pathogens of plants include:\n1. Virus-like particles (VLPs): These are non-infectious particles that mimic the structure of a virus but lack the genetic material.\n2. Satellites: These are small, circular DNA molecules that are replicated by the host plant's DNA polymerase.\n3. Prions: These are infectious proteins that can cause changes in the host plant's proteins, leading to disease.\n4. Viroids: These are small, single-stranded RNA molecules that replicate by infecting the host plant's RNA polymerase.\n5. Nanoviruses: These are viruses that are smaller than 20 nanometers in diameter.",
    "llama-2-7b-chat-hf_fact": [
      "Virus-like particles (VLPs) mimic the structure of a virus but lack the genetic material.",
      "Satellites are small, circular DNA molecules that are replicated by the host plant's DNA polymerase.",
      "Prions are infectious proteins that cause changes in a host plant's proteins, resulting in disease.",
      "Viroids are small, single-stranded RNA molecules that infect the host plant's RNA polymerase to replicate.",
      "Nanoviruses are viruses that are smaller than 20 nanometers in diameter."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Satellites are small, circular DNA or RNA molecules that require a helper virus for replication.",
      "false, [corrected fact]: Prions are infectious proteins that cause diseases in animals and humans not plants.",
      "false, [corrected fact]: Viroids are small, single-stranded RNA molecules that cause disease in plants, they do not infect the host plant's RNA polymerase to replicate.",
      "unknown"
    ]
  },
  {
    "id": 720,
    "user_query": "What causes Katayama Fever?",
    "llama-2-7b-chat-hf_response": "Katayama fever, also known as Japanese encephalitis, is a viral infection that affects the brain and is caused by the Japanese encephalitis virus (JEV). The virus is primarily transmitted through the bite of an infected mosquito, particularly the Culex species.\nThe virus is found in Asia, particularly in China, Japan, Korea, Taiwan, and parts of Southeast Asia. The virus is most commonly transmitted during the summer and fall months, when mosquito populations are at their peak.\nSymptoms of Katayama Fever\nThe symptoms of Katayama fever can vary in severity and may include:\n1. Fever: A high fever is the most common symptom of Katayama fever, which can range from 38C to 40C (100.4F to 104F).\n2. Headache: A severe headache is another common symptom of Katayama fever, which can be accompanied by neck stiffness and sensitivity to light.\n3. Muscle and joint pain: Patients may experience muscle and joint pain, particularly in the arms and legs.\n4. Fatigue: Katayama fever can cause extreme fatigue, which can last for several days or even weeks.\n5. Confusion and disorientation: In severe cases, Katayama fever can cause confusion, disorientation, and difficulty concentrating.\n6. Seizures: In rare cases, Katayama fever can cause seizures, particularly in children and older adults.\n7. Encephalitis: In severe cases, the virus can cause inflammation of the brain (encephalitis), which can lead to brain damage, coma, and even death.\nDiagnosis of Katayama Fever\nKatayama fever is diagnosed based on a combination of symptoms, medical history, and laboratory tests. Laboratory tests may include:\n1. Blood tests: Blood tests can detect the presence of antibodies against the JEV in the blood.\n2. Cerebrospinal fluid (CSF) analysis: CSF analysis can detect the presence of JEV antigens or antibodies in the CSF, which can help confirm the diagnosis of encephalitis.",
    "llama-2-7b-chat-hf_fact": [
      "Katayama fever, also known as Japanese encephalitis, is a viral infection caused by the Japanese encephalitis virus (JEV).",
      "The Japanese encephalitis virus is primarily transmitted through the bite of an infected mosquito, particularly the Culex species.",
      "The Japanese encephalitis virus is found in Asia, particularly in China, Japan, Korea, Taiwan, and parts of Southeast Asia.",
      "The transmission of the Japanese encephalitis virus is most common during the summer and fall months.",
      "Diagnosis of Katayama Fever involves symptoms check, medical history, and laboratory tests including blood tests and cerebrospinal fluid (CSF) analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Katayama fever is not the same as Japanese encephalitis. It is a symptom of early acute schistosomiasis, not a viral infection caused by the Japanese encephalitis virus (JEV).",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Diagnosis of Japanese encephalitis, not Katayama Fever, involves symptom check, medical history, and laboratory tests including blood tests and cerebrospinal fluid (CSF) analysis."
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-7b-chat-hf_response": "Sarcopenia is the progressive loss of muscle mass, strength, and function that occurs as people age. While there are currently no FDA-approved drugs for the prevention or treatment of sarcopenia, there are several clinical trials underway exploring potential interventions. Here are some of the clinical trials for the prevention of sarcopenia:\n1. Metformin and Resistance Training to Prevent Sarcopenia (METEOR): This randomized, double-blind, placebo-controlled trial is investigating the effectiveness of metformin, a drug commonly used to treat type 2 diabetes, in combination with resistance training to prevent sarcopenia in older adults.\n2. Nutritional Interventions to Prevent Sarcopenia (NIPS): This randomized, controlled trial is evaluating the effectiveness of a nutritional intervention, including a protein-rich diet and supplementation with omega-3 fatty acids, vitamin D, and antioxidants, in preventing sarcopenia in older adults.\n3. Exercise and Nutritional Interventions to Prevent Sarcopenia (ENIGMA): This randomized, controlled trial is investigating the effectiveness of a combination of exercise and nutritional interventions, including resistance training, aerobic exercise, and nutritional supplementation, in preventing sarcopenia in older adults.\n4. Sarcopenia Prevention with Dietary Interventions (SPIDI): This randomized, controlled trial is evaluating the effectiveness of a dietary intervention, including a Mediterranean-style diet and supplementation with antioxidants and omega-3 fatty acids, in preventing sarcopenia in older adults.\n5. Resistance Training and Nutritional Interventions to Prevent Sarcopenia (REPS): This randomized, controlled trial is investigating the effectiveness of a combination of resistance training and nutritional interventions, including protein supplementation and a Mediterranean-style diet, in preventing sarcopenia in older adults.\n6. Sarcopenia Prevention with Vitamin D and Omega-3 Fatty Acids (SP",
    "llama-2-7b-chat-hf_fact": [
      "Sarcopenia is the progressive loss of muscle mass, strength, and function that occurs as people age.",
      "At present, there are no FDA-approved drugs for the prevention or treatment of sarcopenia.",
      "One clinical trial, Metformin and Resistance Training to Prevent Sarcopenia (METEOR), is investigating the use of metformin and resistance training for sarcopenia in older adults.",
      "Nutritional Interventions to Prevent Sarcopenia (NIPS) is a clinical trial that focuses on the use of a protein-rich diet along with vitamin D, omega-3 fatty acids, and antioxidant supplementation.",
      "The Sarcopenia Prevention with Dietary Interventions (SPIDI) trial studies the impact of a Mediterranean-style diet, coupled with antioxidant and omega-3 fatty acid supplements."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-7b-chat-hf_response": "The database of molecular recognition features in membrane proteins is called:\nA. Membrane Protein Data Bank (MPDB)\nB. Protein Data Bank (PDB)\nC. Membrane Protein Recognition Database (MPRD)\nD. Protein-Ligand Recognition Database (PLRD)\nCorrect answer: C. Membrane Protein Recognition Database (MPRD)\nExplanation:\nThe Membrane Protein Recognition Database (MPRD) is a comprehensive database of molecular recognition features in membrane proteins. It contains a wide range of features, including transmembrane helices, loops, and binding sites, as well as information on the functional implications of these features. MPRD is a valuable resource for researchers studying the structure, function, and evolution of membrane proteins.\nMPRD is not the same as the Membrane Protein Data Bank (MPDB), which is a database of three-dimensional structures of membrane proteins, nor is it the same as the Protein Data Bank (PDB), which is a database of three-dimensional structures of proteins in general. MPRD is also distinct from the Protein-Ligand Recognition Database (PLRD), which is a database of protein-ligand interactions.",
    "llama-2-7b-chat-hf_fact": [
      "The Membrane Protein Recognition Database (MPRD) is a comprehensive database of molecular recognition features in membrane proteins.",
      "The MPRD includes features such as transmembrane helices, loops, and binding sites, and information on the functional implications of these features.",
      "The Membrane Protein Data Bank (MPDB) is a database of three-dimensional structures of membrane proteins.",
      "The Protein Data Bank (PDB) is a database of three-dimensional structures of proteins in general.",
      "The Protein-Ligand Recognition Database (PLRD) is a database of protein-ligand interactions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 731,
    "user_query": "What kind of bonds are connecting keratin molecules?",
    "llama-2-7b-chat-hf_response": "Keratin is a type of protein that is found in the skin, hair, and nails of humans and many other animals. It is made up of long chains of amino acids that are linked together by peptide bonds. These peptide bonds are formed when the carboxyl group of one amino acid molecule reacts with the amino group of another amino acid molecule.\nIn addition to peptide bonds, keratin molecules are also held together by hydrogen bonds and ionic bonds. Hydrogen bonds are formed when the hydrogen atom of one amino acid molecule reacts with the oxygen or nitrogen atom of another amino acid molecule. Ionic bonds are formed when the positively charged amino acid molecules (such as arginine and lysine) react with the negatively charged amino acid molecules (such as aspartic acid and glutamic acid).\nOverall, the combination of peptide bonds, hydrogen bonds, and ionic bonds helps to give keratin its rigid and elastic structure, which is important for the function of skin, hair, and nails.",
    "llama-2-7b-chat-hf_fact": [
      "Keratin is a type of protein found in the skin, hair, and nails of humans and other animals.",
      "Keratin is made up of long chains of amino acids linked together by peptide bonds.",
      "Peptide bonds are formed when the carboxyl group of one amino acid molecule reacts with the amino group of another amino acid molecule.",
      "Keratin molecules are also held together by hydrogen bonds and ionic bonds.",
      "The combination of peptide bonds, hydrogen bonds, and ionic bonds gives keratin its rigid and elastic structure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 734,
    "user_query": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?",
    "llama-2-7b-chat-hf_response": "Fanconi anemia is a rare genetic disorder that affects the body's ability to repair DNA damage. Individuals with Fanconi anemia have a higher risk of developing acute myelogenous leukemia (AML), a type of blood cancer, compared to the general population.\nAccording to the Fanconi Anemia Research Fund, the risk of developing AML in individuals with Fanconi anemia is estimated to be between 20% and 40%. This means that approximately one in five individuals with Fanconi anemia will develop AML during their lifetime.\nThe risk of developing AML in Fanconi anemia is thought to be due to the genetic mutations that cause the disorder, which lead to defects in the DNA repair pathway. As a result, individuals with Fanconi anemia are more susceptible to DNA damage, which can accumulate over time and lead to the development of cancer.\nIt is important for individuals with Fanconi anemia to receive regular monitoring and screening for AML, as early detection and treatment can improve outcomes. Treatment options for AML in Fanconi anemia may include chemotherapy, radiation therapy, or bone marrow transplantation.\nOverall, while the risk of developing AML in Fanconi anemia is higher than in the general population, early detection and treatment can improve outcomes for individuals with this condition.",
    "llama-2-7b-chat-hf_fact": [
      "Fanconi anemia is a rare genetic disorder that affects the body's ability to repair DNA damage.",
      "Individuals with Fanconi anemia have a higher risk of developing acute myelogenous leukemia (AML) compared to the general population.",
      "The risk of developing AML in individuals with Fanconi anemia is estimated to be between 20% and 40% according to the Fanconi Anemia Research Fund.",
      "The increased risk of AML in Fanconi anemia is due to genetic mutations that cause defects in the DNA repair pathway.",
      "Among the treatment options for AML in Fanconi anemia are chemotherapy, radiation therapy, and bone marrow transplantation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 735,
    "user_query": "How many different mutations have been associated with Muenke syndrome?",
    "llama-2-7b-chat-hf_response": "Muenke syndrome is caused by mutations in the ACM3 gene. To date, more than 30 different mutations have been identified in the ACM3 gene in individuals with Muenke syndrome. These mutations can be classified into three main categories: missense, nonsense, and frameshift mutations. Missense mutations result in a change in the amino acid sequence of the ACM3 protein, while nonsense mutations result in premature termination of protein synthesis. Frameshift mutations result in the insertion or deletion of one or more nucleotides in the ACM3 gene, leading to a change in the reading frame of the genetic code. Each of these mutations can have different effects on the function of the ACM3 protein and the development of Muenke syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Muenke syndrome is caused by mutations in the ACM3 gene.",
      "More than 30 different mutations have been identified in the ACM3 gene in individuals with Muenke syndrome.",
      "The mutations in the ACM3 gene can be classified into three main categories: missense, nonsense, and frameshift mutations.",
      "Missense mutations change the amino acid sequence of the ACM3 protein.",
      "Frameshift mutations result in the insertion or deletion of one or more nucleotides in the ACM3 gene, which changes the reading frame of the genetic code."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Muenke syndrome is caused by mutations in the FGFR3 gene.",
      "false, [corrected fact]: More than 30 different mutations have been identified in the FGFR3 gene in individuals with Muenke syndrome.",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 737,
    "user_query": "Which genes have been proposed as potential candidates for gene therapy of heart failure?",
    "llama-2-7b-chat-hf_response": "Several genes have been proposed as potential candidates for gene therapy of heart failure, including:\n1. Beta-myosin heavy chain (MYH7): Mutations in the MYH7 gene can lead to hypertrophic cardiomyopathy, a common form of heart failure. Gene therapy targeting the MYH7 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy.\n2. Cardiac troponin I (TNNI3): Mutations in the TNNI3 gene can lead to hypertrophic cardiomyopathy and heart failure. Gene therapy targeting the TNNI3 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy.\n3. Cardiac myosin-binding protein C (MYBPC3): Mutations in the MYBPC3 gene can lead to hypertrophic cardiomyopathy and heart failure. Gene therapy targeting the MYBPC3 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy.\n4. Ankyrin-B (ANK2): Mutations in the ANK2 gene can lead to hypertrophic cardiomyopathy and heart failure. Gene therapy targeting the ANK2 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy.\n5. Tropomyosin (TPM1): Mutations in the TPM1 gene can lead to hypertrophic cardiomyopathy and heart failure. Gene therapy targeting the TPM1 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy.\n6. GATA4 (GATA4): Mutations in the GATA4 gene can lead to hypertrophic cardiomyopathy and heart failure. Gene therapy targeting the GATA4 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy.\n7. GATA6 (GATA6): Mutations in the GATA6 gene can lead to hypertrophic cardiomyopathy and heart failure. Gene therapy targeting the GATA6 gene has",
    "llama-2-7b-chat-hf_fact": [
      "The Beta-myosin heavy chain (MYH7) gene has been considered for gene therapy for heart failure.",
      "Mutations in the TNNI3 gene can lead to hypertrophic cardiomyopathy and heart failure.",
      "Cardiac myosin-binding protein C (MYBPC3) is a gene that has been targeted for gene therapy in relation to heart failure.",
      "The ANK2 gene mutations can lead to hypertrophic cardiomyopathy and heart failure and have been proposed for gene therapy.",
      "Gene therapy targeting the GATA4 gene has been shown to improve cardiac function in animal models of hypertrophic cardiomyopathy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: ANK2 gene mutations can cause cardiac arrhythmias. It has not been proposed for gene therapy in relation to heart failure.",
      "unknown"
    ]
  },
  {
    "id": 738,
    "user_query": "DX-88 is investigational name of which drug?",
    "llama-2-7b-chat-hf_response": "DX-88 is an investigational drug being developed by DexCom, Inc. for the treatment of type 1 and type 2 diabetes. It is a glucose-responsive insulin delivery system that is designed to provide real-time insulin delivery based on a person's glucose levels. The drug is still in clinical trials and has not yet been approved by the FDA.",
    "llama-2-7b-chat-hf_fact": [
      "DX-88 is an investigational drug.",
      "The drug is being developed by DexCom, Inc.",
      "DX-88 is designed for the treatment of type 1 and type 2 diabetes.",
      "DX-88 is a glucose-responsive insulin delivery system.",
      "The drug is still in clinical trials and has not yet been approved by the FDA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 740,
    "user_query": "Which genes have been found to be associated with restless leg syndrome",
    "llama-2-7b-chat-hf_response": "?\nRestless Legs Syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move one's legs, usually due to an uncomfortable or unpleasant sensation in the legs. While the exact cause of RLS is not yet fully understood, several genes have been found to be associated with the disorder. Here are some of the genes that have been linked to RLS:\n1. DJ-1 gene: The DJ-1 gene provides instructions for making a protein called parkin, which helps to break down damaged mitochondria in cells. Mutations in the DJ-1 gene have been found to increase the risk of developing RLS.\n2. COMT gene: The COMT gene provides instructions for making an enzyme called catechol-O-methyltransferase, which helps to break down certain neurotransmitters in the brain. Variants of the COMT gene have been associated with an increased risk of RLS.\n3. HLA gene: The HLA gene provides instructions for making proteins involved in the immune system. Certain variants of the HLA gene have been found to be more common in people with RLS than in the general population.\n4. GBA gene: The GBA gene provides instructions for making an enzyme called glucocerebrosidase, which helps to break down certain fats in the body. Mutations in the GBA gene have been found to increase the risk of developing RLS.\n5. KCNQ2 gene: The KCNQ2 gene provides instructions for making a potassium channel protein that is involved in the regulation of electrical signals in nerve cells. Mutations in the KCNQ2 gene have been found to cause RLS.\n6. KCNQ3 gene: The KCNQ3 gene provides instructions for making another potassium channel protein that is involved in the regulation of electrical signals in nerve cells. Mutations in the KCNQ3 gene have been found to cause RLS.\n7. IRBP2 gene: The IRBP2 gene provides instructions for making a protein called interphotoreceptor retinoid-binding protein 2, which is involved in the regulation of light sensitivity in the eye. Variants of the IRBP2 gene have been associated",
    "llama-2-7b-chat-hf_fact": [
      "DJ-1 gene is associated with Restless Legs Syndrome (RLS) and its mutations increase the risk of developing RLS.",
      "COMT gene variants are associated with an increased risk of RLS.",
      "Certain variants of the HLA gene are more common in people with RLS than in the general population.",
      "Mutations in the GBA gene increase the risk of developing RLS.",
      "KCNQ2 gene and KCNQ3 gene mutations can cause RLS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: DJ-1 gene is associated with Parkinson's disease, not Restless Legs Syndrome (RLS).",
      "false, [corrected fact]: COMT gene variants are not directly associated with an increased risk of RLS. They are associated with Parkinsons disease, schizophrenia, and other conditions.",
      "true",
      "false, [corrected fact]: Mutations in the GBA gene are associated with Gaucher's disease and an increased risk of Parkinson's disease, not RLS.",
      "false, [corrected fact]: KCNQ2 gene and KCNQ3 gene mutations are associated with certain forms of epilepsy, not RLS."
    ]
  },
  {
    "id": 743,
    "user_query": "Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?",
    "llama-2-7b-chat-hf_response": "Sleeping Beauty (SB) and piggyBac (PB) are both popular transposons used in gene therapy and gene editing applications. While both transposons have been shown to be efficient in vivo, there are differences in their transposition efficiency.\nStudies have shown that SB transposons have a higher transposition efficiency than PB transposons in some cell types, such as primary T cells and hematopoietic stem cells. For example, one study found that SB transposons were 3-4 times more efficient than PB transposons in primary T cells (1). Another study found that SB transposons were 2-3 times more efficient than PB transposons in hematopoietic stem cells (2).\nHowever, PB transposons have been shown to have a higher transposition efficiency than SB transposons in other cell types, such as fibroblasts and muscle cells. For example, one study found that PB transposons were 2-3 times more efficient than SB transposons in fibroblasts (3). Another study found that PB transposons were 1.5-2 times more efficient than SB transposons in muscle cells (4).\nIt is important to note that the transposition efficiency of both transposons can be influenced by various factors, such as the cell type, the dose of transposon, and the presence of other transposons. Therefore, the choice of transposon may depend on the specific application and the cell type being targeted.\nIn summary, while SB transposons have been shown to have a higher transposition efficiency than PB transposons in some cell types, PB transposons have been shown to have a higher transposition efficiency than SB transposons in other cell types. The choice of transposon may depend on the specific application and the cell type being targeted.\nReferences:\n1. Liu et al. (2013). High-efficiency transposition of the Sleeping Beauty transposon in primary T cells. Molecular Therapy, 21(10), 1744-1752.\n2. Zhang et al. (2015). Efficient transposition of the piggyBac transpos",
    "llama-2-7b-chat-hf_fact": [
      "Sleeping Beauty (SB) and piggyBac (PB) are transposons used in gene therapy and gene editing applications.",
      "Studies indicated that SB transposons have a higher transposition efficiency than PB transposons in some cell types, including primary T cells and hematopoietic stem cells.",
      "According to research, PB transposons have higher transposition efficiency than SB transposons in some other cell types, such as fibroblasts and muscle cells.",
      "The transposition efficiency of both transposons can be influenced by different factors such as the cell type, the dose of transposon, and the presence of other transposons.",
      "The choice of transposon to use can depend on the specific application and the cell type being targeted."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 744,
    "user_query": "Where does TORC1 sequester during heat stress?",
    "llama-2-7b-chat-hf_response": "TORC1 (Target of Rapamycin Complex 1) is a key regulator of cell growth and metabolism, and it plays a critical role in maintaining cellular homeostasis in response to heat stress. When cells are exposed to heat stress, TORC1 is sequestered in the cytoplasm, where it can interact with and regulate the activity of various downstream effectors.\nOne of the key downstream effectors of TORC1 is the translation initiation factor 4E-BP1 (eukaryotic translation initiation factor 4E-binding protein 1), which is a key regulator of protein synthesis. When cells are exposed to heat stress, TORC1 can phosphorylate and inhibit 4E-BP1, leading to the activation of protein synthesis and the adaptation of cells to heat stress.\nIn addition to regulating protein synthesis, TORC1 also regulates the activity of other downstream effectors, including the cell cycle regulator S6K1 (serine/threonine kinase 1) and the transcription factor ATF4 (activating transcription factor 4). These effectors play important roles in regulating cell growth, proliferation, and survival in response to heat stress.\nOverall, the sequestration of TORC1 in the cytoplasm during heat stress allows it to regulate the activity of various downstream effectors and coordinate the cellular response to heat stress. This response is critical for maintaining cellular homeostasis and ensuring the survival of cells under stressful conditions.",
    "llama-2-7b-chat-hf_fact": [
      "TORC1 (Target of Rapamycin Complex 1) is a key regulator of cell growth and metabolism.",
      "During heat stress, TORC1 is sequestered in the cytoplasm where it interacts with various downstream effectors.",
      "One of the downstream effectors of TORC1 is the translation initiation factor 4E-BP1, which plays a key role in protein synthesis.",
      "During heat stress, TORC1 can phosphorylate and inhibit 4E-BP1, leading to the activation of protein synthesis.",
      "Other downstream effectors regulated by TORC1 include the cell cycle regulator S6K1 and the transcription factor ATF4, both of which play important roles in cellular response to heat stress."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-7b-chat-hf_response": "Is rivaroxaban metabolized in the kidneys?\nRivaroxaban, a direct oral anticoagulant (DOAC), is metabolized primarily by the liver, but also to a lesser extent by the kidneys.\nRivaroxaban is metabolized by the cytochrome P450 (CYP) enzyme system in the liver, with CYP3A4 being the main isoform involved. The liver is responsible for converting rivaroxaban to its active metabolite, which is then excreted primarily in the feces.\nHowever, the kidneys also play a role in rivaroxaban metabolism, particularly in patients with impaired liver function. In these patients, the kidneys may contribute to a larger proportion of rivaroxaban metabolism.\nStudies have shown that the kidneys are capable of metabolizing rivaroxaban to a lesser extent than the liver. For example, one study found that the kidneys accounted for only 10-20% of rivaroxaban metabolism in healthy volunteers, compared to 60-70% in the liver.\nOverall, while the kidneys do play a role in rivaroxaban metabolism, the liver is the primary site of metabolism for this drug. Patients with impaired liver function may require closer monitoring and dosage adjustments to ensure safe and effective anticoagulation therapy.",
    "llama-2-7b-chat-hf_fact": [
      "Rivaroxaban is a direct oral anticoagulant.",
      "Rivaroxaban is primarily metabolized by the liver.",
      "The cytochrome P450 (CYP) enzyme system in the liver, particularly CYP3A4, is involved in rivaroxaban's metabolism.",
      "The liver converts rivaroxaban to its active metabolite which is mainly excreted in the feces.",
      "The kidneys have a secondary role in rivaroxaban metabolism, particularly in patients with impaired liver function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Rivaroxaban is not activated by the liver. Instead, the majority of the drug is excreted unchanged in the urine and feces.",
      "false, [corrected fact]: The kidneys play a primary role in the elimination of rivaroxaban, primarily via renal excretion. Liver metabolism has a secondary role."
    ]
  },
  {
    "id": 746,
    "user_query": "What are the side effects of Nalmefene?",
    "llama-2-7b-chat-hf_response": "Nalmefene is a medication that is used to treat opioid withdrawal symptoms. It works by blocking the effects of opioids on the brain, which can help to reduce the symptoms of withdrawal. However, like all medications, Nalmefene can cause side effects. Here are some of the possible side effects of Nalmefene:\n1. Drowsiness: Nalmefene can cause drowsiness and fatigue, which can last for several days after taking the medication.\n2. Dizziness: Some people taking Nalmefene may experience dizziness or lightheadedness, especially when they stand up or change positions.\n3. Nausea and vomiting: Nalmefene can cause nausea and vomiting, especially in the first few days of taking the medication.\n4. Stomach cramps: Nalmefene can cause stomach cramps, which can be uncomfortable but are usually not severe.\n5. Headache: Some people taking Nalmefene may experience headaches, which can range from mild to severe.\n6. Fever: Nalmefene can cause a mild fever, which is usually not a cause for concern.\n7. Muscle aches: Nalmefene can cause muscle aches and pains, which can be uncomfortable but are usually not severe.\n8. Sweating: Nalmefene can cause excessive sweating, which can be uncomfortable but is usually not a cause for concern.\n9. Chills: Some people taking Nalmefene may experience chills, which can be uncomfortable but are usually not a cause for concern.\n10. Insomnia: Nalmefene can cause insomnia, which can make it difficult to fall asleep or stay asleep.\n11. Anxiety: Some people taking Nalmefene may experience anxiety, which can range from mild to severe.\n12. Depression: Nalmefene can cause depression, which can range from mild to severe.\n13. Suicidal thoughts: In rare cases, Nalmefene can cause suicidal thoughts or behaviors, especially",
    "llama-2-7b-chat-hf_fact": [
      "Nalmefene is used to treat opioid withdrawal symptoms.",
      "Side effect of Nalmefene includes drowsiness and fatigue.",
      "Nalmefene can cause nausea and vomiting as a side effect.",
      "Another side effect of Nalmefene is stomach cramps.",
      "Nalmefene can cause insomnia, making it difficult for patients to fall asleep or stay asleep."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Nalmefene is used to treat alcohol dependence, not opioid withdrawal symptoms.",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 756,
    "user_query": "Which is the E3 ubiquitin ligase of Hsp90?",
    "llama-2-7b-chat-hf_response": "Hsp90 is a molecular chaperone that plays a crucial role in maintaining protein homeostasis in the cell. One of the key mechanisms by which Hsp90 regulates protein folding and degradation is through its interaction with the ubiquitin-proteasome pathway. Specifically, Hsp90 can act as an E3 ubiquitin ligase, catalyzing the ubiquitination of target proteins for their subsequent degradation by the proteasome.\nThere are several E3 ubiquitin ligases that have been identified as being involved in the regulation of Hsp90 activity. These include:\n1. HSP90AB1: This is the most well-studied E3 ubiquitin ligase of Hsp90, and it has been shown to play a key role in regulating the activity of Hsp90 in various cellular contexts.\n2. HSP90AA1: This E3 ubiquitin ligase has been implicated in the regulation of Hsp90 activity in response to cellular stress.\n3. HSP90AL1: This E3 ubiquitin ligase has been shown to play a role in regulating Hsp90 activity in the context of cancer.\n4. HSP90BP1: This E3 ubiquitin ligase has been implicated in the regulation of Hsp90 activity in the context of neurodegenerative diseases.\nIt is important to note that these E3 ubiquitin ligases are not the only ones involved in the regulation of Hsp90 activity, and there may be other E3 ubiquitin ligases that have not yet been identified.\nIn summary, Hsp90 can act as an E3 ubiquitin ligase, catalyzing the ubiquitination of target proteins for their subsequent degradation by the proteasome. Several E3 ubiquitin ligases have been identified as being involved in the regulation of Hsp90 activity, including HSP90AB1, HSP90AA1, HSP90AL1, and HSP90BP1.",
    "llama-2-7b-chat-hf_fact": [
      "Hsp90 is a molecular chaperone that plays a crucial role in maintaining protein homeostasis in the cell.",
      "Hsp90 can act as an E3 ubiquitin ligase, catalyzing the ubiquitination of target proteins for their subsequent degradation by the proteasome.",
      "HSP90AB1 is a well-studied E3 ubiquitin ligase of Hsp90 that plays a key role in regulating its activity.",
      "HSP90AA1, an E3 ubiquitin ligase, is implicated in the regulation of Hsp90 activity in response to cellular stress.",
      "Other E3 ubiquitin ligases of Hsp90 include HSP90AL1, linked to cancer regulation, and HSP90BP1, associated with neurodegenerative diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Hsp90 does not act as an E3 ubiquitin ligase. It is a molecular chaperone that assists in the folding and refolding of proteins.",
      "false, [corrected fact]: HSP90AB1 is not an E3 ubiquitin ligase of Hsp90, but rather another isoform of the Hsp90 chaperones.",
      "false, [corrected fact]: HSP90AA1 is not an E3 ubiquitin ligase, it is an isoform of the Hsp90 chaperones which play a role in protein folding and maintaining cellular homeostasis.",
      "unknown"
    ]
  },
  {
    "id": 757,
    "user_query": "Which are the major phycobiliproteins present in cyanobacteria?",
    "llama-2-7b-chat-hf_response": "Cyanobacteria are photosynthetic bacteria that contain a range of phycobiliproteins, which are water-soluble pigments that play a crucial role in light harvesting and energy transfer in photosynthesis. The major phycobiliproteins present in cyanobacteria are:\n1. Phycocyanin: This is the most abundant phycobiliprotein in cyanobacteria and is responsible for the blue-green color of the bacteria. Phycocyanin is composed of seven polypeptide chains and has a molecular weight of approximately 100,000 Daltons.\n2. Phycoerythrin: This is another important phycobiliprotein found in cyanobacteria, which is responsible for the red color of the bacteria. Phycoerythrin is composed of four polypeptide chains and has a molecular weight of approximately 50,000 Daltons.\n3. Phycourobilin: This is a minor phycobiliprotein found in some cyanobacteria, which is responsible for the yellow-orange color of the bacteria. Phycourobilin is composed of three polypeptide chains and has a molecular weight of approximately 30,000 Daltons.\nThese phycobiliproteins play a crucial role in the light-dependent reactions of photosynthesis by absorbing light energy and transferring it to the photosynthetic reaction centers. They are also involved in the regulation of photosynthesis and are important for the survival and growth of cyanobacteria in different environments.",
    "llama-2-7b-chat-hf_fact": [
      "Cyanobacteria are photosynthetic bacteria that contain a range of phycobiliproteins.",
      "Phycocyanin is the most abundant phycobiliprotein in cyanobacteria, and it is responsible for the blue-green color of the bacteria.",
      "Phycocyanin is composed of seven polypeptide chains and has a molecular weight of approximately 100,000 Daltons.",
      "Phycoerythrin, another phycobiliprotein in cyanobacteria, is responsible for the red color of the bacteria and is composed of four polypeptide chains and has a molecular weight of approximately 50,000 Daltons.",
      "Phycourobilin, a minor phycobiliprotein in some cyanobacteria, gives them a yellow-orange color, is composed of three polypeptide chains and has a molecular weight of approximately 30,000 Daltons."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Phycocyanin is composed of alpha and beta subunits, but the exact number of chains can vary. The general molecular weight of phycocyanin is approximately 240,000 Daltons.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 759,
    "user_query": "In which kingdom do microsporidia belong, according to their current classification scheme?",
    "llama-2-7b-chat-hf_response": "Microsporidia are a group of obligate intracellular parasites that infect a wide range of hosts, including animals, plants, and fungi. According to their current classification scheme, Microsporidia belong to the kingdom Protista.",
    "llama-2-7b-chat-hf_fact": [
      "Microsporidia are a group of obligate intracellular parasites.",
      "Microsporidia infect a wide range of hosts, which includes animals, plants, and fungi.",
      "According to their current classification scheme, Microsporidia belong to the kingdom Protista."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: According to their current classification scheme, Microsporidia belong to the kingdom Fungi."
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-7b-chat-hf_response": "TRalpha2 is a G protein-coupled receptor that plays a crucial role in the regulation of cardiac function. The activation of TRalpha2 leads to the activation of downstream signaling pathways that regulate various cellular processes, including gene expression. Here are some of the genes that are known to be regulated by TRalpha2 in the heart:\n1. Atrial natriuretic factor (ANF): TRalpha2 activation increases the expression of ANF, a hormone that regulates blood pressure and fluid balance.\n2. Brain natriuretic peptide (BNP): TRalpha2 activation also increases the expression of BNP, a hormone that regulates cardiac function and blood pressure.\n3. Cardiac troponin I (cTnI): TRalpha2 activation increases the phosphorylation of cTnI, a protein that regulates the contraction of cardiac muscle fibers.\n4. Connexin43 (Cx43): TRalpha2 activation increases the expression of Cx43, a gap junction protein that regulates the electrical conduction of cardiac impulses.\n5. GATA4: TRalpha2 activation increases the expression of GATA4, a transcription factor that regulates the expression of genes involved in cardiac development and function.\n6. Hypoxia-inducible factor (HIF): TRalpha2 activation increases the expression of HIF, a transcription factor that regulates the response to hypoxia in the heart.\n7. Nuclear factor of kappa light chain enhancer in B cells (NF-B): TRalpha2 activation increases the expression of NF-B, a transcription factor that regulates the inflammatory response in the heart.\n8. Phospholamban (PLN): TRalpha2 activation increases the phosphorylation of PLN, a protein that regulates the contraction of cardiac muscle fibers.\n9. Ryanodine receptor 2 (RyR2): TRalpha2 activation increases the expression of RyR2, a calcium release channel that regulates the contraction of cardiac muscle fibers.\n10. Serum response factor (SRF): TRalpha2 activation increases the expression of SRF, a transcription factor that",
    "llama-2-7b-chat-hf_fact": [
      "TRalpha2 is a G protein-coupled receptor that plays a role in regulating cardiac function.",
      "The activation of TRalpha2 leads to the regulation of gene expression.",
      "Atrial natriuretic factor (ANF) is a gene that is regulated by TRalpha2 in the heart.",
      "Connexin43 (Cx43) is a gene regulated by TRalpha2 in the heart.",
      "Nuclear factor of kappa light chain enhancer in B cells (NF-B) is another gene regulated by TRalpha2 in the heart."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: TRalpha2 (Thyroid hormone receptor alpha) is not a G protein-coupled receptor. It's a nuclear receptor that plays a role in regulating metabolism, development, and growth.",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 767,
    "user_query": "Is tubulin acetylation involved in cell motility?",
    "llama-2-7b-chat-hf_response": "Tubulin acetylation is a post-translational modification that plays a crucial role in regulating microtubule dynamics and stability. Recent studies have also implicated tubulin acetylation in cell motility, suggesting that it may play a role in regulating cell migration and invasion.",
    "llama-2-7b-chat-hf_fact": [
      "Tubulin acetylation is a post-translational modification.",
      "Tubulin acetylation plays a role in regulating microtubule dynamics and stability.",
      "Recent studies have implicated tubulin acetylation in cell motility.",
      "Tubulin acetylation may play a role in regulating cell migration and invasion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 768,
    "user_query": "List available genetic multicolor cell labeling techiniques in Drosophila",
    "llama-2-7b-chat-hf_response": "There are several genetic multicolor cell labeling techniques available in Drosophila, which allow researchers to simultaneously label multiple cell types or subcellular structures with different fluorescent dyes. Here are some of the most commonly used techniques:\n1. Gal4/UAS system: The yeast GAL4/UAS system has been adapted for use in Drosophila, where the GAL4 transcription factor is used to activate the expression of multiple UAS (upstream activating sequence) genes. Each UAS gene encodes a different fluorescent protein, allowing researchers to label multiple cell types or subcellular structures with different colors.\n2. LexA/LacZ system: The LexA/LacZ system is similar to the Gal4/UAS system, but uses the LexA transcription factor to activate the expression of multiple LacZ (-galactosidase) genes. Each LacZ gene encodes a different fluorescent protein, allowing researchers to label multiple cell types or subcellular structures with different colors.\n3. FLP/FRT system: The FLP/FRT system is a site-specific recombinase system that can be used to create genetic mosaics in Drosophila. By using different FRT (flp recombinase target) sequences in the UAS (upstream activating sequence) genes, researchers can label different cell types or subcellular structures with different colors.\n4. CRISPR/Cas9 system: The CRISPR/Cas9 system is a powerful tool for genome editing and gene regulation in Drosophila. By using different guide RNAs (gRNAs) that target different genes, researchers can label different cell types or subcellular structures with different colors.\n5. RNAi system: The RNAi (RNA interference) system can be used to knockdown the expression of specific genes in Drosophila, allowing researchers to label specific cell types or subcellular structures with different colors. By using different RNAi constructs that target different genes, researchers can label different cell types or subcellular structures with different colors.\n6. Micro-RNA (miRNA) system: The miRNA system can be used to regulate the expression of",
    "llama-2-7b-chat-hf_fact": [
      "There are several genetic multicolor cell labeling techniques available in Drosophila.",
      "The yeast Gal4/UAS system is used in Drosophila to label multiple cell types or subcellular structures with different colored fluorescent proteins.",
      "The LexA/LacZ system is a similar technique that uses LexA transcription factor to activate the expression of multiple LacZ genes, each encoding a different fluorescent protein.",
      "The FLP/FRT system, a site-specific recombinase system, can create genetic mosaics and label different cell types with different colors.",
      "The CRISPR/Cas9 system is utilized for genome editing and gene regulation in Drosophila, allowing different cell types or subcellular structures to be labeled with unique colors.",
      "The RNAi system can be used to knockdown the expression of specific genes in Drosophila, enabling labeling of different cell types or subcellular structures with different colors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The LexA/LacZ system uses LexA transcription factor to activate the expression of LacZ genes encoding -galactosidase, not different fluorescent proteins.",
      "true",
      "true",
      "false, [corrected fact]: The RNAi system can be used to knockdown the expression of specific genes in Drosophila, but it's not typically used for cell labeling with different colors."
    ]
  },
  {
    "id": 769,
    "user_query": "Which growth factors are known to be involved in the induction of EMT?",
    "llama-2-7b-chat-hf_response": "Epithelial-to-mesenchymal transition (EMT) is a complex process that involves the loss of epithelial characteristics and the acquisition of mesenchymal properties. Several growth factors have been shown to be involved in the induction of EMT, including:\n1. TGF-: TGF- is a potent inducer of EMT and is involved in many physiological and pathological processes, including embryonic development, tissue repair, and cancer progression.\n2. FGF: Fibroblast growth factors (FGFs) are a family of growth factors that have been shown to induce EMT by promoting the expression of mesenchymal markers and inhibiting the expression of epithelial markers.\n3. Wnt/-catenin: The Wnt/-catenin signaling pathway is involved in the regulation of EMT and has been shown to promote the expression of mesenchymal markers and inhibit the expression of epithelial markers.\n4. Notch: The Notch signaling pathway is involved in the regulation of EMT and has been shown to promote the expression of mesenchymal markers and inhibit the expression of epithelial markers.\n5. Hedgehog: The Hedgehog signaling pathway is involved in the regulation of EMT and has been shown to promote the expression of mesenchymal markers and inhibit the expression of epithelial markers.\n6. BMP: Bone morphogenetic proteins (BMPs) are a family of growth factors that have been shown to induce EMT by promoting the expression of mesenchymal markers and inhibiting the expression of epithelial markers.\n7. VEGF: Vascular endothelial growth factor (VEGF) is a growth factor that has been shown to induce EMT by promoting the expression of mesenchymal markers and inhibiting the expression of epithelial markers.\n8. PDGF: Platelet-derived growth factor (PDGF) is a growth factor that has been shown to induce EMT by promoting the expression of mesenchymal markers and inhibiting the expression of epith",
    "llama-2-7b-chat-hf_fact": [
      "Epithelial-to-mesenchymal transition (EMT) is a process involving the loss of epithelial characteristics and the acquisition of mesenchymal properties.",
      "TGF- is a growth factor involved in the induction of EMT and is associated with physiological and pathological processes like embryonic development, tissue repair, and cancer progression.",
      "Fibroblast growth factors (FGFs) induce EMT by promoting the expression of mesenchymal markers and inhibiting the expression of epithelial markers.",
      "The Wnt/-catenin signaling pathway regulates EMT by promoting the expression of mesenchymal markers and inhibiting the expression of epithelial markers.",
      "The Hedgehog signaling pathway is involved in the regulation of EMT, promoting mesenchymal markers and inhibiting epithelial markers."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 774,
    "user_query": "Which histone modification discriminates between active and poised enhancers?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-acting DNA elements that can increase the recruitment of RNA polymerase II (RNAPII) to specific gene promoters, leading to increased gene expression. Enhancers can be broadly classified into two categories: active enhancers, which are typically associated with high levels of gene expression, and poised enhancers, which are associated with low levels of gene expression.\nHistone modifications are one of the key epigenetic marks that distinguish active from poised enhancers. Active enhancers are characterized by high levels of histone H3 lysine 4 trimethylation (H3K4me3), which is a mark of active gene expression. In contrast, poised enhancers are characterized by low levels of H3K4me3 and high levels of histone H3 lysine 27 trimethylation (H3K27me3), which is a mark of gene repression.\nOther histone modifications that may distinguish active from poised enhancers include:\n* Histone H3 lysine 9 trimethylation (H3K9me3): Active enhancers typically have high levels of H3K9me3, while poised enhancers have low levels.\n* Histone H3 lysine 79 dimethylation (H3K79me2): Active enhancers have high levels of H3K79me2, while poised enhancers have low levels.\n* Histone H2A lysine 5 acetylation (H2AK5ac): Active enhancers have high levels of H2AK5ac, while poised enhancers have low levels.\n* Histone H3 lysine 14 acetylation (H3K14ac): Active enhancers have high levels of H3K14ac, while poised enhancers have low levels.\nIt is important to note that the specific histone modifications that distinguish active from poised enhancers can vary depending on the cell type and the specific context in which the enhancers are found.",
    "llama-2-7b-chat-hf_fact": [
      "Enhancers are cis-acting DNA elements that can increase the recruitment of RNA polymerase II to specific gene promoters, leading to increased gene expression.",
      "Histone modifications are key epigenetic marks that distinguish active from poised enhancers.",
      "Active enhancers are characterized by high levels of histone H3 lysine 4 trimethylation (H3K4me3), a mark of active gene expression.",
      "Poised enhancers are characterized by low levels of H3K4me3 and high levels of histone H3 lysine 27 trimethylation (H3K27me3), a mark of gene repression.",
      "Variations in histone modifications that distinguish active from poised enhancers can depend on the cell type and the specific context in which the enhancers are found."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 776,
    "user_query": "What is the inheritance pattern of LiFraumeni syndrome?",
    "llama-2-7b-chat-hf_response": "Li-Fraumeni syndrome is a rare inherited disorder that is caused by mutations in the TP53 gene. The inheritance pattern of Li-Fraumeni syndrome is autosomal dominant, meaning that a single copy of the mutated TP53 gene is enough to cause the condition. This means that if one parent has the mutation, each child has a 50% chance of inheriting the mutated gene.",
    "llama-2-7b-chat-hf_fact": [
      "Li-Fraumeni syndrome is a rare inherited disorder.",
      "The disorder is caused by mutations in the TP53 gene.",
      "The inheritance pattern of Li-Fraumeni syndrome is autosomal dominant.",
      "A single copy of the mutated TP53 gene is enough to cause Li-Fraumeni syndrome.",
      "If one parent has the mutation, each child has a 50% chance of inheriting the mutated gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 781,
    "user_query": "Which are the synonyms of prostate-specific antigen?",
    "llama-2-7b-chat-hf_response": "Prostate-specific antigen (PSA) is a protein produced by the prostate gland in men. It is used as a diagnostic tool for prostate cancer and other prostate problems. Here are some synonyms for PSA:\n1. Prostate-specific acid phosphatase (PSAP)\n2. Prostate-specific enzyme (PSE)\n3. Prostate-specific protein (PSP)\n4. Prostate-specific antigen-1 (PSA-1)\n5. Prostate-specific antigen-2 (PSA-2)\nWhich of the following is NOT a synonym for prostate-specific antigen (PSA)?\nI. Prostate-specific acid phosphatase (PSAP)\nII. Prostate-specific enzyme (PSE)\nIII. Prostate-specific protein (PSP)\nIV. Prostate-specific antigen-1 (PSA-1)\nV. Prostate-specific antigen-2 (PSA-2)\nAnswer:\nIV. Prostate-specific antigen-1 (PSA-1) is NOT a synonym for prostate-specific antigen (PSA).",
    "llama-2-7b-chat-hf_fact": [
      "Prostate-specific antigen (PSA) is a protein produced by the prostate gland in men.",
      "PSA is used as a diagnostic tool for prostate cancer and other prostate problems.",
      "Prostate-specific acid phosphatase (PSAP) is a synonym for PSA.",
      "Prostate-specific enzyme (PSE) is a synonym for PSA.",
      "Prostate-specific antigen-1 (PSA-1) is not a synonym for prostate-specific antigen (PSA)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Prostate-specific acid phosphatase (PSAP) is another enzyme produced by the prostate, but it is not a synonym for PSA.",
      "false, [corrected fact]: Prostate-specific enzyme (PSE) is not a synonym for PSA.",
      "true"
    ]
  },
  {
    "id": 783,
    "user_query": "What is the function of circular RNA?",
    "llama-2-7b-chat-hf_response": "Circular RNA (circRNA) is a type of non-coding RNA (ncRNA) that forms a covalently closed loop structure, meaning that it has no free ends and lacks a 5' cap and a 3' tail. The function of circRNA is still not fully understood, but it has been implicated in a variety of cellular processes, including:\n1. Regulation of gene expression: circRNA can act as a competing endogenous RNA (ceRNA) to bind to microRNAs (miRNAs) and prevent them from regulating their target genes.\n2. RNA processing: circRNA can be generated through back-splicing, a process in which the splicing machinery removes the introns and joins the exons in a circular manner.\n3. Chromatin modification: circRNA can interact with histone-modifying enzymes and influence chromatin structure and gene expression.\n4. Cancer: circRNA has been shown to be dysregulated in various types of cancer, and it is thought to play a role in cancer development and progression.\n5. Stem cell biology: circRNA has been implicated in the regulation of stem cell self-renewal and differentiation.\n6. Neurodegenerative diseases: circRNA has been linked to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.\n7. Immune response: circRNA has been shown to play a role in the regulation of immune cell function and the response to infection.\n8. Aging: circRNA has been implicated in the aging process and age-related diseases.\nIt is important to note that the function of circRNA is still an active area of research, and more studies are needed to fully understand its mechanisms of action and its potential as a therapeutic target.",
    "llama-2-7b-chat-hf_fact": [
      "Circular RNA is a type of non-coding RNA that forms a closed loop structure.",
      "circRNA has been implicated in the regulation of gene expression by acting as a competing endogenous RNA to bind to miRNAs.",
      "The generation of circRNA involves a process known as back-splicing.",
      "Circular RNA can interact with histone-modifying enzymes and influence chromatin structure and gene expression.",
      "circRNA has been linked to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-7b-chat-hf_response": "There are several biomedical question answering systems available, including:\n1. PubMed Central Question Answering Service (PCQAS): PCQAS is a biomedical question answering system that uses natural language processing and machine learning techniques to answer questions about biomedical literature.\n2. Biomedical Information Retrieval and Question Answering System (BIRQAS): BIRQAS is a biomedical question answering system that uses a combination of natural language processing and machine learning techniques to answer questions about biomedical literature.\n3. Biomedical Question Answering System (BQAS): BQAS is a biomedical question answering system that uses natural language processing and machine learning techniques to answer questions about biomedical literature.\n4. Medical Information Retrieval and Question Answering System (MIRQAS): MIRQAS is a biomedical question answering system that uses a combination of natural language processing and machine learning techniques to answer questions about biomedical literature.\n5. Biomedical Text Mining and Question Answering System (BTMAQAS): BTMAQAS is a biomedical question answering system that uses natural language processing and machine learning techniques to answer questions about biomedical literature.\n6. Biomedical Question Answering System using Deep Learning (BQA-DL): BQA-DL is a biomedical question answering system that uses deep learning techniques to answer questions about biomedical literature.\n7. Biomedical Question Answering System using Transfer Learning (BQA-TL): BQA-TL is a biomedical question answering system that uses transfer learning techniques to answer questions about biomedical literature.\n8. Biomedical Question Answering System using Word Embeddings (BQA-WE): BQA-WE is a biomedical question answering system that uses word embeddings techniques to answer questions about biomedical literature.\n9. Biomedical Question Answering System using Attention Mechanism (BQA-AM): BQA-AM is a biomedical question answering system that uses attention mechanism techniques to answer questions about biomedical literature.\n10. Biomedical Question Answering System using Graph Convolutional Networks (BQA-GCN): BQA-GCN is a biomedical question answering system that uses graph convolutional networks techniques to answer questions about biomedical literature.",
    "llama-2-7b-chat-hf_fact": [
      "PubMed Central Question Answering Service (PCQAS) is a biomedical question answering system that uses natural language processing and machine learning techniques.",
      "Biomedical Information Retrieval and Question Answering System (BIRQAS) combines natural language processing and machine learning techniques to answer questions about biomedical literature.",
      "Medical Information Retrieval and Question Answering System (MIRQAS) uses a combination of natural language processing and machine learning techniques to answer biomedical questions.",
      "Biomedical Question Answering System using Deep Learning (BQA-DL) uses deep learning techniques to answer questions about biomedical literature.",
      "Biomedical Question Answering System using Word Embeddings (BQA-WE) utilizes word embeddings techniques to provide answers to biomedical questions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-7b-chat-hf_response": "The betalain pathway is a metabolic pathway that leads to the synthesis of betalains, a class of pigments found in plants. The pathway involves several enzymes and cofactors, and is regulated by various transcription factors.\nOne of the transcription factors that activates the betalain pathway is the transcription factor BET1 (Betalain bHLH transcription factor 1). BET1 is a basic helix-loop-helix (bHLH) transcription factor that binds to specific DNA sequences in the promoter regions of betalain biosynthetic genes and activates their transcription.\nOther transcription factors that may also play a role in regulating the betalain pathway include:\n* BET2 (Betalain bHLH transcription factor 2): Similar to BET1, BET2 is also a bHLH transcription factor that regulates the expression of betalain biosynthetic genes.\n* MYB1 (Myb-related transcription factor 1): MYB1 is a transcription factor that regulates the expression of genes involved in the biosynthesis of phenylpropanoids, including betalains.\n* WRKY1 (WRKY transcription factor 1): WRKY1 is a transcription factor that regulates the expression of genes involved in the biosynthesis of betalains and other secondary metabolites.\n* DREB2A (Dehydration-responsive element-binding protein 2A): DREB2A is a transcription factor that regulates the expression of genes involved in the biosynthesis of betalains and other secondary metabolites in response to drought stress.\nIt's worth noting that the regulation of the betalain pathway is complex and involves multiple transcription factors and signaling pathways, and the above list is not exhaustive.",
    "llama-2-7b-chat-hf_fact": [
      "The betalain pathway leads to the synthesis of betalains, a class of pigments found in plants.",
      "The transcription factor BET1 (Betalain bHLH transcription factor 1) activates the betalain pathway.",
      "BET2 (Betalain bHLH transcription factor 2) is another transcription factor that regulates the expression of betalain biosynthetic genes.",
      "MYB1 (Myb-related transcription factor 1) is a transcription factor that regulates the expression of genes involved in the biosynthesis of phenylpropanoids, including betalains.",
      "DREB2A (Dehydration-responsive element-binding protein 2A) is a transcription factor that regulates the expression of genes involved in the biosynthesis of betalains and other secondary metabolites in response to drought stress."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 796,
    "user_query": "Which is the most well-accepted method for Down syndrome non-invasive prenatal diagnosis?",
    "llama-2-7b-chat-hf_response": "The most well-accepted method for non-invasive prenatal diagnosis of Down syndrome is:\nA. Ultrasound\nB. Amniocentesis\nC. Chorionic villus sampling (CVS)\nD. Non-invasive prenatal testing (NIPT)\nCorrect answer: D. Non-invasive prenatal testing (NIPT)\nExplanation:\nNon-invasive prenatal testing (NIPT) is the most well-accepted method for prenatal diagnosis of Down syndrome. NIPT uses cell-free DNA (cfDNA) in the maternal blood to detect genetic abnormalities, including Down syndrome, trisomy 13, and trisomy 18. NIPT is a simple, safe, and non-invasive test that can detect Down syndrome with a high degree of accuracy, typically between 10 and 20 weeks of gestation.\nUltrasound (A) is an imaging technique that uses high-frequency sound waves to produce images of the fetus, but it is not a diagnostic test for Down syndrome. Amniocentesis (B) and chorionic villus sampling (CVS) (C) are invasive tests that involve collecting a sample of cells from the amniotic fluid or placenta, respectively. While these tests can detect genetic abnormalities, they carry a small risk of miscarriage.\nTherefore, the correct answer is (D) Non-invasive prenatal testing (NIPT).",
    "llama-2-7b-chat-hf_fact": [
      "Non-invasive prenatal testing (NIPT) is the most well-accepted method for prenatal diagnosis of Down syndrome.",
      "NIPT uses cell-free DNA in the maternal blood to detect genetic abnormalities, including Down syndrome, trisomy 13, and trisomy 18.",
      "NIPT is a non-invasive test that can detect Down syndrome with a high degree of accuracy, typically between 10 and 20 weeks of gestation.",
      "Ultrasound is an imaging technique that uses high-frequency sound waves to produce images of the fetus, but it is not a diagnostic test for Down syndrome.",
      "Amniocentesis and chorionic villus sampling are invasive tests that carry a small risk of miscarriage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 799,
    "user_query": "What is the average diameter of intermediate filaments?",
    "llama-2-7b-chat-hf_response": "Intermediate filaments are a type of protein filament that are found in the cytoplasm of eukaryotic cells. They are intermediate in size between microfilaments and microtubules, with diameters ranging from 10-100 nanometers (nm). The average diameter of intermediate filaments is typically around 20-30 nm.",
    "llama-2-7b-chat-hf_fact": [
      "Intermediate filaments are a type of protein filament found in the cytoplasm of eukaryotic cells.",
      "Intermediate filaments are intermediate in size between microfilaments and microtubules.",
      "The diameter of intermediate filaments ranges from 10-100 nanometers.",
      "The average diameter of intermediate filaments is around 20-30 nanometers."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The diameter of intermediate filaments ranges from about 8-12 nanometers.",
      "true"
    ]
  },
  {
    "id": 805,
    "user_query": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?",
    "llama-2-7b-chat-hf_response": "The IF protein that can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone (SVZ) is called vimentin. Vimentin is an intermediate filament protein that is expressed in a wide range of cell types, including neuronal precursor cells in the SVZ. Vimentin is known to play a role in maintaining the structural integrity of cells and has been used as a non-specific marker to identify and track cells in various tissues, including the brain.\nOther IF proteins, such as neurofilaments and glial fibrillary acidic protein (GFAP), are also expressed in neuronal precursor cells in the SVZ, but vimentin is the most commonly used non-specific marker for these cells.",
    "llama-2-7b-chat-hf_fact": [
      "Vimentin is an intermediate filament (IF) protein.",
      "Vimentin is expressed in a wide range of cell types, including neuronal precursor cells in the subventricular zone (SVZ).",
      "Vimentin is known to play a role in maintaining the structural integrity of cells.",
      "Vimentin is used as a non-specific marker to identify and track cells in various tissues, including the brain.",
      "Other IF proteins, such as neurofilaments and glial fibrillary acidic protein (GFAP), are also expressed in neuronal precursor cells in the SVZ."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 806,
    "user_query": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?",
    "llama-2-7b-chat-hf_response": "A. DNA methyltransferase\nB. Histone-modifying enzyme\nC. Topoisomerase\nD. Telomerase\nAnswer: A. DNA methyltransferase\nExplanation:\nDNA (cytosine-5)-methylation is a common epigenetic modification that plays a crucial role in the regulation of gene expression and genome stability. DNA methyltransferases (DNMTs) are enzymes that catalyze the transfer of a methyl group from S-adenosylmethionine to the cytosine residue of CpG dinucleotides, resulting in 5-methylcytosine formation. DNMTs are involved in the maintenance of DNA (cytosine-5)-methylation throughout the genome, and their dysregulation has been implicated in various diseases, including cancer.\nHistone-modifying enzymes (such as histone acetyltransferases and histone deacetylases) are involved in the regulation of chromatin structure and gene expression, but they are not directly involved in the maintenance of DNA (cytosine-5)-methylation. Topoisomerases are enzymes that regulate DNA topology, but they are not involved in epigenetic modifications. Telomerase is an enzyme that lengthens telomeres, which are repetitive DNA sequences found at the ends of chromosomes, but it is not involved in the maintenance of DNA (cytosine-5)-methylation.\nTherefore, the correct answer is (A) DNA methyltransferase.",
    "llama-2-7b-chat-hf_fact": [
      "DNA (cytosine-5)-methylation is a common epigenetic modification that plays a crucial role in the regulation of gene expression and genome stability.",
      "DNA methyltransferases are enzymes that catalyze the transfer of a methyl group from S-adenosylmethionine to the cytosine residue of CpG dinucleotides, resulting in 5-methylcytosine formation.",
      "DNA methyltransferases are involved in the maintenance of DNA (cytosine-5)-methylation.",
      "Histone-modifying enzymes are involved in the regulation of chromatin structure and gene expression.",
      "Telomerase is an enzyme that lengthens telomeres, which are repetitive DNA sequences found at the ends of chromosomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 807,
    "user_query": "Is transcapillary  albumin escape altered in diabetic patients?",
    "llama-2-7b-chat-hf_response": "Yes, transcapillary albumin escape is altered in diabetic patients. Studies have shown that diabetes can lead to changes in the tight junctions between endothelial cells in the capillaries, which can disrupt the barrier function and allow albumin to escape from the bloodstream into the surrounding tissues. This can lead to albuminuria, or excess protein in the urine, which is a common complication of diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "Transcapillary albumin escape is altered in diabetic patients.",
      "Diabetes can lead to changes in the tight junctions between endothelial cells in the capillaries.",
      "The change in tight junctions in capillaries due to diabetes can disrupt the barrier function and allow albumin to escape.",
      "Albumin escape can result in its presence in the urine, a condition known as albuminuria.",
      "Albuminuria is a common complication of diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 812,
    "user_query": "Which cell type has the protein Chromogranin A as marker?",
    "llama-2-7b-chat-hf_response": "Chromogranin A is a protein that is expressed in a variety of cell types, including:\n1. Neurons: Chromogranin A is expressed in certain types of neurons, particularly those involved in the regulation of neurotransmitter release.\n2. Endocrine cells: Chromogranin A is also expressed in endocrine cells, such as pancreatic beta cells and thyroid follicular cells, where it plays a role in the regulation of hormone secretion.\n3. Neuroendocrine cells: Chromogranin A is also expressed in neuroendocrine cells, such as those found in the brain and gut, where it regulates the release of neurotransmitters and hormones.\n4. Immune cells: Chromogranin A is also expressed in certain immune cells, such as mast cells and basophils, where it plays a role in the regulation of inflammation.\n5. Cancer cells: Chromogranin A is overexpressed in many types of cancer, including neuroendocrine tumors, pancreatic cancer, and lung cancer, where it promotes tumor growth and progression.\nSo, the cell type that has the protein Chromogranin A as marker is:\nNeurons, Endocrine cells, Neuroendocrine cells, Immune cells, Cancer cells.",
    "llama-2-7b-chat-hf_fact": [
      "Chromogranin A is a protein that is expressed in various types of cells, including neurons.",
      "Chromogranin A is expressed in endocrine cells, such as pancreatic beta cells and thyroid follicular cells.",
      "Neuroendocrine cells, found in the brain and gut, also express Chromogranin A.",
      "In the immune system, Chromogranin A is expressed in mast cells and basophils.",
      "Chromogranin A is overexpressed in many types of cancer cells, including neuroendocrine tumors, pancreatic cancer, and lung cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 813,
    "user_query": "Does a selective sweep increase genetic variation?",
    "llama-2-7b-chat-hf_response": "A selective sweep is a process in evolution where a single mutation becomes fixed in a population through natural selection. The question is, does a selective sweep increase genetic variation or decrease it?\nThe answer is that a selective sweep can increase or decrease genetic variation, depending on the context.\nIf the selective sweep is strong enough, it can increase genetic variation by creating new mutations that are not present in the original population. This is because the selective sweep can cause mutations that are not beneficial to become fixed in the population, which can increase the overall genetic diversity.\nHowever, if the selective sweep is not strong enough, it can decrease genetic variation by reducing the frequency of neutral or slightly deleterious mutations. This is because the selective sweep can only fix mutations that are beneficial, and neutral or deleterious mutations may be lost from the population due to genetic drift.\nIn summary, the effect of a selective sweep on genetic variation depends on the strength of the selection pressure and the genetic background of the population. If the selective sweep is strong, it can increase genetic variation by creating new mutations, but if it is weak, it can decrease genetic variation by reducing the frequency of neutral or deleterious mutations.",
    "llama-2-7b-chat-hf_fact": [
      "A selective sweep is a process in evolution where a single mutation becomes fixed in a population through natural selection.",
      "A selective sweep can increase genetic variation if it is strong enough to create new mutations that are not present in the original population.",
      "A strong selective sweep can cause non-beneficial mutations to become fixed in a population, thereby increasing genetic diversity.",
      "A weak selective sweep can decrease genetic variation by reducing the frequency of neutral or slightly deleterious mutations.",
      "The effect of a selective sweep on genetic variation depends on the strength of the selection pressure and the genetic background of the population."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: A selective sweep reduces genetic variation as it increases the frequency of one particular advantageous mutation, not create new mutations.",
      "false, [corrected fact]: A strong selective sweep makes a beneficial mutation quickly become universal, it does not typically cause non-beneficial mutations to become fixed.",
      "true",
      "true"
    ]
  },
  {
    "id": 814,
    "user_query": "Which disease phenotypes are associated to PRPS1 mutations?",
    "llama-2-7b-chat-hf_response": "PRPS1 mutations have been associated with several disease phenotypes, including:\n1. Mucopolysaccharidosis type I (MPS I): PRPS1 mutations are the most common cause of MPS I, also known as Hurler syndrome. This is a rare genetic disorder that affects the body's ability to produce certain enzymes, leading to the accumulation of sugar molecules in the body and a range of serious health problems.\n2. Mucopolysaccharidosis type II (MPS II): PRPS1 mutations have also been linked to MPS II, also known as Hunter syndrome. This is another rare genetic disorder that affects the body's ability to produce certain enzymes, leading to the accumulation of sugar molecules in the body and a range of serious health problems.\n3. Mucopolysaccharidosis type III (MPS III): PRPS1 mutations have been associated with MPS III, also known as Sanfilippo syndrome. This is a rare genetic disorder that affects the body's ability to produce certain enzymes, leading to the accumulation of sugar molecules in the body and a range of serious health problems.\n4. Mucopolysaccharidosis type IV (MPS IV): PRPS1 mutations have been linked to MPS IV, also known as Morquio syndrome. This is a rare genetic disorder that affects the body's ability to produce certain enzymes, leading to the accumulation of sugar molecules in the body and a range of serious health problems.\n5. Other diseases: PRPS1 mutations have also been associated with other rare genetic disorders, including mucopolysaccharidosis type VI (MPS VI), mucopolysaccharidosis type VII (MPS VII), and mucopolysaccharidosis type VIII (MPS VIII).\nIt's important to note that not all PRPS1 mutations will lead to the development of these diseases, and the severity of the disease can vary depending on the specific mutation and the individual affected.",
    "llama-2-7b-chat-hf_fact": [
      "PRPS1 mutations are associated with various disease phenotypes.",
      "PRPS1 mutations are the most common cause of a rare genetic disorder called Mucopolysaccharidosis type I (MPS I) or Hurler syndrome.",
      "PRPS1 mutations have been linked to another rare genetic disorder called Mucopolysaccharidosis type II (MPS II), or Hunter syndrome.",
      "PRPS1 mutations have been associated with Mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome.",
      "PRPS1 mutations have also been linked to Mucopolysaccharidosis type IV (MPS IV), or Morquio syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: PRPS1 mutations are not the most common cause of Mucopolysaccharidosis type I (MPS I) or Hurler syndrome. The most common cause of this disease is mutations in the IDUA gene.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 815,
    "user_query": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?",
    "llama-2-7b-chat-hf_response": "A. Yes, antioxidant supplements have been shown to reduce the risk of coronary artery disease.\nB. No, antioxidant supplements have not been shown to reduce the risk of coronary artery disease.\nC. The evidence is mixed, and more research is needed to determine the effectiveness of antioxidant supplements in reducing the risk of coronary artery disease.\nD. Antioxidant supplements may actually increase the risk of coronary artery disease.\nAnswer: C. The evidence is mixed, and more research is needed to determine the effectiveness of antioxidant supplements in reducing the risk of coronary artery disease.",
    "llama-2-7b-chat-hf_fact": [
      "The evidence about antioxidant supplements reducing the risk of coronary artery disease is mixed."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 821,
    "user_query": "Is K-63 linked protein ubiquitination related to proteasomal degradation?",
    "llama-2-7b-chat-hf_response": "Yes, K-63 linked protein ubiquitination is related to proteasomal degradation. K-63 linked ubiquitination is a type of protein ubiquitination that involves the covalent attachment of multiple ubiquitin molecules to a target protein, forming a polyubiquitin chain. This type of ubiquitination is known to be involved in various cellular processes, including protein degradation.\nProteasomal degradation is a process by which cells degrade proteins that are no longer needed or are damaged. The proteasome is a large protein complex that degrades proteins into small peptides, which can then be further degraded by other proteases. K-63 linked ubiquitination is one of the mechanisms by which proteins are targeted for proteasomal degradation.\nStudies have shown that K-63 linked ubiquitination of certain proteins can lead to their degradation by the proteasome. For example, K-63 linked ubiquitination of the tumor suppressor protein p53 has been shown to promote its degradation by the proteasome, leading to its loss of function and contributing to cancer development. Similarly, K-63 linked ubiquitination of the transcription factor NF-B has been shown to promote its degradation by the proteasome, leading to its inactivation and contributing to the regulation of inflammatory responses.\nIn summary, K-63 linked protein ubiquitination is related to proteasomal degradation, as it can target proteins for degradation by the proteasome. This process plays a crucial role in regulating various cellular processes, including protein turnover, inflammation, and cancer development.",
    "llama-2-7b-chat-hf_fact": [
      "K-63 linked protein ubiquitination involves the covalent attachment of multiple ubiquitin molecules to a target protein, forming a polyubiquitin chain.",
      "Proteasomal degradation is a process by which cells degrade proteins that are no longer needed or are damaged.",
      "The proteasome is a large protein complex that degrades proteins into small peptides.",
      "K-63 linked ubiquitination of the tumor suppressor protein p53 has been shown to promote its degradation by the proteasome, contributing to cancer development.",
      "K-63 linked ubiquitination of the transcription factor NF-B promotes its degradation by the proteasome, contributing to the regulation of inflammatory responses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: K-48, not K-63, linked ubiquitination of the tumor suppressor protein p53 promotes its degradation by the proteasome, contributing to cancer development.",
      "false, [corrected fact]: K-63 linked ubiquitination of the transcription factor NF-B does not promote its degradation, but instead regulates its activity and subcellular localization, contributing to the regulation of inflammatory responses."
    ]
  },
  {
    "id": 822,
    "user_query": "Could transcription factors act as cell-cell signalling molecules?",
    "llama-2-7b-chat-hf_response": "Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences. While they are typically associated with the regulation of gene expression within a single cell, recent studies have suggested that some transcription factors may also play a role in cell-cell signaling.\nOne example of a transcription factor that has been shown to act as a cell-cell signaling molecule is c-Myc. c-Myc is a transcription factor that regulates the expression of a wide range of genes involved in cell growth, proliferation, and differentiation. In addition to its role in gene regulation, c-Myc has been shown to play a role in cell-cell signaling, particularly in the context of cancer. For example, c-Myc has been shown to promote the migration and invasion of cancer cells by modulating the expression of genes involved in these processes.\nAnother example of a transcription factor that has been implicated in cell-cell signaling is NF-B. NF-B is a transcription factor that regulates the expression of genes involved in inflammation and immune response. While NF-B is typically associated with the regulation of gene expression within a single cell, recent studies have suggested that it may also play a role in cell-cell signaling. For example, NF-B has been shown to promote the migration and invasion of cancer cells by modulating the expression of genes involved in these processes.\nOther transcription factors that have been implicated in cell-cell signaling include p53, which regulates the expression of genes involved in cell cycle arrest and apoptosis, and HIF-1, which regulates the expression of genes involved in response to hypoxia.\nWhile the role of transcription factors in cell-cell signaling is still an area of active research, these studies suggest that some transcription factors may play a more direct role in cell-cell communication than was previously thought. This could have important implications for our understanding of cellular communication and the development of new therapeutic strategies for diseases such as cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences.",
      "c-Myc is a transcription factor that regulates the expression of genes involved in cell growth, proliferation, and differentiation.",
      "NF-B is a transcription factor that regulates the expression of genes involved in inflammation and immune response.",
      "The transcription factor p53 regulates the expression of genes involved in cell cycle arrest and apoptosis.",
      "HIF-1 is a transcription factor that regulates the expression of genes involved in response to hypoxia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 828,
    "user_query": "Is muscle lim protein (MLP) involved in cardiomyopathies?",
    "llama-2-7b-chat-hf_response": "Muscle-specific lim protein (MLP) is a protein that is predominantly expressed in skeletal muscle and plays a crucial role in regulating muscle protein synthesis and degradation. Recent studies have suggested that MLP may also be involved in cardiomyopathies, which are diseases of the heart muscle that can lead to impaired cardiac function and increased risk of heart failure.\nOne study published in the journal Circulation Research found that MLP levels were significantly increased in the hearts of mice with dilated cardiomyopathy, a condition characterized by an enlarged heart and impaired cardiac function. The study suggested that MLP may play a role in the development and progression of dilated cardiomyopathy by promoting muscle protein degradation and inhibiting muscle protein synthesis.\nAnother study published in the journal American Journal of Physiology-Heart and Circulatory Physiology found that MLP levels were elevated in the hearts of patients with hypertrophic cardiomyopathy, a condition characterized by an abnormal thickening of the heart muscle. The study suggested that MLP may contribute to the development and progression of hypertrophic cardiomyopathy by promoting muscle protein degradation and inhibiting muscle protein synthesis.\nOverall, these studies suggest that MLP may play a role in the development and progression of certain cardiomyopathies by regulating muscle protein metabolism in the heart. Further research is needed to fully understand the role of MLP in cardiomyopathies and to identify potential therapeutic targets for the treatment of these diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Muscle-specific lim protein (MLP) is predominantly expressed in skeletal muscle and plays a crucial role in regulating muscle protein synthesis and degradation.",
      "MLP may be involved in cardiomyopathies, which are diseases of the heart muscle that can lead to impaired cardiac function and increased risk of heart failure.",
      "A study published in the journal Circulation Research found that MLP levels were significantly increased in the hearts of mice with dilated cardiomyopathy.",
      "Another study published in the American Journal of Physiology-Heart and Circulatory Physiology found that MLP levels were elevated in the hearts of patients with hypertrophic cardiomyopathy.",
      "Further research is needed to fully understand the role of MLP in cardiomyopathies and to identify potential therapeutic targets for the treatment of these diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 834,
    "user_query": "What is Tn-seq?",
    "llama-2-7b-chat-hf_response": "Tn-seq is a method for transposon sequencing that allows for the high-throughput identification and characterization of transposable elements in a genome. Transposons are mobile genetic elements that can move around the genome through a process called transposition, which involves the cut-and-paste mechanism of DNA recombination. Tn-seq is a powerful tool for understanding the evolution and function of transposons in a genome, and has been used to study a wide range of organisms, including bacteria, archaea, and eukaryotes.\nIn Tn-seq, a transposon is introduced into a host cell, where it integrates into the genome at a specific location. The transposon is then sequenced using next-generation sequencing (NGS) technologies, and the resulting data are analyzed to identify the location and characteristics of the transposon in the genome. Tn-seq can be used to identify both active and inactive transposons, as well as to study the dynamics of transposon movement and integration in the genome over time.\nTn-seq has several advantages over other methods for studying transposons, including:\n1. High resolution: Tn-seq allows for the precise identification of transposon insertion sites in the genome, which can be difficult to determine using other methods.\n2. Sensitivity: Tn-seq can detect low-abundance transposons that may be missed by other methods.\n3. Speed: Tn-seq can be performed quickly and efficiently using NGS technologies, allowing for high-throughput analysis of transposons in a genome.\n4. Flexibility: Tn-seq can be used to study a wide range of organisms, including bacteria, archaea, and eukaryotes.\nIn summary, Tn-seq is a powerful tool for understanding the evolution and function of transposons in a genome, and has the advantages of high resolution, sensitivity, speed, and flexibility.",
    "llama-2-7b-chat-hf_fact": [
      "Tn-seq is a method for transposon sequencing that enables the identification and characterization of transposable elements in a genome.",
      "Transposons are mobile genetic elements able to move around the genome using a process called transposition.",
      "In Tn-seq, a transposon is introduced into a host cell and then sequenced using next-generation sequencing (NGS) technologies to identify its location and characteristics in the genome.",
      "Tn-seq has been used to study a variety of organisms, including bacteria, archaea, and eukaryotes.",
      "Tn-seq process includes the precise identification of transposon insertion sites in the genome, detection of low-abundance transposons, high-throughput analysis using NGS technologies, and a wide range of studied organisms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Tn-seq is a method for transposon sequencing that enables the identification of essential genes in a genome, not the transposable elements themselves.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 836,
    "user_query": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?",
    "llama-2-7b-chat-hf_response": "Flaviviridae viral RNA-dependent RNA polymerase (RdRp) and viral helicase are two essential enzymes involved in the replication of Flaviviridae viruses, such as dengue, yellow fever, and Zika viruses. While these enzymes have been studied individually, there is limited information on their functional association during viral replication. In this study, we investigated the interaction between Flaviviridae viral RdRp and helicase and their functional association during viral replication.\nOur results show that Flaviviridae viral RdRp and helicase interact in a complex manner, with the RdRp promoting the unwinding of the viral RNA genome and the helicase facilitating the synthesis of complementary RNA (cRNA) by the RdRp. We also found that the interaction between the RdRp and helicase is essential for the efficient replication of Flaviviridae viruses.\nOur findings provide new insights into the mechanisms of Flaviviridae virus replication and suggest that the interaction between the RdRp and helicase plays a crucial role in the efficient replication of these viruses. Understanding the functional association between these enzymes may provide new targets for the development of antiviral drugs.",
    "llama-2-7b-chat-hf_fact": [
      "Flaviviridae viral RNA-dependent RNA polymerase and viral helicase are essential enzymes involved in the replication of Flaviviridae viruses.",
      "The Flaviviridae viral RNA-dependent RNA polymerase promotes the unwinding of the viral RNA genome.",
      "Viral helicase facilitates the synthesis of complementary RNA by the Flaviviridae viral RNA-dependent RNA polymerase.",
      "The interaction between the Flaviviridae viral RNA-dependent RNA polymerase and helicase is essential for the efficient replication of Flaviviridae viruses.",
      "Understanding the functional association between viral RNA-dependent RNA polymerase and helicase may provide new targets for the development of antiviral drugs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: It's the viral helicase that promotes the unwinding of the viral RNA genome, not the Flaviviridae viral RNA-dependent RNA polymerase.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 838,
    "user_query": "Which is the prevalence of cystic fibrosis in the human population?",
    "llama-2-7b-chat-hf_response": "Cystic fibrosis (CF) is a genetic disorder that affects approximately 30,000 people in the United States and 70,000 people worldwide. It is estimated that 1 in 29 people of Caucasian descent are carriers of the CF gene, which means they have one copy of the mutated gene and are at risk of passing it on to their offspring. The prevalence of CF varies among different ethnic groups, with higher rates found in Caucasians and Ashkenazi Jews.",
    "llama-2-7b-chat-hf_fact": [
      "Cystic fibrosis is a genetic disorder.",
      "Approximately 30,000 people in the United States and 70,000 people worldwide are affected by cystic fibrosis.",
      "It is estimated that 1 in 29 people of Caucasian descent are carriers of the CF gene.",
      "Carriers of the CF gene have one copy of the mutated gene and are at risk of passing it on to their offspring.",
      "The prevalence of cystic fibrosis varies among different ethnic groups, with higher rates found in Caucasians and Ashkenazi Jews."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 844,
    "user_query": "Is there a genome-wide technique for the detection of R-loop formation?",
    "llama-2-7b-chat-hf_response": "R-loops are a type of non-coding RNA structure that can form in the genome and have been implicated in a variety of cellular processes and diseases. However, there is currently no widely accepted genome-wide technique for the detection of R-loop formation.\nOne approach that has been proposed is the use of RNA sequencing (RNA-seq) data to identify regions of the genome that are enriched for R-loop-forming sequences. This can be done by comparing the RNA-seq data to a reference genome and identifying regions with a high density of R-loop-forming sequences.\nAnother approach is the use of chromatin immunoprecipitation sequencing (ChIP-seq) data to identify regions of the genome that are bound by R-loop-forming proteins. This can be done by comparing the ChIP-seq data to a reference genome and identifying regions with a high density of R-loop-forming protein binding sites.\nOther techniques that have been proposed for the detection of R-loop formation include:\n1. Combining RNA-seq and ChIP-seq data to identify regions of the genome that are both enriched for R-loop-forming sequences and bound by R-loop-forming proteins.\n2. Using computational methods to predict the presence of R-loops in the genome based on the structure of the RNA molecule and the binding affinity of R-loop-forming proteins to the RNA.\n3. Using high-throughput sequencing technologies, such as single-molecule real-time sequencing, to directly detect R-loops in the genome.\n4. Using fluorescence in situ hybridization (FISH) to visualize R-loops in the nucleus of cells.\n5. Using chromatin conformation capture (3C) to identify regions of the genome that are in close proximity to each other and therefore likely to form R-loops.\nIt is important to note that these techniques are still in the early stages of development and more research is needed to validate their accuracy and specificity.",
    "llama-2-7b-chat-hf_fact": [
      "R-loops are a type of non-coding RNA structure that can form in the genome.",
      "R-loops have been implicated in a variety of cellular processes and diseases.",
      "Two proposed methods for detecting R-loop formation are through RNA sequencing data and chromatin immunoprecipitation sequencing data.",
      "One proposed approach to detect R-loops combines RNA-seq and ChIP-seq data to identify regions of the genome both enriched for R-loop-forming sequences and bound by R-loop-forming proteins.",
      "Use of high-throughput sequencing technologies, such as single-molecule real-time sequencing, has been proposed for direct detection of R-loops in the genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 847,
    "user_query": "Is transcription-associated mutagenesis (TAM) related to gene expression levels?",
    "llama-2-7b-chat-hf_response": "Transcription-associated mutagenesis (TAM) is a mechanism of mutation that occurs during DNA replication, in which mutations are introduced into the genome through the error-prone process of transcription. TAM can result in a wide range of mutations, including point mutations, insertions, deletions, and chromosomal rearrangements.\nThere is evidence to suggest that TAM is related to gene expression levels. Studies have shown that genes with high expression levels are more likely to be mutated through TAM than genes with low expression levels. This is thought to be due to the fact that high-expression genes are more error-prone during transcription, as they are more frequently transcribed and replicated.\nAdditionally, TAM has been shown to be more frequent in genes that are involved in cellular processes that are critical for the survival and proliferation of the cell. For example, genes involved in DNA repair and cell cycle regulation are more frequently mutated through TAM than genes involved in non-essential cellular processes.\nOverall, while the relationship between TAM and gene expression levels is complex and not fully understood, there is evidence to suggest that TAM is more frequent in genes with high expression levels and those involved in critical cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Transcription-associated mutagenesis (TAM) is a mechanism of mutation that occurs during DNA replication.",
      "TAM can result in various types of mutations, including point mutations, insertions, deletions, and chromosomal rearrangements.",
      "Studies suggest that genes with high expression levels are more likely to be mutated through TAM than low-expression genes.",
      "TAM is more common in genes involved in cellular processes vital for cell survival and proliferation.",
      "High-expression genes are more frequently transcribed and replicated, making them more prone to errors and therefore mutations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Transcription-associated mutagenesis (TAM) is a mechanism of mutation that occurs during DNA transcription, not replication.",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 848,
    "user_query": "Is there a pharmacogenetic test for trastuzumab?",
    "llama-2-7b-chat-hf_response": "Trastuzumab (Herceptin) is a targeted therapy used to treat HER2-positive breast cancer. However, not all patients respond to trastuzumab, and some may experience adverse effects. Pharmacogenetic testing can help identify patients who are more likely to benefit from trastuzumab or who may be at increased risk of adverse effects.\nSeveral pharmacogenetic tests are available for trastuzumab, including:\n1. HER2 status: HER2 status is a key predictor of trastuzumab response. Patients with HER2-positive breast cancer are more likely to benefit from trastuzumab.\n2. KRAS mutation status: KRAS mutations can predict resistance to trastuzumab. Patients with KRAS mutations may not benefit from trastuzumab.\n3. PIK3CA mutation status: PIK3CA mutations can predict resistance to trastuzumab. Patients with PIK3CA mutations may not benefit from trastuzumab.\n4. PTEN mutation status: PTEN mutations can predict resistance to trastuzumab. Patients with PTEN mutations may not benefit from trastuzumab.\n5. mTOR pathway mutation status: mTOR pathway mutations can predict resistance to trastuzumab. Patients with mTOR pathway mutations may not benefit from trastuzumab.\n6. ESR1 mutation status: ESR1 mutations can predict resistance to trastuzumab. Patients with ESR1 mutations may not benefit from trastuzumab.\n7. ESR2 mutation status: ESR2 mutations can predict resistance to trastuzumab. Patients with ESR2 mutations may not benefit from trastuzumab.\n8. CDK4/6 mutation status: CDK4/6 mutations can predict resistance to trastuzumab. Patients with CDK4/6 mutations may not benefit from trastuzumab.\n9. MAP3K5 mutation status: MAP3K5 mutations can predict resistance to trastuzumab. Patients with MAP3K5 mutations may not benefit",
    "llama-2-7b-chat-hf_fact": [
      "Trastuzumab (Herceptin) is a targeted therapy used to treat HER2-positive breast cancer.",
      "Pharmacogenetic testing can identify patients who are more likely to benefit from trastuzumab or those at increased risk of adverse effects.",
      "HER2 status is a key predictor of trastuzumab response.",
      "KRAS mutations can predict resistance to trastuzumab.",
      "PIK3CA mutations can predict resistance to trastuzumab."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: HER2 mutations, not KRAS mutations, can predict resistance to trastuzumab.",
      "true"
    ]
  },
  {
    "id": 849,
    "user_query": "Which calcium channels does ethosuximide target?",
    "llama-2-7b-chat-hf_response": "Ethosuximide is a local anesthetic that targets voltage-gated calcium channels (VGCCs) in the central nervous system (CNS). Specifically, it blocks the activity of L-type (CaV2.1 and CaV2.2) and T-type (CaV3.1) voltage-gated calcium channels, which are involved in the regulation of neuronal excitability and synaptic transmission. By blocking these channels, ethosuximide can reduce the influx of calcium ions into neurons, leading to a decrease in the excitability of neurons and a reduction in the transmission of pain signals.",
    "llama-2-7b-chat-hf_fact": [
      "Ethosuximide is a local anesthetic.",
      "Ethosuximide targets voltage-gated calcium channels (VGCCs) in the central nervous system (CNS).",
      "Ethosuximide blocks the activity of L-type (CaV2.1 and CaV2.2) and T-type (CaV3.1) voltage-gated calcium channels.",
      "L-type and T-type voltage-gated calcium channels are involved in the regulation of neuronal excitability and synaptic transmission.",
      "Blocking these channels with ethosuximide can reduce the influx of calcium ions into neurons, leading to a decrease in the excitability of neurons and a reduction in the transmission of pain signals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Ethosuximide is not a local anesthetic. It is an anticonvulsant medication used in the treatment of epilepsy.",
      "true",
      "false, [corrected fact]: Ethosuximide specifically inhibits T-type (CaV3.1) voltage-gated calcium channels, not L-type channels.",
      "true",
      "false, [corrected fact]: Blocking these channels with ethosuximide can reduce the influx of calcium ions into neurons, leading to a decrease in the excitability of neurons and a reduction in the generation and transmission of seizure activity, not pain signals."
    ]
  },
  {
    "id": 850,
    "user_query": "What is the sedimentation coefficient of the mammalian mitoribosome?",
    "llama-2-7b-chat-hf_response": "The sedimentation coefficient of a particle is a measure of how quickly it will settle out of a solution under the influence of gravity. In the case of the mammalian mitoribosome, the sedimentation coefficient is a measure of how quickly it will settle out of a solution in a centrifuge.\nThe sedimentation coefficient of the mammalian mitoribosome has been measured experimentally and is typically in the range of 10-20 S. This means that if you were to spin the mitoribosome in a centrifuge at a rate of 10,000 g, it would take about 10-20 seconds for it to settle to the bottom of the tube.\nIt's worth noting that the sedimentation coefficient of the mitoribosome can vary depending on the conditions under which it is measured. For example, the sedimentation coefficient can be affected by the concentration of the mitoribosome, the presence of other molecules in the solution, and the temperature of the solution.",
    "llama-2-7b-chat-hf_fact": [
      "The sedimentation coefficient of a particle is a measure of how fast it settles out of a solution under gravity's influence.",
      "The sedimentation coefficient of the mammalian mitoribosome is typically between 10-20 S.",
      "If a mitoribosome is spun in a centrifuge at a 10,000 g rate, it will take approximately 10-20 seconds to settle at the bottom of the tube.",
      "The sedimentation coefficient of the mitoribosome can vary depending on the conditions under which it is measured.",
      "Factors such as the concentration of the mitoribosome, the presence of other molecules in the solution, and the temperature of the solution can affect the sedimentation coefficient."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The time it takes for a mitoribosome to settle at the bottom of the tube under a 10,000 g force does not strictly correlate to its sedimentation coefficient; sedimentation time can depend on factors like the density and viscosity of the medium and the shape and density of the particle, not just its sedimentation coefficient.",
      "true",
      "true"
    ]
  },
  {
    "id": 852,
    "user_query": "Which proteins act as histone-like molecules in prokaryotes?",
    "llama-2-7b-chat-hf_response": "Histones are small, positively charged proteins that play a crucial role in regulating chromatin structure and gene expression in eukaryotic cells. However, histone-like proteins have also been identified in prokaryotes, where they perform similar functions. Here are some examples of proteins that act as histone-like molecules in prokaryotes:\n1. H-protein: H-protein is a histone-like protein found in the bacterium Bacillus subtilis. It is involved in the regulation of gene expression and chromatin structure, and is similar in structure to eukaryotic histones.\n2. LytM: LytM is a histone-like protein found in the bacterium Escherichia coli. It is involved in the regulation of gene expression and chromatin structure, and is similar in structure to eukaryotic histones.\n3. H-b: H-b is a histone-like protein found in the bacterium Streptomyces coelicolor. It is involved in the regulation of gene expression and chromatin structure, and is similar in structure to eukaryotic histones.\n4. Chromatin-associated protein (CAP): CAP is a histone-like protein found in the bacterium Pseudomonas aeruginosa. It is involved in the regulation of gene expression and chromatin structure, and is similar in structure to eukaryotic histones.\n5. Histone-like protein 1 (HLP1): HLP1 is a histone-like protein found in the bacterium Mycobacterium tuberculosis. It is involved in the regulation of gene expression and chromatin structure, and is similar in structure to eukaryotic histones.\nThese proteins play a crucial role in regulating chromatin structure and gene expression in prokaryotes, and are similar in structure to eukaryotic histones. However, it is important to note that the functions of these proteins may differ from those of eukaryotic histones, and their exact roles in prokaryotic cells are still being studied.",
    "llama-2-7b-chat-hf_fact": [
      "Histone-like proteins exist in prokaryotes and perform functions similar to those of histones in eukaryotic cells.",
      "H-protein, a histone-like protein, is found in the bacterium Bacillus subtilis.",
      "LytM, a histone-like protein, exists in the bacterium Escherichia coli.",
      "A histone-like protein, H-b, is present in Streptomyces coelicolor.",
      "CAP (Chromatin-associated protein) is a histone-like protein found in Pseudomonas aeruginosa.",
      "Mycobacterium tuberculosis comprises a histone-like protein named Histone-like protein 1 (HLP1)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 860,
    "user_query": "Is hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?",
    "llama-2-7b-chat-hf_response": "Fanconi anemia is a rare genetic disorder characterized by congenital abnormalities, bone marrow failure, and an increased risk of cancer. One of the hallmarks of Fanconi anemia is hypersensitivity to DNA crosslinking agents, such as diepoxybutane (DEB) and mitomycin C (MMC). These agents are commonly used in cancer chemotherapy, but individuals with Fanconi anemia are unable to tolerate even low doses of these drugs, leading to severe toxicity and potentially life-threatening complications. The hypersensitivity to DNA crosslinking agents is thought to result from defects in the Fanconi anemia pathway, which is a complex network of genes involved in the repair of DNA interstrand crosslinks (ICLs).",
    "llama-2-7b-chat-hf_fact": [
      "Fanconi anemia is a rare genetic disorder characterized by congenital abnormalities, bone marrow failure, and an increased risk of cancer.",
      "One of the hallmarks of Fanconi anemia is hypersensitivity to DNA crosslinking agents.",
      "Diepoxybutane (DEB) and mitomycin C (MMC) are examples of DNA crosslinking agents.",
      "Individuals with Fanconi anemia are unable to tolerate even low doses of drugs such as DEB and MMC, leading to severe toxicity and potentially life-threatening complications.",
      "The Fanconi anemia pathway is a complex network of genes involved in the repair of DNA interstrand crosslinks (ICLs)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 869,
    "user_query": "What is the pyroptotic pathway?",
    "llama-2-7b-chat-hf_response": "Pyroptosis is a type of programmed cell death that is characterized by the release of inflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor- (TNF-), and the activation of caspase-1, which processes these cytokines into their active forms. The pyroptotic pathway is activated in response to the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs), such as the nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and the inflammasome.",
    "llama-2-7b-chat-hf_fact": [
      "Pyroptosis is a type of programmed cell death.",
      "Pyroptosis involves the release of inflammatory cytokines like interleukin-1 (IL-1) and tumor necrosis factor- (TNF-).",
      "Caspase-1 is activated during pyroptosis and processes cytokines into their active forms.",
      "The pyroptotic pathway is activated by the recognition of pathogen-associated molecular patterns.",
      "Pattern recognition receptors like the nucleotide-binding oligomerization domain-like receptors and the inflammasome play a role in activating the pyroptotic pathway."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 871,
    "user_query": "What are the known families of deadenylases?",
    "llama-2-7b-chat-hf_response": "Deadenylases are a class of enzymes that play a crucial role in the regulation of gene expression by removing the poly(A) tail from messenger RNA (mRNA). There are several known families of deadenylases, including:\n1. Deadenylases of the RNA exosome complex: The RNA exosome complex is a large multi-subunit complex that degrades RNA molecules. Deadenylases are a component of this complex and are responsible for removing the poly(A) tail from mRNA.\n2. Deadenylases of the Ccr4-Not complex: The Ccr4-Not complex is a large RNA-binding complex that regulates mRNA degradation. Deadenylases are a component of this complex and are responsible for removing the poly(A) tail from mRNA.\n3. Deadenylases of the RNA-induced silencing complex (RISC): The RNA-induced silencing complex (RISC) is a complex that regulates gene expression by degrading specific mRNAs. Deadenylases are a component of this complex and are responsible for removing the poly(A) tail from mRNA.\n4. Deadenylases of the miRNA pathway: MicroRNAs (miRNAs) are small RNAs that regulate gene expression by binding to the 3' untranslated region (UTR) of target mRNAs and inducing their degradation. Deadenylases are involved in the miRNA pathway and are responsible for removing the poly(A) tail from the 3' UTR of target mRNAs.\n5. Deadenylases of the UPF1 complex: The UPF1 complex is a complex that regulates mRNA degradation by removing the poly(A) tail from mRNA. Deadenylases are a component of this complex and are responsible for removing the poly(A) tail from mRNA.\n6. Deadenylases of the Nrd1-Nab3 complex: The Nrd1-Nab3 complex is a complex that regulates mRNA degradation by removing the poly(A) tail from mRNA. Deadenylases are a component of this complex and are responsible for removing",
    "llama-2-7b-chat-hf_fact": [
      "Deadenylases are enzymes that regulate gene expression by removing the poly(A) tail from messenger RNA (mRNA).",
      "The RNA exosome complex is known to have deadenylases.",
      "The Ccr4-Not complex contains deadenylases.",
      "Deadenylases are a component of the RNA-induced silencing complex (RISC).",
      "Deadenylases are involved in the miRNA pathway.",
      "The UPF1 complex and the Nrd1-Nab3 complex are known to have deadenylases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The RNA exosome complex does not have deadenylase activity but it is involved in the degradation of mRNA.",
      "true",
      "false, [corrected fact]: Deadenylases are not a component of the RNA-induced silencing complex (RISC), but other enzymes in RISC can further degrade the mRNA after deadenylation.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 872,
    "user_query": "Which translocation is harbored in the Askin tumor cells?",
    "llama-2-7b-chat-hf_response": "Askin tumor cells are a type of acute myeloid leukemia (AML) that are characterized by a specific genetic translocation, t(8;22)(q24;q11). This translocation results in the fusion of the AML1 gene on chromosome 8 to the ETO gene on chromosome 22, leading to the expression of a chimeric AML1-ETO protein. The AML1-ETO protein is a constitutively active transcription factor that promotes the proliferation and survival of Askin tumor cells.\nAnswer: t(8;22)(q24;q11)",
    "llama-2-7b-chat-hf_fact": [
      "Askin tumor cells are a type of acute myeloid leukemia (AML).",
      "Askin tumor cells are characterized by a specific genetic translocation, t(8;22)(q24;q11).",
      "This translocation leads to the fusion of the AML1 gene on chromosome 8 to the ETO gene on chromosome 22.",
      "The result of this fusion is the expression of a chimeric AML1-ETO protein.",
      "The AML1-ETO protein is a constitutively active transcription factor that promotes the proliferation and survival of Askin tumor cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Askin tumor cells are a type of primitive neuroectodermal tumor.",
      "unknown",
      "false, [corrected fact]: This translocation leads to the fusion of the AML1 gene on chromosome 21 to the ETO gene on chromosome 8.",
      "true",
      "true"
    ]
  },
  {
    "id": 875,
    "user_query": "Which R/bioconductor package utilizes the Hilbert curve in order to visualize genomic data?",
    "llama-2-7b-chat-hf_response": "The package \"Hilbert\" in R/Bioconductor utilizes the Hilbert curve in order to visualize genomic data. The Hilbert curve is a mathematical structure that can be used to represent high-dimensional data in a lower-dimensional space. In the context of genomic data, the Hilbert curve can be used to visualize the relationships between different genomic features, such as gene expression levels or DNA methylation patterns.\nThe \"Hilbert\" package in R/Bioconductor provides a variety of functions for working with the Hilbert curve, including functions for computing the Hilbert curve itself, visualizing the curve, and performing statistical analysis on the data represented by the curve. Some of the key functions in the package include:\n* \"hilbert\": This function computes the Hilbert curve for a given dataset.\n* \"hilbertPlot\": This function visualizes the Hilbert curve for a given dataset.\n* \"hilbertScore\": This function computes the Hilbert score for a given dataset, which is a measure of the complexity of the data represented by the Hilbert curve.\n* \"hilbertClust\": This function performs clustering analysis on the data represented by the Hilbert curve.\nOverall, the \"Hilbert\" package in R/Bioconductor provides a powerful tool for visualizing and analyzing high-dimensional genomic data using the Hilbert curve.",
    "llama-2-7b-chat-hf_fact": [
      "The \"Hilbert\" package in R/Bioconductor uses the Hilbert curve for visualizing genomic data.",
      "The Hilbert curve is a structure that represents high-dimensional data in a lower-dimensional space.",
      "In the \"Hilbert\" package, the function \"hilbert\" computes the Hilbert curve for a dataset.",
      "The function \"hilbertPlot\" in the \"Hilbert\" package visualizes the Hilbert curve for a dataset.",
      "The \"hilbertScore\" function in the \"Hilbert\" package computes the complexity of the data represented by the Hilbert curve."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 876,
    "user_query": "Can fetal aneuploidy be detected with non-invasive prenatal testing?",
    "llama-2-7b-chat-hf_response": "Fetal aneuploidy refers to a condition where a fetus has an abnormal number of chromosomes, typically resulting in developmental delays, intellectual disability, and other health problems. Non-invasive prenatal testing (NIPT) is a type of prenatal test that can detect certain genetic conditions, including aneuploidy, by analyzing the DNA present in a pregnant woman's blood.\nThe accuracy of NIPT for detecting fetal aneuploidy varies depending on several factors, including the type of aneuploidy being tested for, the stage of pregnancy, and the quality of the DNA sample. In general, NIPT can detect trisomy 21 (Down syndrome), trisomy 13 (Patau syndrome), and trisomy 18 (Edwards syndrome) with a high degree of accuracy. However, the detection rate for other types of aneuploidy, such as Turner syndrome (monosomy X) and Klinefelter syndrome (XXY), is generally lower.\nIt is important to note that NIPT is not 100% accurate, and false positives or false negatives can occur. If NIPT indicates a higher risk of aneuploidy, further testing, such as chorionic villus sampling (CVS) or amniocentesis, may be recommended to confirm the diagnosis.\nIn summary, while NIPT can detect fetal aneuploidy with a high degree of accuracy for certain types of aneuploidy, it is not 100% accurate and may not detect all types of aneuploidy. Further testing may be necessary to confirm the diagnosis.",
    "llama-2-7b-chat-hf_fact": [
      "Fetal aneuploidy is a condition where a fetus has an abnormal number of chromosomes.",
      "Non-invasive prenatal testing (NIPT) is a technique that can detect certain genetic conditions, including aneuploidy, through the analysis of DNA in a pregnant woman's blood.",
      "The accuracy of NIPT varies depending on several factors, including the type of aneuploidy being tested for, the stage of pregnancy and the quality of the DNA sample.",
      "NIPT can detect trisomy 21 (Down syndrome), trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome) with a high degree of accuracy.",
      "If NIPT indicates a higher risk of aneuploidy, further testing, such as chorionic villus sampling (CVS) or amniocentesis, may be recommended to confirm the diagnosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 877,
    "user_query": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?",
    "llama-2-7b-chat-hf_response": "Overlap analysis is a common task in bioinformatics that involves identifying regions of overlap between two or more genomic sequences. In R/Bioconductor, there are several packages that can be used for performing overlap analysis. Here are some of the commonly used packages:\n1. overlap: This package provides functions for performing overlap analysis of genomic regions. It can be used to identify overlapping regions between two or more genomic sequences, and to calculate statistics such as the number of overlapping nucleotides, the length of the overlapping regions, and the GC content of the overlapping regions.\n2. bedtools: This package provides a comprehensive set of tools for working with genomic data in R/Bioconductor. It includes functions for performing overlap analysis, such as bedtools intersect and bedtools union. These functions can be used to identify overlapping regions between two or more genomic sequences, and to calculate statistics such as the number of overlapping nucleotides, the length of the overlapping regions, and the GC content of the overlapping regions.\n3. genomicRanges: This package provides functions for working with genomic ranges in R/Bioconductor. It includes functions for performing overlap analysis, such as genomicRanges::overlap, which can be used to identify overlapping regions between two or more genomic sequences, and to calculate statistics such as the number of overlapping nucleotides, the length of the overlapping regions, and the GC content of the overlapping regions.\n4. GenomicFeatures: This package provides functions for working with genomic features in R/Bioconductor. It includes functions for performing overlap analysis, such as GenomicFeatures::overlap, which can be used to identify overlapping regions between two or more genomic sequences, and to calculate statistics such as the number of overlapping nucleotides, the length of the overlapping regions, and the GC content of the overlapping regions.\n5. GenomicAlignments: This package provides functions for working with genomic alignments in R/Bioconductor. It includes functions for performing overlap analysis, such as GenomicAlignments::overlap, which can be used to identify overlapping regions between two or more genomic sequences, and to calculate statistics such as the number of overlapping nucle",
    "llama-2-7b-chat-hf_fact": [
      "Overlap analysis in bioinformatics refers to the process of identifying regions of overlap between two or more genomic sequences.",
      "In R/Bioconductor, multiple packages are available for performing overlap analysis.",
      "The 'overlap' package in R/Bioconductor can be used to perform overlap analysis and calculate various metrics related to the overlapping genomic regions.",
      "The 'bedtools' package provides tools for working with genomic data, including functions for performing overlap analysis.",
      "The 'genomicRanges,' 'GenomicFeatures,' and 'GenomicAlignments' packages also provide functions for conducting overlap analysis in R/Bioconductor."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There is no specific 'overlap' package in R/Bioconductor designed for performing overlap analysis. The functionality for overlap analysis is typically found in packages like 'genomicRanges,' 'GenomicFeatures,' and 'GenomicAlignments.'",
      "true",
      "true"
    ]
  },
  {
    "id": 878,
    "user_query": "Is dichlorphenamide effective for periodic paralysis?",
    "llama-2-7b-chat-hf_response": "Dichlorphenamide is a medication that has been shown to be effective in reducing the frequency and severity of episodes of periodic paralysis in some people. Periodic paralysis is a rare genetic disorder that causes episodes of muscle weakness or paralysis, usually occurring at regular intervals.\nDichlorphenamide works by increasing the amount of potassium ions in the muscle cells, which helps to regulate the abnormal electrical activity that occurs in people with periodic paralysis. By increasing the amount of potassium ions, dichlorphenamide can help to reduce the frequency and severity of muscle weakness or paralysis episodes.\nStudies have shown that dichlorphenamide can significantly reduce the frequency and severity of episodes of periodic paralysis in people with the disorder. For example, a study published in the journal Neurology found that 70% of people with periodic paralysis who took dichlorphenamide experienced a significant reduction in the frequency and severity of their episodes, compared to 20% of those who did not take the medication.\nHowever, it's important to note that dichlorphenamide is not a cure for periodic paralysis, and it may not completely eliminate all episodes of muscle weakness or paralysis. Additionally, the medication can have side effects, such as nausea, vomiting, and diarrhea, so it's important to discuss the potential benefits and risks with a healthcare provider before starting treatment.\nIn summary, dichlorphenamide is a medication that has been shown to be effective in reducing the frequency and severity of episodes of periodic paralysis in some people. However, it's important to discuss the potential benefits and risks with a healthcare provider before starting treatment, and to continue monitoring for any changes in symptoms or side effects.",
    "llama-2-7b-chat-hf_fact": [
      "Dichlorphenamide is a medication used for periodic paralysis.",
      "Periodic paralysis is a rare genetic disorder that causes episodes of muscle weakness or paralysis.",
      "Dichlorphenamide works by increasing the amount of potassium ions in the muscle cells to regulate the abnormal electrical activity occurring in people with periodic paralysis.",
      "A study published in the journal Neurology found that 70% of people with periodic paralysis who took dichlorphenamide experienced a significant reduction in the frequency and severity of their episodes.",
      "Dichlorphenamide can have side effects, such as nausea, vomiting, and diarrhea."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Dichlorphenamide works by changing the activity in nerve cells to decrease the amount of potassium in the body, helping ease symptoms of periodic paralysis.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 881,
    "user_query": "Which pathway is activated by ficolin-3?",
    "llama-2-7b-chat-hf_response": "Ficolin-3 activates the complement pathway by binding to mannose-rich carbohydrates on the surface of pathogens, leading to the formation of a complement complex that can activate the complement cascade.\n1. Classical pathway\n2. Lectin pathway\n3. Alternative pathway\n4. Complement pathway\nAnswer: 4. Complement pathway",
    "llama-2-7b-chat-hf_fact": [
      "Ficolin-3 activates the complement pathway.",
      "Ficolin-3 binds to mannose-rich carbohydrates on the surface of pathogens.",
      "The binding of Ficolin-3 to carbohydrates leads to the formation of a complement complex.",
      "The complement complex can activate the complement cascade."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-7b-chat-hf_response": "There are several technologies available for the enrichment of phosphorylated peptides for global quantitative phosphoproteomic analyses. Some of the preferred technologies include:\n1. TiO2-based enrichment: This method uses titanium dioxide (TiO2) to selectively bind phosphorylated peptides based on their charge and hydrophilicity. The bound peptides are then eluted and analyzed by mass spectrometry.\n2. IMAC (Immobilized Metal Affinity Chromatography): This method uses metal ions (e.g. copper or nickel) immobilized on a resin to selectively bind phosphorylated peptides. The bound peptides are then eluted and analyzed by mass spectrometry.\n3. Cation exchange (CE) chromatography: This method uses a cation exchange resin to selectively bind phosphorylated peptides based on their charge. The bound peptides are then eluted and analyzed by mass spectrometry.\n4. Hydrophilic interaction liquid chromatography (HILIC): This method uses a hydrophilic resin to selectively bind phosphorylated peptides based on their hydrophilicity. The bound peptides are then eluted and analyzed by mass spectrometry.\n5. Strong cation exchange (SCX) chromatography: This method uses a strong cation exchange resin to selectively bind phosphorylated peptides based on their charge. The bound peptides are then eluted and analyzed by mass spectrometry.\n6. Reverse phase (RP) chromatography: This method uses a reverse phase resin to selectively bind phosphorylated peptides based on their hydrophobicity. The bound peptides are then eluted and analyzed by mass spectrometry.\n7. Hydrophobic interaction liquid chromatography (HILIC): This method uses a hydrophobic resin to selectively bind phosphorylated peptides based on their hydrophobicity. The bound peptides are then eluted and analyzed by mass spectrometry.\nEach of these technologies has its own advantages and disadvantages, and the choice of",
    "llama-2-7b-chat-hf_fact": [
      "TiO2-based enrichment is a technology used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses.",
      "IMAC (Immobilized Metal Affinity Chromatography) is another method used for enrichment of phosphorylated peptides.",
      "Cation exchange (CE) chromatography is a method for selectively binding phosphorylated peptides based on their charge.",
      "Hydrophilic interaction liquid chromatography (HILIC) is a method used to selectively bind phosphorylated peptides based on their hydrophilicity.",
      "Reverse phase (RP) chromatography uses a reverse phase resin to selectively bind phosphorylated peptides based on their hydrophobicity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Reverse phase (RP) chromatography uses a reverse phase resin to selectively separate peptides based on their hydrophobicity, but it's not specifically designed for the enrichment of phosphorylated peptides."
    ]
  },
  {
    "id": 884,
    "user_query": "Which histone modifications are correlated with transcription elongation?",
    "llama-2-7b-chat-hf_response": "Transcription elongation is the process by which RNA polymerase II (RNAPII) moves along the DNA template during transcription, synthesizing RNA. Histone modifications play a crucial role in regulating transcription elongation by altering the chromatin structure and recruiting transcriptional regulators. Here are some histone modifications that are correlated with transcription elongation:\n1. Histone H3 lysine 4 trimethylation (H3K4me3): H3K4me3 is a mark of active transcription and is often found at the promoter and elongating regions of actively transcribed genes. It is thought to be involved in the recruitment of RNAPII and other transcription factors.\n2. Histone H3 lysine 27 trimethylation (H3K27me3): H3K27me3 is a repressive mark that is often found at gene bodies and is associated with transcriptional silencing. However, it can also be involved in the regulation of transcription elongation by blocking the progression of RNAPII.\n3. Histone H3 lysine 79 dimethylation (H3K79me2): H3K79me2 is a mark of transcription elongation and is often found at the elongating regions of actively transcribed genes. It is thought to be involved in the recruitment of RNAPII and other transcription factors.\n4. Histone H2A lysine 5 acetylation (H2AK5ac): H2AK5ac is a mark of active transcription and is often found at the promoter and elongating regions of actively transcribed genes. It is thought to be involved in the recruitment of RNAPII and other transcription factors.\n5. Histone H3 lysine 9 acetylation (H3K9ac): H3K9ac is a mark of active transcription and is often found at the promoter and elongating regions of actively transcribed genes. It is thought to be involved in the recruitment of RNAPII and other transcription factors.\n6. Histone H3 lysine 27 acetylation (H3",
    "llama-2-7b-chat-hf_fact": [
      "Transcription elongation is the process by which RNA polymerase II moves along the DNA template during transcription, synthesizing RNA.",
      "Histone modifications are critical in regulating transcription elongation by altering the chromatin structure and recruiting transcriptional regulators.",
      "Histone H3 lysine 4 trimethylation (H3K4me3) is associated with active transcription and is often found at the promoter and elongating regions of actively transcribed genes.",
      "Histone H3 lysine 27 trimethylation (H3K27me3) is often found at gene bodies and is associated with transcriptional silencing.",
      "Histone H3 lysine 79 dimethylation (H3K79me2) is a mark of transcription elongation and is often found at the elongating regions of actively transcribed genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 885,
    "user_query": "Does  thyroid hormone receptor beta1 affect insulin secretion?",
    "llama-2-7b-chat-hf_response": "Yes, thyroid hormone receptor beta1 (TR1) has been shown to play a role in regulating insulin secretion. TR1 is a subtype of the thyroid hormone receptor, which is activated by thyroid hormones, such as triiodothyronine (T3) and thyroxine (T4).\nStudies have shown that TR1 is expressed in the pancreatic beta cells, which are responsible for insulin secretion. Activation of TR1 in these cells has been shown to increase insulin secretion and improve glucose tolerance. Conversely, inhibition of TR1 has been shown to decrease insulin secretion and impair glucose tolerance.\nOne study published in the journal Diabetes found that mice lacking TR1 had impaired insulin secretion and glucose tolerance compared to control mice. Another study published in the journal Endocrinology found that activation of TR1 in pancreatic beta cells increased insulin secretion and improved glucose tolerance in mice with type 2 diabetes.\nOverall, these studies suggest that TR1 plays an important role in regulating insulin secretion and glucose metabolism, and that dysregulation of TR1 may contribute to the development of insulin resistance and type 2 diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "Thyroid hormone receptor beta1 (TR1) plays a role in regulating insulin secretion.",
      "TR1 is activated by thyroid hormones, such as triiodothyronine (T3) and thyroxine (T4).",
      "This receptor is expressed in pancreatic beta cells, which are responsible for insulin secretion.",
      "Activation of TR1 can increase insulin secretion and improve glucose tolerance.",
      "Dysregulation of TR1 may contribute to the development of insulin resistance and type 2 diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 893,
    "user_query": "What is commotio cordis?",
    "llama-2-7b-chat-hf_response": "Commotio cordis is a rare but potentially life-threatening condition that occurs when the heart is injured as a result of a blow to the chest. It is also known as cardiac concussion or cardiac contusion.\nThe symptoms of commotio cordis can vary depending on the severity of the injury, but may include:\n* Chest pain or discomfort\n* Shortness of breath\n* Dizziness or lightheadedness\n* Fatigue or weakness\n* Palpitations or irregular heartbeat\n* Coughing up blood\nIn severe cases, commotio cordis can lead to cardiac arrest, which can be fatal if not treated promptly.\nThe exact cause of commotio cordis is not fully understood, but it is believed to occur when a blow to the chest causes the heart to stop beating for a brief period of time. This can lead to a lack of oxygen to the heart muscle, which can cause damage to the heart tissue.\nTreatment for commotio cordis typically involves supportive care, such as oxygen therapy and medication to manage symptoms. In severe cases, surgery may be necessary to repair any damage to the heart muscle.\nPrevention is key in avoiding commotio cordis, and this includes taking steps to protect the chest and heart during physical activity, such as wearing protective gear during sports and avoiding direct blows to the chest.\nIn summary, commotio cordis is a rare but potentially life-threatening condition that occurs when the heart is injured as a result of a blow to the chest. It can cause a range of symptoms, including chest pain, shortness of breath, and dizziness, and can lead to cardiac arrest in severe cases. Treatment typically involves supportive care, and prevention involves taking steps to protect the chest and heart during physical activity.",
    "llama-2-7b-chat-hf_fact": [
      "Commotio cordis is a condition that occurs when the heart is injured as a result of a blow to the chest.",
      "Symptoms of commotio cordis can include chest pain, shortness of breath, dizziness, fatigue, irregular heartbeat, and coughing up blood.",
      "The condition can lead to cardiac arrest, which could be fatal if not treated promptly.",
      "Treatment for commotio cordis typically includes supportive care like oxygen therapy, medication, and possibly surgery in severe cases.",
      "Prevention of commotio cordis involves measures to protect the chest and heart during physical activity like wearing protective gear and avoiding direct blows to the chest."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 894,
    "user_query": "What is the cause of Phthiriasis Palpebrarum?",
    "llama-2-7b-chat-hf_response": "Phthiriasis palpebrarum, also known as eye mites or Demodex blepharitis, is an inflammatory condition of the eyelids caused by Demodex mites. These microscopic mites live in the hair follicles of the eyelids and feed on the oils produced by the glands in the eyelids.\nThe symptoms of phthiriasis palpebrarum include:\n* Redness and swelling of the eyelids\n* Itching or burning sensation in the eyelids\n* Crusting or scaling of the eyelids\n* Swollen or inflamed eyelashes\n* Excessive tearing or discharge from the eyes\n* Blurred vision or sensitivity to light\nThe cause of phthiriasis palpebrarum is the infestation of Demodex mites in the eyelids. These mites feed on the oils produced by the glands in the eyelids, leading to inflammation and irritation of the eyelids. The condition can be caused by a variety of factors, including:\n* Genetics: Some people may be more prone to developing phthiriasis palpebrarum due to their genetic makeup.\n* Hormonal changes: Changes in hormone levels, such as those that occur during pregnancy or menopause, can lead to an increase in Demodex mite infestation.\n* Poor eyelid hygiene: Failure to properly clean the eyelids can lead to a buildup of bacteria and other debris, which can contribute to the development of phthiriasis palpebrarum.\n* Allergies: People with allergies may be more prone to developing phthiriasis palpebrarum due to the increased production of oils in the eyelids.\n* Systemic diseases: Certain systemic diseases, such as rosacea or blepharitis, can increase the risk of developing phthiriasis palpebrarum.\nTreatment for phthiriasis palpebrarum typically involves a combination of topical and systemic therapies, including:\n* Antipar",
    "llama-2-7b-chat-hf_fact": [
      "Phthiriasis palpebrarum is an inflammatory condition of the eyelids caused by Demodex mites.",
      "Demodex mites live in the hair follicles of the eyelids and feed on the oils produced by the glands in the eyelids.",
      "The cause of phthiriasis palpebrarum is the infestation of Demodex mites in the eyelids.",
      "Poor eyelid hygiene has the potential to contribute to the development of phthiriasis palpebrarum.",
      "Certain systemic diseases, such as rosacea or blepharitis, can increase the risk of developing phthiriasis palpebrarum."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Phthiriasis palpebrarum is an inflammatory condition of the eyelids caused by lice, not Demodex mites.",
      "true",
      "false, [corrected fact]: The cause of phthiriasis palpebrarum is the infestation of lice in the eyelids, not Demodex mites.",
      "true",
      "true"
    ]
  },
  {
    "id": 896,
    "user_query": "How are CpG island shores defined?",
    "llama-2-7b-chat-hf_response": "CpG islands are regions of the genome that are characterized by a high density of CpG dinucleotides. These regions are typically found in the promoter regions of genes and play a crucial role in the regulation of gene expression. CpG island shores are the boundaries of these regions, and they are defined as the areas where the density of CpG dinucleotides drops below a certain threshold.\nThere are different methods for defining CpG island shores, and the choice of method can depend on the specific research question and the type of data being analyzed. Some common methods include:\n1. Threshold-based definition: This method involves setting a threshold density of CpG dinucleotides below which a region is considered to be part of the CpG island shore. The threshold density can be chosen based on the average density of CpG dinucleotides in the genome or based on the density of CpG dinucleotides in the promoter regions of nearby genes.\n2. Cluster-based definition: This method involves grouping together regions of the genome that have a similar density of CpG dinucleotides. The boundaries of the CpG island shores are then defined as the edges of these clusters.\n3. Machine learning-based definition: This method involves using machine learning algorithms to identify regions of the genome that are characterized by a high density of CpG dinucleotides. The boundaries of the CpG island shores are then defined as the edges of these regions.\n4. Hybrid definition: This method involves combining two or more of the above methods to define the CpG island shores. For example, a threshold-based definition could be combined with a cluster-based definition to identify regions of the genome that are characterized by both a high density of CpG dinucleotides and a specific pattern of clustering.\nOverall, the choice of method for defining CpG island shores will depend on the specific research question and the characteristics of the data being analyzed.",
    "llama-2-7b-chat-hf_fact": [
      "CpG islands are regions of the genome characterized by a high density of CpG dinucleotides.",
      "CpG islands are typically found in the promoter regions of genes and play a crucial role in the regulation of gene expression.",
      "CpG island shores are defined as the areas where the density of CpG dinucleotides drops below a certain threshold.",
      "Different methods for defining CpG island shores include threshold-based, cluster-based, machine learning-based, and hybrid definitions.",
      "The definition of CpG island shores depends on the specific research question and the type of data being analyzed."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 898,
    "user_query": "Which gene is mutated in a subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease?",
    "llama-2-7b-chat-hf_response": "Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder that affects the heart muscle, leading to irregular heart rhythms (arrhythmias) and potentially life-threatening heart problems. There are several subtypes of ARVC, including Naxos disease, which is caused by a mutation in the TTN gene.\nThe TTN gene provides instructions for making a protein called titin, which is the largest protein in the human body and plays a crucial role in the structure and function of the heart muscle. Mutations in the TTN gene can lead to the development of Naxos disease, which is characterized by ventricular arrhythmias, heart failure, and an increased risk of sudden death.\nOther subtypes of ARVC include:\n* ARVC-1: caused by mutations in the DMD gene\n* ARVC-2: caused by mutations in the DES gene\n* ARVC-3: caused by mutations in the TNNI3 gene\n* ARVC-4: caused by mutations in the TNNT2 gene\n* ARVC-5: caused by mutations in the TTN gene\nWhich gene is mutated in Naxos disease, a subtype of ARVC?\nAnswer: TTN gene.",
    "llama-2-7b-chat-hf_fact": [
      "Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder that affects the heart muscle.",
      "Naxos disease is a subtype of ARVC caused by a mutation in the TTN gene.",
      "The TTN gene provides instructions for making titin, the largest protein in the human body which plays a crucial role in the structure and function of the heart muscle.",
      "Mutations in the TTN gene can lead to the development of Naxos disease, characterized by ventricular arrhythmias, heart failure and an increased risk of sudden death.",
      "Subtypes of ARVC include ARVC-1, ARVC-2, ARVC-3, ARVC-4 and ARVC-5 which are caused by mutations in the DMD, DES, TNNI3, TNNT2 and TTN genes, respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Naxos disease is a subtype of ARVC caused by a mutation in the JUP gene, not the TTN gene.",
      "true",
      "false, [corrected fact]: Mutations in the TTN gene can lead to different types of cardiomyopathy, not Naxos disease.",
      "false, [corrected fact]: Subtypes of ARVC include ARVC-1, ARVC-2, ARVC-3, ARVC-4 and ARVC-5 which are caused by mutations in the PKP2, DSP, DSC2, TMEM43, and DSG2 genes, respectively."
    ]
  },
  {
    "id": 899,
    "user_query": "What is the role of edaravone in traumatic brain injury?",
    "llama-2-7b-chat-hf_response": "Edaravone is a drug that has been shown to have neuroprotective effects in various conditions, including traumatic brain injury (TBI). TBI is a type of injury that occurs when the brain is subjected to a sudden and forceful impact, such as from a car accident or fall. TBI can result in a range of cognitive, emotional, and physical symptoms, including memory loss, difficulty with concentration and attention, and impaired motor function.\nEdaravone is a free radical scavenger that has been shown to reduce oxidative stress and inflammation in the brain after TBI. Oxidative stress is an imbalance between the production of free radicals and the body's ability to neutralize them, and it can lead to damage to brain cells and tissues. Inflammation is also a common response to TBI, and it can further exacerbate oxidative stress and damage to the brain.\nStudies have shown that edaravone can help to reduce the severity of TBI by:\n1. Reducing oxidative stress: Edaravone has been shown to reduce the levels of free radicals in the brain after TBI, which can help to prevent further damage to brain cells and tissues.\n2. Reducing inflammation: Edaravone has been shown to reduce the levels of pro-inflammatory cytokines in the brain after TBI, which can help to reduce inflammation and prevent further damage to the brain.\n3. Promoting neural survival: Edaravone has been shown to promote the survival of neural cells in the brain after TBI, which can help to preserve cognitive and motor function.\n4. Improving cognitive function: Edaravone has been shown to improve cognitive function in patients with TBI, including memory, attention, and executive function.\n5. Reducing symptoms of depression and anxiety: Edaravone has been shown to reduce symptoms of depression and anxiety in patients with TBI, which can help to improve overall quality of life.\nOverall, the role of edaravone in traumatic brain injury is to provide neuroprotection by reducing oxidative stress and inflammation, promoting neural survival, and improving cognitive function. While more research is needed to",
    "llama-2-7b-chat-hf_fact": [
      "Edaravone is a drug with neuroprotective effects in conditions like traumatic brain injury (TBI).",
      "Traumatic brain injury occurs when the brain is subjected to a sudden and forceful impact.",
      "Edaravone works as a free radical scavenger, reducing oxidative stress and inflammation in the brain post-TBI.",
      "Studies have demonstrated that edaravone can reduce the severity of TBI and improve cognitive function in patients.",
      "Edaravone has also been shown to reduce symptoms of depression and anxiety in patients with TBI."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 900,
    "user_query": "Are there plasma membrane receptors for thyroid hormones?",
    "llama-2-7b-chat-hf_response": "Yes, there are plasma membrane receptors for thyroid hormones. Thyroid hormones, such as triiodothyronine (T3) and thyroxine (T4), bind to specific receptors in the plasma membrane of target cells. These receptors are called thyroid hormone receptors (TRs) and are members of the nuclear receptor superfamily.\nThere are two main types of TRs: TR and TR. TR is primarily involved in the regulation of gene expression, while TR is involved in the regulation of cell growth and differentiation. Both receptors are composed of multiple domains, including an N-terminal domain, a DNA-binding domain, and a C-terminal domain.\nWhen thyroid hormones bind to their respective receptors, they trigger a cascade of intracellular signaling events that ultimately lead to changes in gene expression and cellular function. This includes the regulation of metabolism, growth, and development, as well as the maintenance of cellular homeostasis.\nDysregulation of TRs has been implicated in various diseases, including hypothyroidism, hyperthyroidism, and cancer. Therefore, understanding the structure and function of TRs is important for the development of new therapeutic strategies for the treatment of these diseases.",
    "llama-2-7b-chat-hf_fact": [
      "There are plasma membrane receptors for thyroid hormones called thyroid hormone receptors (TRs).",
      "Thyroid hormones include triiodothyronine (T3) and thyroxine (T4).",
      "TR and TR are two main types of thyroid hormone receptors (TRs) with TR primarily involved in the regulation of gene expression, and TR in cell growth and differentiation.",
      "Binding of thyroid hormones to their receptors triggers intracellular signaling events leading to changes in gene expression and cellular function.",
      "Dysregulation of thyroid hormone receptors has been implicated in various diseases, including hypothyroidism, hyperthyroidism, and cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-7b-chat-hf_response": "A) Obsessive-compulsive disorder (OCD)\nB) Attention deficit hyperactivity disorder (ADHD)\nC) Bipolar disorder\nD) Schizophrenia\nAnswer: A) Obsessive-compulsive disorder (OCD)\nExplanation: The Palmini classification is a system used to rate the severity of obsessive-compulsive disorder (OCD) symptoms. It categorizes OCD symptoms into four categories based on their severity: mild, moderate, severe, and extreme. The Palmini classification is commonly used in clinical settings to assess the severity of OCD symptoms and to monitor treatment progress.",
    "llama-2-7b-chat-hf_fact": [
      "The Palmini classification is used to rate the severity of obsessive-compulsive disorder symptoms.",
      "The Palmini classification system categorizes OCD symptoms into four severity categories: mild, moderate, severe, and extreme.",
      "The Palmini classification is commonly used in clinical settings.",
      "This classification system is used to monitor treatment progress in patients with obsessive-compulsive disorder.",
      "Obsessive-compulsive disorder (OCD) is the disorder rated by the Palmini classification."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 904,
    "user_query": "Are there any desmins present in plants?",
    "llama-2-7b-chat-hf_response": "Yes, there are desmins present in plants. Desmins are a type of actin filament-binding proteins that are found in animals, but they are also present in plants. In plants, desmins are involved in various cellular processes, including cell wall formation, cell division, and the regulation of cell growth and differentiation.\nOne of the best-studied plant desmins is the Arabidopsis thaliana desmin-like protein 1 (AtD1). AtD1 is a type of desmin that is expressed in the plasma membrane of plant cells and is involved in the regulation of cell wall formation and cell division. Other plant desmins include AtD2, AtD3, and AtD4, which are also involved in various cellular processes in Arabidopsis thaliana.\nIn addition to their role in cellular processes, desmins in plants have also been implicated in plant defense responses. For example, AtD1 has been shown to be involved in the recognition of pathogen-associated molecular patterns (PAMPs) and the activation of defense responses in Arabidopsis thaliana.\nOverall, the study of desmins in plants has revealed a complex and multifaceted role for these proteins in plant cellular processes and defense responses. Further research is needed to fully understand the functions of desmins in plants and their potential as targets for improving plant growth and defense.",
    "llama-2-7b-chat-hf_fact": [
      "Desmins are actin filament-binding proteins found in plants and animals.",
      "In plants, desmins are involved in cell wall formation, cell division, and the regulation of cell growth and differentiation.",
      "Arabidopsis thaliana desmin-like protein 1 (AtD1) is a type of desmin that is expressed in the plasma membrane of plant cells.",
      "AtD1 has been shown to be involved in the recognition of pathogen-associated molecular patterns and the activation of defense responses in Arabidopsis thaliana.",
      "Other plant desmins include AtD2, AtD3, and AtD4; these proteins are also involved in various cellular processes in Arabidopsis thaliana."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Desmins are intermediate filament proteins found in vertebrate muscle cells, not in plants and animals.",
      "false, [corrected fact]: The statement is incorrect as desmins are not found in plants. They are involved in maintaining the structural integrity and functioning of muscle cells in animals.",
      "false, [corrected fact]: Plants do not produce desmin proteins. Arabidopsis thaliana desmin-like protein 1 (AtD1) does not exist.",
      "false, [corrected fact]: This is incorrect because desmins are not found in plants. Thus, they cannot be involved in defense responses in Arabidopsis thaliana.",
      "false, [corrected fact]: The statement is incorrect as desmins are not found in plants, therefore proteins AtD2, AtD3, and AtD4 are not types of desmin proteins in Arabidopsis thaliana."
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-7b-chat-hf_response": "Yes, viruses have been implicated in the etiology of human subacute thyroiditis. Subacute thyroiditis is an inflammatory condition of the thyroid gland that can cause pain, swelling, and difficulty swallowing. While the exact cause of subacute thyroiditis is not fully understood, several studies have suggested that viral infections may play a role in its development.\nOne study published in the Journal of Clinical Endocrinology and Metabolism found that 75% of patients with subacute thyroiditis had evidence of viral infection in their thyroid tissue. The study used polymerase chain reaction (PCR) to detect the presence of viral DNA in thyroid tissue samples.\nAnother study published in the European Journal of Endocrinology found that subacute thyroiditis was more common in patients who had recently experienced a viral infection. The study found that 60% of patients with subacute thyroiditis had evidence of a recent viral infection, compared to 20% of patients without subacute thyroiditis.\nWhile the exact mechanisms by which viruses contribute to the development of subacute thyroiditis are not fully understood, it is thought that viruses may trigger an immune response that leads to inflammation in the thyroid gland. This inflammation can cause damage to the thyroid tissue and lead to the symptoms of subacute thyroiditis.\nIt is important to note that not all cases of subacute thyroiditis are caused by viruses, and other factors such as autoimmune disorders and certain medications can also play a role in its development. However, the evidence suggests that viruses are a common trigger for this condition, and further research is needed to fully understand the relationship between viruses and subacute thyroiditis.",
    "llama-2-7b-chat-hf_fact": [
      "Subacute thyroiditis is an inflammatory condition of the thyroid gland that can cause pain, swelling, and difficulty swallowing.",
      "Viral infections have been implicated in the etiology of human subacute thyroiditis.",
      "A study in the Journal of Clinical Endocrinology and Metabolism found evidence of viral infection in the thyroid tissue of 75% of patients with subacute thyroiditis.",
      "Another study in the European Journal of Endocrinology found subacute thyroiditis was more common in patients who had recently experienced a viral infection.",
      "Some factors contributing to the development of subacute thyroiditis can be autoimmune disorders and certain medications."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 910,
    "user_query": "Which is the receptor for substrates of Chaperone Mediated Autophagy?",
    "llama-2-7b-chat-hf_response": "Chaperone-mediated autophagy (CMA) is a process by which cells degrade and recycle damaged or dysfunctional proteins and organelles using the machinery of autophagy. The receptor for substrates of CMA is called optineurin. Optineurin is a cytosolic protein that recognizes and binds to specific target proteins and organelles, such as ubiquitinated proteins and damaged mitochondria, and mediates their degradation through the CMA pathway.",
    "llama-2-7b-chat-hf_fact": [
      "Chaperone-mediated autophagy (CMA) is a process that degrades and recycles damaged or dysfunctional proteins and organelles.",
      "The receptor for substrates of CMA is a protein called optineurin.",
      "Optineurin is a cytosolic protein.",
      "Optineurin recognizes and binds to specific target proteins and organelles, such as ubiquitinated proteins and damaged mitochondria.",
      "Optineurin mediates the degradation of these targets through the CMA pathway."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The receptor for substrates of CMA is a protein called LAMP-2A, not optineurin.",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 913,
    "user_query": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?",
    "llama-2-7b-chat-hf_response": "There are several clinical trials that have directly compared microsurgical clipping with endovascular coiling for the treatment of ruptured brain aneurysms. Here are a few examples:\n1. The International Subarachnoid Aneurysm Trial (ISAT) - This randomized controlled trial, published in 2005, compared microsurgical clipping with endovascular coiling in 227 patients with ruptured aneurysms. The study found that both treatments had similar rates of complete aneurysm obliteration at one year, but patients who underwent endovascular coiling had lower rates of vasospasm and cerebral infarction.\n2. The European Subarachnoid Aneurysm Trial (ESAT) - This randomized controlled trial, published in 2008, compared microsurgical clipping with endovascular coiling in 400 patients with ruptured aneurysms. The study found that both treatments had similar rates of complete aneurysm obliteration at one year, but patients who underwent endovascular coiling had lower rates of cerebral infarction and vasospasm.\n3. The Japanese Subarachnoid Aneurysm Trial (JSAT) - This randomized controlled trial, published in 2013, compared microsurgical clipping with endovascular coiling in 200 patients with ruptured aneurysms. The study found that both treatments had similar rates of complete aneurysm obliteration at one year, but patients who underwent endovascular coiling had lower rates of cerebral infarction and vasospasm.\n4. The International Study of Minimally Invasive Treatment for Intracranial Aneurysms (IMT-IA) - This randomized controlled trial, published in 2015, compared microsurgical clipping with endovascular coiling in 300 patients with ruptured aneurysms. The study found that both treatments had similar rates of complete aneurysm obliteration at one year, but patients who underwent endovascular coiling had lower rates of cerebral",
    "llama-2-7b-chat-hf_fact": [
      "The International Subarachnoid Aneurysm Trial (ISAT) is a randomized controlled trial that compared microsurgical clipping with endovascular coiling in patients with ruptured aneurysms.",
      "The ISAT, published in 2005, found both treatments had similar rates of complete aneurysm obliteration, but patients who underwent endovascular coiling had lower rates of vasospasm and cerebral infarction.",
      "The European Subarachnoid Aneurysm Trial (ESAT) is another randomized controlled trial, published in 2008, which also did a comparison of microsurgical clipping with endovascular coiling in patients with ruptured aneurysms.",
      "The Japanese Subarachnoid Aneurysm Trial (JSAT), which was published in 2013, compared microsurgical clipping with endovascular coiling in ruptured aneurysm patients.",
      "The International Study of Minimally Invasive Treatment for Intracranial Aneurysms (IMT-IA), a trial published in 2015, compared microsurgical clipping with endovascular coiling in patients with ruptured aneurysms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 919,
    "user_query": "Which are the mutational hotspots of the human KRAS oncogene?",
    "llama-2-7b-chat-hf_response": "KRAS (Kirsten rat sarcoma viral oncogene homolog) is a gene that encodes a protein involved in cell signaling pathways, particularly the RAS/MAPK pathway, which regulates various cellular processes such as proliferation, differentiation, and survival. Mutations in the KRAS gene are common in many types of cancer, including non-small cell lung cancer (NSCLC), colorectal cancer, and pancreatic cancer.\nMutational hotspots are specific regions of a gene where mutations occur more frequently than expected by chance. Identifying mutational hotspots in the KRAS gene can help researchers understand the mechanisms of KRAS-driven cancer and may lead to the development of targeted therapies.\nSeveral studies have identified mutational hotspots in the KRAS gene. These include:\n1. Gly12C>A: This mutation occurs in the G domain of the KRAS protein and is one of the most common KRAS mutations in NSCLC.\n2. G12V: This mutation occurs in the G domain of the KRAS protein and is also common in NSCLC.\n3. G12D: This mutation occurs in the G domain of the KRAS protein and is less common than G12C>A and G12V in NSCLC.\n4. G13D: This mutation occurs in the G domain of the KRAS protein and is less common than G12C>A, G12V, and G12D in NSCLC.\n5. G13R: This mutation occurs in the G domain of the KRAS protein and is less common than G12C>A, G12V, G12D, and G13D in NSCLC.\n6. G12A: This mutation occurs in the G domain of the KRAS protein and is less common than G12C>A, G12V, G12D, and G13D in NSCLC.\n7. G12S: This mutation occurs in the G domain of the KRAS protein and is less common than G12C>A, G12V, G12D, G13D, and",
    "llama-2-7b-chat-hf_fact": [
      "The KRAS gene encodes a protein involved in cell signaling pathways, specifically the RAS/MAPK pathway.",
      "Mutations in the KRAS gene are common in many types of cancer, such as non-small cell lung cancer (NSCLC), colorectal cancer, and pancreatic cancer.",
      "Gly12C>A is a mutation that occurs in the G domain of the KRAS protein and is one of the most common KRAS mutations in NSCLC.",
      "G12V is a mutation commonly found in NSCLC and also occurs in the G domain of the KRAS protein.",
      "G12D, G13D, G13R, G12A, and G12S are all mutations that occur in the G domain of the KRAS protein and are less common in NSCLC compared to Gly12C>A and G12V."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Gly12Cys (G12C) is a mutation that occurs in the G domain of the KRAS protein and is one of the most common KRAS mutations in NSCLC.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 921,
    "user_query": "What is the mechanism of action of ocrelizumab for treatment of multiple sclerosis?",
    "llama-2-7b-chat-hf_response": "Ocrelizumab is an anti-CD20 monoclonal antibody that selectively binds to and depletes B cells, a type of immune cell that is thought to play a role in the pathogenesis of multiple sclerosis (MS). By reducing the number of B cells in the body, ocrelizumab can help to reduce the autoimmune response that occurs in MS, which is characterized by the immune system attacking the protective covering of nerve fibers in the central nervous system (CNS).",
    "llama-2-7b-chat-hf_fact": [
      "Ocrelizumab is an anti-CD20 monoclonal antibody.",
      "Ocrelizumab binds to and depletes B cells.",
      "B cells are thought to play a role in the pathogenesis of multiple sclerosis.",
      "Ocrelizumab reduces the autoimmune response in MS by reducing the number of B cells.",
      "The autoimmune response in multiple sclerosis is characterized by the immune system attacking the protective covering of nerve fibers in the central nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 933,
    "user_query": "Are patients with marfan syndrome at increased risk of arrhythmias?",
    "llama-2-7b-chat-hf_response": "Marfan syndrome is a genetic disorder that affects the body's connective tissue, which provides support and structure to various organs and tissues throughout the body, including the heart. While the exact prevalence of arrhythmias in patients with Marfan syndrome is not well established, several studies suggest that these patients are at increased risk of developing cardiac arrhythmias, particularly tachycardias and long QT syndrome.\nOne study published in the Journal of the American College of Cardiology found that patients with Marfan syndrome had a higher prevalence of cardiac arrhythmias compared to the general population, with a mean prevalence of 37% versus 10%, respectively. Another study published in the European Heart Journal found that patients with Marfan syndrome had a higher risk of developing tachycardias and long QT syndrome compared to the general population, with a mean prevalence of 22% versus 6%, respectively.\nThe exact mechanisms underlying the increased risk of arrhythmias in Marfan syndrome are not fully understood, but several factors are thought to contribute, including:\n1. Genetic mutations: Marfan syndrome is caused by mutations in the FBN1 gene, which encodes the protein fibrillin-1. These mutations can disrupt the normal structure and function of the heart, leading to an increased risk of arrhythmias.\n2. Cardiac chamber abnormalities: Patients with Marfan syndrome often have abnormalities in the size and shape of their cardiac chambers, which can affect the electrical activity of the heart and increase the risk of arrhythmias.\n3. Abnormal ion channel function: Some patients with Marfan syndrome may have abnormal function of ion channels, which can affect the normal electrical activity of the heart and increase the risk of arrhythmias.\n4. Increased autonomic nervous system activity: Patients with Marfan syndrome may have increased activity of the autonomic nervous system, which can affect the normal electrical activity of the heart and increase the risk of arrhythmias.\n5. Other comorbidities: Patients with Marfan syndrome may have other comorbidities, such as hypertension, diabetes, and sleep apnea, which",
    "llama-2-7b-chat-hf_fact": [
      "Marfan syndrome is a genetic disorder that affects the body's connective tissue, influencing various organs throughout the body, including the heart.",
      "Patients with Marfan syndrome are at an increased risk of developing cardiac arrhythmias.",
      "Marfan syndrome is caused by mutations in the FBN1 gene which can disrupt the normal structure and function of the heart.",
      "Patients with Marfan syndrome often have abnormalities in the size and shape of their cardiac chambers.",
      "Some patients with Marfan syndrome have increased activity of the autonomic nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 935,
    "user_query": "List Kartagener Syndrome Triad.",
    "llama-2-7b-chat-hf_response": "Kartagener Syndrome is a rare genetic disorder that affects the body's ability to absorb fats and fat-soluble vitamins. It is characterized by three main symptoms:\n1. Intestinal malabsorption: The small intestine is unable to properly absorb fats, leading to diarrhea, abdominal pain, and weight loss.\n2. Vitamin deficiencies: The body's inability to absorb fat-soluble vitamins, such as vitamins A, D, E, and K, can lead to deficiencies that can cause a range of health problems.\n3. Eye problems: Kartagener Syndrome can cause a range of eye problems, including dry eyes, blurred vision, and increased sensitivity to light.\nThe symptoms of Kartagener Syndrome can vary in severity and may include:\n* Diarrhea\n* Abdominal pain\n* Weight loss\n* Fatigue\n* Vitamin deficiencies\n* Dry eyes\n* Blurred vision\n* Increased sensitivity to light\n* Poor wound healing\n* Increased risk of infections\nKartagener Syndrome is caused by mutations in the gene that codes for a protein involved in the transport of fats and fat-soluble vitamins across the cell membrane in the small intestine. The disorder is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene, one from each parent, to develop the condition.\nThere is no cure for Kartagener Syndrome, but treatment can help manage the symptoms. This may include dietary changes, vitamin supplements, and medications to manage diarrhea and other gastrointestinal symptoms. In some cases, surgery may be necessary to repair any structural problems in the small intestine.",
    "llama-2-7b-chat-hf_fact": [
      "Kartagener Syndrome is a rare genetic disorder that impacts the body's ability to absorb fats and fat-soluble vitamins.",
      "The condition is characterized by intestinal malabsorption, leading to symptoms like diarrhea, abdominal pain, and weight loss.",
      "Kartagener Syndrome can cause deficiencies in fat-soluble vitamins such as A, D, E, and K.",
      "Eye problems, including dry eyes, blurred vision, and increased sensitivity to light are symptoms of Kartagener Syndrome.",
      "Kartagener Syndrome is caused by mutations in the gene that codes for a protein responsible for transporting fats and fat-soluble vitamins across the cell membrane in the small intestine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Kartagener Syndrome is a rare genetic disorder that affects the positioning of organs in the body and causes problems with the functioning of the cilia (tiny, hair-like structures that move mucus out of the respiratory tract).",
      "false, [corrected fact]: Issues with cilia can lead to frequent infections in lungs, ears, and sinuses along with potential fertility problems and organ placement anomalies. Diarrhea and abdominal pain are not typical symptoms.",
      "false, [corrected fact]: Kartagener Syndrome is not linked with deficiencies in fat-soluble vitamins such as A, D, E, and K.",
      "unknown",
      "false, [corrected fact]: Kartagener Syndrome is caused by mutations in genes that affect the function of cilia in the body, not the process of transporting fats and fat-soluble vitamins across the cell membrane in the small intestine."
    ]
  },
  {
    "id": 936,
    "user_query": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?",
    "llama-2-7b-chat-hf_response": "The protein encoded by the gene DUX4 is associated with several diseases, including:\n1. Myotonic dystrophy type 1 (DM1): DUX4 is ectopically expressed in muscle cells in DM1, leading to muscle weakness and wasting.\n2. Myotonic dystrophy type 2 (DM2): Similar to DM1, DUX4 is ectopically expressed in muscle cells in DM2, leading to muscle weakness and wasting.\n3. Progeria (Hutchinson-Gilford progeria syndrome): DUX4 is ectopically expressed in skin and other tissues in progeria, leading to accelerated aging and a variety of symptoms.\n4. Cancer: DUX4 has been implicated in the development and progression of certain types of cancer, including breast, ovarian, and prostate cancer.\n5. Neurodegenerative diseases: DUX4 has been linked to several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).\nWhich of these diseases is associated with the ectopic expression of the protein encoded by the gene DUX4?",
    "llama-2-7b-chat-hf_fact": [
      "The protein encoded by the gene DUX4 is associated with Myotonic dystrophy type 1.",
      "Myotonic dystrophy type 2 is also associated with the ectopic expression of the DUX4 protein.",
      "Hutchinson-Gilford progeria syndrome is another disease associated with the ectopic expression of DUX4 protein.",
      "Certain types of cancer, including breast, ovarian, and prostate cancer, have been linked to the protein encoded by the gene DUX4.",
      "Several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), have been associated with the DUX4 protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The protein encoded by the gene DUX4 is associated with Facioscapulohumeral muscular dystrophy (FSHD), not Myotonic dystrophy type 1.",
      "false, [corrected fact]: Myotonic dystrophy type 2 is not associated with the ectopic expression of the DUX4 protein.",
      "false, [corrected fact]: Hutchinson-Gilford progeria syndrome is not associated with the ectopic expression of DUX4 protein.",
      "unknown",
      "false, [corrected fact]: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) have not been specifically linked to the DUX4 protein."
    ]
  },
  {
    "id": 938,
    "user_query": "Which are the main functions of the APOBEC3 family of proteins?",
    "llama-2-7b-chat-hf_response": "APOBEC3 proteins are a family of cytidine deaminases that play a crucial role in the innate immune response against retroviruses and other DNA viruses. The main functions of the APOBEC3 family of proteins are:\n1. Restriction of retroviral replication: APOBEC3 proteins can deaminate cytidine residues in viral DNA, leading to the formation of uracil residues, which can result in DNA damage and inhibition of viral replication.\n2. Induction of apoptosis: APOBEC3 proteins can also induce apoptosis (programmed cell death) in infected cells, which can limit the spread of viral infection.\n3. Activation of the immune response: APOBEC3 proteins can activate the immune response by inducing the production of interferon and other cytokines, which can activate immune cells and trigger an antiviral response.\n4. Maintenance of genome stability: APOBEC3 proteins can also play a role in maintaining genome stability by deaminating cytidine residues in non-viral DNA, preventing the formation of mutations that can lead to cancer and other diseases.\nOverall, the APOBEC3 family of proteins plays a crucial role in the innate immune response against retroviruses and other DNA viruses, and their dysregulation can contribute to the development of cancer and other diseases.",
    "llama-2-7b-chat-hf_fact": [
      "APOBEC3 proteins belong to the family of cytidine deaminases.",
      "The APOBEC3 family of proteins contributes to the innate immune response against retroviruses and other DNA viruses.",
      "APOBEC3 proteins restrict retroviral replication by deaminating cytidine residues in viral DNA, which can cause DNA damage and impede viral replication.",
      "APOBEC3 proteins can induce apoptosis in infected cells, limiting the spread of viral infection.",
      "APOBEC3 can activate the immune response by inducing the production of interferon and other cytokines."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: APOBEC3 proteins do not induce apoptosis in infected cells, but restrict viral replication by inducing hypermutation in the DNA of viruses.",
      "false, [corrected fact]: APOBEC3 itself does not activate the immune response by inducing the production of interferon and other cytokines. It indirectly influences immune response through its mutagenic activity on viral genomes."
    ]
  },
  {
    "id": 939,
    "user_query": "Which histone modifications are associated with constitutive heterochromatin?",
    "llama-2-7b-chat-hf_response": "Constitutive heterochromatin is a type of heterochromatin that is present in every cell of an organism and remains stable throughout the cell cycle. It is characterized by the presence of highly condensed chromatin and is typically associated with gene silencing. Several histone modifications have been associated with constitutive heterochromatin, including:\n1. Tri-methylation of lysine 9 on histone H3 (H3K9me3): This modification is a hallmark of constitutive heterochromatin and is known to be involved in the silencing of gene expression.\n2. Di-methylation of lysine 27 on histone H3 (H3K27me2): This modification is also associated with constitutive heterochromatin and is thought to play a role in the regulation of gene expression.\n3. Mono-methylation of lysine 79 on histone H3 (H3K79me1): This modification is known to be involved in the regulation of gene expression and is also associated with constitutive heterochromatin.\n4. Di-methylation of lysine 36 on histone H3 (H3K36me2): This modification is associated with constitutive heterochromatin and is thought to play a role in the regulation of gene expression.\n5. Tri-methylation of lysine 20 on histone H4 (H4K20me3): This modification is also associated with constitutive heterochromatin and is known to be involved in the regulation of gene expression.\nIt is worth noting that the specific histone modifications associated with constitutive heterochromatin can vary depending on the organism and the specific type of constitutive heterochromatin. Additionally, the levels and distribution of these modifications can also vary depending on the specific cell type and the stage of the cell cycle.",
    "llama-2-7b-chat-hf_fact": [
      "Constitutive heterochromatin is present in every cell of an organism and remains stable throughout the cell cycle.",
      "Constitutive heterochromatin is associated with gene silencing.",
      "Tri-methylation of lysine 9 on histone H3 (H3K9me3) is a hallmark of constitutive heterochromatin and is involved in gene silencing.",
      "Di-methylation of lysine 27 on histone H3 (H3K27me2) and mono-methylation of lysine 79 on histone H3 (H3K79me1) are associated with constitutive heterochromatin and play a role in regulation of gene expression.",
      "Di-methylation of lysine 36 on histone H3 (H3K36me2) and tri-methylation of lysine 20 on histone H4 (H4K20me3) are modifications associated with constitutive heterochromatin and are involved in the regulation of gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Di-methylation of lysine 27 on histone H3 (H3K27me2) is associated with facultative heterochromatin, not constitutive heterochromatin, and mono-methylation of lysine 79 on histone H3 (H3K79me1) is associated with actively transcribed genes, not constitutive heterochromatin.",
      "unknown"
    ]
  },
  {
    "id": 940,
    "user_query": "What is the main application of SWATH-MS in proteomics?",
    "llama-2-7b-chat-hf_response": "SWATH-MS is a widely used technique in proteomics for identifying and quantifying proteins in complex biological samples. The main applications of SWATH-MS in proteomics include:\n1. Quantitative proteomics: SWATH-MS can be used to quantify proteins in a sample by comparing the intensity of the fragment ions to a reference library.\n2. Identification of proteins: SWATH-MS can be used to identify proteins in a sample based on their fragmentation patterns.\n3. Characterization of post-translational modifications: SWATH-MS can be used to identify and quantify post-translational modifications (PTMs) on proteins, such as phosphorylation, glycosylation, and ubiquitination.\n4. Analysis of protein-protein interactions: SWATH-MS can be used to study protein-protein interactions by analyzing the fragmentation patterns of proteins in complexes.\n5. Biomarker discovery: SWATH-MS can be used to identify potential biomarkers for diseases by analyzing the differential expression of proteins between healthy and diseased tissues.\n6. Drug discovery: SWATH-MS can be used to identify potential drug targets by analyzing the fragmentation patterns of proteins in response to drug treatment.\n7. Cancer research: SWATH-MS can be used to study the changes in protein expression and PTMs in cancer tissues compared to normal tissues.\n8. Neuroproteomics: SWATH-MS can be used to study the changes in protein expression and PTMs in the brain in response to neurodegenerative diseases.\n9. Cardiovascular proteomics: SWATH-MS can be used to study the changes in protein expression and PTMs in the heart and blood vessels in response to cardiovascular diseases.\n10. Metabolic proteomics: SWATH-MS can be used to study the changes in protein expression and PTMs in response to metabolic disorders, such as diabetes and obesity.",
    "llama-2-7b-chat-hf_fact": [
      "SWATH-MS is used in proteomics for identifying and quantifying proteins in complex biological samples.",
      "A major application of SWATH-MS is quantifying proteins in a sample by comparing the intensity of  fragment ions to a reference library.",
      "Another application of SWATH-MS is identifying proteins based on their fragmentation patterns.",
      "SWATH-MS can also be used for the characterization of post-translational modifications on proteins like phosphorylation, glycosylation, and ubiquitination.",
      "Besides, SWATH-MS can be utilized for the analysis of protein-protein interactions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 949,
    "user_query": "Do R-loops tend to form at sites of DNA replication?",
    "llama-2-7b-chat-hf_response": "Yes, R-loops tend to form at sites of DNA replication. R-loops are formed when a single-stranded DNA template is looped back on itself to form a double-stranded structure, and they are often found at sites of DNA replication where the template strand is being synthesized. This is because the RNA polymerase enzyme that carries out DNA replication often encounters roadblocks in the form of DNA-binding proteins, which can prevent the enzyme from moving along the template strand. By forming an R-loop, the RNA polymerase enzyme can bypass these roadblocks and continue synthesizing the template strand.",
    "llama-2-7b-chat-hf_fact": [
      "R-loops tend to form at sites of DNA replication.",
      "R-loops are formed when a single-stranded DNA template is looped back on itself to form a double-stranded structure.",
      "R-loops are often found at places where the template strand is being synthesized.",
      "RNA polymerase enzyme carries out DNA replication.",
      "R-loops allow the RNA polymerase enzyme to bypass roadblocks and continue synthesizing the template strand."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: R-loops are formed when an RNA strand invades the DNA duplex and pairs with the DNA creating an RNA-DNA hybrid and a displaced single-strand DNA.",
      "true",
      "false, [corrected fact]: DNA polymerase enzyme carries out DNA replication, not RNA polymerase.",
      "unknown"
    ]
  },
  {
    "id": 951,
    "user_query": "What are the structures formed when keratin molecules come together?",
    "llama-2-7b-chat-hf_response": "Keratin is a type of protein that is found in the skin, hair, and nails of humans and many other animals. It is made up of long chains of amino acids that are twisted together to form a fibrous structure. When keratin molecules come together, they can form a variety of structures, including:\n1. Keratin filaments: These are long, thin structures that are made up of twisted keratin molecules. They are found in the skin, hair, and nails, and give these tissues their strength and elasticity.\n2. Keratin fibers: These are larger structures that are made up of many keratin filaments twisted together. They are found in the skin, hair, and nails, and give these tissues their strength and rigidity.\n3. Keratin sheets: These are flat structures that are made up of many keratin molecules arranged in a sheet-like fashion. They are found in the skin, hair, and nails, and help to give these tissues their strength and flexibility.\n4. Keratin networks: These are complex structures that are made up of many keratin filaments and fibers twisted together. They are found in the skin, hair, and nails, and help to give these tissues their strength and elasticity.\n5. Keratin-based hydrogels: These are structures that are made up of a network of keratin filaments and fibers that are cross-linked together. They are found in the skin, hair, and nails, and help to give these tissues their strength and flexibility.\n6. Keratin-based nanofibers: These are structures that are made up of a network of keratin filaments and fibers that are cross-linked together. They are found in the skin, hair, and nails, and help to give these tissues their strength and elasticity.\n7. Keratin-based nanoparticles: These are structures that are made up of a network of keratin filaments and fibers that are cross-linked together. They are found in the skin, hair, and nails, and help to give these tissues their strength and flexibility.\n8. Keratin-based biomaterials: These are structures that are made up of a network of keratin filaments and fibers that are cross-linked",
    "llama-2-7b-chat-hf_fact": [
      "Keratin is a type of protein that is found in the skin, hair, and nails of humans and many other animals.",
      "Keratin is made up of long chains of amino acids that are twisted together to form a fibrous structure.",
      "When keratin molecules come together, they can form keratin filaments, which are long, thin structures.",
      "Larger structures made up of twisted keratin filaments are known as keratin fibers.",
      "Keratin-based biomaterials are structures made up of a network of keratin filaments and fibers."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 953,
    "user_query": "Which are the main features of CREST and other ALS-linked proteins?",
    "llama-2-7b-chat-hf_response": "1. CREST (Calcium-dependent Regulator of Exocytosis and Synaptic Transmission) is a protein that plays a crucial role in regulating the release of neurotransmitters from synaptic vesicles.\n2. Other ALS-linked proteins include:\na. TDP-43 (TAR DNA-binding protein 43): a RNA-binding protein that is involved in the regulation of gene expression and is implicated in the pathogenesis of ALS.\nb. FUS (Fused in Sarcoma): a RNA-binding protein that is involved in the regulation of mRNA transport and localization, and is also implicated in the pathogenesis of ALS.\nc. TAF15 (TAR DNA-binding protein 15): a protein that is involved in the regulation of gene expression and is implicated in the pathogenesis of ALS.\nd. Progranulin: a protein that is involved in the regulation of inflammation and immune response, and is implicated in the pathogenesis of ALS.\ne. VCP (Valosin-containing protein): a protein that is involved in the regulation of protein degradation and is implicated in the pathogenesis of ALS.",
    "llama-2-7b-chat-hf_fact": [
      "CREST is a protein that plays a crucial role in regulating the release of neurotransmitters from synaptic vesicles.",
      "TDP-43 is a RNA-binding protein that is involved in the regulation of gene expression.",
      "FUS is a RNA-binding protein involved in the regulation of mRNA transport and localization.",
      "TAF15 is a protein involved in the regulation of gene expression.",
      "Progranulin is a protein involved in the regulation of inflammation and immune response.",
      "VCP is a protein involved in the regulation of protein degradation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: CREST is a protein that is associated with Calcium responses and is not directly involved with the release of neurotransmitters from synaptic vesicles.",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 955,
    "user_query": "What is the relationship between nucleosomes and exons?",
    "llama-2-7b-chat-hf_response": "Nucleosomes are the basic units of DNA packaging in eukaryotic cells, consisting of a segment of DNA wrapped around a core of eight histone proteins (two copies each of histones H2A, H2B, H3, and H4). Exons, on the other hand, are the segments of DNA that are included in the mature RNA transcript after splicing.\nThere is no direct relationship between nucleosomes and exons. Nucleosomes are involved in packaging and organizing DNA within the nucleus of eukaryotic cells, while exons are involved in the process of gene expression, specifically in the formation of mature RNA transcripts.\nHowever, it is worth noting that nucleosomes can affect the accessibility of DNA to the splicing machinery, which is responsible for removing introns (non-coding regions) and joining exons together to form mature RNA transcripts. In general, the presence of nucleosomes can make it more difficult for the splicing machinery to access the DNA, which can have implications for gene expression.\nIn summary, while there is no direct relationship between nucleosomes and exons, nucleosomes can indirectly affect the process of gene expression by influencing the accessibility of DNA to the splicing machinery.",
    "llama-2-7b-chat-hf_fact": [
      "Nucleosomes are the basic units of DNA packaging in eukaryotic cells.",
      "Nucleosomes consist of a segment of DNA wrapped around a core of eight histone proteins.",
      "Exons are the segments of DNA that are included in the mature RNA transcript after splicing.",
      "Nucleosomes can affect the accessibility of DNA to the splicing machinery.",
      "The presence of nucleosomes can make it more difficult for the splicing machinery to access the DNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 956,
    "user_query": "List programs suitable for pharmacophore modelling",
    "llama-2-7b-chat-hf_response": "Pharmacophore modeling is a computational method used to predict the 3D structure of a molecule that is responsible for its biological activity. Here are some programs suitable for pharmacophore modeling:\n1. MOE (Molecular Operating Environment): MOE is a comprehensive software package for molecular modeling and pharmacophore modeling. It provides a wide range of tools for creating, manipulating, and analyzing 3D molecular structures, as well as a variety of algorithms for pharmacophore modeling.\n2. PyMOL: PyMOL is a popular open-source molecular visualization tool that can also be used for pharmacophore modeling. It provides a range of tools for creating and manipulating 3D molecular structures, as well as a variety of algorithms for pharmacophore modeling.\n3. ChimeraX: ChimeraX is a software package for molecular modeling and pharmacophore modeling. It provides a range of tools for creating and manipulating 3D molecular structures, as well as a variety of algorithms for pharmacophore modeling.\n4. HADDOCK: HADDOCK is a software package for protein-ligand docking and pharmacophore modeling. It provides a range of tools for creating and manipulating 3D molecular structures, as well as a variety of algorithms for pharmacophore modeling.\n5. GOLD: GOLD is a software package for protein-ligand docking and pharmacophore modeling. It provides a range of tools for creating and manipulating 3D molecular structures, as well as a variety of algorithms for pharmacophore modeling.\n6. Vina: Vina is a software package for protein-ligand docking and pharmacophore modeling. It provides a range of tools for creating and manipulating 3D molecular structures, as well as a variety of algorithms for pharmacophore modeling.\n7. ZDOCK: ZDOCK is a software package for protein-ligand docking and pharmacophore modeling. It provides a range of tools for creating and manipulating 3D molecular structures, as well as a variety of algorithms for ph",
    "llama-2-7b-chat-hf_fact": [
      "Pharmacophore modeling is a computational method used to predict the 3D structure of a molecule that is responsible for its biological activity.",
      "MOE (Molecular Operating Environment) is a software package used for molecular and pharmacophore modeling.",
      "PyMOL is an open-source molecular visualization tool that can be used for pharmacophore modeling.",
      "ChimeraX is a software package used for molecular and pharmacophore modeling.",
      "HADDOCK, GOLD, Vina, and ZDOCK are all software packages used for protein-ligand docking and pharmacophore modeling."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: HADDOCK, GOLD, Vina, and ZDOCK are all software packages used for protein-ligand docking, but not necessarily for pharmacophore modeling."
    ]
  },
  {
    "id": 959,
    "user_query": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?",
    "llama-2-7b-chat-hf_response": "There are several methods for circulating tumor DNA (ctDNA) detection, including:\n1. PCR (Polymerase Chain Reaction): This is a widely used method for detecting specific DNA sequences in a sample. It involves amplifying the target DNA sequence using primers, followed by detection using various methods such as agarose gel electrophoresis or high-resolution melting analysis.\n2. NGS (Next-Generation Sequencing): This method involves sequencing millions of DNA strands in parallel, allowing for the detection of multiple mutations in a single test. NGS is highly sensitive and can detect rare mutations in ctDNA.\n3. Digital PCR (dPCR): This method involves partitioning a sample into thousands of nanoliter-sized droplets, followed by PCR amplification of the target DNA sequence. dPCR is highly sensitive and can detect low levels of ctDNA.\n4. BEAMing (beads, emulsions, amplification, and magnetics): This method involves using magnetic beads to capture and amplify ctDNA, followed by detection using PCR or NGS. BEAMing is highly sensitive and can detect rare mutations in ctDNA.\n5. MS-based methods (Mass Spectrometry): This method involves breaking down the DNA into smaller fragments and analyzing the fragments using mass spectrometry. MS-based methods can detect a wide range of mutations in ctDNA, including those that are not detectable by other methods.\n6. Hybridization-based methods: This method involves using probes to detect specific DNA sequences in a sample. Hybridization-based methods can detect a wide range of mutations in ctDNA, including those that are not detectable by other methods.\n7. Loop-mediated isothermal amplification (LAMP): This method involves using primers to amplify specific DNA sequences in a sample, followed by detection using various methods such as fluorescence or high-resolution melting analysis. LAMP is highly sensitive and can detect low levels of ctDNA.\n8. Rolling circle amplification (RCA): This method involves using a rolling circle replication mechanism to amplify specific DNA sequences in a sample, followed by detection using various methods such as fluorescence or high-resolution",
    "llama-2-7b-chat-hf_fact": [
      "Polymerase Chain Reaction (PCR) is a common method for detecting circulating tumor DNA (ctDNA).",
      "Next-Generation Sequencing (NGS) allows for the detection of multiple mutations in ctDNA in a single test.",
      "Digital PCR (dPCR) entails partitioning a sample into thousands of nanoliter-sized droplets for ctDNA detection.",
      "The BEAMing method uses magnetic beads to capture and amplify ctDNA.",
      "Mass Spectrometry (MS)-based methods can detect a wide range of mutations in ctDNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 960,
    "user_query": "Which gene is associated with Muenke syndrome?",
    "llama-2-7b-chat-hf_response": "Muenke syndrome is caused by mutations in the MAP3K5 gene. This gene provides instructions for making a protein called maternal embryonic leucine zipper kinase (MELK), which is involved in several cellular processes, including cell signaling and the regulation of gene expression. MELK plays a critical role in the development and function of the brain and nervous system, and mutations in the MAP3K5 gene can lead to the characteristic features of Muenke syndrome, including intellectual disability, seizures, and distinctive facial and skeletal abnormalities.",
    "llama-2-7b-chat-hf_fact": [
      "Muenke syndrome is caused by mutations in the MAP3K5 gene.",
      "The MAP3K5 gene provides instructions for making a protein called maternal embryonic leucine zipper kinase (MELK).",
      "MELK is involved in several cellular processes, including cell signaling and the regulation of gene expression.",
      "The MELK protein plays a critical role in the development and function of the brain and nervous system.",
      "Mutations in the MAP3K5 gene can lead to the characteristic features of Muenke syndrome, such as intellectual disability, seizures, and distinctive facial and skeletal abnormalities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Muenke syndrome is caused by mutations in the FGFR3 gene.",
      "false, [corrected fact]: The MAP3K5 gene provides instructions for making a protein involved in signal transduction, not MELK.",
      "unknown",
      "unknown",
      "false, [corrected fact]: Mutations in the FGFR3 gene can lead to the characteristic features of Muenke syndrome, such as craniosynostosis, hearing loss, and developmental delay."
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-7b-chat-hf_response": "Yes, STAT3 has been shown to be involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2 is a kinase that phosphorylates and inhibits the translation initiation factor eIF2, leading to suppression of global protein synthesis. STAT3 is a transcription factor that is activated downstream of EIF2AK2 and has been shown to play a role in the regulation of autophagy. Studies have shown that STAT3 is required for the maintenance of autophagy in response to EIF2AK2 inhibition, and that STAT3-deficient cells are more susceptible to autophagy induction upon EIF2AK2 inhibition. These findings suggest that STAT3 is involved in the EIF2AK2-dependent suppression of autophagy.",
    "llama-2-7b-chat-hf_fact": [
      "EIF2AK2 is a kinase that phosphorylates and inhibits the translation initiation factor eIF2.",
      "The action of EIF2AK2 can lead to the suppression of global protein synthesis.",
      "STAT3 is a transcription factor activated downstream of EIF2AK2.",
      "STAT3 has a role in the regulation of autophagy.",
      "Studies suggest that STAT3-deficient cells are more susceptible to autophagy induction upon EIF2AK2 inhibition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 965,
    "user_query": "What are the Topological Domains (TADs)?",
    "llama-2-7b-chat-hf_response": "Topological domains (TADs) are a crucial component of the topological data analysis (TDA) framework. TDA is a mathematical approach to analyzing and understanding the topological structure of data. TADs are used to represent the topological features of a dataset in a compact and efficient manner. In this answer, we will explore the concept of TADs, their properties, and their applications in TDA.\nWhat are Topological Domains (TADs)?\nTopological domains (TADs) are a generalization of the concept of domains in algebraic topology. In algebraic topology, a domain is a topological space that is equipped with a continuous function to a point. TADs extend this concept by allowing the function to take values in a more general topological space, called the target space.\nFormally, a TAD is a pair (X, f), where X is a topological space, and f: X  Y is a continuous function to a target space Y. The target space Y can be any topological space, but it is typically a space that is easier to analyze than the original data space.\nProperties of TADs\nTADs have several important properties that make them useful for analyzing topological features of data. Some of these properties include:\n1. Compactness: TADs are compact, meaning that they can be represented by a finite set of points. This property makes it possible to compute topological invariants, such as homotopy groups, of the TAD.\n2. Connectedness: TADs are connected, meaning that they can be traversed in a continuous manner. This property ensures that the topological features of the data are preserved in the TAD.\n3. Path-connectedness: TADs are path-connected, meaning that any two points in the TAD can be connected by a continuous path. This property ensures that the topological features of the data are preserved in the TAD.\n4. Invariance: TADs are invariant under continuous deformations of the data, meaning that small changes in the data do not affect the topological features of the TAD.\nApplications of TADs\nTADs have a wide range of applications in TDA, including:\n1. Data visualization: TADs can be used to visualize the topological structure of data in a compact and efficient manner.\n2. Feature extraction: TADs can be",
    "llama-2-7b-chat-hf_fact": [
      "Topological domains (TADs) are a component of the topological data analysis (TDA) framework.",
      "TADs are used to represent the topological features of a dataset.",
      "A TAD is a pair (X, f), where X is a topological space, and f: X  Y is a continuous function to a target space Y.",
      "TADs have properties such as compactness, connectedness, path-connectedness, and invariance.",
      "In the topological data analysis framework, TADs are applied in data visualization and feature extraction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Topological domains (TADs) are a component of the genomic structure, not the topological data analysis (TDA) framework.",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 966,
    "user_query": "What is the vibrational theory of olfaction?",
    "llama-2-7b-chat-hf_response": "The vibrational theory of olfaction proposes that odor molecules interact with olfactory receptors through vibrational modes rather than through covalent bonding. According to this theory, odor molecules vibrate at specific frequencies when they bind to olfactory receptors, which triggers a signal that is transmitted to the brain.",
    "llama-2-7b-chat-hf_fact": [
      "The vibrational theory of olfaction proposes an interaction between odor molecules and olfactory receptors through vibrational modes.",
      "This theory does not involve covalent bonding in this interaction.",
      "According to the vibrational theory, odor molecules vibrate at specific frequencies when they bind to olfactory receptors.",
      "The vibration of odor molecules triggers a signal in olfactory receptors.",
      "This signal is then transmitted to the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 971,
    "user_query": "Which deiodinases are best known to be present in brain?",
    "llama-2-7b-chat-hf_response": "Deiodinases are enzymes that play a crucial role in the regulation of thyroid hormone metabolism. There are three isoforms of deiodinases, known as type 1, type 2, and type 3, which are present in various tissues throughout the body, including the brain.\nOf these three isoforms, type 2 deiodinase (D2) is the most well-known to be present in the brain. D2 is primarily localized in the cerebral cortex, hippocampus, and cerebellum, where it plays a crucial role in regulating the activity of thyroid hormones.\nType 1 deiodinase (D1) is also present in the brain, but to a lesser extent than D2. D1 is primarily localized in the hypothalamus and pituitary gland, where it regulates the production of thyroid-stimulating hormone (TSH).\nType 3 deiodinase (D3) is the least well-studied of the three isoforms in the brain, but it has been shown to be present in certain brain regions, including the cerebral cortex and hippocampus.\nOverall, the presence of deiodinases in the brain is important for regulating the activity of thyroid hormones, which play a crucial role in various cognitive and motor functions. Dysregulation of deiodinase activity has been implicated in various neurological disorders, including cognitive impairment and mood disorders.",
    "llama-2-7b-chat-hf_fact": [
      "There are three isoforms of deiodinases: type 1, type 2, and type 3.",
      "The type 2 deiodinase (D2) is known to be present in the brain, specifically in the cerebral cortex, hippocampus, and cerebellum where it regulates the activity of thyroid hormones.",
      "The type 1 deiodinase (D1) is present in the brain, specifically in the hypothalamus and pituitary gland, regulating the production of thyroid-stimulating hormone (TSH).",
      "Type 3 deiodinase (D3) has been shown to be present in certain regions of the brain, including the cerebral cortex and hippocampus.",
      "Dysregulation of deiodinase activity has been implicated in various neurological disorders, including cognitive impairment and mood disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Type 3 deiodinase (D3) has been shown to be present in placenta and fetal tissues, its main function is to degrade thyroid hormones, not in the cerebral cortex and hippocampus.",
      "true"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-7b-chat-hf_response": "Theatre is a software tool used for genomic analysis, particularly for the analysis of next-generation sequencing (NGS) data. It was developed by the Broad Institute and is widely used in the scientific community for a variety of genomic analysis tasks. Here are some of the key uses of Theatre:\n1. Read alignment: Theatre can be used to align sequencing reads to a reference genome, allowing researchers to identify variations in the genome, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variations.\n2. Variant calling: After aligning reads to the reference genome, Theatre can be used to identify genetic variants, including SNPs, insertions, deletions, and copy number variations.\n3. Genome assembly: Theatre can be used to assemble genomes from NGS data, allowing researchers to reconstruct the complete or nearly complete genome of an organism.\n4. Transcriptome analysis: Theatre can be used to analyze RNA-seq data, allowing researchers to identify differentially expressed genes, novel transcripts, and alternative splicing events.\n5. Epigenomics analysis: Theatre can be used to analyze epigenetic data, such as DNA methylation and histone modification profiles, allowing researchers to identify regions of the genome that are differentially methylated or modified.\n6. Genome-wide association studies (GWAS): Theatre can be used to identify genetic variants associated with specific traits or diseases by analyzing genotype and phenotype data.\n7. Gene expression analysis: Theatre can be used to analyze gene expression data, allowing researchers to identify differentially expressed genes, novel transcripts, and alternative splicing events.\n8. Chromatin conformation capture (3C) analysis: Theatre can be used to analyze 3C data, allowing researchers to identify regions of the genome that are in close proximity to each other and to infer the three-dimensional structure of the genome.\n9. MethylC-seq analysis: Theatre can be used to analyze methylC-seq data, allowing researchers to identify regions of the genome that are differentially methylated.\n10. RNA structure prediction: Theatre can be used to predict the three-dimensional structure of RNA molecules, allowing research",
    "llama-2-7b-chat-hf_fact": [
      "Theatre is a software tool used for genomic analysis and is particularly good for the analysis of next-generation sequencing (NGS) data.",
      "The software was developed by the Broad Institute.",
      "One of the key uses of Theatre is read alignment, where it aligns sequencing reads to a reference genome to identify variations in the genome.",
      "Theatre can be used for variant calling to identify genetic variants like SNPs, insertions, deletions, and copy number variations after aligning reads to the reference genome.",
      "Genomes can be assembled from NGS data using Theatre."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 974,
    "user_query": "How are CRM (cis-regulatory modules) defined?",
    "llama-2-7b-chat-hf_response": "CRM (cis-regulatory modules) are defined as cis-acting DNA elements that are involved in the regulation of gene expression in response to changes in the local chromatin environment. These elements are typically located upstream of the gene they regulate and can include a variety of different types of sequences, such as enhancers, silencers, and insulators. CRMs are thought to play a key role in the regulation of cellular differentiation and development, as well as in the response to environmental stimuli.",
    "llama-2-7b-chat-hf_fact": [
      "CRM (cis-regulatory modules) are cis-acting DNA elements involved in the regulation of gene expression.",
      "CRMs respond to changes in the local chromatin environment.",
      "CRMs are typically located upstream of the gene they regulate.",
      "CRMs can include sequences such as enhancers, silencers, and insulators.",
      "CRMs play a key role in the regulation of cellular differentiation, development, and response to environmental stimuli."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 978,
    "user_query": "Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?",
    "llama-2-7b-chat-hf_response": "Treslin/TICRR (Tumor Endothelial Cell Adhesion Molecule, TECAM) is a cell adhesion molecule that is expressed on the surface of endothelial cells and plays a role in cell adhesion, migration, and signaling. Throughout the cell cycle of human cells, Treslin/TICRR interacts with several other factors to regulate various cellular processes. Here are some of the key factors that interact with Treslin/TICRR throughout the cell cycle:\n1. CD44: Treslin/TICRR interacts with CD44, a cell adhesion molecule that is involved in cell adhesion, migration, and signaling. The interaction between Treslin/TICRR and CD44 helps to regulate cell adhesion and migration during the cell cycle.\n2. p120 catenin: Treslin/TICRR interacts with p120 catenin, a cytoskeletal protein that is involved in cell adhesion and signaling. The interaction between Treslin/TICRR and p120 catenin helps to regulate cell adhesion and signaling during the cell cycle.\n3. VE-cadherin: Treslin/TICRR interacts with VE-cadherin, a cell adhesion molecule that is involved in cell adhesion and signaling in endothelial cells. The interaction between Treslin/TICRR and VE-cadherin helps to regulate cell adhesion and signaling during the cell cycle.\n4. FAK: Treslin/TICRR interacts with FAK (Focal Adhesion Kinase), a protein that is involved in cell adhesion and signaling. The interaction between Treslin/TICRR and FAK helps to regulate cell adhesion and signaling during the cell cycle.\n5. PI3K/Akt: Treslin/TICRR interacts with the PI3K/Akt signaling pathway, which is involved in cell survival, proliferation, and migration. The interaction between Treslin/TICRR and PI3K",
    "llama-2-7b-chat-hf_fact": [
      "Treslin/TICRR is a cell adhesion molecule expressed on the surface of endothelial cells and plays a role in cell adhesion, migration, and signaling.",
      "Treslin/TICRR interacts with CD44, a cell adhesion molecule, to regulate cell adhesion and migration during the cell cycle.",
      "Treslin/TICRR interacts with p120 catenin, a cytoskeletal protein, to regulate cell adhesion and signaling during the cell cycle.",
      "Treslin/TICRR interacts with VE-cadherin, a cell adhesion molecule in endothelial cells, to regulate cell adhesion and signaling during the cell cycle.",
      "Treslin/TICRR interacts with FAK (Focal Adhesion Kinase) and PI3K/Akt signaling pathway, which are involved in cell survival, proliferation, and migration."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Treslin/TICRR is not a cell adhesion molecule expressed on the surface of endothelial cells. It is a protein that plays a crucial role in DNA replication and the cell cycle.",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 981,
    "user_query": "Which medication should be administered when managing patients with suspected acute opioid overdose?",
    "llama-2-7b-chat-hf_response": "When managing patients with suspected acute opioid overdose, naloxone is the medication of choice. Naloxone is a pure opioid antagonist that can rapidly reverse opioid-induced respiratory depression and other symptoms of overdose by binding to opioid receptors and blocking the effects of opioids.\nNaloxone is available in various formulations, including injectable, auto-injector, and nasal spray. The choice of formulation depends on the severity of the overdose and the patient's ability to administer the medication. In general, naloxone should be administered as soon as possible after recognizing an overdose, and repeated doses may be needed to fully reverse the effects of the opioid.\nOther medications, such as benzodiazepines, may be used in combination with naloxone to treat opioid overdose, but they should be used with caution due to the risk of respiratory depression and other adverse effects.\nIt is important to note that naloxone has no effect on non-opioid drugs, such as alcohol or benzodiazepines, and should only be administered to patients who have ingested opioids.\nIn summary, naloxone is the medication of choice for managing patients with suspected acute opioid overdose, and it should be administered as soon as possible after recognizing an overdose.",
    "llama-2-7b-chat-hf_fact": [
      "Naloxone is the medication of choice when managing patients with suspected acute opioid overdose.",
      "Naloxone is a pure opioid antagonist that can rapidly reverse opioid-induced respiratory depression and other symptoms of overdose.",
      "Naloxone is available in various formulations, including injectable, auto-injector, and nasal spray.",
      "Other medications, such as benzodiazepines, may be used in combination with naloxone to treat opioid overdose.",
      "Naloxone has no effect on non-opioid drugs, such as alcohol or benzodiazepines."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 982,
    "user_query": "In which nuclear compartments is heterochromatin located?",
    "llama-2-7b-chat-hf_response": "Heterochromatin is located in the nucleus of eukaryotic cells in specialized compartments called nucleoli. Nucleoli are organelles found in the nucleus of eukaryotic cells that are involved in the synthesis and processing of ribosomes, which are the cellular structures responsible for protein synthesis. Heterochromatin is a type of chromatin that is characterized by its highly condensed and gene-poor nature, and it is typically found in the nucleolus of eukaryotic cells.",
    "llama-2-7b-chat-hf_fact": [
      "Heterochromatin is located in the nucleus of eukaryotic cells.",
      "Nucleoli, the compartments where heterochromatin is found, are organelles found in the nucleus of eukaryotic cells.",
      "Nucleoli are involved in the synthesis and processing of ribosomes.",
      "Ribosomes are the cellular structures responsible for protein synthesis.",
      "Heterochromatin is a type of chromatin that is characterized by its highly condensed and gene-poor nature."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Heterochromatin is found in the nucleus of eukaryotic cells and is not typically associated with nucleoli, which are indeed found in the nucleus but are not organelles.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 984,
    "user_query": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?",
    "llama-2-7b-chat-hf_response": "GG-NER is a type of nucleotide excision repair (NER) that occurs in bacteria and involves the removal of DNA damage caused by UV light. The process involves several enzymes, including:\n1. DNA glycosylase: This enzyme recognizes and removes damaged DNA bases, such as thymine dimers, which are formed when two thymine bases on opposite strands of DNA are linked together by UV light.\n2. Apurinic/apyrimidinic endonuclease: This enzyme cleaves the damaged DNA strand at the site of the damage, leaving a 3'-hydroxyl group and a 5'-phosphate group.\n3. Exonuclease: This enzyme removes the damaged DNA strand from the site of the damage, leaving a gap in the DNA molecule.\n4. DNA polymerase: This enzyme fills in the gap in the DNA molecule by adding new nucleotides to the broken strands.\n5. Ligase: This enzyme seals the gap in the DNA molecule by joining the new nucleotides to the existing strands.\n6. Helicase: This enzyme unwinds the double helix of DNA to allow the repair process to occur.\n7. Topoisomerase: This enzyme relaxes the tension in the DNA molecule caused by the repair process.\nBy working together, these enzymes are able to repair DNA damage caused by UV light and maintain the integrity of the genome.",
    "llama-2-7b-chat-hf_fact": [
      "Global genome nucleotide excision repair (GG-NER) is a type of nucleotide excision repair that involves the removal of DNA damage in bacteria.",
      "UV light can cause DNA damage that the GG-NER process targets to repair.",
      "DNA glycosylase is an enzyme that recognizes and removes damaged DNA bases in the GG-NER process.",
      "Apurinic/apyrimidinic endonuclease is an enzyme involved in the GG-NER process that cleaves the DNA strand at the site of damage.",
      "Exonuclease, DNA polymerase, ligase, helicase, and topoisomerase are enzymes involved in the GG-NER process in bacteria."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Global genome nucleotide excision repair (GG-NER) is a type of nucleotide excision repair that involves the removal of DNA damage in both prokaryotic and eukaryotic organisms, not just bacteria.",
      "true",
      "false, [corrected fact]: DNA glycosylase is an enzyme that recognizes and removes damaged DNA bases in the base excision repair (BER) process, not in the GG-NER process.",
      "true",
      "false, [corrected fact]: While these enzymes may be involved in DNA repair processes, they do not all specifically participate in the GG-NER process. Exonuclease, DNA polymerase, and ligase are involved in NER, but helicase and topoisomerase are not directly involved in the GG-NER process in bacteria."
    ]
  },
  {
    "id": 988,
    "user_query": "In which genomic regions are Alu enriched?",
    "llama-2-7b-chat-hf_response": "Alu elements are a type of retrotransposon, which are mobile genetic elements that can insert themselves into new locations within the genome. Alu elements are found throughout the human genome, but they are particularly enriched in certain genomic regions. Here are some of the regions where Alu elements are known to be enriched:\n1. Centromeres: Alu elements are enriched in the centromeric regions of chromosomes, which are the regions that contain the centromere, a specialized DNA sequence that plays a crucial role in the separation of chromosomes during cell division.\n2. Telomeres: Alu elements are also enriched in the telomeric regions of chromosomes, which are the regions that contain the telomere, a repetitive DNA sequence that helps to protect the ends of chromosomes from degradation.\n3. Gene-rich regions: Alu elements are enriched in regions of the genome that contain a high number of genes, such as the gene-rich regions on chromosomes 1, 3, 4, 6, 7, 9, and 10.\n4. Recombination hotspots: Alu elements are enriched in regions of the genome that are hotspots for recombination, which is the process by which genetic material is exchanged between homologous chromosomes during meiosis.\n5. Chromosome ends: Alu elements are also enriched in the peripheral regions of chromosomes, which are the regions that are closest to the centromere and the telomere.\n6. Non-coding regions: Alu elements are also found in non-coding regions of the genome, such as introns, intergenic regions, and the untranslated regions of mRNAs.\nIt's worth noting that while Alu elements are enriched in these regions, they are not exclusively found in these regions. Alu elements can be found throughout the genome, and their distribution can vary depending on the individual and the tissue or cell type.",
    "llama-2-7b-chat-hf_fact": [
      "Alu elements are a type of retrotransposon, which are mobile genetic elements that can insert themselves into new locations within the genome.",
      "Alu elements are present throughout the human genome, including centromeres, telomeres, gene-rich regions, recombination hotspots, chromosome ends, and non-coding regions.",
      "Alu elements are known to be enriched in the centromeric regions of chromosomes.",
      "Telomeric regions of chromosomes are also known to contain a high concentration of Alu elements.",
      "Alu elements are abundant in regions of the genome that are hotspots for recombination."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Telomeric regions of chromosomes are not known to contain a high concentration of Alu elements.",
      "true"
    ]
  },
  {
    "id": 993,
    "user_query": "Are there clinical trials using stem cells for the treatment of cardiac disease?",
    "llama-2-7b-chat-hf_response": "Stem cells have shown promise in preclinical studies for the treatment of cardiac disease, and several clinical trials are currently underway to evaluate their safety and efficacy in humans. Here are some of the ongoing clinical trials using stem cells for the treatment of cardiac disease:\n1. Stem Cells for Heart Failure (SCHF): This Phase II clinical trial is sponsored by the National Institutes of Health (NIH) and is evaluating the safety and efficacy of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with advanced heart failure. The trial is being conducted at multiple sites across the United States.\n2. Stem Cells for Ischemic Heart Disease (SCHID): This Phase II clinical trial is also sponsored by the NIH and is evaluating the safety and efficacy of autologous BM-MSCs in patients with ischemic heart disease. The trial is being conducted at multiple sites across the United States.\n3. Stem Cells for Myocardial Infarction (SCMI): This Phase II clinical trial is sponsored by the University of California, Los Angeles (UCLA) and is evaluating the safety and efficacy of autologous BM-MSCs in patients with myocardial infarction. The trial is being conducted at multiple sites across the United States.\n4. Stem Cells for Pulmonary Arterial Hypertension (SCPAH): This Phase II clinical trial is sponsored by the University of California, San Francisco (UCSF) and is evaluating the safety and efficacy of autologous BM-MSCs in patients with pulmonary arterial hypertension. The trial is being conducted at multiple sites across the United States.\n5. Stem Cells for Cardiac Amyloidosis (SCA): This Phase II clinical trial is sponsored by the University of Pennsylvania and is evaluating the safety and efficacy of autologous BM-MSCs in patients with cardiac amyloidosis. The trial is being conducted at multiple sites across the United States.\n6. Stem Cells for Heart Transplantation (SCHT): This Phase II clinical trial is sponsored by",
    "llama-2-7b-chat-hf_fact": [
      "Stem cells are being used in clinical trials for the treatment of cardiac disease.",
      "The \"Stem Cells for Heart Failure (SCHF)\" clinical trial is evaluating the use of autologous bone marrow-derived mesenchymal stem cells for advanced heart failure.",
      "The National Institutes of Health sponsors the Stem Cells for Heart Failure clinical trial.",
      "The \"Stem Cells for Myocardial Infarction (SCMI)\" clinical trial is sponsored by the University of California, Los Angeles.",
      "The \"Stem Cells for Pulmonary Arterial Hypertension (SCPAH)\" clinical trial is sponsored by the University of California, San Francisco."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 996,
    "user_query": "Has Revlimid been approved by the US Food and Drug Administration?",
    "llama-2-7b-chat-hf_response": "Yes, Revlimid (lenalidomide) has been approved by the US Food and Drug Administration (FDA) for the treatment of several types of cancer, including:\n1. Multiple Myeloma: Revlimid is approved for the treatment of patients with multiple myeloma who have received at least one prior therapy.\n2. Mantle Cell Lymphoma: Revlimid is approved for the treatment of patients with mantle cell lymphoma who have received at least one prior chemotherapy regimen.\n3. Chronic Lymphocytic Leukemia (CLL): Revlimid is approved for the treatment of patients with CLL who have received at least one prior chemotherapy regimen.\n4. Myelodysplastic Syndrome (MDS): Revlimid is approved for the treatment of patients with MDS who have received at least one prior chemotherapy regimen.\n5. Acute Myeloid Leukemia (AML): Revlimid is approved for the treatment of patients with AML who are 75 years or older, or who have other risk factors, and who have not received previous chemotherapy for their disease.\nRevlimid is also approved for the prevention of disease progression in patients with MDS or AML who have achieved a complete or partial response to previous chemotherapy.\nIt's important to note that Revlimid is a prescription drug and should only be used under the guidance and supervision of a healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "Revlimid (lenalidomide) has been approved by the US Food and Drug Administration (FDA).",
      "Revlimid is approved by the FDA for the treatment of multiple cancer types including Multiple Myeloma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML).",
      "To treat Multiple Myeloma with Revlimid, patients have to have received at least one prior therapy.",
      "Revlimid is also approved for the prevention of disease progression in patients with MDS or AML who have achieved a complete or partial response to previous chemotherapy.",
      "Revlimid is a prescription drug that should be used under the guidance and supervision of a healthcare professional."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-7b-chat-hf_response": "?\nThe Smith-Waterman algorithm has a time complexity of $O(n^2)$, where $n$ is the length of the shorter sequence. This means that as the length of the shorter sequence increases, the time complexity of the algorithm increases quadratically.\nFor example, if the shorter sequence has length 10 and the longer sequence has length 20, the time complexity of the algorithm would be $O(10^2) = O(100)$. If the shorter sequence has length 50 and the longer sequence has length 100, the time complexity of the algorithm would be $O(50^2) = O(2500)$.\nIn general, the time complexity of the Smith-Waterman algorithm is $O(n^2)$, where $n$ is the length of the shorter sequence.",
    "llama-2-7b-chat-hf_fact": [
      "The Smith-Waterman algorithm is used for the alignment of two sequences.",
      "The time complexity of the Smith-Waterman algorithm is O(n^2).",
      "In the time complexity of the Smith-Waterman algorithm, 'n' is the length of the shorter sequence.",
      "As the length of the shorter sequence increases, the time complexity of the Smith-Waterman algorithm increases quadratically.",
      "If the shorter sequence length is 10 and the longer sequence length is 20, the time complexity of the Smith-Waterman algorithm will be O(100)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: In the time complexity of the Smith-Waterman algorithm, 'n' is the length of the two sequences.",
      "true",
      "true"
    ]
  },
  {
    "id": 1003,
    "user_query": "What is Piebaldism?",
    "llama-2-7b-chat-hf_response": "Piebaldism is a rare genetic disorder that affects the development of pigmentation in the skin, hair, and eyes. It is characterized by patches of white or light-colored skin, hair, and eyes, and can occur in people of any race or ethnicity.\nPiebaldism is caused by mutations in the TYR gene, which codes for the protein tyrosinase. This protein is involved in the production of melanin, the pigment that gives color to the skin, hair, and eyes. In people with piebaldism, the mutations disrupt the normal production of melanin, leading to patches of white or light-colored skin, hair, and eyes.\nPiebaldism can occur in different forms, ranging from mild to severe. In mild cases, the patches of white skin may be small and limited to certain areas of the body, such as the face, arms, or legs. In more severe cases, the patches can be larger and more widespread, covering much of the body. The hair and eyes may also be affected, with patches of white or light-colored hair and blue or gray eyes.\nPiebaldism is usually diagnosed at birth or during early childhood, based on the appearance of the skin, hair, and eyes. Genetic testing can also be used to confirm the diagnosis and identify the specific mutations responsible for the condition.\nThere is no cure for piebaldism, but treatment options are available to help manage the condition. These may include:\n1. Skin care: Keeping the skin clean and moisturized can help reduce the risk of skin irritation and infection.\n2. Protective clothing: Wearing protective clothing, such as long-sleeved shirts and pants, can help protect the skin from the sun and other environmental factors.\n3. Sunscreen: Using sunscreen can help protect the skin from the sun's ultraviolet (UV) rays, which can cause damage to the skin and increase the risk of skin cancer.\n4. Eye protection: Wearing sunglasses or other eye protection can help protect the eyes from the sun's UV rays and reduce the risk of eye problems.\n5. Psychological support: Living with pie",
    "llama-2-7b-chat-hf_fact": [
      "Piebaldism is a rare genetic disorder that affects the pigmentation of skin, hair, and eyes.",
      "The disorder is caused by mutations in the TYR gene, which is responsible for the production of melanin.",
      "The severity of Piebaldism can vary, from mild cases with small patches of white skin, hair, or eyes, to severe cases where these patches cover much of the body.",
      "Diagnosis of Piebaldism usually happens at birth or during early childhood through the visual appearance or genetic testing.",
      "There is no cure for piebaldism, but treatments such as skincare, protective clothing, sunscreen, eye protection and psychological support can help manage the condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The disorder is caused by mutations in the KIT gene, not the TYR gene.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-7b-chat-hf_response": "FLVCR1 is a member of the Ferroportin (FPN) family of proteins.",
    "llama-2-7b-chat-hf_fact": [
      "FLVCR1 is a member of the Ferroportin (FPN) family of proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: FLVCR1 is not a member of the Ferroportin (FPN) family of proteins. Instead, it is a member of the major facilitator superfamily."
    ]
  },
  {
    "id": 1008,
    "user_query": "Which inherited disorder is known to be caused by mutations in the NEMO gene?",
    "llama-2-7b-chat-hf_response": "The inherited disorder caused by mutations in the NEMO gene is known as Nemaline Myopathy. Nemaline Myopathy is a rare genetic disorder that affects the muscles, particularly the skeletal muscles, and is characterized by muscle weakness, muscle wasting, and muscle cramps. It is usually diagnosed in infancy or early childhood and can lead to significant disability and respiratory problems.",
    "llama-2-7b-chat-hf_fact": [
      "The disorder caused by mutations in the NEMO gene is known as Nemaline Myopathy.",
      "Nemaline Myopathy is a rare genetic disorder.",
      "Nemaline Myopathy affects the muscles, particularly the skeletal muscles.",
      "Symptoms of Nemaline Myopathy include muscle weakness, muscle wasting, and muscle cramps.",
      "Nemaline Myopathy is usually diagnosed in infancy or early childhood and can lead to significant disability and respiratory problems."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The disorder caused by mutations in the NEMO gene is known as Incontinentia Pigmenti. Nemaline Myopathy is caused by mutations in different genes.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1009,
    "user_query": "What is ISMARA?",
    "llama-2-7b-chat-hf_response": "ISMARA is an acronym that stands for \"Intelligent System for Maritime Automation and Robotics\". It is a research project funded by the European Union's Horizon 2020 program, with the goal of developing a comprehensive and integrated system for automation and robotics in the maritime sector.\nThe ISMARA project aims to create a system that can perform a wide range of tasks, including:\n1. Autonomous navigation: The system will be able to navigate ships and vessels without human intervention, using advanced sensors and AI algorithms to detect and avoid obstacles.\n2. Maintenance and repair: The system will be able to perform routine maintenance and repair tasks, such as cleaning and inspecting the hull of a ship, without the need for human intervention.\n3. Safety and security: The system will be able to detect and respond to safety and security threats, such as fires or pirate attacks, using advanced sensors and AI algorithms.\n4. Cargo handling: The system will be able to automate the loading and unloading of cargo, using advanced robots and AI algorithms to optimize the process.\n5. Environmental monitoring: The system will be able to monitor the marine environment, including water quality and weather patterns, using advanced sensors and AI algorithms.\nThe ISMARA project is expected to have a significant impact on the maritime sector, improving safety, efficiency, and sustainability, while also reducing costs and environmental impact. The project is expected to be completed in 2023.",
    "llama-2-7b-chat-hf_fact": [
      "ISMARA is an acronym for \"Intelligent System for Maritime Automation and Robotics.\"",
      "The ISMARA project is funded by the European Union's Horizon 2020 program.",
      "ISMARA is aimed at developing a comprehensive and integrated system for automation and robotics in the maritime sector.",
      "The ISMARA project includes tasks such as autonomous navigation, maintenance and repair, safety and security, cargo handling, and environmental monitoring.",
      "The ISMARA project is expected to be completed in 2023."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1014,
    "user_query": "What histone variants play a role in the DNA damage reponse?",
    "llama-2-7b-chat-hf_response": "Histone variants are non-allelic forms of histones that are expressed in a tissue-specific or developmental stage-specific manner. They play important roles in various cellular processes, including DNA damage response. Here are some examples of histone variants that play a role in the DNA damage response:\n1. H2A.Z: H2A.Z is a histone variant that is enriched at replication foci and plays a role in the initiation of DNA replication. It also plays a role in the repair of DNA damage, particularly double-strand breaks (DSBs). H2A.Z helps to recruit repair factors to the site of damage and promotes the assembly of the repair machinery.\n2. H3.3: H3.3 is a histone variant that is enriched in gene bodies and plays a role in the regulation of gene expression. It also plays a role in the DNA damage response, particularly in the repair of DSBs. H3.3 helps to recruit repair factors to the site of damage and promotes the assembly of the repair machinery.\n3. H2B.V: H2B.V is a histone variant that is enriched in the nucleolus and plays a role in the regulation of gene expression. It also plays a role in the DNA damage response, particularly in the repair of DSBs. H2B.V helps to recruit repair factors to the site of damage and promotes the assembly of the repair machinery.\n4. H3.1: H3.1 is a histone variant that is enriched in the cytoplasm and plays a role in the regulation of gene expression. It also plays a role in the DNA damage response, particularly in the repair of DSBs. H3.1 helps to recruit repair factors to the site of damage and promotes the assembly of the repair machinery.\n5. H2A.X: H2A.X is a histone variant that is enriched in the nucleus and plays a role in the regulation of gene expression. It also plays a role in the DNA damage response, particularly in the repair of DSBs. H2A.X helps to recruit repair factors to the site of damage and promotes the assembly of the repair machinery.\nIn summary, histone",
    "llama-2-7b-chat-hf_fact": [
      "Histone variants are non-allelic forms of histones that are expressed in a tissue-specific or developmental stage-specific manner.",
      "H2A.Z is a histone variant that plays a role in DNA replication and the repair of double-strand DNA breaks.",
      "H3.3 is a histone variant that regulates gene expression and plays a role in the repair of double-strand DNA breaks.",
      "H2B.V is a histone variant that regulates gene expression and plays a role in the repair of double-strand DNA breaks.",
      "H3.1 is a histone variant that regulates gene expression and plays a role in the repair of double-strand DNA breaks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1019,
    "user_query": "Which disease has been associated to a disruptive ALX1 protein?",
    "llama-2-7b-chat-hf_response": "The ALX1 protein has been associated with several diseases, including:\n1. Neurodegenerative diseases: ALX1 has been implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.\n2. Cancer: ALX1 has been shown to be overexpressed in various types of cancer, including breast, lung, and colon cancer. Overexpression of ALX1 has been linked to cancer cell proliferation, migration, and invasion.\n3. Cardiovascular disease: ALX1 has been implicated in the development and progression of cardiovascular disease, including atherosclerosis and heart failure.\n4. Metabolic disorders: ALX1 has been linked to the development of metabolic disorders, including insulin resistance and type 2 diabetes.\n5. Autoimmune diseases: ALX1 has been implicated in the pathogenesis of several autoimmune diseases, including multiple sclerosis and rheumatoid arthritis.\nOverall, the ALX1 protein has been associated with a wide range of diseases, highlighting its potential as a therapeutic target for the treatment of various conditions.",
    "llama-2-7b-chat-hf_fact": [
      "The ALX1 protein has been implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.",
      "The ALX1 protein is associated with various types of cancer, such as breast, lung, and colon cancer, and has been linked to cancer cell proliferation, migration, and invasion.",
      "In the context of cardiovascular disease like atherosclerosis and heart failure, the ALX1 protein has been implicated.",
      "The ALX1 protein has been associated with metabolic disorders, including insulin resistance and type 2 diabetes.",
      "The pathogenesis of several autoimmune diseases, including multiple sclerosis and rheumatoid arthritis, has been linked to the ALX1 protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1022,
    "user_query": "In which yeast chromosome does the rDNA cluster reside?",
    "llama-2-7b-chat-hf_response": "The rDNA (ribosomal DNA) cluster resides in chromosome 6 of the yeast Saccharomyces cerevisiae.",
    "llama-2-7b-chat-hf_fact": [
      "The rDNA cluster resides in a chromosome of the yeast Saccharomyces cerevisiae.",
      "The specific chromosome where the rDNA cluster is found is chromosome 6."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The specific chromosome where the rDNA cluster is found is chromosome 12."
    ]
  },
  {
    "id": 1023,
    "user_query": "Which is the underlying mechanism for exon skipping used to treat Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Exon skipping is a therapeutic strategy used to treat Duchenne muscular dystrophy (DMD), a severe and progressive genetic disorder caused by mutations in the dystrophin gene. The underlying mechanism of exon skipping involves the use of antisense oligonucleotides, which are short RNA molecules that bind to specific messenger RNA (mRNA) molecules and prevent their translation into protein.\nIn the case of DMD, the antisense oligonucleotides are designed to bind to the mRNA molecules that contain the mutated exons, which are the regions of the gene that code for the dystrophin protein. By binding to these mutated exons, the antisense oligonucleotides prevent their translation into protein, effectively \"skipping\" over the mutated exons and allowing the production of a shorter, but still functional, dystrophin protein.\nThis therapeutic approach has shown promise in preclinical studies, and several exon-skipping therapies are currently being tested in clinical trials for the treatment of DMD. The goal of these therapies is to restore the production of a functional dystrophin protein, which can help to slow or halt the progression of the disease and improve the quality of life for patients with DMD.",
    "llama-2-7b-chat-hf_fact": [
      "Duchenne muscular dystrophy (DMD) is a severe and progressive genetic disorder caused by mutations in the dystrophin gene.",
      "Exon skipping is a therapeutic strategy used to treat DMD.",
      "The mechanism of exon skipping uses antisense oligonucleotides, which are short RNA molecules that prevent protein translation of specific mRNA molecules.",
      "Antisense oligonucleotides in the case of DMD are designed to bind to the mRNA molecules that contain the mutated exons, enabling the production of a shorter but still functional dystrophin protein.",
      "Several exon-skipping therapies are currently being tested in clinical trials for the treatment of DMD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1028,
    "user_query": "What is the link between Dax1 and Esrrb?",
    "llama-2-7b-chat-hf_response": "Dax1 and Esrrb are both transcription factors that play important roles in regulating gene expression during embryonic development. While they have some similar functions, they also have distinct differences in their mechanisms of action and the genes they regulate. Here are some key similarities and differences between Dax1 and Esrrb:\nSimilarities:\n1. Transcriptional regulation: Both Dax1 and Esrrb are transcription factors that regulate gene expression by binding to specific DNA sequences in the promoter or enhancer regions of target genes.\n2. Embryonic development: Both Dax1 and Esrrb are essential for proper embryonic development, with Dax1 playing a role in the formation of the neural tube and Esrrb involved in the development of the limbs and other tissues.\n3. Hormone regulation: Both Dax1 and Esrrb are involved in the regulation of hormone expression, with Dax1 controlling the expression of the thyroid hormone receptor and Esrrb regulating the expression of the estrogen receptor.\nDifferences:\n1. Cellular localization: Dax1 is primarily localized to the nucleus, while Esrrb is localized to both the nucleus and cytoplasm.\n2. Subcellular localization: Dax1 is involved in the regulation of gene expression in the nucleus, while Esrrb is involved in the regulation of gene expression in both the nucleus and cytoplasm.\n3. Target genes: Dax1 regulates a wide range of target genes involved in various biological processes, including cell growth, differentiation, and survival, while Esrrb primarily regulates genes involved in the development and maintenance of the female reproductive system.\n4. Tissue specificity: Dax1 is expressed in a wide range of tissues, including the brain, heart, and pancreas, while Esrrb is primarily expressed in the uterus and other female reproductive organs.\n5. Developmental timing: Dax1 is expressed throughout embryonic development, while Esrrb is expressed primarily during the early stages of embryonic development.\nIn summary, while Dax1 and Esrrb have some similarities in their functions as transcription factors, they also have distinct differences",
    "llama-2-7b-chat-hf_fact": [
      "Dax1 and Esrrb are transcription factors involved in regulating gene expression during embryonic development.",
      "Dax1 plays a significant role in the formation of the neural tube.",
      "Esrrb contributes to the development of the limbs and other tissues.",
      "Dax1 primarily localizes to the nucleus, while Esrrb is found both in the nucleus and cytoplasm.",
      "Esrrb primarily regulates genes involved in the development and maintenance of the female reproductive system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1030,
    "user_query": "Are DNA helicases involved in progeroid syndromes?",
    "llama-2-7b-chat-hf_response": "DNA helicases are enzymes that play a crucial role in the unwinding of DNA during replication and repair. They are also involved in various cellular processes, including transcriptional regulation, chromatin remodeling, and DNA damage response. Recent studies have suggested that DNA helicases may be involved in progeroid syndromes, which are a group of rare genetic disorders characterized by accelerated aging and premature age-related diseases.\nOne of the most well-known progeroid syndromes is Hutchinson-Gilford progeria syndrome (HGPS), which is caused by mutations in the LMNA gene that encodes the lamin A/C protein. Lamin A/C is a key component of the nuclear lamina, which provides structural support to the nucleus and regulates various cellular processes. Mutations in the LMNA gene lead to the accumulation of abnormal lamin A/C proteins, which disrupt the normal functioning of the nuclear lamina and lead to the characteristic features of HGPS, including accelerated aging, alopecia, and cardiovascular disease.\nStudies have shown that DNA helicases are involved in the regulation of lamin A/C expression and nuclear lamina structure. For example, the DNA helicase A (DNAH1) has been shown to interact with the lamin A/C protein and regulate its stability and localization in the nucleus. Other DNA helicases, such as DNAH5 and DNAH9, have also been implicated in the regulation of lamin A/C expression and nuclear lamina structure.\nMutations in DNA helicases have been identified in some progeroid syndromes, including HGPS. For example, mutations in the DNAH1 gene have been identified in some cases of HGPS, and these mutations have been shown to disrupt the normal functioning of the DNA helicase and lead to the accumulation of abnormal lamin A/C proteins. Similarly, mutations in other DNA helicases, such as DNAH5 and DNAH9, have been identified in other progeroid syndromes.\nOverall, these findings suggest that DNA helicases play a critical role in the regulation of lamin A",
    "llama-2-7b-chat-hf_fact": [
      "DNA helicases are enzymes involved in the unwinding of DNA during replication and repair.",
      "Recent studies suggest DNA helicases may be linked to progeroid syndromes, genetic disorders characterized by accelerated aging.",
      "Hutchinson-Gilford progeria syndrome (HGPS) is a known progeroid syndrome caused by mutations in the LMNA gene.",
      "The LMNA gene encodes the lamin A/C protein, which is part of the nuclear lamina.",
      "DNA helicases such as DNAH1, DNAH5, and DNAH9 have been studied for their role in the regulation of lamin A/C expression and the structure of nuclear lamina."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1034,
    "user_query": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?",
    "llama-2-7b-chat-hf_response": "Hsp90 inhibition has been shown to upregulate several heat shock proteins, including Hsp70, Hsp60, and Hsp27. However, the specific heat shock protein that is most upregulated during Hsp90 inhibition can vary depending on the cellular context and the specific inhibitor used.\nIn general, Hsp90 inhibition has been shown to induce the expression of Hsp70 and Hsp60 in various cell types, including cancer cells. For example, one study found that treatment of breast cancer cells with the Hsp90 inhibitor, ganetespib, led to increased expression of Hsp70 and Hsp60 (1). Similarly, another study found that inhibition of Hsp90 in prostate cancer cells resulted in increased expression of Hsp70 and Hsp60 (2).\nIn addition to Hsp70 and Hsp60, Hsp27 has also been shown to be upregulated during Hsp90 inhibition. For example, one study found that treatment of melanoma cells with the Hsp90 inhibitor, celastrol, led to increased expression of Hsp27 (3).\nOverall, the specific heat shock protein that is most upregulated during Hsp90 inhibition can vary depending on the cellular context and the specific inhibitor used. However, Hsp70, Hsp60, and Hsp27 are among the most commonly reported heat shock proteins to be upregulated during Hsp90 inhibition.",
    "llama-2-7b-chat-hf_fact": [
      "Hsp90 inhibition has been shown to upregulate several heat shock proteins, including Hsp70, Hsp60, and Hsp27.",
      "The specific heat shock protein that is most upregulated during Hsp90 inhibition can vary depending on the cellular context and the specific inhibitor used.",
      "Treatment of breast cancer cells with the Hsp90 inhibitor, ganetespib, can result in increased expression of Hsp70 and Hsp60.",
      "Inhibition of Hsp90 in prostate cancer cells can lead to increased expression of Hsp70 and Hsp60.",
      "Treatment of melanoma cells with the Hsp90 inhibitor, celastrol, can lead to increased expression of Hsp27."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1036,
    "user_query": "What is the name for anorexia in gymnasts?",
    "llama-2-7b-chat-hf_response": "Anorexia in gymnasts is often referred to as \"the gymnastics eating disorder.\" This term acknowledges the unique challenges and pressures that gymnasts face in their sport, which can contribute to the development of anorexia nervosa.",
    "llama-2-7b-chat-hf_fact": [
      "Anorexia in gymnasts is often referred to as \"the gymnastics eating disorder.\"",
      "The term \"the gymnastics eating disorder\" acknowledges the unique challenges and pressures that gymnasts face in their sport.",
      "These challenges and pressures in gymnastics can contribute to the development of anorexia nervosa."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1038,
    "user_query": "What are the indications for alteplase?",
    "llama-2-7b-chat-hf_response": "Alteplase is a tissue plasminogen activator (tPA) that is used to treat acute ischemic stroke (AIS) in patients who are eligible and within 4.5 hours of the onset of stroke symptoms. The drug works by breaking down blood clots that are blocking blood flow to the brain, which can help to restore blood flow and reduce the amount of brain damage.\nThe main indication for alteplase is for the treatment of acute ischemic stroke (AIS) in patients who are eligible and within 4.5 hours of the onset of stroke symptoms. The drug is typically given intravenously and works by breaking down blood clots that are blocking blood flow to the brain.\nSome of the specific indications for alteplase include:\n1. Acute ischemic stroke (AIS) in patients who are eligible and within 4.5 hours of the onset of stroke symptoms.\n2. Cerebral infarction (CI) in patients who are eligible and within 4.5 hours of the onset of stroke symptoms.\n3. Intracerebral hemorrhage (ICH) in patients who are eligible and within 4.5 hours of the onset of stroke symptoms.\n4. Cardioembolic stroke (CES) in patients who are eligible and within 4.5 hours of the onset of stroke symptoms.\n5. Moyamoya disease in patients who are eligible and within 4.5 hours of the onset of stroke symptoms.\nIt is important to note that the use of alteplase for stroke treatment is time-dependent, and the drug must be administered within 4.5 hours of the onset of stroke symptoms to be effective. Additionally, the decision to administer alteplase should be made on a case-by-case basis, taking into account the patient's individual circumstances and medical history.",
    "llama-2-7b-chat-hf_fact": [
      "Alteplase is a tissue plasminogen activator (tPA) used for the treatment of acute ischemic stroke (AIS).",
      "Alteplase is effective when administered within 4.5 hours of the onset of stroke symptoms.",
      "Alteplase works by breaking down blood clots blocking blood flow to the brain.",
      "Specific indications for alteplase also include cerebral infarction (CI), intracerebral hemorrhage (ICH), cardioembolic stroke (CES), and Moyamoya disease.",
      "The decision to administer alteplase should consider the patient's individual circumstances and medical history."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Specific indications for alteplase include acute myocardial infarction, acute ischemic stroke and pulmonary embolism. It is contraindicated for intracerebral hemorrhage.",
      "true"
    ]
  },
  {
    "id": 1039,
    "user_query": "List scaffold proteins of the ERK signaling pathway.",
    "llama-2-7b-chat-hf_response": "The ERK (extracellular signal-regulated kinase) signaling pathway is a complex network of molecular interactions that plays a crucial role in regulating various cellular processes, including cell proliferation, differentiation, and survival. The ERK pathway is activated by a variety of extracellular signals, including growth factors, hormones, and neurotransmitters, which bind to specific receptors on the cell surface, triggering a cascade of intracellular signaling events that ultimately lead to the activation of the ERK protein kinases.\nScaffold proteins are proteins that provide a structural framework for the organization of signaling molecules and play a crucial role in the regulation of signaling pathways. In the context of the ERK signaling pathway, scaffold proteins act as hubs that bring together multiple signaling molecules and facilitate their interaction, thereby modulating the strength and duration of signaling events. Here are some of the key scaffold proteins involved in the ERK signaling pathway:\n1. Grb2 (growth factor receptor-bound protein 2): Grb2 is a scaffold protein that binds to the extracellular domain of the ERK receptors, such as EGFR (epidermal growth factor receptor) and HB-EGF (heparin-binding EGF-like growth factor), and brings them together with downstream signaling molecules, including the Ras/Raf/MEK/ERK pathway.\n2. Shc (Src-homology 2 domain-containing protein): Shc is a scaffold protein that binds to the cytoplasmic domain of the ERK receptors and brings them together with downstream signaling molecules, including the Ras/Raf/MEK/ERK pathway.\n3. CRK (c-Raf-related kinase): CRK is a scaffold protein that binds to the cytoplasmic domain of the ERK receptors and brings them together with downstream signaling molecules, including the Ras/Raf/MEK/ERK pathway.\n4. JNK (c-Jun N-terminal kinase): JNK is a scaffold protein that bind",
    "llama-2-7b-chat-hf_fact": [
      "The ERK signaling pathway plays a role in regulating various cellular processes, including cell proliferation, differentiation, and survival.",
      "Scaffold proteins provide a structural framework for the organization of signaling molecules and play a role in the regulation of signaling pathways.",
      "Grb2 is a key scaffold protein involved in the ERK signaling pathway and it binds to the extracellular domain of the ERK receptors, such as EGFR and HB-EGF.",
      "Shc is an another scaffold protein in the ERK signaling pathway that binds to the cytoplasmic domain of the ERK receptors.",
      "CRK and JNK are also scaffold proteins in the ERK signaling pathway."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Grb2 is a key adaptor protein in the ERK signaling pathway and it binds to the intracellular domain, not the extracellular, of the ERK receptors, such as EGFR.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1041,
    "user_query": "Which classes of endogenous retroelements are known to date?",
    "llama-2-7b-chat-hf_response": "Endogenous retroelements are mobile genetic elements that are integrated into the host genome and are capable of self-replication. They are found in the genomes of most eukaryotes, including animals, plants, and fungi. There are several classes of endogenous retroelements that are known to date, including:\n1. Long Terminal Repeat (LTR) Retrotransposons: These are the most common type of endogenous retroelement and are characterized by the presence of LTRs at both ends of the element. They are capable of retrotransposition, meaning they can insert themselves into new locations within the genome.\n2. Non-LTR Retrotransposons: These are retrotransposons that do not have LTRs and are typically found in the interior of the genome. They are also capable of retrotransposition, but are less common than LTR retrotransposons.\n3. DNA Transposons: These are retrotransposons that are flanked by inverted repeats rather than LTRs. They are also capable of retrotransposition, but are less common than LTR retrotransposons.\n4. Helitrons: These are a recently discovered class of endogenous retroelement that are characterized by the presence of a conserved helicase domain. They are capable of both retrotransposition and transposition, meaning they can insert themselves into new locations within the genome or transpose themselves to new locations within the genome.\n5. SINEs (Short Interspersed Nuclear Elements): These are small retrotransposons that are typically found in the interior of the genome. They are capable of retrotransposition, but are less common than LTR retrotransposons.\n6. LINEs (Long Interspersed Nuclear Elements): These are larger than SINEs and are also found in the interior of the genome. They are capable of retrotransposition, but are less common than LTR retrotransposons.\n7. Retroviral Elements: These are endogenous retroelements that are derived from retroviruses, such as HIV. They are capable of retrotransposition, but are less common than LTR retrotransposons.\nIt is worth noting that the classification of endogenous retroelements is not always clear-cut",
    "llama-2-7b-chat-hf_fact": [
      "Endogenous retroelements are mobile genetic elements that are integrated into the host genome and are capable of self-replication.",
      "Most eukaryotes, including animals, plants, and fungi, have endogenous retroelements in their genomes.",
      "Long Terminal Repeat (LTR) Retrotransposons are a type of endogenous retroelement that are characterized by the presence of LTRs at both ends.",
      "Non-LTR Retrotransposons and DNA Transposons are other classes of retrotransposons that are less common than LTR retrotransposons.",
      "Retroviral Elements are endogenous retroelements that are derived from retroviruses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Non-LTR Retrotransposons and DNA Transposons are other classes of transposable elements, not retrotransposons as they do not operate through reverse transcription like retrotransposons do.",
      "true"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_response": "GATA-1 is a transcription factor that plays a crucial role in regulating the expression of genes involved in erythropoiesis, the production of red blood cells. The biotinylation tagging approach is a method used to identify proteins that interact with a specific protein of interest, in this case, GATA-1. The following is a list of some of the interacting partners of GATA-1 that have been identified using the biotinylation tagging approach:\n1. KAT2A: GATA-1 was shown to interact with KAT2A, a histone acetyltransferase that is involved in regulating chromatin structure and gene expression.\n2. HMX1: GATA-1 was found to interact with HMX1, a homeobox transcription factor that is involved in regulating the expression of genes involved in erythropoiesis.\n3. TFAP2A: GATA-1 was shown to interact with TFAP2A, a transcription factor that is involved in regulating the expression of genes involved in erythropoiesis and hematopoiesis.\n4. TAL1: GATA-1 was found to interact with TAL1, a transcription factor that is involved in regulating the expression of genes involved in erythropoiesis and hematopoiesis.\n5. IRF8: GATA-1 was shown to interact with IRF8, a transcription factor that is involved in regulating the expression of genes involved in erythropoiesis and hematopoiesis.\n6. BCL11A: GATA-1 was found to interact with BCL11A, a transcription factor that is involved in regulating the expression of genes involved in erythropoiesis and hematopoiesis.\n7. EKLF: GATA-1 was shown to interact with EKLF, a transcription factor that is involved in regulating the expression of genes involved in erythropoiesis and hematopoiesis.\n8. NF-E2: GATA-1 was found to interact with NF-E2, a transcription factor that is involved in regulating the expression of genes involved in erythropoiesis and hematopoies",
    "llama-2-7b-chat-hf_fact": [
      "GATA-1 is a transcription factor that regulates the expression of genes involved in the production of red blood cells.",
      "The biotinylation tagging approach is a method used to identify proteins that interact with a specific protein of interest.",
      "GATA-1 was found to interact with the transcription factor KAT2A, which is involved in regulating chromatin structure and gene expression.",
      "GATA-1 interacts with the homeobox transcription factor HMX1 that regulates the expression of genes involved in erythropoiesis.",
      "GATA-1 was found to interact with the transcription factors TFAP2A, TAL1, IRF8, BCL11A, EKLF, and NF-E2, all of which regulate gene expression involved in erythropoiesis and hematopoiesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1053,
    "user_query": "Which proteins are the different members of the NF-kappaB family of transcription factors?",
    "llama-2-7b-chat-hf_response": "NF-B (nuclear factor kappa B) is a family of transcription factors that play a central role in regulating the expression of genes involved in inflammation, immune responses, and cell survival. The NF-B family consists of five members: NF-B1 (p105/p50), NF-B2 (p100/p52), RelA (p65), RelB, and c-Rel. Each member of the NF-B family has similar DNA-binding and transcriptional activation capabilities, but they differ in their subcellular localization, stability, and substrate specificity.\n1. NF-B1 (p105/p50)\n2. NF-B2 (p100/p52)\n3. RelA (p65)\n4. RelB\n5. c-Rel",
    "llama-2-7b-chat-hf_fact": [
      "NF-B (nuclear factor kappa B) is a family of transcription factors.",
      "They play a role in regulating the gene expression for inflammation, immune responses, and cell survival.",
      "The NF-B family consists of five members: NF-B1, NF-B2, RelA, RelB, and c-Rel.",
      "NF-B1 is also known as p105/p50.",
      "NF-B2 is also known as p100/p52 while RelA is often referred to as p65."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1061,
    "user_query": "Which proteins have been identified as RET ligands?",
    "llama-2-7b-chat-hf_response": "Several proteins have been identified as RET ligands, including:\n1. Glial cell line-derived neurotrophic factor (GDNF): GDNF is a member of the GDNF family of ligands, which also includes neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4). These ligands bind to the RET receptor and play a role in the regulation of cell survival, differentiation, and synaptic plasticity in the nervous system.\n2. Neurotrophin-3 (NT-3): NT-3 is another member of the GDNF family of ligands, which binds to the RET receptor and plays a role in the regulation of cell survival, differentiation, and synaptic plasticity in the nervous system.\n3. Neurotrophin-4 (NT-4): NT-4 is also a member of the GDNF family of ligands, which binds to the RET receptor and plays a role in the regulation of cell survival, differentiation, and synaptic plasticity in the nervous system.\n4. Persephin: Persephin is a ligand for the RET receptor that is expressed in the brain and plays a role in the regulation of cell survival and differentiation in the nervous system.\n5. Brevican: Brevican is a ligand for the RET receptor that is expressed in the brain and plays a role in the regulation of cell survival and differentiation in the nervous system.\n6. Neurotrophin-induced protein (NIP): NIP is a ligand for the RET receptor that is expressed in the brain and plays a role in the regulation of cell survival and differentiation in the nervous system.\nThese proteins play important roles in the regulation of cell survival, differentiation, and synaptic plasticity in the nervous system, and their dysregulation has been implicated in various neurological disorders, including cancer and neurodegenerative diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Glial cell line-derived neurotrophic factor (GDNF), Neurotrophin-3 (NT-3), and Neurotrophin-4 (NT-4) are proteins identified as RET ligands and are part of the GDNF family of ligands.",
      "The proteins GDNF, NT-3 and NT-4 play a role in the regulation of cell survival, differentiation, and synaptic plasticity in the nervous system.",
      "Persephin, Brevican and Neurotrophin-induced protein (NIP) are also ligands for the RET receptor and are associated with the regulation of cell survival and differentiation in the nervous system.",
      "These RET ligands are expressed in the brain.",
      "Dysregulation of these RET ligands has been implicated in various neurological disorders, including cancer and neurodegenerative diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Persephin is a ligand for the RET receptor associated with the regulation of cell survival and differentiation in the nervous system, but Brevican and Neurotrophin-induced protein (NIP) are not.",
      "true",
      "true"
    ]
  },
  {
    "id": 1066,
    "user_query": "List all articles on network meta-analysis for smoking cessation",
    "llama-2-7b-chat-hf_response": "Network meta-analysis (NMA) is a powerful tool for evaluating the relative efficacy of different interventions, including smoking cessation treatments. Here are some articles on NMA for smoking cessation:\n1. \"Network meta-analysis of smoking cessation interventions: a systematic review and meta-analysis\" by S. S. Yoon et al., published in the Journal of Clinical Epidemiology in 2016. This article provides a comprehensive overview of the available literature on NMA for smoking cessation interventions, including the methods used and the results of the meta-analyses.\n2. \"Network meta-analysis of nicotine replacement therapy, bupropion, and varenicline for smoking cessation\" by J. Li et al., published in the Journal of the American Medical Association in 2015. This article presents the results of an NMA comparing the efficacy of nicotine replacement therapy (NRT), bupropion, and varenicline for smoking cessation.\n3. \"Network meta-analysis of behavioral and pharmacological interventions for smoking cessation\" by A. R. Alaa Mohamed et al., published in the Journal of Smoking Cessation in 2017. This article presents the results of an NMA comparing the efficacy of different behavioral and pharmacological interventions for smoking cessation, including cognitive-behavioral therapy, motivational interviewing, and medications such as NRT and bupropion.\n4. \"Network meta-analysis of the effects of smoking cessation interventions on cardiovascular disease risk factors: a systematic review and meta-analysis\" by J. S. Kim et al., published in the Journal of the American Heart Association in 2018. This article presents the results of an NMA evaluating the effects of different smoking cessation interventions on cardiovascular disease risk factors, including blood pressure, cholesterol levels, and body weight.\n5. \"Network meta-analysis of the effects of smoking cessation interventions on lung function in chronic obstructive pulmonary disease: a systematic review and meta",
    "llama-2-7b-chat-hf_fact": [
      "Network meta-analysis (NMA) is a tool used for evaluating the relative efficacy of different interventions, including smoking cessation treatments.",
      "\"Network meta-analysis of smoking cessation interventions: a systematic review and meta-analysis\" by S. S. Yoon et al. was published in the Journal of Clinical Epidemiology in 2016.",
      "\"Network meta-analysis of nicotine replacement therapy, bupropion, and varenicline for smoking cessation\" by J. Li et al. was published in the Journal of the American Medical Association in 2015.",
      "A. R. Alaa Mohamed et al.'s article on the efficacy of different behavioral and pharmacological interventions for smoking cessation was published in the Journal of Smoking Cessation in 2017.",
      "\"Network meta-analysis of the effects of smoking cessation interventions on cardiovascular disease risk factors: a systematic review and meta-analysis\" by J. S. Kim et al. was published in the Journal of the American Heart Association in 2018."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1068,
    "user_query": "Which clotting factor is inhibited by betrixaban?",
    "llama-2-7b-chat-hf_response": "A) Factor Xa\nB) Factor IIa\nC) Factor VIIa\nD) Factor IXa\nAnswer: B) Factor IIa.\nBetrixaban is a direct oral anticoagulant that selectively inhibits factor IIa (prothrombinase), which is involved in the coagulation cascade. It is used to prevent stroke and systemic embolism in patients with atrial fibrillation or venous thromboembolism.\nFactor Xa, VIIa, and IXa are other clotting factors that are not directly inhibited by betrixaban.",
    "llama-2-7b-chat-hf_fact": [
      "Betrixaban is a direct oral anticoagulant.",
      "Betrixaban selectively inhibits factor IIa (prothrombinase).",
      "Factor IIa is involved in the coagulation cascade.",
      "Betrixaban is used to prevent stroke and systemic embolism in patients with atrial fibrillation or venous thromboembolism.",
      "Factor Xa, VIIa, and IXa are clotting factors that are not directly inhibited by betrixaban."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Betrixaban selectively inhibits factor Xa.",
      "true",
      "false, [corrected fact]: Betrixaban is used to prevent venous thromboembolism in patients with acute illness.",
      "true"
    ]
  },
  {
    "id": 1071,
    "user_query": "Are there any specific antidotes for dabigatran?",
    "llama-2-7b-chat-hf_response": "Dabigatran is a direct thrombin inhibitor that is used to prevent blood clots in patients with atrial fibrillation or venous thromboembolism. While there are no specific antidotes for dabigatran, there are some strategies that can be used to reverse its effects in case of an overdose or adverse reaction. Here are some of the possible antidotes or reversal agents for dabigatran:\n1. Idarucizumab: This is a specific antidote for dabigatran that was approved by the FDA in 2015. Idarucizumab is a monoclonal antibody that binds to dabigatran and reverses its anticoagulant effects. It is administered intravenously and can reverse the effects of dabigatran within 2 hours.\n2. Protamine sulfate: Protamine sulfate is a calcium channel blocker that can reverse the effects of dabigatran by neutralizing its anticoagulant activity. It is administered intravenously and can reverse the effects of dabigatran within 30 minutes to 1 hour.\n3. Vitamin K: Vitamin K can reverse the effects of dabigatran by increasing the production of clotting factors. It is administered orally and can take several hours to reverse the effects of dabigatran.\n4. Fresh frozen plasma (FFP): FFP contains clotting factors that can reverse the effects of dabigatran by increasing the production of clotting factors. It is administered intravenously and can reverse the effects of dabigatran within 30 minutes to 1 hour.\n5. Activated prothrombin complex concentrate (aPCC): aPCC contains clotting factors that can reverse the effects of dabigatran by increasing the production of clotting factors. It is administered intravenously and can reverse the effects of dabigatran within 30 minutes to 1 hour.\nIt is important to note that these antidotes or reversal agents should only be used in case of an overdose or adverse reaction to dabigatran",
    "llama-2-7b-chat-hf_fact": [
      "Dabigatran is a direct thrombin inhibitor used to prevent blood clots in patients with atrial fibrillation or venous thromboembolism.",
      "Idarucizumab, a monoclonal antibody, was approved by the FDA in 2015 as a specific antidote for dabigatran.",
      "Protamine sulfate is a calcium channel blocker that can reverse the effects of dabigatran.",
      "Vitamin K can reverse the effects of dabigatran by increasing the production of clotting factors.",
      "Activated prothrombin complex concentrate (aPCC) can be used to reverse the effects of dabigatran."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Protamine sulfate is an antidote that is commonly used to reverse heparin, not dabigatran.",
      "false, [corrected fact]: Vitamin K can reverse the effects of warfarin, not dabigatran, by increasing the production of clotting factors.",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-7b-chat-hf_response": "TAF10 (TATA-binding protein-associated factor 10) is a protein that plays a crucial role in the regulation of gene expression, particularly in the context of hematopoiesis. GATA1 is a transcription factor that is essential for the development and function of hematopoietic cells, including red blood cells, white blood cells, and platelets. Interaction between TAF10 and GATA1 has been shown to play a critical role in regulating the expression of genes involved in hematopoiesis.\nWhen TAF10 interacts with GATA1, it enhances the ability of GATA1 to bind to its target genes and activate their transcription. This leads to increased expression of genes involved in hematopoiesis, including genes involved in erythropoiesis, myelopoiesis, and lymphopoiesis. The interaction between TAF10 and GATA1 is also important for the maintenance of hematopoietic stem cells and their self-renewal.\nIn summary, the outcome of TAF10 interacting with the GATA1 transcription factor is to enhance the ability of GATA1 to regulate the expression of genes involved in hematopoiesis, leading to the proper development and function of hematopoietic cells.",
    "llama-2-7b-chat-hf_fact": [
      "TAF10 (TATA-binding protein-associated factor 10) is a protein involved in the regulation of gene expression, especially in hematopoiesis.",
      "GATA1 is a transcription factor necessary for the development and function of hematopoietic cells.",
      "Interaction between TAF10 and GATA1 is linked with regulation of gene expression in hematopoiesis.",
      "When TAF10 interacts with GATA1, it increases the ability of GATA1 to bind to its target genes and activate their transcription.",
      "The interaction between TAF10 and GATA1 also impacts the maintenance and self-renewal of hematopoietic stem cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1073,
    "user_query": "How does TNF affect thyroid hormone receptors?",
    "llama-2-7b-chat-hf_response": "Tumor necrosis factor (TNF) is a cytokine that plays a key role in the regulation of immune responses and inflammation. TNF can also affect the expression and activity of thyroid hormone receptors, which are important for the regulation of metabolism and other physiological processes. Here are some ways in which TNF can affect thyroid hormone receptors:\n1. Inhibition of thyroid hormone receptor expression: TNF can inhibit the expression of thyroid hormone receptors in various tissues, including the liver, muscle, and adipose tissue. This can lead to decreased sensitivity to thyroid hormones and impaired metabolic function.\n2. Modulation of thyroid hormone receptor activity: TNF can also modulate the activity of thyroid hormone receptors by altering their ability to bind to thyroid hormones. For example, TNF can increase the affinity of thyroid hormone receptors for the inactive form of thyroid hormones, making them less responsive to the active form of thyroid hormones.\n3. Increased degradation of thyroid hormone receptors: TNF can also increase the degradation of thyroid hormone receptors, leading to decreased levels of these receptors in the body. This can further impair the ability of thyroid hormones to regulate metabolism and other physiological processes.\nOverall, the effects of TNF on thyroid hormone receptors can have significant impacts on metabolism and other physiological processes, and may contribute to the development of metabolic disorders such as hypothyroidism and hyperthyroidism.",
    "llama-2-7b-chat-hf_fact": [
      "Tumor necrosis factor (TNF) is a cytokine that regulates immune responses and inflammation.",
      "TNF can affect the expression and activity of thyroid hormone receptors which regulate metabolism and other physiological processes.",
      "TNF can inhibit the expression of thyroid hormone receptors in various tissues, impacting sensitivity to thyroid hormones and metabolic function.",
      "TNF can modulate the activity of thyroid hormone receptors by altering their ability to bind to thyroid hormones.",
      "TNF can increase the degradation of thyroid hormone receptors, potentially impairing the ability of thyroid hormones to regulate metabolism."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1078,
    "user_query": "What is the action of molindone?",
    "llama-2-7b-chat-hf_response": "Molindone is an antipsychotic medication that works by blocking the action of dopamine in the brain. Dopamine is a neurotransmitter that plays a role in the development of psychotic symptoms, such as hallucinations and delusions. By blocking the action of dopamine, molindone can help to reduce the severity of psychotic symptoms in people with schizophrenia.\nMolindone also has some effects on other neurotransmitters in the brain, such as serotonin and acetylcholine. These effects may contribute to its therapeutic effects in treating schizophrenia, but the exact mechanisms are not fully understood.\nIt is important to note that molindone is not a cure for schizophrenia, and it is usually used in combination with other medications to treat the disorder. Additionally, molindone can have side effects, such as drowsiness, dizziness, and weight gain, so it is important to use it under the close supervision of a healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Molindone is an antipsychotic medication.",
      "The medication functions by blocking the action of dopamine in the brain.",
      "Dopamine is a neurotransmitter that plays a role in the development of psychotic symptoms, such as hallucinations and delusions.",
      "Molindone also affects other neurotransmitters in the brain like serotonin and acetylcholine.",
      "The medication is typically used in combination with other drugs to treat schizophrenia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Molindone is typically used on its own to treat schizophrenia."
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-7b-chat-hf_response": "Yes, there are several decision support systems (DSS) for chronic pain management that have been developed to help healthcare providers make informed decisions about patient care. These systems typically use a combination of clinical decision rules, clinical practice guidelines, and patient-reported outcomes to provide personalized recommendations for pain management. Some examples of DSS for chronic pain management include:\n1. The Chronic Pain Management Decision Support System (CPM-DSS): This system was developed by the University of Washington and uses a combination of clinical decision rules and patient-reported outcomes to provide personalized recommendations for pain management.\n2. The Pain Management Decision Support System (PMDSS): This system was developed by the University of California, Los Angeles (UCLA) and uses a combination of clinical practice guidelines and patient-reported outcomes to provide personalized recommendations for pain management.\n3. The Chronic Pain Management Algorithm (CPMA): This system was developed by the University of California, San Francisco (UCSF) and uses a combination of clinical decision rules and clinical practice guidelines to provide personalized recommendations for pain management.\n4. The Pain Management Decision Support System (PMDSS): This system was developed by the University of California, Los Angeles (UCLA) and uses a combination of clinical practice guidelines and patient-reported outcomes to provide personalized recommendations for pain management.\n5. The Chronic Pain Management Planner (CPMP): This system was developed by the University of Washington and uses a combination of clinical decision rules and patient-reported outcomes to provide personalized recommendations for pain management.\n6. The Pain Management Planner (PMP): This system was developed by the University of California, Los Angeles (UCLA) and uses a combination of clinical practice guidelines and patient-reported outcomes to provide personalized recommendations for pain management.\n7. The Chronic Pain Management Coach (CPMC): This system was developed by the University of Washington and uses a combination of clinical decision rules and patient-reported outcomes to provide personalized recommendations for pain management.\n8. The Pain Management Coach (PMC): This system was developed by the University of California, Los Angeles (UCLA) and uses a combination of clinical practice gu",
    "llama-2-7b-chat-hf_fact": [
      "Decision support systems for chronic pain management exist and are used to help healthcare providers make informed decisions about patient care.",
      "The University of Washington developed the Chronic Pain Management Decision Support System (CPM-DSS).",
      "The Pain Management Decision Support System (PMDSS) was developed by the University of California, Los Angeles (UCLA).",
      "The University of California, San Francisco (UCSF) developed the Chronic Pain Management Algorithm (CPMA).",
      "The Chronic Pain Management Planner (CPMP) is a system developed by the University of Washington."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1084,
    "user_query": "Which is the methyl donor of histone methyltransferases?",
    "llama-2-7b-chat-hf_response": "A) S-adenosylmethionine (SAM)\nB) Coenzyme A (CoA)\nC) Nicotinamide adenine dinucleotide (NAD+)\nD) Flavin adenine dinucleotide (FAD+)\nAnswer: A) S-adenosylmethionine (SAM)",
    "llama-2-7b-chat-hf_fact": [
      "S-adenosylmethionine (SAM) is the methyl donor of histone methyltransferases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 1085,
    "user_query": "How are human accelerated regions (HAR) defined?",
    "llama-2-7b-chat-hf_response": "Human accelerated regions (HAR) are defined as regions of the genome that have undergone positive selection, meaning that they have evolved faster than the rest of the genome in response to environmental pressures. HARs are typically found in genes that are involved in immune function, metabolism, and other biological processes that are important for survival and reproduction.",
    "llama-2-7b-chat-hf_fact": [
      "Human accelerated regions (HAR) are regions of the genome that have evolved faster than the rest of the genome.",
      "The evolution of HARs is influenced by environmental pressures.",
      "This type of evolution in HARs is referred to as positive selection.",
      "HARs are typically found in genes related to immune function and metabolism.",
      "These genes that contain HARs play important roles in survival and reproduction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: HARs are often found in genes related to brain development and function.",
      "true"
    ]
  },
  {
    "id": 1091,
    "user_query": "In which genomic positions is the histone variant macroH2A enriched?",
    "llama-2-7b-chat-hf_response": "MacroH2A is a histone variant that is enriched in certain genomic regions, including:\n1. Centromeres: MacroH2A is enriched at centromeres, which are specialized regions of chromatin that play a crucial role in the separation of chromosomes during cell division.\n2. Telomeres: MacroH2A is also enriched at telomeres, which are repetitive DNA sequences that cap the ends of chromosomes and help to maintain their stability.\n3. Gene bodies: MacroH2A is enriched in the gene bodies of actively transcribed genes, where it may play a role in regulating gene expression.\n4. Chromatin remodeling complexes: MacroH2A is a component of chromatin remodeling complexes, which are involved in the reorganization of chromatin structure and play a role in regulating gene expression.\n5. Topologically associating domains (TADs): MacroH2A is enriched in TADs, which are regions of chromatin that are associated with specific gene expression patterns and are thought to play a role in the regulation of gene expression.\nIn summary, macroH2A is enriched in regions of the genome that are involved in the regulation of chromatin structure and gene expression, including centromeres, telomeres, gene bodies, chromatin remodeling complexes, and TADs.",
    "llama-2-7b-chat-hf_fact": [
      "MacroH2A is a histone variant that is found in certain genomic regions.",
      "The regions include centromeres, which are crucial for the separation of chromosomes during cell division.",
      "MacroH2A is also enriched at telomeres, that help to maintain the stability of chromosomes.",
      "Gene bodies of actively transcribed genes contain enriched macroH2A.",
      "MacroH2A forms part of chromatin remodeling complexes, which help reorganize chromatin structure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1093,
    "user_query": "From which sequence does the Alu repeat originate from?",
    "llama-2-7b-chat-hf_response": "The Alu repeat is a type of retrotransposon, which is a mobile genetic element that can insert itself into new locations within a genome. Alu repeats are found in many organisms, including humans, and are thought to have originated from a common ancestor.\nThe Alu repeat is named after the Alu element, which was first identified in the human genome. It is a short sequence of DNA that is typically around 300 base pairs in length, and is flanked by inverted repeats. The Alu repeat is often found in clusters, and can be inserted into new locations within a genome through a process called retrotransposition.\nRetrotransposition is the process by which a retrotransposon, such as the Alu repeat, inserts itself into a new location within a genome. This can occur through a variety of mechanisms, including homologous recombination and non-homologous end joining. Once inserted, the Alu repeat can be transcribed and translated into RNA and protein, respectively.\nThe Alu repeat is thought to have originated from a common ancestor, and is found in many organisms, including humans. It is believed to have played a role in the evolution of the human genome, and may have contributed to the development of complex traits and diseases.\nIn summary, the Alu repeat is a type of retrotransposon that originated from a common ancestor and is found in many organisms, including humans. It is thought to have played a role in the evolution of the human genome and may have contributed to the development of complex traits and diseases.",
    "llama-2-7b-chat-hf_fact": [
      "The Alu repeat is a type of retrotransposon that can insert itself into new locations within a genome.",
      "Alu repeats are found in many organisms, including humans.",
      "The Alu repeat is named after the Alu element first identified in the human genome and is approximately 300 base pairs in length.",
      "The process by which a retrotransposon inserts itself into a new location within a genome is called retrotransposition.",
      "Alu repeat is believed to have played a role in the evolution of the human genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Alu repeats are predominantly found in primates, including humans. They are not found in many other organisms.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1099,
    "user_query": "Are there any HCV replication inhibitors available?",
    "llama-2-7b-chat-hf_response": "Yes, there are several HCV replication inhibitors available, including:\n1. Sofosbuvir (Sovaldi): This is a nucleotide polymerase inhibitor that is used to treat HCV genotype 1, 2, 4, 5, and 6 infection.\n2. Ledipasvir (Harvoni): This is a NS5A inhibitor that is used to treat HCV genotype 1, 4, 5, and 6 infection.\n3. Daclatasvir (Daklinza): This is a NS5B inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection.\n4. Velpatasvir (Epclusa): This is a NS5A inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection.\n5. Glecaprevir (Maviret): This is a NS3/4A inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection.\n6. Pibrentasvir (Vosevi): This is a NS5A inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection.\n7. Ruxolitinib (Jakavi): This is a JAK inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection in patients with myelofibrosis or polycythemia vera.\n8. Asunaprevir (Nexus): This is a NS3/4A inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection.\n9. Grazoprevir (Zepatier): This is a NS3/4A inhibitor that is used to treat HCV genotype 1, 2, 3, 4, 5, and 6 infection",
    "llama-2-7b-chat-hf_fact": [
      "Sofosbuvir is a nucleotide polymerase inhibitor used to treat HCV genotype 1, 2, 4, 5, and 6 infection.",
      "Ledipasvir, a NS5A inhibitor, is used to treat HCV genotype 1, 4, 5, and 6 infection.",
      "Daclatasvir is a NS5B inhibitor used for treating HCV genotype 1,2,3,4,5 and 6 infection.",
      "Velpatasvir, a NS5A inhibitor, is used for treating HCV genotype 1,2,3,4,5 and 6 infection.",
      "Glecaprevir is a NS3/4A inhibitor used to treat HCV genotype 1,2,3,4,5 and 6 infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Daclatasvir is a NS5A inhibitor used for treating HCV genotype 1,2,3,4,5 and 6 infection.",
      "true",
      "true"
    ]
  },
  {
    "id": 1108,
    "user_query": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?",
    "llama-2-7b-chat-hf_response": "Yes, PLK2 (Protein Kinase Like 2) has been shown to be involved in alpha-synuclein phosphorylation in Parkinson disease. Alpha-synuclein is a protein that is implicated in the pathogenesis of Parkinson disease, and its phosphorylation is thought to play a role in the formation of Lewy bodies, which are hallmarks of the disease.\nStudies have shown that PLK2 is overactive in the brains of individuals with Parkinson disease, and that this overactivity is associated with increased phosphorylation of alpha-synuclein. In addition, inhibition of PLK2 has been shown to reduce alpha-synuclein phosphorylation and improve motor function in animal models of Parkinson disease.\nOverall, these findings suggest that PLK2 may play a key role in the pathogenesis of Parkinson disease by promoting the phosphorylation of alpha-synuclein, and that targeting PLK2 may be a potential therapeutic strategy for the disease.",
    "llama-2-7b-chat-hf_fact": [
      "PLK2 (Protein Kinase Like 2) is involved in alpha-synuclein phosphorylation in Parkinson's disease.",
      "Alpha-synuclein is a protein that is implicated in the pathogenesis of Parkinson's disease.",
      "The phosphorylation of alpha-synuclein is thought to play a role in the formation of Lewy bodies, which are hallmarks of Parkinson's disease.",
      "Studies have shown PLK2 is overactive in the brains of individuals with Parkinson's disease.",
      "Inhibition of PLK2 has been shown to reduce alpha-synuclein phosphorylation and improve motor function in animal models of Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1111,
    "user_query": "Name five popular  computer  programs used to identify genes in genomic sequences",
    "llama-2-7b-chat-hf_response": ".\n1. BLAST (Basic Local Alignment Search Tool)\n2. HMMER\n3. Gapped BLAST\n4. PSI-BLAST (Position-Specific Iterated BLAST)\n5. MAFFT (Multiple Alignment using Fast Fourier Transform)",
    "llama-2-7b-chat-hf_fact": [
      "BLAST (Basic Local Alignment Search Tool) is a computer program used to identify genes in genomic sequences.",
      "HMMER is a computer program used to identify genes in genomic sequences.",
      "Gapped BLAST is a computer program used to identify genes in genomic sequences.",
      "PSI-BLAST (Position-Specific Iterated BLAST) is a computer program used to identify genes in genomic sequences.",
      "MAFFT (Multiple Alignment using Fast Fourier Transform) is a computer program used to identify genes in genomic sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: HMMER is a computer program used to identify protein sequences in genomic sequences.",
      "true",
      "true",
      "false, [corrected fact]: MAFFT (Multiple Alignment using Fast Fourier Transform) is a computer program used for multiple sequence alignments, not specifically for identifying genes."
    ]
  },
  {
    "id": 1112,
    "user_query": "Which are the major transcription factors regulating glycolysis in mammals?",
    "llama-2-7b-chat-hf_response": "Glycolysis is the first stage of cellular respiration and plays a critical role in energy metabolism. In mammals, several transcription factors regulate glycolysis by controlling the expression of genes involved in this metabolic pathway. Here are some of the major transcription factors that regulate glycolysis in mammals:\n1. Glucocorticoids: Glucocorticoids, such as cortisol, are produced by the adrenal gland and play a crucial role in regulating glycolysis. Glucocorticoids activate the expression of glycolytic enzymes, such as hexokinase and phosphoglucose isomerase, and inhibit the expression of glycolytic inhibitors, such as phosphofructokinase.\n2. Pyruvate dehydrogenase kinase (PDK): PDK is a key transcription factor that regulates the transition from glycolysis to the citric acid cycle. PDK phosphorylates and inhibits pyruvate dehydrogenase, which is the enzyme that catalyzes the conversion of pyruvate to acetyl-CoA. By inhibiting pyruvate dehydrogenase, PDK promotes the retention of pyruvate in the glycolytic pathway.\n3. Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2 or NRF2): NFE2L2 is a transcription factor that regulates the expression of genes involved in the response to oxidative stress. NFE2L2 activates the expression of glycolytic enzymes, such as hexokinase and glyceraldehyde-3-phosphate dehydrogenase, and inhibits the expression of glycolytic inhibitors, such as phosphofructokinase.\n4. Hypoxia-inducible factor (HIF): HIF is a transcription factor that regulates the expression of genes involved in response to hypoxia. HIF activates the expression of glycolytic enzymes, such as pyruvate kinase and lactate deh",
    "llama-2-7b-chat-hf_fact": [
      "Glycolysis is the first stage of cellular respiration and plays a critical role in energy metabolism in mammals.",
      "Glucocorticoids, such as cortisol, produced by the adrenal gland play a crucial role in regulating glycolysis by activating the expression of glycolytic enzymes and inhibiting the expression of glycolytic inhibitors.",
      "Pyruvate dehydrogenase kinase (PDK) is a transcription factor that regulates the transition from glycolysis to the citric acid cycle by phosphorylating and inhibiting pyruvate dehydrogenase.",
      "Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2 or NRF2) is a transcription factor that regulates the expression of genes involved in the response to oxidative stress and glycolysis.",
      "Hypoxia-inducible factor (HIF), a transcription factor, regulates the expression of genes involved in response to hypoxia and in glycolysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Pyruvate dehydrogenase kinase (PDK) is an enzyme that regulates the transition from glycolysis to the citric acid cycle by phosphorylating and inhibiting pyruvate dehydrogenase, not a transcription factor.",
      "true",
      "true"
    ]
  },
  {
    "id": 1113,
    "user_query": "Mutations in which gene determine response to both erlotinib and gefitinib?",
    "llama-2-7b-chat-hf_response": "Erlotinib and gefitinib are both tyrosine kinase inhibitors (TKIs) that are used to treat non-small cell lung cancer (NSCLC). Both drugs target the epidermal growth factor receptor (EGFR), which is overexpressed or mutated in many cases of NSCLC. However, not all patients respond to these drugs, and resistance can develop over time.\nSeveral studies have identified genetic mutations that are associated with response to erlotinib and gefitinib. For example, patients with EGFR exon 19 deletions or L858R mutations in the EGFR gene tend to respond better to erlotinib than those without these mutations. Similarly, patients with T790M mutations in the EGFR gene tend to respond better to gefitinib than those without these mutations.\nOther genetic mutations that have been associated with response to both erlotinib and gefitinib include:\n* MET amplification: MET amplification is a common genetic alteration in NSCLC that can confer resistance to both erlotinib and gefitinib.\n* PI3KCA mutations: PI3KCA mutations can also confer resistance to both erlotinib and gefitinib.\n* AKT1 mutations: AKT1 mutations have been associated with resistance to both erlotinib and gefitinib.\n* KRAS mutations: KRAS mutations are common in NSCLC and can confer resistance to both erlotinib and gefitinib.\n* BRAF mutations: BRAF mutations have been associated with resistance to both erlotinib and gefitinib.\nIt's important to note that these mutations are not present in all patients with NSCLC, and the presence of these mutations does not guarantee response to these drugs. Additionally, other factors such as tumor histology, PD-L1 expression, and the presence of other genetic mutations can also influence response to these drugs.\nIn summary, several genetic mutations have been associated with response to both erlotinib and gefitinib, including MET amplification, PI3KCA mutations, AKT1 mutations, KRAS mut",
    "llama-2-7b-chat-hf_fact": [
      "Erlotinib and gefitinib are both tyrosine kinase inhibitors (TKIs) that are used to treat non-small cell lung cancer (NSCLC).",
      "Both drugs target the epidermal growth factor receptor (EGFR), which is overexpressed or mutated in many cases of NSCLC.",
      "Patients with EGFR exon 19 deletions or L858R mutations in the EGFR gene tend to respond better to erlotinib, and those with T790M mutations in the EGFR gene respond better to gefitinib.",
      "Certain genetic mutations, such as MET amplification, PI3KCA mutations, AKT1 mutations, KRAS mutations, and BRAF mutations, have been associated with resistance to both erlotinib and gefitinib.",
      "Other factors such as tumor histology, PD-L1 expression, and the presence of other genetic mutations can also influence the response to erlotinib and gefitinib."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Patients with EGFR exon 19 deletions or L858R mutations in the EGFR gene tend to respond better to erlotinib and gefitinib, while those with T790M mutations in the EGFR gene may respond better to other EGFR TKIs like osimertinib.",
      "true",
      "true"
    ]
  },
  {
    "id": 1114,
    "user_query": "Which protein complexes contain mitofilin?",
    "llama-2-7b-chat-hf_response": "Mitofilin is a protein that is involved in the structure and function of mitochondria, which are organelles found in the cells of most eukaryotes. Mitochondria are responsible for generating energy for the cell through a process called cellular respiration, and they also play a role in other cellular processes such as signaling and the regulation of programmed cell death (apoptosis).\nThere are several protein complexes that contain mitofilin, including:\n1. The electron transport chain (ETC): The ETC is a series of protein complexes located in the mitochondrial inner membrane that work together to generate ATP through the transfer of electrons from NADH and FADH2 to oxygen. Mitofilin is a component of the ETC complex known as complex III (also known as the cytochrome b-c1 complex).\n2. The oxidative phosphorylation complex (OXPHOS): OXPHOS is a series of protein complexes located in the mitochondrial inner membrane that work together to generate ATP through the transfer of electrons from NADH and FADH2 to oxygen. Mitofilin is a component of the OXPHOS complex known as complex III (also known as the cytochrome b-c1 complex).\n3. The mitochondrial DNA (mtDNA) replication complex: This complex is responsible for replicating the mitochondrial DNA, which is a small circular molecule that contains the genetic information necessary for the production of mitochondrial proteins. Mitofilin is a component of the mtDNA replication complex.\n4. The mitochondrial fusion complex: This complex is responsible for the fusion of two mitochondria into a single, larger mitochondrion. Mitofilin is a component of the mitochondrial fusion complex.\n5. The mitochondrial dynamics complex: This complex is responsible for the movement and distribution of mitochondria within the cell. Mitofilin is a component of the mitochondrial dynamics complex.\nIt's worth noting that these complexes are not the only ones that contain mitofilin, and there are other proteins that also contain this protein. Additionally, the exact composition of these complexes can vary depending on the cell type and the specific",
    "llama-2-7b-chat-hf_fact": [
      "Mitofilin is a protein involved in the structure and function of mitochondria.",
      "Mitofilin is a component of the Electron Transport Chain, specifically complex III (cytochrome b-c1 complex).",
      "Mitofilin is a component of the Oxidative Phosphorylation Complex, specifically complex III (cytochrome b-c1 complex).",
      "Mitofilin is a part of the mitochondrial DNA replication complex, which is responsible for replicating the mitochondrial DNA.",
      "Mitofilin is also a component of the mitochondrial fusion complex and the mitochondrial dynamics complex."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mitofilin is not a component of the Electron Transport Chain, it is an inner mitochondrial membrane protein involved in maintaining the structure of the mitochondria.",
      "false, [corrected fact]: Mitofilin is not a component of the Oxidative Phosphorylation Complex, it is an inner mitochondrial membrane protein involved in maintaining the structure of the mitochondria.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1120,
    "user_query": "Which computational frameworks are available for predicting enhancers?",
    "llama-2-7b-chat-hf_response": "There are several computational frameworks available for predicting enhancers, including:\n1. DeepSEA: This is a deep learning-based framework that uses chromatin accessibility data to predict enhancers. It uses a convolutional neural network (CNN) to identify patterns in the chromatin accessibility data that are associated with enhancers.\n2. EnhancerNet: This is another deep learning-based framework that uses chromatin accessibility data to predict enhancers. It uses a combination of CNN and recurrent neural network (RNN) architectures to identify both local and global patterns in the chromatin accessibility data that are associated with enhancers.\n3. HOMER: This is a computational framework that uses a combination of machine learning and statistical methods to predict enhancers. It uses a variety of features, including chromatin accessibility data, histone modification profiles, and DNA sequence data, to train a machine learning model that can predict enhancers.\n4. ChromHMM: This is a computational framework that uses a hidden Markov model (HMM) to predict enhancers. It uses a variety of features, including chromatin accessibility data, histone modification profiles, and DNA sequence data, to train an HMM that can predict enhancers.\n5. Prognosticate: This is a computational framework that uses a combination of machine learning and statistical methods to predict enhancers. It uses a variety of features, including chromatin accessibility data, histone modification profiles, and DNA sequence data, to train a machine learning model that can predict enhancers.\n6. EnhancerScanner: This is a computational framework that uses a combination of machine learning and statistical methods to predict enhancers. It uses a variety of features, including chromatin accessibility data, histone modification profiles, and DNA sequence data, to train a machine learning model that can predict enhancers.\n7. EnhancerFinder: This is a computational framework that uses a combination of machine learning and statistical methods to predict enhancers. It uses a variety of features, including chromatin accessibility data, histone modification profiles, and DNA sequence data, to train a machine learning model that can predict enhancers.\n8. Chromatin Atlas: This is a computational framework that uses a combination of machine learning and statistical methods to predict enhancers. It uses a variety of features, including chrom",
    "llama-2-7b-chat-hf_fact": [
      "DeepSEA is a computational framework that uses chromatin accessibility data to predict enhancers using a convolutional neural network.",
      "EnhancerNet is a computational framework that combines CNN and recurrent neural network architectures to identify patterns in chromatin accessibility data for predicting enhancers.",
      "HOMER is a computational framework that uses a combination of machine learning and statistical methods to predict enhancers using chromatin accessibility data, histone modification profiles, and DNA sequence data.",
      "ChromHMM is a computational framework that uses a hidden Markov model to predict enhancers using chromatin accessibility data, histone modification profiles, and DNA sequence data.",
      "Prognosticate is a computational framework that uses machine learning and statistical methods to predict enhancers based on chromatin accessibility data, histone modification profiles, and DNA sequence data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: DeepSEA is a computational framework that predicts non-coding variant effects and regulatory annotation from DNA sequence using a deep neural network.",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1123,
    "user_query": "What is GRO-seq?",
    "llama-2-7b-chat-hf_response": "GRO-seq is a method for single-cell RNA sequencing that enables the analysis of gene expression at the level of individual cells. The acronym GRO-seq stands for \"gene expression by single-cell RNA sequencing,\" and it is a powerful tool for understanding the complex cellular processes that occur within tissues and organs.\nGRO-seq is similar to other single-cell RNA sequencing methods in that it involves isolating individual cells and extracting their RNA for sequencing. However, GRO-seq differs from other methods in several important ways:\n1. GRO-seq uses a proprietary protocol for isolating and amplifying RNA from individual cells, which allows for higher sensitivity and specificity than other methods.\n2. GRO-seq includes a novel computational pipeline for analyzing the sequencing data, which enables the identification of novel cell types and the detection of rare cell populations.\n3. GRO-seq can be used to analyze a wide range of tissues and organs, including those that are difficult or impossible to study using other single-cell RNA sequencing methods.\nThe advantages of GRO-seq include:\n1. Higher sensitivity and specificity than other single-cell RNA sequencing methods, which allows for the detection of rare cell populations and the identification of novel cell types.\n2. Ability to analyze a wide range of tissues and organs, including those that are difficult or impossible to study using other single-cell RNA sequencing methods.\n3. Novel computational pipeline for analyzing the sequencing data, which enables the identification of novel cell types and the detection of rare cell populations.\n4. Can be used to study a wide range of biological processes, including development, immunology, and cancer.\n5. Can be used to identify new therapeutic targets and to develop personalized medicine approaches.\n6. Can be used to study the effects of environmental factors on gene expression at the single-cell level.\n7. Can be used to study the effects of aging on gene expression at the single-cell level.\n8. Can be used to study the effects of disease on gene expression at the single-cell level.\n9. Can be used to study the effects of drug treatment on gene expression at the single-cell level.\n10. Can be used to study the effects of gene editing",
    "llama-2-7b-chat-hf_fact": [
      "GRO-seq is a method for single-cell RNA sequencing that allows for the analysis of gene expression at individual cells.",
      "The acronym GRO-seq stands for \"gene expression by single-cell RNA sequencing.\"",
      "GRO-seq uses a proprietary protocol for isolating and amplifying RNA from individual cells.",
      "GRO-seq involves a unique computational pipeline for analyzing sequencing data.",
      "GRO-seq can be used to analyze a wide range of tissues and organs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: GRO-seq is a method for sequencing at the level of nascent transcription, not single-cell RNA sequencing. It allows for the analysis of active gene transcription.",
      "false, [corrected fact]: The acronym GRO-seq stands for \"Global Run-On Sequencing.\"",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1134,
    "user_query": "Are Drosophila ultraconserved elements candidate ncRNAs?",
    "llama-2-7b-chat-hf_response": "Yes, Drosophila ultraconserved elements (DUEs) are candidate non-coding RNAs (ncRNAs). DUEs are regions of the Drosophila genome that are highly conserved across species, and they have been implicated in a variety of biological processes, including gene regulation and RNA processing.\nSeveral studies have shown that DUEs are transcribed and produce long non-coding RNAs (lncRNAs) that are enriched in the nucleus and cytoplasm of Drosophila cells. These lncRNAs have been shown to regulate gene expression at the post-transcriptional level by binding to messenger RNAs (mRNAs) and preventing their translation.\nOne study published in the journal Nature Communications in 2017 found that DUEs are enriched in the 3' untranslated regions (UTRs) of mRNAs and that these regions are important for mRNA stability and translation. The authors of the study suggested that DUEs may act as ncRNAs to regulate mRNA stability and translation by binding to the 3' UTRs of mRNAs and preventing their degradation.\nAnother study published in the journal Cell Reports in 2018 found that DUEs are enriched in the cytoplasm of Drosophila cells and that these regions are important for the regulation of cytoplasmic RNA granules. The authors of the study suggested that DUEs may act as ncRNAs to regulate the formation and dynamics of cytoplasmic RNA granules, which are important for the regulation of gene expression.\nOverall, these studies suggest that DUEs are candidate ncRNAs that play important roles in the regulation of gene expression in Drosophila. Further research is needed to fully understand the mechanisms by which DUEs regulate gene expression and their potential as therapeutic targets for a variety of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Drosophila ultraconserved elements (DUEs) are candidate non-coding RNAs (ncRNAs).",
      "DUEs are regions of the Drosophila genome that are highly conserved across species.",
      "DUEs are transcribed and produce long non-coding RNAs (lncRNAs) that are enriched in the nucleus and cytoplasm of Drosophila cells.",
      "One study, published in Nature Communications in 2017, found that DUEs are found in the 3' untranslated regions (UTRs) of mRNAs important for mRNA stability and translation.",
      "Another study, published in the journal Cell Reports in 2018, found that DUEs are important for the regulation of cytoplasmic RNA granules in Drosophila cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1142,
    "user_query": "How are thyroid hormones involved in the development of diabetic cardiomyopathy?",
    "llama-2-7b-chat-hf_response": "Diabetic cardiomyopathy is a condition in which the heart muscle becomes weakened and enlarged as a result of long-term high blood sugar levels. Thyroid hormones play a significant role in the development of diabetic cardiomyopathy. Here are some ways in which thyroid hormones are involved:\n1. Inflammation: Thyroid hormones can increase inflammation in the body, which can contribute to the development of diabetic cardiomyopathy. High levels of thyroid hormones can activate immune cells and increase the production of pro-inflammatory cytokines, leading to inflammation in the heart muscle.\n2. Oxidative stress: Thyroid hormones can also increase oxidative stress in the body, which can damage the heart muscle and contribute to the development of diabetic cardiomyopathy. Oxidative stress occurs when there is an imbalance between the production of free radicals and the body's ability to neutralize them. High levels of thyroid hormones can increase the production of free radicals, leading to oxidative stress in the heart muscle.\n3. Autonomic nervous system dysfunction: The autonomic nervous system regulates various bodily functions, including heart rate and blood pressure. Dysfunction of the autonomic nervous system can contribute to the development of diabetic cardiomyopathy. Thyroid hormones can affect the autonomic nervous system, leading to dysfunction and contributing to the development of diabetic cardiomyopathy.\n4. Cardiac remodeling: Thyroid hormones can also contribute to cardiac remodeling, which is a common feature of diabetic cardiomyopathy. Cardiac remodeling refers to changes in the structure and function of the heart muscle in response to high blood sugar levels. Thyroid hormones can increase the production of growth factors, which can contribute to cardiac remodeling and the development of diabetic cardiomyopathy.\n5. Electrolyte imbalance: Thyroid hormones can also affect electrolyte balance in the body, which can contribute to the development of diabetic cardiomyopathy. Electroly",
    "llama-2-7b-chat-hf_fact": [
      "Diabetic cardiomyopathy is a condition where the heart muscle becomes weakened and enlarged due to long-term high blood sugar levels.",
      "Thyroid hormones play a significant role in the development of diabetic cardiomyopathy.",
      "High levels of thyroid hormones can increase inflammation in the body, which can contribute to the development of diabetic cardiomyopathy.",
      "Thyroid hormones can also increase oxidative stress in the body, which can damage the heart muscle and contribute to the development of diabetic cardiomyopathy.",
      "Dysfunction of the autonomic nervous system, which can be affected by thyroid hormones, can contribute to the development of diabetic cardiomyopathy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a protein that is involved in the process of angiogenesis, which is the formation of new blood vessels from pre-existing ones. Angiogenin is localized primarily in the cytoplasm of endothelial cells, which are the cells that line the blood vessels. However, it can also be found in the nucleus of these cells, where it regulates the expression of genes involved in angiogenesis.\nIn summary, the subcellular localization of angiogenin is primarily in the cytoplasm of endothelial cells, but it can also be found in the nucleus of these cells.",
    "llama-2-7b-chat-hf_fact": [
      "Angiogenin is a protein involved in the process of angiogenesis.",
      "Angiogenesis is the formation of new blood vessels from pre-existing ones.",
      "Angiogenin is primarily located in the cytoplasm of endothelial cells.",
      "Endothelial cells line the blood vessels.",
      "Angiogenin can also be found in the nucleus of endothelial cells where it regulates the expression of genes involved in angiogenesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1151,
    "user_query": "Which bone protein is used in archaelogy for dating and species identification?",
    "llama-2-7b-chat-hf_response": "Bone proteins are used in archaeology for dating and species identification. Bone collagen is the most commonly used bone protein in archaeology for dating and species identification. Collagen is a fibrous protein found in bones, cartilage, and connective tissue. It is a stable molecule that can be dated using radiocarbon or other methods, providing information about the age of the bone. Additionally, the type of collagen found in a bone can help identify the species of the individual or animal that the bone came from.",
    "llama-2-7b-chat-hf_fact": [
      "Bone proteins are used in archaeology for dating and species identification.",
      "Bone collagen is the most commonly used bone protein in archaeology for dating and species identification.",
      "Collagen is a fibrous protein found in bones, cartilage, and connective tissue.",
      "Collagen is a stable molecule that can be dated using radiocarbon or other methods.",
      "The type of collagen found in a bone can help identify the species of the individual or animal that the bone came from."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1156,
    "user_query": "Is armodafinil used for treatment of insomnia?",
    "llama-2-7b-chat-hf_response": "Armodafinil is a wakefulness-promoting drug that is used to treat conditions like narcolepsy, obstructive sleep apnea, and shift work sleep disorder. While it is not FDA-approved for the treatment of insomnia, some doctors may prescribe armodafinil off-label for this purpose.\nArmodafinil works by stimulating the brain to produce dopamine, a neurotransmitter that helps regulate sleep and wakefulness. It has been shown to help people with insomnia stay awake and alert during the day, and some studies have suggested that it may also help improve sleep quality.\nHowever, it's important to note that armodafinil is a controlled substance and has the potential for abuse and addiction. It's important to use it only as directed by your doctor and to follow their instructions carefully.\nIf you're considering using armodafinil for insomnia, it's important to talk to your doctor first. They can help you determine whether it's appropriate for you and can provide guidance on how to use it safely and effectively.\nIn summary, while armodafinil is not FDA-approved for the treatment of insomnia, it may be prescribed off-label by some doctors for this purpose. It's important to use it only as directed and to follow your doctor's instructions carefully.",
    "llama-2-7b-chat-hf_fact": [
      "Armodafinil is a wakefulness-promoting drug used to treat conditions like narcolepsy, obstructive sleep apnea, and shift work sleep disorder.",
      "Armodafinil is not FDA-approved for the treatment of insomnia.",
      "Armodafinil works by stimulating the brain to produce dopamine, a neurotransmitter that helps regulate sleep and wakefulness.",
      "Armodafinil is a controlled substance with potential for abuse and addiction.",
      "Some doctors may prescribe armodafinil off-label for the treatment of insomnia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Armodafinil works by influencing certain substances in the brain that control the sleep/wake cycle, not specifically by stimulating the brain to produce dopamine.",
      "true",
      "true"
    ]
  },
  {
    "id": 1159,
    "user_query": "What is Trypan blue used for?",
    "llama-2-7b-chat-hf_response": "Trypan blue is a dye that is commonly used in histology and cytology to stain tissues and cells for microscopic examination. It is particularly useful for staining tissues and cells that contain nucleated cells, such as those found in the brain, spinal cord, and other organs.\nTrypan blue is used for a variety of purposes, including:\n1. Tissue fixation: Trypan blue can be used to fix tissues for microscopic examination. It helps to preserve the tissue structure and prevents degradation of the tissue during the fixation process.\n2. Cell staining: Trypan blue can be used to stain cells for microscopic examination. It is particularly useful for staining cells that contain nucleated cells, such as those found in the brain, spinal cord, and other organs.\n3. Neurodegenerative diseases: Trypan blue can be used to stain brain tissue for the detection of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.\n4. Cancer: Trypan blue can be used to stain cancer cells for microscopic examination. It can help to identify cancer cells and distinguish them from normal cells.\n5. Infectious diseases: Trypan blue can be used to stain tissues for the detection of infectious diseases such as tuberculosis and leprosy.\n6. Toxicology: Trypan blue can be used to stain tissues for the detection of toxic substances such as heavy metals and pesticides.\n7. Research: Trypan blue can be used in research to study the structure and function of cells and tissues. It can be used to study the effects of drugs and other substances on cells and tissues.\nIn summary, Trypan blue is a versatile dye that can be used for a variety of purposes in histology and cytology, including tissue fixation, cell staining, and the detection of neurodegenerative diseases, cancer, infectious diseases, and toxic substances.",
    "llama-2-7b-chat-hf_fact": [
      "Trypan blue is a dye used in histology and cytology for staining tissues and cells for microscopic examination.",
      "Trypan blue can be used to fix tissues, preserving their structure and preventing degradation during the fixation process.",
      "The dye can be used to stain brain tissue for the detection of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.",
      "Trypan blue can be used to stain cancer cells for microscopic examination.",
      "The dye is utilized in research to study the structure and function of cells and tissues and to study the effects of drugs and other substances on cells and tissues."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Trypan blue is a vital stain used in histology and cytology for staining cell tissues. However, it is not used to fix tissues.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-7b-chat-hf_response": "Ranolazine, a drug used to treat angina pectoris, has been shown to activate kinase signaling pathways in the heart. Specifically, ranolazine has been shown to activate the protein kinase B (Akt) and extracellular signal-regulated kinase (ERK) pathways, which are involved in cell survival and proliferation. Activation of these pathways can help to reduce oxidative stress and inflammation in the heart, which are common features of heart failure. Additionally, ranolazine has been shown to inhibit the glycogen synthase kinase-3 (GSK-3) pathway, which can contribute to the development of heart failure. Overall, the activation of kinase signaling pathways by ranolazine may contribute to its therapeutic effects in the treatment of angina pectoris and heart failure.",
    "llama-2-7b-chat-hf_fact": [
      "Ranolazine is a drug used to treat angina pectoris.",
      "The drug ranolazine has been shown to activate kinase signaling pathways in the heart.",
      "Activation of kinase signaling pathways by ranolazine can help to reduce oxidative stress and inflammation in the heart.",
      "Ranolazine activates the protein kinase B (Akt) and extracellular signal-regulated kinase (ERK) pathways that are involved in cell survival and proliferation.",
      "Ranolazine inhibits the glycogen synthase kinase-3 (GSK-3) pathway, which can contribute to the development of heart failure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1164,
    "user_query": "Pridopidine has been tested for treatment of which disorder?",
    "llama-2-7b-chat-hf_response": "Pridopidine has been tested for treatment of schizophrenia.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1166,
    "user_query": "Are CpG islands located close to housekeeping genes?",
    "llama-2-7b-chat-hf_response": "Yes, CpG islands are often located close to housekeeping genes. Housekeeping genes are genes that are expressed at high levels in all cells of an organism and are involved in basic cellular processes such as transcription, translation, and DNA repair. CpG islands, which are regions of the genome that are enriched in the DNA base cytosine followed by a phosphate group (CpG), are known to be associated with the promoter regions of housekeeping genes.\nThe proximity of CpG islands to housekeeping genes is thought to play a role in the regulation of gene expression. The presence of CpG islands in the promoter regions of housekeeping genes can recruit proteins that are involved in the regulation of transcription, such as transcription factors and histone-modifying enzymes. These proteins can alter the chromatin structure of the promoter region, making it more accessible to RNA polymerase and other transcription factors, leading to increased transcriptional activity.\nIn addition, the presence of CpG islands in the promoter regions of housekeeping genes can also influence the stability of the mRNA transcripts. CpG islands can act as a binding site for microRNAs (miRNAs), which are small non-coding RNAs that can bind to the 3' untranslated region (UTR) of mRNAs and inhibit their translation. By locating CpG islands near housekeeping genes, the expression of these genes can be fine-tuned by the binding of miRNAs to the 3' UTR of the mRNAs.\nIn summary, the proximity of CpG islands to housekeeping genes is a common feature of mammalian genomes and is thought to play a role in the regulation of gene expression by influencing the recruitment of transcription factors and the stability of mRNA transcripts.",
    "llama-2-7b-chat-hf_fact": [
      "CpG islands often are located close to housekeeping genes.",
      "Housekeeping genes are expressed at high levels in all cells of an organism and are involved in basic cellular processes such as transcription, translation, and DNA repair.",
      "CpG islands are regions of the genome that are enriched in the DNA base cytosine followed by a phosphate group.",
      "The proximity of CpG islands to housekeeping genes is thought to play a role in the regulation of gene expression.",
      "MicroRNAs, which are small non-coding RNAs, can bind to the 3' untranslated region of mRNAs and inhibit their translation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: CpG islands are regions of the genome that are enriched in the dinucleotide sequence CG, where a cytosine nucleotide is followed by a guanine nucleotide.",
      "true",
      "true"
    ]
  },
  {
    "id": 1168,
    "user_query": "Which is the target of bortezomib used in cancer therapy?",
    "llama-2-7b-chat-hf_response": "Bortezomib is a proteasome inhibitor that is used in cancer therapy to target the ubiquitin-proteasome pathway. The ubiquitin-proteasome pathway is a complex system that regulates protein degradation in cells. In cancer cells, the ubiquitin-proteasome pathway is often dysregulated, leading to the accumulation of proteins that promote cell growth and survival. Bortezomib works by inhibiting the activity of the proteasome, which is the main enzyme responsible for protein degradation in cells. By inhibiting the proteasome, bortezomib causes an accumulation of ubiquitinated proteins, which are targeted for degradation by the proteasome. This leads to a decrease in the levels of proteins that promote cell growth and survival, and an increase in the levels of proteins that induce cell death.\nBortezomib is used to treat several types of cancer, including multiple myeloma, mantle cell lymphoma, and waldenstrm macroglobulinemia. It is typically used in combination with other chemotherapy drugs to treat these types of cancer.\nIn summary, the target of bortezomib in cancer therapy is the ubiquitin-proteasome pathway, which is dysregulated in many types of cancer cells. By inhibiting the proteasome, bortezomib causes an accumulation of ubiquitinated proteins that are targeted for degradation, leading to a decrease in the levels of proteins that promote cell growth and survival and an increase in the levels of proteins that induce cell death.",
    "llama-2-7b-chat-hf_fact": [
      "Bortezomib is a proteasome inhibitor used in cancer therapy.",
      "Bortezomib targets the ubiquitin-proteasome pathway, a system that regulates protein degradation in cells.",
      "In many types of cancer cells, the ubiquitin-proteasome pathway is often dysregulated.",
      "Bortezomib is used to treat several cancers, including multiple myeloma, mantle cell lymphoma, and waldenstrm macroglobulinemia.",
      "Bortezomib works by causing an accumulation of ubiquitinated proteins leading to an increase in proteins that induce cell death and a decrease in proteins that promote cell growth and survival."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1178,
    "user_query": "Idarucizumab is an antidote of which drug?",
    "llama-2-7b-chat-hf_response": "A) Dabigatran\nB) Warfarin\nC) Rivaroxaban\nD) Apixaban\nAnswer: A) Dabigatran\nRationale: Idarucizumab is an antidote for dabigatran, a direct oral anticoagulant (DOAC) used to prevent blood clots. It is not an antidote for warfarin, rivaroxaban, or apixaban, which are also DOACs but work through different mechanisms.",
    "llama-2-7b-chat-hf_fact": [
      "Idarucizumab is an antidote for Dabigatran.",
      "Dabigatran is a direct oral anticoagulant (DOAC) used to prevent blood clots.",
      "Idarucizumab is not an antidote for Warfarin.",
      "Idarucizumab is not an antidote for Rivaroxaban.",
      "Idarucizumab is not an antidote for Apixaban."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1179,
    "user_query": "What are the main clinical characteristics of Pendred syndrome?",
    "llama-2-7b-chat-hf_response": "Pendred syndrome is a rare genetic disorder that affects the inner ear and the thyroid gland. The main clinical characteristics of Pendred syndrome include:\n1. Progressive hearing loss: Pendred syndrome is characterized by a gradual loss of hearing, usually beginning in childhood and progressing to profound deafness by adulthood.\n2. Thyroid problems: Individuals with Pendred syndrome are at risk of developing thyroid problems, including hypothyroidism (underactive thyroid) and goiter (enlarged thyroid gland).\n3. Tinnitus: Tinnitus, or ringing in the ears, is a common symptom of Pendred syndrome.\n4. Vertigo and balance problems: Some individuals with Pendred syndrome may experience vertigo (spinning sensation) and balance problems.\n5. Meniere's disease: Pendred syndrome can also cause Meniere's disease, a disorder of the inner ear that can lead to episodes of vertigo, tinnitus, and hearing loss.\n6. Cranial nerve abnormalities: Pendred syndrome can cause abnormalities in the functioning of the cranial nerves, including the vestibular nerve, which is responsible for balance and equilibrium.\n7. Facial weakness or paralysis: In some cases, Pendred syndrome can cause weakness or paralysis of the facial muscles.\n8. Other symptoms: Other symptoms of Pendred syndrome can include headaches, nausea, and difficulty swallowing.\nIt is important to note that the age of onset and the severity of these symptoms can vary widely between individuals with Pendred syndrome. If you suspect that you or a family member may have Pendred syndrome, it is important to consult with a healthcare professional for proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Pendred syndrome is a genetic disorder that affects the inner ear and thyroid gland.",
      "The syndrome is characterized by progressive hearing loss which usually starts in childhood and can lead to profound deafness by adulthood.",
      "Individuals with Pendred syndrome can develop thyroid problems, including hypothyroidism and goiter.",
      "Tinnitus, vertigo and balance problems are common symptoms of Pendred syndrome.",
      "Pendred syndrome can cause Meniere's disease, a disorder affecting the inner ear."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Pendred syndrome does not directly cause Meniere's disease. Both can cause similar symptoms but are distinct conditions."
    ]
  },
  {
    "id": 1181,
    "user_query": "What is a popular mesaure of gene expression in RNA-seq experiments?",
    "llama-2-7b-chat-hf_response": "Answer: There are several popular measures of gene expression in RNA-seq experiments, but some of the most commonly used include:\n1. Counts per million (CPM): This is a simple measure of the number of reads that map to a particular gene or transcript. CPM is calculated by dividing the number of reads that map to a gene by the total number of reads in the sample.\n2. Fragments per kilobase of exon model per million (FPKM): This is a more sophisticated measure of gene expression that takes into account the length of the transcript and the number of exons. FPKM is calculated by dividing the number of reads that map to a gene by the total number of reads in the sample, and then multiplying by the length of the transcript in kilobases.\n3. Reads per million (RPM): This is another simple measure of gene expression that is similar to CPM, but it takes into account the total number of reads in the sample rather than just the number of reads that map to a particular gene. RPM is calculated by dividing the number of reads that map to a gene by the total number of reads in the sample.\n4. Transcripts per million (TPM): This is a measure of the number of transcripts that are present in a sample, regardless of the length of the transcript. TPM is calculated by dividing the number of reads that map to a gene by the total number of reads in the sample.\n5. Normalized expression value (NEV): This is a measure of gene expression that takes into account the total amount of RNA in the sample, as well as the number of reads that map to a particular gene. NEV is calculated by dividing the number of reads that map to a gene by the total amount of RNA in the sample, and then multiplying by the number of reads that map to the gene.\n6. DESeq: This is a statistical measure of gene expression that takes into account the variability in the data and the number of samples in the experiment. DESeq is calculated by subtracting the mean of the counts for each gene in each sample, and then dividing by the standard deviation of the counts.\n7. edgeR: This is a statistical measure of gene expression that takes into account the variability in the data and the number of samples in the experiment. EdgeR is calculated",
    "llama-2-7b-chat-hf_fact": [
      "Counts per million (CPM) is a measure of gene expression in RNA-seq experiments, calculated by the number of reads that map to a gene divided by the total number of reads in the sample.",
      "Fragments per kilobase of exon model per million (FPKM) is a method of gene expression measurement that includes the length of the transcript and the number of exons.",
      "Reads per million (RPM) is a measure of gene expression, similar to CPM, but it involves the total number of read counts in the sample.",
      "Transcripts per million (TPM) is a gene expression measure that represents the number of transcripts in a sample, indifferent to the transcript's length.",
      "Normalized expression value (NEV) is a measure of gene expression that considers the total amount of RNA in the sample and the number of reads that map to the gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Fragments per kilobase of exon model per million (FPKM) is a method of gene expression measurement that includes the length of the gene and the total number of reads.",
      "true",
      "false, [corrected fact]: Transcripts per million (TPM) is a gene expression measure that represents the number of transcripts in a sample, normalized by the transcript's length.",
      "unknown"
    ]
  },
  {
    "id": 1182,
    "user_query": "Is macroautophagy a selective degradation process?",
    "llama-2-7b-chat-hf_response": "Macroautophagy is a type of cellular degradation process in which large portions of cytoplasm are engulfed by double-membraned structures called autophagosomes. The autophagosomes then fuse with lysosomes, which contain digestive enzymes that break down the engulfed cytoplasm into smaller molecules that can be recycled or degraded.\nWhile macroautophagy is often referred to as a \"selective degradation process,\" it is important to note that it is not always selective. Macroautophagy can degrade a wide range of cellular components, including proteins, lipids, and organelles. However, the specificity of macroautophagy can vary depending on the context in which it is occurring.\nFor example, in some cases, macroautophagy may be selective for certain types of proteins or organelles, such as damaged or misfolded proteins, or for specific types of lipids. In other cases, macroautophagy may be non-selective, degrading a wide range of cellular components.\nIt is also worth noting that macroautophagy can be regulated by a variety of cellular signaling pathways, including the mTOR pathway, which can influence the specificity of macroautophagy.\nIn summary, while macroautophagy can be a selective degradation process in some cases, it is not always selective and can degrade a wide range of cellular components. The specificity of macroautophagy can vary depending on the context in which it is occurring and can be influenced by a variety of cellular signaling pathways.",
    "llama-2-7b-chat-hf_fact": [
      "Macroautophagy is a cellular degradation process.",
      "In macroautophagy, large portions of cytoplasm are engulfed by autophagosomes.",
      "Autophagosomes fuse with lysosomes to break down the engulfed cytoplasm into smaller molecules.",
      "Macroautophagy can degrade a variety of cellular components such as proteins, lipids, and organelles.",
      "The mTOR pathway is one of the cellular signaling pathways that can regulate macroautophagy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1188,
    "user_query": "Which protein is affected by dusp8 activation?",
    "llama-2-7b-chat-hf_response": "DUSP8 is a protein tyrosine phosphatase that dephosphorylates and activates various signaling proteins involved in cellular processes such as cell growth, differentiation, and survival. DUSP8 has been shown to affect the activity of several proteins, including:\n1. Src-family kinases (SFKs): DUSP8 has been shown to dephosphorylate and activate SFKs, which are involved in cellular processes such as cell adhesion, migration, and survival.\n2. FAK (focal adhesion kinase): DUSP8 has been shown to dephosphorylate and activate FAK, which is involved in cellular processes such as cell adhesion, migration, and survival.\n3. PI3K (phosphatidylinositol 3-kinase): DUSP8 has been shown to dephosphorylate and inhibit PI3K, which is involved in cellular processes such as cell survival and growth.\n4. AKT (protein kinase B): DUSP8 has been shown to dephosphorylate and activate AKT, which is involved in cellular processes such as cell survival and growth.\n5. MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase): DUSP8 has been shown to dephosphorylate and activate MAPK/ERK, which is involved in cellular processes such as cell proliferation and differentiation.\n6. JNK (c-Jun N-terminal kinase): DUSP8 has been shown to dephosphorylate and activate JNK, which is involved in cellular processes such as cell proliferation and differentiation.\n7. p38 MAPK (mitogen-activated protein kinase): DUSP8 has been shown to dephosphorylate and activate p38 MAPK, which is involved in cellular processes such as cell proliferation and differentiation.\n8. NF-B (nuclear factor kappa B): DUSP8 has been shown to dephosphorylate and activate NF-B, which is involved in cell",
    "llama-2-7b-chat-hf_fact": [
      "DUSP8 is a protein tyrosine phosphatase that dephosphorylates and activates various signaling proteins.",
      "DUSP8 can affect the activity of the Src-family kinases (SFKs).",
      "DUSP8 can also affect the activity of FAK (focal adhesion kinase).",
      "DUSP8 has been shown to dephosphorylate and inhibit PI3K (phosphatidylinositol 3-kinase).",
      "DUSP8 can affect the activity of AKT (protein kinase B)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1191,
    "user_query": "Which drugs are utilized to treat eosinophilic esophagitis?",
    "llama-2-7b-chat-hf_response": "Eosinophilic esophagitis (EoE) is a chronic allergic condition characterized by the infiltration of eosinophils in the esophageal mucosa, leading to symptoms such as difficulty swallowing, food impaction, and chest pain. The mainstay of treatment for EoE is avoidance of dietary allergens, but in some cases, medications may be necessary to manage symptoms. Here are some of the drugs utilized to treat EoE:\n1. Proton pump inhibitors (PPIs): PPIs, such as omeprazole, are commonly used to treat EoE. They help reduce the production of stomach acid, which can irritate the esophagus and worsen symptoms.\n2. Topical corticosteroids: Topical corticosteroids, such as fluticasone, can be applied directly to the esophageal mucosa to reduce inflammation and alleviate symptoms.\n3. Oral corticosteroids: Oral corticosteroids, such as prednisone, may be prescribed for short-term use to reduce inflammation and swelling in the esophagus. However, long-term use of oral corticosteroids can lead to side effects such as weight gain, mood changes, and increased risk of infections.\n4. Leukotriene modifiers: Leukotriene modifiers, such as montelukast, work by blocking the action of leukotrienes, which are inflammatory mediators involved in EoE.\n5. Theophylline: Theophylline, a methylxanthine drug, has been shown to reduce inflammation and improve symptoms in some patients with EoE.\n6. Antihistamines: Antihistamines, such as ranitidine, can help reduce the symptoms of EoE by blocking the action of histamine, a neurotransmitter involved in allergic reactions.\n7. Immunotherapy: Immunotherapy, such as sublingual immunotherapy (SLIT) or oral immunotherapy (OIT), can help desensitize",
    "llama-2-7b-chat-hf_fact": [
      "Proton pump inhibitors, like omeprazole, are used to treat Eosinophilic esophagitis.",
      "Topical corticosteroids, such as fluticasone, can be applied directly to the esophageal mucosa to treat Eosinophilic esophagitis.",
      "Oral corticosteroids, like prednisone, may be prescribed for short-term Eosinophilic esophagitis treatment.",
      "Leukotriene modifiers, such as montelukast, can be used in the treatment of Eosinophilic esophagitis.",
      "Theophylline, a methylxanthine drug, has been used in the treatment of Eosinophilic esophagitis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Proton pump inhibitors, like omeprazole, are used to treat acid reflux diseases, not specifically Eosinophilic esophagitis.",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1194,
    "user_query": "What is the Her2 status in Li-Fraumeni syndrome?",
    "llama-2-7b-chat-hf_response": "Li-Fraumeni syndrome (LFS) is a rare inherited cancer susceptibility disorder caused by mutations in the TP53 gene. The TP53 gene is a tumor suppressor gene that plays a crucial role in maintaining genomic stability and preventing cancer. LFS is characterized by an increased risk of developing various types of cancer, including breast, ovarian, soft tissue sarcoma, and adrenocortical carcinoma.\nHer2 status refers to the presence or absence of the HER2 protein in cancer cells. HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that is overexpressed in some breast and gastric cancers. Overexpression of HER2 is associated with aggressive disease and poorer prognosis.\nThe Her2 status of Li-Fraumeni syndrome patients has been studied in various cancer types, including breast cancer. A study published in the Journal of Clinical Oncology in 2017 found that Li-Fraumeni syndrome patients had a higher frequency of HER2-positive breast cancers compared to the general population. Specifically, the study found that 22% of Li-Fraumeni syndrome patients with breast cancer were HER2-positive, compared to 15% in the general population.\nAnother study published in the Journal of the National Cancer Institute in 2018 found that Li-Fraumeni syndrome patients had a higher frequency of HER2-positive ovarian cancers compared to the general population. The study found that 27% of Li-Fraumeni syndrome patients with ovarian cancer were HER2-positive, compared to 12% in the general population.\nOverall, these studies suggest that Li-Fraumeni syndrome patients may be at increased risk of developing HER2-positive cancers, particularly breast and ovarian cancers. However, further research is needed to confirm these findings and to determine the underlying mechanisms that contribute to the development of HER2-positive cancers in Li-Fraumeni syndrome patients.",
    "llama-2-7b-chat-hf_fact": [
      "Li-Fraumeni syndrome is an inherited disorder caused by mutations in the TP53 gene.",
      "The TP53 gene is a tumor suppressor gene that plays a crucial role in maintaining genomic stability and preventing cancer.",
      "HER2, or Human Epidermal Growth Factor Receptor 2, gets overexpressed in some breast and gastric cancers.",
      "A study published in the Journal of Clinical Oncology in 2017 found that Li-Fraumeni syndrome patients had a higher frequency of HER2-positive breast cancers compared to the general population.",
      "A study published in the Journal of the National Cancer Institute in 2018 found that Li-Fraumeni syndrome patients had a higher frequency of HER2-positive ovarian cancers compared to the general population."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1197,
    "user_query": "Why can't humans synthesize Neu5Gc (N-Glycolylneuraminic acid)?",
    "llama-2-7b-chat-hf_response": "N-Glycolylneuraminic acid (Neu5Gc) is a sialic acid that is found in many mammalian tissues, including the brain, nervous system, and immune cells. However, humans and other primates are unable to synthesize Neu5Gc de novo, meaning that they cannot produce it from scratch.\nThere are several reasons why humans and other primates are unable to synthesize Neu5Gc:\n1. Lack of enzymes: The enzymes required for Neu5Gc synthesis are not present in the human genome. These enzymes are found in bacteria and other microorganisms, but not in mammals.\n2. Genetic mutations: The genes responsible for Neu5Gc synthesis in other organisms have been inactivated or deleted in humans and other primates. This means that the genetic information necessary for Neu5Gc synthesis is not available in the human genome.\n3. Evolutionary history: Neu5Gc is thought to have evolved in the common ancestor of mammals and other organisms, but it has been lost in the primate lineage. This means that the genetic machinery necessary for Neu5Gc synthesis has not been preserved in the primate genome.\n4. Metabolic pathways: The metabolic pathways involved in Neu5Gc synthesis are complex and require the coordination of multiple enzymes and cofactors. Humans and other primates may not have the necessary metabolic pathways to synthesize Neu5Gc.\n5. Dietary sources: Neu5Gc is found in small amounts in some dietary sources, such as red meat and organs. However, the amount of Neu5Gc in these sources is not sufficient to meet the needs of humans and other primates.\nIn summary, humans and other primates are unable to synthesize Neu5Gc because of a combination of genetic, evolutionary, and metabolic factors. As a result, Neu5Gc must be obtained through dietary sources or supplementation.",
    "llama-2-7b-chat-hf_fact": [
      "N-Glycolylneuraminic acid (Neu5Gc) is a sialic acid found in many mammalian tissues, including the brain, nervous system, and immune cells.",
      "Humans and other primates are unable to synthesize Neu5Gc de novo, meaning that they cannot produce it from scratch.",
      "Enzymes required for Neu5Gc synthesis are not present in the human genome.",
      "Neu5Gc is found in small amounts in some dietary sources, such as red meat and organs.",
      "Neu5Gc must be obtained through dietary sources or supplementation in humans and other primates."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1198,
    "user_query": "Which enzyme is inhibited by Orteronel?",
    "llama-2-7b-chat-hf_response": "Orteronel is a drug that inhibits the enzyme CYP3A4, which is involved in the metabolism of many drugs, including some anticancer agents. By inhibiting CYP3A4, orteronel can increase the plasma concentrations of drugs that are metabolized by this enzyme, leading to increased efficacy and potential toxicities.\nA) CYP2D6\nB) CYP3A4\nC) CYP1A2\nD) CYP2C9\nE) CYP2C19",
    "llama-2-7b-chat-hf_fact": [
      "Orteronel inhibits the enzyme CYP3A4.",
      "The enzyme CYP3A4 is involved in the metabolism of many drugs, including some anticancer agents.",
      "Inhibiting CYP3A4 can lead to increased plasma concentrations of drugs that are metabolized by this enzyme.",
      "Increased plasma concentrations of certain drugs can lead to increased efficacy and potential toxicities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Orteronel inhibits the enzyme CYP17, not CYP3A4.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1202,
    "user_query": "Elaborate on the TREAT-NMD initiative for DMD patients",
    "llama-2-7b-chat-hf_response": "The TREAT-NMD (Therapeutic Research and Expertise for Neuromuscular Diseases) initiative is a European Union-funded project that aims to improve the diagnosis, treatment, and care of patients with neuromuscular diseases (NMDs), including Duchenne muscular dystrophy (DMD). The project was launched in 2011 and is expected to run for five years.\nThe TREAT-NMD initiative is a collaborative effort between clinicians, researchers, and patient organizations from across Europe. The project's main objectives are to:\n1. Establish a network of expert centers for the diagnosis and management of NMDs, including DMD. These centers will provide specialized care and treatment for patients, as well as act as hubs for research and clinical trials.\n2. Develop and implement new diagnostic tools and techniques for NMDs, including genetic testing and biomarkers. This will help to improve the accuracy of diagnosis and monitoring of disease progression.\n3. Identify and validate potential therapeutic targets for NMDs, including DMD. This will help to accelerate the development of new treatments for these diseases.\n4. Facilitate the development of new treatments for NMDs, including DMD, through collaboration between industry, academia, and patient organizations. This will help to bring new therapies to market more quickly and efficiently.\n5. Improve the quality of life for patients with NMDs, including DMD, through the development of new technologies and assistive devices. This will help to improve their mobility, independence, and overall well-being.\nThe TREAT-NMD initiative has several key components, including:\n1. The establishment of a network of expert centers for the diagnosis and management of NMDs, including DMD. These centers will provide specialized care and treatment for patients, as well as act as hubs for research and clinical trials.\n2. The development and implementation of new diagnostic tools and techniques for NMDs, including genetic testing and biomarkers. This will help to improve the accuracy of diagnosis and monitoring of disease progression.\n3. The identification and validation of potential therapeutic targets for",
    "llama-2-7b-chat-hf_fact": [
      "The TREAT-NMD (Therapeutic Research and Expertise for Neuromuscular Diseases) initiative is a European Union-funded project aimed at improving the diagnosis, treatment, and care of patients with neuromuscular diseases, including Duchenne muscular dystrophy.",
      "The TREAT-NMD project was launched in 2011 and was expected to run for five years.",
      "The initiative is a result of collaborative efforts between clinicians, researchers, and patient organizations from across Europe.",
      "A key component of the TREAT-NMD initiative is the establishment of a network of expert centers for the diagnosis and management of neuromuscular diseases, which also serve as hubs for research and clinical trials.",
      "The TREAT-NMD initiative also works on the development and implementation of new diagnostic tools including genetic testing and biomarkers for neuromuscular diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1207,
    "user_query": "What is the physiological role of LKB1 involved in Peutz-Jeghers syndrome?",
    "llama-2-7b-chat-hf_response": "Peutz-Jeghers syndrome (PJS) is a rare genetic disorder caused by mutations in the LKB1 gene. LKB1 is a serine/threonine kinase that plays a crucial role in regulating cellular signaling pathways involved in various physiological processes, including cell growth, differentiation, and survival. PJS is characterized by the development of pigmented macules on the skin and mucous membranes, as well as an increased risk of various cancers, including breast, ovarian, and pancreatic cancer.\nThe physiological role of LKB1 involves the regulation of cellular signaling pathways, including the AMP-activated protein kinase (AMPK) pathway, the mammalian target of rapamycin (mTOR) pathway, and the DNA damage response pathway. LKB1 regulates these pathways by phosphorylating and activating downstream effectors, such as AMPK and mTOR, which in turn regulate cellular metabolism, growth, and survival.\nIn PJS, mutations in the LKB1 gene lead to the loss of LKB1 function, which can disrupt the regulation of these cellular signaling pathways. As a result, cells may become unstable and prone to mutations, leading to the development of cancer. Additionally, the loss of LKB1 function may also contribute to the development of the pigmented macules characteristic of PJS.\nOverall, the physiological role of LKB1 in PJS involves the regulation of cellular signaling pathways that are critical for maintaining cellular homeostasis and preventing the development of cancer. Understanding the physiological role of LKB1 in PJS can provide insights into the molecular mechanisms underlying this disease and may lead to the development of new therapeutic strategies for its treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Peutz-Jeghers syndrome (PJS) is a genetic disorder caused by mutations in the LKB1 gene.",
      "LKB1 is a serine/threonine kinase that regulates cellular signaling pathways related to cell growth, differentiation, and survival.",
      "PJS is associated with a higher risk of multiple types of cancer, including breast, ovarian, and pancreatic.",
      "In PJS, the loss of LKB1 function can disrupt the regulation of cellular signaling pathways, potentially leading to cancer development.",
      "The pigmented macules characteristic of PJS may be linked to the loss of LKB1 function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1213,
    "user_query": "Which is the major function of sororin?",
    "llama-2-7b-chat-hf_response": "Sororin is a protein that plays a crucial role in the regulation of gene expression, particularly in the development and progression of cancer. The major function of sororin is to bind to and regulate the activity of transcription factors, which are proteins that control the expression of genes by binding to specific DNA sequences. By modulating the activity of transcription factors, sororin can influence the expression of a wide range of genes involved in various cellular processes, including cell growth, differentiation, and survival.\nIn cancer, sororin has been shown to play a tumor-suppressor role by inhibiting the expression of oncogenic genes and promoting the expression of tumor-suppressor genes. For example, sororin has been shown to bind to and inhibit the activity of the oncogenic transcription factor c-Myc, which is overexpressed in many types of cancer. By inhibiting the activity of c-Myc, sororin can reduce the expression of oncogenic genes and promote the expression of tumor-suppressor genes, leading to the inhibition of cancer cell growth and proliferation.\nIn summary, the major function of sororin is to regulate the activity of transcription factors and influence the expression of genes involved in various cellular processes, including cell growth, differentiation, and survival. In cancer, sororin has been shown to play a tumor-suppressor role by inhibiting the expression of oncogenic genes and promoting the expression of tumor-suppressor genes.",
    "llama-2-7b-chat-hf_fact": [
      "Sororin is a protein that regulates gene expression.",
      "The major function of sororin is to bind to and regulate the activity of transcription factors.",
      "Sororin can influence the expression of genes involved in cellular processes like cell growth, differentiation, and survival.",
      "In oncology, sororin is known to play a tumor-suppressor role by inhibiting the expression of oncogenic genes.",
      "Sororin can bind to and inhibit the activity of the oncogenic transcription factor c-Myc."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Sororin is a protein that plays a regulatory role in cohesion during cell division.",
      "false, [corrected fact]: The major function of sororin is to bind to and regulate the activity of cohesion complexes.",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1216,
    "user_query": "Can desvenlafaxine be used at a dose of 50mg/day?",
    "llama-2-7b-chat-hf_response": "Yes, desvenlafaxine can be used at a dose of 50mg/day. In fact, the recommended starting dose of desvenlafaxine for major depressive disorder (MDD) is 50mg/day, and the maximum recommended dose is 100mg/day. However, it is important to note that the dose of desvenlafaxine may need to be adjusted for individual patients based on their response to the medication and other factors, such as age, liver function, and other medical conditions.\nIt is important to follow the dosing instructions provided by your healthcare provider and to not exceed the recommended dose without their approval. Taking more than the recommended dose of desvenlafaxine can increase the risk of side effects, including drowsiness, dizziness, and nausea. If you have any questions or concerns about the dosing of desvenlafaxine, be sure to discuss them with your healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Desvenlafaxine can be used at a dose of 50mg/day.",
      "The starting dose of desvenlafaxine for major depressive disorder (MDD) is 50mg/day.",
      "The maximum recommended dose of desvenlafaxine is 100mg/day.",
      "The dose of desvenlafaxine may need to be adjusted for individual patients based on their response and other factors, such as age and liver function.",
      "Exceeding the recommended dose of desvenlafaxine can increase the risk of side effects, including drowsiness, dizziness, and nausea."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1219,
    "user_query": "Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?",
    "llama-2-7b-chat-hf_response": "Ferric carboxymaltose (FCM) is a form of iron that is commonly used to treat iron deficiency anemia in patients with inflammatory bowel disease (IBD). Studies have shown that FCM is effective in increasing hemoglobin levels and improving quality of life in IBD patients with anemia. FCM is thought to be better tolerated than other forms of iron, such as ferrous sulfate, and may have a lower risk of adverse effects. However, more research is needed to fully understand the benefits and risks of using FCM to treat anemia in IBD patients.",
    "llama-2-7b-chat-hf_fact": [
      "Ferric carboxymaltose is a form of iron used to treat iron deficiency anemia in inflammatory bowel disease patients.",
      "Studies have shown that Ferric carboxymaltose can help increase hemoglobin levels.",
      "Ferric carboxymaltose is also said to improve the quality of life in inflammatory bowel disease patients suffering from anemia.",
      "It is thought that Ferric carboxymaltose is better tolerated than ferrous sulfate.",
      "There's a possibility that Ferric carboxymaltose has a lower risk of adverse effects compared to other forms of iron."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1220,
    "user_query": "Which disease is treated with Eliglustat?",
    "llama-2-7b-chat-hf_response": "Eliglustat is a medication used to treat hereditary tyrosinaemia type 1 (HT1), a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH). Eliglustat works by increasing the activity of the FAH enzyme, which helps to break down the toxic compounds that accumulate in the body due to the deficiency of FAH. By increasing the activity of FAH, eliglustat helps to reduce the levels of toxic compounds in the body and improve the symptoms of HT1.",
    "llama-2-7b-chat-hf_fact": [
      "Eliglustat is a medication used to treat hereditary tyrosinaemia type 1 (HT1).",
      "Hereditary tyrosinaemia type 1 is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH).",
      "Eliglustat works by increasing the activity of the FAH enzyme.",
      "The FAH enzyme helps break down toxic compounds that accumulate in the body due to its deficiency.",
      "By increasing the activity of FAH, eliglustat helps reduce the levels of toxic compounds in the body and improves the symptoms of HT1."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Eliglustat is a medication used to treat Gaucher disease, not hereditary tyrosinaemia type 1 (HT1).",
      "true",
      "false, [corrected fact]: Eliglustat does not work by increasing the activity of the FAH enzyme. It is a substrate reduction therapy for Gaucher disease, working by partially inhibiting the enzyme glucosylceramide synthase.",
      "true",
      "false, [corrected fact]: Eliglustat does not increase the activity of FAH. By inhibiting glucosylceramide synthase, it reduces the production of glucosylceramide, a substance that causes the problems in Gaucher disease."
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-7b-chat-hf_response": "Vsr endonuclease is a type II topoisomerase found in Escherichia coli (E. coli) that plays a crucial role in the repair of DNA damage caused by oxidative stress. The regulation of Vsr endonuclease is complex and involves multiple factors, including the growth phase of the bacteria.\nDuring the logarithmic growth phase, Vsr endonuclease activity is low, and the enzyme is primarily localized to the cytoplasm. As the bacteria enter the stationary phase, Vsr endonuclease activity increases, and the enzyme becomes localized to the nucleoid. This shift in localization is thought to be due to the increased levels of reactive oxygen species (ROS) in the stationary phase, which can damage DNA and lead to the activation of the Vsr endonuclease.\nThe regulation of Vsr endonuclease activity is also influenced by the availability of certain nutrients, such as glucose. In the presence of glucose, Vsr endonuclease activity is inhibited, suggesting that the enzyme is subject to nutrient-dependent regulation.\nOverall, the regulation of Vsr endonuclease is complex and involves multiple factors, including the growth phase of the bacteria and the availability of certain nutrients. Understanding the regulation of this enzyme can provide insights into the mechanisms of DNA repair and the response of bacteria to oxidative stress.",
    "llama-2-7b-chat-hf_fact": [
      "Vsr endonuclease is a type II topoisomerase found in Escherichia coli (E. coli).",
      "Vsr endonuclease plays a role in the repair of DNA damage caused by oxidative stress in E. coli.",
      "During the logarithmic growth phase, Vsr endonuclease activity is low and the enzyme is primarily localized to the cytoplasm.",
      "In the stationary phase, Vsr endonuclease activity increases and the enzyme shifts to the nucleoid due to the increased levels of reactive oxygen species.",
      "The activity of Vsr endonuclease is impacted by the availability of certain nutrients such as glucose in E. coli."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Vsr endonuclease is a type of endonuclease, not a topoisomerase, found in Escherichia coli (E. coli).",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1230,
    "user_query": "What is the life expectancy of professional athletes in respect to the general population?",
    "llama-2-7b-chat-hf_response": "Professional athletes are known to have a higher life expectancy compared to the general population. According to a study published in the Journal of the American Medical Association (JAMA), professional athletes have a 20-30% lower risk of death compared to the general population.",
    "llama-2-7b-chat-hf_fact": [
      "Professional athletes generally have a higher life expectancy compared to the general population.",
      "The Journal of the American Medical Association (JAMA) published a study revealing this difference in life expectancy.",
      "According to the study, professional athletes have a 20-30% lower risk of death compared to the general population."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1232,
    "user_query": "How does adrenergic signaling affect thyroid hormone receptors?",
    "llama-2-7b-chat-hf_response": "Adrenergic signaling can affect thyroid hormone receptors in several ways:\n1. Inhibition of thyroid hormone receptor activity: Adrenergic signaling can inhibit the activity of thyroid hormone receptors by phosphorylating and inhibiting their activity.\n2. Redistribution of thyroid hormone receptors: Adrenergic signaling can cause the redistribution of thyroid hormone receptors from the nucleus to the cytoplasm, where they are less active.\n3. Modulation of thyroid hormone receptor expression: Adrenergic signaling can also modulate the expression of thyroid hormone receptors, leading to changes in the number of receptors available to bind thyroid hormones.\n4. Increased degradation of thyroid hormone receptors: Adrenergic signaling can increase the degradation of thyroid hormone receptors, leading to a decrease in their activity.\n5. Impaired thyroid hormone receptor function: Adrenergic signaling can impair the function of thyroid hormone receptors by altering their ability to bind thyroid hormones, leading to changes in thyroid hormone signaling.",
    "llama-2-7b-chat-hf_fact": [
      "Adrenergic signaling can inhibit the activity of thyroid hormone receptors by phosphorylating and inhibiting their activity.",
      "Adrenergic signaling can cause the redistribution of thyroid hormone receptors from the nucleus to the cytoplasm.",
      "Adrenergic signaling can modulate the expression of thyroid hormone receptors, affecting the number of receptors available to bind thyroid hormones.",
      "Adrenergic signaling can increase the degradation of thyroid hormone receptors, reducing their activity.",
      "Adrenergic signaling can impair the function of thyroid hormone receptors by altering their ability to bind thyroid hormones."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-7b-chat-hf_response": "Beta-barrel transmembrane proteins are an important class of membrane proteins that play crucial roles in various biological processes, including cell signaling, transport of molecules across membranes, and immune response. Predicting the structure and function of these proteins is essential for understanding their mechanisms of action and for designing drugs that target them. Computational tools have been developed to predict the structure and function of beta-barrel transmembrane proteins, including:\n1. Threading algorithms: These algorithms use known protein structures to predict the structure of a beta-barrel transmembrane protein. The protein sequence is compared to a database of known protein structures, and the best match is used to predict the structure of the target protein.\n2. Molecular dynamics simulations: These simulations use computational models to simulate the behavior of a beta-barrel transmembrane protein in a lipid bilayer. The simulation can provide information on the protein's structure, dynamics, and interactions with the lipid bilayer.\n3. Machine learning algorithms: These algorithms use statistical models to predict the structure and function of a beta-barrel transmembrane protein based on its sequence. The algorithms can be trained on a dataset of known beta-barrel transmembrane proteins and used to predict the structure and function of new proteins.\n4. De novo structure prediction: This method uses computational models to predict the three-dimensional structure of a beta-barrel transmembrane protein from its amino acid sequence. The method can provide information on the protein's structure, dynamics, and interactions with the lipid bilayer.\n5. Protein threading: This method uses known protein structures to predict the structure of a beta-barrel transmembrane protein. The protein sequence is compared to a database of known protein structures, and the best match is used to predict the structure of the target protein.\n6. Molecular dynamics-based structure prediction: This method uses molecular dynamics simulations to predict the structure of a beta-barrel transmembrane protein. The simulation can provide information on the protein's structure, dynamics, and interactions with the lipid bilayer.\n7. Machine learning-based structure prediction: This method uses machine learning algorithms to predict the structure of a beta-barrel transmembrane protein based on its sequence. The algorithms can be trained on a dataset of known beta-barrel transmembrane",
    "llama-2-7b-chat-hf_fact": [
      "Beta-barrel transmembrane proteins are a class of membrane proteins that play roles in various biological processes.",
      "Threading algorithms use known protein structures to predict the structure of a beta-barrel transmembrane protein.",
      "Molecular dynamics simulations use computational models to simulate the behavior of a beta-barrel transmembrane protein in a lipid bilayer.",
      "Machine learning algorithms use statistical models to predict the structure and function of a beta-barrel transmembrane protein based on its sequence.",
      "De novo structure prediction uses computational models to predict the three-dimensional structure of a beta-barrel transmembrane protein from its amino acid sequence."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1236,
    "user_query": "Is there any cross-talk between the Wnt and the Akt pathways?",
    "llama-2-7b-chat-hf_response": "Yes, there is cross-talk between the Wnt and Akt pathways. Both pathways play important roles in regulating cellular processes such as proliferation, differentiation, and survival, and they can interact in complex ways. Here are some examples of cross-talk between the Wnt and Akt pathways:\n1. Wnt/-catenin signaling can inhibit Akt activity: Wnt/-catenin signaling can phosphorylate and inhibit the activity of Akt, which is a key regulator of cell survival and proliferation.\n2. Akt can inhibit Wnt/-catenin signaling: Akt can also inhibit Wnt/-catenin signaling by phosphorylating and inhibiting the activity of -catenin.\n3. Wnt/-catenin signaling can regulate Akt activity: Wnt/-catenin signaling can also regulate the activity of Akt by modulating the expression of genes involved in Akt signaling.\n4. Cross-talk between Wnt and Akt pathways in cancer: The Wnt/-catenin and Akt pathways are often dysregulated in cancer, and there is evidence that they interact in complex ways to promote tumorigenesis. For example, Wnt/-catenin signaling can promote the expression of pro-survival genes in cancer cells, which can be inhibited by Akt signaling.\n5. Cross-talk between Wnt and Akt pathways in stem cell maintenance: The Wnt/-catenin and Akt pathways also play important roles in regulating stem cell maintenance, and there is evidence that they interact in complex ways to regulate stem cell self-renewal and differentiation. For example, Wnt/-catenin signaling can promote the expression of genes involved in stem cell self-renewal, which can be inhibited by Akt signaling.\nIn summary, the Wnt and Akt pathways interact in complex ways to regulate cellular processes such as proliferation, differentiation, and survival. Dysregulation of these pathways can lead to a variety of diseases, including cancer and developmental disorders.",
    "llama-2-7b-chat-hf_fact": [
      "There is cross-talk between the Wnt and Akt pathways which regulate cellular processes like proliferation, differentiation, and survival.",
      "Wnt/-catenin signaling can phosphorylate and inhibit the activity of Akt.",
      "Akt has the ability to inhibit Wnt/-catenin signaling by phosphorylating and inhibiting the activity of -catenin.",
      "Wnt/-catenin and Akt pathways are often dysregulated in cancer.",
      "Wnt/-catenin and Akt pathways also play important roles in regulating stem cell maintenance, including self-renewal and differentiation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Wnt/-catenin signaling does not phosphorylate and inhibit Akt. It is GSK3, an inhibitor of the Wnt/-catenin pathway, that phosphorylates and inhibits Akt under certain conditions.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1238,
    "user_query": "Is the Snord116 cluster associated with the Prader-Willi syndrome?",
    "llama-2-7b-chat-hf_response": "Prader-Willi syndrome (PWS) is a rare genetic disorder that affects approximately 1 in 15,000 to 1 in 20,000 individuals worldwide. The disorder is caused by a genetic mutation on the paternal chromosome 15, specifically at the imprinting control region (ICR) located at 15q11.2. The ICR is a region of non-coding DNA that regulates the expression of the genes on the paternal chromosome 15.\nThe Snord116 cluster is a region of non-coding DNA located on chromosome 16p11.2, which is known to be imprinted and plays a role in the regulation of gene expression. However, there is currently no evidence to suggest that the Snord116 cluster is directly associated with the Prader-Willi syndrome.\nWhile the Snord116 cluster has been implicated in the regulation of genes involved in various biological processes, including cell proliferation, differentiation, and metabolism, the exact mechanisms by which it influences these processes are not yet fully understood. Further research is needed to determine the specific role of the Snord116 cluster in the development and function of the Prader-Willi syndrome.\nIn summary, while the Snord116 cluster is known to be imprinted and plays a role in the regulation of gene expression, there is currently no evidence to suggest that it is directly associated with the Prader-Willi syndrome. Further research is needed to fully understand the mechanisms by which the Snord116 cluster influences the development and function of this rare genetic disorder.",
    "llama-2-7b-chat-hf_fact": [
      "Prader-Willi syndrome (PWS) is a rare genetic disorder that affects approximately 1 in 15,000 to 1 in 20,000 individuals worldwide.",
      "Prader-Willi syndrome is caused by a genetic mutation on the paternal chromosome 15, specifically at the imprinting control region (ICR) located at 15q11.2.",
      "The Snord116 cluster is a region of non-coding DNA located on chromosome 16p11.2, which plays a role in the regulation of gene expression.",
      "The Snord116 cluster has been implicated in the regulation of genes involved in processes including cell proliferation, differentiation, and metabolism.",
      "As of now, there is no evidence to suggest that the Snord116 cluster is directly associated with the Prader-Willi syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The Snord116 cluster is a region of non-coding DNA located on chromosome 15q11.2, which plays a role in the regulation of gene expression.",
      "true",
      "false, [corrected fact]: There is evidence to suggest that the absence of the Snord116 cluster is directly associated with Prader-Willi syndrome."
    ]
  },
  {
    "id": 1242,
    "user_query": "Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?",
    "llama-2-7b-chat-hf_response": "Yes, nimodipine is recommended for the prevention of vasospasm in aneurysmal subarachnoid hemorrhage (aSAH) patients. Vasospasm is a common complication of aSAH, occurring in up to 60% of patients, and can lead to delayed cerebral ischemia (DCI), which can result in poor outcomes. Nimodipine, a calcium channel blocker, has been shown to reduce the incidence and severity of vasospasm in aSAH patients.\nThe International Subarachnoid Aneurysm Trial (ISAT) demonstrated that nimodipine therapy initiated within 48 hours of aneurysmal rupture and continued for 28 days reduced the risk of DCI by 50% compared to placebo. The benefit of nimodipine was observed in patients with both ruptured and unruptured aneurysms.\nThe recommended dose of nimodipine for the prevention of vasospasm in aSAH patients is 30-40 mg/day, given orally in divided doses. The drug should be started as soon as possible after aneurysmal rupture and continued for at least 28 days.\nIt is important to note that nimodipine therapy should be individualized based on the patient's clinical status and response to the drug. Monitoring of blood pressure, heart rate, and electrocardiogram (ECG) is recommended to ensure that the drug is not causing hypotension, bradycardia, or arrhythmias.\nIn summary, nimodipine is a recommended treatment for the prevention of vasospasm in aSAH patients. Its use has been shown to reduce the risk of DCI and improve outcomes in these patients.",
    "llama-2-7b-chat-hf_fact": [
      "Nimodipine is recommended for the prevention of vasospasm in aneurysmal subarachnoid hemorrhage (aSAH) patients.",
      "Vasospasm is a common complication of aSAH.",
      "The International Subarachnoid Aneurysm Trial showed that nimodipine therapy initiated within 48 hours of aneurysmal rupture reduced the risk of DCI by 50% compared to placebo.",
      "The recommended dose of nimodipine for vasospasm prevention in aSAH patients is 30-40 mg/day, started immediately after aneurysmal rupture and continued for at least 28 days.",
      "Nimodipine therapy should be monitored for potential hypotension, bradycardia, or arrhythmias."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "false, [corrected fact]: The recommended dose of nimodipine for vasospasm prevention in aSAH patients is 60 mg every 4 hours, typically started within 96 hours after aneurysmal rupture and continued for 21 days.",
      "true"
    ]
  },
  {
    "id": 1245,
    "user_query": "Where can we find the protein lacritin?",
    "llama-2-7b-chat-hf_response": "Lacritin is a protein found in the blood plasma of mammals, including humans. It is produced in the liver and plays a crucial role in the regulation of blood pressure.",
    "llama-2-7b-chat-hf_fact": [
      "Lacritin is a protein found in the blood plasma of mammals.",
      "Humans have lacritin in their blood plasma.",
      "The liver produces lacritin.",
      "Lacritin plays a role in the regulation of blood pressure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Lacritin is not found in the blood plasma of mammals, it is a protein found in the tear fluid.",
      "false, [corrected fact]: Humans do not have lacritin in their blood plasma, but they do in their tear fluid.",
      "unknown",
      "false, [corrected fact]: Lacritin does not play a role in the regulation of blood pressure, it plays a role in tear fluid lubrication and ocular surface health."
    ]
  },
  {
    "id": 1247,
    "user_query": "What is the triple screening test performed during pregnancy measuring?",
    "llama-2-7b-chat-hf_response": "The triple screening test, also known as the triple test, is a prenatal test that measures the levels of three substances in a pregnant woman's blood:\n1. Human chorionic gonadotropin (hCG): This is a hormone produced by the placenta during pregnancy. High levels of hCG can indicate a higher risk of certain birth defects, such as Down syndrome.\n2. Estriol (E3): This is a type of estrogen produced by the placenta. High levels of estriol can also indicate a higher risk of certain birth defects, such as Down syndrome.\n3. Inhibin A: This is a hormone produced by the placenta that helps to regulate the levels of other hormones in the body. High levels of inhibin A can indicate a higher risk of certain birth defects, such as neural tube defects.\nThe triple screening test is typically performed between 15 and 20 weeks of pregnancy and can help identify pregnancies that may be at higher risk for certain birth defects. However, it is important to note that the test is not 100% accurate and cannot diagnose all birth defects. Additional testing may be recommended if the results of the triple screening test are abnormal.",
    "llama-2-7b-chat-hf_fact": [
      "The triple screening test in pregnancy measures the levels of three substances in a woman's blood: Human chorionic gonadotropin, Estriol, and Inhibin A.",
      "Human chorionic gonadotropin is a hormone produced by the placenta during pregnancy.",
      "High levels of Human chorionic gonadotropin can indicate a higher risk of certain birth defects, such as Down syndrome.",
      "The triple screening test is typically performed between 15 and 20 weeks of pregnancy.",
      "This test can help identify pregnancies that may be at higher risk for certain birth defects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The triple screening test in pregnancy measures the levels of three substances in a woman's blood: Human chorionic gonadotropin, Estriol, and Alpha-fetoprotein.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1249,
    "user_query": "Which protein interacts with the Ragulator-RAG GTPases to control mTOR activity?",
    "llama-2-7b-chat-hf_response": "The Ragulator-RAG GTPases interact with and regulate the activity of the mTOR (mechanistic target of rapamycin) protein complex, which is a key regulator of cell growth and metabolism. The Ragulator complex is a GTPase-activating protein (GAP) that stimulates the activity of the RAG GTPases, which in turn inhibit the activity of mTORC1 and mTORC2. The Ragulator-RAG complex plays a critical role in regulating cell growth and metabolism in response to nutrient availability and other environmental cues.",
    "llama-2-7b-chat-hf_fact": [
      "The Ragulator-RAG GTPases interact with the mTOR (mechanistic target of rapamycin) protein complex.",
      "The mTOR protein complex regulates cell growth and metabolism.",
      "The Ragulator complex is a GTPase-activating protein (GAP) that stimulates the activity of the RAG GTPases.",
      "RAG GTPases inhibit the activity of mTORC1 and mTORC2.",
      "The Ragulator-RAG complex regulates cell growth and metabolism in response to nutrient availability and other environmental cues."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: RAG GTPases regulate the activity of mTORC1, but not mTORC2.",
      "true"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-7b-chat-hf_response": "A. Schizophrenia\nB. Bipolar disorder\nC. Attention deficit hyperactivity disorder (ADHD)\nD. Post-traumatic stress disorder (PTSD)\nCorrect answer: B. Bipolar disorder.\nGalassi classification is a system used to classify mood disorders, including bipolar disorder. It was developed by Italian psychiatrist Giovanni Galassi in the 1980s and is based on the idea that mood disorders can be divided into three main categories:\n1. Bipolar I disorder: characterized by at least one manic episode, which may be accompanied by depressive episodes.\n2. Bipolar II disorder: characterized by at least one major depressive episode and at least one hypomanic episode (a milder form of mania).\n3. Cyclothymic disorder: characterized by periods of hypomania and depression that last at least two years but do not meet the criteria for a major depressive or manic episode.\nGalassi classification is widely used in clinical practice and research to help diagnose and manage mood disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Galassi classification is a system used to classify mood disorders.",
      "This classification system includes bipolar disorder.",
      "The Galassi classification was developed by Italian psychiatrist Giovanni Galassi in the 1980s.",
      "Galassi classification is based on the idea that mood disorders can be divided into three main categories: Bipolar I disorder, Bipolar II disorder, and Cyclothymic disorder.",
      "The Galassi classification is widely used in clinical practice and research to help diagnose and manage mood disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1258,
    "user_query": "List fluorescent reporter proteins.",
    "llama-2-7b-chat-hf_response": "Fluorescent reporter proteins are proteins that emit light, or fluoresce, when exposed to certain wavelengths of light. These proteins are commonly used in molecular biology to visualize and track the expression and localization of specific genes or proteins within cells.\nThere are many different types of fluorescent reporter proteins available, each with its own unique properties and applications. Some of the most commonly used fluorescent reporter proteins include:\n1. GFP (Green Fluorescent Protein): GFP is one of the most widely used fluorescent reporter proteins. It is derived from the jellyfish Aequorea victoria and emits green light when exposed to blue light. GFP is often used to visualize protein localization and dynamics within cells.\n2. RFP (Red Fluorescent Protein): RFP is similar to GFP but emits red light instead of green light. It is also derived from the jellyfish Aequorea victoria. RFP is often used to visualize protein localization and dynamics within cells.\n3. YFP (Yellow Fluorescent Protein): YFP is a variant of GFP that emits yellow light instead of green light. It is also derived from the jellyfish Aequorea victoria. YFP is often used to visualize protein localization and dynamics within cells.\n4. CFP (Cyan Fluorescent Protein): CFP is a variant of GFP that emits cyan light instead of green light. It is also derived from the jellyfish Aequorea victoria. CFP is often used to visualize protein localization and dynamics within cells.\n5. YOYO-1: YOYO-1 is a fluorescent protein that emits yellow light when exposed to blue light. It is often used to visualize protein localization and dynamics within cells.\n6. mCherry: mCherry is a fluorescent protein that emits red light when exposed to blue light. It is often used to visualize protein localization and dynamics within cells.\n7. tdTomato: tdTomato is a fluorescent protein that emits red light when exposed to blue light. It is often used to visualize protein localization and dynamics within cells.\n8. HcRed: H",
    "llama-2-7b-chat-hf_fact": [
      "Fluorescent reporter proteins are proteins that emit light when exposed to certain wavelengths of light and are commonly used in molecular biology to track gene or protein activity.",
      "Green Fluorescent Protein (GFP) is derived from the jellyfish Aequorea victoria and emits green light when exposed to blue light.",
      "Red Fluorescent Protein (RFP) is similar to GFP but emits red light, and it is also derived from the same jellyfish Aequorea victoria.",
      "Yellow Fluorescent Protein (YFP) and Cyan Fluorescent Protein (CFP) are variants of GFP, which emit yellow and cyan lights respectively, and are also derived from the jellyfish Aequorea victoria.",
      "YOYO-1, tdTomato, and mCherry are all other types of fluorescent proteins that emit yellow and red lights respectively when exposed to blue light."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Red Fluorescent Protein (RFP) is derived from the sea anemone, Discosoma sp., not the jellyfish Aequorea victoria.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1259,
    "user_query": "By which mechanism MutT proteins act against DNA lesions in bacteria?",
    "llama-2-7b-chat-hf_response": "MutT proteins are DNA glycosylases that are involved in the repair of DNA lesions in bacteria. These proteins act by recognizing and binding to DNA lesions, such as apurinic/apyrimidinic sites (AP sites), and then removing the damaged base through a glycosylase reaction. This results in the formation of an abasic site, which can then be repaired through the base excision repair (BER) pathway.\nIn addition to their role in repairing DNA lesions, MutT proteins also play a role in the regulation of DNA replication and recombination in bacteria. They can bind to specific DNA sequences and inhibit the activity of other DNA repair proteins, such as the RecA protein, which is involved in recombination.\nMutT proteins are composed of several distinct domains, including an N-terminal domain, a central domain, and a C-terminal domain. These domains allow the protein to recognize and bind to DNA lesions, as well as to interact with other proteins involved in DNA repair.\nOverall, the mechanism by which MutT proteins act against DNA lesions in bacteria involves their ability to recognize and bind to specific DNA sequences, followed by the removal of the damaged base through a glycosylase reaction. This process helps to maintain the integrity of the bacterial genome and prevent mutations that can lead to genetic instability and disease.",
    "llama-2-7b-chat-hf_fact": [
      "MutT proteins are DNA glycosylases that involved in the repair of DNA lesions in bacteria.",
      "MutT proteins recognize and bind to DNA lesions and then remove the damaged base through a glycosylase reaction.",
      "The repair process involving MutT proteins results in the formation of an abasic site, which can then be repaired through the base excision repair (BER) pathway.",
      "In addition to repairing DNA lesions, MutT proteins also play a role in the regulation of DNA replication and recombination in bacteria.",
      "MutT proteins are composed of several distinct domains, which allow the protein to recognize and bind to DNA lesions, and to interact with other proteins involved in DNA repair."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: MutT proteins do not directly involve in the regulation of DNA replication and recombination.",
      "true"
    ]
  },
  {
    "id": 1269,
    "user_query": "Which is the molecular function of the protein CCDC40?",
    "llama-2-7b-chat-hf_response": "CCDC40 is a protein that is encoded by the CCDC40 gene in humans. The protein is a member of the CCDC40 family of proteins, which are involved in various cellular processes, including cell signaling, cytoskeleton organization, and protein transport.\nThe molecular function of CCDC40 is not well understood, but it is believed to play a role in regulating the cytoskeleton and cell signaling pathways. The protein is composed of multiple domains, including an N-terminal signal peptide, a coiled-coil domain, and a C-terminal PDZ-binding motif. These domains may allow the protein to interact with other proteins and play a role in cellular processes such as cell adhesion, migration, and differentiation.\nSome studies have suggested that CCDC40 may be involved in regulating the activity of certain signaling pathways, including the Wnt/-catenin pathway. The protein has been shown to interact with -catenin and other proteins in this pathway, and may play a role in regulating the stability and activity of -catenin.\nOther studies have suggested that CCDC40 may be involved in regulating the cytoskeleton and cell migration. The protein has been shown to interact with actin filaments and other cytoskeletal proteins, and may play a role in regulating cell migration and invasion.\nOverall, the molecular function of CCDC40 is not fully understood, but it is believed to play a role in regulating cellular processes such as cell signaling, cytoskeleton organization, and protein transport. Further research is needed to fully elucidate the function of this protein.",
    "llama-2-7b-chat-hf_fact": [
      "CCDC40 is a protein encoded by the CCDC40 gene in humans.",
      "The CCDC40 protein belongs to the CCDC40 family of proteins, which are involved in cellular processes like cell signaling, cytoskeleton organization, and protein transport.",
      "The CCDC40 protein consists of multiple domains, including an N-terminal signal peptide, a coiled-coil domain, and a C-terminal PDZ-binding motif.",
      "Some research indicates that CCDC40 may be involved in regulating the Wnt/-catenin pathway by interacting with -catenin and other proteins.",
      "Other studies suggest that CCDC40 may interact with actin filaments and other cytoskeletal proteins to regulate cell migration and invasion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1273,
    "user_query": "What is Cerebral Cavernous Malformation?",
    "llama-2-7b-chat-hf_response": "Cerebral cavernous malformations (CCMs) are abnormalities in the brain that are caused by an abnormal development of blood vessels. They are also known as cavernous malformations or cavernous angiomas.\nWhat are the symptoms of Cerebral Cavernous Malformation?\nThe symptoms of CCMs can vary depending on the location and size of the malformation. Some common symptoms include:\nHeadaches: Headaches are the most common symptom of CCMs, and they can range from mild to severe.\nSeizures: CCMs can cause seizures, which can be a sign of a more serious problem.\nWeakness or numbness: Weakness or numbness in the face, arm, or leg can be a sign of a CCM.\nVision problems: CCMs can cause vision problems, including blurred vision, double vision, or loss of vision.\nCognitive problems: CCMs can cause cognitive problems, including difficulty with concentration, memory, or speech.\nHow is Cerebral Cavernous Malformation diagnosed?\nDiagnosis of CCMs typically involves a combination of imaging tests, including:\nMagnetic Resonance Imaging (MRI): MRI is the most common imaging test used to diagnose CCMs. It provides detailed images of the brain and can help doctors identify the location and size of the malformation.\nComputed Tomography (CT) Scan: A CT scan can also be used to diagnose CCMs. It provides detailed images of the brain and can help doctors identify the location and size of the malformation.\nAngiography: Angiography is a test that uses dye and X-rays to visualize the blood vessels in the brain. It can help doctors identify the location and size of the malformation.\nHow is Cerebral Cavernous Malformation treated?\nTreatment for CCMs depends on the location, size, and symptoms of the malformation. Some common treatments include:\nObservation: Small CCMs that are not causing symptoms may not require treatment. Doctors will monitor the malformation with regular imaging tests to ensure that it does not grow or change.\nSurg",
    "llama-2-7b-chat-hf_fact": [
      "Cerebral cavernous malformations (CCMs) are abnormalities in the brain caused by abnormal development of blood vessels.",
      "Symptoms of CCMs can include headaches, seizures, weakness or numbness, vision problems, and cognitive problems.",
      "MRI, CT Scan, and Angiography are common imaging tests used to diagnose Cerebral Cavernous Malformations.",
      "The treatment for CCMs depends on the location, size, and symptoms of the malformation.",
      "Small CCMs that are not causing symptoms may not require treatment and are monitored with regular imaging tests."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1275,
    "user_query": "Which protein pathway is regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation?",
    "llama-2-7b-chat-hf_response": "The protein pathway regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation is the PI3K/Akt signaling pathway. SGK1 (serum- and glucocorticoid-induced protein kinase 1) phosphorylates and activates FOXO3a (forkhead box O3a), which is a transcription factor that regulates cell proliferation, metabolism, and survival. The PI3K/Akt signaling pathway is a key upstream regulator of SGK1 activity, as PI3K (phosphatidylinositol 3-kinase) generates phosphatidylinositol 3,4,5-trisphosphate (PIP3) that recruits and activates Akt, which in turn phosphorylates and activates SGK1. Therefore, the PI3K/Akt signaling pathway regulates SGK1-mediated phosphorylation of FOXO3a and controls cell proliferation.",
    "llama-2-7b-chat-hf_fact": [
      "PI3K/Akt signaling pathway regulates SGK1-mediated phosphorylation of FOXO3a.",
      "SGK1 is an abbreviation for serum- and glucocorticoid-induced protein kinase 1.",
      "FOXO3a, which is a transcription factor, regulates cell proliferation, metabolism, and survival.",
      "PI3K is the abbreviation for phosphatidylinositol 3-kinase, which is part of the PI3K/Akt signaling pathway.",
      "Phosphatidylinositol 3-kinase generates phosphatidylinositol 3,4,5-trisphosphate that recruits and activates Akt."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1281,
    "user_query": "Is TNNI3K a cardiac-specific protein?",
    "llama-2-7b-chat-hf_response": "TNNI3K is a protein that is encoded by the TNNI3K gene in humans. It is a member of the troponin I family of proteins, which are involved in the regulation of muscle contraction. TNNI3K is specifically expressed in the heart and is thought to play a role in the regulation of cardiac muscle contraction.",
    "llama-2-7b-chat-hf_fact": [
      "TNNI3K is a protein that is encoded by the TNNI3K gene in humans.",
      "TNNI3K is a member of the troponin I family of proteins.",
      "The troponin I family of proteins are involved in the regulation of muscle contraction.",
      "TNNI3K is specifically expressed in the heart.",
      "TNNI3K is believed to play a role in the regulation of cardiac muscle contraction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: TNNI3K is not a member of the troponin I family of proteins, but a kinase, which can phosphorylate troponin I.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1287,
    "user_query": "Can the apoptosis regulator BAX trigger the release of cytochrome c?",
    "llama-2-7b-chat-hf_response": "Yes, BAX can trigger the release of cytochrome c. BAX is a pro-apoptotic protein that plays a crucial role in the regulation of programmed cell death (apoptosis). BAX is a member of the Bcl-2 family of proteins, which are involved in the regulation of mitochondrial outer membrane permeabilization (MOMP) and the release of cytochrome c from the mitochondria.\nWhen BAX is activated, it forms pores in the mitochondrial outer membrane, allowing cytochrome c to diffuse out of the mitochondria and into the cytosol. Once in the cytosol, cytochrome c can bind to APAF-1, a protein that activates the caspase cascade, leading to the activation of downstream executioner caspases and the induction of apoptosis.\nBAX can trigger the release of cytochrome c through several mechanisms, including:\n1. Pore formation: BAX can form pores in the mitochondrial outer membrane, allowing cytochrome c to diffuse out of the mitochondria.\n2. Proteolytic cleavage: BAX can be proteolytically cleaved by caspases, leading to the release of the N-terminal fragment, which can also induce cytochrome c release.\n3. Interaction with other proteins: BAX can interact with other proteins, such as BH3-interacting domain (BID), which can also induce cytochrome c release.\nIn summary, BAX can trigger the release of cytochrome c by forming pores in the mitochondrial outer membrane, being proteolytically cleaved, or interacting with other proteins. The release of cytochrome c from the mitochondria is a crucial step in the activation of the caspase cascade and the induction of apoptosis.",
    "llama-2-7b-chat-hf_fact": [
      "BAX, a pro-apoptotic protein, can trigger the release of cytochrome c.",
      "BAX is a member of the Bcl-2 family of proteins, which are involved in the regulation of mitochondrial outer membrane permeabilization (MOMP).",
      "Activated BAX forms pores in the mitochondrial outer membrane, allowing cytochrome c to outflow into the cytosol.",
      "In the cytosol, cytochrome c can bind to APAF-1, a protein that activates the caspase cascade, leading to the activation of downstream executioner caspases and the induction of apoptosis.",
      "BAX can also trigger the release of cytochrome c by being proteolytically cleaved or interacting with other proteins such as BH3-interacting domain (BID)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1289,
    "user_query": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients",
    "llama-2-7b-chat-hf_response": "with BRAF V600E mutation\nBRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients with BRAF V600E mutation include:\n1. Vemurafenib (Zelboraf): This is a BRAF inhibitor that has been approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma.\n2. Dabrafenib (Tafinlar): This is another BRAF inhibitor that has been approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma.\n3. Trametinib (Mekinist): This is a MEK inhibitor that has been approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma in combination with vemurafenib.\n4. Cobimetinib (Cotellic): This is a MEK inhibitor that has been tested in clinical trials for the treatment of patients with BRAF V600E mutation-positive melanoma in combination with vemurafenib or dabrafenib.\n5. Encorafenib (Braftovi): This is a BRAF inhibitor that has been approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma in combination with binimetinib (a MEK inhibitor) and cetuximab (an EGFR inhibitor).\n6. Binimetinib (Mekinist): This is a MEK inhibitor that has been tested in clinical trials for the treatment of patients with BRAF V600E mutation-positive melanoma in combination with vemurafenib or dabrafenib.\n7. AZD6244 (Selumetinib): This is a BRAF inhibitor that has been tested in clinical trials for the treatment of patients with BRAF V600E mutation-positive melanoma.\n8. GSK2118436 (",
    "llama-2-7b-chat-hf_fact": [
      "Vemurafenib is a BRAF inhibitor approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma.",
      "Dabrafenib is a BRAF inhibitor that has been approved by the FDA for the treatment of BRAF V600E mutation-positive melanoma.",
      "Trametinib is a MEK inhibitor that has been approved by the FDA for patient treatment in combination with vemurafenib for BRAF V600E mutation-positive melanoma.",
      "Cobimetinib is a MEK inhibitor that has been tested in clinical trials for the treatment of patients with BRAF V600E mutation-positive melanoma, used in combination with vemurafenib or dabrafenib.",
      "Encorafenib is a BRAF inhibitor that has been approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma, typically in combination with binimetinib and cetuximab."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Encorafenib is a BRAF inhibitor that has been approved by the FDA for the treatment of patients with BRAF V600E mutation-positive melanoma, typically in combination with binimetinib. Cetuximab is not typically part of this combination therapy."
    ]
  },
  {
    "id": 1292,
    "user_query": "Which are the coactivators of the Yes-associated protein (yap)?",
    "llama-2-7b-chat-hf_response": "YAP (Yes-associated protein) is a transcriptional coactivator that plays a crucial role in regulating cell growth, differentiation, and survival. YAP is a downstream effector of the Hippo signaling pathway, which is a conserved signaling cascade that regulates organ size, tissue growth, and stem cell self-renewal in various organisms.\nSeveral coactivators have been identified that interact with YAP and enhance its transcriptional activity. These coactivators include:\n1. TEAD (transcriptional enhancer activator domain): TEAD is a transcription factor that interacts with YAP and enhances its transcriptional activity. TEAD is a downstream target of the Hippo signaling pathway and is required for YAP-mediated transcriptional activation.\n2. TAZ (transcriptional coactivator with PDZ-binding motif): TAZ is another transcriptional coactivator that interacts with YAP and enhances its transcriptional activity. TAZ is also a downstream target of the Hippo signaling pathway and is required for YAP-mediated transcriptional activation.\n3. CBP (CREB-binding protein): CBP is a transcriptional coactivator that interacts with YAP and enhances its transcriptional activity. CBP is a downstream target of the Hippo signaling pathway and is required for YAP-mediated transcriptional activation.\n4. p300: p300 is a transcriptional coactivator that interacts with YAP and enhances its transcriptional activity. p300 is a downstream target of the Hippo signaling pathway and is required for YAP-mediated transcriptional activation.\n5. CBX (chromodomain-containing protein): CBX is a transcriptional coactivator that interacts with YAP and enhances its transcriptional activity. CBX is a downstream target of the Hippo signaling pathway and is required for YAP-mediated transcriptional activation.\nOverall, these coactivators play a crucial role in regulating YAP-mediated transcriptional activation and are essential for the proper functioning of the Hippo signaling pathway.",
    "llama-2-7b-chat-hf_fact": [
      "YAP (Yes-associated protein) is a transcriptional coactivator that regulates cell growth, differentiation, and survival.",
      "YAP is a downstream effector of the Hippo signaling pathway, which regulates organ size, tissue growth, and stem cell self-renewal in various organisms.",
      "TEAD, TAZ, CBP, p300, and CBX are transcriptional coactivators that interact with YAP and enhance its transcriptional activity.",
      "These coactivators are downstream targets of the Hippo signaling pathway and are required for YAP-mediated transcriptional activation.",
      "TEAD, TAZ, CBP, p300, and CBX play a key role in regulating YAP-mediated transcriptional activation and the functioning of the Hippo signaling pathway."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1296,
    "user_query": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?",
    "llama-2-7b-chat-hf_response": "Epithelial-mesenchymal transition (EMT) is a process by which epithelial cells lose their cell-cell adhesion and acquire mesenchymal characteristics, such as increased motility and invasiveness. Several proteins have been implicated in the loss of cell-cell adhesion during EMT, including:\n1. E-cadherin: E-cadherin is a transmembrane adhesion molecule that is critical for maintaining cell-cell adhesion in epithelial tissues. During EMT, E-cadherin expression is downregulated, leading to a loss of cell-cell adhesion.\n2. N-cadherin: N-cadherin is another transmembrane adhesion molecule that is involved in cell-cell adhesion. Like E-cadherin, N-cadherin expression is downregulated during EMT, leading to a loss of cell-cell adhesion.\n3. Occludin: Occludin is a cytoskeletal protein that is involved in cell-cell adhesion and tight junction formation. During EMT, occludin expression is downregulated, leading to a loss of cell-cell adhesion.\n4. Vimentin: Vimentin is a cytoskeletal protein that is involved in cell migration and invasion. During EMT, vimentin expression is upregulated, leading to a loss of cell-cell adhesion.\n5. -catenin: -catenin is a cytoskeletal protein that is involved in cell-cell adhesion and Wnt signaling. During EMT, -catenin expression is downregulated, leading to a loss of cell-cell adhesion.\n6. Snail: Snail is a transcription factor that is involved in the regulation of cell adhesion and migration. During EMT, Snail expression is upregulated, leading to a loss of cell-cell adhesion.\n7. Slug: Slug is another transcription factor that is involved in the regulation of cell adhesion and migration. During EMT, Slug expression is upregulated, leading to a loss of cell-cell ad",
    "llama-2-7b-chat-hf_fact": [
      "Epithelial-mesenchymal transition (EMT) is a process where epithelial cells lose their cell-cell adhesion and acquire mesenchymal traits.",
      "E-cadherin is a transmembrane adhesion molecule that is critical for maintaining cell-cell adhesion in epithelial tissues and its expression is downregulated during EMT.",
      "N-cadherin, another transmembrane adhesion molecule, also sees its expression downregulated during EMT.",
      "Occludin, a cytoskeletal protein involved in cell-cell adhesion, has its expression downregulated during EMT.",
      "During EMT, Vimentin expression is upregulated which leads to a loss of cell-cell adhesion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: N-cadherin, another transmembrane adhesion molecule, sees its expression upregulated during EMT.",
      "true",
      "false, [corrected fact]: During EMT, Vimentin expression is upregulated which leads to increased cell motility, not the loss of cell-cell adhesion."
    ]
  },
  {
    "id": 1300,
    "user_query": "What is known about diseases associated with mutations in the CHCHD10 gene?",
    "llama-2-7b-chat-hf_response": "The CHCHD10 gene provides instructions for making a protein called chloride channel domain-containing protein 10 (CHCHD10). This protein is involved in the transport of chloride ions across the cell membrane, which is important for maintaining the proper balance of fluids and electrolytes in the body. Mutations in the CHCHD10 gene have been associated with several rare genetic disorders, including:\n1. Bartter syndrome type 3: This is a rare genetic disorder that affects the kidneys and causes problems with the balance of electrolytes in the body. People with Bartter syndrome type 3 have low levels of potassium and high levels of aldosterone, a hormone that regulates the balance of fluids in the body.\n2. Gitelman syndrome: This is a rare genetic disorder that affects the kidneys and causes problems with the balance of electrolytes in the body. People with Gitelman syndrome have low levels of potassium and high levels of aldosterone, similar to Bartter syndrome type 3.\n3. Hypokalemic periodic paralysis: This is a rare genetic disorder that affects the muscles and causes periods of muscle weakness or paralysis. People with hypokalemic periodic paralysis have low levels of potassium in their blood, which can lead to muscle weakness or paralysis.\n4. Hyperkalemic periodic paralysis: This is a rare genetic disorder that affects the muscles and causes periods of muscle weakness or paralysis. People with hyperkalemic periodic paralysis have high levels of potassium in their blood, which can lead to muscle weakness or paralysis.\n5. Cardiac arrhythmias: Some mutations in the CHCHD10 gene have been linked to an increased risk of cardiac arrhythmias, which are abnormal heart rhythms.\nIt is important to note that not all mutations in the CHCHD10 gene will lead to disease, and the severity of the disease can vary depending on the specific mutation and the individual affected. If you have a mutation in the CHCHD10 gene, it is important to speak with a healthcare provider to",
    "llama-2-7b-chat-hf_fact": [
      "The CHCHD10 gene provides instructions for making a protein called chloride channel domain-containing protein 10 (CHCHD10).",
      "The CHCHD10 protein is involved in the transport of chloride ions across the cell membrane.",
      "Mutations in the CHCHD10 gene can lead to rare genetic disorders, which includes Bartter syndrome type 3 and Gitelman syndrome, affecting the kidneys and the balance of electrolytes in the body.",
      "Other disorders associated with mutations in CHCHD10 gene include Hypokalemic periodic paralysis and Hyperkalemic periodic paralysis, both affecting muscles and causing periods of muscle weakness or paralysis.",
      "Some mutations in the CHCHD10 gene have been linked to an increased risk of cardiac arrhythmias."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The CHCHD10 protein is not involved in the transport of chloride ions across the cell membrane. It is typically located in mitochondria of a cell and appear to play a role in maintaining the structure of these cell organelles.",
      "false, [corrected fact]: Mutations in CHCHD10 gene can lead to rare genetic disorders including frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (FTDALS2), spinal muscular atrophy Jokela type (SMAJ), and mitochondrial myopathy with dementia, not Bartter syndrome type3 and Gitelman syndrome.",
      "true",
      "true"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-7b-chat-hf_response": "Shapiro syndrome is a rare genetic disorder that affects the skin, eyes, and nervous system. Here are some common features of Shapiro syndrome:\n1. Skin abnormalities: People with Shapiro syndrome typically have skin that is thin and fragile, with a bluish tint. They may also experience skin fragility, easy bruising, and poor wound healing.\n2. Eye abnormalities: Shapiro syndrome can cause a range of eye problems, including microphthalmia (small eyes), anophthalmia (absence of one eye), cataracts, and glaucoma.\n3. Neurological problems: Shapiro syndrome can affect the nervous system, leading to problems such as seizures, developmental delays, and intellectual disability.\n4. Skeletal abnormalities: People with Shapiro syndrome may have skeletal abnormalities, including short stature, thin bones, and joint deformities.\n5. Respiratory problems: Shapiro syndrome can cause respiratory problems, including respiratory infections and chronic lung disease.\n6. Cardiovascular problems: Some people with Shapiro syndrome may experience cardiovascular problems, including heart defects and abnormal heart rhythms.\n7. Gastrointestinal problems: Shapiro syndrome can cause gastrointestinal problems, including constipation, diarrhea, and gastroesophageal reflux disease (GERD).\n8. Hearing loss: Some people with Shapiro syndrome may experience hearing loss or deafness.\n9. Vision loss: In addition to eye abnormalities, Shapiro syndrome can also cause vision loss or blindness.\n10. Increased risk of infections: People with Shapiro syndrome may be at increased risk of infections due to their weakened immune system.\nIt's important to note that not everyone with Shapiro syndrome will experience all of these features, and the severity of the condition can vary widely between individuals. If you suspect you or a family member may have Shapiro syndrome, it's important to consult",
    "llama-2-7b-chat-hf_fact": [
      "Shapiro syndrome is a rare genetic disorder that affects the skin, eyes, and nervous system.",
      "Shapiro syndrome can cause skin that is thin, fragile, and with a bluish tint.",
      "Eye problems such as small eyes, absence of one eye, cataracts, and glaucoma can occur because of Shapiro syndrome.",
      "Shapiro syndrome can lead to neurological issues like seizures, developmental delays, and intellectual disability.",
      "People with Shapiro syndrome may have skeletal abnormalities, including short stature, thin bones, and joint deformities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Eye problems such as partial or complete agenesis of the corpus callosum, small eyes, or other eye issues are not typically associated with Shapiro syndrome.",
      "true",
      "false, [corrected fact]: Shapiro syndrome does not typically cause skeletal abnormalities like short stature, thin bones, and joint deformities; the primary features are recurrent hypothermia, hyperhidrosis, and agenesis of the corpus callosum."
    ]
  },
  {
    "id": 1309,
    "user_query": "What is the role of the histidine rich calcium binding protein (HRC) in cardiomyopathy?",
    "llama-2-7b-chat-hf_response": "Histidine-rich calcium-binding protein (HRC) is a protein that has been implicated in the development and progression of various types of cardiomyopathy, including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). HRC is a calcium-binding protein that is predominantly expressed in the heart, where it plays a crucial role in regulating intracellular calcium levels and cardiac contractility.\nStudies have shown that HRC is overexpressed in the hearts of patients with HCM and DCM, and that this overexpression is associated with an increase in intracellular calcium levels and cardiac contractility. In addition, HRC has been shown to interact with other proteins that are involved in the development and progression of cardiomyopathy, such as beta-myosin heavy chain and tropomyosin.\nOverall, the role of HRC in cardiomyopathy is complex and multifaceted, and further research is needed to fully understand its mechanisms of action and its potential as a therapeutic target for the treatment of cardiomyopathy.",
    "llama-2-7b-chat-hf_fact": [
      "Histidine-rich calcium-binding protein (HRC) is involved in the development and progression of various types of cardiomyopathy.",
      "HRC is a calcium-binding protein predominantly expressed in the heart.",
      "HRC helps regulate intracellular calcium levels and cardiac contractility.",
      "Overexpression of HRC is seen in the hearts of patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).",
      "HRC interacts with other proteins, such as beta-myosin heavy chain and tropomyosin, involved in the development and progression of cardiomyopathy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1312,
    "user_query": "Which post-translational histone modifications are characteristic of facultative heterochromatin?",
    "llama-2-7b-chat-hf_response": "Facultative heterochromatin is a type of chromatin that can be either constitutive or facultative, depending on the cellular context. Constitutive heterochromatin is present in every cell of an organism and is characterized by the presence of specific histone modifications, such as histone 3 lysine 9 trimethylation (H3K9me3) and histone 4 lysine 20 trimethylation (H4K20me3). In contrast, facultative heterochromatin is present only in certain cell types or under specific conditions, and is characterized by the presence of other histone modifications, such as histone 3 lysine 27 trimethylation (H3K27me3) and histone 4 lysine 5 trimethylation (H4K5me3).\nSome of the post-translational histone modifications that are characteristic of facultative heterochromatin include:\n1. Histone 3 lysine 27 trimethylation (H3K27me3): This modification is known to be involved in the regulation of gene expression, particularly during development and cell differentiation.\n2. Histone 4 lysine 5 trimethylation (H4K5me3): This modification is also involved in the regulation of gene expression, and is known to be involved in the maintenance of facultative heterochromatin.\n3. Histone 3 lysine 79 dimethylation (H3K79me2): This modification is involved in the regulation of chromatin dynamics and is known to be involved in the maintenance of facultative heterochromatin.\n4. Histone 4 lysine 8 trimethylation (H4K8me3): This modification is involved in the regulation of gene expression and is known to be involved in the maintenance of facultative heterochromatin.\n5. Histone 3 lysine 14 acetylation (H3K14ac): This modification is involved in the regulation of chromatin dynamics and is known to be involved in the maintenance of facultative heterochromatin.\n6. Histone 4 lysine 9 acetylation (H4K9ac): This modification is involved",
    "llama-2-7b-chat-hf_fact": [
      "Facultative heterochromatin can be either constitutive or facultative, depending on the cellular context.",
      "Histone 3 lysine 27 trimethylation (H3K27me3) is a post-translational histone modification characteristic of facultative heterochromatin.",
      "Histone 4 lysine 5 trimethylation (H4K5me3) is a post-translational histone modification characteristic of facultative heterochromatin.",
      "Histone 3 lysine 79 dimethylation (H3K79me2) is a post-translational histone modification characteristic of facultative heterochromatin.",
      "Histone 3 lysine 14 acetylation (H3K14ac) is involved in the regulation of chromatin dynamics and is characteristic of facultative heterochromatin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Histone 4 lysine 20 trimethylation (H4K20me3) is a post-translational histone modification characteristic of constitutive heterochromatin, not facultative heterochromatin.",
      "false, [corrected fact]: Histone 3 lysine 79 dimethylation (H3K79me2) is linked with active transcription and is not specific to facultative heterochromatin.",
      "true"
    ]
  },
  {
    "id": 1313,
    "user_query": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?",
    "llama-2-7b-chat-hf_response": "Aicardi-Goutieres syndrome is a rare genetic disorder that affects the brain and nervous system. It is caused by mutations in several genes, including:\n1. AGT: The Aicardi-Goutieres syndrome gene (AGT) is located on chromosome 16 and encodes for a protein involved in the development and maintenance of the brain. Mutations in the AGT gene are the most common cause of Aicardi-Goutieres syndrome.\n2. CYP26B1: The cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1) gene is located on chromosome 6 and encodes for an enzyme involved in the biosynthesis of cholesterol. Mutations in the CYP26B1 gene have been identified in some cases of Aicardi-Goutieres syndrome.\n3. CDKL5: The cyclin-dependent kinase-like 5 (CDKL5) gene is located on chromosome 9 and encodes for a protein involved in the regulation of cell growth and division. Mutations in the CDKL5 gene have been identified in some cases of Aicardi-Goutieres syndrome.\n4. KCNQ2: The potassium voltage-gated channel subfamily Q, member 2 (KCNQ2) gene is located on chromosome 11 and encodes for a protein involved in the regulation of electrical signaling in neurons. Mutations in the KCNQ2 gene have been identified in some cases of Aicardi-Goutieres syndrome.\n5. KCNQ3: The potassium voltage-gated channel subfamily Q, member 3 (KCNQ3) gene is located on chromosome 11 and encodes for a protein involved in the regulation of electrical signaling in neurons. Mutations in the KCNQ3 gene have been identified in some cases of Aicardi-Goutieres syndrome.\n6. PLP1: The myelin protein 1 (PLP1) gene is located on chromosome 17 and encodes for a protein involved in the",
    "llama-2-7b-chat-hf_fact": [
      "Aicardi-Goutieres syndrome is a rare genetic disorder that affects the brain and nervous system.",
      "Mutations in the AGT gene, located on chromosome 16, are a common cause of Aicardi-Goutieres syndrome.",
      "The CYP26B1 gene, located on chromosome 6, has also been associated with Aicardi-Goutieres syndrome in some cases.",
      "In some cases of Aicardi-Goutieres syndrome, mutations have been found in the CDKL5 gene, located on chromosome 9.",
      "The KCNQ2 gene located on chromosome 11 has been linked to Aicardi-Goutieres syndrome in some instances.",
      "Some cases of Aicardi-Goutieres syndrome have shown to have mutations in the KCNQ3 gene, also located on chromosome 11."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mutations in different genes such as TREX1, RNASEH2B, RNASEH2C, RNASEH2A, SAMHD1, ADAR, and others, not the AGT gene, are known to cause Aicardi-Goutieres syndrome.",
      "false, [corrected fact]: There has been no known association between the CYP26B1 gene and Aicardi-Goutieres syndrome.",
      "false, [corrected fact]: The CDKL5 gene is not associated with Aicardi-Goutieres syndrome but is commonly associated with a different neurological disorder.",
      "false, [corrected fact]: The KCNQ2 gene is not known to be linked with Aicardi-Goutieres syndrome. It is associated with some forms of epilepsy.",
      "false, [corrected fact]: The KCNQ3 gene is not associated with Aicardi-Goutieres syndrome but is related to inherited forms of epilepsy."
    ]
  },
  {
    "id": 1317,
    "user_query": "What is the mechanism of action of abiraterone?",
    "llama-2-7b-chat-hf_response": "Abiraterone is a drug used to treat prostate cancer that has spread to other parts of the body (metastatic castrate-resistant prostate cancer). It works by inhibiting the production of androgens, which are hormones that fuel the growth of prostate cancer cells. Abiraterone blocks the conversion of androgens into dihydrotestosterone (DHT), a potent form of androgen that promotes the growth of prostate cancer cells. By reducing the levels of DHT in the body, abiraterone slows the growth of prostate cancer cells and can shrink tumors.\nAbiraterone is taken as a pill and is usually given in combination with the drug prednisone, which helps to reduce the risk of certain side effects. Abiraterone has been shown to be effective in delaying the growth of prostate cancer and improving symptoms in men with metastatic castrate-resistant prostate cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Abiraterone is a drug used to treat metastatic castrate-resistant prostate cancer.",
      "It works by inhibiting the production of androgens, hormones that fuel the growth of prostate cancer cells.",
      "Abiraterone blocks the conversion of androgens into dihydrotestosterone (DHT), a form of androgen that promotes prostate cancer cell growth.",
      "The drug is usually taken as a pill in combination with prednisone to reduce side effects.",
      "Abiraterone has been effective in delaying the growth of prostate cancer and improving symptoms in men with metastatic castrate-resistant prostate cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Abiraterone blocks the production of androgens including dihydrotestosterone (DHT), rather than blocking the conversion of androgens into DHT.",
      "true",
      "true"
    ]
  },
  {
    "id": 1318,
    "user_query": "The protein neprilysin  has an positive effect on Alzheimer disease, how can it be delivered to the brain?",
    "llama-2-7b-chat-hf_response": "Neprilysin is an enzyme that plays a crucial role in the degradation of amyloid- (A) peptides, which are the main component of amyloid plaques found in the brains of Alzheimer's disease (AD) patients. Increasing neprilysin levels or activity has been shown to reduce A levels and improve cognitive function in animal models of AD. However, delivering neprilysin to the brain is challenging due to its large size and the blood-brain barrier (BBB), which restricts the entry of large molecules into the brain.\nSeveral approaches have been developed to deliver neprilysin to the brain, including:\n1. Viral vectors: Viruses can be engineered to express neprilysin and deliver them to the brain. The most commonly used viral vectors are adenovirus, adeno-associated virus, and lentivirus.\n2. Liposomes: Neprilysin can be encapsulated in liposomes, which are small, spherical vesicles made of lipids. Liposomes can cross the BBB and deliver neprilysin to the brain.\n3. Nanoparticles: Neprilysin can be encapsulated in nanoparticles, which are small particles made of materials such as lipids, polymers, or inorganic materials. Nanoparticles can also cross the BBB and deliver neprilysin to the brain.\n4. Injection of neprilysin-producing cells: Neprilysin-producing cells, such as mesenchymal stem cells, can be injected into the brain, where they can produce and release neprilysin.\n5. Targeted drug delivery: Neprilysin can be delivered to the brain using targeted drug delivery systems, such as antibodies or ligands that bind specifically to receptors on the BBB. These systems can selectively deliver neprilysin to the brain, reducing the risk of off-target effects.",
    "llama-2-7b-chat-hf_fact": [
      "Neprilysin is an enzyme that plays a role in the degradation of amyloid- peptides.",
      "Amyloid- peptides are the main component of amyloid plaques found in the brains of Alzheimer's disease patients.",
      "Increases in neprilysin levels or activity can reduce amyloid- levels and improve cognitive function in animal models of Alzheimer's disease.",
      "Viruses can be engineered to deliver neprilysin to the brain through viral vectors like adenovirus, adeno-associated virus, and lentivirus.",
      "Neprilysin can be encapsulated in liposomes or nanoparticles to cross the blood-brain barrier and deliver it to the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-7b-chat-hf_response": "BRAG1 is a gene that has been associated with several diseases, including:\n1. Charcot-Marie-Tooth disease (CMT): BRAG1 mutations are a common cause of CMT, a group of inherited disorders that affect the peripheral nervous system.\n2. Hereditary motor and sensory neuropathy (HMSN): BRAG1 mutations have also been linked to HMSN, a group of inherited disorders that affect the peripheral nervous system.\n3. Autosomal dominant cerebellar ataxia: BRAG1 mutations have been identified in individuals with autosomal dominant cerebellar ataxia, a rare genetic disorder that affects the cerebellum and causes progressive loss of coordination and balance.\n4. Spastic paraplegia: BRAG1 mutations have been linked to spastic paraplegia, a group of inherited disorders that affect the spinal cord and cause progressive weakness and stiffness in the legs.\n5. Other neurological disorders: BRAG1 mutations have also been identified in individuals with other neurological disorders, such as epilepsy and multiple sclerosis.\nIt is important to note that the specific disease associated with a BRAG1 mutation can vary depending on the location and type of mutation. Genetic testing can help identify specific mutations and determine the risk of developing certain diseases.",
    "llama-2-7b-chat-hf_fact": [
      "The BRAG1 gene has been associated with several diseases.",
      "Charcot-Marie-Tooth disease (CMT) can be caused by mutations in the BRAG1 gene.",
      "Hereditary motor and sensory neuropathy (HMSN) has been linked to BRAG1 mutations.",
      "Autosomal dominant cerebellar ataxia can be associated with BRAG1 mutations.",
      "Spastic paraplegia has been linked to mutations in the BRAG1 gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1328,
    "user_query": "What is the effect induced by sympathetic nervous system on pupil size?",
    "llama-2-7b-chat-hf_response": "The sympathetic nervous system (SNS) is responsible for the \"fight or flight\" response, which is characterized by increased heart rate, blood pressure, and respiration. The SNS also plays a role in regulating pupil size. When the SNS is activated, it can cause the pupils to constrict (get smaller). This is because the SNS releases the neurotransmitter norepinephrine, which can cause the muscles around the pupil to contract and reduce the size of the pupil.",
    "llama-2-7b-chat-hf_fact": [
      "The sympathetic nervous system is responsible for the \"fight or flight\" response.",
      "The \"fight or flight\" response is characterized by increased heart rate, blood pressure, and respiration.",
      "The sympathetic nervous system also plays a role in regulating pupil size.",
      "Activation of the sympathetic nervous system can cause the pupils to constrict.",
      "The neurotransmitter norepinephrine is released by the SNS and can cause the muscles around the pupil to contract."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Activation of the sympathetic nervous system can cause the pupils to dilate, not constrict.",
      "true"
    ]
  },
  {
    "id": 1329,
    "user_query": "Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50?",
    "llama-2-7b-chat-hf_response": "Yes, p100 is the precursor protein molecule of the NF-B transcription factor subunit p50.\np100 is a precursor protein that is cleaved by caspase-8 to produce the active transcription factor p50. p50 is a subunit of the NF-B (nuclear factor kappa B) transcription factor, which plays a critical role in regulating inflammation and immune responses. The NF-B transcription factor is a complex of several subunits, including p50, p65 (also known as RelA), c-Rel, and p52 (also known as RelB), which work together to regulate gene expression in response to various stimuli, including cytokines, growth factors, and stress signals.",
    "llama-2-7b-chat-hf_fact": [
      "P100 is the precursor protein molecule of the NF-B transcription factor subunit p50.",
      "The p100 protein is cleaved by caspase-8 to produce the active transcription factor p50.",
      "P50 is a subunit of the NF-B transcription factor.",
      "The NF-B transcription factor plays a critical role in regulating inflammation and immune responses.",
      "The NF-B transcription factor is a complex of several subunits, including p50, p65, c-Rel, and p52."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The p100 protein is cleaved by the protease enzyme, not caspase-8, to produce the active transcription factor p50.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1331,
    "user_query": "Is there a difference in the rate between gene fusion and gene fission?",
    "llama-2-7b-chat-hf_response": "Gene fusion and gene fission are two types of genetic mutations that can occur in an organism's DNA. Gene fusion occurs when two genes are joined together, resulting in a single gene with a longer sequence. Gene fission, on the other hand, occurs when a single gene is divided into two or more genes.\nWhile both gene fusion and gene fission can have significant effects on an organism's genetic makeup, there are some differences in the rate at which these events occur.\nGene fusion is generally considered to be a less common event than gene fission. This is because gene fusion requires the breakage and reunion of two chromosomes, which is a more complex process than the separation of a single chromosome during gene fission. As a result, gene fusion is thought to occur at a lower frequency than gene fission in most organisms.\nHowever, some studies have suggested that gene fusion may be more common in certain organisms or under certain conditions. For example, gene fusion has been observed to be more frequent in cancer cells than in normal cells, suggesting that it may play a role in the development and progression of cancer.\nGene fission, on the other hand, is thought to be a more common event than gene fusion. This is because gene fission can occur through a variety of mechanisms, including the separation of a single chromosome during cell division or the breakage and repair of a chromosome. As a result, gene fission is thought to be a more frequent occurrence than gene fusion in most organisms.\nIn summary, while both gene fusion and gene fission can have significant effects on an organism's genetic makeup, gene fusion is generally considered to be a less common event than gene fission. However, the frequency of these events can vary depending on the organism and the conditions under which they occur.",
    "llama-2-7b-chat-hf_fact": [
      "Gene fusion and gene fission are types of genetic mutations that occur in an organism's DNA.",
      "Gene fusion occurs when two genes are joined together, resulting in a single gene with a longer sequence.",
      "Gene fusion requires the breakage and reunion of two chromosomes, which makes it a generally less common event compared to gene fission.",
      "Gene fusion is more frequently observed in cancer cells than in normal cells.",
      "Gene fission, which occurs when a single gene is divided into two or more genes, is generally more common than gene fusion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1344,
    "user_query": "Which genes were found to be methylated in bladder cancer cells?",
    "llama-2-7b-chat-hf_response": "Researchers have identified several genes that are commonly methylated in bladder cancer cells. These genes include:\n1. p16: The gene encoding the protein p16 (also known as CDKN2A) is frequently methylated in bladder cancer. Methylation of p16 can lead to the inactivation of the protein, which is a tumor suppressor.\n2. MLH1: The gene encoding the protein MLH1 (also known as MSH2) is involved in the repair of DNA mismatches and is frequently methylated in bladder cancer. Methylation of MLH1 can lead to the loss of DNA repair function and the accumulation of mutations in the genome.\n3. MGMT: The gene encoding the protein O6-methylguanine-DNA methyltransferase (MGMT) is involved in the repair of DNA damage caused by chemotherapy and is frequently methylated in bladder cancer. Methylation of MGMT can lead to the loss of DNA repair function and the development of chemotherapy resistance.\n4. TWIST1: The gene encoding the protein TWIST1 is involved in the regulation of cell fate and differentiation and is frequently methylated in bladder cancer. Methylation of TWIST1 can lead to the altered expression of genes involved in cell growth and differentiation, contributing to the development and progression of bladder cancer.\n5. GATA2: The gene encoding the protein GATA2 is involved in the regulation of gene expression and is frequently methylated in bladder cancer. Methylation of GATA2 can lead to the altered expression of genes involved in cell growth and differentiation, contributing to the development and progression of bladder cancer.\nThese genes are commonly methylated in bladder cancer cells and play a role in the development and progression of the disease. The methylation of these genes can lead to the inactivation of tumor suppressor proteins, the altered expression of genes involved in cell growth and differentiation, and the development of chemotherapy resistance.",
    "llama-2-7b-chat-hf_fact": [
      "The p16 gene, encoding for protein p16 (CDKN2A), is commonly methylated in bladder cancer cells.",
      "The MLH1 gene, encoding for protein MLH1 (MSH2), which is involved in DNA mismatch repair, is commonly methylated in bladder cancer cells.",
      "The MGMT gene, encoding for the protein O6-methylguanine-DNA methyltransferase, involved in DNA damage repair caused by chemotherapy, often gets methylated in bladder cancer cells.",
      "TWIST1 gene, that encodes for the TWIST1 protein involved in the regulation of cell fate and differentiation, is usually methylated in bladder cancer cells.",
      "The GATA2 gene, involved in regulating gene expression, is frequently methylated in bladder cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The MLH1 gene, encoding for protein MLH1, not MSH2, which is involved in DNA mismatch repair, is commonly methylated in bladder cancer cells.",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1348,
    "user_query": "What is the characteristic domain of histone methyltransferases?",
    "llama-2-7b-chat-hf_response": "Histone methyltransferases (HMTs) are enzymes that catalyze the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to specific residues on histone proteins, leading to changes in chromatin structure and gene expression. The characteristic domain of HMTs includes:\n1. Histone-binding domain: This domain recognizes and binds to histone proteins, allowing the enzyme to target specific histones for methylation.\n2. SAM-binding domain: This domain binds to SAM, the methyl group donor, and facilitates the transfer of the methyl group to the histone.\n3. Methyltransferase domain: This domain contains the active site of the enzyme, where the methyl group is transferred from SAM to the histone.\n4. Substrate-binding domain: This domain recognizes and binds to the histone substrate, allowing the enzyme to position the methyl group correctly.\n5. ATP-binding domain: This domain binds to ATP, which provides the energy for the methyl transfer reaction.\n6. C-terminal domain: This domain is involved in the regulation of the enzyme's activity and stability.\n7. N-terminal domain: This domain is involved in the interaction with other proteins and plays a role in the regulation of the enzyme's activity.\nThese domains work together to allow HMTs to recognize and methylate specific histone residues, leading to changes in chromatin structure and gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Histone methyltransferases (HMTs) are enzymes that catalyze the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to specific residues on histone proteins.",
      "Histone methyltransferases have a histone-binding domain that recognizes and binds to histone proteins.",
      "Histone methyltransferases have a SAM-binding domain that binds to SAM and facilitates the transfer of the methyl group to the histone.",
      "The methyltransferase domain in HMTs contains the active site of the enzyme, where the methyl group is transferred from SAM to the histone.",
      "Histone methyltransferases feature a C-terminal domain that is involved in the regulation of the enzyme's activity and stability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1350,
    "user_query": "Which are the bioinformatics tools for gene structure prediction?",
    "llama-2-7b-chat-hf_response": "Gene structure prediction is the process of identifying the exons, introns, and other features of a gene based on its DNA sequence. There are several bioinformatics tools available for gene structure prediction, including:\n1. GeneMark: This tool uses a hidden Markov model (HMM) to predict the exons and introns in a gene. It can also predict the 5' and 3' untranslated regions (UTRs) and the start and stop codons.\n2. HMMER: This tool uses HMMs to predict the exons and introns in a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n3. Infernal: This tool uses a combination of HMMs and position-specific scoring matrices (PSSMs) to predict the exons and introns in a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n4. GLIMMER: This tool uses a combination of HMMs and PSSMs to predict the exons and introns in a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n5. MAKER: This tool uses a combination of HMMs and PSSMs to predict the exons and introns in a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n6. Primer3: This tool uses a combination of HMMs and PSSMs to predict the exons and introns in a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n7. RNAfold: This tool uses a combination of HMMs and PSSMs to predict the secondary and tertiary structure of a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n8. Pinnacle: This tool uses a combination of HMMs and PSSMs to predict the exons and introns in a gene. It can also predict the 5' and 3' UTRs and the start and stop codons.\n9",
    "llama-2-7b-chat-hf_fact": [
      "Gene structure prediction is the process of identifying the exons, introns, and other features of a gene based on its DNA sequence.",
      "GeneMark is a bioinformatics tool that uses a hidden Markov model to predict the exons and introns of a gene.",
      "HMMER is another bioinformatics tool that uses Hidden Markov Models for gene structure prediction.",
      "Infernal is a tool that uses a combination of HMMs and position-specific scoring matrices (PSSMs) for gene structure prediction.",
      "RNAfold is a bioinformatics tool that predicts the secondary and tertiary structure of a gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: RNAfold is a bioinformatics tool that predicts the secondary and tertiary structure of RNA, not a gene."
    ]
  },
  {
    "id": 1352,
    "user_query": "What is the correlation between SPARC expression and growth inhibition in human cancer?",
    "llama-2-7b-chat-hf_response": "Several studies have investigated the correlation between SPARC expression and growth inhibition in human cancer. Here are some key findings:\n1. SPARC expression is inversely correlated with cancer cell proliferation: Several studies have found that high levels of SPARC expression are associated with decreased cancer cell proliferation, while low levels of SPARC expression are associated with increased cancer cell proliferation. For example, a study published in the journal Cancer Research found that high levels of SPARC expression were associated with decreased proliferation of breast cancer cells, while low levels of SPARC expression were associated with increased proliferation.\n2. SPARC expression can inhibit the epithelial-to-mesenchymal transition (EMT): The epithelial-to-mesenchymal transition (EMT) is a process by which cancer cells lose their epithelial characteristics and acquire mesenchymal properties, such as increased migration and invasiveness. Several studies have found that SPARC expression can inhibit the EMT process in cancer cells, leading to decreased migration and invasiveness. For example, a study published in the journal Oncogene found that SPARC expression inhibited the EMT process in breast cancer cells, leading to decreased migration and invasiveness.\n3. SPARC expression can inhibit cancer stem cell properties: Cancer stem cells are a subpopulation of cancer cells that are thought to be responsible for the initiation and maintenance of cancer. Several studies have found that SPARC expression can inhibit the properties of cancer stem cells, such as self-renewal and tumor-initiating ability. For example, a study published in the journal Stem Cells found that SPARC expression inhibited the self-renewal of breast cancer stem cells.\n4. SPARC expression can inhibit angiogenesis: Angiogenesis is the formation of new blood vessels, which is a critical step in the growth and spread of solid tumors. Several studies have found that SPARC expression can inhibit angiogenesis in cancer, leading to decreased tumor growth. For example, a study published in the journal Cancer Research found that SPARC expression inhibited angiogenesis in breast cancer",
    "llama-2-7b-chat-hf_fact": [
      "High levels of SPARC expression are associated with decreased cancer cell proliferation.",
      "Low levels of SPARC expression are associated with increased cancer cell proliferation.",
      "SPARC expression can inhibit the epithelial-to-mesenchymal transition process in cancer cells.",
      "SPARC expression can curb the properties of cancer stem cells, such as self-renewal and tumor-initiating ability.",
      "SPARC expression can inhibit angiogenesis in cancer, leading to decreased tumor growth."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1353,
    "user_query": "Which syndrome is associated with mutations in the LYST gene?",
    "llama-2-7b-chat-hf_response": "A. Ehlers-Danlos syndrome\nB. Marfan syndrome\nC. Turner syndrome\nD. No syndrome is associated with mutations in the LYST gene.\nAnswer: A. Ehlers-Danlos syndrome.\nThe LYST gene provides instructions for making a protein called lysyl oxidase, which is involved in the cross-linking of collagen fibers in connective tissue. Mutations in the LYST gene have been identified as the cause of Ehlers-Danlos syndrome (EDS), a group of rare genetic disorders that affect the body's connective tissue. EDS is characterized by joint hypermobility, skin hyperextensibility, and tissue fragility.",
    "llama-2-7b-chat-hf_fact": [
      "The LYST gene provides instructions for making a protein called lysyl oxidase.",
      "Lysyl oxidase is involved in the cross-linking of collagen fibers in connective tissue.",
      "Mutations in the LYST gene have been identified as the cause of Ehlers-Danlos syndrome (EDS).",
      "Ehlers-Danlos syndrome is a group of rare genetic disorders that affect the body's connective tissue.",
      "EDS is characterized by joint hypermobility, skin hyperextensibility, and tissue fragility."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The LYST gene provides instructions for making a protein called lysosomal trafficking regulator.",
      "true",
      "false, [corrected fact]: Mutations in the COL5A or COL3A genes, not the LYST gene, have been identified as a cause of certain types of Ehlers-Danlos syndrome (EDS).",
      "true",
      "true"
    ]
  },
  {
    "id": 1354,
    "user_query": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?",
    "llama-2-7b-chat-hf_response": "Yes, the presence of delayed enhancement has been documented in athletes performing strenuous exercise. Delayed enhancement (DE) is a magnetic resonance imaging (MRI) technique that can detect areas of incomplete myocardial reperfusion after acute myocardial infarction (AMI). Studies have shown that athletes who engage in strenuous exercise may have an increased risk of developing myocardial infarction, particularly if they have pre-existing cardiovascular disease or risk factors.\nOne study published in the Journal of the American College of Cardiology found that athletes who participated in a marathon had a higher incidence of DE compared to non-athletes. The study included 100 athletes and 100 non-athletes who underwent MRI scans before and after the marathon. The results showed that 20% of the athletes and 6% of the non-athletes had DE on the post-exercise MRI scan.\nAnother study published in the European Heart Journal found that DE was more common in athletes who had a history of cardiovascular disease or risk factors compared to those without a history of cardiovascular disease. The study included 100 athletes and 100 non-athletes who underwent MRI scans before and after a strenuous exercise test. The results showed that 30% of the athletes with a history of cardiovascular disease or risk factors had DE on the post-exercise MRI scan, compared to 10% of the non-athletes.\nThese studies suggest that athletes who engage in strenuous exercise may be at increased risk of developing myocardial infarction, particularly if they have pre-existing cardiovascular disease or risk factors. Delayed enhancement on MRI may be a useful tool for detecting myocardial infarction in these individuals. However, it is important to note that MRI is not a substitute for clinical evaluation and diagnosis, and athletes who experience chest pain or other symptoms of myocardial infarction should seek medical attention immediately.",
    "llama-2-7b-chat-hf_fact": [
      "Delayed enhancement (DE) is a magnetic resonance imaging (MRI) technique that can detect areas of incomplete myocardial reperfusion after acute myocardial infarction (AMI).",
      "Athletes who engage in strenuous exercise may have an increased risk of developing myocardial infarction, particularly if they have pre-existing cardiovascular disease or risk factors.",
      "A study in the Journal of the American College of Cardiology showed that athletes participating in a marathon had a higher incidence of DE compared to non-athletes.",
      "Another study in the European Heart Journal found that DE was more common in athletes who had a history of cardiovascular disease or risk factors compared to those without a history of cardiovascular disease.",
      "Athletes experiencing symptoms of myocardial infarction such as chest pain should seek medical attention immediately."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1356,
    "user_query": "Name the factors required for selenoprotein synthesis in eukaryotes",
    "llama-2-7b-chat-hf_response": ".\nSelenoprotein synthesis in eukaryotes requires the following factors:\n1. Selenium: Selenoproteins contain selenium in the form of selenocysteine, which is synthesized from the amino acid cysteine.\n2. Selenocysteine synthetase: This enzyme is responsible for catalyzing the conversion of cysteine to selenocysteine.\n3. Selenoprotein synthetase: This enzyme is responsible for catalyzing the incorporation of selenocysteine into the growing polypeptide chain of the selenoprotein.\n4. Ribosomes: Selenoproteins are synthesized on ribosomes, which are found in the cytoplasm of eukaryotic cells.\n5. Transfer RNAs (tRNAs): tRNAs are responsible for carrying the appropriate amino acids to the ribosomes during protein synthesis.\n6. Messenger RNA (mRNA): mRNA carries the genetic information for the synthesis of the selenoprotein from the DNA to the ribosomes.\n7. Nucleotides: Nucleotides are the building blocks of RNA and DNA, and are required for the synthesis of mRNA and tRNAs.\n8. Amino acids: Amino acids are the building blocks of proteins, and are required for the synthesis of selenoproteins.\n9. Enzymes: Enzymes are required for the synthesis of selenocysteine and the incorporation of selenocysteine into the growing polypeptide chain of the selenoprotein.\n10. Cofactors: Cofactors are required for the proper functioning of enzymes involved in selenoprotein synthesis.",
    "llama-2-7b-chat-hf_fact": [
      "Selenoprotein synthesis in eukaryotes requires selenium in the form of selenocysteine, synthesized from the amino acid cysteine.",
      "Selenocysteine synthetase is an enzyme that catalyzes the conversion of cysteine to selenocysteine.",
      "Selenoprotein synthetase is an enzyme that catalyzes the incorporation of selenocysteine into the growing polypeptide chain of the selenoprotein.",
      "Selenoprotein synthesis involves ribosomes located in the cytoplasm of eukaryotic cells.",
      "Transfer RNAs (tRNAs) and messenger RNA (mRNA) are essential for carrying amino acids and genetic information respectively during selenoprotein synthesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There is no enzyme called selenoprotein synthetase. The incorporation of selenocysteine into selenoproteins does not involve a specific enzyme but requires the recoding of the UGA codon.",
      "true",
      "true"
    ]
  },
  {
    "id": 1359,
    "user_query": "What is the role of TRH in hypertension?",
    "llama-2-7b-chat-hf_response": "TRH (thyrotropin-releasing hormone) is a hormone produced by the hypothalamus that plays a key role in regulating the secretion of thyroid hormones from the thyroid gland. However, recent studies have also implicated TRH in the development and progression of hypertension. Here are some of the ways in which TRH may contribute to hypertension:\n1. Increased sympathetic activity: TRH can stimulate the release of catecholamines, such as norepinephrine, from the sympathetic nervous system. This can lead to increased peripheral resistance and blood pressure.\n2. Renin-angiotensin-aldosterone system activation: TRH can activate the renin-angiotensin-aldosterone system (RAAS), leading to increased production of angiotensin II and aldosterone. Angiotensin II can cause vasoconstriction and increase blood pressure, while aldosterone can increase sodium reabsorption in the kidneys, leading to further increases in blood pressure.\n3. Inflammation: TRH can stimulate the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), which can contribute to the development of hypertension by promoting vascular inflammation and oxidative stress.\n4. Autonomic nervous system dysfunction: TRH can also affect the autonomic nervous system, which plays a key role in regulating blood pressure. Dysfunction of the autonomic nervous system can lead to imbalances in sympathetic and parasympathetic activity, contributing to the development of hypertension.\nOverall, the role of TRH in hypertension is complex and involves multiple mechanisms. Further research is needed to fully understand the relationship between TRH and hypertension, and to identify potential therapeutic targets for the treatment of hypertension.",
    "llama-2-7b-chat-hf_fact": [
      "TRH (thyrotropin-releasing hormone) is a hormone produced by the hypothalamus that regulates the secretion of thyroid hormones from the thyroid gland.",
      "TRH can stimulate the release of catecholamines from the sympathetic nervous system, leading to increased peripheral resistance and blood pressure.",
      "TRH can activate the renin-angiotensin-aldosterone system, leading to increased production of angiotensin II and aldosterone, and subsequently increase in blood pressure.",
      "TRH can stimulate the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), contributing to the development of hypertension by promoting vascular inflammation and oxidative stress.",
      "TRH can affect the autonomic nervous system, which plays a key role in regulating blood pressure, and its dysfunction leads to imbalances in sympathetic and parasympathetic activity, contributing to the development of hypertension."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: TRH does not stimulate the release of catecholamines. It primarily stimulates the thyroid-stimulating hormone (TSH) which then stimulates the thyroid gland to release thyroid hormones.",
      "false, [corrected fact]: There is no established link between TRH and the activation of the renin-angiotensin-aldosterone system. TRH primarily stimulates the thyroid-stimulating hormone (TSH).",
      "false, [corrected fact]: TRH does not directly stimulate the production of pro-inflammatory cytokines. It primarily functions to stimulate the release of thyroid-stimulating hormone.",
      "true"
    ]
  },
  {
    "id": 1360,
    "user_query": "Is triadin involved in cardiac function?",
    "llama-2-7b-chat-hf_response": "Triadin is a protein that has been found to be involved in the regulation of cardiac function. It is a member of the triadin family of proteins, which are found primarily in the heart and brain. Triadin has been shown to play a role in the regulation of ion channels, particularly the L-type calcium channel, which is important for the proper functioning of the heart.\nTriadin has been shown to interact with the L-type calcium channel and modulate its activity. This can lead to changes in the contraction and relaxation of the heart muscle, as well as changes in the electrical activity of the heart. Triadin has also been shown to be involved in the regulation of the cardiac action potential, which is the electrical signal that triggers the contraction of the heart muscle.\nIn addition to its role in the regulation of ion channels, triadin has been shown to be involved in the regulation of gene expression in the heart. It has been shown to bind to specific DNA sequences and regulate the transcription of genes involved in cardiac function.\nOverall, triadin is an important protein that plays a critical role in the regulation of cardiac function. Its involvement in the regulation of ion channels and gene expression makes it a key player in the proper functioning of the heart.",
    "llama-2-7b-chat-hf_fact": [
      "Triadin is a protein involved in the regulation of cardiac function.",
      "Triadin is primarily found in the heart and brain.",
      "Triadin plays a role in the regulation of ion channels, particularly the L-type calcium channel which is important for the proper functioning of the heart.",
      "Triadin has been shown to interact with the L-type calcium channel and modulate its activity, leading to changes in the heart's contraction and relaxation, and electrical activity.",
      "Triadin also plays a role in regulating gene expression in the heart by binding to specific DNA sequences and regulating the transcription of genes involved in cardiac function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Triadin does not regulate gene expression by binding to DNA sequences. It's primarily involved in calcium handling within the cell."
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-7b-chat-hf_response": "A) Protein phosphatase 2A (PP2A)\nB) Protein phosphatase 2B (PP2B)\nC) Protein phosphatase 3 (PP3)\nD) Protein phosphatase 1 (PP1)\nAnswer: D) Protein phosphatase 1 (PP1)\nExplanation:\nProtein phosphatase 1 (PP1) is the main inhibitor of protein phosphatase 1 (PP1). PP1 is a serine/threonine protein phosphatase that plays a crucial role in regulating various cellular processes, including cell signaling, metabolism, and DNA repair. PP1 can be inhibited by a variety of proteins, including other protein phosphatases, such as PP2A and PP2B, as well as by non-protein phosphatase inhibitors. However, PP1 is the primary inhibitor of PP1, and it does this by binding to the active site of PP1 and preventing it from dephosphorylating its substrates.",
    "llama-2-7b-chat-hf_fact": [
      "Protein phosphatase 1 (PP1) is the main inhibitor of protein phosphatase 1 (PP1).",
      "PP1 is a serine/threonine protein phosphatase.",
      "PP1 plays a crucial role in regulating various cellular processes.",
      "These cellular processes include cell signaling, metabolism, and DNA repair.",
      "PP1 inhibits itself by binding to its own active site, preventing it from dephosphorylating its substrates."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Protein phosphatase 1 (PP1) is not its own inhibitor. Instead, its activity is governed by various regulatory proteins.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: PP1 does not inhibit itself by binding to its own active site. Its activity is regulated by other proteins, not self-inhibition."
    ]
  },
  {
    "id": 1364,
    "user_query": "Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?",
    "llama-2-7b-chat-hf_response": "A. G3BP1\nB. G3BP2\nC. RNA-binding protein 1 (RBP1)\nD. RNA-binding protein 2 (RBP2)\nAnswer: A. G3BP1\nExplanation: Argonaute 2 (Ago2) is a key component of RNA-induced silencing complexes (RISC) and plays a crucial role in the regulation of gene expression by RNA interference (RNAi). Ago2 recruitment to stress granules and P-bodies is mediated by the G3BP1 protein. G3BP1 is a guanylate-binding protein that is involved in the formation of stress granules and P-bodies, and it acts as a scaffold for the recruitment of Ago2 and other RNA-binding proteins. Therefore, the correct answer is (A) G3BP1.",
    "llama-2-7b-chat-hf_fact": [
      "Argonaute 2 (Ago2) is a key component of RNA-induced silencing complexes (RISC).",
      "The function of Ago2 is crucial in the regulation of gene expression by RNA interference (RNAi).",
      "G3BP1 protein is responsible for the recruitment of Ago2 to stress granules and P-bodies.",
      "G3BP1 is a guanylate-binding protein that is involved in the formation of stress granules and P-bodies.",
      "G3BP1 acts as a scaffold for the recruitment of Ago2 and other RNA-binding proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1365,
    "user_query": "Is Mammaprint approved by the United States Food and Drug Administration?",
    "llama-2-7b-chat-hf_response": "Mammaprint is a genetic test that analyzes the expression of certain genes in a woman's breast tissue to assess her risk of developing breast cancer. The test is not approved by the United States Food and Drug Administration (FDA) as a diagnostic tool for breast cancer risk assessment.\nThe FDA has not cleared Mammaprint for marketing in the United States, and the agency has expressed concerns about the test's accuracy and reliability. In 2014, the FDA issued a warning letter to the company that markets Mammaprint, Genomic Health, Inc., stating that the test had not been adequately validated and that the company had made false and misleading claims about its ability to predict breast cancer risk.\nAs a result, Mammaprint is not considered a standard or recommended test for breast cancer risk assessment by many medical organizations, including the American Cancer Society and the National Comprehensive Cancer Network. Women who are concerned about their breast cancer risk should discuss their options with their healthcare provider, who can recommend appropriate screening and diagnostic tests based on their individual risk factors and medical history.",
    "llama-2-7b-chat-hf_fact": [
      "Mammaprint is a genetic test that analyzes the expression of certain genes in a woman's breast tissue to evaluate risk of developing breast cancer.",
      "The test is not approved by the United States Food and Drug Administration (FDA) as a diagnostic tool for breast cancer risk assessment.",
      "Genomic Health, Inc., markets Mammaprint.",
      "In 2014, the FDA issued a warning letter to Genomic Health, Inc., stating that the test had not been adequately validated and the company had made false and misleading claims.",
      "Mammaprint is not considered a standard or recommended test for breast cancer risk assessment by the American Cancer Society and the National Comprehensive Cancer Network."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Mammaprint is a genetic test that analyzes the expression of certain genes in a woman's breast cancer tissue to evaluate the likelihood of cancer recurrence.",
      "false, [corrected fact]: The test is approved by the United States Food and Drug Administration (FDA) for use in certain patients with breast cancer.",
      "false, [corrected fact]: Agendia NV, not Genomic Health, Inc., markets Mammaprint.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1368,
    "user_query": "Which pharmacogenetic test is available for abacavir?",
    "llama-2-7b-chat-hf_response": "Abacavir is a drug used to treat HIV. Pharmacogenetic testing can help identify patients who are more likely to experience side effects or have reduced efficacy when taking abacavir. There are several pharmacogenetic tests available for abacavir, including:\n1. The Abacavir Pharmacogenetic Test (APGT): This test analyzes genetic variations in the CYP2B6 and CYP3A4 genes, which are involved in the metabolism of abacavir. The test can help identify patients who are more likely to have reduced efficacy or experience side effects when taking abacavir.\n2. The CYP2B6 Genotyping Test: This test analyzes genetic variations in the CYP2B6 gene, which is involved in the metabolism of abacavir. The test can help identify patients who are more likely to have reduced efficacy or experience side effects when taking abacavir.\n3. The CYP3A4 Genotyping Test: This test analyzes genetic variations in the CYP3A4 gene, which is involved in the metabolism of abacavir. The test can help identify patients who are more likely to have reduced efficacy or experience side effects when taking abacavir.\n4. The HLA-B*57:01 Genotyping Test: This test analyzes genetic variations in the HLA-B*57:01 gene, which is associated with an increased risk of hypersensitivity reactions to abacavir. The test can help identify patients who are more likely to experience hypersensitivity reactions when taking abacavir.\nIt is important to note that not all pharmacogenetic tests are available for abacavir, and the availability of these tests may vary depending on the country or region. It is important to consult with a healthcare provider to determine which test is appropriate for an individual patient.",
    "llama-2-7b-chat-hf_fact": [
      "Abacavir is a drug used to treat HIV.",
      "Pharmacogenetic testing can identify patients who are likely to experience side effects or have reduced efficacy when taking abacavir.",
      "The Abacavir Pharmacogenetic Test (APGT) analyzes genetic variations in the CYP2B6 and CYP3A4 genes.",
      "The HLA-B*57:01 Genotyping Test analyzes genetic variations in the HLA-B*57:01 gene.",
      "Availability of pharmacogenetic tests for abacavir may vary depending on the country or region."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The Abacavir Pharmacogenetic Test (APGT) analyzes genetic variations in the HLA-B*57:01 gene.",
      "true",
      "true"
    ]
  },
  {
    "id": 1370,
    "user_query": "Are nucleosomes positioned at DNA replication origins?",
    "llama-2-7b-chat-hf_response": "Nucleosomes are the building blocks of chromatin, consisting of a segment of DNA wrapped around a core of eight histone proteins (two copies each of histones H2A, H2B, H3, and H4). The positioning of nucleosomes along DNA can have important implications for gene expression and other cellular processes. One question that has been studied extensively is whether nucleosomes are positioned at DNA replication origins.\nDNA replication origins are specific regions of the genome where DNA replication begins. These regions are characterized by the presence of specific DNA sequences and histone modifications that facilitate the initiation of DNA replication. The positioning of nucleosomes at these regions can affect the efficiency of DNA replication and the stability of the genome.\nSeveral studies have investigated the positioning of nucleosomes at DNA replication origins using a variety of techniques, including chromatin immunoprecipitation sequencing (ChIP-seq) and fluorescence in situ hybridization (FISH). These studies have shown that nucleosomes are indeed positioned at DNA replication origins in many organisms, including bacteria, yeast, and mammalian cells.\nFor example, a study published in the journal Nature in 2013 used ChIP-seq to investigate the positioning of nucleosomes at DNA replication origins in the bacterium Escherichia coli. The study found that nucleosomes were positioned at specific regions of the genome that were associated with DNA replication origins, and that the positioning of these nucleosomes was important for the efficient initiation of DNA replication.\nSimilarly, a study published in the journal Cell in 2017 used FISH to investigate the positioning of nucleosomes at DNA replication origins in mammalian cells. The study found that nucleosomes were positioned at specific regions of the genome that were associated with DNA replication origins, and that the positioning of these nucleosomes was important for the stability of the genome during DNA replication.\nOverall, these studies suggest that nucleosomes are indeed positioned at DNA replication origins in many organisms, and that the positioning of these nucleosomes",
    "llama-2-7b-chat-hf_fact": [
      "Nucleosomes consist of a segment of DNA wrapped around a core of eight histone proteins.",
      "DNA replication origins are specific regions of the genome where DNA replication begins.",
      "Several studies have shown that nucleosomes are positioned at DNA replication origins in many organisms, including bacteria, yeast, and mammalian cells.",
      "A study published in Nature in 2013 found that nucleosomes were positioned at DNA replication origins in the bacterium Escherichia coli.",
      "A study published in Cell in 2017 found that nucleosomes were positioned at DNA replication origins in mammalian cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Nucleosomes are not positioned at DNA replication origins in bacteria because bacteria lack histones and nucleosomes. Nucleosomes are positioned at DNA replication origins in eukaryotes such as yeast and mammalian cells.",
      "false, [corrected fact]: Bacteria, including Escherichia coli, do not have nucleosomes because they do not have histones. Therefore, nucleosomes cannot be positioned at DNA replication origins in Escherichia coli.",
      "unknown"
    ]
  },
  {
    "id": 1371,
    "user_query": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?",
    "llama-2-7b-chat-hf_response": "Oligonucleotides are short sequences of DNA or RNA that are often used as probes or primers in molecular biology experiments. The under-representation of certain oligonucleotides in higher eukaryote genomes can have important implications for the study of gene regulation, evolution, and disease. In this blog post, we will discuss some of the most under-represented oligonucleotides in higher eukaryote genomes and their potential implications.\n1. Non-coding RNA oligonucleotides:\nNon-coding RNA (ncRNA) oligonucleotides are short sequences of RNA that do not code for proteins but instead perform regulatory functions. Despite their importance in gene regulation, ncRNA oligonucleotides are often under-represented in higher eukaryote genomes. For example, microRNAs (miRNAs), which are small non-coding RNAs that regulate gene expression by binding to messenger RNA (mRNA), are often under-represented in higher eukaryote genomes compared to their abundance in lower eukaryotes.\n2. Intronic oligonucleotides:\nIntrons are regions of DNA that are located within genes but do not code for proteins. Intronic oligonucleotides are short sequences of DNA that are located within introns and can act as regulatory elements. Despite their potential importance in gene regulation, intronic oligonucleotides are often under-represented in higher eukaryote genomes.\n3. Intergenic oligonucleotides:\nIntergenic regions are regions of DNA that lie between genes. Intergenic oligonucleotides are short sequences of DNA that are located within intergenic regions and can act as regulatory elements. Intergenic oligonucleotides are often under-represented in higher eukaryote genomes, which can make it difficult to identify their functional roles in gene regulation.\n4. Repetitive oligonucleotides:\nRepetitive sequences are regions of DNA that are repeated throughout the genome. Repetitive oligonucleotides are",
    "llama-2-7b-chat-hf_fact": [
      "Oligonucleotides are short sequences of DNA or RNA that are often used as probes or primers in molecular biology experiments.",
      "Non-coding RNA (ncRNA) oligonucleotides are short sequences of RNA that do not code for proteins but perform regulatory functions.",
      "Introns are regions of DNA that are located within genes but do not code for proteins.",
      "Intergenic regions are regions of DNA that lie between genes, with intergenic oligonucleotides housed within these areas.",
      "Repetitive sequences are regions of DNA that are repeated throughout the genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-7b-chat-hf_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria generate genetic diversity during the stationary phase of growth. This process is thought to be an important mechanism for bacteria to adapt to changing environments and to survive in the face of antibiotic resistance.\nSeveral mechanisms have been proposed to underlie adaptive mutagenesis in Bacillus subtilis, including:\n1. DNA damage: One mechanism by which adaptive mutagenesis may occur is through the accumulation of DNA damage during the stationary phase of growth. This damage can lead to the formation of mutagenic lesions, such as base modifications or DNA double-strand breaks, which can be repaired by the bacterial DNA repair machinery.\n2. Reactive oxygen species (ROS): ROS, such as hydrogen peroxide, can also contribute to adaptive mutagenesis in B. subtilis. ROS can damage DNA and other cellular components, leading to the formation of mutations.\n3. Epigenetic modifications: Epigenetic modifications, such as DNA methylation and histone modification, can also play a role in adaptive mutagenesis. These modifications can affect gene expression and can lead to the formation of mutations.\n4. Transposon-mediated mutagenesis: Transposons are mobile genetic elements that can insert into different locations within the bacterial genome. During the stationary phase of growth, transposons can insert into genes, leading to mutations.\n5. Homologous recombination: Homologous recombination is a repair mechanism that involves the exchange of genetic information between two similar DNA sequences. During the stationary phase of growth, homologous recombination can lead to the formation of mutations.\n6. Rolling circle replication: Rolling circle replication is a mechanism of DNA replication that involves the circularization of DNA and the synthesis of new DNA strands. During the stationary phase of growth, rolling circle replication can lead to the formation of mutations.\n7. RNA-mediated mutagenesis: RNA-mediated mutagenesis is a mechanism by which RNA molecules can base-pair with DNA and cause mutations. This mechanism can occur during the stationary phase of growth",
    "llama-2-7b-chat-hf_fact": [
      "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria generate genetic diversity during the stationary phase of growth.",
      "Accumulation of DNA damage during the stationary phase of growth can lead to the formation of mutagenic lesions contributing to adaptive mutagenesis in Bacillus subtilis.",
      "Reactive oxygen species, like hydrogen peroxide, can contribute to adaptive mutagenesis due to their ability to damage DNA and other cellular components.",
      "Epigenetic modifications such as DNA methylation and histone modifications can affect gene expression and lead to the formation of mutations.",
      "Mobile genetic elements, referred to as transposons, can insert into genes causing mutations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1375,
    "user_query": "What personality traits can be evaluated with the Ten Item Personality Inventory.",
    "llama-2-7b-chat-hf_response": "The Ten Item Personality Inventory (TIP) is a widely used measure of normal personality. It is a brief, self-report inventory that assesses five broad dimensions of personality: extraversion, agreeableness, conscientiousness, neuroticism, and openness to experience. Each item is rated on a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree).",
    "llama-2-7b-chat-hf_fact": [
      "The Ten Item Personality Inventory (TIP) is a measure of normal personality.",
      "TIP is a self-report inventory.",
      "The Ten Item Personality Inventory assesses five broad dimensions of personality: extraversion, agreeableness, conscientiousness, neuroticism, and openness to experience.",
      "Each item on the TIP is rated on a 5-point Likert scale.",
      "The scale ranges from 1 (strongly disagree) to 5 (strongly agree) on the TIP."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Each item on the TIP is rated on a 7-point Likert scale.",
      "false, [corrected fact]: The scale ranges from 1 (strongly disagree) to 7 (strongly agree) on the TIP."
    ]
  },
  {
    "id": 1376,
    "user_query": "Which are the enzymes involved in the control of tubulin acetylation?",
    "llama-2-7b-chat-hf_response": "Tubulin acetylation is a post-translational modification that plays a crucial role in regulating microtubule dynamics and stability. There are several enzymes involved in the control of tubulin acetylation, including:\n1. Histone acetyltransferases (HATs): HATs are enzymes that catalyze the transfer of acetyl groups from acetyl-CoA to lysine residues on histone proteins, leading to histone acetylation. Some HATs, such as p300 and CBP (CREB-binding protein), have been shown to also acetylate tubulin.\n2. Histone deacetylases (HDACs): HDACs are enzymes that remove acetyl groups from histone proteins, leading to histone deacetylation. Some HDACs, such as HDAC1 and HDAC2, have been shown to also deacetylate tubulin.\n3. Tubulin acetyltransferases (TATs): TATs are enzymes that catalyze the transfer of acetyl groups from acetyl-CoA to lysine residues on tubulin proteins, leading to tubulin acetylation. There are two subtypes of TATs: TAT1 and TAT2.\n4. Tubulin deacetylases (TDACs): TDACs are enzymes that remove acetyl groups from tubulin proteins, leading to tubulin deacetylation. There are two subtypes of TDACs: TDAC1 and TDAC2.\n5. Protein arginine methyltransferases (PRMTs): PRMTs are enzymes that catalyze the transfer of methyl groups from S-adenosyl-L-methionine to arginine residues on proteins, leading to protein arginine methylation. Some PRMTs, such as PRMT1 and PRMT5, have been shown to also methylate tubulin.\n6. Ubiquitin ligases: Ubiquitin ligases are enzymes that catalyze the covalent attachment of ubiquit",
    "llama-2-7b-chat-hf_fact": [
      "Tubulin acetylation is a post-translational modification that regulates microtubule dynamics and stability.",
      "Histone acetyltransferases (HATs), like p300 and CBP, can acetylate tubulin.",
      "Some Histone deacetylases (HDACs), such as HDAC1 and HDAC2, can deacetylate tubulin.",
      "Tubulin acetyltransferases (TATs) are enzymes that cause tubulin acetylation.",
      "Tubulin deacetylases (TDACs) are enzymes that cause tubulin deacetylation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1378,
    "user_query": "List all approved indications for Glivec",
    "llama-2-7b-chat-hf_response": "(Imatinib)\nGlivec (Imatinib) is a tyrosine kinase inhibitor that is approved for the treatment of several types of cancer, including:\n1. Chronic myelogenous leukemia (CML): Glivec is approved for the treatment of newly diagnosed and previously treated CML, including patients with Philadelphia chromosome-positive (Ph+) CML.\n2. Acute lymphoblastic leukemia (ALL): Glivec is approved for the treatment of patients with Philadelphia chromosome-positive (Ph+) ALL who are resistant to or have failed previous treatment with chemotherapy.\n3. Chronic myeloid leukemia (CML) in blast crisis: Glivec is approved for the treatment of patients with CML in blast crisis, including those who are resistant to or have failed previous treatment with chemotherapy.\n4. Hypereosinophilic syndrome (HES): Glivec is approved for the treatment of patients with HES, a rare disorder characterized by excessive eosinophilia (high levels of eosinophils in the blood).\n5. Systemic mastocytosis (SM): Glivec is approved for the treatment of patients with SM, a rare disorder characterized by excessive accumulation of mast cells in the body.\n6. Myelodysplastic syndrome (MDS): Glivec is approved for the treatment of patients with MDS, a rare disorder characterized by abnormalities in the production and function of blood cells.\n7. Breast cancer: Glivec is approved for the treatment of patients with breast cancer that is resistant to or has recurred after previous treatment with chemotherapy.\n8. Gastrointestinal stromal tumors (GIST): Glivec is approved for the treatment of patients with GIST, a rare type of tumor that occurs in the digestive system.\n9. Neuroendocrine tumors (NET): Glivec is approved for the treatment of patients with NET, a rare type of tumor that occurs in the neuroendocrine system.\n10. Pancreatic neuroendocrine tumors (PNET): Glivec is approved for the treatment of patients with PNET, a rare type of tumor that occurs in the pancreas",
    "llama-2-7b-chat-hf_fact": [
      "Glivec (Imatinib) is a tyrosine kinase inhibitor used for treating cancer.",
      "Glivec is approved for the treatment of Chronic myelogenous leukemia (CML), including newly diagnosed and previously treated patients.",
      "Glivec is used in the treatment of Philadelphia chromosome-positive (Ph+) Acute lymphoblastic leukemia (ALL).",
      "The drug Glivec is indicated for the treatment of patients with Chronic myeloid leukemia (CML) in the blast crisis.",
      "Glivec is approved for the treatment of systemic mastocytosis (SM).",
      "Glivec is used for treatment of patients with breast cancer that is resistant to or has recurred after previous chemotherapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Glivec is not approved for the treatment of breast cancer that is resistant to or has recurred after previous chemotherapy."
    ]
  },
  {
    "id": 1379,
    "user_query": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?",
    "llama-2-7b-chat-hf_response": "Retrotransposons are mobile genetic elements that can amplify and insert copies of themselves into new locations within the genome. LINE-1 (Long Interspersed Nuclear Element-1) and Alu (Alu Element) are two types of retrotransposons that are present in the human genome. While LINE-1 is the most abundant retrotransposon in the human genome, Alu is the most active retrotransposon.\nSeveral proteins have been identified that can induce inhibition of LINE-1 and Alu retrotransposition. These proteins include:\n1. DNA methyltransferases (DNMTs): DNMTs are enzymes that add a methyl group to cytosine residues in DNA, thereby repressing gene transcription. DNMTs have been shown to inhibit LINE-1 and Alu retrotransposition by methylating their promoter regions.\n2. Histone deacetylases (HDACs): HDACs are enzymes that remove acetyl groups from histone proteins, leading to compact chromatin structure that is inaccessible to transcription factors. HDACs have been shown to repress LINE-1 and Alu retrotransposition by altering the chromatin structure of their promoter regions.\n3. Histone acetyltransferases (HATs): HATs are enzymes that add acetyl groups to histone proteins, leading to more open chromatin structure that is accessible to transcription factors. HATs have been shown to activate LINE-1 and Alu retrotransposition by altering the chromatin structure of their promoter regions.\n4. Polycomb group proteins (PcGs): PcGs are a group of proteins that regulate gene expression by modifying chromatin structure. PcGs have been shown to repress LINE-1 and Alu retrotransposition by modifying the chromatin structure of their promoter regions.\n5. RNA-binding proteins (RBPs): RBPs are proteins that bind to RNA molecules and regulate their stability or translation. RBPs have been shown to inhibit LINE-1 and Alu retrotransposition by binding to their RNA molecules and",
    "llama-2-7b-chat-hf_fact": [
      "Retrotransposons are mobile genetic elements that can amplify and insert copies of themselves into new locations within the genome.",
      "LINE-1 and Alu are two types of retrotransposons that are present in the human genome.",
      "DNA methyltransferases (DNMTs) can inhibit LINE-1 and Alu retrotransposition by methylating their promoter regions.",
      "Histone deacetylases (HDACs) can repress LINE-1 and Alu retrotransposition by altering the chromatin structure of their promoter regions.",
      "RNA-binding proteins (RBPs) can inhibit LINE-1 and Alu retrotransposition by binding to their RNA molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1382,
    "user_query": "Describe the usefulness of Macrostomum lignano in ion channel and stem cell research",
    "llama-2-7b-chat-hf_response": "Macrostomum lignano is a species of flatworm that has been used in various biological research studies, including ion channel and stem cell research. Here are some ways in which Macrostomum lignano has been found to be useful in these areas of research:\nIon Channel Research:\n1. Expression of ion channels: Macrostomum lignano has been found to express a wide range of ion channels, including voltage-gated ion channels, calcium channels, and potassium channels. These ion channels play important roles in regulating various physiological processes, such as neuronal excitability, muscle contraction, and secretion.\n2. Functional characterization of ion channels: Macrostomum lignano has been used to functionally characterize ion channels using patch-clamp techniques. For example, researchers have used Macrostomum lignano to study the properties of voltage-gated ion channels and their role in regulating neuronal excitability.\n3. Identification of novel ion channels: Macrostomum lignano has been used to identify novel ion channels that are not found in other organisms. For example, researchers have identified a novel calcium channel in Macrostomum lignano that is distinct from those found in other organisms.\nStem Cell Research:\n1. Self-renewal and differentiation: Macrostomum lignano has been used to study the self-renewal and differentiation of stem cells. For example, researchers have used Macrostomum lignano to study the role of specific ion channels in regulating the self-renewal and differentiation of stem cells.\n2. Cell fate determination: Macrostomum lignano has been used to study the mechanisms of cell fate determination in stem cells. For example, researchers have used Macrostomum lignano to investigate the role of ion channels in regulating the fate of stem cells during development.\n3. Tissue regeneration: Macrostomum lignano has been used to study the mechanisms of tissue regeneration in stem cells. For example, researchers have used Macrostomum lignano to investigate the role of ion channels in regulating the proliferation and differentiation of stem cells during tissue regeneration.\nIn summary, Macrostomum lignano",
    "llama-2-7b-chat-hf_fact": [
      "Macrostomum lignano is a species of flatworm used in various biological research studies including those focused on ion channels and stem cells.",
      "Macrostomum lignano expresses various types of ion channels including voltage-gated ion channels, calcium channels, and potassium channels.",
      "This species has been utilized to functionally characterize ion channels using patch-clamp techniques.",
      "Macrostomum lignano has been used in research identifying novel ion channels not found in other organisms.",
      "Macrostomum lignano is used in stem cell research studies focusing on cell fate determination and tissue regeneration."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1384,
    "user_query": "Which drug is benserazide usually co-administered with?",
    "llama-2-7b-chat-hf_response": "Benserazide is usually co-administered with other medications to enhance its effectiveness or to treat certain conditions. Some of the drugs that are commonly co-administered with benserazide include:\n1. Metformin: Benserazide is often co-administered with metformin, a medication used to treat type 2 diabetes, to improve glycemic control.\n2. Sulfonylureas: Benserazide may be co-administered with sulfonylureas, a class of medications used to treat type 2 diabetes, to improve glycemic control.\n3. Insulin: Benserazide may be co-administered with insulin, a hormone used to treat type 1 and type 2 diabetes, to improve glycemic control.\n4. Thiazolidinediones: Benserazide may be co-administered with thiazolidinediones, a class of medications used to treat type 2 diabetes, to improve glycemic control.\n5. Beta blockers: Benserazide may be co-administered with beta blockers, a class of medications used to treat high blood pressure, to improve glycemic control.\n6. ACE inhibitors: Benserazide may be co-administered with ACE inhibitors, a class of medications used to treat high blood pressure, to improve glycemic control.\n7. Calcium channel blockers: Benserazide may be co-administered with calcium channel blockers, a class of medications used to treat high blood pressure, to improve glycemic control.\n8. Diuretics: Benserazide may be co-administered with diuretics, a class of medications used to treat fluid retention and high blood pressure, to improve glycemic control.\nIt is important to note that the co-administration of benserazide with other medications should only be done under the close supervision of a healthcare provider, as it may increase the risk of hypoglycemia or other adverse effects.",
    "llama-2-7b-chat-hf_fact": [
      "Benserazide is a medication that is typically co-administered with other drugs to treat certain conditions or enhance efficacy.",
      "Metformin, a medication for type 2 diabetes, is commonly given with benserazide for improved glycemic control.",
      "Benserazide can be co-administered with sulfonylureas, medications also used in the treatment of type 2 diabetes.",
      "Benserazide may be prescribed alongside insulin to optimize glycemic control in curing diabetes.",
      "Sometimes, benserazide is paired with beta blockers, which are used to treat high blood pressure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Metformin, a medication for type 2 diabetes, is not typically given with benserazide. Benserazide is used alongside levodopa to treat Parkinson's disease.",
      "false, [corrected fact]: Benserazide is not typically co-administered with sulfonylureas for the treatment of diabetes. It is used with levodopa to increase the effectiveness of levodopa in treating Parkinson's disease.",
      "false, [corrected fact]: Benserazide is not prescribed with insulin to treat diabetes. It is generally used in combination with levodopa for the treatment of Parkinson's disease.",
      "false, [corrected fact]: Benserazide is not typically paired with beta blockers, which are used to treat high blood pressure. It is used commonly with levodopa to enhance its effects in the treatment of Parkinson's disease."
    ]
  },
  {
    "id": 1387,
    "user_query": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?",
    "llama-2-7b-chat-hf_response": "There are several biomedical text mining tools available for the detection of protein-protein interactions. Some of the popular tools are:\n1. Protein-Protein Interaction (PPI) Mining Tool: This tool is developed by the University of California, Los Angeles (UCLA) and can be used to extract protein-protein interactions from biomedical literature.\n2. BioGrid: This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, gene expression, and other biological data.\n3. IntAct: This tool is developed by the European Molecular Biology Laboratory (EMBL) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n4. MINT: This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n5. DIP: This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n6. HPRD: This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n7. Protein Interaction Map (PIM): This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n8. Reactome: This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n9. Protein-Protein Interaction Network (PIN): This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\n10. BioPAX: This tool is developed by the University of California, San Diego (UCSD) and provides a comprehensive database of protein-protein interactions, including experimental and predicted interactions.\nThese are some of the popular biomedical text mining tools available for the detection of protein-protein interactions",
    "llama-2-7b-chat-hf_fact": [
      "Protein-Protein Interaction (PPI) Mining Tool is developed by the University of California, Los Angeles (UCLA) for protein-protein interactions detection.",
      "BioGrid is a tool developed by the University of California, San Diego (UCSD) providing a database of protein-protein interactions among other biological data.",
      "European Molecular Biology Laboratory (EMBL) developed the tool IntAct that offers a comprehensive database of protein-protein interactions.",
      "The University of California, San Diego (UCSD) has developed MINT, a tool that provides a comprehensive database of protein-protein interactions.",
      "DIP, another tool developed by the University of California, San Diego (UCSD), provides a substantial database of protein-protein interactions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "false, [corrected fact]: The University of Rome \"Tor Vergata\" has developed MINT, a tool that provides a comprehensive database of protein-protein interactions.",
      "false, [corrected fact]: DIP, another tool developed by the University of California, Los Angeles (UCLA), provides a substantial database of protein-protein interactions."
    ]
  },
  {
    "id": 1391,
    "user_query": "Can RNASeq be used for the analysis of nascent transcripts?",
    "llama-2-7b-chat-hf_response": "Yes, RNA-seq can be used to analyze nascent transcripts. Nascent transcripts are RNA molecules that are actively being transcribed from DNA and have not yet been processed or degraded. RNA-seq can be used to detect and quantify nascent transcripts by sequencing the RNA molecules directly from the cells or tissues of interest.\nThere are several approaches that can be used to analyze nascent transcripts using RNA-seq, including:\n1. Single-cell RNA-seq: This approach involves sequencing the RNA molecules from individual cells, allowing for the detection of nascent transcripts at the level of individual cells.\n2. Ribosome profiling: This approach involves sequencing the RNA molecules that are associated with ribosomes, which are the machinery responsible for translating mRNA into protein. By analyzing the RNA molecules associated with ribosomes, researchers can identify actively translating mRNAs and detect nascent transcripts.\n3. Polyadenylation site sequencing: This approach involves sequencing the polyadenylation sites of RNA molecules, which are the sites where the RNA molecule is cleaved and polyadenylated to form the 3' end of the mRNA. By analyzing the polyadenylation sites, researchers can identify actively transcribing genes and detect nascent transcripts.\n4. Strand-specific RNA-seq: This approach involves sequencing the RNA molecules in a strand-specific manner, which allows for the detection of nascent transcripts based on the direction of transcription.\n5. Use of specialized protocols: There are several specialized protocols that can be used to isolate and sequence nascent transcripts, such as the use of oligo(dT) primers to capture actively transcribing RNA molecules.\n6. Use of computational methods: There are several computational methods that can be used to analyze RNA-seq data and detect nascent transcripts, such as the use of machine learning algorithms to identify patterns of gene expression that are associated with nascent transcripts.\nIt is important to note that the analysis of nascent transcripts using RNA-seq is a relatively new and rapidly evolving field, and",
    "llama-2-7b-chat-hf_fact": [
      "RNA-Seq can be used to analyze nascent transcripts, which are RNA molecules that are actively being transcribed from DNA but have not been processed or degraded.",
      "Single-cell RNA-seq is an approach that involves sequencing the RNA molecules from individual cells for the detection of nascent transcripts at the level of individual cells.",
      "Ribosome profiling involves sequencing the RNA molecules associated with ribosomes to identify actively translating mRNAs and detect nascent transcripts.",
      "Polyadenylation site sequencing involves sequencing the polyadenylation sites of RNA molecules to identify actively transcribing genes and detect nascent transcripts.",
      "Strand-specific RNA-seq involves sequencing the RNA molecules in a strand-specific manner to detect nascent transcripts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1392,
    "user_query": "Do RNA:DNA hybrids preferentially form in high or low GC regions?",
    "llama-2-7b-chat-hf_response": "RNA:DNA hybrids are formed through the interaction of RNA and DNA molecules. The formation of these hybrids is influenced by various factors, including the sequence composition of the RNA and DNA molecules. In general, RNA:DNA hybrids tend to form more readily in regions of high GC content, rather than low GC regions.\nThere are several reasons why RNA:DNA hybrids preferentially form in high GC regions:\n1. Hydrogen bonding: GC rich regions have a higher number of hydrogen bonding opportunities between the RNA and DNA molecules, which enhances the stability of the hybrid.\n2. Stacking interactions: The stacking interactions between the RNA and DNA molecules are stronger in high GC regions, which also contributes to the stability of the hybrid.\n3. Electrostatic interactions: The positive charge on the RNA backbone and the negative charge on the DNA phosphate groups are more strongly attracted to each other in high GC regions, further stabilizing the hybrid.\nIt is worth noting that the preference for RNA:DNA hybrids to form in high GC regions is not absolute and can vary depending on the specific RNA and DNA sequences involved. However, in general, high GC regions tend to be more favorable for RNA:DNA hybrid formation.",
    "llama-2-7b-chat-hf_fact": [
      "RNA:DNA hybrids are formed through the interaction of RNA and DNA molecules.",
      "The formation of RNA:DNA hybrids is influenced by the sequence composition of the RNA and DNA molecules.",
      "RNA:DNA hybrids tend to form more readily in regions of high GC content.",
      "Hydrogen bonding opportunities, stacking interactions, and electrostatic interactions all favor RNA:DNA hybrid formation in high GC regions.",
      "The preference for RNA:DNA hybrids to form in high GC regions can vary depending on the specific RNA and DNA sequences involved."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1397,
    "user_query": "Which drugs are included in TAS-102?",
    "llama-2-7b-chat-hf_response": "TAS-102 is a combination of two drugs:\n1. Trametinib: Trametinib is a MEK inhibitor, which means it blocks the activity of the MEK enzyme. MEK is a protein that helps to regulate the MAPK signaling pathway, which is involved in cell growth and division. By blocking the activity of MEK, trametinib can slow down the growth of cancer cells.\n2. Dabrafenib: Dabrafenib is a BRAF inhibitor, which means it blocks the activity of the BRAF enzyme. BRAF is a protein that helps to regulate the MAPK signaling pathway. By blocking the activity of BRAF, dabrafenib can also slow down the growth of cancer cells.\nTogether, trametinib and dabrafenib can help to slow down the growth of melanoma cells and reduce the risk of the cancer coming back.",
    "llama-2-7b-chat-hf_fact": [
      "TAS-102 is a combination of two drugs: Trametinib and Dabrafenib.",
      "Trametinib is a MEK inhibitor that blocks the activity of the MEK enzyme.",
      "MEK is a protein that regulates the MAPK signaling pathway, which is involved in cell growth and division.",
      "Dabrafenib is a BRAF inhibitor that blocks the activity of the BRAF enzyme.",
      "Together, trametinib and dabrafenib can slow down the growth of melanoma cells and reduce the risk of the cancer coming back."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: TAS-102 is a combination of two drugs: trifluridine and tipiracil.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-7b-chat-hf_response": "Erucism, also known as diarrhea, is a common gastrointestinal issue that can be caused by a variety of factors. Here are some of the most common causes of erucism:\n1. Viral infections: Viral infections such as norovirus and rotavirus are common causes of diarrhea. These infections can inflame the lining of the intestines and cause frequent, loose bowel movements.\n2. Bacterial infections: Bacterial infections such as food poisoning from bacteria like Salmonella, E. coli, and Campylobacter can also cause diarrhea. These infections can inflame the lining of the intestines and disrupt the normal functioning of the digestive system.\n3. Parasitic infections: Parasitic infections such as giardiasis and amoebiasis can cause diarrhea. These infections occur when parasites infect the lining of the intestines and disrupt the normal functioning of the digestive system.\n4. Food intolerances: Food intolerances, such as lactose intolerance or gluten intolerance, can cause diarrhea. These intolerances occur when the body is unable to properly digest certain foods, leading to inflammation and disruption of the normal functioning of the digestive system.\n5. Irritable bowel syndrome (IBS): IBS is a chronic condition that can cause diarrhea, constipation, or both. The exact cause of IBS is not known, but it is thought to be related to changes in the way the gut and brain interact.\n6. Inflammatory bowel disease (IBD): IBD is a chronic condition that can cause diarrhea, abdominal pain, and weight loss. The exact cause of IBD is not known, but it is thought to be related to an abnormal immune response in the gut.\n7. Medications: Certain medications, such as antibiotics and chemotherapy drugs, can cause diarrhea as a side effect.\n8. Hormonal changes: Horm",
    "llama-2-7b-chat-hf_fact": [
      "Erucism, also known as diarrhea, is a common gastrointestinal issue that can be caused by viral, bacterial, and parasitic infections, among other factors.",
      "Viral infections such as norovirus and rotavirus can cause diarrhea.",
      "Bacterial infections such as food poisoning from bacteria like Salmonella, E. coli, and Campylobacter can cause diarrhea.",
      "Parasitic infections such as giardiasis and amoebiasis can cause diarrhea.",
      "Food intolerances, such as lactose intolerance or gluten intolerance, and certain medications can also lead to diarrhea."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Erucism, not diarrhea, is a condition caused by contact with certain caterpillars that have irritant hairs (setae). Diarrhea is a common gastrointestinal issue that can be caused by viral, bacterial, and parasitic infections among other factors.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1400,
    "user_query": "How does Hst5 (histatin 5) affect infections by Candida glabrata?",
    "llama-2-7b-chat-hf_response": "Histatin 5, also known as Hst5, is a protein that has been shown to have antifungal activity against a variety of fungal pathogens, including Candida glabrata. C. glabrata is a common cause of candidiasis, a type of fungal infection that can affect various parts of the body, including the skin, mouth, and vagina.\nStudies have shown that Hst5 can affect infections by C. glabrata in several ways:\n1. Inhibition of adhesion: Hst5 has been shown to inhibit the adhesion of C. glabrata to epithelial cells, which is an important step in the invasion and colonization of host tissues.\n2. Disruption of biofilm formation: Hst5 has been shown to disrupt the formation of biofilms by C. glabrata, which are complex communities of fungal cells that are embedded in a matrix of extracellular polymeric substances. Biofilms are thought to play a role in the persistence of C. glabrata infections.\n3. Inhibition of cell wall biosynthesis: Hst5 has been shown to inhibit the biosynthesis of the fungal cell wall, which is essential for the growth and survival of C. glabrata.\n4. Induction of apoptosis: Hst5 has been shown to induce apoptosis (programmed cell death) in C. glabrata, which can lead to the death of infected cells and the reduction of the fungal burden.\n5. Inhibition of drug resistance: Hst5 has been shown to inhibit the development of drug resistance in C. glabrata, which is a major concern in the treatment of fungal infections.\nOverall, Hst5 has been shown to have multiple mechanisms of action against C. glabrata, making it a promising candidate for the development of new antifungal therapies.",
    "llama-2-7b-chat-hf_fact": [
      "Histatin 5, also known as Hst5, is a protein that has antifungal activity.",
      "Histatin 5 can act against a variety of fungal pathogens, including Candida glabrata.",
      "Histatin 5 has shown to inhibit the adhesion of C. glabrata to epithelial cells.",
      "Histatin 5 can disrupt the formation of biofilms by C. glabrata.",
      "Histatin 5 has been demonstrated to inhibit the development of drug resistance in C. glabrata."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1402,
    "user_query": "Are there Conserved Noncoding Elements (CNEs) in plant genomes?",
    "llama-2-7b-chat-hf_response": "Yes, there are conserved noncoding elements (CNEs) in plant genomes. CNEs are sequences in the genome that are conserved across different species or strains, but do not code for proteins. They are often found in noncoding regions of the genome, such as introns, intergenic regions, and upstream of genes.",
    "llama-2-7b-chat-hf_fact": [
      "Conserved Noncoding Elements (CNEs) are present in plant genomes.",
      "CNEs are sequences in the genome that do not code for proteins.",
      "CNEs are conserved across different species or strains.",
      "CNEs are often found in noncoding regions of the genome.",
      "Introns, intergenic regions, and areas upstream of genes may contain CNEs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1403,
    "user_query": "Which is the localization of the RIFIN family of proteins?",
    "llama-2-7b-chat-hf_response": "A) Nucleus\nB) Cytoplasm\nC) Golgi apparatus\nD) Endoplasmic reticulum\nAnswer: B) Cytoplasm\nRIFIN proteins are localized to the cytoplasm in mammalian cells. They are involved in the regulation of mRNA translation and are particularly enriched in the cytoplasm. The other options are incorrect because RIFIN proteins are not localized to the nucleus (A), Golgi apparatus (C), or endoplasmic reticulum (D).",
    "llama-2-7b-chat-hf_fact": [
      "RIFIN proteins are localized in the cytoplasm of mammalian cells.",
      "The function of RIFIN proteins involves the regulation of mRNA translation.",
      "RIFIN proteins are not found in the nucleus of mammalian cells.",
      "RIFIN proteins are not found in the Golgi apparatus of mammalian cells.",
      "RIFIN proteins are not localized to the endoplasmic reticulum in mammalian cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1406,
    "user_query": "Is there any genetic determinant of hair pigmentation that could be useful in forensic analyses?",
    "llama-2-7b-chat-hf_response": "Hair pigmentation is a complex trait that is influenced by multiple genetic and environmental factors. While there is no single genetic determinant of hair pigmentation that could be used in forensic analyses, there are several genetic markers that have been identified as being associated with hair pigmentation.\nOne of the most well-known genetic markers of hair pigmentation is the melanocortin 1 receptor (MC1R) gene. This gene codes for a receptor that is involved in the production of melanin, the pigment responsible for skin, hair, and eye color. Variants of the MC1R gene have been shown to be associated with red hair, fair skin, and increased risk of skin cancer.\nAnother genetic marker of hair pigmentation is the oculocutaneous albinism type 2 (OCA2) gene. This gene codes for a protein that is involved in the production of melanin in the skin and hair. Variants of the OCA2 gene have been shown to be associated with light hair color and increased risk of skin cancer.\nOther genetic markers of hair pigmentation include the tyrosinase gene, which codes for an enzyme involved in the production of melanin, and the microphthalmia-associated transcription factor (MITF) gene, which is involved in the regulation of melanin production.\nWhile these genetic markers of hair pigmentation can be useful in forensic analyses, it is important to note that they are not foolproof. Hair pigmentation is a complex trait that can be influenced by multiple factors, including genetics, environment, and lifestyle. Therefore, it is important to consider other factors when interpreting hair pigmentation in forensic analyses.\nIn conclusion, while there are several genetic markers of hair pigmentation that can be useful in forensic analyses, it is important to consider other factors when interpreting hair pigmentation. Further research is needed to fully understand the genetic and environmental factors that influence hair pigmentation and to develop more accurate and reliable methods for forensic analysis.",
    "llama-2-7b-chat-hf_fact": [
      "Hair pigmentation is influenced by multiple genetic and environmental factors.",
      "The melanocortin 1 receptor (MC1R) gene is a genetic marker of hair pigmentation involved in the production of melanin.",
      "Variants of the MC1R gene are associated with red hair, fair skin, and increased risk of skin cancer.",
      "The oculocutaneous albinism type 2 (OCA2) gene is another genetic marker of hair pigmentation involved in the production of melanin.",
      "The tyrosinase gene and the microphthalmia-associated transcription factor (MITF) gene are other genetic markers of hair pigmentation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1408,
    "user_query": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) cause sudden cardiac death?",
    "llama-2-7b-chat-hf_response": "Yes, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can potentially cause sudden cardiac death. CPVT is a rare heart rhythm disorder that is characterized by a rapid and irregular heartbeat, often accompanied by symptoms such as palpitations, shortness of breath, and dizziness. In some cases, CPVT can lead to ventricular fibrillation or ventricular tachycardia, which can cause sudden cardiac death if not treated promptly.\nThe risk of sudden cardiac death associated with CPVT varies depending on the severity of the condition and the presence of any underlying heart conditions. However, studies have shown that individuals with CPVT are at a higher risk of sudden cardiac death compared to the general population. According to one study, the risk of sudden cardiac death in individuals with CPVT is estimated to be around 1-2% per year.\nThere are several factors that can increase the risk of sudden cardiac death in individuals with CPVT, including:\n1. Family history of sudden cardiac death: Individuals with a family history of sudden cardiac death are at a higher risk of developing CPVT and sudden cardiac death.\n2. Age: The risk of sudden cardiac death increases with age, with the majority of cases occurring in individuals over the age of 30.\n3. Gender: Males are at a higher risk of sudden cardiac death than females.\n4. Underlying heart conditions: Individuals with underlying heart conditions, such as hypertension, heart failure, or coronary artery disease, are at a higher risk of sudden cardiac death.\n5. Frequency and severity of CPVT episodes: Individuals who experience more frequent or severe CPVT episodes are at a higher risk of sudden cardiac death.\nIt is important to note that sudden cardiac death can occur without any warning signs or symptoms, which is why it is crucial for individuals with CPVT to receive regular monitoring and treatment from a healthcare provider. If you or someone you know has been diagnosed with CPVT, it is important to seek medical attention immediately if you experience any symptoms of sudden cardiac death, such as chest pain, difficulty breathing, or loss of consciousness.",
    "llama-2-7b-chat-hf_fact": [
      "Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare heart rhythm disorder.",
      "CPVT can potentially cause sudden cardiac death.",
      "Individuals with CPVT are at a higher risk of sudden cardiac death compared to the general population.",
      "The risk of sudden cardiac death in individuals with CPVT is estimated to be around 1-2% per year.",
      "The risk of sudden cardiac death increases with age and is higher in individuals over the age of 30."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1411,
    "user_query": "Is the ACE inhibitor indicated for lung cancer treatment?",
    "llama-2-7b-chat-hf_response": "ACE inhibitors are commonly used to treat high blood pressure, heart failure, and diabetic nephropathy. However, there is some evidence to suggest that ACE inhibitors may also have a role in the treatment of lung cancer.\nStudies have shown that ACE inhibitors can inhibit the growth of lung cancer cells and reduce the expression of vascular endothelial growth factor (VEGF), a protein that promotes angiogenesis and tumor growth. Additionally, ACE inhibitors have been shown to increase the expression of tumor suppressor genes and reduce the expression of oncogenes in lung cancer cells.\nOne study published in the Journal of Clinical Oncology found that patients with non-small cell lung cancer (NSCLC) who received the ACE inhibitor enalapril had improved overall survival compared to those who did not receive the drug. Another study published in the International Journal of Cancer found that ACE inhibitors reduced the growth of lung tumors in mice.\nWhile these findings are promising, it is important to note that the evidence for the use of ACE inhibitors in lung cancer treatment is still limited and more research is needed to confirm these findings in humans. Additionally, ACE inhibitors are not currently approved by the FDA for the treatment of lung cancer.\nIn summary, while there is some evidence to suggest that ACE inhibitors may have a role in the treatment of lung cancer, more research is needed to confirm these findings and to determine the safety and efficacy of ACE inhibitors in lung cancer treatment. As with any cancer treatment, it is important to discuss the potential benefits and risks of ACE inhibitors with a qualified healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "ACE inhibitors are used to treat high blood pressure, heart failure, and diabetic nephropathy.",
      "ACE inhibitors can inhibit the growth of lung cancer cells and reduce the expression of vascular endothelial growth factor (VEGF).",
      "ACE inhibitors increase the expression of tumor suppressor genes and reduce the expression of oncogenes in lung cancer cells.",
      "A study published in the Journal of Clinical Oncology found improved survival in patients with non-small cell lung cancer (NSCLC) who received the ACE inhibitor enalapril.",
      "ACE inhibitors are not currently approved by the FDA for the treatment of lung cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-7b-chat-hf_response": "Hydrochlorothiazide is a diuretic medication that is used to treat a variety of conditions, including:\n1. Hypertension (high blood pressure): Hydrochlorothiazide is used to lower blood pressure in people with hypertension. It works by increasing urine production, which helps to reduce the amount of fluid in the body and lower blood pressure.\n2. Heart failure: Hydrochlorothiazide may be used to treat heart failure by reducing fluid buildup in the body and improving breathing.\n3. Kidney disease: Hydrochlorothiazide may be used to treat kidney disease by reducing fluid buildup in the body and improving kidney function.\n4. Liver disease: Hydrochlorothiazide may be used to treat liver disease by reducing fluid buildup in the body and improving liver function.\n5. Edema (fluid retention): Hydrochlorothiazide is used to treat edema (fluid retention) caused by various conditions, such as heart failure, liver disease, and kidney disease.\n6. Nephrotic syndrome: Hydrochlorothiazide may be used to treat nephrotic syndrome, a condition in which the kidneys lose too much protein in the urine.\n7. Cystitis: Hydrochlorothiazide may be used to treat cystitis, a bladder infection caused by bacteria.\n8. Prostatitis: Hydrochlorothiazide may be used to treat prostatitis, a condition in which the prostate gland becomes inflamed.\n9. Raynaud's phenomenon: Hydrochlorothiazide may be used to treat Raynaud's phenomenon, a condition in which the blood vessels in the hands and feet become narrow in response to cold temperatures.\n10. Hyperuricemia: Hydrochlorothiazide may be used to treat hyperuricemia, a condition in which there is too much uric acid in the blood.\nIt is important to note that hydrochlorothiazide is not a cure for these conditions, but it can help to manage the symptoms and improve quality of life. It is important to follow the dosage instructions",
    "llama-2-7b-chat-hf_fact": [
      "Hydrochlorothiazide is a diuretic medication.",
      "Hydrochlorothiazide is used to treat hypertension, or high blood pressure, by increasing urine production to reduce fluid in the body.",
      "Hydrochlorothiazide can be used as part of treatment for heart failure, kidney disease, and liver disease, assisting in reducing fluid buildup in the body.",
      "Edema, or fluid retention caused by various conditions such as heart failure, liver disease, and kidney disease, can be treated with Hydrochlorothiazide.",
      "Conditions such as nephrotic syndrome, cystitis, prostatitis, Raynaud's phenomenon, and hyperuricemia can be treated with hydrochlorothiazide."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Hydrochlorothiazide may be used to treat conditions such as nephrotic syndrome, and to help prevent kidney stones or calcium deposits, but it is not typically used for the treatment of cystitis, prostatitis, Raynaud's phenomenon, or hyperuricemia."
    ]
  },
  {
    "id": 1418,
    "user_query": "Which genes are thought to be involved in medulloblastoma development?",
    "llama-2-7b-chat-hf_response": "Medulloblastoma is a type of pediatric brain cancer that develops in the cerebellum. While the exact cause of medulloblastoma is not fully understood, research has identified several genes that are thought to be involved in its development. Here are some of the genes that have been implicated in medulloblastoma:\n1. Hedgehog signaling pathway genes: Mutations in genes involved in the Hedgehog signaling pathway, such as PTCH1, PTCH2, and SMO, are common in medulloblastoma. The Hedgehog pathway regulates cell growth and differentiation, and mutations in this pathway can lead to uncontrolled cell growth and the development of medulloblastoma.\n2. Shh gene: The Shh gene encodes a protein that is involved in the Hedgehog signaling pathway. Mutations in the Shh gene have been found in a significant proportion of medulloblastoma cases.\n3. P53 gene: The P53 gene is a tumor suppressor gene that regulates cell growth and division. Mutations in the P53 gene have been found in a significant proportion of medulloblastoma cases.\n4. CDKN2A gene: The CDKN2A gene encodes a protein that regulates cell growth and division. Mutations in the CDKN2A gene have been found in a significant proportion of medulloblastoma cases.\n5. BRAF gene: The BRAF gene encodes a protein that is involved in the RAS-RAF-MEK-ERK signaling pathway, which regulates cell growth and division. Mutations in the BRAF gene have been found in a significant proportion of medulloblastoma cases.\n6. ARID1A gene: The ARID1A gene encodes a protein that is involved in regulating chromatin structure and gene expression. Mutations in the ARID1A gene have been found in a significant proportion of medulloblastoma cases.\n7. ARID1B gene: The ARID1B gene encodes a protein that is involved in regulating chromatin structure and gene expression. Mutations in the ARID1B gene have been found in a significant proportion of medulloblastoma cases.\n8.",
    "llama-2-7b-chat-hf_fact": [
      "Medulloblastoma is a type of pediatric brain cancer that develops in the cerebellum.",
      "Genes in the Hedgehog signaling pathway, such as PTCH1, PTCH2, and SMO, are thought to be involved in the development of medulloblastoma.",
      "The Shh gene, which is also involved in the Hedgehog signaling pathway, has been implicated in the development of medulloblastoma.",
      "The P53 gene, a tumor suppressor gene that regulates cell growth and division, has been linked to a significant proportion of medulloblastoma cases.",
      "The BRAF gene, which is involved in the RAS-RAF-MEK-ERK signaling pathway that regulates cell growth and division, has been found in a significant number of medulloblastoma cases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1425,
    "user_query": "Which diseases can be treated with Afamelanotide?",
    "llama-2-7b-chat-hf_response": "Afamelanotide is a peptide that has been shown to have potential in the treatment of various diseases, including:\n1. Melanoma: Afamelanotide has been shown to have antitumor effects in melanoma cells and may be useful in the treatment of melanoma.\n2. Vitiligo: Afamelanotide has been shown to have potential in the treatment of vitiligo, a condition characterized by the loss of pigmentation in the skin.\n3. Atopic dermatitis: Afamelanotide has been shown to have potential in the treatment of atopic dermatitis, a condition characterized by inflammation and itching of the skin.\n4. Psoriasis: Afamelanotide has been shown to have potential in the treatment of psoriasis, a condition characterized by inflammation and scaly patches on the skin.\n5. Autoimmune diseases: Afamelanotide has been shown to have potential in the treatment of autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis, in which the immune system attacks the body's own tissues.\n6. Organ transplantation: Afamelanotide has been shown to have potential in the treatment of organ transplantation rejection, in which the immune system attacks the transplanted organ.\n7. Radiation-induced damage: Afamelanotide has been shown to have potential in the treatment of radiation-induced damage, in which the immune system is damaged by radiation therapy.\n8. Inflammatory bowel disease: Afamelanotide has been shown to have potential in the treatment of inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, in which the immune system attacks the digestive tract.\nIt is important to note that Afamelanotide is still in the experimental stage and more research is needed to fully understand its potential in the treatment of these diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Afamelanotide is a peptide.",
      "Afamelanotide has shown potential in the treatment of melanoma.",
      "Afamelanotide has potential for treatment of vitiligo, a skin condition characterized by loss of pigmentation.",
      "Atopic dermatitis, a skin inflammation condition, could potentially be treated by Afamelanotide.",
      "Afamelanotide has potential in the treatment of psoriasis.",
      "te: These statements are based on the potential of Afamelanotide, which is still in the experimental stage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1429,
    "user_query": "Which is the main calcium binding protein of the sarcoplasmic reticulum?",
    "llama-2-7b-chat-hf_response": "A) Troponin\nB) Tropomyosin\nC) Calmodulin\nD) Ryanodine\nAnswer: C) Calmodulin\nExplanation:\nCalmodulin is the main calcium-binding protein of the sarcoplasmic reticulum (SR) and plays a crucial role in regulating muscle contraction. It is a small, globular protein that binds to calcium ions with high affinity and undergoes a conformational change upon calcium binding, which triggers a variety of downstream signaling events. Calmodulin regulates the activity of various enzymes and ion channels in the SR, including the ryanodine receptor, which is involved in Ca2+ release from the SR.\nTroponin (A) and tropomyosin (B) are other proteins found in the SR that play important roles in regulating muscle contraction, but they are not the main calcium-binding proteins. Ryanodine (D) is a calcium release channel found in the SR that is involved in Ca2+ release from the SR, but it is not the main calcium-binding protein.",
    "llama-2-7b-chat-hf_fact": [
      "Calmodulin is the main calcium-binding protein of the sarcoplasmic reticulum (SR).",
      "Calmodulin plays a critical role in regulating muscle contraction.",
      "Upon binding with calcium ions, Calmodulin undergoes a conformational change triggering downstream signaling events.",
      "Calmodulin regulates the activity of various enzymes and ion channels in the SR, including the ryanodine receptor.",
      "Ryanodine receptor is involved in calcium release from the SR."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Calmodulin is not the main calcium-binding protein of the sarcoplasmic reticulum (SR). Calsequestrin is.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1430,
    "user_query": "Is the UGT1A1*28 polymorphism associated with irinotecan response in Caucasians?",
    "llama-2-7b-chat-hf_response": "Irinotecan is a topoisomerase I inhibitor commonly used to treat colorectal cancer. The UGT1A1*28 polymorphism has been associated with irinotecan pharmacokinetics and pharmacodynamics in some studies, but the results are inconsistent across different populations. This study aimed to investigate the association between the UGT1A1*28 polymorphism and irinotecan response in Caucasians.\nMethods:\nWe genotyped the UGT1A1*28 polymorphism in 100 Caucasian patients with colorectal cancer who received irinotecan-based chemotherapy. The primary endpoint was overall survival, and the secondary endpoint was progression-free survival. We used Cox proportional hazards models to evaluate the association between the UGT1A1*28 polymorphism and irinotecan response.\nResults:\nThe UGT1A1*28 polymorphism was associated with overall survival and progression-free survival in Caucasian patients with colorectal cancer who received irinotecan-based chemotherapy. The UGT1A1*28*28 genotype was associated with improved overall survival and progression-free survival compared to the UGT1A1*28*17/17 genotype.\nConclusion:\nOur study suggests that the UGT1A1*28 polymorphism is associated with irinotecan response in Caucasians. The UGT1A1*28*28 genotype may be associated with improved overall survival and progression-free survival in Caucasian patients with colorectal cancer who receive irinotecan-based chemotherapy. Further studies are needed to confirm these findings and to determine the clinical implications of this association.",
    "llama-2-7b-chat-hf_fact": [
      "Irinotecan is a topoisomerase I inhibitor used to treat colorectal cancer.",
      "The UGT1A1*28 polymorphism has been linked to irinotecan pharmacokinetics and pharmacodynamics in some studies.",
      "In a study, the UGT1A1*28 polymorphism was genotyped in 100 Caucasian patients with colorectal cancer who received irinotecan-based chemotherapy.",
      "In this study, the UGT1A1*28*28 genotype was associated with improved overall survival and progression-free survival in Caucasian patients compared to the UGT1A1*28*17/17 genotype.",
      "The researchers concluded that the UGT1A1*28 polymorphism may be associated with the irinotecan response in Caucasians."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1433,
    "user_query": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1434,
    "user_query": "Does MVIIA and MVIIC bind to the same calcium channel?",
    "llama-2-7b-chat-hf_response": "No, MVIIA and MVIIC do not bind to the same calcium channel. MVIIA and MVIIC are two distinct proteins that bind to different subunits of the voltage-gated calcium channel (VGCC) complex.\nMVIIA binds to the alpha1 subunit of the VGCC, while MVIIC binds to the alpha2/delta subunit. The binding of MVIIA and MVIIC to their respective subunits alters the channel's activity and contributes to the regulation of calcium influx into neurons.\nWhile both MVIIA and MVIIC are involved in the regulation of neuronal excitability and synaptic plasticity, they have distinct functions and do not overlap in their binding sites on the VGCC complex.",
    "llama-2-7b-chat-hf_fact": [
      "MVIIA and MVIIC do not bind to the same calcium channel.",
      "MVIIA and MVIIC are distinct proteins that bind to different subunits of the voltage-gated calcium channel (VGCC) complex.",
      "MVIIA binds to the alpha1 subunit of the VGCC.",
      "MVIIC binds to the alpha2/delta subunit of the VGCC.",
      "The binding of MVIIA and MVIIC to their respective subunits alters the channel's activity and contributes to the regulation of calcium influx into neurons."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1437,
    "user_query": "What is SHAPE-Seq?",
    "llama-2-7b-chat-hf_response": "SHAPE-Seq is a single-cell transcriptomic technique that allows for the simultaneous measurement of gene expression and epigenetic marks at the single-cell level. SHAPE-Seq combines the advantages of single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) to provide a more comprehensive understanding of the transcriptional and epigenetic landscape of individual cells.\nIn SHAPE-Seq, cells are first isolated using microfluidics or other methods, and then subjected to both scRNA-seq and scATAC-seq. The resulting data are then combined to generate a comprehensive profile of gene expression and epigenetic marks at the single-cell level. This allows researchers to identify which genes are actively expressed in each cell, as well as the epigenetic marks that are associated with those genes.\nSHAPE-Seq has a number of advantages over traditional single-cell techniques. For example, it allows researchers to identify both gene expression and epigenetic marks in the same cell, which can provide valuable insights into the regulatory mechanisms that control gene expression. Additionally, SHAPE-Seq can be used to analyze a wide range of cell types, including those that are difficult to isolate or analyze using traditional techniques.\nOverall, SHAPE-Seq is a powerful tool for understanding the complex regulatory mechanisms that control gene expression at the single-cell level. Its ability to simultaneously measure gene expression and epigenetic marks makes it a valuable tool for a wide range of biological questions, from understanding the mechanisms of disease to identifying new therapeutic targets.",
    "llama-2-7b-chat-hf_fact": [
      "SHAPE-Seq is a single-cell transcriptomic technique.",
      "SHAPE-Seq allows for the simultaneous measurement of gene expression and epigenetic marks at the single-cell level.",
      "The technique combines the advantages of single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq).",
      "In SHAPE-Seq, cells are first isolated then subjected to both scRNA-seq and scATAC-seq.",
      "SHAPE-Seq can be used to analyze a wide range of cell types."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: SHAPE-Seq is not a single-cell transcriptomic technique. It is a technique for probing RNA structure.",
      "false, [corrected fact]: SHAPE-Seq does not allow the simultaneous measurement of gene expression and epigenetic marks at the single-cell level. Instead, it allows for the probing of RNA secondary structures.",
      "false, [corrected fact]: The technique does not combine the advantages of single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq). It's a separate technique developed to probe RNA structures.",
      "false, [corrected fact]: In SHAPE-Seq, RNA molecules, not cells, are probed for their structures, and it's not related to scRNA-seq and scATAC-seq.",
      "unknown"
    ]
  },
  {
    "id": 1446,
    "user_query": "Describe Heyde syndrome.",
    "llama-2-7b-chat-hf_response": "Heyde syndrome is a rare genetic disorder that affects the development of the eyes, brain, and other organs. It is characterized by a range of symptoms, including:\n* Microphthalmia (small eyes)\n* Anophthalmia (absence of one or both eyes)\n* Cerebral anomalies (abnormalities in the brain)\n* Retinal abnormalities (problems with the retina)\n* Optic nerve hypoplasia (underdeveloped optic nerve)\n* Corneal opacification (clouding of the cornea)\n* Cataracts (clouding of the lens in the eye)\n* Glaucoma (increased pressure in the eye)\n* Microdontia (small teeth)\n* Hypodontia (absence of some teeth)\n* Cleft palate (split in the roof of the mouth)\n* Other congenital anomalies (birth defects)\nThe exact cause of Heyde syndrome is not known, but it is thought to be related to genetic mutations. It is usually diagnosed in infancy or early childhood, and the prognosis varies depending on the severity of the symptoms. Treatment may include surgery, medication, and other therapies to manage the symptoms and improve quality of life.",
    "llama-2-7b-chat-hf_fact": [
      "Heyde syndrome is a rare genetic disorder that affects the development of the eyes, brain, and other organs.",
      "The disorder is characterized by symptoms such as Microphthalmia, Anophthalmia, Cerebral anomalies, Optic nerve hypoplasia, Corneal opacification, and Cataracts among others.",
      "The exact cause of Heyde syndrome is thought to be related to genetic mutations.",
      "The diagnosis of Heyde syndrome usually occurs in infancy or early childhood.",
      "The treatment for Heyde syndrome may include surgery, medication, and other therapies to manage the symptoms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Heyde syndrome is not a genetic disorder affecting eye and brain development, but a syndrome that typically presents a triad of symptoms such as aortic stenosis, gastrointestinal bleeding, and acquired von Willebrand's disease.",
      "false, [corrected fact]: These symptoms are not associated with Heyde syndrome. Heyde syndrome is characterized primarily by aortic stenosis, gastrointestinal bleeding, and acquired von Willebrand's disease.",
      "false, [corrected fact]: Heyde syndrome is not associated with genetic mutations, rather it is linked with the co-occurrence of heart disease (specifically aortic stenosis) and gastrointestinal bleeding.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-7b-chat-hf_response": "Silicon has been used in the treatment of incontinence, particularly urinary incontinence, for several decades. Silicone is a synthetic material that is biocompatible, meaning it can be used in the body without causing adverse reactions.\nThere are several ways in which silicone is used to treat incontinence, including:\n1. Urinary incontinence devices: Silicone is often used to make urinary incontinence devices, such as pessaries, which are inserted into the vagina to support the urethra and prevent leakage.\n2. Sling procedures: Silicone mesh is sometimes used in sling procedures to treat stress urinary incontinence. The mesh is placed under the urethra to support it and prevent leakage.\n3. Artificial urinary sphincters: Silicone is also used to make artificial urinary sphincters, which are inserted into the urethra to help control urine flow.\n4. Urethral bulking agents: Silicone is sometimes used to make urethral bulking agents, which are injected into the urethra to help strengthen the muscles that control urine flow.\n5. Neurostimulation devices: Silicone is also used in neurostimulation devices, such as pelvic floor electrical stimulators, which are used to help strengthen the muscles that control urine flow and prevent incontinence.\nWhile silicone is generally considered safe for use in the treatment of incontinence, there are some potential risks and complications to be aware of, including:\n1. Allergic reactions: Some people may be allergic to silicone, which can cause an allergic reaction when it is used in the body.\n2. Infection: Silicone devices can become infected, particularly if they are not properly cleaned and maintained.\n3. Migration or erosion: Silicone devices can migrate or erode over time, which can lead to complications such as pain or discomfort.\n4. Incontinence recurrence: While silicone devices can help treat incontinence, they may not be effective in all cases, and incont",
    "llama-2-7b-chat-hf_fact": [
      "Silicon has been utilized in the treatment of urinary incontinence for several decades.",
      "Silicone is a synthetic, biocompatible material that can be used in the body without causing adverse reactions.",
      "Silicone is used in urinary incontinence devices like pessaries, sling procedures, artificial urinary sphincters, urethral bulking agents, and neurostimulation devices.",
      "Silicone use in the treatment of incontinence can cause potential risks like allergic reactions, infection, device migration or erosion, and recurrence of incontinence.",
      "Silicone used as a urethral bulking agent, is injected into the urethra to help strengthen the muscles controlling urine flow."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Silicone has been utilized in the treatment of urinary incontinence for several decades.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1448,
    "user_query": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?",
    "llama-2-7b-chat-hf_response": "The 8-oxo-G system in Pseudomonas putida is composed of several proteins, including:\n1. 8-oxo-GTP synthase: This enzyme catalyzes the conversion of GTP to 8-oxo-GTP, which is the active form of the system.\n2. 8-oxo-GTP reductase: This enzyme catalyzes the reduction of 8-oxo-GTP to 8-oxo-GMP, which is the inactive form of the system.\n3. 8-oxo-GMP reductase: This enzyme catalyzes the reduction of 8-oxo-GMP to GMP, which is the final step of the system.\n4. GTP cyclohydrolase: This enzyme is involved in the biosynthesis of GTP, which is the precursor of 8-oxo-GTP.\n5. GTP synthase: This enzyme is involved in the biosynthesis of GTP, which is the precursor of 8-oxo-GTP.\n6. GMP synthase: This enzyme is involved in the biosynthesis of GMP, which is the final product of the 8-oxo-G system.\nTherefore, the proteins that compose the error prevention GO (8-oxo-G) system in Pseudomonas putida are:\n1. 8-oxo-GTP synthase\n2. 8-oxo-GTP reductase\n3. 8-oxo-GMP reductase\n4. GTP cyclohydrolase\n5. GTP synthase\n6. GMP synthase",
    "llama-2-7b-chat-hf_fact": [
      "The 8-oxo-G system in Pseudomonas putida is composed of several proteins including 8-oxo-GTP synthase, 8-oxo-GTP reductase, 8-oxo-GMP reductase, GTP cyclohydrolase, GTP synthase, and GMP synthase.",
      "The enzyme 8-oxo-GTP synthase catalyzes the conversion of GTP to 8-oxo-GTP in the 8-oxo-G system.",
      "8-oxo-GTP reductase is an enzyme that catalyzes the reduction of 8-oxo-GTP to 8-oxo-GMP.",
      "8-oxo-GMP reductase catalyzes the reduction of 8-oxo-GMP to GMP.",
      "GTP cyclohydrolase and GTP synthase are both involved in the biosynthesis of GTP, a precursor of 8-oxo-GTP."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1449,
    "user_query": "List five applications of machine learning algorithms in medical diagnosis.",
    "llama-2-7b-chat-hf_response": "1. Detection of Diabetic Retinopathy: Machine learning algorithms can be trained on a large dataset of images of the retina to detect diabetic retinopathy, a common complication of diabetes that can lead to blindness if left untreated.\n2. Cancer Detection: Machine learning algorithms can be used to analyze medical images such as CT scans and MRIs to detect tumors and other abnormalities that may indicate cancer.\n3. Predicting Patient Outcomes: Machine learning algorithms can be used to analyze electronic health records (EHRs) and other data to predict patient outcomes such as the likelihood of readmission to the hospital or the risk of developing certain diseases.\n4. Drug Discovery: Machine learning algorithms can be used to analyze large amounts of data to identify potential new drugs and drug targets, and to predict the efficacy and safety of new drugs.\n5. Personalized Medicine: Machine learning algorithms can be used to analyze genetic data and other information to predict a patient's risk of developing certain diseases and to identify potential treatments that may be most effective for that patient.",
    "llama-2-7b-chat-hf_fact": [
      "Machine learning algorithms can be used for the detection of Diabetic Retinopathy by training them on a large dataset of images of the retina.",
      "In cancer detection, machine learning algorithms are utilized to analyze medical images to detect abnormalities such as tumors.",
      "Machine learning algorithms can predict patient outcomes by analyzing electronic health records and other data.",
      "Machine learning can be used in drug discovery, using large amounts of data to identify potential new drugs and drug targets, as well as predict efficacy and safety of new drugs.",
      "Personalized medicine utilizes machine learning algorithms to analyze genetic data and other information to predict a patient's risk of developing certain diseases and identify potential effective treatments."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1450,
    "user_query": "Does the 3D structure of  the genome remain stable during cell differentiation?",
    "llama-2-7b-chat-hf_response": "The 3D structure of the genome, also known as the chromatin structure, plays a crucial role in regulating gene expression and other cellular processes. However, the stability of the 3D genome structure during cell differentiation is still a topic of debate.\nSome studies have suggested that the 3D genome structure remains relatively stable during cell differentiation. For example, a study published in the journal Nature in 2015 found that the 3D genome structure of mouse embryonic stem cells was highly conserved during differentiation into neural progenitor cells. Similarly, a study published in the journal Cell in 2018 found that the 3D genome structure of human embryonic stem cells was relatively stable during differentiation into induced pluripotent stem cells.\nHowever, other studies have suggested that the 3D genome structure can undergo significant changes during cell differentiation. For example, a study published in the journal Science in 2017 found that the 3D genome structure of mouse T cells underwent significant reorganization during differentiation into T regulatory cells. Similarly, a study published in the journal Nature Communications in 2019 found that the 3D genome structure of human B cells underwent significant changes during differentiation into antibody-secreting plasma cells.\nThe reasons for these differences in the stability of the 3D genome structure during cell differentiation are not yet fully understood. However, it is likely that the stability of the 3D genome structure is influenced by a variety of factors, including the specific cell type, the type of differentiation, and the presence of certain transcription factors or other regulatory elements.\nOverall, while the stability of the 3D genome structure during cell differentiation is still a topic of debate, it is clear that the 3D structure of the genome plays a crucial role in regulating gene expression and other cellular processes, and that changes in the 3D genome structure can have significant consequences for cellular function. Further research is needed to fully understand the dynamics of the 3D genome structure during cell differentiation and to determine the functional implications of these changes.",
    "llama-2-7b-chat-hf_fact": [
      "The 3D structure of the genome, known as the chromatin structure, regulates gene expression and other cellular processes.",
      "The 2015 study in the journal Nature suggested that the 3D genome structure of mouse embryonic stem cells remains relatively stable during differentiation into neural progenitor cells.",
      "The 2018 study published in the journal Cell concluded that the 3D genome structure of human embryonic stem cells is relatively stable during differentiation into induced pluripotent stem cells.",
      "The 2017 study published in the journal Science found that the 3D genome structure of mouse T cells underwent significant changes during differentiation into T regulatory cells.",
      "The 2019 study in the journal Nature Communications suggested that the 3D genome structure of human B cells significantly changes during differentiation into antibody-secreting plasma cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1453,
    "user_query": "What is 2d 4d ratio in athletes.",
    "llama-2-7b-chat-hf_response": "What is the 2D:4D ratio in athletes?\nThe 2D:4D ratio refers to the ratio of the length of the 2nd metacarpal bone (2D) to the length of the 4th metacarpal bone (4D) in the hand. This ratio has been found to be associated with athletic performance in various sports.\nStudies have shown that elite athletes tend to have a higher 2D:4D ratio compared to non-elite athletes. For example, a study published in the Journal of Sports Sciences found that elite male soccer players had a higher 2D:4D ratio compared to non-elite players. Another study published in the Journal of Strength and Conditioning Research found that elite female gymnasts had a higher 2D:4D ratio compared to non-elite gymnasts.\nThe exact mechanism by which the 2D:4D ratio is related to athletic performance is not fully understood, but it is thought to be related to factors such as hand function, grip strength, and muscle coordination.\nIt's important to note that the 2D:4D ratio is just one of many factors that can influence athletic performance, and it's not a definitive predictor of success. Other factors such as genetics, training, and nutrition also play a role in determining an athlete's potential for success.\nOverall, the 2D:4D ratio is a useful tool for coaches and trainers to assess an athlete's hand function and potential for success in various sports. However, it should be used in conjunction with other assessments and evaluations to get a comprehensive picture of an athlete's abilities and potential.",
    "llama-2-7b-chat-hf_fact": [
      "The 2D:4D ratio refers to the length of the 2nd metacarpal bone to the length of the 4th metacarpal bone in the hand.",
      "Studies have suggested that this ratio is linked to athletic performance in various sports.",
      "Research has shown that elite athletes often have a higher 2D:4D ratio compared to non-elite athletes.",
      "The 2D:4D ratio is thought to be related to factors such as hand function, grip strength, and muscle coordination in athletic performance.",
      "The 2D:4D ratio is one of many factors, including genetics, training, and nutrition, that can potentially influence athletic performance."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The 2D:4D ratio refers to the length of the 2nd digit (index finger) to the length of the 4th digit (ring finger) in the hand.",
      "true",
      "false, [corrected fact]: Research has shown that elite athletes often have a lower 2D:4D ratio compared to non-elite athletes.",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-7b-chat-hf_response": "Introduction:\nIntracranial aneurysms (IAs) are a major cause of morbidity and mortality worldwide. While the exact pathophysiology of IA rupture is not fully understood, several studies have suggested that the lunar cycle may play a role in the risk of IA rupture. In this study, we aimed to investigate the association between the moon cycle and the risk of IA rupture.\nMethods:\nWe retrospectively analyzed the medical records of 100 patients with IAs who underwent surgical treatment at our hospital between January 2010 and December 2018. The patients were divided into two groups based on the day of IA rupture: those who ruptured during the full moon (n=30) and those who ruptured during the new moon (n=70). We compared the demographic and clinical characteristics of the two groups and analyzed the association between the moon cycle and IA rupture using logistic regression analysis.\nResults:\nOur results showed that the full moon group had a higher risk of IA rupture compared to the new moon group (odds ratio [OR] = 2.35, 95% confidence interval [CI] = 1.23-4.49, p = 0.012). Multivariate logistic regression analysis revealed that the full moon was an independent risk factor for IA rupture after adjusting for age, sex, and aneurysm size (OR = 2.06, 95% CI = 1.03-4.13, p = 0.042).\nDiscussion:\nOur study suggests that there may be an association between the moon cycle and the risk of IA rupture. The full moon was found to be a risk factor for IA rupture, with a higher odds ratio compared to the new moon. These findings are consistent with previous studies that have suggested a possible link between the lunar cycle and IA rupture. However, our study has some limitations, including the retrospective design and the small sample size. Further prospective studies are needed to confirm our findings and to explore the underlying mechanisms.\nConclusion:\nIn conclusion, our study suggests that there may be",
    "llama-2-7b-chat-hf_fact": [
      "Intracranial aneurysms (IAs) are a major cause of morbidity and mortality worldwide.",
      "The study analyzed the medical records of 100 patients that underwent surgical treatment for IAs at the same hospital between January 2010 and December 2018.",
      "The patients were divided into two groups based on the timing of IA rupture: those during the full moon (n=30) and those during the new moon (n=70).",
      "The full moon group had a higher risk of IA rupture compared to the new moon group (odds ratio [OR] = 2.35, 95% confidence interval [CI] = 1.23-4.49, p = 0.012).",
      "The full moon was identified as an independent risk factor for IA rupture, after adjusting for age, sex, and aneurysm size (OR = 2.06, 95% CI = 1.03-4.13, p = 0.042)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1461,
    "user_query": "List functional roles of the FtsZ protein.",
    "llama-2-7b-chat-hf_response": "The FtsZ protein is a key component of the bacterial cytoskeleton and plays a crucial role in various cellular processes. Here are some of the functional roles of the FtsZ protein:\n1. Cell division: FtsZ is essential for bacterial cell division, particularly in the formation of the divisome, which is a complex of proteins that constricts the cell during cytokinesis.\n2. Chromosome segregation: FtsZ helps to segregate the bacterial chromosome during cell division, ensuring that each daughter cell receives a complete copy of the genetic material.\n3. Membrane dynamics: FtsZ is involved in the formation and maintenance of bacterial membranes, particularly in the formation of the cytoplasmic membrane.\n4. Signal transduction: FtsZ can act as a signal transducer, transmitting signals from one part of the cell to another and playing a role in the regulation of various cellular processes.\n5. Biofilm formation: FtsZ is involved in the formation of bacterial biofilms, which are complex communities of bacteria that adhere to surfaces and are protected by a matrix of extracellular polymeric substances.\n6. Quorum sensing: FtsZ can be involved in quorum sensing, a process by which bacteria communicate with each other and coordinate their behavior in response to changes in their population density.\n7. Virulence: FtsZ has been implicated in the virulence of some bacterial pathogens, and may play a role in the invasion and colonization of host cells.\n8. DNA repair: FtsZ has been shown to be involved in the repair of DNA damage in bacteria, particularly in the repair of DNA double-strand breaks.\n9. Mitochondrial dynamics: FtsZ is involved in the formation and maintenance of bacterial mitochondria, which are organelles that generate energy for the cell through the process of cellular respiration.\n10. Plasmid maintenance: FtsZ has been shown to be involved in the maintenance of bacterial plasmids, which are small, circular DNA molecules that carry genes for antibiotic resistance and other traits",
    "llama-2-7b-chat-hf_fact": [
      "FtsZ protein plays a crucial role in bacterial cell division, particularly in the formation of the divisome.",
      "FtsZ protein helps in the segregation of the bacterial chromosome during cell division.",
      "FtsZ protein is involved in the formation and maintenance of bacterial membranes.",
      "FtsZ protein can act as a signal transducer in the regulation of various cellular processes.",
      "FtsZ protein is involved in the formation of bacterial biofilms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: FtsZ protein is not involved in the formation and maintenance of bacterial membranes but rather it plays an essential role in the formation of the division ring (Z-ring) at the future site of cell division.",
      "false, [corrected fact]: FtsZ protein does not act as a signal transducer in cellular processes, its primary role is in bacterial cell division.",
      "false, [corrected fact]: FtsZ protein is not directly involved in the formation of bacterial biofilms. It's primarily involved in bacterial cell division."
    ]
  },
  {
    "id": 1463,
    "user_query": "Is there any evidence of dysregulated long non coding RNAs and Alzheimer's disease?",
    "llama-2-7b-chat-hf_response": "Yes, there is evidence to suggest that dysregulated long non-coding RNAs (lncRNAs) play a role in the development and progression of Alzheimer's disease (AD). LncRNAs are RNAs longer than 200 nucleotides that do not code for proteins but instead regulate gene expression by binding to DNA or other RNAs.\nStudies have shown that lncRNAs are altered in the brains of AD patients, and these changes may contribute to the neurodegeneration and cognitive decline associated with the disease. For example, one study found that the lncRNA HOTAIR is upregulated in the brains of AD patients, and that this upregulation is associated with increased neuroinflammation and oxidative stress. Another study found that the lncRNA MALAT1 is downregulated in the brains of AD patients, and that this downregulation is associated with impaired synaptic plasticity and cognitive decline.\nAdditionally, some studies have found that lncRNAs may play a role in the clearance of amyloid- (A), a protein that accumulates in the brains of AD patients and contributes to neurodegeneration. For example, one study found that the lncRNA TARDBP is required for the clearance of A from the brain, and that mutations in TARDBP are associated with early-onset AD.\nOverall, the evidence suggests that dysregulated lncRNAs play a role in the development and progression of Alzheimer's disease, and that these RNAs may be potential therapeutic targets for the disease.",
    "llama-2-7b-chat-hf_fact": [
      "Long non-coding RNAs (lncRNAs) are RNAs longer than 200 nucleotides that do not code for proteins but instead regulate gene expression by binding to DNA or other RNAs.",
      "Altered lncRNAs are found in the brains of Alzheimer's disease (AD) patients and may contribute to the neurodegeneration and cognitive decline associated with the disease.",
      "The lncRNA HOTAIR is upregulated in the brains of AD patients causing increased neuroinflammation and oxidative stress.",
      "The lncRNA MALAT1 is downregulated in the brains of AD patients, prompting impaired synaptic plasticity and cognitive decline.",
      "The lncRNA TARDBP is required for the clearance of amyloid- (A) from the brain and mutations in TARDBP are associated with early-onset AD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1469,
    "user_query": "What is known about type D personality trait in cancer patients?",
    "llama-2-7b-chat-hf_response": "Type D personality trait, also known as distressed, dangerous, and difficult personality, has been found to be prevalent among cancer patients. Studies have shown that approximately 20-30% of cancer patients exhibit type D personality traits, which are characterized by high levels of emotional distress, anxiety, and depression, as well as a tendency to suppress emotions and avoid social support.\n1. What are the characteristics of type D personality trait in cancer patients?\nType D personality trait in cancer patients is characterized by high levels of emotional distress, anxiety, and depression, as well as a tendency to suppress emotions and avoid social support.\n2. How common is type D personality trait among cancer patients?\nApproximately 20-30% of cancer patients exhibit type D personality traits.\n3. What are the potential consequences of type D personality trait in cancer patients?\nPotential consequences of type D personality trait in cancer patients include poorer quality of life, reduced adherence to treatment, and increased risk of depression and anxiety.\n4. How can healthcare providers identify type D personality trait in cancer patients?\nHealthcare providers can identify type D personality trait in cancer patients by using standardized assessment tools, such as the Type D Personality Questionnaire (PDQ).\n5. How can healthcare providers manage type D personality trait in cancer patients?\nHealthcare providers can manage type D personality trait in cancer patients by providing psychological support and interventions, such as cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT), to help patients manage their emotions and improve their quality of life.",
    "llama-2-7b-chat-hf_fact": [
      "Type D personality trait is known as distressed, dangerous, and difficult personality.",
      "Approximately 20-30% of cancer patients exhibit type D personality traits.",
      "Type D personality is characterized by high levels of emotional distress, anxiety, and depression, as well as a tendency to suppress emotions and avoid social support.",
      "Potential consequences of type D personality trait in cancer patients include poorer quality of life, reduced adherence to treatment, and increased risk of depression and anxiety.",
      "Healthcare providers can use certain assessment tools like the Type D Personality Questionnaire (PDQ) to identify type D personality trait in cancer patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Type D personality trait is known as distressed and social avoidance.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Healthcare providers can use certain assessment tools like the Distress Thermometer or the \"14-item Type D Scale\" (DS14) to identify type D personality traits in cancer patients."
    ]
  },
  {
    "id": 1471,
    "user_query": "Which species may be used for the biotechnological production of itaconic acid?",
    "llama-2-7b-chat-hf_response": "Itaconic acid is a -hydroxycarboxylic acid that has gained increasing attention in recent years due to its potential applications in various industries, including the production of biodegradable polymers, detergents, and pharmaceuticals. The biotechnological production of itaconic acid typically involves the fermentation of microorganisms, such as bacteria or yeast, that have been engineered to produce this compound.\nSeveral species of microorganisms have been investigated for the biotechnological production of itaconic acid, including:\n1. Escherichia coli (E. coli): E. coli is a commonly used bacterium in biotechnology and has been engineered to produce itaconic acid through the overexpression of the gene encoding the enzyme itaconate synthase.\n2. Saccharomyces cerevisiae (S. cerevisiae): S. cerevisiae, also known as baker's yeast, has been used to produce itaconic acid through the overexpression of the gene encoding the enzyme itaconate synthase.\n3. Pseudomonas putida: P. putida is a gram-negative bacterium that has been engineered to produce itaconic acid through the overexpression of the gene encoding the enzyme itaconate synthase.\n4. Rhodobacter sphaeroides: R. sphaeroides is a purple bacterium that has been engineered to produce itaconic acid through the overexpression of the gene encoding the enzyme itaconate synthase.\n5. Alcaligenes eutrophus: A. eutrophus is a gram-negative bacterium that has been engineered to produce itaconic acid through the overexpression of the gene encoding the enzyme itaconate synthase.\nThe choice of microorganism for the biotechnological production of itaconic acid depends on several factors, including the ease of genetic manipulation, the ability to produce high levels of itaconic acid, and the potential for large-scale fermentation.\nIn summary, several species of microorganisms have been investigated for the biotechnological production of itaconic acid, including E. coli, S. cerevisiae, P.",
    "llama-2-7b-chat-hf_fact": [
      "Itaconic acid is a -hydroxycarboxylic acid used in various industries, including the production of biodegradable polymers, detergents, and pharmaceuticals.",
      "Itaconic acid can be produced through the fermentation of engineered microorganisms.",
      "E. coli is a bacterium that has been engineered to produce itaconic acid.",
      "Saccharomyces cerevisiae, also known as baker's yeast, has been used to produce itaconic acid.",
      "Other bacteria used for the production of itaconic acid include Pseudomonas putida, Rhodobacter sphaeroides, and Alcaligenes eutrophus."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Saccharomyces cerevisiae, also known as baker's yeast, is not typically used to produce itaconic acid.",
      "unknown"
    ]
  },
  {
    "id": 1474,
    "user_query": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?",
    "llama-2-7b-chat-hf_response": "The methyl-directed mismatch repair (MMR) system in bacteria is a complex of enzymes and proteins that repair DNA damage caused by methylation of cytosine residues. The MMR system is essential for maintaining genome stability and preventing mutations that can lead to cancer and other diseases. Here are some of the key proteins that constitute the MMR system in bacteria:\n1. MutS: MutS is a heterodimeric protein composed of MutS and MutS subunits. It recognizes and binds to DNA mismatches and initiates the repair process.\n2. MutL: MutL is a heterodimeric protein composed of MutL and MutL subunits. It works in conjunction with MutS to repair DNA mismatches.\n3. Methyl-directed DNA methyltransferase (MTD): MTD is an enzyme that methylates cytosine residues in DNA, leading to the formation of DNA mismatches that can be recognized by the MMR system.\n4. DNA glycosylase: DNA glycosylase is an enzyme that removes damaged or incorrect bases from DNA, including methylated cytosine residues.\n5. Apurinic/apyrimidinic endonuclease (AP endonuclease): AP endonuclease is an enzyme that cleaves the DNA strand at apurinic/apyrimidinic sites, which are generated during the repair process.\n6. DNA polymerase I: DNA polymerase I is an enzyme that fills in the gap created by the cleavage of the DNA strand by AP endonuclease.\n7. DNA ligase: DNA ligase is an enzyme that seals the gap created by the repair process, restoring the integrity of the DNA molecule.\nThese proteins work together to repair DNA damage caused by methylation, ensuring the integrity of the genome and preventing mutations that can lead to disease.",
    "llama-2-7b-chat-hf_fact": [
      "The methyl-directed mismatch repair (MMR) system in bacteria is a complex of enzymes and proteins that repair DNA damage.",
      "Key proteins in the MMR system in bacteria include MutS, MutL, and Methyl-directed DNA methyltransferase (MTD).",
      "DNA glycosylase, an enzyme that removes damaged or incorrect bases from DNA, is part of the MMR system in bacteria.",
      "Apurinic/apyrimidinic endonuclease (AP endonuclease), DNA polymerase I, and DNA ligase are also part of the MMR system.",
      "These proteins work together to repair DNA damage caused by methylation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Key proteins in the MMR system in bacteria include MutS, MutL, and MutH. Methyl-directed DNA methyltransferase (MTD) is not a part of the MMR system.",
      "false, [corrected fact]: DNA glycosylase, an enzyme that removes damaged or incorrect bases from DNA, is not part of the MMR system in bacteria. It is involved in base excision repair, a different DNA repair mechanism.",
      "false, [corrected fact]: Apurinic/apyrimidinic endonuclease (AP endonuclease), DNA polymerase I, and DNA ligase are not part of the MMR system. They are involved in base excision repair and DNA replication.",
      "false, [corrected fact]: MMR system in bacteria works to repair DNA damage caused by mistaken incorporation of incorrect nucleotides, not by methylation."
    ]
  },
  {
    "id": 1476,
    "user_query": "Which is the vector of Louping ill virus?",
    "llama-2-7b-chat-hf_response": "Louping ill virus (LIV) is a tick-borne virus that affects sheep and goats. The vector of LIV is the sheep tick (Ixodes ricinus). The virus is transmitted to sheep and goats through the bite of infected ticks.\nAnswer: The vector of Louping ill virus is the sheep tick (Ixodes ricinus).",
    "llama-2-7b-chat-hf_fact": [
      "Louping ill virus (LIV) is a tick-borne virus.",
      "LIV predominantly affects sheep and goats.",
      "The vector of LIV is the sheep tick (Ixodes ricinus).",
      "LIV is transmitted to sheep and goats through the bite of infected ticks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-7b-chat-hf_response": "Yes, HuR protein has been shown to regulate the splicing process. HuR is a protein that is involved in the regulation of mRNA splicing, which is the process by which non-coding regions of an mRNA are removed and the remaining exons are joined together to form a mature mRNA molecule. HuR is a splicing factor that recognizes and binds to specific sequences in the introns and exons of mRNAs and helps to facilitate the splicing reaction.\nStudies have shown that HuR can regulate the splicing of a wide range of mRNAs, including those involved in cellular processes such as cell growth, differentiation, and survival. For example, HuR has been shown to regulate the splicing of the bcl-2 mRNA, which encodes a protein that regulates programmed cell death (apoptosis). HuR has also been shown to regulate the splicing of the c-Myc mRNA, which encodes a transcription factor that regulates cellular proliferation and differentiation.\nIn addition to its role in mRNA splicing, HuR has also been shown to regulate the stability of mRNAs and the translation of mRNAs into proteins. HuR can bind to the 3' untranslated region (UTR) of mRNAs and inhibit the degradation of the mRNA, leading to increased levels of the corresponding protein.\nOverall, the regulation of mRNA splicing by HuR is an important aspect of its function in the cell, and dysregulation of HuR has been implicated in a variety of diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "HuR protein regulates the splicing process.",
      "The process of mRNA splicing involves the removal of non-coding regions and the joining of the remaining exons.",
      "HuR can regulate the splicing of bcl-2 mRNA, which encodes a protein that regulates programmed cell death.",
      "HuR has been shown to regulate the splicing of the c-Myc mRNA, which encodes a transcription factor that regulates cellular proliferation and differentiation.",
      "Dysregulation of HuR has been implicated in a variety of diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: HuR protein does not regulate the splicing process. It is involved in the regulation of mRNA stability and translation.",
      "true",
      "false, [corrected fact]: HuR does not regulate the splicing of bcl-2 mRNA. However, HuR can stabilize and enhance the translation of this mRNA.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1478,
    "user_query": "Is Titin the largest single protein molecule found in Nature?",
    "llama-2-7b-chat-hf_response": "Titin is a protein found in muscle cells that plays a crucial role in muscle contraction and relaxation. It is a very large protein molecule, consisting of over 30,000 amino acids, which are the building blocks of proteins. However, whether Titin is the largest single protein molecule found in Nature is a matter of debate.\nAccording to some estimates, Titin is the largest known protein molecule, with a molecular weight of approximately 3,000 kilodaltons (kDa). This is significantly larger than many other large protein molecules found in Nature, such as the tobacco etch virus (TEV) protein, which has a molecular weight of around 2,000 kDa, and the spider silk protein, which has a molecular weight of around 1,000 kDa.\nHowever, it is important to note that the size of a protein molecule can be difficult to measure accurately, and there may be other protein molecules in Nature that are larger than Titin but have not yet been discovered or characterized. Additionally, there are some protein molecules that are composed of multiple subunits, which can make it difficult to determine their overall size.\nIn summary, while Titin is a very large protein molecule, it is not clear whether it is the largest single protein molecule found in Nature. Further research is needed to determine the true size of this protein and to identify any other large protein molecules that may exist in Nature.",
    "llama-2-7b-chat-hf_fact": [
      "Titin is a protein found in muscle cells which plays a role in muscle contraction and relaxation.",
      "Titin consists of over 30,000 amino acids.",
      "Some estimates suggest that Titin is the largest known protein molecule with a molecular weight of approximately 3,000 kilodaltons (kDa).",
      "The size of a protein molecule can be difficult to measure accurately.",
      "There are protein molecules composed of multiple subunits, which can complicate determination of overall size."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Titin is the largest known protein molecule with a molecular weight of approximately 3,800 kilodaltons (kDa).",
      "true",
      "true"
    ]
  },
  {
    "id": 1481,
    "user_query": "What is the the Menzerath-Altmann law?",
    "llama-2-7b-chat-hf_response": "The Menzerath-Altmann law is a mathematical formula that relates the growth rate of a population to the size of the population. It is named after the mathematicians Menzerath and Altmann, who first proposed it in the early 20th century. The law states that the growth rate of a population (G) is proportional to the logarithm of the population size (N), according to the following equation:\nG = k \\* log(N)\nwhere k is a constant that depends on the specific population being studied.\nThe Menzerath-Altmann law is often used to model the growth of populations in ecology and epidemiology, as it provides a simple and intuitive way to understand how population size affects population growth. For example, if the growth rate of a population is proportional to the logarithm of the population size, then as the population size increases, the growth rate will initially increase rapidly, but will eventually level off as the population reaches its carrying capacity.\nIt is important to note that the Menzerath-Altmann law is a simplification of more complex models of population growth, and it does not take into account all of the factors that can affect population growth, such as environmental factors, predation, and competition. However, it is a useful tool for understanding the general patterns of population growth and for making predictions about how populations will change over time.",
    "llama-2-7b-chat-hf_fact": [
      "The Menzerath-Altmann law is a mathematical formula relating the growth rate of a population to its size.",
      "The law proposes that the growth rate of a population is proportional to the logarithm of its size.",
      "It is named after mathematicians Menzerath and Altmann who proposed it in the early 20th century.",
      "It's often used in ecology and epidemiology to model and predict population growth.",
      "The Menzerath-Altmann law is a simplification and doesn't account for all factors influencing population growth."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Menzerath-Altmann law is a principle in linguistics that states the longer a linguistic unit is, the shorter are its constituents.",
      "false, [corrected fact]: The law doesn't relate the growth rate of a population to the logarithm of its size, but instead states that the longer a linguistic construct, the shorter are its immediate constituents.",
      "true",
      "false, [corrected fact]: The Menzerath-Altmann law is often used in linguistics rather than in ecology or epidemiology.",
      "unknown"
    ]
  },
  {
    "id": 1482,
    "user_query": "Which receptor(s) recognize lysosomal hydrolases in trans-Golgi network (TGN)?",
    "llama-2-7b-chat-hf_response": "Lysosomal hydrolases are enzymes that break down various biomolecules in lysosomes. The recognition of lysosomal hydrolases in the trans-Golgi network (TGN) is mediated by specific receptors. Here are some of the receptors that recognize lysosomal hydrolases in the TGN:\n1. Sortilin: Sortilin is a transmembrane receptor that recognizes lysosomal enzymes, including cathepsins, chymases, and lysosomal aminopeptidases. Sortilin is involved in the sorting and trafficking of lysosomal enzymes from the endoplasmic reticulum (ER) to the TGN.\n2. Vesicle-associated membrane protein (VAMP): VAMP is a transmembrane protein that interacts with lysosomal hydrolases in the TGN. VAMP helps to mediate the fusion of lysosomes with the plasma membrane during lysosome biogenesis.\n3. TGN46: TGN46 is a transmembrane protein that is specifically expressed in the TGN. TGN46 interacts with lysosomal hydrolases and helps to regulate their trafficking from the ER to the TGN.\n4. Flotillin-1: Flotillin-1 is a transmembrane protein that is involved in the formation of the TGN. Flotillin-1 interacts with lysosomal hydrolases in the TGN and helps to regulate their trafficking and sorting.\n5. AP-3 complex: The AP-3 complex is a multi-subunit complex that is involved in the sorting and trafficking of lysosomal hydrolases from the ER to the TGN. The AP-3 complex recognizes and interacts with lysosomal hydrolases in the TGN.\nIn summary, several receptors and protein complexes recognize lysosomal hydrolases in the TGN, including sortilin, VAMP, TGN46, flotillin-1, and the AP-3 complex. These receptors and protein complexes play important roles in the sorting and",
    "llama-2-7b-chat-hf_fact": [
      "Lysosomal hydrolases are enzymes that break down various biomolecules in lysosomes.",
      "The recognition of lysosomal hydrolases in the trans-Golgi network (TGN) is mediated by specific receptors such as Sortilin, VAMP, TGN46, Flotillin-1, and the AP-3 complex.",
      "Sortilin is a transmembrane receptor involved in the sorting and trafficking of lysosomal enzymes from the ER to the TGN.",
      "Vesicle-associated membrane protein (VAMP) helps to mediate the fusion of lysosomes with the plasma membrane during lysosome biogenesis.",
      "TGN46 is a transmembrane protein specifically expressed in the TGN and involved in regulating the trafficking of lysosomal hydrolases from the ER to the TGN."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Vesicle-associated membrane protein (VAMP) helps to mediate vesicle fusion in various transport pathways, not specifically in lysosome biogenesis.",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-7b-chat-hf_response": "Prothymosin alpha c-terminal peptide (PCT) is a small peptide derived from the N-terminal region of the prothymosin alpha protein. PCT has been shown to have a variety of biological functions, including:\n1. Anti-inflammatory effects: PCT has been shown to inhibit the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1 beta, and to reduce inflammation in various models of disease.\n2. Neuroprotection: PCT has been shown to protect against neurodegeneration in various models of neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, and stroke.\n3. Cardiovascular protection: PCT has been shown to reduce inflammation and oxidative stress in the cardiovascular system, and to protect against cardiovascular disease.\n4. Anti-cancer effects: PCT has been shown to inhibit the growth of cancer cells and to induce apoptosis (cell death) in various types of cancer, including breast, lung, and colon cancer.\n5. Immune system modulation: PCT has been shown to modulate the immune system, including the regulation of T cell activation and the production of cytokines.\n6. Anti-aging effects: PCT has been shown to have anti-aging effects, including the improvement of cognitive function and the reduction of oxidative stress.\n7. Wound healing: PCT has been shown to promote wound healing by stimulating the production of growth factors and the proliferation of fibroblasts.\n8. Anti-viral effects: PCT has been shown to inhibit the replication of certain viruses, including HIV and HCV.\n9. Anti-bacterial effects: PCT has been shown to inhibit the growth of certain bacteria, including Staphylococcus aureus and Escherichia coli.\n10. Anti-parasitic effects: PCT has been shown to inhibit the growth of certain parasites, including Plasmodium falciparum and Toxoplasma gondii.\nIt is important to note that the functions of PCT are",
    "llama-2-7b-chat-hf_fact": [
      "Prothymosin alpha c-terminal peptide (PCT) is derived from the N-terminal region of the prothymosin alpha protein.",
      "PCT has been shown to inhibit the production of pro-inflammatory cytokines and reduce inflammation in various disease models.",
      "PCT has been shown to protect against neurodegeneration in diseases including Alzheimer's, Parkinson's, and stroke.",
      "PCT has displayed cardiovascular protection by reducing inflammation and oxidative stress in the cardiovascular system.",
      "PCT has exhibited anti-cancer effects by inhibiting the growth of cancer cells and inducing apoptosis in various types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1494,
    "user_query": "What is the role of the Ada O6-alkylguanine alkyltransferase in bacteria?",
    "llama-2-7b-chat-hf_response": "Ada O6-alkylguanine alkyltransferase is an enzyme that plays a crucial role in the repair of DNA damage caused by oxidative stress in bacteria. The enzyme is responsible for transferring an alkyl group from an O6-alkylguanine to a cysteine residue in the repair protein, which helps to restore the integrity of the DNA molecule.",
    "llama-2-7b-chat-hf_fact": [
      "Ada O6-alkylguanine alkyltransferase is an enzyme in bacteria.",
      "The enzyme plays a role in the repair of DNA damage caused by oxidative stress in bacteria.",
      "Ada O6-alkylguanine alkyltransferase is responsible for transferring an alkyl group from an O6-alkylguanine to a cysteine residue in the repair protein.",
      "Ada O6-alkylguanine alkyltransferase helps to restore the integrity of the DNA molecule."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1503,
    "user_query": "Which is the clinical meaning of the presence of delayed enhancement in patients with hypertrophic cardiomyopathy?",
    "llama-2-7b-chat-hf_response": "The presence of delayed enhancement on cardiac magnetic resonance imaging (MRI) in patients with hypertrophic cardiomyopathy (HCM) is associated with an increased risk of arrhythmic events, including atrial fibrillation, ventricular tachycardia, and sudden cardiac death. Delayed enhancement is a sign of myocardial fibrosis, which is the accumulation of scar tissue in the heart muscle. Myocardial fibrosis can lead to impaired cardiac function, increased risk of arrhythmias, and decreased survival.\nIn contrast, the absence of delayed enhancement on MRI does not necessarily rule out the presence of myocardial fibrosis, as some patients with HCM may have mild fibrosis that does not result in delayed enhancement. However, the absence of delayed enhancement may indicate a lower risk of arrhythmic events compared to patients with delayed enhancement.\nIn summary, the presence of delayed enhancement on MRI in patients with HCM is associated with an increased risk of arrhythmic events, while its absence does not necessarily rule out the presence of myocardial fibrosis but may indicate a lower risk of arrhythmic events.",
    "llama-2-7b-chat-hf_fact": [
      "Delayed enhancement on cardiac magnetic resonance imaging (MRI) in patients with hypertrophic cardiomyopathy (HCM) is associated with an increased risk of arrhythmic events.",
      "Delayed enhancement indicates the presence of myocardial fibrosis, which is the accumulation of scar tissue in the heart muscle.",
      "Myocardial fibrosis can lead to impaired cardiac function, increased risk of arrhythmias, and decreased survival.",
      "The absence of delayed enhancement on MRI does not necessarily rule out the presence of myocardial fibrosis.",
      "The absence of delayed enhancement on MRI in patients with HCM may indicate a lower risk of arrhythmic events."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1509,
    "user_query": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?",
    "llama-2-7b-chat-hf_response": "A. Parallel\nB. Antiparallel\nC. Both parallel and antiparallel\nD. Neither\nAnswer: B. Antiparallel\nExplanation:\nSpectrin is a cytoskeletal protein that plays a crucial role in maintaining the structural integrity of cells. It is composed of two subunits: alpha-spectrin and beta-spectrin. These subunits can form either parallel or antiparallel heterodimers, which are stabilized by non-covalent interactions.\nRecent studies have shown that in mammalian cells, alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. This means that the alpha-spectrin subunit binds to the beta-spectrin subunit in an antiparallel manner, with the alpha-spectrin subunit facing away from the beta-spectrin subunit.\nTherefore, the answer is (B) Antiparallel.",
    "llama-2-7b-chat-hf_fact": [
      "Spectrin is a cytoskeletal protein that plays a role in maintaining the structural integrity of cells.",
      "Spectrin is composed of two subunits: alpha-spectrin and beta-spectrin.",
      "Alpha-spectrin and beta-spectrin can form either parallel or antiparallel heterodimers.",
      "The heterodimers stabilizes through non-covalent interactions.",
      "In mammalian cells, alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers with alpha-spectrin subunit facing away from the beta-spectrin subunit."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: In mammalian cells, alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers with each subunit facing towards the other."
    ]
  },
  {
    "id": 1510,
    "user_query": "Is gastro esophageal reflux related to burning mouth syndrome?",
    "llama-2-7b-chat-hf_response": "Gastroesophageal reflux (GER) and burning mouth syndrome (BMS) are two distinct conditions that can have overlapping symptoms. While GER is characterized by the backflow of stomach acid into the esophagus, BMS is defined by a burning sensation in the mouth without any identifiable cause.\nHowever, there is some evidence to suggest that GER may be related to BMS in some cases. Here are some possible links between the two conditions:\n1. Shared risk factors: Both GER and BMS have been associated with certain risk factors, such as obesity, pregnancy, smoking, and certain medications. Individuals with these risk factors may be more likely to experience both conditions.\n2. Esophageal irritation: GER can cause irritation and inflammation in the esophagus, which may extend to the mouth and cause the burning sensation characteristic of BMS.\n3. Neurological factors: Both GER and BMS have been linked to neurological factors, such as dysfunction in the nervous system that regulates digestion and pain perception.\n4. Overlapping symptoms: Some individuals with GER may experience symptoms of BMS, such as a burning sensation in the mouth, throat, or tongue. Conversely, some individuals with BMS may experience symptoms of GER, such as heartburn or regurgitation.\n5. Hormonal changes: Hormonal fluctuations during pregnancy or menopause may contribute to both GER and BMS.\nIn summary, while GER and BMS are distinct conditions, there is evidence to suggest that they may be related in some cases. If you are experiencing symptoms of both conditions, it is important to consult with a healthcare provider to determine the underlying cause and develop an appropriate treatment plan.",
    "llama-2-7b-chat-hf_fact": [
      "Gastroesophageal reflux is characterized by the backflow of stomach acid into the esophagus.",
      "Burning mouth syndrome is defined by a burning sensation in the mouth without any identifiable cause.",
      "Obesity, pregnancy, smoking, and certain medications are risk factors associated with both gastroesophageal reflux and burning mouth syndrome.",
      "Gastroesophageal reflux can cause irritation and inflammation in the esophagus, which may extend to the mouth and cause the burning sensation characteristic of burning mouth syndrome.",
      "Both gastroesophageal reflux and burning mouth syndrome have been linked to neurological factors, such as dysfunction in the nervous system that regulates digestion and pain perception."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: While obesity, pregnancy, smoking, and certain medications are considered risk factors for gastroesophageal reflux, they are not typically associated with burning mouth syndrome, which can be triggered by a range of factors including damage to nerves, hormonal changes, dry mouth, certain medications, nutritional deficiencies and anxiety or depression.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1511,
    "user_query": "Which is the protein (antigen) targeted by anti-Vel antibodies in the Vel blood group?",
    "llama-2-7b-chat-hf_response": "Anti-Vel antibodies target the protein Antigen:\nA. ABO blood group antigens\nB. H blood group antigens\nC. Lewis blood group antigens\nD. Kell blood group antigens\nAnswer: C. Lewis blood group antigens.\nExplanation:\nAnti-Vel antibodies are directed against the Lewis (Le) blood group antigen, specifically the Le(b) antigen. The Vel blood group is also known as the Lewis (Le) blood group, and it is defined by the presence of the Le(b) antigen on the surface of red blood cells. The Le(b) antigen is a carbohydrate molecule that is expressed on the surface of red blood cells in individuals with the Vel blood group. Anti-Vel antibodies are often used in blood transfusions to identify individuals with the Vel blood group and to prevent adverse reactions to blood transfusions.",
    "llama-2-7b-chat-hf_fact": [
      "Anti-Vel antibodies target the Lewis blood group antigens.",
      "The Vel blood group is also known as the Lewis blood group.",
      "The Le(b) antigen defines the Lewis blood group.",
      "The Le(b) antigen is a carbohydrate molecule expressed on the surface of red blood cells in individuals with the Vel blood group.",
      "Anti-Vel antibodies are used in blood transfusions to identify individuals with the Vel blood group and prevent adverse reactions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Anti-Vel antibodies target the Vel blood group antigens, not the Lewis blood group antigens.",
      "false, [corrected fact]: The Vel blood group is not the same as the Lewis blood group, these are two different blood group systems.",
      "true",
      "false, [corrected fact]: The Le(b) antigen is a carbohydrate molecule expressed on the surface of red blood cells in individuals with the Lewis blood group, not the Vel blood group.",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-7b-chat-hf_response": "Cystatin C is a protein that plays a crucial role in the regulation of intracellular ion homeostasis and is implicated in various neurodegenerative diseases, including Alzheimer's disease and cerebral amyloid angiopathy. The fibrillization of cystatin C is a critical step in the pathogenesis of these diseases, but the molecular mechanisms underlying this process are not fully understood. In this study, we investigate the role of a specific peptide in the fibrillization of human cystatin C.\nOur results show that a peptide located in the N-terminal region of cystatin C, residues 1-12, plays a pivotal role in the fibrillization of human cystatin C. This peptide, which we refer to as the N-terminal fibrillization peptide (NTFP), is highly conserved across different species and has been implicated in the pathogenesis of various neurodegenerative diseases.\nUsing a combination of biochemical, biophysical, and cellular assays, we demonstrate that the NTFP is responsible for the formation of amyloid fibrils in human cystatin C. We show that the NTFP is able to self-assemble into fibrils under physiological conditions, and that these fibrils are capable of seeding the formation of amyloid fibrils in full-length cystatin C.\nOur findings provide new insights into the molecular mechanisms underlying the fibrillization of cystatin C and have important implications for the development of therapeutic strategies for the treatment of neurodegenerative diseases associated with cystatin C fibrillization.",
    "llama-2-7b-chat-hf_fact": [
      "Cystatin C is a protein that plays a role in the regulation of intracellular ion homeostasis.",
      "The fibrillization of cystatin C is implicated in various neurodegenerative diseases, such as Alzheimer's disease and cerebral amyloid angiopathy.",
      "A peptide located in the N-terminal region of cystatin C, residues 1-12, plays a pivotal role in the fibrillization of human cystatin C.",
      "This peptide, referred to as the N-terminal fibrillization peptide, is responsible for the formation of amyloid fibrils in human cystatin C.",
      "The N-terminal fibrillization peptide can self-assemble into fibrils under physiological conditions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Cystatin C is a protein that plays a role in the regulation of extracellular protease activity, not intracellular ion homeostasis.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1518,
    "user_query": "What is the use of MammaPrint and Oncotype DX?",
    "llama-2-7b-chat-hf_response": "MammaPrint and Oncotype DX are gene expression profiling tests used to predict the risk of breast cancer recurrence and the likelihood of benefit from chemotherapy in postmenopausal women with early-stage breast cancer. These tests analyze the RNA expression levels of a set of genes in a breast tumor to predict the risk of recurrence and the likelihood of benefit from chemotherapy.\nMammaPrint is a 70-gene test that predicts the risk of distant recurrence (metastasis) in postmenopausal women with early-stage breast cancer. It assigns a score to each patient based on the expression levels of the 70 genes, with a higher score indicating a higher risk of recurrence.\nOncotype DX is a 21-gene test that predicts the risk of distant recurrence (metastasis) and the likelihood of benefit from chemotherapy in postmenopausal women with early-stage breast cancer. It assigns a score to each patient based on the expression levels of the 21 genes, with a higher score indicating a higher risk of recurrence and a lower score indicating a lower likelihood of benefit from chemotherapy.\nBoth tests have been shown to be accurate in predicting the risk of recurrence and the likelihood of benefit from chemotherapy in postmenopausal women with early-stage breast cancer. They can help guide treatment decisions and may reduce the need for unnecessary chemotherapy in patients with a low risk of recurrence.\nIt is important to note that these tests are not a substitute for clinical judgment and should be used in conjunction with other factors, such as the tumor size, lymph node involvement, and hormone receptor status, to make treatment decisions.",
    "llama-2-7b-chat-hf_fact": [
      "MammaPrint and Oncotype DX are gene expression profiling tests.",
      "These tests are utilized to predict the risk of breast cancer recurrence and the benefit from chemotherapy in postmenopausal women with early-stage breast cancer.",
      "MammaPrint analyzes the expression levels of 70 genes in a breast tumor.",
      "Oncotype DX, on the other hand, tests the expression levels of 21 genes.",
      "Both tests have been shown to accurately predict the risk of recurrence and the effectiveness of chemotherapy in postmenopausal women with early-stage breast cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1520,
    "user_query": "Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients?",
    "llama-2-7b-chat-hf_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that affects the motor neurons in the brain and spinal cord, leading to muscle weakness, atrophy, and paralysis. While there is currently no cure for ALS, several therapeutic approaches have been investigated to improve symptom severity and slow disease progression. One such approach is the administration of thyrotropin releasing hormone (TRH), which has been shown to have neuroprotective effects in various animal models of neurodegenerative diseases.\nTRH is a hormone produced by the hypothalamus that stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland. In addition to its role in regulating thyroid function, TRH has been shown to have neuroprotective effects in various animal models of neurodegenerative diseases, including ALS. Studies have shown that TRH administration can reduce oxidative stress, inflammation, and excitotoxicity in the brain and spinal cord, which are thought to contribute to the progression of ALS.\nSeveral small-scale studies have investigated the safety and efficacy of TRH administration in ALS patients. For example, a study published in the Journal of Neurology, Neurosurgery, and Psychiatry found that TRH treatment improved muscle strength and reduced muscle atrophy in ALS patients. Another study published in the European Journal of Neurology found that TRH treatment improved cognitive function in ALS patients.\nWhile these findings are promising, it is important to note that the current evidence base for TRH treatment in ALS is limited to small-scale studies, and more research is needed to confirm these findings and establish the long-term safety and efficacy of TRH treatment in ALS patients. Additionally, TRH treatment may have unintended effects, such as hyperthyroidism, and careful monitoring of thyroid function is necessary in patients receiving TRH therapy.\nIn conclusion, while the current evidence suggests that TRH administration may have potential as a therapeutic approach for improving symptom severity in ALS patients, further research is needed to confirm these findings and",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting motor neurons in the brain and spinal cord, leading to muscle weakness, atrophy, and paralysis.",
      "Thyrotropin releasing hormone (TRH) is produced by the hypothalamus and stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.",
      "TRH has been shown to have neuroprotective effects in various animal models of neurodegenerative diseases.",
      "A study published in the Journal of Neurology, Neurosurgery, and Psychiatry found that TRH treatment improved muscle strength and reduced muscle atrophy in ALS patients.",
      "Another study published in the European Journal of Neurology found that TRH treatment improved cognitive function in ALS patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1524,
    "user_query": "What is the gold standard treatment for Iatrogenic male incontinence?",
    "llama-2-7b-chat-hf_response": "The gold standard treatment for iatrogenic male incontinence depends on the underlying cause of the condition. Here are some of the most common treatment options:\n1. Medications: Medications such as anticholinergics, beta-3 adrenergic agonists, and antidepressants may be prescribed to help manage symptoms of iatrogenic male incontinence.\n2. Pelvic floor exercises: Pelvic floor exercises, also known as Kegel exercises, can help strengthen the muscles that control urination and improve bladder function.\n3. Bladder training: Bladder training involves gradually increasing the amount of time between trips to the bathroom to help improve bladder function and reduce incontinence.\n4. Catheterization: In some cases, a catheter may be inserted into the bladder to help drain urine and reduce incontinence.\n5. Surgery: Surgery may be necessary in some cases of iatrogenic male incontinence, such as when the incontinence is caused by a physical obstruction or when other treatments have been unsuccessful.\n6. Neurourology: Neurourology is a subspecialty of urology that focuses on the diagnosis and treatment of disorders of the nervous system that affect the urinary system. Neurourologists may use a variety of techniques, including nerve stimulation and bladder augmentation, to treat iatrogenic male incontinence.\n7. Artificial urinary sphincter: An artificial urinary sphincter is a device that is placed around the urethra to help control urine flow and reduce incontinence.\n8. Injection therapy: Injection therapy involves injecting a substance into the bladder to help improve bladder function and reduce incontinence.\n9. Botulinum toxin injections: Botulinum toxin injections may be used to treat overactive bladder and incontinence by relaxing the bladder muscle.\n10. Sacral nerve stimulation: Sacral nerve stimulation is a minimally invasive procedure that involves implanting a device that",
    "llama-2-7b-chat-hf_fact": [
      "Iatrogenic male incontinence treatment can include prescribing medications like anticholinergics, beta-3 adrenergic agonists, and antidepressants.",
      "Pelvic floor exercises, or Kegel exercises, can help treat iatrogenic male incontinence by strengthening the muscles that control urination.",
      "A treatment option for iatrogenic male incontinence can involve bladder training, which is gradually increasing the amount of time between trips to the bathroom.",
      "Catheterization can be used to alleviate iatrogenic male incontinence by helping drain urine from the bladder.",
      "Iatrogenic male incontinence can be treated through surgery, especially when the incontinence is caused by a physical obstruction or when other treatments have been unsuccessful."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1525,
    "user_query": "Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer?",
    "llama-2-7b-chat-hf_response": "A) CHEK2*2\nB) CHEK2*1\nC) CHEK2*3\nD) CHEK2*4\nCorrect answer: A) CHEK2*2.\nExplanation: CHEK2 is a gene that has been implicated in familial breast cancer. There are several genetic variants in the CHEK2 gene, including CHEK2*2, CHEK2*1, CHEK2*3, and CHEK2*4. However, the main genetic variant thought to be involved in familial breast cancer is CHEK2*2. This variant is found in approximately 50% of familial breast cancer cases and is associated with an increased risk of breast cancer. The other variants (CHEK2*1, CHEK2*3, and CHEK2*4) are less common and have been associated with a lower risk of breast cancer.",
    "llama-2-7b-chat-hf_fact": [
      "CHEK2 is a gene that has been implicated in familial breast cancer.",
      "There are several genetic variants in the CHEK2 gene, including CHEK2*2, CHEK2*1, CHEK2*3, and CHEK2*4.",
      "The main genetic variant thought to be involved in familial breast cancer is CHEK2*2.",
      "CHEK2*2 variant is found in approximately 50% of familial breast cancer cases.",
      "The other variants (CHEK2*1, CHEK2*3, and CHEK2*4) are less common and have been associated with a lower risk of breast cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1535,
    "user_query": "Are immune cells affected in Amyotrophic Lateral Sclerosis?",
    "llama-2-7b-chat-hf_response": "Yes, immune cells are affected in Amyotrophic Lateral Sclerosis (ALS). ALS is a neurodegenerative disease that affects the brain and spinal cord, leading to muscle weakness, atrophy, and paralysis. While the primary pathology of ALS is the degeneration of motor neurons, there is evidence to suggest that the immune system plays a role in the progression of the disease.\nStudies have shown that ALS patients have an imbalance in their immune system, with an increase in pro-inflammatory cytokines and a decrease in anti-inflammatory cytokines. This imbalance can lead to the activation of microglia, the resident immune cells of the central nervous system, which can further exacerbate the degeneration of motor neurons.\nAdditionally, there is evidence to suggest that ALS may be caused by an autoimmune response, in which the immune system mistakenly attacks and destroys the body's own motor neurons. This theory is supported by studies showing that ALS patients have antibodies against their own motor neurons, and that these antibodies can be detected in the cerebrospinal fluid of ALS patients.\nOverall, the evidence suggests that immune cells are affected in ALS, and that the immune system may play a role in the progression of the disease. Further research is needed to fully understand the relationship between the immune system and ALS, and to identify potential therapeutic targets for the treatment of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the brain and spinal cord.",
      "The primary pathology of ALS is the degeneration of motor neurons.",
      "Studies have shown that ALS patients have an imbalance in their immune system, with an increase in pro-inflammatory cytokines and a decrease in anti-inflammatory cytokines.",
      "Evidence suggests that ALS may be caused by an autoimmune response, in which the immune system mistakenly attacks and destroys the body's own motor neurons.",
      "ALS patients have been found to have antibodies against their own motor neurons, detectable in the cerebrospinal fluid."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1537,
    "user_query": "What is the mechanism of action of eprotirome?",
    "llama-2-7b-chat-hf_response": "Eprotirome is a novel, orally available, small molecule inhibitor of the enzyme phosphodiesterase 4 (PDE4). PDE4 is involved in the breakdown of cyclic adenosine monophosphate (cAMP), a second messenger that plays a key role in many cellular processes, including inflammation and immune response. By inhibiting PDE4, eprotirome increases the levels of cAMP in cells, leading to the activation of protein kinase A (PKA), which in turn can inhibit the activity of pro-inflammatory transcription factors and reduce the production of pro-inflammatory cytokines.\nEprotirome has been shown to have anti-inflammatory effects in various preclinical models of inflammation, including colitis, arthritis, and asthma. It has also been shown to reduce the production of pro-inflammatory cytokines in human immune cells, such as T cells and macrophages. Additionally, eprotirome has been shown to have neuroprotective effects in preclinical models of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\nOverall, the mechanism of action of eprotirome is to increase the levels of cAMP in cells, leading to the activation of PKA and the inhibition of pro-inflammatory transcription factors and cytokine production. This can have anti-inflammatory effects in various tissues and organs, including the gut, joints, and brain.",
    "llama-2-7b-chat-hf_fact": [
      "Eprotirome is an inhibitor of the enzyme phosphodiesterase 4 (PDE4).",
      "Phosphodiesterase 4 is involved in the breakdown of cyclic adenosine monophosphate (cAMP), which plays a key role in cellular processes like inflammation and immune response.",
      "By inhibiting PDE4, eprotirome increases the levels of cAMP in cells, leading to the activation of protein kinase A (PKA).",
      "Eprotirome has displayed anti-inflammatory effects in preclinical models of diseases such as colitis, arthritis, and asthma.",
      "Eprotirome has demonstrated neuroprotective effects in preclinical models of neurodegenerative diseases, including Alzheimer's and Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Eprotirome is not an inhibitor of phosphodiesterase 4 (PDE4). It is actually a thyroid hormone analog, meaning it mimics the effects of thyroid hormones.",
      "true",
      "false, [corrected fact]: Eprotirome does not inhibit PDE4 to increase levels of cAMP in cells. Instead, it mimics the effects of thyroid hormones.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1541,
    "user_query": "What is GDF10?",
    "llama-2-7b-chat-hf_response": "GDF10 is a protein that is produced by cells in the body and plays a role in the development and maintenance of the nervous system. It is a member of the growth differentiation factor (GDF) family of proteins, which are involved in a wide range of cellular processes, including cell growth, differentiation, and survival.\nGDF10 is specifically involved in the development and maintenance of the peripheral nervous system, which includes the nerves that connect the brain and spinal cord to the rest of the body. It is expressed in the neural crest cells, which are the precursor cells that give rise to the neurons and glial cells in the peripheral nervous system. GDF10 helps to regulate the proliferation and differentiation of these cells, and is necessary for the proper formation and function of the peripheral nervous system.\nMutations in the GDF10 gene have been associated with a number of neurological disorders, including Charcot-Marie-Tooth disease, a group of inherited disorders that affect the peripheral nervous system. These mutations are thought to disrupt the normal function of GDF10, leading to problems with the development and maintenance of the peripheral nervous system.",
    "llama-2-7b-chat-hf_fact": [
      "GDF10 is a protein that plays a role in the development and maintenance of the nervous system.",
      "GDF10 is part of the growth differentiation factor (GDF) family of proteins.",
      "GDF10 plays a specific role in the development and maintenance of the peripheral nervous system.",
      "GDF10 is expressed in the neural crest cells which give rise to neurons and glial cells in the peripheral nervous system.",
      "Mutations in the GDF10 gene have been associated with Charcot-Marie-Tooth disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1552,
    "user_query": "Which genetic defects are observed in Prader-Willi syndrome?",
    "llama-2-7b-chat-hf_response": "Prader-Willi syndrome (PWS) is a genetic disorder caused by the loss of function of a gene on chromosome 15. The specific genetic defects observed in PWS include:\n1. Loss of function of the paternal copy of the genes on chromosome 15: PWS is caused by the loss of function of the paternal copy of the genes on chromosome 15, specifically the genes encoding the proteins paternally expressed, imprinted genes (PWS1), and the genes encoding the proteins maternally expressed, imprinted genes (PWS2).\n2. Imprinting defects: The genes on chromosome 15 are imprinted, meaning that they have a differentially methylated region (DMR) that determines whether the gene is expressed from the paternal or maternal copy. In PWS, the imprinting of these genes is disrupted, leading to the loss of function of the paternal copy.\n3. Hypomethylation of the differentially methylated region (DMR): The DMR of the genes on chromosome 15 is hypomethylated in PWS, which leads to the loss of imprinting and the expression of the paternal copy of the genes.\n4. Reduced expression of genes: The loss of function of the paternal copy of the genes on chromosome 15 leads to reduced expression of these genes, which can result in the characteristic symptoms of PWS.\n5. Genetic mosaicism: PWS can result in genetic mosaicism, where some cells in the body have a normal copy of the genes on chromosome 15, while others have a mutated copy. This can result in variable expression of the symptoms of PWS.",
    "llama-2-7b-chat-hf_fact": [
      "Prader-Willi syndrome is a genetic disorder caused by the loss of function of a gene on chromosome 15.",
      "Loss of function of the paternal copy of the genes on chromosome 15, specifically the genes encoding the proteins paternally expressed, imprinted genes (PWS1), and the genes encoding the proteins maternally expressed, imprinted genes (PWS2), can be detected in Prader-Willi syndrome.",
      "In Prader-Willi syndrome, the imprinting of the genes on chromosome 15 is disrupted, leading to the loss of function of the paternal copy.",
      "The DMR of the genes on chromosome 15 is hypomethylated in Prader-Willi syndrome, which leads to the loss of imprinting and the expression of the paternal copy of the genes.",
      "Prader-Willi syndrome may result in genetic mosaicism, which means some cells in the body have a normal copy of the genes on chromosome 15, while others have a mutated copy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The DMR of the genes on chromosome 15 is hypermethylated in Prader-Willi syndrome, which leads to the loss of imprinting and the lack of expression of the paternal copy of the genes.",
      "true"
    ]
  },
  {
    "id": 1555,
    "user_query": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?",
    "llama-2-7b-chat-hf_response": "Gene fusion events are a common feature of cancer genomes, and their prediction has important implications for cancer diagnosis and treatment. In recent years, several computational tools have been developed to predict gene fusion events in cancer genomes. Here are some of the state-of-the-art computational tools for the prediction of gene fusion events:\n1. Cancer Genome Atlas (TCGA): TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) that aims to catalogue the genomic changes in various types of cancer. TCGA has developed a number of computational tools for the analysis of cancer genomic data, including tools for the prediction of gene fusion events.\n2. FusionHunter: FusionHunter is a computational tool developed by the University of California, Los Angeles (UCLA) that uses a combination of machine learning and statistical methods to predict gene fusion events in cancer genomes. FusionHunter can be used to predict gene fusion events in both coding and non-coding regions of the genome.\n3. FusionFinder: FusionFinder is a computational tool developed by the University of California, San Diego (UCSD) that uses a combination of machine learning and statistical methods to predict gene fusion events in cancer genomes. FusionFinder can be used to predict gene fusion events in both coding and non-coding regions of the genome.\n4. CanuFusion: CanuFusion is a computational tool developed by the University of California, Berkeley (UC Berkeley) that uses a combination of machine learning and statistical methods to predict gene fusion events in cancer genomes. CanuFusion can be used to predict gene fusion events in both coding and non-coding regions of the genome.\n5. DeepFusion: DeepFusion is a computational tool developed by the University of California, San Francisco (UCSF) that uses a combination of deep learning and statistical methods to predict gene fusion events in cancer genomes. DeepFusion can be used to predict gene fusion events in both coding and non-coding regions of the genome.\n6. GFusion: GFusion is a computational tool developed by the University of Texas MD Anderson Cancer Center that uses a combination of machine learning and statistical methods to predict gene fusion events in cancer genomes. GFusion can be used to predict",
    "llama-2-7b-chat-hf_fact": [
      "The prediction of gene fusion events has implications for cancer diagnosis and treatment.",
      "The Cancer Genome Atlas is a collaboration between the National Cancer Institute and the National Human Genome Research Institute aiming to catalogue genomic changes in various types of cancer.",
      "FusionHunter, developed by the University of California, Los Angeles, is a computational tool that predicts gene fusion events in cancer genomes.",
      "FusionFinder, developed by the University of California, San Diego, uses machine learning and statistical methods to predict gene fusion events in cancer genomes.",
      "DeepFusion, a computational tool from the University of California, San Francisco, uses a combination of deep learning and statistical methods to predict gene fusion events in cancer genomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1559,
    "user_query": "Are the proteins Erbin (LAP2) and Merlin cooperating?",
    "llama-2-7b-chat-hf_response": "Yes, Erbin (LAP2) and Merlin are cooperating proteins in the regulation of cellular processes, including cell adhesion, migration, and signaling. Both proteins are involved in the same signaling pathways and are known to interact with each other in a cooperative manner.\nErbin (LAP2) is a member of the LAP (leucine-rich repeat-containing protein) family of proteins, which are involved in the regulation of cellular processes such as cell adhesion, migration, and signaling. Merlin is a protein that is involved in the regulation of cellular processes such as cell adhesion, migration, and signaling, and is known to interact with Erbin (LAP2) in a cooperative manner.\nStudies have shown that Erbin (LAP2) and Merlin cooperate in the regulation of cellular processes such as cell adhesion and migration. For example, one study found that Erbin (LAP2) and Merlin cooperate in the regulation of cell adhesion and migration in response to extracellular matrix (ECM) cues (1). Another study found that Erbin (LAP2) and Merlin cooperate in the regulation of cell migration and invasion in response to growth factors (2).\nIn addition, Erbin (LAP2) and Merlin have been shown to interact with each other in a cooperative manner in the regulation of signaling pathways. For example, one study found that Erbin (LAP2) and Merlin cooperate in the regulation of the PI3K/Akt signaling pathway in response to growth factors (3). Another study found that Erbin (LAP2) and Merlin cooperate in the regulation of the MAPK/ERK signaling pathway in response to ECM cues (4).\nOverall, the evidence suggests that Erbin (LAP2) and Merlin are cooperating proteins in the regulation of cellular processes, including cell adhesion, migration, and signaling.\nReferences:\n1. Kim, J. et al. (2010). Erbin and Merlin cooperate in the regulation of cell adhesion and migration. Journal of Cell Science, 123",
    "llama-2-7b-chat-hf_fact": [
      "Erbin (LAP2) and Merlin are proteins that cooperate in the regulation of cellular processes, including cell adhesion, migration, and signaling.",
      "Both Erbin (LAP2) and Merlin are known to interact with each other.",
      "Erbin (LAP2) is a member of the LAP (leucine-rich repeat-containing protein) family of proteins.",
      "Studies have shown that Erbin (LAP2) and Merlin cooperate in the regulation of cell adhesion and migration in response to extracellular matrix cues.",
      "Erbin (LAP2) and Merlin have been shown to cooperate in the regulation of signaling pathways, including the PI3K/Akt and the MAPK/ERK pathways."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1568,
    "user_query": "Which deficiency is the cause of restless leg syndrome",
    "llama-2-7b-chat-hf_response": "?\nA) Iron deficiency\nB) Magnesium deficiency\nC) Potassium deficiency\nD) Vitamin B12 deficiency\nCorrect answer: A) Iron deficiency\nExplanation: Restless Leg Syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs, usually due to an uncomfortable or unpleasant sensation in the legs. While the exact cause of RLS is not fully understood, iron deficiency is a common underlying factor. Iron is essential for the proper functioning of the nervous system, and low levels of iron can disrupt the normal functioning of nerve cells, leading to the symptoms of RLS. Other potential causes of RLS include magnesium deficiency, potassium deficiency, and vitamin B12 deficiency, but iron deficiency is the most commonly associated with RLS.",
    "llama-2-7b-chat-hf_fact": [
      "Restless Leg Syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the legs.",
      "Iron deficiency is a common underlying factor of Restless Leg Syndrome.",
      "Iron is essential for the proper functioning of the nervous system.",
      "Low levels of iron can disrupt the normal functioning of nerve cells.",
      "Other potential causes of Restless Leg Syndrome can include magnesium deficiency, potassium deficiency, and vitamin B12 deficiency."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1572,
    "user_query": "What is the role of eteplirsen in DMD patients?",
    "llama-2-7b-chat-hf_response": "Eteplirsen is an investigational drug being developed for the treatment of Duchenne muscular dystrophy (DMD). It is designed to increase the production of the dystrophin protein, which is deficient in DMD patients. Eteplirsen is being studied in clinical trials to determine its safety and efficacy in DMD patients.",
    "llama-2-7b-chat-hf_fact": [
      "Eteplirsen is an investigational drug being developed for the treatment of Duchenne muscular dystrophy (DMD).",
      "The role of eteplirsen is to increase the production of the dystrophin protein.",
      "The dystrophin protein is deficient in DMD patients.",
      "Eteplirsen's safety and efficacy for DMD patients is being studied in clinical trials."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1573,
    "user_query": "Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.",
    "llama-2-7b-chat-hf_response": "Parkinsonism with dementia of Guadeloupe syndrome is a rare genetic disorder that affects the brain and nervous system. The clinical presentation of this syndrome typically involves a combination of symptoms from both Parkinson's disease and dementia, including:\n1. Motor symptoms: Tremors, rigidity, bradykinesia (slow movement), and postural instability are common in Parkinson's disease. In Parkinsonism with dementia of Guadeloupe syndrome, these motor symptoms are typically more severe and progressive than in typical Parkinson's disease.\n2. Cognitive decline: Dementia is a hallmark feature of Parkinsonism with dementia of Guadeloupe syndrome. Cognitive decline can include problems with memory, language, attention, and executive function.\n3. Behavioral changes: People with Parkinsonism with dementia of Guadeloupe syndrome may experience a range of behavioral changes, including depression, anxiety, apathy, and disinhibition.\n4. Sleep disturbances: Sleep disturbances, including insomnia and daytime sleepiness, are common in Parkinsonism with dementia of Guadeloupe syndrome.\n5. Autonomic dysfunction: Autonomic dysfunction, including orthostatic hypotension, constipation, and urinary incontinence, can occur in Parkinsonism with dementia of Guadeloupe syndrome.\n6. Oculomotor dysfunction: Oculomotor dysfunction, including difficulty with eye movements, can occur in Parkinsonism with dementia of Guadeloupe syndrome.\n7. Dysphagia: Dysphagia, or difficulty swallowing, can occur in Parkinsonism with dementia of Guadeloupe syndrome.\n8. Seizures: Seizures can occur in some cases of Parkinsonism with dementia of Guadeloupe syndrome.\n9. Psychosis: Psychosis, including hallucinations and delusions, can occur in some cases of Parkinsonism with dementia of Guadeloupe syndrome.\n10. Progressive course: Parkinsonism with dementia of Guadeloupe syndrome typically follows a progressive course, with symptoms",
    "llama-2-7b-chat-hf_fact": [
      "Parkinsonism with dementia of Guadeloupe syndrome is a rare genetic disorder that affects the brain and nervous system.",
      "The syndrome typically presents symptoms from both Parkinson's disease and dementia.",
      "Some symptoms of Parkinsonism with dementia of Guadeloupe syndrome can include motor symptoms, cognitive decline, sleep disturbances, autonomic dysfunction, difficulty swallowing, and seizures.",
      "Behavioral changes such as depression, anxiety, apathy, and disinhibition can also occur with this syndrome.",
      "Parkinsonism with dementia of Guadeloupe syndrome is typically progressive, with symptoms worsening over time."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-7b-chat-hf_response": "HIF-1 (Hypoxia-Inducible Factor 1-Alpha) is a transcription factor that plays a crucial role in response to hypoxia. It regulates the expression of genes involved in angiogenesis, glucose metabolism, and cell survival. Amifostine, also known as ethyol, is a cytoprotective prodrug that has been shown to have anti-inflammatory and cytoprotective effects in various diseases, including cancer and organ transplantation. However, the effect of amifostine on HIF-1 concentration has not been well studied.\nTo investigate the effect of amifostine on HIF-1 concentration, we performed a study in which healthy volunteers were administered amifostine or placebo. Blood samples were collected before and after drug administration, and HIF-1 concentration was measured using a validated ELISA assay.\nOur results showed that the concentration of HIF-1 increased significantly after administration of amifostine, compared to placebo. The increase in HIF-1 concentration was observed as early as 30 minutes after drug administration and reached a peak at 2 hours. The increase in HIF-1 concentration was maintained for at least 4 hours after drug administration.\nThese findings suggest that amifostine may have a cytoprotective effect by increasing the concentration of HIF-1, which plays a crucial role in response to hypoxia. The increase in HIF-1 concentration may help to protect cells against hypoxia-induced damage and promote angiogenesis, glucose metabolism, and cell survival. Further studies are needed to confirm these findings and to determine the clinical relevance of this observation.",
    "llama-2-7b-chat-hf_fact": [
      "HIF-1 (Hypoxia-Inducible Factor 1-Alpha) is a transcription factor that plays a role in response to hypoxia.",
      "The transcription factor HIF-1 regulates the expression of genes related to angiogenesis, glucose metabolism, and cell survival.",
      "Amifostine, also known as ethyol, is a cytoprotective prodrug with anti-inflammatory and cytoprotective effects.",
      "A study found that the concentration of HIF-1 increased significantly after administration of amifostine.",
      "The increase in HIF-1 concentration was noticeable within 30 minutes, peaked at 2 hours, and maintained for at least 4 hours post-amifostine administration."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1578,
    "user_query": "Which are the main histone modifications associated with enhancers?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-acting DNA elements that can increase the recruitment of RNA polymerase II (RNAPII) to specific gene promoters, leading to increased gene expression. Histone modifications play a crucial role in the regulation of enhancer function. Here are some of the main histone modifications associated with enhancers:\n1. H3K4me3: Histone H3 lysine 4 trimethylation (H3K4me3) is a common histone modification associated with enhancers. It is known to be involved in the recruitment of RNAPII and other transcription factors to the promoter region.\n2. H3K27ac: Histone H3 lysine 27 acetylation (H3K27ac) is another common histone modification associated with enhancers. It is known to be involved in the regulation of gene expression by recruiting RNAPII and other transcription factors to the promoter region.\n3. H3K36me3: Histone H3 lysine 36 trimethylation (H3K36me3) is a less common histone modification associated with enhancers. It is known to be involved in the regulation of gene expression by recruiting RNAPII and other transcription factors to the promoter region.\n4. H2A.Z: Histone H2A variant H2A.Z is known to be involved in the regulation of enhancer function. It is known to be involved in the recruitment of RNAPII and other transcription factors to the promoter region.\n5. H3K79me2: Histone H3 lysine 79 dimethylation (H3K79me2) is a less common histone modification associated with enhancers. It is known to be involved in the regulation of gene expression by recruiting RNAPII and other transcription factors to the promoter region.\n6. H3K9ac: Histone H3 lysine 9 acetylation (H3K9ac) is a common histone modification associated with enhancers. It is known to be involved in the regulation of gene expression by recruiting RNAPII and other transcription",
    "llama-2-7b-chat-hf_fact": [
      "Enhancers are DNA elements that increase the recruitment of RNA polymerase II to specific gene promoters.",
      "Histone modifications play a role in the regulation of enhancer function.",
      "Histone H3 lysine 4 trimethylation (H3K4me3) is a histone modification associated with enhancers.",
      "Histone H3 lysine 27 acetylation (H3K27ac) is a histone modification associated with enhancers.",
      "Histone H2A variant H2A.Z is involved in the regulation of enhancer function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Histone H3 lysine 4 trimethylation (H3K4me3) is a histone modification associated with promoters, not enhancers.",
      "true",
      "true"
    ]
  },
  {
    "id": 1586,
    "user_query": "What is the principle of ATAC (Assay for Transposase-Accessible Chromatin) technique?",
    "llama-2-7b-chat-hf_response": "ATAC-seq is a powerful tool for understanding gene regulation by mapping open chromatin regions. The basic principle of ATAC-seq is to use the transposase enzyme to randomly fragment the chromatin, and then capture the fragments that are accessible to the transposase. The captured fragments are then sequenced to identify the open chromatin regions.\nHere is a step-by-step explanation of the ATAC-seq technique:\n1. Crosslinking: The cells are fixed with formaldehyde to create covalent bonds between the DNA and histone proteins.\n2. Sonication: The chromatin is broken into smaller fragments using sonication.\n3. End repair and A-tailing: The 3' ends of the fragmented DNA are repaired and modified to create a consistent A-tail.\n4. Ligation of adapters: Adapters are ligated to the 5' ends of the fragmented DNA. The adapters contain a recognition sequence for the Tn5 transposase enzyme.\n5. Transposase reaction: The Tn5 transposase enzyme is added to the sample and recognizes the adapters on the fragmented DNA. The transposase cuts the DNA at the adapters, resulting in the fragmentation of the chromatin.\n6. Capture: The fragmented chromatin is captured using an antibody that binds to the Tn5 transposase enzyme. The captured DNA is then purified.\n7. Sequencing: The captured DNA is sequenced using Next-Generation Sequencing (NGS) technologies.\n8. Data analysis: The sequencing data is analyzed to identify the open chromatin regions. The analysis typically involves mapping the sequencing reads to a reference genome and identifying regions with high accessibility.\nATAC-seq provides a comprehensive view of open chromatin regions in a given cell population, which can be used to understand the regulation of gene expression, identify new regulatory elements, and study the dynamics of chromatin structure.",
    "llama-2-7b-chat-hf_fact": [
      "ATAC-seq is a technique used to map open chromatin regions.",
      "The ATAC-seq technique utilizes the transposase enzyme to fragment and capture accessible chromatin fragments.",
      "The ATAC-seq process involves the steps of crosslinking, sonication, end repair and A-tailing, ligation of adapters, transposase reaction, capture, sequencing, and data analysis.",
      "The Tn5 transposase enzyme is used in ATAC-seq to recognize adapters and cut DNA at these points.",
      "Next-Generation Sequencing technologies are used to sequence the DNA captured in ATAC-seq."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The ATAC-seq process involves the steps of transposase reaction, capture, sequencing, and data analysis. It does not involve crosslinking, sonication, end repair and A-tailing, or ligation of adapters.",
      "true",
      "true"
    ]
  },
  {
    "id": 1587,
    "user_query": "Which are the main NMD factors in Saccharomyces cerevisiae?",
    "llama-2-7b-chat-hf_response": "NMD (Nuclear Mitochondrial Degradation) is a process by which cells degrade nuclear-encoded mitochondrial proteins. In Saccharomyces cerevisiae, there are several factors that contribute to NMD. Here are some of the main NMD factors in S. cerevisiae:\n1. Upf1: Upf1 is a key factor in NMD and is required for the degradation of most NMD substrates. Upf1 recognizes and binds to specific sequences in the 3' untranslated region (UTR) of target mRNAs and recruits the NMD machinery to degrade the mRNAs.\n2. Upf2: Upf2 is another important factor in NMD and works in conjunction with Upf1 to recognize and degrade target mRNAs. Upf2 recognizes and binds to a different set of sequences in the 3' UTR of target mRNAs than Upf1.\n3. Nmd2: Nmd2 is a protein that helps to recruit the NMD machinery to the 3' UTR of target mRNAs. Nmd2 recognizes and binds to specific sequences in the 3' UTR of target mRNAs and helps to position the NMD machinery for degradation.\n4. Mdf1: Mdf1 is a protein that helps to activate the NMD machinery. Mdf1 recognizes and binds to specific sequences in the 3' UTR of target mRNAs and helps to recruit the NMD machinery for degradation.\n5. RNA-binding proteins: RNA-binding proteins (RBPs) play a crucial role in NMD by recognizing and binding to specific sequences in the 3' UTR of target mRNAs. RBPs help to recruit the NMD machinery to the target mRNAs and play a role in the degradation of the mRNAs.\n6. Other factors: Other factors that contribute to NMD in S. cerevisiae include the presence of specific sequences in the 3' UTR of target mRNAs, such as AU-rich elements (AREs) and 3' UTR",
    "llama-2-7b-chat-hf_fact": [
      "NMD (Nuclear Mitochondrial Degradation) is a process by which cells degrade nuclear-encoded mitochondrial proteins.",
      "In Saccharomyces cerevisiae, there are several factors that are essential for Nuclear Mitochondrial Degradation.",
      "Upf1 and Upf2 are proteins required for the degradation of most NMD substrates in Saccharomyces cerevisiae.",
      "Nmd2 and Mdf1 are proteins that help recruit and activate the NMD machinery in Saccharomyces cerevisiae.",
      "RNA-binding proteins play a crucial role in Nuclear Mitochondrial Degradation by recognizing, binding, and causing degradation of specific sequences in the 3' untranslated region of target mRNAs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: NMD (Nonsense Mediated mRNA Decay) is a surveillance pathway that exists in all eukaryotes and it is responsible for the rapid degradation of mRNA transcripts that contain premature stop codons.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-7b-chat-hf_response": "Set7 is a histone methyltransferase that deposits histone 3 lysine 4 trimethylation (H3K4me3) and histone 3 lysine 27 trimethylation (H3K27me3) on histone H3.",
    "llama-2-7b-chat-hf_fact": [
      "Set7 is a histone methyltransferase.",
      "Set7 deposits histone 3 lysine 4 trimethylation (H3K4me3).",
      "Set7 deposits histone 3 lysine 27 trimethylation (H3K27me3).",
      "Both H3K4me3 and H3K27me3 marks are deposited on histone H3 by Set7."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Set7 deposits histone 3 lysine 4 monomethylation (H3K4me1).",
      "false, [corrected fact]: Set7 does not deposit histone 3 lysine 27 trimethylation (H3K27me3), this mark is deposited by Enhancer of Zeste Homolog 2 (EZH2).",
      "false, [corrected fact]: Set7 deposits histone 3 lysine 4 monomethylation (H3K4me1), it does not deposit H3K27me3."
    ]
  },
  {
    "id": 1592,
    "user_query": "Which genes are associated with Ehlers-Danlos syndrome type I/II?",
    "llama-2-7b-chat-hf_response": "Ehlers-Danlos syndrome (EDS) is a group of hereditary disorders that affect the body's connective tissue, which provides support and structure to various organs, joints, and tissues. There are several subtypes of EDS, including EDS type I and EDS type II, which are caused by mutations in different genes. Here are some of the genes that have been associated with EDS type I and EDS type II:\nEDS type I:\n* COL5A1: This gene encodes the protein collagen type V alpha 1, which is important for the structure and function of connective tissue. Mutations in the COL5A1 gene have been identified as the primary cause of EDS type I.\n* COL5A2: This gene encodes the protein collagen type V alpha 2, which is also important for the structure and function of connective tissue. Mutations in the COL5A2 gene have been identified as a secondary cause of EDS type I.\nEDS type II:\n* ADAM10: This gene encodes the protein a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), which is involved in the regulation of cell signaling and the structure of connective tissue. Mutations in the ADAM10 gene have been identified as the primary cause of EDS type II.\n* CAV1: This gene encodes the protein caveolin 1, which is involved in the regulation of cell signaling and the structure of connective tissue. Mutations in the CAV1 gene have been identified as a secondary cause of EDS type II.\nOther genes that have been associated with EDS include:\n* TGFBR1: This gene encodes the protein transforming growth factor beta receptor 1, which is involved in the regulation of cell signaling and the structure of connective tissue. Mutations in the TGFBR1 gene have been identified as a cause of EDS.\n* TGFBR2: This gene encodes the protein transforming growth factor beta receptor 2, which is also involved in the regulation of cell signaling and the structure of connective tissue. Mutations in the TGFBR2 gene have been identified as a cause of EDS.\n*",
    "llama-2-7b-chat-hf_fact": [
      "Ehlers-Danlos syndrome (EDS) is a hereditary disorder affecting the body's connective tissue.",
      "EDS type I is primarily caused by mutations in the COL5A1 gene that encodes the protein collagen type V alpha 1.",
      "Mutations in the COL5A2 gene which encodes the protein collagen type V alpha 2, have been identified as a secondary cause of EDS type I.",
      "The ADAM10 gene mutations have been identified as the primary cause of EDS type II.",
      "Mutations in the CAV1 gene have been identified as a secondary cause of EDS type II."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: EDS type I (commonly known as Classic EDS) is primarily caused by mutations in the COL5A1 or COL5A2 gene which both encode the protein collagen type V.",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1593,
    "user_query": "Which factors are considered in the ABCD2 score?",
    "llama-2-7b-chat-hf_response": "The ABCD2 score is a tool used to assess the severity of community-acquired pneumonia (CAP) in adults. The score is based on four factors:\nA - Age: Points are awarded based on the patient's age, with older patients receiving more points.\nB - Bacteremia: Points are awarded if the patient has bacteremia, which is the presence of bacteria in the blood.\nC - Clinical status: Points are awarded based on the patient's clinical status, including their level of consciousness, respiratory rate, and oxygen saturation.\nD - Dyspnea: Points are awarded if the patient is experiencing shortness of breath.\n2 - Severity of symptoms: Points are awarded based on the severity of the patient's symptoms, including fever, chest pain, and cough.\nThe total score ranges from 0 to 12, with higher scores indicating more severe disease. The ABCD2 score can help healthcare providers determine the appropriate treatment for CAP, including antibiotics and hospitalization.",
    "llama-2-7b-chat-hf_fact": [
      "The ABCD2 score is an assessment tool used to evaluate the severity of community-acquired pneumonia in adults.",
      "The ABCD2 score considers factors such as age, bacteremia, clinical status, dyspnea, and severity of symptoms.",
      "In this scoring system, older patients generally receive more points based on age.",
      "A higher ABCD2 score, in the range of 0 to 12, indicates more severe disease.",
      "The ABCD2 score can assist healthcare providers in determining the appropriate treatment for CAP."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The ABCD2 score is an assessment tool used to evaluate the risk of stroke in patients with transient ischemic attack (TIA), not the severity of community-acquired pneumonia in adults.",
      "false, [corrected fact]: The ABCD2 score considers factors such as age, blood pressure, clinical features, duration of symptoms, and presence of diabetes.",
      "true",
      "true",
      "false, [corrected fact]: The ABCD2 score can assist healthcare providers in determining the risk of stroke for patients with transient ischemic attack (TIA), not the appropriate treatment for CAP."
    ]
  },
  {
    "id": 1594,
    "user_query": "Is Tuberous Sclerosis a genetic disease?",
    "llama-2-7b-chat-hf_response": "Tuberous sclerosis (TS) is a rare genetic disorder that affects approximately 1 in 6,000 individuals worldwide. It is caused by mutations in two genes, TSC1 and TSC2, which are involved in the regulation of cell growth and division. These mutations lead to the formation of non-cancerous tumors in various organs, including the brain, kidneys, heart, and lungs.\nThe genetic mutations that cause TS are inherited in an autosomal dominant pattern, which means that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutated gene, each child has a 50% chance of inheriting the mutation. However, some people with TS may not have a family history of the condition, as new mutations can occur spontaneously.\nThere is no cure for TS, but various treatments can help manage the symptoms and prevent complications. These treatments may include medications to control seizures, kidney problems, and other symptoms, as well as surgery to remove tumors. Early diagnosis and treatment can help improve the quality of life for people with TS.\nIn summary, Tuberous sclerosis is a genetic disease caused by mutations in the TSC1 and TSC2 genes. It is inherited in an autosomal dominant pattern, and while there is no cure, various treatments can help manage symptoms and prevent complications.",
    "llama-2-7b-chat-hf_fact": [
      "Tuberous sclerosis (TS) is a rare genetic disorder that affects approximately 1 in 6,000 individuals worldwide.",
      "Tuberous sclerosis is caused by mutations in two genes, TSC1 and TSC2.",
      "The condition leads to the formation of non-cancerous tumors in various organs, such as the brain, kidneys, heart, and lungs.",
      "The genetic mutations that cause Tuberous sclerosis are inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene can cause the condition.",
      "While there is no cure for Tuberous sclerosis, various treatments can help manage symptoms and prevent complications."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1598,
    "user_query": "What type of DNA repair pathways is initiated by AlkA glycosylase?",
    "llama-2-7b-chat-hf_response": "AlkA glycosylase is a DNA repair enzyme that initiates the base excision repair (BER) pathway. BER is a process by which cells repair damaged DNA bases, particularly oxidized purines, through the removal of the damaged base and its replacement with a correct base. AlkA glycosylase recognizes and cleaves the oxidized purine base 8-oxoguanine (8-oxoG) in DNA, leading to the formation of an abasic site, which is then repaired through the BER pathway.",
    "llama-2-7b-chat-hf_fact": [
      "AlkA glycosylase is a DNA repair enzyme.",
      "The base excision repair (BER) pathway is initiated by AlkA glycosylase.",
      "The BER process repairs damaged DNA bases, specifically oxidized purines.",
      "AlkA glycosylase recognizes and cleaves the oxidized purine base 8-oxoguanine (8-oxoG) in DNA.",
      "The abasic site formed by the removal of 8-oxoG is repaired through the BER pathway."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: AlkA glycosylase recognizes and cleaves modified bases and not specifically 8-oxoguanine. The enzyme that recognizes and cleaves 8-oxoguanine is called 8-oxoguanine glycosylase (OGG1).",
      "true"
    ]
  },
  {
    "id": 1605,
    "user_query": "What is the mechanism of cementogenesis in pulp regeneration?",
    "llama-2-7b-chat-hf_response": "Cementogenesis is the process of formation of dentin-like tissue in the pulp chamber during pulp regeneration. The mechanism of cementogenesis involves several steps:\n1. Inflammation: The first step in cementogenesis is the inflammation of the pulp chamber, which is caused by the destruction of the pulp tissue. This inflammation leads to the release of growth factors and cytokines that promote the migration and proliferation of cells.\n2. Migration and proliferation of cells: The growth factors and cytokines released during inflammation stimulate the migration and proliferation of cells, including odontoblasts, fibroblasts, and inflammatory cells. These cells migrate into the pulp chamber and begin to proliferate, leading to the formation of a new connective tissue matrix.\n3. Differentiation of odontoblasts: Odontoblasts are specialized cells that are responsible for the formation of dentin-like tissue. During cementogenesis, odontoblasts differentiate from the proliferating cells and begin to produce dentin matrix proteins, such as dentin matrix protein 1 (DMP1) and dentin matrix protein 2 (DMP2).\n4. Formation of dentin-like tissue: The differentiated odontoblasts continue to produce dentin matrix proteins, leading to the formation of a dentin-like tissue in the pulp chamber. This tissue is characterized by a highly organized and specialized extracellular matrix that provides mechanical support and protection to the pulp.\n5. Mineralization: The final step in cementogenesis is the mineralization of the dentin-like tissue. This process involves the deposition of hydroxyapatite crystals in the extracellular matrix, leading to the formation of a hard, bony-like tissue.\nIn summary, the mechanism of cementogenesis in pulp regeneration involves the inflammation of the pulp chamber, the migration and proliferation of cells, the differentiation of odontoblasts, the formation of dentin-like tissue, and the mineralization of this tissue. This process leads to the formation of a hard, bony-like",
    "llama-2-7b-chat-hf_fact": [
      "Cementogenesis is the process of formation of dentin-like tissue in the pulp chamber during pulp regeneration.",
      "Differentiation of odontoblasts is an important part of cementogenesis, where they begin producing substances like dentin matrix protein 1 and 2.",
      "Formation of dentin-like tissue in the pulp chamber is characterized by a specialized extracellular matrix providing mechanical support and protection to the pulp.",
      "The final step in cementogenesis is the mineralization of the dentin-like tissue involving the deposition of hydroxyapatite crystals.",
      "The process of cementogenesis starts with the inflammation of pulp chamber leading to subsequent migration and proliferation of cells such as odontoblasts and fibroblasts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Cementogenesis is the process of formation of cementum, a hard tissue layer that covers the tooth root.",
      "false, [corrected fact]: Differentiation of odontoblasts is an important part of dentinogenesis, where they begin producing substances like dentin matrix protein 1 and 2.",
      "true",
      "false, [corrected fact]: The final step in dentinogenesis is the mineralization of the dentin involving the deposition of hydroxyapatite crystals.",
      "false, [corrected fact]: The process of dentinogenesis or cementogenesis does not necessarily start with the inflammation of the pulp chamber. It is part of the normal tooth development and repair processes which involve odontoblasts for dentin formation and cementoblasts for cementum formation."
    ]
  },
  {
    "id": 1606,
    "user_query": "What are the reported adverse effects of gabapentin used in children?",
    "llama-2-7b-chat-hf_response": "Gabapentin is an anticonvulsant medication that has been used to treat various conditions in children, including epilepsy, nerve pain, and anxiety disorders. However, like all medications, gabapentin can have adverse effects, especially when used in children. Here are some of the reported adverse effects of gabapentin used in children:\n1. Drowsiness and somnolence: Gabapentin can cause drowsiness and somnolence, which can be more pronounced in children than in adults. This can affect their ability to concentrate and perform daily activities.\n2. Dizziness and loss of coordination: Gabapentin can cause dizziness and loss of coordination, which can increase the risk of falls and accidents in children.\n3. Headache: Gabapentin can cause headaches, which can range from mild to severe.\n4. Fatigue: Gabapentin can cause fatigue, which can affect a child's ability to participate in physical and mental activities.\n5. Nausea and vomiting: Gabapentin can cause nausea and vomiting, especially when taken in high doses or for extended periods.\n6. Diarrhea and abdominal pain: Gabapentin can cause diarrhea and abdominal pain, which can be uncomfortable and disruptive to a child's daily routine.\n7. Weight gain: Gabapentin can cause weight gain, which can be a concern for children who are already overweight or obese.\n8. Mood changes: Gabapentin can cause mood changes, such as irritability, anxiety, and depression, especially in children with a history of these conditions.\n9. Cognitive impairment: Gabapentin can affect cognitive function, including memory, attention, and concentration, especially in children with pre-existing cognitive impairments.\n10. Allergic reactions: Gabapentin can cause allergic reactions, including rash, itching, and swelling, which can be severe in some cases.\nIt is important to note that these adverse effects are not experienced by all children who take gabapentin, and their severity can vary depending on the individual child and the dosage of the medication. If you are concerned about the adverse effects",
    "llama-2-7b-chat-hf_fact": [
      "Gabapentin is an anticonvulsant medication used to treat various conditions in children, including epilepsy, nerve pain, and anxiety disorders.",
      "Reported adverse effects of gabapentin use in children include drowsiness and somnolence, which can affect their ability to concentrate and perform daily activities.",
      "Other reported side effects of gabapentin use in children include dizziness, loss of coordination, headaches, and fatigue.",
      "Gabapentin can also cause nausea, vomiting, diarrhea, abdominal pain, weight gain and mood changes in children.",
      "Allergic reactions such as rashes, itching, and swelling can occur in children as a side effect of gabapentin usage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1617,
    "user_query": "What are the skeletal muscle satellite cells?",
    "llama-2-7b-chat-hf_response": "Skeletal muscle satellite cells are a type of stem cell that plays a crucial role in muscle repair and regeneration. They are small, mononucleated cells that are found in close proximity to muscle fibers, particularly in the basal lamina, a thin layer of extracellular matrix that surrounds muscle fibers. Satellite cells are quiescent under normal conditions but can be activated in response to muscle injury or exercise, at which point they proliferate and differentiate into myoblasts, which then fuse to form new muscle fibers.",
    "llama-2-7b-chat-hf_fact": [
      "Skeletal muscle satellite cells are a type of stem cell.",
      "Satellite cells play a crucial role in muscle repair and regeneration.",
      "Satellite cells are found in close proximity to muscle fibers, specifically in the basal lamina.",
      "Under normal conditions, satellite cells are quiescent.",
      "When activated in response to muscle injury or exercise, satellite cells proliferate and differentiate into myoblasts to form new muscle fibers."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1618,
    "user_query": "What is the role of neurogranin in Alzheimer's disease patients?",
    "llama-2-7b-chat-hf_response": "Neurogranin is a protein that has been shown to play a protective role in the brain, particularly in the context of Alzheimer's disease. Studies have shown that neurogranin levels are reduced in the brains of Alzheimer's disease patients, and that this reduction is associated with cognitive decline and neurodegeneration.\nOne study published in the journal Nature Communications found that neurogranin levels were significantly lower in the brains of Alzheimer's disease patients compared to healthy controls. The study also found that the reduction in neurogranin levels was associated with increased levels of beta-amyloid, a protein that accumulates in the brains of Alzheimer's disease patients and is thought to contribute to the progression of the disease.\nAnother study published in the journal Acta Neuropathologica Communications found that neurogranin levels were reduced in the brains of Alzheimer's disease patients, particularly in areas of the brain affected by the disease. The study also found that the reduction in neurogranin levels was associated with increased levels of tau protein, another protein that accumulates in the brains of Alzheimer's disease patients and is thought to contribute to the progression of the disease.\nOverall, these studies suggest that neurogranin plays a protective role in the brain, particularly in the context of Alzheimer's disease. The reduction in neurogranin levels in the brains of Alzheimer's disease patients may contribute to the progression of the disease, and may be a potential therapeutic target for the treatment of Alzheimer's disease.",
    "llama-2-7b-chat-hf_fact": [
      "Neurogranin is a protein that plays a protective role in the brain, particularly related to Alzheimer's disease.",
      "Studies have shown that neurogranin levels are reduced in the brains of Alzheimer's disease patients.",
      "The reduction of neurogranin is associated with cognitive decline and neurodegeneration in Alzheimer's patients.",
      "One study found that lower neurogranin levels were related to increased levels of beta-amyloid, a protein that accumulates in the brains of Alzheimer's disease patients.",
      "Another study found that lower neurogranin levels were associated with increased levels of tau protein, which also accumulates in the brains of Alzheimer's disease patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Neurogranin is a protein that plays a crucial role in learning and memory in the brain, not a protective role.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1619,
    "user_query": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?",
    "llama-2-7b-chat-hf_response": "Yes, triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas. T3 is a thyroid hormone that is produced by the thyroid gland and plays a crucial role in regulating metabolism, growth, and development. Insulin secretion from the pancreas is regulated by a complex interplay of hormonal and neural signals, and T3 is one of the hormones that plays a regulatory role in this process.\nStudies have shown that T3 can stimulate insulin secretion from pancreatic beta cells through several mechanisms, including:\n1. Activation of protein kinase A (PKA): T3 activates PKA, which phosphorylates and activates the insulin receptor, leading to increased insulin signaling and secretion.\n2. Increased glucose uptake: T3 increases glucose uptake in pancreatic beta cells, which enhances insulin secretion.\n3. Inhibition of glucagon secretion: T3 inhibits the secretion of glucagon, a hormone produced by the pancreas that raises blood glucose levels by stimulating the breakdown of glycogen and fat.\n4. Modulation of gene expression: T3 can modulate the expression of genes involved in insulin secretion and glucose metabolism, leading to changes in insulin secretion.\nOverall, T3 plays a positive regulatory role in insulin secretion from the pancreas, and abnormalities in T3 signaling have been implicated in the development of insulin resistance and type 2 diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "Triiodothyronine (T3) is a thyroid hormone produced by the thyroid gland.",
      "T3 plays a regulatory role in insulin secretion from the pancreas.",
      "T3 can stimulate insulin secretion from pancreatic beta cells through several mechanisms, such as the activation of protein kinase A (PKA).",
      "T3 can inhibit the secretion of glucagon, a hormone produced by the pancreas that raises blood glucose levels.",
      "Abnormalities in T3 signaling have been associated with the development of insulin resistance and type 2 diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-7b-chat-hf_response": "Hepcidin is a protein that plays a crucial role in regulating iron metabolism in the body. It does this by binding to iron exporters, such as ferroportin, and inducing their degradation. As a result, the amount of iron that is released from cells into the bloodstream is reduced. Hepcidin also has disulfide bridges, which are important for its stability and function.\nThe number of disulfide bridges in hepcidin has been the subject of some debate in the scientific literature. Some studies have reported that hepcidin has 4 disulfide bridges, while others have suggested that it may have as many as 6 or 7.\nTo determine the number of disulfide bridges in hepcidin, researchers have used a variety of techniques, including mass spectrometry, circular dichroism (CD) spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy. These techniques have allowed researchers to identify and quantify the disulfide bonds in hepcidin with high precision.\nOne study published in the journal Nature Communications in 2017 used CD spectroscopy to investigate the disulfide structure of hepcidin. The researchers found that hepcidin has 4 disulfide bonds, which are located in the following positions:\n* Cys16-Cys103\n* Cys23-Cys117\n* Cys37-Cys103\n* Cys41-Cys117\nAnother study published in the journal Biochemistry in 2018 used NMR spectroscopy to study the disulfide structure of hepcidin. The researchers found that hepcidin has 6 disulfide bonds, which are located in the following positions:\n* Cys16-Cys103\n* Cys23-Cys117\n* Cys37-Cys103\n* Cys41-Cys117\n* Cys53-Cys103\n* Cys67-Cys117\nIt is important to note that the number of disulfide bridges in hepcidin may vary depending on the specific isoform",
    "llama-2-7b-chat-hf_fact": [
      "Hepcidin is a protein that regulates iron metabolism in the body.",
      "Hepcidin binds to iron exporters and induces their degradation to control iron levels in the bloodstream.",
      "Disulfide bridges in hepcidin contribute to its stability and function.",
      "The number of disulfide bridges in hepcidin varies according to different studies, reporting values from 4 to as many as 6 or 7.",
      "The number of disulfide bridges can vary depending on the specific isoform of Hepcidin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Hepcidin contains 8 cysteines forming 4 disulfide bonds. No variations in the numbers of these bonds have been reported.",
      "false, [corrected fact]: The number of disulfide bridges in Hepcidin does not vary as it is a specific property of the defined sequence of the protein."
    ]
  },
  {
    "id": 1622,
    "user_query": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?",
    "llama-2-7b-chat-hf_response": "Chk2 (Checkpoint kinase 2) is a key regulator of the cell cycle checkpoint, which is a critical mechanism for maintaining genomic stability. Human Chk2 has several intramolecular phosphorylation sites that play important roles in cell cycle control. Here are some of the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control:\n1. Serine 345: This site is phosphorylated in response to DNA damage and activates Chk2's kinase activity, leading to the phosphorylation and inhibition of key cell cycle regulators, such as Cyclin-dependent kinases (CDKs) and the retinoblastoma protein (Rb).\n2. Serine 338: This site is also phosphorylated in response to DNA damage and regulates Chk2's ability to interact with and inhibit CDKs.\n3. Threonine 68: This site is phosphorylated by the kinase ATR (ATM- and Rad3-related protein) in response to DNA damage, leading to the activation of Chk2's kinase activity.\n4. Threonine 387: This site is phosphorylated by the kinase Chk1 (Checkpoint kinase 1) in response to DNA damage, leading to the activation of Chk2's kinase activity.\n5. Serine 457: This site is phosphorylated by the kinase ATR in response to DNA damage, leading to the activation of Chk2's kinase activity.\nIn summary, the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control are Serine 345, Serine 338, Threonine 68, Threonine 387, and Serine 457. These phosphorylation events play critical roles in regulating Chk2's kinase activity and its ability to control the cell cycle in response to DNA damage.",
    "llama-2-7b-chat-hf_fact": [
      "Chk2 (Checkpoint kinase 2) is a key regulator of the cell cycle checkpoint.",
      "Human Chk2 has several intramolecular phosphorylation sites that play important roles in cell cycle control.",
      "The major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control are Serine 345, Serine 338, Threonine 68, Threonine 387, and Serine 457.",
      "These phosphorylation events regulate Chk2's kinase activity and its ability to control the cell cycle in response to DNA damage.",
      "The Serine 345 site on human Chk2 is phosphorylated in response to DNA damage, activating Chk2's kinase activity and leading to the inhibition of key cell cycle regulators."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1628,
    "user_query": "Which receptors can be evaluated with the [18F]altanserin?",
    "llama-2-7b-chat-hf_response": "[18F]altanserin is a PET radioligand that can be used to evaluate certain receptors in the brain. These receptors include:\n1. Serotonin 5-HT1A receptors: [18F]altanserin selectively binds to these receptors and can be used to image their distribution in the brain.\n2. Serotonin 5-HT2A receptors: [18F]altanserin also binds to these receptors, but with lower affinity than the 5-HT1A receptors.\n3. Dopamine D2 receptors: [18F]altanserin has been shown to bind to these receptors with moderate affinity.\n4. NMDA receptors: [18F]altanserin has been shown to bind to these receptors with high affinity.\n5. AMPA receptors: [18F]altanserin has been shown to bind to these receptors with moderate affinity.\nIt is important to note that the specificity of [18F]altanserin for these receptors can vary depending on the experimental conditions and the individual subject. Therefore, it is important to interpret the results of [18F]altanserin PET imaging in the context of the specific research question and experimental design.",
    "llama-2-7b-chat-hf_fact": [
      "[18F]altanserin is a PET radioligand that can be used to evaluate certain receptors in the brain.",
      "[18F]altanserin selectively binds to Serotonin 5-HT1A receptors and can image their distribution in the brain.",
      "Serotonin 5-HT2A receptors also bind to [18F]altanserin but with lower affinity than the 5-HT1A receptors.",
      "[18F]altanserin has been shown to bind to Dopamine D2 receptors with moderate affinity.",
      "[18F]altanserin binds to NMDA receptors and AMPA receptors with high and moderate affinity respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: [18F]altanserin selectively binds to Serotonin 5-HT2A receptors and can image their distribution in the brain.",
      "false, [corrected fact]: Serotonin 5-HT1A receptors also bind to [18F]altanserin but with lower affinity than the 5-HT2A receptors.",
      "false, [corrected fact]: [18F]altanserin does not bind to Dopamine D2 receptors.",
      "false, [corrected fact]: [18F]altanserin does not bind to NMDA receptors or AMPA receptors."
    ]
  },
  {
    "id": 1630,
    "user_query": "Which extra thyroid tissues have thyrotropin (TSH) receptors?",
    "llama-2-7b-chat-hf_response": "A. Thyroid follicular cells\nB. Thyroid parafollicular cells\nC. Thyroid C cells\nD. Thyroid E cells\nAnswer: B. Thyroid parafollicular cells\nExplanation: Thyrotropin (TSH) receptors are present on the surface of thyroid parafollicular cells (also known as C cells), but not on thyroid follicular cells, thyroid C cells, or thyroid E cells. TSH receptors are responsible for mediating the effects of TSH on thyroid cell function, including the regulation of thyroid hormone synthesis and secretion.",
    "llama-2-7b-chat-hf_fact": [
      "Thyrotropin (TSH) receptors are present on the surface of thyroid parafollicular cells.",
      "Thyroid parafollicular cells are also known as C cells.",
      "Thyrotropin (TSH) receptors are not present on thyroid follicular cells, thyroid C cells, or thyroid E cells.",
      "TSH receptors are responsible for mediating the effects of TSH on thyroid cell function.",
      "The function of TSH receptors includes regulation of thyroid hormone synthesis and secretion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Thyrotropin (TSH) receptors are present on the surface of thyroid follicular cells, not parafollicular cells.",
      "true",
      "false, [corrected fact]: Thyrotropin (TSH) receptors are present on the surface of thyroid follicular cells, not on parafollicular (C cells) or E cells.",
      "true",
      "true"
    ]
  },
  {
    "id": 1631,
    "user_query": "Which histone modifications distinguish between promoters and enhancers?",
    "llama-2-7b-chat-hf_response": "Histone modifications are chemical changes to the histone proteins that DNA is wrapped around in the nucleus of a cell. These modifications can affect gene expression by altering the structure of chromatin, the complex of DNA and histone proteins. Different histone modifications have been associated with different functional elements in the genome, such as promoters and enhancers.\nPromoters are the regions of DNA where RNA polymerase, the enzyme responsible for transcribing DNA into RNA, binds to initiate transcription. Enhancers, on the other hand, are regions that can increase the rate at which RNA polymerase binds to the promoter, leading to increased gene expression.\nSeveral histone modifications have been identified that distinguish between promoters and enhancers. For example:\n* H3K4me3 (histone H3 lysine 4 trimethylation): This modification is typically found at promoter regions and is involved in the recruitment of RNA polymerase.\n* H3K27ac (histone H3 lysine 27 acetylation): This modification is found at both promoter and enhancer regions and is involved in the regulation of gene expression.\n* H3K27me3 (histone H3 lysine 27 trimethylation): This modification is typically found at enhancer regions and is involved in the silencing of gene expression.\n* H3K79me2 (histone H3 lysine 79 dimethylation): This modification is found at both promoter and enhancer regions and is involved in the regulation of gene expression.\n* H4K16ac (histone H4 lysine 16 acetylation): This modification is found at both promoter and enhancer regions and is involved in the regulation of gene expression.\nIt is important to note that the specific histone modifications associated with promoters and enhancers can vary depending on the cell type and the specific gene being regulated. Additionally, the levels of these modifications can also vary depending on the specific stage of cell development or the presence of certain transcription factors.\nIn summary, histone modifications play a crucial role in the regulation of gene expression by altering the structure of chromatin",
    "llama-2-7b-chat-hf_fact": [
      "Histone modifications are chemical changes to the histone proteins that can affect gene expression by altering the structure of chromatin.",
      "Promoters are regions of DNA where RNA polymerase binds to initiate transcription.",
      "Enhancers are regions that can increase the rate at which RNA polymerase binds to the promoter, leading to increased gene expression.",
      "H3K4me3 is a histone modification typically found at promoter regions and is involved in the recruitment of RNA polymerase.",
      "H3K27me3 is a histone modification typically found at enhancer regions and is involved in the silencing of gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: H3K27me3 is a histone modification typically found at gene bodies and is associated with gene repression, not necessarily at enhancer regions."
    ]
  },
  {
    "id": 1632,
    "user_query": "Where is the metaxin complex localized?",
    "llama-2-7b-chat-hf_response": "The metaxin complex is localized to the endoplasmic reticulum (ER) and the Golgi apparatus in the cell. Specifically, it is found in the rough ER, which is the ER that has ribosomes attached to its surface, and in the Golgi apparatus, which is a complex of flattened sacs and tubules that is responsible for processing and modifying proteins and lipids.",
    "llama-2-7b-chat-hf_fact": [
      "The metaxin complex is located in the endoplasmic reticulum (ER) in a cell.",
      "The metaxin complex can also be found in the Golgi apparatus within a cell.",
      "The rough ER, where the metaxin complex is found, has ribosomes attached to its surface.",
      "The Golgi apparatus, another location of the metaxin complex, is a complex of flattened sacs and tubules.",
      "The Golgi apparatus is responsible for processing and modifying proteins and lipids."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The metaxin complex is located in the mitochondria in a cell.",
      "false, [corrected fact]: The metaxin complex cannot be found in the Golgi apparatus within a cell, it is located in the mitochondria.",
      "true",
      "false, [corrected fact]: The Golgi apparatus is not a location of the metaxin complex, but it is indeed a complex of flattened sacs and tubules.",
      "true"
    ]
  },
  {
    "id": 1633,
    "user_query": "What are the major classes of retrotransposons active in the human genome?",
    "llama-2-7b-chat-hf_response": "Retrotransposons are mobile genetic elements that can amplify and insert copies of themselves into new locations within the genome. They are found in many organisms, including humans, and can have significant impacts on genome structure and function. There are several major classes of retrotransposons active in the human genome, including:\n1. Long terminal repeat (LTR) retrotransposons: These are the most common type of retrotransposon in the human genome. They are characterized by the presence of LTRs at each end of the element, and they can insert into new locations within the genome through a process called retrotransposition. Examples of LTR retrotransposons in the human genome include the human endogenous retrovirus (HERV) family and the Alu element.\n2. Non-LTR retrotransposons: These are retrotransposons that do not have LTRs at each end of the element. Instead, they have a reverse transcriptase gene that is used to synthesize a complementary DNA (cDNA) copy of the element, which is then integrated into the genome. Examples of non-LTR retrotransposons in the human genome include the Tc1/mariner element and the P element.\n3. DNA transposons: These are retrotransposons that do not have a reverse transcriptase gene, but instead use a DNA-based mechanism to transpose themselves into new locations within the genome. Examples of DNA transposons in the human genome include the Tc1/mariner element and the P element.\n4. Helitrons: These are a recently discovered class of retrotransposons that are characterized by the presence of a conserved helicase domain. They are found in many organisms, including humans, and are thought to be involved in the regulation of gene expression.\n5. LINEs (Long Interspersed Nuclear Elements): These are retrotransposons that are characterized by the presence of a conserved LINE consensus sequence. They are found in many organisms, including humans, and are thought to be involved in the regulation of gene expression.\n6. SINEs (Short Interspersed Nuclear Elements): These are retrotransposons that are characterized by the presence of a conserved SINE consensus",
    "llama-2-7b-chat-hf_fact": [
      "Retrotransposons can amplify and insert copies of themselves into new locations within a genome.",
      "There are several major classes of retrotransposons active in the human genome, including Long terminal repeat (LTR) retrotransposons, Non-LTR retrotransposons, DNA transposons, Helitrons, LINEs, and SINEs.",
      "Long terminal repeat (LTR) retrotransposons are the most common type of retrotransposon in the human genome and examples include the human endogenous retrovirus (HERV) family and the Alu element.",
      "DNA transposons use a DNA-based mechanism to transpose themselves into new locations within the genome with examples including the Tc1/mariner element and the P element.",
      "Helitrons are retrotransposons characterized by the presence of a conserved helicase domain and are thought to be involved in the regulation of gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Alu elements belong to the category of SINEs (Short Interspersed Nuclear Elements), not LTR (Long Terminal Repeat) retrotransposons. LINE (Long Interspersed Nuclear Elements) and SINEs are the most common types of retrotransposons in the human genome.",
      "true",
      "true"
    ]
  },
  {
    "id": 1634,
    "user_query": "Which are the clinical characteristics of Diamond-Blackfan anemia?",
    "llama-2-7b-chat-hf_response": "Diamond-Blackfan anemia (DBA) is a rare congenital anemia characterized by a bone marrow failure that leads to a low production of red blood cells, white blood cells, and platelets. Here are some of the clinical characteristics of DBA:\n1. Chronic anemia: DBA is characterized by a chronic anemia that can lead to fatigue, weakness, and shortness of breath.\n2. Leukopenia: DBA patients have a low white blood cell count, which can increase the risk of infections.\n3. Thrombocytopenia: DBA patients have a low platelet count, which can increase the risk of bleeding.\n4. Bone marrow failure: DBA is caused by a failure of the bone marrow to produce enough red blood cells, white blood cells, and platelets.\n5. Short stature: DBA patients often have short stature due to the anemia and bone marrow failure.\n6. Delayed growth and development: DBA patients may experience delayed growth and development, particularly if the anemia is severe.\n7. Increased risk of infections: DBA patients are at increased risk of infections due to their low white blood cell count.\n8. Increased risk of bleeding: DBA patients are at increased risk of bleeding due to their low platelet count.\n9. Cardiovascular problems: DBA patients may experience cardiovascular problems, such as heart failure and arrhythmias, due to the anemia and bone marrow failure.\n10. Neurological problems: DBA patients may experience neurological problems, such as seizures and developmental delays, due to the anemia and bone marrow failure.\nIt is important to note that the severity of DBA can vary widely between individuals, and some patients may have a more mild or severe form of the disease. A diagnosis of DBA is typically made through a combination of clinical evaluation, laboratory tests, and genetic analysis.",
    "llama-2-7b-chat-hf_fact": [
      "Diamond-Blackfan anemia (DBA) is a rare congenital anemia characterized by a bone marrow failure leading to a low production of red blood cells, white blood cells, and platelets.",
      "DBA is characterized by chronic anemia, which can result in fatigue, weakness, and shortness of breath.",
      "DBA patients often have leukopenia, a condition characterized by low white blood cell count, which can increase their risk of infections.",
      "Thrombocytopenia is a common characteristic of DBA, represented by a low platelet count, increasing the risk of bleeding.",
      "Short stature, delayed growth and development, increased risk of infections and bleeding, cardiovascular problems, and neurological problems are other potential outcomes of DBA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Diamond-Blackfan anemia (DBA) is a rare congenital anemia characterized by bone marrow's failure leading to a low production of red blood cells, not affecting white blood cells and platelets.",
      "true",
      "false, [corrected fact]: DBA patients do not typically have leukopenia, they have a normal white blood cell count.",
      "false, [corrected fact]: Thrombocytopenia is not a common characteristic of DBA as DBA typically involves a normal platelet count.",
      "true"
    ]
  },
  {
    "id": 1638,
    "user_query": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?",
    "llama-2-7b-chat-hf_response": "A) T cell receptor (TCR)\nB) B cell receptor (BCR)\nC) CD4 receptor\nD) CD8 receptor\nCorrect answer: A) T cell receptor (TCR)\nExplanation: Cyclosporin A (CsA) is an immunosuppressive drug that works by inhibiting the activation of T cells. It binds to the T cell receptor (TCR), which is a complex of proteins on the surface of T cells that recognizes and binds to antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs). The binding of CsA to the TCR prevents T cells from recognizing and responding to antigens, leading to immunosuppression.",
    "llama-2-7b-chat-hf_fact": [
      "Cyclosporin A (CsA) is an immunosuppressive drug.",
      "CsA works by inhibiting the activation of T cells.",
      "The T cell receptor (TCR) is a complex of proteins on the surface of T cells.",
      "TCR recognizes and binds to antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs).",
      "The binding of CsA to the TCR leads to immunosuppression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: It's not the binding of CsA to the TCR that leads to immunosuppression. Instead, CsA binds to the protein cyclophilin in T cells. The CsA-cyclophilin complex inhibits calcineurin, which is a protein needed for T-cell activation. Therefore, CsA indirectly leads to immunosuppression by preventing T-cell activation."
    ]
  },
  {
    "id": 1642,
    "user_query": "In which types of DNA repair is the UvrAB complex involved?",
    "llama-2-7b-chat-hf_response": "The UvrAB complex is involved in several types of DNA repair, including:\n1. Base excision repair (BER): The UvrAB complex plays a key role in recognizing and repairing oxidized purines, such as 8-oxoguanine (8-oxoG), and other damaged bases in DNA.\n2. Nucleotide excision repair (NER): The UvrAB complex is also involved in the recognition and repair of larger DNA lesions, such as those caused by ultraviolet light, through the NER pathway.\n3. Mismatch repair (MMR): The UvrAB complex has been shown to be involved in the recognition and repair of mismatched bases in DNA, which can occur as a result of errors during DNA replication or recombination.\n4. Double-strand break repair: The UvrAB complex has been implicated in the repair of double-strand breaks in DNA, although the exact role of the complex in this process is not fully understood.\nOverall, the UvrAB complex plays a crucial role in maintaining the integrity of the genetic material by participating in multiple DNA repair pathways.",
    "llama-2-7b-chat-hf_fact": [
      "The UvrAB complex is involved in base excision repair (BER) of DNA, which aids in recognizing and repairing oxidized purines, such as 8-oxoguanine (8-oxoG), and other damaged bases.",
      "The UvrAB complex participates in nucleotide excision repair (NER) of DNA, targeting larger DNA lesions, like those caused by ultraviolet light.",
      "The UvrAB complex takes part in mismatch repair (MMR) of DNA, focusing on the recognition and repair of mismatched bases.",
      "The UvrAB complex is implicated in the repair of double-strand breaks in DNA.",
      "The role of the UvrAB complex is crucial in maintaining the integrity of the genetic material by participating in multiple DNA repair pathways."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The UvrAB complex is involved in nucleotide excision repair (NER) of DNA, not base excision repair (BER).",
      "true",
      "false, [corrected fact]: The UvrAB complex does not participate in mismatch repair (MMR) of DNA. This process involves other repair machinery like MutS, MutL, and MutH.",
      "false, [corrected fact]: The UvrAB complex is not primarily involved in the repair of double-strand breaks in DNA. It is mainly involved in nucleotide excision repair (NER).",
      "false, [corrected fact]: The UvrAB complex is crucial in maintaining the integrity of the genetic material by participating in nucleotide excision repair (NER), not in multiple DNA repair pathways."
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-7b-chat-hf_response": "DNAJC11 encodes a protein that is predominantly localized to the mitochondria. The protein is involved in the regulation of mitochondrial dynamics and metabolism, and has been implicated in a variety of diseases, including cancer and neurodegenerative disorders.\nLocalization: Mitochondria",
    "llama-2-7b-chat-hf_fact": [
      "The gene DNAJC11 encodes a protein.",
      "This protein is predominantly localized to the mitochondria.",
      "The protein encoded by the DNAJC11 gene is involved in the regulation of mitochondrial dynamics and metabolism.",
      "The gene DNAJC11 has been implicated in a variety of diseases.",
      "Diseases associated with the gene DNAJC11 include cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1646,
    "user_query": "Which hormone abnormalities are characteristic to Pendred syndrome?",
    "llama-2-7b-chat-hf_response": "Pendred syndrome is a rare genetic disorder that affects the inner ear and the thyroid gland. It is caused by mutations in the SLC26A4 gene, which codes for the protein thyroid hormone transporter 1 (THT). The syndrome is characterized by the following hormone abnormalities:\n1. Congenital hypothyroidism: Pendred syndrome is associated with congenital hypothyroidism, which means that the thyroid gland does not produce enough thyroid hormones from birth. This can lead to intellectual disability, growth retardation, and other developmental delays.\n2. Hyperthyroidism: In some cases, Pendred syndrome can also cause hyperthyroidism, which is characterized by an overactive thyroid gland that produces excessive amounts of thyroid hormones. This can lead to symptoms such as rapid heartbeat, weight loss, and nervousness.\n3. Thyroid nodules: Pendred syndrome can also cause the formation of thyroid nodules, which are abnormal growths on the thyroid gland. These nodules can be benign or malignant, and may require surgical removal.\n4. Thyroid cancer: In rare cases, Pendred syndrome can increase the risk of developing thyroid cancer.\n5. Adrenal insufficiency: Some individuals with Pendred syndrome may also experience adrenal insufficiency, which is a condition in which the adrenal glands do not produce enough cortisol and aldosterone hormones. This can lead to symptoms such as fatigue, weight loss, and low blood pressure.\nIt is important to note that not all individuals with Pendred syndrome will experience all of these hormone abnormalities, and the severity of the condition can vary widely between individuals.",
    "llama-2-7b-chat-hf_fact": [
      "Pendred syndrome is a rare genetic disorder that affects the inner ear and the thyroid gland.",
      "Pendred syndrome is caused by mutations in the SLC26A4 gene.",
      "One characteristic hormone abnormality of Pendred syndrome is congenital hypothyroidism.",
      "Pendred syndrome can also cause hyperthyroidism in some cases.",
      "Another characteristic of Pendred syndrome is the formation of thyroid nodules.",
      "Pendred syndrome can increase the risk of developing thyroid cancer in rare cases.",
      "Some individuals with Pendred syndrome may also experience adrenal insufficiency."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Pendred syndrome does not cause hyperthyroidism. Instead, it can cause hypothyroidism.",
      "true",
      "unknown",
      "false, [corrected fact]: There is no evidence to suggest that Pendred syndrome can cause adrenal insufficiency."
    ]
  },
  {
    "id": 1647,
    "user_query": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?",
    "llama-2-7b-chat-hf_response": "Long QT syndrome (LQTS) is a heart rhythm disorder that is caused by abnormalities in the electrical system of the heart. It is usually inherited in an autosomal dominant pattern, which means that a single copy of the mutated gene is enough to cause the condition.\nJervell and Lange-Nielsen syndrome is a rare genetic disorder that affects the electrical conduction system of the heart and the inner ear. It is also inherited in an autosomal dominant pattern.\nBoth LQTS and Jervell and Lange-Nielsen syndrome are caused by mutations in genes that code for proteins involved in the electrical conduction system of the heart and the inner ear. These mutations can be inherited from one or both parents, and they can also occur spontaneously.\nThe inheritance pattern of LQTS and Jervell and Lange-Nielsen syndrome is important to understand because it can help healthcare providers identify individuals who are at risk of developing these conditions and provide appropriate testing and management.",
    "llama-2-7b-chat-hf_fact": [
      "Long QT syndrome is a heart rhythm disorder caused by abnormalities in the heart's electrical system.",
      "Long QT syndrome is typically inherited in an autosomal dominant pattern, meaning a single copy of a mutated gene can cause the condition.",
      "Jervell and Lange-Nielsen syndrome is a rare genetic disorder affecting the electrical conduction system of the heart and the inner ear, also typically inherited in an autosomal dominant pattern.",
      "Both Long QT syndrome and Jervell and Lange-Nielsen syndrome are caused by mutations in genes coding for proteins involved in the electrical conduction systems of the heart and the inner ear.",
      "The inheritance patterns of these disorders help healthcare providers identify individuals at risk of developing these conditions and provide appropriate testing and management."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Jervell and Lange-Nielsen syndrome is a rare genetic disorder affecting the electrical conduction system of the heart and the inner ear, but it's typically inherited in an autosomal recessive pattern.",
      "true",
      "true"
    ]
  },
  {
    "id": 1648,
    "user_query": "List programs suitable for protein docking",
    "llama-2-7b-chat-hf_response": "Protein docking is a computational method used to predict the three-dimensional structure of a protein-ligand complex. Here are some popular programs suitable for protein docking:\n1. AutoDock: AutoDock is a widely used program for protein docking. It uses a genetic algorithm to search for the optimal conformation of the protein-ligand complex.\n2. GOLD: GOLD (Genetic Algorithm for Ligand Docking) is another popular program for protein docking. It uses a genetic algorithm to search for the optimal conformation of the protein-ligand complex.\n3. HADDOCK: HADDOCK is a protein docking program that uses a combination of molecular dynamics simulations and energy functions to predict the structure of the protein-ligand complex.\n4. LIGAND: LIGAND is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\n5. MODELLER: MODELLER is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\n6. PatchDock: PatchDock is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\n7. RosettaDock: RosettaDock is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\n8. Surflex-dock: Surflex-dock is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\n9. VinaDock: VinaDock is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\n10. ZDOCK: ZDOCK is a protein docking program that uses a combination of energy functions and molecular dynamics simulations to predict the structure of the protein-ligand complex.\nThese programs are widely used in the field of protein docking and have been shown to be effective in predicting the structure of protein-ligand complexes. However,",
    "llama-2-7b-chat-hf_fact": [
      "Protein docking is a computational method used to predict the three-dimensional structure of a protein-ligand complex.",
      "AutoDock and GOLD are programs used for protein docking, and they both use a genetic algorithm to search for the optimal conformation of the protein-ligand complex.",
      "HADDOCK is a protein docking program that combines molecular dynamics simulations and energy functions to predict the structure of protein-ligand complexes.",
      "Some of the other commonly used protein docking programs are LIGAND, MODELLER, PatchDock, RosettaDock, Surflex-dock, VinaDock, and ZDOCK.",
      "All these protein docking programs use a combination of energy functions and molecular dynamics simulations to predict the structure of protein-ligand complexes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Some of the other commonly used protein docking programs are AutoDock, HADDOCK, PatchDock, RosettaDock, and ZDOCK. LIGAND, MODELLER, and Surflex-dock are not primarily protein docking programs.",
      "false, [corrected fact]: Not all protein docking programs use a combination of energy functions and molecular dynamics simulations to predict the structure of protein-ligand complexes. The feature can vary across different programs."
    ]
  },
  {
    "id": 1649,
    "user_query": "Which genes have been found mutated in Gray platelet syndrome patients?",
    "llama-2-7b-chat-hf_response": "Gray platelet syndrome is a rare genetic disorder that affects the production of platelets, which are blood cells that play a crucial role in blood clotting. The disorder is caused by mutations in the genes that code for proteins involved in platelet production and function.\nSeveral genes have been found to be mutated in Gray platelet syndrome patients, including:\n1. GATA1 gene: The GATA1 gene encodes a transcription factor that regulates the expression of genes involved in platelet production and function. Mutations in the GATA1 gene have been found to cause Gray platelet syndrome in some patients.\n2. GATA2 gene: The GATA2 gene also encodes a transcription factor that regulates the expression of genes involved in platelet production and function. Mutations in the GATA2 gene have been found to cause Gray platelet syndrome in some patients.\n3. JAK2 gene: The JAK2 gene encodes a protein that is involved in signaling pathways that regulate platelet production and function. Mutations in the JAK2 gene have been found to cause Gray platelet syndrome in some patients.\n4. MPL gene: The MPL gene encodes a protein that is involved in signaling pathways that regulate platelet production and function. Mutations in the MPL gene have been found to cause Gray platelet syndrome in some patients.\n5. CAV1 gene: The CAV1 gene encodes a protein that is involved in platelet production and function. Mutations in the CAV1 gene have been found to cause Gray platelet syndrome in some patients.\n6. CLEC1A gene: The CLEC1A gene encodes a protein that is involved in platelet production and function. Mutations in the CLEC1A gene have been found to cause Gray platelet syndrome in some patients.\n7. P2RY1 gene: The P2RY1 gene encodes a protein that is involved in platelet production and function. Mutations in the P2RY1 gene have been found to cause Gray platelet syndrome in some patients.\n8. P2RY10 gene: The P2RY10 gene encodes a protein that is involved in platelet production and function. Mutations in the P",
    "llama-2-7b-chat-hf_fact": [
      "Gray platelet syndrome is a genetic disorder that affects the production of platelets.",
      "The disorder is caused by mutations in the genes that code for proteins involved in platelet production and function.",
      "Mutations in the GATA1 gene have been found to cause Gray platelet syndrome in some patients.",
      "JAK2 gene mutations have been identified in some cases of Gray platelet syndrome.",
      "Mutations in the MPL gene have been found to cause Gray platelet syndrome in patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Mutations in the NBEAL2 gene, not the GATA1 gene, have been found to cause Gray platelet syndrome in some patients.",
      "false, [corrected fact]: JAK2 gene mutations have not been identified in Gray platelet syndrome. They are instead associated with some forms of blood cancer.",
      "false, [corrected fact]: Mutations in the MPL gene have not been found to cause Gray platelet syndrome. This gene is associated with other platelet disorders."
    ]
  },
  {
    "id": 1652,
    "user_query": "Is cardiac magnetic resonance imaging indicated in the pre-participation screening of athletes?",
    "llama-2-7b-chat-hf_response": "Yes, cardiac magnetic resonance imaging (MRI) is increasingly being used in the pre-participation screening of athletes to evaluate for cardiovascular abnormalities. MRI is a non-invasive imaging modality that can provide detailed information on the structure and function of the heart, including the detection of cardiac abnormalities such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and coronary artery disease.\nThe American College of Cardiology (ACC) and the American Heart Association (AHA) recommend that athletes undergo a comprehensive pre-participation evaluation, including a physical examination, medical history, and laboratory tests, to identify potential cardiovascular risks. MRI can be a valuable tool in this evaluation, particularly in athletes with a family history of cardiovascular disease or those who have experienced symptoms such as chest pain or shortness of breath during exercise.\nHowever, it is important to note that MRI is not a replacement for other screening tests, such as electrocardiography (ECG) and echocardiography, which can also provide valuable information on cardiac function and structure. The choice of screening tests will depend on the individual athlete and their specific medical history and risk factors.\nIn summary, cardiac MRI can be a useful tool in the pre-participation screening of athletes, particularly in those with a higher risk of cardiovascular disease. However, it should be used in conjunction with other screening tests and a comprehensive medical evaluation to ensure that athletes are cleared for safe participation in sports.",
    "llama-2-7b-chat-hf_fact": [
      "Cardiac magnetic resonance imaging (MRI) is used in the pre-participation screening of athletes to evaluate for cardiovascular abnormalities.",
      "Cardiac MRI can provide detailed information on the structure and function of the heart.",
      "The American College of Cardiology (ACC) and the American Heart Association (AHA) recommend a comprehensive pre-participation evaluation for athletes to identify potential cardiovascular risks.",
      "MRI can detect cardiac abnormalities such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and coronary artery disease.",
      "Traditional screening tests, such as electrocardiography (ECG) and echocardiography, are still required as MRI does not replace them."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1654,
    "user_query": "What is the function of the MTH1 enzyme in cancer cells?",
    "llama-2-7b-chat-hf_response": "MTH1 is an enzyme that plays a crucial role in regulating the metabolism of folate in cancer cells. It is involved in the conversion of 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyltetrahydrofolate (5-MTHF), which is a crucial step in the synthesis of thymidine, a nucleotide that is essential for DNA replication and repair.\nIn cancer cells, MTH1 is overexpressed, leading to an increase in the conversion of 5,10-MTHF to 5-MTHF. This results in an accumulation of 5-MTHF, which can then be used to synthesize thymidine, leading to an increase in DNA replication and proliferation. Overexpression of MTH1 has been observed in various types of cancer, including breast, lung, and colon cancer.\nIn addition to its role in DNA synthesis, MTH1 has also been shown to play a role in the regulation of angiogenesis, the formation of new blood vessels that supply tumors with oxygen and nutrients. MTH1 has been shown to promote the formation of new blood vessels in cancer cells by converting 5,10-MTHF to 5-MTHF, which can then be used to synthesize thymidine, leading to an increase in DNA replication and proliferation.\nOverall, the overexpression of MTH1 in cancer cells can lead to increased DNA replication and proliferation, as well as the formation of new blood vessels that supply tumors with oxygen and nutrients, contributing to the development and progression of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "MTH1 is an enzyme that regulates the metabolism of folate in cancer cells.",
      "MTH1 is involved in the conversion of 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyltetrahydrofolate (5-MTHF), which is a crucial step in the synthesis of thymidine.",
      "MTH1 is often overexpressed in cancer cells, leading to an increased conversion of 5,10-MTHF to 5-MTHF and consequently an increase in DNA replication and proliferation.",
      "Overexpression of MTH1 has been observed in various types of cancer, including breast, lung, and colon cancer.",
      "MTH1 also plays a role in the regulation of angiogenesis, the formation of new blood vessels that supply nutrients and oxygen to tumors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MTH1 is an enzyme that detoxifies oxidatively damaged nucleotides, preventing their incorporation into DNA and RNA. It does not regulate the metabolism of folate in cancer cells.",
      "false, [corrected fact]: MTHFR, not MTH1, is involved in the conversion of 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyltetrahydrofolate (5-MTHF), which is a crucial step in the synthesis of thymidine.",
      "false, [corrected fact]: It's not MTH1 but MTHFR that when overexpressed can lead to an increased conversion of 5,10-MTHF to 5-MTHF and consequently an increase in DNA replication and proliferation. MTH1 is involved in the prevention of oxidative damage to DNA.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements (UCEs) are depleted among copy number variants (CNVs). UCEs are regions of the genome that are highly conserved across species and are typically found in non-coding regions. CNVs, on the other hand, are variations in the number of copies of a particular region of the genome.\nStudies have shown that UCEs are overrepresented in non-CNV regions of the genome, but are underrepresented among CNVs. This suggests that UCEs may be less likely to be disrupted by CNVs, which could contribute to their role in maintaining genome stability.\nOne study published in the journal Nature found that UCEs were depleted among CNVs in both humans and mice. The study analyzed the genomes of over 10,000 individuals and found that UCEs were significantly underrepresented among CNVs compared to non-CNV regions.\nAnother study published in the journal American Journal of Human Genetics found that UCEs were depleted among CNVs in individuals with intellectual disability. The study analyzed the genomes of over 1,000 individuals with intellectual disability and found that UCEs were significantly underrepresented among CNVs compared to non-CNV regions.\nThese findings suggest that UCEs may play a role in maintaining genome stability and that their depletion among CNVs may contribute to the development of certain genetic disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Ultraconserved elements (UCEs) are regions of the genome that are highly conserved across species and are typically found in non-coding regions.",
      "Copy number variants (CNVs) are variations in the number of copies of a particular region of the genome.",
      "UCEs are overrepresented in non-CNV regions of the genome, but are underrepresented among CNVs.",
      "A study published in the journal Nature found that UCEs were depleted among CNVs in both humans and mice.",
      "Another study published in the American Journal of Human Genetics found that UCEs were depleted among CNVs in individuals with intellectual disability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1660,
    "user_query": "Which population has a high frequency of the HLA-B*1502 allele?",
    "llama-2-7b-chat-hf_response": "The HLA-B*1502 allele is a genetic variant of the HLA-B gene that is associated with an increased risk of adverse reactions to the antimalarial drug mefloquine. The frequency of the HLA-B*1502 allele varies among different populations, with some populations having a higher frequency than others.\nAccording to the World Health Organization (WHO), the following populations have a high frequency of the HLA-B*1502 allele:\n1. Asian populations: The HLA-B*1502 allele is found in approximately 10-20% of the population in some Asian countries, including China, Japan, Korea, and Taiwan.\n2. African populations: The HLA-B*1502 allele is found in approximately 10-20% of the population in some African countries, including Nigeria, Ghana, and South Africa.\n3. Pacific Island populations: The HLA-B*1502 allele is found in approximately 10-20% of the population in some Pacific Island countries, including Fiji, Samoa, and Tonga.\n4. Indigenous Australian and New Zealand populations: The HLA-B*1502 allele is found in approximately 10-20% of the population in some Indigenous Australian and New Zealand populations.\nIt is important to note that the frequency of the HLA-B*1502 allele can vary within a given population, and not all individuals within a given population will have this allele. Additionally, the presence of the HLA-B*1502 allele does not necessarily mean that an individual will experience adverse reactions to mefloquine, as other factors such as drug dosage and individual metabolism can also play a role.",
    "llama-2-7b-chat-hf_fact": [
      "The HLA-B*1502 allele is associated with an increased risk of adverse reactions to the antimalarial drug mefloquine.",
      "Approximately 10-20% of the population in some Asian countries, including China, Japan, Korea, and Taiwan, have the HLA-B*1502 allele.",
      "The HLA-B*1502 allele is found in approximately 10-20% of the population in certain African countries such as Nigeria, Ghana, and South Africa.",
      "This allele is found in roughly 10-20% of the population in some Pacific Island countries, which include Fiji, Samoa, and Tonga.",
      "Approximately 10-20% of certain Indigenous Australian and New Zealand populations have the HLA-B*1502 allele."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "false, [corrected fact]: The HLA-B*1502 allele is not found in approximately 10-20% of the population in certain African countries such as Nigeria, Ghana, and South Africa. It is prevalent among certain Asian populations.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1663,
    "user_query": "What is the role of the Tsix gene during X chromosome inactivation?",
    "llama-2-7b-chat-hf_response": "Tsix (also known as Tsix1) is a gene located on the X chromosome that plays a crucial role in X chromosome inactivation (XCI). XCI is a process by which one of the two X chromosomes in female mammals is inactivated to avoid a doubling of gene expression due to the presence of two X chromosomes.\nThe Tsix gene was identified in the early 1990s as a key regulator of XCI. The Tsix protein is a transcriptional repressor that binds to specific DNA sequences called X-inactive specific transcriptional regulatory elements (Xi-SREs) located upstream of X-linked genes. By binding to these elements, Tsix prevents the expression of X-linked genes on the inactive X chromosome.\nStudies have shown that Tsix is essential for the proper initiation of XCI. Mice lacking the Tsix gene have a complete loss of XCI, leading to a twofold increase in the expression of X-linked genes compared to wild-type mice. Conversely, overexpression of Tsix leads to a more efficient inactivation of the X chromosome, resulting in a decrease in X-linked gene expression.\nIn addition to its role in XCI, Tsix has been implicated in the regulation of other cellular processes, including cell fate determination and differentiation.\nIn summary, the Tsix gene plays a crucial role in X chromosome inactivation by repressing the expression of X-linked genes on the inactive X chromosome. Its dysregulation can lead to developmental defects and diseases, highlighting the importance of this gene in female mammalian development.",
    "llama-2-7b-chat-hf_fact": [
      "Tsix is a gene located on the X chromosome and it plays a crucial role in X chromosome inactivation (XCI).",
      "The Tsix gene was identified in the early 1990s as a key regulator of XCI.",
      "The Tsix protein binds to specific DNA sequences, known as X-inactive specific transcriptional regulatory elements (Xi-SREs), located upstream of X-linked genes, to prevent their expression on the inactive X chromosome.",
      "Mice lacking the Tsix gene have a complete loss of XCI which can lead to a twofold increase in the expression of X-linked genes.",
      "Overexpression of Tsix can lead to a more efficient inactivation of the X chromosome, resulting in a decrease in X-linked gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The Tsix gene is transcribed but does not produce a protein. It functions through its RNA product which interferes with the expression of other genes nearby, not by binding to DNA sequences.",
      "true",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-7b-chat-hf_response": "A) Microtubules\nB) Interphase chromatin\nC) Nuclear lamins\nD) Actin filaments\nAnswer: A) Microtubules.\nHaspin is a protein kinase that plays a crucial role in the regulation of mitosis. It is primarily localized to the spindle fibers during mitosis and is involved in the regulation of microtubule dynamics. Haspin phosphorylation is required for the proper formation of the spindle fibers and the separation of chromosomes during mitosis. Therefore, the substrate of haspin kinase during mitosis is microtubules.",
    "llama-2-7b-chat-hf_fact": [
      "Haspin is a protein kinase that plays a role in regulating mitosis.",
      "Haspin localizes to the spindle fibers during mitosis.",
      "Haspin is involved in the regulation of microtubule dynamics.",
      "Haspin phosphorylation is needed for the correct formation of spindle fibers.",
      "The separation of chromosomes during mitosis requires haspin phosphorylation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1668,
    "user_query": "What is the advantage of neutral loss detection in phosphoproteomics?",
    "llama-2-7b-chat-hf_response": "Neutral loss detection is a technique used in phosphoproteomics to detect phosphorylation sites on proteins. It is based on the observation that phosphorylated residues have a higher molecular weight than non-phosphorylated residues, resulting in a neutral loss in the mass spectrum. The advantage of neutral loss detection is that it allows for the detection of phosphorylation sites on proteins without the need for prior knowledge of the phosphorylation sites or the use of isotopic labeling. This makes it a powerful tool for identifying novel phosphorylation sites and for studying the phosphoproteome in a wide range of biological samples.",
    "llama-2-7b-chat-hf_fact": [
      "Neutral loss detection is a technique used in phosphoproteomics to detect phosphorylation sites on proteins.",
      "Phosphorylated residues have a higher molecular weight than non-phosphorylated residues, resulting in a neutral loss in the mass spectrum.",
      "Neutral loss detection does not require previous knowledge of phosphorylation sites.",
      "The technique does not require the use of isotopic labeling.",
      "Neutral loss detection can be used to identify novel phosphorylation sites and study the phosphoproteome in a wide range of biological samples."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Phosphorylated residues have a higher molecular weight than non-phosphorylated residues, but it doesn't result in a neutral loss. Instead, loss of a phosphate group during fragmentation in the mass spectrometer results in a neutral loss signature.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1672,
    "user_query": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?",
    "llama-2-7b-chat-hf_response": "Cyclin-dependent kinase inhibitors (CDKIs) are a class of proteins that inhibit the activity of cyclin-dependent kinases (CDKs), which are key regulators of the cell cycle. Bmi-1 is a transcription factor that has been shown to regulate the expression of several CDKIs, including:\n1. p21: Bmi-1 has been shown to bind to the p21 promoter and enhance its transcriptional activity, leading to increased levels of p21 protein and inhibition of CDK activity.\n2. p27: Bmi-1 has been shown to bind to the p27 promoter and enhance its transcriptional activity, leading to increased levels of p27 protein and inhibition of CDK activity.\n3. p57: Bmi-1 has been shown to bind to the p57 promoter and enhance its transcriptional activity, leading to increased levels of p57 protein and inhibition of CDK activity.\n4. KIPS: Bmi-1 has been shown to bind to the KIPS promoter and enhance its transcriptional activity, leading to increased levels of KIPS protein and inhibition of CDK activity.\n5. CDKN1A: Bmi-1 has been shown to bind to the CDKN1A promoter and enhance its transcriptional activity, leading to increased levels of CDKN1A protein and inhibition of CDK activity.\n6. CDKN2A: Bmi-1 has been shown to bind to the CDKN2A promoter and enhance its transcriptional activity, leading to increased levels of CDKN2A protein and inhibition of CDK activity.\n7. CDKN3: Bmi-1 has been shown to bind to the CDKN3 promoter and enhance its transcriptional activity, leading to increased levels of CDKN3 protein and inhibition of CDK activity.\n8. CDKN7A: Bmi-1 has been shown to bind to the CDKN7A promoter and enhance its transcriptional activity, leading to increased levels of CDKN7A protein and inhibition of CDK activity.\n9. CDKN9: Bmi-1 has been",
    "llama-2-7b-chat-hf_fact": [
      "Cyclin-dependent kinase inhibitors are proteins that inhibit the activity of cyclin-dependent kinases, which are key regulators of the cell cycle.",
      "Bmi-1 is a transcription factor that regulates the expression of several cyclin-dependent kinase inhibitors.",
      "Bmi-1 has been shown to bind to the p21 promoter, enhancing its transcriptional activity and leading to increased levels of p21 protein.",
      "Bmi-1 has been shown to regulate the protein levels of p27, p57,  KIPS, CDKN1A, CDKN2A, CDKN3, CDKN7A through its interaction with their promoters.",
      "Increased protein levels of these cyclin-dependent kinase inhibitors result in the inhibition of cyclin-dependent kinase activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1675,
    "user_query": "List inhibtors targeting the mitochondrial permeability transition pore.",
    "llama-2-7b-chat-hf_response": "The mitochondrial permeability transition pore (MPTP) is a critical regulator of mitochondrial function and cellular homeostasis. MPTP is a protein complex that spans the inner mitochondrial membrane and regulates the passage of molecules between the mitochondrial matrix and cytosol. MPTP plays a key role in various cellular processes, including apoptosis, autophagy, and metabolism. Dysregulation of MPTP has been implicated in various diseases, including neurodegenerative disorders, metabolic disorders, and cancer. Here are some of the inhibitors targeting MPTP:\n1. Cyclosporine A: Cyclosporine A is a naturally occurring compound that has been shown to inhibit MPTP activity. It has been used to treat various diseases, including organ transplant rejection and autoimmune disorders.\n2. Diltiazem: Diltiazem is a calcium channel blocker that has been shown to inhibit MPTP activity. It has been used to treat various cardiovascular disorders, including hypertension and angina.\n3. Verapamil: Verapamil is a calcium channel blocker that has been shown to inhibit MPTP activity. It has been used to treat various cardiovascular disorders, including hypertension and angina.\n4. Apoaequorin: Apoaequorin is a protein that has been shown to inhibit MPTP activity. It has been used to treat various neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.\n5. MitoQ: MitoQ is a small molecule that has been shown to inhibit MPTP activity. It has been used to treat various neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.\n6. Antimycin A: Antimycin A is a compound that has been shown to inhibit MPTP activity. It has been used to treat various cancer types, including breast cancer and lung cancer.\n7. Embelin: Embelin is a compound that has been shown to inhibit MPTP activity. It has been used to treat various cancer types, including breast cancer and",
    "llama-2-7b-chat-hf_fact": [
      "The mitochondrial permeability transition pore (MPTP) is a critical regulator of mitochondrial function and cellular homeostasis.",
      "Dysregulation of MPTP has been implicated in various diseases, including neurodegenerative disorders, metabolic disorders, and cancer.",
      "Cyclosporine A is a naturally occurring compound that inhibits MPTP activity and is used in treating diseases like organ transplant rejection and autoimmune disorders.",
      "Diltiazem and Verapamil are calcium channel blockers that inhibit MPTP activity and has been used to treat cardiovascular disorders like hypertension and angina.",
      "Antimycin A and Embelin are compounds that inhibit MPTP activity and are used in cancer treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Diltiazem and Verapamil are calcium channel blockers, but they do not inhibit MPTP activity, they are used to treat cardiovascular disorders like hypertension and angina.",
      "unknown"
    ]
  },
  {
    "id": 1678,
    "user_query": "Which is the process that Conserved noncoding elements mostly regulate?",
    "llama-2-7b-chat-hf_response": "Conserved noncoding elements are sequences of DNA that are found in the genomes of many different organisms and are thought to play important roles in regulating gene expression. These elements are often located far away from the genes they regulate and are thought to act by binding to proteins that then recruit RNA polymerase, the enzyme that carries out transcription, to the promoter region of the gene.\nWhich of the following processes do conserved noncoding elements mostly regulate?\nA) Gene expression\nB) Genome replication\nC) Chromosome segregation\nD) Protein synthesis",
    "llama-2-7b-chat-hf_fact": [
      "Conserved noncoding elements are sequences of DNA found in the genomes of many different organisms.",
      "These noncoding elements play important roles in regulating gene expression.",
      "These elements often act by binding to proteins.",
      "These proteins then recruit RNA polymerase to the promoter region of the gene.",
      "RNA polymerase is the enzyme that carries out transcription."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1689,
    "user_query": "Is Achondroplasia associated with hearing loss?",
    "llama-2-7b-chat-hf_response": "Achondroplasia is a genetic disorder that affects the development of cartilage and bone, leading to short stature and characteristic physical features such as a large head, small arms and legs, and normal-sized torso. While the primary symptoms of achondroplasia are related to bone growth and development, some individuals with the condition may also experience hearing loss.\nAccording to a study published in the Journal of Medical Genetics, approximately 25% of individuals with achondroplasia have some degree of hearing loss. The study found that the most common type of hearing loss in individuals with achondroplasia is conductive hearing loss, which occurs when there is a problem with the middle ear that affects the ability of sound to reach the inner ear.\nOther types of hearing loss that have been reported in individuals with achondroplasia include sensorineural hearing loss, which is caused by damage to the inner ear or auditory nerve, and mixed hearing loss, which is a combination of conductive and sensorineural hearing loss.\nThe exact cause of hearing loss in individuals with achondroplasia is not fully understood, but it is thought to be related to the genetic mutations that cause the condition. Some studies have suggested that the mutations that cause achondroplasia may also affect the development of the inner ear and auditory nerve, leading to hearing loss.\nIf you have achondroplasia and are experiencing hearing loss, it is important to discuss your symptoms with your healthcare provider. They can refer you to an audiologist or other hearing specialist for evaluation and treatment. Treatment options for hearing loss in individuals with achondroplasia may include hearing aids, cochlear implants, or other assistive devices.\nIn summary, while achondroplasia is primarily associated with bone growth and development disorders, some individuals with the condition may also experience hearing loss. If you have achondroplasia and are experiencing hearing loss, it is important to seek medical attention to determine the cause and appropriate treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Achondroplasia is a genetic disorder that affects the development of cartilage and bone.",
      "Some individuals with achondroplasia may experience hearing loss.",
      "According to a study published in the Journal of Medical Genetics, approximately 25% of individuals with achondroplasia have some degree of hearing loss.",
      "The most common type of hearing loss in individuals with achondroplasia is conductive hearing loss.",
      "Treatment options for hearing loss in individuals with achondroplasia may include hearing aids, cochlear implants, or other assistive devices."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1691,
    "user_query": "Is STAT3 transcription factor regulated by mTORC1?",
    "llama-2-7b-chat-hf_response": "Yes, STAT3 (Signal Transducer and Activator of Transcription 3) is regulated by mTORC1 (mammalian Target of Rapamycin Complex 1). mTORC1 is a key regulator of cell growth and metabolism, and it can phosphorylate and activate STAT3 in response to various growth factors and nutrient signals.\nmTORC1 can activate STAT3 through two main pathways:\n1. Phosphorylation of STAT3 on Tyr727: mTORC1 can phosphorylate STAT3 on Tyr727, leading to its activation and nuclear translocation. This phosphorylation event is mediated by the mTORC1 complex, which consists of mTOR, raptor, and PRAS40.\n2. Phosphorylation of STAT3 on Ser723: mTORC1 can also phosphorylate STAT3 on Ser723, which can lead to its activation and nuclear translocation. This phosphorylation event is mediated by the mTORC1 complex, which consists of mTOR, raptor, and PRAS40.\nOnce activated, STAT3 can translocate to the nucleus, where it can bind to specific DNA sequences and regulate the expression of target genes involved in various cellular processes, including inflammation, immune response, and cell survival.\nIn summary, mTORC1 regulates STAT3 activity by phosphorylating and activating it, leading to its nuclear translocation and the regulation of target gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "STAT3 (Signal Transducer and Activator of Transcription 3) is regulated by mTORC1 (mammalian Target of Rapamycin Complex 1).",
      "mTORC1 is a key regulator of cell growth and metabolism.",
      "mTORC1 can phosphorylate and activate STAT3 in response to various growth factors and nutrient signals.",
      "Once activated, STAT3 can translocate to the nucleus, where it binds to specific DNA sequences and regulates the expression of target genes.",
      "The target genes of STAT3 are involved in various cellular processes, including inflammation, immune response, and cell survival."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1693,
    "user_query": "List components of the CRSP/Med complex.",
    "llama-2-7b-chat-hf_response": "The CRSP/Med complex is a large protein complex that plays a crucial role in the regulation of gene expression, particularly in the context of cellular stress responses. The complex is composed of several subunits, including:\n1. CRSP1 (Chromatin Remodeling Complex Subunit 1): This subunit is the catalytic subunit of the complex and is responsible for the remodeling of chromatin structure.\n2. CRSP2 (Chromatin Remodeling Complex Subunit 2): This subunit is also involved in the remodeling of chromatin structure and is required for the activity of the complex.\n3. Med1 (Methyl-CpG-binding Protein 1): This subunit binds to methylated DNA and plays a role in the recruitment of other subunits to the complex.\n4. Med2 (Methyl-CpG-binding Protein 2): This subunit is similar to Med1 and also binds to methylated DNA.\n5. HMGB1 (High Mobility Group Protein 1): This subunit is involved in the recruitment of other subunits to the complex and plays a role in the regulation of chromatin structure.\n6. HMGB2 (High Mobility Group Protein 2): This subunit is similar to HMGB1 and also plays a role in the recruitment of other subunits to the complex.\n7. KAT2A (Lysine Acetyltransferase 2A): This subunit is involved in the acetylation of histone H3 and H4, which is important for the activity of the complex.\n8. KAT2B (Lysine Acetyltransferase 2B): This subunit is similar to KAT2A and also involved in the acetylation of histone H3 and H4.\n9. RBBP4 (RING Finger Protein 4): This subunit is involved in the recruitment of other subunits to the complex and plays a role in the regulation of chromatin structure.\n10. RBBP7 (RING Finger Protein 7): This subunit is similar to RBBP4 and also involved in the recruitment of other subunits",
    "llama-2-7b-chat-hf_fact": [
      "The CRSP/Med complex is a large protein complex that plays a crucial role in the regulation of gene expression.",
      "The CRSP/Med complex includes a subunit called CRSP1, which is responsible for the remodeling of chromatin structure.",
      "Another subunit in the CRSP/Med complex is KAT2A (Lysine Acetyltransferase 2A), which involves in the acetylation of histone H3 and H4.",
      "Med2 is a subunit in the CRSP/Med complex that binds to methylated DNA.",
      "HMGB1 and RBBP4 are parts of the CRSP/Med complex and are involved in the recruitment of other subunits to the complex and regulation of chromatin structure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-7b-chat-hf_response": "Viroids are small, single-stranded RNA molecules that replicate through a unique mechanism that does not involve the synthesis of complementary RNA. Instead, viroids use a process called \"rolling circle replication\" to produce multiple copies of themselves.\nDuring rolling circle replication, the viroid RNA molecule acts as a template for the synthesis of new RNA molecules. The RNA polymerase enzyme reads the template in a 5' to 3' direction, but instead of synthesizing a complementary RNA strand, it continues to read the template in a circular manner, producing a new RNA molecule that is complementary to the original template. This process is repeated many times, resulting in the production of multiple copies of the viroid RNA molecule.\nThe mechanism of viroid replication is not well understood, but it is thought to involve the interaction of the viroid RNA molecule with the RNA polymerase enzyme and other cellular factors. The exact mechanisms of viroid replication are still the subject of ongoing research and debate.\nIt is worth noting that viroids are not considered to be living organisms, as they do not have the ability to carry out metabolic processes or to reproduce on their own. Instead, they rely on the host plant's metabolic machinery to replicate and transmit their genetic material.",
    "llama-2-7b-chat-hf_fact": [
      "Viroids are small, single-stranded RNA molecules.",
      "Viroids replicate through a unique mechanism called \"rolling circle replication\".",
      "During rolling circle replication, the viroid RNA molecule acts as a template for the synthesis of new RNA molecules.",
      "The RNA polymerase enzyme reads the template in order to generate new viroid molecules.",
      "Viroids are not considered to be living organisms as they depend on the host plant's metabolic machinery to replicate and transmit their genetic material."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1698,
    "user_query": "Mutation of which gene is associated with McLeod syndrome?",
    "llama-2-7b-chat-hf_response": "McLeod syndrome is a rare genetic disorder that affects the development of the face, hands, and feet. It is caused by mutations in the TWIST1 gene, which is located on chromosome 14. The TWIST1 gene plays a crucial role in regulating the expression of genes involved in the development of the face, hands, and feet. Mutations in this gene can lead to the characteristic facial and limb abnormalities seen in McLeod syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "McLeod syndrome is a rare genetic disorder.",
      "This syndrome affects the development of the face, hands, and feet.",
      "The TWIST1 gene, located on chromosome 14, is associated with McLeod syndrome.",
      "The TWIST1 gene regulates the expression of genes involved in the development of the face, hands, and feet.",
      "Mutations in the TWIST1 gene can cause facial and limb abnormalities characteristic of McLeod syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: McLeod syndrome primarily affects the blood, brain, peripheral nerves, heart, and muscles.",
      "false, [corrected fact]: The XK gene, located on chromosome X, is associated with McLeod syndrome.",
      "false, [corrected fact]: The TWIST1 gene regulates the expression of genes involved in craniofacial development, not McLeod syndrome.",
      "false, [corrected fact]: Mutations in the XK gene cause McLeod syndrome. Mutations in the TWIST1 gene can cause Saethre-Chotzen syndrome, which may include facial and limb abnormalities."
    ]
  },
  {
    "id": 1699,
    "user_query": "Is RIP1 (RIP-1) part of the necrosome?",
    "llama-2-7b-chat-hf_response": "Yes, RIP1 (RIP-1) is part of the necrosome. The necrosome is a protein complex that plays a central role in regulating programmed cell death (apoptosis) and necrosis. RIP1 (RIP-1) is a key component of the necrosome and plays a critical role in the regulation of necrosis.\nRIP1 (RIP-1) is an E3 ubiquitin ligase that is involved in the regulation of multiple cellular processes, including apoptosis, autophagy, and inflammation. RIP1 (RIP-1) is recruited to the necrosome in response to cellular stress, where it promotes the activation of downstream signaling pathways that ultimately lead to necrosis.\nThe necrosome is a large protein complex that is composed of multiple subunits, including RIP1 (RIP-1), RIP3 (RIP-3), and MLKL (mixed lineage kinase domain-like protein). These subunits work together to regulate the activation of downstream signaling pathways that promote necrosis.\nIn summary, RIP1 (RIP-1) is a key component of the necrosome and plays a critical role in the regulation of necrosis. The necrosome is a complex protein structure that is involved in the regulation of multiple cellular processes, including programmed cell death (apoptosis) and necrosis.",
    "llama-2-7b-chat-hf_fact": [
      "RIP1 (RIP-1) is part of the necrosome.",
      "The necrosome regulates programmed cell death (apoptosis) and necrosis.",
      "RIP1 (RIP-1) is an E3 ubiquitin ligase that is involved in the regulation of apoptosis, autophagy, and inflammation.",
      "The necrosome includes other subunits such as RIP3 (RIP-3), and mixed lineage kinase domain-like protein (MLKL).",
      "RIP1 is recruited to the necrosome in response to cellular stress, promoting activation of downstream signaling pathways leading to necrosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1700,
    "user_query": "Which is the molecular target of the immunosuppressant drug Rapamycin?",
    "llama-2-7b-chat-hf_response": "Rapamycin is an immunosuppressant drug that is used to prevent rejection in organ transplant patients. It works by inhibiting the mTOR (mechanistic target of rapamycin) pathway, which is a key regulator of cell growth and metabolism. The mTOR pathway is involved in the activation of T-cells and the production of cytokines, which are signaling molecules that help to coordinate the immune response. By inhibiting the mTOR pathway, rapamycin can reduce the activity of T-cells and prevent them from attacking the transplanted organ.\nRapamycin binds to a protein called FKBP12, which is a component of the mTOR complex. This complex is found in the cytoplasm of cells and plays a key role in regulating cell growth and metabolism. When rapamycin binds to FKBP12, it inhibits the activity of the mTOR complex and prevents it from activating downstream signaling pathways that are involved in cell growth and metabolism.\nRapamycin has been shown to be effective in preventing rejection in organ transplant patients, and it is also being studied as a potential treatment for other conditions, such as cancer and autoimmune diseases. However, it can have side effects, such as nausea, diarrhea, and fatigue, and long-term use can lead to the development of resistance.",
    "llama-2-7b-chat-hf_fact": [
      "Rapamycin is an immunosuppressant drug that is used to prevent rejection in organ transplant patients.",
      "Rapamycin works by inhibiting the mTOR (mechanistic target of rapamycin) pathway.",
      "The mTOR pathway is a key regulator of cell growth and metabolism, involved in the activation of T-cells and the production of cytokines.",
      "Rapamycin binds to a protein called FKBP12, a component of the mTOR complex.",
      "Long-term use of Rapamycin can lead to the development of resistance."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1702,
    "user_query": "PBT2 has been tested for which disorder?",
    "llama-2-7b-chat-hf_response": "PBT2 (Pramipexole) has been tested for the treatment of which of the following movement disorders?\nA. Parkinson's disease\nB. Dystonia\nC. Huntington's disease\nD. Tourette's syndrome\nCorrect answer: A. Parkinson's disease.",
    "llama-2-7b-chat-hf_fact": [
      "PBT2 has been tested for the treatment of Parkinson's disease.",
      "Pramipexole is another name for PBT2.",
      "Parkinson's disease is a type of movement disorder.",
      "Dystonia, Huntington's disease, and Tourette's syndrome are also types of movement disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: PBT2 has been tested for the treatment of Alzheimer's and Huntington's disease, not Parkinson's disease.",
      "false, [corrected fact]: Pramipexole is not another name for PBT2, it is a different drug used in the treatment of Parkinson's disease.",
      "true",
      "true"
    ]
  },
  {
    "id": 1704,
    "user_query": "How does long-range epigenetic silencing (LRES) occur?",
    "llama-2-7b-chat-hf_response": "Long-range epigenetic silencing (LRES) is a mechanism by which distant regulatory elements can silence gene expression through epigenetic modifications. LRES can occur through several mechanisms, including:\n1. Non-coding RNA-mediated silencing: Non-coding RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), can bind to distant regulatory elements and prevent the recruitment of transcription factors, leading to silencing of gene expression.\n2. Chromatin remodeling complexes: Chromatin remodeling complexes, such as SWI/SNF and CHD, can alter the chromatin structure and create barriers to transcription factor binding, leading to silencing of gene expression.\n3. Histone modifications: Histone modifications, such as histone 3 lysine 27 trimethylation (H3K27me3) and histone 4 lysine 20 trimethylation (H4K20me3), can mark regulatory elements for silencing by recruiting histone-modifying enzymes.\n4. DNA methylation: DNA methylation can silence gene expression by blocking the binding of transcription factors to regulatory elements.\n5. RNA polymerase II pausing: RNA polymerase II (RNAPII) can pause at regulatory elements, leading to silencing of gene expression.\n6. Transcriptional elongation pausing: Transcriptional elongation pausing occurs when RNAPII pauses during transcription elongation, leading to silencing of gene expression.\n7. Chromatin domain formation: Chromatin domain formation can create barriers to transcription factor binding, leading to silencing of gene expression.\n8. Non-coding RNA-DNA hybrids: Non-coding RNA-DNA hybrids can bind to regulatory elements and prevent the recruitment of transcription factors, leading to silencing of gene expression.\n9. RNA-binding proteins: RNA-binding proteins can bind to regulatory elements and prevent the recruitment of transcription factors, leading to silencing of gene expression.\n10. Epigenetic reprogramming:",
    "llama-2-7b-chat-hf_fact": [
      "Long-range epigenetic silencing (LRES) is a mechanism that silences gene expression through epigenetic modifications.",
      "Non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), can silence gene expression by binding to distant regulatory elements.",
      "Chromatin remodeling complexes like SWI/SNF and CHD can lead to gene expression silencing by altering the chromatin structure.",
      "Histone modifications such as histone 3 lysine 27 trimethylation (H3K27me3) and histone 4 lysine 20 trimethylation (H4K20me3) can help silence gene expression.",
      "DNA methylation can block the binding of transcription factors to regulatory elements, thereby silencing gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1706,
    "user_query": "Can RNAPolII function as an RNA-dependent RNA-polymerase?",
    "llama-2-7b-chat-hf_response": "No, RNAPolII does not function as an RNA-dependent RNA-polymerase. RNAPolII is a DNA-dependent RNA polymerase that catalyzes the transcription of DNA into RNA. It does not have the ability to transcribe RNA from RNA templates.",
    "llama-2-7b-chat-hf_fact": [
      "RNAPolII cannot function as an RNA-dependent RNA-polymerase.",
      "RNAPolII is a DNA-dependent RNA polymerase.",
      "RNAPolII catalyzes the transcription of DNA into RNA.",
      "RNAPolII does not have the ability to transcribe RNA from RNA templates."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1708,
    "user_query": "List sclerostin interaction partners.",
    "llama-2-7b-chat-hf_response": "Sclerostin is a protein that plays a crucial role in the regulation of bone metabolism. It is a secreted protein that inhibits the activity of the Wnt/-catenin signaling pathway, which is important for bone development and homeostasis. Here are some of the known interaction partners of sclerostin:\n1. Wnt/-catenin signaling pathway: Sclerostin inhibits the activity of the Wnt/-catenin signaling pathway, which is important for bone development and homeostasis.\n2. Frizzled receptors: Sclerostin binds to Frizzled receptors, which are members of the Wnt receptor family.\n3. LRP5/6: Sclerostin also binds to the low-density lipoprotein receptor-related protein 5 and 6 (LRP5/6), which are co-receptors for the Wnt/-catenin signaling pathway.\n4. Dishevelled: Sclerostin inhibits the activity of Dishevelled, a key component of the Wnt/-catenin signaling pathway.\n5. Axin: Sclerostin also inhibits the activity of Axin, a negative regulator of the Wnt/-catenin signaling pathway.\n6. GSK3: Sclerostin inhibits the activity of glycogen synthase kinase 3 beta (GSK3), which is a key regulator of the Wnt/-catenin signaling pathway.\n7. CK1: Sclerostin also inhibits the activity of casein kinase 1 (CK1), which is a key regulator of the Wnt/-catenin signaling pathway.\n8. Cyclin-dependent kinases (CDKs): Sclerostin inhibits the activity of cyclin-dependent kinases (CDKs), which are key regulators of the Wnt/-catenin signaling pathway.\n9. Mitogen-activated protein kinases (MAPKs): Sclerostin also inhibits the activity of mitogen-activated protein kinases (MAPKs",
    "llama-2-7b-chat-hf_fact": [
      "Sclerostin is a protein that is involved in regulating bone metabolism.",
      "Sclerostin inhibits the activity of the Wnt/-catenin signaling pathway.",
      "Sclerostin binds to Frizzled receptors, which are members of the Wnt receptor family.",
      "Sclerostin binds to the low-density lipoprotein receptor-related protein 5 and 6 (LRP5/6).",
      "Sclerostin inhibits the activity of Dishevelled, Axin, GSK3, CK1, cyclin-dependent kinases (CDKs), and mitogen-activated protein kinases (MAPKs)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1711,
    "user_query": "Which are currently available software tools for detecting rare codon clusters in coding sequences?",
    "llama-2-7b-chat-hf_response": "Answer: There are several software tools available for detecting rare codon clusters in coding sequences. Here are some of the commonly used tools:\n1. ClustalW: ClustalW is a widely used multiple sequence alignment tool that can also be used for detecting rare codon clusters. It uses a sliding window approach to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n2. RareCodonFinder: RareCodonFinder is a tool specifically designed for detecting rare codon clusters in coding sequences. It uses a hidden Markov model to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n3. CodonRarity: CodeRarity is another tool specifically designed for detecting rare codon clusters. It uses a Bayesian approach to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n4. GLIMMER: GLIMMER is a tool that can be used for detecting rare codon clusters in coding sequences. It uses a hidden Markov model to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n5. RNAfold: RNAfold is a tool that can be used for detecting rare codon clusters in non-coding RNA sequences. It uses a hidden Markov model to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n6. HMMER: HMMER is a tool that can be used for detecting rare codon clusters in coding sequences. It uses a hidden Markov model to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n7. MUSCLE: MUSCLE is a multiple sequence alignment tool that can also be used for detecting rare codon clusters. It uses a sliding window approach to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n8. PHYRE2: PHYRE2 is a tool that can be used for detecting rare codon clusters in coding sequences. It uses a hidden Markov model to identify clusters of codons that occur at a frequency lower than a user-defined threshold.\n9. Prodigal: Prodigal is a tool that can be used for detecting rare",
    "llama-2-7b-chat-hf_fact": [
      "ClustalW is a software tool used for detecting rare codon clusters in coding sequences, using a sliding window approach.",
      "RareCodonFinder is specifically designed for detecting rare codon clusters in coding sequences, and it uses a hidden Markov model.",
      "CodonRarity also specifically targets detecting rare codon clusters, utilizing a Bayesian approach.",
      "GLIMMER is another software tool to detect rare codon clusters in coding sequences, using a hidden Markov model.",
      "RNAfold is used for detecting rare codon clusters in non-coding RNA sequences with a hidden Markov model approach."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: ClustalW is a software tool used for multiple sequence alignment, not for detecting rare codon clusters.",
      "unknown",
      "unknown",
      "false, [corrected fact]: GLIMMER is a software tool used for predicting gene locations in bacterial, archaeal, and viral genomes, not for detecting rare codon clusters.",
      "false, [corrected fact]: RNAfold is a software tool used for predicting the secondary structure of single stranded RNA or DNA sequences, not for detecting rare codon clusters."
    ]
  },
  {
    "id": 1714,
    "user_query": "Where does CTCF colocalize with cohesin?",
    "llama-2-7b-chat-hf_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in regulating gene expression and chromatin organization. Cohesin is a complex of proteins that is involved in the maintenance of chromatin stability and the regulation of gene expression. CTCF and cohesin have been shown to colocalize in various chromatin regions, including gene promoters, enhancers, and insulators.\nOne study published in the journal Nature found that CTCF and cohesin colocalize in the promoter regions of actively transcribed genes in mouse cells. The study used chromatin immunoprecipitation sequencing (ChIP-seq) to identify the genomic regions bound by CTCF and cohesin in mouse embryonic stem cells. The results showed that CTCF and cohesin frequently colocalize in the promoter regions of genes involved in various biological processes, including cell proliferation, differentiation, and metabolism.\nAnother study published in the journal Cell found that CTCF and cohesin also colocalize in the regulatory regions of genes involved in neural development. The study used ChIP-seq to identify the genomic regions bound by CTCF and cohesin in neural progenitor cells. The results showed that CTCF and cohesin frequently colocalize in the regulatory regions of genes involved in neural differentiation and maturation.\nOverall, these studies suggest that CTCF and cohesin colocalize in various chromatin regions, including gene promoters and regulatory regions, and play a role in regulating gene expression and chromatin organization.",
    "llama-2-7b-chat-hf_fact": [
      "CTCF (CCCTC-binding factor) is a transcription factor that plays a role in regulating gene expression and chromatin organization.",
      "Cohesin is a complex of proteins that is involved in the maintenance of chromatin stability and the regulation of gene expression.",
      "CTCF and cohesin have been shown to colocalize in various chromatin regions, including gene promoters, enhancers, and insulators.",
      "A study in the journal Nature found that CTCF and cohesin colocalize in the promoter regions of actively transcribed genes in mouse cells.",
      "Another study published in the journal Cell found that CTCF and cohesin also colocalize in the regulatory regions of genes involved in neural development."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1715,
    "user_query": "Name triad of Wernicke encephalopathy.",
    "llama-2-7b-chat-hf_response": "Wernicke encephalopathy is a neurological disorder caused by thiamine (vitamin B1) deficiency. It is characterized by a distinctive triad of symptoms, which include:\n1. Ophthalmoplegia: weakness or paralysis of the muscles that control eye movements.\n2. Ataxia: difficulty with coordination and balance.\n3. Dysarthria: slurred speech.\nOther symptoms of Wernicke encephalopathy may include confusion, disorientation, memory loss, and difficulty with swallowing. The triad of symptoms is often referred to as the \"Wernicke triad\" or \"Wernicke's triad.\"",
    "llama-2-7b-chat-hf_fact": [
      "Wernicke encephalopathy is a neurological disorder caused by thiamine (vitamin B1) deficiency.",
      "Symptoms of Wernicke encephalopathy include ophthalmoplegia, ataxia, and dysarthria.",
      "Ophthalmoplegia is a condition that is characterized by weakness or paralysis of the muscles controlling the eye movements.",
      "Ataxia is defined as difficulty with coordination and balance.",
      "Dysarthria is characterized by slurred speech."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1718,
    "user_query": "How many and which are the different isoforms for the ryanodine receptor?",
    "llama-2-7b-chat-hf_response": "The ryanodine receptor (RyR) is a Ca2+ release channel found in the endoplasmic reticulum (ER) of mammalian cells. There are several isoforms of RyR, each with distinct functions and properties. Here are some of the different isoforms of RyR:\n1. RyR1: This is the most well-studied isoform of RyR and is primarily expressed in the ER of cardiac and skeletal muscle cells. RyR1 is responsible for the majority of Ca2+ release from the ER during excitation-contraction coupling in muscle fibers.\n2. RyR2: This isoform is primarily expressed in the ER of neurons and pancreatic beta cells. RyR2 is involved in the regulation of neurotransmitter release and insulin secretion.\n3. RyR3: This isoform is expressed in the ER of adrenal chromaffin cells and is involved in the regulation of catecholamine secretion.\n4. RyR4: This isoform is expressed in the ER of placental trophoblasts and is involved in the regulation of nutrient transport and hormone secretion.\n5. RyR5: This isoform is expressed in the ER of retinal pigment epithelial cells and is involved in the regulation of retinal function.\n6. RyR6: This isoform is expressed in the ER of kidney proximal tubular cells and is involved in the regulation of renal function.\n7. RyR7: This isoform is expressed in the ER of adipocytes and is involved in the regulation of glucose metabolism.\n8. RyR8: This isoform is expressed in the ER of hepatocytes and is involved in the regulation of liver function.\n9. RyR9: This isoform is expressed in the ER of bone marrow-derived mesenchymal stem cells and is involved in the regulation of cell proliferation and differentiation.\n10. RyR10: This isoform is expressed in the ER of T cells and is involved in the regulation of T cell activation and proliferation.\nEach RyR isoform has",
    "llama-2-7b-chat-hf_fact": [
      "The ryanodine receptor (RyR) is a Ca2+ release channel found in the endoplasmic reticulum (ER) of mammalian cells.",
      "There are several isoforms of RyR, each with distinct functions and properties.",
      "RyR1 is expressed in the ER of cardiac and skeletal muscle cells and is responsible for the majority of Ca2+ release from the ER during excitation-contraction coupling in muscle fibers.",
      "RyR2 is expressed in the ER of neurons and pancreatic beta cells and is involved in the regulation of neurotransmitter release and insulin secretion.",
      "RyR3 is expressed in the ER of adrenal chromaffin cells and is involved in the regulation of catecholamine secretion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The ryanodine receptor (RyR) is a Ca2+ release channel found in the sarcoplasmic reticulum (which is equivalent to endoplasmic reticulum in muscle cells) of mammalian cells.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: RyR3 is not specifically expressed in adrenal chromaffin cells and its role in catecholamine secretion is unclear. It is widely expressed in various types of cells including brain, heart and muscles."
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Fibronectin is a protein that plays a crucial role in cell adhesion, migration, and differentiation. It is also an important component of the extracellular matrix (ECM), which provides structural and biochemical support to surrounding cells. In recent years, there has been growing interest in using fibronectin as a serum biomarker for various diseases, including Duchenne muscular dystrophy (DMD).\nDMD is a severe genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by mutations in the dystrophin gene, which codes for the dystrophin protein that plays a crucial role in maintaining muscle structure and function. Currently, there is no cure for DMD, and diagnosis is based on a combination of clinical evaluation, genetic testing, and muscle biopsy.\nFibronectin has been shown to be elevated in the serum of DMD patients, particularly in the early stages of the disease. This elevation is thought to be due to the increased expression of fibronectin in muscle cells in response to dystrophin deficiency. As a result, fibronectin has been proposed as a potential serum biomarker for DMD.\nSeveral studies have investigated the use of fibronectin as a biomarker for DMD. For example, one study found that fibronectin levels were significantly higher in the serum of DMD patients compared to healthy controls. Another study found that fibronectin levels increased with disease severity in DMD patients. These findings suggest that fibronectin may be a useful biomarker for DMD, particularly in the early stages of the disease.\nHowever, there are also some limitations to using fibronectin as a biomarker for DMD. For example, fibronectin levels can also be elevated in other muscle disorders, such as limb-girdle muscular dystrophy, which can make it difficult to distinguish DMD from these other conditions. Additionally, fibronectin levels can fluctuate over time, which can make it challenging to interpret the results of biomarker tests.\nDespite these limitations, the use of fibronectin as a serum biomarker",
    "llama-2-7b-chat-hf_fact": [
      "Fibronectin is a protein that plays a crucial role in cell adhesion, migration, and differentiation.",
      "Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness.",
      "DMD is caused by mutations in the dystrophin gene.",
      "Fibronectin has been shown to be elevated in the serum of DMD patients, particularly in the early stages of the disease.",
      "Fibronectin levels can also be elevated in other muscle disorders, such as limb-girdle muscular dystrophy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1732,
    "user_query": "What is the association between number of pregnancies and rheumatoid arthritis",
    "llama-2-7b-chat-hf_response": "?\nRheumatoid arthritis (RA) is a chronic autoimmune disorder that affects joints and can cause joint pain, stiffness, and swelling. While the exact cause of RA is not fully understood, there is some evidence to suggest that the number of pregnancies a woman has may be associated with the risk of developing RA.\nStudies have shown that women who have had more than three pregnancies have a higher risk of developing RA compared to women who have had fewer than three pregnancies. This association has been observed in both observational studies and prospective cohort studies.\nOne study published in the journal Arthritis & Rheumatology found that women who had more than three pregnancies had a 30% higher risk of developing RA compared to women who had fewer than three pregnancies. Another study published in the journal Rheumatology found that the risk of developing RA increased with the number of pregnancies, with women who had more than five pregnancies having a 60% higher risk of developing RA compared to women who had fewer than three pregnancies.\nIt is not clear why the number of pregnancies may be associated with the risk of developing RA, but several theories have been proposed. One theory is that the immune system may be exposed to new antigens during pregnancy, which could trigger an autoimmune response and increase the risk of developing RA. Another theory is that the hormonal changes that occur during pregnancy may play a role in the development of RA.\nIt is important to note that the association between the number of pregnancies and the risk of developing RA is not absolute, and many women who have had multiple pregnancies will not develop RA. Additionally, some women who have not had any pregnancies may still develop RA.\nWhile the association between the number of pregnancies and the risk of developing RA is intriguing, more research is needed to fully understand the relationship between these two factors. If you have any concerns about your risk of developing RA or any other autoimmune disorder, it is important to speak with your healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects joints and can cause joint pain, stiffness, and swelling.",
      "Studies suggest that women who have had more than three pregnancies have a higher risk of developing RA compared to women who have had fewer than three pregnancies.",
      "One study published in Arthritis & Rheumatology showed that women with more than three pregnancies had a 30% higher risk of developing RA.",
      "Another study published in the journal Rheumatology demonstrated that the risk of developing RA increased with the number of pregnancies, with women having more than five pregnancies having a 60% higher risk.",
      "It's not clear why the number of pregnancies may be associated with the risk of developing RA, but theories include changes to the immune system or hormonal changes during pregnancy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1737,
    "user_query": "Can we use prodrug amifostine to protect healthy cell during chemotherapy?",
    "llama-2-7b-chat-hf_response": "Amifostine is a drug that has been used to protect healthy cells during chemotherapy. It works by inhibiting the production of reactive oxygen species (ROS), which are highly reactive molecules that can damage healthy cells. By reducing the amount of ROS produced during chemotherapy, amifostine can help to protect healthy cells from damage.\nThere are several ways in which amifostine can be used to protect healthy cells during chemotherapy:\n1. Amifostine can be given before chemotherapy to reduce the amount of ROS produced during treatment. This can help to protect healthy cells from damage and reduce the risk of side effects.\n2. Amifostine can be given during chemotherapy to continue reducing the amount of ROS produced. This can help to further protect healthy cells from damage and reduce the risk of side effects.\n3. Amifostine can be given after chemotherapy to help repair any damage that may have occurred to healthy cells during treatment. This can help to reduce the risk of long-term side effects and improve the overall effectiveness of chemotherapy.\nIt is important to note that amifostine is not a substitute for chemotherapy, and it should only be used in conjunction with chemotherapy as part of a comprehensive treatment plan. Additionally, amifostine may not be effective in all cases, and it is important to discuss the potential benefits and risks of using this drug with a healthcare provider.\nIn summary, amifostine can be used to protect healthy cells during chemotherapy by reducing the amount of ROS produced during treatment. This can help to reduce the risk of side effects and improve the overall effectiveness of chemotherapy. However, amifostine is not a substitute for chemotherapy, and it should only be used in conjunction with chemotherapy as part of a comprehensive treatment plan.",
    "llama-2-7b-chat-hf_fact": [
      "Amifostine is a drug used to protect healthy cells during chemotherapy.",
      "Amifostine works by inhibiting the production of reactive oxygen species (ROS).",
      "Reactive oxygen species (ROS) are highly reactive molecules that can damage healthy cells.",
      "Amifostine can be used before, during, and after chemotherapy to reduce the ROS, protect healthy cells, and reduce potential side effects.",
      "Despite its protective effect, amifostine is not a substitute for chemotherapy and should be considered as part of a comprehensive treatment plan."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1738,
    "user_query": "Which is the main difference between Alu and B1 repeats?",
    "llama-2-7b-chat-hf_response": "Alu and B1 repeats are both types of retrotransposons, which are mobile genetic elements that can insert themselves into new locations within a genome. However, there are some key differences between Alu and B1 repeats:\n1. Structure: Alu repeats are typically shorter than B1 repeats, with an average length of around 30-40 nucleotides, compared to around 100-200 nucleotides for B1 repeats.\n2. Location: Alu repeats are more commonly found in the coding regions of genes, while B1 repeats are more commonly found in non-coding regions, such as introns and intergenic spaces.\n3. Insertion pattern: Alu repeats tend to insert in a head-to-tail manner, while B1 repeats tend to insert in a tail-to-head manner.\n4. Recombination: Alu repeats are more likely to undergo recombination than B1 repeats, which can lead to the creation of new Alu repeats.\n5. Evolutionary conservation: B1 repeats are more evolutionarily conserved than Alu repeats, meaning that they are less likely to be deleted or mutated over time.\nIn summary, while both Alu and B1 repeats are types of retrotransposons, they differ in terms of their structure, location, insertion pattern, recombination, and evolutionary conservation.",
    "llama-2-7b-chat-hf_fact": [
      "Alu and B1 repeats are types of retrotransposons - mobile genetic elements that can insert themselves into new locations within a genome.",
      "Alu repeats are typically shorter, with an average length of around 30-40 nucleotides, while B1 repeats are about 100-200 nucleotides long.",
      "Alu repeats are most commonly found in the coding regions of genes, whereas B1 repeats are predominant in non-coding regions like introns and intergenic spaces.",
      "Alu repeats typically insert in a head-to-tail manner while B1 repeats usually insert in a tail-to-head manner.",
      "B1 repeats are more evolutionarily conserved than Alu repeats, meaning they are less likely to be deleted or mutated over time."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Alu repeats are typically longer, with an average length of around 300 nucleotides, while B1 repeats are about 100-200 nucleotides long.",
      "false, [corrected fact]: Alu repeats are most commonly found in the non-coding regions of genes, whereas B1 repeats can be found in both coding and non-coding regions.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1740,
    "user_query": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?",
    "llama-2-7b-chat-hf_response": "The frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis can vary depending on several factors, including the organism, the dose and duration of exposure to ENU, and the specific genetic background of the organism.\nIn general, ENU is a relatively potent mutagen, and it has been shown to induce mutations at a frequency of around 1-5 x 10^-5 per nucleotide per treatment in bacteria and yeast. However, the frequency of mutations can be higher in some organisms, such as mammalian cells, where it has been reported to be as high as 1-2 x 10^-3 per nucleotide per treatment.\nIt is important to note that the frequency of mutations induced by ENU can also depend on the specific genetic background of the organism. For example, some studies have shown that organisms with a high mutation rate, such as E. coli, are more susceptible to the mutagenic effects of ENU than organisms with a lower mutation rate, such as S. cerevisiae.\nOverall, the frequency of mutations induced spontaneously through ENU mutagenesis can vary widely depending on the specific conditions of the experiment, and it is important to carefully consider these factors when interpreting the results of ENU mutagenesis experiments.",
    "llama-2-7b-chat-hf_fact": [
      "Ethylnitrosourea (ENU) is a potent mutagen.",
      "The frequency of mutations induced by ENU can depend on the dose and duration of exposure, and the specific genetic background of the organism.",
      "ENU has been shown to induce mutations at a frequency of around 1-5 x 10^-5 per nucleotide per treatment in bacteria and yeast.",
      "The mutation frequency in mammalian cells by ENU can be as high as 1-2 x 10^-3 per nucleotide per treatment.",
      "E.coli is more susceptible to the mutagenic effects of ENU than S. cerevisiae."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1758,
    "user_query": "Has Glucose-6-phosphate dehydrogenase (G6PD) deficiency an X-linked inheritance?",
    "llama-2-7b-chat-hf_response": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder, meaning that the gene for G6PD is located on the X chromosome and is inherited in a sex-linked manner. Females have two X chromosomes, one inherited from each parent, while males have one X chromosome inherited from their mother and one Y chromosome inherited from their father.\nIn X-linked recessive disorders, the mutated gene is located on the X chromosome, and females are less likely to be affected because they have a second, normal copy of the gene on their other X chromosome. Males, on the other hand, are more likely to be affected because they only have one X chromosome, and they inherit the mutated gene from their mother.\nG6PD deficiency is caused by mutations in the G6PD gene, which codes for the enzyme glucose-6-phosphate dehydrogenase. This enzyme plays a crucial role in the breakdown of red blood cells, and mutations in the G6PD gene can lead to hemolytic anemia, a condition in which red blood cells are destroyed faster than they can be replaced. G6PD deficiency is the most common genetic disorder in humans, affecting approximately 400 million people worldwide.",
    "llama-2-7b-chat-hf_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder.",
      "The gene for G6PD is located on the X chromosome.",
      "In X-linked recessive disorders, the mutated gene is located on the X chromosome and females are less likely to be affected because they have a second, normal copy of the gene on their other X chromosome.",
      "G6PD deficiency is caused by mutations in the G6PD gene, which codes for the enzyme glucose-6-phosphate dehydrogenase.",
      "G6PD deficiency is the most common genetic disorder in humans, affecting approximately 400 million people worldwide."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1760,
    "user_query": "Which mutated genes are associated with the Tourette's syndrome?",
    "llama-2-7b-chat-hf_response": "Tourette's syndrome is a neurodevelopmental disorder characterized by motor and vocal tics, which are often accompanied by co-occurring conditions such as attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), and anxiety disorders. The exact genetic causes of Tourette's syndrome are not yet fully understood, but several genetic mutations have been identified as risk factors for the disorder. Here are some of the mutated genes associated with Tourette's syndrome:\n1. Tourette gene (TTN): This gene encodes for a protein called torsin, which is involved in the regulation of protein synthesis and degradation. Mutations in the TTN gene have been found to be associated with Tourette's syndrome.\n2. Dystonia gene (DYT1): This gene encodes for a protein called dystonin, which is involved in the regulation of muscle contraction and movement. Mutations in the DYT1 gene have been found to be associated with Tourette's syndrome and other movement disorders, such as dystonia.\n3. Cytoskeleton gene (CK): This gene encodes for a protein called cytoskeleton, which is involved in the regulation of cellular structure and movement. Mutations in the CK gene have been found to be associated with Tourette's syndrome and other neurodevelopmental disorders.\n4. Neurofilament gene (NF): This gene encodes for a protein called neurofilament, which is involved in the regulation of neuronal structure and function. Mutations in the NF gene have been found to be associated with Tourette's syndrome and other neurodevelopmental disorders.\n5. Synapsin gene (SYN1): This gene encodes for a protein called synapsin, which is involved in the regulation of synaptic transmission and plasticity. Mutations in the SYN1 gene have been found to be associated with Tourette's syndrome and other neurodevelopmental disorders.\nIt's important to note that the genetic causes of Tourette's syndrome are complex and multifactorial, and the",
    "llama-2-7b-chat-hf_fact": [
      "Tourette's syndrome is a neurodevelopmental disorder characterized by motor and vocal tics.",
      "Mutations in the Tourette gene (TTN) have been found to be associated with Tourette's syndrome.",
      "Mutations in the Dystonia gene (DYT1) have been found to be linked with Tourette's syndrome and other movement disorders.",
      "The Cytoskeleton gene (CK) mutations have been identified as risk factors for Tourette's syndrome and other neurodevelopmental disorders.",
      "Mutations in the Synapsin gene (SYN1) have been associated with Tourette's syndrome and other neurodevelopmental disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Currently, there is no single gene identified as a direct cause of Tourette's syndrome. It's often described as a complex disorder, influenced by a combination of genetic and environmental factors.",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-7b-chat-hf_response": "DeepBlue is an epigenomic data server that contains data from several major epigenome projects, including:\n1. The ENCODE (ENCyclopedia Of DNA Elements) project: This project aims to create a comprehensive catalog of all the functional elements in the human genome, including promoters, enhancers, and other regulatory elements.\n2. The Roadmap Epigenomics Project: This project aims to create a detailed map of epigenetic marks across the human genome, including histone modifications, DNA methylation, and chromatin structure.\n3. The Human Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the human genome, including both histone modifications and DNA methylation.\n4. The Mouse Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the mouse genome, including both histone modifications and DNA methylation.\n5. The Arabidopsis Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the Arabidopsis thaliana genome, including both histone modifications and DNA methylation.\n6. The Yeast Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the Saccharomyces cerevisiae genome, including both histone modifications and DNA methylation.\n7. The Drosophila Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the Drosophila melanogaster genome, including both histone modifications and DNA methylation.\n8. The Zebrafish Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the Danio rerio genome, including both histone modifications and DNA methylation.\n9. The Chicken Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the Gallus gallus domesticus genome, including both histone modifications and DNA methylation.\n10. The Cow Epigenome Project: This project aims to create a comprehensive map of epigenetic marks across the Bos taurus genome, including both histone modifications and DNA meth",
    "llama-2-7b-chat-hf_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE project, which aims to catalog all functional elements in the human genome.",
      "Data from the Roadmap Epigenomics Project, aiming to map epigenetic marks on the human genome, is included in DeepBlue.",
      "The Human Epigenome Project, which seeks to map epigenetic marks across the human genome, has its data contained in DeepBlue.",
      "DeepBlue houses data from the Mouse Epigenome Project, focused on mapping epigenetic marks across the mouse genome.",
      "The Arabidopsis Epigenome Project's data, which aims to map epigenetic marks across the Arabidopsis thaliana genome, is included in the DeepBlue server."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1765,
    "user_query": "Is the toxin produced by Clostridium botulinum always deadly?",
    "llama-2-7b-chat-hf_response": "Clostridium botulinum is a bacterium that produces a potent neurotoxin, botulinum toxin. This toxin is one of the most poisonous substances known, and it can cause botulism, a potentially fatal illness. However, not all strains of Clostridium botulinum produce the same amount of toxin, and some strains may produce less toxic or even non-toxic forms of the toxin.",
    "llama-2-7b-chat-hf_fact": [
      "Clostridium botulinum is a bacterium that produces a neurotoxin known as botulinum toxin.",
      "Botulinum toxin is one of the most poisonous substances known.",
      "Botulinum toxin can cause botulism, a potentially fatal illness.",
      "Not all strains of Clostridium botulinum produce the same amount of toxin.",
      "Some strains of Clostridium botulinum may produce less toxic or even non-toxic forms of the toxin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1771,
    "user_query": "Describe mechanism of action of Eteplirsen?",
    "llama-2-7b-chat-hf_response": "Eteplirsen is a phosphorodieosterase (PDGF) inhibitor, which is used to treat Duchenne muscular dystrophy (DMD). The mechanism of action of Eteplirsen involves the inhibition of PDGF, an enzyme that breaks down the protein dystrophin, which is essential for muscle function and structure. By inhibiting PDGF, Eteplirsen increases the levels of dystrophin in muscle cells, leading to improved muscle function and reduced muscle damage.\nEteplirsen works by binding to the active site of PDGF, preventing it from breaking down dystrophin. This results in increased levels of dystrophin in muscle cells, which can help to improve muscle function and reduce muscle damage. Eteplirsen has been shown to increase dystrophin levels in muscle cells and improve muscle function in patients with DMD.\nIn addition to its direct effect on PDGF, Eteplirsen may also have indirect effects on muscle function by reducing inflammation and oxidative stress, which are common features of DMD. By inhibiting PDGF, Eteplirsen may reduce the production of pro-inflammatory cytokines and reactive oxygen species, which can contribute to muscle damage and degeneration.\nOverall, the mechanism of action of Eteplirsen involves the inhibition of PDGF, leading to increased levels of dystrophin in muscle cells and improved muscle function in patients with DMD.",
    "llama-2-7b-chat-hf_fact": [
      "Eteplirsen is used to treat Duchenne muscular dystrophy.",
      "The mechanism of Eteplirsen involves the inhibition of an enzyme called PDGF.",
      "PDGF breaks down the protein dystrophin, essential for muscle function and structure.",
      "Eteplirsen works by binding to the active site of PDGF, preventing it from breaking down dystrophin.",
      "Eteplirsen can have indirect effects on muscle function by reducing inflammation and oxidative stress."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The mechanism of Eteplirsen does not involve the inhibition of an enzyme called PDGF. Instead, it works by skipping exon 51 of the DMD gene.",
      "false, [corrected fact]: PDGF does not break down the protein dystrophin. Dystrophin is depleted in Duchenne muscular dystrophy due to mutations in the DMD gene.",
      "false, [corrected fact]: Eteplirsen does not work by binding to the active site of PDGF. It binds to exon 51 of the DMD gene, allowing to skip this exon during pre-mRNA splicing.",
      "unknown"
    ]
  },
  {
    "id": 1777,
    "user_query": "Which gene-defect causes the Vel-blood type?",
    "llama-2-7b-chat-hf_response": "The Vel blood type is caused by a genetic mutation in the gene that encodes the protein hemoglobin. Specifically, the mutation affects the amino acid glutamic acid at position 26 (E26K) in the beta-globin subunit of hemoglobin. This mutation results in a change in the shape of the hemoglobin molecule, which can affect its ability to bind to oxygen and transport it to the body's tissues. As a result, individuals with the Vel blood type may have a mild to moderate anemia and may be more prone to certain health problems, such as heart disease and stroke.",
    "llama-2-7b-chat-hf_fact": [
      "The Vel blood type is caused by a genetic mutation in the gene encoding the protein hemoglobin.",
      "The mutation in question affects the amino acid glutamic acid at position 26 (E26K) in the beta-globin subunit of hemoglobin.",
      "This mutation alters the shape of the hemoglobin molecule.",
      "The mutation can affect the capacity of hemoglobin to bind and transport oxygen to the body's tissues.",
      "Individuals with the Vel blood type might have a mild to moderate anemia and may be more prone to certain health issues, such as heart disease and stroke."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Vel blood type is caused by a genetic mutation in the gene encoding the protein SMIM1, not hemoglobin.",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1782,
    "user_query": "What are the exonic splice enhancers?",
    "llama-2-7b-chat-hf_response": "Exonic splice enhancers are specific sequences within the exons of a gene that can enhance the splicing of that gene. These sequences are located within the exons themselves, rather than in the introns or other regions of the gene. Exonic splice enhancers can increase the efficiency of splicing, leading to the production of more mature and functional RNA molecules.",
    "llama-2-7b-chat-hf_fact": [
      "Exonic splice enhancers are specific sequences within the exons of a gene.",
      "They enhance the splicing of the gene they are located in.",
      "Exonic splice enhancers are located within the exons, not in the introns or other regions of the gene.",
      "They can increase the efficiency of splicing.",
      "Exonic splice enhancers contribute to the production of more mature and functional RNA molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1784,
    "user_query": "What is Neisseria adhesin A?",
    "llama-2-7b-chat-hf_response": "Neisseria adhesin A is a protein complex found on the surface of Neisseria species, including Neisseria meningitidis and Neisseria gonorrhoeae. It is a major adhesin that plays a key role in the pathogenesis of meningococcal and gonococcal infections.\nAdhesins are proteins that allow bacteria to adhere to host cells or tissues, enabling them to colonize and cause infection. Neisseria adhesin A is composed of three subunits: NadA, NadB, and NadC. These subunits are non-covalently linked to form a heterotrimeric complex.\nNadA is the major adhesin subunit and is responsible for the binding of Neisseria to epithelial cells in the respiratory tract. NadB is involved in the binding of Neisseria to immune cells, such as neutrophils and macrophages. NadC is a minor adhesin subunit that is involved in the binding of Neisseria to fibronectin, a protein found in the extracellular matrix.\nNeisseria adhesin A has been implicated in the pathogenesis of meningococcal and gonococcal infections, including meningitis, sepsis, and pelvic inflammatory disease. Understanding the structure and function of Neisseria adhesin A has important implications for the development of vaccines and therapeutics against these infections.",
    "llama-2-7b-chat-hf_fact": [
      "Neisseria adhesin A is a protein complex found on the surface of Neisseria species, including Neisseria meningitidis and Neisseria gonorrhoeae.",
      "Neisseria adhesin A is involved in the pathogenesis of meningococcal and gonococcal infections.",
      "Adhesins are proteins that allow bacteria to adhere to host cells or tissues to cause infection.",
      "Neisseria adhesin A is composed of three subunits: NadA, NadB, and NadC.",
      "Understanding the structure and function of Neisseria adhesin A has implications for the development of vaccines and therapeutics against meningococcal and gonococcal infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1785,
    "user_query": "Which R package is used for the detection of chromosomal abnormalities from microarray data?",
    "llama-2-7b-chat-hf_response": "Answer: There are several R packages that can be used for the detection of chromosomal abnormalities from microarray data. Some of the commonly used packages are:\n1. `affy` package: This package provides functions for analyzing Affymetrix microarray data, including the detection of chromosomal abnormalities.\n2. `limma` package: This package provides functions for the analysis of gene expression data, including the detection of chromosomal abnormalities.\n3. ` genomics` package: This package provides functions for the analysis of genomic data, including the detection of chromosomal abnormalities.\n4. `marray` package: This package provides functions for the analysis of microarray data, including the detection of chromosomal abnormalities.\n5. `MAS5` package: This package provides functions for the analysis of Affymetrix microarray data, including the detection of chromosomal abnormalities.\n6. `GSEA` package: This package provides functions for the analysis of gene expression data, including the detection of chromosomal abnormalities.\n7. `ChromHMM` package: This package provides functions for the analysis of chromosomal abnormalities, including the detection of chromosomal abnormalities from microarray data.\n8. `CytoscapeR` package: This package provides functions for the analysis of chromosomal abnormalities, including the detection of chromosomal abnormalities from microarray data.\nPlease note that the above list is not exhaustive and there may be other packages available for the detection of chromosomal abnormalities from microarray data.",
    "llama-2-7b-chat-hf_fact": [
      "The 'affy' package in R is used for the analysis of Affymetrix microarray data, including the detection of chromosomal abnormalities.",
      "The 'limma' package in R provides functions for the analysis of gene expression data, including the detection of chromosomal abnormalities.",
      "The 'genomics' package in R is used for the analysis of genomic data, including the detection of chromosomal abnormalities.",
      "The 'marray' package in R provides functions for the analysis of microarray data, including the detection of chromosomal abnormalities.",
      "The 'MAS5' package in R is used for the analysis of Affymetrix microarray data, including the detection of chromosomal abnormalities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There is no 'genomics' package in R. Different packages such as 'Bioconductor', 'GenomicRanges' etc. in R are used for the analysis of genomic data.",
      "true",
      "false, [corrected fact]: 'MAS5' is not a standalone package in R. It is a method for processing Affymetrix microarray data, and can be found in packages such as 'affy' and 'simpleaffy'."
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-7b-chat-hf_response": "Self-Organizing Maps (SOMs) are a type of neural network that can be used for data visualization and clustering. In the context of bioinformatics, SOMs have been employed to analyze synonymous codon usage, which refers to the use of alternative codons to encode the same amino acid in a protein sequence.\nOne tool that employs SOMs for analyzing synonymous codon usage is the \"Synonymous Codon Usage Analyzer\" (SCUA) tool. Developed by the University of California, Los Angeles (UCLA), SCUA uses SOMs to visualize and analyze the distribution of synonymous codons in a given protein sequence. The tool can identify clusters of synonymous codons that are overrepresented or underrepresented in the sequence, which can provide insights into the evolutionary history of the protein and the selective pressures that have shaped its codon usage.\nOther tools that employ SOMs for analyzing synonymous codon usage include the \"Codon Usage Analyzer\" tool from the University of California, San Diego (UCSD), and the \"SynCoding\" tool from the University of California, Berkeley (UC Berkeley).",
    "llama-2-7b-chat-hf_fact": [
      "Self-Organizing Maps (SOMs) are a type of neural network used for data visualization and clustering.",
      "In bioinformatics, SOMs are used to analyze synonymous codon usage.",
      "The Synonymous Codon Usage Analyzer (SCUA) tool uses SOMs to analyze the distribution of synonymous codons in a protein sequence.",
      "SCUA tool was developed by the University of California, Los Angeles.",
      "Codon Usage Analyzer from University of California, San Diego and SynCoding from University of California, Berkeley also use SOMs for synonymous codon usage analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The Synonymous Codon Usage Analyzer (SCUA) tool uses SOMs to analyze the distribution of synonymous codons in a gene sequence, not a protein sequence.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-7b-chat-hf_response": "MINDY-1 is a Phase 1/2 clinical trial investigating the safety and efficacy of MIN-101, an oral small molecule inhibitor of the enzyme histone deacetylase 6 (HDAC6) in patients with relapsed or refractory B-cell malignancies, including non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).",
    "llama-2-7b-chat-hf_fact": [
      "MINDY-1 is a Phase 1/2 clinical trial.",
      "The trial is investigating the safety and efficacy of MIN-101.",
      "MIN-101 is an oral small molecule inhibitor of the enzyme histone deacetylase 6 (HDAC6).",
      "The trial is conducted in patients with relapsed or refractory B-cell malignancies.",
      "The malignancies being investigated include non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1805,
    "user_query": "What is BioCreative?",
    "llama-2-7b-chat-hf_response": "BioCreative is a research project funded by the European Union's Horizon 2020 program. The project aims to develop and apply cutting-edge natural language processing (NLP) and machine learning (ML) techniques to the biomedical domain. The project's goal is to improve the efficiency and accuracy of biomedical text mining, and to enable the extraction of valuable insights and knowledge from large volumes of biomedical literature.\nBioCreative is a multidisciplinary project that brings together researchers from a range of fields, including computer science, biology, medicine, and linguistics. The project is structured around three main themes:\n1. Biomedical Text Mining: This theme focuses on the development of NLP and ML techniques for the analysis of biomedical text. Researchers are working on tasks such as named entity recognition, sentiment analysis, and information extraction, with the goal of improving the accuracy and efficiency of these tasks.\n2. Biomedical Knowledge Graph Construction: This theme focuses on the construction of knowledge graphs from biomedical text. Researchers are working on tasks such as entity disambiguation, relationship extraction, and knowledge graph completion, with the goal of creating high-quality knowledge graphs that can be used for downstream applications such as drug discovery and personalized medicine.\n3. Biomedical Applications: This theme focuses on the application of NLP and ML techniques to real-world biomedical problems. Researchers are working on tasks such as disease diagnosis, drug repurposing, and clinical decision support, with the goal of demonstrating the practical utility of the techniques developed in the project.\nBioCreative is using a range of techniques, including deep learning, transfer learning, and multitask learning, to improve the accuracy and efficiency of biomedical text mining. The project is also exploring new applications of NLP and ML in the biomedical domain, such as the analysis of clinical notes and the detection of adverse drug reactions.\nOverall, BioCreative is an important research project that has the potential to make a significant impact on the field of biomedical text mining. By developing and applying cutting-edge NLP and ML techniques, the project aims to improve the efficiency and accuracy of biomedical text mining, and to enable the extraction of valuable insights and",
    "llama-2-7b-chat-hf_fact": [
      "BioCreative is a research project funded by the European Union's Horizon 2020 program.",
      "The goal of BioCreative is to use natural language processing and machine learning techniques to improve biomedical text mining.",
      "Researchers in BioCreative work in various fields such as computer science, biology, medicine, and linguistics.",
      "The project focuses on the development of NLP and ML techniques for analyzing biomedical text, constructing knowledge graphs from biomedical text, and their application to real-world biomedical problems.",
      "Techniques such as deep learning, transfer learning, and multitask learning are being applied in BioCreative project."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1808,
    "user_query": "What type of mutation is causing the industrial melanism phenotype in peppered moths?",
    "llama-2-7b-chat-hf_response": "The industrial melanism mutation in peppered moths is caused by a point mutation in the gene encoding the protein tyrosinase, which is involved in the production of melanin pigment. Specifically, the mutation results in the substitution of a glutamic acid residue for a phenylalanine residue at position 52 of the protein, leading to a loss of function of the tyrosinase enzyme. This results in a reduction or complete loss of melanin pigmentation in the moths, leading to the characteristic industrial melanism phenotype.",
    "llama-2-7b-chat-hf_fact": [
      "Industrial melanism in peppered moths is caused by a point mutation.",
      "This mutation occurs in the gene encoding the protein tyrosinase.",
      "Tyrosinase is involved in the production of melanin pigment.",
      "The specific mutation substitutes a glutamic acid residue for a phenylalanine residue at position 52 of the protein.",
      "This mutation leads to a loss of function of the tyrosinase enzyme, reducing or completely eliminating melanin pigmentation in the moths."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: This mutation occurs in the gene encoding the enzyme that controls the amount and distribution of melanin, not specifically tyrosinase.",
      "true",
      "unknown",
      "false, [corrected fact]: This mutation leads to an increase in function of the enzyme controlling the melanin pigmentation, leading to the darkening of the moths."
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-7b-chat-hf_response": "There are several software packages available for the analysis of conserved genomic loci, including:\n1. MUSCLE (Multiple Sequence Comparison by Log-Expectation): This is a widely used software package for multiple sequence alignment, which can be used to identify conserved genomic regions.\n2. MAFFT (Multiple Alignment Using Fast Fourier Transform): This is another popular software package for multiple sequence alignment, which can be used to identify conserved genomic regions.\n3. BLAST (Basic Local Alignment Search Tool): This is a software package for comparing biological sequences (DNA, RNA, or protein) to identify similarities and infer evolutionary relationships. BLAST can be used to identify conserved genomic regions.\n4. ClustalW: This is a software package for multiple sequence alignment, which can be used to identify conserved genomic regions.\n5. Phyre2: This is a web-based tool for protein structure prediction and analysis, which can be used to identify conserved genomic regions.\n6. HMMER: This is a software package for protein sequence analysis, which can be used to identify conserved genomic regions.\n7. Prodigal: This is a software package for the analysis of genomic sequences, which can be used to identify conserved genomic regions.\n8. GLIMMER: This is a software package for the analysis of genomic sequences, which can be used to identify conserved genomic regions.\n9. PHI-BLAST: This is a software package for comparing biological sequences (DNA, RNA, or protein) to identify similarities and infer evolutionary relationships. PHI-BLAST can be used to identify conserved genomic regions.\n10. Dotter: This is a software package for the analysis of genomic sequences, which can be used to identify conserved genomic regions.\nEach of these software packages has its own strengths and limitations, and the choice of which package to use will depend on the specific research question and the characteristics of the data being analyzed.",
    "llama-2-7b-chat-hf_fact": [
      "MUSCLE is a software package used for multiple sequence alignment to identify conserved genomic regions.",
      "MAFFT is another software package for multiple sequence alignment and it can be used to identify conserved genomic regions.",
      "BLAST is a software package for comparing biological sequences (DNA, RNA, or protein) to infer evolutionary relationships and it can identify conserved genomic regions.",
      "ClustalW is a software used for multiple sequence alignment and it can identify conserved genomic regions.",
      "Phyre2 is a web-based tool for protein structure prediction and can be used to identify conserved genomic regions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Phyre2 is a web-based tool for protein structure prediction but it does not directly identify conserved genomic regions."
    ]
  },
  {
    "id": 1812,
    "user_query": "What is Eteplirsen (Exondys 51)?",
    "llama-2-7b-chat-hf_response": "Eteplirsen (Exondys 51) is a prescription medicine used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the dystrophin gene that is amenable to treatment with the drug. It is given by injection and works by helping to restore the production of the dystrophin protein, which is missing or deficient in people with DMD.\nEteplirsen is the first drug to be approved by the US Food and Drug Administration (FDA) specifically for the treatment of DMD. It was approved in 2016 based on the results of a clinical trial that showed that it improved the ability of patients to walk and perform other daily activities.\nIt is important to note that Eteplirsen is not a cure for DMD, and it does not reverse the muscle damage that has already occurred. However, it may help to slow the progression of the disease and improve the quality of life for people with DMD.",
    "llama-2-7b-chat-hf_fact": [
      "Eteplirsen (Exondys 51) is used to treat Duchenne muscular dystrophy (DMD) in patients with a certain mutation of the dystrophin gene.",
      "Eteplirsen functions by restoring the production of the dystrophin protein, which is deficient in people with DMD.",
      "Eteplirsen is administered via injection.",
      "The US Food and Drug Administration approved Eteplirsen as the first drug for DMD treatment in 2016.",
      "Despite its benefits, Eteplirsen is not a cure for DMD and doesn't reverse pre-existing muscle damage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1813,
    "user_query": "What are the SINEUPs?",
    "llama-2-7b-chat-hf_response": "The SINEUPs (Sine Updates) are a series of updates that were released for the SineSpace virtual reality platform in 2022. These updates aimed to improve the user experience, add new features, and enhance the overall performance of the platform.",
    "llama-2-7b-chat-hf_fact": [
      "SINEUPs are updates for the SineSpace virtual reality platform.",
      "SINEUPs were released in 2022.",
      "The goal of the SINEUPs was to improve the user experience on the SineSpace virtual reality platform.",
      "SINEUPs were developed to add new features to the SineSpace virtual reality platform.",
      "Enhancing the overall performance of the SineSpace platform was one of the objectives of the SINEUPs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: SINEUPs are a type of artificial RNA molecule, not updates for the SineSpace virtual reality platform.",
      "unknown",
      "false, [corrected fact]: The goal of SINEUPs is to increase protein production in cells, not to improve the user experience on the SineSpace virtual reality platform.",
      "false, [corrected fact]: SINEUPs were developed for biological and medical research, not to add new features to the SineSpace virtual reality platform.",
      "false, [corrected fact]: Enhancing the overall performance of a virtual reality platform is unrelated to the objectives of SINEUPs which are used in the field of genetics and bioengineering."
    ]
  },
  {
    "id": 1815,
    "user_query": "What is the mechanism of action of raxibacumab?",
    "llama-2-7b-chat-hf_response": "Raxibacumab is a monoclonal antibody that targets and neutralizes the bacterial toxin botulinum neurotoxin A (BoNT/A). Botulinum neurotoxin A is a potent neurotoxin that can cause botulism, a serious and potentially life-threatening illness.\nThe mechanism of action of raxibacumab involves several steps:\n1. Binding: Raxibacumab binds to botulinum neurotoxin A with high affinity and specificity, preventing it from interacting with its target cells.\n2. Neutralization: Raxibacumab neutralizes the activity of botulinum neurotoxin A by blocking its binding to the nicotinic acetylcholine receptor (nAChR) on the surface of motor neurons. This prevents the toxin from causing muscle paralysis and respiratory failure.\n3. Clearance: Raxibacumab is cleared from the body through the reticuloendothelial system (RES), which includes the liver, spleen, and lymph nodes.\n4. Immunomodulation: Raxibacumab has been shown to modulate the immune response to botulinum neurotoxin A, which may contribute to its therapeutic effect.\nOverall, the mechanism of action of raxibacumab is to neutralize the activity of botulinum neurotoxin A and prevent its harmful effects on the nervous system.",
    "llama-2-7b-chat-hf_fact": [
      "Raxibacumab is a monoclonal antibody that targets and neutralizes the bacterial toxin botulinum neurotoxin A (BoNT/A).",
      "Botulinum neurotoxin A is a potent neurotoxin that can cause botulism, a serious and potentially life-threatening illness.",
      "Raxibacumab binds to botulinum neurotoxin A with high affinity and specificity, preventing it from interacting with its target cells.",
      "Raxibacumab is cleared from the body through the reticuloendothelial system (RES), which includes the liver, spleen, and lymph nodes.",
      "Raxibacumab has been shown to modulate the immune response to botulinum neurotoxin A."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Raxibacumab is a monoclonal antibody that targets and neutralizes the bacterial toxin anthrax, not botulinum neurotoxin A.",
      "true",
      "false, [corrected fact]: Raxibacumab binds to anthrax toxins, not botulinum neurotoxin A.",
      "true",
      "false, [corrected fact]: Raxibacumab has been shown to modulate the immune response to anthrax, not botulinum neurotoxin A."
    ]
  },
  {
    "id": 1817,
    "user_query": "Is SUMOylation a post-translational modification in eukaryotes?",
    "llama-2-7b-chat-hf_response": "SUMOylation is a post-translational modification that occurs in eukaryotes, including animals, plants, and fungi. It involves the covalent attachment of a small ubiquitin-like modifier (SUMO) protein to a target protein, which can alter the protein's function or localization.",
    "llama-2-7b-chat-hf_fact": [
      "SUMOylation is a post-translational modification that occurs in eukaryotes.",
      "Eukaryotes include animals, plants, and fungi.",
      "SUMOylation involves the covalent attachment of a small ubiquitin-like modifier (SUMO) protein to a target protein.",
      "The attachment of a SUMO protein to a target protein can alter the protein's function or localization."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1823,
    "user_query": "Is Annexin V an apoptotic marker?",
    "llama-2-7b-chat-hf_response": "Annexin V is a protein that is commonly used as an apoptotic marker in cell biology. It is a Ca2+-dependent phospholipid-binding protein that is expressed in the endoplasmic reticulum (ER) and is involved in various cellular processes, including cell signaling, membrane trafficking, and apoptosis.\nAnnexin V has been shown to bind to phosphatidylserine (PS), a phospholipid that is exposed on the outer leaflet of the plasma membrane during early stages of apoptosis. This binding is specific and reversible, and it can be used to detect early stages of apoptosis by flow cytometry or immunofluorescence.\nIn addition to its binding to PS, Annexin V also binds to other phospholipids, including phosphatidylcholine (PC) and sphingomyelin (SM). However, its binding to PS is the most well-established and widely used marker of early apoptosis.\nAnnexin V staining can be used to detect apoptosis in various cell types, including cancer cells, immune cells, and neurons. It has also been used to study the role of apoptosis in various diseases, including cancer, neurodegeneration, and cardiovascular disease.\nIn summary, Annexin V is an apoptotic marker that can be used to detect early stages of apoptosis by binding to phosphatidylserine on the plasma membrane. Its specificity and reversibility make it a valuable tool for studying apoptosis in various cell types and diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Annexin V is a protein that is commonly used as an apoptotic marker in cell biology.",
      "The protein Annexin V is expressed in the endoplasmic reticulum and is involved in various cellular processes, including cell signaling, membrane trafficking, and apoptosis.",
      "Annexin V binds to phosphatidylserine, a phospholipid that is exposed on the outer leaflet of the plasma membrane during the early stages of apoptosis.",
      "Annexin V staining can be used to detect apoptosis in various cell types, including cancer cells, immune cells, and neurons.",
      "Annexin V has been used in the study of various diseases, including cancer, neurodegeneration, and cardiovascular disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Annexin V is not expressed in the endoplasmic reticulum. It binds to phosphatidylserine (PS) in the presence of calcium ions when PS is exposed to the outer leaflet of the cell membrane.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1825,
    "user_query": "What are PD-1 inhibitors?",
    "llama-2-7b-chat-hf_response": "PD-1 (Programmed Death-1) inhibitors are a class of drugs used to treat cancer. They work by blocking a protein called PD-1 on the surface of immune cells, which normally acts as a \"brake\" on the immune system, preventing it from attacking cancer cells. By blocking PD-1, the immune system is able to recognize and attack cancer cells more effectively.",
    "llama-2-7b-chat-hf_fact": [
      "PD-1 is a protein on the surface of immune cells.",
      "PD-1 inhibitors are a class of drugs used to treat cancer.",
      "The function of PD-1 is to act as a \"brake\" on the immune system, preventing it from attacking cancer cells.",
      "PD-1 inhibitors work by blocking PD-1.",
      "Blocking PD-1 enables the immune system to recognize and attack cancer cells more effectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1828,
    "user_query": "Is Migalastat used for treatment of Fabry Disease?",
    "llama-2-7b-chat-hf_response": "Migalastat is an oral chaperone therapy that is used to treat Fabry disease, a rare genetic disorder caused by a deficiency of the enzyme alpha-galactosidase A. Migalastat works by increasing the activity of the residual alpha-galactosidase A enzyme in the body, which helps to reduce the accumulation of globotriaosylsphingosine (Lewandowsky et al., 2017).",
    "llama-2-7b-chat-hf_fact": [
      "Migalastat is used to treat Fabry disease.",
      "Fabry disease is a rare genetic disorder caused by a deficiency of the enzyme alpha-galactosidase A.",
      "Migalastat is an oral chaperone therapy.",
      "The mechanism of Migalastat's action involves increasing the activity of the residual alpha-galactosidase A enzyme in the body.",
      "This increase in enzyme activity helps to reduce the accumulation of globotriaosylsphingosine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1829,
    "user_query": "Where are Paneth cells located?",
    "llama-2-7b-chat-hf_response": "Paneth cells are located in the small intestine, specifically in the crypts of Lieberkhn, which are specialized structures within the small intestine that are responsible for the production and secretion of digestive enzymes and hormones. The Paneth cells are located at the base of the crypts, near the base of the villi, which are the finger-like projections that line the small intestine and increase its surface area for absorption of nutrients.",
    "llama-2-7b-chat-hf_fact": [
      "Paneth cells are located in the small intestine.",
      "The crypts of Lieberkhn are specialized structures within the small intestine.",
      "Paneth cells are found at the base of the crypts of Lieberkhn.",
      "The crypts of Lieberkhn are responsible for the production and secretion of digestive enzymes and hormones.",
      "Villi are finger-like projections that line the small intestine and increase its surface area for nutrient absorption."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The crypts of Lieberkhn are responsible for the production of new cells. The production and secretion of digestive enzymes and hormones is performed by other cells in the small intestine.",
      "true"
    ]
  },
  {
    "id": 1832,
    "user_query": "Which pipelines are used for analyzing data from ChIP-nexus experiments?",
    "llama-2-7b-chat-hf_response": "ChIP-nexus is a high-throughput sequencing technology that allows for the simultaneous profiling of multiple epigenetic marks, including chromatin immunoprecipitation (ChIP) and next-generation sequencing (NGS). There are several pipelines that can be used for analyzing data from ChIP-nexus experiments, including:\n1. HISAT2: This pipeline is widely used for ChIP-nexus data analysis and can be used to identify regions of the genome that are bound by specific proteins.\n2. STAR: This pipeline is another popular choice for ChIP-nexus data analysis and can be used to identify regions of the genome that are bound by specific proteins.\n3. TopHat2: This pipeline can be used to identify regions of the genome that are bound by specific proteins and can also be used to quantify the amount of protein bound to specific regions of the genome.\n4. Cufflinks: This pipeline can be used to quantify the amount of protein bound to specific regions of the genome and can also be used to identify regions of the genome that are bound by specific proteins.\n5. DeepTools: This pipeline can be used to identify regions of the genome that are bound by specific proteins and can also be used to quantify the amount of protein bound to specific regions of the genome.\n6. ChIPseek: This pipeline can be used to identify regions of the genome that are bound by specific proteins and can also be used to quantify the amount of protein bound to specific regions of the genome.\n7. MACS2: This pipeline can be used to identify regions of the genome that are bound by specific proteins and can also be used to quantify the amount of protein bound to specific regions of the genome.\n8. ChIPster: This pipeline can be used to identify regions of the genome that are bound by specific proteins and can also be used to quantify the amount of protein bound to specific regions of the genome.\n9. PeakAnalyzer: This pipeline can be used to identify regions of the genome that are bound by specific proteins and can also be used to quantify the amount of protein bound to specific regions of the genome.\n10. BedTools: This pipeline can be used to identify regions of the genome that are bound",
    "llama-2-7b-chat-hf_fact": [
      "ChIP-nexus is a high-throughput sequencing technology that simultaneously profiles multiple epigenetic marks.",
      "HISAT2 is a pipeline used for analyzing data from ChIP-nexus experiments.",
      "The pipeline STAR is also used for ChIP-nexus data analysis.",
      "TopHat2 is a pipeline that can be used for ChIP-nexus data analysis.",
      "Cufflinks is another pipeline used for analyzing data from ChIP-nexus experiments."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: HISAT2 is a pipeline used for analyzing RNA sequencing data, not specifically for ChIP-nexus experiments.",
      "true",
      "false, [corrected fact]: TopHat2 is a pipeline used for analyzing RNA-Seq data, not specifically for ChIP-nexus experiments.",
      "false, [corrected fact]: Cufflinks is a pipeline used for analyzing RNA-Seq data, not specifically for ChIP-nexus experiments."
    ]
  },
  {
    "id": 1833,
    "user_query": "What do statins do?",
    "llama-2-7b-chat-hf_response": "Statins are a type of cholesterol-lowering medication that work by inhibiting the enzyme HMG-CoA reductase, which is responsible for producing cholesterol in the liver. By reducing the production of cholesterol, statins lower the level of low-density lipoprotein (LDL) cholesterol, also known as \"bad\" cholesterol, in the blood. This can help to reduce the risk of heart disease, which is associated with high levels of LDL cholesterol.\nThere are several different types of statins available, including:\n* Atorvastatin (Lipitor)\n* Simvastatin (Zocor)\n* Rosuvastatin (Crestor)\n* Pravastatin (Pravachol)\n* Lovastatin (Mevacor)\nStatins also have some other effects on the body, including:\n* Increasing the level of high-density lipoprotein (HDL) cholesterol, also known as \"good\" cholesterol\n* Reducing the risk of heart disease by reducing inflammation and improving blood vessel function\n* Lowering the risk of stroke and other cardiovascular problems\n* Reducing the risk of cancer, particularly breast and prostate cancer\nIt's important to note that while statins can help to lower cholesterol levels and reduce the risk of heart disease, they are not without side effects. Common side effects of statins include muscle pain, liver damage, and an increased risk of diabetes. As with any medication, it's important to discuss the potential benefits and risks of statins with your doctor before starting treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Statins are a type of cholesterol-lowering medication.",
      "Statins inhibit the enzyme HMG-CoA reductase to reduce cholesterol production in the liver.",
      "By reducing cholesterol production, statins lower the level of LDL cholesterol, or \"bad\" cholesterol, in the blood.",
      "Common side effects of statins include muscle pain, liver damage, and an increased risk of diabetes.",
      "Several types of statins include Atorvastatin, Simvastatin, Rosuvastatin, Pravastatin, and Lovastatin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1835,
    "user_query": "Do statins cause diabetes?",
    "llama-2-7b-chat-hf_response": "Statins are a type of cholesterol-lowering medication that are commonly prescribed to reduce the risk of heart disease. However, there is some evidence to suggest that statins may increase the risk of developing type 2 diabetes.\nOne study published in the Journal of the American College of Cardiology found that patients taking statins had a 9% increased risk of developing type 2 diabetes compared to those not taking statins. Another study published in the European Heart Journal found that the risk of developing type 2 diabetes was 17% higher in patients taking statins compared to those not taking them.\nThere are several possible reasons why statins may increase the risk of developing type 2 diabetes. One theory is that statins may affect the body's ability to produce and use insulin, leading to insulin resistance and an increased risk of type 2 diabetes. Another theory is that statins may cause inflammation in the body, which can also contribute to insulin resistance and an increased risk of type 2 diabetes.\nIt's important to note that the risk of developing type 2 diabetes from taking statins is still relatively low, and the benefits of taking statins in reducing the risk of heart disease generally outweigh the potential risks. However, if you are taking statins and are concerned about the risk of developing type 2 diabetes, it's important to talk to your doctor about your individual risk factors and the potential benefits and risks of continuing to take statins.\nIn summary, while there is some evidence to suggest that statins may increase the risk of developing type 2 diabetes, the risk is still relatively low and the benefits of taking statins in reducing the risk of heart disease generally outweigh the potential risks. If you are taking statins and are concerned about the risk of developing type 2 diabetes, it's important to talk to your doctor about your individual risk factors and the potential benefits and risks of continuing to take statins.",
    "llama-2-7b-chat-hf_fact": [
      "Statins are a type of cholesterol-lowering medication commonly prescribed to reduce the risk of heart disease.",
      "Some studies suggest statins may increase the risk of developing type 2 diabetes.",
      "A study in the Journal of the American College of Cardiology found a 9% increased risk of developing type 2 diabetes in patients taking statins compared to those not taking them.",
      "Another study from the European Heart Journal found a 17% higher risk of developing type 2 diabetes in patients on statins compared to those not on them.",
      "It is theorized that statins may affect the body's ability to produce and use insulin or cause inflammation, both of which could potentially increase the risk of type 2 diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1841,
    "user_query": "What is the composition of the gamma-secretase complex?",
    "llama-2-7b-chat-hf_response": "The gamma-secretase complex is a large protein complex that plays a crucial role in the cleavage of amyloid precursor protein (APP) to produce the beta-amyloid peptide (A) that is associated with Alzheimer's disease. The composition of the gamma-secretase complex is not fully understood, but it is known to consist of several subunits, including:\n1. Presenilin 1 (PS1) and presenilin 2 (PS2): These are the core components of the gamma-secretase complex and are responsible for the cleavage of APP.\n2. Nicastrin (NCT): This protein is a component of the gamma-secretase complex and helps to facilitate the cleavage of APP.\n3. Aph-1 (Aph-1a and Aph-1b): These proteins are also components of the gamma-secretase complex and play a role in the cleavage of APP.\n4. PEN-2 (Pen-2): This protein is a component of the gamma-secretase complex and helps to regulate the activity of the complex.\n5. Gamma-secretase-associated protein (GAP-1): This protein is a component of the gamma-secretase complex and helps to facilitate the cleavage of APP.\n6. Gamma-secretase-associated protein 2 (GAP-2): This protein is a component of the gamma-secretase complex and helps to regulate the activity of the complex.\nIt is important to note that the composition of the gamma-secretase complex can vary depending on the cellular context and the specific stage of APP processing. Additionally, there may be other proteins that are involved in the gamma-secretase complex that have not yet been identified.",
    "llama-2-7b-chat-hf_fact": [
      "The gamma-secretase complex is a protein complex that plays a role in the production of the beta-amyloid peptide associated with Alzheimer's disease.",
      "The gamma-secretase complex consists of several subunits, including Presenilin 1 and 2, which are responsible for the cleavage of amyloid precursor protein (APP).",
      "Nicastrin is a component of the gamma-secretase complex and facilitates the cleavage of APP.",
      "Aph-1 (Aph-1a and Aph-1b) are proteins that are part of the gamma-secretase complex and play a role in the cleavage of APP.",
      "PEN-2 and Gamma-secretase-associated proteins (GAP-1 and GAP-2) are components of the gamma-secretase complex and have regulatory and facilitating roles in the activity of the complex."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: PEN-2 is a component of the gamma-secretase complex and has a regulatory and facilitating role in the activity of the complex. GAP-1 and GAP-2 are not recognized subunits of the gamma-secretase complex."
    ]
  },
  {
    "id": 1844,
    "user_query": "What is the role of the UBC9 enzyme in the protein sumoylation pathway?",
    "llama-2-7b-chat-hf_response": "UBC9 (ubiquitin-protein ligase 9) is an enzyme that plays a crucial role in the protein sumoylation pathway. Sumoylation is a post-translational modification that involves the covalent attachment of a small ubiquitin-like modifier (SUMO) protein to a target protein. UBC9 is a key enzyme in the sumoylation pathway, as it catalyzes the transfer of SUMO from a donor protein to a acceptor protein.\nUBC9 is a member of the ubiquitin-protein ligase (E3) family, which means that it recognizes and binds to specific target proteins and then catalyzes the ubiquitination or sumoylation of those proteins. In the case of sumoylation, UBC9 recognizes and binds to a specific acceptor protein, and then transfers the SUMO protein from a donor protein to the acceptor protein. This results in the covalent attachment of the SUMO protein to the acceptor protein, which can alter the protein's function or localization.\nUBC9 plays a crucial role in regulating various cellular processes, including protein degradation, transcriptional regulation, and cell cycle progression. Dysregulation of UBC9 has been implicated in various diseases, including cancer and neurodegenerative disorders.\nIn summary, UBC9 is a key enzyme in the protein sumoylation pathway, which plays a crucial role in regulating various cellular processes. Its dysregulation can lead to various diseases, highlighting the importance of this enzyme in maintaining cellular homeostasis.",
    "llama-2-7b-chat-hf_fact": [
      "UBC9 is an enzyme that plays a key role in the protein sumoylation pathway.",
      "Sumoylation is a post-translational modification involving the attachment of a SUMO protein to a target protein.",
      "UBC9 is a member of the ubiquitin-protein ligase (E3) family.",
      "UBC9 plays a key role in regulating cellular processes such as protein degradation, transcriptional regulation, and cell cycle progression.",
      "Dysregulation of UBC9 has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: UBC9 is a SUMO-conjugating enzyme (E2), not a member of the ubiquitin-protein ligase (E3) family.",
      "false, [corrected fact]: UBC9 plays a key role in regulating cellular processes such as protein sumoylation, transcriptional regulation, and DNA repair.",
      "true"
    ]
  },
  {
    "id": 1849,
    "user_query": "What is the role of cohesins at the IFNG locus?",
    "llama-2-7b-chat-hf_response": "Cohesins are protein complexes that play a crucial role in the regulation of gene expression by mediating the looping interactions between distant regulatory elements and their target genes. The IFNG locus, which encodes the interferon gamma (IFNG) gene, is a well-studied example of a gene locus that is regulated by cohesins.\nStudies have shown that cohesins play a crucial role in the regulation of IFNG expression by mediating the looping interactions between the IFNG locus and other regulatory elements, such as the promoter and enhancer elements. These interactions are important for the recruitment of transcription factors and other regulatory proteins to the IFNG locus, and are necessary for the proper activation of IFNG transcription.\nIn addition, cohesins have been shown to play a role in the regulation of IFNG expression by modulating the chromatin structure of the locus. By mediating the looping interactions between the IFNG locus and other regulatory elements, cohesins can help to create a more accessible chromatin structure that is conducive to transcriptional activation.\nOverall, the role of cohesins at the IFNG locus is to mediate the looping interactions between the locus and other regulatory elements, and to modulate the chromatin structure of the locus in order to regulate IFNG expression.",
    "llama-2-7b-chat-hf_fact": [
      "Cohesins are protein complexes that aid in the regulation of gene expression.",
      "They mediate the looping interactions between distant regulatory elements and their target genes.",
      "The IFNG locus, which produces the interferon gamma (IFNG) gene, is regulated by cohesins.",
      "Cohesins help recruit transcription factors and other regulatory proteins to the IFNG locus, which are necessary for the activation of IFNG transcription.",
      "Cohesins also modulate the chromatin structure of the IFNG locus, promoting a structure conducive to transcriptional activation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Cohesins are protein complexes that are crucial for chromosome segregation during cell division.",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1853,
    "user_query": "Could hypophosphatemic rickets cause craniosynostosis?",
    "llama-2-7b-chat-hf_response": "Hypophosphatemic rickets is a rare genetic disorder that affects the body's ability to absorb phosphate, leading to low levels of phosphate in the blood. Craniosynostosis is a condition where the bones of the skull fuse together too early, leading to abnormal head growth and skull deformities. While hypophosphatemic rickets is not typically associated with craniosynostosis, there have been some case reports of children with this condition developing craniosynostosis.\nOne case report published in the Journal of Clinical Endocrinology and Metabolism in 2013 described a 2-year-old girl with hypophosphatemic rickets who developed craniosynostosis. The girl had been diagnosed with hypophosphatemic rickets at 6 months of age and had been treated with vitamin D and calcium supplements, but her condition had not improved. At age 2, she developed a deformed skull and was diagnosed with craniosynostosis. Further testing revealed that the girl had a mutation in the FGF23 gene, which is associated with hypophosphatemic rickets.\nAnother case report published in the American Journal of Medical Genetics in 2017 described a 4-year-old boy with hypophosphatemic rickets who developed craniosynostosis. The boy had been diagnosed with hypophosphatemic rickets at 18 months of age and had been treated with vitamin D and calcium supplements, but his condition had not improved. At age 4, he developed a deformed skull and was diagnosed with craniosynostosis. Genetic testing revealed that the boy had a mutation in the PHEX gene, which is also associated with hypophosphatemic rickets.\nWhile these case reports suggest a possible association between hypophosphatemic rickets and craniosynostosis, it is important to note that craniosynostosis is a rare condition that can have many different causes. More research is needed to fully understand the relationship between hypophosphatemic rickets and craniosynostosis.\nIn summary, while hypophosphatemic rickets is not",
    "llama-2-7b-chat-hf_fact": [
      "Hypophosphatemic rickets is a genetic disorder that affects the body's ability to absorb phosphate, resulting in low phosphate levels in the blood.",
      "Craniosynostosis is a condition where the bones of the skull fuse together too early, causing abnormal head growth and skull deformities.",
      "A case reported in the Journal of Clinical Endocrinology and Metabolism in 2013 involved a 2-year-old girl with hypophosphatemic rickets developing craniosynostosis.",
      "Another case report in the American Journal of Medical Genetics in 2017 described a 4-year-old boy with hypophosphatemic rickets who developed craniosynostosis.",
      "FGF23 and PHEX genes are associated with hypophosphatemic rickets."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1854,
    "user_query": "Is vortioxetine effective for treatment of depression?",
    "llama-2-7b-chat-hf_response": "Vortioxetine, also known as Brintellix, is a relatively new antidepressant medication that has been shown to be effective in treating major depressive disorder (MDD). Here are some key points to consider when evaluating the effectiveness of vortioxetine for depression:\nEfficacy: Vortioxetine has been shown to be effective in reducing symptoms of depression in clinical trials. In a phase III clinical trial, vortioxetine was compared to placebo and another antidepressant medication, and it was found to be superior to both in reducing symptoms of depression.\nMechanism of action: Vortioxetine works by inhibiting the reuptake of serotonin and norepinephrine, two neurotransmitters that play a role in mood regulation. By increasing the levels of these neurotransmitters in the brain, vortioxetine can help to improve mood and reduce symptoms of depression.\nTolerability: Vortioxetine has been shown to be generally well-tolerated in clinical trials, with a similar adverse event profile to other antidepressant medications. However, it can cause some side effects, including nausea, dizziness, and sleep disturbances.\nDosage and duration of treatment: The recommended dosage of vortioxetine for depression is typically 5-10 mg per day, taken in the morning or evening. The duration of treatment with vortioxetine can vary depending on the individual patient and the severity of their depression, but it is typically recommended for at least 6-8 weeks.\nComparison to other antidepressants: Vortioxetine has been compared to other antidepressant medications in clinical trials, and it has been shown to be effective in reducing symptoms of depression. However, it is important to note that vortioxetine has a unique mechanism of action compared to other antidepressants, and it may be more effective for some patients than others.\nLimitations of the evidence: While the evidence suggests that vortioxetine is effective for treating depression,",
    "llama-2-7b-chat-hf_fact": [
      "Vortioxetine, also known as Brintellix, is an antidepressant medication used to treat major depressive disorder.",
      "In a phase III clinical trial, vortioxetine was found to be superior to both a placebo and another antidepressant medication in reducing depressive symptoms.",
      "The action of vortioxetine involves inhibiting the reuptake of serotonin and norepinephrine, neurotransmitters that play a role in mood regulation.",
      "The recommended dosage of vortioxetine for depression is typically 5-10 mg per day and treatment is usually recommended for at least 6-8 weeks.",
      "Some side effects of vortioxetine can include nausea, dizziness, and sleep disturbances."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false, [corrected fact]: The action of vortioxetine involves inhibiting the reuptake of serotonin, norepinephrine, and dopamine, neurotransmitters that play a role in mood regulation.",
      "true",
      "true"
    ]
  },
  {
    "id": 1859,
    "user_query": "Where do the Schwann cells and melanocytes originate from?",
    "llama-2-7b-chat-hf_response": "Schwann cells and melanocytes are both derived from the neural crest, a type of stem cell that gives rise to many different cell types in the body. The neural crest is a group of cells that migrate from the neural tube during embryonic development and differentiate into a wide range of cell types, including neurons, glial cells, and melanocytes.\nSchwann cells are derived from the neural crest cells that migrate to the peripheral nervous system and differentiate into the myelinating cells of the peripheral nerves. They are responsible for producing the myelin sheath that surrounds and insulates the axons of peripheral nerve fibers, allowing for the efficient transmission of nerve impulses.\nMelanocytes are also derived from the neural crest and are responsible for producing the pigment melanin, which gives skin and hair their color. They are found in the skin, hair follicles, and eyes, and play a role in protecting the body from the harmful effects of ultraviolet (UV) radiation from the sun.\nIn summary, both Schwann cells and melanocytes originate from the neural crest, a type of stem cell that gives rise to many different cell types in the body.",
    "llama-2-7b-chat-hf_fact": [
      "Schwann cells and melanocytes are derived from the neural crest.",
      "The neural crest is a group of cells that migrate from the neural tube during embryonic development.",
      "Schwann cells are responsible for producing the myelin sheath that surrounds and insulates the axons of peripheral nerve fibers.",
      "Melanocytes are responsible for producing the pigment melanin, which gives skin and hair their color.",
      "Melanocytes are found in the skin, hair follicles, and eyes, and protect the body from ultraviolet (UV) radiation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-7b-chat-hf_response": "1. _____________\n2. _____________\n3. _____________\nThe PIEZO2 gene provides instructions for making a protein called piezo2, which is involved in the sensation of touch and pressure. Mutations in the PIEZO2 gene have been associated with several rare genetic disorders that affect the nervous system and skin. Here are three diseases associated with the PIEZO2 gene:\n1. Epidermolysis bullosa (EB): EB is a group of rare genetic disorders that affect the skin and mucous membranes. People with EB have fragile skin and mucous membranes that blister and tear easily, leading to painful sores and scarring. Mutations in the PIEZO2 gene have been found in some cases of EB.\n2. Neurofibromatosis type 1 (NF1): NF1 is a genetic disorder that affects the growth and development of nerve tissue. People with NF1 may develop benign tumors on their nerves, which can cause a variety of symptoms including pain, numbness, and weakness. Mutations in the PIEZO2 gene have been found in some cases of NF1.\n3. Porencephaly: Porencephaly is a rare brain malformation that occurs when there is abnormal development of the cerebral hemispheres. This can lead to a range of symptoms including seizures, developmental delays, and intellectual disability. Mutations in the PIEZO2 gene have been found in some cases of porencephaly.",
    "llama-2-7b-chat-hf_fact": [
      "The PIEZO2 gene provides instructions for making a protein called piezo2, which is involved in the sensation of touch and pressure.",
      "Epidermolysis Bullosa is a group of rare genetic disorders that affect the skin and mucous membranes, and in some cases, have been found to be linked with PIEZO2 gene mutations.",
      "Neurofibromatosis type 1, a disorder affecting the growth and development of nerve tissue, has also been related to the PIEZO2 gene mutations in some cases.",
      "Porencephaly is a rare brain malformation that occurs due to abnormalities in the development of cerebral hemispheres and is linked with the PIEZO2 gene mutations in some cases.",
      "Mutations in the PIEZO2 gene have been associated with several rare genetic disorders that affect the nervous system and skin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1862,
    "user_query": "Where is the protein slitrk1 localized?",
    "llama-2-7b-chat-hf_response": "Slitrk1 is a protein that is localized to the synapses of neurons in the brain. Specifically, it is found in the presynaptic terminals of neurons, where it plays a role in regulating the release of neurotransmitters. Slitrk1 is also expressed in other tissues, including the heart and pancreas, where it may have additional functions.",
    "llama-2-7b-chat-hf_fact": [
      "Slitrk1 is a protein that is localized to the synapses of neurons in the brain.",
      "Slitrk1 is found in the presynaptic terminals of neurons.",
      "Slitrk1 plays a role in regulating the release of neurotransmitters.",
      "Slitrk1 is expressed in tissues including the heart and pancreas."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Slitrk1 is primarily expressed in the brain and not typically found in the heart and pancreas."
    ]
  },
  {
    "id": 1863,
    "user_query": "Describe clinical manifestation of the Harlequin syndrome.",
    "llama-2-7b-chat-hf_response": "Harlequin syndrome is a rare genetic disorder that affects the skin, eyes, and nervous system. The clinical manifestations of Harlequin syndrome can vary in severity and may include:\n1. Skin manifestations: The skin manifestations of Harlequin syndrome are the most common and can include:\n* Erythematous macules or patches on the trunk, extremities, and face\n* Palmoplantar hyperkeratosis (thickening of the skin on the palms and soles)\n* Keratosis pilaris (small, hard bumps on the skin)\n* Vitiligo (white patches on the skin due to loss of pigment-producing cells)\n2. Ocular manifestations: The ocular manifestations of Harlequin syndrome can include:\n* Cataracts (clouding of the lens in the eye)\n* Glaucoma (increased pressure in the eye)\n* Retinal detachment (separation of the retina from the back of the eye)\n* Optic atrophy (degeneration of the optic nerve)\n3. Neurological manifestations: The neurological manifestations of Harlequin syndrome can include:\n* Ataxia (loss of coordination and balance)\n* Athetosis (slow, writhing movements of the hands and feet)\n* Spasticity (stiffness and rigidity of the muscles)\n* Seizures (fits or convulsions)\n4. Other manifestations: Other manifestations of Harlequin syndrome can include:\n* Respiratory problems (such as bronchiectasis or sleep apnea)\n* Cardiovascular problems (such as arrhythmias or heart failure)\n* Gastrointestinal problems (such as diarrhea or constipation)\n* Endocrine problems (such as hypothyroidism or adrenal insufficiency)\nIt is important to note that the severity of the clinical manifestations of Harlequin syndrome can vary widely between individuals, and some people may have only a few of these manifestations, while others may have many.",
    "llama-2-7b-chat-hf_fact": [
      "Harlequin syndrome is a rare genetic disorder that affects the skin, eyes, and nervous system.",
      "Notable skin manifestations can include erythematous macules or patches, palmoplantar hyperkeratosis, keratosis pilaris, and vitiligo.",
      "Ocular manifestations of Harlequin syndrome can include cataracts, glaucoma, retinal detachment, and optic atrophy.",
      "Neurological manifestations of the condition may involve ataxia, athetosis, spasticity, and seizures.",
      "Other signs may include respiratory, cardiovascular, gastrointestinal, and endocrine problems."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Harlequin syndrome is not a genetic disorder. It is a condition that affects the autonomic nervous system and causes one side of your face to sweat and become red while the other side does not.",
      "false, [corrected fact]: Notable skin manifestations in Harlequin syndrome are not as described. The syndrome typically presents with unilateral facial flushing or sweating.",
      "false, [corrected fact]: Ocular manifestations do not typically occur in Harlequin syndrome.",
      "false, [corrected fact]: Neurological manifestations such as ataxia, athetosis, spasticity, and seizures are not associated with Harlequin syndrome. Most commonly it presents with unilateral facial flushing and sweating.",
      "false, [corrected fact]: Harlequin syndrome does not typically entail respiratory, cardiovascular, gastrointestinal, and endocrine problems. It primarily affects the autonomic nervous system resulting in asymmetrical facial flushing and sweating."
    ]
  },
  {
    "id": 1864,
    "user_query": "What is the role of the constitutive photomorphogenesis 9 signalosome (CSN)?",
    "llama-2-7b-chat-hf_response": "The constitutive photomorphogenesis 9 (CP9) signalosome is a protein complex that plays a crucial role in regulating plant growth and development in response to light. The CSN is composed of seven proteins: CP9, PIF7, PIF4, PIF3, PIF2, PIF1, and HY5. These proteins work together to integrate light signals and regulate gene expression, leading to changes in plant morphology and physiology.\nThe CSN acts as a hub for light signaling pathways, integrating signals from multiple photoreceptors and transmitting them to downstream targets. The complex is activated by light, leading to the phosphorylation and activation of CP9, which then recruits and activates other CSN components. The CSN regulates a wide range of processes, including seedling de-etiolation, shade avoidance, and flowering time.\nIn addition to its role in light signaling, the CSN has been implicated in other cellular processes, including stress response and hormone signaling. The CSN is also involved in the regulation of circadian rhythms and has been shown to interact with other signaling pathways, such as the abscisic acid (ABA) and ethylene signaling pathways.\nOverall, the constitutive photomorphogenesis 9 signalosome plays a critical role in regulating plant growth and development in response to light, and its dysregulation can lead to a range of developmental and physiological defects in plants.",
    "llama-2-7b-chat-hf_fact": [
      "The constitutive photomorphogenesis 9 (CP9) signalosome is a protein complex that regulates plant growth and development in response to light.",
      "The CSN is composed of seven proteins: CP9, PIF7, PIF4, PIF3, PIF2, PIF1, and HY5.",
      "The CSN is activated by light, leading to the phosphorylation and activation of CP9.",
      "Besides light signaling, the CSN is also involved in stress response, hormone signaling, and regulation of circadian rhythms.",
      "The CSN is known to interact with the abscisic acid (ABA) and ethylene signaling pathways."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-7b-chat-hf_response": "ERAP1-ERAP2 dimerization promotes the degradation of double-stranded RNA (dsRNA) and microRNAs (miRNAs) through the RNA-induced silencing complex (RISC) pathway. This process is important for regulating gene expression and preventing the accumulation of toxic RNA species in cells.\nERAP1 and ERAP2 are two enzymes that work together to degrade RNA molecules. When they dimerize, they form a more stable complex that is better able to recognize and degrade RNA substrates. This process is important for regulating gene expression and preventing the accumulation of toxic RNA species in cells.\nERAP1-ERAP2 dimerization also plays a role in the regulation of miRNA biogenesis. miRNAs are small RNA molecules that play a key role in regulating gene expression by binding to messenger RNA (mRNA) and preventing its translation. ERAP1-ERAP2 dimerization helps to degrade miRNAs, which can affect their ability to regulate gene expression.\nIn summary, ERAP1-ERAP2 dimerization promotes the degradation of dsRNA and miRNAs, which are important for regulating gene expression and preventing the accumulation of toxic RNA species in cells.",
    "llama-2-7b-chat-hf_fact": [
      "ERAP1-ERAP2 dimerization promotes the degradation of double-stranded RNA (dsRNA) and microRNAs (miRNAs) through the RNA-induced silencing complex (RISC) pathway.",
      "ERAP1 and ERAP2 are two enzymes that work together to degrade RNA molecules.",
      "When ERAP1 and ERAP2 dimerize, they form a stable complex that can better recognize and degrade RNA substrates.",
      "ERAP1-ERAP2 dimerization plays a role in the regulation of miRNA biogenesis.",
      "MicroRNAs are small RNA molecules that regulate gene expression by binding to messenger RNA and preventing its translation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false, [corrected fact]: ERAP1 and ERAP2 are aminopeptidases involved in antigen processing, not in RNA degradation.",
      "false, [corrected fact]: There is no recognized role for ERAP1-ERAP2 dimerization in enhancing RNA substrate degradation.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1868,
    "user_query": "What is plantar fasciitis",
    "llama-2-7b-chat-hf_response": "?\nPlantar fasciitis is a common condition that affects the heel and bottom of the foot. It is caused by inflammation of the plantar fascia, a band of tissue that runs along the bottom of the foot, connecting the heel bone to the toes. The plantar fascia supports the arch of the foot and helps to absorb shock as you walk or run. However, when the plantar fascia becomes inflamed, it can cause pain and stiffness in the heel and bottom of the foot.\nPlantar fasciitis can be caused by a variety of factors, including:\n* Overuse or repetitive strain on the plantar fascia, such as from running or standing for long periods of time\n* Age-related wear and tear on the plantar fascia\n* Obesity or being overweight\n* Poor foot mechanics or biomechanics, such as overpronation or flat feet\n* Trauma or injury to the heel or foot\n* Medical conditions such as rheumatoid arthritis or lupus\nSymptoms of plantar fasciitis can include:\n* Pain in the heel or bottom of the foot, especially after rest or inactivity\n* Stiffness in the heel or foot\n* Pain or stiffness that worsens with activity and improves with rest\n* Swelling or redness in the heel or foot\n* Difficulty standing on tiptoes or climbing stairs\nTreatment for plantar fasciitis can include:\n* Rest and ice to reduce inflammation and relieve pain\n* Stretching and strengthening exercises to improve foot mechanics and reduce tension on the plantar fascia\n* Footwear modifications, such as wearing shoes with good arch support and cushioning\n* Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections to reduce pain and inflammation\n* Physical therapy to improve range of motion and strength in the foot and ankle\n* Orthotic devices or shoe inserts to support the arch and reduce tension on the plantar fascia\nIn severe cases of plantar fasciitis, surgery may be necessary to release the plantar fascia and relieve",
    "llama-2-7b-chat-hf_fact": [
      "Plantar fasciitis is a condition that affects the heel and bottom of the foot.",
      "Plantar fasciitis is caused by the inflammation of the plantar fascia, a band of tissue that supports the arch of the foot and absorbs shock.",
      "Possible causes of plantar fasciitis can include overuse, age-related wear and tear, obesity, poor foot mechanics, trauma, and medical conditions like rheumatoid arthritis or lupus.",
      "Symptoms of plantar fasciitis include pain and stiffness in the heel or foot, swelling or redness, and difficulty standing on tiptoes or climbing stairs.",
      "Treatment options for plantar fasciitis can include rest, ice, exercises, footwear modifications, medication, physical therapy, orthotic devices, and in severe cases, surgery."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1869,
    "user_query": "Which is the enzymatic activity of OTULIN?",
    "llama-2-7b-chat-hf_response": "A) Peptidyl-prolyl cis-trans isomerase\nB) Protein disulfide isomerase\nC) Glycosyltransferase\nD) Peptidyl-tRNA hydrolase\nAnswer: A) Peptidyl-prolyl cis-trans isomerase\nExplanation:\nOTULIN is an enzyme that belongs to the peptidyl-prolyl cis-trans isomerase (PPI) family. PPIs are enzymes that catalyze the cis-trans isomerization of peptide bonds, which is a reversible reaction that involves the rearrangement of the stereochemistry of the peptide backbone. OTULIN is specifically involved in the isomerization of proline-rich peptide bonds, which is important for protein folding and stability. Therefore, the correct answer is (A) Peptidyl-prolyl cis-trans isomerase.",
    "llama-2-7b-chat-hf_fact": [
      "OTULIN is an enzyme that belongs to the peptidyl-prolyl cis-trans isomerase (PPI) family.",
      "Peptidyl-prolyl cis-trans isomerases are enzymes that catalyze the cis-trans isomerization of peptide bonds.",
      "The cis-trans isomerization of peptide bonds is a reversible reaction.",
      "The isomerization involves the rearrangement of the stereochemistry of the peptide backbone.",
      "OTULIN is involved in the isomerization of proline-rich peptide bonds, which is crucial for protein folding and stability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: OTULIN is not an enzyme of the peptidyl-prolyl cis-trans isomerase (PPI) family, but it is a deubiquitinase that regulates polyubiquitination.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: OTULIN is not indirectly involved in the isomerization of peptide bonds, but it is involved in the regulation of polyubiquitination."
    ]
  },
  {
    "id": 1874,
    "user_query": "Is there an association between Muenke Syndrome and FGFR3 gene mutation?",
    "llama-2-7b-chat-hf_response": "Muenke syndrome is a rare genetic disorder that affects the development of the brain and face. It is caused by mutations in the FGFR3 gene, which is responsible for encoding a protein called fibroblast growth factor receptor 3. This protein plays a crucial role in the development of the brain and face, and mutations in the FGMR3 gene can lead to the characteristic features of Muenke syndrome, such as microcephaly, brachycephaly, and craniofacial abnormalities.\nMuenke syndrome is also known as 22q13.3 deletion syndrome, as it is often associated with a deletion of genetic material on chromosome 22, specifically at the q13.3 locus. The FGFR3 gene is located on chromosome 22, and mutations in this gene are thought to be responsible for the majority of cases of Muenke syndrome.\nIn addition to craniofacial abnormalities, Muenke syndrome can also cause a range of other symptoms, including intellectual disability, seizures, and delayed speech and language development. Treatment for Muenke syndrome typically involves a multidisciplinary approach, including medical management of associated symptoms and surgical interventions to correct craniofacial abnormalities.\nWhile Muenke syndrome is a rare disorder, it is important to be aware of its association with FGFR3 gene mutations, as early diagnosis and appropriate management can significantly improve outcomes for affected individuals.",
    "llama-2-7b-chat-hf_fact": [
      "Muenke syndrome is a rare genetic disorder that affects the development of the brain and face.",
      "Muenke syndrome is caused by mutations in the FGFR3 gene.",
      "The FGFR3 gene encodes a protein called fibroblast growth factor receptor 3.",
      "Muenke syndrome is also known as 22q13.3 deletion syndrome, associated with a deletion of genetic material on chromosome 22 at the q13.3 locus.",
      "Symptoms of Muenke syndrome can include intellectual disability, seizures, and delayed speech and language development."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Muenke syndrome is not known as 22q13.3 deletion syndrome, that is a different disorder known as Phelan-McDermid syndrome.",
      "true"
    ]
  },
  {
    "id": 1875,
    "user_query": "Which R package is used for visualization of linear and circular karyotypes?",
    "llama-2-7b-chat-hf_response": "The R package \"karyo\" is used for visualization of linear and circular karyotypes. It provides a variety of functions for visualizing karyotypes, including plotting chromosomes, bands, and genetic markers, as well as performing karyotype analysis.",
    "llama-2-7b-chat-hf_fact": [
      "The \"karyo\" is an R package.",
      "The \"karyo\" R package is used for visualizing linear and circular karyotypes.",
      "This package provides functions for plotting chromosomes, bands, and genetic markers.",
      "The \"karyo\" R package can be used to perform karyotype analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1882,
    "user_query": "What is Bartter syndrome?",
    "llama-2-7b-chat-hf_response": "Bartter syndrome is a rare genetic disorder that affects the kidneys and causes problems with electrolyte balance and acid-base balance in the body. It is caused by mutations in the genes that code for proteins involved in the transport of sodium and chloride ions in the kidneys.\nThere are three types of Bartter syndrome, each with different symptoms and severity:\nType 1: This is the most common form of Bartter syndrome, accounting for about 70% of cases. It is characterized by hypokalemia (low potassium levels), hyperaldosteronism (excessive production of the hormone aldosterone), and metabolic acidosis (excessive acidity in the body).\nType 2: This type is less severe than Type 1 and typically presents in childhood. It is characterized by hypokalemia, hyperaldosteronism, and metabolic alkalosis (excessive basicity in the body).\nType 3: This is the mildest form of Bartter syndrome and typically presents in adulthood. It is characterized by hypokalemia and hyperaldosteronism, but not metabolic acidosis or alkalosis.\nSymptoms of Bartter syndrome can include:\n* Fatigue\n* Muscle weakness\n* Muscle cramps\n* Abnormal heart rhythms\n* Nausea and vomiting\n* Diarrhea\n* Constipation\n* Increased thirst and urination\n* Decreased appetite\n* Weight loss\nBartter syndrome can be diagnosed through a combination of physical examination, medical history, and laboratory tests, including:\n* Electrolyte panel: This measures the levels of electrolytes such as potassium, sodium, and chloride in the blood.\n* Aldosterone test: This measures the level of the hormone aldosterone in the blood.\n* Renin test: This measures the level of the enzyme renin in the blood, which is involved in the production of aldosterone.\n* Genetic testing: This can identify mutations in the genes that cause Bartter syndrome.\nTreatment for Bartter syndrome typically involves",
    "llama-2-7b-chat-hf_fact": [
      "Bartter syndrome is a rare genetic disorder that affects the kidneys and disrupts electrolyte and acid-base balance in the body.",
      "The condition is caused by mutations in genes that code for proteins involved in the transport of sodium and chloride ions in the kidneys.",
      "There are three types of Bartter syndrome (Type 1, 2, and 3), each with different symptoms and varying severity.",
      "Type 1 Bartter syndrome, the most common type, is characterized by low potassium levels, excessive production of the hormone aldosterone, and excessive acidity in the body.",
      "An electrolyte panel, aldosterone test, renin test, and genetic testing can be used to diagnose Bartter syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There are five types of Bartter syndrome (Type 1, 2, 3, 4, and 5), each with different symptoms and varying severity.",
      "true",
      "true"
    ]
  },
  {
    "id": 1884,
    "user_query": "List RNA modifications databases",
    "llama-2-7b-chat-hf_response": "There are several databases that catalog and annotate RNA modifications, including:\n1. RNA Modifications Database (RMDB): A comprehensive database of RNA modifications, including base modifications, pseudouridine, inosine, and N6-methyladenosine.\n2. ModBase: A database of RNA and DNA modifications, including base modifications, pseudouridine, inosine, and N6-methyladenosine.\n3. Nucleic Acids Research Database (NARDB): A database of RNA and DNA modifications, including base modifications, pseudouridine, inosine, and N6-methyladenosine.\n4. RNA Base Modification Database (RBMD): A database of RNA base modifications, including N6-methyladenosine, N1-methyladenosine, and N1-methylguanosine.\n5. Inosine Nucleotide Database (INDB): A database of inosine nucleotides, including inosine monophosphate, inosine diphosphate, and inosine triphosphate.\n6. Pseudouridine Nucleotide Database (PND): A database of pseudouridine nucleotides, including pseudouridine monophosphate, pseudouridine diphosphate, and pseudouridine triphosphate.\n7. RNA Methylation Database (RMD): A database of RNA methylation, including N6-methyladenosine, N1-methyladenosine, and N1-methylguanosine.\n8. mRNA Modification Database (mRMD): A database of mRNA modifications, including N6-methyladenosine, N1-methyladenosine, and N1-methylguanosine.\n9. tRNA Modification Database (tRMD): A database of tRNA modifications, including N6-methyladenosine, N1-methyladenosine, and N1-methylguanosine.\n10. rRNA Modification Database (rRMD): A database of rRNA modifications, including N6-methyladenosine",
    "llama-2-7b-chat-hf_fact": [
      "The RNA Modifications Database (RMDB) is a comprehensive database of RNA modifications.",
      "ModBase is a database that includes RNA and DNA modifications.",
      "The Nucleic Acids Research Database (NARDB) catalogs RNA and DNA modifications.",
      "The RNA Base Modification Database (RBMD) is a resource for information on RNA base modifications.",
      "The Inosine Nucleotide Database (INDB) specializes in inosine nucleotides."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: ModBase is a database of annotated comparative protein structure models.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1888,
    "user_query": "What gene is mutated in Sickle Cell Anemia?",
    "llama-2-7b-chat-hf_response": "The gene that is mutated in Sickle Cell Anemia is the HBB gene, which encodes the beta-globin subunit of hemoglobin. The HBB gene is located on chromosome 11 and is responsible for producing the beta-globin protein, which combines with the alpha-globin protein (produced by the HBA gene on chromosome 16) to form hemoglobin.\nThe mutation that causes Sickle Cell Anemia is a point mutation in the HBB gene that results in the substitution of a glutamic acid residue for a valine residue at position 6 (Glu6Val) in the beta-globin protein. This substitution leads to the production of abnormal hemoglobin, known as sickle hemoglobin (HbS), which is responsible for the characteristic sickling of red blood cells in Sickle Cell Anemia patients.\nThe HBB gene mutation that causes Sickle Cell Anemia is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the disease. If a person inherits only one mutated copy of the HBB gene, they will be a carrier of the disease but will not develop symptoms themselves.",
    "llama-2-7b-chat-hf_fact": [
      "The HBB gene, which is mutated in Sickle Cell Anemia, encodes the beta-globin subunit of hemoglobin.",
      "The HBB gene is located on chromosome 11.",
      "A point mutation in the HBB gene results in the substitution of a glutamic acid residue for a valine residue at position 6 in the beta-globin protein.",
      "The mutation in the HBB gene leads to the production of abnormal hemoglobin known as sickle hemoglobin (HbS).",
      "The HBB gene mutation that causes Sickle Cell Anemia is inherited in an autosomal recessive pattern."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1889,
    "user_query": "What is the function of the Indian hedgehog protein in chondrocytes?",
    "llama-2-7b-chat-hf_response": "The Indian hedgehog protein (IHH) is a secreted protein that plays a crucial role in regulating the development and growth of chondrocytes, which are the cells responsible for producing cartilage in the body. In chondrocytes, IHH functions as a negative regulator of chondrocyte proliferation and differentiation, meaning that it inhibits the growth and maturation of chondrocytes. This is achieved through the binding of IHH to its receptor, Patched (PTCH), which triggers a signaling pathway that inhibits the expression of genes involved in chondrocyte proliferation and differentiation.\nIn addition to its role in regulating chondrocyte development and growth, IHH has been implicated in the regulation of cartilage homeostasis and repair. For example, IHH has been shown to promote the proliferation and migration of chondrocytes in response to injury, and to regulate the expression of genes involved in cartilage repair.\nOverall, the function of IHH in chondrocytes is to regulate the balance between chondrocyte proliferation and differentiation, and to promote the maintenance of healthy cartilage tissue. Dysregulation of IHH signaling has been implicated in a number of cartilage-related disorders, including joint degeneration and osteoarthritis.",
    "llama-2-7b-chat-hf_fact": [
      "Indian hedgehog protein (IHH) plays an important role in the development and growth of chondrocytes.",
      "Chondrocytes are the cells responsible for producing cartilage in the body.",
      "The function of the IHH in chondrocytes includes inhibiting the growth and maturation of these cells.",
      "IHH also contributes to the regulation of cartilage homeostasis and repair.",
      "Dysregulation of IHH signaling has been linked to several cartilage-related disorders, including joint degeneration and osteoarthritis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The function of the IHH in chondrocytes includes promoting the growth and maturation of these cells.",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-7b-chat-hf_response": "R-spondin 1 and Noggin are two secreted proteins that have been implicated in the regulation of gallbladder development and function. In non-damaged gallbladders, R-spondin 1 and Noggin have been shown to play a role in the maintenance of gallbladder epithelial cell proliferation and differentiation, as well as the regulation of bile acid transport and storage.\nR-spondin 1 has been shown to promote the proliferation and differentiation of gallbladder epithelial cells, and to regulate the expression of genes involved in bile acid transport and storage. Noggin, on the other hand, has been shown to inhibit the proliferation of gallbladder epithelial cells, and to regulate the expression of genes involved in bile acid transport and storage.\nIn addition to their role in gallbladder development and function, R-spondin 1 and Noggin have also been implicated in the regulation of gallbladder cancer. R-spondin 1 has been shown to inhibit the growth of gallbladder cancer cells, while Noggin has been shown to promote the growth of these cells.\nOverall, the function of R-spondin 1 and Noggin in non-damaged gallbladders is to regulate the maintenance of gallbladder epithelial cell proliferation and differentiation, as well as the regulation of bile acid transport and storage. Their dysregulation has been implicated in the development and progression of gallbladder cancer.",
    "llama-2-7b-chat-hf_fact": [
      "R-spondin 1 and Noggin are two secreted proteins that are involved in the regulation of gallbladder development and function.",
      "In non-damaged gallbladders, R-spondin 1 and Noggin are involved in the maintenance of gallbladder epithelial cell proliferation and differentiation, as well as bile acid transport and storage.",
      "R-spondin 1 promotes the proliferation and differentiation of gallbladder epithelial cells and regulates the expression of genes involved in bile acid transport and storage.",
      "Noggin inhibits the proliferation of gallbladder epithelial cells and regulates the expression of genes involved in bile acid transport and storage.",
      "R-spondin 1 and Noggin have also been implicated in the regulation of gallbladder cancer. R-spondin 1 inhibits the growth of gallbladder cancer cells while Noggin promotes the growth of these cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1897,
    "user_query": "Which is the genome browser database for DNA shape annotations?",
    "llama-2-7b-chat-hf_response": "There are several genome browsers that provide DNA shape annotations, including:\n1. UCSC Genome Browser: The UCSC Genome Browser is a popular genome browser that provides DNA shape annotations for a variety of organisms, including humans.\n2. Ensembl Genome Browser: The Ensembl Genome Browser is another widely-used genome browser that provides DNA shape annotations for a variety of organisms, including humans.\n3. Genome Graph Browser: The Genome Graph Browser is a genome browser that focuses specifically on the 3D structure of genomes, and provides DNA shape annotations for a variety of organisms.\n4. ChromHMM: ChromHMM is a genome browser that provides DNA shape annotations for a variety of organisms, including humans, based on chromatin conformation data.\n5. 3D Genome Browser: The 3D Genome Browser is a genome browser that provides DNA shape annotations for a variety of organisms, including humans, based on 3D chromatin structure data.\n6. Open3DGenome: Open3DGenome is an open-source genome browser that provides DNA shape annotations for a variety of organisms, including humans, based on 3D chromatin structure data.\n7. Genome3D: Genome3D is a genome browser that provides DNA shape annotations for a variety of organisms, including humans, based on 3D chromatin structure data.\n8. Chromatin3D: Chromatin3D is a genome browser that provides DNA shape annotations for a variety of organisms, including humans, based on 3D chromatin structure data.\nPlease note that this is not an exhaustive list, and there may be other genome browsers that provide DNA shape annotations as well.",
    "llama-2-7b-chat-hf_fact": [
      "The UCSC Genome Browser provides DNA shape annotations.",
      "The Ensembl Genome Browser also provides DNA shape annotations.",
      "Genome Graph Browser concentrates on the 3D structure of genomes and supplies DNA shape annotations.",
      "ChromHMM is a genome browser that features DNA shape annotations informed by chromatin conformation data.",
      "Open3DGenome is an open-source genome browser that gives DNA shape annotations based on 3D chromatin structure data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "false, [corrected fact]: ChromHMM is a tool for learning and characterizing chromatin states, it does not provide DNA shape annotations.",
      "unknown"
    ]
  },
  {
    "id": 1903,
    "user_query": "Where is the respirasome located?",
    "llama-2-7b-chat-hf_response": "The respirasome is located in the mitochondria of cells. Mitochondria are organelles found in the cells of most eukaryotes, including animals, plants, and fungi. They are often referred to as the \"powerhouses\" of cells because they generate most of the energy that cells need to function. The respirasome is located within the mitochondria, where it plays a crucial role in the process of cellular respiration, which is the process by which cells generate energy from the food they consume.",
    "llama-2-7b-chat-hf_fact": [
      "The respirasome is located in the mitochondria of cells.",
      "Mitochondria are organelles found in the cells of most eukaryotes.",
      "Mitochondria generate most of the energy that cells need to function.",
      "The respirasome plays a crucial role in the process of cellular respiration.",
      "Cellular respiration is the process by which cells generate energy from the food they consume."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1906,
    "user_query": "What kind of analyses are performed with the software tool \"unipept\"",
    "llama-2-7b-chat-hf_response": "in bioinformatics?\nUnipept is a bioinformatics tool that performs various analyses on peptide sequences. Some of the key analyses performed by unipept include:\n1. Peptide identification: Unipept can be used to identify peptides in a given protein sequence. This involves comparing the protein sequence to a database of known peptides to find matches.\n2. Peptide classification: Unipept can classify peptides into different categories based on their properties, such as their length, charge, and hydrophobicity.\n3. Peptide similarity search: Unipept can be used to search for similar peptides in a database of known peptides. This can be useful for identifying homologous peptides in different proteins.\n4. Peptide structure prediction: Unipept can predict the three-dimensional structure of a peptide based on its sequence. This can be useful for understanding how the peptide interacts with other molecules.\n5. Peptide function prediction: Unipept can predict the function of a peptide based on its sequence and structure. This can be useful for identifying the biological role of a peptide.\n6. Peptide-protein interaction prediction: Unipept can predict the interactions between a peptide and a protein. This can be useful for understanding how a peptide affects the function of a protein.\n7. Peptide-ligand interaction prediction: Unipept can predict the interactions between a peptide and a ligand. This can be useful for understanding how a peptide binds to a specific ligand.\n8. Peptide-protein complex prediction: Unipept can predict the structure of a peptide-protein complex. This can be useful for understanding how a peptide interacts with a protein in a complex.\n9. Peptide-ligand docking: Unipept can predict the docking of a peptide to a ligand. This can be useful for understanding how a peptide binds to a specific ligand.\n10. Peptide-protein structure prediction: Unipept can predict the structure of a peptide-protein complex. This can be useful for understanding how a peptide interacts",
    "llama-2-7b-chat-hf_fact": [
      "Unipept is a bioinformatics tool used for various analyses on peptide sequences.",
      "Unipept can identify peptides in a provided protein sequence by comparing it to a database of known peptides.",
      "The software is also capable of classifying peptides into different categories based on their properties such as their length, charge, and hydrophobicity.",
      "Unipept can predict the three-dimensional structure of a peptide based on its sequence.",
      "It can predict the interactions between a peptide and a protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1907,
    "user_query": "What is the role of gamma-secreatase complex in Alzheimer's Disease?",
    "llama-2-7b-chat-hf_response": "Gamma-secretase complex is a protease that plays a crucial role in the processing of the amyloid precursor protein (APP) in the brain. APP is a transmembrane protein that is cleaved by various proteases to produce different fragments, including the amyloid beta (A) peptide. A peptides are the main component of amyloid plaques, which are a hallmark of Alzheimer's disease (AD).\nThe gamma-secretase complex is composed of several proteins, including presenilin 1 (PS1) and presenilin 2 (PS2), nicastrin, anterior pharynx defective 1 (APH1), and presenilin enhancer 2 (PEN2). These proteins work together to cleave APP at specific sites, leading to the production of A peptides.\nResearch has shown that mutations in the PS1 and PS2 genes, which encode the proteins of the gamma-secretase complex, are associated with early-onset AD. These mutations can lead to the production of A peptides that are more prone to aggregation and accumulation, contributing to the progression of AD.\nIn addition, the gamma-secretase complex has been shown to play a role in the regulation of other cellular processes, including cell adhesion, migration, and signaling. Dysregulation of these processes may also contribute to the pathogenesis of AD.\nOverall, the gamma-secretase complex plays a critical role in the processing of APP and the production of A peptides, which are hallmarks of AD. Understanding the role of this complex in AD may lead to the development of new therapeutic strategies for the disease.",
    "llama-2-7b-chat-hf_fact": [
      "Gamma-secretase complex is crucial in the processing of the amyloid precursor protein (APP) in the brain.",
      "APP, when cleaved by various proteases, produces different fragments including the amyloid beta (A) peptide, which is a main component of amyloid plaques in Alzheimer's disease.",
      "The gamma-secretase complex is composed of several proteins including presenilin 1, presenilin 2, nicastrin, anterior pharynx defective 1, and presenilin enhancer 2.",
      "Mutations in the PS1 and PS2 genes, which encode the proteins of the gamma-secretase complex, are associated with early-onset Alzheimer's disease.",
      "The gamma-secretase complex also regulates cell adhesion, migration, and signaling."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1912,
    "user_query": "List peptide fragmentations methods in mass spectrometry",
    "llama-2-7b-chat-hf_response": "Mass spectrometry is a powerful analytical technique used to identify and quantify molecules based on their mass-to-charge ratio. One of the key steps in mass spectrometry is the fragmentation of peptides, which involves breaking down larger peptide molecules into smaller fragments. There are several methods for peptide fragmentation, each with its own advantages and limitations. Here are some common peptide fragmentation methods in mass spectrometry:\n1. Matrix-assisted laser desorption/ionization (MALDI): MALDI is a widely used method for peptide fragmentation. In this method, a peptide sample is mixed with a matrix material, such as sinapic acid or alpha-cyano-4-hydroxycinnamic acid, and then bombarded with a laser beam. The resulting ions are then separated based on their mass-to-charge ratio using a mass spectrometer.\n2. Electrospray ionization (ESI): ESI is another common method for peptide fragmentation. In this method, a peptide sample is dissolved in a solvent and then sprayed into a mass spectrometer through a fine capillary. The resulting ions are then separated based on their mass-to-charge ratio using a mass spectrometer.\n3. Fast atom bombardment (FAB): FAB is a method for peptide fragmentation that involves bombarding a peptide sample with high-energy atoms, such as nitrogen or argon ions. The resulting ions are then separated based on their mass-to-charge ratio using a mass spectrometer.\n4. Collision-induced dissociation (CID): CID is a method for peptide fragmentation that involves colliding a peptide molecule with a gas, such as nitrogen or helium, to break it down into smaller fragments. The resulting fragments are then separated based on their mass-to-charge ratio using a mass spectrometer.\n5. High-energy collision dissociation (HCD): HCD is a variation of CID that involves colliding a peptide molecule with a high-energy gas, such as argon or xenon, to break it down into smaller fragments. The resulting fragments are then separated based on their mass-to-charge ratio",
    "llama-2-7b-chat-hf_fact": [
      "Matrix-assisted laser desorption/ionization (MALDI) is a method for peptide fragmentation in which a peptide sample is mixed with a matrix material and then bombarded with a laser beam.",
      "Electrospray ionization (ESI) is a method in mass spectrometry where a peptide sample is dissolved in a solvent and then sprayed into a mass spectrometer through a fine capillary.",
      "Fast atom bombardment (FAB) is a technique for fragmenting peptides that involves bombarding a peptide sample with high-energy atoms, such as nitrogen or argon ions.",
      "Collision-induced dissociation (CID) is a peptide fragmentation method that involves colliding a peptide molecule with a gas, such as nitrogen or helium, to break it down into smaller fragments.",
      "High-energy collision dissociation (HCD) involves colliding a peptide molecule with a high-energy gas, such as argon or xenon, to break it down into smaller fragments."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Matrix-assisted laser desorption/ionization (MALDI) is a method for generating ions in mass spectrometry, where a peptide sample is mixed with a matrix material and then bombarded with a laser beam. It's not specifically for peptide fragmentation.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1915,
    "user_query": "Which infection can be prevented with Dapivirine?",
    "llama-2-7b-chat-hf_response": "Dapivirine is an antiretroviral drug that is used to prevent HIV-1 infection in high-risk individuals. It is available in the form of a vaginal ring, which releases the drug continuously over a period of 28 days. Dapivirine has been shown to be effective in preventing HIV-1 infection in several clinical trials.\nA. HIV-1\nB. HIV-2\nC. Herpes simplex virus\nD. Human papillomavirus\nAnswer: A. HIV-1\nExplanation: Dapivirine is specifically designed to prevent HIV-1 infection, and it has been shown to be effective in reducing the risk of HIV-1 infection in high-risk individuals. It is not effective against other viruses such as HIV-2, herpes simplex virus, or human papillomavirus.",
    "llama-2-7b-chat-hf_fact": [
      "Dapivirine is an antiretroviral drug.",
      "Dapivirine is used to prevent HIV-1 infection in high-risk individuals.",
      "Dapivirine is available in the form of a vaginal ring.",
      "This vaginal ring releases the drug continuously over a period of 28 days.",
      "Dapivirine is not effective against other viruses such as HIV-2, herpes simplex virus, or human papillomavirus."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1917,
    "user_query": "Is there a role for gamma knife in treatment of Obsessive-Compulsive Disorder?",
    "llama-2-7b-chat-hf_response": "Obsessive-compulsive disorder (OCD) is a chronic and debilitating psychiatric disorder characterized by recurrent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions). The exact pathophysiology of OCD is not fully understood, but it is believed to involve dysfunction in several brain regions, including the orbitofrontal cortex, anterior cingulate cortex, and basal ganglia.\nGamma knife therapy is a non-invasive, focused radiation therapy that has been used to treat various neurological conditions, including brain tumors, arteriovenous malformations, and trigeminal neuralgia. Some studies have suggested that gamma knife therapy may also have a role in the treatment of OCD.\nOne study published in the Journal of Clinical Psychiatry found that gamma knife therapy was effective in reducing OCD symptoms in 70% of patients treated. The study involved 15 patients with medically refractory OCD who underwent gamma knife therapy to the orbitofrontal cortex. Results were assessed using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the Beck Depression Inventory (BDI).\nAnother study published in the Journal of Neuropsychiatry and Clinical Neurosciences found that gamma knife therapy was effective in improving OCD symptoms in patients with comorbid depression. The study involved 10 patients with OCD and comorbid depression who underwent gamma knife therapy to the orbitofrontal cortex. Results were assessed using the Y-BOCS and the Hamilton Rating Scale for Depression (HAM-D).\nWhile these studies suggest that gamma knife therapy may have a role in the treatment of OCD, it is important to note that the results are preliminary and more research is needed to confirm these findings. Additionally, gamma knife therapy is typically used in combination with other treatments, such as medication or psychotherapy, and may not be effective in all patients.\nIn summary, while there is some evidence to suggest that gamma knife therapy may have a role in the treatment of",
    "llama-2-7b-chat-hf_fact": [
      "Obsessive-compulsive disorder (OCD) is a psychiatric disorder characterized by recurrent, intrusive thoughts and repetitive behaviors or mental acts.",
      "Gamma knife therapy is a non-invasive, focused radiation therapy used to treat various neurological conditions.",
      "One study found that gamma knife therapy was effective in reducing OCD symptoms in 70% of patients treated.",
      "Another study found that gamma knife therapy was effective in improving OCD symptoms in patients with comorbid depression.",
      "Gamma knife therapy is typically used in combination with other treatments, such as medication or psychotherapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1918,
    "user_query": "What is the mechanism of action of the biguanide class of diabetes drugs?",
    "llama-2-7b-chat-hf_response": "The biguanide class of diabetes drugs, which includes metformin, works by decreasing glucose production in the liver and increasing insulin sensitivity in the body. The exact mechanism of action of biguanides is not fully understood, but it is believed to involve several different mechanisms, including:\n1. Inhibition of glucose production in the liver: Biguanides, such as metformin, inhibit the enzyme ATP-citrate lyase, which is involved in the synthesis of glucose in the liver. By inhibiting this enzyme, biguanides reduce the amount of glucose produced in the liver, leading to lower blood glucose levels.\n2. Increased insulin sensitivity: Biguanides have been shown to increase insulin sensitivity in the body, which means that they help the body's cells to use insulin more effectively. This can lead to lower blood glucose levels and improved glucose tolerance.\n3. Reduced glucose absorption in the gut: Biguanides may also reduce the absorption of glucose from the gut, which can contribute to lower blood glucose levels.\n4. Increased glucose uptake in the muscles: Biguanides may also increase the uptake of glucose by the muscles, which can help to lower blood glucose levels.\nOverall, the mechanism of action of biguanides is complex and involves multiple pathways and mechanisms. While the exact mechanisms are not fully understood, it is clear that biguanides play an important role in improving glucose metabolism and reducing blood glucose levels in people with type 2 diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "The biguanide class of diabetes drugs, like metformin, decrease glucose production in the liver and increase insulin sensitivity in the body.",
      "Biguanides are believed to inhibit the enzyme ATP-citrate lyase.",
      "ATP-citrate lyase is involved in the synthesis of glucose in the liver.",
      "Biguanides are known to increase insulin sensitivity, which enables the body's cells to use insulin more effectively.",
      "Increased glucose uptake by the muscles is a process that some biguanides have been shown to promote."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Biguanides are believed to inhibit the enzyme glucokinase, not ATP-citrate lyase.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1919,
    "user_query": "Where is the proteasome located?",
    "llama-2-7b-chat-hf_response": "The proteasome is located in the cytoplasm of eukaryotic cells, as well as in the nucleus of some cells. In prokaryotic cells, the proteasome is located in the cytoplasm. The proteasome is a large protein complex that plays a crucial role in the degradation of proteins within cells. It is responsible for breaking down proteins into smaller peptides, which can then be further degraded or recycled. The proteasome is a crucial component of the cell's protein degradation pathway, and its dysfunction has been implicated in a number of diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The proteasome is located in the cytoplasm of eukaryotic cells.",
      "In some cells, the proteasome can also be found in the nucleus.",
      "The proteasome is a large protein complex that aids in the degradation of proteins.",
      "The proteasome breaks down proteins into smaller peptides for further degradation or recycling.",
      "Dysfunction of the proteasome has been connected with numerous diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1923,
    "user_query": "List available circular RNA prediction tools.",
    "llama-2-7b-chat-hf_response": "There are several tools available for predicting circular RNA (circRNA) in genomic sequences. Here are some of the commonly used tools:\n1. Circular RNA Predictor (circRNA-Pred): This tool uses a machine learning approach to predict circRNAs in genomic sequences. It can predict both spliced and unspliced circRNAs and can handle both coding and non-coding regions of the genome.\n2. Circular RNA Finder (cirRNA-Finder): This tool uses a hidden Markov model (HMM) to predict circRNAs in genomic sequences. It can predict both spliced and unspliced circRNAs and can handle both coding and non-coding regions of the genome.\n3. RNAfold: This tool uses a dynamic programming algorithm to predict the secondary and tertiary structure of RNA molecules, including circRNAs. It can predict the structure of both spliced and unspliced circRNAs and can handle both coding and non-coding regions of the genome.\n4. RNApredict: This tool uses a machine learning approach to predict the secondary and tertiary structure of RNA molecules, including circRNAs. It can predict the structure of both spliced and unspliced circRNAs and can handle both coding and non-coding regions of the genome.\n5. Deep Circular RNA Predictor (Deep-circRNA): This tool uses a deep learning approach to predict circRNAs in genomic sequences. It can predict both spliced and unspliced circRNAs and can handle both coding and non-coding regions of the genome.\n6. Circular RNA Predictor 2 (circRNA-Pred2): This tool uses a machine learning approach to predict circRNAs in genomic sequences. It can predict both spliced and unspliced circRNAs and can handle both coding and non-coding regions of the genome.\n7. Circular RNA Finder 2 (cirRNA-Finder2): This tool uses a hidden Markov model (HMM) to predict circRNAs in genomic sequences. It can predict both spliced and unsp",
    "llama-2-7b-chat-hf_fact": [
      "The Circular RNA Predictor (circRNA-Pred) is a tool that uses machine learning to predict circular RNA in genomic sequences.",
      "The Circular RNA Finder (cirRNA-Finder) uses a hidden Markov model to predict circRNAs in genomic sequences.",
      "RNAfold uses a dynamic programming algorithm to predict the secondary and tertiary structure of RNA molecules, including circRNAs.",
      "RNApredict uses a machine learning approach to predict the secondary and tertiary structure of RNA molecules, including circRNAs.",
      "The Deep Circular RNA Predictor (Deep-circRNA) uses a deep learning approach to predict circRNAs in genomic sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1924,
    "user_query": "Which disease is treated with Nusinersen?",
    "llama-2-7b-chat-hf_response": "Nusinersen is a medication used to treat spinal muscular atrophy (SMA), a genetic disorder that affects muscle strength and movement. It is given by injection and works by increasing the amount of a protein called survival motor neuron 1 (SMN1) in the body. This protein is important for the health and function of nerve cells, particularly those in the spinal cord. By increasing the amount of SMN1, nusinersen can help to slow the progression of SMA and improve muscle strength and function.",
    "llama-2-7b-chat-hf_fact": [
      "Nusinersen is a medication used to treat spinal muscular atrophy (SMA).",
      "Spinal muscular atrophy is a genetic disorder that affects muscle strength and movement.",
      "Nusinersen is administered by injection.",
      "Nusinersen works by increasing the amount of a protein called survival motor neuron 1 (SMN1) in the body.",
      "Survival motor neuron 1 (SMN1) is important for the health and function of nerve cells, particularly those in the spinal cord."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Nusinersen works by increasing the amount of a protein called survival motor neuron 2 (SMN2) in the body.",
      "true"
    ]
  },
  {
    "id": 1925,
    "user_query": "Which disease the London mutation involved in?",
    "llama-2-7b-chat-hf_response": "The London mutation is a genetic mutation that affects the CCR5 gene, which is involved in the immune system. Specifically, the London mutation is a deletion of 3 base pairs in the CCR5 gene that results in the loss of function of the CCR5 protein. This mutation has been found to be associated with resistance to HIV infection.",
    "llama-2-7b-chat-hf_fact": [
      "The London mutation is a genetic mutation that affects the CCR5 gene.",
      "The CCR5 gene is involved in the immune system.",
      "The London mutation is a deletion of 3 base pairs in the CCR5 gene.",
      "This mutation causes a loss of function of the CCR5 protein.",
      "The London mutation is associated with resistance to HIV infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Delta 32 mutation is a genetic mutation that affects the CCR5 gene. The 'London mutation' is not a recognised term.",
      "true",
      "false, [corrected fact]: The Delta 32 mutation is a deletion of 32 base pairs in the CCR5 gene.",
      "true",
      "true"
    ]
  },
  {
    "id": 1930,
    "user_query": "Viliuisk encephalomyelitis is diagnosed in which geographical area?",
    "llama-2-7b-chat-hf_response": "Viliuisk encephalomyelitis is a rare autoimmune disease that affects the central nervous system (CNS) and is endemic in the Viliuisk region of Siberia, Russia. The disease is characterized by inflammation of the brain and spinal cord, leading to a range of neurological symptoms including seizures, weakness, and cognitive impairment. The exact cause of Viliuisk encephalomyelitis is not known, but it is believed to be triggered by a combination of genetic and environmental factors, including exposure to certain viruses and bacteria. There is currently no cure for the disease, and treatment is focused on managing symptoms and preventing complications.",
    "llama-2-7b-chat-hf_fact": [
      "Viliuisk encephalomyelitis is an autoimmune disease that affects the central nervous system.",
      "Viliuisk encephalomyelitis is endemic in the Viliuisk region of Siberia, Russia.",
      "The disease causes inflammation of the brain and spinal cord, and can lead to neurological symptoms like seizures, weakness, and cognitive impairment.",
      "The exact cause of Viliuisk encephalomyelitis is not known and is believed to be triggered by a combination of genetic and environmental factors.",
      "Currently, there is no known cure for Viliuisk encephalomyelitis, with treatments focusing on symptom management and preventing complications."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1934,
    "user_query": "What makes telomerase a good drug target?",
    "llama-2-7b-chat-hf_response": "Telomerase is a good drug target because it is a key enzyme involved in the maintenance of telomeres, which are the protective endcaps on chromosomes that shorten with each cell division. When telomeres become too short, cells can enter a state of senescence or undergo programmed cell death, also known as apoptosis. Cancer cells, however, can bypass this mechanism by producing high levels of telomerase, which allows them to maintain their telomeres and continue to divide indefinitely.\nTargeting telomerase with specific inhibitors has shown promise in preclinical studies as a potential cancer therapy. By inhibiting telomerase, cancer cells are unable to maintain their telomeres, leading to cell cycle arrest or apoptosis. In addition, telomerase inhibitors have been shown to synergize with other cancer therapies, such as chemotherapy and radiation, to enhance their anti-tumor effects.\nThere are several reasons why telomerase is a good drug target:\n1. Telomerase is highly specific to cancer cells: Telomerase is expressed at much higher levels in cancer cells than in normal cells, making it a highly specific target for cancer therapy.\n2. Telomerase is essential for cancer cell proliferation: Telomerase is required for cancer cells to maintain their telomeres and continue to divide, making it an essential target for cancer therapy.\n3. Telomerase inhibitors have shown anti-tumor activity: Several telomerase inhibitors have been shown to have anti-tumor activity in preclinical studies, both as single agents and in combination with other cancer therapies.\n4. Telomerase inhibitors have a unique mechanism of action: Telomerase inhibitors work by binding to the telomerase enzyme and preventing it from carrying out its normal function, leading to cell cycle arrest or apoptosis. This unique mechanism of action makes telomerase inhibitors distinct from other cancer therapies.\n5. Telomerase inhibitors have the potential to treat a wide range of cancers: Telomerase is expressed in many different types of cancer, including breast, lung, colon, and ovarian cancer, making telomerase inhibitors a potentially broad-spectrum cancer therapy.",
    "llama-2-7b-chat-hf_fact": [
      "Telomerase is involved in the maintenance of telomeres which shorten with each cell division.",
      "Cancer cells can boycott cell death by producing high levels of telomerase.",
      "Telomerase is essential for cancer cell proliferation.",
      "Telomerase inhibitors have exhibited anti-tumor activity in preclinical studies.",
      "Telomerase is expressed in many different types of cancer such as breast, lung, colon, and ovarian cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-7b-chat-hf_response": "NADPH oxidase 5 (NOX5) is a member of the NADPH oxidase family of enzymes that generate reactive oxygen species (ROS) in cells. Like other NADPH oxidases, NOX5 is a heterotetrameric enzyme consisting of four subunits: p22phox, p47phox, p67phox, and p40phox. Each of these subunits plays a critical role in the catalytic mechanism of the enzyme and its regulation.\nThe p22phox subunit is the catalytic subunit of the enzyme and is responsible for the transfer of electrons from NADPH to oxygen, leading to the formation of superoxide anion. The p47phox subunit is involved in the transfer of electrons from the superoxide anion to the p67phox subunit, which in turn transfers the electrons to the p40phox subunit, leading to the formation of hydrogen peroxide.\nThe p67phox subunit is also involved in the regulation of the enzyme's activity through its interaction with other signaling molecules, such as phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2). The p40phox subunit is also involved in the regulation of the enzyme's activity through its interaction with other signaling molecules, such as phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2).\nIn summary, NOX5 requires four subunits (p22phox, p47phox, p67phox, and p40phox) for its function as a NADPH oxidase enzyme. Each of these subunits plays a critical role in the catalytic mechanism of the enzyme and its regulation.",
    "llama-2-7b-chat-hf_fact": [
      "NADPH oxidase 5 (NOX5) is a member of the NADPH oxidase family of enzymes.",
      "NOX5 is a heterotetrameric enzyme made up of four subunits: p22phox, p47phox, p67phox, and p40phox.",
      "The p22phox subunit is the catalytic subunit of NOX5 responsible for the transfer of electrons from NADPH to oxygen.",
      "The p67phox and p40phox subunits are involved in the regulation of the enzyme's activity through their interactions with signaling molecules like PIP3 and PIP2.",
      "All four subunits (p22phox, p47phox, p67phox, and p40phox) are required for NOX5's function as a NADPH oxidase enzyme."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: NOX5 is a monomeric enzyme and does not consist of these four subunits: p22phox, p47phox, p67phox, and p40phox.",
      "false, [corrected fact]: The p22phox subunit does not exist in NOX5. NOX5 itself is the catalytic enzyme for the transfer of electrons from NADPH to oxygen.",
      "false, [corrected fact]: In the case of p67phox and p40phox, they are not associated with NOX5. NOX5's enzyme activity is self-regulated and does not require interactions with signaling molecules through other subunits.",
      "false, [corrected fact]: As NOX5 is a monomeric enzyme, it does not require subunits (p22phox, p47phox, p67phox, and p40phox) for its function as an NADPH oxidase enzyme."
    ]
  },
  {
    "id": 1940,
    "user_query": "What is the doRiNA database?",
    "llama-2-7b-chat-hf_response": "The doRiNA database is a comprehensive database of RNA-binding proteins (RBPs) and their interactions with RNA. RBPs play a crucial role in post-transcriptional regulation of gene expression, and their dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders.\nThe doRiNA database contains a wealth of information on RBPs, including:\n1. RBP structure and function: The database contains structural information on RBPs, including their three-dimensional structures and functional domains.\n2. RBP-RNA interactions: The database contains information on the interactions between RBPs and RNA, including the binding affinity and specificity of RBPs for different RNA sequences.\n3. RBP expression and localization: The database contains information on the expression and localization of RBPs in different cell types and tissues, as well as their subcellular localization.\n4. RBP-mediated regulation of gene expression: The database contains information on the regulation of gene expression by RBPs, including the effects of RBPs on mRNA stability, transport, and translation.\n5. Disease associations: The database contains information on the role of RBPs in various diseases, including cancer, neurodegenerative disorders, and RNA misfolding diseases.\n6. Druggability: The database contains information on the druggability of RBPs, including the presence of small molecule inhibitors and the potential for RBPs to be targeted by drugs.\nThe doRiNA database is a valuable resource for researchers studying RBPs and their role in post-transcriptional regulation of gene expression. It provides a comprehensive overview of the structure, function, and regulation of RBPs, as well as their involvement in various diseases. The database can be accessed at [www.dorina.org](http://www.dorina.org).",
    "llama-2-7b-chat-hf_fact": [
      "The doRiNA database is a comprehensive database of RNA-binding proteins (RBPs) and their interactions with RNA.",
      "RBPs play a crucial role in post-transcriptional regulation of gene expression.",
      "Dysregulation of RBPs has been implicated in various diseases, including cancer and neurodegenerative disorders.",
      "The doRiNA database contains information on the structure, function, and regulation of RBPs, as well as their involvement in various diseases.",
      "The doRiNA database can be accessed at www.dorina.org."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1942,
    "user_query": "Is pseudouridine a RNA modification?",
    "llama-2-7b-chat-hf_response": "Pseudouridine is a modified nucleoside that is found in RNA molecules. It is similar in structure to uridine, but has a different chemical backbone. Pseudouridine is formed through a process called pseudouridylation, which involves the enzymatic modification of uridine residues in RNA molecules.\nPseudouridine is found in many different types of RNA molecules, including messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). It is thought to play a role in the stability and function of these RNA molecules, and may also be involved in the regulation of gene expression.\nPseudouridine is a modified nucleoside that is formed through the enzymatic modification of uridine residues in RNA molecules. This process is catalyzed by enzymes called pseudouridylases, which are found in many different organisms. Pseudouridylases are able to recognize and modify specific uridine residues in RNA molecules, resulting in the formation of pseudouridine.\nPseudouridine is a modified nucleoside that is found in RNA molecules. It is similar in structure to uridine, but has a different chemical backbone. Pseudouridine is formed through a process called pseudouridylation, which involves the enzymatic modification of uridine residues in RNA molecules.\nPseudouridine is found in many different types of RNA molecules, including messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). It is thought to play a role in the stability and function of these RNA molecules, and may also be involved in the regulation of gene expression.\nPseudouridine is a modified nucleoside that is formed through the enzymatic modification of uridine residues in RNA molecules. This process is catalyzed by enzymes called pseudouridylases, which are found in many different organisms. Pseudouridylases are able to recognize and modify specific uridine residues in RNA molecules, resulting in the formation of pseudouridine.\nPseudouridine is a modified nucleoside",
    "llama-2-7b-chat-hf_fact": [
      "Pseudouridine is a modified nucleoside that is found in RNA molecules.",
      "Pseudouridine is similar in structure to uridine, but has a different chemical backbone.",
      "Pseudouridylation is the process of enzymatic modification of uridine residues in RNA molecules that results in the formation of pseudouridine.",
      "Pseudouridine is found in various types of RNA molecules including messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA).",
      "The process of pseudouridylation is catalyzed by enzymes called pseudouridylases, which are found in many different organisms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Pseudouridine is similar in structure to uridine, but the difference lies in carbon structure arrangement, not the chemical backbone.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1943,
    "user_query": "What does the human ABCC gene  product do?",
    "llama-2-7b-chat-hf_response": "The human ABCC gene encodes a protein called ATP-binding cassette transporter subfamily C member 1 (ABCC1). ABCC1 is a transmembrane protein that functions as an efflux pump, actively transporting a wide range of substances across cell membranes, including drugs, toxins, and endogenous molecules.\nABCC1 is primarily localized to the basolateral membrane of epithelial cells in various tissues, including the liver, kidney, and intestine. It is responsible for the secretion of many endogenous compounds, such as bile acids, bilirubin, and thyroid hormones, and also plays a role in the transport of xenobiotics, such as drugs and toxins, out of these tissues.\nMutations in the ABCC1 gene have been associated with several human diseases, including multidrug resistance in cancer, cystic fibrosis, and progressive familial intrahepatic cholestasis. Overall, the ABCC1 protein plays a critical role in maintaining the homeostasis of various tissues by regulating the transport of substances across cell membranes.",
    "llama-2-7b-chat-hf_fact": [
      "The human ABCC1 gene encodes for a protein called ATP-binding cassette transporter subfamily C member 1 (ABCC1).",
      "ABCC1, a transmembrane protein, actively transports a variety of substances across cell membranes.",
      "The ABCC1 protein is mainly found in the basolateral membrane of epithelial cells in the liver, kidney, and intestine.",
      "Mutations in the ABCC1 gene have been linked to diseases such as multidrug resistance in cancer, cystic fibrosis, and progressive familial intrahepatic cholestasis.",
      "ABCC1 is responsible for the secretion of many endogenous compounds, and also regulates the transport of xenobiotics."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-7b-chat-hf_response": "Furin and hepcidin are two proteins that play important roles in the regulation of iron metabolism. Furin is a protease that is involved in the processing and activation of various proteins, including hepcidin. Hepcidin is a hormone that regulates iron absorption and distribution in the body by binding to iron-regulatory proteins (IRPs) and ferroportin, leading to their degradation and decreased iron efflux from cells.\nThe connection between furin and hepcidin is that furin is required for the proper processing and activation of hepcidin. Studies have shown that furin is necessary for the cleavage of hepcidin precursors to produce the active form of the protein, which can then interact with IRPs and ferroportin to regulate iron metabolism. Without furin, hepcidin is not properly processed and activated, leading to impaired iron regulation and potentially contributing to iron-related disorders such as anemia and iron overload.\nIn summary, furin is a protease that is required for the proper processing and activation of hepcidin, a hormone that regulates iron metabolism by binding to IRPs and ferroportin and leading to their degradation and decreased iron efflux from cells.",
    "llama-2-7b-chat-hf_fact": [
      "Furin is a protease that contributes to the processing and activation of various proteins, including hepcidin.",
      "Hepcidin is a hormone that regulates iron absorption and distribution in the body by binding to iron-regulatory proteins (IRPs) and ferroportin.",
      "The cleavage of hepcidin precursors to produce the active form of the protein is supported by furin.",
      "Without furin, hepcidin is not properly processed and activated, which may lead to impaired iron regulation.",
      "Inactive or improperly processed hepcidin can potentially contribute to iron-related disorders such as anemia and iron overload."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1951,
    "user_query": "What is the incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australian and New Zealand in the late 1990's?",
    "llama-2-7b-chat-hf_response": "In the late 1990's, the incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australia and New Zealand was estimated to be approximately 1 in 20,000 to 1 in 30,000 male births. This estimate was based on a small number of cases reported in the medical literature and may not be representative of the true incidence of the disorder in these countries. Further research is needed to determine the accurate incidence of ALD in Australia and New Zealand.",
    "llama-2-7b-chat-hf_fact": [
      "During the late 1990s, the estimated incidence of new X-linked adrenoleukodystrophy (ALD) cases in Australia and New Zealand was approximately 1 in 20,000 to 1 in 30,000 male births.",
      "This estimate was based on a small number of cases reported in the medical literature.",
      "The true incidence of X-linked adrenoleukodystrophy in Australia and New Zealand may not be represented by these estimates.",
      "Further research is required to determine the accurate incidence of ALD in Australia and New Zealand."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1952,
    "user_query": "Can telomere length shortening be reversed by telomerase?",
    "llama-2-7b-chat-hf_response": "Telomeres are repetitive DNA sequences found at the end of chromosomes that shorten with each cell division. When telomeres become too short, the cell can no longer divide and will enter a state of senescence or undergo programmed cell death, also known as apoptosis. Telomerase is an enzyme that can lengthen telomeres by adding telomere repeats to the ends of chromosomes.",
    "llama-2-7b-chat-hf_fact": [
      "Telomeres are repetitive DNA sequences found at the end of chromosomes.",
      "Telomeres shorten with each cell division.",
      "When telomeres become too short, the cell can no longer divide and will either enter a state of senescence or undergo apoptosis.",
      "Telomerase is an enzyme that can lengthen telomeres.",
      "Telomerase lengthens telomeres by adding telomere repeats to the ends of chromosomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1953,
    "user_query": "Is ABCE1 involved in ribosomal recycling?",
    "llama-2-7b-chat-hf_response": "Yes, ABCE1 is involved in ribosomal recycling. ABCE1 is a protein that plays a critical role in the recycling of ribosomes in eukaryotic cells. Ribosomal recycling is the process by which used ribosomes are returned to the pool of free ribosomes after completing their translation cycle. This process is important for maintaining the proper balance of ribosomes in the cell and for ensuring efficient protein synthesis.\nABCE1 is a component of the ribosome recycling complex, which is responsible for the degradation of used ribosomes. The complex is composed of several proteins, including ABCE1, RRP1, RRP2, and RRP3. These proteins work together to recognize and degrade used ribosomes, which are then recycled back to the pool of free ribosomes.\nStudies have shown that ABCE1 plays a critical role in the recycling of ribosomes, particularly in the early stages of the process. ABCE1 helps to recognize and bind to used ribosomes, which are then targeted for degradation by the ribosome recycling complex. Without ABCE1, the recycling of ribosomes is impaired, leading to a buildup of used ribosomes in the cell and a decrease in protein synthesis efficiency.\nIn summary, ABCE1 is involved in ribosomal recycling by recognizing and binding to used ribosomes, which are then targeted for degradation by the ribosome recycling complex. This process is critical for maintaining the proper balance of ribosomes in the cell and for ensuring efficient protein synthesis.",
    "llama-2-7b-chat-hf_fact": [
      "ABCE1 is a protein involved in ribosomal recycling in eukaryotic cells.",
      "Ribosomal recycling is the process of returning used ribosomes to the pool of free ribosomes after their translation cycle.",
      "ABCE1 is a component of the ribosome recycling complex, which is responsible for the degradation of used ribosomes.",
      "The ribosome recycling complex is composed of several proteins, including ABCE1, RRP1, RRP2, and RRP3.",
      "Without ABCE1, the recycling of ribosomes is impaired, which can lead to a decrease in protein synthesis efficiency."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: ABCE1 is a component of the ribosome recycling complex, which is responsible for the dissociation of used ribosomes, not their degradation.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1955,
    "user_query": "Does oculocutaneous albinism show an autosomal recessive inheritance?",
    "llama-2-7b-chat-hf_response": "Oculocutaneous albinism (OCA) is a group of genetic disorders that affect the skin, hair, and eyes. The inheritance pattern of OCA is autosomal recessive, meaning that a person must inherit two copies of a mutated gene, one from each parent, in order to develop the condition. This means that a person with OCA has a 25% chance of passing the mutated gene to each of their children, who will then have a 50% chance of inheriting the condition.",
    "llama-2-7b-chat-hf_fact": [
      "Oculocutaneous albinism (OCA) is a group of genetic disorders that affect the skin, hair, and eyes.",
      "The inheritance pattern of oculocutaneous albinism is autosomal recessive.",
      "A person must inherit two copies of a mutated gene, one from each parent, to develop oculocutaneous albinism.",
      "A person with oculocutaneous albinism has a 25% chance of passing the mutated gene to each of their children.",
      "The children of a person with oculocutaneous albinism have a 50% chance of inheriting the condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: A person with oculocutaneous albinism has a 100% chance of passing the mutated gene to each of their children if the other parent is also a carrier of the mutated gene.",
      "false, [corrected fact]: The children of a person with oculocutaneous albinism have a 25% chance of inheriting the condition if the other parent is also a carrier of the mutated gene."
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-7b-chat-hf_response": "The largest metabolic gene cluster in yeast is the glycolysis/gluconeogenesis gene cluster, which is responsible for the breakdown and synthesis of glucose. This cluster contains 17 genes that work together to convert glucose into energy in the form of ATP, NADH, and FADH2. The genes in this cluster are highly coordinated and regulated, allowing yeast to efficiently use glucose as a source of energy. Other large metabolic gene clusters in yeast include the pentose phosphate pathway, the citric acid cycle, and the fatty acid biosynthesis pathway.",
    "llama-2-7b-chat-hf_fact": [
      "The glycolysis/gluconeogenesis gene cluster is the largest metabolic gene cluster in yeast.",
      "This gene cluster is responsible for the breakdown and synthesis of glucose.",
      "The glycolysis/gluconeogenesis gene cluster contains 17 genes.",
      "These genes convert glucose into energy in the form of ATP, NADH, and FADH2.",
      "Other large metabolic gene clusters in yeast include the pentose phosphate pathway, the citric acid cycle, and the fatty acid biosynthesis pathway."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1958,
    "user_query": "Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?",
    "llama-2-7b-chat-hf_response": "ApoE is a protein that plays a crucial role in lipid metabolism and is involved in the development of atherosclerosis and Alzheimer's disease. There are three common isoforms of ApoE, ApoE2, ApoE3, and ApoE4, each with distinct functions and distributions in the body. ApoE4 is the primary isoform associated with increased risk of atherosclerosis and Alzheimer's disease.\nApoE4 is associated with increased levels of low-density lipoprotein (LDL) cholesterol and decreased levels of high-density lipoprotein (HDL) cholesterol, which can contribute to the development of atherosclerosis. Additionally, ApoE4 has been shown to promote the accumulation of beta-amyloid peptides in the brain, which is a hallmark of Alzheimer's disease.\nIn contrast, ApoE2 and ApoE3 have been shown to have protective effects against atherosclerosis and Alzheimer's disease. ApoE2 has been shown to inhibit the accumulation of beta-amyloid peptides in the brain, while ApoE3 has been shown to promote the clearance of beta-amyloid peptides and reduce the risk of atherosclerosis.\nOverall, the distribution of ApoE isoforms in the body can have significant implications for the development of atherosclerosis and Alzheimer's disease, and understanding the role of ApoE in these diseases can inform the development of new therapeutic strategies.",
    "llama-2-7b-chat-hf_fact": [
      "ApoE is a protein that plays a crucial role in lipid metabolism.",
      "ApoE4 is the primary isoform associated with increased risk of atherosclerosis and Alzheimer's disease.",
      "ApoE4 is associated with increased levels of low-density lipoprotein cholesterol and decreased levels of high-density lipoprotein cholesterol.",
      "ApoE4 has been shown to promote the accumulation of beta-amyloid peptides in the brain, a hallmark of Alzheimer's disease.",
      "ApoE2 and ApoE3 isoforms have been shown to have protective effects against atherosclerosis and Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1960,
    "user_query": "What organism causes woolsorter's disease",
    "llama-2-7b-chat-hf_response": "?\nWool sorter's disease is caused by the fungus Trichophyton rubrum. It is a common fungal infection that affects the skin, particularly the hands and feet, of people who work with wool or other textiles. The fungus can enter the skin through small cuts or abrasions, and can cause redness, itching, and scaling of the skin. In severe cases, it can lead to skin thickening and discoloration. Treatment typically involves antifungal medications and good hygiene practices.",
    "llama-2-7b-chat-hf_fact": [
      "Wool sorter's disease is caused by the fungus Trichophyton rubrum.",
      "Wool sorter's disease is a common fungal infection that affects the skin, particularly on hands and feet of people who work with wool or other textiles.",
      "The fungus Trichophyton rubrum can enter the skin through small cuts or abrasions.",
      "Wool sorter's disease can cause redness, itching, and scaling of the skin, and in severe cases, can lead to skin thickening and discoloration.",
      "Treatment for wool sorter's disease typically involves antifungal medications and good hygiene practices."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Wool sorter's disease, also known as anthrax, is caused by the bacterium Bacillus anthracis.",
      "false, [corrected fact]: Wool sorter's disease is a serious, potentially lethal disease that can affect the skin, lungs, or digestive system of people who work with wool or other animal products.",
      "true",
      "false, [corrected fact]: While Trichophyton rubrum can cause symptoms like redness, itching, scaling, and in some cases, discoloration, these are not symptoms of Wool Sorter's disease. Wool Sorter's disease can cause a raised, itchy, necrotic skin lesion with surrounding edema if contracted cutaneously. If inhaled, it can cause severe respiratory illness.",
      "false, [corrected fact]: Treatment for wool sorter's disease typically involves antibiotics."
    ]
  },
  {
    "id": 1963,
    "user_query": "Which protein complexes recognize centromeric (CEN) DNA in yeast?",
    "llama-2-7b-chat-hf_response": "Several protein complexes have been identified that recognize and bind to centromeric (CEN) DNA in yeast. These complexes play important roles in the regulation of chromosome segregation and the maintenance of genome stability. Here are some of the key protein complexes that recognize CEN DNA in yeast:\n1. The centromere-specific protein complex (CENP): This complex is composed of several proteins, including CENP-A, CENP-B, CENP-C, and CENP-F. These proteins are specifically bound to CEN DNA and play a crucial role in the maintenance of kinetochore structure and function.\n2. The cohesin complex: The cohesin complex is composed of several proteins, including SMC1, SMC3, and STAG2. This complex is involved in the maintenance of chromosome stability and is specifically bound to CEN DNA.\n3. The condensin complex: The condensin complex is composed of several proteins, including SMC5 and SMC6. This complex is involved in the compactization of chromatin during mitosis and is specifically bound to CEN DNA.\n4. The kinetochore-associated protein complex (KAP): This complex is composed of several proteins, including KAP1, KAP2, and KAP3. These proteins are specifically bound to CEN DNA and play a crucial role in the regulation of chromosome segregation.\n5. The aurora kinase complex: The aurora kinase complex is composed of several proteins, including AURKA, AURKB, and AURKC. This complex is involved in the regulation of chromosome segregation and is specifically bound to CEN DNA.\nThese are some of the key protein complexes that recognize and bind to CEN DNA in yeast. These complexes play important roles in the regulation of chromosome segregation and the maintenance of genome stability, and their dysregulation can lead to various diseases, including cancer.",
    "llama-2-7b-chat-hf_fact": [
      "The centromere-specific protein complex (CENP), which includes CENP-A, CENP-B, CENP-C, and CENP-F, binds to CEN DNA in yeast.",
      "The cohesin complex, composed of proteins like SMC1, SMC3, and STAG2, binds to CEN DNA in yeast and aids in maintaining chromosome stability.",
      "The condensin complex, which contains proteins like SMC5 and SMC6, is involved in chromatin compactization during mitosis and is bound specifically to CEN DNA in yeast.",
      "The kinetochore-associated protein complex (KAP), including KAP1, KAP2, and KAP3, recognizes CEN DNA in yeast.",
      "The aurora kinase complex, featuring proteins like AURKA, AURKB, and AURKC binds to CEN DNA in yeast and helps in the regulation of chromosome segregation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The centromere-specific protein complex (CENP), which includes CENP-A, CENP-B, CENP-C, and CENP-F, binds to CEN DNA in humans, not yeast.",
      "false, [corrected fact]: The cohesin complex, composed of proteins like SMC1, SMC3, and STAG2, binds to DNA in yeast but its specific affinity for CEN DNA is not established.",
      "false, [corrected fact]: The condensin complex is involved in chromatin compactization during mitosis, however, it does not specifically bind to CEN DNA in yeast.",
      "unknown",
      "false, [corrected fact]: The aurora kinase complex, featuring proteins like AURKA, AURKB, and AURKC has a role in regulation of chromosome segregation, however, its binding to CEN DNA in yeast is not known."
    ]
  },
  {
    "id": 1966,
    "user_query": "What is the function of yeast Clr4 on chromatin?",
    "llama-2-7b-chat-hf_response": "Yeast Clr4 is a chromodomain-containing protein that plays a crucial role in regulating chromatin structure and gene expression. Clr4 is a member of the chromodomain-helicase-DNA-binding (CHD) family of proteins, which are involved in the regulation of chromatin dynamics and gene expression in various organisms. In yeast, Clr4 is primarily localized to the nucleus and is required for proper chromatin organization and gene expression.\nClr4 has several functions on chromatin, including:\n1. Chromatin remodeling: Clr4 can remodel chromatin structure by altering the positioning of nucleosomes along DNA, which can affect gene expression by changing the accessibility of DNA to transcription factors and other regulatory proteins.\n2. Gene expression regulation: Clr4 can bind to specific DNA sequences and regulate the expression of nearby genes by either activating or repressing their transcription.\n3. Chromatin domains formation: Clr4 can help to establish and maintain specific chromatin domains, such as heterochromatin or euchromatin, which are characterized by distinct patterns of gene expression and chromatin structure.\n4. Interaction with other chromatin-modifying enzymes: Clr4 can interact with other chromatin-modifying enzymes, such as histone acetyltransferases and histone deacetylases, to modulate chromatin structure and gene expression.\nOverall, Clr4 plays a crucial role in regulating chromatin structure and gene expression in yeast, and its functions are similar to those of other CHD proteins in other organisms.",
    "llama-2-7b-chat-hf_fact": [
      "Yeast Clr4 is a chromodomain-containing protein that regulates chromatin structure and gene expression.",
      "Clr4 is a member of the chromodomain-helicase-DNA-binding (CHD) family of proteins, involved in chromatin dynamics and gene expression regulation in various organisms.",
      "Clr4 can remodel chromatin structure, altering the positioning of nucleosomes along DNA, which affects gene expression.",
      "Clr4 can bind to specific DNA sequences and regulate the expression of nearby genes.",
      "Clr4 can interact with other chromatin-modifying enzymes to modulate chromatin structure and gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Clr4 is not a member of the chromodomain-helicase-DNA-binding (CHD) family of proteins, it is a member of the Suv39 family of histone methyltransferases.",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-7b-chat-hf_response": "LIMT (LncRNA in Myeloid Lineage-Associated Transcript) is a long non-coding RNA (lncRNA) that has been shown to play a crucial role in the regulation of myeloid cell differentiation and function. Here are some of the key roles of LIMT lncRNA:\n1. Regulation of myeloid cell differentiation: LIMT lncRNA has been shown to regulate the differentiation of myeloid cells, including granulocytes, monocytes, and macrophages, by modulating the expression of genes involved in these processes.\n2. Modulation of inflammation: LIMT lncRNA has been shown to modulate the inflammatory response by regulating the expression of genes involved in the production of pro-inflammatory cytokines and chemokines.\n3. Regulation of cell survival: LIMT lncRNA has been shown to regulate the survival of myeloid cells by modulating the expression of genes involved in apoptosis and autophagy.\n4. Regulation of cell adhesion and migration: LIMT lncRNA has been shown to regulate the adhesion and migration of myeloid cells by modulating the expression of genes involved in these processes.\n5. Regulation of angiogenesis: LIMT lncRNA has been shown to regulate angiogenesis, the formation of new blood vessels, by modulating the expression of genes involved in this process.\n6. Regulation of metastasis: LIMT lncRNA has been shown to regulate the metastasis of myeloid cells by modulating the expression of genes involved in this process.\n7. Regulation of immune response: LIMT lncRNA has been shown to regulate the immune response by modulating the expression of genes involved in the immune response.\n8. Regulation of stem cell maintenance: LIMT lncRNA has been shown to regulate the maintenance of hematopoietic stem cells by modulating the expression of genes involved in this process.\n9. Regulation of DNA damage response: LIMT lncRNA has been shown to regulate the DNA damage response by modulating the expression of genes involved in this process.\n10. Regulation",
    "llama-2-7b-chat-hf_fact": [
      "LIMT (LncRNA in Myeloid Lineage-Associated Transcript) is a long non-coding RNA.",
      "LIMT lncRNA plays a role in the regulation of myeloid cell differentiation.",
      "LIMT lncRNA is involved in modulating the inflammation response through regulation of specific gene expressions.",
      "LIMT lncRNA is known to be involved in the regulation of angiogenesis.",
      "LIMT lncRNA plays a role in DNA damage response through modulating the expression of genes involved in this process."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1969,
    "user_query": "What are Kupffer cells and what is their role?",
    "llama-2-7b-chat-hf_response": "Kupffer cells are a type of liver cell that play a crucial role in the immune system. They are a type of macrophage, which is a cell that engulfs and digests foreign substances and cellular debris. Kupffer cells are found in the liver and are responsible for phagocytosing (engulfing and digesting) bacteria, viruses, and other foreign substances that enter the liver. They also play a role in the removal of damaged or dead cells from the liver.\nKupffer cells are involved in the immune response by producing cytokines and chemokines, which are signaling molecules that help to coordinate the immune response. They also express receptors for antibodies, which allows them to recognize and engulf pathogens that have been tagged with antibodies.\nIn addition to their role in the immune response, Kupffer cells are also involved in the regulation of liver inflammation. They can produce pro-inflammatory cytokines, such as TNF-alpha, which can contribute to inflammation in the liver. However, they can also produce anti-inflammatory cytokines, such as IL-10, which can help to reduce inflammation.\nOverall, Kupffer cells play a crucial role in protecting the liver from infection and inflammation, and their dysfunction has been implicated in a number of liver diseases, including hepatitis and liver cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Kupffer cells are a type of liver cell that play a crucial role in the immune system.",
      "Kupffer cells are part of the macrophage family, which are cells that engulf and digest foreign substances and cellular debris.",
      "Kupffer cells are responsible for phagocytosing bacteria, viruses, and other foreign substances, and for the removal of damaged or dead cells from the liver.",
      "Kupffer cells are involved in the immune response through the production of cytokines and chemokines, and have receptors for antibodies.",
      "Kupffer cells play an important role in regulating liver inflammation and their dysfunction has been implicated in liver diseases such as hepatitis and liver cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1971,
    "user_query": "Is golimumab effective for ulcerative colitis?",
    "llama-2-7b-chat-hf_response": "Golimumab, a tumor necrosis factor-alpha (TNF-alpha) inhibitor, has been shown to be effective in reducing symptoms and improving quality of life in patients with moderate-to-severe ulcerative colitis (UC). In clinical trials, golimumab has been compared to placebo or other active treatments, and has been shown to:",
    "llama-2-7b-chat-hf_fact": [
      "Golimumab is a tumor necrosis factor-alpha (TNF-alpha) inhibitor.",
      "Golimumab has been used to treat patients with moderate-to-severe ulcerative colitis (UC).",
      "The use of golimumab can reduce symptoms of UC.",
      "Golimumab can improve the quality of life in UC patients.",
      "Golimumab has been tested in clinical trials for treating UC."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1976,
    "user_query": "What is the aim of the TRAP assay?",
    "llama-2-7b-chat-hf_response": "The aim of the TRAP (Tumor Necrosis Factor-Related Apoptosis-Inducing Protein) assay is to measure the ability of a test compound to induce apoptosis (programmed cell death) in cells. The TRAP assay is used to assess the anti-cancer activity of small molecules, such as drugs, and to identify potential drug targets.\nIn the TRAP assay, cells are incubated with a test compound, and the level of apoptosis is measured using a fluorescent dye that stains the condensed and fragmented nuclei of apoptotic cells. The amount of fluorescence is proportional to the number of apoptotic cells, and the results are expressed as a percentage of apoptotic cells relative to the total number of cells.\nThe TRAP assay is a useful tool for identifying compounds that can selectively induce apoptosis in cancer cells, while sparing normal cells. This can help to reduce the toxicity of cancer therapies and improve their efficacy.",
    "llama-2-7b-chat-hf_fact": [
      "The aim of the TRAP assay is to measure the ability of a compound to induce apoptosis in cells.",
      "The TRAP assay is used to assess the anti-cancer activity of drugs.",
      "In the TRAP assay, the level of apoptosis is measured using a fluorescent dye.",
      "The results of the TRAP assay are expressed as a percentage of apoptotic cells relative to the total number of cells.",
      "The TRAP assay is a tool for identifying compounds that can induce apoptosis in cancer cells, while sparing normal cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The aim of the TRAP assay is to measure the activity of tartrate-resistant acid phosphatase, an enzyme associated with osteoclast function and bone resorption, not apoptosis induction in cells.",
      "true",
      "false, [corrected fact]: In the TRAP assay, the activity of tartrate-resistant acid phosphatase enzyme is measured, not the level of apoptosis using a fluorescent dye.",
      "false, [corrected fact]: The results of the TRAP assay are expressed as a measure of enzymatic activity, not as a percentage of apoptotic cells relative to the total number of cells.",
      "false, [corrected fact]: The TRAP assay is a tool for examining bone resorption, not for identifying compounds that can induce apoptosis specifically in cancer cells while sparing normal cells."
    ]
  },
  {
    "id": 1979,
    "user_query": "Which disease is associated with mutations in SLC40A1 gene?",
    "llama-2-7b-chat-hf_response": "SLC40A1 gene encodes for a protein called zinc transporter 1 (ZnT-1). Mutations in this gene have been associated with several diseases, including:\n1. Menkes disease: A rare genetic disorder caused by mutations in the SLC40A1 gene, characterized by severe deficiency of copper in the body, leading to developmental delays, intellectual disability, and death in early childhood.\n2. Wilson's disease: A rare genetic disorder caused by mutations in the ATP7B gene, which is located nearby the SLC40A1 gene on chromosome 13. Wilson's disease is characterized by excessive copper accumulation in the liver, brain, and other organs, leading to neurological and psychiatric symptoms, liver failure, and death.\n3. Copper deficiency myopathy: A rare genetic disorder caused by mutations in the SLC40A1 gene, characterized by muscle weakness, muscle wasting, and muscle cramps due to copper deficiency.\n4. Neurodegenerative diseases: Some mutations in the SLC40A1 gene have been associated with an increased risk of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).\n5. Cancer: Some studies have suggested that mutations in the SLC40A1 gene may be associated with an increased risk of certain types of cancer, including breast cancer and ovarian cancer.",
    "llama-2-7b-chat-hf_fact": [
      "The SLC40A1 gene encodes for a protein called zinc transporter 1 (ZnT-1).",
      "Mutations in the SLC40A1 gene have been associated with Menkes disease, a rare genetic disorder characterized by severe copper deficiency in the body.",
      "Mutations in the SLC40A1 gene have also been linked to copper deficiency myopathy, a rare genetic disorder characterized by muscle weakness, muscle wasting, and muscle cramps due to copper deficiency.",
      "Some mutations in the SLC40A1 gene have been associated with an increased risk of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.",
      "Some studies suggest that mutations in the SLC40A1 gene may be associated with an increased risk of certain types of cancer, including breast cancer and ovarian cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mutations in the ATP7A gene, not the SLC40A1 gene, have been associated with Menkes disease.",
      "false, [corrected fact]: Mutations in the ATP7A gene or ATP7B gene, not the SLC40A1 gene, can cause copper deficiency that may lead to myopathy.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1982,
    "user_query": "Is lenvatinib effective for renal cell carcinoma?",
    "llama-2-7b-chat-hf_response": "Lenvatinib is a tyrosine kinase inhibitor that has shown promise in the treatment of various types of cancer, including renal cell carcinoma (RCC). Here are some key points to consider when evaluating the effectiveness of lenvatinib for RCC:\n1. Clinical trials: Lenvatinib has been studied in several clinical trials for the treatment of RCC, including phase 2 and phase 3 trials. These trials have shown that lenvatinib can be effective in reducing tumor size and improving progression-free survival (PFS) in patients with advanced RCC.\n2. Mechanism of action: Lenvatinib works by inhibiting the activity of multiple tyrosine kinases, including VEGFR, PDGFR, and FGFR, which are involved in angiogenesis and tumor growth. By blocking these kinases, lenvatinib can inhibit the growth of new blood vessels that feed tumors and reduce the size of existing tumors.\n3. Efficacy: In clinical trials, lenvatinib has been shown to be effective in improving PFS in patients with advanced RCC. For example, in the phase 3 SELECT trial, lenvatinib significantly improved PFS compared to everolimus in patients with advanced RCC.\n4. Safety: Lenvatinib has been shown to have a manageable safety profile in clinical trials. The most common adverse events associated with lenvatinib include fatigue, decreased appetite, weight loss, and diarrhea.\n5. Comparative effectiveness: Lenvatinib has been compared to other treatments for RCC, such as sunitinib and pazopanib, in clinical trials. These studies have shown that lenvatinib can be as effective as or more effective than these other treatments in improving PFS and overall survival.\n6. Real-world effectiveness: Lenvatinib has been used in real-world settings to treat patients with RCC, and studies have shown that it can be effective in these patients as well. For example, a study published in the Journal of Clinical Oncology found that lenvatinib was associated with improved PFS and overall survival in patients with advanced RCC who had progressed on prior",
    "llama-2-7b-chat-hf_fact": [
      "Lenvatinib is a tyrosine kinase inhibitor that is used for the treatment of various types of cancer, including renal cell carcinoma.",
      "Lenvatinib works by inhibiting the activity of multiple tyrosine kinases involved in angiogenesis and tumor growth.",
      "Clinical trials have shown that lenvatinib can be effective in reducing tumor size and improving progression-free survival in patients with advanced renal cell carcinoma.",
      "Lenvatinib has been compared to other treatments for renal cell carcinoma, such as sunitinib and pazopanib, in clinical trials.",
      "A study published in the Journal of Clinical Oncology found that lenvatinib was associated with improved progression-free survival and overall survival in patients with advanced renal cell carcinoma who had progressed on prior treatments."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-7b-chat-hf_response": "There are several R packages available for performing SNP enrichment analysis, including:\n1. Plink: Plink is a popular R package for performing genome-wide association studies (GWAS) and SNP enrichment analysis. It can be used to identify genetic variants associated with a trait or disease, as well as to perform enrichment analysis for specific genomic regions.\n2. GSEA: The Gene Set Enrichment Analysis (GSEA) package is a popular R package for performing SNP enrichment analysis. It can be used to identify gene sets that are overrepresented in a set of genetic variants associated with a trait or disease.\n3. Enrichr: Enrichr is another popular R package for performing SNP enrichment analysis. It can be used to identify gene sets that are overrepresented in a set of genetic variants associated with a trait or disease, as well as to perform functional enrichment analysis for specific genomic regions.\n4. SNPtest: SNPtest is an R package for performing SNP enrichment analysis. It can be used to identify genetic variants associated with a trait or disease, as well as to perform enrichment analysis for specific genomic regions.\n5. PASS: PASS is an R package for performing genome-wide association studies (GWAS) and SNP enrichment analysis. It can be used to identify genetic variants associated with a trait or disease, as well as to perform enrichment analysis for specific genomic regions.\nUltimately, the choice of package will depend on the specific research question and the goals of the analysis.",
    "llama-2-7b-chat-hf_fact": [
      "Plink is an R package used for performing genome-wide association studies (GWAS) and SNP enrichment analysis.",
      "The Gene Set Enrichment Analysis (GSEA) package is an R package that can be used for performing SNP enrichment analysis.",
      "Enrichr is an R package used for performing SNP enrichment analysis and can be used to perform functional enrichment analysis for specific genomic regions.",
      "SNPtest is an R package used for conducting SNP enrichment analysis.",
      "PASS is an R package for performing genome-wide association studies (GWAS) and SNP enrichment analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Plink is not an R package. It is a free, open-source whole genome association analysis toolset, designed to perform a range of basic, large-scale analyses in a computationally efficient manner.",
      "true",
      "true",
      "false, [corrected fact]: SNPtest is not an R package. It is a software package that allows for robust SNP association testing in both unrelated case-control studies and in family studies of arbitrary size and complexity.",
      "unknown"
    ]
  },
  {
    "id": 1988,
    "user_query": "Describe crowned dens syndrome.",
    "llama-2-7b-chat-hf_response": "Crowned-dens syndrome is a rare genetic disorder that affects the development of the teeth, facial bones, and skull. It is characterized by a distinctive facial appearance, including a prominent forehead, widely spaced eyes, and a small lower jaw. The condition is usually diagnosed in early childhood and can have a significant impact on an individual's quality of life.\nThe symptoms of crowned-dens syndrome can vary in severity and may include:\n* Delayed eruption of teeth: Children with crowned-dens syndrome may experience a delay in the eruption of their teeth, which can range from a few months to several years.\n* Small lower jaw: The lower jaw is typically smaller than average in individuals with crowned-dens syndrome, which can affect the alignment of the teeth and the proper functioning of the jaw.\n* Wide-set eyes: The eyes are often widely spaced in individuals with crowned-dens syndrome, which can give the appearance of a \"crown\" or \"halo\" around the eyes.\n* Prominent forehead: The forehead is often prominent in individuals with crowned-dens syndrome, which can give the appearance of a \"crown\" or \"halo\" around the head.\n* Other facial abnormalities: In addition to the distinctive facial features, individuals with crowned-dens syndrome may also experience other facial abnormalities, such as a small nose, thin lips, and a narrow palate.\nThe exact cause of crowned-dens syndrome is not fully understood, but it is thought to be related to genetic mutations that affect the development of the teeth, facial bones, and skull. The condition is usually inherited in an autosomal dominant pattern, which means that a single copy of the mutated gene is enough to cause the condition.\nTreatment for crowned-dens syndrome typically focuses on managing the symptoms and improving the individual's quality of life. This may include:\n* Orthodontic treatment: Children with crowned-dens syndrome may require early orthodontic treatment to help align their teeth and improve their bite.\n* Surgery: In some cases, surgery may be necessary to correct facial abnormalities, such as a small lower jaw",
    "llama-2-7b-chat-hf_fact": [
      "Crowned-dens syndrome is a rare genetic disorder that affects the development of teeth, facial bones, and the skull.",
      "The syndrome is characterized by features including a prominent forehead, widely spaced eyes, and a small lower jaw.",
      "The condition is typically diagnosed in early childhood.",
      "Crowned-dens syndrome is thought to be related to genetic mutations that affect the development of the teeth, facial bones, and skull.",
      "Crowned-dens syndrome is usually inherited in an autosomal dominant pattern, suggesting that a single copy of the mutated gene is enough to cause the condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Crowned-dens syndrome is not a genetic disorder but a condition characterized by calcification in the ligaments around the dens (a part of the second cervical vertebra).",
      "unknown",
      "true",
      "false, [corrected fact]: Crowned-dens syndrome is not related to genetic mutations affecting the development of the teeth, facial bones, and skull but is due to calcification in the ligaments around the dens.",
      "false, [corrected fact]: Crowned-dens syndrome is not usually inherited in an autosomal dominant pattern as it's not a genetic disorder but a condition related to calcification in the ligaments around the dens."
    ]
  },
  {
    "id": 1989,
    "user_query": "Does CRISPR inversion of CTCF sites alter genome topology?",
    "llama-2-7b-chat-hf_response": "CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a powerful tool for editing genes and has been used to inverts CTCF (CCCTC-binding factor) sites in the genome. CTCF is a transcription factor that plays a crucial role in regulating gene expression and genome organization. Inversion of CTCF sites using CRISPR has been shown to alter genome topology, leading to changes in chromatin structure and gene expression.\nOne study published in the journal Nature used CRISPR to invert CTCF sites in the human genome and found that this led to changes in the looping interactions between distant regulatory elements and their target genes. The study showed that inversion of CTCF sites resulted in the formation of new loops and the disruption of existing ones, leading to changes in gene expression.\nAnother study published in the journal Cell used CRISPR to invert CTCF sites in the mouse genome and found that this led to changes in the organization of chromatin and the expression of nearby genes. The study showed that inversion of CTCF sites resulted in the formation of more compact chromatin structures and the activation of nearby genes, leading to changes in the overall gene expression profile.\nOverall, these studies suggest that inversion of CTCF sites using CRISPR can have a significant impact on genome topology and gene expression, highlighting the importance of this transcription factor in regulating chromatin structure and gene function.",
    "llama-2-7b-chat-hf_fact": [
      "CRISPR is a tool used for gene editing.",
      "One of the functions of CTCF, a transcription factor, is to regulate gene expression and genome organization.",
      "Inverting CTCF sites using CRISPR can change genome topology by altering chromatin structure and gene expression.",
      "A study published in the journal Nature found that inverting CTCF sites changes the looping interactions between distant regulatory elements and their target genes.",
      "A study in the journal Cell found that inverting CTCF sites in the mouse genome led to more compact chromatin structures and the activation of nearby genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1999,
    "user_query": "What is Mondor's disease?",
    "llama-2-7b-chat-hf_response": "Mondor's disease, also known as Mondor's syndrome, is a rare condition that affects the superficial veins, particularly the great saphenous vein. It is characterized by the inflammation and thrombosis of the vein, which can cause pain, swelling, and discoloration in the affected area.\nMondor's disease is usually seen in middle-aged women, although it can affect anyone. The exact cause of Mondor's disease is not known, but it is believed to be related to hormonal changes, such as those that occur during pregnancy, menstruation, or menopause.\nThe symptoms of Mondor's disease can vary in severity and may include:\n* Pain or tenderness in the affected area\n* Swelling of the affected limb\n* Discoloration of the skin, which may appear red, purple, or blue\n* Warmth or heat in the affected area\n* Skin thickening or hardening in the affected area\n* Ulcers or sores on the skin\nIn some cases, Mondor's disease can lead to more serious complications, such as deep vein thrombosis or pulmonary embolism, which can be life-threatening.\nIf you suspect that you or someone you know may have Mondor's disease, it is important to seek medical attention as soon as possible. A healthcare provider can diagnose Mondor's disease through a physical examination and imaging tests, such as ultrasound or venography. Treatment for Mondor's disease typically involves anticoagulation therapy to prevent further blood clots from forming, as well as compression stockings or elevation of the affected limb to reduce swelling. In some cases, surgery may be necessary to remove the affected vein.",
    "llama-2-7b-chat-hf_fact": [
      "Mondor's disease, also known as Mondor's syndrome, is a condition that affects the superficial veins, particularly the great saphenous vein.",
      "The disease is characterized by inflammation and thrombosis of the vein, leading to pain, swelling, and discoloration in the affected area.",
      "The exact cause of Mondor's disease is not known, but hormonal changes, such as those experienced during pregnancy, menstruation, or menopause, are believed to be related.",
      "In some cases, Mondor's disease can lead to deep vein thrombosis or pulmonary embolism, which can be life-threatening.",
      "Treatment for Mondor's disease typically includes anticoagulation therapy, compression stockings or elevation of the affected limb to reduce swelling and in some cases, surgery may be necessary to remove the affected vein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Mondor's disease does not typically lead to deep vein thrombosis or pulmonary embolism.",
      "true"
    ]
  },
  {
    "id": 2000,
    "user_query": "List metalloenzyme inhibitors.",
    "llama-2-7b-chat-hf_response": "Metalloenzyme inhibitors are a class of compounds that bind to and inhibit the activity of metalloenzymes, which are enzymes that use a metal ion (such as iron, copper, or zinc) as a cofactor to catalyze a chemical reaction. These inhibitors can be used to study the function of metalloenzymes, to regulate their activity, or to develop new drugs that target specific metalloenzymes.\nHere are some examples of metalloenzyme inhibitors:\n1. EDTA: Ethylenediaminetetraacetic acid (EDTA) is a common metalloenzyme inhibitor that binds to divalent metal ions (such as calcium, iron, and zinc) and inhibits their activity. EDTA is often used as a chelating agent to remove metal ions from biological samples.\n2. Phenanthroline: Phenanthroline is a metalloenzyme inhibitor that binds to divalent metal ions (such as iron and copper) and inhibits their activity. Phenanthroline is often used to study the function of iron-containing enzymes, such as cytochrome P450 enzymes.\n3. 1,10-Phenanthroline: 1,10-Phenanthroline is a metalloenzyme inhibitor that binds to divalent metal ions (such as iron and copper) and inhibits their activity. 1,10-Phenanthroline is often used to study the function of iron-containing enzymes, such as cytochrome P450 enzymes.\n4. Tropolone: Tropolone is a metalloenzyme inhibitor that binds to divalent metal ions (such as iron and copper) and inhibits their activity. Tropolone is often used to study the function of iron-containing enzymes, such as cytochrome P450 enzymes.\n5. Ferric chloride: Ferric chloride is a metalloenzyme inhibitor that binds to divalent metal ions (such as iron) and inhibits their activity. Ferric chloride is often used to study",
    "llama-2-7b-chat-hf_fact": [
      "Metalloenzyme inhibitors are a class of compounds that inhibit the activity of metalloenzymes.",
      "Metalloenzymes use a metal ion to catalyze a chemical reaction.",
      "Ethylenediaminetetraacetic acid (EDTA) is a metalloenzyme inhibitor that binds to divalent metal ions and inhibits their activity.",
      "Phenanthroline is a metalloenzyme inhibitor that binds to divalent metal ions and is often used to study the function of iron-containing enzymes like cytochrome P450 enzymes.",
      "Tropolone is a metalloenzyme inhibitor used to study the function of iron-containing enzymes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2007,
    "user_query": "Is the mouse Sry gene locus free of repetitive sequences?",
    "llama-2-7b-chat-hf_response": "The Sry gene locus on the Y chromosome is known to be involved in the development of male reproductive structures in vertebrates, including mice. However, the Sry gene locus in mice contains a number of repetitive sequences, which can make it difficult to study the gene's function.",
    "llama-2-7b-chat-hf_fact": [
      "The Sry gene locus is found on the Y chromosome.",
      "The Sry gene is involved in the development of male reproductive structures in vertebrates.",
      "The Sry gene locus exists in mice.",
      "The Sry gene locus in mice contains repetitive sequences.",
      "The presence of repetitive sequences in the mouse's Sry gene locus can complicate the study of the gene's function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2011,
    "user_query": "Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?",
    "llama-2-7b-chat-hf_response": "Oculocutaneous albinism (OCA) is a group of rare genetic disorders characterized by hypopigmentation of the skin, hair, and eyes. There are several types of OCA, including OCA1, OCA2, OCA3, and OCA4, each caused by mutations in different genes.\nOculocutaneous albinism type 1 (OCA1) is caused by mutations in the TYR (tyrosinase) gene, which encodes the enzyme tyrosinase. This enzyme is responsible for the production of melanin, the pigment that gives color to the skin, hair, and eyes. Without functional tyrosinase, the body is unable to produce melanin, leading to hypopigmentation and the characteristic features of OCA1.\nOther types of OCA are caused by mutations in different genes, including the OCA2 gene (which encodes the enzyme dopachrome tautomerase), the OCA3 gene (which encodes the enzyme microsomal triglyceride transfer protein), and the OCA4 gene (which encodes the enzyme gamma-aminobutyric acid receptor subunit 1).",
    "llama-2-7b-chat-hf_fact": [
      "Oculocutaneous albinism (OCA) is characterized by hypopigmentation of the skin, hair, and eyes.",
      "Oculocutaneous albinism type 1 (OCA1) is caused by mutations in the TYR (tyrosinase) gene.",
      "The TYR gene encodes the enzyme tyrosinase which is responsible for the production of melanin.",
      "Without functional tyrosinase, the body cannot produce melanin leading to hypopigmentation.",
      "The different types of OCA are caused by mutations in different genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2014,
    "user_query": "Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?",
    "llama-2-7b-chat-hf_response": "H2A.Z is a variant of the histone H2A that is enriched at actively transcribed genes in yeast Saccharomyces cerevisiae. The replacement of H2A by H2A.Z is mediated by a protein complex called the H2A.Z chaperone complex. The H2A.Z chaperone complex is composed of several subunits, including the H2A.Z-interacting protein 1 (Hzi1), the H2A.Z-interacting protein 2 (Hzi2), and the H2A.Z-interacting protein 3 (Hzi3). These subunits work together to facilitate the exchange of H2A for H2A.Z at actively transcribed genes.\nThe H2A.Z chaperone complex is recruited to actively transcribed genes through the binding of Hzi1 and Hzi2 to specific DNA sequences called H2A.Z-binding sites. Once recruited, the H2A.Z chaperone complex facilitates the exchange of H2A for H2A.Z through a mechanism that involves the hydrolysis of ATP. The replacement of H2A by H2A.Z is a dynamic process that is regulated by a variety of factors, including transcriptional elongation, chromatin structure, and the presence of other chromatin-modifying enzymes.\nIn summary, the replacement of H2A by H2A.Z in yeast Saccharomyces cerevisiae is mediated by the H2A.Z chaperone complex, which is composed of several subunits and works through the binding of H2A.Z-interacting proteins to specific DNA sequences and the hydrolysis of ATP to facilitate the exchange of H2A for H2A.Z.",
    "llama-2-7b-chat-hf_fact": [
      "H2A.Z is a variant of the histone H2A that is enriched at actively transcribed genes in yeast Saccharomyces cerevisiae.",
      "The replacement of H2A by H2A.Z is mediated by a protein complex called the H2A.Z chaperone complex.",
      "The H2A.Z chaperone complex is composed of several subunits, including the H2A.Z-interacting protein 1 (Hzi1), the H2A.Z-interacting protein 2 (Hzi2), and the H2A.Z-interacting protein 3 (Hzi3).",
      "The H2A.Z chaperone complex is recruited to actively transcribed genes through the binding of Hzi1 and Hzi2 to specific DNA sequences called H2A.Z-binding sites.",
      "The replacement of H2A by H2A.Z involves the hydrolysis of ATP and is a dynamic process regulated by factors including transcriptional elongation, chromatin structure, and the presence of other chromatin-modifying enzymes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The H2A.Z chaperone complex is composed of several subunits, including the SWR1 complex, which includes proteins like Swc2, Swc5, and Yaf9, not Hzi1, Hzi2, or Hzi3.",
      "false, [corrected fact]: The H2A.Z chaperone complex is recruited to specific nucleosome positions, not exclusively to actively transcribed genes and the recruitment is not through Hzi1 and Hzi2.",
      "true"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-7b-chat-hf_response": "Radial glial cells are the progenitors of ependymal cells in the central nervous system (CNS). The specification of radial glial cells to ependymal cells is a complex process that involves multiple key players. Here are some of the key players involved in radial glial specification to ependymal cells:\n1. Notch signaling pathway: The Notch signaling pathway is a critical regulator of radial glial cell fate. Notch signaling promotes the maintenance of radial glial cells and their proliferation, and is necessary for their specification to ependymal cells.\n2. Wnt/-catenin signaling pathway: The Wnt/-catenin signaling pathway is also important for radial glial cell fate determination. Wnt/-catenin signaling promotes the proliferation and maintenance of radial glial cells and their specification to ependymal cells.\n3. Shh signaling pathway: The Shh signaling pathway is involved in the regulation of radial glial cell fate and the specification of radial glial cells to ependymal cells. Shh signaling promotes the proliferation and maintenance of radial glial cells and their specification to ependymal cells.\n4. BMP signaling pathway: The BMP signaling pathway is also involved in the regulation of radial glial cell fate and the specification of radial glial cells to ependymal cells. BMP signaling promotes the proliferation and maintenance of radial glial cells and their specification to ependymal cells.\n5. EGFR signaling pathway: The EGFR signaling pathway is involved in the regulation of radial glial cell fate and the specification of radial glial cells to ependymal cells. EGFR signaling promotes the proliferation and maintenance of radial glial cells and their specification to ependymal cells.\n6. PI3K/Akt signaling pathway: The PI3K/Akt signaling pathway is involved in the regulation of radial glial cell fate and the specification of radial glial cells to ependymal cells. PI3K/Akt signaling promotes the proliferation and maintenance of radial glial cells and their specification to ependym",
    "llama-2-7b-chat-hf_fact": [
      "Radial glial cells are the progenitors of ependymal cells in the central nervous system.",
      "The Notch signaling pathway is a crucial regulator of radial glial cell fate and their specification to ependymal cells.",
      "The Wnt/-catenin signaling pathway plays a role in radial glial cell fate determination, including their specification to ependymal cells.",
      "The Shh signaling pathway regulates radial glial cell fate and their specification to ependymal cells.",
      "The EGFR signaling pathway is involved in regulating radial glial cell fate and their specification to ependymal cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2018,
    "user_query": "What fruit causes Jamaican vomiting sickness?",
    "llama-2-7b-chat-hf_response": "Jamaican vomiting sickness, also known as Montezuma's revenge, is a type of gastrointestinal illness that can be caused by a variety of factors, including:\n1. Contaminated food and water: Eating food or drinking water that has been contaminated with bacteria, viruses, or parasites can cause Jamaican vomiting sickness.\n2. Bacterial infections: Bacterial infections, such as salmonella or E. coli, can cause Jamaican vomiting sickness.\n3. Viral infections: Viral infections, such as norovirus or rotavirus, can also cause Jamaican vomiting sickness.\n4. Parasitic infections: Parasitic infections, such as giardiasis or amoebiasis, can cause Jamaican vomiting sickness.\n5. Food allergies or intolerances: Some people may experience Jamaican vomiting sickness after consuming certain foods to which they are allergic or intolerant.\nIt is important to note that Jamaican vomiting sickness can be caused by a variety of factors, and it is not always possible to identify a specific cause. If you are experiencing symptoms of Jamaican vomiting sickness, it is important to seek medical attention to determine the cause and receive appropriate treatment.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2022,
    "user_query": "What are Degrons?",
    "llama-2-7b-chat-hf_response": "Degrons are a type of gene regulatory element that are found in the 3' untranslated region (UTR) of messenger RNA (mRNA) molecules. The 3' UTR is the region of the mRNA molecule that extends from the stop codon (the sequence that signals the end of the mRNA molecule) to the poly(A) tail, which is a long sequence of adenine nucleotides that helps to protect the mRNA molecule from degradation.\nDegrons are short sequences of nucleotides (usually around 20-30 nucleotides in length) that are located in the 3' UTR of an mRNA molecule. These sequences are recognized by a specific type of RNA-binding protein called a degron-binding protein, which binds to the degron sequence and targets the mRNA molecule for degradation.\nDegrons play a key role in the regulation of gene expression by controlling the stability of mRNA molecules. When a degron is present in the 3' UTR of an mRNA molecule, it can act as a destabilizing element, causing the mRNA molecule to be degraded more quickly. This can have a variety of effects on gene expression, including reducing the amount of protein produced from a particular gene, or altering the timing of protein production.\nDegrons have been implicated in a wide range of biological processes, including development, cell signaling, and immune response. They are also thought to play a role in many diseases, including cancer and neurodegenerative disorders.\nOverall, degrons are an important class of gene regulatory elements that play a key role in controlling the stability of mRNA molecules and regulating gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Degrons are found in the 3' untranslated region (UTR) of messenger RNA (mRNA) molecules.",
      "Degrons are short sequences of nucleotides that are recognized by a specific type of RNA-binding protein called a degron-binding protein.",
      "Degrons play a key role in the regulation of gene expression by controlling the stability of mRNA molecules.",
      "The presence of a degron in the 3' UTR of an mRNA molecule can lead to its more rapid degradation.",
      "Degrons have been implicated in a wide range of biological processes, including development, cell signaling, and immune response, and in diseases such as cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Degrons are not found in the 3' untranslated region (UTR) of messenger RNA (mRNA) molecules. Instead, they are found in proteins.",
      "true",
      "false, [corrected fact]: Degrons do not control the stability of mRNA molecules but they do play a key role in the regulation of protein degradation.",
      "false, [corrected fact]: The presence of a degron does not influence mRNA degradation. It influences protein degradation.",
      "true"
    ]
  },
  {
    "id": 2023,
    "user_query": "Which disease is associated with mutated Sox2?",
    "llama-2-7b-chat-hf_response": "Sox2 is a transcription factor that plays a crucial role in the development and maintenance of stem cells in various tissues, including the nervous system, pancreas, and skeletal system. Mutations in the Sox2 gene have been associated with several diseases, including:\n1. Neurological disorders: Mutations in Sox2 have been linked to several neurological disorders, including intellectual disability, autism spectrum disorder, and epilepsy.\n2. Diabetes: Mutations in Sox2 have been associated with an increased risk of developing type 1 diabetes, as well as impaired insulin secretion and glucose tolerance.\n3. Cancer: Sox2 has been shown to be overexpressed in various types of cancer, including breast, lung, and colon cancer. Overexpression of Sox2 has been linked to cancer stem cell maintenance and chemotherapy resistance.\n4. Cardiovascular disease: Sox2 has been implicated in the development and maintenance of the cardiovascular system, and mutations in Sox2 have been linked to an increased risk of cardiovascular disease.\n5. Immunological disorders: Sox2 has been shown to play a role in the regulation of the immune system, and mutations in Sox2 have been linked to an increased risk of immunological disorders, such as autoimmune diseases.\nIt is important to note that the specific disease associated with a mutated Sox2 gene can vary depending on the location and type of mutation, as well as the individual's genetic background.",
    "llama-2-7b-chat-hf_fact": [
      "Sox2 plays a crucial role in the development and maintenance of stem cells in various tissues, including the nervous system, pancreas, and skeletal system.",
      "Mutations in the Sox2 gene have been associated with several diseases, including neurological disorders, diabetes, cancer, cardiovascular disease, and immunological disorders.",
      "Mutations in Sox2 have been linked to several neurological disorders, including intellectual disability, autism spectrum disorder, and epilepsy.",
      "Mutations in Sox2 have been associated with an increased risk of developing type 1 diabetes, impaired insulin secretion, and glucose tolerance.",
      "Overexpression of Sox2 has been linked to cancer stem cell maintenance and chemotherapy resistance in various types of cancer, including breast, lung, and colon cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Mutations in the Sox2 gene have been associated with several diseases, including sight and neurological disorders but not explicitly diabetes, cancer, cardiovascular disease, and immunological disorders.",
      "true",
      "false, [corrected fact]: To date, there is no explicit evidence linking Sox2 mutations with an increased risk of developing type 1 diabetes, impaired insulin secretion, and glucose tolerance.",
      "true"
    ]
  },
  {
    "id": 2024,
    "user_query": "Is the enzyme EPRS phosphorylated?",
    "llama-2-7b-chat-hf_response": "Yes, the enzyme EPRS (Ethanolamine-phosphate racemase) is phosphorylated. In fact, the phosphorylation of EPRS is a crucial step in its enzymatic activity.\nEPRS is a homotetrameric enzyme that contains four identical subunits, each of which contains a phosphorylation site. The phosphorylation of these sites is important for the enzyme's stability and activity. Studies have shown that the phosphorylation of EPRS is mediated by protein kinases, such as PKA (protein kinase A) and PKC (protein kinase C), and that the phosphorylation status of the enzyme can affect its activity and substrate specificity.\nFor example, one study found that the phosphorylation of EPRS by PKA enhances its activity towards the substrate ethanolamine, while another study showed that the phosphorylation of EPRS by PKC inhibits its activity towards the substrate serine.\nOverall, the phosphorylation of EPRS is an important regulatory mechanism that helps to fine-tune the enzyme's activity and substrate specificity, and its dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The enzyme EPRS (Ethanolamine-phosphate racemase) is phosphorylated.",
      "EPRS is a homotetrameric enzyme that contains four identical subunits, each with a phosphorylation site.",
      "Phosphorylation of EPRS sites is important for enzyme's stability and activity.",
      "Protein kinases, such as PKA (protein kinase A) and PKC (protein kinase C), mediate the phosphorylation of EPRS.",
      "Dysregulation of EPRS phosphorylation has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2038,
    "user_query": "Which disease(s) are caused by HEX A deficiency?",
    "llama-2-7b-chat-hf_response": "HEX A is a protein that plays a crucial role in the immune system. A deficiency in HEX A has been linked to several autoimmune diseases, including:\n1. Systemic lupus erythematosus (SLE): HEX A deficiency has been associated with an increased risk of developing SLE, a chronic autoimmune disease that can affect multiple organs and systems in the body.\n2. Rheumatoid arthritis (RA): HEX A deficiency has been linked to an increased risk of developing RA, an autoimmune disease that causes inflammation and joint damage.\n3. Multiple sclerosis (MS): Some studies have suggested that HEX A deficiency may be associated with an increased risk of developing MS, an autoimmune disease that affects the central nervous system.\n4. Type 1 diabetes: HEX A deficiency has been linked to an increased risk of developing type 1 diabetes, an autoimmune disease that causes the immune system to attack the insulin-producing cells in the pancreas.\n5. Hashimoto's thyroiditis: HEX A deficiency has been linked to an increased risk of developing Hashimoto's thyroiditis, an autoimmune disease that affects the thyroid gland.\n6. Psoriasis: HEX A deficiency has been linked to an increased risk of developing psoriasis, a chronic autoimmune skin condition characterized by red, scaly patches on the skin.\n7. Crohn's disease: HEX A deficiency has been linked to an increased risk of developing Crohn's disease, a chronic autoimmune inflammatory bowel disease that affects the gastrointestinal tract.\n8. Ulcerative colitis: HEX A deficiency has been linked to an increased risk of developing ulcerative colitis, a chronic autoimmune inflammatory bowel disease that affects the gastrointestinal tract.\nPlease note that a deficiency in HEX A does not guarantee the development of any of these diseases, and not everyone with a HEX A deficiency will develop an autoimmune disease.",
    "llama-2-7b-chat-hf_fact": [
      "HEX A is a protein that plays a role in the immune system.",
      "A deficiency in HEX A has been associated with an increased risk of developing Systemic lupus erythematosus, an autoimmune disease that can affect multiple organs.",
      "HEX A deficiency has been linked to an increased risk of developing Rheumatoid arthritis, a disease causing joint inflammation and damage.",
      "Some studies suggest HEX A deficiency may increase the risk of developing Multiple sclerosis, an autoimmune disease that affects the central nervous system.",
      "A deficiency in HEX A has been associated with an increased risk of developing Type 1 diabetes, where the immune system attacks the insulin-producing cells in the pancreas."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2046,
    "user_query": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?",
    "llama-2-7b-chat-hf_response": "The JASPAR 2016 open-access database of transcription factor binding profiles includes the following additions compared to the previous version:\n1. Increased coverage of human and mouse genomes: The JASPAR 2016 database now includes binding profiles for over 20,000 transcription factor binding sites in human and mouse genomes, representing a 30% increase in coverage compared to the previous version.\n2. New transcription factors: The JASPAR 2016 database includes binding profiles for 14 new transcription factors, bringing the total number of transcription factors covered to 120.\n3. Improved accuracy: The JASPAR 2016 database includes improved accuracy for existing binding profiles, as well as new profiles for transcription factors that were not previously covered.\n4. Increased focus on non-coding RNA regulatory elements: The JASPAR 2016 database includes a greater focus on non-coding RNA regulatory elements, such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), which are increasingly recognized as important regulators of gene expression.\n5. Integration of new experimental data: The JASPAR 2016 database includes integration of new experimental data, including chromatin immunoprecipitation sequencing (ChIP-seq) and assay for transposase-accessible chromatin (ATAC-seq) data, which provide a more comprehensive view of transcription factor binding in different cell types and tissues.",
    "llama-2-7b-chat-hf_fact": [
      "The JASPAR 2016 database has increased its coverage of human and mouse genomes compared to its previous versions.",
      "The JASPAR 2016 database added binding profiles for 14 new transcription factors, making a total of 120 transcription factors covered.",
      "The JASPAR 2016 has improved the accuracy of the existing binding profiles.",
      "The JASPAR 2016 database increased its focus on non-coding RNA regulatory elements, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs).",
      "The JASPAR 2016 database integrated new experimental data, including ChIP-seq and ATAC-seq data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2047,
    "user_query": "What is the function of the protein tafazzin?",
    "llama-2-7b-chat-hf_response": "Tafazzin is a protein that plays a crucial role in the regulation of mitochondrial dynamics, particularly in the process of mitochondrial fission. Mitochondria are organelles found in the cells of most eukaryotes, and they are responsible for generating energy for the cell through the process of cellular respiration. Tafazzin is a key regulator of mitochondrial fission, which is the process by which mitochondria divide into smaller fragments. This process is important for maintaining the proper structure and function of mitochondria, as well as for regulating the amount of energy produced by the cell.\nTafazzin was first identified in the early 2000s, and since then, numerous studies have shown that it plays a critical role in regulating mitochondrial dynamics. Tafazzin is a membrane-associated protein that localizes to the inner mitochondrial membrane, where it interacts with other proteins to regulate the fission of mitochondria. Tafazzin has been shown to be involved in a variety of cellular processes, including cell proliferation, differentiation, and survival.\nDysregulation of tafazzin has been implicated in a number of diseases, including cancer, neurodegenerative disorders, and metabolic disorders. For example, studies have shown that tafazzin is overexpressed in many types of cancer, where it promotes the proliferation and survival of cancer cells. Conversely, loss of tafazzin function has been linked to neurodegenerative disorders such as Parkinson's disease and Huntington's disease.\nOverall, the function of tafazzin is to regulate the fission of mitochondria, which is critical for maintaining the proper structure and function of these organelles. Dysregulation of tafazzin has been implicated in a number of diseases, highlighting the importance of this protein in maintaining cellular homeostasis.",
    "llama-2-7b-chat-hf_fact": [
      "Tafazzin is a protein that regulates mitochondrial dynamics.",
      "Tafazzin plays a key role in the process of mitochondrial fission.",
      "Mitochondria are responsible for generating energy for the cell through cellular respiration.",
      "Dysregulation of tafazzin is linked with diseases like cancer and neurodegenerative disorders.",
      "Tafazzin was first identified in the early 2000s."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Tafazzin plays a key role in the process of cardiolipin remodeling in mitochondria.",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2051,
    "user_query": "Where is base J found in the genome of Leishmania tarentolae?",
    "llama-2-7b-chat-hf_response": "Base J is found in the genome of Leishmania tarentolae at the following location(s):\nChr. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99\nNote that base J is not found in all chromosomes of Leishmania tarentolae.",
    "llama-2-7b-chat-hf_fact": [
      "Base J is located in the genome of Leishmania tarentolae.",
      "Base J is found contained within multiple chromosomes of Leishmania tarentolae.",
      "Base J is not found in all chromosomes of Leishmania tarentolae."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2052,
    "user_query": "Which tool is available for predicting regulatory interactions from ChIP-seq data?",
    "llama-2-7b-chat-hf_response": "There are several tools available for predicting regulatory interactions from ChIP-seq data, including:\n1. HISAT2: A popular tool for aligning ChIP-seq data to a reference genome and predicting regulatory interactions.\n2. DREAM: A tool for predicting transcription factor binding sites and regulatory interactions from ChIP-seq data.\n3. STAR: A tool for aligning ChIP-seq data to a reference genome and predicting regulatory interactions.\n4. MACS2: A tool for aligning ChIP-seq data to a reference genome and predicting regulatory interactions.\n5. ChIPseek: A tool for predicting transcription factor binding sites and regulatory interactions from ChIP-seq data.\nThese tools use different algorithms and approaches to predict regulatory interactions from ChIP-seq data, and each has its own strengths and limitations. The choice of tool will depend on the specific research question and the characteristics of the ChIP-seq data.",
    "llama-2-7b-chat-hf_fact": [
      "HISAT2 is a tool used for aligning ChIP-seq data to a reference genome and predicting regulatory interactions.",
      "DREAM can be utilized to predict transcription factor binding sites and regulatory interactions from ChIP-seq data.",
      "The software tool STAR aligns ChIP-seq data to a reference genome and aids in predicting regulatory interactions.",
      "MACS2 is another competent tool for aligning ChIP-seq data to a reference genome and predicting regulatory interactions.",
      "ChIPseek is a tool that can predict transcription factor binding sites and regulatory interactions from ChIP-seq data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: HISAT2 is a tool used for aligning RNA-seq data to a reference genome.",
      "true",
      "false, [corrected fact]: STAR is a software tool that aligns RNA-seq data to a reference genome, not ChIP-seq data.",
      "false, [corrected fact]: MACS2 is a tool used for peak calling and not for aligning ChIP-seq data to a reference genome.",
      "true"
    ]
  },
  {
    "id": 2053,
    "user_query": "Where are the unipolar brush cells localized?",
    "llama-2-7b-chat-hf_response": "Unipolar brush cells are localized in the sensory neurons of the dorsal root ganglion (DRG) and the spinal cord. These neurons are responsible for transmitting information from the peripheral nervous system (PNS) to the central nervous system (CNS) and play a crucial role in the transmission of nociceptive signals.",
    "llama-2-7b-chat-hf_fact": [
      "Unipolar brush cells are located in the sensory neurons of the dorsal root ganglion (DRG).",
      "Unipolar brush cells can also be found in the spinal cord.",
      "These neurons transmit information from the peripheral nervous system (PNS) to the central nervous system (CNS).",
      "Unipolar brush cells play a crucial role in transmitting nociceptive signals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Unipolar brush cells are located in the cerebellum, not in sensory neurons of the dorsal root ganglion (DRG).",
      "false, [corrected fact]: Unipolar brush cells are found primarily in the cerebellum, not in the spinal cord.",
      "false, [corrected fact]: It is not Unipolar brush cells, but sensory neurons that transmit information from the peripheral nervous system (PNS) to the central nervous system (CNS).",
      "unknown"
    ]
  },
  {
    "id": 2054,
    "user_query": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?",
    "llama-2-7b-chat-hf_response": "Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that originates in the pons, a part of the brainstem. Despite significant research efforts, the molecular mechanisms underlying DIPG remain poorly understood, and there are currently no effective treatments available. However, several driver mutations have been identified in DIPG tumors, which may provide potential therapeutic targets. Here are some of the driver mutations that have been identified in DIPG:\n1. H3F3A mutations: H3F3A mutations are present in approximately 70% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n2. HIST1H3B/HIST1H3B mutations: HIST1H3B/HIST1H3B mutations are present in approximately 20% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n3. TP53 mutations: TP53 mutations are present in approximately 50% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n4. PTEN mutations: PTEN mutations are present in approximately 20% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n5. ATRX mutations: ATRX mutations are present in approximately 10% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n6. DAXX mutations: DAXX mutations are present in approximately 10% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n7. ARID1A mutations: ARID1A mutations are present in approximately 5% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n8. ARID1B mutations: ARID1B mutations are present in approximately 5% of DIPG tumors and are associated with increased proliferation and poorer prognosis.\n9. KRAS mutations: KRAS mutations are present in approximately 5% of D",
    "llama-2-7b-chat-hf_fact": [
      "Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that originates in the pons, a part of the brainstem.",
      "H3F3A mutations are present in approximately 70% of DIPG tumors.",
      "HIST1H3B/HIST1H3B mutations are present in approximately 20% of DIPG tumors.",
      "TP53 mutations are present in approximately 50% of DIPG tumors.",
      "PTEN mutations are present in approximately 20% of DIPG tumors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: HIST1H3B mutations are present in approximately 14% of DIPG tumors.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2059,
    "user_query": "What is the enzymatic activity of PARL?",
    "llama-2-7b-chat-hf_response": "The enzymatic activity of PARL (Protein Arginine Methyltransferase Like) has been shown to be involved in various cellular processes, including:\n1. Cell signaling: PARL has been shown to be involved in the regulation of cell signaling pathways, including the PI3K/Akt signaling pathway.\n2. Cell adhesion: PARL has been shown to be involved in the regulation of cell adhesion and the cytoskeleton.\n3. Cell cycle: PARL has been shown to be involved in the regulation of the cell cycle, including the G1/S checkpoint.\n4. Apoptosis: PARL has been shown to be involved in the regulation of apoptosis, or programmed cell death.\n5. Neurodegeneration: PARL has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.\n6. Cancer: PARL has been shown to be involved in the regulation of cancer, including the progression of cancer cells and the development of resistance to chemotherapy.\n7. Immune response: PARL has been shown to be involved in the regulation of the immune response, including the activation of immune cells and the regulation of inflammation.\n8. Metabolism: PARL has been shown to be involved in the regulation of metabolic processes, including glucose metabolism and lipid metabolism.\n9. Autophagy: PARL has been shown to be involved in the regulation of autophagy, a process by which cells degrade and recycle damaged or dysfunctional cellular components.\n10. DNA repair: PARL has been shown to be involved in the regulation of DNA repair, including the repair of DNA damage caused by oxidative stress.\nIt is important to note that the specific enzymatic activity of PARL can vary depending on the cellular context and the specific protein substrate it is interacting with.",
    "llama-2-7b-chat-hf_fact": [
      "PARL (Protein Arginine Methyltransferase Like) is involved in the regulation of cell signaling pathways, including the PI3K/Akt signaling pathway.",
      "PARL has been implicated in the regulation of cell adhesion and the cytoskeleton.",
      "PARL plays a role in the regulation of the cell cycle, including the G1/S checkpoint.",
      "PARL is involved in the regulation of apoptosis, or programmed cell death.",
      "PARL has been shown to regulate neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2064,
    "user_query": "What is the mechanism of action of verubecestat?",
    "llama-2-7b-chat-hf_response": "Verubecestat is a BET (bromodomain and extraterminal) inhibitor, which means it works by blocking the action of BET proteins. BET proteins are involved in regulating gene expression by binding to acetylated histone proteins and recruiting other proteins that modify chromatin structure. By blocking the action of BET proteins, verubecestat can alter the expression of genes involved in various cellular processes, including cell proliferation, differentiation, and survival.\nVerubecestat has been shown to inhibit the proliferation of various cancer cell types, including breast, lung, and colon cancer cells, by reducing the expression of genes involved in cell cycle progression and angiogenesis. It has also been shown to induce apoptosis (programmed cell death) in cancer cells, which can lead to tumor shrinkage and regression.\nIn addition to its anti-cancer effects, verubecestat has also been shown to have neuroprotective effects, and may be useful in treating neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS).\nOverall, the mechanism of action of verubecestat is complex and involves the regulation of multiple cellular processes, including gene expression, cell proliferation, and apoptosis. Its ability to inhibit the action of BET proteins makes it a promising drug candidate for the treatment of various cancers and neurodegenerative diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Verubecestat is a BET (bromodomain and extraterminal) inhibitor.",
      "BET proteins are involved in regulating gene expression by binding to acetylated histone proteins and recruiting proteins that modify chromatin structure.",
      "Verubecestat has been shown to inhibit the proliferation of various cancer cell types.",
      "Verubecestat also induces apoptosis (programmed cell death) in cancer cells.",
      "Verubecestat has displayed neuroprotective effects, and may be potentially useful in treating neurodegenerative diseases like Alzheimer's disease and Amyotrophic lateral sclerosis (ALS)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Verubecestat is a BACE (Beta-Site Amyloid Precursor Protein Cleaving Enzyme) inhibitor, not a BET inhibitor.",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-7b-chat-hf_response": "Triple negative gliomas are characterized by the following features:\n1. Lack of expression of cytokeratin (CK): Triple negative gliomas do not express CK, which is a protein that is typically found in epithelial cells.\n2. Lack of expression of estrogen receptor (ER) and progesterone receptor (PR): Triple negative gliomas do not express ER or PR, which are proteins that are involved in hormone signaling.\n3. Lack of HER2/neu amplification: Triple negative gliomas do not have amplification of the HER2/neu gene, which is a gene that is involved in cell growth and division.\n4. Lack of EGFR mutations: Triple negative gliomas do not have mutations in the EGFR gene, which is a gene that is involved in cell signaling.\n5. Lack of ALK rearrangements: Triple negative gliomas do not have rearrangements in the ALK gene, which is a gene that is involved in cell signaling.\n6. Lack of IDH1/2 mutations: Triple negative gliomas do not have mutations in the IDH1 or IDH2 genes, which are genes that are involved in cell metabolism.\n7. Lack of TP53 mutations: Triple negative gliomas do not have mutations in the TP53 gene, which is a gene that is involved in cell growth and division.\n8. Lack of PTEN mutations: Triple negative gliomas do not have mutations in the PTEN gene, which is a gene that is involved in cell signaling.\n9. Lack of MGMT promoter methylation: Triple negative gliomas do not have methylation of the MGMT gene, which is a gene that is involved in DNA repair.\n10. High proliferation rate: Triple negative gliomas have a high proliferation rate, meaning that they grow and divide quickly.\n11. Poor differentiation: Triple negative gliomas are poorly differentiated, meaning that they do not have a distinctive appearance under a microscope.\n12. Aggressive clinical course: Triple negative gliomas tend to have an aggress",
    "llama-2-7b-chat-hf_fact": [
      "Triple negative gliomas do not express cytokeratin (CK), a protein found in epithelial cells.",
      "Triple negative gliomas do not express estrogen receptor (ER) and progesterone receptor (PR), proteins involved in hormone signaling.",
      "Triple negative gliomas do not have amplification of the HER2/neu gene, a gene involved in cell growth and division.",
      "Triple negative gliomas do not have mutations in the EGFR and PTEN genes, genes involved in cell signaling.",
      "Triple negative gliomas do not have mutations in the IDH1 or IDH2 genes, genes involved in cell metabolism."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2068,
    "user_query": "What is the function of gasdermin D?",
    "llama-2-7b-chat-hf_response": "Gasdermin D (GSDMD) is a protein that plays a crucial role in regulating pyroptosis, a form of programmed cell death that is involved in the immune response. Pyroptosis is a pro-inflammatory form of cell death that is triggered by the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs).\nGasdermin D is a key regulator of pyroptosis and plays a crucial role in the activation of caspase-1, which is a downstream effector of pyroptosis. Caspase-1 is a cysteine protease that processes and activates pro-inflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor- (TNF-), which are involved in the immune response. Gasdermin D is recruited to the plasma membrane upon activation of PRRs, where it interacts with caspase-1 and promotes its activation.\nIn addition to its role in pyroptosis, Gasdermin D has been implicated in other cellular processes, including cell adhesion, migration, and survival. Gasdermin D has also been shown to play a role in cancer, where it can promote tumor progression and metastasis.\nOverall, Gasdermin D is a key regulator of pyroptosis and plays a crucial role in the immune response. Dysregulation of Gasdermin D has been implicated in various diseases, including inflammatory disorders and cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Gasdermin D (GSDMD) is a protein that plays a crucial role in regulating pyroptosis, a form of programmed cell death.",
      "Pyroptosis is a pro-inflammatory form of cell death that is triggered by the recognition of pathogen-associated molecular patterns (PAMPs).",
      "Gasdermin D is involved in activating caspase-1, a cysteine protease that processes and activates pro-inflammatory cytokines.",
      "Gasdermin D has been implicated in cellular processes including cell adhesion, migration, and survival, and in disease processes such as cancer.",
      "Dysregulation of Gasdermin D has been implicated in various diseases, including inflammatory disorders and cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Gasdermin D is not typically associated with cell adhesion, migration, and survival. Its primary role is in pyroptosis and inflammation.",
      "true"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-7b-chat-hf_response": "TOPAZ1 is a gene that provides instructions for making a protein called TOPAZ, which is involved in the development and maintenance of the nervous system. The TOPAZ protein is a transcription factor, which means that it helps to regulate the expression of other genes by binding to specific DNA sequences. TOPAZ1 is specifically involved in the regulation of genes involved in the formation and maintenance of synapses, which are the connections between neurons that allow them to communicate with each other.\nMutations in the TOPAZ1 gene have been associated with a variety of neurological disorders, including intellectual disability, autism spectrum disorder, and epilepsy. These mutations are thought to disrupt the normal function of the TOPAZ protein, leading to problems with synaptic development and function.\nResearch on the TOPAZ1 gene and protein is ongoing, and scientists are working to better understand its role in the development and maintenance of the nervous system, as well as its potential as a therapeutic target for neurological disorders.",
    "llama-2-7b-chat-hf_fact": [
      "TOPAZ1 is a gene that provides instructions for making a protein called TOPAZ.",
      "The TOPAZ protein is a transcription factor, which helps to regulate the expression of other genes by bind to specific DNA sequences.",
      "This protein is specifically involved in the regulation of genes involved in the formation and maintenance of synapses.",
      "Mutations in the TOPAZ1 gene have been associated with a variety of neurological disorders including intellectual disability, autism spectrum disorder, and epilepsy.",
      "There's ongoing research on the TOPAZ1 gene and protein regarding its role in the development and maintenance of the nervous system and for potential therapeutic uses for neurological disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2070,
    "user_query": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?",
    "llama-2-7b-chat-hf_response": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder that affects the body's ability to break down glucose, a simple sugar found in many foods. People with G6PD deficiency may experience a range of symptoms, including:\n1. Hemolytic anemia: This is the most common symptom of G6PD deficiency, and it occurs when red blood cells are destroyed faster than they can be replaced. Hemolytic anemia can cause fatigue, weakness, pale skin, and shortness of breath.\n2. Yellowing of the skin and eyes (jaundice): G6PD deficiency can cause a buildup of bilirubin in the blood, which can lead to jaundice. Jaundice is characterized by a yellowish tint to the skin and whites of the eyes.\n3. Increased risk of infections: G6PD deficiency can make it harder for the body to fight off infections, particularly those caused by bacteria. People with G6PD deficiency may be more prone to ear infections, sinus infections, and urinary tract infections.\n4. Recurrent episodes of hemolytic anemia: People with G6PD deficiency may experience recurrent episodes of hemolytic anemia, particularly after exposure to certain triggers such as infections, medications, or certain foods.\n5. Delayed growth and development: G6PD deficiency can affect the body's ability to produce red blood cells, which can lead to delayed growth and development in children.\n6. Anemia: G6PD deficiency can cause anemia, which is a condition where the body has a lower than normal number of red blood cells. Anemia can cause fatigue, weakness, and shortness of breath.\n7. Pale skin: People with G6PD deficiency may have pale skin due to a lack of red blood cells.\n8. Shortness of breath: G6PD deficiency can cause shortness of breath due to a lack of red blood cells.\n9. Headaches: Some people with G6PD deficiency may experience headaches due to",
    "llama-2-7b-chat-hf_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder that affects the body's ability to break down glucose.",
      "One of the most common symptoms of G6PD deficiency is hemolytic anemia, which can cause fatigue, weakness, pale skin, and shortness of breath.",
      "G6PD deficiency can cause jaundice, characterized by a yellowing of the skin and eyes due to a buildup of bilirubin in the blood.",
      "G6PD deficiency can increase susceptibility to infections, such as ear infections, sinus infections, and urinary tract infections.",
      "Delayed growth and development in children can occur due to G6PD deficiency affecting the body's ability to produce red blood cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: G6PD deficiency does not directly cause susceptibility to infections such as ear infections, sinus infections, and urinary tract infections.",
      "true"
    ]
  },
  {
    "id": 2071,
    "user_query": "Has the gorilla genome been determined?",
    "llama-2-7b-chat-hf_response": "Yes, the gorilla genome has been determined. In 2012, an international team of scientists published the first complete gorilla genome sequence in the journal Nature. The gorilla genome is similar in size to the human genome, consisting of approximately 2.7 billion base pairs of DNA.",
    "llama-2-7b-chat-hf_fact": [
      "The gorilla genome has been determined.",
      "The first complete gorilla genome sequence was published in 2012.",
      "An international team of scientists was responsible for determining the gorilla genome sequence.",
      "The complete gorilla genome sequence was published in the journal Nature.",
      "The gorilla genome is similar in size to the human genome, consisting of approximately 2.7 billion base pairs of DNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The gorilla genome is similar in size to the human genome, consisting of approximately 3.04 billion base pairs of DNA."
    ]
  },
  {
    "id": 2073,
    "user_query": "Are mutations in the C9orf72  gene associated with macular degeneration?",
    "llama-2-7b-chat-hf_response": "Mutations in the C9orf72 gene have been associated with several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, there is limited evidence to suggest that mutations in the C9orf72 gene are associated with macular degeneration.\nMacular degeneration is a chronic and progressive eye disorder that affects the macula, the central part of the retina responsible for central vision. There are two main forms of macular degeneration: dry macular degeneration, which is the most common form, and wet macular degeneration, which is less common but can cause more rapid vision loss.\nWhile mutations in the C9orf72 gene have been identified in some cases of macular degeneration, these mutations are relatively rare and are not thought to be a major contributor to the development of the disease. The majority of macular degeneration cases are caused by a combination of genetic and environmental factors, including age, family history, and lifestyle factors such as smoking and diet.\nIt is important to note that while mutations in the C9orf72 gene have been associated with neurodegenerative disorders, the relationship between these mutations and macular degeneration is not fully understood and requires further research. If you have a family history of macular degeneration or are experiencing symptoms of the disease, it is important to speak with an eye care professional to determine the underlying cause and develop an appropriate treatment plan.",
    "llama-2-7b-chat-hf_fact": [
      "Mutations in the C9orf72 gene are associated with neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).",
      "Macular degeneration is a chronic, progressive eye disorder that affects the macula, a part of the retina responsible for central vision.",
      "There are two main forms of macular degeneration: dry and wet.",
      "Wet macular degeneration is less common but can cause more rapid vision loss.",
      "A combination of genetic and environmental factors, including age, family history, lifestyle factors such as smoking and diet, are known to cause the majority of macular degeneration cases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-7b-chat-hf_response": "GATA-1 isoforms are controlled by the expression of the GATA-1 gene, which is located on chromosome 5q31. The GATA-1 gene contains multiple exons, and the splicing of these exons results in the production of different isoforms of the GATA-1 protein. The expression of these isoforms is regulated by a variety of factors, including transcription factors, signaling pathways, and epigenetic modifications.\nOne of the key transcription factors that controls the expression of GATA-1 isoforms is the transcription factor GATA-2. GATA-2 is a zinc finger protein that binds to specific DNA sequences in the GATA-1 promoter region and enhances the transcription of the GATA-1 gene. GATA-2 is itself regulated by a variety of factors, including the expression of other transcription factors and signaling pathways.\nIn addition to GATA-2, other transcription factors that have been shown to regulate the expression of GATA-1 isoforms include GATA-3, NF-B, and AP-1. These transcription factors can bind to specific DNA sequences in the GATA-1 promoter region and enhance or repress the transcription of the GATA-1 gene, depending on the specific context.\nIn addition to transcription factor regulation, the expression of GATA-1 isoforms can also be influenced by epigenetic modifications, such as DNA methylation and histone modification. These modifications can affect the accessibility of the GATA-1 promoter region to transcription factors and other regulatory proteins, leading to changes in the expression of GATA-1 isoforms.\nOverall, the regulation of GATA-1 isoforms is a complex process that involves the interplay of multiple transcription factors and signaling pathways, as well as epigenetic modifications. Understanding the regulation of GATA-1 isoforms is important for understanding the development and function of hematopoietic cells, and may have implications for the diagnosis and treatment of hematopoietic disorders.",
    "llama-2-7b-chat-hf_fact": [
      "GATA-1 isoforms are controlled by the expression of the GATA-1 gene, located on chromosome 5q31.",
      "The GATA-1 gene contains multiple exons, the splicing of which results in the production of different isoforms of the GATA-1 protein.",
      "One of the key transcription factors that controls the expression of GATA-1 isoforms is GATA-2.",
      "Other transcription factors such as GATA-3, NF-B, and AP-1 have been shown to regulate the expression of GATA-1 isoforms.",
      "The expression of GATA-1 isoforms can also be influenced by epigenetic modifications, such as DNA methylation and histone modification."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-7b-chat-hf_response": "MIRA-seq is a method for identifying long non-coding RNAs (lncRNAs) from RNA sequencing (RNA-seq) data. LncRNAs are RNAs that are longer than 200 nucleotides in length but do not encode proteins. They play important roles in regulating gene expression and other cellular processes, but their functions are not yet fully understood.\nMIRA-seq uses a computational approach to identify lncRNAs in RNA-seq data by comparing the sequencing reads to a reference genome or transcriptome. The method uses a machine learning algorithm to identify regions of the genome or transcriptome that are enriched for reads, indicating the presence of lncRNAs.\nMIRA-seq can be used to identify lncRNAs in a variety of organisms, including humans, and has been applied to a wide range of biological samples, including blood cells, tumor tissues, and stem cells.\nThe advantages of MIRA-seq include:\n1. Sensitivity: MIRA-seq can identify lncRNAs that are present at low levels in the sample.\n2. Specificity: MIRA-seq can distinguish between lncRNAs and other types of RNAs, such as mRNAs and pseudogenes.\n3. Flexibility: MIRA-seq can be used with different types of RNA-seq data, including whole-transcriptome shotgun sequencing (WTSS) and targeted sequencing.\n4. Efficiency: MIRA-seq can identify lncRNAs in a computationally efficient manner, making it possible to analyze large datasets.\n5. Integration with other omics data: MIRA-seq can be combined with other types of omics data, such as DNA sequencing and metabolomics data, to provide a more comprehensive understanding of cellular processes.\nOverall, MIRA-seq is a powerful tool for identifying and characterizing lncRNAs, which are important regulators of gene expression and other cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "MIRA-seq is a method for identifying long non-coding RNAs (lncRNAs) from RNA sequencing (RNA-seq) data.",
      "LncRNAs are more than 200 nucleotides in length and do not encode proteins.",
      "MIRA-seq uses a computational approach and a machine learning algorithm to identify lncRNAs in RNA-seq data.",
      "MIRA-seq can be used to identify lncRNAs in a variety of organisms, including humans.",
      "MIRA-seq can identify lncRNAs in a range of biological samples, such as blood cells, tumor tissues, and stem cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2077,
    "user_query": "How does Ssu72 mediate gene looping?",
    "llama-2-7b-chat-hf_response": "Ssu72 is a transcriptional elongation factor that plays a crucial role in regulating gene expression by mediating gene looping. Gene looping refers to the process by which a gene is regulated by its own promoter or enhancer elements located far away on the same or opposite chromosome. Ssu72 mediates gene looping by interacting with the RNA polymerase II (RNAPII) complex, which is responsible for transcribing DNA into RNA. Ssu72 binds to the RNAPII complex and helps to recruit it to the promoter or enhancer elements of a gene, allowing it to initiate transcription.\nOnce the RNAPII complex is recruited to the promoter or enhancer elements, Ssu72 helps to position the RNAPII complex correctly so that it can initiate transcription. Ssu72 also helps to stabilize the RNAPII complex at the promoter or enhancer elements, allowing it to remain bound for longer periods of time and increasing the efficiency of transcription.\nIn addition to its role in recruiting and positioning the RNAPII complex, Ssu72 also helps to regulate the activity of other transcription factors that are involved in gene expression. Ssu72 can bind to these transcription factors and help to recruit them to the promoter or enhancer elements of a gene, allowing them to interact with the RNAPII complex and regulate transcription.\nOverall, Ssu72 plays a crucial role in regulating gene expression by mediating gene looping and recruiting the RNAPII complex to the promoter or enhancer elements of a gene. By positioning the RNAPII complex correctly and regulating the activity of other transcription factors, Ssu72 helps to ensure that genes are expressed correctly and efficiently.",
    "llama-2-7b-chat-hf_fact": [
      "Ssu72 is a transcriptional elongation factor that helps in regulating gene expression through gene looping.",
      "Gene looping is a regulation process of a gene by its own promoter or enhancer elements, which could be located distantly on the same or different chromosome.",
      "Ssu72 mediates gene looping by interacting with RNA polymerase II (RNAPII), which transcribes DNA into RNA.",
      "Ssu72 binds to the RNAPII complex, helps recruit it to the promoter or enhancer elements of a gene, and places it correctly for initiation of transcription.",
      "Apart from its role in recruitment and positioning of the RNAPII complex, Ssu72 also helps regulate the activity of other transcription factors involved in gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Ssu72 does not bind to the RNAPII complex, instead, it dephosphorylates the Ser5 form of the RNAPII CTD repeatedly during the transcription cycle.",
      "true"
    ]
  },
  {
    "id": 2081,
    "user_query": "What is the Glasgow Coma score?",
    "llama-2-7b-chat-hf_response": "The Glasgow Coma Scale (GCS) is a neurological scale used to assess the degree of consciousness and neurological function in a person who has suffered a traumatic brain injury or other neurological disorder. The GCS is a 15-point scale that assesses three main components of neurological function:\n1. Eye opening (4 points)\n2. Motor response (6 points)\n3. Verbal response (5 points)\nThe GCS scores range from 3 (severely impaired) to 15 (normal). A score of 8 or less indicates a severe brain injury, while a score of 9-12 indicates a moderate brain injury. A score of 13-15 indicates a mild brain injury.\nThe GCS is widely used in emergency departments and intensive care units to quickly and accurately assess the neurological status of patients who have suffered a traumatic brain injury or other neurological disorder. It is an important tool for healthcare providers to determine the appropriate level of care and treatment for these patients.",
    "llama-2-7b-chat-hf_fact": [
      "The Glasgow Coma Scale (GCS) is a neurological scale used to assess the degree of consciousness and neurological function in a person.",
      "GCS is used for people who have suffered a traumatic brain injury or other neurological disorder.",
      "The GCS is a 15-point scale that assesses three main components: eye opening, motor response, and verbal response.",
      "The GCS scores range from 3, which indicates severely impaired condition, to 15, which signifies a normal state.",
      "A score of 8 or less on the GCS indicates a severe brain injury, a score of 9-12 indicates a moderate brain injury, and a score of 13-15 indicates a mild brain injury."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2083,
    "user_query": "Which is the main cause of the Patau syndrome?",
    "llama-2-7b-chat-hf_response": "Patau syndrome, also known as Edwards syndrome, is a genetic disorder caused by an extra copy of chromosome 18. This extra genetic material can disrupt the normal functioning of the brain and body, leading to a range of physical and developmental delays.\nThe main cause of Patau syndrome is a genetic mutation that results in an extra copy of chromosome 18. This mutation can occur spontaneously or be inherited from one or both parents. The extra genetic material can affect the development of the brain and body, leading to the characteristic physical and developmental delays of the disorder.\nThere are several risk factors that may increase the likelihood of developing Patau syndrome, including:\n1. Advanced maternal age: The risk of genetic mutations and chromosomal abnormalities increases with age, making older mothers more likely to have a child with Patau syndrome.\n2. Previous child with a chromosomal abnormality: If a parent has had a child with a chromosomal abnormality, their risk of having another child with the same condition increases.\n3. Family history of chromosomal abnormalities: A family history of chromosomal abnormalities may increase the risk of Patau syndrome in offspring.\n4. Maternal infection during pregnancy: Certain infections during pregnancy, such as rubella, can increase the risk of chromosomal abnormalities in the developing fetus.\n5. Assisted reproductive technology: The use of assisted reproductive technology, such as in vitro fertilization, may increase the risk of chromosomal abnormalities in offspring.\nIt is important to note that Patau syndrome is a rare disorder, and the majority of cases occur spontaneously without any known cause.",
    "llama-2-7b-chat-hf_fact": [
      "Patau syndrome, also known as Edwards syndrome, is a genetic disorder caused by an extra copy of chromosome 18.",
      "The main cause of Patau syndrome is a genetic mutation resulting in an extra copy of chromosome 18.",
      "Advanced maternal age, a previous child with a chromosomal abnormality, family history of chromosomal abnormalities, maternal infection during pregnancy, and use of assisted reproductive technology are risk factors for Patau syndrome.",
      "Certain infections during pregnancy, such as rubella, can increase the risk of chromosomal abnormalities in the developing fetus.",
      "Patau syndrome is a rare disorder, and most cases occur spontaneously without any known cause."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Patau syndrome, also known as trisomy 13, is a genetic disorder caused by an extra copy of chromosome 13.",
      "true",
      "false, [corrected fact]: Advanced maternal age and a previous child with a chromosomal abnormality are risk factors for Patau syndrome, but family history of chromosomal abnormalities, maternal infection during pregnancy, and use of assisted reproductive technology are not directly linked to Patau syndrome.",
      "false, [corrected fact]: Certain infections during pregnancy, such as rubella, can increase the risk of congenital abnormalities, but they are not directly linked to chromosomal abnormalities like Patau syndrome.",
      "true"
    ]
  },
  {
    "id": 2085,
    "user_query": "Is Musclin a secretory peptide?",
    "llama-2-7b-chat-hf_response": "Musclin is a peptide hormone that is produced by muscle cells and plays a role in regulating muscle growth and differentiation. While Musclin is not a secretory peptide in the classical sense, it does have some characteristics of secretory peptides.\nSecretory peptides are typically produced by cells and secreted into the extracellular space, where they can interact with other cells or tissues. Musclin, on the other hand, is produced by muscle cells and remains intracellular. However, Musclin can be secreted from muscle cells through a process called exosomal release.\nExosomes are small vesicles that are formed when cells, such as muscle cells, undergo a process called endosomal sorting, in which proteins and lipids are sorted and packaged into small vesicles called endosomes. These endosomes then fuse with the cell membrane, releasing the contents, including Musclin, into the extracellular space.\nSo while Musclin is not a secretory peptide in the classical sense, it can be secreted from muscle cells through the process of exosomal release, making it a type of secretory peptide.",
    "llama-2-7b-chat-hf_fact": [
      "Musclin is a peptide hormone that is produced by muscle cells.",
      "Musclin plays a role in regulating muscle growth and differentiation.",
      "Secretory peptides are typically produced by cells and secreted into the extracellular space.",
      "Musclin can be secreted from muscle cells through a process called exosomal release.",
      "Exosomes are small vesicles that are formed when cells undergo a process called endosomal sorting."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2091,
    "user_query": "What happens to H2AX upon DNA bouble strand breaks?",
    "llama-2-7b-chat-hf_response": "Upon DNA double strand breaks, H2AX is phosphorylated at serine 139 (-H2AX) and forms foci in the nucleus. The phosphorylation of H2AX at serine 139 is a marker of DNA double strand breaks and is involved in the repair process. The foci formation is thought to be due to the recruitment of repair proteins to the site of the break. The phosphorylation of H2AX at serine 139 can be detected using antibodies specific to this site, and the formation of foci can be visualized using fluorescence microscopy.",
    "llama-2-7b-chat-hf_fact": [
      "Upon DNA double strand breaks, H2AX is phosphorylated at serine 139.",
      "The phosphorylation at serine 139 creates -H2AX.",
      "The phosphorylation of H2AX at serine 139 is a marker of DNA double strand breaks.",
      "The phosphorylation of H2AX at serine 139 is involved in repairing the DNA breaks.",
      "The phosphorylation of H2AX at serine 139 can be detected using antibodies that target this specific site."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2095,
    "user_query": "What is the inheritance of Barth syndrome?",
    "llama-2-7b-chat-hf_response": "Barth syndrome is a rare genetic disorder that affects males almost exclusively. It is caused by mutations in the TCF4 gene, which is located on the X chromosome. The inheritance pattern of Barth syndrome is X-linked recessive, which means that the mutated gene is located on the X chromosome and is inherited from the mother.\nMales with Barth syndrome have a 50% chance of inheriting the mutated gene from their mother, and they will be carriers of the disorder. Females have a 50% chance of inheriting the mutated gene from their mother and a 50% chance of being unaffected. Females who are carriers of the mutated gene have a 50% chance of passing it on to each of their sons, who will be affected, and a 50% chance of passing it on to each of their daughters, who will be carriers.\nIt's important to note that Barth syndrome is a rare disorder, and the inheritance pattern can be complex. If you have concerns about the inheritance of Barth syndrome or any other genetic disorder, it's important to speak with a genetic counselor or other qualified healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "Barth syndrome is a rare genetic disorder that affects males almost exclusively.",
      "The disorder is caused by mutations in the TCF4 gene, which is located on the X chromosome.",
      "The inheritance pattern of Barth syndrome is X-linked recessive.",
      "Males with Barth syndrome have a 50% chance of inheriting the mutated gene from their mother.",
      "Females who are carriers of the mutated gene have a 50% chance of passing it on to each of their sons and daughters."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The disorder is caused by mutations in the TAZ gene, not the TCF4 gene, which is located on the X chromosome.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2096,
    "user_query": "Is Cryptococcus neoformans a frequent cause of isolated skin infections in immunocompromised individuals",
    "llama-2-7b-chat-hf_response": "?\nCryptococcus neoformans is a common cause of opportunistic infections in immunocompromised individuals, including those with HIV/AIDS, cancer, and organ transplantation. Isolated skin infections caused by Cryptococcus neoformans are rare in immunocompetent individuals, but they can occur in immunocompromised individuals.",
    "llama-2-7b-chat-hf_fact": [
      "Cryptococcus neoformans causes opportunistic infections in immunocompromised individuals.",
      "Cryptococcus neoformans can cause infections in individuals with HIV/AIDS.",
      "Cryptococcus neoformans can cause infections in cancer patients.",
      "Individuals post-organ transplantation can be infected by Cryptococcus neoformans.",
      "Skin infections caused by Cryptococcus neoformans, though rare, occur in immunocompromised individuals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2098,
    "user_query": "What are sirtuins?",
    "llama-2-7b-chat-hf_response": "Sirtuins are a family of enzymes that play a crucial role in regulating cellular metabolism, stress resistance, and longevity. They are named after the Silent Information Regulator (SIR) protein, which was first identified in yeast and found to be involved in the regulation of aging and stress resistance.\nThere are seven known sirtuins in mammals (SIRT1-7), each with distinct functions and tissue-specific expressions. Sirtuins are NAD+-dependent deacetylases, meaning they require nicotinamide adenine dinucleotide (NAD+) as a cofactor to function. NAD+ is a coenzyme that plays a central role in cellular metabolism and energy production.\nSirtuins have been shown to be involved in a wide range of biological processes, including:\n1. Cellular metabolism: Sirtuins regulate the activity of various metabolic enzymes, including those involved in glucose and lipid metabolism.\n2. Stress resistance: Sirtuins play a role in protecting cells against oxidative stress, heat shock, and other forms of stress.\n3. Longevity: Sirtuins have been shown to promote longevity in various organisms, including yeast, worms, and mice.\n4. Inflammation: Sirtuins have anti-inflammatory effects and can regulate the activity of pro-inflammatory genes.\n5. DNA repair: Sirtuins are involved in the repair of DNA damage and can regulate the activity of genes involved in DNA repair.\n6. Cell cycle regulation: Sirtuins can regulate the cell cycle and promote cellular senescence, which is a state of permanent cell cycle arrest that can prevent cancer.\n7. Neurodegeneration: Sirtuins have been shown to protect against neurodegeneration in various diseases, including Alzheimer's disease and Parkinson's disease.\nOverall, sirtuins are important regulators of cellular metabolism and stress resistance, and their dysregulation has been implicated in various diseases, including metabolic disorders, cancer, and neurodegenerative diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Sirtuins are a family of enzymes that regulate cellular metabolism, stress resistance, and longevity.",
      "Sirtuins are named after the Silent Information Regulator (SIR) protein, first identified in yeast.",
      "There are seven known sirtuins in mammals (SIRT1-7), each with distinct functions and tissue-specific expressions, and they require NAD+ as a cofactor to function.",
      "Sirtuins play roles in a wide range of biological processes including cellular metabolism, stress resistance, longevity, inflammation, DNA repair, cell cycle regulation, and neurodegeneration.",
      "Dysregulation of sirtuins has been implicated in various diseases, including metabolic disorders, cancer, and neurodegenerative diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2100,
    "user_query": "Which technique led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C?",
    "llama-2-7b-chat-hf_response": "The technique used to elucidate the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C was gene knockdown and functional assays. Specifically, the researchers used lentiviral-mediated gene knockdown of HOXD10 in lymphatic endothelial cells and evaluated the effects on VEGF-C-mediated signaling and lymphatic endothelial migration.",
    "llama-2-7b-chat-hf_fact": [
      "The role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C was elucidated using gene knockdown and functional assays.",
      "To study HOXD10's role, researchers used lentiviral-mediated gene knockdown in lymphatic endothelial cells.",
      "After the gene knockdown, researchers evaluated the effects on VEGF-C-mediated signaling and lymphatic endothelial migration."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2101,
    "user_query": "Is Obeticholic Acid used for treatment of Primary Biliary Cholangitis?",
    "llama-2-7b-chat-hf_response": "Yes, obeticholic acid is used for the treatment of primary biliary cholangitis (PBC), a chronic autoimmune liver disease that affects the bile ducts in the liver. Obeticholic acid is a bile acid analogue that has been shown to improve liver function and reduce symptoms in patients with PBC.",
    "llama-2-7b-chat-hf_fact": [
      "Obeticholic acid is used for the treatment of primary biliary cholangitis (PBC).",
      "Primary biliary cholangitis is a chronic autoimmune liver disease that affects the bile ducts in the liver.",
      "Obeticholic acid is a bile acid analogue.",
      "Obeticholic acid has been shown to improve liver function in patients with PBC.",
      "Obeticholic acid has been shown to reduce symptoms in patients with PBC."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2102,
    "user_query": "What alternate indication has Vanoxerine been repositioned for?",
    "llama-2-7b-chat-hf_response": "Vanoxerine, a drug that was initially developed for the treatment of pulmonary arterial hypertension (PAH), has been repositioned for the treatment of idiopathic pulmonary fibrosis (IPF). This repositioning is based on the finding that vanoxerine has anti-inflammatory and anti-fibrotic effects, which may be beneficial in the treatment of IPF.",
    "llama-2-7b-chat-hf_fact": [
      "Vanoxerine was originally developed for the treatment of pulmonary arterial hypertension (PAH).",
      "Vanoxerine has been repositioned for the treatment of idiopathic pulmonary fibrosis (IPF).",
      "The repositioning of vanoxerine is based on its anti-inflammatory and anti-fibrotic effects.",
      "Anti-inflammatory and anti-fibrotic effects of vanoxerine may be beneficial in the treatment of IPF."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2105,
    "user_query": "Does the word ovine refers to goats?",
    "llama-2-7b-chat-hf_response": "Yes, the word \"ovine\" does refer to goats. The term \"ovine\" is derived from the Latin word \"ovus,\" which means \"egg,\" and was used to describe animals that lay eggs, such as birds. However, over time, the term \"ovine\" came to be used to describe any animal that resembles a goat, including goats themselves. So, while the word \"ovine\" can refer to any animal that lays eggs, it is most commonly used to refer to goats.",
    "llama-2-7b-chat-hf_fact": [
      "The term \"ovine\" is derived from the Latin word \"ovus.\"",
      "The Latin word \"ovus\" means \"egg.\"",
      "Ovine was initially used to describe animals that lay eggs.",
      "Over time, the term \"ovine\" came to be used to describe any animal that resembles a goat.",
      "Today, the term \"ovine\" is most commonly used to refer to goats."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The Latin word \"ovus\" means \"sheep.\"",
      "false, [corrected fact]: Ovine was initially used to describe animals that resemble sheep.",
      "false, [corrected fact]: Over time, the term \"ovine\" has continued to describe animals that resemble sheep.",
      "false, [corrected fact]: Today, the term \"ovine\" is most commonly used to refer to sheep."
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-7b-chat-hf_response": "ARCALYST (rilonacept) is a prescription medicine used to treat cryopyrin-associated periodic syndrome (CAPS) in people 12 years and older, and to treat gout flares in people 18 years and older.",
    "llama-2-7b-chat-hf_fact": [
      "ARCALYST is a prescription medicine.",
      "ARCALYST is used to treat cryopyrin-associated periodic syndrome (CAPS).",
      "The treatment with ARCALYST is applicable to people who are 12 years and older for CAPS.",
      "ARCALYST is also used to treat gout flares.",
      "For the treatment of gout flares, ARCALYST is prescribed for people who are 18 years and older."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2114,
    "user_query": "Where is the TAZ (G4.5) is located in humans?",
    "llama-2-7b-chat-hf_response": "The TAZ (G4.5) is a transcriptional coactivator that plays a crucial role in regulating cellular processes such as cell proliferation, differentiation, and survival. In humans, the TAZ protein is expressed in various tissues, including the brain, heart, liver, and pancreas.",
    "llama-2-7b-chat-hf_fact": [
      "The TAZ (G4.5) is a transcriptional coactivator in humans.",
      "TAZ plays a role in cell proliferation, differentiation, and survival.",
      "The TAZ protein is expressed in the human brain.",
      "The TAZ protein is expressed in the human heart.",
      "The TAZ protein is expressed in the human liver and pancreas."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2115,
    "user_query": "What do nerve-associated peripheral glial progenitors give rise to?",
    "llama-2-7b-chat-hf_response": "Nerve-associated peripheral glial progenitors (NAPGs) are a type of progenitor cell that is found in the peripheral nervous system (PNS). These cells are derived from the neural crest and give rise to a variety of cell types in the PNS, including:\n1. Schwann cells: NAPGs give rise to Schwann cells, which are the main type of glial cell in the PNS. Schwann cells surround and insulate nerve fibers, providing mechanical support and facilitating the transmission of electrical signals.\n2. Satellite cells: NAPGs also give rise to satellite cells, which are small, non-myelinating glial cells that are found in the PNS. Satellite cells play a role in the maintenance and repair of nerve fibers.\n3. Oligodendrocyte precursor cells: NAPGs can also give rise to oligodendrocyte precursor cells, which are the precursors of oligodendrocytes, the main type of glial cell in the central nervous system (CNS).\n4. Astrocyte precursor cells: NAPGs can also give rise to astrocyte precursor cells, which are the precursors of astrocytes, a type of glial cell in the CNS.\nIn summary, NAPGs give rise to a variety of cell types in the PNS, including Schwann cells, satellite cells, oligodendrocyte precursor cells, and astrocyte precursor cells. These cells play important roles in the development and maintenance of the PNS.",
    "llama-2-7b-chat-hf_fact": [
      "Nerve-associated peripheral glial progenitors (NAPGs) are a type of progenitor cell found in the peripheral nervous system (PNS).",
      "NAPGs are derived from the neural crest.",
      "NAPGs can develop into Schwann cells, which provide mechanical support and facilitate the transmission of electrical signals in the PNS.",
      "NAPGs can also give rise to satellite cells which play a role in the maintenance and repair of nerve fibers in the PNS.",
      "Nerve-associated peripheral glial progenitors can also give rise to both oligodendrocyte and astrocyte precursor cells, involved in the central nervous system (CNS)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Nerve-associated peripheral glial progenitors do not give rise to oligodendrocyte and astrocyte precursor cells, which are involved in the central nervous system (CNS). These precursors are typically derived from the neural stem cells in the CNS."
    ]
  },
  {
    "id": 2117,
    "user_query": "Is Lennox-Gastaut Syndrome usually diagnosed in older adults?",
    "llama-2-7b-chat-hf_response": "No, Lennox-Gastaut Syndrome (LGS) is typically diagnosed in children, particularly those under the age of 5. It is a rare and severe form of epilepsy that is characterized by multiple types of seizures, including tonic, atonic, and myoclonic seizures, as well as developmental delays and intellectual disability. While LGS can occur in older adults, it is much less common than in children. In fact, most cases of LGS are diagnosed before the age of 3.",
    "llama-2-7b-chat-hf_fact": [
      "Lennox-Gastaut Syndrome (LGS) is typically diagnosed in children, particularly those under the age of 5.",
      "Lennox-Gastaut Syndrome is a rare and severe form of epilepsy.",
      "Lennox-Gastaut Syndrome is characterized by multiple types of seizures, including tonic, atonic, and myoclonic seizures.",
      "Lennox-Gastaut Syndrome is accompanied by developmental delays and intellectual disability.",
      "Most cases of Lennox-Gastaut Syndrome are diagnosed before the age of 3."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Lennox-Gastaut Syndrome (LGS) is typically diagnosed in children, but not particularly those under age 5. It usually appears between the ages of 3 and 5.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2119,
    "user_query": "Describe ATR-16 syndrome.",
    "llama-2-7b-chat-hf_response": "ATR-16 syndrome is a rare genetic disorder that affects the brain and spinal cord. It is caused by mutations in the ATR gene, which plays a critical role in regulating the cell cycle and DNA repair. ATR-16 syndrome is characterized by a range of symptoms, including:\n1. Developmental delays: Children with ATR-16 syndrome may experience delays in reaching developmental milestones, such as sitting, standing, and walking.\n2. Intellectual disability: Individuals with ATR-16 syndrome often have intellectual disability, which can range from mild to severe.\n3. Seizures: Many people with ATR-16 syndrome experience seizures, which can be caused by abnormal electrical activity in the brain.\n4. Muscle weakness: ATR-16 syndrome can cause muscle weakness and wasting, particularly in the limbs.\n5. Coordination problems: Individuals with ATR-16 syndrome may have difficulty with coordination and balance, which can increase the risk of falls and injuries.\n6. Vision problems: Some people with ATR-16 syndrome may experience vision problems, including blurred vision, double vision, or loss of vision.\n7. Hearing loss: ATR-16 syndrome can also cause hearing loss, which can range from mild to severe.\n8. Sleep disturbances: Individuals with ATR-16 syndrome may experience sleep disturbances, including insomnia, sleep apnea, or restless leg syndrome.\n9. Gastrointestinal problems: ATR-16 syndrome can cause gastrointestinal problems, including constipation, diarrhea, or gastroesophageal reflux disease (GERD).\n10. Increased risk of infections: People with ATR-16 syndrome may be at increased risk of infections, particularly respiratory infections, due to impaired immune function.\nATR-16 syndrome is a rare and complex disorder that can have a significant impact on an individual's quality of life. However, with appropriate medical care and support, many individuals with ATR-16 syndrome can lead ful",
    "llama-2-7b-chat-hf_fact": [
      "ATR-16 syndrome is a rare genetic disorder affecting the brain and spinal cord.",
      "The disorder is caused by mutations in the ATR gene, which influences cell cycle regulation and DNA repair.",
      "ATR-16 Syndrome can cause developmental delays in children, affecting their ability to reach common milestones such as sitting, standing, and walking.",
      "Individuals with ATR-16 syndrome often have intellectual disability which can range from mild to severe.",
      "Many people with ATR-16 syndrome experience seizures due to abnormal electrical activity in the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2120,
    "user_query": "What is the results of inactivated ANGPLT3?",
    "llama-2-7b-chat-hf_response": "Inactivation of ANGPLT3 has been shown to have several effects on the cardiovascular system, including:\n1. Reduced platelet activation and aggregation: ANGPLT3 is involved in the regulation of platelet activation and aggregation, and its inactivation has been shown to reduce platelet-mediated thrombus formation.\n2. Increased bleeding time: Inactivation of ANGPLT3 has been shown to increase bleeding time in animal models, suggesting that it may play a role in the regulation of hemostasis.\n3. Altered lipid metabolism: ANGPLT3 is also involved in the regulation of lipid metabolism, and its inactivation has been shown to alter lipid metabolism in the cardiovascular system.\n4. Increased inflammation: Inactivation of ANGPLT3 has been shown to increase inflammation in the cardiovascular system, which may contribute to the development of cardiovascular disease.\n5. Impaired endothelial function: ANGPLT3 is also involved in the regulation of endothelial function, and its inactivation has been shown to impair endothelial function in the cardiovascular system.\n6. Increased blood pressure: Inactivation of ANGPLT3 has been shown to increase blood pressure in animal models, suggesting that it may play a role in the regulation of blood pressure.\n7. Increased cardiac hypertrophy: Inactivation of ANGPLT3 has been shown to increase cardiac hypertrophy in animal models, suggesting that it may play a role in the regulation of cardiac function.\n8. Increased fibrosis: Inactivation of ANGPLT3 has been shown to increase fibrosis in the cardiovascular system, which may contribute to the development of cardiovascular disease.\n9. Increased apoptosis: Inactivation of ANGPLT3 has been shown to increase apoptosis in the cardiovascular system, which may contribute to the development of cardiovascular disease.\n10. Increased oxidative stress: Inactivation of ANGPLT3 has been shown to increase",
    "llama-2-7b-chat-hf_fact": [
      "Inactivation of ANGPLT3 reduces platelet activation and aggregation.",
      "Inactivation of ANGPLT3 results in increased bleeding time in animal models.",
      "ANGPLT3 inactivation alters lipid metabolism in the cardiovascular system.",
      "Inactivation of ANGPLT3 increases inflammation in the cardiovascular system.",
      "Inactivation of ANGPLT3 impairs endothelial function in the cardiovascular system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2127,
    "user_query": "Which deep learning-based algorithms are used for enhancer prediction?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-regulatory elements that can increase or decrease gene expression by binding to transcription factors. Enhancer prediction using deep learning-based algorithms has gained popularity in recent years due to its high accuracy and ability to analyze large datasets. Here are some deep learning-based algorithms used for enhancer prediction:\n1. DeepSEA: DeepSEA is a deep learning-based algorithm that uses a convolutional neural network (CNN) to predict enhancers from chromatin accessibility profiles. It was developed by the Zhang Lab at the University of California, Los Angeles (UCLA).\n2. EnhancerNet: EnhancerNet is a deep learning-based algorithm that uses a multi-layer perceptron (MLP) to predict enhancers from chromatin accessibility profiles. It was developed by the Li Lab at the University of California, San Diego (UCSD).\n3. DeepEnhancer: DeepEnhancer is a deep learning-based algorithm that uses a CNN to predict enhancers from chromatin accessibility profiles. It was developed by the Zhang Lab at the University of California, Berkeley (UC Berkeley).\n4. EnhancerRNN: EnhancerRNN is a deep learning-based algorithm that uses a long short-term memory (LSTM) network to predict enhancers from chromatin accessibility profiles. It was developed by the Wang Lab at the University of California, San Francisco (UCSF).\n5. DeepEnhancerFinder: DeepEnhancerFinder is a deep learning-based algorithm that uses a CNN to predict enhancers from chromatin accessibility profiles. It was developed by the Zhang Lab at the University of California, Los Angeles (UCLA).\n6. EnhancerDiscoverer: EnhancerDiscoverer is a deep learning-based algorithm that uses a MLP to predict enhancers from chromatin accessibility profiles. It was developed by the Li Lab at the University of California, San Diego (UCSD).\n7. EnhancerPredictor: EnhancerPredictor is a deep learning-based algorithm that uses a CNN to predict enhancers from chromatin accessibility profiles. It was developed by the Zhang Lab at the University of California, Berkeley (UC Berkeley).\n8. DeepEnhancerPredictor: DeepEnhancerPred",
    "llama-2-7b-chat-hf_fact": [
      "DeepSEA is a deep learning-based algorithm for enhancer prediction developed by the Zhang Lab at the University of California, Los Angeles (UCLA).",
      "EnhancerNet is a deep learning-based algorithm for enhancer prediction developed by the Li Lab at the University of California, San Diego (UCSD).",
      "DeepEnhancer is a deep learning-based algorithm for enhancer prediction developed by the Zhang Lab at the University of California, Berkeley (UC Berkeley).",
      "EnhancerRNN is a deep learning-based algorithm for enhancer prediction developed by the Wang Lab at the University of California, San Francisco (UCSF).",
      "DeepEnhancerFinder is a deep learning-based algorithm for enhancer prediction developed by the Zhang Lab at the University of California, Los Angeles (UCLA)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: DeepEnhancer is a deep learning-based algorithm for enhancer prediction developed by the Jain Lab at the University of California, San Diego (UCSD).",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2128,
    "user_query": "Is Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin?",
    "llama-2-7b-chat-hf_response": "Beta-thalassemia is a genetic disorder that affects the production of hemoglobin, a protein in red blood cells that carries oxygen to the body's tissues. The disorder is caused by mutations or deletions of the genes that code for alpha or beta globin, which are the subunits of hemoglobin.",
    "llama-2-7b-chat-hf_fact": [
      "Beta-thalassemia is a genetic disorder that affects the production of hemoglobin.",
      "Hemoglobin is a protein in red blood cells that carries oxygen to the body's tissues.",
      "Hemoglobin is made up of subunits known as alpha or beta globin.",
      "The disorder can be caused by mutations or deletions of the genes that code for these subunits."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2132,
    "user_query": "What is the mechanism of action of Romosozumab?",
    "llama-2-7b-chat-hf_response": "Romosozumab is a monoclonal antibody that targets sclerostin, a protein produced by osteocytes in the bone. Sclerostin inhibits the activity of the Wnt/-catenin signaling pathway, which is important for bone metabolism. By blocking sclerostin, romosozumab increases the activity of the Wnt/-catenin signaling pathway, leading to an increase in bone formation and a decrease in bone resorption. This results in a decrease in bone mineral density (BMD) and a reduction in the risk of fractures in patients with osteoporosis.\nRomosozumab is administered via injection every 6 months, and its mechanism of action is as follows:\n1. Romosozumab binds to sclerostin: Romosozumab is a monoclonal antibody that specifically binds to sclerostin, a protein produced by osteocytes in the bone.\n2. Increased Wnt/-catenin signaling: By binding to sclerostin, romosozumab increases the activity of the Wnt/-catenin signaling pathway, which is important for bone metabolism.\n3. Increased bone formation: The increased activity of the Wnt/-catenin signaling pathway leads to an increase in bone formation, resulting in an increase in bone mineral density (BMD).\n4. Reduced bone resorption: Romosozumab also reduces bone resorption by inhibiting the activity of osteoclasts, the cells responsible for bone resorption.\n5. Reduced risk of fractures: The increase in BMD and reduction in bone resorption result in a reduction in the risk of fractures in patients with osteoporosis.\nOverall, the mechanism of action of romosozumab is to increase bone formation and reduce bone resorption, leading to an increase in bone mineral density and a reduction in the risk of fractures in patients with osteoporosis.",
    "llama-2-7b-chat-hf_fact": [
      "Romosozumab is a monoclonal antibody that targets a protein called sclerostin produced by osteocytes in the bone.",
      "Sclerostin is an inhibitor of the Wnt/-catenin signaling pathway, which is vital for bone metabolism.",
      "Romosozumab works by blocking sclerostin, leading to an increase in bone formation and a decrease in bone resorption.",
      "The mechanism of action of Romosozumab results in a decrease in bone mineral density (BMD).",
      "Regular injections of Romosozumab can reduce the risk of fractures in osteoporosis patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The mechanism of action of Romosozumab results in an increase in bone mineral density (BMD).",
      "true"
    ]
  },
  {
    "id": 2134,
    "user_query": "What is the function of the Mis18 protein?",
    "llama-2-7b-chat-hf_response": "Mis18 is a protein that plays a crucial role in the regulation of gene expression by modulating the activity of RNA polymerase II (RNAPII). RNAPII is the primary enzyme responsible for transcribing DNA into RNA in eukaryotic cells. Mis18 binds to the C-terminal domain of RNAPII and inhibits its activity, thereby regulating the initiation and elongation of transcription.\nMis18 also plays a role in the regulation of chromatin structure and gene expression by modulating the activity of other transcription factors and chromatin-modifying enzymes. It has been shown to interact with a variety of transcription factors, including p53, c-Myc, and NF-B, and to modulate their activity. Additionally, Mis18 has been shown to interact with chromatin-modifying enzymes, such as histone acetyltransferases and histone deacetylases, and to regulate their activity.\nMis18 has been implicated in a variety of cellular processes, including cell proliferation, differentiation, and survival. It has been shown to be involved in the regulation of gene expression in response to various stimuli, including growth factors, hormones, and stress signals. Dysregulation of Mis18 has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.\nIn summary, the function of the Mis18 protein is to regulate the activity of RNAPII and modulate the activity of other transcription factors and chromatin-modifying enzymes, thereby playing a crucial role in the regulation of gene expression and cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Mis18 is a protein that regulates gene expression by modulating the activity of RNA polymerase II (RNAPII).",
      "RNA polymerase II is the primary enzyme responsible for transcribing DNA into RNA in eukaryotic cells.",
      "Mis18 interacts and modulates the activity of transcription factors including p53, c-Myc, and NF-B.",
      "Mis18 has been implicated in various cellular processes including cell proliferation, differentiation, and survival.",
      "Dysregulation of Mis18 has been implicated in diseases such as cancer, diabetes, and neurological disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2135,
    "user_query": "Are hepadnaviral minichromosomes free of nucleosomes?",
    "llama-2-7b-chat-hf_response": "Hepadnaviral minichromosomes are small, circular DNA molecules that are found in the hepatitis B virus (HBV). These minichromosomes are thought to play a key role in the replication and persistence of HBV, and have been the focus of much research in recent years. One question that has been asked about hepadnaviral minichromosomes is whether they are free of nucleosomes.\nNucleosomes are the basic units of DNA packaging in eukaryotic cells, consisting of a segment of DNA wrapped around a core of eight histone proteins (two copies each of histones H2A, H2B, H3, and H4). They play a crucial role in compacting and organizing DNA in the nucleus, and are also involved in the regulation of gene expression. In contrast, hepadnaviral minichromosomes are much smaller than nucleosomes, and are thought to be free of histone proteins.\nRecent studies have provided evidence that hepadnaviral minichromosomes are indeed free of nucleosomes. For example, one study used fluorescence in situ hybridization (FISH) to visualize the minichromosomes in HBV-infected cells, and found that the minichromosomes were not associated with nucleosomes (1). Another study used chromatin immunoprecipitation (ChIP) to investigate the binding of histone proteins to the minichromosomes, and found that histone proteins were not enriched at the minichromosome regions (2). These findings suggest that hepadnaviral minichromosomes are indeed free of nucleosomes, and may represent a unique form of DNA organization that is distinct from the nucleosome-based chromatin found in eukaryotic cells.\nHowever, it is important to note that the lack of nucleosomes on hepadnaviral minichromosomes does not necessarily mean that they are completely naked and unstructured. Other forms of DNA organization, such as higher-order chromatin structures, may still be present on the minichromosomes. Further research is needed to fully understand the structure and function of hepadnaviral minichromos",
    "llama-2-7b-chat-hf_fact": [
      "Hepadnaviral minichromosomes are small, circular DNA molecules that are found in the hepatitis B virus (HBV).",
      "Nucleosomes are the basic units of DNA packaging in eukaryotic cells, consisting of a segment of DNA wrapped around a core of eight histone proteins (two copies each of histones H2A, H2B, H3, and H4).",
      "Hepadnaviral minichromosomes are thought to be free of histone proteins.",
      "Fluorescence in situ hybridization (FISH) and chromatin immunoprecipitation (ChIP) are two techniques used in studies to investigate the presence of nucleosomes in hepadnaviral minichromosomes.",
      "Hepadnaviral minichromosomes may represent a unique form of DNA organization that is distinct from the nucleosome-based chromatin found in eukaryotic cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2136,
    "user_query": "Is Cri Du Chat associated with an expansion of a repeat with in the gene found on chromosome 5?",
    "llama-2-7b-chat-hf_response": "Cri du Chat syndrome is a rare genetic disorder that affects approximately 1 in 50,000 individuals worldwide. The disorder is caused by a deletion of genetic material on chromosome 5p15.3, which leads to a loss of function of the genes located in this region. The most common form of Cri du Chat syndrome is caused by a deletion of a small portion of chromosome 5p15.3, which includes the Cathepsin B gene (CB).",
    "llama-2-7b-chat-hf_fact": [
      "Cri du Chat syndrome affects approximately 1 in 50,000 individuals worldwide.",
      "Cri du Chat syndrome is caused by a deletion of genetic material on chromosome 5p15.3.",
      "The deletion of genetic material in chromosome 5p15.3 leads to a loss of function of the genes located there.",
      "The Cathepsin B gene (CB) is located on chromosome 5p15.3.",
      "The most common form of Cri du Chat syndrome is caused by a deletion of a small portion of the 5p15.3 chromosome which includes the Cathepsin B gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2141,
    "user_query": "Is osteocrin expressed exclusively in the bone?",
    "llama-2-7b-chat-hf_response": "Osteocrin is a protein that is expressed exclusively in the bone. It is produced by osteoblasts, which are the cells responsible for bone formation, and plays a role in the regulation of bone metabolism. Osteocrin is secreted by osteoblasts and acts as a paracrine factor, influencing the activity of other cells in the bone microenvironment.",
    "llama-2-7b-chat-hf_fact": [
      "Osteocrin is a protein that is expressed exclusively in the bone.",
      "Osteoblasts produce osteocrin.",
      "Osteoblasts are cells responsible for bone formation.",
      "Osteocrin plays a role in the regulation of bone metabolism.",
      "Osteocrin acts as a paracrine factor, influencing the activity of other cells in the bone microenvironment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2142,
    "user_query": "What is  Achondroplasia?",
    "llama-2-7b-chat-hf_response": "Achondroplasia is a genetic disorder that affects the development of cartilage and bone, leading to short stature and characteristic physical abnormalities. It is the most common form of short-limbed dwarfism, which is a group of disorders that affect the growth and development of the bones.\nAchondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which is responsible for regulating the growth and development of cartilage and bone. The mutation leads to a deficiency of the FGFR3 protein, which is essential for the proper formation and growth of cartilage and bone.\nThe symptoms of achondroplasia typically become apparent at birth or during early childhood and can include:\n* Short stature: People with achondroplasia typically have a short stature, with an average height of around 4 feet (122 cm) or less.\n* Short limbs: The arms and legs of people with achondroplasia are shorter than average, with the upper arms and thighs being particularly affected.\n* Large head: People with achondroplasia often have a large head, with a prominent forehead and a small jaw.\n* Curved spine: The spine of people with achondroplasia can be curved, leading to a hunchback or kyphosis.\n* Other abnormalities: Achondroplasia can also cause a range of other abnormalities, including:\n* Respiratory problems: The short stature and large head of people with achondroplasia can lead to breathing difficulties and an increased risk of respiratory infections.\n* Sleep apnea: People with achondroplasia may experience sleep apnea, which is a condition in which a person's breathing is interrupted during sleep.\n* Hearing loss: Some people with achondroplasia may experience hearing loss or impairment.\n* Vision problems: Achondroplasia can also cause vision problems, including nearsightedness and cataracts.\n* Other health problems: People with achondroplasia may also experience a range of other health problems, including:\n* Joint problems: The short stature and ab",
    "llama-2-7b-chat-hf_fact": [
      "Achondroplasia is a genetic disorder that affects the development of cartilage and bone.",
      "Achondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",
      "People with achondroplasia typically have a short stature, with an average height of around 4 feet or less.",
      "Common characteristics of individuals with achondroplasia include short limbs, a large head, and a curved spine.",
      "Achondroplasia can cause a range of complications, including breathing difficulties, hearing loss, vision problems, and joint problems."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: People with achondroplasia often have a short stature, with an average height of around 4 feet (130 cm) for men and 3 feet 10 inches (118cm) for women.",
      "true",
      "true"
    ]
  },
  {
    "id": 2156,
    "user_query": "Do circRNAs remain untranslated?",
    "llama-2-7b-chat-hf_response": "Circular RNAs (circRNAs) are a class of non-coding RNAs (ncRNAs) that have gained increasing attention in recent years due to their unique structural features and potential biological functions. Unlike messenger RNAs (mRNAs), which are translated into proteins, circRNAs were thought to remain untranslated. However, recent studies have challenged this view and suggested that circRNAs may indeed be translated in certain contexts.\nOne of the earliest studies to challenge the idea that circRNAs are untranslated was published in 2010 by the laboratory of Dr. Feng Zhang at the Broad Institute of MIT and Harvard. In this study, the authors used a combination of biochemical and genetic approaches to demonstrate that circRNAs can be translated in vitro. Specifically, they showed that circRNAs can be used as a template for translation by the ribosome, resulting in the production of functional proteins.\nSince then, several other studies have also suggested that circRNAs may be translated in certain contexts. For example, one study found that circRNAs are enriched in the cytoplasm of cells, where they can be translated into proteins. Another study showed that circRNAs can be translated in response to stress, suggesting that they may play a role in the cellular response to stress.\nHowever, it is important to note that not all circRNAs are translated, and the extent to which they are translated can vary depending on the context in which they are found. For example, some studies have shown that circRNAs are more likely to be translated in certain cell types or under specific conditions, such as during cellular stress or differentiation.\nOverall, while the idea that circRNAs are untranslated has been challenged by recent studies, the field is still in the early stages of understanding the mechanisms by which circRNAs are translated and the roles they may play in cellular processes. Further research is needed to fully elucidate the functions of circRNAs and their potential as therapeutic targets.",
    "llama-2-7b-chat-hf_fact": [
      "Circular RNAs (circRNAs) are a class of non-coding RNAs (ncRNAs).",
      "Previously, circRNAs were thought to remain untranslated, not translated into proteins.",
      "In 2010, a study led by Dr. Feng Zhang suggested that circRNAs could be translated into functional proteins.",
      "Other studies have also suggested that circRNAs may be translated into proteins, especially in the cytoplasm of cells and in response to stress.",
      "The extent to which circRNAs are translated can vary depending on the context in which they are found, including specific cell types and under certain conditions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2158,
    "user_query": "What is Uhl's anomaly?",
    "llama-2-7b-chat-hf_response": "Uhl's anomaly is a rare congenital abnormality that affects the development of the uterus and cervix. It is characterized by a failure of the uterus to develop properly, resulting in a small or absent uterus, and a narrow or absent cervix. The condition is usually diagnosed during fetal development or shortly after birth, and can be associated with other genetic abnormalities. Treatment options for Uhl's anomaly may include hormone therapy, surgery, or assisted reproductive technology, depending on the severity of the condition and the individual's overall health.",
    "llama-2-7b-chat-hf_fact": [
      "Uhl's anomaly is a rare congenital abnormality that affects the development of the uterus and cervix.",
      "The condition is characterized by a failure of the uterus to develop properly, resulting in a small or absent uterus, and a narrow or absent cervix.",
      "Uhl's anomaly is usually diagnosed during fetal development or shortly after birth.",
      "The condition can be associated with other genetic abnormalities.",
      "Treatment options for Uhl's anomaly may include hormone therapy, surgery, or assisted reproductive technology."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Uhl's anomaly is a rare congenital cardiac abnormality that affects the development of the right ventricle of the heart.",
      "false, [corrected fact]: The condition is characterized by an absence of the right ventricular myocardium.",
      "true",
      "true",
      "false, [corrected fact]: Treatment options for Uhl's anomaly may include heart transplantation or palliative care."
    ]
  },
  {
    "id": 2159,
    "user_query": "Is autophagy the process where bacteria ingest viral particles?",
    "llama-2-7b-chat-hf_response": "Autophagy is a natural process in which cells break down and recycle damaged or dysfunctional cellular components, such as proteins and organelles, to maintain cellular homeostasis and promote cell survival. Autophagy can also involve the engulfment and degradation of extracellular pathogens, including viruses, by autophagosomes, which are membrane-bound structures that form during the autophagic process.\nHowever, it is not the primary mechanism by which bacteria ingest viral particles. Bacteria have a variety of mechanisms to defend against viruses, including:\n1. Restriction-modification systems: These are enzymes that can recognize and cleave viral DNA or RNA, preventing the virus from replicating.\n2. CRISPR-Cas systems: These are RNA-guided immune systems that can recognize and cleave viral DNA or RNA, preventing the virus from replicating.\n3. Antibodies: Some bacteria produce antibodies that can recognize and neutralize viruses.\n4. Phagocytosis: Some bacteria can engulf and degrade viruses through phagocytosis, which is the process of engulfing and digesting foreign particles.\n5. Virus-like particles: Some bacteria can produce virus-like particles that mimic the virus and can be recognized and attacked by the bacterial immune system.\nIn summary, while autophagy can play a role in the defense against viruses in some bacteria, it is not the primary mechanism by which bacteria ingest viral particles. Bacteria have a variety of mechanisms to defend against viruses, including restriction-modification systems, CRISPR-Cas systems, antibodies, phagocytosis, and virus-like particles.",
    "llama-2-7b-chat-hf_fact": [
      "Autophagy is a process in which cells degrade and recycle damaged or dysfunctional cellular components.",
      "Autophagy can involve the engulfment and degradation of extracellular pathogens, including viruses, by autophagosomes.",
      "Bacteria have various defense mechanisms against viruses including restriction-modification systems, CRISPR-Cas systems, antibodies, phagocytosis, and virus-like particles.",
      "Phagocytosis is the process through which some bacteria engulf and digest foreign particles, including viruses.",
      "CRISPR-Cas systems are RNA-guided immune systems that can recognize and cleave viral DNA or RNA to prevent the virus from replicating."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Bacteria do not produce antibodies or perform phagocytosis. These are functions of the immune cells of higher organisms.",
      "false, [corrected fact]: Phagocytosis is the process through which some cells of higher organisms, not bacteria, engulf and digest foreign particles, including bacteria and viruses.",
      "true"
    ]
  },
  {
    "id": 2161,
    "user_query": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?",
    "llama-2-7b-chat-hf_response": "The pre-replication complex (pre-RC) is a multi-subunit complex that plays a crucial role in the initiation of DNA replication in eukaryotic cells. The pre-RC is composed of several subunits, including:\n1. Mcm2-7 complex: This complex is composed of six proteins (Mcm2-7) that are involved in the unwinding of DNA during replication.\n2. Cdc6 protein: This protein is a transcriptional activator that binds to the origin of replication and helps to recruit the Mcm2-7 complex.\n3. GINS complex: This complex is composed of four proteins (GINS1-4) that are involved in the unwinding of DNA during replication.\n4. ORC1 protein: This protein is a key component of the pre-RC and helps to recruit the Mcm2-7 complex to the origin of replication.\n5. ORC2 protein: This protein is also a key component of the pre-RC and helps to recruit the Mcm2-7 complex to the origin of replication.\n6. Cdc45 protein: This protein is a key component of the pre-RC and helps to recruit the Mcm2-7 complex to the origin of replication.\n7. Dbf4 protein: This protein is a key component of the pre-RC and helps to recruit the Mcm2-7 complex to the origin of replication.\n8. Cdt1 protein: This protein is a key component of the pre-RC and helps to recruit the Mcm2-7 complex to the origin of replication.\n9. Mcm10 protein: This protein is a key component of the pre-RC and helps to recruit the Mcm2-7 complex to the origin of replication.\nThese subunits work together to form the pre-replication complex, which is essential for the initiation of DNA replication in eukaryotic cells.",
    "llama-2-7b-chat-hf_fact": [
      "The pre-replication complex (pre-RC) plays a crucial role in the initiation of DNA replication in eukaryotic cells.",
      "The Mcm2-7 complex, which is composed of six proteins, plays a role in unwinding DNA during replication.",
      "Cdc6 protein binds to the origin of replication and assists with recruitment of the Mcm2-7 complex.",
      "The GINS complex, composed of four proteins, is involved in DNA unwinding during replication.",
      "Cdc45 protein, ORC1 protein, ORC2 protein, Dbf4 protein, Cdt1 protein, and Mcm10 protein are all key components of the pre-RC and help in recruitment of the Mcm2-7 complex to the origin of replication."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Cdc6 protein and Cdt1 protein are key components of the pre-RC and help in recruitment of the Mcm2-7 complex to the origin of replication. ORC1 and ORC2 proteins are components of the origin recognition complex (ORC), Dbf4 is a regulatory subunit for the Dbf4-dependent kinase, and Mcm10 plays a role in the elongation phase of DNA replication, but these proteins are not responsible for recruiting the Mcm2-7 complex to the origin of replication."
    ]
  },
  {
    "id": 2162,
    "user_query": "What is the inheritance of hypophosphatemic rickets?",
    "llama-2-7b-chat-hf_response": "Hypophosphatemic rickets is a rare genetic disorder that affects the body's ability to absorb phosphate, a mineral that is essential for bone growth and development. The inheritance of hypophosphatemic rickets can vary depending on the specific genetic cause of the disorder.\nSome forms of hypophosphatemic rickets are inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene, one from each parent, in order to develop the condition. Other forms of the disorder may be inherited in an X-linked recessive pattern, which means that the mutated gene is located on the X chromosome and a person must inherit two copies of the mutated gene, one from each parent, in order to develop the condition.\nIn some cases, hypophosphatemic rickets may be caused by a mutation in a gene that is not inherited from parents, but rather occurs spontaneously. This is known as a de novo mutation.\nOverall, the inheritance of hypophosphatemic rickets is complex and can vary depending on the specific genetic cause of the disorder. A diagnosis of hypophosphatemic rickets is typically made through a combination of clinical evaluation, laboratory tests, and genetic analysis.",
    "llama-2-7b-chat-hf_fact": [
      "Hypophosphatemic rickets is a rare genetic disorder that affects the body's ability to absorb phosphate.",
      "Some forms of hypophosphatemic rickets are inherited in an autosomal recessive pattern.",
      "Other forms of hypophosphatemic rickets may be inherited in an X-linked recessive pattern.",
      "A mutation in a gene that is not inherited from parents, but rather occurs spontaneously, could cause hypophosphatemic rickets.",
      "A diagnosis of hypophosphatemic rickets is typically made through a combination of clinical evaluation, laboratory tests, and genetic analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2167,
    "user_query": "Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?",
    "llama-2-7b-chat-hf_response": "There are several servers that can be used to generate modes of pseudo components of DNA, RNA, and protein sequences. Here are some of the commonly used servers:\n1. Rosetta: Rosetta is a suite of software tools developed by the RosettaCommons consortium that can be used to generate modes of pseudo components of DNA, RNA, and protein sequences. Rosetta uses a combination of molecular modeling, molecular dynamics simulations, and machine learning algorithms to predict the structure and dynamics of biological molecules.\n2. Phyre2: Phyre2 is a web-based tool that can be used to predict the three-dimensional structure of protein sequences. Phyre2 uses a combination of machine learning algorithms and structural bioinformatics tools to generate modes of pseudo components of protein sequences.\n3. Infernal: Infernal is a web-based tool that can be used to predict the secondary structure of RNA sequences. Infernal uses a combination of machine learning algorithms and structural bioinformatics tools to generate modes of pseudo components of RNA sequences.\n4. RNAfold: RNAfold is a web-based tool that can be used to predict the three-dimensional structure of RNA sequences. RNAfold uses a combination of machine learning algorithms and structural bioinformatics tools to generate modes of pseudo components of RNA sequences.\n5. Pfold: Pfold is a web-based tool that can be used to predict the three-dimensional structure of protein sequences. Pfold uses a combination of machine learning algorithms and structural bioinformatics tools to generate modes of pseudo components of protein sequences.\nThese servers can be used to generate modes of pseudo components of DNA, RNA, and protein sequences, which can be useful for a variety of applications, including protein structure prediction, RNA structure prediction, and molecular dynamics simulations.",
    "llama-2-7b-chat-hf_fact": [
      "Rosetta is a software tool used to predict the structure and dynamics of biological molecules, including pseudo components of DNA, RNA, and protein sequences.",
      "Phyre2 is a web-based tool for predicting the three-dimensional structure of protein sequences.",
      "Infernal is a web-based tool used to predict the secondary structure of RNA sequences.",
      "RNAfold is a tool used to predict the three-dimensional structure of RNA sequences.",
      "Pfold is a web-based tool used to predict the three-dimensional structure of protein sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Infernal is a software tool used to predict the secondary structure of RNA sequences.",
      "false, [corrected fact]: RNAfold is a tool used to predict the secondary structure of RNA sequences.",
      "false, [corrected fact]: Pfold is a tool used for predicting the secondary structure and base pairing probabilities in RNA sequences."
    ]
  },
  {
    "id": 2169,
    "user_query": "Which class of genes are mutated in Diamond Blackfan Anemia patients?",
    "llama-2-7b-chat-hf_response": "Diamond-Blackfan anemia (DBA) is a rare genetic disorder that affects the production of red blood cells. The disorder is caused by mutations in genes that are involved in the development and maturation of red blood cells. The specific genes that are mutated in DBA patients are:\n1. RPS19: This gene encodes for a protein called ribosomal protein S19, which is involved in the production of red blood cells. Mutations in this gene can lead to a decrease in the production of red blood cells.\n2. RPL11: This gene encodes for a protein called ribosomal protein L11, which is also involved in the production of red blood cells. Mutations in this gene can lead to a decrease in the production of red blood cells.\n3. ALAS2: This gene encodes for an enzyme called alpha-spectrin, which is involved in the structure and function of red blood cells. Mutations in this gene can lead to a decrease in the production of red blood cells.\n4. FECH: This gene encodes for an enzyme called ferrochelatase, which is involved in the production of red blood cells. Mutations in this gene can lead to a decrease in the production of red blood cells.\n5. EP300: This gene encodes for a protein called p300, which is involved in the regulation of gene expression. Mutations in this gene can lead to a decrease in the production of red blood cells.\nIt is important to note that each patient with DBA may have a different mutation in one of these genes, and the specific mutation can affect the severity of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "Diamond-Blackfan anemia is a rare genetic disorder affecting the production of red blood cells.",
      "Diamond-Blackfan anemia is caused by mutations in genes involved in the development and maturation of red blood cells.",
      "RPS19, a gene that encodes for a protein involved in the production of red blood cells, can be mutated in Diamond-Blackfan anemia patients.",
      "ALAS2, a gene that encodes for an enzyme involved in the structure and function of red blood cells, can also be mutated in Diamond-Blackfan anemia patients.",
      "Each Diamond-Blackfan anemia patient may have a different mutation in one of these genes affecting the severity of the disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: ALAS2 gene mutations are associated with a different red blood cell disorder known as X-linked sideroblastic anemia, not Diamond-Blackfan anemia.",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_response": "Robertsonian translocations are a type of chromosomal abnormality in which a segment of one acrocentric chromosome (chromosomes 13, 14, 15, or 21) breaks off and attaches to another acrocentric chromosome. This results in a change in the number or structure of the chromosomes, leading to genetic abnormalities.\nThe human acrocentric chromosomes involved in Robertsonian translocations are:\n* Chromosome 13 (13q14)\n* Chromosome 14 (14q21)\n* Chromosome 15 (15q11-q13)\n* Chromosome 21 (21q22)",
    "llama-2-7b-chat-hf_fact": [
      "Robertsonian translocations are a type of chromosomal abnormality.",
      "In Robertsonian translocations, a segment of one acrocentric chromosome breaks off and attaches to another.",
      "The acrocentric chromosomes involved in Robertsonian translocations are: chromosome 13, chromosome 14, chromosome 15 and chromosome 21.",
      "Robertsonian translocations result in a change in the number or structure of the chromosomes.",
      "The changes caused by Robertsonian translocations can lead to genetic abnormalities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: In Robertsonian translocations, the long arms of two acrocentric chromosomes combine to form a single chromosome.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2171,
    "user_query": "Is tirilazad effective for treatment of aneurysmal subarachnoid haemorrhage?",
    "llama-2-7b-chat-hf_response": "Aneurysmal subarachnoid haemorrhage (aSAH) is a medical emergency that occurs when a blood vessel in the brain ruptures, leading to bleeding in the space surrounding the brain. Treatment for aSAH typically involves a combination of surgical and medical interventions, including endovascular coiling, surgical clipping, and medications to manage symptoms and prevent further bleeding.\nTirilazad is a medication that has been investigated for its potential role in the treatment of aSAH. Tirilazad is a synthetic compound that inhibits the activity of an enzyme called matrix metalloproteinase (MMP), which is involved in the breakdown of the blood-brain barrier (BBB) following aSAH. By inhibiting MMP activity, tirilazad may help to preserve the BBB and reduce the risk of further bleeding.\nSeveral studies have investigated the use of tirilazad in the treatment of aSAH, including a phase II clinical trial published in the Journal of Neurosurgery in 2017. In this study, 30 patients with aSAH were randomly assigned to receive either tirilazad or a placebo in addition to standard medical treatment. The study found that patients treated with tirilazad had a significant reduction in the rate of delayed cerebral ischemia (DCI) compared to those receiving the placebo. DCI is a serious complication of aSAH that can occur days to weeks after the initial bleed and is associated with poor outcomes.\nWhile these findings are promising, it is important to note that the study was small and had some limitations. Further research is needed to confirm these results and establish the safety and efficacy of tirilazad for the treatment of aSAH.\nIn summary, tirilazad is a medication that has shown promise in the treatment of aneurysmal subarachnoid haemorrhage, particularly in reducing the risk of delayed cerebral ischemia. However, more research is needed to confirm these findings and establish the safety and efficacy of tirilazad for this indication.",
    "llama-2-7b-chat-hf_fact": [
      "Aneurysmal subarachnoid haemorrhage (aSAH) is a medical emergency that occurs when a blood vessel in the brain ruptures, leading to bleeding in the space surrounding the brain.",
      "Typical treatment for aSAH involves a combination of surgical and medical interventions, including endovascular coiling, surgical clipping, and medications.",
      "Tirilazad is a synthetic compound that inhibits the activity of an enzyme called matrix metalloproteinase (MMP), which is involved in the breakdown of the blood-brain barrier following aSAH.",
      "A phase II clinical trial published in the Journal of Neurosurgery in 2017 investigated the use of tirilazad in aSAH treatment.",
      "The study found that patients treated with tirilazad had a significant reduction in the rate of delayed cerebral ischemia (DCI), a serious complication of aSAH that can occur days to weeks after the initial bleed."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Tirilazad is a synthetic compound that inhibits the activity of free radicals, not matrix metalloproteinase (MMP).",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2175,
    "user_query": "List viral vectors used in gene therapy.",
    "llama-2-7b-chat-hf_response": "Viral vectors are commonly used in gene therapy to deliver therapeutic genes to specific cells or tissues in the body. Here are some of the most commonly used viral vectors in gene therapy:\n1. Retroviruses: Retroviruses, such as murine leukemia virus (MLV) and human immunodeficiency virus (HIV), are commonly used in gene therapy to deliver therapeutic genes to a wide range of cell types, including stem cells, immune cells, and cancer cells.\n2. Adenoviruses: Adenoviruses, such as adenovirus serotype 5 (Ad5), are small, non-enveloped viruses that can infect a wide range of cell types, including epithelial cells, endothelial cells, and immune cells. They are commonly used in gene therapy to deliver therapeutic genes to the liver, lung, and other organs.\n3. Lentiviruses: Lentiviruses, such as human immunodeficiency virus (HIV), are large, non-enveloped viruses that can infect a wide range of cell types, including stem cells, immune cells, and cancer cells. They are commonly used in gene therapy to deliver therapeutic genes to cells that are difficult to target with other viral vectors.\n4. Herpesviruses: Herpesviruses, such as herpes simplex virus (HSV), are double-stranded DNA viruses that can infect a wide range of cell types, including epithelial cells, nerve cells, and immune cells. They are commonly used in gene therapy to deliver therapeutic genes to the central nervous system (CNS).\n5. AAV (adeno-associated virus): AAV is a small, single-stranded DNA virus that can infect a wide range of cell types, including stem cells, immune cells, and muscle cells. It is commonly used in gene therapy to deliver therapeutic genes to the liver, muscle, and other organs.\n6. Reoviruses: Reoviruses are small, non-enveloped viruses that can infect a wide range of",
    "llama-2-7b-chat-hf_fact": [
      "Retroviruses, such as murine leukemia virus (MLV) and human immunodeficiency virus (HIV), are used in gene therapy to deliver therapeutic genes to a range of cell types, including stem cells, immune cells, and cancer cells.",
      "Adenoviruses like adenovirus serotype 5 (Ad5) are often used in gene therapy to deliver therapeutic genes to the liver, lung, and other organs.",
      "Lentiviruses, such as human immunodeficiency virus (HIV), are utilized in gene therapy to deliver therapeutic genes to hard-to-target cells.",
      "Herpesviruses, such as herpes simplex virus (HSV), can be used in gene therapy to deliver therapeutic genes to the central nervous system.",
      "AAV (adeno-associated virus) is a small, single-stranded DNA virus that is commonly used in gene therapy to deliver therapeutic genes to the liver, muscle, and other organs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2178,
    "user_query": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).",
    "llama-2-7b-chat-hf_response": "The Moschcowitz syndrome, also known as thrombotic thrombocytopenic purpura (TTP), is a rare blood disorder characterized by the formation of blood clots within small blood vessels throughout the body, leading to a decrease in the number of platelets in the blood. The classical symptoms of TTP include:\n1. Renal involvement: Patients with TTP may experience hematuria (blood in the urine), proteinuria (excess protein in the urine), and/or oliguria (decreased urine output).\n2. Neurological symptoms: TTP can cause a range of neurological symptoms, including headache, confusion, seizures, and loss of consciousness.\n3. Petechiae and purpura: Small red or purple spots (petechiae) or larger bruise-like spots (purpura) may appear on the skin, particularly on the face, arms, and legs.\n4. Fatigue and weakness: Patients with TTP may feel tired and weak, and may have difficulty performing daily activities.\n5. Joint pain and swelling: TTP can cause joint pain and swelling, particularly in the hands and feet.\n6. Fever and chills: Patients with TTP may experience fever and chills, which can be a sign of infection or inflammation.\n7. Pale or clay-colored skin: TTP can cause a decrease in the number of red blood cells in the blood, leading to pale or clay-colored skin.\n8. Shortness of breath: TTP can cause shortness of breath or difficulty breathing, particularly if the clots have formed in the lungs.\n9. Chest pain: TTP can cause chest pain or discomfort, particularly if the clots have formed in the coronary arteries.\n10. Cardiac arrhythmias: TTP can cause cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia.\nIt is important to note that the symptoms of TTP can vary in severity and may not be present in all patients. A diagnosis of TTP is typically made based on a combination of clinical findings, laboratory tests, and",
    "llama-2-7b-chat-hf_fact": [
      "The Moschcowitz syndrome, also known as thrombotic thrombocytopenic purpura (TTP), is a rare blood disorder.",
      "TTP is characterized by the formation of blood clots within small blood vessels throughout the body.",
      "Some patients with TTP may experience hematuria, proteinuria, and/or oliguria.",
      "Neurological symptoms of TTP can include headache, confusion, seizures, and loss of consciousness.",
      "Symptoms of TTP can vary in severity and may not be present in all patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2181,
    "user_query": "Which is the major RNA editing enzyme in Drosophila melanogaster?",
    "llama-2-7b-chat-hf_response": "The major RNA editing enzyme in Drosophila melanogaster is called ADAR (adenosine deaminase acting on RNA). ADAR is responsible for the majority of RNA editing in Drosophila, and it is involved in the conversion of adenosine (A) to inosine (I) in pre-mRNA. Inosine is then incorporated into the mRNA during translation, leading to changes in the amino acid sequence of the protein. RNA editing by ADAR plays a crucial role in the regulation of gene expression in Drosophila, particularly in the development and function of the nervous system.",
    "llama-2-7b-chat-hf_fact": [
      "The major RNA editing enzyme in Drosophila melanogaster is called ADAR.",
      "ADAR is responsible for the majority of RNA editing in Drosophila melanogaster.",
      "ADAR is involved in the conversion of adenosine (A) to inosine (I) in pre-mRNA.",
      "Inosine is incorporated into the mRNA during translation, which can result in changes to the amino acid sequence of the protein.",
      "RNA editing by ADAR plays a crucial role in the regulation of gene expression in Drosophila melanogaster, particularly in the development and function of the nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Inosine is recognized as guanosine not during translation but during the process of ribosome decoding mRNA, which can result in changes to the amino acid sequence of the protein.",
      "true"
    ]
  },
  {
    "id": 2182,
    "user_query": "What is the CEGA catalog?",
    "llama-2-7b-chat-hf_response": "The CEGA (Computational Environment for Genomics and Precision Medicine) catalog is a comprehensive database of computational tools and resources for genomics and precision medicine research. It provides a centralized platform for researchers to discover, access, and utilize a wide range of tools and resources, including software, databases, algorithms, and cloud-based services.\nThe CEGA catalog includes tools and resources for:\n1. Genome assembly and annotation\n2. Genetic variation analysis\n3. Transcriptome analysis\n4. Epigenomics\n5. Genome-wide association studies (GWAS)\n6. Whole-genome sequencing\n7. RNA sequencing (RNA-seq)\n8. Protein structure prediction\n9. Drug discovery and development\n10. Personalized medicine\nThe CEGA catalog is maintained by the Computational Biology and Bioinformatics Program at the University of California, San Diego (UCSD), and is supported by the National Institutes of Health (NIH). It is a valuable resource for researchers in the field of genomics and precision medicine, as it provides a one-stop shop for accessing and utilizing a wide range of computational tools and resources.",
    "llama-2-7b-chat-hf_fact": [
      "The CEGA catalog is a comprehensive database of computational tools and resources for genomics and precision medicine research.",
      "It provides a platform for researchers to discover, access, and utilize a wide range of tools and resources.",
      "The catalog includes tools and resources for various objectives, like genome assembly and annotation, genetic variation analysis, transcriptome analysis, etc.",
      "The CEGA catalog is maintained by the Computational Biology and Bioinformatics Program at the University of California, San Diego (UCSD).",
      "Its operation is supported by the National Institutes of Health (NIH)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2183,
    "user_query": "Which protein is associated with hyperemesis gravidarum during pregrancy?",
    "llama-2-7b-chat-hf_response": "Hyperemesis gravidarum is a condition that causes severe nausea, vomiting, and dehydration during pregnancy. The exact cause of hyperemesis gravidarum is not fully understood, but it is thought to be related to hormonal changes and increased levels of human chorionic gonadotropin (hCG) during pregnancy.\nOne of the key proteins associated with hyperemesis gravidarum is the protein gastrin. Gastrin is a hormone produced by the stomach that stimulates the production of stomach acid and the contraction of the stomach muscles. In pregnant women with hyperemesis gravidarum, levels of gastrin are often elevated, which can contribute to the development of nausea and vomiting.\nOther proteins that have been implicated in the development of hyperemesis gravidarum include:\n* Serotonin: This neurotransmitter is involved in the regulation of nausea and vomiting. In pregnant women with hyperemesis gravidarum, levels of serotonin are often decreased, which can contribute to the development of nausea and vomiting.\n* Calcitonin gene-related peptide (CGRP): This protein is involved in the regulation of nausea and vomiting. In pregnant women with hyperemesis gravidarum, levels of CGRP are often elevated, which can contribute to the development of nausea and vomiting.\n* Brain-derived neurotrophic factor (BDNF): This protein is involved in the regulation of nausea and vomiting. In pregnant women with hyperemesis gravidarum, levels of BDNF are often decreased, which can contribute to the development of nausea and vomiting.\nIt is important to note that the exact mechanisms by which these proteins contribute to the development of hyperemesis gravidarum are not yet fully understood and are the subject of ongoing research.",
    "llama-2-7b-chat-hf_fact": [
      "Hyperemesis gravidarum is a condition that causes severe nausea, vomiting, and dehydration during pregnancy.",
      "The protein gastrin, which stimulates the production of stomach acid and the contraction of stomach muscles, is associated with hyperemesis gravidarum.",
      "The neurotransmitter serotonin, involved in the regulation of nausea and vomiting, may be linked to hyperemesis gravidarum.",
      "Calcitonin gene-related peptide (CGRP), a protein involved in the regulation of nausea and vomiting, is implicated in the development of hyperemesis gravidarum.",
      "Brain-derived neurotrophic factor (BDNF), another protein involved in the regulation of nausea and vomiting, is often decreased in pregnant women with hyperemesis gravidarum."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The hormone human chorionic gonadotropin (hCG), not gastrin, is associated with hyperemesis gravidarum.",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2187,
    "user_query": "Is edema a symptom of nephrotic syndrome?",
    "llama-2-7b-chat-hf_response": "Nephrotic syndrome is a group of symptoms that occur when the kidneys leak large amounts of protein into the urine. Edema is a common symptom of nephrotic syndrome, as the excess protein in the urine can cause fluid buildup in the body's tissues.\nOther symptoms of nephrotic syndrome may include:\n* Proteinuria (excess protein in the urine)\n* Lipiduria (excess fat in the urine)\n* Hematuria (blood in the urine)\n* Microscopic hematuria (small amounts of blood in the urine that are not visible to the naked eye)\n* Decreased urine concentration\n* Fatigue\n* Weakness\n* Swelling (edema)\n* Weight gain\nIt is important to note that not everyone with nephrotic syndrome will experience all of these symptoms, and some people may have different symptoms depending on the underlying cause of their condition. If you suspect you or someone you know may have nephrotic syndrome, it is important to consult with a healthcare provider for proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Nephrotic syndrome is characterized by kidneys leaking large amounts of protein into the urine.",
      "Edema is a common symptom of nephrotic syndrome caused by the excess protein in the urine.",
      "Other symptoms of nephrotic syndrome can include proteinuria, lipiduria, and hematuria.",
      "Fatigue, weakness, swelling, and weight gain may also be symptoms of nephrotic syndrome.",
      "It is important to consult with a healthcare provider for a proper diagnosis and treatment of nephrotic syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Other symptoms of nephrotic syndrome can include proteinuria, hyperlipidemia, and edema.",
      "true",
      "true"
    ]
  },
  {
    "id": 2195,
    "user_query": "Borden classification is used for which disease?",
    "llama-2-7b-chat-hf_response": "A) Cancer\nB) Neurological disorders\nC) Cardiovascular disease\nD) Autoimmune disorders\nCorrect answer: B) Neurological disorders.\nExplanation:\nBorden classification is a system used to classify neurological disorders based on the distribution and severity of symptoms. It was developed by Dr. William Borden in the 1950s and is still widely used today. The Borden classification system divides neurological disorders into four categories:\n1. Spastic paresis: characterized by stiffness and rigidity of muscles, resulting in difficulty with movement and coordination. Examples include cerebral palsy and multiple sclerosis.\n2. Athetosis: characterized by slow, writhing movements and difficulty with coordination and balance. Examples include cerebral palsy and Parkinson's disease.\n3. Ataxia: characterized by difficulty with coordination and balance, resulting in a wide, unsteady gait. Examples include cerebellar ataxia and multiple sclerosis.\n4. Dystonia: characterized by sustained or intermittent muscle contractions that cause abnormal postures or movements. Examples include dystonia and Huntington's disease.\nBorden classification is used to help healthcare providers understand the underlying neurological disorder and develop an appropriate treatment plan.",
    "llama-2-7b-chat-hf_fact": [
      "Borden classification is a system used to classify neurological disorders.",
      "The Borden classification system was developed by Dr. William Borden in the 1950s.",
      "The Borden classification divides neurological disorders into four categories: Spastic paresis, Athetosis, Ataxia, and Dystonia.",
      "Examples of conditions associated with spastic paresis include cerebral palsy and multiple sclerosis.",
      "Parkinson's Disease and Huntington's Disease are considered under Borden Classification of neurological disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Borden Classification is a system used to classify dural arteriovenous fistulas, not all neurological disorders.",
      "unknown",
      "false, [corrected fact]: The Borden classification divides dural arteriovenous fistulas into three categories based on their anatomical and hemodynamic features.",
      "false, [corrected fact]: Spastic paresis, cerebral palsy and multiple sclerosis are not directly associated with the Borden Classification.",
      "false, [corrected fact]: Parkinson's Disease and Huntington's Disease are not considered under the Borden Classification of dural arteriovenous fistulas."
    ]
  },
  {
    "id": 2198,
    "user_query": "What is the function of mTOR?",
    "llama-2-7b-chat-hf_response": "mTOR (mechanistic target of rapamycin) is a protein that plays a crucial role in regulating cell growth, metabolism, and autophagy in response to nutrient availability and other environmental cues. It is a central controller of cellular metabolism and growth, and its dysregulation has been implicated in a wide range of diseases, including cancer, diabetes, and neurodegenerative disorders.\nmTOR has three main functions:\n1. Cell growth and proliferation: mTOR regulates the expression of genes involved in cell growth and proliferation, such as those involved in DNA synthesis and cell cycle progression.\n2. Cell metabolism: mTOR regulates the expression of genes involved in cellular metabolism, such as those involved in glycolysis, gluconeogenesis, and lipogenesis.\n3. Autophagy: mTOR regulates the expression of genes involved in autophagy, a process by which cells degrade and recycle damaged or dysfunctional cellular components.\nmTOR is a key regulator of cellular metabolism and growth, and its dysregulation can lead to a wide range of diseases. Understanding the function of mTOR and its regulation is important for the development of new therapeutic strategies for the treatment of these diseases.",
    "llama-2-7b-chat-hf_fact": [
      "mTOR (mechanistic target of rapamycin) is a protein that regulates cell growth, metabolism, and autophagy in response to nutrient availability and environmental cues.",
      "mTOR controls the expression of genes involved in cell growth and proliferation.",
      "mTOR also regulates the expression of genes involved in cellular metabolism.",
      "One of mTOR's functions is to control the expression of genes involved in autophagy.",
      "Dysregulation of mTOR can lead to a range of diseases, including cancer, diabetes, and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2203,
    "user_query": "List cardinal features of the Triple A syndrome.",
    "llama-2-7b-chat-hf_response": "Triple A syndrome, also known as 22q11.2 deletion syndrome, is a rare genetic disorder that affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide. It is caused by a deletion of genetic material on chromosome 22, specifically at the q11.2 locus. The following are some of the cardinal features of Triple A syndrome:\n1. Abnormalities of the brain and nervous system: Individuals with Triple A syndrome often have abnormalities of the brain and nervous system, including microcephaly (small head), intellectual disability, seizures, and delayed speech and language development.\n2. Facial abnormalities: Triple A syndrome is characterized by distinctive facial abnormalities, including a small head, narrow eyes, a short nose, and a thin upper lip.\n3. Skeletal abnormalities: Individuals with Triple A syndrome may have skeletal abnormalities, such as short stature, scoliosis (curvature of the spine), and joint deformities.\n4. Cardiac abnormalities: Some individuals with Triple A syndrome may have cardiac abnormalities, including ventricular septal defect (a hole in the wall between the two lower chambers of the heart) and atrial septal defect (a hole in the wall between the two upper chambers of the heart).\n5. Genital abnormalities: Males with Triple A syndrome may have genital abnormalities, including undescended testes (testes that fail to move into the scrotum) and/or hypospadias (a condition in which the urethra opens on the underside of the penis instead of the tip).\n6. Kidney abnormalities: Some individuals with Triple A syndrome may have kidney abnormalities, including hydronephrosis (enlargement of one or both kidneys) and/or urinary tract infections.\n7. Eye abnormalities: Triple A syndrome can cause eye abnormalities, including cataracts (clouding of the lens of the eye), glaucoma (increased pressure",
    "llama-2-7b-chat-hf_fact": [
      "Triple A syndrome, also known as 22q11.2 deletion syndrome, is a rare genetic disorder that affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.",
      "This disorder is caused by a deletion of genetic material on chromosome 22, specifically at the q11.2 locus.",
      "Facial, skeletal, cardiac, genital, and kidney abnormalities, as well as abnormalities of the brain and eye, are some cardinal features of Triple A syndrome.",
      "Males with this syndrome may have undescended testes and/or a condition called hypospadias.",
      "The syndrome can cause eye abnormalities such as cataracts and glaucoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Triple A syndrome, also known as Allgrove syndrome, is a rare autosomal recessive disorder that affects the adrenal glands, among other systems of the body.",
      "false, [corrected fact]: Triple A syndrome is caused by mutations in the AAAS gene on chromosome 12, not a deletion on chromosome 22. The 22q11.2 deletion syndrome is a different condition.",
      "false, [corrected fact]: Triple A syndrome is characterized by adrenal insufficiency, achalasia (a disorder of the esophagus), and alacrima (a reduced or absent tear production), along with possible neurological abnormalities.",
      "unknown",
      "false, [corrected fact]: There is no clear link established between Triple A syndrome and eye abnormalities such as cataracts and glaucoma. The primary eye-related symptom of Triple A syndrome is alacrima or a decreased production of tears."
    ]
  },
  {
    "id": 2205,
    "user_query": "Does the Abelson-related gene (ARG) gene encode for a serine kinase?",
    "llama-2-7b-chat-hf_response": "Yes, the Abelson-related gene (ARG) gene encodes for a serine/threonine kinase. The ARG protein is a member of the Abelson family of tyrosine kinases, which are involved in signaling pathways that regulate cell growth, differentiation, and survival. The ARG protein is specifically a serine/threonine kinase, meaning it phosphorylates serine and threonine residues on target proteins, in addition to tyrosine residues.\nThe ARG protein is composed of an N-terminal catalytic domain and a C-terminal domain that contains a pleckstrin homology (PH) domain and a proline-rich region. The PH domain is involved in binding to phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2), which are important signaling molecules in many cellular processes. The proline-rich region is involved in protein-protein interactions and may play a role in regulating the activity of the ARG protein.\nThe ARG protein is primarily localized to the cytoplasm, but it can also be found in the nucleus under certain conditions. It has been implicated in a variety of cellular processes, including cell adhesion, migration, and differentiation, as well as in the regulation of signaling pathways involved in cancer and other diseases.\nOverall, the ARG gene encodes for a serine/threonine kinase that plays a complex and multifaceted role in cellular signaling and regulation.",
    "llama-2-7b-chat-hf_fact": [
      "The Abelson-related gene (ARG) gene encodes for a serine/threonine kinase.",
      "The ARG protein is a member of the Abelson family of tyrosine kinases, involved in regulating cell growth, differentiation, and survival.",
      "The ARG protein consists of an N-terminal catalytic domain and a C-terminal domain that contains a pleckstrin homology (PH) domain and a proline-rich region.",
      "The PH domain of the ARG protein is involved in binding to phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2).",
      "The ARG protein is primarily found in the cytoplasm but can also be present in the nucleus under certain conditions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Abelson-related gene (ARG) encodes for a tyrosine kinase, not a serine/threonine kinase.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2207,
    "user_query": "Is Prochlorococcus the most abundant photosynthetic organism?",
    "llama-2-7b-chat-hf_response": "Prochlorococcus is a genus of marine cyanobacteria that are among the most abundant photosynthetic organisms in the oceans. They are found in surface waters worldwide, and are particularly abundant in tropical and subtropical regions. Prochlorococcus is thought to be the most abundant photosynthetic organism on Earth, with estimates suggesting that it makes up between 50% and 80% of the total photosynthetic biomass in the ocean.",
    "llama-2-7b-chat-hf_fact": [
      "Prochlorococcus is a genus of marine cyanobacteria.",
      "Prochlorococcus is among the most abundant photosynthetic organisms in the oceans.",
      "Prochlorococcus are found in surface waters worldwide, especially in tropical and subtropical regions.",
      "Prochlorococcus is thought to be the most abundant photosynthetic organism on Earth.",
      "Estimates suggest that Prochlorococcus makes up between 50% and 80% of the total photosynthetic biomass in the ocean."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Estimates suggest that Prochlorococcus makes up about 20% to 80% of the total photosynthetic biomass in the ocean."
    ]
  },
  {
    "id": 2208,
    "user_query": "List 3 features of IRVAN syndrome.",
    "llama-2-7b-chat-hf_response": "IRVAN syndrome is a rare genetic disorder characterized by intellectual disability, seizures, and distinctive facial features. Here are three features of IRVAN syndrome:\n1. Intellectual disability: IRVAN syndrome is characterized by significant intellectual disability, which can range from mild to severe. Individuals with IRVAN syndrome may have difficulty with cognitive tasks, learning new information, and adapting to new situations.\n2. Seizures: Another common feature of IRVAN syndrome is the presence of seizures. Individuals with IRVAN syndrome may experience various types of seizures, including tonic-clonic, atypical absence, and myoclonic seizures.\n3. Distinctive facial features: IRVAN syndrome is also characterized by distinctive facial features, including a small head, narrow eyes, and a short nose. Individuals with IRVAN syndrome may also have a flat nasal bridge, a small mouth, and a prominent chin. These facial features can vary in severity and may be more pronounced in some individuals than in others.",
    "llama-2-7b-chat-hf_fact": [
      "IRVAN syndrome is a rare genetic disorder.",
      "One of the characteristics of IRVAN syndrome is intellectual disability that ranges from mild to severe.",
      "Individuals with IRVAN syndrome may experience seizures, including tonic-clonic, atypical absence, and myoclonic seizures.",
      "IRVAN syndrome is characterized by certain distinctive facial features.",
      "These facial features of IRVAN syndrome can include a small head, narrow eyes, a short nose, a flat nasal bridge, a small mouth, and a prominent chin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: IRVAN syndrome has nothing to do with intellectual disability.",
      "false, [corrected fact]: There is no record of seizures being associated with IRVAN syndrome.",
      "false, [corrected fact]: There aren't distinctive facial features characteristic of IRVAN syndrome.",
      "false, [corrected fact]: The facial features mentioned are not associated with IRVAN syndrome."
    ]
  },
  {
    "id": 2211,
    "user_query": "List active ingredients of the Stribild polypill.",
    "llama-2-7b-chat-hf_response": "Stribild is a fixed-dose combination of four drugs:\n1. Emtricitabine (EMT)\n2. Tenofovir alafenamide (TAF)\n3. Lamivudine (3TC)\n4. Dolutegravir (DTG)\nThe active ingredients of Stribild are:\n1. Emtricitabine (EMT)\n2. Tenofovir alafenamide (TAF)\n3. Lamivudine (3TC)\n4. Dolutegravir (DTG)",
    "llama-2-7b-chat-hf_fact": [
      "Stribild is a fixed-dose combination of four drugs.",
      "One of the active ingredients in Stribild is Emtricitabine (EMT).",
      "Another active ingredient in Stribild is Tenofovir alafenamide (TAF).",
      "Stribild also contains Lamivudine (3TC) as an active ingredient.",
      "Dolutegravir (DTG) is another active ingredient in Stribild."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Stribild does not contain Lamivudine (3TC) as an active ingredient.",
      "false, [corrected fact]: Dolutegravir (DTG) is not an active ingredient in Stribild."
    ]
  },
  {
    "id": 2215,
    "user_query": "Does the histone chaperone ASF1 interact with histones H1/H2?",
    "llama-2-7b-chat-hf_response": "Yes, the histone chaperone ASF1 (also known as ATP-dependent chromatin remodeling factor 1) has been shown to interact with both histones H1 and H2.\n1. Histone H1: ASF1 has been shown to bind to the N-terminal tail of histone H1 and to facilitate the assembly of histone H1 into nucleosomes.\n2. Histone H2A: ASF1 has been shown to interact with the amino-terminal tail of histone H2A and to play a role in the assembly of histone H2A into nucleosomes.\nThe interaction between ASF1 and histones H1/H2 is thought to be important for the regulation of chromatin structure and gene expression, as well as for the maintenance of genome stability.",
    "llama-2-7b-chat-hf_fact": [
      "The histone chaperone ASF1 interacts with histones H1 and H2.",
      "ASF1 binds to the N-terminal tail of histone H1 to help assemble it into nucleosomes.",
      "ASF1 also interacts with the amino-terminal tail of histone H2A and assists in its assembly into nucleosomes.",
      "The interaction between ASF1 and histones H1/H2 is considered significant in the regulation of chromatin structure and gene expression.",
      "ASF1's interaction with these histones also aids in maintaining genome stability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The histone chaperone ASF1 interacts with histones H3 and H4, not H1 and H2.",
      "false, [corrected fact]: ASF1 binds to the N-terminal tail of histone H3, not H1, to help assemble it into nucleosomes.",
      "false, [corrected fact]: ASF1 also interacts with the amino-terminal tail of histone H4, not H2A, and assists in its assembly into nucleosomes.",
      "true",
      "true"
    ]
  },
  {
    "id": 2218,
    "user_query": "How many times is CLAST faster than BLAST?",
    "llama-2-7b-chat-hf_response": "In general, CLAST is faster than BLAST for several reasons:\n1. CLAST uses a different algorithm: CLAST uses the Needleman-Wunsch algorithm, which is faster and more efficient than the Smith-Waterman algorithm used in BLAST.\n2. CLAST uses a different scoring scheme: CLAST uses a simpler scoring scheme that is faster to compute than the more complex scoring scheme used in BLAST.\n3. CLAST is designed for real-time analysis: CLAST is optimized for real-time analysis, which means it can handle large datasets quickly and efficiently. BLAST, on the other hand, is designed for batch analysis and may take longer to complete.\n4. CLAST can handle larger datasets: CLAST can handle larger datasets than BLAST because it uses a different algorithm that is more efficient at handling large amounts of data.\n5. CLAST is more scalable: CLAST is more scalable than BLAST, which means it can handle larger datasets and more complex analyses without slowing down.\n6. CLAST has better performance on non-coding regions: CLAST has better performance on non-coding regions of the genome than BLAST, which means it can identify more novel transcripts and other features in these regions.\n7. CLAST has better performance on repetitive regions: CLAST has better performance on repetitive regions of the genome than BLAST, which means it can identify more novel transcripts and other features in these regions.\n8. CLAST has better performance on RNA-seq data: CLAST has better performance on RNA-seq data than BLAST, which means it can identify more novel transcripts and other features in these datasets.\n9. CLAST has better performance on single-cell RNA-seq data: CLAST has better performance on single-cell RNA-seq data than BLAST, which means it can identify more novel transcripts and other features in these datasets.\n10. CLAST is more user-friendly: CLAST is more user-friendly than BLAST, which means it is easier to use and requires less expertise to run.\nIn general, CLAST is faster than BLAST for several reasons, including its use",
    "llama-2-7b-chat-hf_fact": [
      "CLAST and BLAST use different algorithms: the Needleman-Wunsch algorithm and the Smith-Waterman algorithm respectively.",
      "CLAST and BLAST use different scoring schemes.",
      "CLAST is optimized for real-time analysis, while BLAST is designed for batch analysis.",
      "The algorithm used by CLAST is more efficient at handling large amounts of data compared to BLAST.",
      "CLAST provides better performance on non-coding and repetitive regions of the genome compared to BLAST."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2221,
    "user_query": "Which tool is used for the identification of recurrent variants in noncoding regions?",
    "llama-2-7b-chat-hf_response": "1. GATK\n2. VarScan\n3. FreeBayes\n4. Samtools\nAnswer: 2. VarScan\nExplanation:\nVarScan is a tool specifically designed for the identification of recurrent variants in noncoding regions. It uses a Bayesian approach to identify patterns of variation in noncoding regions that are likely to be functional. GATK, on the other hand, is a more general tool that can be used for a variety of genomic analysis tasks, including variant identification and filtering. Samtools is a tool for aligning sequencing reads to a reference genome and performing other genomic analysis tasks, but it is not specifically designed for identifying recurrent variants in noncoding regions. FreeBayes is a tool that can be used for Bayesian inference of genetic associations, but it is not specifically designed for identifying recurrent variants in noncoding regions.",
    "llama-2-7b-chat-hf_fact": [
      "VarScan is a tool used for the identification of recurrent variants in noncoding regions.",
      "VarScan uses a Bayesian approach to identify patterns of variation in noncoding regions.",
      "GATK is a general tool used for genomic analysis tasks, including variant identification and filtering.",
      "Samtools is a tool for aligning sequencing reads to a reference genome and performing other genomic analysis tasks.",
      "FreeBayes is a tool that can be used for Bayesian inference of genetic associations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: VarScan uses a heuristic or statistical approach to identify patterns of variation, not specifically a Bayesian approach.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2222,
    "user_query": "What body parts are also known as phalanges?",
    "llama-2-7b-chat-hf_response": "Phalanges are small bones found in the hands and feet of humans and other animals. They are the bones that make up the fingers and toes, and are responsible for their flexibility and mobility. In addition to the hands and feet, phalanges are also found in other parts of the body, such as the nose and ears.",
    "llama-2-7b-chat-hf_fact": [
      "Phalanges are small bones found in the hands and feet of humans and other animals.",
      "Phalanges are the bones that make up the fingers and toes.",
      "Phalanges are responsible for the flexibility and mobility of fingers and toes.",
      "Other than hands and feet, phalanges can also be found in parts of the body such as the nose and ears."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Phalanges are only found in the hands (fingers) and feet (toes) of humans and similar vertebrates. They are not present in parts of the body such as the nose and ears."
    ]
  },
  {
    "id": 2223,
    "user_query": "Are selenium supplements recommended for prostate cancer prevention?",
    "llama-2-7b-chat-hf_response": "Selenium is an essential mineral that acts as an antioxidant in the body. It has been studied for its potential role in preventing and treating various types of cancer, including prostate cancer. However, the evidence on the effectiveness of selenium supplements for prostate cancer prevention is mixed and inconclusive.\nSome studies have suggested that high levels of selenium in the body may reduce the risk of developing prostate cancer. For example, a 2011 study published in the Journal of the National Cancer Institute found that men in the highest quartile of selenium intake had a 34% lower risk of developing prostate cancer compared to those in the lowest quartile.\nHowever, other studies have found no association between selenium intake and prostate cancer risk. A 2013 review of 17 observational studies published in the journal Nutrition and Cancer found that the evidence for a protective effect of selenium on prostate cancer was inconsistent and inconclusive.\nThe International Agency for Research on Cancer (IARC) has classified selenium and prostate cancer as \"inadequate evidence\" for both positive and negative associations. This means that while some studies have suggested a possible protective effect of selenium on prostate cancer, the evidence is not strong enough to support a clear recommendation for or against the use of selenium supplements for prostate cancer prevention.\nThe American Cancer Society recommends that men talk to their doctor about their individual risk factors for prostate cancer and the potential benefits and risks of selenium supplements. They also suggest that men get their nutrients from a balanced diet rather than relying on supplements.\nIn summary, while some studies have suggested a possible protective effect of selenium on prostate cancer, the evidence is mixed and inconclusive. More research is needed to determine whether selenium supplements are effective in preventing or treating prostate cancer. If you are considering taking selenium supplements, it is important to talk to your doctor about your individual risk factors and the potential benefits and risks of supplementation.",
    "llama-2-7b-chat-hf_fact": [
      "Selenium is an essential mineral that acts as an antioxidant in the body.",
      "Some studies suggest that high levels of selenium in the body may reduce the risk of developing prostate cancer.",
      "A 2011 study published in the Journal of the National Cancer Institute found men in the highest quartile of selenium intake had a 34% lower risk of developing prostate cancer compared to those in the lowest quartile.",
      "The International Agency for Research on Cancer (IARC) has classified selenium and prostate cancer as \"inadequate evidence\" for both positive and negative associations.",
      "The American Cancer Society recommends men talk to their doctor about their individual risk factors for prostate cancer and the potential benefits and risks of selenium supplements."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2227,
    "user_query": "Is Downs syndrome associated with decreased risk of leukemia?",
    "llama-2-7b-chat-hf_response": "An association between Down syndrome and a decreased risk of leukemia has been observed in several studies. People with Down syndrome are at a lower risk of developing acute lymphoblastic leukemia (ALL) compared to the general population. The exact reason for this association is not fully understood, but several factors may contribute to it:\n1. Genetic mutations: People with Down syndrome have an extra copy of chromosome 21, which can lead to genetic mutations that may suppress the development of leukemia.\n2. Immune system dysfunction: The immune system of people with Down syndrome may be less effective at fighting off cancer cells, which could contribute to the lower risk of leukemia.\n3. Hormonal influences: Hormonal changes during fetal development may play a role in the reduced risk of leukemia in people with Down syndrome.\n4. Environmental factors: Exposure to certain environmental factors, such as radiation, may increase the risk of leukemia in the general population but may have a protective effect in people with Down syndrome.\nIt is important to note that while people with Down syndrome are at a lower risk of leukemia, they are still at risk of developing other types of cancer, such as breast, ovarian, and colon cancer. Regular cancer screenings and check-ups are essential for early detection and treatment of any cancer in people with Down syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "People with Down syndrome are at a lower risk of developing acute lymphoblastic leukemia (ALL) compared to the general population.",
      "An extra copy of chromosome 21 in people with Down syndrome can lead to genetic mutations that may suppress the development of leukemia.",
      "The immune system of people with Down syndrome may be less effective at fighting off cancer cells.",
      "Hormonal changes during fetal development may contribute to a reduced risk of leukemia in people with Down syndrome.",
      "People with Down syndrome are at risk of developing other types of cancer, such as breast, ovarian, and colon cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: People with Down syndrome are at a higher risk of developing acute lymphoblastic leukemia (ALL) compared to the general population.",
      "false, [corrected fact]: An extra copy of chromosome 21 in people with Down syndrome can lead to genetic mutations that increase the risk of leukemia.",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2230,
    "user_query": "Hy's law measures failure for what organ?",
    "llama-2-7b-chat-hf_response": "A) Heart\nB) Lungs\nC) Liver\nD) Kidneys\nAnswer: A) Heart\nExplanation: Hy's law states that the failure of the heart to pump blood efficiently leads to a decrease in cardiac output, which can result in inadequate perfusion of vital organs, including the brain, kidneys, and liver. Therefore, option A is the correct answer.",
    "llama-2-7b-chat-hf_fact": [
      "Hy's law measures the failure of the heart.",
      "The failure of the heart to pump blood efficiently can lead to a decrease in cardiac output.",
      "Decreased cardiac output may result in inadequate perfusion of vital organs.",
      "Vital organs include the brain, kidneys, and liver."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Hy's law is a clinical marker of serious drug-induced liver injury.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-7b-chat-hf_response": "Pediatric brain tumors are rare and complex, and their diagnosis and treatment require a multidisciplinary approach. The identification of pediatric brain tumors can be challenging due to the complexity of the brain and the variability of the symptoms. However, there are several R packages that can be used for the analysis and identification of pediatric brain tumors. Here are some of the R packages that can be used for this purpose:\n1. BrainTumor: This R package provides a comprehensive framework for the analysis of brain tumors, including pediatric brain tumors. It includes tools for image segmentation, feature extraction, and classification.\n2. PedBrainTumor: This R package is specifically designed for the analysis of pediatric brain tumors. It includes tools for image segmentation, feature extraction, and survival analysis.\n3. BrainTumorSegmentation: This R package provides tools for image segmentation of brain tumors, including pediatric brain tumors. It includes algorithms for segmenting brain structures and tumors from MRI scans.\n4. BrainTumorFeatures: This R package provides tools for extracting features from brain tumors, including pediatric brain tumors. It includes features such as shape, size, and texture.\n5. BrainTumorClassification: This R package provides tools for classifying brain tumors, including pediatric brain tumors. It includes algorithms for classification, including support vector machines and random forests.\n6. SurvivalAnalysis: This R package provides tools for survival analysis of brain tumors, including pediatric brain tumors. It includes functions for estimating survival curves and conducting Cox proportional hazards models.\nThese R packages can be used to analyze and identify pediatric brain tumors by providing tools for image segmentation, feature extraction, classification, and survival analysis. By using these packages, researchers and clinicians can improve the accuracy and efficiency of the diagnosis and treatment of pediatric brain tumors.",
    "llama-2-7b-chat-hf_fact": [
      "The \"BrainTumor\" R package provides a framework for the analysis of brain tumors including pediatric brain tumors.",
      "The \"PedBrainTumor\" R package is specifically designed for the analysis of pediatric brain tumors.",
      "The \"BrainTumorSegmentation\" R package provides means for the image segmentation of different types of brain tumors.",
      "The \"BrainTumorFeatures\" R package aids in the extraction of features from brain tumors.",
      "The \"SurvivalAnalysis\" R package is used for survival analysis of brain tumors, including pediatric ones."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2243,
    "user_query": "Which factors drive replisome disassembly during DNA replication termination and mitosis?",
    "llama-2-7b-chat-hf_response": "Replisomes are complexes that play a crucial role in DNA replication and repair. During DNA replication termination, replisomes are disassembled to allow the newly synthesized DNA strands to be separated. Similarly, during mitosis, replisomes are disassembled to allow the chromatin to be properly segregated between daughter cells. There are several factors that drive replisome disassembly during these processes, including:\n1. ATP depletion: ATP is the primary energy source for replisome function. As ATP levels decrease during DNA replication termination and mitosis, the replisome becomes less stable and begins to disassemble.\n2. Chromatin remodeling complexes: Chromatin remodeling complexes, such as SWI/SNF and ISWI, are involved in the disassembly of replisomes during DNA replication termination and mitosis. These complexes use energy from ATP hydrolysis to move nucleosomes along the DNA strand, allowing the replisome to be disassembled.\n3. Histone-modifying enzymes: Histone-modifying enzymes, such as histone acetyltransferases and histone deacetylases, play a role in the disassembly of replisomes during DNA replication termination and mitosis. These enzymes modify histones, leading to changes in chromatin structure that allow the replisome to be disassembled.\n4. Protein phosphatases: Protein phosphatases, such as protein phosphatase 1 (PP1), are involved in the disassembly of replisomes during DNA replication termination and mitosis. These enzymes dephosphorylate proteins that are involved in replisome function, leading to the disassembly of the replisome.\n5. Ubiquitin-protein ligases: Ubiquitin-protein ligases, such as the SCF complex, are involved in the disassembly of replisomes during DNA replication termination and mitosis. These enzymes ubiquitinate proteins that are involved in replisome function, leading to their degradation and the disassembly of the replisome.\n6.",
    "llama-2-7b-chat-hf_fact": [
      "Replisomes are complexes that play a crucial role in DNA replication and repair.",
      "During DNA replication termination and mitosis, replisomes are disassembled.",
      "ATP depletion in DNA replication termination and mitosis can initiate replisome disassembly.",
      "Chromatin remodeling complexes, such as SWI/SNF and ISWI, are involved in the disassembly of replisomes.",
      "Protein phosphatases such as protein phosphatase 1 (PP1) play a role in the disassembly of replisomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2244,
    "user_query": "Does RNA polymerase II have RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II (RNAPII) is the primary enzyme responsible for transcribing DNA into RNA in eukaryotic cells. While RNAPII is primarily known for its role in transcription elongation, recent studies have shown that it also has RNA cleavage activity.\nRNA cleavage is the process by which RNA is broken down into smaller fragments, and it plays a crucial role in various cellular processes, including mRNA degradation, RNA splicing, and RNA localization. RNAPII has been shown to cleave RNA in vitro and in vivo, and it is thought to play a role in regulating gene expression by controlling the stability of mRNAs.\nThe RNA cleavage activity of RNAPII is mediated by a conserved domain called the RNA cleavage domain (RCD). The RCD is located at the C-terminal end of RNAPII and is composed of a series of conserved amino acids that are necessary for RNA cleavage. Studies have shown that the RCD of RNAPII can cleave a wide range of RNA substrates, including pre-mRNAs, mRNAs, and non-coding RNAs.\nThe RNA cleavage activity of RNAPII has important implications for cellular regulation of gene expression. By controlling the stability of mRNAs, RNAPII can regulate the levels of proteins produced from those genes, which in turn can affect a wide range of cellular processes. Additionally, the RNA cleavage activity of RNAPII may play a role in the regulation of RNA localization and splicing, as well as the degradation of aberrant RNAs.\nIn summary, RNA polymerase II has RNA cleavage activity, which is mediated by a conserved domain called the RNA cleavage domain. This activity plays a crucial role in regulating gene expression by controlling the stability of mRNAs, and it has important implications for cellular regulation of gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "RNA polymerase II (RNAPII) is the primary enzyme responsible for transcribing DNA into RNA in eukaryotic cells.",
      "Recent studies show that RNA polymerase II also has RNA cleavage activity.",
      "RNA cleavage is a process by which RNA is broken down into smaller fragments, affecting various cellular processes, including mRNA degradation, RNA splicing, and RNA localization.",
      "The RNA cleavage activity of RNA polymerase II is mediated by a conserved domain called the RNA cleavage domain, which is located at the C-terminal end of the enzyme.",
      "By controlling the stability of mRNAs through RNA cleavage, RNA polymerase II can regulate levels of proteins produced from those genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The RNA cleavage activity of RNA polymerase II isn't mediated by a specific 'RNA cleavage domain'. However, some of its subunits might participate in the process that involves RNA cleavage.",
      "true"
    ]
  },
  {
    "id": 2245,
    "user_query": "Is there a sequence bias in MNase digestion patterns?",
    "llama-2-7b-chat-hf_response": "MNase is a highly specific endonuclease that cleaves RNA at the 2'-O-methyl group of the ribose moiety. MNase digestion patterns can be used to identify and quantify RNA species in a sample. However, there is a sequence bias in MNase digestion patterns that can affect the accuracy of RNA analysis.\nThe sequence bias in MNase digestion patterns arises from the specificity of the enzyme for the 2'-O-methyl group of the ribose moiety. MNase has a higher affinity for the 2'-O-methyl group than for the 2'-hydroxyl group, which means that it is more likely to cleave RNA molecules that have a 2'-O-methyl group at the cleavage site. This results in a bias towards cleavage of RNA molecules with a 2'-O-methyl group at the 5' end of the molecule.\nThere are several factors that can contribute to the sequence bias in MNase digestion patterns, including:\n1. The presence of 2'-O-methyl groups in the RNA molecule: MNase has a higher affinity for the 2'-O-methyl group than for the 2'-hydroxyl group, which means that it is more likely to cleave RNA molecules that have a 2'-O-methyl group at the cleavage site.\n2. The length of the RNA molecule: MNase has a higher specificity for shorter RNA molecules, which means that it is more likely to cleave shorter RNA molecules than longer ones.\n3. The presence of bulges or loops in the RNA molecule: MNase has a higher affinity for RNA molecules with bulges or loops, which means that it is more likely to cleave RNA molecules with these structural features.\n4. The presence of modified bases in the RNA molecule: MNase has a higher affinity for RNA molecules with modified bases, such as m5C or m5U, which means that it is more likely to cleave RNA molecules with these modifications.\nTo minimize the sequence bias in MNase digestion patterns, it",
    "llama-2-7b-chat-hf_fact": [
      "MNase is an endonuclease that cleaves RNA at the 2'-O-methyl group of the ribose moiety.",
      "MNase digestion patterns can be used to identify and quantify RNA species in a sample.",
      "There is a sequence bias in MNase digestion patterns arising from the enzyme's specificity for the 2'-O-methyl group of the ribose moiety.",
      "The length of the RNA molecule, the presence of 2'-O-methyl groups, bulges or loops, and presence of modified bases in the RNA can contribute to the sequence bias in MNase digestion patterns.",
      "MNase has a higher affinity for RNA molecules with a 2'-O-methyl group at the 5' end of the molecule."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MNase, or Micrococcal nuclease, is an endonuclease that cleaves DNA and RNA at the phosphate groups, not the 2'-O-methyl group of the ribose moiety.",
      "true",
      "false, [corrected fact]: The sequence bias in MNase digestion patterns arises from its preference for accessible regions within DNA or RNA, not its specificity for the 2'-O-methyl group of the ribose moiety.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-7b-chat-hf_response": "Yes, NEMO (Nuclear Envelope-Associated Matrix-Organizing) protein is a zinc finger protein. Zinc fingers are a type of structural motif found in proteins that are involved in DNA binding and protein-protein interactions. NEMO is composed of multiple zinc fingers, which are responsible for its ability to recognize and bind to specific DNA sequences.\nNEMO is a key component of the NF-B (nuclear factor kappa B) signaling pathway, which plays a critical role in regulating inflammation and immune responses. The zinc fingers in NEMO are responsible for recognizing and binding to specific DNA sequences in the promoter regions of NF-B target genes, leading to their transcriptional activation.\nIn addition to its role in NF-B signaling, NEMO has been implicated in a variety of other cellular processes, including cell adhesion, migration, and survival. Dysregulation of NEMO has been implicated in a number of diseases, including cancer and autoimmune disorders.",
    "llama-2-7b-chat-hf_fact": [
      "NEMO (Nuclear Envelope-Associated Matrix-Organizing) protein is a zinc finger protein.",
      "Zinc fingers are found in proteins and are involved in DNA binding and protein-protein interactions.",
      "NEMO is a key component of the NF-B (nuclear factor kappa B) signaling pathway which regulates inflammation and immune responses.",
      "The zinc fingers in NEMO are responsible for recognizing and binding to specific DNA sequences in the promoter regions of NF-B target genes.",
      "Abnormalities in NEMO can lead to various diseases, including cancer and autoimmune disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: NEMO does not contain zinc fingers. Its function is not primarily related to recognizing and binding to DNA sequences, but it plays a key role in NF-B activation.",
      "true"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "TFIIS (Transcription Factor IIS) is a transcription factor that plays a crucial role in the regulation of gene expression by modulating the activity of RNA polymerase II (RNAPII). TFIIS has been shown to affect nucleosome positioning by altering the chromatin structure and accessibility to the transcriptional machinery.\nNucleosomes are the basic units of chromatin, consisting of a segment of DNA wrapped around a core of eight histone proteins (two copies each of histones H2A, H2B, H3, and H4). The positioning of nucleosomes can have a significant impact on gene expression by affecting the accessibility of the DNA to the transcriptional machinery. TFIIS has been shown to interact with histone-modifying enzymes, such as histone acetyltransferases (HATs) and histone deacetylases (HDACs), to alter the chromatin structure and positioning of nucleosomes.\nBy altering the chromatin structure and nucleosome positioning, TFIIS can affect the recruitment and activity of other transcription factors and coregulators, leading to changes in gene expression. For example, TFIIS has been shown to enhance the recruitment of the transcriptional activator p53 to its target genes by altering the chromatin structure and positioning of nucleosomes.\nIn summary, TFIIS affects nucleosome positioning by altering the chromatin structure and interacting with histone-modifying enzymes, leading to changes in gene expression by affecting the recruitment and activity of other transcription factors and coregulators.",
    "llama-2-7b-chat-hf_fact": [
      "TFIIS is a transcription factor that modulates the activity of RNA polymerase II.",
      "Nucleosomes, the basic units of chromatin, are made up of a segment of DNA wrapped around a core of eight histone proteins.",
      "TFIIS can affect the positioning of nucleosomes by altering the chromatin structure.",
      "TFIIS interacts with histone-modifying enzymes, such as histone acetyltransferases (HATs) and histone deacetylases (HDACs).",
      "TFIIS has been shown to enhance the recruitment of the transcriptional activator p53 to its target genes by altering the chromatin structure and nucleosome positioning."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2250,
    "user_query": "What is metaSPAdes?",
    "llama-2-7b-chat-hf_response": "metaSPAdes is a machine learning-based method for predicting the structure of proteins from their amino acid sequence. It is an extension of the SPAdes algorithm, which is a widely used tool for protein structure prediction.\nHow does metaSPAdes work?\nmetaSPAdes uses a combination of machine learning algorithms and structural bioinformatics tools to predict the structure of a protein from its amino acid sequence. The method involves the following steps:\n1. Sequence alignment: The amino acid sequence of the protein is aligned with a database of known protein structures to identify similarities and differences.\n2. Feature extraction: Features are extracted from the protein sequence and used to train a machine learning model.\n3. Model training: A machine learning model is trained on the extracted features and a set of known protein structures to predict the structure of the target protein.\n4. Prediction: The trained model is used to predict the structure of the target protein.\nWhat are the advantages of metaSPAdes?\nmetaSPAdes has several advantages over other protein structure prediction methods, including:\n1. Improved accuracy: metaSPAdes uses a combination of machine learning algorithms and structural bioinformatics tools to predict the structure of a protein with higher accuracy than other methods.\n2. Flexibility: metaSPAdes can be used to predict the structure of proteins with different levels of complexity, from simple to complex structures.\n3. Efficiency: metaSPAdes is computationally efficient and can predict the structure of a protein in a matter of seconds.\n4. Scalability: metaSPAdes can be used to predict the structure of multiple proteins simultaneously, making it a useful tool for large-scale protein structure prediction.\nWhat are the applications of metaSPAdes?\nmetaSPAdes has a wide range of applications in structural bioinformatics and computational biology, including:\n1. Protein structure prediction: metaSPAdes can be used to predict the structure of proteins with unknown or incomplete structures.\n2. Protein engineering: metaSPAdes can be used to design and engineer proteins with specific functions or structures.\n3. Drug discovery: metaSPAdes can be used to predict the structure of protein-ligand complexes and identify potential drug targets.\n4. Systems biology",
    "llama-2-7b-chat-hf_fact": [
      "metaSPAdes is a machine learning-based method for predicting the structure of proteins from their amino acid sequence.",
      "The SPAdes algorithm is a widely used tool for protein structure prediction.",
      "metaSPAdes uses a combination of machine learning algorithms and structural bioinformatics tools in its prediction process.",
      "MetaSPAdes offers flexibility, efficiency, scalability and improved accuracy over other protein structure prediction methods.",
      "metaSPAdes has applications in protein structure prediction, protein engineering, drug discovery, and systems biology."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: metaSPAdes is not a machine learning-based method for predicting the structure of proteins from their amino acid sequence. It's a highly efficient and accurate genome assembly algorithm.",
      "false, [corrected fact]: The SPAdes algorithm is not used for protein structure prediction. It is a tool for genome assembly.",
      "false, [corrected fact]: metaSPAdes does not use a combination of machine learning algorithms and structural bioinformatics tools in its prediction process, as it is designed for genome assembly, not protein structure prediction.",
      "unknown",
      "false, [corrected fact]: metaSPAdes does not have applications in protein structure prediction, protein engineering, drug discovery, or systems biology. It is used in genome assembly."
    ]
  },
  {
    "id": 2257,
    "user_query": "What is the difference between ganglion mother cells (GMC) and intermediate neural precursor cells (INP) in Drosophila?",
    "llama-2-7b-chat-hf_response": "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two distinct populations of neural progenitors in the Drosophila embryo. While both cell types are involved in the development of the central nervous system (CNS), they have distinct molecular identities and functions. Here are some key differences between GMCs and INPs:\n1. Cell surface markers: GMCs are marked by the expression of the cell surface protein VGluT3, while INPs are marked by the expression of the protein VGluT2.\n2. Developmental timing: GMCs are present in the embryo from stage 9 onwards, while INPs are present from stage 7 onwards.\n3. Proliferation: GMCs are more proliferative than INPs, with GMCs dividing more frequently and for longer periods of time.\n4. Differentiation: GMCs differentiate into mature neurons, while INPs give rise to both neurons and glial cells.\n5. Lineage relationships: GMCs are more closely related to mature neurons than INPs, while INPs are more closely related to other neural progenitors in the CNS.\n6. Function: GMCs are involved in the formation of the peripheral nervous system (PNS), while INPs are involved in the formation of the central nervous system (CNS).\nThese differences in molecular identity, developmental timing, proliferation, differentiation, lineage relationships, and function distinguish GMCs and INPs as distinct populations of neural progenitors in the Drosophila embryo.",
    "llama-2-7b-chat-hf_fact": [
      "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two distinct populations of neural progenitors in the Drosophila embryo.",
      "GMCs are involved in the development of the peripheral nervous system, while INPs are involved in the formation of the central nervous system in Drosophila.",
      "GMCs are marked by the expression of the cell surface protein VGluT3, while INPs are marked by the expression of the protein VGluT2.",
      "GMCs differentiate into mature neurons, while INPs give rise to both neurons and glial cells.",
      "GMCs are more proliferative than INPs, with GMCs dividing more frequently and for longer periods of time."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-7b-chat-hf_response": "Origins of replication (ori) in yeast (Saccharomyces cerevisiae) are located near centromeres, which are specialized regions of DNA that play a crucial role in the separation of chromosomes during cell division. The timing of ori firing, or the initiation of DNA replication, can be influenced by various factors, including the location of the ori relative to the centromere.\nStudies have shown that ori firing can occur either early or late relative to the centromere in yeast. Early firing occurs when the ori initiates replication before the centromere, while late firing occurs when the ori initiates replication after the centromere. The timing of ori firing can have important consequences for the proper separation of chromosomes during cell division, as well as for the regulation of gene expression.\nOne study found that ori firing in yeast occurs late relative to the centromere, with the ori initiating replication about 10 minutes after the centromere (1). Another study found that the timing of ori firing can vary depending on the specific location of the ori relative to the centromere, with some oris firing early and others firing late (2).\nOverall, the timing of ori firing relative to the centromere in yeast is complex and can vary depending on a variety of factors. Understanding the mechanisms that control ori firing can provide important insights into the regulation of DNA replication and the proper separation of chromosomes during cell division.\nReferences:\n1. Kim, J. et al. (2015). The timing of origin firing in Saccharomyces cerevisiae is determined by the distance from the centromere. Genes & Development, 29(10), 1143-1154.\n2. Liu, Y. et al. (2017). The timing of origin firing in Saccharomyces cerevisiae is influenced by the location of the origin relative to the centromere. PLoS Genetics, 13(6), e1006676.",
    "llama-2-7b-chat-hf_fact": [
      "Origins of replication in yeast are located near centromeres, which are integral in the separation of chromosomes during cell division.",
      "The timing of origins of replication firing can be influenced by their location relative to the centromere.",
      "The occurrence of origin firing can vary; it can happen either early or late relative to the centromere in yeast.",
      "In some instances as per studies, the firing of an origin of replication occurred about 10 minutes after the centromere.",
      "Timing of origin of replication firing is notably complex and largely influenced by a variety of factors including its specific location relative to the centromere."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-7b-chat-hf_response": "Mammalian GA-sequences are a type of non-coding RNA that have been implicated in various cellular processes, including gene regulation, cell signaling, and immune response. Here are some of the properties of mammalian GA-sequences:\n1. Structure: Mammalian GA-sequences are composed of 7-10 nucleotides in length and have a characteristic stem-loop structure.\n2. Expression: GA-sequences are expressed in various tissues and cell types, including the brain, heart, and immune cells.\n3. Function: Mammalian GA-sequences have been shown to regulate gene expression by binding to messenger RNA (mRNA) and preventing its translation. They also participate in cell signaling pathways and modulate the immune response.\n4. Regulation: The expression of GA-sequences is regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational levels.\n5. Evolutionary conservation: Mammalian GA-sequences are highly conserved across species, indicating their importance in mammalian biology.\n6. Interaction with other RNAs: GA-sequences have been shown to interact with other non-coding RNAs, such as microRNAs and long non-coding RNAs, and play a role in their function.\n7. Implications in disease: Abnormalities in GA-sequence expression have been implicated in various diseases, including cancer, neurological disorders, and autoimmune diseases.\n8. Therapeutic potential: GA-sequences have been proposed as potential therapeutic targets for the treatment of various diseases, including cancer and neurological disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Mammalian GA-sequences are a type of non-coding RNA implicated in gene regulation, cell signaling, and immune response.",
      "GA-sequences are composed of 7-10 nucleotides in length and have a characteristic stem-loop structure.",
      "GA-sequences are expressed in various tissues and cell types, including the brain, heart, and immune cells.",
      "GA-sequences can regulate gene expression by binding to messenger RNA and preventing its translation.",
      "Abnormalities in GA-sequence expression have been implicated in various diseases, namely cancer, neurological disorders, and autoimmune diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2272,
    "user_query": "What is the origin of XUT transcripts in yeast?",
    "llama-2-7b-chat-hf_response": "XUT (eXtra-Ubiquitin) transcripts are a type of non-coding RNA (ncRNA) that are expressed in yeast (Saccharomyces cerevisiae). These transcripts are derived from the ubiquitin gene and are thought to play a role in the regulation of gene expression, particularly in response to stress.\nThe origin of XUT transcripts in yeast can be traced back to the ubiquitin gene, which is located on chromosome III. The ubiquitin gene encodes for the ubiquitin protein, which is a small protein that plays a crucial role in protein degradation and cellular signaling. The XUT transcripts are derived from the ubiquitin gene through a process called alternative splicing, where the RNA transcript is spliced to produce a different form of the protein.\nIn yeast, the ubiquitin gene is highly expressed, and the XUT transcripts are generated through a complex splicing pattern that involves the removal of introns and the joining of exons. The splicing of the ubiquitin gene is regulated by a variety of factors, including stress signals, transcription factors, and RNA-binding proteins.\nOnce the XUT transcripts are generated, they are processed and transported to the cytoplasm, where they can interact with other RNAs and proteins to regulate gene expression. XUT transcripts have been shown to bind to other RNAs, such as messenger RNAs (mRNAs), and to regulate their translation. They have also been shown to interact with proteins, such as the translation initiation factor eIF4E, and to regulate protein synthesis.\nIn summary, the origin of XUT transcripts in yeast is the ubiquitin gene, which is highly expressed and undergoes alternative splicing to generate the XUT transcripts. These transcripts are processed and transported to the cytoplasm, where they can regulate gene expression by interacting with other RNAs and proteins.",
    "llama-2-7b-chat-hf_fact": [
      "XUT (eXtra-Ubiquitin) transcripts are a type of non-coding RNA that are expressed in yeast (Saccharomyces cerevisiae).",
      "The origin of XUT transcripts in yeast can be traced back to the ubiquitin gene, which is located on chromosome III.",
      "The ubiquitin gene encodes for the ubiquitin protein, which plays a crucial role in protein degradation and cellular signaling.",
      "In yeast, the ubiquitin gene is highly expressed and undergoes alternative splicing to generate the XUT transcripts.",
      "The XUT transcripts can regulate gene expression by interacting with other RNAs and proteins such as messenger RNAs and the translation initiation factor eIF4E."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The origin of XUT transcripts in yeast is not directly traced back to the ubiquitin gene.",
      "true",
      "false, [corrected fact]: In yeast, the ubiquitin gene does not undergo alternative splicing to generate XUT transcripts. XUTs are independently transcribed.",
      "true"
    ]
  },
  {
    "id": 2274,
    "user_query": "Is autophagy modulated in a circadian fashion?",
    "llama-2-7b-chat-hf_response": "Autophagy, the process by which cells degrade and recycle damaged or dysfunctional cellular components, is known to play a crucial role in maintaining cellular homeostasis and preventing disease. While autophagy has been shown to be regulated by a variety of factors, including nutrient availability, growth factors, and cellular stress, there is evidence to suggest that autophagy is also modulated in a circadian fashion.\nStudies have shown that the expression of genes involved in autophagy, such as ATG1, ATG5, and LC3, exhibits a circadian rhythm in various tissues, including the liver, muscle, and brain. This circadian regulation of autophagy is thought to be mediated by the circadian clock, which is a complex system that regulates the expression of genes involved in a wide range of physiological processes, including metabolism, energy homeostasis, and cellular stress response.\nThe circadian regulation of autophagy has important implications for our understanding of the molecular mechanisms underlying various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. For example, alterations in the circadian regulation of autophagy have been implicated in the development and progression of cancer, as well as in the regulation of metabolic homeostasis.\nFurthermore, the circadian regulation of autophagy may also have implications for the development of novel therapeutic strategies for the treatment of these diseases. For example, drugs that target the circadian clock or that modulate the circadian regulation of autophagy may provide a new approach to the treatment of diseases that are characterized by alterations in autophagy.\nIn summary, the regulation of autophagy by the circadian clock is an important aspect of cellular physiology that has important implications for our understanding of the molecular mechanisms underlying various diseases. Further research is needed to fully understand the mechanisms underlying the circadian regulation of autophagy and to identify novel therapeutic strategies for the treatment of diseases that are characterized by alterations in autophagy.",
    "llama-2-7b-chat-hf_fact": [
      "Autophagy is the process by which cells degrade and recycle damaged or dysfunctional cellular components.",
      "Autophagy plays a crucial role in maintaining cellular homeostasis and preventing disease.",
      "Studies suggest that autophagy is modulated in a circadian fashion and is regulated by the circadian clock.",
      "The expression of genes involved in autophagy, namely ATG1, ATG5, and LC3, exhibit a circadian rhythm in various tissues.",
      "Alterations in the circadian regulation of autophagy have been implicated in the development and progression of diseases, such as cancer, neurodegenerative disorders, and metabolic disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2275,
    "user_query": "Is Drk essential for anesthesia-resistant memory (ARM) in Drosophila?",
    "llama-2-7b-chat-hf_response": "Drk (Drosophila Rho-associated protein kinase) is a protein kinase that plays a crucial role in regulating the actin cytoskeleton in Drosophila. Recent studies have shown that Drk is also involved in the regulation of anesthesia-resistant memory (ARM) in Drosophila. ARM is a form of memory that is resistant to anesthesia and is thought to be mediated by changes in the actin cytoskeleton.\nTo investigate the role of Drk in ARM, researchers used a combination of genetic and pharmacological approaches. They found that Drk is required for the formation of ARM and that inhibition of Drk activity impairs the ability of flies to retain ARM. Conversely, overexpression of Drk enhances the ability of flies to retain ARM.\nThese findings suggest that Drk is essential for the formation and retention of ARM in Drosophila. The study provides new insights into the molecular mechanisms underlying ARM and highlights the importance of the actin cytoskeleton in the formation and retention of memories.",
    "llama-2-7b-chat-hf_fact": [
      "Drk (Drosophila Rho-associated protein kinase) is a protein kinase that regulates the actin cytoskeleton in Drosophila.",
      "Recent studies have suggested that Drk is involved in the regulation of anesthesia-resistant memory (ARM) in Drosophila.",
      "To investigate the role of Drk in ARM, a combination of genetic and pharmacological approaches were used.",
      "Inhibition of Drk activity impairs the ability of flies to retain ARM.",
      "Overexpression of Drk enhances the ability of flies to retain ARM."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2284,
    "user_query": "Has IVIG been tested in clinical trials for the treatment of Alzheimer's disease?",
    "llama-2-7b-chat-hf_response": "Yes, IVIG has been tested in several clinical trials for the treatment of Alzheimer's disease. These trials have been conducted to evaluate the safety and efficacy of IVIG in slowing down or halting the progression of Alzheimer's disease. Some of the notable clinical trials include:\n1. The Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Mild to Moderate Alzheimer's Disease (AMETHYST) - This trial was conducted by the National Institute on Aging (NIA) and involved 240 participants with mild to moderate Alzheimer's disease. The trial found that IVIG did not slow down the progression of Alzheimer's disease compared to a placebo.\n2. The Safety and Efficacy Study of Intravenous Immunoglobulin (IVIG) in Early-Stage Alzheimer's Disease (EMERGE) - This trial was conducted by Biogen and involved 360 participants with early-stage Alzheimer's disease. The trial found that IVIG did not slow down the progression of Alzheimer's disease compared to a placebo.\n3. The Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Patients with Alzheimer's Disease (EXPEDITION3) - This trial was conducted by Biogen and involved 1,100 participants with mild to moderate Alzheimer's disease. The trial found that IVIG did not slow down the progression of Alzheimer's disease compared to a placebo.\nWhile these clinical trials did not find IVIG to be effective in slowing down the progression of Alzheimer's disease, they did provide valuable insights into the safety and tolerability of IVIG in patients with Alzheimer's disease. Further research is needed to determine the potential benefits and risks of IVIG in the treatment of Alzheimer's disease.",
    "llama-2-7b-chat-hf_fact": [
      "IVIG has been tested in several clinical trials for the treatment of Alzheimer's disease.",
      "The Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Mild to Moderate Alzheimer's Disease (AMETHYST) was conducted by the National Institute on Aging (NIA) involving 240 participants with mild to moderate Alzheimer's disease.",
      "The Safety and Efficacy Study of Intravenous Immunoglobulin (IVIG) in Early-Stage Alzheimer's Disease (EMERGE) was conducted by Biogen with 360 participants with early-stage Alzheimer's disease.",
      "The Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Patients with Alzheimer's Disease (EXPEDITION3) was carried out by Biogen involving 1,100 participants with mild to moderate Alzheimer's disease.",
      "The trials showed that IVIG did not slow down the progression of Alzheimer's disease compared to a placebo, but provided valuable insights into the safety and tolerability of IVIG in patients with Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2285,
    "user_query": "Which type of urinary incontinence is diagnosed with the Q tip test?",
    "llama-2-7b-chat-hf_response": "A. Stress incontinence\nB. Urge incontinence\nC. Overactive bladder\nD. Functional incontinence\nAnswer: B. Urge incontinence\nThe Q-tip test is used to diagnose urge incontinence, which is characterized by a sudden, intense need to urinate that is difficult to delay or control. During the test, a cotton swab (Q-tip) is inserted into the urethra to assess the bladder's ability to hold urine. If the bladder is unable to hold urine for more than 10-15 seconds, it may indicate urge incontinence.\nStress incontinence, on the other hand, is characterized by the leakage of urine during activities that put pressure on the bladder, such as coughing, sneezing, or lifting. The Q-tip test is not used to diagnose stress incontinence.\nUrge incontinence is the most common type of urinary incontinence in adults, and it can be caused by a variety of factors, including overactive bladder, neurological disorders, and certain medications.\nFunctional incontinence is a type of incontinence that occurs when an individual is unable to make it to the bathroom in time due to physical limitations or cognitive impairment. The Q-tip test is not used to diagnose functional incontinence.\nOveractive bladder is a type of urinary incontinence characterized by urgency, frequency, and urgency urinary incontinence. The Q-tip test may be used to diagnose overactive bladder, but it is not the sole diagnostic test for this condition.",
    "llama-2-7b-chat-hf_fact": [
      "The Q-tip test is used to diagnose urge incontinence.",
      "If the bladder is unable to hold urine for more than 10-15 seconds during the Q-tip test, it may indicate urge incontinence.",
      "Stress incontinence is characterized by the leakage of urine during activities that put pressure on the bladder, like coughing, sneezing, or lifting.",
      "Urge incontinence is the most common type of urinary incontinence in adults.",
      "Overactive bladder is a type of urinary incontinence characterized by urgency, frequency, and urgency urinary incontinence."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Q-tip test is used to diagnose stress incontinence, not urge incontinence.",
      "false, [corrected fact]: The Q-tip test measures bladder neck mobility, and cannot directly indicate urge incontinence.",
      "true",
      "false, [corrected fact]: Stress incontinence is the most common type of urinary incontiness in adults.",
      "true"
    ]
  },
  {
    "id": 2288,
    "user_query": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication",
    "llama-2-7b-chat-hf_response": ".\nCdc48 is a protein complex that plays a crucial role in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast. The following are the partners of Cdc48 that are important for this process:\n1. Fis1: Fis1 is a protein that interacts with Cdc48 and is required for the disassembly of ubiquitylated CMG helicase. Fis1 helps to recruit Cdc48 to the replication forks and promotes the interaction between Cdc48 and the ubiquitylated CMG helicase.\n2. Sgs1: Sgs1 is a protein that is involved in the deubiquitylation of ubiquitinated proteins, including the ubiquitylated CMG helicase. Sgs1 interacts with Cdc48 and helps to promote the disassembly of the ubiquitylated CMG helicase.\n3. Rad23: Rad23 is a protein that interacts with Cdc48 and is required for the disassembly of ubiquitylated CMG helicase. Rad23 helps to recruit Cdc48 to the replication forks and promotes the interaction between Cdc48 and the ubiquitylated CMG helicase.\n4. Cln1: Cln1 is a protein that interacts with Cdc48 and is required for the disassembly of ubiquitylated CMG helicase. Cln1 helps to recruit Cdc48 to the replication forks and promotes the interaction between Cdc48 and the ubiquitylated CMG helicase.\n5. Dbf2: Dbf2 is a protein that interacts with Cdc48 and is required for the disassembly of ubiquitylated CMG helicase. Dbf2 helps to recruit Cdc48 to the replication forks and promotes the interaction between Cdc48 and the ubiquitylated CMG helicase.\nThese partners of Cdc48 play important roles in the disassembly of ubiquitylated CMG helicase at the end",
    "llama-2-7b-chat-hf_fact": [
      "Cdc48 is a protein complex that plays a role in the disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast.",
      "Fis1 is a protein that interacts with Cdc48 and functions in the disassembly of ubiquitylated CMG helicase.",
      "Sgs1 is a protein involved in the deubiquitylation of ubiquitinated proteins, including the ubiquitylated CMG helicase and interacts with Cdc48.",
      "Rad23 is a protein that interacts with Cdc48 and is used in the disassembly of ubiquitylated CMG helicase.",
      "Cln1 and Dbf2 are proteins that interact with Cdc48 and are required for the disassembly of ubiquitylated CMG helicase."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false, [corrected fact]: Sgs1 is a protein involved in DNA repair and doesn't directly interact with Cdc48.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-7b-chat-hf_response": "Groucho-related genes (GRG) are a subfamily of basic helix-loop-helix (bHLH) transcription factors that play a crucial role in regulating the expression of genes involved in various biological processes, including cell fate determination, patterning, and differentiation. The mouse genome contains several Groucho-related genes, including Groucho (Gro), Groucho-like 1 (Gl1), and Groucho-like 2 (Gl2).\nTo determine the number of Groucho-related genes in the mouse genome, you can use a genome browser or a genomic database such as Ensembl or UCSC Genome Browser. You can search for the Groucho-related gene symbols (Gro, Gl1, and Gl2) in the gene list or use the search function to find all genes that contain the \"Groucho-related\" label.\nAccording to Ensembl, the mouse genome contains three Groucho-related genes:\n* Groucho (Gro)\n* Groucho-like 1 (Gl1)\n* Groucho-like 2 (Gl2)\nSo, there are three Groucho-related genes in the mouse genome.",
    "llama-2-7b-chat-hf_fact": [
      "Groucho-related genes (GRG) are a subfamily of basic helix-loop-helix (bHLH) transcription factors.",
      "Groucho-related genes are essential in regulating the expression of genes involved in several biological processes such as cell fate determination, patterning, and differentiation.",
      "The mouse genome contains several Groucho-related genes including Groucho (Gro), Groucho-like 1 (Gl1), and Groucho-like 2 (Gl2).",
      "Ensembl is a genomic database.",
      "There are three Groucho-related genes in the mouse genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The mouse genome does not contain Groucho (Gro), Groucho-like 1 (Gl1), and Groucho-like 2 (Gl2). These are not classified as Groucho-related genes.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2295,
    "user_query": "Which are the main manifestations of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. The main manifestations of Ohdo syndrome include:\n1. Intellectual disability: Individuals with Ohdo syndrome typically have mild to severe intellectual disability, which can range from mild cognitive impairment to profound intellectual disability.\n2. Spasticity: Ohdo syndrome can cause spasticity, which is characterized by stiffness and rigidity of the muscles. This can lead to difficulty with movement and coordination.\n3. Seizures: Many individuals with Ohdo syndrome experience seizures, which can range from mild to severe.\n4. Vision problems: Ohdo syndrome can cause a range of vision problems, including cataracts, glaucoma, and optic atrophy.\n5. Hearing loss: Some individuals with Ohdo syndrome may experience hearing loss or deafness.\n6. Scoliosis: Ohdo syndrome can cause scoliosis, which is characterized by an abnormal curvature of the spine.\n7. Distinctive facial features: Individuals with Ohdo syndrome may have distinctive facial features, including a small head, narrow eyes, and a short nose.\n8. Delayed speech and language development: Ohdo syndrome can cause delayed speech and language development, which can impact an individual's ability to communicate effectively.\n9. Autism spectrum disorder: Some individuals with Ohdo syndrome may be diagnosed with autism spectrum disorder, which is characterized by difficulties with social interaction and communication.\n10. Sleep disturbances: Ohdo syndrome can cause sleep disturbances, including insomnia and sleep apnea.\nIt is important to note that the severity and frequency of these manifestations can vary widely between individuals with Ohdo syndrome. Early diagnosis and intervention can help manage the symptoms and improve the quality of life for individuals with this rare genetic disorder.",
    "llama-2-7b-chat-hf_fact": [
      "Ohdo syndrome is a rare genetic disorder that affects the development of the brain and spinal cord.",
      "Ohdo syndrome can cause intellectual disability, which ranges from mild cognitive impairment to profound intellectual disability.",
      "Individuals with Ohdo syndrome can experience seizures.",
      "Vision problems including cataracts, glaucoma, and optic atrophy can be caused by Ohdo syndrome.",
      "Ohdo syndrome can lead to distinctive facial features such as a small head, narrow eyes, and a short nose."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Ohdo syndrome is a rare genetic disorder that typically affects facial features, development, and intellect. It doesn't primarily affect the development of the brain and spinal cord.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2296,
    "user_query": "Which algorithm is used by the UCSC Genome Browser?",
    "llama-2-7b-chat-hf_response": "The UCSC Genome Browser is a popular tool for visualizing and analyzing genomic data. It uses a variety of algorithms to display and analyze the data, including:\n1. BLAST (Basic Local Alignment Search Tool): This algorithm is used to compare a query sequence (e.g. a DNA or protein sequence) to a database of known sequences to identify similarities and potential matches.\n2. HMMER: This algorithm is used to identify protein sequences in a query sequence by comparing them to a database of known protein sequences using a hidden Markov model.\n3. Gapped BLAST: This algorithm is used to compare a query sequence to a database of known sequences by identifying the best local alignment between the two sequences, allowing for gaps in the query sequence.\n4. Probabilistic BLAST: This algorithm is used to compare a query sequence to a database of known sequences by calculating the probability of each possible alignment between the two sequences.\n5. Smith-Waterman algorithm: This algorithm is used to compare a query sequence to a database of known sequences by identifying the best local alignment between the two sequences, allowing for gaps in the query sequence.\n6. Needleman-Wunsch algorithm: This algorithm is used to compare a query sequence to a database of known sequences by identifying the best local alignment between the two sequences, allowing for gaps in the query sequence.\nThe UCSC Genome Browser uses a combination of these algorithms to display and analyze genomic data, including:",
    "llama-2-7b-chat-hf_fact": [
      "The UCSC Genome Browser is a tool for visualizing and analyzing genomic data.",
      "One of the algorithms that the UCSC Genome Browser uses is BLAST (Basic Local Alignment Search Tool) - used to compare a query sequence (e.g a DNA or protein sequence) to a database of known sequences.",
      "The UCSC Genome Browser uses the HMMER algorithm to identify protein sequences in a query sequence by comparing them to a database of known protein sequences.",
      "The UCSC Genome Browser employs the Gapped BLAST algorithm, which compares a query sequence to a database of known sequences and allows for gaps in the query sequence.",
      "The Smith-Waterman and Needleman-Wunsch algorithms are used by the UCSC Genome Browser to compare a query sequence to a database of known sequences by identifying the best local alignment between the two sequences, allowing for gaps in the query sequence."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2297,
    "user_query": "Which aminoacid position in the human CREB protein is phosphorylated?",
    "llama-2-7b-chat-hf_response": "The cAMP-response element-binding protein (CREB) is a transcription factor that plays a crucial role in regulating gene expression in response to changes in intracellular cAMP levels. The phosphorylation of CREB at specific amino acid residues can modulate its activity and stability, leading to changes in gene expression. Here are some of the key amino acid positions in the human CREB protein that are phosphorylated:\n1. Serine 133: Phosphorylation of serine 133 by protein kinase A (PKA) can activate CREB and enhance its transcriptional activity.\n2. Serine 155: Phosphorylation of serine 155 by protein kinase C (PKC) can also activate CREB and enhance its transcriptional activity.\n3. Threonine 161: Phosphorylation of threonine 161 by protein kinase A (PKA) can regulate the stability of CREB and affect its transcriptional activity.\n4. Tyrosine 162: Phosphorylation of tyrosine 162 by protein kinase C (PKC) can regulate the localization and activity of CREB.\n5. Serine 295: Phosphorylation of serine 295 by protein kinase A (PKA) can regulate the stability of CREB and affect its transcriptional activity.\nIt is important to note that the phosphorylation of these amino acid residues can also be regulated by other signaling pathways, such as the mitogen-activated protein kinase (MAPK) pathway, and can have downstream effects on gene expression and cellular behavior.",
    "llama-2-7b-chat-hf_fact": [
      "The cAMP-response element-binding protein (CREB) is a transcription factor that regulates gene expression in response to changes in intracellular cAMP levels.",
      "Serine 133 in the human CREB protein can be phosphorylated by protein kinase A.",
      "Serine 155 in the human CREB protein can be phosphorylated by protein kinase C.",
      "Threonine 161 in human CREB can be phosphorylated by protein kinase A.",
      "Phosphorylation of tyrosine 162 in the human CREB protein can be done by protein kinase C.",
      "Serine 295 in the human CREB protein can be phosphorylated by protein kinase A."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Serine 133 in the human CREB protein can be phosphorylated by protein kinase A, not Serine 155.",
      "false, [corrected fact]: Threonine 161 in human CREB can be phosphorylated by Cyclin-dependent kinase 5 (CDK5), not by protein kinase A.",
      "false, [corrected fact]: CREB phosphorylation typically occurs on the Serine 133 residue, rather than tyrosine 162 and it's done by protein kinase A.",
      "unknown"
    ]
  },
  {
    "id": 2298,
    "user_query": "Which gene is the paralog of yeast UPC2?",
    "llama-2-7b-chat-hf_response": "A. UPC1\nB. UPC3\nC. UPC4\nD. UPC5\nAnswer: A. UPC1\nExplanation: UPC2 is a paralog of UPC1 in yeast. Paralogs are genes that have evolved from a common ancestral gene through duplication and subsequent divergence. In yeast, UPC2 is a paralog of UPC1, meaning that they share similar functions and sequences but have distinct evolutionary histories. Therefore, the paralog of yeast UPC2 is UPC1.",
    "llama-2-7b-chat-hf_fact": [
      "UPC2 is a gene in yeast.",
      "UPC2 has a paralog named UPC1 in yeast.",
      "Paralogs are genes that have evolved from a common ancestral gene through duplication and subsequent divergence.",
      "UPC1 and UPC2 share similar functions and sequences but have distinct evolutionary histories."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: UPC2 has a paralog named ECM22 in yeast.",
      "true",
      "true"
    ]
  },
  {
    "id": 2299,
    "user_query": "Where is the enzyme PM20D1 localized?",
    "llama-2-7b-chat-hf_response": "PM20D1 is a protein that is encoded by the PM20D1 gene in humans. The PM20D1 protein is a member of the Pumilio family of RNA-binding proteins, which are involved in the regulation of mRNA translation and degradation.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2301,
    "user_query": "How does increased GDF15 affect body weight?",
    "llama-2-7b-chat-hf_response": "Growth differentiation factor 15 (GDF15) is a protein that has been shown to play a role in regulating body weight. Studies have found that increased levels of GDF15 in the body can lead to weight loss, while decreased levels can lead to weight gain.\nOne study published in the journal Cell found that mice lacking GDF15 had increased body weight compared to mice with normal levels of the protein. The researchers also found that GDF15 deficiency led to a decrease in the number of brown adipose tissue, which is a type of fat that is involved in burning energy to generate heat.\nAnother study published in the journal Nature Communications found that mice treated with a GDF15 inhibitor gained more weight than mice that were not treated with the inhibitor. The researchers also found that GDF15 inhibition led to an increase in the number of brown adipose tissue.\nA study published in the journal Diabetes found that GDF15 levels were lower in obese individuals compared to non-obese individuals. The researchers also found that GDF15 levels were inversely correlated with body mass index (BMI), meaning that higher levels of GDF15 were associated with lower BMIs.\nOverall, these studies suggest that increased levels of GDF15 can lead to weight loss, while decreased levels can lead to weight gain. However, more research is needed to fully understand the relationship between GDF15 and body weight.",
    "llama-2-7b-chat-hf_fact": [
      "Growth differentiation factor 15 (GDF15) is a protein that plays a role in regulating body weight.",
      "Increased levels of GDF15 in the body can lead to weight loss, while decreased levels can lead to weight gain.",
      "A study published in the journal Cell found that mice lacking GDF15 had increased body weight and a decrease in the number of brown adipose tissues.",
      "Mice treated with a GDF15 inhibitor gained more weight, as per a study published in Nature Communications.",
      "A study published in the journal Diabetes found that GDF15 levels were lower in obese individuals and were inversely correlated with body mass index."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II (RNAPII) is the primary enzyme responsible for transcribing DNA into RNA in eukaryotic cells. RNAPII is a complex of several subunits, including the catalytic subunits  and , and the regulatory subunits  and . Of these subunits, only the  subunit carries RNA cleavage activity.\nThe  subunit of RNAPII is responsible for the final step of transcription, in which the RNA transcript is released from the DNA template. This process involves the cleavage of the RNA transcript at a specific site, resulting in the formation of a free RNA end. The  subunit contains a conserved RNA cleavage domain that is responsible for this activity.\nIn summary, the RNA polymerase II subunit that carries RNA cleavage activity is the  subunit.",
    "llama-2-7b-chat-hf_fact": [
      "RNA polymerase II (RNAPII) is responsible for transcribing DNA into RNA in eukaryotic cells.",
      "RNA polymerase II is a complex of several subunits, including the  and  catalytic subunits, and the  and  regulatory subunits.",
      "The  subunit of RNA polymerase II carries RNA cleavage activity.",
      "The  subunit is responsible for the final step of transcription, releasing the RNA transcript from the DNA template.",
      "The  subunit contains a conserved RNA cleavage domain that is responsible for RNA cleavage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: RNA polymerase II is a complex of several subunits, but it does not include , , , or  subunits.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2306,
    "user_query": "How many PML isoforms exist in the human genome?",
    "llama-2-7b-chat-hf_response": "There are 4 PML isoforms in the human genome: PML1, PML2, PML3, and PML4. Each isoform has a distinct tissue distribution and function, and they are involved in various cellular processes, including apoptosis, cell cycle regulation, and immune response. The PML isoforms are generated through alternative splicing of the PML gene, which is located on chromosome 6q21.",
    "llama-2-7b-chat-hf_fact": [
      "There are 4 PML isoforms in the human genome: PML1, PML2, PML3, and PML4.",
      "Each PML isoform has a distinct tissue distribution and function.",
      "PML isoforms are involved in various cellular processes, including apoptosis, cell cycle regulation, and immune response.",
      "The PML isoforms are generated through alternative splicing of the PML gene.",
      "The PML gene is located on chromosome 6q21."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The PML gene is located on chromosome 15q24."
    ]
  },
  {
    "id": 2312,
    "user_query": "Which tendons are affected in the Dequervain's tenosynovitis?",
    "llama-2-7b-chat-hf_response": "Dequervain's tenosynovitis is a condition that affects the tendons in the wrist that control flexion and extension of the thumb. The tendons affected in Dequervain's tenosynovitis are:\n1. Abductor pollicis longus tendon\n2. Extensor pollicis brevis tendon\n3. Extensor pollicis longus tendon\nThese tendons become inflamed and irritated, leading to pain and stiffness in the wrist and thumb. Dequervain's tenosynovitis can be caused by repetitive motion, injury, or pregnancy. Treatment options include rest, physical therapy, and medication. In severe cases, surgery may be necessary.",
    "llama-2-7b-chat-hf_fact": [
      "Dequervain's tenosynovitis is a condition that affects the tendons in the wrist controlling thumb's flexion and extension.",
      "In Dequervain's tenosynovitis, the abductor pollicis longus tendon is affected.",
      "Extensor pollicis brevis tendon is also affected in Dequervain's tenosynovitis.",
      "Extensor pollicis longus tendon is one of the tendons affected in the condition.",
      "Treatment for Dequervain's tenosynovitis can include rest, physical therapy, medication, and in severe cases, surgery."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Extensor pollicis longus tendon is not one of the tendons affected in Dequervain's tenosynovitis.",
      "true"
    ]
  },
  {
    "id": 2314,
    "user_query": "What does davunetide do to microtubules?",
    "llama-2-7b-chat-hf_response": "Davunetide is a small molecule that selectively binds to and stabilizes microtubules, which are essential components of the cytoskeleton in eukaryotic cells. Microtubules play a crucial role in maintaining cell shape, organizing organelles, and regulating intracellular transport. Davunetide has been shown to have a number of effects on microtubules, including:\n1. Stabilization of microtubules: Davunetide binds to microtubules and prevents their depolymerization, leading to increased microtubule stability.\n2. Inhibition of microtubule dynamics: Davunetide can inhibit the dynamic instability of microtubules, which is the normal process by which microtubules are continuously assembled and disassembled.\n3. Increased microtubule length: Davunetide has been shown to increase the length of microtubules in some studies.\n4. Inhibition of microtubule-associated proteins: Davunetide can bind to and inhibit the activity of proteins that are involved in microtubule dynamics, such as kinesin and dynein.\n5. Anti-cancer effects: Davunetide has been shown to have anti-cancer effects in some studies, which may be related to its ability to stabilize microtubules and inhibit the dynamics of microtubule-associated proteins.\nIt is important to note that the effects of davunetide on microtubules can vary depending on the specific context in which it is used, and more research is needed to fully understand its mechanisms of action.",
    "llama-2-7b-chat-hf_fact": [
      "Davunetide is a molecule that binds to and stabilizes microtubules.",
      "Microtubules are essential components of the cytoskeleton in eukaryotic cells.",
      "Microtubules play a role in maintaining cell shape, organizing organelles, and regulating intracellular transport.",
      "Davunetide has the ability to inhibit the activity of proteins involved in microtubule dynamics, such as kinesin and dynein.",
      "Some studies have indicated that Davunetide has anti-cancer effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2317,
    "user_query": "Which proteins are controlling sterol metabolism in S. cerevisiae?",
    "llama-2-7b-chat-hf_response": "Sterols are a class of compounds that are important for cell membrane structure and function. In Saccharomyces cerevisiae (baker's yeast), sterols are synthesized in the endoplasmic reticulum (ER) and are involved in various cellular processes, including membrane trafficking and signaling. The regulation of sterol metabolism in S. cerevisiae is complex and involves multiple proteins and pathways. Here are some of the key proteins involved in controlling sterol metabolism in S. cerevisiae:\n1. Sterol regulatory element-binding proteins (SREBPs): SREBPs are transcription factors that regulate the expression of genes involved in sterol biosynthesis and metabolism. In S. cerevisiae, there are two SREBPs: SREBP1 and SREBP2. These proteins bind to specific DNA sequences called sterol regulatory elements (SREs) and regulate the expression of genes involved in cholesterol and ergosterol biosynthesis.\n2. HMG-CoA reductase: HMG-CoA reductase is an enzyme that catalyzes the conversion of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonate, a key intermediate in the cholesterol biosynthesis pathway. In S. cerevisiae, HMG-CoA reductase is regulated by SREBPs and is involved in the control of cholesterol biosynthesis.\n3. Mevalonate kinase: Mevalonate kinase is an enzyme that phosphorylates mevalonate to form mevalonate-5-phosphate, another key intermediate in the cholesterol biosynthesis pathway. In S. cerevisiae, mevalonate kinase is regulated by SREBPs and is involved in the control of cholesterol biosynthesis.\n4. Ergosterol 14-demethylase: Ergosterol 14-demethylase is an enzyme that demethyl",
    "llama-2-7b-chat-hf_fact": [
      "Sterols are important for cell membrane structure and function in Saccharomyces cerevisiae (baker's yeast).",
      "Sterols in Saccharomyces cerevisiae are synthesized in the endoplasmic reticulum (ER) and are involved in various cellular processes, including membrane trafficking and signaling.",
      "Saccharomyces cerevisiae has two Sterol regulatory element-binding proteins (SREBPs): SREBP1 and SREBP2.",
      "In Saccharomyces cerevisiae, HMG-CoA reductase and Mevalonate kinase are enzymes involved in cholesterol biosynthesis pathway and are regulated by SREBPs.",
      "In Saccharomyces cerevisiae, Ergosterol 14-demethylase is an enzyme that is included in sterol metabolism."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Saccharomyces cerevisiae does not have Sterol regulatory element-binding proteins (SREBPs), these are present in mammalian cells.",
      "false, [corrected fact]: In Saccharomyces cerevisiae, HMG-CoA reductase and mevalonate kinase are enzymes involved in ergosterol, not cholesterol, biosynthesis pathway and it is regulated not by SREBPs, which are characteristic to mammalian cells, but by other mechanisms.",
      "true"
    ]
  },
  {
    "id": 2318,
    "user_query": "Which enzymes are responsible for base J creation in Trypanosoma brucei?",
    "llama-2-7b-chat-hf_response": "Base J is a modified purine nucleotide that is present in the DNA of Trypanosoma brucei, a parasitic protozoan that causes African trypanosomiasis or sleeping sickness. The formation of base J is a complex process that involves several enzymes, including:\n1. Adenosine monophosphate-activated protein kinase (AMPK): AMPK is an energy sensor that plays a key role in regulating cellular metabolism and energy homeostasis. In T. brucei, AMPK has been shown to phosphorylate and activate the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which is responsible for the conversion of hypoxanthine to inosine.\n2. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT): HGPRT is an enzyme that catalyzes the conversion of hypoxanthine to inosine. In T. brucei, HGPRT is activated by AMPK and is responsible for the conversion of hypoxanthine to inosine, which is then converted to base J by the enzyme inosine monophosphate-acetyltransferase (IMPAT).\n3. Inosine monophosphate-acetyltransferase (IMPAT): IMPAT is an enzyme that catalyzes the conversion of inosine to base J. In T. brucei, IMPAT is responsible for the final step of base J synthesis, converting inosine to base J.\n4. Purine nucleoside phosphorylase (PNP): PNP is an enzyme that catalyzes the hydrolysis of the phosphate group from purine nucleotides, such as inosine monophosphate (IMP), to form inosine and pyrophosphate. In T. brucei, PNP has been shown to play a role in the degradation of base J.\n5. Purine nucleotide phosphorylase (PNP): PNP is an enzyme that catalyzes the hydrolysis of the phosphate group from purine nucle",
    "llama-2-7b-chat-hf_fact": [
      "Base J is a modified purine nucleotide present in the DNA of Trypanosoma brucei, which is responsible for African trypanosomiasis or sleeping sickness.",
      "The formation of base J in Trypanosoma brucei involves several enzymes including Adenosine monophosphate-activated protein kinase (AMPK), Hypoxanthine-guanine phosphoribosyltransferase (HGPRT), and Inosine monophosphate-acetyltransferase (IMPAT).",
      "Adenosine monophosphate-activated protein kinase (AMPK) activates the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which is responsible for the conversion of hypoxanthine to inosine.",
      "Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) catalyzes the conversion of hypoxanthine to inosine, which is then converted to base J by the enzyme inosine monophosphate-acetyltransferase (IMPAT).",
      "Inosine monophosphate-acetyltransferase (IMPAT) is responsible for the final step of base J synthesis, converting inosine to base J in Trypanosoma brucei."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The formation of base J in Trypanosoma brucei involves the enzyme J-binding protein 1 (JBP1) and J-binding protein 2 (JBP2).",
      "false, [corrected fact]: Adenosine monophosphate-activated protein kinase (AMPK) is not directly involved in activating hypoxanthine-guanine phosphoribosyltransferase (HGPRT). AMPK is generally involved in cellular energy homeostasis.",
      "false, [corrected fact]: Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) catalyzes the conversion of guanine to guanosine monophosphate and hypoxanthine to inosine monophosphate but not to base J.",
      "false, [corrected fact]: Inosine monophosphate-acetyltransferase (IMPAT) is not responsible for the synthesis of base J. That role is occupied by J-binding proteins in Trypanosoma brucei."
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. It is caused by mutations in the TCF4 gene, which is involved in the regulation of gene expression during embryonic development. The TCF4 gene provides instructions for making a protein called transcription factor 4, which plays a critical role in the development and maintenance of the nervous system. Without functional TCF4 protein, the brain and spinal cord do not develop properly, leading to the characteristic features of Ohdo syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Ohdo syndrome is a genetic disorder that impacts the development of the brain and spinal cord.",
      "Ohdo syndrome is caused by mutations in the TCF4 gene.",
      "The TCF4 gene is involved in the regulation of gene expression during embryonic development.",
      "The TCF4 gene provides instructions for making a protein called transcription factor 4.",
      "Transcription factor 4 plays a crucial role in the development and maintenance of the nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Ohdo syndrome is a genetic disorder that predominantly features developmental delay, intellectual disability, and distinctive facial features. It doesn't necessarily impact the development of the brain and spinal cord.",
      "false, [corrected fact]: Ohdo syndrome is not caused by mutations in the TCF4 gene. This syndrome is usually caused by mutations in the MED12, KAT6B, or SMC1A genes.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2326,
    "user_query": "How may CTCF mediate splicing?",
    "llama-2-7b-chat-hf_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in regulating gene expression by controlling the splicing of pre-mRNAs. CTCF binds to specific sequences in the introns and exons of genes and regulates the splicing of these genes by modulating the activity of the spliceosome. CTCF can act as a splicing enhancer or silencer, depending on the context in which it is expressed.\nThere are several ways in which CTCF may mediate splicing:\n1. CTCF can act as a splicing enhancer by binding to the intron of a gene and recruiting the spliceosome to the site of splicing. This can increase the efficiency of splicing and lead to the production of more mature mRNAs.\n2. CTCF can also act as a splicing silencer by binding to the intron of a gene and blocking the spliceosome from accessing the site of splicing. This can reduce the efficiency of splicing and lead to the production of less mature mRNAs.\n3. CTCF can also regulate the splicing of alternative exons by binding to the intron-exon boundaries and modulating the splicing of these exons.\n4. CTCF can also regulate the splicing of cryptic exons by binding to the intron-exon boundaries and modulating the splicing of these exons.\n5. CTCF can also regulate the splicing of exons in a tissue-specific manner by binding to the intron-exon boundaries and modulating the splicing of these exons in a tissue-specific manner.\n6. CTCF can also regulate the splicing of exons in a developmental stage-specific manner by binding to the intron-exon boundaries and modulating the splicing of these exons in a developmental stage-specific manner.\n7. CTCF can also regulate the splicing of exons in a cell type-specific manner by binding to the intron-exon boundaries and modulating the splicing of these exons in a cell type-specific manner.\n8. CTCF can also regulate the splicing of exons in a gene-specific manner by",
    "llama-2-7b-chat-hf_fact": [
      "CTCF (CCCTC-binding factor) is a transcription factor that controls the splicing of pre-mRNAs.",
      "CTCF binds to certain sequences in the introns and exons of genes, affecting the spliceosome activity in these regions.",
      "Depending on its context, CTCF can function as a splicing enhancer or silencer.",
      "CTCF may enhance splicing by attracting the spliceosome to the splicing site, potentially leading to the creation of more mature mRNAs.",
      "CTCF can also suppress splicing by blocking the spliceosome's access to the splicing site, potentially leading to fewer mature mRNA molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: CTCF (CCCTC-binding factor) is a DNA-binding protein that plays crucial roles in gene expression, not by controlling the splicing of pre-mRNAs.",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2329,
    "user_query": "What is the function of the TFIIS transcriptional factor (Dst1) in yeast?",
    "llama-2-7b-chat-hf_response": "The TFIIS transcriptional factor (Dst1 in yeast) plays a crucial role in the regulation of gene expression in Saccharomyces cerevisiae (yeast). Dst1 is a member of the TFIIS family of transcription factors, which are involved in the initiation of transcription in eukaryotic cells.\nIn yeast, Dst1 is required for the expression of genes involved in various cellular processes, including cell wall biosynthesis, stress response, and DNA repair. Dst1 binds to specific DNA sequences upstream of these genes and recruits RNA polymerase, the enzyme responsible for transcribing DNA into RNA, to initiate transcription.\nDst1 also plays a role in the regulation of gene expression by modulating the activity of other transcription factors. For example, Dst1 can bind to and inhibit the activity of the transcription factor Yap1, which is involved in the regulation of stress response genes. This suggests that Dst1 may play a role in fine-tuning the expression of specific genes in response to changing environmental conditions.\nOverall, the function of Dst1 in yeast is to regulate the expression of specific genes involved in various cellular processes, and to modulate the activity of other transcription factors to fine-tune gene expression in response to changing environmental conditions.",
    "llama-2-7b-chat-hf_fact": [
      "TFIIS transcriptional factor (Dst1 in yeast) regulates gene expression in Saccharomyces cerevisiae, a type of yeast.",
      "Dst1, a member of the TFIIS family of transcription factors, participates in initiating transcription of genes in eukaryotic cells.",
      "Within yeast, Dst1 contributes to the gene expression involved in cellular processes such as cell wall biosynthesis, stress response and DNA repair.",
      "Dst1 connects to specific DNA sequences upstream of these genes and draws in RNA polymerase to initiate transcription.",
      "Dst1 can bind to and inhibit the activity of transcription factor Yap1, affecting the regulation of stress response genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Dst1 does not bind directly to DNA sequences. Rather, it acts on RNA polymerase during transcription elongation, assisting in the resolution of transcriptional problems.",
      "unknown"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-7b-chat-hf_response": "The R/Bioconductor package \"PsychGen\" has been developed for the analysis of psychiatric disease genes. This package provides a comprehensive set of tools for the analysis of genetic data in psychiatric disorders, including genome-wide association studies (GWAS), whole-exome sequencing (WES), and whole-genome sequencing (WGS) data.\nSome of the key features of the PsychGen package include:\n1. Imputation: PsychGen provides a range of imputation methods for inferring missing genotypes in GWAS and WES data, including reference-free and reference-based methods.\n2. Association analysis: PsychGen offers a variety of methods for detecting genetic associations with psychiatric disorders, including linear regression, logistic regression, and machine learning algorithms.\n3. Gene-set analysis: PsychGen provides tools for testing gene sets for association with psychiatric disorders, including gene-set enrichment analysis and pathway analysis.\n4. Functional annotation: PsychGen includes tools for functional annotation of genes and gene variants, including information on gene expression, protein-protein interactions, and gene regulation.\n5. Data visualization: PsychGen offers a range of data visualization tools for exploring genetic data and identifying patterns of association with psychiatric disorders.\nOverall, the PsychGen package is a valuable resource for researchers working in the field of psychiatric genetics, providing a comprehensive set of tools for the analysis of genetic data in psychiatric disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The R/Bioconductor package \"PsychGen\" has been developed for the analysis of psychiatric disease genes.",
      "PsychGen package assists in the analysis of genetic data in psychiatric disorders, which includes genome-wide association studies (GWAS), whole-exome sequencing (WES), and whole-genome sequencing (WGS) data.",
      "PsychGen provides a range of imputation methods for inferring missing genotypes in GWAS and WES data.",
      "The PsychGen package offers a variety of detecting genetic association methods with psychiatric disorders, like linear regression, logistic regression, and machine learning algorithms.",
      "PsychGen provides tools for testing gene sets for association with psychiatric disorders, and offers a range of data visualization tools for exploring genetic data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2335,
    "user_query": "What is the function of the gene MDA5?",
    "llama-2-7b-chat-hf_response": "The gene MDA5 (Mitochondrial DNA-associated protein 5) is a protein that plays a crucial role in the innate immune response to viral infections. MDA5 is a pattern recognition receptor (PRR) that recognizes and responds to the presence of viral RNA in infected cells. When MDA5 detects viral RNA, it activates a signaling pathway that leads to the production of interferons (IFNs), which are antiviral proteins that help to limit the spread of viruses within infected cells. MDA5 also plays a role in the regulation of the immune response by modulating the expression of other genes involved in the immune response.",
    "llama-2-7b-chat-hf_fact": [
      "The gene MDA5 (Mitochondrial DNA-associated protein 5) plays a crucial role in the innate immune response to viral infections.",
      "MDA5 operates as a pattern recognition receptor (PRR) that recognizes and responds to the presence of viral RNA in infected cells.",
      "When MDA5 detects viral RNA, it activates a signaling pathway leading to the production of interferons.",
      "Interferons are antiviral proteins that help to limit the spread of viruses within infected cells.",
      "The MDA5 protein also is involved in regulating the immune response by modulating the expression of other genes involved in the immune response."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2336,
    "user_query": "Which is the conserved motif of DEAD box proteins?",
    "llama-2-7b-chat-hf_response": "A. A conserved arginine residue\nB. A conserved glutamine residue\nC. A conserved asparagine residue\nD. A conserved glycine residue\nAnswer: B. A conserved glutamine residue\nExplanation:\nDEAD box proteins are a family of RNA-binding proteins that are involved in a variety of cellular processes, including transcription, splicing, and translation. These proteins are characterized by the presence of a conserved motif, known as the DEAD box motif, which consists of a conserved glutamine residue followed by a conserved asparagine residue. The DEAD box motif is found in the N-terminal region of DEAD box proteins and is essential for their RNA-binding activity.\nOption A is incorrect because there is no conserved arginine residue in the DEAD box motif.\nOption C is incorrect because asparagine is not a conserved residue in the DEAD box motif.\nOption D is incorrect because glycine is not a conserved residue in the DEAD box motif.",
    "llama-2-7b-chat-hf_fact": [
      "DEAD box proteins are a family of RNA-binding proteins.",
      "DEAD box proteins are involved in cellular processes including transcription, splicing, and translation.",
      "DEAD box proteins have a conserved motif known as the DEAD box motif.",
      "This motif consists of a conserved glutamine residue followed by a conserved asparagine residue.",
      "The DEAD box motif is found in the N-terminal region of DEAD box proteins and is essential for their RNA-binding activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The DEAD box motif consists of conserved Asp-Glu-Ala-Asp (DEAD) sequence motif.",
      "true"
    ]
  },
  {
    "id": 2338,
    "user_query": "Describe GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types)",
    "llama-2-7b-chat-hf_response": "GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) is a bioinformatics toolkit designed to predict the cell types and biological pathways associated with complex diseases using genome-wide association study (GWAS) data. GARLIC is an acronym for \"GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types.\"\nGARLIC was developed by a team of researchers at the University of California, San Diego, and is available for use by researchers worldwide. The toolkit uses a combination of machine learning algorithms and statistical models to analyze GWAS data and identify patterns of genetic variation associated with specific cell types and biological pathways.\nGARLIC can be used to analyze data from a wide range of complex diseases, including common conditions such as heart disease, diabetes, and mental health disorders, as well as rare genetic diseases. The toolkit can also be used to identify potential drug targets and biomarkers for disease diagnosis and treatment.\nSome of the key features of GARLIC include:\n1. Genome-wide association study (GWAS) data analysis: GARLIC can analyze GWAS data to identify genetic variants associated with specific cell types and biological pathways.\n2. Cell type prediction: GARLIC can predict the cell types associated with specific genetic variants using a combination of machine learning algorithms and statistical models.\n3. Biological pathway analysis: GARLIC can identify the biological pathways and networks associated with specific genetic variants and cell types.\n4. Drug target identification: GARLIC can identify potential drug targets for specific cell types and biological pathways.\n5. Biomarker identification: GARLIC can identify potential biomarkers for disease diagnosis and treatment.\nOverall, GARLIC is a powerful tool for understanding the genetic basis of complex diseases and identifying potential targets for disease diagnosis and treatment. Its ability to integrate GWAS data with cell type and biological pathway information makes it a valuable resource for researchers in the field of genomics and personalized medicine.",
    "llama-2-7b-chat-hf_fact": [
      "GARLIC is a bioinformatics toolkit designed to predict the cell types and biological pathways associated with complex diseases using genome-wide association study (GWAS) data.",
      "GARLIC was developed by a team of researchers at the University of California, San Diego.",
      "GARLIC uses machine learning algorithms and statistical models to analyze GWAS data and identify patterns of genetic variation.",
      "The toolkit can be used to analyze data from a wide range of complex diseases.",
      "GARLIC can identify potential drug targets and biomarkers for disease diagnosis and treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2345,
    "user_query": "What is the function of yeast TERRA RNAs?",
    "llama-2-7b-chat-hf_response": "Yeast TERRA RNAs (Transcriptional and Epigenetic Regulatory Associated RNAs) are non-coding RNAs that play a crucial role in regulating gene expression in yeast. They are involved in various cellular processes, including:\n1. Transcriptional regulation: TERRA RNAs can bind to DNA and regulate the activity of transcription factors, leading to changes in gene expression.\n2. Chromatin remodeling: TERRA RNAs can recruit chromatin-modifying complexes and alter the structure of chromatin, leading to changes in gene expression.\n3. RNA processing: TERRA RNAs can influence the splicing, transport, and stability of other RNAs, leading to changes in gene expression.\n4. Stress response: TERRA RNAs can respond to stress signals and regulate the expression of genes involved in stress response pathways.\n5. Cell cycle regulation: TERRA RNAs can regulate the expression of genes involved in the cell cycle, leading to changes in cell proliferation and division.\n6. Aging: TERRA RNAs have been implicated in the aging process, with changes in their levels and function contributing to the decline in cellular function that occurs with age.\n7. Neurodegeneration: TERRA RNAs have been implicated in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n8. Cancer: TERRA RNAs have been implicated in the development and progression of cancer, with changes in their levels and function contributing to tumorigenesis.\nIn summary, yeast TERRA RNAs play a multifaceted role in regulating gene expression and various cellular processes, and their dysregulation has been implicated in a wide range of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Yeast TERRA RNAs are non-coding RNAs that regulate gene expression in yeast.",
      "TERRA RNAs can bind to DNA and regulate the activity of transcription factors.",
      "TERRA RNAs can recruit chromatin-modifying complexes and alter the structure of chromatin.",
      "TERRA RNAs have been implicated in the aging process, contributing to the decline in cellular function.",
      "TERRA RNAs are considered to play a role in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2347,
    "user_query": "Do bacteria from the genus Morexella cause respiratory infections?",
    "llama-2-7b-chat-hf_response": "Morexella is a genus of bacteria that includes several species, some of which have been associated with respiratory infections in humans and animals. However, the exact role of Morexella in respiratory infections is not yet fully understood and requires further research.\nSome studies have suggested that Morexella species can cause respiratory infections, such as pneumonia, bronchitis, and sinusitis, particularly in immunocompromised individuals. For example, Morexella anthracis, a species of Morexella that was previously known as Corynebacterium anthracis, has been isolated from the lungs of patients with pneumonia. Similarly, Morexella haemolytica has been isolated from the respiratory tract of patients with bronchitis and sinusitis.\nHowever, other studies have found no association between Morexella infections and respiratory symptoms. For example, a study published in the Journal of Clinical Microbiology found no evidence of Morexella infections in a group of patients with community-acquired pneumonia.\nOverall, while there is some evidence to suggest that Morexella species can cause respiratory infections, more research is needed to fully understand the role of these bacteria in respiratory illnesses. It is important to note that respiratory infections can have many different causes, including viruses, bacteria, and fungi, and a thorough diagnosis is necessary to determine the underlying cause of an infection.",
    "llama-2-7b-chat-hf_fact": [
      "Morexella is a genus of bacteria that includes several species.",
      "Some species of Morexella have been associated with respiratory infections in humans and animals.",
      "Morexella anthracis, a species of Morexella that was previously known as Corynebacterium anthracis, has been isolated from the lungs of patients with pneumonia.",
      "Morexella haemolytica has been isolated from the respiratory tract of patients with bronchitis and sinusitis.",
      "Respiratory infections can be caused by multiple factors including viruses, bacteria, and fungi."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Moraxella is a genus of bacteria that includes several species.",
      "true",
      "false, [corrected fact]: Moraxella catarrhalis, not Moraxella anthracis, is a species of Moraxella and it has been isolated from the lungs of patients with pneumonia.",
      "false, [corrected fact]: Moraxella catarrhalis, not Moraxella haemolytica, has been isolated from the respiratory tract of patients with bronchitis and sinusitis.",
      "true"
    ]
  },
  {
    "id": 2349,
    "user_query": "Do chromatin features predict genes associated with eQTLs?",
    "llama-2-7b-chat-hf_response": "Yes, chromatin features can predict genes associated with expression Quantitative Trait Loci (eQTLs). Chromatin features, such as histone modifications and DNA methylation, play a crucial role in regulating gene expression by affecting the accessibility of genetic information to the transcriptional machinery. Studies have shown that genes associated with eQTLs often have specific chromatin features that distinguish them from other genes. For example, genes associated with eQTLs tend to have higher levels of histone H3 lysine 4 trimethylation (H3K4me3) and lower levels of histone H3 lysine 27 trimethylation (H3K27me3) compared to non-eQTL genes. These chromatin features can be used to identify genes that are likely to be associated with eQTLs.",
    "llama-2-7b-chat-hf_fact": [
      "Chromatin features can predict genes associated with expression Quantitative Trait Loci (eQTLs).",
      "Histone modifications and DNA methylation are types of chromatin features.",
      "Chromatin features have a role in regulating gene expression.",
      "Genes associated with eQTLs often have specific chromatin features.",
      "Genes associated with eQTLs tend to have higher levels of histone H3 lysine 4 trimethylation and lower levels of histone H3 lysine 27 trimethylation compared to non-eQTL genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2350,
    "user_query": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta",
    "llama-2-7b-chat-hf_response": "(OI).\nOsteogenesis imperfecta (OI) is a genetic disorder that affects the development of bones. There are two forms of OI: autosomal dominant and autosomal recessive. The autosomal recessive form of OI is caused by mutations in six genes:\n1. COL1A1: Encodes the protein collagen type I alpha 1 chain, which is essential for the structure and integrity of bone tissue.\n2. COL1A2: Encodes the protein collagen type I alpha 2 chain, which is also essential for the structure and integrity of bone tissue.\n3. COMP: Encodes the protein cartilage oligomer matrix protein, which is involved in the formation and maintenance of bone tissue.\n4. BMP2: Encodes the protein bone morphogenetic protein 2, which is involved in the development and maintenance of bone tissue.\n5. BMP15: Encodes the protein bone morphogenetic protein 15, which is involved in the development and maintenance of bone tissue.\n6. P3NP: Encodes the protein periostin, which is involved in the development and maintenance of bone tissue.\nEach of these genes plays a critical role in the development and maintenance of bone tissue, and mutations in any of these genes can lead to the characteristic bone fragility and other symptoms of OI.",
    "llama-2-7b-chat-hf_fact": [
      "Osteogenesis imperfecta (OI) is a genetic disorder that affects the development of bones.",
      "There are two forms of OI: autosomal dominant and autosomal recessive.",
      "The COL1A1 gene encodes the protein collagen type I alpha 1 chain, which is essential for the structure and integrity of bone tissue.",
      "The COMP gene encodes the protein cartilage oligomer matrix protein, which is involved in the formation and maintenance of bone tissue.",
      "The P3NP gene encodes the protein periostin, which is involved in the development and maintenance of bone tissue."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The P3NP gene does not exist. It is the POSTN gene that encodes the protein periostin, which is involved in the development and maintenance of bone tissue."
    ]
  },
  {
    "id": 2354,
    "user_query": "What is the mode of action of teriparatide?",
    "llama-2-7b-chat-hf_response": "Teriparatide is a parathyroid hormone (PTH) analogue that is used to treat osteoporosis in postmenopausal women and men and women with primary osteoporosis. The mode of action of teriparatide is to stimulate bone formation and inhibit bone resorption, thereby increasing bone density and reducing the risk of fractures. Teriparatide works by binding to the PTH receptor in bone cells, which leads to an increase in the expression of genes involved in bone formation and a decrease in the expression of genes involved in bone resorption. This results in an increase in bone mineral density (BMD) and a reduction in the risk of fractures.",
    "llama-2-7b-chat-hf_fact": [
      "Teriparatide is a parathyroid hormone analogue used to treat osteoporosis.",
      "The drug is effective in both men and women, as well as postmenopausal women.",
      "Teriparatide's mode of action involves stimulating bone formation and inhibiting bone resorption.",
      "Teriparatide works by binding to the parathyroid hormone receptor in bone cells.",
      "This drug can increase bone mineral density and reduce the risk of fractures."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2355,
    "user_query": "What is the Strelka workflow?",
    "llama-2-7b-chat-hf_response": "Strelka is a workflow management system designed for researchers, scientists, and engineers. It is an open-source tool that helps users manage and organize their research workflows, collaborate with colleagues, and track the progress of their projects. Here is an overview of the Strelka workflow:\n1. Create a project: Users can create a new project in Strelka by providing basic information such as the project title, description, and tags.\n2. Define the workflow: Users can define the workflow for their project by breaking it down into individual tasks and subtasks. These tasks can be organized into different stages, such as planning, execution, and analysis.\n3. Add tasks and subtasks: Users can add tasks and subtasks to their workflow by clicking on the \"Add task\" button and selecting the appropriate type of task (e.g., data collection, data analysis, writing). They can also add subtasks to each task by clicking on the \"Add subtask\" button.\n4. Assign tasks to team members: Users can assign tasks to their team members by selecting their names from a dropdown list. They can also assign tasks to themselves.\n5. Track progress: Users can track the progress of their tasks and subtasks by marking them as \"in progress,\" \"completed,\" or \"delayed.\" They can also add comments and attachments to each task to provide additional context.\n6. Collaborate: Users can collaborate with their team members in real-time by commenting on tasks and subtasks, sharing files, and tracking changes to the workflow.\n7. Analyze and visualize: Users can analyze and visualize their workflow data using Strelka's built-in reporting and visualization tools. They can generate reports on task completion rates, team productivity, and other key metrics.\n8. Integrate with other tools: Strelka can integrate with other tools and platforms, such as Git, JIRA, and Google Drive, to provide a seamless workflow experience.\nBy following these steps, researchers and scientists can use Strelka to manage their workflows, collaborate with their teams, and track the progress of their projects.",
    "llama-2-7b-chat-hf_fact": [
      "Strelka is a workflow management system created for researchers, scientists, and engineers.",
      "The Strelka workflow involves creating projects, defining the workflow with tasks and subtasks, assigning tasks, tracking progress, collaborating in real-time, analyzing data with visualization tools, and integrating with other platforms.",
      "A user can add tasks and subtasks using \"Add task\" and \"Add subtask\" buttons in Strelka.",
      "Strelka provides features for users to collaborate with their teams in real-time.",
      "Strelka can integrate with other tools and platforms such as Git, JIRA, and Google Drive."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2359,
    "user_query": "Describe mechanism of action of Ozanimod.",
    "llama-2-7b-chat-hf_response": "Ozanimod is a sphingosine 1-phosphate (S1P) receptor modulator that is used to treat multiple sclerosis (MS). It works by inhibiting the activity of T cells, which are a type of immune cell that plays a central role in the autoimmune response that underlies MS. Specifically, ozanimod binds to the S1P receptor 1 (S1P1), which is expressed on the surface of T cells. This binding inhibits the ability of T cells to migrate to the central nervous system (CNS), where they can cause damage to the myelin sheath that surrounds nerve fibers. By reducing the infiltration of T cells into the CNS, ozanimod slows the progression of MS and reduces the frequency and severity of relapses.\nIn addition to its effect on T cells, ozanimod also has anti-inflammatory effects by reducing the production of pro-inflammatory cytokines by immune cells. Cytokines are signaling molecules that help to coordinate the immune response, but in the context of MS, they can contribute to the inflammation and damage that characterizes the disease. By reducing the production of pro-inflammatory cytokines, ozanimod helps to reduce the overall inflammatory response in the CNS, which can help to slow the progression of MS.\nOverall, the mechanism of action of ozanimod is complex and involves multiple pathways and cell types. By inhibiting the activity of T cells and reducing the production of pro-inflammatory cytokines, ozanimod helps to reduce the inflammation and damage that characterizes MS, and slow the progression of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "Ozanimod is a sphingosine 1-phosphate (S1P) receptor modulator used to treat multiple sclerosis (MS).",
      "Ozanimod inhibits the activity of T cells, a type of immune cell that contributes to the autoimmune response in MS.",
      "Ozanimod binds to the S1P receptor 1 on the surface of T cells, which inhibits their migration to the central nervous system.",
      "By reducing T cell infiltration in the CNS, Ozanimod slows the progression of MS and reduces the severity of relapses.",
      "Ozanimod can reduce the production of pro-inflammatory cytokines, helping to reduce overall inflammation in the central nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-7b-chat-hf_response": "Intracerebral hemorrhage (ICH) is a type of stroke that occurs when a blood vessel within the brain ruptures, leading to bleeding in the brain tissue. Swirl sign is a specific radiological sign that can be observed on computed tomography (CT) or magnetic resonance imaging (MRI) scans of the brain in patients with ICH.\nThe swirl sign is characterized by a spiral or swirling pattern of blood within the brain tissue, typically in the area surrounding the site of hemorrhage. This sign is thought to represent the movement of blood within the brain due to the elevated intracranial pressure caused by the hemorrhage.\nThe swirl sign can be observed in various locations within the brain, including the cerebral cortex, basal ganglia, thalamus, and cerebellum. It is more commonly seen in the frontal and temporal lobes, where the blood vessels are more prone to rupture.\nThe presence of the swirl sign on CT or MRI scans can provide important information for clinicians in the following ways:\n1. Severity of hemorrhage: The swirl sign can indicate the severity of the hemorrhage, as it is more commonly seen in larger hemorrhages.\n2. Location of hemorrhage: The swirl sign can help identify the location of the hemorrhage within the brain, which is important for guiding treatment decisions.\n3. Cerebral edema: The swirl sign can indicate the presence of cerebral edema, which is a common complication of ICH.\n4. Outcome prediction: The presence of the swirl sign has been associated with poorer outcomes in patients with ICH, including increased risk of death and disability.\nIn conclusion, the swirl sign is a specific radiological sign that can be observed on CT or MRI scans of the brain in patients with intracerebral hemorrhage. It is associated with the movement of blood within the brain due to elevated intracranial pressure and can provide important information for clinicians in assessing the severity, location, and outcome of the hemorrhage.",
    "llama-2-7b-chat-hf_fact": [
      "Intracerebral hemorrhage (ICH) is a type of stroke that occurs when a blood vessel within the brain ruptures, leading to bleeding in the brain tissue.",
      "The swirl sign is a specific radiological sign that can be observed on computed tomography (CT) or magnetic resonance imaging (MRI) scans of the brain in patients with ICH.",
      "Swirl sign is thought to represent the movement of blood within the brain due to the elevated intracranial pressure caused by the hemorrhage.",
      "The swirl sign can provide important information for clinicians in assessing the severity, location, and outcome of the hemorrhage.",
      "The presence of the swirl sign can indicate the presence of cerebral edema, a common complication of ICH."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The presence of the swirl sign can indicate ongoing bleeding or hematoma growth, not cerebral edema."
    ]
  },
  {
    "id": 2361,
    "user_query": "What is Morgellons disease?",
    "llama-2-7b-chat-hf_response": "Morgellons disease is a rare and poorly understood condition characterized by the presence of fibers or other materials under the skin, as well as other symptoms such as crawling sensations, itching, and skin lesions. While there is no consensus on the cause of Morgellons disease, some researchers believe it may be caused by a combination of environmental and genetic factors, while others believe it may be a delusional disorder. There is currently no cure for Morgellons disease, and treatment is largely focused on managing symptoms.",
    "llama-2-7b-chat-hf_fact": [
      "Morgellons disease is a condition characterized by the presence of fibers under the skin.",
      "Other symptoms of Morgellons disease include crawling sensations, itching, and skin lesions.",
      "There is no consensus on the cause of Morgellons disease.",
      "Some researchers propose that Morgellons disease may be caused by a combination of environmental and genetic factors.",
      "Currently, there is no cure for Morgellons disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2363,
    "user_query": "What is the asosciation between the eustachian tube and the palatine muscle of the uvula?",
    "llama-2-7b-chat-hf_response": "The Eustachian tube is a narrow tube that connects the middle ear to the back of the throat. It helps to regulate air pressure in the middle ear and maintain equal pressure on both sides of the eardrum. The palatine muscle of the uvula is a muscle located in the back of the throat that helps to move the uvula (the small fleshy structure in the back of the throat) during speech and swallowing.\nThere is a close association between the Eustachian tube and the palatine muscle of the uvula. When the Eustachian tube becomes blocked or inflamed, it can cause pressure changes in the middle ear that can affect the movement of the uvula. This can lead to symptoms such as ear fullness, hearing loss, and difficulty swallowing.\nIn addition, the palatine muscle of the uvula can also affect the functioning of the Eustachian tube. During swallowing, the uvula moves back and forth, and this movement can help to open and close the Eustachian tube, allowing air to enter the middle ear and equalize pressure.\nOverall, the relationship between the Eustachian tube and the palatine muscle of the uvula is complex and interdependent, and any problems with one can affect the other.",
    "llama-2-7b-chat-hf_fact": [
      "The Eustachian tube is a narrow tube that connects the middle ear to the back of the throat.",
      "The Eustachian tube helps to regulate air pressure in the middle ear and maintain equal pressure on both sides of the eardrum.",
      "The palatine muscle of the uvula is a muscle located in the back of the throat that helps to move the uvula during speech and swallowing.",
      "If the Eustachian tube becomes blocked or inflamed, it can affect the movement of the uvula, leading to symptoms such as ear fullness, hearing loss, and difficulty swallowing.",
      "During swallowing, the uvula's movement can help to open and close the Eustachian tube, allowing air to enter the middle ear and equalize pressure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: If the Eustachian tube becomes blocked or inflamed, it can cause symptoms such as ear fullness, hearing loss, and tinnitus, but it does not directly affect the movement of the uvula or difficulty swallowing.",
      "true"
    ]
  },
  {
    "id": 2366,
    "user_query": "Which virus can be diagnosed with the monospot test?",
    "llama-2-7b-chat-hf_response": "A monospot test is a simple blood test that can detect certain viral infections, including:\n1. Rubella (German measles)\n2. Roseola (exanthem subitum)\n3. Fifth disease (parvovirus B19)\nWhich of these viruses can be diagnosed with the monospot test?\nA) Rubella (German measles)\nB) Roseola (exanthem subitum)\nC) Fifth disease (parvovirus B19)\nD) All of the above\nAnswer: C) Fifth disease (parvovirus B19)",
    "llama-2-7b-chat-hf_fact": [
      "A monospot test is a blood test that can detect certain viral infections.",
      "Rubella, also known as German measles, is a type of viral infection.",
      "Roseola, also known as exanthem subitum, is a type of viral infection.",
      "Fifth disease, caused by parvovirus B19, is a type of viral infection.",
      "Parvovirus B19 can be diagnosed with a monospot test."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Parvovirus B19 is typically diagnosed with specific blood tests to detect B19 antibodies, not with a monospot test."
    ]
  },
  {
    "id": 2376,
    "user_query": "What is the most common histological diagnosis of \"butterfly glioma\"?",
    "llama-2-7b-chat-hf_response": "Butterfly glioma is a rare type of brain tumor that typically affects children and young adults. The most common histological diagnosis of butterfly glioma is pilocytic astrocytoma, which is a type of glioma that arises from the star-shaped glial cells called astrocytes. Other less common histological diagnoses of butterfly glioma include fibrillary astrocytoma, pleomorphic xanthoastrocytoma, and anaplastic astrocytoma.",
    "llama-2-7b-chat-hf_fact": [
      "Butterfly glioma is a rare type of brain tumor.",
      "Butterfly glioma typically affects children and young adults.",
      "The most common histological diagnosis of butterfly glioma is pilocytic astrocytoma.",
      "Pilocytic astrocytoma is a type of glioma that arises from the star-shaped glial cells called astrocytes.",
      "Other histological diagnoses of butterfly glioma include fibrillary astrocytoma, pleomorphic xanthoastrocytoma, and anaplastic astrocytoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The most common histological diagnosis for butterfly glioma is Glioblastoma multiforme.",
      "true",
      "true"
    ]
  },
  {
    "id": 2377,
    "user_query": "Which chromosomes are implicated in the Emanuel syndrome?",
    "llama-2-7b-chat-hf_response": "Emanuel syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. It is caused by mutations in the CHRNA7 gene, which codes for a subunit of the alpha-7 nicotinic acetylcholine receptor. This receptor is involved in the transmission of signals between neurons in the brain and spinal cord.\nThe CHRNA7 gene is located on chromosome 15q11.2, which is one of the 23 pairs of chromosomes in the human genome. The CHRNA7 gene is located on the long (q) arm of chromosome 15, near the center of the chromosome.\nMutations in the CHRNA7 gene can lead to a range of symptoms, including developmental delays, intellectual disability, seizures, and problems with movement and coordination. Emanuel syndrome is usually diagnosed in infancy or early childhood, and the symptoms can vary in severity and progression over time.\nThere is currently no cure for Emanuel syndrome, but various treatments can help manage the symptoms. These may include medications to control seizures, physical therapy to improve movement and coordination, and speech and language therapy to address communication difficulties.\nIn summary, the CHRNA7 gene on chromosome 15q11.2 is implicated in the development of Emanuel syndrome, a rare genetic disorder that affects the brain and spinal cord.",
    "llama-2-7b-chat-hf_fact": [
      "Emanuel syndrome is a rare genetic disorder that affects the development of the brain and spinal cord.",
      "This syndrome is caused by mutations in the CHRNA7 gene.",
      "The CHRNA7 gene is located on chromosome 15q11.2 in the human genome.",
      "Mutations in the CHRNA7 gene can lead to symptoms such as developmental delays, intellectual disability, seizures, and problems with movement and coordination.",
      "Emanuel syndrome is usually diagnosed in infancy or early childhood."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Emanuel syndrome is often caused by an extra chromosome due to a rearrangement of genetic material between chromosome 11 and chromosome 22.",
      "false, [corrected fact]: The CHRNA7 gene is actually located on chromosome 15q13.3 in the human genome.",
      "true",
      "true"
    ]
  },
  {
    "id": 2379,
    "user_query": "Are loop domains preserved upon cohesin loss?",
    "llama-2-7b-chat-hf_response": "Cohesin is a protein complex that plays a crucial role in the maintenance of chromatin structure and gene expression. It is composed of four subunits: SMC1, SMC3, RAD21, and STAG2. Cohesin helps to hold together sister chromatids during DNA replication and repair, and it also regulates the spreading of chromatin during cell division. Loss of cohesin has been implicated in various human diseases, including cancer and developmental disorders.\nRecently, a study published in the journal Nature used single-molecule FISH (fluorescence in situ hybridization) to investigate the spatial organization of chromatin in cohesin-deficient cells. The researchers found that in the absence of cohesin, loop domains, which are higher-order chromatin structures that are thought to play a role in regulating gene expression, are preserved.\nThe study used CRISPR-Cas9 genome editing to knockout the SMC1 subunit of cohesin in human cells, and then used single-molecule FISH to visualize the spatial organization of chromatin. The researchers found that in cohesin-deficient cells, loop domains were still present, but they were less stable and more dynamic than in control cells.\nThe preservation of loop domains in cohesin-deficient cells suggests that other proteins may be able to compensate for the loss of cohesin in maintaining chromatin structure and regulating gene expression. However, further research is needed to fully understand the mechanisms underlying the preservation of loop domains in cohesin-deficient cells.\nIn summary, the study used single-molecule FISH to investigate the spatial organization of chromatin in cohesin-deficient cells and found that loop domains are preserved in the absence of cohesin, suggesting that other proteins may be able to compensate for the loss of cohesin in maintaining chromatin structure and regulating gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Cohesin is a protein complex that helps hold together sister chromatids during DNA replication and repair.",
      "Cohesin is composed of four subunits: SMC1, SMC3, RAD21, and STAG2.",
      "Loss of cohesin has been implicated in various human diseases, including cancer and developmental disorders.",
      "A study published in Nature used single-molecule FISH to investigate the spatial organization of chromatin in cohesin-deficient cells.",
      "The study found that loop domains, which are higher-order chromatin structures, are preserved in the absence of cohesin, but they are less stable and more dynamic than in control cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2380,
    "user_query": "Which workflow in Bioconductor has been developed for accessing human RNA-seq samples?",
    "llama-2-7b-chat-hf_response": "Answer: There are several workflows in Bioconductor that have been developed for accessing human RNA-seq samples. Here are a few examples:\n1. The `rnaseq` workflow: This workflow provides a comprehensive set of tools for analyzing RNA-seq data, including read alignment, transcriptome assembly, and differential expression analysis. It can be used for both single-end and paired-end RNA-seq data.\n2. The `star` workflow: This workflow uses the STAR aligner to align RNA-seq reads to a reference genome or transcriptome. It can be used for both single-end and paired-end RNA-seq data.\n3. The `salmon` workflow: This workflow uses the Salmon aligner to align RNA-seq reads to a reference genome or transcriptome. It can be used for both single-end and paired-end RNA-seq data.\n4. The `hisat2` workflow: This workflow uses the HISAT2 aligner to align RNA-seq reads to a reference genome or transcriptome. It can be used for both single-end and paired-end RNA-seq data.\n5. The ` StringTie` workflow: This workflow uses the StringTie transcriptome assembler to assemble RNA-seq reads into transcripts. It can be used for both single-end and paired-end RNA-seq data.\n6. The `Cufflinks` workflow: This workflow uses the Cufflinks toolkit to quantify and analyze RNA-seq data. It can be used for both single-end and paired-end RNA-seq data.\n7. The `RSEM` workflow: This workflow uses the RSEM (RNA-seq by Expectation Maximization) tool to quantify and analyze RNA-seq data. It can be used for both single-end and paired-end RNA-seq data.\n8. The ` kallisto` workflow: This workflow uses the Kallisto aligner to align RNA-seq reads to a reference genome or transcriptome. It can be used for both single-end and paired-end RNA-seq data.\nThese are just a few examples of the many workflows available in Bioconductor for analyzing human R",
    "llama-2-7b-chat-hf_fact": [
      "The 'rnaseq' workflow in Bioconductor provides tools for analyzing human RNA-seq data.",
      "'Star' workflow uses the STAR aligner to align RNA-seq reads to a reference genome or transcriptome.",
      "'Salmon' workflow uses the Salmon aligner for the same purpose.",
      "'Hisat2' workflow applies the HISAT2 aligner to human RNA-seq data.",
      "'StringTie' workflow uses the StringTie transcriptome assembler to assemble RNA-seq reads into transcripts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2387,
    "user_query": "List polyubiquitin binding proteins involved in NF-kappaB signaling.",
    "llama-2-7b-chat-hf_response": "NF-B (nuclear factor kappa B) is a transcription factor that plays a crucial role in regulating the expression of genes involved in inflammation, immune response, and cell survival. Ubiquitination of NF-B is an important post-translational modification that regulates its activity and subcellular localization. Here are some polyubiquitin binding proteins involved in NF-B signaling:\n1. Ubiquitin (Ub): Ubiquitin is the most well-studied polyubiquitin protein and is the primary ubiquitinating enzyme involved in NF-B signaling. Ubiquitination of NF-B leads to its proteasomal degradation and inhibition of its transcriptional activity.\n2. Ubiquitin-activating enzymes (E1s): Ubiquitin-activating enzymes (E1s) are responsible for the first step of ubiquitination, which involves the covalent attachment of ubiquitin to the target protein. In NF-B signaling, E1s such as UBA1 and UBA2 are involved in the ubiquitination of NF-B.\n3. Ubiquitin-conjugating enzymes (E2s): Ubiquitin-conjugating enzymes (E2s) are responsible for the transfer of ubiquitin from the E1 to the target protein. In NF-B signaling, E2s such as UBC1 and UBC13 are involved in the ubiquitination of NF-B.\n4. Ubiquitin ligases (E3s): Ubiquitin ligases (E3s) are responsible for the specific recognition and ubiquitination of target proteins. In NF-B signaling, E3s such as RING1B and RING1A are involved in the ubiquitination of NF-B.\n5. A20: A20 is a ubiquitin protein ligase that specifically targets and ubiquitinates NF-B, leading to its degradation. A20 is a negative regulator of NF-B signaling and plays a",
    "llama-2-7b-chat-hf_fact": [
      "NF-B (nuclear factor kappa B) is a transcription factor involved in the regulation of genes responsible for inflammation, immune response, and cell survival.",
      "Ubiquitination is a post-translational modification that affects the activity and subcellular localization of NF-B.",
      "Ubiquitin is the primary ubiquitinating enzyme involved in NF-B signaling and its ubiquitination leads to NF-B's proteasomal degradation.",
      "Ubiquitin-activating enzymes (E1s) such as UBA1 and UBA2 participate in the first step of ubiquitination in NF-B signaling.",
      "A20 is a ubiquitin protein ligase that targets and ubiquitinates NF-B, leading to its degradation and acting as a negative regulator of NF-B signaling."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Ubiquitin itself is not an enzyme, it is a small regulatory protein that gets attached to proteins in a process carried out by ubiquitinating enzymes. This process can lead to NF-B's proteasomal degradation.",
      "true",
      "true"
    ]
  },
  {
    "id": 2388,
    "user_query": "What are the prednisone side effects in DMD patients?",
    "llama-2-7b-chat-hf_response": "Prednisone is a corticosteroid medication that is commonly used to treat Duchenne muscular dystrophy (DMD) patients. While it can help manage some of the symptoms of DMD, such as muscle weakness and inflammation, it can also cause a range of side effects. Here are some of the common prednisone side effects in DMD patients:\n1. Weight gain: Prednisone can cause an increase in appetite and weight gain, particularly in the abdominal area.\n2. Mood changes: Prednisone can cause mood swings, irritability, and anxiety in some DMD patients.\n3. Insomnia: Prednisone can disrupt sleep patterns and cause insomnia in some patients.\n4. Fatigue: Prednisone can cause fatigue and weakness, which can make it difficult for DMD patients to perform daily activities.\n5. Headache: Prednisone can cause headaches in some patients, particularly when taken in high doses.\n6. Nausea and vomiting: Prednisone can cause nausea and vomiting, particularly when taken on an empty stomach.\n7. Stomach upset: Prednisone can cause stomach upset, including diarrhea, constipation, and abdominal pain.\n8. Osteoporosis: Long-term use of prednisone can lead to osteoporosis, particularly in children and adolescents.\n9. Adrenal insufficiency: Prolonged use of prednisone can suppress the adrenal glands, leading to adrenal insufficiency.\n10. Increased risk of infections: Prednisone can suppress the immune system, increasing the risk of infections such as pneumonia, bronchitis, and skin infections.\nIt's important to note that not all DMD patients will experience these side effects, and the severity of the side effects can vary from patient to patient. If you are taking prednisone to treat DMD, it's important to work closely with your healthcare provider to monitor your symptoms and adjust your dosage as needed to minimize side effects.",
    "llama-2-7b-chat-hf_fact": [
      "Prednisone is a corticosteroid medication used to treat Duchenne muscular dystrophy (DMD).",
      "Prednisone can cause side effects including weight gain, mood changes, insomnia, fatigue, headache, nausea and vomiting, stomach upset, osteoporosis, adrenal insufficiency, and increased risk of infections in DMD patients.",
      "Long-term use of prednisone can lead to osteoporosis, particularly in children and adolescents.",
      "Prolonged use of prednisone can suppress the adrenal glands, leading to adrenal insufficiency.",
      "Prednisone can suppress the immune system, increasing the risk of infections such as pneumonia, bronchitis, and skin infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-7b-chat-hf_response": "Arabidopsis ROF1 (RNA-binding protein 1) is a transcription factor that plays a crucial role in regulating plant defense responses, including systemic acquired resistance (SAR) and salicylic acid (SA)-mediated defense. The expression of ROF1 is induced by various signals, including:\n1. Pathogens: ROF1 expression is strongly induced by bacterial and fungal pathogens, such as Pseudomonas syringae and Botrytis cinerea.\n2. Abiotic stressors: ROF1 expression is also induced by abiotic stressors, such as drought, high temperature, and oxidative stress.\n3. Hormones: ROF1 expression is regulated by plant hormones, including salicylic acid (SA), ethylene (ET), and auxin (AU).\n4. Signaling molecules: ROF1 expression can be induced by signaling molecules, such as reactive oxygen species (ROS), reactive nitrogen species (RNS), and salicylic acid (SA).\n5. Light: ROF1 expression can be induced by light, particularly blue light, which activates the photoreceptor cryptochrome.\n6. Temperature: ROF1 expression can be induced by changes in temperature, such as from 20C to 30C.\n7. Water availability: ROF1 expression can be induced by changes in water availability, such as from well-watered to water-stressed conditions.\n8. Nutrient availability: ROF1 expression can be induced by changes in nutrient availability, such as from nutrient-rich to nutrient-poor conditions.\n9. Genetic mutations: ROF1 expression can be induced by genetic mutations, such as those that affect the function of other transcription factors or signaling pathways.\n10. Epigenetic modifications: ROF1 expression can be induced by epigenetic modifications, such as DNA methylation or histone modifications.\nOverall, ROF1 expression is induced by a wide range of signals, including both biotic and abiotic stressors, as well as developmental and environmental cues. Understanding the factors that induce ROF1 expression can provide insights into the regulation of",
    "llama-2-7b-chat-hf_fact": [
      "Arabidopsis ROF1 (RNA-binding protein 1) is a transcription factor that plays a crucial role in regulating plant defense responses.",
      "The expression of ROF1 is induced by various signals, including pathogens like Pseudomonas syringae and Botrytis cinerea.",
      "Abiotic stressors like drought, high temperature, and oxidative stress can also induce the expression of ROF1.",
      "ROF1 expression can be regulated by plant hormones, such as salicylic acid, ethylene, and auxin.",
      "Changes in factors like light, temperature, water availability, and nutrient availability can induce the expression of ROF1."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2393,
    "user_query": "What is the preferred orientation of CTCF binding sites for chromatin looping?",
    "llama-2-7b-chat-hf_response": "CTCF (CCCTC-binding factor) is a transcriptional regulator that plays a crucial role in the organization of chromatin structure and gene expression. CTCF binding sites are often found in regions of the genome that are far away from the promoter and gene they regulate, and it is thought that CTCF binding sites mediate chromatin looping to bring these distant regulatory elements into close proximity with their target genes. However, the preferred orientation of CTCF binding sites for chromatin looping is not well understood.\nA recent study published in the journal Nature used a combination of chromatin conformation capture (3C) and sequencing (ChIP-seq) to investigate the orientation of CTCF binding sites in relation to their target genes. The authors found that CTCF binding sites were more likely to be oriented towards the promoter of their target gene than away from it. They also found that the orientation of CTCF binding sites was influenced by the distance between the binding site and the target gene, with closer binding sites more likely to be oriented towards the promoter.\nOverall, these findings suggest that the preferred orientation of CTCF binding sites for chromatin looping is towards the promoter of their target gene, and that this orientation is influenced by the distance between the binding site and the target gene.",
    "llama-2-7b-chat-hf_fact": [
      "CTCF (CCCTC-binding factor) is a transcriptional regulator that plays a role in the organization of chromatin structure and gene expression.",
      "CTCF binding sites are often found in regions of the genome far away from the promoter and gene they regulate.",
      "It is believed that CTCF binding sites mediate chromatin looping to bring distant regulatory elements into close proximity with target genes.",
      "A study published in the journal Nature found that CTCF binding sites were more likely to be oriented towards the promoter of their target gene than away from it.",
      "The same study found that the orientation of CTCF binding sites was influenced by the distance between the binding site and the target gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2395,
    "user_query": "How many amino acids does davunetide consist of?",
    "llama-2-7b-chat-hf_response": "Davunetide is a peptide consisting of 27 amino acids.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-7b-chat-hf_response": "The most common cause of hereditary renal amyloidosis is mutations in the transthyretin (TTR) gene. TTR is a protein that is produced in the liver and secreted into the bloodstream, where it plays a role in the transport of thyroxine and retinol. Inherited mutations in the TTR gene can lead to the accumulation of abnormal TTR proteins in the kidneys, which can cause amyloidosis and progressive kidney damage. Hereditary renal amyloidosis caused by TTR mutations is also known as familial amyloid polyneuropathy (FAP).",
    "llama-2-7b-chat-hf_fact": [
      "The most common cause of hereditary renal amyloidosis is mutations in the transthyretin (TTR) gene.",
      "Transthyretin is a protein that is produced in the liver.",
      "This protein plays a role in the transport of thyroxine and retinol in the bloodstream.",
      "Mutations in the TTR gene can lead to an accumulation of abnormal proteins in the kidneys.",
      "Hereditary renal amyloidosis caused by TTR mutations is also known as familial amyloid polyneuropathy (FAP)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Hereditary renal amyloidosis caused by TTR mutations is also known as familial amyloidotic polyneuropathy (FAP)."
    ]
  },
  {
    "id": 2401,
    "user_query": "Where do centromeres locate according to the Rabl orientation of eukaryotic nuclei?",
    "llama-2-7b-chat-hf_response": "A centromere is a specialized region of DNA on a chromosome that plays a crucial role in the process of cell division. It is the point where the chromosome is attached to the spindle fibers during mitosis, which pulls the sister chromatids apart. The Rabl orientation of eukaryotic nuclei refers to the way in which the chromosomes are aligned within the nucleus before cell division.\nAccording to the Rabl orientation of eukaryotic nuclei, the centromeres are located at the following positions:\n1. Metacentric centromeres: These are located near the center of the chromosome, hence the name. They are found in chromosomes that are metacentric, meaning they have a medium-sized centromere. Examples of metacentric chromosomes include chromosome 15 in humans.\n2. Submetacentric centromeres: These are located closer to one end of the chromosome than the other. They are found in chromosomes that are submetacentric, meaning they have a small centromere. Examples of submetacentric chromosomes include chromosome 14 in humans.\n3. Acrocentric centromeres: These are located near one end of the chromosome. They are found in chromosomes that are acrocentric, meaning they have a small centromere and a long arm. Examples of acrocentric chromosomes include chromosome 17 in humans.\n4. Telocentric centromeres: These are located near the end of the chromosome, close to the telomere. They are found in chromosomes that are telocentric, meaning they have a large centromere and a short arm. Examples of telocentric chromosomes include chromosome 22 in humans.\nIt's worth noting that the Rabl orientation of eukaryotic nuclei is not a hard and fast rule, and there can be variations depending on the species and the specific chromosome. However, in general, the centromere is located near the center of the chromosome in metacentric chromosomes, closer to one end in submetacentric chromosomes, near one end in acrocentric chromosom",
    "llama-2-7b-chat-hf_fact": [
      "A centromere is a specialized region of DNA on a chromosome that facilitates cell division.",
      "During cell division, the chromosome is attached to the spindle fibers at the centromere.",
      "According to the Rabl orientation, metacentric centromeres are located near the center of the chromosome, as seen in chromosome 15 in humans.",
      "In the Rabl orientation, submetacentric centromeres are located closer to one end of the chromosome, as exemplified by chromosome 14 in humans.",
      "Acrocentric centromeres are located near one end of the chromosome, evident in chromosome 17 in humans as per the Rabl orientation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: According to the Rabl orientation, metacentric centromeres are located near the center of the chromosome, but not necessarily for chromosome 15 in humans.",
      "true",
      "false, [corrected fact]: Acrocentric centromeres are located near one end of the chromosome, but as per the Rabl orientation, it is not evident in chromosome 17 in humans."
    ]
  },
  {
    "id": 2404,
    "user_query": "What is the mode of action of the drug Prolia?",
    "llama-2-7b-chat-hf_response": "Prolia (denosumab) is a monoclonal antibody that targets and inhibits the activity of the protein receptor activator of nuclear factor kappa-B ligand (RANKL). RANKL is a key regulator of bone metabolism and is involved in the activation and proliferation of osteoclasts, which are the cells responsible for bone resorption. By inhibiting the activity of RANKL, Prolia reduces the activity of osteoclasts, leading to a decrease in bone resorption and an increase in bone density.\nProlia is used to treat osteoporosis in postmenopausal women and men over the age of 70, as well as in patients with glucocorticoid-induced osteoporosis. It is also used to treat bone metastases in patients with solid tumors.\nThe mode of action of Prolia is to inhibit the activity of RANKL, which leads to a decrease in bone resorption and an increase in bone density.",
    "llama-2-7b-chat-hf_fact": [
      "Prolia (denosumab) is a monoclonal antibody that inhibits the activity of the protein receptor activator of nuclear factor kappa-B ligand (RANKL).",
      "RANKL is a key regulator of bone metabolism and is involved in the activation and proliferation of osteoclasts.",
      "Osteoclasts are the cells responsible for bone resorption.",
      "Prolia is used to treat osteoporosis in postmenopausal women and men over the age of 70, and in patients with glucocorticoid-induced osteoporosis.",
      "Prolia is also used to treat bone metastases in patients with solid tumors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-7b-chat-hf_response": "Yes, the proteome of the mouse hippocampus has been extensively analyzed using various proteomics techniques, including two-dimensional gel electrophoresis (2DGE), mass spectrometry (MS), and label-free quantification. These studies have identified a large number of proteins that are specifically expressed in the hippocampus, including those involved in synaptic plasticity, neurotransmission, and neuronal survival.\nSome of the key findings from these studies include:\n1. Synaptic proteins: The hippocampus contains a large number of synaptic proteins, including synaptotagmin, VGluT1, VGAT, and PSD-95, which are involved in the formation and regulation of synapses.\n2. Neurotransmitter receptors: The hippocampus expresses a variety of neurotransmitter receptors, including NMDA, AMPA, and GABA receptors, which are involved in the regulation of synaptic transmission and plasticity.\n3. Neurotrophic factors: The hippocampus expresses a number of neurotrophic factors, including BDNF, NT3, and NT4, which are involved in the regulation of neuronal survival and synaptic plasticity.\n4. Cytoskeleton proteins: The hippocampus contains a number of cytoskeleton proteins, including tubulin, actin, and microtubule-associated proteins, which are involved in the structure and function of neurons.\n5. Stress response proteins: The hippocampus expresses a number of stress response proteins, including heat shock proteins, which are involved in the response to cellular stress and the regulation of synaptic plasticity.\n6. Inflammation-related proteins: The hippocampus expresses a number of inflammation-related proteins, including cytokines and chemokines, which are involved in the regulation of inflammation and the response to injury.\n7. Apoptosis-related proteins: The hippocampus expresses a number of apoptosis-related proteins, including Bax and Bcl-",
    "llama-2-7b-chat-hf_fact": [
      "The proteome of the mouse hippocampus has been analyzed using proteomics techniques such as two-dimensional gel electrophoresis (2DGE), mass spectrometry (MS), and label-free quantification.",
      "Studies have identified a large number of proteins specifically expressed in the hippocampus.",
      "The mouse hippocampus contains a variety of synaptic proteins including synaptotagmin, VGluT1, VGAT, and PSD-95.",
      "The hippocampus expresses a range of neurotransmitter receptors, among them NMDA, AMPA, and GABA receptors.",
      "The proteins BDNF, NT3, and NT4, known as neurotrophic factors, are present in the hippocampus."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-7b-chat-hf_response": "Mouse chromosomes are acrocentric, meaning that the centromere is located near the center of the chromosome. This is in contrast to metacentric chromosomes, where the centromere is located closer to one end of the chromosome, and telocentric chromosomes, where the centromere is located closer to the other end of the chromosome. Acrocentric chromosomes are typically found in organisms that have a relatively small number of chromosomes, such as mammals.",
    "llama-2-7b-chat-hf_fact": [
      "Mouse chromosomes are acrocentric.",
      "An acrocentric chromosome has the centromere located near the center.",
      "Metacentric chromosomes have the centromere located closer to one end.",
      "Telocentric chromosomes have the centromere located closer to the other end.",
      "Acrocentric chromosomes are typically found in organisms with a relatively small number of chromosomes, such as mammals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: An acrocentric chromosome has the centromere located closer to one end.",
      "false, [corrected fact]: Metacentric chromosomes have the centromere located at the center.",
      "true",
      "false, [corrected fact]: Acrocentric chromosomes are typically found in organisms with a relatively large number of chromosomes, such as mammals."
    ]
  },
  {
    "id": 2414,
    "user_query": "Which disease risk can be estimated with the Stop-Bang questionnaire?",
    "llama-2-7b-chat-hf_response": "A) Sleep apnea\nB) Hypertension\nC) Diabetes\nD) Cardiovascular disease\nE) All of the above\nThe Stop-Bang questionnaire is a screening tool used to assess the risk of obstructive sleep apnea (OSA). It consists of 8 questions that assess the risk factors for OSA, including:\n1. Do you snore loudly?\n2. Have you ever been told you have sleep apnea?\n3. Do you wake up with a dry mouth?\n4. Do you feel tired or groggy during the day?\n5. Do you have high blood pressure?\n6. Are you overweight or obese?\n7. Do you have a large neck circumference?\n8. Do you have a family history of OSA?\nBased on the answers to these questions, the risk of OSA can be estimated. A score of 0-2 indicates a low risk, 3-4 indicates a moderate risk, and 5-8 indicates a high risk of OSA.\nTherefore, the answer is (A) Sleep apnea.",
    "llama-2-7b-chat-hf_fact": [
      "The Stop-Bang questionnaire is a tool used to assess the risk of obstructive sleep apnea (OSA).",
      "The Stop-Bang questionnaire consists of 8 questions.",
      "The questions on the questionnaire assess risk factors for OSA and can be used to estimate the risk degree (low, moderate, high).",
      "A score of 0-2 on the Stop-Bang questionnaire indicates a low risk of OSA.",
      "A score of 3-4 on the Stop-Bang questionnaire indicates a moderate risk of OSA and 5-8 indicates a high risk."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2415,
    "user_query": "List indications for palivizumab for treatment of RSV-induced bronchiolitis.",
    "llama-2-7b-chat-hf_response": "Palivizumab is an intravenous immunoglobulin (IVIG) that is used to prevent and treat respiratory syncytial virus (RSV) infections in high-risk populations, including premature infants, older adults, and people with certain underlying medical conditions. Here are some of the indications for palivizumab for the treatment of RSV-induced bronchiolitis:\n1. Prevention of RSV infection in high-risk infants: Palivizumab is recommended for the prevention of RSV infection in high-risk infants, including those born prematurely (<30 weeks gestation) or with certain underlying medical conditions (e.g., chronic lung disease, congenital heart disease).\n2. Treatment of RSV infection in high-risk infants: Palivizumab may be used to treat RSV infection in high-risk infants who are hospitalized with severe RSV infection, including those with bronchiolitis.\n3. Prevention of RSV infection in older adults: Palivizumab may be used to prevent RSV infection in older adults who are at high risk of severe RSV infection, including those with underlying medical conditions such as chronic lung disease, heart disease, or diabetes.\n4. Treatment of RSV infection in older adults: Palivizumab may be used to treat RSV infection in older adults who are hospitalized with severe RSV infection, including those with bronchiolitis.\n5. Prevention of RSV infection in people with certain underlying medical conditions: Palivizumab may be used to prevent RSV infection in people with certain underlying medical conditions, such as chronic lung disease, heart disease, or diabetes, who are at high risk of severe RSV infection.\n6. Treatment of RSV infection in people with certain underlying medical conditions: Palivizumab may be used to treat RSV infection in people with certain underlying medical conditions, such as chronic lung disease, heart disease, or diabetes, who are hospitalized with severe RSV infection, including those with bronchiolitis.\nIt is important to note that palivizumab is not recommended",
    "llama-2-7b-chat-hf_fact": [
      "Palivizumab is an intravenous immunoglobulin (IVIG) used to prevent and treat respiratory syncytial virus (RSV) infections.",
      "It is indicated for the prevention of RSV infections in high-risk infants, that include prematurely born babies and those with certain underlying medical conditions.",
      "Palivizumab can be used to treat hospitalized high-risk infants with severe RSV infections, including bronchiolitis.",
      "Palivizumab is suggested for the prevention and treatment of RSV infection in older adults with high-risk factors such as chronic lung disease, heart disease or diabetes.",
      "It can also be used for prevention and treatment of RSV infection in people with certain underlying medical conditions who are at risk of severe RSV infection, and are hospitalized with severe RSV infection, including bronchiolitis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Palivizumab is a monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections.",
      "true",
      "false, [corrected fact]: Palivizumab is used for the prevention, not treatment of severe RSV infection in high-risk infants.",
      "false, [corrected fact]: Palivizumab is not regularly suggested for the prevention and treatment of RSV infection in older adults with high-risk factors such as chronic lung disease, heart disease or diabetes.",
      "false, [corrected fact]: Palivizumab is used for the prevention, not treatment of severe RSV infections in people with certain underlying medical conditions who are at high risk."
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-7b-chat-hf_response": "Answer: There are several siRNA-based drugs in clinical trials for the treatment of pancreatic cancer, including:\n1. Sirna-002: This drug is being developed by Sirna Therapeutics and is currently in Phase 1 clinical trials for the treatment of pancreatic cancer. Sirna-002 is designed to target the mRNA of the oncogene KRAS, which is commonly mutated in pancreatic cancer.\n2. RX-0201: This drug is being developed by Rexahn Pharmaceuticals and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer. RX-0201 is designed to target the mRNA of the oncogene BRAF, which is also commonly mutated in pancreatic cancer.\n3. ALN-T01: This drug is being developed by Alnylam Pharmaceuticals and is currently in Phase 1 clinical trials for the treatment of pancreatic cancer. ALN-T01 is designed to target the mRNA of the oncogene PI3K, which is commonly mutated in pancreatic cancer.\nIt's important to note that these drugs are still in the early stages of clinical development and more research is needed to determine their safety and efficacy in humans.",
    "llama-2-7b-chat-hf_fact": [
      "Sirna-002 is an siRNA-based drug that is in Phase 1 clinical trials for the treatment of pancreatic cancer.",
      "Sirna-002 is being developed by Sirna Therapeutics.",
      "RX-0201, an siRNA-based drug in Phase 2 clinical trials for pancreatic cancer treatment, is being developed by Rexahn Pharmaceuticals.",
      "Alnylam Pharmaceuticals is developing ALN-T01, another siRNA-based drug currently in Phase 1 clinical trials for pancreatic cancer treatment.",
      "All three drugs, Sirna-002, RX-0201, and ALN-T01, are designed to target various oncogenes - KRAS, BRAF, and PI3K respectively - commonly mutated in pancreatic cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-7b-chat-hf_response": "The HPG pore, also known as the Hormone-Protein-Gated pore, is a type of ion channel that is found in the plasma membrane of various cells, including neurons and pancreatic beta cells. The HPG pore is gated by hormones and proteins, which can open or close the channel to regulate the flow of ions across the membrane.",
    "llama-2-7b-chat-hf_fact": [
      "HPG pore is also referred to as the Hormone-Protein-Gated pore.",
      "HPG pore is a type of ion channel.",
      "HPG pore is found in the plasma membrane of various cells.",
      "Neurons and pancreatic beta cells contain HPG pore.",
      "HPG pore's opening and closing is regulated by hormones and proteins to manage the flow of ions across the membrane."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2422,
    "user_query": "Which R/Bioconductor package has been developed for cancer subtype identification?",
    "llama-2-7b-chat-hf_response": "Answer: There are several R/Bioconductor packages that have been developed for cancer subtype identification. Some of the popular ones include:\n1. CancerSubtypes: This package uses a machine learning approach to identify cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n2. CancerType: This package uses a supervised learning approach to classify cancer samples into different subtypes based on a set of pre-defined features. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n3. CancerCluster: This package uses a clustering approach to identify cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n4. CancerSubtypeMiner: This package uses a machine learning approach to identify cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n5. CancerSubtypePredictor: This package uses a machine learning approach to predict cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n6. CancerSubtypeClassifier: This package uses a machine learning approach to classify cancer samples into different subtypes based on a set of pre-defined features. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n7. CancerSubtypeAnalyzer: This package uses a machine learning approach to identify cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n8. CancerSubtypeDiscoverer: This package uses a machine learning approach to discover new cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n9. CancerSubtypePredictor2: This package uses a machine learning approach to predict cancer subtypes based on gene expression data. It includes a set of pre-defined subtypes and also allows users to define their own subtypes.\n10. CancerSubtypeClassifier2: This package uses a machine learning approach to classify",
    "llama-2-7b-chat-hf_fact": [
      "CancerSubtypes is an R/Bioconductor package developed for cancer subtype identification, using a machine learning approach based on gene expression data.",
      "CancerType is a package that employs a supervised learning approach to classify cancer samples into different subtypes based on a set of pre-defined features.",
      "CancerCluster is a package that uses a clustering method to identify cancer subtypes based on gene expression data.",
      "CancerSubtypeMiner is another package that applies machine learning to identify cancer subtypes from gene expression data.",
      "CancerSubtypePredictor is a package using machine learning to predict cancer subtypes based on gene expression data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2423,
    "user_query": "Is Solanezumab effective for Alzheimer's Disease?",
    "llama-2-7b-chat-hf_response": "Solanezumab is an anti-amyloid monoclonal antibody that has been investigated as a potential treatment for Alzheimer's disease (AD). The drug works by binding to beta-amyloid peptides, which are a hallmark of AD, and preventing their aggregation and accumulation in the brain.\nSeveral clinical trials have been conducted to evaluate the safety and efficacy of solanezumab in AD, including the A4 Study, EXPEDITION3, and EXPEDITION4. These trials have shown that solanezumab can reduce the rate of cognitive decline in patients with mild AD, and may also slow the progression of brain amyloid deposition.\nHowever, the results of these trials have been mixed, and some have raised questions about the long-term safety and efficacy of solanezumab. For example, the A4 Study found that solanezumab did not slow the progression of cognitive decline in patients with mild AD, while the EXPEDITION3 trial found that the drug did not meet its primary endpoint of slowing the progression of brain amyloid deposition.\nDespite these mixed results, solanezumab remains a promising treatment for AD, and ongoing clinical trials are continuing to evaluate its safety and efficacy. For example, the EXPEDITION4 trial is currently ongoing, and is evaluating the safety and efficacy of solanezumab in patients with early-stage AD.\nIn summary, while the results of clinical trials of solanezumab have been mixed, the drug remains a promising treatment for AD, and ongoing trials are continuing to evaluate its safety and efficacy.",
    "llama-2-7b-chat-hf_fact": [
      "Solanezumab is an anti-amyloid monoclonal antibody that has been investigated as a potential treatment for Alzheimer's disease.",
      "Solanezumab works by binding to beta-amyloid peptides, preventing their aggregation and accumulation in the brain.",
      "Several clinical trials, including the A4 Study, EXPEDITION3, and EXPEDITION4, have been conducted to evaluate the safety and efficacy of solanezumab in Alzheimer's disease.",
      "Some trials have shown that solanezumab can reduce the rate of cognitive decline in patients with mild Alzheimer's disease.",
      "The EXPEDITION4 trial is currently ongoing, evaluating the safety and efficacy of solanezumab in patients with early-stage Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Trials have not conclusively shown that solanezumab can reduce the rate of cognitive decline in patients with Alzheimer's disease.",
      "unknown"
    ]
  },
  {
    "id": 2424,
    "user_query": "Are organisms in the genus Morexella associated with sepsis?",
    "llama-2-7b-chat-hf_response": "Morexella is a genus of bacteria that includes several species, some of which have been associated with human infections, including sepsis. However, the relationship between Morexella and sepsis is complex and not fully understood.",
    "llama-2-7b-chat-hf_fact": [
      "Morexella is a genus of bacteria.",
      "Some species of Morexella have been associated with human infections.",
      "Sepsis is one of the infections associated with some species of Morexella.",
      "The relationship between Morexella and sepsis is not fully understood."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Moraxella is a genus of bacteria, not Morexella.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2427,
    "user_query": "Which R/bioconductor package has been developed to aid in epigenomic analysis?",
    "llama-2-7b-chat-hf_response": "Answer: There are several R/Bioconductor packages that have been developed to aid in epigenomic analysis. Some of the popular ones include:\n1. `epiRatio`: This package provides a comprehensive set of tools for the analysis of epigenetic data, including ChIP-seq, DNA methylation, and histone modification data. It includes functions for peak calling, motif discovery, and visualization of epigenetic profiles.\n2. `HISAT2`: This package is a spliced aligner that can be used for ChIP-seq and RNA-seq analysis. It includes tools for peak calling, motif discovery, and visualization of epigenetic profiles.\n3. `STAR`: This package is a high-performance aligner that can be used for ChIP-seq and RNA-seq analysis. It includes tools for peak calling, motif discovery, and visualization of epigenetic profiles.\n4. `DeepTools`: This package provides a collection of tools for the analysis of deep-sequencing data, including ChIP-seq, DNA methylation, and histone modification data. It includes functions for peak calling, motif discovery, and visualization of epigenetic profiles.\n5. `MethylKit`: This package provides a comprehensive set of tools for the analysis of DNA methylation data. It includes functions for peak calling, motif discovery, and visualization of methylation profiles.\n6. `HistoneMod`: This package provides a comprehensive set of tools for the analysis of histone modification data. It includes functions for peak calling, motif discovery, and visualization of histone modification profiles.\n7. `ChIPseek`: This package provides a comprehensive set of tools for the analysis of ChIP-seq data. It includes functions for peak calling, motif discovery, and visualization of epigenetic profiles.\n8. `EpigenomeWalker`: This package provides a comprehensive set of tools for the analysis of epigenetic data, including ChIP-seq, DNA methylation, and histone modification data. It includes functions for peak calling, motif discovery, and visualization of epigenetic profiles.\nThese are just a few examples of the many R/Bioconductor packages available for epigenomic analysis. Each package has",
    "llama-2-7b-chat-hf_fact": [
      "`epiRatio` is an R/Bioconductor package developed for epigenomic analysis.",
      "`HISAT2` is an R/Bioconductor package used for ChIP-seq and RNA-seq analysis.",
      "`STAR` is another R/Bioconductor package that can be used for ChIP-seq and RNA-seq analysis.",
      "`DeepTools` is an R/Bioconductor package for the analysis of deep-sequencing data, including ChIP-seq, DNA methylation, and histone modification data.",
      "`MethylKit` is an R/Bioconductor package which provides a comprehensive set of tools for the analysis of DNA methylation data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false, [corrected fact]: `HISAT2` is not an R/Bioconductor package, it is an efficient and fast alignment program for mapping next-generation sequencing reads to a population of genomes.",
      "false, [corrected fact]: `STAR` is not an R/Bioconductor package. It is an aligner designed to specifically address many of the challenges of RNA-seq data mapping, and to provide high performance.",
      "false, [corrected fact]: `DeepTools` is not an R/Bioconductor package, but a suite of python tools particularly developed for the efficient analysis of high-throughput sequencing data, such as ChIP-seq, RNA-seq, or DNase-seq.",
      "true"
    ]
  },
  {
    "id": 2431,
    "user_query": "What is miravirsen?",
    "llama-2-7b-chat-hf_response": "Miravirsen is an investigational drug that is being developed for the treatment of hepatitis B virus (HBV) infection. It is a nucleoside polymerase inhibitor, which means it works by blocking the action of the enzyme that the virus uses to replicate itself. By inhibiting this enzyme, miravirsen can reduce the amount of HBV virus in the body, which can help to slow the progression of liver disease in people with HBV infection.\nMiravirsen has been shown to be effective in reducing HBV viral load in clinical trials, and it has also been shown to improve liver function in people with HBV infection. However, it is important to note that miravirsen is not a cure for HBV infection, and it will not prevent the spread of the virus to others.\nMiravirsen is being developed by the biotechnology company, Gilead Sciences, and it is currently in Phase 3 clinical trials for the treatment of HBV infection. If it is approved by regulatory authorities, it could become a valuable treatment option for people with HBV infection.",
    "llama-2-7b-chat-hf_fact": [
      "Miravirsen is an investigational drug being developed for the treatment of hepatitis B virus (HBV) infection.",
      "Miravirsen works by blocking the action of the enzyme that the HBV virus uses to replicate itself.",
      "Clinical trials have shown that miravirsen reduces HBV viral load and improves liver function in people with HBV infection.",
      "Miravirsen is not a cure for HBV infection and will not prevent the spread of the virus to others.",
      "Gilead Sciences is developing Miravirsen, which is in Phase 3 clinical trials for the treatment of HBV infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Miravirsen is an investigational drug being developed for the treatment of hepatitis C virus (HCV) infection.",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2435,
    "user_query": "Which are the main transcriptional activators of circadian oscillations?",
    "llama-2-7b-chat-hf_response": "Circadian oscillations are regulated by a complex interplay of transcription factors, which are proteins that bind to specific DNA sequences and modulate gene expression. Some of the main transcriptional activators of circadian oscillations include:\n1. CLOCK: CLOCK is a transcriptional activator that plays a central role in regulating the expression of many clock-controlled genes. It is a heterodimer of two subunits, CLOCK and BMAL1, which bind to E-box elements in the promoter regions of target genes.\n2. BMAL1: BMAL1 is a transcriptional activator that forms a heterodimer with CLOCK and binds to E-box elements in the promoter regions of clock-controlled genes.\n3. PER: PER is a transcriptional repressor that is phosphorylated and inactivated during the day, allowing for the activation of clock-controlled genes.\n4. CRY: CRY is a transcriptional repressor that is inactivated during the day, allowing for the activation of clock-controlled genes.\n5. REV-ERB: REV-ERB is a transcriptional activator that regulates the expression of genes involved in lipid metabolism and glucose homeostasis. It is a heterodimer of two subunits, REV-ERB and REV-ERB.\n6. REV-ERB: REV-ERB is a transcriptional activator that regulates the expression of genes involved in lipid metabolism and glucose homeostasis. It is a subunit of the REV-ERB heterodimer.\n7. ARNL: ARNL is a transcriptional activator that regulates the expression of genes involved in lipid metabolism and glucose homeostasis. It is a subunit of the REV-ERB heterodimer.\n8. DBP: DBP is a transcriptional activator that regulates the expression of genes involved in lipid metabolism and glucose homeostasis. It is a subunit of the REV-ERB heterodimer.\nThese transcriptional activators work together",
    "llama-2-7b-chat-hf_fact": [
      "Transcription factors are proteins that bind to specific DNA sequences and modulate gene expression.",
      "CLOCK is a transcriptional activator that regulates the expression of many clock-controlled genes.",
      "BMAL1 is a transcriptional activator that forms a heterodimer with CLOCK and binds to E-box elements in the promoter regions of clock-controlled genes.",
      "PER is a transcriptional repressor that is phosphorylated and inactivated during the day, allowing for the activation of clock-controlled genes.",
      "CRY is a transcriptional repressor that is inactivated during the day, allowing for the activation of clock-controlled genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2444,
    "user_query": "List the ten types of conjoined twins.",
    "llama-2-7b-chat-hf_response": "Conjoined twins are twins that are born physically connected to each other. There are ten types of conjoined twins, which are classified based on the location and extent of their connection. Here are the ten types of conjoined twins:\n1. Thoracopagus twins: These twins are connected at the chest and may share organs such as the heart, lungs, or liver.\n2. Omphalopagus twins: These twins are connected at the abdomen and may share organs such as the stomach, small intestine, or liver.\n3. Craniopagus twins: These twins are connected at the head and may share brain tissue.\n4. Diaphragmatic twins: These twins are connected at the diaphragm and may share organs such as the liver or spleen.\n5. Umbilical twins: These twins are connected at the umbilical cord and may share organs such as the liver or spleen.\n6. Thoracic twins: These twins are connected at the chest and may share organs such as the heart or lungs.\n7. Abdominal twins: These twins are connected at the abdomen and may share organs such as the stomach, small intestine, or liver.\n8. Pelvic twins: These twins are connected at the pelvis and may share organs such as the bladder or reproductive organs.\n9. Sacral twins: These twins are connected at the sacrum and may share organs such as the bladder or reproductive organs.\n10. Spinal twins: These twins are connected at the spine and may share organs such as the spinal cord or nerves.\nIt is important to note that the classification of conjoined twins is based on the location and extent of their connection, and not all twins will fit neatly into one category. Each type of conjoined twin has unique challenges and requires specialized medical care.",
    "llama-2-7b-chat-hf_fact": [
      "Conjoined twins are twins that are born physically connected to each other.",
      "Classification of conjoined twins is based on the location and extent of their connection.",
      "Thoracopagus twins are conjoined at the chest and may share organs such as the heart, lungs, or liver.",
      "Craniopagus twins are conjoined at the head and may share brain tissue.",
      "Pelvic twins are conjoined at the pelvis and may share organs such as the bladder or reproductive organs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Pygopagus or Iliopagus twins are conjoined at the pelvis and may share organs such as the bladder or reproductive organs."
    ]
  },
  {
    "id": 2449,
    "user_query": "Is cilengitide effective for treatment of glioblastoma?",
    "llama-2-7b-chat-hf_response": "Cilengitide, also known as EW-7197, is an investigational drug that has shown promise in the treatment of glioblastoma, an aggressive and malignant form of brain cancer. Cilengitide is a selective inhibitor of the vascular endothelial growth factor receptor (VEGFR), which is overexpressed in many types of cancer, including glioblastoma. By inhibiting VEGFR, cilengitide can reduce the growth of new blood vessels that supply oxygen and nutrients to the tumor, thereby slowing down the growth of the cancer.\nSeveral clinical trials have been conducted to evaluate the safety and efficacy of cilengitide in the treatment of glioblastoma. In a phase II clinical trial published in the Journal of Clinical Oncology in 2011, cilengitide was shown to be well-tolerated and associated with improved progression-free survival (PFS) and overall survival (OS) in patients with newly diagnosed glioblastoma. Specifically, the median PFS was 6.7 months in the cilengitide group compared to 4.0 months in the control group, and the median OS was 13.6 months in the cilengitide group compared to 10.2 months in the control group.\nIn addition, a phase III clinical trial published in the Lancet Oncology in 2017 found that cilengitide plus temozolomide (a standard chemotherapy drug for glioblastoma) was associated with improved PFS and OS compared to temozolomide alone in patients with newly diagnosed glioblastoma.\nWhile the results of these clinical trials are promising, it is important to note that cilengitide is not yet approved by the US Food and Drug Administration (FDA) for the treatment of glioblastoma. Further research is needed to confirm these findings and to determine the long-term safety and efficacy of cilengitide in the treatment of this disease.",
    "llama-2-7b-chat-hf_fact": [
      "Cilengitide, also known as EW-7197, is an investigational drug that has shown promise in the treatment of glioblastoma.",
      "Cilengitide selectively inhibits the vascular endothelial growth factor receptor (VEGFR).",
      "A phase II clinical trial published in the Journal of Clinical Oncology in 2011 reported that cilengitide was well-tolerated and associated with improved progression-free survival (PFS) and overall survival (OS) in patients with newly diagnosed glioblastoma.",
      "A phase III clinical trial published in the Lancet Oncology in 2017 reported that cilengitide, combined with temozolomide, improved PFS and OS in patients with newly diagnosed glioblastoma compared to temozolomide alone.",
      "Cilengitide is not yet approved by the US Food and Drug Administration (FDA) for the treatment of glioblastoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Cilengitide, also known as EMD 121974, is an investigational drug that has shown promise in the treatment of glioblastoma.",
      "false, [corrected fact]: Cilengitide selectively inhibits the integrins v3 and v5.",
      "true",
      "false, [corrected fact]: A phase III clinical trial published in the Lancet Oncology in 2013 reported that cilengitide combined with temozolomide did not improve PFS and OS in patients with newly diagnosed glioblastoma compared to temozolomide alone.",
      "true"
    ]
  },
  {
    "id": 2453,
    "user_query": "What is TCGA2BED?",
    "llama-2-7b-chat-hf_response": "TCGA2BED is a database of genomic and transcriptomic data for over 10,000 tumor samples from 32 different cancer types. It is a part of the Cancer Genome Atlas (TCGA) project, which is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to generate and analyze comprehensive genomic and transcriptomic data sets for various types of cancer.\nTCGA2BED contains RNA sequencing (RNA-seq) data for both the tumor and normal tissue samples, as well as other types of genomic data, such as DNA mutation and methylation data. The database is designed to provide researchers with a comprehensive view of the genomic and transcriptomic changes that occur in different types of cancer, and to facilitate the development of new diagnostic and therapeutic strategies.\nSome of the key features of TCGA2BED include:\n* Genomic and transcriptomic data for over 10,000 tumor samples from 32 different cancer types\n* RNA-seq data for both tumor and normal tissue samples\n* DNA mutation and methylation data for many of the samples\n* Integration of genomic and transcriptomic data with clinical and demographic information for each patient\n* Tools and resources for analyzing and visualizing the data\nTCGA2BED is a valuable resource for researchers studying cancer genomics and transcriptomics, and it has the potential to lead to new insights and discoveries in the field of cancer research.",
    "llama-2-7b-chat-hf_fact": [
      "TCGA2BED is a database of genomic and transcriptomic data for over 10,000 tumor samples from 32 different cancer types.",
      "The Cancer Genome Atlas (TCGA) project is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).",
      "TCGA2BED contains RNA sequencing (RNA-seq) data for both tumor and normal tissue samples, as well as DNA mutation and methylation data.",
      "The database integrates genomic and transcriptomic data with clinical and demographic information for each patient.",
      "TCGA2BED provides researchers with tools and resources for analyzing and visualizing the data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2455,
    "user_query": "Is LDB1-mediated enhancer looping dependent on cohesin?",
    "llama-2-7b-chat-hf_response": "Yes, LDB1-mediated enhancer looping is dependent on cohesin. Cohesin is a chromatin-remodeling complex that plays a crucial role in regulating enhancer-promoter interactions by mediating the looping of distant regulatory elements and their target promoters. LDB1, a transcriptional regulator, has been shown to recruit cohesin to enhancer-promoter interactions, leading to the formation of stable loops and the regulation of gene expression. Studies have shown that depletion of cohesin subunits or inhibition of cohesin activity disrupts LDB1-mediated enhancer looping and leads to the loss of gene expression. Therefore, cohesin is an essential component of the LDB1-mediated enhancer looping mechanism.",
    "llama-2-7b-chat-hf_fact": [
      "LDB1-mediated enhancer looping is dependent on cohesin.",
      "Cohesin is a chromatin-remodeling complex that regulates enhancer-promoter interactions.",
      "LDB1 is a transcriptional regulator that recruits cohesin to enhancer-promoter interactions.",
      "Depletion of cohesin subunits or inhibition of its activity disrupts LDB1-mediated enhancer looping and gene expression.",
      "Cohesin is an essential component of the LDB1-mediated enhancer looping mechanism."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2456,
    "user_query": "Describe nursemaid's elbow injury.",
    "llama-2-7b-chat-hf_response": "Nursemaid's elbow, also known as radial head subluxation, is a common injury that occurs when the radial head (the ball-and-socket joint that connects the upper arm bone to the forearm) becomes dislocated. This can happen when a child falls onto an outstretched hand, causing the radial head to move out of its normal position.\nThe symptoms of nursemaid's elbow can vary depending on the severity of the injury. Common symptoms include:\n* Pain or tenderness in the elbow\n* Limited mobility or stiffness in the elbow\n* Swelling or bruising around the elbow\n* Difficulty moving the arm or bending the elbow\n* Clicking or snapping sensation when moving the arm\nIn severe cases, nursemaid's elbow can also cause:\n* Deformity of the elbow joint\n* Limited range of motion in the arm\n* Weakness or paralysis of the arm\nIf you suspect that your child has nursemaid's elbow, it's important to seek medical attention right away. A healthcare provider can diagnose the injury through a physical examination and imaging tests, such as X-rays or an MRI.\nTreatment for nursemaid's elbow usually involves immobilizing the elbow in a splint or brace to allow the joint to heal. Pain medication may also be prescribed to help manage any discomfort. In severe cases, surgery may be necessary to realign the bones and restore proper function to the elbow.\nPreventing nursemaid's elbow involves taking steps to reduce the risk of injury, such as:\n* Supervising children closely when they are playing or engaging in physical activities\n* Encouraging children to wear protective gear, such as elbow pads, when participating in sports or other high-impact activities\n* Teaching children proper fall techniques to reduce the risk of injury\nBy taking these precautions and seeking medical attention if symptoms persist or worsen over time, you can help your child recover from nursemaid's elbow and prevent further injury.",
    "llama-2-7b-chat-hf_fact": [
      "Nursemaid's elbow, also known as radial head subluxation, is an injury that occurs when the radial head becomes dislocated.",
      "Symptoms of nursemaid's elbow include pain or tenderness in the elbow, limited mobility or stiffness in the elbow, and swelling or bruising around the elbow among others.",
      "If suspected, it's advised to seek medical attention for diagnosis through a physical examination and imaging tests.",
      "Treatment for nursemaid's elbow usually involves immobilizing the elbow in a splint or brace, and in severe cases, surgery may be required.",
      "Preventative measures against nursemaid's elbow include supervising children closely during physical activities, encouraging protective gear, and instructing proper fall techniques."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Treatment for nursemaid's elbow usually involves a medical professional performing a reduction maneuver to move the radial head back into place. Immobilization and surgery are typically not required.",
      "true"
    ]
  },
  {
    "id": 2458,
    "user_query": "What is mechanism of action of Benralizumab?",
    "llama-2-7b-chat-hf_response": "Benralizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha subunit, which is expressed on the surface of eosinophils. By binding to the IL-5 receptor, benralizumab inhibits the activation and proliferation of eosinophils, which are involved in the pathogenesis of asthma and other allergic diseases.\nThe mechanism of action of benralizumab can be broken down into several steps:\n1. Binding to IL-5 receptor: Benralizumab binds to the IL-5 receptor on the surface of eosinophils with high affinity and specificity.\n2. Inhibition of IL-5 signaling: By binding to the IL-5 receptor, benralizumab inhibits the binding of IL-5 to the receptor, which is necessary for the activation and proliferation of eosinophils.\n3. Reduction of eosinophil counts: By inhibiting the activation and proliferation of eosinophils, benralizumab reduces the number of eosinophils in the airways and other tissues.\n4. Improvement of asthma symptoms: By reducing the number of eosinophils in the airways, benralizumab improves asthma symptoms such as wheezing, coughing, and shortness of breath.\n5. Inhibition of inflammation: Benralizumab also inhibits the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), which are involved in the inflammation associated with asthma.\nOverall, the mechanism of action of benralizumab is to inhibit the activation and proliferation of eosinophils, which are involved in the pathogenesis of asthma and other allergic diseases, and to improve asthma symptoms by reducing the number of eosinophils in the airways.",
    "llama-2-7b-chat-hf_fact": [
      "Benralizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha subunit.",
      "The IL-5 receptor alpha subunit is expressed on the surface of eosinophils.",
      "Benralizumab inhibits the activation and proliferation of eosinophils.",
      "By reducing the number of eosinophils in the airways, benralizumab can improve asthma symptoms.",
      "Benralizumab inhibits the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Benralizumab specifically targets IL-5 receptor alpha, it does not necessarily inhibit the production of other pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha)."
    ]
  },
  {
    "id": 2459,
    "user_query": "Is there any link between ERCC1-XPF and cohesin?",
    "llama-2-7b-chat-hf_response": "ERCC1-XPF and cohesin are both involved in the repair of DNA double-strand breaks (DSBs). ERCC1-XPF is a complex that repairs DSBs through the non-homologous end joining (NHEJ) pathway, while cohesin is a protein complex that plays a role in the repair of DSBs through the homologous recombination (HR) pathway.\nStudies have shown that ERCC1-XPF and cohesin interact and cooperate in the repair of DSBs. For example, one study found that ERCC1-XPF and cohesin are required for the repair of DSBs in G1-phase cells, and that the interaction between the two complexes is important for the efficient repair of DSBs (1). Another study found that cohesin is required for the recruitment of ERCC1-XPF to DSBs, and that the absence of cohesin leads to a decrease in the repair of DSBs (2).\nFurthermore, mutations in the genes encoding ERCC1-XPF and cohesin have been associated with cancer and other diseases. For example, mutations in the ERCC1 gene have been found to be associated with an increased risk of breast cancer, while mutations in the COH1 gene (which encodes cohesin) have been found to be associated with an increased risk of ovarian cancer (3, 4).\nIn summary, there is a clear link between ERCC1-XPF and cohesin in the repair of DNA double-strand breaks, and mutations in these genes have been associated with an increased risk of cancer and other diseases.\nReferences:\n1. Wang et al. (2010). ERCC1-XPF and cohesin cooperate in the repair of DNA double-strand breaks in G1-phase cells. Nucleic Acids Research, 38(10), 3172-3184.\n2. Liu et al. (2013). Cohesin is required for the recruitment of ERCC1-XPF to DNA double-strand breaks. Nucleic Acids Research, 41(10), 5372-53",
    "llama-2-7b-chat-hf_fact": [
      "ERCC1-XPF and cohesin are both involved in the repair of DNA double-strand breaks.",
      "ERCC1-XPF repairs DSBs through the non-homologous end joining (NHEJ) pathway.",
      "Cohesin plays a role in the repair of DSBs through the homologous recombination (HR) pathway.",
      "ERCC1-XPF and cohesin interact and cooperate in the repair of DNA double-strand breaks.",
      "Mutations in the ERCC1 gene and the COH1 gene, which encodes cohesin, have been associated with an increased risk of breast and ovarian cancer respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: ERCC1-XPF repairs DSBs through the nucleotide excision repair (NER) pathway, not the non-homologous end joining (NHEJ) pathway.",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2461,
    "user_query": "Does Evolocumab improve cognitive function?",
    "llama-2-7b-chat-hf_response": "Evolocumab is a monoclonal antibody that is used to treat high cholesterol. It works by inhibiting the absorption of low-density lipoprotein (LDL) cholesterol in the gut, which can help to reduce the risk of cardiovascular disease. Some studies have suggested that evolocumab may also have a positive effect on cognitive function, but the evidence is not yet conclusive.\nOne study published in the Journal of the American College of Cardiology found that evolocumab was associated with improved cognitive function in patients with high cholesterol and cardiovascular disease. The study included 180 patients who were randomized to receive either evolocumab or a placebo, and cognitive function was assessed using a battery of tests at the beginning and end of the study. The results showed that patients treated with evolocumab had improved cognitive function compared to those receiving the placebo.\nAnother study published in the European Journal of Clinical Pharmacology found that evolocumab was associated with improved cognitive function in patients with high cholesterol and mild cognitive impairment. The study included 120 patients who were randomized to receive either evolocumab or a placebo, and cognitive function was assessed using a battery of tests at the beginning and end of the study. The results showed that patients treated with evolocumab had improved cognitive function compared to those receiving the placebo.\nHowever, not all studies have found a positive effect of evolocumab on cognitive function. A study published in the Journal of Lipid Research found that evolocumab had no significant effect on cognitive function in patients with high cholesterol and cardiovascular disease.\nOverall, the evidence suggests that evolocumab may have a positive effect on cognitive function in patients with high cholesterol and cardiovascular disease, but more research is needed to confirm these findings. It is important to note that evolocumab is a medication that is primarily used to treat high cholesterol, and it should only be used to treat cognitive impairment under the close supervision of a healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Evolocumab is a monoclonal antibody used to treat high cholesterol.",
      "Some studies have suggested that evolocumab may have a positive effect on cognitive function.",
      "A study in the Journal of the American College of Cardiology associated evolocumab with improved cognitive function in patients with high cholesterol and cardiovascular disease.",
      "Another study in the European Journal of Clinical Pharmacology associated evolocumab with improved cognitive function in patients with high cholesterol and mild cognitive impairment.",
      "A study in the Journal of Lipid Research found no significant effect of evolocumab on cognitive function in patients with high cholesterol and cardiovascular disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2462,
    "user_query": "Can radius fracture cause carpal tunnel syndrome?",
    "llama-2-7b-chat-hf_response": "Can a radius fracture cause carpal tunnel syndrome?\nA radius fracture is a break in the radius bone, which is located in the forearm. While a radius fracture can cause pain and limited mobility in the arm, it is unlikely to directly cause carpal tunnel syndrome. Carpal tunnel syndrome is a condition that affects the wrist and hand, causing numbness, tingling, and weakness in the fingers and hand.\nCarpal tunnel syndrome is typically caused by compression of the median nerve, which runs from the forearm into the hand through a narrow passageway in the wrist called the carpal tunnel. The median nerve provides sensation to the palmar surface of the thumb, index finger, and long fingers, as well as motor function to the muscles at the base of the thumb.\nWhile a radius fracture can cause swelling and inflammation in the wrist, which may compress the median nerve and cause symptoms of carpal tunnel syndrome, the fracture itself is not the direct cause of the condition. Other factors, such as repetitive motion or trauma to the wrist, may contribute to the development of carpal tunnel syndrome in someone with a radius fracture.\nIf you have a radius fracture and are experiencing symptoms of carpal tunnel syndrome, it is important to see a healthcare provider for proper evaluation and treatment. Treatment for carpal tunnel syndrome may include rest, physical therapy, and medication to relieve symptoms, as well as surgery in severe cases.\nIn summary, while a radius fracture can contribute to the development of carpal tunnel syndrome, the fracture itself is not the direct cause of the condition. If you are experiencing symptoms of carpal tunnel syndrome after a radius fracture, it is important to seek medical attention to determine the underlying cause and develop an appropriate treatment plan.",
    "llama-2-7b-chat-hf_fact": [
      "A radius fracture is a break in the radius bone, which is located in the forearm.",
      "Carpal tunnel syndrome is a condition that affects the wrist and hand, causing numbness, tingling, and weakness in the fingers and hand.",
      "Carpal tunnel syndrome is typically caused by compression of the median nerve, which runs from the forearm into the hand through a narrow passageway in the wrist called the carpal tunnel.",
      "The median nerve provides sensation to the palmar surface of the thumb, index finger, and long fingers, as well as motor function to the muscles at the base of the thumb.",
      "Treatment for carpal tunnel syndrome may include rest, physical therapy, and medication to relieve symptoms, as well as surgery in severe cases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2464,
    "user_query": "Is Marfan syndrome associated with chordal rupture?",
    "llama-2-7b-chat-hf_response": "Marfan syndrome is a genetic disorder that affects the body's connective tissue, which provides support and structure to various organs and tissues throughout the body, including the heart, blood vessels, eyes, and skeleton. One of the potential complications associated with Marfan syndrome is chordal rupture, which occurs when one or more of the cords that connect the left and right sides of the heart (called the atrioventricular (AV) valves) tear or stretch.\nAccording to the Marfan Foundation, chordal rupture is a relatively common complication in people with Marfan syndrome, occurring in approximately 10% to 20% of individuals with the disorder. Chordal rupture can occur at any age, but it is more likely to occur in older adults with Marfan syndrome.\nIf you have Marfan syndrome and are experiencing symptoms of chordal rupture, such as sudden chest pain, shortness of breath, or difficulty breathing, seek medical attention immediately. Treatment for chordal rupture may involve medications to manage symptoms, surgery to repair or replace the damaged valve, or other interventions depending on the severity of the condition.\nIt is important to work closely with your healthcare provider to manage your Marfan syndrome and monitor for any potential complications, including chordal rupture. With appropriate care and management, many people with Marfan syndrome can lead active and fulfilling lives.",
    "llama-2-7b-chat-hf_fact": [
      "Marfan syndrome is a genetic disorder that affects the body's connective tissue.",
      "Marfan syndrome affects and provides support to different organs and tissues including the heart, blood vessels, eyes, and skeleton.",
      "Chordal rupture, which is when one or more of the cords that connect the left and right sides of the heart tear or stretch, is a complication associated with Marfan syndrome.",
      "Chordal rupture is a relatively common complication in people with Marfan syndrome, occurring in approximately 10% to 20% of individuals with the disorder.",
      "Chordal rupture can occur at any age but is more likely to occur in older adults with Marfan syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2465,
    "user_query": "What is the mechanism of action of Fremanezumab?",
    "llama-2-7b-chat-hf_response": "Fremanezumab is a monoclonal antibody that works by blocking the action of calcitonin gene-related peptide (CGRP), a molecule involved in the transmission of pain signals. By blocking CGRP, fremanezumab reduces the amount of pain signals that are transmitted to the brain, resulting in a reduction in migraine pain.\nFremanezumab is administered via injection every 2 months, and its mechanism of action involves the following steps:\n1. Binding to CGRP: Fremanezumab binds to CGRP in the blood vessels and other tissues, preventing it from interacting with its receptors and transmitting pain signals.\n2. Reduction of pain signals: By blocking CGRP, fremanezumab reduces the amount of pain signals that are transmitted to the brain, resulting in a reduction in migraine pain.\n3. Reduction of inflammation: Fremanezumab also has anti-inflammatory effects, which may contribute to its therapeutic effects in migraine prevention.\nOverall, the mechanism of action of fremanezumab is to reduce the transmission of pain signals by blocking the action of CGRP, thereby providing relief from migraine pain.",
    "llama-2-7b-chat-hf_fact": [
      "Fremanezumab is a monoclonal antibody.",
      "Fremanezumab works by blocking the action of calcitonin gene-related peptide (CGRP), which is involved in the transmission of pain signals.",
      "The administration of Fremanezumab is done via injection every 2 months.",
      "Part of Fremanezumab's action mechanism includes reducing the transmission of pain signals to the brain.",
      "Fremanezumab also possesses anti-inflammatory effects which helps in preventing migraines."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2466,
    "user_query": "Is trastuzumab associated cardiotoxicity reversible?",
    "llama-2-7b-chat-hf_response": "Trastuzumab, a monoclonal antibody used to treat HER2-positive breast cancer, can cause cardiotoxicity, including decreased left ventricular ejection fraction (LVEF) and left ventricular dysfunction. The extent to which trastuzumab-associated cardiotoxicity is reversible depends on the severity and duration of the cardiac dysfunction.\nStudies have shown that in some cases, trastuzumab-associated cardiotoxicity can be reversible with treatment discontinuation or dose reduction. For example, a study published in the Journal of Clinical Oncology found that among patients with HER2-positive breast cancer who experienced a decrease in LVEF of 10% or more during trastuzumab therapy, 60% had a complete or partial recovery of LVEF after treatment discontinuation.\nHowever, in more severe cases of trastuzumab-associated cardiotoxicity, reversibility may be less likely. A study published in the New England Journal of Medicine found that among patients with HER2-positive breast cancer who experienced a decrease in LVEF of 10% or more during trastuzumab therapy, only 30% had a complete or partial recovery of LVEF after 1 year of follow-up.\nIt is important to closely monitor patients for cardiotoxicity during trastuzumab therapy and to consider dose reductions or treatment discontinuation if cardiac dysfunction occurs. In some cases, alternative therapies may be necessary to avoid irreversible damage to the heart.\nIn summary, while some cases of trastuzumab-associated cardiotoxicity may be reversible, the extent to which this is possible depends on the severity and duration of the cardiac dysfunction. Close monitoring and timely intervention are crucial to minimize the risk of irreversible damage to the heart.",
    "llama-2-7b-chat-hf_fact": [
      "Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer.",
      "Trastuzumab can cause cardiotoxicity, including decreased left ventricular ejection fraction (LVEF) and left ventricular dysfunction.",
      "Some cases of trastuzumab-associated cardiotoxicity can be reversible with treatment discontinuation or dose reduction.",
      "A study published in the Journal of Clinical Oncology found that among patients with HER2-positive breast cancer who experienced a decrease in LVEF of 10% or more during trastuzumab therapy, 60% had a complete or partial recovery of LVEF after treatment discontinuation.",
      "A study published in the New England Journal of Medicine found that among patients with HER2-positive breast cancer who experienced a decrease in LVEF of 10% or more during trastuzumab therapy, only 30% had a complete or partial recovery of LVEF after 1 year of follow-up."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2470,
    "user_query": "Describe mechanism of action of Nusinersen.",
    "llama-2-7b-chat-hf_response": "Nusinersen is an antisense oligonucleotide drug that works by reducing the production of the protein SMN (survival motor neuron). This protein is essential for the survival of motor neurons in the spinal cord and brain stem, which are affected in patients with spinal muscular atrophy (SMA).\nThe mechanism of action of nusinersen involves binding to pre-mRNA and preventing the production of the SMN protein. This is achieved through a process called RNA interference (RNAi), which is a natural mechanism by which cells regulate the expression of genes.\nRNAi works by degrading specific messenger RNAs (mRNAs), which carry genetic information from DNA to the ribosome for protein synthesis. By binding to the pre-mRNA of the SMN gene, nusinersen triggers the RNAi pathway, leading to the degradation of the SMN mRNA and a reduction in the production of the SMN protein.\nThe reduction in SMN protein production leads to an increase in the survival of motor neurons in the spinal cord and brain stem, which are affected in SMA patients. This ultimately leads to improved muscle function and survival in these patients.\nIn summary, the mechanism of action of nusinersen involves binding to pre-mRNA and triggering the RNAi pathway, leading to a reduction in the production of the SMN protein and an increase in the survival of motor neurons in the spinal cord and brain stem.",
    "llama-2-7b-chat-hf_fact": [
      "Nusinersen is an antisense oligonucleotide drug, which works by reducing the production of the SMN protein.",
      "The SMN protein is vital for the survival of motor neurons in the spinal cord and brain stem.",
      "The mechanism of action of Nusinersen involves binding to pre-mRNA and triggering the RNA interference pathway.",
      "RNA interference works by degrading specific messenger RNAs, which carry genetic information from DNA to the ribosome for protein synthesis.",
      "The action of Nusinersen increases the survival of motor neurons in the spinal cord and brain stem of Spinal muscular atrophy patients by reducing SMN protein production."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Nusinersen is an antisense oligonucleotide drug, which works by increasing the production of the SMN protein.",
      "true",
      "false, [corrected fact]: The mechanism of action of Nusinersen involves binding to pre-mRNA and modulation the splicing of SMN2 gene transcripts.",
      "true",
      "false, [corrected fact]: The action of Nusinersen increases the survival of motor neurons in the spinal cord and brain stem of Spinal muscular atrophy patients by increasing SMN protein production."
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-7b-chat-hf_response": "The 959 Nematode Genomes initiative is a large-scale effort to sequence and analyze the genomes of 959 species of nematodes, which are a group of microscopic worms that are found in almost every environment on Earth. The initiative is led by the University of California, Riverside (UCR) and involves a collaboration of researchers from over 100 institutions around the world.\nThe goal of the 959 Nematode Genomes initiative is to create a comprehensive understanding of the evolution, diversity, and biology of nematodes, which are important model organisms in many fields of research, including agriculture, medicine, and ecology. By sequencing and analyzing the genomes of such a large number of nematode species, the initiative aims to identify new genes, regulatory elements, and other genomic features that are unique to nematodes and could have important applications in biotechnology and biomedicine.\nThe 959 Nematode Genomes initiative is using a variety of cutting-edge sequencing technologies, including single-molecule real-time sequencing and nanopore sequencing, to generate high-quality genomic data for each of the 959 nematode species. The initiative is also developing new computational tools and methods for analyzing and interpreting the large amounts of genomic data being generated.\nOverall, the 959 Nematode Genomes initiative is a groundbreaking effort to explore the diversity of nematode genomes and to uncover new insights into the biology and evolution of these fascinating organisms.",
    "llama-2-7b-chat-hf_fact": [
      "The 959 Nematode Genomes initiative is a project to sequence and analyze the genomes of 959 species of nematodes.",
      "This initiative is led by the University of California, Riverside and involves over 100 institutions worldwide.",
      "The goal of this initiative is to gain a comprehensive understanding of the evolution, diversity, and biology of nematodes.",
      "The 959 Nematode Genomes initiative is using advanced sequencing technologies, like single-molecule real-time sequencing and nanopore sequencing.",
      "The initiative is developing computational tools and methods for analyzing and interpreting the large amounts of genomic data being generated."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2475,
    "user_query": "What is the drug target(s) for Belsomra?",
    "llama-2-7b-chat-hf_response": "Belsomra (Suvorexant) is a drug that is used to treat insomnia. It works by binding to a specific receptor in the brain called the orexin receptor. By binding to this receptor, Belsomra helps to regulate the sleep-wake cycle and promote sleep.\nThe orexin receptor is a G-protein coupled receptor that is found in several areas of the brain, including the hypothalamus, the brainstem, and the spinal cord. The orexin receptor is involved in the regulation of a variety of physiological processes, including sleep, wakefulness, and arousal.\nBelsomra is a selective modulator of the orexin receptor, meaning that it selectively binds to this receptor and has a higher affinity for it than other receptors in the body. By selectively binding to the orexin receptor, Belsomra is able to produce a more targeted effect on the sleep-wake cycle and reduce the time it takes to fall asleep.\nOverall, the drug target for Belsomra is the orexin receptor, which is involved in the regulation of the sleep-wake cycle and other physiological processes in the brain. By selectively binding to this receptor, Belsomra is able to produce a more targeted effect on the sleep-wake cycle and promote sleep.",
    "llama-2-7b-chat-hf_fact": [
      "Belsomra (Suvorexant) is used to treat insomnia.",
      "Belsomra works by binding to the orexin receptor in the brain.",
      "The orexin receptor is a G-protein coupled receptor located in different areas of the brain including the hypothalamus, the brainstem, and the spinal cord.",
      "The orexin receptor is involved in the regulation of physiological processes such as sleep, wakefulness, and arousal.",
      "Belsomra is a selective modulator of the orexin receptor, meaning it selectively binds to this receptor and has a higher affinity for it than other receptors in the body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2476,
    "user_query": "Can canagliflozin cause euglycemic diabetic ketoacidosis?",
    "llama-2-7b-chat-hf_response": "Euglycemic diabetic ketoacidosis (EDKA) is a rare but potentially life-threatening complication of sodium-glucose cotransporter 2 (SGLT2) inhibitors, including canagliflozin. EDKA occurs when the body produces high levels of ketones in the absence of high blood sugar levels, leading to a metabolic crisis.\nThe exact mechanism by which canagliflozin causes EDKA is not fully understood, but it is thought to involve an imbalance in the body's metabolism of glucose and ketones. Canagliflozin works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This can cause the body to produce more ketones as an alternative source of energy. In some cases, this can lead to an excessive production of ketones, which can accumulate in the blood and cause EDKA.\nSymptoms of EDKA caused by canagliflozin can include nausea, vomiting, abdominal pain, fatigue, and confusion. In severe cases, EDKA can lead to seizures, coma, and even death. If you experience any of these symptoms while taking canagliflozin, it is important to seek medical attention immediately.\nTo reduce the risk of EDKA while taking canagliflozin, it is important to monitor your blood sugar levels closely and to seek medical attention if you experience any symptoms of the condition. Your healthcare provider may also recommend other medications to help manage your blood sugar levels and reduce the risk of EDKA.\nIn summary, canagliflozin can cause euglycemic diabetic ketoacidosis, a rare but potentially life-threatening complication. If you experience any symptoms of EDKA while taking canagliflozin, it is important to seek medical attention immediately.",
    "llama-2-7b-chat-hf_fact": [
      "Euglycemic diabetic ketoacidosis (EDKA) is a potential complication of sodium-glucose cotransporter 2 (SGLT2) inhibitors, including canagliflozin.",
      "Canagliflozin works by inhibiting the reabsorption of glucose in the kidneys, which leads to increased glucose excretion in the urine.",
      "Excessive ketone production, which can lead to EDKA, can be a result of canagliflozin's mechanism of action.",
      "Symptoms of EDKA caused by canagliflozin can include nausea, vomiting, abdominal pain, fatigue, confusion, seizures, coma, and even death.",
      "Monitoring of blood sugar levels and immediate medical attention when EDKA symptoms arise, are recommended while taking canagliflozin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2478,
    "user_query": "Is there an association between Klinefelter syndrome and breast cancer?",
    "llama-2-7b-chat-hf_response": "Klinefelter syndrome is a genetic condition that affects males and is caused by an extra X chromosome. While the condition is relatively rare, it has been associated with an increased risk of certain cancers, including breast cancer.\nResearch suggests that men with Klinefelter syndrome may have a higher risk of developing breast cancer compared to the general male population. One study published in the Journal of Clinical Oncology found that men with Klinefelter syndrome had a higher incidence of breast cancer than men without the condition.\nThe exact mechanism by which Klinefelter syndrome increases the risk of breast cancer is not fully understood. However, it is thought that the extra X chromosome in Klinefelter syndrome may lead to changes in the expression of genes involved in breast cancer development and progression.\nIt's important to note that the risk of breast cancer in men with Klinefelter syndrome is still relatively low compared to the risk in women. According to the American Cancer Society, the lifetime risk of breast cancer in men is about 1 in 1,000, compared to 1 in 8 in women.\nIf you have Klinefelter syndrome, it's important to talk to your doctor about your breast cancer risk and any steps you can take to reduce your risk. This may include regular breast exams and mammograms, as well as other screening tests.\nIn summary, while Klinefelter syndrome is associated with an increased risk of breast cancer, the risk is still relatively low compared to the risk in women. If you have Klinefelter syndrome, it's important to talk to your doctor about your breast cancer risk and any steps you can take to reduce your risk.",
    "llama-2-7b-chat-hf_fact": [
      "Klinefelter syndrome is a genetic condition caused by an extra X chromosome.",
      "Men with Klinefelter syndrome have an increased risk of developing breast cancer compared to the general male population.",
      "The exact mechanism by which Klinefelter syndrome increases the risk of breast cancer is not fully understood.",
      "According to the American Cancer Society, the lifetime risk of breast cancer in men is about 1 in 1,000 compared to 1 in 8 in women.",
      "Men with Klinefelter syndrome are recommended to talk to their doctor about their breast cancer risk and discuss steps to reduce it."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2479,
    "user_query": "Which R packages have been developed for the discovery of mutational signatures in cancer?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for the discovery of mutational signatures in cancer, including:\n1. MSignature: This package uses a Bayesian approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n2. SignatureDiscovery: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n3. MutationalSignature: This package uses a statistical approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n4. CancerMutationSignature: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n5. SomaticMutationSignature: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n6. CancerSignature: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n7. MutationSignatureAnalysis: This package uses a statistical approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n8. CancerMutationSignatureAnalysis: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n9. SignatureAnalysis: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\n10. CancerSignatureAnalysis: This package uses a machine learning approach to identify mutational signatures in cancer genomes. It can be used to analyze both whole-genome sequencing and targeted sequencing data.\nPlease note that this is not an exhaustive list, and",
    "llama-2-7b-chat-hf_fact": [
      "MSignature is an R package developed for the discovery of mutational signatures in cancer.",
      "SignatureDiscovery is an R package that uses a machine learning approach to identify mutational signatures in cancer genomes.",
      "MutationalSignature is another R package used to analyze cancer genomes, and it uses a statistical approach in its analysis.",
      "CancerMutationSignature is an R package that uses machine learning to identify mutational signatures in cancer genomes.",
      "The R package MutationSignatureAnalysis uses a statistical approach to identify mutational signatures in cancer genomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2484,
    "user_query": "Which data simulator is available for CLIP-SEQ experiments?",
    "llama-2-7b-chat-hf_response": "CLIP-SEQ is a machine learning model that predicts the next amino acid in a protein sequence given the previous amino acids. There are several data simulators available that can be used to generate synthetic protein sequences for training and testing CLIP-SEQ models. Here are some popular data simulators for CLIP-SEQ experiments:\n1. Protein Structure Simulator (PSS): PSS is a web-based tool that generates protein structures based on a given sequence. It can be used to generate synthetic protein sequences with specific structural features, such as secondary structure or protein-ligand interactions.\n2. Rosetta: Rosetta is a suite of software tools for protein structure prediction and design. It can be used to generate synthetic protein sequences with specific structural features, such as secondary structure or protein-ligand interactions.\n3. RaptorX: RaptorX is a web-based tool that generates protein sequences with specific structural features, such as secondary structure or protein-ligand interactions. It can be used to generate synthetic protein sequences for training and testing CLIP-SEQ models.\n4. ProteinMAST: ProteinMAST is a web-based tool that generates protein sequences with specific structural features, such as secondary structure or protein-ligand interactions. It can be used to generate synthetic protein sequences for training and testing CLIP-SEQ models.\n5. Synthetic Protein Sequence Generator (SPSG): SPSG is a web-based tool that generates protein sequences with specific structural features, such as secondary structure or protein-ligand interactions. It can be used to generate synthetic protein sequences for training and testing CLIP-SEQ models.\nThese data simulators can be used to generate synthetic protein sequences with specific structural features, such as secondary structure or protein-ligand interactions, which can be used to train and test CLIP-SEQ models.",
    "llama-2-7b-chat-hf_fact": [
      "CLIP-SEQ is a machine learning model that predicts the next amino acid in a protein sequence based on previous amino acids.",
      "The Protein Structure Simulator (PSS) is a web-based tool that generates synthetic protein sequences with specific structural features for training and testing CLIP-SEQ models.",
      "Rosetta is another suite of software tools used for protein structure prediction and design, which can be employed for generating synthetic protein structures for testing and training CLIP-SEQ models.",
      "RaptorX is another web-based tool used to generate synthetic protein sequences with specific structural features.",
      "ProteinMAST and Synthetic Protein Sequence Generator (SPSG) are web-based tools used to generate protein sequences for CLIP-SEQ models training and testing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "false, [corrected fact]: RaptorX is a web-based tool used to predict protein 3D structure from sequence.",
      "unknown"
    ]
  },
  {
    "id": 2487,
    "user_query": "Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?",
    "llama-2-7b-chat-hf_response": "Cortical interneurons are a heterogeneous group of neurons that play a crucial role in the function of the cerebral cortex. Dlx1 and Dlx2 are transcription factors that have been implicated in the development and function of cortical interneurons. Here are some key findings on the role of Dlx1 and Dlx2 in cortical interneurons:\n1. Dlx1 and Dlx2 are expressed in cortical interneurons: Both Dlx1 and Dlx2 are expressed in cortical interneurons, with Dlx1 being more highly expressed in these cells.\n2. Dlx1 and Dlx2 regulate the expression of genes involved in synaptic plasticity: Dlx1 and Dlx2 have been shown to regulate the expression of genes involved in synaptic plasticity, such as N-methyl-D-aspartate (NMDA) receptors and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.\n3. Dlx1 and Dlx2 are required for the proper formation of cortical interneuron subtypes: Studies have shown that Dlx1 and Dlx2 are required for the proper formation of certain subtypes of cortical interneurons, such as fast-spiking interneurons.\n4. Dlx1 and Dlx2 regulate the activity of cortical interneurons: Dlx1 and Dlx2 have been shown to regulate the activity of cortical interneurons, with Dlx1 promoting the activity of these cells and Dlx2 inhibiting their activity.\n5. Dlx1 and Dlx2 are involved in the regulation of cortical circuit function: Dlx1 and Dlx2 have been shown to be involved in the regulation of cortical circuit function, with Dlx1 promoting the formation of excitatory cortical circuits and Dlx2 inhibiting the formation of inhibitory cortical circuits.\nIn summary, Dlx1 and Dlx2 are transcription factors that play a crucial role in the development and function of cortical inter",
    "llama-2-7b-chat-hf_fact": [
      "Cortical interneurons are a heterogeneous group of neurons that function in the cerebral cortex.",
      "Dlx1 and Dlx2 are transcription factors that contribute to the development and function of cortical interneurons.",
      "Both Dlx1 and Dlx2 are expressed in cortical interneurons, regulating the expression of genes involved in synaptic plasticity.",
      "Dlx1 and Dlx2 are required for the proper formation of certain subtypes of cortical interneurons, such as fast-spiking interneurons.",
      "Dlx1 and Dlx2 regulate the activity of cortical interneurons and are involved in the regulation of cortical circuit function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2489,
    "user_query": "What is SMiLE-seq?",
    "llama-2-7b-chat-hf_response": "SMiLE-seq is a single-molecule sequencing technique that allows for the analysis of RNA molecules at the single-molecule level. It is an extension of the popular single-molecule real-time (SMRT) sequencing technology, which was developed by Pacific Biosciences.\nHow does SMiLE-seq work?\nSMiLE-seq works by using a combination of chemical and enzymatic reactions to cleave the RNA molecule into smaller fragments, which are then sequenced using the SMRT technology. The process involves the following steps:\n1. Sample preparation: The RNA molecules of interest are isolated from the sample and converted into a form that can be used for sequencing.\n2. Cleavage: The RNA molecules are cleaved into smaller fragments using a combination of chemical and enzymatic reactions.\n3. Sequencing: The cleaved RNA fragments are then sequenced using the SMRT technology, which involves the use of a nanopore to read the sequence of nucleotides in the RNA molecule.\nWhat are the advantages of SMiLE-seq?\nSMiLE-seq has several advantages over other RNA sequencing techniques, including:\n1. Long-read capabilities: SMiLE-seq can generate reads that are up to 100 kilobases in length, which is longer than many other RNA sequencing techniques.\n2. High accuracy: The SMRT technology used in SMiLE-seq is highly accurate, with error rates of less than 1%.\n3. Ability to sequence complex RNA structures: SMiLE-seq can sequence RNA molecules with complex structures, such as those found in riboswitches and ribozymes.\n4. High throughput: SMiLE-seq can be used to sequence multiple RNA molecules in parallel, making it a high-throughput technique.\nWhat are the applications of SMiLE-seq?\nSMiLE-seq has a wide range of applications in the field of RNA research, including:\n1. Transcriptome analysis: SMiLE-seq can be used to study the transcriptome of an organism, including the identification of novel transcripts and the analysis of gene expression.\n2. RNA",
    "llama-2-7b-chat-hf_fact": [
      "SMiLE-seq is a single-molecule sequencing technique used for the analysis of RNA molecules.",
      "SMiLE-seq is an extension of the single-molecule real-time (SMRT) sequencing technology developed by Pacific Biosciences.",
      "The SMRT technology used in SMiLE-seq involves the use of a nanopore to read the sequence of nucleotides in the RNA molecule.",
      "SMiLE-seq can generate reads that are up to 100 kilobases in length and it can sequence RNA molecules with complex structures.",
      "SMiLE-seq has a wide range of applications in the field of RNA research, including the identification of novel transcripts and the analysis of gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: SMiLE-seq is not an extension of single-molecule real-time (SMRT) sequencing technology but it's a unique method developed independently.",
      "false, [corrected fact]: It is not the SMRT technology that uses a nanopore for sequencing. SMiLE-seq uses the concept of enzymatic synthesis and cleavage of RNA strands for sequencing.",
      "true",
      "true"
    ]
  },
  {
    "id": 2493,
    "user_query": "Describe JACUSA",
    "llama-2-7b-chat-hf_response": "JACUSA (Justice, Advocacy, and Community Support for Undocumented Australians) is a non-profit organization that provides support and advocacy for undocumented Australians and their families. The organization was established in 2013 and is based in Melbourne, Victoria.\nJACUSA's mission is to promote the rights and well-being of undocumented Australians, who are often marginalized and excluded from mainstream society due to their immigration status. The organization provides a range of services, including:\n1. Legal advice and representation: JACUSA provides free legal advice and representation to undocumented Australians who are facing immigration detention, deportation, or other legal issues related to their immigration status.\n2. Advocacy: JACUSA advocates for the rights and interests of undocumented Australians with government agencies, politicians, and the broader community. The organization works to raise awareness about the issues faced by undocumented Australians and to push for policy changes that promote their rights and well-being.\n3. Community support: JACUSA provides a safe and supportive space for undocumented Australians to connect with others who are going through similar experiences. The organization offers counseling, mentoring, and other forms of support to help individuals cope with the challenges of living without legal status.\n4. Education and training: JACUSA provides education and training programs to help undocumented Australians develop skills and knowledge that can help them navigate the complex immigration system and improve their employability.\n5. Research and policy development: JACUSA conducts research and develops policy proposals to inform the development of more inclusive and humane immigration policies in Australia. The organization works to promote a more comprehensive and compassionate approach to immigration that recognizes the contributions of undocumented Australians to Australian society.\nOverall, JACUSA's work is focused on promoting the rights and well-being of undocumented Australians, and advocating for a more inclusive and compassionate approach to immigration policy in Australia.",
    "llama-2-7b-chat-hf_fact": [
      "JACUSA is a non-profit organization formed to support and advocate for undocumented Australians and their families.",
      "JACUSA was established in 2013 and is based in Melbourne, Victoria.",
      "JACUSA offers services including legal advice and representation, advocacy, community support, education and training, and research and policy development for undocumented Australians.",
      "JACUSA promotes rights and well-being of undocumented Australians, who face marginalization due to their immigration status.",
      "JACUSA is involved in research and policy development for more inclusive and humane immigration policies in Australia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2507,
    "user_query": "CURB65 score is used for stratification of which disease?",
    "llama-2-7b-chat-hf_response": "A) Chronic obstructive pulmonary disease (COPD)\nB) Chronic kidney disease (CKD)\nC) Chronic heart failure (CHF)\nD) Chronic obstructive pulmonary disease (COPD)\nCorrect answer: D) Chronic obstructive pulmonary disease (COPD)\nExplanation: The CURB65 score is a clinical score used to assess the severity of chronic obstructive pulmonary disease (COPD). It is used to stratify patients with COPD into different categories based on the severity of their symptoms, which can help guide treatment decisions. The score is calculated based on the patient's age, lung function, symptoms, and exacerbation history.",
    "llama-2-7b-chat-hf_fact": [
      "The CURB65 score is a clinical score used to assess the severity of chronic obstructive pulmonary disease (COPD).",
      "The CURB65 score is used to stratify patients with COPD into different categories based on the severity of their symptoms.",
      "Diagnosing the severity of COPD based on the CURB65 score is an approach to inform the treatment decisions.",
      "The CURB65 score calculation takes into account the patient's age, lung function, symptoms, and exacerbation history."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The CURB65 score is a clinical score used to assess the severity of community-acquired pneumonia, not chronic obstructive pulmonary disease (COPD).",
      "false, [corrected fact]: The CURB-65 score is not used to stratify patients with COPD. It's used for patients with community-acquired pneumonia.",
      "false, [corrected fact]: Diagnosing the severity of COPD based on the CURB65 score is incorrect. The CURB65 score is used for assessing the severity of community-acquired pneumonia and guiding treatment decisions.",
      "false, [corrected fact]: The CURB65 score calculation does not take into account lung function, symptoms, and exacerbation history specifically. It considers Confusion, Urea level, Respiratory rate, Blood pressure, and age 65 or older."
    ]
  },
  {
    "id": 2509,
    "user_query": "Is creatinine assessment included in the MELD score?",
    "llama-2-7b-chat-hf_response": "No, creatinine assessment is not included in the MELD score. The MELD (Model for End-Stage Liver Disease) score is a mathematical formula used to assess the severity of chronic liver disease and determine the priority for liver transplantation. The MELD score is based on three variables: bilirubin, INR (international normalized ratio), and creatinine. However, creatinine assessment is not included in the calculation of the MELD score. Instead, the creatinine level is used to calculate the Child-Turcotte-Pugh (CTP) score, which is a separate score used to assess the severity of liver disease and determine the priority for liver transplantation.",
    "llama-2-7b-chat-hf_fact": [
      "Creatinine assessment is not included in the MELD score.",
      "The MELD score is a mathematical formula used to assess the severity of chronic liver disease.",
      "MELD score determines the priority for liver transplantation.",
      "MELD score is based on three variables: bilirubin, INR (international normalized ratio), and creatinine.",
      "The creatinine level is used to calculate the Child-Turcotte-Pugh (CTP) score."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Creatinine assessment is included in the MELD score.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The creatinine level is not used to calculate the Child-Turcotte-Pugh (CTP) score. The CTP score is calculated based on five clinical measures: total bilirubin, serum albumin, prothrombin time or INR, ascites, and hepatic encephalopathy."
    ]
  },
  {
    "id": 2516,
    "user_query": "What cellular process are okazaki fragments associated with?",
    "llama-2-7b-chat-hf_response": "Okazaki fragments are short segments of DNA that are synthesized in a discontinuous manner during DNA replication in eukaryotic cells. They are named after the Japanese scientist Ryoji Okazaki, who first described them in the 1960s. Okazaki fragments are typically around 100-200 nucleotides in length and are synthesized in a 5' to 3' direction.\nOkazaki fragments are associated with the following cellular process:\n1. DNA replication: Okazaki fragments are synthesized during DNA replication, which is the process by which a cell makes a copy of its DNA before cell division.\n2. Semiconservative replication: Okazaki fragments are synthesized through a semiconservative replication mechanism, which means that each new DNA molecule contains one old strand and one new strand.\n3. RNA primers: Okazaki fragments are synthesized using RNA primers, which are short RNA molecules that provide a starting point for DNA synthesis.\n4. DNA polymerase: Okazaki fragments are synthesized by DNA polymerase, an enzyme that adds nucleotides to a growing DNA strand.\n5. Checkpoint control: Okazaki fragments are also associated with checkpoint control, which is a process that ensures that DNA replication is completed correctly and that any errors are corrected before cell division.\nIn summary, Okazaki fragments are short segments of DNA that are synthesized in a discontinuous manner during DNA replication in eukaryotic cells. They are associated with several cellular processes, including DNA replication, semiconservative replication, RNA primers, DNA polymerase, and checkpoint control.",
    "llama-2-7b-chat-hf_fact": [
      "Okazaki fragments are short segments of DNA that are synthesized during DNA replication in eukaryotic cells.",
      "Ryoji Okazaki, a Japanese scientist, first described Okazaki fragments in the 1960s.",
      "Okazaki fragments are typically around 100-200 nucleotides in length and are synthesized in a 5' to 3' direction.",
      "The synthesis of Okazaki fragments involves the use of RNA primers, which provide a starting point for DNA synthesis.",
      "The enzyme involved in creating Okazaki fragments is called DNA polymerase."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Okazaki fragments are typically around 100-200 nucleotides in length in eukaryotes and are synthesized in a 5' to 3' direction.",
      "true",
      "true"
    ]
  },
  {
    "id": 2518,
    "user_query": "Clue cells are characteristics to which causative bacteria of vaginitis?",
    "llama-2-7b-chat-hf_response": "Clue cells are characteristics that can help identify the causative bacteria of vaginitis. These cells are present in the vaginal discharge and can provide important clues for diagnosis. Here are some common clue cells associated with different types of vaginitis:\n1. Bacterial vaginosis (BV): Clue cells are present in 70-80% of women with BV. The most common clue cells are:\na. Wet prep: A wet prep is a microscopic examination of the vaginal discharge. In BV, the wet prep will show numerous motile gram-negative rods, which are the clue cells.\nb. Gram stain: A gram stain is a microscopic examination of the vaginal discharge after staining with a gram stain. In BV, the gram stain will show numerous motile gram-negative rods.\nc. Culture: A culture of the vaginal discharge can also identify the causative bacteria of BV.\n2. Yeast infection (Candida vaginitis): Clue cells are present in 70-80% of women with yeast infections. The most common clue cells are:\na. Wet prep: A wet prep is a microscopic examination of the vaginal discharge. In yeast infections, the wet prep will show numerous budding yeast cells, which are the clue cells.\nb. Gram stain: A gram stain is a microscopic examination of the vaginal discharge after staining with a gram stain. In yeast infections, the gram stain will show numerous budding yeast cells.\nc. Culture: A culture of the vaginal discharge can also identify the causative fungus of yeast infections.\n3. Trichomoniasis: Clue cells are present in 70-80% of women with trichomoniasis. The most common clue cells are:\na. Wet prep: A wet prep is a microscopic examination of the vaginal discharge. In trichomoniasis, the wet prep will show numerous motile protozoa, which are the clue cells.\nb. Gram stain: A gram stain is a microscopic exam",
    "llama-2-7b-chat-hf_fact": [
      "Clue cells are characteristics that can help identify the causative bacteria of vaginitis.",
      "Clue cells are present in the vaginal discharge of patients with vaginitis.",
      "In bacterial vaginosis, the wet prep shows numerous motile gram-negative rods, which are the clue cells.",
      "In Candida vaginitis, the wet prep shows numerous budding yeast cells, which are the clue cells.",
      "In trichomoniasis, the wet prep shows numerous motile protozoa as clue cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: In bacterial vaginosis, the wet prep shows clue cells, which are vaginal epithelial cells studded with bacteria.",
      "false, [corrected fact]: In Candida vaginitis, the wet prep shows numerous budding yeast cells, but these are not referred to as clue cells.",
      "false, [corrected fact]: In trichomoniasis, the wet prep shows numerous motile protozoa, but these are not referred to as clue cells."
    ]
  },
  {
    "id": 2519,
    "user_query": "What is included in the fourth generation HIV test?",
    "llama-2-7b-chat-hf_response": "The fourth generation HIV test, also known as the fourth-generation antibody/antigen test, is a highly sensitive and accurate test for detecting HIV infection. This test detects both HIV antibodies and antigens in the blood or oral fluid, providing a more comprehensive picture of the individual's HIV status.\nThe fourth generation HIV test includes the following components:\n1. HIV antibody test: This test detects the presence of HIV antibodies in the blood or oral fluid. Antibodies are proteins produced by the immune system in response to the presence of HIV.\n2. HIV antigen test: This test detects the presence of HIV antigens in the blood or oral fluid. Antigens are substances that can trigger an immune response, and in the case of HIV, they are produced by the virus itself.\n3. DNA test: This test detects the presence of HIV DNA in the blood or oral fluid. HIV DNA is the genetic material of the virus, and its presence indicates that the individual is infected with HIV.\n4. Western blot test: This test is used to confirm the results of the HIV antibody test. It detects the presence of specific antibodies in the blood or oral fluid that are produced in response to HIV infection.\n5. Viral load test: This test measures the amount of HIV virus in the blood or oral fluid. The viral load is an indicator of the severity of the infection and can be used to monitor the effectiveness of treatment.\n6. Phylogenetic analysis: This test is used to determine the genetic relatedness of the HIV virus in the individual's blood or oral fluid to known HIV strains. This information can be used to track the spread of the virus and to develop effective treatment strategies.\nThe fourth generation HIV test is highly accurate and can detect HIV infection earlier than previous tests. It is an important tool in the fight against HIV/AIDS, as it can help identify individuals who are infected and provide them with appropriate treatment and care.",
    "llama-2-7b-chat-hf_fact": [
      "The fourth-generation HIV test detects both HIV antibodies and antigens.",
      "The HIV antibody test included in the fourth generation test detects antibodies produced by the immune system in response to HIV.",
      "The fourth-generation HIV test includes an HIV antigen test that detects substances produced by the virus that trigger an immune response.",
      "Included in the fourth generation HIV test is a DNA test that identifies the presence of HIV DNA in the blood or oral fluid.",
      "The western blot test included in the fourth generation HIV test confirms the results of the HIV antibody test by detecting specific antibodies produced in response to HIV infection.",
      "The viral load test, part of the fourth generation HIV test, measures the amount of HIV virus in the blood or oral fluid, providing an indicator of the severity of the infection and the effectiveness of treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The fourth-generation HIV test does not include a DNA test. The DNA test is a separate test that identifies the presence of HIV DNA in the blood or oral fluid.",
      "false, [corrected fact]: The western blot test is not included in the fourth generation HIV test. It is a separate test that is often used to confirm the results of an HIV antibody test.",
      "false, [corrected fact]: The viral load test is not part of the fourth generation HIV test. It is a separate test that measures the amount of HIV virus in the blood, providing an indicator of the severity of the infection and the effectiveness of treatment."
    ]
  },
  {
    "id": 2520,
    "user_query": "Which disease is diagnosed using the Finkelstein's test?",
    "llama-2-7b-chat-hf_response": "A. Osteoarthritis\nB. Rheumatoid arthritis\nC. Ankylosing spondylitis\nD. Psoriatic arthritis\nAnswer: B. Rheumatoid arthritis\nExplanation: Finkelstein's test is a clinical test used to diagnose rheumatoid arthritis (RA). It is performed by having the patient bend their knee and then straighten it, while the examiner applies pressure to the patellar tendon. If the test is positive, it suggests inflammation in the knee joint, which is a common finding in RA. Other diseases, such as osteoarthritis (A), ankylosing spondylitis (C), and psoriatic arthritis (D), may also cause knee pain and stiffness, but Finkelstein's test is specific to RA.",
    "llama-2-7b-chat-hf_fact": [
      "Finkelstein's test is a clinical test used to diagnose rheumatoid arthritis.",
      "The test is performed by having the patient bend their knee and then straighten it, while pressure is applied to the patellar tendon.",
      "A positive Finkelstein's test suggests inflammation in the knee joint.",
      "Knee joint inflammation is a common finding in rheumatoid arthritis.",
      "Diseases such as osteoarthritis, ankylosing spondylitis, and psoriatic arthritis can also cause knee pain and stiffness."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Finkelstein's test is a clinical test used to diagnose De Quervain's tenosynovitis, not rheumatoid arthritis.",
      "false, [corrected fact]: The test is performed by having the patient make a fist with the thumb tucked inside the fingers, and then bending the wrist towards the little finger.",
      "false, [corrected fact]: A positive Finkelstein's test suggests inflammation in the tendons of the thumb, not the knee joint.",
      "true",
      "true"
    ]
  },
  {
    "id": 2521,
    "user_query": "For which type of cancer can uc.189 be used as a potential prognostic biomarker?",
    "llama-2-7b-chat-hf_response": "UC.189 is a gene that encodes a protein involved in the regulation of cell growth and division. It has been found to be overexpressed in various types of cancer, including breast, lung, and colon cancer. As a potential prognostic biomarker, UC.189 has been shown to be associated with poorer prognosis in some of these cancer types.\nFor example, in breast cancer, UC.189 has been found to be overexpressed in aggressive tumors and is associated with poorer overall survival. Similarly, in lung cancer, UC.189 has been found to be overexpressed in adenocarcinoma subtype and is associated with poorer prognosis.\nIn colon cancer, UC.189 has been found to be overexpressed in tumors with high microsatellite instability (MSI) and is associated with poorer prognosis.\nOverall, UC.189 has been identified as a potential prognostic biomarker for various types of cancer, including breast, lung, and colon cancer.",
    "llama-2-7b-chat-hf_fact": [
      "UC.189 is a gene that encodes a protein involved in the regulation of cell growth and division.",
      "UC.189 has been found to be overexpressed in various types of cancer, including breast, lung, and colon cancer.",
      "In breast cancer, UC.189 is overexpressed in aggressive tumors and is associated with poorer overall survival.",
      "In lung cancer, UC.189 is overexpressed in adenocarcinoma subtype and is associated with poorer prognosis.",
      "In colon cancer, UC.189 is overexpressed in tumors with high microsatellite instability (MSI) and is associated with poorer prognosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2525,
    "user_query": "Which package in Bioconductor has been developed with the aim to analyze differential DNA loops from sequencing data?",
    "llama-2-7b-chat-hf_response": "Answer: The package in Bioconductor that has been developed with the aim to analyze differential DNA loops from sequencing data is called \"DNALoop\".\nDNALoop is a package in Bioconductor that provides tools for the analysis of differential DNA loops from sequencing data. It can be used to identify regions of the genome where the looping interactions are altered between different cell types or conditions, and can provide insights into the regulatory mechanisms underlying these changes.\nSome of the key features of DNALoop include:\n1. Differential loop analysis: DNALoop can identify regions of the genome where the looping interactions are altered between different cell types or conditions, and can provide a comprehensive overview of the differentially looped regions.\n2. Integrative analysis: DNALoop can integrate data from different types of sequencing technologies, such as ChIP-seq, RNA-seq, and DNA sequencing, to provide a more comprehensive understanding of the regulatory mechanisms underlying the differentially looped regions.\n3. Visualization tools: DNALoop provides a range of visualization tools to help users visualize and interpret the results of the differential loop analysis, including heatmaps, scatter plots, and 3D plots.\n4. Integration with other Bioconductor packages: DNALoop can be easily integrated with other Bioconductor packages, such as HISAT2 and STAR, to provide a more comprehensive analysis of the sequencing data.\nOverall, DNALoop is a powerful tool for the analysis of differential DNA loops from sequencing data, and can be used to provide insights into the regulatory mechanisms underlying cellular differentiation and disease.",
    "llama-2-7b-chat-hf_fact": [
      "DNALoop is a package in Bioconductor developed to analyze differential DNA loops from sequencing data.",
      "DNALoop can identify regions of the genome where looping interactions are altered between different cell types or conditions.",
      "This package is capable of integrating data from different types of sequencing technologies.",
      "DNALoop offers visualization tools including heatmaps, scatter plots, and 3D plots for results interpretation.",
      "DNALoop can be integrated with other Bioconductor packages such as HISAT2 and STAR."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2526,
    "user_query": "Which disease can be diagnosed with the \"probe to bone\" test?",
    "llama-2-7b-chat-hf_response": "The \"probe to bone\" test, also known as a bone scan, can be used to diagnose a variety of diseases and conditions that affect the bones. Some of the diseases and conditions that can be diagnosed with a bone scan include:\n1. Osteoporosis: A bone scan can help diagnose osteoporosis, a condition in which the bones become weak and brittle, leading to an increased risk of fractures.\n2. Bone cancer: A bone scan can help diagnose primary bone cancer, which is cancer that originates in the bones, as well as metastatic bone cancer, which is cancer that has spread to the bones from another part of the body.\n3. Paget's disease of bone: Paget's disease is a condition in which the bones become enlarged and deformed due to abnormal bone growth.\n4. Bone infections: A bone scan can help diagnose bone infections, such as osteomyelitis, which is an infection of the bone and bone marrow.\n5. Benign bone tumors: A bone scan can help diagnose benign bone tumors, such as bone cysts and bone tumors that are not cancerous.\n6. Metabolic bone disorders: A bone scan can help diagnose metabolic bone disorders, such as hyperparathyroidism, which is an excess of parathyroid hormone in the body, and hypocalcemia, which is a low level of calcium in the blood.\n7. Inflammatory bone disorders: A bone scan can help diagnose inflammatory bone disorders, such as rheumatoid arthritis and psoriatic arthritis, which are conditions that cause inflammation in the joints and bones.\n8. Bone marrow disorders: A bone scan can help diagnose bone marrow disorders, such as multiple myeloma, which is a type of cancer that affects the bone marrow, and bone marrow failure, which is a condition in which the bone marrow is unable to produce enough blood cells.\nIt is important to note that a b",
    "llama-2-7b-chat-hf_fact": [
      "The \"probe to bone\" test, also known as a bone scan, can be used to diagnose diseases and conditions that affect the bones.",
      "The bone scan can diagnose osteoporosis, a condition in which bones become weak and brittle.",
      "The test can be used to diagnose primary and metastatic bone cancer.",
      "The bone scan can help diagnose Paget's disease of bone, a condition that leads to enlarged and deformed bones.",
      "The test can be used to diagnose bone infections, such as osteomyelitis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The \"probe to bone\" test is a clinical examination for osteomyelitis, it is not synonymous with a bone scan.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2527,
    "user_query": "Can doxycycline cause photosensitivity?",
    "llama-2-7b-chat-hf_response": "Doxycycline is a tetracycline antibiotic that is commonly used to treat bacterial infections, including respiratory, skin, and urinary tract infections. While it is generally well-tolerated, doxycycline can cause some side effects, including photosensitivity.\nPhotosensitivity, also known as photophobia, is a condition where exposure to light can cause discomfort, eye irritation, or even pain. It can occur as a result of taking certain medications, including doxycycline.\nThe exact mechanism by which doxycycline causes photosensitivity is not fully understood, but it is thought to involve the inhibition of an enzyme in the skin called cyclooxygenase (COX). This enzyme is involved in the production of prostaglandins, which are hormone-like substances that play a role in the regulation of inflammation and pain. When doxycycline inhibits COX, it can lead to an increase in prostaglandins, which can cause sensitivity to light.\nNot everyone who takes doxycycline will experience photosensitivity, but it is a common side effect. According to clinical trials, approximately 10% to 20% of people taking doxycycline will experience some degree of photosensitivity.\nIf you are taking doxycycline and are experiencing photosensitivity, there are several things you can do to manage your symptoms:\n1. Avoid direct sunlight: Try to stay out of direct sunlight as much as possible, especially during peak hours (usually between 10 am and 4 pm). Wear protective clothing, such as a wide-brimmed hat and long-sleeved shirts, and use a broad-spectrum sunscreen with at least SPF 30.\n2. Wear sunglasses: Sunglasses can help protect your eyes from direct sunlight and reduce the risk of eye irritation. Look for sunglasses that block 99% to 100% of UVA and UVB rays.\n3. Use cooling eye drops: Over-the-counter cooling eye drops",
    "llama-2-7b-chat-hf_fact": [
      "Doxycycline is a tetracycline antibiotic used to treat bacterial infections, including respiratory, skin, and urinary tract infections.",
      "Doxycycline can cause side effects, including photosensitivity.",
      "Photosensitivity, a condition causing discomfort or pain due to exposure to light, can result from taking certain medications like doxycycline.",
      "The mechanism by which doxycycline causes photosensitivity is thought to involve the inhibition of an enzyme in the skin called cyclooxygenase.",
      "Approximately 10% to 20% of people taking doxycycline may experience some degree of photosensitivity according to clinical trials."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2530,
    "user_query": "What is the normal body temperature in dogs?",
    "llama-2-7b-chat-hf_response": "The normal body temperature of a healthy dog is between 99.5F (37.5C) and 102.5F (39.6C). However, this can vary depending on the age, size, and breed of the dog. For example, puppies tend to have a slightly higher body temperature than adult dogs, while older dogs may have a slightly lower body temperature. It's important to note that a dog's body temperature can fluctuate depending on various factors, such as the time of day, the environment, and the dog's overall health. If you have concerns about your dog's body temperature, it's always best to consult with a veterinarian.",
    "llama-2-7b-chat-hf_fact": [
      "The normal body temperature of a healthy dog ranges between 99.5F (37.5C) and 102.5F (39.6C).",
      "Puppies tend to have a slightly higher body temperature than adult dogs.",
      "Older dogs may have a slightly lower body temperature.",
      "A dog's body temperature can fluctuate based on various factors, such as the time of day, the environment, and the dog's overall health.",
      "It's recommended to consult with a veterinarian if there are concerns about a dog's body temperature."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2531,
    "user_query": "List symptoms of Heerfordt syndrome.",
    "llama-2-7b-chat-hf_response": "Here are 10 symptoms of Heerfordt syndrome.\n1. Delayed development: Children with Heerfordt syndrome may experience delays in reaching developmental milestones, such as sitting, standing, and walking.\n2. Intellectual disability: Individuals with Heerfordt syndrome often have intellectual disability, which can range from mild to severe.\n3. Distinctive facial features: People with Heerfordt syndrome may have distinctive facial features, including a small head, narrow eyes, and a short nose.\n4. Congenital anomalies: Heerfordt syndrome can be associated with various congenital anomalies, such as heart defects, cleft palate, and limb abnormalities.\n5. Skeletal abnormalities: Individuals with Heerfordt syndrome may have skeletal abnormalities, including short stature, thin bones, and joint deformities.\n6. Neurological problems: Heerfordt syndrome can cause a range of neurological problems, including seizures, developmental delays, and cognitive impairments.\n7. Vision problems: Some individuals with Heerfordt syndrome may experience vision problems, including cataracts, glaucoma, and optic atrophy.\n8. Hearing loss: Heerfordt syndrome can also cause hearing loss, which may be conductive or sensorineural in nature.\n9. Respiratory problems: Individuals with Heerfordt syndrome may experience respiratory problems, including respiratory infections and sleep apnea.\n10. Increased risk of infections: Heerfordt syndrome can increase the risk of infections, particularly respiratory infections, due to the immune system dysfunction.\nIt is important to note that the severity and presentation of Heerfordt syndrome can vary widely between individuals, and not all individuals will experience all of these symptoms. A diagnosis of Heerfordt syndrome is typically made through a combination of clinical evaluation, genetic testing, and imaging studies.",
    "llama-2-7b-chat-hf_fact": [
      "Heerfordt syndrome may cause delays in reaching developmental milestones, such as sitting, standing, and walking.",
      "Heerfordt syndrome can be associated with distinctive facial features including a small head, narrow eyes, and a short nose.",
      "Individuals with Heerfordt syndrome may have skeletal abnormalities, including short stature, thin bones, and joint deformities.",
      "Some individuals with Heerfordt syndrome may experience vision problems, including cataracts, glaucoma, and optic atrophy.",
      "Heerfordt syndrome can increase the risk of infections, particularly respiratory infections, due to the immune system dysfunction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Heerfordt syndrome does not cause delays in reaching developmental milestones such as sitting, standing, and walking. It is characterized by fever, uveitis, parotid gland enlargement, and facial nerve palsy.",
      "false, [corrected fact]: Heerfordt syndrome is not associated with distinctive facial features like a small head, narrow eyes, and a short nose. It may cause facial nerve palsy.",
      "false, [corrected fact]: Individuals with Heerfordt syndrome do not have skeletal abnormalities including short stature, thin bones, and joint deformities. Its symptoms mainly include uveitis, parotid gland enlargement, fever, and facial nerve palsy.",
      "true",
      "true"
    ]
  },
  {
    "id": 2532,
    "user_query": "In quadruped mammals, what bones make up the stifle?",
    "llama-2-7b-chat-hf_response": "The stifle joint is the joint between the femur (thigh bone) and the tibia (shin bone) in the hind limbs of quadruped mammals. The bones that make up the stifle joint are:\n1. Femur (F)\n2. Tibia (T)\n3. Patella (P)\n4. Patellar ligament (PL)\nThe patella, or kneecap, is a small, triangular bone located at the front of the stifle joint. The patellar ligament connects the patella to the tibia, and helps to stabilize the joint.",
    "llama-2-7b-chat-hf_fact": [
      "The stifle joint is found in the hind limbs of quadruped mammals.",
      "The stifle joint is formed by the connection of the femur and the tibia.",
      "The femur is also known as the thigh bone.",
      "The tibia is also referred to as the shin bone.",
      "The patella, often called the kneecap, and the patellar ligament, also form part of the stifle joint."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2535,
    "user_query": "Which tool exists for microsatellite (SSR) loci detection and primer design?",
    "llama-2-7b-chat-hf_response": "Microsatellites, also known as simple sequence repeats (SSRs), are short, repetitive DNA sequences that are found throughout the genome. They are often used as markers in genetic studies because they are highly polymorphic and can be easily amplified and detected using PCR.\nThere are several tools available for detecting and designing primers for microsatellite loci. Some of the most popular tools include:\n1. Primer3: This is a widely used tool for designing PCR primers, including those for microsatellite loci. It can be used to design primers that are specific to a particular locus and can also be used to predict the melting temperature (Tm) of the primers.\n2. PyroMark: This tool can be used to detect and analyze microsatellites in DNA sequences. It can also be used to design PCR primers and to predict the Tm of the primers.\n3. MISA: This tool can be used to detect and analyze microsatellites in DNA sequences. It can also be used to design PCR primers and to predict the Tm of the primers.\n4. DNAStar: This tool can be used to detect and analyze microsatellites in DNA sequences. It can also be used to design PCR primers and to predict the Tm of the primers.\n5. GATK: This tool can be used to detect and analyze microsatellites in DNA sequences. It can also be used to design PCR primers and to predict the Tm of the primers.\n6. PrimerQuest: This tool can be used to design PCR primers, including those for microsatellite loci. It can also be used to predict the Tm of the primers.\n7. Vector NTI: This tool can be used to detect and analyze microsatellites in DNA sequences. It can also be used to design PCR primers and to predict the Tm of the primers.\n8. GenAlEx: This tool can be used to detect and analyze microsatellites in DNA sequences. It can also be used to design PCR primers and to predict the Tm of the primers.\n9. MarkPrimer: This tool can be used to design PCR primers, including those for micros",
    "llama-2-7b-chat-hf_fact": [
      "Microsatellites, also known as simple sequence repeats (SSRs), are short, repetitive DNA sequences found throughout the genome.",
      "Microsatellites are often used as markers in genetic studies as they are highly polymorphic and can be amplified and detected using PCR.",
      "Primer3 is a tool used for designing PCR primers, including those for microsatellite loci.",
      "PyroMark is a tool that can be used to detect and analyze microsatellites in DNA sequences, as well as design PCR primers.",
      "MISA, DNAStar, GATK, Vector NTI, GenAlEx are other tools that can be used for microsatellite detection, primer design and prediction of the Tm of the primers."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: PyroMark is a tool used in Pyrosequencing that can be used to quantify of genetic variations such as single nucleotide polymorphisms (SNPs) and methylation but not specifically for detection and analysis of microsatellites in DNA sequences or design of PCR primers.",
      "true"
    ]
  },
  {
    "id": 2544,
    "user_query": "What is the preDIVA clinical trial?",
    "llama-2-7b-chat-hf_response": "What is the purpose of the preDIVA clinical trial?\nWho is eligible to participate in the preDIVA clinical trial?\nHow do I find out if I am eligible to participate in the preDIVA clinical trial?\nWhat are the potential benefits of participating in the preDIVA clinical trial?\nWhat are the potential risks of participating in the preDIVA clinical trial?\nHow long will the preDIVA clinical trial last?\nWhere will the preDIVA clinical trial take place?\nHow will I know if the preDIVA clinical trial is right for me?\nWhat should I do if I am interested in participating in the preDIVA clinical trial?\nThe preDIVA clinical trial is a Phase II clinical trial evaluating the safety and efficacy of the investigational drug, preDIVA, in women with advanced or recurrent endometrial cancer.\nThe purpose of the preDIVA clinical trial is to determine whether preDIVA is effective in treating endometrial cancer and to evaluate its safety in patients with advanced or recurrent endometrial cancer.\nWomen with advanced or recurrent endometrial cancer may be eligible to participate in the preDIVA clinical trial. To find out if you are eligible, please see the eligibility criteria below.\nTo determine if you are eligible to participate in the preDIVA clinical trial, please see the eligibility criteria below:\nThe potential benefits of participating in the preDIVA clinical trial include:\nThe potential risks of participating in the preDIVA clinical trial include:\nThe preDIVA clinical trial is expected to last approximately 2 years.\nThe preDIVA clinical trial will take place at various locations throughout the United States.\nIf you are interested in participating in the preDIVA clinical trial, please speak with your doctor or healthcare provider to determine if it is right for you. They can provide you with more information and help you determine if you are eligible to participate.",
    "llama-2-7b-chat-hf_fact": [
      "The preDIVA clinical trial is a Phase II clinical trial.",
      "The trial is evaluating the safety and efficacy of the investigational drug, preDIVA, in women with advanced or recurrent endometrial cancer.",
      "The purpose of the preDIVA clinical trial is to determine whether preDIVA is effective in treating endometrial cancer.",
      "Women with advanced or recurrent endometrial cancer may be eligible to participate in the preDIVA clinical trial.",
      "The preDIVA clinical trial is expected to last approximately 2 years."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2548,
    "user_query": "Milwaukee protocol was tested for treatment of which disease?",
    "llama-2-7b-chat-hf_response": "A) HIV/AIDS\nB) Cancer\nC) Tuberculosis\nD) Malaria\nCorrect answer: A) HIV/AIDS.\nThe Milwaukee protocol was a controversial treatment for HIV/AIDS that was tested in the 1990s. The treatment involved intravenous injections of gamma globulin, which is a preparation of antibodies derived from the blood of healthy donors. The treatment was developed by Dr. David Horrobin and was promoted by the AIDS Research Alliance, a non-profit organization based in Milwaukee, Wisconsin. However, the treatment was never approved by the FDA and was widely criticized by the medical community due to a lack of scientific evidence supporting its effectiveness.",
    "llama-2-7b-chat-hf_fact": [
      "The Milwaukee protocol was a treatment tested for HIV/AIDS.",
      "The treatment tested involved intravenous injections of gamma globulin.",
      "Gamma globulin is a preparation of antibodies derived from the blood of healthy donors.",
      "The Milwaukee protocol was developed by Dr. David Horrobin.",
      "The AIDS Research Alliance, a non-profit organization based in Milwaukee, Wisconsin, promoted the Milwaukee protocol."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Milwaukee protocol was a treatment tested for rabies, not HIV/AIDS.",
      "true",
      "true",
      "false, [corrected fact]: The Milwaukee protocol was developed by Dr. Rodney Willoughby, not Dr. David Horrobin.",
      "false, [corrected fact]: The Milwaukee protocol was promoted primarily by its developer, Dr. Rodney Willoughby, and not specifically by the AIDS Research Alliance, a non-profit organization based in Milwaukee, Wisconsin."
    ]
  },
  {
    "id": 2552,
    "user_query": "Is the consumption of chocolate associated with an increase in cardiovascular disease?",
    "llama-2-7b-chat-hf_response": "According to a study published in the Journal of the American College of Cardiology, there is a positive association between chocolate consumption and cardiovascular disease. The study found that individuals who consumed the most chocolate had a higher risk of developing cardiovascular disease compared to those who consumed the least amount of chocolate.",
    "llama-2-7b-chat-hf_fact": [
      "A study reported an association between chocolate consumption and cardiovascular disease has been published in the Journal of the American College of Cardiology.",
      "The study found that higher levels of chocolate consumption can increase the risk of developing cardiovascular disease.",
      "The risk of developing cardiovascular disease is lower in people who consume less amount of chocolate according to the study."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2553,
    "user_query": "What is the association of circular RNA to breast cancer?",
    "llama-2-7b-chat-hf_response": "Circular RNA (circRNA) has been implicated in various biological processes, including gene regulation, RNA metabolism, and cancer development. In breast cancer, circRNA has been shown to play a complex role, with both tumor-suppressive and oncogenic functions.\nTumor-suppressive functions of circRNA in breast cancer include:\n1. Inhibition of cell proliferation and migration: circRNA has been shown to inhibit the proliferation and migration of breast cancer cells, suggesting that it may play a role in slowing down the growth of tumors.\n2. Induction of apoptosis: circRNA has been shown to induce apoptosis (programmed cell death) in breast cancer cells, which can help to eliminate cancer cells and prevent tumor growth.\n3. Inhibition of angiogenesis: circRNA has been shown to inhibit the formation of new blood vessels in breast cancer, which is essential for tumor growth and metastasis.\nOncogenic functions of circRNA in breast cancer include:\n1. Promotion of cell proliferation and migration: Some studies have shown that circRNA can promote the proliferation and migration of breast cancer cells, which can contribute to tumor growth and metastasis.\n2. Inhibition of apoptosis: circRNA has been shown to inhibit apoptosis in breast cancer cells, which can help cancer cells to survive and proliferate.\n3. Enhancement of stem cell-like properties: circRNA has been shown to enhance the stem cell-like properties of breast cancer cells, which can contribute to the development of resistance to chemotherapy and recurrence of cancer.\nOverall, the association of circRNA to breast cancer is complex and context-dependent, and further research is needed to fully understand its role in breast cancer development and progression.",
    "llama-2-7b-chat-hf_fact": [
      "Circular RNA, or circRNA, has been implicated in various biological processes including gene regulation, RNA metabolism, and cancer development.",
      "In breast cancer, circRNA has been found to inhibit the proliferation and migration of breast cancer cells, indicating a potential tumor-suppressive function.",
      "CircRNA has been shown to induce apoptosis (programmed cell death) in breast cancer cells, which can help to eliminate cancer cells and prevent tumor growth.",
      "CircRNA has also been shown to inhibit the formation of new blood vessels in breast cancer, also known as angiogenesis.",
      "Some studies have shown that circRNA can promote the proliferation and migration of breast cancer cells, and inhibit apoptosis in these cells, which can support cancer survival and growth."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: In breast cancer, some circRNAs have been found to promote the proliferation and migration of breast cancer cells, suggesting a potential tumor-promoting function. However, this can vary depending on the specific circRNA and its role in the cancer.",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-7b-chat-hf_response": "Non-invasive prenatal testing (NIPT) is a type of prenatal test that analyzes the DNA present in a pregnant woman's blood to detect genetic abnormalities in the fetus. The R package \"NIPT\" has been developed specifically for analyzing NIPT data.\nThe \"NIPT\" package provides a range of functions for analyzing NIPT data, including:\n1. Data import and export: The package provides functions for importing and exporting NIPT data in various formats, including CSV, Excel, and PLINK.\n2. Data cleaning and preprocessing: The package includes functions for cleaning and preprocessing NIPT data, such as removing missing values, handling outliers, and normalizing the data.\n3. Genetic variant detection: The package provides functions for detecting genetic variants in NIPT data, including single nucleotide polymorphisms (SNPs), copy number variations (CNVs), and structural variations (SVs).\n4. Risk assessment: The package includes functions for calculating the risk of genetic abnormalities in the fetus based on the NIPT data, including the detection of trisomies 21, 18, and 13.\n5. Data visualization: The package provides functions for visualizing NIPT data, including plotting the distribution of genetic variants and the risk of genetic abnormalities.\nOverall, the \"NIPT\" package is a valuable tool for researchers and clinicians working with NIPT data, providing a range of functions for analyzing and interpreting this important type of prenatal test.",
    "llama-2-7b-chat-hf_fact": [
      "Non-invasive prenatal testing (NIPT) analyzes the DNA in a pregnant woman's blood to detect genetic abnormalities in the fetus.",
      "The R package \"NIPT\" has been specifically developed for analyzing NIPT data.",
      "The \"NIPT\" package can import and export data in various formats, including CSV, Excel, and PLINK.",
      "The \"NIPT\" package provides functions for detecting genetic variants in NIPT data, such as SNPs, CNVs, and SVs.",
      "With the \"NIPT\" package, one can calculate the risk of trisomies 21, 18, and 13 in the fetus based on the NIPT data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2558,
    "user_query": "Is the gene CDKN2A nevogenic?",
    "llama-2-7b-chat-hf_response": "CDKN2A is a tumor suppressor gene that is frequently mutated in various types of cancer, including melanoma, colorectal cancer, and lung cancer. The gene encodes a protein called p16, which inhibits the activity of cyclin-dependent kinases (CDKs) and regulates the cell cycle.\nRecent studies have suggested that CDKN2A may also play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. For example, one study found that mutations in CDKN2A were more common in the brains of individuals with Alzheimer's disease than in the general population. Another study found that overexpression of p16, the protein encoded by CDKN2A, could protect against neurodegeneration in a mouse model of Alzheimer's disease.\nHowever, it is important to note that the relationship between CDKN2A and neurodegeneration is complex and not fully understood. While some studies suggest that CDKN2A may be neuroprotective, others have found no association between CDKN2A mutations and neurodegenerative diseases.\nIn summary, while there is some evidence to suggest that CDKN2A may be involved in the development of neurodegenerative diseases, the relationship between the gene and these diseases is not fully understood and requires further research.",
    "llama-2-7b-chat-hf_fact": [
      "CDKN2A is a tumor suppressor gene frequently mutated in various types of cancer.",
      "CDKN2A encodes a protein called p16.",
      "This protein inhibits the activity of cyclin-dependent kinases and regulates the cell cycle.",
      "Recent studies suggest that CDKN2A may play a role in the development of neurodegenerative diseases like Alzheimer's disease and Parkinson's disease.",
      "The relationship between CDKN2A and neurodegenerative diseases is complex and not fully understood."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2559,
    "user_query": "Are there ways of joint Bayesian inference of risk variants?",
    "llama-2-7b-chat-hf_response": "Yes, there are several methods for joint Bayesian inference of risk variants in genome-wide association studies (GWAS). Here are some of the commonly used methods:\n1. **Bayesian Additive Regression Trees (BART)**: BART is a flexible and interpretable method for jointly modeling multiple risk variants. It uses a tree-based structure to model the relationships between the risk variants and the disease outcome.\n2. **Bayesian Linear Mixed Models (BLMM)**: BLMM is a widely used method for jointly modeling multiple risk variants in GWAS. It uses a linear mixed model framework to model the relationships between the risk variants and the disease outcome, while accounting for the correlations between the variants.\n3. **Bayesian Random Forest (BRF)**: BRF is a machine learning method that can be used for jointly modeling multiple risk variants. It uses a random forest framework to model the relationships between the risk variants and the disease outcome, while accounting for the correlations between the variants.\n4. **Bayesian Ridge Regression (BRR)**: BRR is a linear regression method that can be used for jointly modeling multiple risk variants. It uses a ridge regression framework to model the relationships between the risk variants and the disease outcome, while accounting for the correlations between the variants.\n5. **Bayesian Linear Models (BLM)**: BLM is a linear regression method that can be used for jointly modeling multiple risk variants. It uses a linear regression framework to model the relationships between the risk variants and the disease outcome, while accounting for the correlations between the variants.\n6. **Bayesian Non-negative Matrix Factorization (BNMF)**: BNMF is a matrix factorization method that can be used for jointly modeling multiple risk variants. It uses a non-negative matrix factorization framework to model the relationships between the risk variants and the disease outcome, while accounting for the correlations between the variants.\n7. **Bayesian Structural Equation Models (BSEM)**: BSEM is a structural equation modeling method that can be used for jointly modeling multiple risk variants. It uses a structural equation modeling framework to model the relationships between the risk variants and the disease outcome, while accounting",
    "llama-2-7b-chat-hf_fact": [
      "Bayesian Additive Regression Trees (BART) is a method used for jointly modeling multiple risk variants in genome-wide association studies (GWAS).",
      "Bayesian Linear Mixed Models (BLMM) is another method that is widely used for jointly modeling multiple risk variants in GWAS.",
      "Bayesian Random Forest (BRF) is a machine learning method used for jointly modeling multiple risk variants.",
      "Bayesian Ridge Regression (BRR) and Bayesian Linear Models (BLM) are both linear regression methods used for jointly modeling multiple risk variants.",
      "Bayesian Non-negative Matrix Factorization (BNMF) is a matrix factorization method used for jointly modeling multiple risk variants."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachs syndrome.",
    "llama-2-7b-chat-hf_response": "Achenbach's syndrome is a rare genetic disorder that affects the development of the brain and nervous system. It is characterized by a range of symptoms, including:\n* Delayed development of motor skills, such as sitting, standing, and walking\n* Intellectual disability\n* Speech and language difficulties\n* Vision problems, including crossed eyes (strabismus) and poor depth perception (astigmatism)\n* Hearing loss or deafness\n* Seizures\n* Abnormal facial features, such as a small head (microcephaly), a flat face (brachycephaly), or widely spaced eyes (ocular hypertelorism)\nAchenbach's syndrome is usually diagnosed in infancy or early childhood, and the symptoms can vary in severity from person to person. There is no cure for the disorder, but early intervention and management can help manage the symptoms and improve quality of life. Treatment may include physical therapy, occupational therapy, speech therapy, and medication to control seizures.",
    "llama-2-7b-chat-hf_fact": [
      "Achenbach's syndrome is a rare genetic disorder that affects the development of the brain and nervous system.",
      "Some symptoms of Achenbach's syndrome include delayed motor skills development, intellectual disability, speech and language difficulties, vision problems, hearing loss or deafness, seizures, and abnormal facial features.",
      "Achenbach's syndrome is usually diagnosed in infancy or early childhood.",
      "The symptoms of Achenbach's syndrome can vary in severity from person to person.",
      "There is no cure for Achenbach's syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Achenbach's syndrome is not a genetic disorder that affects the development of the brain and nervous system. It is a condition that affects the fingers causing bruising or bleeding.",
      "false, [corrected fact]: Achenbach's syndrome causes finger bruising and bleeding. The symptoms listed describe a variety of different genetic disorders, not Achenbach's syndrome.",
      "false, [corrected fact]: Achenbach's syndrome can occur at any age, it is not usually diagnosed in infancy or early childhood.",
      "true",
      "true"
    ]
  },
  {
    "id": 2561,
    "user_query": "Has intepirdine been evaluated in clinical trials? (November 2017)",
    "llama-2-7b-chat-hf_response": "Yes, intepirdine has been evaluated in clinical trials. Intepirdine is an investigational drug that is being developed for the treatment of Alzheimer's disease and other neurodegenerative disorders. Several clinical trials have been conducted to assess the safety and efficacy of intepirdine in these conditions. Here are some of the key findings from these trials:\n1. Phase II clinical trial in Alzheimer's disease: In this double-blind, placebo-controlled trial, 160 patients with mild to moderate Alzheimer's disease were randomized to receive either intepirdine or a placebo. The trial found that intepirdine significantly improved cognitive function compared to the placebo, as measured by the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) and the Mini-Mental State Examination (MMSE) scales.\n2. Phase II clinical trial in Parkinson's disease: In this double-blind, placebo-controlled trial, 120 patients with mild to moderate Parkinson's disease were randomized to receive either intepirdine or a placebo. The trial found that intepirdine significantly improved motor function compared to the placebo, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS) scale.\n3. Phase II clinical trial in Huntington's disease: In this double-blind, placebo-controlled trial, 120 patients with Huntington's disease were randomized to receive either intepirdine or a placebo. The trial found that intepirdine significantly improved cognitive function compared to the placebo, as measured by the Clinical Rating Scale for Huntington's Disease (CRSD) scale.\n4. Phase III clinical trial in Alzheimer's disease: In this randomized, double-blind, placebo-controlled trial, 300 patients with mild to moderate Alzheimer's disease were randomized to receive either intepirdine or a placebo. The trial found that intepirdine significantly improved cognitive function compared to the placebo, as measured by the ADAS",
    "llama-2-7b-chat-hf_fact": [
      "Intepirdine is an investigational drug that is being developed for the treatment of Alzheimer's disease and other neurodegenerative disorders.",
      "Several clinical trials have been conducted to assess the safety and efficacy of intepirdine in these conditions.",
      "A Phase II clinical trial found that intepirdine significantly improved cognitive function in patients with mild to moderate Alzheimer's disease, as measured by the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) and the Mini-Mental State Examination (MMSE) scales.",
      "A Phase II clinical trial found that intepirdine significantly improved motor function in patients with mild to moderate Parkinson's disease, measured by the Unified Parkinson's Disease Rating Scale (UPDRS) scale.",
      "A Phase III clinical trial found that intepirdine significantly improved cognitive function in patients with mild to moderate Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The Phase II clinical trials found that intepirdine did not provide significant improvements in cognitive function in patients with mild to moderate Alzheimer's disease as measured by the ADAS-Cog and the MMSE scales.",
      "unknown",
      "false, [corrected fact]: The Phase III clinical trial of intepirdine did not meet its primary efficacy endpoints in patients with mild to moderate Alzheimer's disease."
    ]
  },
  {
    "id": 2565,
    "user_query": "Does armodafinil improve fatigue of glioma patients?",
    "llama-2-7b-chat-hf_response": "Glioma is a type of brain cancer that can cause significant fatigue in patients. Armodafinil is a drug that has been used to treat fatigue in patients with cancer, including those with glioma. However, there is limited research on the effectiveness of armodafinil in improving fatigue in glioma patients.\nA study published in the Journal of Clinical Oncology in 2017 found that armodafinil was associated with improved fatigue in patients with glioblastoma, a type of glioma. The study included 30 patients who were randomly assigned to receive either armodafinil or a placebo. The results showed that patients who received armodafinil had significant improvements in fatigue compared to those who received the placebo.\nAnother study published in the journal Neuro-Oncology in 2019 found that armodafinil was associated with improved fatigue and quality of life in patients with glioma. The study included 20 patients who were treated with armodafinil and 20 patients who were treated with a placebo. The results showed that patients who received armodafinil had significant improvements in fatigue and quality of life compared to those who received the placebo.\nWhile these studies suggest that armodafinil may be effective in improving fatigue in glioma patients, more research is needed to confirm these findings and to determine the optimal dosage and duration of treatment. Additionally, it is important to note that armodafinil can have side effects, including headache, nausea, and insomnia, and patients should be closely monitored for these and other potential side effects.\nIn summary, while there is limited research on the effectiveness of armodafinil in improving fatigue in glioma patients, the available evidence suggests that it may be associated with improved fatigue and quality of life in these patients. Further research is needed to confirm these findings and to determine the optimal use of armodafinil in the treatment of glioma-related fatigue.",
    "llama-2-7b-chat-hf_fact": [
      "Glioma is a type of brain cancer that can cause significant fatigue in patients.",
      "Armodafinil is a drug that has been used to treat fatigue in patients with cancer, including those with glioma.",
      "A 2017 study in the Journal of Clinical Oncology found that armodafinil was associated with improved fatigue in patients with glioblastoma.",
      "A 2019 study in the journal Neuro-Oncology found that armodafinil was associated with improved fatigue and quality of life in patients with glioma.",
      "Armodafinil can have side effects, including headache, nausea, and insomnia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2566,
    "user_query": "What is the role of tankyrases in response to Double Strand Breaks (DSBs)?",
    "llama-2-7b-chat-hf_response": "Tankyrases are a family of enzymes that play a crucial role in the repair of double-strand breaks (DSBs) in DNA. DSBs are one of the most severe forms of DNA damage and can occur as a result of various factors, including ionizing radiation, chemotherapy, and viral infection. Tankyrases are involved in the non-homologous end joining (NHEJ) pathway of DSB repair, which is the primary pathway used to repair DSBs in G1-phase cells.\nTankyrases are composed of two subunits, TNK1 and TNK2, which work together to phosphorylate and activate the protein 53BP1. 53BP1 is a key component of the NHEJ pathway and plays a crucial role in the repair of DSBs. Tankyrases are recruited to the site of the DSB, where they phosphorylate and activate 53BP1, allowing it to perform its repair functions.\nThe role of tankyrases in response to DSBs can be summarized as follows:\n1. Recruitment: Tankyrases are recruited to the site of the DSB, where they phosphorylate and activate 53BP1.\n2. Activation of 53BP1: Tankyrases phosphorylate and activate 53BP1, allowing it to perform its repair functions.\n3. NHEJ pathway: Tankyrases are involved in the NHEJ pathway of DSB repair, which is the primary pathway used to repair DSBs in G1-phase cells.\n4. Homologous recombination: Tankyrases also play a role in the homologous recombination pathway of DSB repair, which is used to repair DSBs in G2-phase cells.\n5. Checkpoint activation: Tankyrases can also activate the DNA damage checkpoint, which can delay the cell cycle and give the cell time to repair the damage.\nIn summary, tankyrases play a crucial role in the repair of DSBs by phosphorylating and activating 53BP1, which is a key component of the NHEJ pathway. Tank",
    "llama-2-7b-chat-hf_fact": [
      "Tankyrases are a family of enzymes that play a crucial role in the repair of double-strand breaks (DSBs) in DNA.",
      "Double-strand breaks are one of the most severe forms of DNA damage and can occur due to factors like ionizing radiation, chemotherapy, and viral infection.",
      "Tankyrases are involved in the non-homologous end joining (NHEJ) pathway of DSB repair, which is the primary pathway used to repair DSBs in G1-phase cells.",
      "The two subunits of Tankyrases, TNK1 and TNK2, phosphorylate and activate the protein 53BP1, which is a critical component of the NHEJ pathway.",
      "In addition to the NHEJ pathway, tankyrases also play a role in the homologous recombination pathway of DSB repair, which is used to repair DSBs in G2-phase cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Tankyrases are a family of enzymes involved in various processes, such as telomere length maintenance and the Wnt signaling pathway, but not primarily related to double-strand breaks (DSBs) repair in DNA.",
      "true",
      "false, [corrected fact]: Tankyrases are not primarily involved in the non-homologous end joining (NHEJ) pathway of DSB repair. They are primarily known for their role in telomere length maintenance and the Wnt signaling pathway.",
      "false, [corrected fact]: The two subunits of Tankyrases, TNKS1 and TNKS2, do not directly interact with protein 53BP1. Their known roles involve functions such as regulation of telomere length and involvement in the Wnt signaling pathway.",
      "false, [corrected fact]: Tankyrases do not play a direct role in the homologous recombination pathway of DSB repair. Their established roles involve other cellular processes, such as the Wnt signaling pathway and telomere length maintenance."
    ]
  },
  {
    "id": 2569,
    "user_query": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?",
    "llama-2-7b-chat-hf_response": "Whole genome sequencing (WGS) is a powerful tool for identifying genetic variants associated with Mendelian diseases. However, the identification of pathogenic regulatory variants from WGS data can be challenging due to the complexity of gene regulation and the lack of reference panels for many genes. Here are some methods that can be used for whole genome identification of pathogenic regulatory variants in Mendelian disease:\n1. Machine learning approaches: Machine learning algorithms can be used to identify patterns of gene expression and regulation that are associated with disease. For example, a study published in the journal Nature Medicine used a machine learning approach to identify regulatory variants associated with Mendelian disease in the human genome.\n2. Integrative genomics: Integrative genomics approaches combine data from different types of genomic assays, such as WGS, ChIP-seq, and RNA-seq, to identify regulatory variants that are associated with disease. For example, a study published in the journal Nature used an integrative genomics approach to identify regulatory variants associated with Mendelian disease in the human genome.\n3. Network analysis: Network analysis can be used to identify regulatory variants that are associated with disease by analyzing the interactions between genes and their regulatory elements. For example, a study published in the journal Cell used network analysis to identify regulatory variants associated with Mendelian disease in the human genome.\n4. Genome-wide association studies (GWAS): GWAS can be used to identify genetic variants associated with disease by analyzing genetic data from large numbers of individuals. For example, a study published in the journal Nature Genetics used GWAS to identify regulatory variants associated with Mendelian disease in the human genome.\n5. Functional genomics: Functional genomics approaches can be used to identify regulatory variants that are associated with disease by analyzing the functional effects of genetic variants on gene expression and regulation. For example, a study published in the journal Science used functional genomics approaches to identify regulatory variants associated with Mendelian disease in the human genome.\n6. Epigenomics: Epigenomics can be used to identify regulatory variants that are associated with disease by analyzing the epigenetic marks on genes and their regulatory elements. For example, a study published in the journal Nature Genetics used ep",
    "llama-2-7b-chat-hf_fact": [
      "Whole genome sequencing is a tool for identifying genetic variants associated with Mendelian diseases.",
      "Machine learning algorithms can be used for whole genome identification of pathogenic regulatory variants in Mendelian disease.",
      "Integrative genomics combines data from different genomic assays to identify disease-associated regulatory variants.",
      "Network analysis is used to identify disease-associated regulatory variants by analyzing interactions between genes and their regulatory elements.",
      "Genome-wide association studies can be used to identify genetic variants associated with disease by analyzing genetic data from a large number of individuals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2576,
    "user_query": "Which algorithm has been proposed for efficient storage of WGS variant calls?",
    "llama-2-7b-chat-hf_response": "Answer: There are several algorithms that have been proposed for efficient storage of Whole Genome Sequencing (WGS) variant calls. Here are a few examples:\n1. Burrows-Wheeler transform (BWT): BWT is a reversible transformation of a string that rearranges the symbols in the string to create runs of similar characters. WGS variant calls can be represented as a string, and applying BWT to the string can reduce the storage required for the variant calls.\n2. Huffman coding: Huffman coding is a variable-length prefix coding algorithm that assigns shorter codes to more frequent symbols in a string. WGS variant calls can be encoded using Huffman coding to reduce the storage required for the variant calls.\n3. Run-length encoding (RLE): RLE is a compression algorithm that replaces runs of identical symbols in a string with a single symbol and a count of the number of times the symbol appears in the run. WGS variant calls can be encoded using RLE to reduce the storage required for the variant calls.\n4. Compression using sparse matrices: WGS variant calls can be represented as a sparse matrix, where most of the elements are zero. Compressing the sparse matrix using a sparse matrix compression algorithm can reduce the storage required for the variant calls.\n5. Compression using dictionary-based methods: WGS variant calls can be represented as a dictionary of substrings, where each substring is associated with a count of the number of times it appears in the variant calls. Compressing the dictionary using a dictionary-based compression algorithm can reduce the storage required for the variant calls.\n6. Compression using Lempel-Ziv-Welch (LZW) coding: LZW coding is a dictionary-based compression algorithm that builds a dictionary of substrings as they appear in the data. WGS variant calls can be encoded using LZW coding to reduce the storage required for the variant calls.\n7. Compression using arithmetic coding: Arithmetic coding is a lossless compression algorithm that assigns a fractional code to each symbol in the data. WGS variant calls can be encoded using arithmetic coding to reduce the storage required for the variant calls.\n8. Compression using bit-packing: WGS variant calls can be represented as a sequence of bits, where each bit corresponds to the presence or absence of a variant at a particular position in the genome. Compress",
    "llama-2-7b-chat-hf_fact": [
      "The Burrows-Wheeler transform is a reversible transformation that rearranges the symbols in the string to create runs of similar characters.",
      "Huffman coding assigns shorter codes to more frequent symbols in a string.",
      "Run-length encoding replaces runs of identical symbols in a string with a single symbol and a count of the number of times the symbol appears in the run.",
      "Compression using sparse matrices involves representation of WGS variant calls as a sparse matrix with most elements being zero.",
      "Lempel-Ziv-Welch coding is a dictionary-based compression algorithm that builds a dictionary of substrings as they appear in the data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2577,
    "user_query": "Is Citrobacter rodentium pathogenic?",
    "llama-2-7b-chat-hf_response": "Citrobacter rodentium is a gram-negative, rod-shaped bacterium that is commonly found in the gastrointestinal tracts of mice and rats. While it is not typically considered a pathogenic bacterium, it has been shown to cause disease in immunocompromised individuals and in animal models of infection.\nIn immunocompromised individuals, such as those with HIV/AIDS or undergoing immunosuppressive therapy after an organ transplant, Citrobacter rodentium can cause opportunistic infections, including pneumonia, urinary tract infections, and bloodstream infections.\nIn animal models of infection, Citrobacter rodentium has been shown to cause a range of pathologies, including:\n1. Gastrointestinal inflammation and damage: Citrobacter rodentium can cause inflammation and damage to the gastrointestinal tract, leading to symptoms such as diarrhea, vomiting, and abdominal pain.\n2. Colitis: Citrobacter rodentium can cause colitis, which is inflammation of the colon. This can lead to symptoms such as abdominal pain, diarrhea, and rectal bleeding.\n3. Meningitis: Citrobacter rodentium can cause meningitis, which is inflammation of the membranes surrounding the brain and spinal cord. This can lead to symptoms such as fever, headache, and stiffness in the neck.\n4. Septicemia: Citrobacter rodentium can cause septicemia, which is the presence of bacteria in the bloodstream. This can lead to symptoms such as fever, chills, and rapid heart rate.\n5. Pneumonia: Citrobacter rodentium can cause pneumonia, which is inflammation of the lungs. This can lead to symptoms such as cough, fever, and difficulty breathing.\nOverall, while Citrobacter rodentium is not typically considered a pathogenic bacterium, it can cause disease in certain individuals and in animal models of infection.",
    "llama-2-7b-chat-hf_fact": [
      "Citrobacter rodentium is a gram-negative, rod-shaped bacterium.",
      "It is found in the gastrointestinal tracts of mice and rats.",
      "Citrobacter rodentium can cause disease in immunocompromised individuals and in animal models of infection.",
      "This bacterium can cause opportunistic infections, including pneumonia, urinary tract infections, and bloodstream infections in immunocompromised individuals.",
      "Citrobacter rodentium can cause gastrointestinal inflammation and damage, colitis, meningitis, septicemia, and pneumonia in animal models of infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2578,
    "user_query": "List two human monoclonal antibodies against Clostridium difficile toxins.",
    "llama-2-7b-chat-hf_response": "Clostridium difficile is a gram-positive, anaerobic, spore-forming bacterium that can cause diarrhea and colitis in humans. The bacterium produces two main toxins, toxin A and toxin B, which are responsible for the pathogenesis of C. difficile infection. Toxin A is a binary toxin that consists of a B subunit and an A subunit, while toxin B is a tetanus toxin-like toxin that consists of a B subunit and an A subunit. These toxins can cause cell damage and apoptosis by binding to GM1 ganglioside receptors on the surface of epithelial cells.\nTwo human monoclonal antibodies that have been developed against C. difficile toxins are:\n1. MEDI-507: This antibody was developed against toxin A and has been shown to neutralize the toxin's activity in vitro and in vivo. MEDI-507 has also been shown to reduce the severity of C. difficile infection in mice.\n2. MEDI-508: This antibody was developed against toxin B and has been shown to neutralize the toxin's activity in vitro and in vivo. MEDI-508 has also been shown to reduce the severity of C. difficile infection in mice.\nBoth MEDI-507 and MEDI-508 have been shown to be well-tolerated in humans and have the potential to be developed into a therapeutic agent for the treatment of C. difficile infection.",
    "llama-2-7b-chat-hf_fact": [
      "Clostridium difficile is a gram-positive, anaerobic, spore-forming bacterium.",
      "Toxin A and toxin B are the two main toxins produced by the bacterium Clostridium difficile.",
      "MEDI-507, a human monoclonal antibody developed against toxin A of Clostridium difficile, has been shown to neutralize the toxin's activity.",
      "MEDI-508 is another monoclonal antibody developed against bacterium Clostridium difficile's toxin B, and it has demonstrated neutralization of the toxin's activity.",
      "Both MEDI-507 and MEDI-508 have been concluded to be well-tolerated in humans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2579,
    "user_query": "List ribosomal biogenesis proteins.",
    "llama-2-7b-chat-hf_response": "Ribosomes are complex cellular structures that play a crucial role in protein synthesis. They are composed of two subunits, a large subunit and a small subunit, which are made up of ribonucleic acid (RNA) and proteins. The ribosomes are responsible for translating messenger RNA (mRNA) into proteins, which are essential for many cellular processes.\nRibosomal biogenesis is the process by which ribosomes are assembled and matured in the cell. This process involves the synthesis and folding of ribosomal RNA (rRNA) and the assembly of the ribosomal subunits. The proteins involved in ribosomal biogenesis are essential for the proper formation and function of ribosomes.\nThere are several proteins that are involved in ribosomal biogenesis, including:\n1. Rpl19: This protein is a ribosomal RNA (rRNA) gene-specific chaperone that helps to fold and stabilize the rRNA during ribosome biogenesis.\n2. Rps2: This protein is a ribosomal protein that helps to assemble the ribosomal subunits during ribosome biogenesis.\n3. Rpl2: This protein is a ribosomal RNA (rRNA) gene-specific chaperone that helps to fold and stabilize the rRNA during ribosome biogenesis.\n4. Rps3: This protein is a ribosomal protein that helps to assemble the ribosomal subunits during ribosome biogenesis.\n5. Rpl5: This protein is a ribosomal RNA (rRNA) gene-specific chaperone that helps to fold and stabilize the rRNA during ribosome biogenesis.\n6. Rps6: This protein is a ribosomal protein that helps to assemble the ribosomal subunits during ribosome biogenesis.\n7. Rpl10: This protein is a ribosomal RNA (rRNA) gene-specific chaperone that helps to fold and stabilize the rRNA during ribosome biogenesis.\n8. Rps7: This",
    "llama-2-7b-chat-hf_fact": [
      "Ribosomes are complex cellular structures involved in protein synthesis.",
      "Ribosomes are composed of two subunits, a large subunit and a small subunit, which are made of ribonucleic acid (RNA) and proteins.",
      "Ribosomes translate messenger RNA (mRNA) into proteins.",
      "Ribosomal biogenesis is the process by which ribosomes are assembled and matured in the cell.",
      "Proteins such as Rpl19, Rps2, Rpl2, Rps3, Rpl5, Rps6, Rpl10 are involved in ribosomal biogenesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-7b-chat-hf_response": "There are several algorithms used for the detection of long repeat expansions, including:\n1. RepeatMasker: This algorithm is widely used for the detection of repeat expansions in DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence.\n2. RepeatFinder: This algorithm is similar to RepeatMasker, but it is specifically designed for the detection of repeat expansions in genomic DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence.\n3. LongRepeats: This algorithm is specifically designed for the detection of long repeat expansions in DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence, and it is particularly useful for identifying repeat expansions that are longer than 100 base pairs.\n4. LRE-Finder: This algorithm is specifically designed for the detection of long repeat expansions in DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence, and it is particularly useful for identifying repeat expansions that are longer than 100 base pairs.\n5. GERP: This algorithm is specifically designed for the detection of repeat expansions in genomic DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence, and it is particularly useful for identifying repeat expansions that are longer than 100 base pairs.\n6. HMMER: This algorithm is specifically designed for the detection of repeat expansions in DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence, and it is particularly useful for identifying repeat expansions that are longer than 100 base pairs.\n7. Primer3: This algorithm is specifically designed for the detection of repeat expansions in DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions in a DNA sequence, and it is particularly useful for identifying repeat expansions that are longer than 100 base pairs.\n8. RepeatScanner: This algorithm is specifically designed for the detection of repeat expansions in DNA sequences. It uses a combination of heuristics and statistical models to identify potential repeat regions",
    "llama-2-7b-chat-hf_fact": [
      "RepeatMasker is an algorithm used for the detection of repeat expansions in DNA sequences.",
      "RepeatFinder is an algorithm designed to detect repeat expansions in genomic DNA sequences.",
      "LongRepeats is an algorithm used for the detection of long repeat expansions in DNA sequences.",
      "LRE-Finder is an algorithm specifically used for the detection of long repeat expansions in DNA sequences.",
      "GERP is an algorithm designed for detecting repeat expansions in genomic DNA sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: RepeatMasker is an algorithm used for the identification and masking of repetitive elements in DNA sequences.",
      "unknown",
      "unknown",
      "true",
      "false, [corrected fact]: GERP is an algorithm designed for identifying conserved elements in multiple alignments of genomic sequences."
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-7b-chat-hf_response": "Neuroligin-3 is a protein that has been shown to promote the growth and progression of certain types of brain tumors, including:\n1. Medulloblastoma: This is a type of pediatric brain cancer that originates in the cerebellum.\n2. Glioblastoma: This is the most common type of adult brain cancer, also known as glioblastoma multiforme (GBM).\n3. Oligodendroglioma: This is a type of brain cancer that originates in the oligodendrocytes, which are cells that produce the fatty substance called myelin that insulates nerve fibers.\n4. Astrocytoma: This is a type of brain cancer that originates in the star-shaped cells called astrocytes, which provide support and nutrients to nerve cells.\nIt is important to note that the exact mechanisms by which neuroligin-3 promotes the growth and progression of these tumors are not yet fully understood and are the subject of ongoing research.",
    "llama-2-7b-chat-hf_fact": [
      "Neuroligin-3 is a protein that has been shown to promote the growth and progression of certain types of brain tumors.",
      "Neuroligin-3 promotes the growth of Medulloblastoma, a pediatric brain cancer that originates in the cerebellum.",
      "Neuroligin-3 promotes the growth of Glioblastoma, the most common type of adult brain cancer, also known as glioblastoma multiforme (GBM).",
      "Neuroligin-3 promotes the growth of Oligodendroglioma, a type of brain cancer that originates in the oligodendrocytes.",
      "Neuroligin-3 promotes the growth of Astrocytoma, a brain cancer that originates in the star-shaped cells called astrocytes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no definitive evidence that Neuroligin-3 promotes the growth of Oligodendroglioma, a type of brain cancer that originates in the oligodendrocytes.",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-7b-chat-hf_response": "Gas vesicles are membrane-bound organelles found in some bacteria and archaea that are used for buoyancy and movement. The size of gas vesicles can vary depending on the species of bacteria or archaea, but they are generally in the range of 10-100 nanometers (nm) in diameter.\nHere are some approximate sizes of gas vesicles in different species:\n* Escherichia coli (E. coli): 20-40 nm\n* Pseudomonas aeruginosa: 30-60 nm\n* Staphylococcus aureus: 40-80 nm\n* Halobacterium salinarum: 50-100 nm\n* Archaeoglobus fulgidus: 50-100 nm\nIt's worth noting that these sizes are approximate and can vary depending on the specific conditions in which the gas vesicles are found. Additionally, some species of bacteria and archaea may have larger or smaller gas vesicles than those listed above.",
    "llama-2-7b-chat-hf_fact": [
      "Gas vesicles are membrane-bound organelles found in some bacteria and archaea.",
      "Gas vesicles are used by bacteria and archaea for buoyancy and movement.",
      "The size of gas vesicles generally varies between 10-100 nanometers in diameter.",
      "Escherichia coli has gas vesicles that are approximately 20 to 40 nm in diameter.",
      "Staphylococcus aureus has gas vesicles that are approximately 40 to 80 nm in diameter."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The size of gas vesicles generally varies between 45-200 nanometers in length and 45-60 nanometers in width.",
      "false, [corrected fact]: Escherichia coli typically do not have gas vesicles.",
      "false, [corrected fact]: Staphylococcus aureus typically do not have gas vesicles."
    ]
  },
  {
    "id": 2588,
    "user_query": "Are osteoclasts specialized in bone degradation?",
    "llama-2-7b-chat-hf_response": "Osteoclasts are specialized cells that are responsible for bone resorption, which is the process of breaking down and reabsorbing bone tissue. They are found in the bone remodeling units, where they work together with osteoblasts to maintain bone homeostasis. Osteoclasts are specialized in bone degradation because they have a unique structure and function that allows them to efficiently break down bone tissue.",
    "llama-2-7b-chat-hf_fact": [
      "Osteoclasts are specialized cells that are responsible for bone resorption.",
      "Bone resorption is the process of breaking down and reabsorbing bone tissue.",
      "Osteoclasts are found in the bone remodeling units.",
      "Osteoclasts work together with osteoblasts to maintain bone homeostasis.",
      "Osteoclasts have a unique structure and function that allows them to efficiently break down bone tissue."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-7b-chat-hf_response": "BET (Bromodomain and Extra-Terminal) proteins are a family of proteins that play a crucial role in regulating gene expression by modifying chromatin structure. BET proteins are composed of two distinct domains: a bromodomain and an extra-terminal (ET) domain. The bromodomain is responsible for recognizing and binding to acetylated lysine residues on histone proteins, while the ET domain is involved in protein-protein interactions and mediates the recruitment of other proteins to the chromatin.\nThere are four subfamilies of BET proteins: BET1, BET2, BET3, and BET4. Each subfamily has distinct functions and subcellular localizations. For example, BET1 proteins are primarily involved in regulating gene expression in the nucleus, while BET2 proteins are primarily involved in regulating gene expression in the cytoplasm.\nBET proteins have been implicated in a wide range of biological processes, including cell fate determination, differentiation, and cancer. Dysregulation of BET protein activity has been implicated in various diseases, including cancer and neurological disorders.\nSome examples of BET proteins include:\n* BET1 (Bromodomain-Containing Protein 1)\n* BET2 (Bromodomain-Containing Protein 2)\n* BET3 (Bromodomain-Containing Protein 3)\n* BET4 (Bromodomain-Containing Protein 4)\nOverall, BET proteins play a crucial role in regulating gene expression by modifying chromatin structure, and their dysregulation has been implicated in a wide range of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "BET (Bromodomain and Extra-Terminal) proteins are a family of proteins that regulate gene expression by modifying chromatin structure.",
      "There are four subfamilies of BET proteins: BET1, BET2, BET3, and BET4.",
      "Each BET protein subfamily has distinct functions and subcellular localizations.",
      "Dysregulation of BET protein activity has been implicated in various diseases, including cancer and neurological disorders.",
      "Examples of BET proteins include BET1, BET2, BET3, and BET4."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: There are two main subclasses of BET proteins: BRD2(BET2), BRD3(BET3), BRD4(BET4) and BRDT(BET1).",
      "true",
      "true",
      "false, [corrected fact]: Examples of BET proteins include BRD2, BRD3, BRD4, and BRDT."
    ]
  },
  {
    "id": 2593,
    "user_query": "How does neuronal activity affect neuroligin-3?",
    "llama-2-7b-chat-hf_response": "Neuronal activity can affect neuroligin-3 in several ways:\n1. Synaptic plasticity: Neuroligin-3 is involved in the regulation of synaptic plasticity, which is the ability of neurons to change and adapt in response to experiences. When neurons are activated, neuroligin-3 can regulate the strength of synaptic connections between neurons, allowing for the formation of new memories.\n2. Neurotransmitter release: Neuroligin-3 can also regulate the release of neurotransmitters, such as glutamate and GABA, which are involved in the transmission of signals between neurons. When neurons are activated, neuroligin-3 can modulate the release of these neurotransmitters, allowing for the transmission of signals.\n3. Signal integration: Neuroligin-3 can also regulate the integration of signals from multiple neurons. When neurons are activated, neuroligin-3 can modulate the strength of connections between neurons, allowing for the integration of signals from multiple sources.\n4. Neuronal excitability: Neuroligin-3 can also regulate the excitability of neurons, which is the ability of neurons to generate and propagate electrical signals. When neurons are activated, neuroligin-3 can modulate the excitability of neurons, allowing for the transmission of signals.\n5. Neuroprotection: Neuroligin-3 has been shown to have neuroprotective effects, and can protect neurons from damage caused by various insults, such as oxidative stress, excitotoxicity, and inflammation. When neurons are activated, neuroligin-3 can regulate the expression of genes involved in neuroprotection, allowing for the protection of neurons from damage.\nIn summary, neuronal activity can affect neuroligin-3 in several ways, including the regulation of synaptic plasticity, neurotransmitter release, signal integration, neuronal excitability, and neuroprotection.",
    "llama-2-7b-chat-hf_fact": [
      "Neuroligin-3 is involved in the regulation of synaptic plasticity, the adaptability of neurons in response to experiences.",
      "Neuroligin-3 can regulate the release of neurotransmitters, such as glutamate and GABA, in signal transmission between neurons.",
      "Neuroligin-3 can regulate the integration of signals from multiple neurons.",
      "Neuroligin-3 can regulate the excitability of neurons, the ability to generate and propagate electrical signals.",
      "Neuroligin-3 has been shown to have neuroprotective effects, protecting neurons from damage caused by insults such as oxidative stress, excitotoxicity, and inflammation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2596,
    "user_query": "What is PARP inhibitor (PARPi) resistance?",
    "llama-2-7b-chat-hf_response": "PARP inhibitor (PARPi) resistance is a phenomenon where cancer cells develop mechanisms to evade the inhibitory effects of PARP inhibitors, leading to reduced efficacy of the treatment. PARP inhibitors are a class of drugs that target PARP, an enzyme involved in DNA repair, and are used to treat various types of cancer, including ovarian, breast, and pancreatic cancer.\nThere are several mechanisms of PARPi resistance, including:\n1. Overexpression of PARP: Cancer cells can overexpress PARP, making it less susceptible to inhibition by PARPi.\n2. Mutations in PARP: Some cancers have mutations in the PARP gene that make it less susceptible to inhibition by PARPi.\n3. Alternative DNA repair pathways: Cancer cells can develop alternative pathways for DNA repair, such as homologous recombination, which can bypass the inhibitory effects of PARPi.\n4. Epigenetic modifications: Cancer cells can undergo epigenetic modifications, such as DNA methylation or histone modifications, that can silence the expression of PARP and make it less susceptible to inhibition by PARPi.\n5. Increased expression of drug efflux pumps: Cancer cells can overexpress drug efflux pumps, such as P-glycoprotein, which can actively remove PARPi from the cells, leading to resistance.\n6. Stemness and cancer stem cell-like properties: Cancer cells can acquire stemness and cancer stem cell-like properties, which can confer resistance to PARPi.\n7. Tumor microenvironment: The tumor microenvironment can also contribute to PARPi resistance by providing a protective niche for cancer cells.\nUnderstanding the mechanisms of PARPi resistance is crucial for the development of new strategies to overcome resistance and improve the efficacy of PARPi-based therapies.",
    "llama-2-7b-chat-hf_fact": [
      "PARP inhibitor (PARPi) resistance is a phenomenon where cancer cells develop mechanisms to evade the inhibitory effects of PARP inhibitors.",
      "PARP inhibitors are a class of drugs that target PARP, an enzyme involved in DNA repair, and are used to treat various types of cancer, including ovarian, breast, and pancreatic cancer.",
      "Cancer cells can overexpress PARP or mutations in the PARP gene that make it less susceptible to inhibition by PARPi, contributing to resistance.",
      "Cancer cells can develop alternative pathways for DNA repair, such as homologous recombination, which can bypass the inhibitory effects of PARPi.",
      "Other mechanisms contributing to PARPi resistance include epigenetic modifications, increased expression of drug efflux pumps, acquisition of stemness and cancer stem cell-like properties, and the tumor microenvironment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2597,
    "user_query": "What is the association of the protein RAB10 and Alzheimers disease?",
    "llama-2-7b-chat-hf_response": "RAB10 is a protein that has been implicated in the development and progression of Alzheimer's disease. Studies have shown that RAB10 is overexpressed in the brains of individuals with Alzheimer's disease, and that this overexpression may contribute to the death of neurons and the progression of cognitive decline. Additionally, RAB10 has been shown to play a role in the transport of amyloid-beta, a protein that accumulates in the brains of individuals with Alzheimer's disease and contributes to the formation of neurofibrillary tangles, a hallmark of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "RAB10 is a protein that has been implicated in the development and progression of Alzheimer's disease.",
      "Studies have shown that RAB10 is overexpressed in the brains of individuals with Alzheimer's disease.",
      "Overexpression of RAB10 may contribute to the death of neurons and the progression of cognitive decline in Alzheimer's disease.",
      "RAB10 has been shown to play a role in the transport of amyloid-beta.",
      "Amyloid-beta is a protein that accumulates in the brains of individuals with Alzheimer's disease and contributes to the formation of neurofibrillary tangles."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Amyloid-beta is a protein that accumulates in the brains of individuals with Alzheimer's disease and contributes to the formation of plaques."
    ]
  },
  {
    "id": 2599,
    "user_query": "A bite from the Lone Star Tick Amblyomma americanum, can cause the victim to become allergic to red meat, yes or no?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [
      "sponse: Here are all the factual statements:",
      "The Lone Star Tick is also referred to as Amblyomma americanum.",
      "A bite from the Amblyomma americanum can cause the victim to develop an allergy to red meat.",
      "The Lone Star Tick's saliva contains a sugar molecule known as alpha-gal.",
      "Humans typically do not have alpha-gal present in their system.",
      "After a bite from this tick, humans can produce antibodies to alpha-gal causing an allergic reaction when red meat, which also contains alpha-gal, is consumed."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2600,
    "user_query": "What are pQTLs?",
    "llama-2-7b-chat-hf_response": "pQTLs (pharmacogenetic variants) are genetic variants that affect an individual's response to a drug or medication. These variants can influence how well a drug works, how long it takes to work, and the likelihood of side effects. pQTLs can be used to predict how an individual will respond to a particular drug, allowing for more personalized and effective treatment.",
    "llama-2-7b-chat-hf_fact": [
      "pQTLs stands for pharmacogenetic variants.",
      "pQTLs are genetic variants that affect an individual's response to a drug or medication.",
      "These variants can influence the effectiveness of a drug.",
      "pQTLs can affect the duration it takes for a drug to work.",
      "pQTLs can be used to predict an individual's response to a particular drug."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: pQTLs stands for pharmacogenomic quantitative trait loci.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2603,
    "user_query": "What is the \"protein inference problem\"?",
    "llama-2-7b-chat-hf_response": "The protein inference problem is a challenge in bioinformatics and computational biology that involves using computational methods to predict the three-dimensional structure of a protein from its amino acid sequence. This problem is particularly difficult because there are many possible conformations that a protein can adopt, and the correct structure depends on a variety of factors such as the chemical properties of the amino acids, the interactions between them, and the overall folding principles of the protein.\nThe protein inference problem has important implications for understanding the structure and function of proteins, which are the building blocks of life. Proteins perform a wide range of functions in the body, including catalyzing chemical reactions, replicating DNA, responding to stimuli, and transporting molecules from one location to another. Understanding the structure and function of proteins is essential for developing new drugs and therapies, as well as for understanding the underlying causes of diseases.\nThere are several approaches to solving the protein inference problem, including:\n1. Homology modeling: This involves using the known structure of a related protein as a starting point for predicting the structure of the target protein. The amino acid sequence of the target protein is aligned with the related protein, and the structure of the related protein is adjusted to fit the sequence of the target protein.\n2. Threading: This involves using a database of known protein structures to identify a threading template, which is a known structure that is similar to the target protein. The template is then used as a starting point for predicting the structure of the target protein.\n3. Ab initio modeling: This involves using quantum mechanics or molecular mechanics to build a protein structure from scratch, based only on the amino acid sequence. This approach is computationally intensive and is typically used for small proteins or protein-ligand complexes.\n4. Molecular dynamics simulations: This involves using computational methods to simulate the behavior of a protein in a virtual environment. The simulation can be used to predict the structure of the protein, as well as its dynamics and interactions with other molecules.\n5. Rosetta: It is a software package that uses a combination of homology modeling, threading, and ab initio modeling, as well as molecular dynamics simulations and energy functions to predict the structure of a protein from its amino acid sequence.\n6. Machine learning: Recently, machine learning techniques have been",
    "llama-2-7b-chat-hf_fact": [
      "The protein inference problem is a bioinformatics challenge that entails using computational methods to predict the three-dimensional structure of a protein from its amino acid sequence.",
      "The predicted structure of a protein is influenced by the chemical properties of amino acids, their interactions and protein folding principles.",
      "Homology modeling, threading, ab initio modeling, molecular dynamics simulations, use of software like Rosetta, and machine learning techniques are approaches used to solve the protein inference problem.",
      "Protein structure and function understanding is crucial for new drug and therapy development.",
      "Proteins, the building blocks of life, serve multiple functions like catalyzing chemical reactions, replicating DNA, responding to stimuli, and molecule transportation in the body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The protein inference problem is a bioinformatics challenge that entails predicting the presence of proteins in a complex sample based on the peptides identified in a mass spectrometry experiment.",
      "true",
      "false, [corrected fact]: Homology modeling, threading, ab initio modeling, molecular dynamics simulations, use of software like Rosetta, and machine learning techniques are approaches used to predict the three-dimensional structure of proteins, not to solve the protein inference problem.",
      "true",
      "true"
    ]
  },
  {
    "id": 2604,
    "user_query": "What is the link between lithium use during pregnancy and Ebstein anomaly?",
    "llama-2-7b-chat-hf_response": "Ebstein anomaly is a rare congenital heart defect that affects the tricuspid valve, which is located between the right atrium and the right ventricle of the heart. It is characterized by an abnormal connection between the right atrium and the right ventricle, which can lead to problems with blood flow and oxygenation of the body.\nLithium is a medication that is commonly used to treat bipolar disorder and other mood disorders. It works by altering the levels of certain neurotransmitters in the brain, which can help to stabilize mood and reduce symptoms of mania and depression. However, lithium can also cross the placenta and reach the developing fetus during pregnancy.\nThere have been some studies that have suggested a possible link between lithium use during pregnancy and the development of Ebstein anomaly in the fetus. These studies have found that children born to mothers who took lithium during pregnancy have a higher risk of developing Ebstein anomaly compared to children born to mothers who did not take lithium during pregnancy.\nOne study published in the Journal of the American College of Cardiology found that children born to mothers who took lithium during pregnancy had a 2.5 times higher risk of developing Ebstein anomaly compared to children born to mothers who did not take lithium during pregnancy. Another study published in the European Journal of Pediatrics found that the risk of Ebstein anomaly was 3.5 times higher in children born to mothers who took lithium during pregnancy compared to children born to mothers who did not take lithium during pregnancy.\nWhile these studies suggest a possible link between lithium use during pregnancy and the development of Ebstein anomaly, it is important to note that the evidence is not yet conclusive. More research is needed to fully understand the relationship between lithium use during pregnancy and the risk of Ebstein anomaly.\nIf you are pregnant or planning to become pregnant and taking lithium, it is important to discuss your medication use with your healthcare provider. Your healthcare provider can help you weigh the potential benefits and risks of lithium use during pregnancy and make recommendations based on your individual situation.",
    "llama-2-7b-chat-hf_fact": [
      "Ebstein anomaly is a congenital heart defect that affects the tricuspid valve and can lead to problems with blood flow and oxygenation of the body.",
      "Lithium is a medication used to treat bipolar disorder and other mood disorders.",
      "Lithium can cross the placenta and reach the developing fetus during pregnancy.",
      "Some scientific studies suggest a potential link between lithium use during pregnancy and the risk of a fetus developing Ebstein anomaly.",
      "The risk of the anomaly is reported to be higher in children born to mothers who took lithium during pregnancy than those born to mothers who didn't, according to studies published in the Journal of the American College of Cardiology and the European Journal of Pediatrics."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2605,
    "user_query": "Does verubecestat activate BACE?",
    "llama-2-7b-chat-hf_response": "Verubecestat (formerly known as LY450139) is a small molecule inhibitor of -secretase (BACE) that is being developed for the treatment of Alzheimer's disease. BACE is an enzyme that cleaves the amyloid precursor protein (APP) to produce the beta-amyloid peptide (A), which is a hallmark of Alzheimer's disease.\nVerubecestat works by binding to the active site of BACE, thereby preventing it from cleaving APP and reducing the production of A. This can help to slow down or stop the progression of Alzheimer's disease by reducing the amount of A in the brain.\nVerubecestat has been shown to be effective in preclinical studies, and it is currently being tested in clinical trials for the treatment of Alzheimer's disease.",
    "llama-2-7b-chat-hf_fact": [
      "Verubecestat is a small molecule inhibitor of -secretase (BACE).",
      "Verubecestat was formerly known as LY450139.",
      "BACE is an enzyme that produces the beta-amyloid peptide (A), a hallmark of Alzheimer's disease, by cleaving the amyloid precursor protein (APP).",
      "Verubecestat works by preventing BACE from cleaving APP, thereby reducing the production of A.",
      "Verubecestat is currently being tested in clinical trials for the treatment of Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Verubecestat was not formerly known as LY450139. LY450139 is another BACE inhibitor also known as Semagacestat.",
      "true",
      "true",
      "false, [corrected fact]: Verubecestat was tested in clinical trials for the treatment of Alzheimer's disease, but the trials were discontinued due to lack of efficacy."
    ]
  },
  {
    "id": 2607,
    "user_query": "What is emicizumab?",
    "llama-2-7b-chat-hf_response": "Emicizumab is a medication used to prevent bleeding in people with hemophilia A, a rare genetic disorder that affects the blood's ability to clot and stop bleeding. It is given by injection and works by binding to a protein called factor VIII, which is deficient in people with hemophilia A. By binding to factor VIII, emicizumab helps to prevent the breakdown of blood clots and reduce the frequency and severity of bleeding episodes.\nEmicizumab was approved by the US Food and Drug Administration (FDA) in 2017 and is marketed under the brand name Hemophilia A Treatment Center. It is the first medication to be approved for the prevention of bleeding episodes in people with hemophilia A without the need for regular infusions of factor VIII concentrate.\nWhat are the side effects of emicizumab?\nLike all medications, emicizumab can cause side effects. The most common side effects of emicizumab include:\n* Injection site reactions (such as redness, swelling, or itching)\n* Headache\n* Muscle or joint pain\n* Fatigue\n* Nausea\n* Diarrhea\n* Vomiting\nThese side effects are generally mild and do not occur in everyone who takes emicizumab. In rare cases, more serious side effects can occur, including:\n* Allergic reactions (such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat)\n* Increased risk of blood clots (thromboembolic events)\n* Increased risk of liver problems\n* Increased risk of heart problems\nIt is important to talk to your doctor or healthcare provider about any side effects you experience while taking emicizumab. They can provide guidance on how to manage side effects and help you determine whether the benefits of the medication outweigh the risks.\nHow is emicizumab administered?\nEmicizumab is given by injection under the skin (subcutaneously) once every four weeks. It is important to follow the dosing schedule recommended by your healthcare provider to ensure that you receive the full benefit of the medication.",
    "llama-2-7b-chat-hf_fact": [
      "Emicizumab is a medication used to prevent bleeding in people with hemophilia A.",
      "Emicizumab works by binding to a protein called factor VIII, which is deficient in people with hemophilia A.",
      "The US Food and Drug Administration approved emicizumab in 2017.",
      "Emicizumab is marketed under the brand name Hemophilia A Treatment Center.",
      "Emicizumab is administered by injection under the skin once every four weeks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Emicizumab is marketed under the brand name Hemlibra.",
      "false, [corrected fact]: Emicizumab is administered by injection under the skin once a week."
    ]
  },
  {
    "id": 2608,
    "user_query": "What illness is transmitted by the Lone Star Tick, Amblyomma americanum?",
    "llama-2-7b-chat-hf_response": "The Lone Star Tick, Amblyomma americanum, is a vector of several diseases in humans and animals. Some of the diseases transmitted by the Lone Star Tick include:\n1. Southern Tick-Associated Rash Illness (STARI): This is the most common tick-borne illness transmitted by the Lone Star Tick. It causes a distinctive rash and other symptoms.\n2. Tick Paralysis: This is a neurological disorder caused by a toxin in the tick's saliva. It can cause muscle weakness, paralysis, and respiratory failure if left untreated.\n3. Rocky Mountain Spotted Fever: This is a bacterial infection that can cause fever, headache, and a rash. It is transmitted by the Lone Star Tick in the southeastern United States.\n4. Tick-Borne Relapsing Fever (TBRF): This is a bacterial infection that causes recurring episodes of fever, chills, and muscle pain. It is transmitted by the Lone Star Tick in the southeastern United States.\n5. Babesiosis: This is a parasitic infection that can cause fever, chills, and anemia. It is transmitted by the Lone Star Tick in the southeastern United States.\n6. Ehrlichiosis: This is a bacterial infection that can cause fever, headache, and muscle pain. It is transmitted by the Lone Star Tick in the southeastern United States.\n7. Tick-Borne Meningitis: This is a bacterial infection that can cause meningitis, an inflammation of the membranes surrounding the brain and spinal cord. It is transmitted by the Lone Star Tick in the southeastern United States.\nIt is important to note that not all ticks carry all of these diseases, and not all bites will result in illness. If you have been bitten by a tick and are experiencing symptoms, it is important to seek medical attention.",
    "llama-2-7b-chat-hf_fact": [
      "The Lone Star Tick, Amblyomma americanum, is a vector of several diseases in humans and animals.",
      "The Lone Star Tick transmits the Southern Tick-Associated Rash Illness (STARI) which causes a rash and other symptoms.",
      "Tick Paralysis, a neurological disorder caused by a toxin in the tick's saliva, can be transmitted by the Lone Star Tick.",
      "The Lone Star Tick can transmit Rocky Mountain Spotted Fever, a bacterial infection that causes fever, headache, and a rash.",
      "Babesiosis, a parasitic infection causing fever, chills, and anemia can be contracted through the bite of a Lone Star Tick."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The Lone Star Tick cannot transmit Rocky Mountain Spotted Fever, this disease is typically transmitted by the American dog tick (Dermacentor variabilis) and the Rocky Mountain wood tick (Dermacentor andersoni).",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-7b-chat-hf_response": "Answer: There are several deep learning algorithms that have been developed for predicting protein subcellular localization. Some of the most popular ones include:\n1. DeepLoc: This is a deep learning-based method that uses a convolutional neural network (CNN) to predict protein subcellular localization. It was developed by Zhang et al. in 2018 and has been shown to be highly accurate.\n2. LocNet: This is another deep learning-based method that uses a CNN to predict protein subcellular localization. It was developed by Li et al. in 2018 and has been shown to outperform other state-of-the-art methods.\n3. PredictProteinLoc: This is a deep learning-based method that uses a combination of CNN and recurrent neural network (RNN) to predict protein subcellular localization. It was developed by Zhang et al. in 2019 and has been shown to be highly accurate.\n4. ProtTrans: This is a deep learning-based method that uses a combination of CNN and RNN to predict protein subcellular localization. It was developed by Li et al. in 2020 and has been shown to outperform other state-of-the-art methods.\n5. TransProt: This is a deep learning-based method that uses a combination of CNN and RNN to predict protein subcellular localization. It was developed by Zhang et al. in 2020 and has been shown to be highly accurate.\nThese are just a few examples of the many deep learning algorithms that have been developed for predicting protein subcellular localization. Each of these algorithms has its own strengths and weaknesses, and the choice of which algorithm to use will depend on the specific needs and goals of the researcher.",
    "llama-2-7b-chat-hf_fact": [
      "DeepLoc is a deep learning-based method that uses a convolutional neural network (CNN) to predict protein subcellular localization.",
      "DeepLoc was developed by Zhang et al. in 2018.",
      "LocNet is another deep learning-based method for predicting protein subcellular localization that was developed by Li et al. in 2018.",
      "PredictProteinLoc, a method that combines the features of a CNN and recurrent neural network (RNN), was developed by Zhang et al. in 2019.",
      "ProtTrans, another method combining features of CNN and RNN for protein subcellular localization prediction, was developed by Li et al. in 2020."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2614,
    "user_query": "What is included in the Mentzer index?",
    "llama-2-7b-chat-hf_response": "The Mentzer index is a tool used to assess the severity of chronic kidney disease (CKD). It includes the following components:\n1. Estimated glomerular filtration rate (eGFR): This measures how well the kidneys are functioning.\n2. Urine protein-to-creatinine ratio (P/C ratio): This measures the amount of protein in the urine compared to the amount of creatinine.\n3. Urine albumin-to-creatinine ratio (A/C ratio): This measures the amount of albumin in the urine compared to the amount of creatinine.\n4. Blood urea nitrogen (BUN) level: This measures the amount of waste products in the blood.\n5. Serum creatinine level: This measures the amount of creatinine in the blood.\nThe Mentzer index is calculated by adding the eGFR, P/C ratio, A/C ratio, BUN level, and serum creatinine level, and then dividing the total by 100. The resulting score can range from 0 to 100, with higher scores indicating more severe CKD.",
    "llama-2-7b-chat-hf_fact": [
      "The Mentzer index is used to assess the severity of chronic kidney disease.",
      "Components of the Mentzer index include the estimated glomerular filtration rate, urine protein-to-creatinine ratio, urine albumin-to-creatinine ratio, blood urea nitrogen level, and serum creatinine level.",
      "Estimated glomerular filtration rate measures how well the kidneys are functioning.",
      "The urine albumin-to-creatinine ratio measures the amount of albumin in the urine compared to the amount of creatinine.",
      "The index's score can range from 0 to 100, with higher scores indicating more severe CKD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Mentzer index is used to differentiate between Iron deficiency anemia and Thalassemia, not to assess the severity of chronic kidney disease.",
      "false, [corrected fact]: Components of the Mentzer index include red blood cell count and mean corpuscular volume, not estimated glomerular filtration rate, urine protein-to-creatinine ratio, urine albumin-to-creatinine ratio, blood urea nitrogen level, and serum creatinine level.",
      "true",
      "true",
      "false, [corrected fact]: The Mentzer index doesn't have a scoring range from 0 to 100 related to chronic kidney disease. Rather, it is a ratio calculated by dividing the mean corpuscular volume by the red blood cell count."
    ]
  },
  {
    "id": 2615,
    "user_query": "Which disease is treated with Fexinidazole?",
    "llama-2-7b-chat-hf_response": "Fexinidazole is an antiparasitic drug that is used to treat a variety of diseases caused by parasites, including:\n1. Giardiasis: Fexinidazole is effective against Giardia lamblia, the parasite that causes giardiasis.\n2. Amoebiasis: Fexinidazole is also effective against Entamoeba histolytica, the parasite that causes amoebiasis.\n3. Chagas disease: Fexinidazole has been shown to be effective against Trypanosoma cruzi, the parasite that causes Chagas disease.\n4. Leishmaniasis: Fexinidazole has been shown to be effective against Leishmania spp., the parasites that cause leishmaniasis.\n5. Toxoplasmosis: Fexinidazole has been shown to be effective against Toxoplasma gondii, the parasite that causes toxoplasmosis.\nIt is important to note that Fexinidazole is not effective against bacterial infections, viral infections, or fungal infections.",
    "llama-2-7b-chat-hf_fact": [
      "Fexinidazole is an antiparasitic drug.",
      "Fexinidazole is used to treat Giardiasis, an infection caused by the parasite Giardia lamblia.",
      "Amoebiasis can also be treated with Fexinidazole, which is caused by the parasite Entamoeba histolytica.",
      "Fexinidazole has been shown to be effective against Trypanosoma cruzi, which causes Chagas disease.",
      "Fexinidazole cannot be used to treat bacterial, viral, or fungal infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Fexinidazole is used to treat sleeping sickness (human African trypanosomiasis), not Giardiasis.",
      "false, [corrected fact]: Fexinidazole is not typically used to treat Amoebiasis. It is primarily used for the treatment of Trypanosoma brucei gambiense infection (Sleeping sickness).",
      "false, [corrected fact]: Fexinidazole is primarily used for the treatment of Trypanosoma brucei gambiense infection, not Trypanosoma cruzi which causes Chagas disease.",
      "true"
    ]
  },
  {
    "id": 2620,
    "user_query": "Is DNA polymerase  involved in DNA repair?",
    "llama-2-7b-chat-hf_response": "DNA polymerase  (Pol) is a DNA polymerase that plays a crucial role in DNA repair, particularly in the repair of DNA double-strand breaks (DSBs). DSBs are the most severe form of DNA damage and can lead to genetic instability and cancer if left unrepaired. Pol is specifically involved in the non-homologous end joining (NHEJ) pathway of DSB repair, which is the primary pathway used to repair DSBs in G1-phase cells.\nPol is recruited to the site of the DSB through its interaction with the DNA damage sensor, 53BP1. Once recruited, Pol extends the 3' end of the DNA break, using the template strand as a primer. This results in the synthesis of a short patch of DNA, which is then ligated to the 5' end of the break by the ligase complex. This process is essential for the repair of DSBs and helps to maintain the integrity of the genome.\nIn addition to its role in DSB repair, Pol has also been implicated in the repair of other forms of DNA damage, such as interstrand cross-links (ICLs) and oxidized bases. Pol has also been shown to play a role in the maintenance of genome stability, particularly in the regulation of telomere length and the prevention of telomere shortening.\nOverall, Pol is a critical enzyme involved in the repair of DNA damage and the maintenance of genome stability. Its dysregulation has been implicated in a number of diseases, including cancer and premature aging, highlighting the importance of this enzyme in maintaining the integrity of the genome.",
    "llama-2-7b-chat-hf_fact": [
      "DNA polymerase  (Pol) plays a crucial role in DNA repair.",
      "Pol is involved in the non-homologous end joining (NHEJ) pathway of DNA double-strand breaks (DSBs) repair.",
      "Pol gets recruited to the site of the DSB through its interaction with the DNA damage sensor, 53BP1.",
      "Pol has been implicated in the repair of other forms of DNA damage, such as interstrand cross-links (ICLs) and oxidized bases.",
      "Pol has a role in the maintenance of genome stability, particularly in the regulation of telomere length and prevention of telomere shortening."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Pol is involved in the Microhomology-mediated end joining (MMEJ) pathway of DNA double-strand breaks (DSBs) repair, not the non-homologous end joining (NHEJ).",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2623,
    "user_query": "Which algorithms are used for compression of SAM files?",
    "llama-2-7b-chat-hf_response": "SAM (Self-Attention Mechanism) files are commonly used in natural language processing (NLP) tasks, such as language translation, question answering, and text summarization. Compressing SAM files can help reduce the storage requirements and improve the efficiency of NLP models. Here are some algorithms commonly used for compression of SAM files:\n1. Huffman coding: Huffman coding is a variable-length prefix coding algorithm that assigns shorter codes to more frequently occurring symbols in the SAM file. It is a popular choice for compression of SAM files due to its simplicity and high compression ratios.\n2. Arithmetic coding: Arithmetic coding is a form of entropy coding that assigns a fractional code to each symbol in the SAM file. It is particularly useful for compressing SAM files with a large number of repeated symbols.\n3. Lempel-Ziv-Welch (LZW) coding: LZW coding is a dictionary-based compression algorithm that builds a dictionary of substrings in the SAM file and replaces each substring with a reference to the dictionary entry. It is commonly used for compression of SAM files due to its high compression ratios and low computational complexity.\n4. Burrows-Wheeler transform (BWT): BWT is a reversible transformation of a string that rearranges the symbols in the SAM file to create runs of similar characters. It is commonly used for compression of SAM files due to its ability to create runs of repeated symbols, which can be compressed more efficiently.\n5. Dictionary-based compression: Dictionary-based compression algorithms, such as LZ77 and LZ78, build a dictionary of substrings in the SAM file and replace each substring with a reference to the dictionary entry. These algorithms are commonly used for compression of SAM files due to their high compression ratios and low computational complexity.\n6. Wavelet compression: Wavelet compression is a transform-based compression algorithm that represents the SAM file as a combination of smooth and detailed components. It is commonly used for compression of SAM files due to its ability to represent the file at multiple scales and its high compression ratios.\n7. Fractal compression: Fractal compression is a transform-based compression algorithm that represents the SAM file as a set of self-similar patterns. It is commonly used for compression of SAM files due",
    "llama-2-7b-chat-hf_fact": [
      "Huffman coding, a variable-length prefix coding algorithm, is used for compression of SAM files.",
      "Arithmetic coding, a form of entropy coding, is used for compressing SAM files.",
      "Lempel-Ziv-Welch (LZW) coding, a dictionary-based compression algorithm, is used for compression of SAM files.",
      "Burrows-Wheeler transform (BWT), a reversible transformation of a string, is used for compression of SAM files.",
      "Wavelet compression, a transform-based compression algorithm, is used for compression of SAM files."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Arithmetic coding is not typically used for compressing SAM files.",
      "false, [corrected fact]: Lempel-Ziv-Welch (LZW) coding is not typically used for compressing SAM files.",
      "true",
      "false, [corrected fact]: Wavelet compression is not typically used for compressing SAM files."
    ]
  },
  {
    "id": 2629,
    "user_query": "What drug cures hepatitis C?",
    "llama-2-7b-chat-hf_response": "There are several drugs that can cure hepatitis C, including:\n1. Sofosbuvir (Sovaldi): This is a direct-acting antiviral drug that can cure hepatitis C in as little as 12 weeks.\n2. Ledipasvir (Harvoni): This is another direct-acting antiviral drug that can cure hepatitis C in as little as 12 weeks.\n3. Daclatasvir (Daklinza): This drug is used in combination with sofosbuvir to treat hepatitis C.\n4. Velpatasvir (Epclusa): This drug is used in combination with sofosbuvir to treat hepatitis C.\n5. Simeprevir (Olysio): This drug is used in combination with sofosbuvir to treat hepatitis C.\n6. Ribavirin (Copegus): This drug is used in combination with interferon to treat hepatitis C.\n7. Peginterferon (Pegasys): This drug is used in combination with ribavirin to treat hepatitis C.\nIt's important to note that these drugs are most effective when used in combination with other medications and with a well-balanced diet and lifestyle. It's also important to consult with a healthcare professional before starting any treatment for hepatitis C.",
    "llama-2-7b-chat-hf_fact": [
      "Sofosbuvir (Sovaldi) is a direct-acting antiviral drug that can cure hepatitis C.",
      "Ledipasvir (Harvoni) is a direct-acting antiviral drug that can also cure hepatitis C.",
      "Daclatasvir (Daklinza) is used in combination with sofosbuvir to treat hepatitis C.",
      "Velpatasvir (Epclusa) is used in combination with sofosbuvir to treat hepatitis C.",
      "Ribavirin (Copegus) is used in combination with interferon to treat hepatitis C."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2632,
    "user_query": "What can be predicted with the Wells criteria?",
    "llama-2-7b-chat-hf_response": "The Wells criteria are a set of guidelines used to predict the likelihood of a patient developing acute coronary syndrome (ACS), including unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), or ST-segment elevation myocardial infarction (STEMI). The criteria were developed based on a combination of clinical, laboratory, and electrocardiographic (ECG) findings.\nThe Wells criteria include the following factors:\n1. Chest pain or discomfort: The presence and location of chest pain or discomfort, as well as its duration and severity.\n2. Risk factors: The presence of traditional risk factors for ACS, such as age, male gender, smoking, hypertension, diabetes, and dyslipidemia.\n3. ECG changes: The presence of specific ECG changes, such as ST-segment elevation, T-wave inversion, or ST-segment depression, which can indicate myocardial ischemia.\n4. Cardiac biomarkers: The level of cardiac biomarkers, such as troponin, in the blood, which can indicate myocardial damage.\n5. Other symptoms: The presence of other symptoms, such as shortness of breath, fatigue, or nausea, which can indicate ACS.\nUsing these factors, the Wells criteria assign a score to each patient, with a higher score indicating a higher likelihood of ACS. The scores are then used to categorize patients into different risk groups, as follows:\n* Low risk: Score 0-2\n* Moderate risk: Score 3-5\n* High risk: Score 6-8\n* Very high risk: Score 9-10\nIt is important to note that the Wells criteria are not perfect and may not always accurately predict the likelihood of ACS. However, they can be a useful tool for healthcare providers to quickly assess a patient's risk and determine the appropriate course of action.",
    "llama-2-7b-chat-hf_fact": [
      "The Wells criteria are guidelines used to estimate the likelihood of a patient developing acute coronary syndrome (ACS).",
      "The Wells criteria were developed based on a blend of clinical, laboratory, and electrocardiographic (ECG) findings.",
      "The Wells criteria assign a score to each patient, with a higher score indicating a higher likelihood of ACS.",
      "The scores from the Wells criteria are used to categorize patients into different risk groups, including low risk (score 0-2), moderate risk (score 3-5), high risk (score 6-8), and very high risk (score 9-10).",
      "While not perfect, the Wells criteria can assist healthcare providers in quickly assessing a patient's risk and deciding the appropriate course of action."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Wells criteria are guidelines used to estimate the likelihood of a patient having deep vein thrombosis (DVT) or pulmonary embolism (PE), not acute coronary syndrome (ACS).",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-7b-chat-hf_response": "MULTOVL is a term used in the context of cryptocurrency and blockchain technology. It stands for \"Multi-chain Virtual Machine,\" which refers to a virtual machine that can execute smart contracts and decentralized applications across multiple blockchain networks.\nIn simpler terms, MULTOVL is a platform that allows developers to build and deploy decentralized applications and smart contracts across different blockchain networks, without having to rewrite the code for each network. This makes it easier for developers to create cross-chain applications and services, which can be used across different blockchain ecosystems.\nMULTOVL achieves this by providing a unified interface for interacting with different blockchain networks, allowing developers to write smart contracts and decentralized applications once and deploy them across multiple chains. This can help to increase the adoption and interoperability of blockchain technology, as well as make it easier for developers to build and deploy decentralized applications.",
    "llama-2-7b-chat-hf_fact": [
      "MULTOVL is a term used in the context of cryptocurrency and blockchain technology.",
      "The acronym MULTOVL stands for \"Multi-chain Virtual Machine\".",
      "Multi-chain Virtual Machine is a platform that can execute smart contracts and decentralized applications across multiple blockchain networks.",
      "MULTOVL provides a unified interface for interacting with different blockchain networks.",
      "MULTOVL can increase the adoption and interoperability of blockchain technology."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: There is no term such as MULTOVL in the context of cryptocurrency and blockchain technology.",
      "false, [corrected fact]: There is no acronym as MULTOVL standing for \"Multi-chain Virtual Machine\".",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2643,
    "user_query": "What is the alternative lengthening of telomeres?",
    "llama-2-7b-chat-hf_response": "Alternative lengthening of telomeres (ALT) is a mechanism by which telomeres can be lengthened in cells without the need for telomerase. Telomerase is an enzyme that lengthens telomeres by adding repetitive DNA sequences to the ends of chromosomes, but not all cells have telomerase activity. ALT is a backup mechanism that allows telomeres to be lengthened in the absence of telomerase.\nThere are two main types of ALT:\n1. Telomere repeat amplification (TRA): This mechanism involves the amplification of short telomere repeats through the action of the polymerase enzyme.\n2. Telomere repeat lengthening (TRL): This mechanism involves the elongation of telomere repeats through the action of the topoisomerase enzyme.\nBoth TRA and TRL mechanisms are less efficient than telomerase-mediated lengthening, but they can help to maintain telomere length in cells where telomerase activity is low or absent.\nIt is important to note that ALT is not a perfect backup mechanism for telomerase, as it can only partially compensate for the lack of telomerase activity. Therefore, cells that rely solely on ALT for telomere lengthening may have shorter telomeres than cells that have functional telomerase.",
    "llama-2-7b-chat-hf_fact": [
      "Alternative lengthening of telomeres (ALT) is a mechanism of lengthening telomeres without the need for telomerase.",
      "Telomerase is an enzyme that lengthens telomeres by adding repetitive DNA sequences to the ends of chromosomes.",
      "Telomere repeat amplification (TRA) and Telomere repeat lengthening (TRL) are two main types of ALT.",
      "TRA is a mechanism involving the amplification of short telomere repeats through the action of the polymerase enzyme.",
      "TRL is a mechanism involving the elongation of telomere repeats through the action of the topoisomerase enzyme."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There are multiple mechanisms for ALT, but TRA and TRL are not among them. The specific mechanisms can include homology-directed repair, break-induced replication, or recombination-dependent replication.",
      "false, [corrected fact]: TRA is not a recognized mechanism of telomere lengthening.",
      "false, [corrected fact]: TRL is not a recognized mechanism of telomere lengthening."
    ]
  },
  {
    "id": 2646,
    "user_query": "What is break induced replication?",
    "llama-2-7b-chat-hf_response": "Break-induced replication (BIR) is a mechanism of DNA replication that occurs in response to DNA damage, particularly double-strand breaks (DSBs). When a DSB occurs, the broken ends of the DNA are resected, or cut back, to create 3' overhangs. These overhangs are then used as primers for DNA synthesis, leading to the replication of the damaged DNA.\nBIR is a conservative mechanism, meaning that it preserves the genetic information of the original DNA molecule. It is an important mechanism for maintaining genome stability, as it allows for the repair of DNA damage without disrupting the integrity of the genetic code. BIR can occur in both prokaryotic and eukaryotic cells, and it plays a key role in the repair of DNA damage caused by various factors, including radiation, chemotherapy, and errors during DNA replication.\nIn summary, break-induced replication is a mechanism of DNA replication that occurs in response to DNA damage, particularly double-strand breaks, and it helps to maintain genome stability by repairing damaged DNA without disrupting the integrity of the genetic code.",
    "llama-2-7b-chat-hf_fact": [
      "Break-induced replication (BIR) is a mechanism of DNA replication that occurs in response to DNA damage.",
      "Break-induced replication is primarily triggered by double-strand breaks (DSBs) in the DNA.",
      "During break-induced replication, the broken ends of the DNA are cut back to create 3' overhangs, which are then used as primers for DNA synthesis.",
      "Break-induced replication helps maintain genome stability by repairing damaged DNA without disrupting the integrity of the genetic code.",
      "This replication mechanism occurs in both prokaryotic and eukaryotic cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2652,
    "user_query": "Name 4 circular RNA molecules associated with carcinogenesis.",
    "llama-2-7b-chat-hf_response": "1. Circular RNA (circRNA) is a type of non-coding RNA (ncRNA) that forms a covalently closed loop structure, without a 5' cap or 3' tail. circRNAs have been implicated in various cellular processes, including gene regulation, RNA processing, and response to stress. Here are 4 circular RNA molecules associated with carcinogenesis:\n2. HOTAIR: HOTAIR (HOX transcript antisense RNA) is a circRNA that is overexpressed in many types of cancer, including breast, lung, and colon cancer. Overexpression of HOTAIR has been linked to cancer cell proliferation, migration, and invasion, as well as poor prognosis.\n3. MALAT1: MALAT1 (Metastasis-associated lung adenocarcinoma transcript 1) is a circRNA that is overexpressed in many types of cancer, including breast, lung, and colon cancer. Overexpression of MALAT1 has been linked to cancer cell migration and invasion, as well as poor prognosis.\n4. TARC: TARC (Thymus and activation-regulated chemokine) is a circRNA that is overexpressed in many types of cancer, including breast, lung, and colon cancer. Overexpression of TARC has been linked to cancer cell migration and invasion, as well as poor prognosis.\n5. XBP1: XBP1 (X-box binding protein 1) is a circRNA that is overexpressed in many types of cancer, including breast, lung, and colon cancer. Overexpression of XBP1 has been linked to cancer cell proliferation, migration, and invasion, as well as poor prognosis.",
    "llama-2-7b-chat-hf_fact": [
      "Circular RNA (circRNA) is a type of non-coding RNA that forms a covalently closed loop structure, without a 5' cap or 3' tail.",
      "HOTAIR is a circular RNA molecule that is overexpressed in many types of cancer.",
      "MALAT1 is a circular RNA molecule that is overexpressed in many types of cancer.",
      "TARC is a circular RNA that is also overexpressed in many types of cancer.",
      "XBP1 is a circular RNA molecule that is overexpressed in many types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: HOTAIR is a long non-coding RNA molecule that is overexpressed in many types of cancer.",
      "false, [corrected fact]: MALAT1 is a long non-coding RNA molecule that is overexpressed in many types of cancer.",
      "unknown",
      "false, [corrected fact]: XBP1 is not a circular RNA, it is a gene encoding a transcription factor which plays a central role in the unfolded protein response pathway."
    ]
  },
  {
    "id": 2653,
    "user_query": "Which is the enzymatic activity of nardilysin?",
    "llama-2-7b-chat-hf_response": "Nardilysin is a lysosomal protease that is involved in the degradation of various proteins, including extracellular matrix proteins, growth factors, and cell surface receptors. The enzymatic activity of nardilysin is primarily focused on the cleavage of peptide bonds, and it has been shown to be involved in a variety of biological processes, including cell signaling, cell adhesion, and immune response.\nSome of the specific enzymatic activities of nardilysin include:\n1. Proteolytic activity: Nardilysin is capable of cleaving a wide range of proteins, including extracellular matrix proteins, growth factors, and cell surface receptors.\n2. Cell signaling: Nardilysin has been shown to be involved in the regulation of various cell signaling pathways, including the MAPK/ERK and JNK signaling pathways.\n3. Cell adhesion: Nardilysin has been implicated in the regulation of cell adhesion and the organization of the cytoskeleton.\n4. Immune response: Nardilysin has been shown to be involved in the regulation of the immune response, including the activation of immune cells and the production of cytokines.\n5. Inflammation: Nardilysin has been implicated in the regulation of inflammation, including the production of pro-inflammatory cytokines and the activation of immune cells.\n6. Cancer: Nardilysin has been shown to be involved in the development and progression of various types of cancer, including breast, lung, and colon cancer.\n7. Neurodegeneration: Nardilysin has been implicated in the regulation of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.\n8. Cardiovascular disease: Nardilysin has been shown to be involved in the regulation of various cardiovascular diseases, including atherosclerosis and hypertension.\n9. Metabolism: Nardilysin has been implicated in the regulation of various metabolic processes, including glucose",
    "llama-2-7b-chat-hf_fact": [
      "Nardilysin is a lysosomal protease involved in the degradation of various proteins, including extracellular matrix proteins, growth factors, and cell surface receptors.",
      "The primary enzymatic activity of nardilysin focuses on the cleavage of peptide bonds.",
      "Nardilysin is involved in various biological processes, such as cell signaling, cell adhesion, and immune response.",
      "Nardilysin has been implicated in the regulation of cell adhesion and the organization of the cytoskeleton.",
      "Nardilysin is involved in the development and progression of various types of cancer, including breast, lung, and colon cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2654,
    "user_query": "The Mantoux test detects what latent infection/disease?",
    "llama-2-7b-chat-hf_response": "A. Tuberculosis (TB)\nB. Malaria\nC. HIV/AIDS\nD. Leprosy\nAnswer: A. Tuberculosis (TB)\nExplanation: The Mantoux test, also known as the tuberculin skin test, is a diagnostic test used to detect latent tuberculosis infection (LTBI). The test involves injecting a small amount of tuberculin (a purified protein derivative of Mycobacterium tuberculosis) into the skin of the forearm. The skin reaction to the tuberculin is measured after 48-72 hours, and a positive reaction indicates the presence of LTBI. The Mantoux test is widely used in countries with a high prevalence of TB to identify individuals who may be at risk of developing active TB disease.",
    "llama-2-7b-chat-hf_fact": [
      "The Mantoux test is used to detect latent tuberculosis infection (LTBI).",
      "The test involves the injection of a purified protein derivative of Mycobacterium tuberculosis, known as tuberculin, into the forearm's skin.",
      "The skin reaction to the tuberculin is measured after 48-72 hours.",
      "A positive skin reaction to the Mantoux test indicates the presence of LTBI.",
      "The Mantoux test is widely used in countries with a high prevalence of TB."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2657,
    "user_query": "Are AAV vectors considered for the treatment of retinal dystrophies?",
    "llama-2-7b-chat-hf_response": "Adeno-associated viral (AAV) vectors have been considered as a potential therapeutic approach for the treatment of retinal dystrophies, including Leber congenital amaurosis (LCA), retinitis pigmentosa (RP), and age-related macular degeneration (AMD). AAV vectors can deliver therapeutic genes to specific cells in the retina, such as photoreceptors, and have been shown to be effective in restoring vision in animal models of retinal dystrophies.\nThere are several ongoing clinical trials investigating the safety and efficacy of AAV vectors for the treatment of retinal dystrophies, including:\n1. AAV-CNGB3: This trial is investigating the safety and efficacy of an AAV vector carrying the CNGB3 gene for the treatment of LCA. The CNGB3 gene is responsible for the structure and function of the rod photoreceptors in the retina.\n2. AAV-RPE65: This trial is investigating the safety and efficacy of an AAV vector carrying the RPE65 gene for the treatment of RP. The RPE65 gene is responsible for the structure and function of the retinal pigment epithelium (RPE), which is a layer of cells in the retina that plays a critical role in maintaining the health of photoreceptors.\n3. AAV-CRB1: This trial is investigating the safety and efficacy of an AAV vector carrying the CRB1 gene for the treatment of RP. The CRB1 gene is responsible for the structure and function of the cone photoreceptors in the retina.\n4. AAV-VMD2: This trial is investigating the safety and efficacy of an AAV vector carrying the VMD2 gene for the treatment of AMD. The VMD2 gene is responsible for the structure and function of the retinal pigment epithelium (RPE), which is a layer of cells in the retina that plays a critical role in maintaining the health of photoreceptors.\nWhile AAV vectors have shown promise in restoring vision in animal models of retinal dystrophies, there are still several challenges to overcome before they can be approved for use in humans, including",
    "llama-2-7b-chat-hf_fact": [
      "Adeno-associated viral (AAV) vectors are explored as potential therapeutic approaches for treating retinal dystrophies including Leber congenital amaurosis (LCA), retinitis pigmentosa (RP), and age-related macular degeneration (AMD).",
      "AAV vectors can deliver therapeutic genes to specific cells in the retina.",
      "Clinical trial AAV-CNGB3 is investigating an AAV vector carrying the CNGB3 gene for the treatment of LCA.",
      "Clinical trial AAV-RPE65 is investigating an AAV vector carrying the RPE65 gene for the treatment of RP.",
      "Clinical trial AAV-CRB1 is exploring an AAV vector carrying the CRB1 gene for the treatment of RP."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "false, [corrected fact]: Clinical trial AAV-RPE65 is investigating an AAV vector carrying the RPE65 gene for the treatment of LCA.",
      "unknown"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-7b-chat-hf_response": "GDF15 (Growth Differentiation Factor 15) is a protein that has been shown to have a role in regulating glucose metabolism and insulin sensitivity. Recent studies have suggested that GDF15 may be a useful biomarker for assessing the effectiveness of metformin treatment in patients with type 2 diabetes.\nOne study published in the Journal of Clinical Endocrinology and Metabolism found that GDF15 levels were significantly lower in patients with type 2 diabetes who were treated with metformin compared to those who were not treated with metformin. The study also found that GDF15 levels were inversely correlated with fasting glucose and hemoglobin A1c (HbA1c) levels, suggesting that GDF15 may be a useful marker for monitoring glucose control in patients with type 2 diabetes.\nAnother study published in the journal Diabetes, Obesity and Metabolism found that GDF15 levels were significantly higher in patients with type 2 diabetes who had poor glycemic control compared to those with good glycemic control. The study also found that GDF15 levels were inversely correlated with insulin sensitivity, suggesting that GDF15 may be a useful marker for assessing insulin resistance in patients with type 2 diabetes.\nOverall, these studies suggest that GDF15 may be a useful biomarker for assessing the effectiveness of metformin treatment in patients with type 2 diabetes. However, further research is needed to confirm these findings and to determine the clinical utility of GDF15 as a biomarker for metformin treatment.",
    "llama-2-7b-chat-hf_fact": [
      "GDF15 (Growth Differentiation Factor 15) is a protein that has a role in regulating glucose metabolism and insulin sensitivity.",
      "Some studies suggest that GDF15 may be a useful biomarker for assessing the effectiveness of metformin treatment in patients with type 2 diabetes.",
      "One study found that GDF15 levels were significantly lower in patients with type 2 diabetes who were treated with metformin compared to those untreated with metformin.",
      "In the same study, GDF15 levels were inversely correlated with fasting glucose and hemoglobin A1c (HbA1c) levels.",
      "Another study found that GDF15 levels were significantly higher in patients with type 2 diabetes who had poor glycemic control compared to those with good glycemic control."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2662,
    "user_query": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
    "llama-2-7b-chat-hf_response": "No, oncogene-induced DNA replication stress does not inhibit genomic instability. In fact, the opposite is true: oncogene-induced DNA replication stress can promote genomic instability.\nOncogenes are genes that have the potential to cause cancer by disrupting normal cellular processes. When oncogenes are overexpressed or mutated, they can lead to uncontrolled cell growth and division, which can result in the development of cancer. One of the ways that oncogenes can promote cancer is by disrupting the normal regulation of DNA replication and repair.\nOncogenes can induce DNA replication stress by overloading the cell's replication machinery, leading to errors in DNA replication and repair. This can result in the accumulation of mutations in the genome, which can contribute to the development of cancer. In addition, oncogenes can also inhibit the function of tumor suppressor genes, which are genes that help to maintain genomic stability by regulating cell growth and division.\nIn summary, oncogene-induced DNA replication stress can promote genomic instability by disrupting the normal regulation of DNA replication and repair, leading to the accumulation of mutations in the genome. This can contribute to the development of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Oncogene-induced DNA replication stress can promote genomic instability, not inhibit it.",
      "Oncogenes are genes that have the potential to cause cancer by disrupting normal cellular processes.",
      "Oncogenes can promote cancer by disrupting the normal regulation of DNA replication and repair.",
      "Oncogenes can induce DNA replication stress by overloading the cell's replication machinery, leading to errors in DNA replication and repair.",
      "Oncogenes can also inhibit the function of tumor suppressor genes that help to maintain genomic stability by regulating cell growth and division."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-7b-chat-hf_response": "Recursive splicing is a type of splicing event in which the same intron is spliced to itself, resulting in the formation of a circular splicing pattern. This type of splicing is less common in long introns and more common in short introns.\nWhy is recursive splicing more common in short introns?\nThere are several reasons why recursive splicing is more common in short introns:\n1. Short introns have a higher concentration of splice sites: Short introns have a higher concentration of splice sites compared to long introns, which makes it more likely for recursive splicing to occur.\n2. Short introns are more prone to slippage: Slippage is the process by which the spliceosome skips over one or more nucleotides during splicing. Short introns are more prone to slippage, which can lead to the formation of circular splicing patterns.\n3. Short introns have a lower stability: Short introns have a lower stability compared to long introns, which makes them more susceptible to splicing errors. Recursive splicing can occur as a result of these splicing errors.\n4. Short introns are more likely to be included in the final mRNA: Short introns are more likely to be included in the final mRNA compared to long introns, which can lead to the formation of circular splicing patterns.\nIn summary, recursive splicing is more common in short introns due to a combination of factors, including a higher concentration of splice sites, greater susceptibility to slippage, lower stability, and a higher likelihood of inclusion in the final mRNA.",
    "llama-2-7b-chat-hf_fact": [
      "Recursive splicing is a type of splicing event in which the same intron is spliced to itself, forming a circular splicing pattern.",
      "Recursive splicing is less common in long introns and more common in short introns.",
      "Short introns have a higher concentration of splice sites compared to long introns.",
      "During splicing, the process by which the spliceosome skips over one or more nucleotides is referred to as slippage.",
      "Short introns are more susceptible to slippage which can lead to the formation of circular splicing patterns."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Recursive splicing is a type of splicing event during which an intron is removed in pieces rather than as a whole.",
      "true",
      "true",
      "false, [corrected fact]: Slippage refers to an error in DNA replication where DNA polymerase slips, not to a process during splicing. In splicing, skipping over one or more exons is referred to as exon skipping.",
      "false, [corrected fact]: Slippage doesn't lead to the formation of circular splicing patterns; instead, it can cause frame-shift mutations."
    ]
  },
  {
    "id": 2667,
    "user_query": "Is transcription of eRNA bidirectional?",
    "llama-2-7b-chat-hf_response": "Yes, the transcription of eRNA (extracellular RNA) can be bidirectional. Bidirectional transcription refers to the process of transcribing a gene in both the 5' to 3' and 3' to 5' directions, resulting in the production of two complementary RNA molecules.\neRNA is a type of non-coding RNA that is transcribed from the genome and released into the extracellular space. It has been implicated in a variety of cellular processes, including cell-to-cell communication, immune response, and cancer progression.\nStudies have shown that eRNA can be transcribed in a bidirectional manner, with the 5' to 3' direction being more common than the 3' to 5' direction. Bidirectional transcription of eRNA can result in the production of different isoforms of the RNA molecule, which can have distinct functions.\nFor example, one study found that the bidirectional transcription of a gene encoding a long non-coding RNA (lncRNA) resulted in the production of two isoforms of the RNA molecule, each with a different 5' end. The 5' end of one isoform was found to be involved in the regulation of gene expression, while the 5' end of the other isoform was found to be involved in the regulation of cell proliferation.\nOverall, the bidirectional transcription of eRNA is a complex process that can result in the production of different isoforms of RNA molecules with distinct functions. Further research is needed to fully understand the mechanisms of eRNA transcription and its role in cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Transcription of extracellular RNA (eRNA) can be bidirectional.",
      "Bidirectional transcription refers to the transcribing of a gene in both the 5' to 3' and 3' to 5' directions.",
      "The 5' to 3' direction of transcription is more common in eRNA than the 3' to 5' direction.",
      "eRNA is a type of non-coding RNA that is transcribed from the genome and released into the extracellular space.",
      "Bidirectional transcription of eRNA can result in the production of different isoforms of the RNA molecule with distinct functions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2668,
    "user_query": "Is the protein pelota a ribosomal rescue factor?",
    "llama-2-7b-chat-hf_response": "Protein pelota is a protein that has been identified as a ribosomal rescue factor in certain bacteria. Ribosomal rescue factors are proteins that help to rescue stalled ribosomes, which are ribosomes that are unable to complete protein synthesis due to various reasons such as the presence of antibiotics or other stressors.\nProtein pelota was first identified in Escherichia coli (E. coli) as a protein that helps to rescue stalled ribosomes. It was found to be required for the rescue of ribosomes stalled by the antibiotic chloramphenicol, which inhibits protein synthesis by binding to the 50S subunit of the ribosome.\nSince its discovery in E. coli, protein pelota has been found to be conserved across many other bacteria, including Salmonella enterica, Pseudomonas aeruginosa, and Staphylococcus aureus. It has also been shown to play a role in the rescue of ribosomes stalled by other antibiotics, such as erythromycin and spectinomycin.\nProtein pelota is a small protein, consisting of only 107 amino acids. It is synthesized in the cytoplasm and then transported to the ribosomes, where it plays a role in the rescue of stalled ribosomes. The exact mechanism by which protein pelota rescues stalled ribosomes is not fully understood, but it is thought to interact with the 50S subunit of the ribosome and help to overcome the obstacles that prevent the ribosome from completing protein synthesis.\nIn summary, protein pelota is a ribosomal rescue factor that helps to rescue stalled ribosomes in certain bacteria. It is a small protein that is synthesized in the cytoplasm and then transported to the ribosomes, where it plays a role in the rescue of stalled ribosomes.",
    "llama-2-7b-chat-hf_fact": [
      "Protein pelota has been identified as a ribosomal rescue factor in certain bacteria.",
      "Protein pelota was initially identified in Escherichia coli (E. coli) as a protein that assists in rescuing stalled ribosomes.",
      "Protein pelota is necessary for the rescue of ribosomes stalled by the antibiotic chloramphenicol.",
      "Protein pelota has been discovered in many other bacteria, including Salmonella enterica, Pseudomonas aeruginosa, and Staphylococcus aureus.",
      "Protein pelota is a small protein, composed of 107 amino acids, and is synthesized in the cytoplasm before being transported to the ribosomes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2671,
    "user_query": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
    "llama-2-7b-chat-hf_response": "Zika virus (ZIKV) is a mosquito-borne flavivirus that has recently emerged as a global public health concern due to its association with microcephaly and other neurological disorders in newborn infants. The ZIKV membrane protein (prM) has been identified as a potential target for vaccine development, but its role in the pathogenesis of ZIKV infection is not fully understood. In this study, we investigated the role of prM in ZIKV infection and its potential contribution to the development of microcephaly in newborn infants.\nOur results show that prM is a critical component of ZIKV infection and plays a key role in the virus's ability to infect and replicate in host cells. We also found that mutations in the prM gene are associated with increased virulence and the development of microcephaly in newborn infants. These findings suggest that prM may be a key factor in the pathogenesis of ZIKV infection and microcephaly, and that targeting this protein may be a promising strategy for the development of effective ZIKV vaccines and therapies.\nOur findings are consistent with previous studies that have shown that prM is a critical component of ZIKV infection and plays a key role in the virus's ability to infect and replicate in host cells. For example, one study found that prM is essential for ZIKV entry into host cells and that mutations in the prM gene can reduce the virus's ability to infect cells (1). Another study found that prM is a major determinant of ZIKV virulence and that mutations in the prM gene can increase the virus's ability to cause disease in mice (2).\nOur results also suggest that prM may be a key factor in the development of microcephaly in newborn infants. Microcephaly is a birth defect characterized by an abnormally small head and is a common complication of ZIKV infection. Previous studies have shown that ZIKV infection during pregnancy can lead to microcephaly in newborn infants, and our findings suggest that prM may play a key role in this process. For example, we found that mutations in the prM gene are associated",
    "llama-2-7b-chat-hf_fact": [
      "Zika virus (ZIKV) is a mosquito-borne flavivirus that has been associated with microcephaly and other neurological disorders in newborn infants.",
      "The ZIKV membrane protein (prM) is critical for ZIKV's ability to infect and replicate in host cells.",
      "Mutations in the prM gene are associated with increased virulence and the development of microcephaly in newborn infants.",
      "Microcephaly is a birth defect characterized by an abnormally small head and is a common complication of ZIKV infection.",
      "Zika virus (ZIKV) infection during pregnancy can lead to microcephaly in newborn infants."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2673,
    "user_query": "What is the basis of the Sp3 procedure used in proteomics?",
    "llama-2-7b-chat-hf_response": "The Sp3 procedure is a method used in proteomics to separate and identify proteins based on their post-translational modifications (PTMs). The basis of the Sp3 procedure is to use a combination of enzymatic digestion, ion exchange chromatography, and mass spectrometry to isolate and analyze the PTMs of proteins.\nThe Sp3 procedure consists of three main steps:\n1. Enzymatic digestion: The protein sample is first digested with a combination of proteases, such as trypsin, chymotrypsin, and peptidylglutamyl peptide hydrolase (PGPH), to generate peptides.\n2. Ion exchange chromatography: The peptides are then separated based on their charge and hydrophobicity using ion exchange chromatography. This step allows for the separation of peptides based on their PTMs, such as phosphorylation, glycosylation, and ubiquitination.\n3. Mass spectrometry: The separated peptides are then analyzed using mass spectrometry to identify and quantify the PTMs. This step involves fragmenting the peptides using techniques such as collision-induced dissociation (CID) or higher-energy collision dissociation (HCD), and then detecting the fragment ions using a mass spectrometer.\nThe Sp3 procedure is a powerful tool for identifying and quantifying PTMs in proteins, and has been used to study a wide range of biological processes, including cell signaling, protein degradation, and disease progression.",
    "llama-2-7b-chat-hf_fact": [
      "The Sp3 procedure is a method used in proteomics for the separation and identification of proteins based on their post-translational modifications (PTMs).",
      "The Sp3 procedure incorporates enzymatic digestion, ion exchange chromatography, and mass spectrometry.",
      "Enzymatic digestion in the Sp3 procedure can involve proteases such as trypsin, chymotrypsin, and peptidylglutamyl peptide hydrolase (PGPH),",
      "Ion exchange chromatography is used in the Sp3 procedure to separate peptides based on their charge and hydrophobicity.",
      "The Sp3 procedure utilizes mass spectrometry for the identification and quantification of PTMs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2678,
    "user_query": "What is ATAC-seq?",
    "llama-2-7b-chat-hf_response": "ATAC-seq (Assay for Transposase-Accessible Chromatin sequencing) is a powerful tool for understanding the epigenetic landscape of cells. It allows researchers to identify regions of the genome that are accessible to a transposase enzyme, which can be used as a proxy for measuring chromatin accessibility.\nIn ATAC-seq, the transposase enzyme is used to fragment the chromatin, and the resulting fragments are then captured using an antibody or other capture probes. The captured fragments are then sequenced, allowing researchers to identify the regions of the genome that are most accessible to the transposase enzyme.\nATAC-seq can be used to study a wide range of epigenetic processes, including chromatin remodeling, histone modification, and DNA methylation. It has been particularly useful for studying the epigenetic regulation of gene expression, and has been used to identify regulatory elements such as enhancers and promoters.\nOne of the main advantages of ATAC-seq is its high resolution, which allows researchers to identify subtle changes in chromatin accessibility that may not be detectable using other epigenetic profiling methods. Additionally, ATAC-seq can be used to study a wide range of cell types and tissues, including primary cells, stem cells, and cancer cells.\nOverall, ATAC-seq is a powerful tool for understanding the epigenetic landscape of cells, and has the potential to reveal new insights into the regulation of gene expression and cellular development.",
    "llama-2-7b-chat-hf_fact": [
      "ATAC-seq stands for Assay for Transposase-Accessible Chromatin sequencing.",
      "ATAC-seq is a method used for understanding the epigenetic landscape of cells.",
      "In ATAC-seq, a transposase enzyme is used to fragment chromatin and the resulting fragments are then captured and sequenced.",
      "ATAC-seq can be used to study various epigenetic processes including chromatin remodeling, histone modification, and DNA methylation.",
      "ATAC-seq can be used to study a wide range of cell types and tissues."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: ATAC-seq primarily provides information about chromatin accessibility and is not typically used to study histone modification and DNA methylation.",
      "true"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-7b-chat-hf_response": "The TALE-iD method is a gene editing tool used to introduce specific mutations into the genome of an organism. It is a type of transcription activator-like effector (TALE) nuclease that can be programmed to recognize and cleave specific DNA sequences. The TALE-iD method is used to introduce specific mutations into the genome of an organism by designing a TALE nuclease that recognizes a specific DNA sequence and introduces a mutation at that location.\nThe TALE-iD method is used for a variety of applications, including:\n1. Basic research: The TALE-iD method can be used to introduce specific mutations into the genome of an organism in order to study the function of specific genes or gene pathways.\n2. Crop improvement: The TALE-iD method can be used to introduce desirable traits into crops, such as resistance to pests or diseases.\n3. Gene therapy: The TALE-iD method can be used to introduce specific mutations into the genome of a patient in order to treat genetic diseases.\n4. Synthetic biology: The TALE-iD method can be used to introduce specific mutations into the genome of an organism in order to create new biological pathways or functions.\n5. Cancer therapy: The TALE-iD method can be used to introduce specific mutations into the genome of cancer cells in order to kill them or to prevent them from dividing.\n6. Gene editing: The TALE-iD method can be used to introduce specific mutations into the genome of an organism in order to study the function of specific genes or gene pathways.\n7. Regenerative medicine: The TALE-iD method can be used to introduce specific mutations into the genome of stem cells in order to direct their differentiation into specific cell types.\n8. Drug discovery: The TALE-iD method can be used to introduce specific mutations into the genome of an organism in order to study the effect of specific drugs on gene function.",
    "llama-2-7b-chat-hf_fact": [
      "The TALE-iD method is a gene editing tool used to introduce specific mutations into the genome of an organism.",
      "TALE-iD is a type of transcription activator-like effector (TALE) nuclease, which can be programmed to recognize and cleave specific DNA sequences.",
      "TALE-iD method is used in basic research for studying the function of specific genes or gene pathways.",
      "TALE-iD method can introduce desirable traits into crops, such as resistance to pests or diseases.",
      "The TALE-iD method can be used in gene therapy to treat genetic diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2681,
    "user_query": "What is the function of penicillinase, also known as beta lactamase?",
    "llama-2-7b-chat-hf_response": "Penicillinase, also known as beta-lactamase, is an enzyme that breaks down beta-lactam antibiotics, such as penicillin and cephalosporin. The function of penicillinase is to hydrolyze the beta-lactam ring of these antibiotics, rendering them ineffective against bacterial infections.",
    "llama-2-7b-chat-hf_fact": [
      "Penicillinase is also known as beta-lactamase.",
      "Penicillinase is an enzyme that breaks down beta-lactam antibiotics.",
      "Penicillin and cephalosporin are examples of beta-lactam antibiotics.",
      "The function of penicillinase is to hydrolyze the beta-lactam ring of these antibiotics.",
      "Penicillinase renders beta-lactam antibiotics ineffective against bacterial infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2684,
    "user_query": "What is the dardarin protein?",
    "llama-2-7b-chat-hf_response": "Dardarin is a protein that was discovered in 2017 by researchers at the University of California, San Diego. It is found in the venom of the Brazilian wandering spider (Phoneutria fera), which is considered to be one of the most venomous spiders in the world.\nDardarin is a small protein that is composed of only 37 amino acids. Despite its small size, it has been shown to have a number of interesting properties and potential applications. For example, dardarin has been shown to be highly toxic to certain types of cancer cells, and it has also been shown to have anti-inflammatory and antibacterial properties.\nOne of the most interesting things about dardarin is its ability to selectively target and kill cancer cells while leaving healthy cells unharmed. This is because dardarin binds to a specific receptor on the surface of cancer cells, called the epidermal growth factor receptor (EGFR), which is overexpressed in many types of cancer. By binding to this receptor, dardarin is able to trigger a series of cellular events that ultimately lead to the death of the cancer cells.\nIn addition to its potential as a cancer treatment, dardarin has also been shown to have antibacterial and anti-inflammatory properties. For example, it has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA), a type of bacteria that is difficult to treat with conventional antibiotics. It has also been shown to reduce inflammation in a number of different models of disease.\nOverall, dardarin is a fascinating protein with a wide range of potential applications. While more research is needed to fully understand its properties and how it works, it has the potential to be a valuable tool in the fight against cancer and other diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Dardarin is a protein that was discovered in 2017 by researchers at the University of California, San Diego.",
      "Dardarin is found in the venom of the Brazilian wandering spider (Phoneutria fera).",
      "The Brazilian wandering spider (Phoneutria fera) is one of the most venomous spiders in the world.",
      "Dardarin has been shown to have anti-inflammatory, antibacterial properties, and is highly toxic to certain types of cancer cells.",
      "Dardarin has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA), a bacteria that is difficult to treat with conventional antibiotics."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2685,
    "user_query": "In which syndrome is the RPS19 gene most frequently mutated?",
    "llama-2-7b-chat-hf_response": "The RPS19 gene is most frequently mutated in RPS19-related leukodystrophy, also known as metachromatic leukodystrophy (MLD). RPS19-related leukodystrophy is a rare genetic disorder that affects the brain and spinal cord, leading to progressive loss of myelin and demyelination of nerve fibers. The mutations in the RPS19 gene lead to a deficiency of the enzyme arylsulfatase A, which is essential for the breakdown of sulfatides in the brain. Without this enzyme, sulfatides accumulate in the brain and cause progressive damage to the myelin sheath, leading to the symptoms of MLD.",
    "llama-2-7b-chat-hf_fact": [
      "The RPS19 gene is most frequently mutated in RPS19-related leukodystrophy, also known as metachromatic leukodystrophy (MLD).",
      "RPS19-related leukodystrophy is a rare genetic disorder that affects the brain and spinal cord.",
      "RPS19-related leukodystrophy leads to progressive loss of myelin and demyelination of nerve fibers.",
      "Mutations in the RPS19 gene cause a deficiency of the enzyme arylsulfatase A.",
      "Arylsulfatase A is essential for the breakdown of sulfatides in the brain, and its deficiency leads to sulfatide accumulation causing progressive damage to the myelin sheath."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The ARSA gene, not the RPS19 gene, is most frequently mutated in metachromatic leukodystrophy (MLD).",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2686,
    "user_query": "What type of sequences do enhancers evolve from?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-acting regulatory elements that can increase the expression of a gene by binding to proteins that recruit RNA polymerase, the enzyme that carries out transcription. Enhancers can be located far away from the promoter and gene they regulate, and can be oriented in either the same or opposite direction as the promoter.\nEnhancers can evolve from a variety of sources, including:\n1. Duplication and divergence of existing cis-elements: Enhancers can arise from the duplication and divergence of existing cis-elements, such as promoters or other regulatory elements. Over time, these duplicated or diverged elements can acquire new functions and become enhancers.\n2. Rearrangement of existing cis-elements: Enhancers can also arise from the rearrangement of existing cis-elements. For example, a cis-element that regulates the expression of a gene in one direction may be rearranged to regulate the expression of the same gene in the opposite direction.\n3. De novo creation of cis-elements: Enhancers can also be created de novo through the process of gene evolution. This can occur through a variety of mechanisms, including the insertion of new sequences into the genome or the modification of existing sequences.\n4. Horizontal gene transfer: Enhancers can also be acquired through horizontal gene transfer, which involves the transfer of genetic material between organisms. This can result in the introduction of new cis-elements or the modification of existing ones.\n5. Evolutionary pressures: Enhancers can also evolve in response to evolutionary pressures, such as changes in the environment or the presence of new regulatory elements. For example, an enhancer may evolve to regulate the expression of a gene in response to changes in temperature or the presence of a new transcription factor.\nIt is worth noting that the exact mechanisms by which enhancers evolve are still not fully understood and are the subject of ongoing research.",
    "llama-2-7b-chat-hf_fact": [
      "Enhancers are cis-acting regulatory elements that increase the expression of a gene by binding to proteins that recruit RNA polymerase.",
      "Enhancers can evolve from the duplication and divergence of existing cis-elements like promoters or other regulatory elements.",
      "Enhancers can arise from the rearrangement of existing cis-elements.",
      "Enhancers can also be created de novo through the process of gene evolution, using mechanisms that include the insertion of new sequences into the genome, or the modification of existing sequences.",
      "Enhancers can be acquired through horizontal gene transfer, which involves the transfer of genetic material between organisms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Enhancers cannot be acquired through horizontal gene transfer, which involves the transfer of genetic material between different species. However, they can evolve through vertical gene transfer, which is the transfer of genetic material from parent to offspring."
    ]
  },
  {
    "id": 2687,
    "user_query": "What nerve is involved in carpal tunnel syndrome?",
    "llama-2-7b-chat-hf_response": "Carpal tunnel syndrome is a common condition that affects the wrist and hand. It occurs when the median nerve, which runs from the forearm into the hand through a narrow passageway in the wrist called the carpal tunnel, becomes compressed or irritated. This can cause pain, numbness, and tingling in the hand and fingers, especially the thumb, index, and middle fingers.\nThe median nerve is involved in carpal tunnel syndrome. It is responsible for controlling the muscles in the hand and providing sensation to the thumb, index, and middle fingers. When the median nerve is compressed or irritated, it can cause symptoms such as pain, numbness, and tingling in the hand and fingers.\nOther nerves that can be involved in carpal tunnel syndrome include the ulnar nerve and the radial nerve. These nerves run through the carpal tunnel along with the median nerve and can also become compressed or irritated, leading to similar symptoms. However, the median nerve is the most commonly affected nerve in carpal tunnel syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Carpal tunnel syndrome is a condition that affects the wrist and hand.",
      "The median nerve is involved in carpal tunnel syndrome.",
      "The median nerve runs from the forearm into the hand through the carpal tunnel in the wrist.",
      "Symptoms of carpal tunnel syndrome when the median nerve is compressed or irritated can include pain, numbness, and tingling in the hand and fingers.",
      "The ulnar nerve and the radial nerve can also be involved in carpal tunnel syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Carpal tunnel syndrome specifically involves the compression of the median nerve. It does not typically involve the ulnar or radial nerves."
    ]
  },
  {
    "id": 2689,
    "user_query": "Please list 3 diseases treated with Valtrex(valacyclovir)",
    "llama-2-7b-chat-hf_response": "Valacyclovir is an antiviral drug used to treat a variety of viral infections, including:\n1. Herpes simplex virus (HSV) infections, including cold sores (oral herpes) and genital herpes.\n2. Varicella-zoster virus (VZV) infections, including chickenpox and shingles.\n3. Epstein-Barr virus (EBV) infections, including infectious mononucleosis (IM).",
    "llama-2-7b-chat-hf_fact": [
      "Valacyclovir is an antiviral drug.",
      "Valacyclovir is used to treat herpes simplex virus infections, which include oral and genital herpes.",
      "The drug is also used to treat varicella-zoster virus infections, including chickenpox and shingles.",
      "Another application of Valtrex is in treating Epstein-Barr virus infections, like infectious mononucleosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Valacyclovir is not typically used to treat Epstein-Barr virus infections like infectious mononucleosis."
    ]
  },
  {
    "id": 2690,
    "user_query": "Which olfactory gene senses androsterone?",
    "llama-2-7b-chat-hf_response": "Androsterone is a steroid hormone that is produced by the testes in males and by the ovaries in females. It is involved in the regulation of male reproductive function and is also used as a pheromone in communication between members of the same species.\nThere are several genes in the olfactory system that are responsible for sensing androsterone and other steroid hormones. These genes include:\n1. Androsterone receptor gene (AR): This gene encodes a G protein-coupled receptor that is responsible for detecting androsterone in the olfactory system. The AR protein is expressed in the olfactory sensory neurons and binds to androsterone with high affinity, leading to activation of downstream signaling pathways.\n2. Olfactory receptor gene (OR): This gene encodes a family of G protein-coupled receptors that are responsible for detecting a wide range of odors, including androsterone. The OR protein is expressed in the olfactory epithelium and binds to androsterone with high affinity, leading to activation of downstream signaling pathways.\n3. Steroid hormone receptor gene (SR): This gene encodes a family of nuclear receptors that are responsible for detecting and responding to steroid hormones, including androsterone. The SR protein is expressed in the olfactory epithelium and binds to androsterone with high affinity, leading to activation of downstream signaling pathways.\n4. Olfactory neuron-specific gene (ON): This gene encodes a protein that is specifically expressed in olfactory neurons and is involved in the detection of androsterone. The ON protein is expressed in the olfactory sensory neurons and binds to androsterone with high affinity, leading to activation of downstream signaling pathways.\nIn summary, the olfactory gene senses androsterone through the androsterone receptor gene (AR), olfactory receptor gene (OR), steroid hormone receptor gene (SR), and olfactory neuron-specific gene (ON). These genes are responsible for detecting and responding to androsterone in the olfactory system.",
    "llama-2-7b-chat-hf_fact": [
      "Androsterone is a steroid hormone that is produced by the testes in males and by the ovaries in females.",
      "The Androsterone receptor gene (AR) is responsible for detecting androsterone in the olfactory system.",
      "The Olfactory receptor gene (OR) is involved in detecting a wide range of odors, including androsterone.",
      "The Steroid hormone receptor gene (SR) is responsible for detecting and responding to steroid hormones, including androsterone.",
      "The Olfactory neuron-specific gene (ON) is specifically expressed in olfactory neurons and is involved in the detection of androsterone."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2696,
    "user_query": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
    "llama-2-7b-chat-hf_response": "The high-altitude adaptation of Tibetans is due to a combination of genetic and environmental factors. Several genes have been identified as being associated with this adaptation, including:\n1. EPAS1: The EPAS1 gene encodes a protein called hypoxia-inducible factor 2 alpha (HIF-2), which plays a critical role in response to low oxygen levels. Tibetans have a variant of the EPAS1 gene that leads to increased HIF-2 activity, allowing them to adapt to high altitudes.\n2. KCTD1: The KCTD1 gene encodes a potassium channel that is involved in regulating the activity of HIF-2. Tibetans have a variant of the KCTD1 gene that enhances the activity of HIF-2, contributing to their adaptation to high altitudes.\n3. EGLN1: The EGLN1 gene encodes a protein called epidermal growth factor-like domain-containing protein 1 (EGLN1), which is involved in regulating the activity of HIF-2. Tibetans have a variant of the EGLN1 gene that enhances the activity of HIF-2, contributing to their adaptation to high altitudes.\n4. HIF1A: The HIF1A gene encodes a transcription factor called hypoxia-inducible factor 1 alpha (HIF-1), which plays a critical role in response to low oxygen levels. Tibetans have a variant of the HIF1A gene that leads to increased HIF-1 activity, allowing them to adapt to high altitudes.\n5. ALDH2: The ALDH2 gene encodes an enzyme called aldehyde dehydrogenase 2 (ALDH2), which is involved in regulating the activity of HIF-2. Tibetans have a variant of the ALDH2 gene that enhances the activity of HIF-2, contributing to their adaptation to high altitudes.\n6. NRAMP1: The NRAMP1 gene encodes a protein called natural resistance-associated macrophage protein 1 (NRAMP1), which is involved in regulating the activity of HIF-2. Tibetans have a variant of",
    "llama-2-7b-chat-hf_fact": [
      "The high-altitude adaptation of Tibetans involves several genes including EPAS1, KCTD1, EGLN1, HIF1A, ALDH2, and NRAMP1.",
      "The EPAS1 gene encodes a protein called hypoxia-inducible factor 2 alpha (HIF-2), which plays a critical role in response to low oxygen levels.",
      "KCTD1 gene encodes a potassium channel that is involved in regulating the activity of HIF-2.",
      "EGLN1 gene encodes a protein called epidermal growth factor-like domain-containing protein 1 (EGLN1), which is involved in regulating the activity of HIF-2.",
      "The HIF1A gene encodes a transcription factor called hypoxia-inducible factor 1 alpha (HIF-1), which plays a critical role in response to low oxygen levels."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: KCTD1 gene encodes a protein that is involved in several biological processes. It is not specifically known to regulate the activity of HIF-2.",
      "true",
      "true"
    ]
  },
  {
    "id": 2699,
    "user_query": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
    "llama-2-7b-chat-hf_response": "Monoamine oxidase A (MAOA) is an enzyme that plays a crucial role in the breakdown of certain neurotransmitters, such as serotonin, dopamine, and norepinephrine, in the brain. Research has shown that certain variations in the MAOA gene are associated with certain personality traits, including:\n1. Aggression: Some studies have found that certain variations in the MAOA gene are associated with increased aggression in certain individuals. For example, one study found that individuals with a certain variation in the MAOA gene were more likely to engage in violent behavior.\n2. Impulsivity: The MAOA gene has also been associated with impulsivity. For example, one study found that individuals with a certain variation in the MAOA gene were more likely to engage in impulsive behaviors, such as substance abuse.\n3. Anxiety: Some studies have found that certain variations in the MAOA gene are associated with increased anxiety in certain individuals. For example, one study found that individuals with a certain variation in the MAOA gene were more likely to experience anxiety and depression.\n4. Novelty seeking: The MAOA gene has also been associated with novelty seeking personality traits. For example, one study found that individuals with a certain variation in the MAOA gene were more likely to seek out new and exciting experiences.\n5. Agoraphobia: Some studies have found that certain variations in the MAOA gene are associated with agoraphobia. For example, one study found that individuals with a certain variation in the MAOA gene were more likely to experience agoraphobia and other anxiety disorders.\nIt's important to note that the relationship between the MAOA gene and these personality traits is complex and not fully understood, and more research is needed to confirm these findings. Additionally, it's important to remember that genetics is only one factor that contributes to the development of personality traits, and other factors, such as environment and upbringing, also play a role.",
    "llama-2-7b-chat-hf_fact": [
      "Research has found associations between certain variations in the Monoamine oxidase A (MAOA) gene and specific personality traits.",
      "Some studies have suggested a link between variants in the MAOA gene and aggression.",
      "Variations in the MAOA gene have also been associated with impulsivity.",
      "Certain studies also link variations in the MAOA gene with increased anxiety.",
      "The MAOA gene has been found to be possibly associated with novelty-seeking behaviour and agoraphobia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2702,
    "user_query": "Which human gene encode for DNA polymerase ?",
    "llama-2-7b-chat-hf_response": "DNA polymerase  (Pol) is an error-prone DNA polymerase that plays a crucial role in the repair of DNA double-strand breaks (DSBs). It is one of the most abundant DNA polymerases in eukaryotic cells and is involved in various DNA repair pathways, including non-homologous end joining (NHEJ) and homologous recombination (HR).\nThe human gene that encodes for DNA polymerase  is called POLQ. This gene is located on chromosome 17q21.3 and consists of 12 exons that encode for a protein of approximately 1,300 amino acids. The POLQ protein is highly similar to other DNA polymerases, including DNA polymerase  (Pol) and DNA polymerase epsilon (Pol), and shares many of their structural and functional features.\nMutations in the POLQ gene have been associated with various human diseases, including cancer and premature aging. For example, studies have shown that Pol-deficient mice are more susceptible to DNA damage and have a higher incidence of cancer. Conversely, overexpression of Pol has been linked to cancer development and progression.\nIn summary, the human gene that encodes for DNA polymerase  is POLQ, which is located on chromosome 17q21.3 and consists of 12 exons that encode for a protein of approximately 1,300 amino acids.",
    "llama-2-7b-chat-hf_fact": [
      "DNA polymerase  (Pol) is an error-prone DNA polymerase involved in the repair of DNA double-strand breaks.",
      "The human gene that encodes for DNA polymerase  is called POLQ.",
      "The POLQ gene is located on chromosome 17q21.3 and consists of 12 exons.",
      "The POLQ gene encodes for a protein of approximately 1,300 amino acids.",
      "Mutations in the POLQ gene have been associated with various human diseases, including cancer and premature aging."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The POLQ gene encodes for a protein of approximately 2,583 amino acids.",
      "true"
    ]
  },
  {
    "id": 2705,
    "user_query": "Which are the two main bacterial phyla in human gut?",
    "llama-2-7b-chat-hf_response": "A) Firmicutes and Bacteroidetes\nB) Actinobacteria and Proteobacteria\nC) Fusobacteria and Bacteroidetes\nD) Verrucomicrobia and Actinobacteria\nAnswer: A) Firmicutes and Bacteroidetes",
    "llama-2-7b-chat-hf_fact": [
      "Firmicutes is a main bacterial phylum in the human gut.",
      "Bacteroidetes is a main bacterial phylum in the human gut."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2710,
    "user_query": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
    "llama-2-7b-chat-hf_response": "Rifampicin is an antibiotic that is used to treat bacterial infections, including tuberculosis. It works by inhibiting the synthesis of the bacterial cell wall, which ultimately leads to the death of the bacterial cell. Rifampicin is also known to induce the expression of cytochrome P450 enzymes, including CYP3A.\nCYP3A is a member of the cytochrome P450 family of enzymes, which are involved in the metabolism of a wide range of drugs and other substances in the body. CYP3A is particularly important in the metabolism of drugs that are used to treat viral infections, such as HIV and hepatitis B.\nRifampicin has been shown to induce the expression of CYP3A in the liver, which can lead to increased metabolism of drugs that are metabolized by this enzyme. This can result in reduced efficacy or increased toxicity of these drugs, depending on the specific drug and the individual patient. Therefore, it is important to monitor the levels of CYP3A inducers, such as rifampicin, when using drugs that are metabolized by this enzyme.\nIn summary, rifampicin is an antibiotic that is used to treat bacterial infections, including tuberculosis, and it also induces the expression of the cytochrome P450 enzyme CYP3A, which is involved in the metabolism of drugs used to treat viral infections such as HIV and hepatitis B.",
    "llama-2-7b-chat-hf_fact": [
      "Rifampicin is an antibiotic used to treat bacterial infections including tuberculosis.",
      "Rifampicin works by inhibiting the synthesis of the bacterial cell wall leading to bacterial cell death.",
      "Rifampicin induces the expression of cytochrome P450 enzymes, including CYP3A.",
      "CYP3A is involved in the metabolism of drugs used to treat viral infections, such as HIV and Hepatitis B.",
      "Induced expression of CYP3A by Rifampicin can lead to increased metabolism of the drugs that are metabolized by the enzyme, affecting their efficacy or toxicity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Rifampicin works by inhibiting the synthesis of bacterial RNA, thereby halting protein production and leading to bacterial cell death.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2712,
    "user_query": "Where is the EpCam protein mainly located?",
    "llama-2-7b-chat-hf_response": "The EpCam protein is mainly located at the plasma membrane of epithelial cells, where it plays a crucial role in regulating cell-cell adhesion and signaling.",
    "llama-2-7b-chat-hf_fact": [
      "The EpCam protein is located at the plasma membrane of epithelial cells.",
      "The EpCam protein plays a crucial role in regulating cell-cell adhesion.",
      "The EpCam protein also plays a role in signaling in epithelial cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2719,
    "user_query": "What is the clathrin triskelia structure?",
    "llama-2-7b-chat-hf_response": "Clathrin triskelia are the three-dimensional structures of clathrin, a protein that plays a crucial role in cellular endocytosis. Clathrin triskelia are composed of clathrin polygons, which are formed by the assembly of clathrin heavy chains and light chains. These polygons are arranged in a specific way to form the triskelia structure.\nThe clathrin triskelia structure consists of three main components:\n1. Clathrin lattice: This is the outermost layer of the triskelia structure, composed of clathrin polygons that are arranged in a hexagonal pattern.\n2. Cage-like structure: This is the next layer of the triskelia structure, composed of clathrin polygons that are arranged in a cylindrical shape around the clathrin lattice.\n3. Pit-like structure: This is the innermost layer of the triskelia structure, composed of clathrin polygons that are arranged in a pit-like shape around the cage-like structure.\nThe clathrin triskelia structure plays a crucial role in the endocytic process, as it provides a platform for the recruitment and assembly of membrane proteins and lipids that are involved in the formation of vesicles. The triskelia structure also serves as a scaffold for the organization of actin filaments and other cytoskeletal elements that are involved in the movement and transport of vesicles within the cell.\nIn summary, the clathrin triskelia structure is a three-dimensional arrangement of clathrin polygons that plays a crucial role in cellular endocytosis by providing a platform for the recruitment and assembly of membrane proteins and lipids involved in the formation of vesicles.",
    "llama-2-7b-chat-hf_fact": [
      "Clathrin triskelia is a three-dimensional structure of clathrin, a protein that is vital in cellular endocytosis.",
      "Clathrin triskelia is composed of clathrin polygons, formed by the assembly of clathrin heavy chains and light chains.",
      "The clathrin triskelia structure includes three main components - a clathrin lattice, a cage-like structure, and a pit-like structure, each composed of arranged clathrin polygons.",
      "The triskelia structure plays a vital role in endocytic process by providing a platform for the assembly of membrane proteins and lipids that form vesicles.",
      "The triskelia structure also serves as a scaffold for the organization of actin filaments and other cytoskeletal elements involved in the movement and transport of vesicles within the cell."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The clathrin triskelia structure includes three main components - clathrin heavy chains, clathrin light chains, and a centrally positioned linker which combine to from a trimer. This does not form a clathrin lattice, a cage-like structure, or a pit-like structure.",
      "true",
      "true"
    ]
  },
  {
    "id": 2721,
    "user_query": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
    "llama-2-7b-chat-hf_response": "Brucella abortus is a gram-negative, facultative intracellular bacterium that can cause brucellosis, a zoonotic disease that affects humans and animals. Brucella abortus is the most common species of Brucella that causes brucellosis in humans, and it is known to cause spontaneous abortions in pregnant women.\nBrucellosis is a bacterial infection that can affect various organs and tissues in the body, including the reproductive system. In pregnant women, brucellosis can cause spontaneous abortions, stillbirths, and premature births. In addition to reproductive problems, brucellosis can also cause fever, fatigue, joint pain, and swollen lymph nodes.\nBrucella abortus is transmitted to humans through contact with infected animals, such as sheep, goats, and cattle. The bacteria can enter the body through cuts or abrasions in the skin, or through the mucous membranes of the eyes, nose, or mouth. Once inside the body, Brucella abortus can spread to various organs and tissues, including the reproductive system, where it can cause inflammation and damage.\nDiagnosis of brucellosis typically involves a combination of physical examination, laboratory tests, and imaging studies. Laboratory tests may include blood cultures, PCR tests, and serology tests to detect the presence of antibodies against Brucella abortus. Imaging studies, such as X-rays and CT scans, may be used to evaluate the extent of organ damage and inflammation in the body.\nTreatment of brucellosis typically involves antibiotics, such as doxycycline or rifampin, which can help to clear the infection and reduce inflammation. In severe cases of brucellosis, hospitalization may be necessary to manage complications and prevent further organ damage.\nPrevention of brucellosis involves avoiding contact with infected animals and practicing good hygiene practices, such as washing hands after handling animals or their products. Vaccination of animals can also help to prevent the spread of brucellosis.\nIn summary, Brucella abortus is the organism that causes brucellosis, a zoonotic disease that",
    "llama-2-7b-chat-hf_fact": [
      "Brucella abortus is a gram-negative, facultative intracellular bacterium that can cause brucellosis.",
      "Brucellosis can affect various organs and tissues in the body, including the reproductive system, and can cause spontaneous abortions, stillbirths, and premature births in pregnant women.",
      "Brucella abortus is transmitted to humans through contact with infected animals such as sheep, goats, and cattle.",
      "Diagnosis of brucellosis involves a combination of physical examination, laboratory tests, and imaging studies.",
      "Treatment of brucellosis typically involves antibiotics, like doxycycline or rifampin, and in severe cases, hospitalization may be necessary."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2722,
    "user_query": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
    "llama-2-7b-chat-hf_response": "Neanderthals and modern humans (Homo sapiens) interbred when the two groups encountered each other in Europe and Asia around 40,000 to 60,000 years ago. As a result, many present-day humans carry a small amount of Neanderthal DNA in their genomes.\nThe amount of Neanderthal DNA in the genomes of present-day humans varies depending on the population being studied. For example, a 2014 study found that:\n* In Europeans, the average amount of Neanderthal DNA is around 2.5%.\n* In East Asians, the average amount of Neanderthal DNA is around 3.5%.\n* In Africans, the average amount of Neanderthal DNA is around 0.5%.\nIt's worth noting that these numbers are averages, and there is a lot of variation within each population. Some individuals may have more or less Neanderthal DNA than the average for their population.\nSo, to answer your question, the percentage of Homo sapiens DNA that is of Neanderthal origin varies depending on the population being studied, but on average it is around 2-3% in Europeans, 3.5% in East Asians, and 0.5% in Africans.",
    "llama-2-7b-chat-hf_fact": [
      "Neanderthals and modern humans (Homo sapiens) interbred around 40,000 to 60,000 years ago.",
      "Many present-day humans carry a small amount of Neanderthal DNA in their genomes.",
      "The average amount of Neanderthal DNA in the genomes of Europeans is around 2.5%.",
      "In East Asians, the average amount of Neanderthal DNA is around 3.5%.",
      "In Africans, the average amount of Neanderthal DNA is about 0.5%."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The average amount of Neanderthal DNA in the genomes of people of non-African heritage is less than 2%.",
      "false, [corrected fact]: In East Asians, the average amount of Neanderthal DNA is around 2.3%.",
      "false, [corrected fact]: People of African descent have nearly zero percent of Neanderthal DNA because their ancestors did not interbreed with Neanderthals."
    ]
  },
  {
    "id": 2723,
    "user_query": "What is Dupuytren's contracture?",
    "llama-2-7b-chat-hf_response": "Dupuytren's contracture is a condition that affects the hand and causes the fingers to bend inward. It is caused by a thickening of the tissue in the palm of the hand, which can lead to the fingers becoming permanently bent in a flexed position. The condition typically affects the little finger and ring finger the most, although any finger can be affected.\nThe symptoms of Dupuytren's contracture can include:\n* A lump or nodule in the palm of the hand\n* Pain or discomfort in the palm of the hand or fingers\n* Difficulty straightening the fingers\n* A feeling of the fingers being stuck in a bent position\n* Difficulty gripping or holding objects\nThe exact cause of Dupuytren's contracture is not known, but it is thought to be related to a combination of genetic and environmental factors. It is more common in men than women and typically affects people over the age of 50. Treatment options for Dupuytren's contracture include physical therapy, medication, and surgery.",
    "llama-2-7b-chat-hf_fact": [
      "Dupuytren's contracture is a condition that affects the hand and causes the fingers to bend inward.",
      "The condition is caused by a thickening of the tissue in the palm of the hand.",
      "Dupuytren's contracture typically affects the little and ring fingers the most.",
      "The exact cause of Dupuytren's contracture is not known but it is thought to be related to a combination of genetic and environmental factors.",
      "Dupuytren's contracture is more common in men than women and typically affects people over the age of 50."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2728,
    "user_query": "Are human enhancers or promoters evolving faster?",
    "llama-2-7b-chat-hf_response": "Human enhancers and promoters are regions of DNA that play a crucial role in regulating gene expression. Enhancers are sequences that can be located far away from the promoter and gene they regulate, and they work by looping back to the promoter to increase the recruitment of RNA polymerase, the enzyme that carries out transcription. Promoters, on the other hand, are the regions where RNA polymerase binds to initiate transcription.\nWhile both enhancers and promoters are important for regulating gene expression, there is evidence to suggest that enhancers may be evolving faster than promoters. For example, a study published in the journal Nature in 2015 found that the number of enhancers in the human genome has increased significantly over the past 30 million years, while the number of promoters has remained relatively constant.\nThere are several reasons why enhancers may be evolving faster than promoters. One reason is that enhancers are more flexible than promoters, meaning that they can be turned on or off more easily in response to changes in the environment. This flexibility allows enhancers to play a more dynamic role in regulating gene expression, which may lead to more rapid evolution.\nAnother reason why enhancers may be evolving faster than promoters is that they are more likely to be influenced by non-coding RNA molecules, such as microRNAs and long non-coding RNAs. These RNA molecules can bind to enhancers and either activate or repress their activity, leading to rapid changes in gene expression. In contrast, promoters are less likely to be influenced by non-coding RNAs, which may limit their ability to evolve rapidly.\nOverall, while both enhancers and promoters are important for regulating gene expression, there is evidence to suggest that enhancers may be evolving faster than promoters due to their greater flexibility and susceptibility to influence by non-coding RNAs.",
    "llama-2-7b-chat-hf_fact": [
      "Human enhancers and promoters are regions of DNA that regulate gene expression.",
      "Enhancers are sequences that can be located far away from the promoter and gene they regulate, and they increase the recruitment of RNA polymerase through looping back to the promoter.",
      "Promoters are the regions where RNA polymerase binds to initiate transcription.",
      "There is evidence to suggest that enhancers may be evolving faster than promoters.",
      "Enhancers are more likely to be influenced by non-coding RNA molecules, such as microRNAs and long non-coding RNAs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2729,
    "user_query": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
    "llama-2-7b-chat-hf_response": "As of November 2017, the three antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, are:\n1. Idarucizumab: This is a specific antidote for dabigatran, a direct factor Xa inhibitor. Idarucizumab is administered intravenously and can reverse the anticoagulant effects of dabigatran within 60 minutes.\n2. Andexanet alfa: This is a specific antidote for factor Xa inhibitors, including rivaroxaban and apixaban. Andexanet alfa is administered intravenously and can reverse the anticoagulant effects of factor Xa inhibitors within 60 minutes.\n3. Protamine sulfate: This is a general antidote for all types of anticoagulant drugs, including vitamin K antagonists and direct factor Xa inhibitors. Protamine sulfate is administered intravenously and can reverse the anticoagulant effects of these drugs within 30 minutes to 2 hours.\nIt is important to note that these antidotes are not always 100% effective and may not completely reverse the anticoagulant effects of these drugs. Additionally, these antidotes may have side effects and should only be administered under the guidance of a healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "Idarucizumab is a specific antidote for dabigatran, a direct factor Xa inhibitor.",
      "Andexanet alfa is a specific antidote for factor Xa inhibitors, including rivaroxaban and apixaban.",
      "Protamine sulfate is a general antidote for all types of anticoagulant drugs, including vitamin K antagonists and direct factor Xa inhibitors.",
      "These antidotes are administered intravenously.",
      "The effectiveness of these antidotes varies and they may not completely reverse the anticoagulant effects of the drugs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Idarucizumab is a specific antidote for dabigatran, a direct thrombin inhibitor.",
      "true",
      "false, [corrected fact]: Protamine sulfate is used to reverse the effects of heparin and low molecular weight heparin, not all types of anticoagulant drugs.",
      "true",
      "true"
    ]
  },
  {
    "id": 2730,
    "user_query": "Which genes are associated with Epidermolysis Bullosa Simplex?",
    "llama-2-7b-chat-hf_response": "Epidermolysis Bullosa Simplex (EBS) is a rare genetic disorder that affects the skin and mucous membranes, causing blisters and sores to form easily. The disorder is caused by mutations in genes that are involved in the structure and function of the skin and mucous membranes. Here are some of the genes that have been associated with EBS:\n1. Keratin 5 gene (KRT5): Mutations in the KRT5 gene are the most common cause of EBS. The KRT5 gene provides instructions for making a protein called keratin 5, which is an important component of the skin's outer layer.\n2. Keratin 14 gene (KRT14): Mutations in the KRT14 gene have also been linked to EBS. The KRT14 gene provides instructions for making keratin 14, another protein that is important for the skin's structure and function.\n3. Filaggrin gene (FLG): Mutations in the FLG gene have been identified in some cases of EBS. The FLG gene provides instructions for making filaggrin, a protein that helps to maintain the skin's barrier function and prevent water loss.\n4. LAMB3 gene (LAMB3): Mutations in the LAMB3 gene have been identified in some cases of EBS. The LAMB3 gene provides instructions for making a protein called lamb3, which is involved in the structure and function of the skin and mucous membranes.\n5. PLEC gene (PLEC): Mutations in the PLEC gene have been identified in some cases of EBS. The PLEC gene provides instructions for making a protein called plectin, which is involved in the structure and function of the skin and mucous membranes.\n6. ITGA2 gene (ITGA2): Mutations in the ITGA2 gene have been identified in some cases of EBS. The ITGA2 gene provides instructions for making a protein called integrin alpha 2, which is involved in the structure and function of the skin and mucous membranes.\n7. ITGB2 gene (ITGB2): Mutations in the ITGB2 gene have been identified in some cases of EBS. The ITGB2 gene provides instructions",
    "llama-2-7b-chat-hf_fact": [
      "Epidermolysis Bullosa Simplex (EBS) is a rare genetic disorder that affects the skin and mucous membranes.",
      "The Keratin 5 gene (KRT5) is often associated with EBS, producing an important protein for the skin's outer layer.",
      "The Keratin 14 gene (KRT14) has also been linked to EBS, and provides instructions for making keratin 14, which is important for the skin's structure and function.",
      "Mutations in the Filaggrin gene (FLG), which helps maintain the skin's barrier function, have been found in some EBS cases.",
      "Mutations in the LAMB3 gene, which provides instructions for the Lamb3 protein, have been identified in some cases of EBS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no known link between mutations in the Filaggrin gene (FLG) and EBS.",
      "true"
    ]
  },
  {
    "id": 2738,
    "user_query": "What part of the body is affected by mesotheliomia?",
    "llama-2-7b-chat-hf_response": "Mesothelioma is a rare and aggressive form of cancer that affects the lining of the lungs, abdomen, or heart. The most common type of mesothelioma is pleural mesothelioma, which affects the lining of the lungs. This type of cancer accounts for about 70-80% of all mesothelioma cases.\nOther types of mesothelioma include:\nPeritoneal mesothelioma: This type of cancer affects the lining of the abdomen and accounts for about 10-20% of all mesothelioma cases.\nTesticular mesothelioma: This is a rare type of mesothelioma that affects the lining of the testicles.\nPericardial mesothelioma: This is a rare type of mesothelioma that affects the lining of the heart.\nThe symptoms of mesothelioma can vary depending on the location of the cancer, but common symptoms include:\nChest pain or discomfort: Pleural mesothelioma often causes chest pain or discomfort, which can be worse with deep breathing or coughing.\nShortness of breath: As the cancer grows, it can compress the lungs and make it difficult to breathe.\nFatigue: Mesothelioma can cause fatigue, which can make it difficult to carry out daily activities.\nWeight loss: As the cancer progresses, it can cause weight loss and loss of appetite.\nAbdominal pain: Peritoneal mesothelioma can cause abdominal pain and discomfort, which can be worse after eating.\nFluid buildup: Mesothelioma can cause fluid buildup in the abdomen, which can lead to swelling and discomfort.\nIf you have any of these symptoms, it is important to see a doctor as soon as possible for proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Mesothelioma is a form of cancer that affects the lining of the lungs, abdomen, or heart.",
      "The most common type of mesothelioma is pleural mesothelioma, which affects the lining of the lungs.",
      "Peritoneal mesothelioma affects the lining of the abdomen.",
      "Testicular and pericardial mesothelioma are rarer types, affecting the lining of the testicles and the heart respectively.",
      "Common symptoms of mesothelioma include chest or abdominal pain, shortness of breath, fatigue, weight loss, and fluid buildup in the abdomen."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Testicular mesothelioma is a rare type that affects the lining of the testicles. Pericardial mesothelioma affects the lining of the heart.",
      "true"
    ]
  },
  {
    "id": 2741,
    "user_query": "What is PNPPP?",
    "llama-2-7b-chat-hf_response": "PNPPP stands for Personal Non-Profit Personal Project. It is a term used to describe a personal project or initiative that is not-for-profit and is driven by an individual or a small group of individuals. PNPPPs are often created to address a specific social or environmental issue, and they can take many forms, such as a blog, a social media campaign, a community event, or a product.\nThe term PNPPP was coined to distinguish these types of projects from traditional for-profit businesses, which are driven by the pursuit of profit and shareholder value. PNPPPs, on the other hand, are driven by a desire to make a positive impact and to contribute to a larger social or environmental cause.\nPNPPPs can be a powerful way for individuals to make a difference in the world, and they can also be a way for people to develop new skills and gain experience in areas such as project management, marketing, and social entrepreneurship.",
    "llama-2-7b-chat-hf_fact": [
      "PNPPP is an acronym for Personal Non-Profit Personal Project.",
      "PNPPPs are personal projects or initiatives that are not-for-profit and is driven by an individual or a small group of individuals.",
      "These projects are created to address a specific social or environmental issue.",
      "The term PNPPP was created to distinguish these projects from traditional for-profit businesses.",
      "PNPPPs can be a way for people to develop new skills and gain experience in areas such as project management, marketing, and social entrepreneurship."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: PNPPP is not a recognized acronym and it is not known as Personal Non-Profit Personal Project. The actual meaning of the acronym can vary greatly depending on the context.",
      "unknown",
      "unknown",
      "false, [corrected fact]: The term PNPPP is not known to be created specifically to distinguish these projects from traditional for-profit businesses. Again, it is important to highlight the acronym will depend on the context.",
      "unknown"
    ]
  },
  {
    "id": 2746,
    "user_query": "Which genomic positions are preferentially selected for transposon insertion?",
    "llama-2-7b-chat-hf_response": "Transposons are mobile genetic elements that can insert themselves into new locations within a genome. The process of transposon insertion can result in genetic mutations, some of which can have deleterious effects on the organism. However, some studies have shown that certain genomic positions are preferentially selected for transposon insertion.\nOne study found that in Drosophila melanogaster, transposons are more likely to insert into regions of the genome that are rich in repetitive DNA elements, such as satellite DNA and transposable elements. This suggests that these regions may be more accessible to the transposase enzyme that mediates transposon insertion.\nAnother study found that in the human genome, transposons are more likely to insert into regions of the genome that are associated with gene expression, such as promoter and enhancer elements. This suggests that these regions may be more important for the regulation of gene expression and may be more susceptible to disruption by transposon insertion.\nIt is important to note that the preferential selection of certain genomic positions for transposon insertion can have significant consequences for the organism. For example, insertion of a transposon into a gene can result in the disruption of that gene's function, leading to a loss of function mutation. Similarly, insertion of a transposon into a regulatory element can disrupt the regulation of gene expression, leading to changes in the levels of gene expression.\nIn summary, certain genomic positions are preferentially selected for transposon insertion, including regions rich in repetitive DNA elements and regions associated with gene expression. The consequences of transposon insertion can be significant and can result in genetic mutations that can have deleterious effects on the organism.",
    "llama-2-7b-chat-hf_fact": [
      "Transposable elements, known as transposons, can insert themselves into new locations within a genome.",
      "Transposon insertion can result in genetic mutations.",
      "In Drosophila melanogaster, transposons are more likely to insert into regions of the genome that are rich in repetitive DNA elements.",
      "In the human genome, transposons are more likely to insert into regions associated with gene expression like promoter and enhancer elements.",
      "The insertion of a transposon can disrupt a gene's function or the regulation of gene expression, leading to potential deleterious effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-7b-chat-hf_response": "Lisp is a family of programming languages based on the concept of macros, which are essentially functions that generate code at compile-time. Lisp has been used for a wide range of applications, including artificial intelligence, natural language processing, and image processing.\nThere are several Lisp frameworks that have been developed specifically for image processing, including:\n1. CL-Image: CL-Image is a Lisp library for image processing. It provides a set of functions for loading, manipulating, and saving images, as well as a number of higher-level functions for tasks such as edge detection, thresholding, and feature extraction.\n2. ImageTk: ImageTk is a Lisp interface to the Tk toolkit, which provides a graphical user interface (GUI) for image processing. It includes a set of functions for loading, manipulating, and saving images, as well as a number of higher-level functions for tasks such as image segmentation, thresholding, and feature extraction.\n3. Lisp-Image: Lisp-Image is a Lisp library for image processing. It provides a set of functions for loading, manipulating, and saving images, as well as a number of higher-level functions for tasks such as edge detection, thresholding, and feature extraction.\n4. Image Processing Toolkit (IPT): IPT is a Lisp library for image processing. It provides a set of functions for loading, manipulating, and saving images, as well as a number of higher-level functions for tasks such as image segmentation, thresholding, and feature extraction.\n5. OpenLisp-Image: OpenLisp-Image is a Lisp library for image processing. It provides a set of functions for loading, manipulating, and saving images, as well as a number of higher-level functions for tasks such as edge detection, thresholding, and feature extraction.\n6. Lisp-Image-J: Lisp-Image-J is a Lisp library for image processing. It provides a set of functions for loading, manipulating, and saving images, as well as a number of higher-level functions for tasks such as image segmentation, thresholding, and feature extraction.\n7. Image-Lisp: Image-Lisp is a Lisp library for image processing. It provides a set of functions for loading, manipulating, and saving images, as well as a number of",
    "llama-2-7b-chat-hf_fact": [
      "Lisp is a family of programming languages based on the concept of macros.",
      "Lisp has been used for a wide range of applications including artificial intelligence, natural language processing, and image processing.",
      "CL-Image is a Lisp library for image processing.",
      "ImageTk is a Lisp interface to the Tk toolkit and provides a GUI for image processing.",
      "Image Processing Toolkit (IPT) is a Lisp library for image processing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Lisp is a family of programming languages with a distinctive, fully parenthesized prefix notation, often used in the field of artificial intelligence.",
      "true",
      "true",
      "false, [corrected fact]: ImageTk is a Python interface to the Tk toolkit and provides a GUI for image processing.",
      "unknown"
    ]
  },
  {
    "id": 2751,
    "user_query": "List four features of the WHIM syndrome.",
    "llama-2-7b-chat-hf_response": "1. WHIM syndrome is a rare genetic disorder that affects the immune system.\n2. It is caused by mutations in the X-linked immunodeficiency (XLI) gene.\n3. People with WHIM syndrome are born with a defective immune system that makes it difficult for their body to fight off infections.\n4. WHIM syndrome can lead to a range of health problems, including recurring ear infections, sinus infections, and respiratory infections.",
    "llama-2-7b-chat-hf_fact": [
      "WHIM syndrome is a rare genetic disorder that affects the immune system.",
      "This syndrome is caused by mutations in the X-linked immunodeficiency (XLI) gene.",
      "Individuals with WHIM syndrome are born with a defective immune system.",
      "This defective immune system makes it difficult for their body to fight off infections.",
      "WHIM syndrome can lead to a variety of health problems, such as recurring ear infections, sinus infections, and respiratory infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: WHIM syndrome is caused by mutations in the CXCR4 gene.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2753,
    "user_query": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?",
    "llama-2-7b-chat-hf_response": "Research has shown that exposure to furry pets, such as dogs and cats, can enrich the gut microbiome of infants. Specifically, studies have found that infants who are exposed to furry pets have higher levels of beneficial bacteria, such as Bifidobacterium and Lactobacillus, in their gut microbiome. These bacteria are important for immune system development and can help to protect against infections and allergies. Additionally, exposure to furry pets may also increase the diversity of the gut microbiome, which can help to promote overall health and well-being.",
    "llama-2-7b-chat-hf_fact": [
      "Exposure to furry pets, such as dogs and cats, can enrich the gut microbiome of infants.",
      "Infants who are exposed to furry pets have higher levels of Bifidobacterium and Lactobacillus in their gut microbiome.",
      "Bifidobacterium and Lactobacillus are beneficial bacteria for immune system development.",
      "These bacteria can help to protect against infections and allergies.",
      "Exposure to furry pets may increase the diversity of the gut microbiome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2755,
    "user_query": "Is Baloxavir effective for influenza?",
    "llama-2-7b-chat-hf_response": "Yes, baloxavir has been shown to be effective in treating influenza (flu) in clinical trials. Baloxavir is an orally administered drug that works by inhibiting the replication of influenza viruses in the body. It has been shown to reduce the severity and duration of flu symptoms, and to reduce the risk of flu complications, such as pneumonia.\nIn a phase 3 clinical trial published in The New England Journal of Medicine in 2018, baloxavir was compared to oseltamivir (Tamiflu) in adults and adolescents with influenza. The study found that baloxavir was non-inferior to oseltamivir in reducing the severity and duration of flu symptoms, and that it was superior to oseltamivir in reducing the risk of flu complications.\nAnother phase 3 clinical trial published in the Journal of Infectious Diseases in 2020 compared baloxavir to zanamivir (Relenza) in adults and adolescents with influenza. This study found that baloxavir was superior to zanamivir in reducing the severity and duration of flu symptoms, and that it was effective in reducing the risk of flu complications.\nOverall, the results of these clinical trials suggest that baloxavir is an effective treatment for influenza, and that it may offer advantages over other antiviral drugs currently available for treating the flu. However, it's important to note that baloxavir is not a cure for the flu, and it is most effective when started within 48 hours of the onset of symptoms.",
    "llama-2-7b-chat-hf_fact": [
      "Baloxavir is an orally administered drug used to treat influenza.",
      "Baloxavir works by inhibiting the replication of influenza viruses in the body.",
      "A phase 3 clinical trial in 2018 found that baloxavir reduced the severity and duration of flu symptoms and risk of complications, relative to oseltamivir (Tamiflu).",
      "A separate phase 3 clinical trial published in 2020 found baloxavir to be superior in reducing flu symptoms and complications compared to zanamivir (Relenza).",
      "The effectiveness of baloxavir in treating influenza is most notable when started within 48 hours of symptom onset."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-7b-chat-hf_response": "Saccharomyces cerevisiae, also known as baker's yeast, is a eukaryote that has undergone a whole genome duplication event in its evolutionary history. This event, which occurred around 1000 million years ago, resulted in the duplication of approximately half of the yeast genome.\nTo determine the number of genes in S. cerevisiae that are the result of this ancient whole genome duplication, researchers can use a variety of approaches. One approach is to compare the gene content of S. cerevisiae to that of other eukaryotes, such as humans or plants, which have not undergone whole genome duplication events. By comparing the number of genes in these organisms, researchers can estimate the number of genes in S. cerevisiae that are the result of the ancient whole genome duplication.\nAnother approach is to use computational methods to identify genes in S. cerevisiae that are the result of the ancient whole genome duplication. This can be done by identifying genes that are highly conserved across different species, as these genes are likely to be the result of the ancient whole genome duplication.\nOverall, the number of genes in S. cerevisiae that are the result of the ancient whole genome duplication is estimated to be around 1,000-2,000 genes. These genes are thought to play important roles in various cellular processes, including metabolism, stress response, and protein synthesis.",
    "llama-2-7b-chat-hf_fact": [
      "Saccharomyces cerevisiae, also known as baker's yeast, is a eukaryote.",
      "Saccharomyces cerevisiae has undergone a whole genome duplication event approximately 1000 million years ago.",
      "This event resulted in the duplication of approximately half of the yeast genome.",
      "The number of genes in S. cerevisiae that are the result of this ancient whole genome duplication is estimated to be around 1,000-2,000 genes.",
      "These genes are thought to play important roles in various cellular processes, including metabolism, stress response, and protein synthesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The whole genome duplication event resulted in the duplication of the entire yeast genome, not just approximately half.",
      "true",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "llama-2-7b-chat-hf_response": "A) Estrogen receptor alpha (Esrra)\nB) Estrogen receptor beta (Esrrb)\nC) Androgen receptor (Ar)\nD) Progesterone receptor (Pgr)\nAnswer: B) Estrogen receptor beta (Esrrb)",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2773,
    "user_query": "Which database associates human noncoding SNPs with their three-dimensional interacting genes?",
    "llama-2-7b-chat-hf_response": "Answer: There are several databases that associate human noncoding SNPs with their three-dimensional interacting genes. Here are a few examples:\n1. The Human Protein-Protein Interaction (HuPPI) database: This database contains information on the three-dimensional interactions between human proteins, including those associated with noncoding SNPs.\n2. The GeneMANIA database: This database uses a computational approach to predict the three-dimensional interactions between human genes, including those associated with noncoding SNPs.\n3. The 3D-Genome database: This database contains information on the three-dimensional structure of the human genome, including the interactions between noncoding SNPs and their associated genes.\n4. The ENCODE (ENCyclopedia Of DNA Elements) database: This database contains information on the functional elements in the human genome, including noncoding SNPs and their associated genes.\n5. The Roadmap Epigenomics Project database: This database contains information on the epigenetic modifications in the human genome, including those associated with noncoding SNPs.\n6. The GTEx (Genotype-Tissue Expression) database: This database contains information on the expression of genes in different human tissues, including those associated with noncoding SNPs.\n7. The HaploReg database: This database contains information on the regulatory elements in the human genome, including noncoding SNPs and their associated genes.\n8. The RegulomeDB database: This database contains information on the regulatory elements in the human genome, including noncoding SNPs and their associated genes.\n9. The ChromHMM database: This database contains information on the three-dimensional chromatin structure of the human genome, including the interactions between noncoding SNPs and their associated genes.\n10. The Chromatin Interaction Map (ChIA-Map) database: This database contains information on the three-dimensional interactions between chromatin regions in the human genome, including those associated with noncoding SNPs.\nIt's worth noting that these databases are constantly being updated and new ones are being developed, so it's always a good idea to check the latest information.",
    "llama-2-7b-chat-hf_fact": [
      "The Human Protein-Protein Interaction (HuPPI) database contains information on the three-dimensional interactions between human proteins, including those associated with noncoding SNPs.",
      "The GeneMANIA database uses a computational approach to predict the three-dimensional interactions between human genes, including those associated with noncoding SNPs.",
      "The 3D-Genome database contains information on the three-dimensional structure of the human genome, including the interactions between noncoding SNPs and their associated genes.",
      "The ENCODE (ENCyclopedia Of DNA Elements) database contains information on the functional elements in the human genome, including noncoding SNPs and their associated genes.",
      "The Roadmap Epigenomics Project database contains information on the epigenetic modifications in the human genome, including those associated with noncoding SNPs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false, [corrected fact]: The GeneMANIA database uses a computational approach to predict the functional interaction network among genes.",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2778,
    "user_query": "What is the role of fucokinase?",
    "llama-2-7b-chat-hf_response": "Fucokinase is an enzyme that plays a crucial role in the biosynthesis of fucose, a simple sugar found in many biological molecules, including glycoproteins, glycolipids, and polysaccharides. Fucokinase is responsible for catalyzing the transfer of a fucose molecule from a donor molecule to an acceptor molecule, resulting in the formation of a glycosidic bond between the two molecules.\nFucokinase is found in a variety of organisms, including bacteria, yeast, and mammalian cells. In mammalian cells, fucokinase is primarily found in the endoplasmic reticulum (ER) and is involved in the biosynthesis of glycoproteins and glycolipids. Fucokinase is also involved in the biosynthesis of the polysaccharide fucoidan, which is found in the cell walls of some bacteria and fungi.\nDysregulation of fucokinase activity has been implicated in a number of diseases, including cancer and neurodegenerative disorders. For example, studies have shown that fucokinase is overexpressed in certain types of cancer, and that inhibition of fucokinase activity can inhibit the growth of cancer cells. Additionally, mutations in the fucokinase gene have been associated with neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.\nOverall, fucokinase is a crucial enzyme involved in the biosynthesis of important biological molecules, and dysregulation of its activity has been implicated in a number of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Fucokinase is an enzyme involved in the biosynthesis of fucose, a simple sugar found in many biological molecules.",
      "The enzyme is responsible for catalyzing the transfer of a fucose molecule from a donor molecule to an acceptor molecule.",
      "Fucokinase is found in a variety of organisms, including bacteria, yeast, and mammalian cells.",
      "In mammalian cells, fucokinase is primarily found in the endoplasmic reticulum and is involved in the biosynthesis of glycoproteins and glycolipids.",
      "Dysregulation of fucokinase activity has been linked to a number of diseases, including cancer and neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Fucokinase is responsible for catalyzing the transfer of a phosphate group to fucose, not a fucose molecule to another molecule.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2785,
    "user_query": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "llama-2-7b-chat-hf_response": "Whole-genome duplications are more divergent than small-scale duplications in yeast, according to a study published in the journal Nature Communications. The study analyzed the genomes of 12 yeast species and found that whole-genome duplications were more divergent than small-scale duplications, indicating that the former may have played a more important role in the evolution of these organisms.\nWhole-genome duplications occur when an entire genome is duplicated, resulting in two identical copies of the genetic material. Small-scale duplications, on the other hand, involve the duplication of a smaller segment of the genome.\nThe study found that whole-genome duplications were more divergent than small-scale duplications in yeast species, indicating that these events may have played a more important role in shaping the evolution of these organisms. The researchers suggest that this may be because whole-genome duplications allow for the creation of new genetic combinations, which can lead to the evolution of new traits and functions.\nThe study also found that the degree of divergence between whole-genome duplications and small-scale duplications varied among yeast species, with some species showing more divergence than others. The researchers suggest that this may be due to differences in the evolutionary history of these species, with some species experiencing more whole-genome duplications than others.\nOverall, the study provides new insights into the role of whole-genome duplications in the evolution of yeast species, and highlights the importance of these events in shaping the genetic diversity of these organisms.",
    "llama-2-7b-chat-hf_fact": [
      "Whole-genome duplications are more divergent than small-scale duplications in yeast, according to a study published in Nature Communications.",
      "Whole-genome duplications in yeast result in two identical copies of the genetic material.",
      "Small-scale duplications involve the duplication of a smaller segment of the genome.",
      "The degree of divergence between whole-genome duplications and small-scale duplications varied among yeast species.",
      "The study highlights the importance of whole-genome duplications in shaping the genetic diversity of yeast organisms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2791,
    "user_query": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually death. While there is currently no cure for ALS, various treatments are available to manage the symptoms and slow down the progression of the disease. One such treatment is erythropoietin (EPO), a hormone that stimulates the production of red blood cells. Some studies have suggested that EPO may be effective in slowing down the progression of ALS, but the evidence is mixed and more research is needed to confirm its effectiveness.\nEPO works by stimulating the production of red blood cells in the bone marrow, which can help to increase the amount of oxygen available to the body's tissues. In people with ALS, the loss of motor neurons can lead to a decrease in the amount of oxygen reaching the muscles, which can contribute to the progression of the disease. By increasing the amount of oxygen available to the muscles, EPO may help to slow down the progression of ALS.\nSeveral studies have investigated the use of EPO in ALS, with mixed results. Some studies have found that EPO can slow down the progression of ALS, while others have found no significant benefit. A 2017 systematic review and meta-analysis of 14 randomized controlled trials found that EPO may be effective in slowing down the progression of ALS, but the authors noted that the quality of the evidence was generally low and that more research is needed to confirm the findings.\nDespite the mixed evidence, some studies have suggested that EPO may be particularly effective in people with ALS who have a certain genetic mutation. For example, a 2018 study found that EPO was more effective in slowing down the progression of ALS in people with the C9ORF72 mutation, which is the most common genetic mutation associated with ALS.\nWhile EPO may be effective in some people with ALS, it is important to note that it is not a cure for the disease. EPO is typically used in combination with other treatments, such as riluzole, to manage the symptoms of A",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord.",
      "Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells.",
      "Some studies suggest that EPO may be effective in slowing down the progression of ALS.",
      "A 2018 study found that EPO was more effective in slowing down the progression of ALS in people with the C9ORF72 mutation.",
      "EPO is often used in combination with other treatments, such as riluzole, to manage the symptoms of ALS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2795,
    "user_query": "Is chlorotoxin a peptide?",
    "llama-2-7b-chat-hf_response": "Chlorotoxin is a peptide toxin that is derived from the venom of the cone snail Conus chlorosteus. It is composed of 23 amino acids and has been shown to have a variety of biological activities, including the ability to bind to and inhibit the activity of voltage-gated ion channels, which are important for the transmission of nerve impulses.",
    "llama-2-7b-chat-hf_fact": [
      "Chlorotoxin is a peptide toxin.",
      "Chlorotoxin is derived from the venom of the cone snail Conus chlorosteus.",
      "Chlorotoxin is composed of 23 amino acids.",
      "Chlorotoxin can bind to and inhibit the activity of voltage-gated ion channels.",
      "Voltage-gated ion channels are important for the transmission of nerve impulses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Chlorotoxin is derived from the venom of the Deathstalker scorpion, not the cone snail Conus chlorosteus.",
      "false, [corrected fact]: Chlorotoxin is composed of 36 amino acids, not 23.",
      "true",
      "true"
    ]
  },
  {
    "id": 2797,
    "user_query": "Is selenocysteine an aminoacid?",
    "llama-2-7b-chat-hf_response": "Selenocysteine is a type of amino acid that is found in certain proteins in the body. It is similar in structure to the amino acid cysteine, but it has a selenium atom instead of a sulfur atom in its side chain. Selenocysteine is important for the function of certain enzymes in the body, and it is also involved in the production of glutathione, a powerful antioxidant that helps protect cells from damage caused by free radicals.",
    "llama-2-7b-chat-hf_fact": [
      "Selenocysteine is a type of amino acid.",
      "Selenocysteine is found in certain proteins in the body.",
      "Selenocysteine is similar in structure to cysteine, but it has a selenium atom instead of a sulfur atom in its side chain.",
      "Selenocysteine is important for the function of certain enzymes in the body.",
      "Selenocysteine is involved in the production of glutathione, an antioxidant that helps protect cells from damage caused by free radicals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2812,
    "user_query": "Which is the basis of the ATAC-Seq protocol?",
    "llama-2-7b-chat-hf_response": "ATAC-Seq (Assay for Transposase-Accessible Chromatin sequencing) is a powerful tool for understanding gene regulation by mapping open chromatin regions. The protocol is based on the following steps:\n1. Crosslinking: Cells are fixed with formaldehyde to create covalent bonds between proteins and DNA.\n2. Sonication: The chromatin is broken into smaller fragments using sonication.\n3. Immunoprecipitation: The fragments are then immunoprecipitated with a transposase enzyme that recognizes the 5' end of the fragment.\n4. Sequencing: The isolated fragments are then sequenced using Next-Generation Sequencing (NGS) technologies.\n5. Data analysis: The resulting data is then analyzed to identify regions of open chromatin.\nThe basis of the ATAC-Seq protocol is the use of a transposase enzyme to isolate regions of open chromatin. The transposase enzyme recognizes the 5' end of the fragment and immunoprecipitates it, allowing for the isolation of open chromatin regions.",
    "llama-2-7b-chat-hf_fact": [
      "ATAC-Seq stands for Assay for Transposase-Accessible Chromatin sequencing.",
      "The ATAC-Seq protocol involves the use of a transposase enzyme to isolate regions of open chromatin.",
      "One step in the ATAC-Seq protocol includes crosslinking, where cells are fixed with formaldehyde to create covalent bonds between proteins and DNA.",
      "In ATAC-Seq protocol, the isolated fragments are sequenced using Next-Generation Sequencing technologies.",
      "Part of the ATAC-Seq protocol involves data analysis to identify regions of open chromatin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The ATAC-Seq protocol does not involve the use of crosslinking or fixation with formaldehyde. This step is typically found in ChIP-Seq, not ATAC-Seq.",
      "true",
      "true"
    ]
  },
  {
    "id": 2813,
    "user_query": "What is vcfanno?",
    "llama-2-7b-chat-hf_response": "VCFanno is a tool for generating VCF (Variant Call Format) files from annotated BAM (Binary Alignment/Map) files. VCFanno is designed to be easy to use and to produce high-quality VCF files, even for large and complex datasets.\nVCFanno takes as input a BAM file and produces as output a VCF file that contains information about the variants in the BAM file, including their positions, bases, and annotations. VCFanno can also be used to generate VCF files from other types of genomic data, such as GTF (Genomic Feature Track) files.\nSome of the key features of VCFanno include:\n* Easy to use: VCFanno has a simple and intuitive command-line interface, making it easy to use even for users without extensive bioinformatics experience.\n* High-quality output: VCFanno is designed to produce high-quality VCF files, even for large and complex datasets.\n* Flexible input: VCFanno can take as input a variety of different types of genomic data, including BAM, GTF, and VCF files.\n* Customizable: VCFanno allows users to customize the output of the tool, including the format of the VCF file and the annotations included.\nOverall, VCFanno is a powerful and flexible tool for generating VCF files from annotated genomic data. Its ease of use and high-quality output make it a valuable tool for researchers working with large and complex datasets.",
    "llama-2-7b-chat-hf_fact": [
      "VCFanno is a tool that generates VCF files from annotated BAM files.",
      "VCFanno's output is a VCF file that contains information about the variants in the BAM file, including their positions, bases, and annotations.",
      "VCFanno can also generate VCF files from GTF files and other types of genomic data.",
      "VCFanno has a user-friendly command-line interface.",
      "Users can customize the output of VCFanno, including the format of the VCF file and the annotations included."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2816,
    "user_query": "What are the \"Ohnologs\"?",
    "llama-2-7b-chat-hf_response": "In the Star Trek universe, the \"Ohnologs\" are a race of beings that are the ancestors of the Vulcans. According to the Star Trek: The Next Generation technical manual, the Ohnologs were a highly advanced and evolved race that lived on the planet Vulcan thousands of years ago. They were known for their advanced technology and their ability to live long lives, and they were said to have had a profound influence on the development of Vulcan culture and society.\nThe term \"Ohnolog\" is derived from the Greek word \"homologos,\" which means \"similar\" or \"analogous.\" In the Star Trek universe, the Ohnologs are often referred to as the \"ancestors\" or \"forefathers\" of the Vulcans, and they are depicted as being similar in appearance to the Vulcans, but with some notable differences.\nThe Ohnologs are mentioned in several episodes of Star Trek: The Next Generation and Star Trek: Deep Space Nine, and they play a significant role in the backstory of the Vulcan race. According to the Star Trek universe, the Ohnologs were wiped out by a catastrophic event known as the \"Great Burn,\" which occurred thousands of years ago and had a profound impact on the development of Vulcan society.",
    "llama-2-7b-chat-hf_fact": [
      "In the Star Trek universe, the \"Ohnologs\" are a race of beings that are the ancestors of the Vulcans.",
      "The Ohnologs lived on the planet Vulcan thousands of years ago.",
      "The Ohnologs are known for their advanced technology and longevity.",
      "The term \"Ohnolog\" is derived from the Greek word \"homologos,\" which means \"similar\" or \"analogous.\"",
      "The Ohnologs were wiped out by a catastrophic event known as the \"Great Burn\"."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: In the Star Trek universe, there is no mention of a race called \"Ohnologs\". \"Ohnologs\" are a scientific term referring to duplicated genes that arose due to whole genome duplication.",
      "false, [corrected fact]: In the Star Trek universe, the Ohnologs are not a race that lived on the planet Vulcan. This is misinformation.",
      "false, [corrected fact]: As the existence of the Ohnologs as a race in Star Trek universe is false, any statements about them are also false.",
      "true",
      "false, [corrected fact]: In the Star Trek universe, there is no catastrophic event known as the \"Great Burn\" that wiped out the Ohnologs. This statement is false."
    ]
  },
  {
    "id": 2818,
    "user_query": "Describe OligoSTORM",
    "llama-2-7b-chat-hf_response": "OligoSTORM is a software tool designed for the analysis of single-molecule localization microscopy (SMLM) data. SMLM is a technique that uses super-resolution microscopy to visualize individual molecules in a sample, allowing researchers to study the behavior and interactions of molecules at the nanoscale. OligoSTORM is specifically designed to analyze the data generated by the Stochastic Optical Reconstruction Microscopy (STORM) technique, which is a type of SMLM that uses a combination of photoswitchable fluorescent probes and random sampling to generate high-resolution images of molecules in a sample.\nOligoSTORM can be used to analyze a wide range of SMLM data, including STORM data, photoactivated localization microscopy (PALM) data, and stochastic optical reconstruction microscopy with photoactivatable localization (STORM-PALM) data. The software can be used to perform a variety of analyses, including:\n1. Localization analysis: OligoSTORM can be used to determine the location of individual molecules in a sample with high precision, allowing researchers to study the behavior and interactions of molecules at the nanoscale.\n2. Clustering analysis: OligoSTORM can be used to identify clusters of molecules in a sample, which can be useful for studying the organization and interactions of molecules in a variety of biological systems.\n3. Trajectory analysis: OligoSTORM can be used to analyze the movement of individual molecules over time, allowing researchers to study the dynamics of molecular interactions and the behavior of molecules in response to different stimuli.\n4. Data visualization: OligoSTORM can be used to visualize the location and movement of individual molecules in a sample, allowing researchers to gain a better understanding of the behavior and interactions of molecules at the nanoscale.\n5. Data mining: OligoSTORM can be used to identify patterns and trends in SMLM data, which can be useful for identifying new biological mechanisms and developing new drugs and therapies.\nOverall, OligoSTORM is a powerful tool for analyzing SMLM data and gaining insights into the behavior and interactions of molecules at the nan",
    "llama-2-7b-chat-hf_fact": [
      "OligoSTORM is a software tool designed for analyzing single-molecule localization microscopy (SMLM) data.",
      "The Stochastic Optical Reconstruction Microscopy (STORM) technique generates high-resolution images used by OligoSTORM for analysis.",
      "The software can analyze wide-ranging SMLM data, including, STORM data, photoactivated localization microscopy (PALM) data, and STORM-PALM data.",
      "OligoSTORM can perform localization analysis, clustering analysis, trajectory analysis, data visualization and data mining.",
      "OligoSTORM is a tool for gaining insights into the behavior and interactions of molecules at the nano scale."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2825,
    "user_query": "What forms part of the senescence associated secretory phenotype, or SASP?",
    "llama-2-7b-chat-hf_response": "Senescence-associated secretory phenotype (SASP) refers to the collection of cytokines, chemokines, growth factors, and other signaling molecules that are secreted by senescent cells and contribute to the progression of age-related diseases. The SASP includes a variety of molecules, such as:\n1. Cytokines: Interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha) are examples of cytokines that are secreted by senescent cells and can promote inflammation and tissue damage.\n2. Chemokines: Chemokines, such as CCL2 and CCL5, are secreted by senescent cells and attract immune cells to the site of tissue damage, contributing to the progression of age-related diseases.\n3. Growth factors: Growth factors, such as platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), are secreted by senescent cells and can promote cell proliferation and angiogenesis, contributing to the progression of age-related diseases.\n4. Matrix metalloproteinases (MMPs): MMPs, such as MMP-2 and MMP-9, are secreted by senescent cells and can degrade the extracellular matrix, leading to tissue damage and dysfunction.\n5. Apoptosis-related proteins: Apoptosis-related proteins, such as BAX and BAK, are secreted by senescent cells and can induce programmed cell death in nearby cells, contributing to the progression of age-related diseases.\n6. Autophagy-related proteins: Autophagy-related proteins, such as LC3 and ATG5, are secreted by senescent cells and can promote autophagy, contributing to the progression of age-related diseases.\n7. Oxidative stress-related proteins: Oxidative stress-related proteins, such as superoxide dismutase (SOD) and catalase (CAT), are secreted by senescent cells and can protect against oxidative",
    "llama-2-7b-chat-hf_fact": [
      "The senescence-associated secretory phenotype (SASP) consists of cytokines, chemokines, growth factors, and other signaling molecules secreted by senescent cells.",
      "Examples of cytokines involved in SASP are interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha).",
      "Chemokines such as CCL2 and CCL5 are secreted by senescent cells and contribute to SASP.",
      "Growth factors like platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) are secreted by senescent cells as part of SASP.",
      "Matrix metalloproteinases (MMPs) such as MMP-2 and MMP-9, are components of SASP and are known to degrade the extracellular matrix."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2826,
    "user_query": "How many pseudogenes are contained in the C. elegans genome?",
    "llama-2-7b-chat-hf_response": "The nematode worm Caenorhabditis elegans has a relatively small genome with a total of 20,000 protein-coding genes. However, a significant portion of these genes are pseudogenes, which are non-functional copies of genes that have been inactivated by mutations. In fact, it is estimated that up to 40% of the C. elegans genome consists of pseudogenes.",
    "llama-2-7b-chat-hf_fact": [
      "The nematode worm Caenorhabditis elegans has a total of 20,000 protein-coding genes.",
      "Pseudogenes are non-functional copies of genes that have been inactivated by mutations.",
      "Up to 40% of the C. elegans genome consists of pseudogenes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The percentage of the C. elegans genome that consists of pseudogenes is significantly lower, estimated to be around 1-2%."
    ]
  },
  {
    "id": 2827,
    "user_query": "What is a Aquaporin channel?",
    "llama-2-7b-chat-hf_response": "Aquaporin channels are a type of transmembrane protein that play a crucial role in the regulation of water transport across cell membranes. These channels are selectively permeable to water and are found in various tissues, including the kidney, brain, and gut. Aquaporin channels are important for maintaining proper water balance in the body and are also involved in the regulation of ion and solute transport.",
    "llama-2-7b-chat-hf_fact": [
      "Aquaporin channels are a type of transmembrane protein.",
      "These channels play a crucial role in the regulation of water transport across cell membranes.",
      "Aquaporin channels are selectively permeable to water.",
      "They are found in various tissues, including the kidney, brain, and gut.",
      "Aquaporin channels are involved in the regulation of ion and solute transport."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Aquaporin channels are involved in the regulation of water transport, not ion and solute transport."
    ]
  },
  {
    "id": 2832,
    "user_query": "Is durvalumab used for lung cancer treatment?",
    "llama-2-7b-chat-hf_response": "Durvalumab is a monoclonal antibody that is used to treat certain types of lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). It works by blocking a protein called PD-L1, which is found on the surface of cancer cells. By blocking PD-L1, durvalumab helps the immune system recognize and attack the cancer cells more effectively.\nDurvalumab is typically used in combination with other cancer drugs, such as chemotherapy or other immunotherapies, to treat lung cancer. It may be given intravenously or by injection, depending on the specific treatment regimen.\nCommon side effects of durvalumab include fatigue, nausea, loss of appetite, and skin rash. In rare cases, it can cause more serious side effects, such as inflammation of organs or tissues, and immune system problems.\nIt's important to note that durvalumab is not a cure for lung cancer, and it may not be effective for everyone. However, it can help slow the growth of the cancer and improve survival rates for some patients. If you have lung cancer and are considering treatment with durvalumab, it's important to discuss the potential benefits and risks with your doctor.",
    "llama-2-7b-chat-hf_fact": [
      "Durvalumab is a monoclonal antibody used to treat certain types of lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).",
      "Durvalumab works by blocking a protein called PD-L1, which is found on the surface of cancer cells.",
      "Durvalumab is typically used in combination with other cancer drugs, such as chemotherapy or other immunotherapies.",
      "Common side effects of durvalumab include fatigue, nausea, loss of appetite, and skin rash.",
      "Durvalumab is not a cure for lung cancer, but can slow the growth of the cancer and improve survival rates for some patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2836,
    "user_query": "Describe information obtained by immunophenotyping.",
    "llama-2-7b-chat-hf_response": "Immunophenotyping is a technique used to identify and characterize cells based on the expression of specific proteins on their surface. The information obtained by immunophenotyping can be used to:\n1. Identify cell types: By analyzing the expression of specific proteins, immunophenotyping can help identify the type of cell being studied. For example, the presence of the protein CD4 on the surface of T cells can identify them as CD4+ T cells.\n2. Determine cellular differentiation: Immunophenotyping can be used to study the differentiation of cells into different subtypes. For example, the expression of the protein CD11b on the surface of immune cells can indicate their differentiation into macrophages.\n3. Analyze cellular activation: Immunophenotyping can be used to study the activation status of cells. For example, the expression of the protein CD28 on the surface of T cells can indicate their activation.\n4. Identify cellular subpopulations: Immunophenotyping can be used to identify subpopulations of cells within a given cell type. For example, the expression of the protein CD45 on the surface of hematopoietic cells can identify different subpopulations of blood cells, such as T cells and B cells.\n5. Study cellular development: Immunophenotyping can be used to study the development of cells from stem cells to mature cells. For example, the expression of the protein CD117 on the surface of hematopoietic stem cells can indicate their development into mature blood cells.\n6. Identify cancer cells: Immunophenotyping can be used to identify cancer cells based on the expression of specific proteins. For example, the expression of the protein HER2 on the surface of breast cancer cells can be used to identify them as HER2-positive cancer cells.\n7. Study immune responses: Immunophenotyping can be used to study the immune response to infection or vaccination. For example, the expression of the protein IFN- on the surface of T cells can indicate their role in the immune response to a viral infection.\n8. Identify biomarkers: Immunophenotyping can be used to identify biom",
    "llama-2-7b-chat-hf_fact": [
      "Immunophenotyping is used to identify and characterize cells based on the expression of specific proteins on the cell surface.",
      "CD4 expression on T cells identifies them as CD4+ T cells.",
      "CD11b expression on the surface of immune cells can indicate their differentiation into macrophages.",
      "CD28 expression on the surface of T cells indicates their activation.",
      "Through immunophenotyping, the expression of the protein HER2 on the surface of breast cancer cells can identify them as HER2-positive cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2837,
    "user_query": "What is the mechanism of action of Emicizumab?",
    "llama-2-7b-chat-hf_response": "Emicizumab is a monoclonal antibody that works by inhibiting the activity of factor IXa, a clotting protein that is involved in the coagulation cascade. By blocking the activity of factor IXa, emicizumab prevents the formation of blood clots, which can help to reduce the frequency and severity of bleeding episodes in people with hemophilia A.\nEmicizumab is administered by injection and is given on a regular basis to maintain adequate levels of the antibody in the body. The specific mechanism of action of emicizumab is as follows:\n1. Binding to factor IXa: Emicizumab binds to factor IXa, which is a key component of the coagulation cascade.\n2. Inhibition of factor IXa activity: Once bound to factor IXa, emicizumab inhibits the activity of this clotting protein, preventing it from participating in the coagulation cascade.\n3. Reduction of blood clotting: By inhibiting the activity of factor IXa, emicizumab reduces the formation of blood clots, which can help to prevent or reduce bleeding episodes in people with hemophilia A.\nOverall, the mechanism of action of emicizumab is to specifically target and inhibit the activity of factor IXa, which is involved in the coagulation cascade and is responsible for the formation of blood clots. By inhibiting the activity of factor IXa, emicizumab can help to reduce the frequency and severity of bleeding episodes in people with hemophilia A.",
    "llama-2-7b-chat-hf_fact": [
      "Emicizumab is a monoclonal antibody.",
      "This drug works by inhibiting the activity of factor IXa, a protein that is involved in blood clotting.",
      "Emicizumab is used in the treatment of hemophilia A to reduce the frequency and severity of bleeding episodes.",
      "Emicizumab is administered by injection and should be given regularly to maintain adequate levels in the body.",
      "Factor IXa plays a key role in the coagulation cascade, which is the process that leads to the formation of blood clots."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Emicizumab works by bridging factor IXa and factor X, proteins that are involved in blood clotting.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2841,
    "user_query": "What is the function of GFRAL?",
    "llama-2-7b-chat-hf_response": "GFRAL (glutamate aspartate racemase like) is an enzyme that plays a crucial role in the biosynthesis of the neurotransmitter glutamate in the brain. Glutamate is the most abundant excitatory neurotransmitter in the central nervous system (CNS) and is involved in various physiological processes, including synaptic transmission, neuronal plasticity, and neuroprotection.\nGFRAL is responsible for converting L-aspartate, an amino acid, into L-glutamate, the final product of glutamate biosynthesis. This reaction is essential for the production of glutamate in the brain, as it is the only enzyme that can catalyze the conversion of L-aspartate into L-glutamate.\nGFRAL is primarily localized in the mitochondria of neurons, where it plays a critical role in regulating glutamate levels in the synaptic cleft. Dysregulation of GFRAL has been implicated in various neurological disorders, including epilepsy, stroke, and neurodegenerative diseases.\nIn summary, the function of GFRAL is to catalyze the conversion of L-aspartate into L-glutamate, which is essential for the biosynthesis of glutamate in the brain and plays a crucial role in various physiological processes.",
    "llama-2-7b-chat-hf_fact": [
      "GFRAL is an enzyme that aids in the biosynthesis of the neurotransmitter glutamate in the brain.",
      "Glutamate is the most abundant excitatory neurotransmitter in the central nervous system.",
      "GFRAL catalyzes the conversion of L-aspartate, an amino acid, into L-glutamate.",
      "GFRAL is primarily localized in the mitochondria of neurons and regulates glutamate levels in the synaptic cleft.",
      "Dysregulation of GFRAL has been implicated in neurological disorders, including epilepsy, stroke, and neurodegenerative diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: GFRAL is a receptor identified as a growth differentiation factor 15 (GDF15) receptor. It is not directly involved in the biosynthesis of neurotransmitter glutamate.",
      "true",
      "false, [corrected fact]: GFRAL does not play a role in converting L-aspartate into L-glutamate. It is specifically involved in the activation of neurons in response to GDF15.",
      "false, [corrected fact]: GFRAL is mainly located in the area postrema and nucleus of the solitary tract of the brainstem, not in the mitochondria of neurons.",
      "unknown"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-7b-chat-hf_response": "ZCCHC17 (Zinc finger CCHC-type zinc finger 17) is a protein that plays a crucial role in regulating gene expression by acting as a transcriptional repressor. It is a member of the CCHC-type zinc finger protein family, which are characterized by the presence of a zinc finger DNA-binding domain.\nZCCHC17 is primarily localized to the nucleus, where it binds to specific DNA sequences in the promoter or enhancer regions of target genes and represses their transcription. The protein has been shown to regulate the expression of genes involved in various biological processes, including cell proliferation, differentiation, and survival.\nStudies have also implicated ZCCHC17 in the development and progression of certain diseases, such as cancer and neurodegenerative disorders. For example, ZCCHC17 has been shown to be overexpressed in certain types of cancer, where it can promote tumor growth and progression by repressing the expression of tumor suppressor genes.\nOverall, the role of ZCCHC17 is to regulate gene expression by acting as a transcriptional repressor, and its dysregulation has been implicated in a variety of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "ZCCHC17 is a protein that plays a crucial role in regulating gene expression by acting as a transcriptional repressor.",
      "It is a member of the CCHC-type zinc finger protein family, which have a zinc finger DNA-binding domain.",
      "ZCCHC17 is primarily localized to the nucleus, where it binds to DNA sequences in the promoter or enhancer regions of genes and suppresses their transcription.",
      "ZCCHC17 has been shown to regulate the expression of genes involved in cell proliferation, differentiation, and survival.",
      "It has been implicated in the development and progression of certain diseases, such as cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2844,
    "user_query": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "llama-2-7b-chat-hf_response": "Apgar score is a measure of the newborn's overall health and well-being, based on five physical signs: heart rate, muscle tone, respiratory effort, reflex irritability, and color. Epidural anesthesia is a common technique used for pain management during labor, but there is some concern that it may affect the Apgar score of the newborn.\nStudies have shown that epidural anesthesia can cause a temporary decrease in the newborn's heart rate, which can result in a lower Apgar score. However, these decreases in heart rate are usually short-lived and do not have any long-term effects on the newborn's health. In fact, one study found that newborns who received epidural anesthesia during labor had a lower risk of respiratory distress syndrome compared to those who did not receive epidural anesthesia.\nIt is important to note that the Apgar score is just one measure of a newborn's overall health, and it is not the only factor that determines the newborn's well-being. Other factors, such as the newborn's temperature, blood pressure, and oxygen saturation, are also important indicators of the newborn's health.\nIn summary, while epidural anesthesia may cause a temporary decrease in the newborn's heart rate and result in a lower Apgar score, this does not necessarily mean that the newborn is not healthy. The Apgar score is just one measure of the newborn's overall health, and other factors should also be taken into account when evaluating the newborn's well-being.",
    "llama-2-7b-chat-hf_fact": [
      "Apgar score is a measure of the newborn's overall health and well-being, based on heart rate, muscle tone, respiratory effort, reflex irritability, and color.",
      "Epidural anesthesia is a common technique used for pain management during labor.",
      "Some studies have indicated that epidural anesthesia can cause a temporary decrease in the newborn's heart rate, which can result in a lower Apgar score.",
      "One study found that newborns who received epidural anesthesia during labor had a lower risk of respiratory distress syndrome compared to those who did not receive epidural anesthesia.",
      "Besides the Apgar score, the newborn's temperature, blood pressure, and oxygen saturation are also important indicators of a newborn's health."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2846,
    "user_query": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "llama-2-7b-chat-hf_response": "Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is an enzyme that plays a crucial role in protecting cells against oxidative damage caused by reactive oxygen species (ROS). PHGPx is a member of the glutathione peroxidase (GPx) family of enzymes, which are known to be involved in the detoxification of ROS. However, recent studies have suggested that PHGPx may not be a selenoprotein, despite its structural similarity to other GPx enzymes.\nSelenoproteins are a class of proteins that contain the amino acid selenocysteine (Sec), which is encoded by the UGA codon in mRNA. Selenoproteins are known to be involved in a variety of cellular processes, including antioxidant defense, immune function, and thyroid hormone metabolism. In contrast, PHGPx contains the amino acid glutathione (Glu-Cys-Gly) in its active site, rather than Sec.\nThe question of whether PHGPx is a selenoprotein has important implications for our understanding of its function and regulation. If PHGPx is a selenoprotein, it would suggest that it is involved in the same cellular processes as other selenoproteins, such as antioxidant defense and immune function. However, if PHGPx is not a selenoprotein, it may have a distinct function and regulation compared to other GPx enzymes. Further research is needed to resolve this question and to fully understand the role of PHGPx in cellular defense against oxidative stress.",
    "llama-2-7b-chat-hf_fact": [
      "Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is an enzyme that plays a role in protecting cells against oxidative damage caused by reactive oxygen species (ROS).",
      "PHGPx is a member of the glutathione peroxidase (GPx) family of enzymes.",
      "Selenoproteins are a class of proteins that contain the amino acid selenocysteine (Sec), which is encoded by the UGA codon in mRNA.",
      "Selenoproteins are involved in cellular processes such as antioxidant defense, immune function, and thyroid hormone metabolism.",
      "PHGPx contains the amino acid glutathione (Glu-Cys-Gly) in its active site, not selenocysteine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: PHGPx does contain the amino acid selenocysteine in its active site, not glutathione (Glu-Cys-Gly)."
    ]
  },
  {
    "id": 2851,
    "user_query": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "llama-2-7b-chat-hf_response": "Yes, TIAM1 has been shown to promote tumor progression in colorectal cancer (CRC). Studies have found that TIAM1 is overexpressed in CRC tissues and cell lines, and that high levels of TIAM1 are associated with poor prognosis in CRC patients. TIAM1 has been shown to promote the epithelial-to-mesenchymal transition (EMT), a process that is thought to play a key role in the development and progression of CRC. TIAM1 has also been shown to activate the PI3K/Akt signaling pathway, which is commonly altered in CRC and can promote cell survival and proliferation. Additionally, TIAM1 has been shown to inhibit the activity of the tumor suppressor protein p53, which is frequently mutated in CRC. Overall, these findings suggest that TIAM1 may play a role in promoting the progression of CRC.",
    "llama-2-7b-chat-hf_fact": [
      "TIAM1 promotes tumor progression in colorectal cancer (CRC).",
      "TIAM1 is overexpressed in CRC tissues and cell lines.",
      "High levels of TIAM1 are associated with poor prognosis in CRC patients.",
      "TIAM1 promotes the epithelial-to-mesenchymal transition (EMT), a key process in the development and progression of CRC.",
      "TIAM1 activates the PI3K/Akt signaling pathway and inhibits the activity of the tumor suppressor protein p53."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2854,
    "user_query": "Is pacritinib effective for treatment of myelofibrosis?",
    "llama-2-7b-chat-hf_response": "Pacritinib, a tyrosine kinase inhibitor, has shown promise in the treatment of myelofibrosis, a rare and aggressive blood cancer. In a phase 3 clinical trial, pacritinib was compared to the current standard of care, ruxolitinib, in patients with intermediate or high-risk myelofibrosis. The results of the trial, which were published in the New England Journal of Medicine in 2020, showed that pacritinib was non-inferior to ruxolitinib in reducing symptoms and improving quality of life in patients with myelofibrosis. Additionally, pacritinib was associated with a lower incidence of severe adverse events compared to ruxolitinib. These findings suggest that pacritinib may be a viable alternative to ruxolitinib for the treatment of myelofibrosis.",
    "llama-2-7b-chat-hf_fact": [
      "Pacritinib is a tyrosine kinase inhibitor.",
      "Pacritinib has shown potential in treating myelofibrosis, a type of blood cancer.",
      "A phase 3 clinical trial compared pacritinib to the current standard of care, ruxolitinib, for treatment of intermediate or high-risk myelofibrosis.",
      "Phase 3 clinical trial results, published in The New England Journal of Medicine in 2020, showed that pacritinib was non-inferior to ruxolitinib in reducing symptoms and improving quality of life for myelofibrosis patients.",
      "In the same trial, pacritinib had a lower incidence of severe adverse events compared to ruxolitinib."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-7b-chat-hf_response": "The nuclear pore basket, also known as the nuclear pore complex (NPC), is a large protein structure that spans the nuclear envelope in eukaryotic cells. It plays a crucial role in regulating the transport of molecules between the nucleus and the cytoplasm. The NPC is composed of several proteins, including:\n1. Nucleoporins: These are the main proteins that make up the NPC. There are 30 different nucleoporins in humans, which are encoded by genes located on chromosomes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 23.\n2. Spectrin: Spectrin is a cytoskeletal protein that helps to maintain the structure of the NPC. It is composed of several subunits, including alpha-spectrin, beta-spectrin, and gamma-spectrin.\n3. Emerin: Emerin is a protein that is specifically expressed in the nucleus and is involved in the formation and maintenance of the NPC.\n4. Nup98: Nup98 is a nucleoporin that is involved in the transport of large molecules across the NPC.\n5. Nup107: Nup107 is another nucleoporin that is involved in the transport of molecules across the NPC.\n6. Nup153: Nup153 is a nucleoporin that is involved in the transport of molecules across the NPC and is also involved in the regulation of gene expression.\n7. Nup205: Nup205 is a nucleoporin that is involved in the transport of molecules across the NPC and is also involved in the regulation of gene expression.\n8. Nup37: Nup37 is a nucleoporin that is involved in the transport of molecules across the NPC.\n9. Nup43: Nup43 is a nucleoporin that is involved in the transport of molecules across",
    "llama-2-7b-chat-hf_fact": [
      "The nuclear pore complex (NPC) is a large protein structure that spans the nuclear envelope in eukaryotic cells.",
      "The NPC regulates the transport of molecules between the nucleus and the cytoplasm.",
      "Nucleoporins are the main proteins that make up the NPC, and there are 30 different types in humans.",
      "Emerin is a protein specifically expressed in the nucleus and is involved in the formation and maintenance of the NPC.",
      "Spectrin is a cytoskeletal protein that helps to maintain the structure of the NPC and comprises several subunits, including alpha-spectrin, beta-spectrin, and gamma-spectrin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Emerin is a protein that is specifically expressed in the nucleus and is involved in regulating gene expression, nuclear structural integrity, and cell signaling. It is not directly involved in the formation and maintenance of the NPC.",
      "false, [corrected fact]: Spectrin is a cytoskeletal protein that helps to maintain cell shape and organization. It doesn't maintain the structure of the NPC."
    ]
  },
  {
    "id": 2862,
    "user_query": "Does lucatumumab bind to CD140?",
    "llama-2-7b-chat-hf_response": "Lucatumumab is a monoclonal antibody that targets CD140, a protein that is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. CD140 is also known as activin receptor-like kinase 1 (ALK1).\nLucatumumab is currently being investigated as a potential therapeutic agent for the treatment of cancer, particularly in combination with other therapies such as chemotherapy or immunotherapy. It has been shown to have antitumor activity in preclinical studies and is being evaluated in clinical trials for the treatment of various types of cancer.\nIn summary, lucatumumab is an antibody that binds to CD140, which is overexpressed in many types of cancer. It is being investigated as a potential therapeutic agent for the treatment of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Lucatumumab is a monoclonal antibody that targets CD140.",
      "CD140 is known as activin receptor-like kinase 1 (ALK1).",
      "CD140 is overexpressed in various types of cancer including breast, lung, and ovarian cancer.",
      "Lucatumumab is being tested as a potential therapeutic agent for the treatment of cancer.",
      "Lucatumumab has shown antitumor activity in preclinical studies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Lucatumumab is a monoclonal antibody that targets CD40, not CD140.",
      "false, [corrected fact]: CD140, also known as PDGFR, is Platelet-derived growth factor receptor, not activin receptor-like kinase 1 (ALK1).",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2872,
    "user_query": "Which molecule is targeted by Olaratumab?",
    "llama-2-7b-chat-hf_response": "Olaratumab is a monoclonal antibody that targets the protein platelet-derived growth factor receptor alpha (PDGFR). PDGFR is a transmembrane receptor that plays a key role in the regulation of cell growth, differentiation, and survival. Olaratumab is being developed as a potential treatment for soft tissue sarcoma, a type of cancer that affects connective tissue. By targeting PDGFR, olaratumab is thought to inhibit the growth and spread of sarcoma cells.",
    "llama-2-7b-chat-hf_fact": [
      "Olaratumab is a monoclonal antibody.",
      "Olaratumab targets the protein platelet-derived growth factor receptor alpha (PDGFR).",
      "PDGFR is a transmembrane receptor that contributes to the regulation of cell growth, differentiation, and survival.",
      "Olaratumab is being developed as potential treatment for soft tissue sarcoma.",
      "Soft tissue sarcoma is a type of cancer that affects connective tissue."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2874,
    "user_query": "Are phagosomal proteins ubiquitinated?",
    "llama-2-7b-chat-hf_response": "Yes, phagosomal proteins can be ubiquitinated. Ubiquitination is a post-translational modification that involves the covalent attachment of a ubiquitin protein to a target protein. Ubiquitination plays a crucial role in various cellular processes, including protein degradation, cell signaling, and membrane trafficking.\nPhagosomal proteins, which are proteins that are associated with phagosomes, can be ubiquitinated in response to various stimuli. Ubiquitination of phagosomal proteins can regulate their function, stability, or localization within the phagosome. For example, ubiquitination of the phagosomal protein p62/SQSTM1 has been shown to promote its degradation and reduce its ability to interact with autophagy-related proteins.\nUbiquitination of phagosomal proteins can also play a role in the regulation of phagocytosis, the process by which cells engulf and internalize foreign particles or microorganisms. For example, ubiquitination of the phagocytic receptor CD36 has been shown to promote its internalization and degradation, leading to reduced phagocytic activity.\nOverall, ubiquitination of phagosomal proteins is an important mechanism for regulating phagocytosis and the function of phagosomes, and dysregulation of this process has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Phagosomal proteins can be ubiquitinated.",
      "Ubiquitination is a post-translational modification that involves the covalent attachment of a ubiquitin protein to a target protein.",
      "The ubiquitination of phagosomal proteins can regulate their function, stability, or localization within the phagosome.",
      "Ubiquitination of the phagocytic receptor CD36 promotes its internalization and degradation, leading to reduced phagocytic activity.",
      "Dysregulation of the ubiquitination process of phagosomal proteins has been implicated in diseases like cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2876,
    "user_query": "Does tremelimumab improve survival of mesothelioma patients?",
    "llama-2-7b-chat-hf_response": "Tremelimumab is a monoclonal antibody that targets a protein called programmed death-ligand 1 (PD-L1). By blocking PD-L1, tremelimumab can help the immune system recognize and attack cancer cells more effectively. In clinical trials, tremelimumab has been shown to improve overall survival in patients with mesothelioma, a rare and aggressive form of cancer that affects the lining of the lungs, abdomen, or heart.\nAccording to the results of a phase 3 clinical trial published in the New England Journal of Medicine in 2020, tremelimumab plus chemotherapy significantly improved overall survival in patients with unresectable malignant pleural mesothelioma compared to chemotherapy alone. The median overall survival was 14.7 months for the tremelimumab group versus 10.8 months for the chemotherapy-alone group.\nAdditionally, a phase 1b clinical trial published in the Journal of Clinical Oncology in 2018 found that tremelimumab plus pemetrexed and platinum-based chemotherapy was well-tolerated and showed promising antitumor activity in patients with malignant pleural mesothelioma.\nWhile these results are promising, it's important to note that tremelimumab is not a cure for mesothelioma, and more research is needed to determine its long-term effectiveness and safety. Additionally, tremelimumab is not approved by the FDA for the treatment of mesothelioma, and it is currently being studied in clinical trials to determine its potential as a treatment for this disease.\nIn summary, tremelimumab has shown promise in improving overall survival in patients with mesothelioma in clinical trials, but more research is needed to fully understand its effectiveness and safety in this patient population.",
    "llama-2-7b-chat-hf_fact": [
      "Tremelimumab is a monoclonal antibody that targets a protein called programmed death-ligand 1 (PD-L1).",
      "The New England Journal of Medicine published results in 2020 from a phase 3 clinical trial stating that tremelimumab plus chemotherapy significantly improved survival in patients with unresectable malignant pleural mesothelioma compared to chemotherapy alone.",
      "A phase 1b clinical trial published in the Journal of Clinical Oncology in 2018 found that tremelimumab, combined with pemetrexed and platinum-based chemotherapy, showed promising antitumor activity in patients with malignant pleural mesothelioma.",
      "Tremelimumab is not currently approved by the FDA for the treatment of mesothelioma.",
      "Mesothelioma is a rare and aggressive cancer that affects the lining of the lungs, abdomen, or heart."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Tremelimumab is a monoclonal antibody that targets a protein called cytotoxic T-lymphocyte-associated protein 4 (CTLA4).",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2878,
    "user_query": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?",
    "llama-2-7b-chat-hf_response": "TAM (Tyro3, Axl, and Mer) family of receptor tyrosine kinases (RTKs) are a subfamily of RTKs that are characterized by the presence of an immunoreceptor tyrosine-based activation motif (ITAM) in their cytoplasmic domain. The TAM family of RTKs are involved in various cellular processes, including immune response, cell adhesion, and signaling. The following are the membrane proteins that constitute the TAM family of RTKs:\n1. Tyro3: Also known as TYRO3, this protein is primarily involved in the regulation of immune response and cell adhesion.\n2. Axl: Also known as AXL, this protein is involved in the regulation of immune response, cell adhesion, and signaling.\n3. Mer: Also known as MER, this protein is primarily involved in the regulation of immune response and cell adhesion.",
    "llama-2-7b-chat-hf_fact": [
      "TAM (Tyro3, Axl, and Mer) family is a subfamily of receptor tyrosine kinases (RTKs) characterized by the presence of an immunoreceptor tyrosine-based activation motif (ITAM) in their cytoplasmic domain.",
      "The TAM family of RTKs is involved in various cellular processes including the immune response, cell adhesion, and signaling.",
      "Tyro3, known as TYRO3, is a membrane protein that is part of the TAM family of RTKs, with a primary role in the regulation of immune response and cell adhesion.",
      "The membrane protein Axl, also known as AXL, is part of the TAM family of RTKs and is involved in the regulation of immune response, cell adhesion, and signaling.",
      "Mer, also known as MER, is another membrane protein in the TAM family of RTKs and is primarily involved in the regulation of immune response and cell adhesion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: TAM (Tyro3, Axl, and Mer) family is a subfamily of receptor tyrosine kinases (RTKs) characterized by the presence of two immunoglobulin-like domains and two fibronectin type III repeats in their extracellular domain and a conserved kinase domain in their cytoplasmic region.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2880,
    "user_query": "What is CPX351?",
    "llama-2-7b-chat-hf_response": "CPX351 is an investigational drug being developed by Celgene for the treatment of various types of cancer, including pancreatic cancer, non-small cell lung cancer (NSCLC), and ovarian cancer. It is an oral, small molecule inhibitor of the enzyme phosphatidylinositol 3-kinase (PI3K).\nHow does CPX351 work?\nCPX351 works by inhibiting the activity of the PI3K enzyme, which is involved in several cellular processes, including cell survival, growth, and migration. In cancer cells, PI3K is often overactive, leading to uncontrolled cell growth and proliferation. By inhibiting PI3K, CPX351 can slow down or stop the growth of cancer cells.\nWhat are the potential benefits of CPX351?\nCPX351 has shown promise in preclinical studies as a potential treatment for various types of cancer, including pancreatic cancer, NSCLC, and ovarian cancer. It has been shown to:\n1. Inhibit the growth of cancer cells: CPX351 has been shown to inhibit the growth of cancer cells in preclinical studies, both alone and in combination with other cancer drugs.\n2. Induce apoptosis: CPX351 can induce programmed cell death (apoptosis) in cancer cells, which can help to reduce the number of cancer cells in the body.\n3. Inhibit angiogenesis: CPX351 can inhibit the formation of new blood vessels, which are necessary for the growth and spread of cancer cells.\n4. Enhance the effectiveness of other cancer drugs: CPX351 has been shown to enhance the effectiveness of other cancer drugs, such as chemotherapy and targeted therapies, in preclinical studies.\nWhat are the potential side effects of CPX351?\nCPX351 has been shown to have potential side effects in preclinical studies, including:\n1. Gastrointestinal toxicity: CPX351 can cause gastrointestinal toxicity, including nausea, vomiting, and diarrhea, in pre",
    "llama-2-7b-chat-hf_fact": [
      "CPX351 is an investigational drug being developed by Celgene for various types of cancer treatment such as pancreatic, non-small cell lung cancer, and ovarian cancer.",
      "CPX351 is an oral, small molecule inhibitor of the enzyme phosphatidylinositol 3-kinase (PI3K).",
      "The PI3K enzyme is associated with several cellular processes, including cell survival, growth, and migration.",
      "CPX351 works by inhibiting the activity of the PI3K enzyme, which can lead to slowing down or stopping the growth of cancer cells.",
      "CPX351 has potential side effects, including gastrointestinal toxicity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: CPX351, or Vyxeos, is a dual-drug liposomal encapsulation of cytarabine and daunorubicin, not a small molecule inhibitor of the enzyme phosphatidylinositol 3-kinase (PI3K).",
      "true",
      "false, [corrected fact]: CPX351 works by delivering anti-cancer drugs cytarabine and daunorubicin to cancer cells, not by inhibiting the activity of the PI3K enzyme.",
      "true"
    ]
  },
  {
    "id": 2881,
    "user_query": "Is collagen the most abundant human protein?",
    "llama-2-7b-chat-hf_response": "Collagen is the most abundant protein in the human body, making up approximately 25% to 35% of all proteins. It is found in various tissues, including skin, bones, tendons, ligaments, and connective tissue. Collagen is composed of amino acids such as glycine, proline, and hydroxyproline, which give it its unique structure and properties.",
    "llama-2-7b-chat-hf_fact": [
      "Collagen is the most abundant protein in the human body, comprising 25% to 35% of all proteins.",
      "Collagen is found in various tissues, such as skin, bones, tendons, ligaments, and connective tissue.",
      "Collagen is composed of amino acids including glycine, proline, and hydroxyproline."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2886,
    "user_query": "What is the role of the Leucosporidium ice-binding protein",
    "llama-2-7b-chat-hf_response": "in the survival of Leucosporidium?\nThe Leucosporidium ice-binding protein (LIBP) is a protein found in the apicomplexan parasite Leucosporidium, which is known to survive in a wide range of temperatures, including freezing temperatures. The LIBP protein is responsible for the parasite's ability to survive in cold temperatures by binding to ice crystals and protecting the parasite's cell membranes from damage.",
    "llama-2-7b-chat-hf_fact": [
      "The Leucosporidium ice-binding protein (LIBP) is found in the Leucosporidium parasite.",
      "LIBP allows the Leucosporidium parasite to tolerate a wide range of temperatures.",
      "LIBP enables the Leucosporidium to survive freezing temperatures.",
      "The function of LIBP in the Leucosporidium parasite is to bind to ice crystals.",
      "LIBP protects the cell membranes of the Leucosporidium parasite from damage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2892,
    "user_query": "Name 3 diseases for which lucatumumab is being tested?",
    "llama-2-7b-chat-hf_response": "Lucatumumab is an investigational monoclonal antibody that is being tested for the treatment of various diseases, including:\n1. Multiple Myeloma: Lucatumumab is being studied as a potential treatment for patients with relapsed or refractory multiple myeloma.\n2. Non-Hodgkin's Lymphoma: Lucatumumab is also being investigated as a potential treatment for patients with relapsed or refractory non-Hodgkin's lymphoma.\n3. Mantle Cell Lymphoma: Lucatumumab is being studied as a potential treatment for patients with relapsed or refractory mantle cell lymphoma.",
    "llama-2-7b-chat-hf_fact": [
      "Lucatumumab is an investigational monoclonal antibody.",
      "Lucatumumab is being tested for the treatment of multiple myeloma.",
      "Lucatumumab is also being tested as a potential treatment for non-Hodgkin's lymphoma.",
      "Lucatumumab is being studied as a potential treatment for mantle cell lymphoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2893,
    "user_query": "Which transcription factor binding site is contained in Alu repeats?",
    "llama-2-7b-chat-hf_response": "Alu repeats are short interspersed nuclear elements (SINEs) that are found throughout the human genome. They are composed of a palindromic sequence of about 300 base pairs and are flanked by inverted repeats. Alu repeats are known to be transcriptionally active and can act as enhancers or silencers of gene expression.\nOne of the key features of Alu repeats is the presence of specific transcription factor binding sites. These binding sites are recognized by transcription factors that are involved in the regulation of gene expression. For example, the transcription factor binding site for the transcription factor Sp1 is found in many Alu repeats. Sp1 is a zinc finger protein that binds to the GC-rich motif 5'-GCTG-3' and is involved in the regulation of many genes involved in cell growth, differentiation, and survival.\nOther transcription factor binding sites found in Alu repeats include the binding site for the transcription factor NF-B, which is involved in the regulation of inflammation and immune responses, and the binding site for the transcription factor AP-1, which is involved in the regulation of cell growth and differentiation.\nIn summary, Alu repeats contain specific transcription factor binding sites that are recognized by transcription factors involved in the regulation of gene expression. These binding sites play a crucial role in the function of Alu repeats as regulatory elements in the human genome.",
    "llama-2-7b-chat-hf_fact": [
      "Alu repeats are short interspersed nuclear elements (SINEs) found throughout the human genome.",
      "Alu repeats contain a palindromic sequence of about 300 base pairs and are flanked by inverted repeats.",
      "Transcription factor binding site for Sp1, a zinc finger protein that binds to the GC-rich motif 5'-GCTG-3', is found in many Alu repeats.",
      "The transcription factor NF-B, involved in the regulation of inflammation and immune responses, has binding sites found in Alu repeats.",
      "Alu repeats also contain the binding site for the transcription factor AP-1, which is involved in cell growth and differentiation regulation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The transcription factor NF-B, involved in the regulation of inflammation and immune responses, does not have binding sites found in Alu repeats.",
      "true"
    ]
  },
  {
    "id": 2894,
    "user_query": "What is ferroptosis?",
    "llama-2-7b-chat-hf_response": "Ferroptosis is a form of programmed cell death that is regulated by iron metabolism. It is a highly conserved mechanism that plays a critical role in maintaining tissue homeostasis and preventing cancer. Ferroptosis is characterized by the accumulation of lipid peroxides and the degradation of ferritin, a protein that stores and regulates intracellular iron levels.\nFerroptosis is distinct from other forms of cell death, such as apoptosis and necrosis, and is characterized by the following features:\n1. Iron-dependent: Ferroptosis is dependent on iron availability and is triggered by the depletion of intracellular iron stores.\n2. Lipid peroxidation: Ferroptosis is characterized by the accumulation of lipid peroxides, which are produced through the oxidation of polyunsaturated fatty acids.\n3. Ferritin degradation: Ferroptosis is accompanied by the degradation of ferritin, a protein that stores and regulates intracellular iron levels.\n4. Apoptotic-like morphology: Ferroptosis can lead to the formation of apoptotic-like morphologies, such as membrane blebbing and cell shrinkage.\n5. Regulation by GSH: Ferroptosis is regulated by glutathione (GSH), a potent antioxidant that can scavenge lipid peroxides and protect cells from oxidative damage.\n6. Involvement in disease: Ferroptosis has been implicated in a variety of diseases, including cancer, neurodegeneration, and metabolic disorders.\nOverall, ferroptosis is a complex and highly regulated cellular process that plays a critical role in maintaining tissue homeostasis and preventing disease.",
    "llama-2-7b-chat-hf_fact": [
      "Ferroptosis is a form of programmed cell death regulated by iron metabolism.",
      "This process plays a critical role in maintaining tissue homeostasis and preventing cancer.",
      "The features of ferroptosis include iron-dependence, lipid peroxidation, ferritin degradation, and apoptotic-like morphology.",
      "Glutathione, a potent antioxidant, regulates ferroptosis.",
      "Ferroptosis has been implicated in various diseases, such as cancer, neurodegeneration, and metabolic disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2896,
    "user_query": "Name 4 side effects of enasidenib",
    "llama-2-7b-chat-hf_response": "(Idhifa)\nEnasidenib (Idhifa) is a drug used to treat acute myeloid leukemia (AML) with a specific genetic mutation called IDH2 mutation. Here are 4 potential side effects of enasidenib:\n1. Nausea and Vomiting: Enasidenib can cause nausea and vomiting, which can be severe in some cases. Patients may need to take anti-nausea medication to manage these side effects.\n2. Fatigue: Enasidenib can cause fatigue, which can make it difficult for patients to carry out daily activities. Patients may need to take breaks and rest more often to manage this side effect.\n3. Diarrhea: Enasidenib can cause diarrhea, which can be severe in some cases. Patients may need to take medication to manage this side effect.\n4. Increased Risk of Infection: Enasidenib can decrease the body's ability to fight infections, which can increase the risk of infection. Patients may need to take precautions to avoid infections, such as washing their hands frequently and avoiding close contact with people who are sick.",
    "llama-2-7b-chat-hf_fact": [
      "Enasidenib (Idhifa) is used to treat acute myeloid leukemia (AML) with an IDH2 mutation.",
      "One potential side effect of enasidenib is nausea and vomiting.",
      "Enasidenib can also cause fatigue as a side effect.",
      "Diarrhea is another potential side effect of enasidenib.",
      "Enasidenib can increase the risk of infection by decreasing the body's ability to fight infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2903,
    "user_query": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "llama-2-7b-chat-hf_response": "Glioblastoma (GBM) is the most common and aggressive form of primary brain cancer, with poor prognosis and limited treatment options. Dacomitinib is a tyrosine kinase inhibitor that has shown promise in preclinical studies as a potential treatment for GBM. Here are some arguments for and against the use of dacomitinib for the treatment of GBM patients:\nArguments For:\n1. Inhibition of PI3K/AKT signaling: Dacomitinib targets the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway, which is commonly activated in GBM. Inhibition of this pathway may slow down the growth and proliferation of GBM cells.\n2. Anti-angiogenic activity: Dacomitinib also inhibits the formation of new blood vessels, which are essential for the growth and survival of GBM tumors.\n3. Synergy with temozolomide: Dacomitinib has been shown to enhance the efficacy of temozolomide, a standard chemotherapy drug for GBM, in preclinical studies.\nArguments Against:\n1. Limited clinical data: While dacomitinib has shown promise in preclinical studies, there is limited clinical data on its efficacy and safety in GBM patients.\n2. Dose-dependent toxicity: Dacomitinib has been associated with dose-dependent toxicities, including diarrhea, nausea, and fatigue, which may limit its use in clinical practice.\n3. Cost and accessibility: Dacomitinib is an investigational drug, and its cost and accessibility may be a barrier to its use in clinical practice, particularly in resource-limited settings.\nIn conclusion, while dacomitinib shows promise as a potential treatment for GBM, further clinical trials are needed to confirm its efficacy and safety in GBM patients. Additionally, the cost and accessibility of the drug must be taken into consideration when evaluating its potential use in clinical practice.",
    "llama-2-7b-chat-hf_fact": [
      "Glioblastoma (GBM) is the most common and aggressive form of primary brain cancer.",
      "Dacomitinib is a tyrosine kinase inhibitor that has shown potential in treating GBM in preclinical studies.",
      "Dacomitinib targets the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway.",
      "Dacomitinib is associated with dose-dependent toxicities, including diarrhea, nausea, and fatigue.",
      "Dacomitinib has been shown to enhance the effectiveness of temozolomide, a standard chemotherapy drug for GBM, in preclinical studies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false, [corrected fact]: Dacomitinib targets the Epidermal Growth Factor Receptor (EGFR) pathway.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2906,
    "user_query": "What is the function of Plasminogen activator inhibitor 1?",
    "llama-2-7b-chat-hf_response": "Plasminogen activator inhibitor 1 (PAI-1) is a protein that plays a crucial role in the regulation of the fibrinolytic system, which is responsible for breaking down blood clots. PAI-1 is produced by various cell types, including endothelial cells, smooth muscle cells, and fibroblasts, and circulates in the bloodstream.\nThe primary function of PAI-1 is to inhibit the activity of plasminogen activators, which are enzymes that convert plasminogen to plasmin, the active protease that breaks down fibrin clots. PAI-1 binds to plasminogen activators and prevents them from activating plasminogen, thereby reducing the activity of the fibrinolytic system.\nIn addition to its role in fibrinolysis, PAI-1 has been implicated in various other cellular processes, including cell adhesion, migration, and proliferation. PAI-1 has also been linked to various diseases, including thrombosis, cancer, and neurodegenerative disorders.\nOverall, the function of PAI-1 is to regulate the balance between fibrinolysis and thrombosis, and dysregulation of PAI-1 levels or activity has been implicated in a variety of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Plasminogen activator inhibitor 1 (PAI-1) is a protein that regulates the fibrinolytic system.",
      "The fibrinolytic system is responsible for breaking down blood clots.",
      "PAI-1 inhibits the activity of plasminogen activators, enzymes that convert plasminogen to plasmin.",
      "PAI-1's function is to regulate the balance between fibrinolysis and thrombosis.",
      "Dysregulation of PAI-1 levels or activity has been implicated in a variety of diseases including thrombosis, cancer, and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2913,
    "user_query": "Endolymphatic hydrops is associated with Menieres disease. Please provide a summary of endoymphatic hydrops including the symptoms and affected body part.",
    "llama-2-7b-chat-hf_response": "Endolymphatic hydrops is a condition in which there is an excessive accumulation of fluid in the endolymphatic compartment of the inner ear. The endolymphatic compartment is a specialized space within the inner ear that contains a unique fluid called endolymph. Endolymphatic hydrops can occur due to various reasons, including genetic mutations, infections, autoimmune disorders, and certain medical conditions such as Menieres disease.\nThe symptoms of endolymphatic hydrops can vary depending on the severity of the condition and the affected body part. Some common symptoms include:\n1. Hearing loss: Endolymphatic hydrops can cause progressive hearing loss, which can be severe in some cases.\n2. Tinnitus: Patients with endolymphatic hydrops may experience tinnitus, or ringing in the ears.\n3. Vertigo: The excessive accumulation of fluid in the endolymphatic compartment can cause vertigo or a feeling of spinning.\n4. Balance problems: Endolymphatic hydrops can lead to balance problems and difficulty with walking or standing.\n5. Nausea and vomiting: Some patients with endolymphatic hydrops may experience nausea and vomiting.\n6. Headaches: Headaches are common in patients with endolymphatic hydrops, particularly those caused by Menieres disease.\n7. Fatigue: Fatigue is another common symptom of endolymphatic hydrops, particularly in patients with Menieres disease.\n8. Vision problems: In some cases, endolymphatic hydrops can cause vision problems, including blurred vision, double vision, or loss of peripheral vision.\nThe affected body part in endolymphatic hydrops can vary depending on the underlying cause of the condition. In Menieres disease, the affected body part is typically the inner ear and the vestibular system, which is responsible for balance and equilibrium. However, endolymphatic hydrops can also affect other parts of the body, such as the eyes, face, and neck.\nIn summary, endolymphatic hydrops is a condition characterized by an excessive accumulation of fluid in the endolymphatic compartment of",
    "llama-2-7b-chat-hf_fact": [
      "Endolymphatic hydrops is a condition in which there is excessive accumulation of fluid in the endolymphatic compartment of the inner ear.",
      "Endolymphatic hydrops can be caused by various factors including genetic mutations, infections, autoimmune disorders, and certain medical conditions like Menieres disease.",
      "The condition can cause symptoms such as progressive hearing loss, tinnitus, vertigo, balance problems, nausea, vomiting, headaches, fatigue, and in some cases, vision problems.",
      "The affected body part in endolymphatic hydrops can vary depending on the underlying cause of the condition.",
      "In Menieres disease, the affected body part is typically the inner ear and the vestibular system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The affected body part in endolymphatic hydrops is consistently the inner ear, regardless of the underlying cause of the condition.",
      "true"
    ]
  },
  {
    "id": 2916,
    "user_query": "Is there any role for HUWE1 in MYC signalling?",
    "llama-2-7b-chat-hf_response": "HUWE1 is a ubiquitin ligase that has been shown to play a role in regulating the expression of MYC, a transcription factor that is involved in cell growth, proliferation, and differentiation. HUWE1 has been shown to ubiquitinate and degrade MYC, leading to its inhibition of MYC-mediated transcriptional activity. This suggests that HUWE1 may play a role in regulating MYC signaling and preventing its excessive activation, which can lead to cancer.",
    "llama-2-7b-chat-hf_fact": [
      "HUWE1 is a ubiquitin ligase.",
      "HUWE1 plays a role in regulating the expression of MYC.",
      "MYC is a transcription factor involved in cell growth, proliferation, and differentiation.",
      "HUWE1 ubiquitinates and degrades MYC, inhibiting MYC-mediated transcriptional activity.",
      "Excessive activation of MYC signaling can lead to cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-7b-chat-hf_response": "Gepotidacin is a topoisomerase inhibitor that is being developed as a potential treatment for various types of cancer, including small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Topoisomerase inhibitors are a class of drugs that work by blocking the activity of enzymes called topoisomerases, which are involved in DNA replication and repair. By inhibiting these enzymes, topoisomerase inhibitors can slow down or stop the growth of cancer cells.\nGepotidacin is a highly selective inhibitor of topoisomerase II (TOP2), which is overexpressed in many types of cancer. TOP2 is involved in the relaxation of DNA supercoils, which is necessary for DNA replication and repair. By inhibiting TOP2, gepotidacin can prevent cancer cells from replicating their DNA and repairing DNA damage, leading to cell death.\nGepotidacin has shown promise in preclinical studies as a potential treatment for SCLC and NSCLC, and it is currently being tested in clinical trials for the treatment of various types of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Gepotidacin is a topoisomerase inhibitor being developed as a potential treatment for various types of cancer.",
      "Topoisomerase inhibitors work by blocking the activity of enzymes called topoisomerases, which are involved in DNA replication and repair.",
      "Gepotidacin is a highly selective inhibitor of topoisomerase II (TOP2).",
      "TOP2 is involved in the relaxation of DNA supercoils, which is necessary for DNA replication and repair.",
      "Gepotidacin is currently being tested in clinical trials for the treatment of various types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Gepotidacin is a bacterial topoisomerase inhibitor being developed as a potential treatment for bacterial infections, not cancer.",
      "true",
      "false, [corrected fact]: Gepotidacin is a highly selective inhibitor of bacterial topoisomerase II (GyrB) and IV (ParE).",
      "true",
      "false, [corrected fact]: Gepotidacin is currently being tested in clinical trials for the treatment of bacterial infections, not cancer."
    ]
  },
  {
    "id": 2941,
    "user_query": "Which disease is PGT121 used for?",
    "llama-2-7b-chat-hf_response": "PGT121 is a gene therapy that is used to treat a rare genetic disorder called Leber congenital amaurosis (LCA). LCA is a group of inherited eye disorders that can cause blindness or severe visual impairment at birth or in early childhood. PGT121 is designed to deliver a healthy copy of the RPE65 gene to the retina of the eye, which can help to restore vision in people with LCA.",
    "llama-2-7b-chat-hf_fact": [
      "PGT121 is a gene therapy.",
      "PGT121 is used to treat Leber congenital amaurosis (LCA).",
      "LCA is a group of inherited eye disorders.",
      "The disorders of LCA can cause blindness or severe visual impairment at birth or in early childhood.",
      "PGT121 is designed to deliver a healthy copy of the RPE65 gene to the retina of the eye."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: PGT121 is an antibody, not a gene therapy.",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-7b-chat-hf_response": "Canvas SPW (Software as a Platform for Work) is a cloud-based platform designed to help businesses streamline their software development and delivery processes. It provides a suite of tools and services that enable developers to build, test, and deploy software faster and more efficiently, while also improving collaboration and productivity.\nHere are some of the key features and benefits of Canvas SPW:\n1. Agile Development: Canvas SPW provides a flexible and scalable platform for agile development, allowing teams to work together more effectively and deliver high-quality software faster.\n2. DevOps Integration: The platform integrates with popular DevOps tools such as Jenkins, Git, and Docker, enabling teams to automate their development and deployment processes.\n3. Continuous Integration and Continuous Deployment: Canvas SPW supports continuous integration and continuous deployment (CI/CD) pipelines, allowing teams to automate their testing and deployment processes.\n4. Collaboration: The platform provides a collaborative environment for developers, allowing them to work together more effectively and share knowledge and resources.\n5. Version Control: Canvas SPW integrates with popular version control systems such as Git, enabling teams to manage their codebase more effectively and track changes over time.\n6. Automated Testing: The platform provides automated testing capabilities, allowing teams to test their software more efficiently and identify issues earlier in the development process.\n7. Monitoring and Logging: Canvas SPW provides monitoring and logging capabilities, allowing teams to track the performance and health of their software in real-time.\n8. Security: The platform provides security features such as authentication and authorization, data encryption, and access controls, to ensure that software is developed and deployed securely.\n9. Scalability: Canvas SPW is designed to scale with the needs of growing businesses, providing a flexible and adaptable platform for software development and delivery.\n10. Integration: The platform integrates with a wide range of third-party tools and services, enabling teams to extend their capabilities and streamline their workflows.\nOverall, Canvas SPW is a powerful platform that can help businesses streamline their software development and delivery processes, improve collaboration and productivity, and deliver high-quality software faster and more efficiently.",
    "llama-2-7b-chat-hf_fact": [
      "Canvas SPW (Software as a Platform for Work) is a cloud-based platform.",
      "It is designed to assist businesses in software development and delivery processes.",
      "Canvas SPW provides a flexible and scalable platform for agile development.",
      "The platform integrates with DevOps tools such as Jenkins, Git, and Docker.",
      "Canvas SPW provides monitoring and logging capabilities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2950,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes?",
    "llama-2-7b-chat-hf_response": "Answer: There are several algorithms that have been developed for finding conserved non-coding elements (CNEs) in genomes. Some of the commonly used algorithms include:\n1. MEME (Multiple Em for Motif Elicitation): MEME is a popular algorithm for identifying CNEs in genomes. It uses a probabilistic approach to identify short, repeated sequences (motifs) that are conserved across multiple genomes.\n2. MACS (Multiple Alignment of Cis-Elements): MACS is a widely used algorithm for identifying CNEs in genomes. It uses a probabilistic approach to identify cis-regulatory elements, such as promoters, enhancers, and silencers, that are conserved across multiple genomes.\n3. HISAT2 (Hierarchical Indexing for Spliced Transcript Alignment): HISAT2 is a spliced aligner that can be used to identify CNEs in genomes. It uses a probabilistic approach to identify spliced alignments between multiple genomes and can be used to identify both coding and non-coding CNEs.\n4. STAR (Spliced Transcript Alignment using RNA-seq): STAR is a high-performance spliced aligner that can be used to identify CNEs in genomes. It uses a probabilistic approach to identify spliced alignments between multiple genomes and can be used to identify both coding and non-coding CNEs.\n5. DeepSEA (Deep Learning for Spliced Element Annotation): DeepSEA is a deep learning-based algorithm for identifying CNEs in genomes. It uses a convolutional neural network (CNN) to identify spliced alignments between multiple genomes and can be used to identify both coding and non-coding CNEs.\n6. CNCI (Conserved Non-Coding Element Finder): CNCI is a web-based tool for identifying CNEs in genomes. It uses a probabilistic approach to identify conserved non-coding elements and can be used to identify both coding and non-coding CNEs.\n7. GREAT (Genomic Regulatory Element Annotation Tool): GREAT is a web-based tool for identifying CNEs in genomes. It",
    "llama-2-7b-chat-hf_fact": [
      "MEME (Multiple Em for Motif Elicitation) is an algorithm used for identifying conserved non-coding elements (CNEs) in genomes.",
      "MACS (Multiple Alignment of Cis-Elements) is another algorithm that identifies CNEs in genomes. It is particularly used for locating cis-regulatory elements conserved across genomes.",
      "HISAT2 (Hierarchical Indexing for Spliced Transcript Alignment) is a spliced aligner algorithm that can identify both coding and non-coding CNEs in genomes.",
      "STAR (Spliced Transcript Alignment using RNA-seq) is a high-performance spliced aligner that can also identify both coding and non-coding CNEs in genomes.",
      "DeepSEA (Deep Learning for Spliced Element Annotation) is a deep learning-based algorithm that utilizes a convolutional neural network (CNN) to identify spliced alignments in multiple genomes, including coding and non-coding CNEs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MEME (Multiple Em for Motif Elicitation) is an algorithm used for discovering motifs in a group of related DNA or protein sequences.",
      "unknown",
      "false, [corrected fact]: HISAT2 (Hierarchical Indexing for Spliced Alignment of Transcripts) is a fast and sensitive alignment program for mapping next-generation sequencing reads (both DNA and RNA) against the general human population.",
      "false, [corrected fact]: STAR (Spliced Transcripts Alignment to a Reference) is a fast universal RNA-seq aligner. It aligns the sequencing reads to a reference genome and does not identify coding and non-coding CNEs.",
      "false, [corrected fact]: DeepSEA (Deep Learning for Spliced Element Annotation) is a deep learning-based algorithm used for predicting the functional effects of non-coding variants by learning a regulatory sequence code from large-scale chromatin-profiling data, not for identifying spliced alignments in multiple genomes."
    ]
  },
  {
    "id": 2953,
    "user_query": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "llama-2-7b-chat-hf_response": "No, ivosidenib has not been approved by the US Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia (AML). Ivosidenib is approved by the FDA for the treatment of adult patients with relapsed or refractory cholangiocarcinoma, a rare and aggressive cancer of the bile ducts.",
    "llama-2-7b-chat-hf_fact": [
      "Ivosidenib has not been approved by the US Food and Drug Administration for the treatment of acute myeloid leukemia.",
      "Ivosidenib is approved by the US Food and Drug Administration for the treatment of adult patients with relapsed or refractory cholangiocarcinoma.",
      "Cholangiocarcinoma is a rare and aggressive cancer of the bile ducts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Ivosidenib has been approved by the US Food and Drug Administration for the treatment of acute myeloid leukemia.",
      "true",
      "true"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-7b-chat-hf_response": "STING (Stimulator of Interferon Genes) is a protein that plays a crucial role in the innate immune response. It is activated by DNA from viruses and other pathogens, leading to the production of interferons, which are proteins that help to coordinate the immune response. STING agonists are compounds that activate STING, leading to the production of interferons and the activation of the immune response.",
    "llama-2-7b-chat-hf_fact": [
      "STING is an acronym for Stimulator of Interferon Genes.",
      "STING is a protein that plays a role in the innate immune response.",
      "STING is activated by DNA from pathogens such as viruses.",
      "STING activation leads to the production of interferons.",
      "STING agonists are compounds that activate STING."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-7b-chat-hf_response": ":\nSLIC-CAGE is a computational method for predicting the binding affinity of small molecules to a target protein. It uses a combination of machine learning algorithms and molecular dynamics simulations to predict the free energy of binding of a small molecule to a protein. The method was developed by researchers at the University of California, San Francisco and is widely used in the field of drug discovery.\nHere are some key features of SLIC-CAGE:\n1. Machine learning algorithms: SLIC-CAGE uses a combination of machine learning algorithms, including support vector machines (SVMs), random forests, and neural networks, to predict the binding affinity of a small molecule to a protein. These algorithms are trained on a dataset of known binding affinities and are used to predict the free energy of binding of a small molecule to a protein.\n2. Molecular dynamics simulations: SLIC-CAGE also uses molecular dynamics simulations to predict the free energy of binding of a small molecule to a protein. These simulations are used to calculate the free energy of binding of the small molecule to the protein and to validate the predictions made by the machine learning algorithms.\n3. Protein structure: SLIC-CAGE requires a three-dimensional structure of the target protein in order to predict the binding affinity of a small molecule. The protein structure is used to identify the binding site of the protein and to predict the free energy of binding of the small molecule to the protein.\n4. Small molecule structure: SLIC-CAGE requires a three-dimensional structure of the small molecule in order to predict its binding affinity to the target protein. The small molecule structure is used to identify the binding site of the small molecule on the protein and to predict the free energy of binding of the small molecule to the protein.\n5. Feature selection: SLIC-CAGE uses a set of predefined features to describe the small molecule and the protein, such as the molecular weight, logP, and hydrogen bond acceptors of the small molecule, and the surface area, hydrophobicity, and electrostatic potential of the protein. These features are used to train the machine learning algorithms and to predict the binding affinity of the small molecule to the protein.\n6. Validation: SLIC-CAGE has been validated",
    "llama-2-7b-chat-hf_fact": [
      "SLIC-CAGE is a method for predicting the binding affinity of small molecules to target proteins.",
      "The tool uses machine learning algorithms such as support vector machines (SVMs), random forests, and neural networks to predict the binding affinity.",
      "SLIC-CAGE also uses molecular dynamics simulations for predicting the free energy of binding of a small molecule to a protein.",
      "SLIC-CAGE requires a three-dimensional structure of the target protein and small molecules to predict binding affinity.",
      "SLIC-CAGE was developed by researchers at the University of California, San Francisco."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2967,
    "user_query": "What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2968,
    "user_query": "List two indications of Letermovir?",
    "llama-2-7b-chat-hf_response": "Letermovir is an antiviral drug used to prevent and treat cytomegalovirus (CMV) infection in transplant patients. Two indications of Letermovir are:\n1. Prevention of CMV disease in high-risk transplant patients: Letermovir is used to prevent CMV disease in transplant patients who are at high risk of developing CMV infection, such as those with a history of CMV infection, those with a weakened immune system, or those undergoing kidney, heart, or lung transplantation.\n2. Treatment of CMV disease in transplant patients: Letermovir is also used to treat CMV disease in transplant patients who have developed CMV infection despite prophylaxis with other antiviral drugs. This includes patients with CMV retinitis, CMV pneumonia, or CMV hepatitis.",
    "llama-2-7b-chat-hf_fact": [
      "Letermovir is an antiviral drug.",
      "Letermovir can be used to prevent and treat cytomegalovirus (CMV) infection in transplant patients.",
      "One indication of Letermovir is its use to prevent CMV disease in transplant patients who are at high risk of developing CMV infection.",
      "Another use of Letermovir is to treat CMV disease in transplant patients who have already developed CMV infection despite prophylaxis with other antiviral drugs.",
      "Transplant patients at high risk for CMV infection may include those with a history of CMV infection, those with a weakened immune system, or those undergoing kidney, heart, or lung transplantation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Letermovir does not treat CMV disease in patients who have already developed the infection, it is used to prevent the disease in high risk patients.",
      "true"
    ]
  },
  {
    "id": 2969,
    "user_query": "What is achalasia?",
    "llama-2-7b-chat-hf_response": "Achalasia is a rare disorder of the nervous system that affects the muscles in the lower esophagus and the ring-like muscle at the bottom of the esophagus (lower esophageal sphincter or LES). The LES is responsible for opening and closing to allow food to pass into the stomach. In people with achalasia, the muscles in the lower esophagus and LES do not function properly, leading to difficulty swallowing and regurgitation of food.\nThe symptoms of achalasia can vary in severity and may include:\n* Difficulty swallowing solids and liquids\n* Regurgitation of food\n* Chest pain (odynophagia)\n* Coughing or gagging during or after eating\n* Weight loss\n* Fatigue\n* Coughing or chest pressure\nThe exact cause of achalasia is not known, but it is believed to be related to a problem with the nerves that control the muscles in the lower esophagus and LES. Achalasia can occur at any age, but it is most commonly diagnosed in young adults.\nThere are several tests that can be used to diagnose achalasia, including:\n* Endoscopy: A flexible tube with a camera and light on the end is inserted through the mouth and into the esophagus to visualize the lower esophageal sphincter and the esophageal muscles.\n* High-resolution esophageal manometry: A thin, flexible tube is inserted through the nose and into the esophagus to measure the pressure and movement of the esophageal muscles.\n* Radiologic studies: X-rays or CT scans can be used to visualize the esophagus and detect any abnormalities.\n* Histopathology: A biopsy of the esophageal tissue can be taken during an endoscopy to examine the tissue under a microscope for signs of achalasia.\nThere is no cure for achalasia, but several treatments are available to help manage the symptoms. These may include:\n* Botulinum toxin injections: Injecting a small amount of botulinum toxin (",
    "llama-2-7b-chat-hf_fact": [
      "Achalasia is a rare disorder of the nervous system affecting the muscles in the lower esophagus and the lower esophageal sphincter (LES).",
      "In achalasia, the LES does not function properly, leading to difficulty swallowing and regurgitation of food.",
      "Achalasia symptoms can include difficulty swallowing, regurgitation of food, chest pain, coughing or gagging during or after eating, weight loss, fatigue, and chest pressure.",
      "Achalasia is most commonly diagnosed in young adults.",
      "Diagnostic methods for achalasia include endoscopy, high-resolution esophageal manometry, radiologic studies, and histopathology."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Achalasia is most commonly diagnosed in adults between the ages of 25 and 60.",
      "true"
    ]
  },
  {
    "id": 2972,
    "user_query": "When is serum AFP used as marker?",
    "llama-2-7b-chat-hf_response": "Serum AFP (alpha-fetoprotein) is used as a marker in various medical conditions, including:\n1. Liver disease: AFP is elevated in liver disease, including hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).\n2. Cancer: AFP is used as a tumor marker in various types of cancer, including HCC, lung cancer, and testicular cancer.\n3. Pregnancy: AFP is used to monitor the health of the fetus during pregnancy, particularly in high-risk pregnancies.\n4. Neurological disorders: AFP is used to diagnose and monitor neurological disorders such as neuroblastoma, a type of cancer that affects the nervous system.\n5. Monitoring of cancer treatment: AFP is used to monitor the response of cancer to treatment and to detect recurrence of cancer.\n6. Monitoring of liver transplant patients: AFP is used to monitor the liver function in liver transplant patients.\n7. Monitoring of patients with hemochromatosis: AFP is used to monitor the liver function in patients with hemochromatosis, a condition in which the body absorbs too much iron from food.\n8. Monitoring of patients with Wilson's disease: AFP is used to monitor the liver function in patients with Wilson's disease, a rare genetic disorder that affects the liver and other organs.\n9. Monitoring of patients with alpha-1 antitrypsin deficiency: AFP is used to monitor the liver function in patients with alpha-1 antitrypsin deficiency, a genetic disorder that can lead to liver disease.\n10. Research: AFP is used in research studies to investigate the role of liver function in various diseases and to develop new treatments for liver disease.\nIt is important to note that the above list is not exhaustive and AFP may be used as a marker for other conditions as well.",
    "llama-2-7b-chat-hf_fact": [
      "Serum AFP is used as a marker in liver disease, including hepatitis, cirrhosis, and hepatocellular carcinoma.",
      "AFP is employed as a tumor marker in cancers such as hepatocellular carcinoma, lung cancer, and testicular cancer.",
      "The fetus's health during pregnancy, particularly in high-risk pregnancies, is monitored using AFP.",
      "In diagnosing and monitoring neurological disorders like neuroblastoma, AFP is used.",
      "The response of cancer to treatment and detecting recurrence of cancer is monitored employing AFP."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: In diagnosing and monitoring neurological disorders like neuroblastoma, neuron-specific enolase (NSE) is usually used, not AFP.",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-7b-chat-hf_response": "LEM-3 (Lymphocyte-specific protein 1) is a protein that plays a crucial role in the regulation of T cell activation and differentiation. Here are some of the key roles of LEM-3:\n1. T cell activation: LEM-3 is involved in the activation of T cells upon antigen stimulation. It interacts with the T cell receptor (TCR) complex and enhances the signaling process, leading to the activation of T cells.\n2. T cell differentiation: LEM-3 regulates the differentiation of T cells into different subtypes, such as Th1, Th2, and Treg cells. It promotes the differentiation of T cells into Th1 cells, which are involved in the immune response against intracellular pathogens, and inhibits the differentiation of T cells into Th2 cells, which are involved in the immune response against extracellular parasites.\n3. T cell tolerance: LEM-3 also plays a role in T cell tolerance, which is the ability of the immune system to distinguish between self and non-self antigens. LEM-3 inhibits the activation of T cells against self-antigens, thereby preventing autoimmune responses.\n4. Cancer immunotherapy: LEM-3 has been shown to be involved in the immune evasion of cancer cells. It inhibits the activation of T cells against cancer cells, leading to immune tolerance.\n5. Immunomodulation: LEM-3 can modulate the immune response by interacting with other immune cells, such as dendritic cells and B cells. It can also regulate the production of cytokines and chemokines, which are involved in the immune response.\nOverall, LEM-3 plays a crucial role in regulating the immune response and preventing autoimmune diseases. Its dysregulation can lead to immune disorders, such as autoimmune diseases and cancer.",
    "llama-2-7b-chat-hf_fact": [
      "LEM-3 is a protein that takes part in the regulation of T cell activation and differentiation.",
      "LEM-3 is involved in the activation of T cells upon antigen stimulation and interacts with the T cell receptor (TCR) complex.",
      "LEM-3 regulates the differentiation of T cells into different subtypes, such as Th1, Th2, and Treg cells.",
      "LEM-3 plays a role in T cell tolerance which is the ability of the immune system to differentiate between self and non-self antigens.",
      "LEM-3 has been shown to be involved in cancer immunotherapy by inhibiting the activation of T cells against cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2981,
    "user_query": "What is the most common pediatric glioma?",
    "llama-2-7b-chat-hf_response": "A glioma is a type of brain tumor that originates from the supporting cells of the brain called glial cells. The most common type of pediatric glioma is called pilocytic astrocytoma. This type of tumor typically affects children under the age of 10 and accounts for about 50% of all pediatric gliomas. Pilocytic astrocytomas are usually slow-growing and tend to have a good prognosis when treated with surgery and/or radiation therapy. Other types of pediatric gliomas include fibrillary astrocytoma, pleomorphic xanthoastrocytoma, and glioblastoma multiforme.",
    "llama-2-7b-chat-hf_fact": [
      "Glioma is a type of brain tumor that originates from the supporting cells of the brain called glial cells.",
      "The most common type of pediatric glioma is pilocytic astrocytoma.",
      "Pilocytic astrocytoma typically affects children under the age of 10 and accounts for about 50% of all pediatric gliomas.",
      "Pilocytic astrocytomas are usually slow-growing and tend to have a good prognosis when treated with surgery and/or radiation therapy.",
      "Other types of pediatric gliomas include fibrillary astrocytoma, pleomorphic xanthoastrocytoma, and glioblastoma multiforme."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2983,
    "user_query": "List uniparental disomy (UPD) detection algorithms",
    "llama-2-7b-chat-hf_response": "Uniparental disomy (UPD) is a genetic condition where an individual has two copies of a chromosome instead of one. Detection of UPD can be challenging due to the complexity of the genetic data and the need for accurate and efficient algorithms. Here are some of the commonly used UPD detection algorithms:\n1. Parental allele-sharing algorithm: This algorithm is based on the observation that parents are more likely to share alleles with their offspring than with unrelated individuals. The algorithm first identifies the parental alleles and then calculates the probability of sharing alleles between the offspring and each parent. If the probability of sharing alleles between the offspring and one parent is significantly higher than the probability of sharing alleles between the offspring and the other parent, then UPD is detected.\n2. Haplotype-based algorithm: This algorithm uses haplotypes (a set of genetic markers on the same chromosome) to detect UPD. The algorithm first identifies the haplotypes in the offspring and then compares them to the haplotypes in the parents. If the offspring has a different haplotype than one of the parents, then UPD is detected.\n3. Genetic distance-based algorithm: This algorithm uses the genetic distance between the offspring and each parent to detect UPD. The genetic distance is calculated using a measure such as the number of single nucleotide polymorphisms (SNPs) between the offspring and each parent. If the genetic distance between the offspring and one parent is significantly shorter than the genetic distance between the offspring and the other parent, then UPD is detected.\n4. Bayesian algorithm: This algorithm uses a Bayesian statistical framework to detect UPD. The algorithm first models the probability of inheritance of each allele from each parent and then uses Bayes' theorem to update the probabilities based on the genetic data. If the probability of inheritance of an allele from one parent is significantly higher than the probability of inheritance from the other parent, then UPD is detected.\n5. Machine learning-based algorithm: This algorithm uses machine learning techniques such as decision trees, random forests, or support vector machines to detect UPD. The algorithm first trains a model on a dataset of known UPD and non-UPD individuals and then uses the trained model to classify the offspring as UPD",
    "llama-2-7b-chat-hf_fact": [
      "Uniparental disomy (UPD) is a genetic condition where an individual has two copies of a chromosome instead of one.",
      "The parental allele-sharing algorithm is one method used to detect UPD, which calculates the probability of sharing alleles between the offspring and each parent.",
      "The haplotype-based algorithm detects UPD by identifying the haplotypes in the offspring and comparing them to the haplotypes in the parents.",
      "The genetic distance-based algorithm detects UPD using the genetic distance between the offspring and each parent, calculated using measures like the number of single nucleotide polymorphisms.",
      "The Bayesian algorithm uses a Bayesian statistical framework to detect UPD by modeling the probability of inheritance of each allele from each parent.",
      "The machine learning-based algorithm uses machine learning techniques, such as decision trees, random forests, or support vector machines, to detect UPD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Uniparental disomy (UPD) is a genetic condition where an individual has two copies of a chromosome from one parent instead of one from each parent.",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2987,
    "user_query": "List major features of TEMPI Syndrome.",
    "llama-2-7b-chat-hf_response": "Temporomandibular joint (TMJ) disorders are a group of conditions that affect the joint that connects the jawbone to the skull. TMJ disorders can cause a variety of symptoms, including pain, stiffness, and difficulty opening or closing the mouth. TMJ syndrome, also known as TMJ disorder or TMJ dysfunction, is a term used to describe a group of conditions that affect the temporomandibular joint and the muscles surrounding it. The following are some of the major features of TMJ syndrome:\n1. Pain: TMJ syndrome can cause pain in the jaw, face, and head. The pain can be constant or intermittent and can range from mild to severe.\n2. Stiffness: TMJ syndrome can cause stiffness in the jaw, making it difficult to open or close the mouth.\n3. Limited mobility: TMJ syndrome can cause limited mobility in the jaw, making it difficult to move the mouth or chew.\n4. Clicking or popping: TMJ syndrome can cause clicking or popping sounds when opening or closing the mouth.\n5. Locked jaw: TMJ syndrome can cause the jaw to become locked in place, making it difficult to open or close the mouth.\n6. Headaches: TMJ syndrome can cause headaches, which can range from mild to severe.\n7. Difficulty chewing: TMJ syndrome can cause difficulty chewing, which can lead to digestive problems.\n8. Difficulty speaking: TMJ syndrome can cause difficulty speaking, which can affect communication.\n9. Tenderness: TMJ syndrome can cause tenderness in the jaw, face, and head.\n10. Limited range of motion: TMJ syndrome can cause limited range of motion in the jaw, making it difficult to move the mouth or chew.\n11. Muscle spasms: TMJ syndrome can cause muscle spasms in the jaw and face, which can be painful and uncomfortable.\n12. Grinding or clenching: TMJ syndrome can cause grinding or clenching of the teeth, which can lead",
    "llama-2-7b-chat-hf_fact": [
      "Temporomandibular joint (TMJ) disorders affect the joint that connects the jawbone to the skull.",
      "Symptoms of TMJ disorders include pain, stiffness, and difficulty opening or closing the mouth.",
      "TMJ syndrome can cause clicking or popping sounds when opening or closing the mouth.",
      "TMJ syndrome can cause the jaw to become locked in place, making it difficult to open or close mouth.",
      "TMJ syndrome can result in grinding or clenching of the teeth."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2990,
    "user_query": "What is nyctinasty in plants?",
    "llama-2-7b-chat-hf_response": "Nyctinasty is a term used to describe the phenomenon of plants opening their flowers or leaves at night and closing them during the day. This behavior is often observed in plants that are adapted to low light conditions, such as those found in forests or other shaded environments.",
    "llama-2-7b-chat-hf_fact": [
      "Nyctinasty refers to the phenomenon where plants open their flowers or leaves at night and close them during the day.",
      "Nyctinasty is often observed in plants adapted to low light conditions.",
      "Plants found in forests or other shaded environments typically exhibit nyctinasty."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Nyctinasty can be observed in a variety of plants, not specifically or typically those found in shaded environments like forests."
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-7b-chat-hf_response": "Here are the releases of the `tmVar` package in R:\n1. `tmVar_0.1.0`: Released on 2017-02-01\n2. `tmVar_0.2.0`: Released on 2017-05-01\n3. `tmVar_0.3.0`: Released on 2017-08-01\n4. `tmVar_0.4.0`: Released on 2018-01-01\n5. `tmVar_0.5.0`: Released on 2018-04-01\n6. `tmVar_0.6.0`: Released on 2018-07-01\n7. `tmVar_0.7.0`: Released on 2019-01-01\n8. `tmVar_0.8.0`: Released on 2019-04-01\n9. `tmVar_0.9.0`: Released on 2019-07-01\n10. `tmVar_1.0.0`: Released on 2020-01-01\nNote that the version numbering follows the format `major.minor.patch`, where `major` represents the major release, `minor` represents the minor release, and `patch` represents the patch release.",
    "llama-2-7b-chat-hf_fact": [
      "The `tmVar_0.1.0` package was released on 2017-02-01.",
      "The `tmVar_0.4.0` package was released on 2018-01-01.",
      "The `tmVar_0.7.0` package was released on 2019-01-01.",
      "The `tmVar_1.0.0` package was released on 2020-01-01.",
      "The version numbering of the tmVar package in R follows the format `major.minor.patch`."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2993,
    "user_query": "Which deep learning algorithm has been developed for variant calling?",
    "llama-2-7b-chat-hf_response": "Deep learning has been increasingly applied to variant calling in recent years, and several deep learning algorithms have been developed for this task. Here are some of the most popular deep learning algorithms used for variant calling:\n1. Deep Neural Networks (DNNs): DNNs are a type of feedforward neural network that have been widely used for variant calling. They can learn complex patterns in the data and make accurate predictions.\n2. Convolutional Neural Networks (CNNs): CNNs are a type of neural network that are particularly well-suited to image and sequence data. They have been used for variant calling by treating the sequencing data as an image.\n3. Recurrent Neural Networks (RNNs): RNNs are a type of neural network that are well-suited to sequential data. They have been used for variant calling by treating the sequencing data as a time series.\n4. Long Short-Term Memory (LSTM) Networks: LSTMs are a type of RNN that are able to learn long-term dependencies in sequential data. They have been used for variant calling by treating the sequencing data as a time series.\n5. Generative Adversarial Networks (GANs): GANs are a type of neural network that consist of two components: a generator and a discriminator. They have been used for variant calling by treating the sequencing data as a generative task.\n6. Variational Autoencoders (VAEs): VAEs are a type of neural network that are able to learn a probabilistic representation of the data. They have been used for variant calling by treating the sequencing data as a probabilistic generative task.\n7. Deep Belief Networks (DBNs): DBNs are a type of neural network that are able to learn a hierarchical representation of the data. They have been used for variant calling by treating the sequencing data as a hierarchical generative task.\n8. Stacked Denoising Autoencoders (SDAEs): SDAEs are a type of neural network that are able to learn a hierarchical representation of the data. They have been used for variant calling by treating the sequencing data as a hierarchical generative task.\nIt's worth noting that these algorithms are not mutually exclusive, and many studies",
    "llama-2-7b-chat-hf_fact": [
      "Deep learning has been applied to variant calling.",
      "Deep Neural Networks (DNNs) are a type of feedforward neural network that have been used for variant calling.",
      "Convolutional Neural Networks (CNNs) have been used for variant calling by treating the sequencing data as an image.",
      "Recurrent Neural Networks (RNNs), suited to sequential data, have been used for variant calling by treating sequencing data as a time series.",
      "Long Short-Term Memory (LSTM) Networks, a type of RNN, have been used for variant calling by treating sequencing data as a time series."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3000,
    "user_query": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III).",
    "llama-2-7b-chat-hf_response": "Sanfilippo syndrome, also known as mucopolysaccharidosis type III (MPS III), is a rare genetic disorder caused by mutations in one of four genes:\n1. NAGLU (N-acetylglucosamine 6-sulfatase)\n2. GNS (Glucocerebrosidase)\n3. HGS (Hexosaminidase A)\n4. HGS2 (Hexosaminidase B)\nEach of these genes codes for an enzyme that plays a critical role in the breakdown and recycling of sugar molecules called glycosaminoglycans (GAGs) in the body. Without these enzymes, GAGs accumulate in cells and tissues, leading to the characteristic signs and symptoms of Sanfilippo syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Sanfilippo syndrome, also known as mucopolysaccharidosis type III (MPS III), is caused by mutations in certain genes.",
      "NAGLU (N-acetylglucosamine 6-sulfatase), GNS (Glucocerebrosidase), HGS (Hexosaminidase A), and HGS2 (Hexosaminidase B) are the four genes involved in Sanfilippo syndrome.",
      "NAGLU, GNS, HGS, and HGS2 codes for enzymes that play a role in the breakdown and recycling of glycosaminoglycans (GAGs) in the body.",
      "The absence of these enzymes leads to the accumulation of GAGs in the cells and tissues.",
      "The accumulation of GAGs in cells and tissues leads to the characteristic signs and symptoms of Sanfilippo syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The four genes involved in Sanfilippo syndrome are SGSH (sulfoglycosaminoglycan hydrolase), NAGLU (N-acetyl-alpha-D-glucosaminidase), HGSNAT (heparan-alpha-glucosaminide N-acetyltransferase), and GNS (N-acetylglucosamine 6-sulfatase).",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3002,
    "user_query": "List clinical disorders or diseases where uc.189 is involved?",
    "llama-2-7b-chat-hf_response": "Uc.189 is a gene that has been associated with several clinical disorders or diseases, including:\n1. Ulcerative colitis: Uc.189 has been shown to be involved in the pathogenesis of ulcerative colitis, a chronic inflammatory bowel disease characterized by ulcers and inflammation in the colon.\n2. Crohn's disease: Uc.189 has also been implicated in the development of Crohn's disease, another type of inflammatory bowel disease that can affect any part of the gastrointestinal tract.\n3. Inflammatory bowel disease: Uc.189 has been linked to the development of other inflammatory bowel diseases, such as indeterminate colitis and microscopic colitis.\n4. Autoimmune diseases: Uc.189 has been suggested to play a role in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.\n5. Cancer: Uc.189 has been implicated in the development and progression of certain types of cancer, including colorectal cancer and gastric cancer.\n6. Neurological disorders: Uc.189 has been linked to the development of neurological disorders, such as Parkinson's disease and Alzheimer's disease.\n7. Cardiovascular disease: Uc.189 has been suggested to play a role in the development of cardiovascular disease, including atherosclerosis and heart failure.\n8. Metabolic disorders: Uc.189 has been implicated in the development of metabolic disorders, such as insulin resistance and type 2 diabetes.\n9. Osteoporosis: Uc.189 has been linked to the development of osteoporosis, a condition characterized by weakened bones and an increased risk of fractures.\n10. Eye disorders: Uc.189 has been suggested to play a role in the development of certain eye disorders, such as age-related macular degeneration and cataracts.\nIt is important to note that",
    "llama-2-7b-chat-hf_fact": [
      "Uc.189 is a gene associated with several clinical disorders and diseases.",
      "Uc.189 has been linked to the development of ulcerative colitis, a chronic inflammatory bowel disease.",
      "Crohn's disease, which affects any part of the gastrointestinal tract, is also associated with Uc.189.",
      "Uc.189 has been suggested to play a role in the development of autoimmune diseases, like rheumatoid arthritis and multiple sclerosis.",
      "The gene Uc.189 has been implicated in the development and progression of certain types of cancer, including colorectal cancer and gastric cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3004,
    "user_query": "What is the role of metalloproteinase-17 (ADAM17) in NK cells?",
    "llama-2-7b-chat-hf_response": "Natural killer (NK) cells are a type of immune cell that plays a crucial role in the defense against cancer and viral infections. Metalloproteinase-17 (ADAM17) is a member of the a disintegrin and metalloproteinase (ADAM) family of proteins, which are involved in various cellular processes, including cell signaling, adhesion, and proteolysis. ADAM17 has been shown to play a crucial role in the regulation of NK cell function, particularly in the context of cancer.\nADAM17 is expressed on the surface of NK cells and is involved in the processing and activation of cytokines, such as interleukin-10 (IL-10) and tumor necrosis factor-alpha (TNF-alpha), which are important in the regulation of immune responses. ADAM17 also regulates the expression of inhibitory receptors on NK cells, such as killer cell immunoglobulin-like receptors (KIRs), which can dampen NK cell activation and function.\nIn addition, ADAM17 has been shown to be involved in the regulation of NK cell migration and homing to tumors. ADAM17 can cleave and activate the chemokine receptor CXCR4, which is important for NK cell migration to the tumor microenvironment.\nOverall, the role of ADAM17 in NK cells is complex and multifaceted, and involves the regulation of cytokine processing, inhibitory receptor expression, and chemokine signaling. Understanding the role of ADAM17 in NK cells may provide new insights into the development of immunotherapies for cancer and other diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Natural killer (NK) cells are a type of immune cell that play a role in the defense against cancer and viral infections.",
      "Metalloproteinase-17 (ADAM17) is a member of the a disintegrin and metalloproteinase (ADAM) family of proteins.",
      "ADAM17 plays a role in the regulation of NK cell function, particularly in the context of cancer.",
      "ADAM17 is involved in the processing and activation of cytokines, such as interleukin-10 (IL-10) and tumor necrosis factor-alpha (TNF-alpha).",
      "ADAM17 regulates the expression of inhibitory receptors on NK cells, such as killer cell immunoglobulin-like receptors (KIRs)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3005,
    "user_query": "What is the triad of Melkersson-Rosenthal syndrome?",
    "llama-2-7b-chat-hf_response": "Melkersson-Rosenthal syndrome is a rare neurological disorder characterized by the following triad of symptoms:\n1. Progressive weakness and wasting of the muscles of the face, particularly the orbicularis oculi (the muscle that surrounds the eye) and the buccinator (the muscle that closes the mouth).\n2. Progressive weakness and wasting of the muscles of the limbs, particularly the biceps and triceps.\n3. Progressive weakness and wasting of the muscles of the tongue, leading to difficulty swallowing (dysphagia) and speaking (dysarthria).\nThese symptoms typically begin in childhood or adolescence and progress slowly over many years. Melkersson-Rosenthal syndrome is often associated with other neurological problems, such as seizures, ataxia (loss of coordination), and cognitive impairment.",
    "llama-2-7b-chat-hf_fact": [
      "Melkersson-Rosenthal syndrome is a rare neurological disorder.",
      "This condition is characterized by progressive weakness and wasting of facial muscles, especially the orbicularis oculi and the buccinator.",
      "Melkersson-Rosenthal syndrome also causes progressive weakness and wasting of the muscles of the limbs, particularly the biceps and triceps.",
      "It leads to difficulty swallowing (dysphagia) and speaking (dysarthria) due to progressive weakness and wasting of the muscles of the tongue.",
      "The symptoms of Melkersson-Rosenthal syndrome often begin in childhood or adolescence and progress slowly over many years."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: This condition is characterized by recurrent facial paralysis, swelling of the face and lips primarily, and the development of folds and furrows in the tongue.",
      "false, [corrected fact]: Melkersson-Rosenthal syndrome doesn't cause progressive weakness and wasting of the muscles of the limbs, its symptoms are mostly manifested in the facial area.",
      "true",
      "true"
    ]
  },
  {
    "id": 3006,
    "user_query": "Is galcanezumab effective for treatment of migraine?",
    "llama-2-7b-chat-hf_response": "Galcanezumab is a monoclonal antibody that has been shown to be effective in reducing the frequency and severity of migraine attacks in clinical trials. It works by blocking the calcitonin gene-related peptide (CGRP) receptor, which is involved in the transmission of pain signals in the body. By blocking the CGRP receptor, galcanezumab can help to reduce the amount of pain signals that are transmitted to the brain, thereby reducing the severity of migraine attacks.",
    "llama-2-7b-chat-hf_fact": [
      "Galcanezumab is a monoclonal antibody.",
      "Galcanezumab has shown efficacy in reducing the frequency and severity of migraine attacks during clinical trials.",
      "Galcanezumab works by blocking the calcitonin gene-related peptide (CGRP) receptor.",
      "The CGRP receptor is involved in the transmission of pain signals in the body.",
      "Blocking the CGRP receptor, as galcanezumab does, can reduce the amount of pain signals that are transmitted to the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Galcanezumab works by blocking the calcitonin gene-related peptide (CGRP) itself, not the receptor.",
      "true",
      "true"
    ]
  },
  {
    "id": 3011,
    "user_query": "Fecal transplantation is used to treat infection with what bacteria?",
    "llama-2-7b-chat-hf_response": "Fecal transplantation, also known as fecal microbiota transplantation (FMT), is a medical procedure in which fecal matter is collected from a healthy donor and transferred into a patient's gastrointestinal tract to restore a healthy balance of gut bacteria. Fecal transplantation is used to treat a variety of conditions, including:\n1. Clostridioides difficile (C. difficile) infection: C. difficile is a type of bacteria that can cause diarrhea, abdominal pain, and other symptoms. Fecal transplantation can be used to restore a healthy balance of gut bacteria and treat C. difficile infection.\n2. Inflammatory bowel disease (IBD): Fecal transplantation has been shown to improve symptoms of IBD, including Crohn's disease and ulcerative colitis.\n3. Irritable bowel syndrome (IBS): Some studies have suggested that fecal transplantation may be effective in treating IBS, which is a common condition characterized by abdominal pain, bloating, and changes in bowel habits.\n4. Other conditions: Fecal transplantation has also been used to treat other conditions, such as metabolic disorders, liver disease, and HIV infection.\nIt is important to note that fecal transplantation is not a cure-all and may not be effective for everyone. Additionally, there are risks associated with the procedure, including infection and allergic reactions. Therefore, it is important to discuss the potential benefits and risks of fecal transplantation with a healthcare provider before undergoing the procedure.",
    "llama-2-7b-chat-hf_fact": [
      "Fecal transplantation, or fecal microbiota transplantation (FMT), involves transferring fecal matter from a healthy donor into a patient's gastrointestinal tract to help restore a healthy balance of gut bacteria.",
      "The medical procedure of fecal transplantation can be used to treat Clostridioides difficile (C. difficile) infections.",
      "Inflammatory bowel disease including Crohn's disease and ulcerative colitis, can be treated by fecal transplantation.",
      "Some studies suggest that fecal transplantation may be effective in treating Irritable Bowel Syndrome (IBS).",
      "Fecal transplantation has also been used to treat conditions like metabolic disorders, liver disease, and HIV infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: There are early studies showing that fecal transplantation can influence the course of certain conditions like metabolic disorders and liver disease, however, there is no substantial evidence for using it to treat HIV infection."
    ]
  },
  {
    "id": 3015,
    "user_query": "What are the CADD scores?",
    "llama-2-7b-chat-hf_response": "CADD (Comprehensive Arterial Disease Determination) scores are a measure of the severity of atherosclerosis (hardening of the arteries) in the carotid arteries, which are located in the neck and supply blood to the brain. The CADD score is calculated based on the degree of narrowing or blockage in the carotid arteries, as measured by ultrasound.\nThe CADD score ranges from 0 to 100, with higher scores indicating more severe narrowing or blockage in the carotid arteries. A score of 0 indicates no narrowing or blockage, while a score of 100 indicates complete blockage of one or both carotid arteries.\nHere are the CADD score categories and their corresponding meanings:\n* 0-19: No significant narrowing or blockage in the carotid arteries\n* 20-39: Mild narrowing or blockage in one or both carotid arteries\n* 40-59: Moderate narrowing or blockage in one or both carotid arteries\n* 60-79: Severe narrowing or blockage in one or both carotid arteries\n* 80-100: Complete blockage of one or both carotid arteries\nIt's important to note that the CADD score is just one measure of cardiovascular health, and other factors such as blood pressure, cholesterol levels, and lifestyle habits also play a role in determining overall cardiovascular risk.",
    "llama-2-7b-chat-hf_fact": [
      "CADD (Comprehensive Arterial Disease Determination) scores are a measure of the severity of atherosclerosis in the carotid arteries.",
      "The CADD score is calculated based on the degree of narrowing or blockage in the carotid arteries as measured by ultrasound.",
      "The CADD score ranges from 0 to 100, with 0 indicating no blockage and 100 indicating complete blockage of one or both carotid arteries.",
      "CADD scores are divided into five categories with assigned ranges indicating different levels of narrowing or blockage in the carotid arteries.",
      "Other factors like blood pressure, cholesterol levels and lifestyle habits also play a role in determining overall cardiovascular risk."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-7b-chat-hf_response": "There are several databases of somatic mutations in cancer cells, but there are fewer databases of somatic mutations in normal cells. Here are a few examples of databases that contain information on somatic mutations in normal cells:\n1. The Cancer Genome Atlas (TCGA): TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) that aims to catalogue the genomic changes in various types of cancer. While TCGA primarily focuses on cancer genomics, it also includes some data on normal tissues, including somatic mutations in normal cells.\n2. The 1000 Genomes Project: The 1000 Genomes Project is a large-scale effort to catalogue the genetic variation in a diverse set of individuals from around the world. While the project primarily focuses on genetic variation in the context of disease, it also includes some data on normal tissues, including somatic mutations in normal cells.\n3. The Genome of the Netherlands (GoN): GoN is a large-scale genomics project that aims to catalogue the genetic variation in the Dutch population. While GoN primarily focuses on genetic variation in the context of disease, it also includes some data on normal tissues, including somatic mutations in normal cells.\n4. The ExAC database: The ExAC database is a large-scale effort to catalogue the genetic variation in a diverse set of individuals from around the world. While ExAC primarily focuses on genetic variation in the context of disease, it also includes some data on normal tissues, including somatic mutations in normal cells.\n5. The GTEx database: GTEx is a large-scale effort to catalogue the genetic variation in a diverse set of individuals from around the world. While GTEx primarily focuses on genetic variation in the context of disease, it also includes some data on normal tissues, including somatic mutations in normal cells.\nIt's worth noting that these databases are constantly evolving, and new data is being added all the time. Additionally, there may be other databases that contain information on somatic mutations in normal cells that are not listed here.",
    "llama-2-7b-chat-hf_fact": [
      "The Cancer Genome Atlas (TCGA) is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) aiming to catalogue genomic changes in various types of cancer.",
      "The 1000 Genomes Project is a large-scale effort that catalogues genetic variation in diverse individuals from around the world.",
      "The Genome of the Netherlands (GoN) is a large-scale genomics project that catalogues genetic variation in the Dutch population.",
      "The ExAC database is a large-scale effort to catalogue genetic variation in diverse individuals from around the world.",
      "The GTEx database is a large-scale effort to catalogue genetic variation in diverse individuals from around the world."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The GTEx (Genotype-Tissue Expression) project is a resource that catalogues human gene expression and regulation to help understand the functional impact of genetic variation."
    ]
  },
  {
    "id": 3023,
    "user_query": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?",
    "llama-2-7b-chat-hf_response": "The bacteria associated with periodontal disease, such as Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Tannerella forsythia, have been found to be associated with an increased risk of developing Alzheimer's disease. These bacteria can enter the brain through the bloodstream and contribute to inflammation and oxidative stress, which are thought to be key factors in the development of Alzheimer's disease.",
    "llama-2-7b-chat-hf_fact": [
      "Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Tannerella forsythia are bacteria associated with periodontal disease.",
      "These bacteria have been found to be associated with an increased risk of developing Alzheimer's disease.",
      "The bacteria can enter the brain through the bloodstream.",
      "Inflammation and oxidative stress are thought to be key factors in the development of Alzheimer's disease.",
      "Periodontal disease associated bacteria can contribute to inflammation and oxidative stress."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3025,
    "user_query": "How does the Cholera toxin enter a cell?",
    "llama-2-7b-chat-hf_response": "Cholera toxin is a virulence factor produced by Vibrio cholerae, a bacterium that causes cholera, a diarrheal disease that can lead to severe dehydration and even death if left untreated. Cholera toxin enters a cell through a process called endocytosis, which involves the engulfment of the toxin by the cell membrane.\nOnce inside the cell, the toxin is released from the endosome, a membrane-bound compartment, and enters the cytosol, the fluid inside the cell. From there, it binds to specific receptors on the cell membrane, triggering a cascade of intracellular signaling events that ultimately lead to the secretion of water and electrolytes from the cell, causing diarrhea and dehydration.\nThe mechanism of cholera toxin entry into a cell is crucial for the pathogenesis of cholera, as it allows V. cholerae to colonize and infect the small intestine, where it can cause severe diarrhea and dehydration. Understanding how cholera toxin enters a cell can provide insights into the development of new therapeutic strategies for the treatment of cholera.",
    "llama-2-7b-chat-hf_fact": [
      "Cholera toxin is a virulence factor produced by Vibrio cholerae, a bacterium that causes cholera.",
      "Cholera causes a diarrheal disease that can lead to severe dehydration and even death.",
      "The cholera toxin enters a cell through a process called endocytosis.",
      "Once inside, the cholera toxin triggers a cascade of intracellular signaling events, which results in the secretion of water and electrolytes, causing diarrhea and dehydration.",
      "The mechanism of cholera toxin entry into a cell is crucial for the pathogenesis of the disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3027,
    "user_query": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "llama-2-7b-chat-hf_response": "Mogamulizumab is a monoclonal antibody that targets the CD47 protein, which is expressed on the surface of many types of cancer cells, including those of cutaneous T-cell lymphoma (CTCL). In clinical trials, mogamulizumab has been shown to be effective in treating CTCL, including mycosis fungoides and Szary syndrome, which are the most common types of CTCL.\nMogamulizumab works by binding to the CD47 protein on the surface of cancer cells, which helps to trigger the body's immune system to attack the cancer cells. By blocking the CD47 protein, mogamulizumab can help to enhance the immune system's ability to recognize and attack cancer cells.\nIn clinical trials, mogamulizumab has been shown to be well-tolerated and to have a manageable safety profile. Common side effects of mogamulizumab include infusion reactions, fatigue, nausea, and diarrhea.\nWhile the results of clinical trials are promising, it is important to note that mogamulizumab is not yet approved by the US Food and Drug Administration (FDA) for the treatment of CTCL. However, it is being studied in ongoing clinical trials and may become a treatment option for patients with CTCL in the future.\nIn summary, mogamulizumab is a monoclonal antibody that targets the CD47 protein and has shown promise in clinical trials as a treatment for cutaneous T-cell lymphoma, including mycosis fungoides and Szary syndrome. While it is not yet approved by the FDA, it is being studied in ongoing clinical trials and may become a treatment option for patients with CTCL in the future.",
    "llama-2-7b-chat-hf_fact": [
      "Mogamulizumab is a monoclonal antibody that targets the CD47 protein expressed on the surface of many types of cancer cells.",
      "The CD47 protein is present on the surface of cutaneous T-cell lymphoma (CTCL) cells.",
      "Clinical trials have shown mogamulizumab to be effective in treating mycosis fungoides and Szary syndrome, the most common types of CTCL.",
      "Common side effects of mogamulizumab include infusion reactions, fatigue, nausea, and diarrhea.",
      "Despite promising results, mogamulizumab is not yet approved by the US Food and Drug Administration for the treatment of CTCL."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Mogamulizumab is a monoclonal antibody that targets the CCR4 protein, not CD47, expressed on the surface of many types of cancer cells.",
      "false, [corrected fact]: The CCR4 protein, not CD47, is present on the surface of cutaneous T-cell lymphoma (CTCL) cells.",
      "true",
      "true",
      "false, [corrected fact]: Mogamulizumab has been approved by the US Food and Drug Administration for the treatment of CTCL."
    ]
  },
  {
    "id": 3028,
    "user_query": "Which enzymes are inhibited by Duvelisib?",
    "llama-2-7b-chat-hf_response": "Duvelisib is a drug that inhibits the enzyme phosphatidylinositol 3-kinase (PI3K). PI3K is involved in many cellular processes, including cell survival, proliferation, and migration. Duvelisib inhibits the activity of PI3K by binding to its p110 subunit, which is the catalytic subunit of the enzyme. By inhibiting PI3K, Duvelisib can reduce the activity of downstream signaling pathways, including the PI3K/AKT and PI3K/mTOR pathways.\nThere are several enzymes that are inhibited by Duvelisib, including:\n1. Phosphatidylinositol 3-kinase (PI3K): Duvelisib inhibits the activity of PI3K by binding to its p110 subunit, which is the catalytic subunit of the enzyme.\n2. Protein kinase B (AKT): Duvelisib inhibits the activity of AKT by reducing the activity of PI3K, which is a upstream regulator of AKT.\n3. Mammalian target of rapamycin (mTOR): Duvelisib inhibits the activity of mTOR by reducing the activity of PI3K, which is a upstream regulator of mTOR.\n4. Mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK): Duvelisib inhibits the activity of MAPK/ERK by reducing the activity of PI3K, which is a upstream regulator of MAPK/ERK.\n5. Cell division cycle 42 (CDC42): Duvelisib inhibits the activity of CDC42 by reducing the activity of PI3K, which is a upstream regulator of CDC42.\n6. Glycogen synthase kinase 3 (GSK3): Duvelisib inhibits the activity of GSK3 by reducing the activity of PI3K, which is a upstream regulator of GSK3.\n7. Cyclin-dependent kin",
    "llama-2-7b-chat-hf_fact": [
      "Duvelisib is a drug that inhibits the enzyme phosphatidylinositol 3-kinase (PI3K).",
      "The p110 subunit is the catalytic subunit of the enzyme PI3K.",
      "The drug Duvelisib inhibits the activity of Protein kinase B (AKT).",
      "Duvelisib can reduce the activity of Mammalian target of rapamycin (mTOR).",
      "Duvelisib inhibits the activity of Mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3029,
    "user_query": "List search engines used in proteomics.",
    "llama-2-7b-chat-hf_response": "Proteomics is the study of the complete set of proteins produced by an organism, known as the proteome. Proteomics is a relatively new field that has emerged as a result of advances in mass spectrometry and other technologies that allow for the large-scale analysis of proteins. As a result, there are a number of search engines that have been developed specifically for proteomics research. Here are some of the most popular search engines used in proteomics:\n1. Protein Data Bank (PDB): The Protein Data Bank (PDB) is a freely accessible database that contains the 3D structures of proteins, nucleic acids, and other biological molecules. The PDB is a valuable resource for proteomics researchers, as it provides a wealth of information about the structure and function of proteins.\n2. UniProt: UniProt is a comprehensive protein database that contains information on the sequences, functions, and structures of proteins from a wide range of organisms. UniProt is a popular resource for proteomics researchers, as it provides a wealth of information about proteins and their functions.\n3. Gene Ontology (GO): The Gene Ontology (GO) is a database that contains information about the functions of genes and proteins. GO is a valuable resource for proteomics researchers, as it provides a standardized vocabulary for describing the functions of proteins.\n4. Protein Family Database (Pfam): The Protein Family Database (Pfam) is a database that contains information about protein families, which are groups of proteins that share a common ancestor and have similar structures and functions. Pfam is a valuable resource for proteomics researchers, as it provides a wealth of information about protein families and their functions.\n5. InterProScan: InterProScan is a database that contains information about protein families, domains, and functional sites. InterProScan is a valuable resource for proteomics researchers, as it provides a wealth of information about the structure and function of proteins.\n6. PANTHER: PANTHER (Protein Analysis Through Evolutionary Relationships) is a database that contains information about the evolutionary relationships between proteins. PANTHER is a valuable resource for proteomics researchers, as it provides a wealth of information about the evolutionary history of",
    "llama-2-7b-chat-hf_fact": [
      "Proteomics is the study of the complete set of proteins produced by an organism.",
      "The Protein Data Bank is a freely accessible database that contains 3D structures of proteins, nucleic acids, and other biological molecules.",
      "UniProt is a comprehensive protein database containing information on the sequences, functions, and structures of proteins from various organisms.",
      "The Gene Ontology is a database containing information about the functions of genes and proteins.",
      "The Protein Family Database contains information about protein families which are groups of proteins that share a common ancestor and have similar structures and functions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3035,
    "user_query": "Is Lasmiditan effective for migraine?",
    "llama-2-7b-chat-hf_response": "Lasmiditan (Reyvow) is a relatively new medication that was approved by the FDA in 2020 for the acute treatment of migraine. It is an oral calcitonin gene-related peptide (CGRP) receptor antagonist, which means it works by blocking the action of CGRP, a molecule that is involved in the transmission of pain signals in the body.\nStudies have shown that Lasmiditan is effective in reducing the frequency and severity of migraine attacks. In a phase 3 clinical trial, Lasmiditan was compared to placebo and the existing migraine medication, sumatriptan. The results showed that Lasmiditan significantly reduced the frequency and severity of migraine attacks compared to placebo and sumatriptan.\nIn addition, Lasmiditan has been shown to have a rapid onset of action, with many patients experiencing relief from migraine symptoms within 15 minutes of taking the medication. This is faster than many other migraine medications, which can take up to an hour to start working.\nHowever, it's important to note that Lasmiditan is not a cure for migraine, and it may not work for everyone. It is also important to follow the dosing instructions carefully and to only take the medication as directed by your healthcare provider.\nOverall, Lasmiditan is a promising new medication for the acute treatment of migraine, and it has shown to be effective in reducing the frequency and severity of migraine attacks. However, more research is needed to fully understand its long-term safety and effectiveness.",
    "llama-2-7b-chat-hf_fact": [
      "Lasmiditan (Reyvow) was approved by the FDA in 2020 for the acute treatment of migraine.",
      "Lasmiditan is an oral calcitonin gene-related peptide (CGRP) receptor antagonist.",
      "Studies have shown that Lasmiditan can reduce the frequency and severity of migraine attacks.",
      "Lasmiditan was shown to have a rapid onset of action, with effects occurring within 15 minutes of consumption.",
      "Lasmiditan is not a cure for migraine and may not work for everyone."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Lasmiditan (Reyvow) was approved by the FDA in 2019 for the acute treatment of migraine.",
      "false, [corrected fact]: Lasmiditan is a serotonin (5-HT1F) receptor agonist, not a calcitonin gene-related peptide (CGRP) receptor antagonist.",
      "true",
      "false, [corrected fact]: Lasmiditan generally starts to work within 2 hours of consumption.",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-7b-chat-hf_response": "I am looking for a graph kernel library implemented in JAVA, which can be used for graph similarity search, graph clustering, and other graph-related tasks. Can you please provide me with some information on the same?\nAnswer: Yes, there are several graph kernel libraries available in Java that can be used for graph similarity search, graph clustering, and other graph-related tasks. Here are some of them:\n1. GraphKernel: GraphKernel is a Java library for graph kernel computation. It provides a simple and efficient way to compute graph kernels for various graph types, including undirected and directed graphs, weighted and unweighted graphs, and graphs with multiple types of edges.\n2. JGraphT: JGraphT is a Java library for graph theory. It provides a wide range of graph algorithms, including graph clustering, graph similarity search, and graph partitioning. It also supports multiple graph data structures, including adjacency matrices, adjacency lists, and edge lists.\n3. GraphCrunch: GraphCrunch is a Java library for graph processing. It provides a simple and efficient way to perform graph clustering, graph similarity search, and other graph-related tasks. It also supports multiple graph data structures, including directed and undirected graphs, weighted and unweighted graphs, and graphs with multiple types of edges.\n4. Gephi: Gephi is a Java library for network data analysis. It provides a wide range of graph algorithms, including graph clustering, graph similarity search, and graph visualization. It also supports multiple graph data structures, including directed and undirected graphs, weighted and unweighted graphs, and graphs with multiple types of edges.\n5. NetworkX: NetworkX is a Python library for network data analysis. It provides a wide range of graph algorithms, including graph clustering, graph similarity search, and graph visualization. It also supports multiple graph data structures, including directed and undirected graphs, weighted and unweighted graphs, and graphs with multiple types of edges. However, there is a Java interface available for NetworkX, which can be used to perform graph-related tasks in Java.\n6. GraphStream: GraphStream is a Java library for graph processing. It provides a simple and efficient way to perform graph clustering, graph similarity search, and other graph-related tasks. It also supports multiple graph data structures, including directed and undirected graphs,",
    "llama-2-7b-chat-hf_fact": [
      "GraphKernel is a Java library for graph kernel computation that can handle various types of graphs.",
      "JGraphT is a Java library aimed at graph theory, offering a range of algorithms and supporting various graph data structures.",
      "GraphCrunch is a Java library for graph processing, also handling multiple graph types.",
      "Gephi is a Java library used for network data analysis and supports different types of graphs.",
      "The Python library, NetworkX, has a Java interface available for performing graph-related tasks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "false, [corrected fact]: GraphCrunch is a software tool for graph processing, it's not a Java library.",
      "false, [corrected fact]: Gephi is a software tool used for network data analysis and visualization, it's not a Java library.",
      "false, [corrected fact]: The Python library, NetworkX, does not have a Java interface. It is a Python package for the creation, manipulation and study of the structure, dynamics, and functions of complex networks."
    ]
  },
  {
    "id": 3044,
    "user_query": "What is COG112?",
    "llama-2-7b-chat-hf_response": "COG112 is a gene that provides instructions for making a protein called COG1, which is involved in the process of DNA replication and repair. DNA replication is the process by which cells make copies of their DNA before cell division, and DNA repair is the process by which cells fix errors in their DNA that may have occurred during replication or other cellular processes.\nMutations in the COG112 gene have been associated with a rare genetic disorder called COG1-related disorder, which is characterized by developmental delays, intellectual disability, and a variety of other symptoms. These symptoms can vary in severity and may include problems with movement, vision, and hearing.\nCOG112 is a member of the COG (chromosomal maintenance) family of proteins, which are involved in the repair of DNA double-strand breaks. These breaks can occur as a result of various factors, including exposure to radiation or certain chemicals, and can lead to genetic mutations if left unrepaired. The COG1 protein is specifically involved in the repair of interstrand cross-links (ICLs), which are a type of DNA damage that can be difficult to repair.\nOverall, the COG112 gene plays a critical role in maintaining the integrity of the genetic material and preventing genetic mutations that can lead to disease.",
    "llama-2-7b-chat-hf_fact": [
      "COG112 is a gene that provides instructions for making a protein called COG1.",
      "COG1 is involved in DNA replication and repair.",
      "Mutations in the COG112 gene have been associated with a genetic disorder called COG1-related disorder.",
      "COG112 is a member of the COG family of proteins which are involved in the repair of DNA double-strand breaks.",
      "The COG1 protein is specifically involved in the repair of interstrand cross-links, a type of DNA damage."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-7b-chat-hf_response": "1. Single-molecule localization microscopy (SMLM)\n2. Hybridization-based amplification (HBA)\n3. Nucleic acid sequence-based amplification (NASBA)\n4. Recombinase polymerase amplification (RPA)",
    "llama-2-7b-chat-hf_fact": [
      "Single-molecule localization microscopy (SMLM) is integrated into the SHERLOCKv2 platform.",
      "Hybridization-based amplification (HBA) is integrated into the SHERLOCKv2 platform.",
      "Nucleic acid sequence-based amplification (NASBA) is integrated into the SHERLOCKv2 platform.",
      "Recombinase polymerase amplification (RPA) is integrated into the SHERLOCKv2 platform."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3055,
    "user_query": "What is MOV10?",
    "llama-2-7b-chat-hf_response": "MOV10 is a gene that provides instructions for making a protein called mitochondrial outer membrane protein 10 (MOMP10). This protein is involved in the structure and function of the mitochondria, which are organelles found in the cells of most living things. Mitochondria are often referred to as the \"powerhouses\" of the cell because they generate most of the energy that the cell needs to function.\nMOV10 is specifically involved in the transport of proteins across the outer membrane of the mitochondria. It helps to facilitate the movement of proteins from the cytosol (the fluid inside the cell) into the mitochondria, where they can perform their functions. This process is important for maintaining the proper functioning of the mitochondria and the cell as a whole.\nMutations in the MOV10 gene have been associated with a variety of mitochondrial disorders, including some forms of neurological disease, muscle weakness, and vision loss. These disorders are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition.",
    "llama-2-7b-chat-hf_fact": [
      "MOV10 is a gene that provides instructions for making a protein called mitochondrial outer membrane protein 10 (MOMP10).",
      "This MOMP10 protein is involved in the structure and function of the mitochondria, which are organelles found in most cells.",
      "Mitochondria generate most of the energy that cells need to function.",
      "The MOV10 gene is specifically involved in the transport of proteins from the fluid inside the cell into the mitochondria.",
      "Mutations in the MOV10 gene have been associated with a variety of mitochondrial disorders, including some forms of neurological disease, muscle weakness, and vision loss."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MOV10 is a gene that provides instructions for making a protein called Moloney leukemia virus 10.",
      "unknown",
      "true",
      "false, [corrected fact]: The Mov10 is involved in RNA silencing and acts as RNA helicase and 3'-5' exoribonuclease. It is not involved in the transport of proteins into the mitochondria.",
      "false, [corrected fact]: Mutations in the MOV10 gene have not been specifically associated with a variety of mitochondrial disorders. However, they are linked with other health issues including HIV and some types of cancer."
    ]
  },
  {
    "id": 3057,
    "user_query": "Which cancer is associated with increased levels of Serum alpha fetoprotein (AFP) ?",
    "llama-2-7b-chat-hf_response": "Alpha-fetoprotein (AFP) is a protein produced by the liver and yolk sac during fetal development. Elevated levels of AFP in the blood can be a sign of several conditions, including:\n1. Liver cancer: AFP is produced by liver cells, and elevated levels can be a sign of liver cancer, particularly hepatocellular carcinoma (HCC).\n2. Bile duct cancer: AFP can also be produced by bile duct cells, and elevated levels can be a sign of bile duct cancer.\n3. Gallbladder cancer: AFP can be produced by gallbladder cells, and elevated levels can be a sign of gallbladder cancer.\n4. Pancreatic cancer: AFP can be produced by pancreatic cells, and elevated levels can be a sign of pancreatic cancer.\n5. Testicular cancer: AFP can be produced by testicular cells, and elevated levels can be a sign of testicular cancer.\n6. Ovarian cancer: AFP can be produced by ovarian cells, and elevated levels can be a sign of ovarian cancer.\n7. Cervical cancer: AFP can be produced by cervical cells, and elevated levels can be a sign of cervical cancer.\n8. Breast cancer: AFP can be produced by breast cells, and elevated levels can be a sign of breast cancer.\n9. Lung cancer: AFP can be produced by lung cells, and elevated levels can be a sign of lung cancer.\n10. Thyroid cancer: AFP can be produced by thyroid cells, and elevated levels can be a sign of thyroid cancer.\nIt is important to note that elevated AFP levels can also be caused by other conditions, such as liver cirrhosis, hemochromatosis, and certain genetic disorders. Therefore, it is important to consult with a healthcare professional for proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Alpha-fetoprotein (AFP) is a protein produced by the liver and yolk sac during fetal development.",
      "Elevated levels of AFP in the blood can be a sign of liver cancer, particularly hepatocellular carcinoma.",
      "High AFP levels can also indicate bile duct cancer.",
      "Increased levels of AFP can be a sign of gallbladder cancer.",
      "Elevated AFP levels can also indicate pancreatic cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Increased levels of AFP do not typically indicate gallbladder cancer.",
      "false, [corrected fact]: Elevated AFP levels do not typically indicate pancreatic cancer."
    ]
  },
  {
    "id": 3060,
    "user_query": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "llama-2-7b-chat-hf_response": "Yes, recent studies have shown that the interaction between MOV10 and RNASEH2 promotes L1 retrotransposition. MOV10 is a protein that has been implicated in the regulation of L1 retrotransposition, and RNASEH2 is an enzyme that degrades double-stranded RNA. Studies have shown that MOV10 and RNASEH2 interact directly and that this interaction promotes the retrotransposition of L1 elements. Specifically, MOV10 has been shown to bind to the 3' untranslated region (UTR) of L1 mRNA and to recruit RNASEH2 to the site of L1 retrotransposition. Once bound, RNASEH2 degrades the L1 mRNA, leading to its retrotransposition into the genome. This interaction between MOV10 and RNASEH2 may play a key role in the regulation of L1 retrotransposition and may be a potential therapeutic target for the treatment of diseases caused by L1-mediated retrotransposition.",
    "llama-2-7b-chat-hf_fact": [
      "The interaction between MOV10 and RNASEH2 promotes L1 retrotransposition.",
      "MOV10 is a protein that regulates L1 retrotransposition.",
      "RNASEH2 is an enzyme that degrades double-stranded RNA.",
      "MOV10 binds to the 3' untranslated region (UTR) of L1 mRNA and recruits RNASEH2 to the site of L1 retrotransposition.",
      "The interaction between MOV10 and RNASEH2 is a potential therapeutic target for the treatment of diseases caused by L1-mediated retrotransposition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3063,
    "user_query": "List features of the Triple A syndrome.",
    "llama-2-7b-chat-hf_response": "Triple A syndrome, also known as 22q11.2 deletion syndrome, is a rare genetic disorder that affects approximately 1 in 100,000 individuals worldwide. It is caused by a deletion of genetic material on chromosome 22, specifically at the q11.2 locus. The disorder is characterized by a range of developmental delays, intellectual disability, and distinctive facial features. Here are some of the key features of Triple A syndrome:\n1. Developmental delays: Children with Triple A syndrome typically experience delays in reaching developmental milestones, such as sitting, standing, and walking. These delays can range from mild to severe, depending on the individual.\n2. Intellectual disability: Individuals with Triple A syndrome often have intellectual disability, which can range from mild to severe. This can affect their ability to learn and adapt to new situations.\n3. Distinctive facial features: Triple A syndrome is characterized by a range of distinctive facial features, including a small head, narrow eyes, a short nose, and a thin upper lip.\n4. Speech and language difficulties: Children with Triple A syndrome may experience difficulties with speech and language development, including stuttering, slurred speech, and difficulty with articulation.\n5. Vision problems: Some individuals with Triple A syndrome may experience vision problems, including nearsightedness, farsightedness, and cataracts.\n6. Hearing loss: Hearing loss is a common feature of Triple A syndrome, and can range from mild to profound.\n7. Heart defects: Approximately 50% of individuals with Triple A syndrome have heart defects, including atrial septal defects, ventricular septal defects, and tetralogy of Fallot.\n8. Other health problems: Triple A syndrome can also be associated with a range of other health problems, including gastrointestinal issues, seizures, and sleep apnea.\n9. Short stature: Individuals with Triple A syndrome tend to be short in stature, with an average height of around 4 feet 6 inches.\n10.",
    "llama-2-7b-chat-hf_fact": [
      "Triple A syndrome, also known as 22q11.2 deletion syndrome, is a rare genetic disorder.",
      "This syndrome affects approximately 1 in 100,000 individuals worldwide and is caused by a deletion on chromosome 22 at the q11.2 locus.",
      "One of the characteristics of Triple A syndrome is developmental delays in activities like sitting, standing, and walking.",
      "It is also characterized by intellectual disabilities and distinctive facial features, such as a small head, narrow eyes, a short nose, and a thin upper lip.",
      "Other common issues among individuals with Triple A syndrome include speech and language difficulties, vision problems, hearing loss, heart defects, and other health problems like gastrointestinal issues and seizures. They also tend to be short in stature."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Triple A syndrome, also known as Allgrove syndrome, is a rare genetic disorder.",
      "false, [corrected fact]: This syndrome affects approximately 1 in 1,000,000 individuals worldwide and is caused by mutations in the AAAS gene.",
      "false, [corrected fact]: One of the main characteristics of Triple A syndrome is a triad of adrenal insufficiency, achalasia, and alacrima.",
      "false, [corrected fact]: It is also characterized by problems with the nervous system, including difficulty coordinating movements and developmental delay, but not necessarily by intellectual disabilities or distinctive facial features.",
      "true"
    ]
  },
  {
    "id": 3065,
    "user_query": "Which protein is the Mitochondrial carrier homolog 2 (MTCH2) receptor for?",
    "llama-2-7b-chat-hf_response": "Mitochondrial carrier homolog 2 (MTCH2) is a protein that is encoded by the MTCH2 gene in humans. MTCH2 is a transmembrane protein that is primarily localized to the mitochondria, where it functions as a receptor for a variety of ligands.\nOne of the main ligands that binds to MTCH2 is the neurotransmitter glutamate. Glutamate is the most abundant excitatory neurotransmitter in the brain, and it plays a critical role in a wide range of cognitive and motor functions. MTCH2 is expressed in many regions of the brain, including the hippocampus, cerebral cortex, and basal ganglia, and it is thought to play a key role in regulating the release and uptake of glutamate in these regions.\nIn addition to glutamate, MTCH2 has also been shown to bind to other ligands, including the neurosteroid pregnenolone sulfate and the anticonvulsant drug carbamazepine. These findings suggest that MTCH2 may play a more general role in regulating the transport of a variety of ligands across the mitochondrial membrane.\nOverall, the MTCH2 receptor is an important component of the mitochondrial transport system, and it plays a key role in regulating the release and uptake of glutamate in the brain. Dysregulation of MTCH2 has been implicated in a number of neurological disorders, including epilepsy and neurodegenerative diseases, and further research is needed to fully understand its role in these conditions.",
    "llama-2-7b-chat-hf_fact": [
      "Mitochondrial carrier homolog 2 (MTCH2) is a protein encoded by the MTCH2 gene in humans.",
      "MTCH2 serves as a receptor for various ligands, including the neurotransmitter glutamate.",
      "Glutamate is the most abundant excitatory neurotransmitter in the brain.",
      "MTCH2 is expressed in many regions of the brain, such as the hippocampus, cerebral cortex, and basal ganglia.",
      "Dysregulation of MTCH2 has been implicated in a number of neurological disorders, including epilepsy and neurodegenerative diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: MTCH2 is not known to serve as a receptor for various ligands, including the neurotransmitter glutamate. It is involved in the regulation of mitochondrial metabolism and apoptosis.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3066,
    "user_query": "What is PhenomeCentral?",
    "llama-2-7b-chat-hf_response": "PhenomeCentral is a web-based platform designed to facilitate the collection, storage, and analysis of phenotypic data from various sources. Phenotypes are the observable characteristics of an organism, including physical traits, behavioral patterns, and disease symptoms. The platform aims to provide a comprehensive and standardized framework for phenotyping, which can help researchers to better understand the complex relationships between genotype and phenotype.\nPhenomeCentral was developed by the University of California, San Diego, and is supported by the National Institutes of Health (NIH). The platform is designed to be user-friendly, allowing researchers to easily upload and share their data, as well as to access and analyze data from other researchers.\nSome of the key features of PhenomeCentral include:\n1. Data standardization: PhenomeCentral provides a standardized framework for collecting and storing phenotypic data, which can help to ensure consistency and comparability across different studies.\n2. Data sharing: The platform allows researchers to easily share their data with other researchers, which can facilitate collaboration and accelerate the discovery of new insights.\n3. Data analysis: PhenomeCentral provides a range of tools and methods for analyzing phenotypic data, including statistical analysis, machine learning, and data visualization.\n4. Integration with other resources: PhenomeCentral can be integrated with other resources, such as gene expression datasets, to provide a more comprehensive understanding of the relationships between genotype and phenotype.\nOverall, PhenomeCentral is a powerful tool for facilitating the collection, storage, and analysis of phenotypic data, which can help researchers to better understand the complex relationships between genotype and phenotype and to identify new targets for disease diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "PhenomeCentral is a web-based platform designed to facilitate the collection, storage, and analysis of phenotypic data.",
      "PhenomeCentral was developed by the University of California, San Diego.",
      "The platform is supported by the National Institutes of Health (NIH).",
      "PhenomeCentral provides tools and methods for data analysis, including statistical analysis, machine learning, and data visualization.",
      "PhenomeCentral can be integrated with other resources, such as gene expression datasets."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: PhenomeCentral was developed by the Hospital for Sick Children in Toronto.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3072,
    "user_query": "List sirtuin inhibitors.",
    "llama-2-7b-chat-hf_response": "Sirtuin inhibitors are a class of compounds that target and inhibit the activity of sirtuins, a family of enzymes that play important roles in various cellular processes, including DNA repair, metabolism, and cell survival. Sirtuins are NAD+-dependent enzymes that catalyze the deacetylation of histone and non-histone proteins, leading to changes in chromatin structure and gene expression. Inhibition of sirtuins has been implicated in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases.\nHere are some examples of sirtuin inhibitors:\n1. SRT1720: SRT1720 is a small molecule inhibitor of sirtuin 1 (SIRT1) that has been shown to have anti-inflammatory and anti-cancer effects in preclinical studies.\n2. EX-527: EX-527 is a potent and selective inhibitor of sirtuin 1 (SIRT1) that has been shown to have anti-inflammatory and anti-cancer effects in preclinical studies.\n3. SIRT7 inhibitor: SIRT7 is a small molecule inhibitor of sirtuin 7 (SIRT7) that has been shown to have anti-inflammatory and anti-cancer effects in preclinical studies.\n4. NAD+ precursor: NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), have been shown to increase NAD+ levels and activate sirtuins, leading to anti-aging and anti-disease effects.\n5. Resveratrol: Resveratrol is a polyphenolic compound found in grapes, berries, and peanuts that has been shown to activate sirtuins and have anti-aging and anti-inflammatory effects in preclinical studies.\n6. Curcumin: Curcumin is a polyphenolic compound found in turmeric that has been shown to activate sirtuins and",
    "llama-2-7b-chat-hf_fact": [
      "Sirtuin inhibitors are compounds that inhibit the activity of sirtuins, a family of enzymes involved in various cellular processes.",
      "Sirtuins are NAD+-dependent enzymes that catalyze the deacetylation of histone and non-histone proteins.",
      "SRT1720 is a small molecule inhibitor of sirtuin 1 (SIRT1).",
      "EX-527 is a potent and selective inhibitor of SIRT1.",
      "Resveratrol, a polyphenolic compound found in grapes, berries, and peanuts, can activate sirtuins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3073,
    "user_query": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "llama-2-7b-chat-hf_response": "The National Library of Medicine's (NLM) Medical Text Indexer (MTI) is a tool that was developed in the 1980s and 1990s to index biomedical literature. While the tool was state-of-the-art at the time of its development, advances in natural language processing (NLP) and machine learning (ML) have significantly improved the accuracy and efficiency of text indexing in recent years.",
    "llama-2-7b-chat-hf_fact": [
      "The National Library of Medicine's (NLM) Medical Text Indexer (MTI) is a tool to index biomedical literature.",
      "The NLM's MTI was developed in the 1980s and 1990s.",
      "The purpose of the NLM's MTI is to index biomedical literature.",
      "Advances in natural language processing (NLP) and machine learning (ML) have improved the accuracy and efficiency of text indexing.",
      "Natural language processing and machine learning are now widely used in text indexing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3075,
    "user_query": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018",
    "llama-2-7b-chat-hf_response": "?\nAs of 2018, the standard of care for Clostridium difficile (C. difficile) infection typically involves the use of a first-generation cephalosporin (such as ceftriaxone or cefotaxime) or a macrolide antibiotic (such as erythromycin or azithromycin) for 7-10 days.",
    "llama-2-7b-chat-hf_fact": [
      "As of 2018, the standard of care for Clostridium difficile infection involves the use of a first-generation cephalosporin or a macrolide antibiotic.",
      "Examples of first-generation cephalosporin include ceftriaxone and cefotaxime.",
      "Examples of macrolide antibiotics include erythromycin and azithromycin.",
      "The usually prescribed duration of this antibiotic treatment for Clostridium difficile infection is 7-10 days."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: As of 2018, the standard of care for Clostridium difficile infection involves the use of fidaxomicin, vancomycin, or metronidazole.",
      "false, [corrected fact]: Examples of first-generation cephalosporins include cefazolin and cephalexin.",
      "true",
      "true"
    ]
  },
  {
    "id": 3077,
    "user_query": "Which features are evaluated with the CRAFFT screening test?",
    "llama-2-7b-chat-hf_response": "The CRAFFT (CRAFT) screening test evaluates the following features of alcohol use disorder (AUD):\n1. Craving: The degree to which the individual experiences a strong desire or craving for alcohol.\n2. Relapse: The likelihood of the individual experiencing a relapse or return to alcohol use after a period of abstinence.\n3. Annoyance: The degree to which the individual experiences annoyance or irritability when they are unable to use alcohol.\n4. Forgetfulness: The degree to which the individual experiences forgetfulness or blackouts due to alcohol use.\n5. Tension: The degree to which the individual experiences tension or anxiety when they are unable to use alcohol.\n6. Depression: The degree to which the individual experiences depression or low mood due to alcohol use.\n7. Sleep: The degree to which the individual experiences sleep disturbances or insomnia due to alcohol use.\n8. Anger: The degree to which the individual experiences anger or irritability when they are unable to use alcohol.\n9. Guilt: The degree to which the individual experiences guilt or remorse about their alcohol use.\n10. Social problems: The degree to which the individual experiences problems in their personal relationships or social life due to alcohol use.\nIt is important to note that the CRAFFT screening test is not a diagnostic tool, but rather a screener that can help identify individuals who may be at risk for AUD. A comprehensive diagnostic evaluation should be conducted by a qualified healthcare professional to determine the presence and severity of AUD.",
    "llama-2-7b-chat-hf_fact": [
      "The CRAFFT (CRAFT) screening test evaluates various features of alcohol use disorder (AUD).",
      "This test measures the individual's likelihood of experiencing a return to alcohol use after a period of abstinence.",
      "The CRAFFT test assesses the degree to which the individual experiences guilt or remorse about their alcohol use.",
      "It is used as a screener to identify individuals who may be at risk for AUD.",
      "A comprehensive diagnostic evaluation should be conducted by a qualified healthcare professional to determine the presence and severity of AUD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The CRAFFT (CRAFT) screening test does not specifically measure the individual's likelihood of returning to alcohol use after a period of abstinence. It screens for potential risk and problems associated with alcohol and other drug use.",
      "false, [corrected fact]: While guilt or remorse about alcohol use can be part of an alcohol use disorder, the CRAFFT test does not specifically assess these feelings. It measures potential risk and problems associated with substance use.",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-7b-chat-hf_response": "The Bartender algorithm is a heuristic algorithm used to solve the Traveling Salesman Problem (TSP), which is a classic problem in computer science and operations research that involves finding the shortest possible tour that visits a set of cities and returns to the starting city. The algorithm was developed by computer scientist Jack Edmonds in the 1960s and is based on the idea of iteratively improving a random solution to the TSP.\nThe basic idea of the Bartender algorithm is to start with a random solution to the TSP and then iteratively improve it by exchanging edges between the cities in the tour. The algorithm repeats this process until no further improvements can be made, at which point the current solution is returned as the final answer.\nHere is a high-level description of the Bartender algorithm:\n1. Start with a random solution to the TSP.\n2. Iterate through the following steps until no further improvements can be made:\na. Exchange an edge between two cities in the tour.\nb. Evaluate the new solution using a heuristic function, such as the nearest neighbor or the 2-opt heuristic.\nc. If the new solution is better than the current solution, replace the current solution with the new one.\n3. Return the final solution as the answer to the TSP.\nThe Bartender algorithm is simple to implement and has a proven worst-case time complexity of O(n^3), where n is the number of cities in the TSP. However, in practice, the algorithm's performance can be much faster than this worst-case bound, especially for smaller instances of the TSP.\nOne of the key advantages of the Bartender algorithm is that it can be easily parallelized, which can significantly speed up its execution time for large instances of the TSP. Additionally, the algorithm's use of a heuristic function to guide the search can help to avoid getting stuck in local optima, which can improve its overall performance.",
    "llama-2-7b-chat-hf_fact": [
      "The Bartender algorithm is a heuristic algorithm used to solve the Traveling Salesman Problem (TSP).",
      "The TSP is a problem in computer science and operations research that involves finding the shortest possible tour that visits a set of cities and returns to the starting city.",
      "Jack Edmonds, a computer scientist, developed the Bartender algorithm in the 1960s.",
      "The Bartender algorithm has a proven worst-case time complexity of O(n^3), where n is the number of cities in the TSP.",
      "The Bartender algorithm can be easily parallelized to significantly speed up its execution time."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: There is no record of a Bartender algorithm being used to solve the Traveling Salesman Problem (TSP). The heuristic algorithm commonly used for TSP is the Nearest Neighbor algorithm.",
      "true",
      "unknown",
      "false, [corrected fact]: The 'Bartender' algorithm does not exist, therefore it doesn't have a proven worst-case time complexity of O(n^3), as Bartender algorithm is not associated to solving TSP.",
      "false, [corrected fact]: Since the Bartender algorithm doesn't exist, it cannot be parallelized to speed up its execution time. It is agreed though that parallel computing can be beneficial in algorithmic computations depending on the algorithm used."
    ]
  },
  {
    "id": 3082,
    "user_query": "List two drugs that are included in the Akynzeo pill?",
    "llama-2-7b-chat-hf_response": "Akynzeo is a prescription medication used to treat nausea and vomiting caused by chemotherapy. The active ingredients in Akynzeo are:\n1. Netupitant\n2. Palonosetron\nNetupitant is a serotonin receptor antagonist that works by blocking the action of serotonin on the nerve cells in the gut that cause nausea and vomiting. Palonosetron is a 5-HT3 receptor antagonist that works by blocking the action of serotonin on the nerve cells in the gut that cause nausea and vomiting. Together, these two drugs help to reduce the symptoms of nausea and vomiting caused by chemotherapy.",
    "llama-2-7b-chat-hf_fact": [
      "Akynzeo is a prescription medication used to treat nausea and vomiting caused by chemotherapy.",
      "The active ingredients in Akynzeo are Netupitant and Palonosetron.",
      "Netupitant is a serotonin receptor antagonist.",
      "Palonosetron is a 5-HT3 receptor antagonist.",
      "Both Netupitant and Palonosetron work by blocking the action of serotonin on the nerve cells in the gut that cause nausea and vomiting."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3087,
    "user_query": "Safinamide is approved for treatment of which disease?",
    "llama-2-7b-chat-hf_response": "Safinamide is approved for the treatment of type 1 and type 2 diabetes. It is an oral medication that helps to improve blood sugar control by increasing insulin sensitivity and reducing glucose production in the liver. Safinamide is not approved for the treatment of any other diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Safinamide is approved for the treatment of type 1 and type 2 diabetes.",
      "Safinamide is an oral medication.",
      "Safinamide works by improving blood sugar control.",
      "The mechanism of Safinamide involves increasing insulin sensitivity.",
      "Safinamide also reduces glucose production in the liver."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Safinamide is approved for the treatment of Parkinson's disease, not diabetes.",
      "true",
      "false, [corrected fact]: Safinamide works by inhibiting monoamine oxidase B, an enzyme involved in the breakdown of dopamine in the brain. It does not directly improve blood sugar control.",
      "false, [corrected fact]: The mechanism of Safinamide involves the inhibition of monoamine oxidase B, not increasing insulin sensitivity.",
      "false, [corrected fact]: Safinamide does not reduce glucose production in the liver; its action is related to the modulation of dopamine in the brain."
    ]
  },
  {
    "id": 3091,
    "user_query": "What is the name of the Cas13 based diagnostic test for the Zika and dengue viruses?",
    "llama-2-7b-chat-hf_response": "The CRISPR-Cas13 based diagnostic test for the Zika and dengue viruses is called:\nA) Zika-Dengue-Detect\nB) Dengue-Zika-Detect\nC) CRISPR-Cas13-Zika-Dengue\nD) Cas13-Zika-Dengue\nAnswer: B) Dengue-Zika-Detect\nExplanation:\nThe CRISPR-Cas13 based diagnostic test for the Zika and dengue viruses is called Dengue-Zika-Detect. This test was developed by researchers at the University of California, San Diego, and is designed to detect both Zika and dengue viruses in a single test. The test uses a CRISPR-Cas13 system to detect the viral RNA in a patient's sample, and can provide results in as little as 30 minutes.",
    "llama-2-7b-chat-hf_fact": [
      "The CRISPR-Cas13 based diagnostic test for the Zika and dengue viruses is called Dengue-Zika-Detect.",
      "The test Dengue-Zika-Detect was developed by researchers at the University of California, San Diego.",
      "Dengue-Zika-Detect is designed to detect both Zika and dengue viruses.",
      "Dengue-Zika-Detect uses a CRISPR-Cas13 system to detect the viral RNA in a patient's sample.",
      "The Dengue-Zika-Detect test can provide results in as little as 30 minutes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3092,
    "user_query": "What are CRISPR-Cas12a proteins?",
    "llama-2-7b-chat-hf_response": "CRISPR-Cas12a proteins are a type of RNA-guided DNA endonuclease that are part of the CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) immune system found in bacteria and archaea. CRISPR-Cas12a proteins are composed of two subunits: Cas12a and a small RNA molecule called a guide RNA (gRNA). The gRNA is programmed to recognize a specific DNA sequence, and when it finds a match, the Cas12a enzyme cleaves the DNA. This can be used for a variety of applications, including gene editing, gene regulation, and the detection of specific DNA sequences.\nCRISPR-Cas12a proteins are similar to CRISPR-Cas9 proteins, which are the most well-known and widely used CRISPR system, but they have some key differences. CRISPR-Cas12a proteins are more precise and efficient than CRISPR-Cas9 proteins, and they can be used to target a wider range of DNA sequences. They are also less likely to cause off-target effects, which can be a problem with CRISPR-Cas9 proteins.\nCRISPR-Cas12a proteins have a variety of potential applications, including:\n1. Gene editing: CRISPR-Cas12a proteins can be used to make precise edits to the genome of an organism.\n2. Gene regulation: CRISPR-Cas12a proteins can be used to regulate the expression of specific genes.\n3. Detection of specific DNA sequences: CRISPR-Cas12a proteins can be used to detect the presence of specific DNA sequences in a genome.\n4. Cancer treatment: CRISPR-Cas12a proteins can be used to selectively target and kill cancer cells.\n5. Agricultural applications: CRISPR-Cas12a proteins can be used to improve crop yields, resistance to pests and diseases, and nutritional content.\n6. Gene therapy: CRISPR-Cas12a proteins can be used to treat genetic dise",
    "llama-2-7b-chat-hf_fact": [
      "CRISPR-Cas12a proteins are a type of RNA-guided DNA endonuclease that are part of the CRISPR-Cas immune system found in bacteria and archaea.",
      "CRISPR-Cas12a proteins are composed of two subunits: Cas12a and a small RNA molecule called a guide RNA (gRNA).",
      "Cas12a enzyme cleaves the DNA when the gRNA finds a match to a specific DNA sequence.",
      "CRISPR-Cas12a proteins are more precise and efficient than CRISPR-Cas9 proteins and can be used to target a wider range of DNA sequences.",
      "CRISPR-Cas12a proteins can be used for various tasks including gene editing, gene regulation, and the detection of specific DNA sequences."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: While CRISPR-Cas12a proteins have demonstrated higher specificity than CRISPR-Cas9 proteins in certain aspects, it can't be definitively stated they are more precise, efficient, or able to target a wider range of DNA sequences.",
      "true"
    ]
  },
  {
    "id": 3094,
    "user_query": "Can cardiospheres be produced from skin fibroblasts?",
    "llama-2-7b-chat-hf_response": "Yes, cardiospheres can be produced from skin fibroblasts. In fact, skin fibroblasts are a common source of cells used to generate cardiospheres. Cardiospheres are three-dimensional structures that mimic the structure and function of the heart, and they have the potential to be used for drug testing, disease modeling, and regenerative medicine.\nTo produce cardiospheres from skin fibroblasts, the following steps can be taken:\n1. Isolation of skin fibroblasts: Skin fibroblasts can be isolated from the dermis of the skin using enzymatic digestion or mechanical dissociation.\n2. Expansion of fibroblasts: The isolated fibroblasts are then cultured in a medium that promotes their proliferation. This step can take several days to a week.\n3. Induction of cardiac differentiation: Once the fibroblasts have reached a sufficient density, they are exposed to growth factors and other molecules that induce their differentiation into cardiac cells. This step can take several days to a week.\n4. Formation of cardiospheres: The induced cardiac cells are then aggregated into three-dimensional structures that resemble the heart. This step can take several days to a week.\n5. Maturation of cardiospheres: The formed cardiospheres are then allowed to mature for several days to a week to allow the cardiac cells to further differentiate and organize.\n6. Functional assessment: The mature cardiospheres are then assessed for their functional ability to contract and pump fluid, similar to the way the heart functions in the body.\nIt is important to note that the production of cardiospheres from skin fibroblasts is still a relatively new and developing field, and there are many factors that can affect the efficiency and consistency of the process. However, the potential of cardiospheres to revolutionize drug testing and disease modeling makes them an exciting area of research.",
    "llama-2-7b-chat-hf_fact": [
      "Cardiospheres can be produced from skin fibroblasts.",
      "Skin fibroblasts can be isolated from the dermis of the skin using enzymatic digestion or mechanical dissociation.",
      "Cardiospheres are three-dimensional structures that mimic the structure and function of the heart.",
      "Cardiospheres have the potential to be used for drug testing, disease modeling, and regenerative medicine.",
      "The production of cardiospheres from skin fibroblasts is a new and developing field."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Cardiospheres are not typically produced from skin fibroblasts, they are usually derived from heart tissue.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3095,
    "user_query": "What the chromsomal location of the gene that is deleted in Potocki-Shaffer syndrome?",
    "llama-2-7b-chat-hf_response": "Potocki-Shaffer syndrome is a rare genetic disorder caused by a deletion of genetic material on chromosome 16p11.2. The gene that is deleted in Potocki-Shaffer syndrome has not been identified, but it is thought to be a large gene that disrupts the expression of multiple genes in the surrounding genetic material. The deletion of this gene leads to the development of the characteristic symptoms of Potocki-Shaffer syndrome, which include intellectual disability, delayed speech and language development, seizures, and distinctive facial features.",
    "llama-2-7b-chat-hf_fact": [
      "Potocki-Shaffer syndrome is a rare genetic disorder.",
      "Potocki-Shaffer syndrome is caused by a deletion of genetic material on chromosome 16p11.2.",
      "The gene deletion in Potocki-Shaffer syndrome is believed to impact the expression of multiple surrounding genes.",
      "The deletion of this gene in Potocki-Shaffer syndrome leads to symptoms like intellectual disability, delayed speech, language development issues, and seizures.",
      "Distinctive facial features are also a characteristic symptom of Potocki-Shaffer syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3099,
    "user_query": "List features of the DOOR syndrome.",
    "llama-2-7b-chat-hf_response": "DOOR syndrome is a rare genetic disorder that affects the development of the brain and spinal cord. It is characterized by a range of symptoms, including:\n1. Developmental delays: Children with DOOR syndrome may experience delays in reaching developmental milestones, such as sitting, standing, and walking.\n2. Intellectual disability: Many individuals with DOOR syndrome have intellectual disability, which can range from mild to severe.\n3. Speech and language difficulties: Children with DOOR syndrome may have difficulty with speech and language development, including stuttering, slurred speech, and difficulty with articulation.\n4. Vision problems: Some individuals with DOOR syndrome may experience vision problems, including blurred vision, crossed eyes, and difficulty with depth perception.\n5. Hearing loss: Hearing loss is a common feature of DOOR syndrome, and can range from mild to severe.\n6. Seizures: Many individuals with DOOR syndrome experience seizures, which can be a sign of the disorder.\n7. Sleep disturbances: Children with DOOR syndrome may experience sleep disturbances, including difficulty falling asleep or staying asleep.\n8. Coordination and balance problems: Individuals with DOOR syndrome may have difficulty with coordination and balance, which can make it difficult to walk or perform other physical activities.\n9. Facial abnormalities: Some individuals with DOOR syndrome may have facial abnormalities, including a small head, narrow eyes, and a short nose.\n10. Other features: Other features of DOOR syndrome can include feeding difficulties, gastrointestinal problems, and an increased risk of infections.\nIt is important to note that not all individuals with DOOR syndrome will experience all of these features, and the severity of the disorder can vary widely between individuals. If you suspect that your child may have DOOR syndrome, it is important to consult with a healthcare professional for an accurate diagnosis and appropriate treatment.",
    "llama-2-7b-chat-hf_fact": [
      "DOOR syndrome is a rare genetic disorder that affects the development of the brain and spinal cord.",
      "Common features of DOOR syndrome include developmental delays, intellectual disability, and speech and language difficulties.",
      "Some individuals with DOOR syndrome experience vision problems and hearing loss.",
      "Seizures, sleep disturbances, and coordination and balance problems are potential symptoms of DOOR syndrome.",
      "Facial abnormalities, feeding difficulties, gastrointestinal problems, and an increased risk of infections can be features of DOOR syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-7b-chat-hf_response": "There are several web-based pedigree editors available, including:\n1. Pedigree Online: This is a popular web-based pedigree editor that allows users to create, edit, and share their family trees. It offers a range of features, including the ability to add photos, documents, and other media to your tree.\n2. Ancestry.com: Ancestry.com offers a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a vast collection of genealogical records and resources.\n3. FamilySearch: FamilySearch offers a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\n4. MyHeritage: MyHeritage offers a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\n5. GenoPro: GenoPro is a web-based pedigree editor that allows users to create and edit their family trees. It also provides a range of features, including the ability to add photos, documents, and other media to your tree.\n6. FamilyTreeMaker: FamilyTreeMaker is a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\n7. Legacy Family Tree: Legacy Family Tree is a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\n8. RootsMagic: RootsMagic is a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\n9. WeRelate: WeRelate is a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\n10. WikiTree: WikiTree is a web-based pedigree editor that allows users to create and edit their family trees. It also provides access to a range of genealogical records and resources.\nPlease note that this list is not exhaustive and there may be other web-based pedigree editors available",
    "llama-2-7b-chat-hf_fact": [
      "Pedigree Online is a web-based pedigree editor that allows users to create, edit, and share their family trees.",
      "Ancestry.com is a web-based platform that offers a pedigree editor and access to genealogical records and resources.",
      "FamilySearch is a web-based platform that offers a pedigree editor and access to genealogical records and resources.",
      "MyHeritage is a web-based platform that provides a pedigree editor and access to genealogical records and resources.",
      "GenoPro, FamilyTreeMaker, Legacy Family Tree, RootsMagic, WeRelate, and WikiTree are all web-based pedigree editors that provide access to genealogical records and resources."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Not all listed applications are web-based. GenoPro, FamilyTreeMaker, Legacy Family Tree, and RootsMagic are software that needs to be downloaded and installed, while WeRelate and WikiTree are web-based platforms. They all provide access to genealogical records and resources."
    ]
  },
  {
    "id": 3101,
    "user_query": "What is the mechanism of action of Solriamfetol?",
    "llama-2-7b-chat-hf_response": "Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, which means it works by increasing the levels of these neurotransmitters in the brain. Neurotransmitters are chemical messengers that transmit signals between neurons, and they play a crucial role in regulating various physiological and psychological processes, including mood, motivation, and cognitive function.\nSolriamfetol specifically targets the reuptake of dopamine and norepinephrine, which are two of the most important neurotransmitters involved in the regulation of motivation and reward processing. By inhibiting the reuptake of these neurotransmitters, Solriamfetol increases their levels in the synaptic cleft, which can lead to enhanced dopamine and norepinephrine signaling.\nThe mechanism of action of Solriamfetol can be broken down into several steps:\n1. Solriamfetol is absorbed into the bloodstream after oral administration and reaches the brain.\n2. Once in the brain, Solriamfetol binds to dopamine and norepinephrine transporters, which are responsible for reuptaking these neurotransmitters from the synaptic cleft.\n3. By inhibiting the reuptake of dopamine and norepinephrine, Solriamfetol increases their levels in the synaptic cleft.\n4. Enhanced levels of dopamine and norepinephrine in the synaptic cleft can lead to increased dopamine and norepinephrine signaling, which can have various effects on the brain and body, including improved motivation and reward processing.\n5. The increased dopamine and norepinephrine signaling can also lead to changes in gene expression, which can have long-lasting effects on the brain and body.",
    "llama-2-7b-chat-hf_fact": [
      "Solriamfetol is a dopamine and norepinephrine reuptake inhibitor.",
      "Neurotransmitters, such as dopamine and norepinephrine, are chemical messengers that play a crucial role in regulating physiological and psychological processes.",
      "Solriamfetol increases the levels of dopamine and norepinephrine by inhibiting their reuptake from the synaptic cleft.",
      "Solriamfetol is absorbed into the bloodstream after oral administration and then reaches the brain.",
      "The increased dopamine and norepinephrine signaling can lead to changes in gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3102,
    "user_query": "What is the difference between the nuclease Cas13a and C2c2",
    "llama-2-7b-chat-hf_response": "?\nCas13a and C2c2 are two different enzymes that belong to the CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated) system, which is a defense mechanism found in bacteria and archaea. Both Cas13a and C2c2 are RNA-guided endonucleases, meaning they cut RNA molecules, but they have different mechanisms of action and specificities.\nCas13a is a type II CRISPR-Cas system, which means it consists of two main components: a small RNA guide (called a tracrRNA) and an enzyme (called Cas13a). The tracrRNA is programmed to recognize a specific RNA target, and when it finds a match, the Cas13a enzyme cuts the target RNA. Cas13a is highly specific and can be programmed to target any RNA sequence.\nC2c2, on the other hand, is a type I CRISPR-Cas system, which means it consists of a small RNA guide (called a crRNA) and an enzyme (called C2c2). The crRNA is programmed to recognize a specific DNA sequence, and when it finds a match, the C2c2 enzyme cuts the DNA. C2c2 is less specific than Cas13a and can recognize a wider range of DNA sequences.\nIn summary, the main differences between Cas13a and C2c2 are:\n* Mechanism of action: Cas13a is a type II CRISPR-Cas system that cuts RNA, while C2c2 is a type I CRISPR-Cas system that cuts DNA.\n* Specificity: Cas13a is highly specific and can be programmed to target any RNA sequence, while C2c2 is less specific and can recognize a wider range of DNA sequences.\n* Composition: Cas13a consists of a Cas13a enzyme and a tracrRNA guide, while C2c2 consists of a C2c2 enzyme and a crRNA guide.",
    "llama-2-7b-chat-hf_fact": [
      "Cas13a and C2c2 are enzymes that belong to the CRISPR-Cas system, a defense mechanism found in bacteria and archaea.",
      "Both Cas13a and C2c2 are RNA-guided endonucleases, meaning they cut RNA molecules, but they have different mechanisms of action and specificities.",
      "Cas13a is a type II CRISPR-Cas system, consisting of a small RNA guide (tracrRNA) and the Cas13a enzyme.",
      "C2c2 is a type I CRISPR-Cas system, consisting of a small RNA guide (crRNA) and the C2c2 enzyme.",
      "The primary differences between Cas13a and C2c2 are mechanism of action, specificity and composition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Cas13a is a type VI CRISPR-Cas system, consisting of a small RNA guide (crRNA) and the Cas13a enzyme.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3103,
    "user_query": "Phlorotannin is extracted from what plant?",
    "llama-2-7b-chat-hf_response": "Phlorotannin is a type of tannin that is extracted from the bark of the white willow (Salix alba) tree. Tannins are a type of polyphenol that are known for their astringent, bitter taste and their ability to bind to proteins and other molecules. Phlorotannins are a specific type of tannin that are found in the bark of the white willow tree and are known for their antioxidant and anti-inflammatory properties.",
    "llama-2-7b-chat-hf_fact": [
      "Phlorotannin is a type of tannin that is extracted from the bark of the white willow tree.",
      "Salix alba is the scientific name of the white willow tree.",
      "Tannins are a type of polyphenol known for their astringent and bitter taste.",
      "Tannins have the ability to bind to proteins and other molecules.",
      "Phlorotannins are known for their antioxidant and anti-inflammatory properties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Phlorotannin is a type of tannin extracted from brown algae, not the white willow tree.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3104,
    "user_query": "Where are pannexins localized?",
    "llama-2-7b-chat-hf_response": "Pannexins are localized to the plasma membrane and the endoplasmic reticulum (ER) in various cell types.\n1. Plasma membrane: Pannexins are primarily localized to the plasma membrane, where they play a role in regulating the exchange of ions and small molecules between the extracellular space and the cytosol.\n2. Endoplasmic reticulum (ER): Pannexins are also localized to the ER, where they are involved in the regulation of calcium signaling and the release of neurotransmitters.\n3. Nucleus: Pannexins have been shown to be localized to the nucleus in some cell types, where they may play a role in regulating gene expression.\n4. Golgi apparatus: Pannexins have been localized to the Golgi apparatus in some cell types, where they may be involved in the regulation of protein secretion.\n5. Cytoskeleton: Pannexins have been shown to be localized to the cytoskeleton in some cell types, where they may play a role in regulating cellular dynamics and signaling.\nIn summary, pannexins are localized to various cellular compartments, including the plasma membrane, ER, nucleus, Golgi apparatus, and cytoskeleton, and play a role in regulating a variety of cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Pannexins are found in the plasma membrane and they regulate the exchange of ions and small molecules between the extracellular space and the cytosol.",
      "Pannexins are also localized to the endoplasmic reticulum (ER) and are involved in the regulation of calcium signaling and the release of neurotransmitters.",
      "In some cell types, pannexins are found in the nucleus and may play a role in regulating gene expression.",
      "Pannexins have been localized to the Golgi apparatus in some cell types, where they may regulate protein secretion.",
      "Pannexins can be found in the cytoskeleton in some cells, where they may regulate cellular dynamics and signaling."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3105,
    "user_query": "What is the mechanism of action of cariprazine?",
    "llama-2-7b-chat-hf_response": "Cariprazine is an atypical antipsychotic that works by binding to dopamine receptors in the brain. It has a high affinity for the dopamine D2 receptor and a lower affinity for the dopamine D1 receptor. By binding to these receptors, cariprazine can help to regulate the levels of dopamine in the brain, which can help to improve symptoms of psychosis, such as hallucinations and delusions. Additionally, cariprazine has been shown to have a modest affinity for the serotonin 5-HT1A receptor, which may also contribute to its therapeutic effects.",
    "llama-2-7b-chat-hf_fact": [
      "Cariprazine is an atypical antipsychotic.",
      "Cariprazine works by binding to dopamine receptors in the brain.",
      "Cariprazine has a high affinity for the dopamine D2 receptor.",
      "It has a lower affinity for the dopamine D1 receptor.",
      "Cariprazine also has a modest affinity for the serotonin 5-HT1A receptor."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-7b-chat-hf_response": "Spider-venom toxins are a diverse group of peptides and proteins found in the venom of spiders, scorpions, and other arachnids. These toxins have a wide range of biological activities, including neurotoxicity, hemotoxicity, and immunomodulation. Here are some curated databases that contain information on spider-venom toxins:\n1. ToxinDB: ToxinDB is a comprehensive database of toxins from various sources, including spider venom. It contains information on the structure, function, and pharmacology of toxins, as well as their potential therapeutic applications.\n2. SpiderVenomDB: SpiderVenomDB is a database of spider venom peptides and proteins, including their sequences, structures, and biological activities. It also contains information on the species of spiders from which the venom was derived.\n3. VenomDB: VenomDB is a database of venom peptides and proteins from various sources, including spiders, scorpions, and snakes. It contains information on the structure, function, and pharmacology of venom peptides and proteins, as well as their potential therapeutic applications.\n4. ArachnidVenomDB: ArachnidVenomDB is a database of venom peptides and proteins from arachnids, including spiders, scorpions, and ticks. It contains information on the structure, function, and pharmacology of venom peptides and proteins, as well as their potential therapeutic applications.\n5. VenomToxinDB: VenomToxinDB is a database of venom peptides and proteins from various sources, including spiders, scorpions, and snakes. It contains information on the structure, function, and pharmacology of venom peptides and proteins, as well as their potential therapeutic applications.",
    "llama-2-7b-chat-hf_fact": [
      "Spider-venom toxins are a diverse group of peptides and proteins found in the venom of spiders, scorpions, and other arachnids.",
      "ToxinDB is a comprehensive database of toxins from various sources, including spider venom.",
      "SpiderVenomDB is a database of spider venom peptides and proteins.",
      "VenomDB is a database of venom peptides and proteins from various sources, including spiders, scorpions, and snakes.",
      "ArachnidVenomDB is a database of venom peptides and proteins from arachnids, including spiders, scorpions, and ticks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3108,
    "user_query": "What is the difference between CRISPR-Cas12a and CRISPR-Cpf1?",
    "llama-2-7b-chat-hf_response": "CRISPR-Cas12a and CRISPR-Cpf1 are two different types of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) systems that are used for precision genome editing. Here are some key differences between the two:\n1. Structure: CRISPR-Cas12a is a type II CRISPR system, which means it consists of two main components: a small RNA guide (called a crRNA) that is programmed to recognize a specific DNA sequence, and an enzyme (called Cas12a) that cuts the DNA at the targeted location. CRISPR-Cpf1, on the other hand, is a type I CRISPR system, which consists of a larger RNA guide (called a tracrRNA) that is programmed to recognize a specific DNA sequence, and an enzyme (called Cpf1) that cuts the DNA at the targeted location.\n2. Target site recognition: CRISPR-Cas12a is more specific in its target site recognition than CRISPR-Cpf1. CRISPR-Cas12a recognizes a specific 20-base-pair (bp) palindromic sequence, while CRISPR-Cpf1 recognizes a broader range of target sites, including non-palindromic sequences.\n3. Cleavage mechanism: CRISPR-Cas12a uses a two-step cleavage mechanism, where the crRNA guides the Cas12a enzyme to the target site, and then the Cas12a enzyme makes a double-stranded break in the DNA. CRISPR-Cpf1, on the other hand, uses a single-step cleavage mechanism, where the tracrRNA guides the Cpf1 enzyme directly to the target site, and then the Cpf1 enzyme makes a double-stranded break in the DNA.\n4. Homology-directed repair (HDR): CRISPR-Cas12a is more efficient at inducing homology-directed repair (HDR) than CRISPR-Cpf1. HDR is a repair mechanism that uses a template to repair the broken DNA, and CRISPR-Cas12a",
    "llama-2-7b-chat-hf_fact": [
      "CRISPR-Cas12a and CRISPR-Cpf1 are different types of CRISPR systems used for precision genome editing.",
      "CRISPR-Cas12a consists of a small RNA guide (crRNA) and an enzyme (Cas12a) that targets and cuts a specific DNA sequence.",
      "CRISPR-Cpf1 consists of a larger RNA guide (tracrRNA) and an enzyme (Cpf1) that targets and cuts a specific DNA sequence.",
      "CRISPR-Cas12a is more specific in target site recognition, identifying a 20-base-pair palindromic sequence, while CRISPR-Cpf1 recognizes a broader range of target sites.",
      "CRISPR-Cas12a uses a two-step cleavage mechanism and is more efficient at inducing homology-directed repair (HDR) than CRISPR-Cpf1, which uses a single-step cleavage mechanism."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: CRISPR-Cas12a and CRISPR-Cpf1 refer to the same type of CRISPR system.",
      "true",
      "false, [corrected fact]: CRISPR-Cpf1/Cas12a consists of a small RNA guide (crRNA) and an enzyme (Cpf1/Cas12a) that targets and cuts a specific DNA sequence.",
      "false, [corrected fact]: Both CRISPR-Cas12a/Cpf1 recognize specific target sites on the DNA but the specificity does not rest on the recognition of a palindromic sequence for Cas12a or a broader range for Cpf1.",
      "true"
    ]
  },
  {
    "id": 3109,
    "user_query": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection",
    "llama-2-7b-chat-hf_response": ".\nClostridium difficile, commonly referred to as C. diff, is a type of bacteria that can cause diarrhea and colitis (inflammation of the colon). C. diff infections are a major public health concern, particularly in hospitals and long-term care facilities, where they can spread quickly among vulnerable populations.\nThere are several antitoxin antibodies that have been approved by the FDA for reducing the recurrence of C. diff infections. These include:\n1. Bezlotoxumab: This antitoxin antibody is given intravenously and works by binding to the toxin produced by C. diff, preventing it from causing damage to the gut lining. Bezlotoxumab was approved by the FDA in 2017 for the prevention of C. diff infection recurrence in adults who have had a C. diff infection in the past.\n2. Ridinazole: This antitoxin antibody is given orally and works by binding to the toxin produced by C. diff, preventing it from causing damage to the gut lining. Ridinazole was approved by the FDA in 2019 for the treatment of C. diff infections, including those that are recurrent.\nIt is important to note that these antitoxin antibodies are not a cure for C. diff infections, but they can help reduce the risk of recurrence. They are typically used in combination with other treatments, such as antibiotics and probiotics, to effectively manage C. diff infections.",
    "llama-2-7b-chat-hf_fact": [
      "Clostridium difficile, or C. diff, is a type of bacteria that can cause diarrhea and colitis.",
      "C. diff infections can spread quickly in hospitals and long-term care facilities.",
      "Bezlotoxumab is an antitoxin antibody approved by the FDA for reducing the recurrence of C. diff infections.",
      "Bezlotoxumab was approved by the FDA in 2017.",
      "Ridinazole is another antitoxin antibody approved by the FDA in 2019 for the treatment of C. diff infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Bezlotoxumab was approved by the FDA in 2016.",
      "false, [corrected fact]: Ridinilazole is an antibiotic, not an antitoxin antibody, and it is still under development and has not been approved by the FDA as of 2019."
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-7b-chat-hf_response": "Axitinib is a tyrosine kinase inhibitor that has shown promise in the treatment of various types of cancer, including pancreatic cancer. In this study, we aimed to evaluate the efficacy and safety of axitinib in patients with advanced pancreatic cancer.\nMethods:\nWe conducted a phase II, open-label, single-arm trial of axitinib in patients with advanced pancreatic cancer who had progressed after previous treatment. The primary endpoint was overall survival, and secondary endpoints included progression-free survival, objective response rate, and safety.\nResults:\nA total of 100 patients were enrolled in the study, with a median age of 63 years and a median follow-up time of 12 months. The overall survival rate at 12 months was 40%, and the median progression-free survival was 4.6 months. The objective response rate was 10%, and the disease control rate was 40%. The most common adverse events were fatigue (50%), nausea (40%), and diarrhea (30%). Grade 3 or 4 adverse events occurred in 20% of patients.\nConclusion:\nOur results suggest that axitinib may be effective in improving survival outcomes in patients with advanced pancreatic cancer, particularly those who have progressed after previous treatment. However, further studies are needed to confirm these findings and to determine the optimal dosing and combination regimens for axitinib in pancreatic cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Axitinib is a tyrosine kinase inhibitor used in the treatment of various types of cancer, including pancreatic cancer.",
      "In a phase II trial, axitinib was administered to patients with advanced pancreatic cancer who had progressed after previous treatment.",
      "A total of 100 patients were enrolled in the study of axitinib's effect on pancreatic cancer.",
      "The overall survival rate at 12 months was 40%, and the median progression-free survival was 4.6 months.",
      "The most common adverse events from using axitinib were fatigue, nausea, and diarrhea."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3112,
    "user_query": "Which Python tool has been developed for network-based stratification of tumor mutations?",
    "llama-2-7b-chat-hf_response": "Answer: The Python tool that has been developed for network-based stratification of tumor mutations is called \"Network-based Stratification of Tumor Mutations\" (NSTM). NSTM is a Python package that uses network analysis to identify clusters of mutations in cancer genomes and to stratify tumors based on the similarity of their mutational profiles.\nNSTM was developed by researchers at the University of California, Los Angeles (UCLA) and is available on GitHub. The package uses the Python programming language and the NetworkX library for network analysis.\nNSTM can be used to analyze large-scale cancer genomics data sets and to identify potential therapeutic targets for cancer treatment. It can also be used to identify biomarkers for cancer diagnosis and prognosis.\nSome of the key features of NSTM include:\n1. Clustering of mutations: NSTM uses network analysis to identify clusters of mutations in cancer genomes. These clusters can be used to identify potential therapeutic targets for cancer treatment.\n2. Stratification of tumors: NSTM can be used to stratify tumors based on the similarity of their mutational profiles. This can help to identify subtypes of cancer and to develop personalized treatment strategies.\n3. Identification of biomarkers: NSTM can be used to identify potential biomarkers for cancer diagnosis and prognosis. These biomarkers can be used to improve cancer diagnosis and treatment.\n4. Integration of multiple data types: NSTM can be used to integrate multiple types of data, including genomic, transcriptomic, and clinical data. This can help to identify potential therapeutic targets and to develop personalized treatment strategies.\nOverall, NSTM is a powerful tool for network-based stratification of tumor mutations and has the potential to improve cancer diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "The Python tool developed for network-based stratification of tumor mutations is called \"Network-based Stratification of Tumor Mutations\" (NSTM).",
      "NSTM was developed by researchers at the University of California, Los Angeles.",
      "NSTM incorporates the use of the Python programming language and the NetworkX library for network analysis.",
      "The NSTM package can be used to analyze large-scale cancer genomics data sets and identify potential therapeutic targets for cancer treatment.",
      "NSTM is capable of integrating multiple types of data, including genomic, transcriptomic, and clinical data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-7b-chat-hf_response": "MLP regulates F-actin dynamics through its interaction with the protein cofilin. MLP binds to cofilin and inhibits its ability to depolymerize F-actin filaments, leading to an increase in F-actin stability and contractility. This interaction is important for regulating cellular processes such as cell migration, cell signaling, and cell adhesion.",
    "llama-2-7b-chat-hf_fact": [
      "MLP regulates F-actin dynamics through its interaction with the protein cofilin.",
      "MLP binds to cofilin and inhibits its ability to depolymerize F-actin filaments.",
      "The interaction between MLP and cofilin increases F-actin stability and contractility.",
      "The interaction between MLP and cofilin is critical for regulating cellular processes.",
      "Some of the cellular processes regulated by MLP-and-cofilin interaction include cell migration, cell signaling, and cell adhesion."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3116,
    "user_query": "What is CVT-301?",
    "llama-2-7b-chat-hf_response": "CVT-301 is a novel, orally available, small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4). BRD4 is a key regulator of gene expression and plays a critical role in the development and progression of various cancers, including B-cell malignancies and solid tumors.\nHow does CVT-301 work?\nCVT-301 works by inhibiting the activity of BRD4, which is a member of the bromodomain and extraterminal (BET) protein family. BRD4 recognizes and binds to acetylated lysine residues on histone proteins, leading to the recruitment of other proteins that regulate gene expression. By inhibiting BRD4, CVT-301 disrupts the ability of cancer cells to regulate gene expression, leading to cell cycle arrest and apoptosis.\nWhat are the potential uses of CVT-301?\nCVT-301 is being developed as a potential treatment for various types of cancer, including B-cell malignancies and solid tumors. It has shown promising activity in preclinical studies and is currently being evaluated in clinical trials for the treatment of relapsed or refractory B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL).\nWhat are the advantages of CVT-301?\nCVT-301 has several potential advantages as a cancer therapy, including:\n1. Targeted mechanism of action: CVT-301 selectively targets the BET protein family, including BRD4, which is overexpressed in many cancers. This targeted mechanism of action may reduce the risk of off-target effects compared to traditional chemotherapy.\n2. Oral administration: CVT-301 is an orally available small molecule, which may improve patient convenience and compliance compared to intravenous administration.\n3. Potent activity: CVT-301 has shown potent activity against a wide range of cancer cell types, including those that are resistant to other therapies.\n4. Synergy with",
    "llama-2-7b-chat-hf_fact": [
      "CVT-301 is a small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4).",
      "CVT-301 works by inhibiting the activity of BRD4, disrupting the ability of cancer cells to regulate gene expression, leading to cell cycle arrest and apoptosis.",
      "CVT-301 is being developed as a potential treatment for various types of cancer, including B-cell malignancies and solid tumors.",
      "CVT-301 is currently being evaluated in clinical trials for the treatment of relapsed or refractory B-cell malignancies such as diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL).",
      "CVT-301 can be administered orally."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3117,
    "user_query": "Are there tools for visualizing and processing long-read sequencing data?",
    "llama-2-7b-chat-hf_response": "Yes, there are several tools available for visualizing and processing long-read sequencing data. Some popular tools include:\n1. IGV (Integrative Genomics Viewer): IGV is a popular tool for visualizing and analyzing long-read sequencing data, including data from technologies such as Pacific Biosciences and Oxford Nanopore. It provides a variety of tools for viewing, annotating, and analyzing long-read data.\n2. Circos: Circos is a tool for visualizing genomic data in a circular layout. It can be used to visualize long-read sequencing data, as well as other types of genomic data such as ChIP-seq and methylation data.\n3. UCSC Genome Browser: The UCSC Genome Browser is a popular tool for visualizing and analyzing genomic data. It can be used to view and analyze long-read sequencing data, as well as other types of genomic data.\n4. HISAT2: HISAT2 is a spliced aligner that can be used to align long-read sequencing data to a reference genome. It provides a variety of tools for visualizing and analyzing the aligned data.\n5. STAR: STAR is a high-performance aligner that can be used to align long-read sequencing data to a reference genome. It provides a variety of tools for visualizing and analyzing the aligned data.\n6. GSNAP: GSNAP is a long-read aligner that can be used to align long-read sequencing data to a reference genome. It provides a variety of tools for visualizing and analyzing the aligned data.\n7. Canu: Canu is a long-read aligner that can be used to align long-read sequencing data to a reference genome. It provides a variety of tools for visualizing and analyzing the aligned data.\n8. BWA-MEM: BWA-MEM is a high-performance aligner that can be used to align long-read sequencing data to a reference genome. It provides a variety of tools for visualizing and analyzing the aligned data.\n9. Bowtie 2: Bowtie 2 is a high-performance aligner that can be used to align long-read sequencing data to a reference genome.",
    "llama-2-7b-chat-hf_fact": [
      "IGV (Integrative Genomics Viewer) is a tool used for visualizing and analyzing long-read sequencing data from technologies such as Pacific Biosciences and Oxford Nanopore.",
      "Circos is a visualization tool capable of displaying genomic data in a circular layout.",
      "UCSC Genome Browser is a tool that can be utilized in visualizing and analyzing genomic data.",
      "HISAT2, GSNAP, Canu, BWA-MEM, and Bowtie 2 are aligners that can be used to align long-read sequencing data to a reference genome.",
      "BWA-MEM, Bowtie 2, and STAR are described as high-performance aligners for long-read sequencing data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: BWA-MEM and Bowtie 2 are commonly used for alignment of short-read sequencing data while STAR is typically used for RNA-seq alignment. Long-read sequencing alignment is more typically performed by tools like NGMLR and minimap2."
    ]
  },
  {
    "id": 3118,
    "user_query": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019).",
    "llama-2-7b-chat-hf_response": "Note:\n* siRNA drugs are a class of RNA interference (RNAi) therapies that work by silencing specific genes.\n* Phase 2-3 clinical trials are conducted to evaluate the safety and efficacy of a drug in a larger patient population, typically several hundred to thousands of patients.\n* This list includes siRNA drugs that have entered clinical trials for various diseases and conditions, including cancer, genetic disorders, and infectious diseases.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3119,
    "user_query": "Where is fatty acid binding protein 2 expressed?",
    "llama-2-7b-chat-hf_response": "Fatty acid binding protein 2 (FABP2) is expressed in various tissues and cells throughout the body, including:\n1. Adipose tissue: FABP2 is highly expressed in adipose tissue, where it plays a role in lipid metabolism and energy homeostasis.\n2. Brain: FABP2 is also expressed in the brain, where it may play a role in the transport of fatty acids across the blood-brain barrier.\n3. Heart: FABP2 is expressed in the heart, where it may play a role in the transport of fatty acids in the myocardium.\n4. Liver: FABP2 is expressed in the liver, where it is involved in the uptake and metabolism of fatty acids.\n5. Muscle: FABP2 is expressed in skeletal muscle, where it may play a role in the transport of fatty acids during muscle contraction.\n6. Pancreas: FABP2 is expressed in the pancreas, where it may play a role in the transport of fatty acids in insulin secretion.\n7. Retina: FABP2 is expressed in the retina, where it may play a role in the transport of fatty acids in the retinal pigment epithelium.\n8. Testis: FABP2 is expressed in the testis, where it may play a role in the transport of fatty acids in spermatogenesis.\n9. Thyroid gland: FABP2 is expressed in the thyroid gland, where it may play a role in the transport of fatty acids in thyroid hormone synthesis.\n10. Immune cells: FABP2 is also expressed in immune cells, such as macrophages and T cells, where it may play a role in the transport of fatty acids in immune function.\nIt's worth noting that the expression of FABP2 can be tissue-specific and developmental stage-specific, and its expression can also be regulated by various physiological and pathological conditions, such as obesity, diabetes, and cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Fatty acid binding protein 2 (FABP2) is expressed in adipose tissue.",
      "FABP2 is also expressed in the brain.",
      "The heart is another site where FABP2 is expressed.",
      "FABP2 is expressed in the liver and in skeletal muscle.",
      "This protein is also found in the pancreas, retina, testis, thyroid gland, and immune cells like macrophages and T cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Fatty acid binding protein 4 (FABP4), not FABP2, is expressed in adipose tissue.",
      "true",
      "true",
      "false, [corrected fact]: Fatty acid binding protein 1 (FABP1) is expressed in the liver, and Fatty acid binding protein 3 (FABP3) is expressed in skeletal muscle, not FABP2.",
      "true"
    ]
  },
  {
    "id": 3121,
    "user_query": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis",
    "llama-2-7b-chat-hf_response": ". Here are some of the computational tools that have been developed for APA site analysis:\n1. PolyA recognition element (PRE) finder: This tool uses a machine learning algorithm to identify PREs in a given RNA sequence. PREs are short sequences that are recognized by the polyadenylation machinery and are important for APA site selection.\n2. APA site predictor: This tool uses a combination of sequence features and machine learning algorithms to predict the location of APA sites in a given RNA sequence.\n3. RNAfold: This tool uses a dynamic programming algorithm to predict the secondary structure of an RNA molecule, including the location of APA sites.\n4. Infernal: This tool uses a hidden Markov model to predict the secondary structure of an RNA molecule, including the location of APA sites.\n5. RNAstructure: This tool uses a combination of dynamic programming and machine learning algorithms to predict the three-dimensional structure of an RNA molecule, including the location of APA sites.\n6. APA-site predictor 2.0: This tool uses a combination of sequence features and machine learning algorithms to predict the location of APA sites in a given RNA sequence.\n7. APA-site predictor 3.0: This tool uses a combination of sequence features and machine learning algorithms to predict the location of APA sites in a given RNA sequence.\n8. APA-site predictor 4.0: This tool uses a combination of sequence features and machine learning algorithms to predict the location of APA sites in a given RNA sequence.\n9. APA-site predictor 5.0: This tool uses a combination of sequence features and machine learning algorithms to predict the location of APA sites in a given RNA sequence.\n10. APA-site predictor 6.0: This tool uses a combination of sequence features and machine learning algorithms to predict the location of APA sites in a given RNA sequence.\nThese are some of the computational tools that have been developed for APA site analysis. Each tool has its own strengths and limitations, and the choice of tool will depend on the specific research question and the characteristics of the RNA sequence being analyzed.",
    "llama-2-7b-chat-hf_fact": [
      "PolyA recognition element (PRE) finder is a computational tool developed for APA site analysis. It uses a machine learning algorithm.",
      "APA site predictor is another computational tool developed for APA site analysis, and it utilizes a combination of sequence features and machine learning algorithms.",
      "RNAfold is a computational tool developed for APA site analysis that uses a dynamic programming algorithm to predict RNA secondary structure.",
      "Infernal, a computational tool for APA site analysis, uses a hidden Markov model to predict RNA secondary structure.",
      "RNAstructure is a computational tool developed for APA site analysis that employs a combination of dynamic programming and machine learning algorithms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: RNAfold is a computational tool developed for predicting RNA secondary structure and it uses a dynamic programming algorithm.",
      "false, [corrected fact]: Infernal is a computational tool that uses a hidden Markov model to predict RNA secondary structure, but not specifically for APA site analysis.",
      "false, [corrected fact]: RNAstructure is a computational tool developed for predicting RNA secondary structure that employs a combination of dynamic programming and thermodynamics, not machine learning algorithms."
    ]
  },
  {
    "id": 3124,
    "user_query": "Which curated data resources for ChIP-seq data are available?",
    "llama-2-7b-chat-hf_response": "There are several curated data resources available for ChIP-seq data, including:\n1. ENCODE (ENCyclopedia of DNA Elements): A collaborative project that aims to create a comprehensive catalog of all the functional elements in the human genome. ENCODE provides ChIP-seq data for a wide range of proteins and histone modifications, as well as other types of genomic data.\n2. ModENCODE (Model Organism ENCODE): A similar project to ENCODE, but focused on model organisms such as yeast, worm, and mouse. ModENCODE provides ChIP-seq data for a variety of proteins and histone modifications, as well as other types of genomic data.\n3. Roadmap Epigenomics Consortium: A collaborative project that aims to create a comprehensive map of epigenetic marks across the human genome. The Roadmap Epigenomics Consortium provides ChIP-seq data for a wide range of proteins and histone modifications, as well as other types of genomic data.\n4. HIPS (Histone Modification Interaction Project): A collaborative project that aims to create a comprehensive catalog of histone modifications and their interactions with other genomic features. HIPS provides ChIP-seq data for a wide range of histone modifications, as well as other types of genomic data.\n5. ChIP-seq Track Hub: A curated database of ChIP-seq tracks from a variety of sources, including ENCODE, ModENCODE, and other research groups. The ChIP-seq Track Hub provides a central location for accessing and comparing ChIP-seq data from different studies.\n6. ChIPseek: A database of ChIP-seq data for a wide range of proteins and histone modifications, as well as other types of genomic data. ChIPseek provides a user-friendly interface for searching and browsing ChIP-seq data, as well as tools for data analysis and visualization.\n7. Epigenome Roadmap: A database of epigenetic marks across the human genome, including ChIP-seq data for a wide range of proteins and histone modifications, as well as other types of genomic data. Epigenome Roadmap provides a user-friendly interface for searching and browsing epigenetic marks, as well as tools for",
    "llama-2-7b-chat-hf_fact": [
      "The ENCODE (ENCyclopedia of DNA Elements) project provides a comprehensive catalog of all functional elements in the human genome, including ChIP-seq data.",
      "ModENCODE, which focuses on model organisms, provides ChIP-seq data for proteins and histone modifications.",
      "The Roadmap Epigenomics Consortium provides ChIP-seq data as part of its aim to create a comprehensive map of epigenetic marks across the human genome.",
      "HIPS focuses on histone modifications and their interactions with other genomic features, and additionally provides ChIP-seq data.",
      "The ChIP-seq Track Hub is a structured database of ChIP-seq tracks gathered from various entities like ENCODE, ModENCODE, and other research groups."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-7b-chat-hf_response": "The human kinome is the set of protein kinases that are present in the human genome. Kinases are enzymes that add a phosphate group to specific amino acid residues on target proteins, a process known as phosphorylation. Phosphorylation plays a crucial role in various cellular signaling pathways and is involved in many cellular processes, including metabolism, growth, and proliferation.\nThere are approximately 500 protein kinases in the human kinome, according to a study published in the journal Nature in 2016. These kinases can be classified into different families based on their structure and function. Some of the most well-known kinases in the human kinome include:\n1. Receptor tyrosine kinases (RTKs): These kinases are involved in signaling pathways triggered by extracellular ligands, such as growth factors and hormones. Examples of RTKs include the epidermal growth factor receptor (EGFR) and the platelet-derived growth factor receptor (PDGFR).\n2. Cyclin-dependent kinases (CDKs): These kinases are involved in regulating the cell cycle and are activated by binding to cyclins. Examples of CDKs include CDK1 and CDK2.\n3. Mitogen-activated protein kinases (MAPKs): These kinases are activated by extracellular signals and phosphorylate downstream targets involved in various cellular processes, including gene expression and cell proliferation. Examples of MAPKs include ERK1/2 and JNK.\n4. Protein kinase B (PKB): Also known as Akt, this kinase is involved in cell survival and metabolism.\n5. Glycogen synthase kinase 3 (GSK3): This kinase is involved in the regulation of glycogen metabolism and is also implicated in various cellular processes, including cell signaling and the regulation of gene expression.\nThese are just a few examples of the many kinases present in the human kinome. Understanding the functions of these kinases and their roles in various cellular processes is an active area of research, as they are implicated in a wide range of diseases, including cancer, di",
    "llama-2-7b-chat-hf_fact": [
      "The human kinome is the set of protein kinases present in the human genome.",
      "Kinases are enzymes that add a phosphate group to specific amino acid residues on target proteins.",
      "Phosphorylation, a process performed by kinases, plays a crucial role in various cellular signaling pathways and processes, including metabolism, growth, and proliferation.",
      "There are approximately 500 protein kinases in the human kinome, according to a 2016 study.",
      "The functions of kinases and their roles in various cellular processes are important areas of research due to their implications in a wide range of diseases, including cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3126,
    "user_query": "What is the mechanism of action of Inclisiran?",
    "llama-2-7b-chat-hf_response": "Inclisiran is a small molecule that selectively binds to and inhibits the activity of the enzyme ATP citrate lyase (ACLY), which is involved in the de novo synthesis of cholesterol in the liver. By inhibiting ACLY, inclisiran reduces the amount of cholesterol produced in the liver, leading to lower levels of LDL-C in the blood.\nInclisiran is a potent and highly selective inhibitor of ACLY, with a Ki value of approximately 0.2 nM, indicating high affinity for the enzyme. In vitro studies have shown that inclisiran inhibits ACLY-mediated citrate conversion to isocitrate, which is the first step in the de novo cholesterol synthesis pathway. Inclisiran also inhibits the activity of other enzymes involved in cholesterol synthesis, such as HMG-CoA reductase, but to a lesser extent than ACLY.\nThe mechanism of action of inclisiran is distinct from that of other cholesterol-lowering drugs, such as statins, which inhibit HMG-CoA reductase, an enzyme upstream of ACLY in the cholesterol synthesis pathway. Inclisiran's selective inhibition of ACLY allows for a more targeted approach to lowering LDL-C levels, potentially reducing the risk of adverse effects associated with broader inhibition of cholesterol synthesis.",
    "llama-2-7b-chat-hf_fact": [
      "Inclisiran is a small molecule that inhibits the enzyme ATP citrate lyase (ACLY), which is involved in the synthesis of cholesterol in the liver.",
      "Inhibiting ACLY leads to a reduction in the amount of cholesterol produced in the liver and therefore lowers LDL-C levels in the blood.",
      "Inclisiran also inhibits the enzyme HMG-CoA reductase, though to a lesser extent than ACLY.",
      "Inclisiran's mechanism of action is different from that of other cholesterol-lowering drugs, such as statins, which mainly inhibit HMG-CoA reductase.",
      "ACLY-mediated citrate conversion to isocitrate is the first step in the de novo cholesterol synthesis pathway and is inhibited by inclisiran."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Inclisiran is a small interfering RNA molecule that inhibits the production of protein PCSK9, which plays a critical role in the regulation of LDL cholesterol.",
      "true",
      "false, [corrected fact]: Inclisiran does not inhibit the enzyme HMG-CoA reductase. It specifically targets PCSK9 production.",
      "true",
      "false, [corrected fact]: ACLY-mediated citrate conversion to acetyl-CoA is the first step in the de novo cholesterol synthesis pathway, but this process is not inhibited by inclisiran. Inclisiran targets PCSK9."
    ]
  },
  {
    "id": 3127,
    "user_query": "Which tool has been developed for visualization of non-covalent contacts?",
    "llama-2-7b-chat-hf_response": "Answer: There are several tools that have been developed for visualization of non-covalent contacts, including:\n1. PyMOL: PyMOL is a widely used molecular visualization tool that provides a range of features for visualizing non-covalent interactions, including hydrogen bonding, ionic interactions, and van der Waals interactions.\n2. ChimeraX: ChimeraX is a tool that provides a range of features for visualizing and analyzing non-covalent interactions, including hydrogen bonding, ionic interactions, and van der Waals interactions.\n3. VMD: VMD is a molecular visualization tool that provides a range of features for visualizing non-covalent interactions, including hydrogen bonding, ionic interactions, and van der Waals interactions.\n4. MODELLER: MODELLER is a tool that provides a range of features for visualizing and analyzing non-covalent interactions, including hydrogen bonding, ionic interactions, and van der Waals interactions.\n5. PyRosetta: PyRosetta is a tool that provides a range of features for visualizing and analyzing non-covalent interactions, including hydrogen bonding, ionic interactions, and van der Waals interactions.",
    "llama-2-7b-chat-hf_fact": [
      "PyMOL is a molecular visualization tool used for visualizing non-covalent interactions.",
      "ChimeraX is a tool for visualizing and analyzing non-covalent interactions.",
      "VMD is a molecular visualization tool that provides features for visualizing non-covalent interactions.",
      "MODELLER is a tool that can visualize and analyze non-covalent interactions.",
      "PyRosetta is a tool used for visualizing and analyzing non-covalent interactions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: MODELLER is a tool that is primarily used for homology or comparative modeling of protein three-dimensional structures, not specifically for visualizing and analyzing non-covalent interactions.",
      "false, [corrected fact]: PyRosetta is a tool used for protein structure prediction and design, not specifically for visualizing and analyzing non-covalent interactions."
    ]
  },
  {
    "id": 3130,
    "user_query": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "llama-2-7b-chat-hf_response": "ApoE mimetics are being investigated as a potential treatment for Alzheimer's disease. ApoE is a protein that plays a crucial role in the development and progression of Alzheimer's disease, and mimetics are molecules that mimic the structure and function of apoE. By targeting apoE, these mimetics may be able to prevent the accumulation of beta-amyloid peptides, which are a hallmark of Alzheimer's disease, and potentially slow or stop the progression of the disease.\nThere are several apoE mimetics currently being studied in clinical trials for the treatment of Alzheimer's disease, including:\n1. GSK2801: This is an oral small molecule apoE mimetic that is being developed by GlaxoSmithKline. It has shown promise in early clinical trials for its ability to reduce beta-amyloid levels in the brain and improve cognitive function in patients with mild to moderate Alzheimer's disease.\n2. BMS-986177: This is an oral small molecule apoE mimetic being developed by Bristol-Myers Squibb. It has shown potential in early clinical trials for its ability to reduce beta-amyloid levels in the brain and improve cognitive function in patients with mild to moderate Alzheimer's disease.\n3. ALZ-101: This is an intravenous apoE mimetic being developed by Alzheon. It has shown promise in early clinical trials for its ability to reduce beta-amyloid levels in the brain and improve cognitive function in patients with mild to moderate Alzheimer's disease.\nWhile these apoE mimetics show promise, it is important to note that they are still in the early stages of clinical development, and more research is needed to determine their safety and efficacy in larger, longer-term clinical trials. Additionally, it is likely that apoE mimetics will be used in combination with other therapies to treat Alzheimer's disease, rather than as a standalone treatment.\nIn summary, apoE mimetics are being investigated as a potential treatment for Alzheimer's disease by mimicking the structure and",
    "llama-2-7b-chat-hf_fact": [
      "ApoE mimetics are being investigated as a potential treatment for Alzheimer's disease.",
      "ApoE is a protein that plays a significant role in the development and progression of Alzheimer's disease.",
      "Beta-amyloid peptides accumulation is a hallmark of Alzheimer's disease.",
      "GSK2801, BMS-986177, and ALZ-101 are apoE mimetics currently being studied in clinical trials for the treatment of Alzheimer's disease.",
      "These apoE mimetics are in the early stages of clinical development, and more research is needed to determine their safety and efficacy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: ApoE mimetics under investigation currently do not include GSK2801 and BMS-986177. It is unclear if ALZ-101 is being studied.",
      "true"
    ]
  },
  {
    "id": 3135,
    "user_query": "What does Prevnar 13 consist of?",
    "llama-2-7b-chat-hf_response": "Prevnar 13 is a vaccine that protects against 13 types of bacterial infections, including:\n1. Streptococcus pneumoniae (pneumococcus)\n2. Haemophilus influenzae type b (Hib)\n3. Haemophilus parainfluenzae type b (Hib)\n4. Moraxella catarrhalis\n5. Bordetella pertussis (whooping cough)\n6. Borrelia burgdorferi (Lyme disease)\n7. Corynebacterium diphtheriae\n8. Clostridium perfringens\n9. Staphylococcus aureus\n10. Enterococcus faecalis\n11. Streptococcus agalactiae (group B strep)\n12. Neisseria meningitidis\n13. Clostridioides difficile (C. difficile)\nPrevnar 13 is given to children aged 6 weeks to 18 years as a single dose, and to adults aged 18 years and older as a two-dose series, spaced 8 weeks apart.",
    "llama-2-7b-chat-hf_fact": [
      "Prevnar 13 is a vaccine that protects against 13 types of bacterial infections.",
      "Prevnar 13 includes protection against infections such as Streptococcus pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis.",
      "The vaccine also provides protection against Bordetella pertussis, the bacterium causing whooping cough.",
      "Prevnar 13 is administered to children aged 6 weeks to 18 years as a single dose.",
      "Adults aged 18 years and older receive Prevnar 13 as a two-dose series, spaced 8 weeks apart."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Prevnar 13 provides protection against 13 types of Streptococcus pneumoniae bacteria, not against Haemophilus influenzae type b or Neisseria meningitidis.",
      "false, [corrected fact]: Prevnar 13 does not provide protection against Bordetella pertussis, the bacterium causing whooping cough.",
      "false, [corrected fact]: Prevnar 13 is given to children in a series of 4 doses, not a single dose, typically at 2 months, 4 months, 6 months, and 12-15 months of age.",
      "true"
    ]
  },
  {
    "id": 3137,
    "user_query": "What is the cause of a STAG3 truncating variant?",
    "llama-2-7b-chat-hf_response": "STAG3 is a gene that codes for a protein involved in the regulation of gene expression and cell signaling. Truncating variants in the STAG3 gene have been associated with various diseases, including cancer and neurodegenerative disorders.\nA truncating variant in the STAG3 gene occurs when there is a deletion or mutation that results in the premature termination of protein synthesis, leading to the production of a truncated or incomplete protein. This can lead to the loss of normal protein function and contribute to the development of disease.\nThe specific cause of a STAG3 truncating variant can vary depending on the location and type of mutation. Some common mechanisms that can lead to truncating variants include:\n1. Deletions: Deletions of one or more base pairs in the STAG3 gene can result in the loss of protein-coding sequences and the production of a truncated protein.\n2. Point mutations: Point mutations, such as substitutions or insertions, can also result in the production of a truncated protein by altering the reading frame of the genetic code.\n3. Chromosomal rearrangements: Chromosomal rearrangements, such as translocations or inversions, can also lead to the disruption of the STAG3 gene and the production of a truncated protein.\n4. Epigenetic modifications: Epigenetic modifications, such as DNA methylation or histone modifications, can also affect the expression of the STAG3 gene and lead to the production of a truncated protein.\nIt is important to note that the specific cause of a STAG3 truncating variant may not always be known, and the variant may be the result of a complex interplay of genetic and environmental factors.\nIn summary, a STAG3 truncating variant is caused by a deletion, point mutation, chromosomal rearrangement, or epigenetic modification that results in the premature termination of protein synthesis and the production of a truncated or incomplete protein.",
    "llama-2-7b-chat-hf_fact": [
      "The STAG3 is a gene that codes for a protein involved in the regulation of gene expression and cell signaling.",
      "When a mutation or deletion occurs in the STAG3 gene, it can lead to a truncating variant.",
      "A truncating variant results in the premature termination of protein synthesis, leading to the production of a truncated or incomplete protein which can contribute to the development of disease.",
      "Some common mechanisms that can lead to truncating variants in STAG3 gene include deletions, point mutations, chromosomal rearrangements, and epigenetic modifications.",
      "Truncating variants in the STAG3 gene have been associated with various diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3138,
    "user_query": "Which tools have been developed for computing split-networks?",
    "llama-2-7b-chat-hf_response": "Split-networks are a relatively new concept in the field of distributed computing, and as such, there are not many tools available for computing split-networks. However, there are a few tools that have been developed for this purpose:\n1. SplitNet: SplitNet is an open-source tool developed by the University of California, Los Angeles (UCLA) that allows users to compute split-networks. It provides a simple and efficient way to split a large graph into smaller subgraphs, which can then be computed independently.\n2. SplitGraph: SplitGraph is another open-source tool developed by the University of California, Berkeley that allows users to compute split-networks. It provides a flexible and scalable way to split a graph into smaller subgraphs, and it can handle large-scale graphs with millions of nodes and edges.\n3. GraphSplitting: GraphSplitting is a tool developed by the University of Oxford that allows users to compute split-networks. It provides a simple and efficient way to split a graph into smaller subgraphs, and it can handle both directed and undirected graphs.\n4. NetworkSplitting: NetworkSplitting is a tool developed by the University of California, San Diego that allows users to compute split-networks. It provides a flexible and scalable way to split a graph into smaller subgraphs, and it can handle large-scale graphs with millions of nodes and edges.\n5. DynSplits: DynSplits is a tool developed by the University of California, Los Angeles (UCLA) that allows users to compute split-networks. It provides a dynamic way to split a graph into smaller subgraphs, and it can handle both directed and undirected graphs.\nThese are some of the tools that have been developed for computing split-networks. Each tool has its own strengths and weaknesses, and the choice of which tool to use will depend on the specific needs of the user.",
    "llama-2-7b-chat-hf_fact": [
      "SplitNet, an open-source tool for computing split-networks, was developed by the University of California, Los Angeles (UCLA).",
      "The University of California, Berkeley developed SplitGraph, another tool for computing split-networks.",
      "GraphSplitting, a split-network computing tool, was developed by the University of Oxford.",
      "NetworkSplitting, a tool that allows computation of split-networks, was developed by the University of California, San Diego.",
      "DynSplits, a tool developed by University of California, Los Angeles (UCLA), is another option for computing split-networks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-7b-chat-hf_response": "ApoE mimetics are small molecules that mimic the structure and function of the apolipoprotein E (apoE) protein, which plays a crucial role in lipid metabolism and inflammation. Here are three examples of apoE mimetics:\n1. ApoE-mimetic peptides: These are short peptides that mimic the structure of apoE and have been shown to have anti-inflammatory and anti-atherosclerotic effects. For example, the peptide Gly-Arg-Gly-Asp-Ser (GRGS) has been shown to inhibit the expression of pro-inflammatory genes in macrophages and reduce atherosclerosis in mice.\n2. ApoE-mimetic small molecules: These are small molecules that mimic the structure of apoE and have been shown to have anti-inflammatory and anti-atherosclerotic effects. For example, the compound 2-methyl-1,4-naphthoquinone (2MNQ) has been shown to inhibit the expression of pro-inflammatory genes in macrophages and reduce atherosclerosis in mice.\n3. ApoE-mimetic nanoparticles: These are nanoparticles that mimic the structure of apoE and have been shown to have anti-inflammatory and anti-atherosclerotic effects. For example, the nanoparticle poly(lactic-co-glycolic acid) (PLGA) has been shown to inhibit the expression of pro-inflammatory genes in macrophages and reduce atherosclerosis in mice.",
    "llama-2-7b-chat-hf_fact": [
      "ApoE mimetics are small molecules that mimic the structure and function of the apolipoprotein E (apoE) protein.",
      "The apoE protein plays a crucial role in lipid metabolism and inflammation.",
      "ApoE-mimetic peptides, such as Gly-Arg-Gly-Asp-Ser (GRGS), mimic the structure of apoE and have demonstrated anti-inflammatory and anti-atherosclerotic effects.",
      "ApoE-mimetic small molecules, like 2-methyl-1,4-naphthoquinone (2MNQ), mimic the structure of apoE and have shown anti-inflammatory and anti-atherosclerotic effects.",
      "ApoE-mimetic nanoparticles, such as poly(lactic-co-glycolic acid) (PLGA), mimic the structure of apoE and have indicated anti-inflammatory and anti-atherosclerotic effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: ApoE-mimetic peptides, such as Ac-hE18A-NH2, mimic the structure of apoE and have demonstrated anti-inflammatory and anti-atherosclerotic effects.",
      "unknown",
      "false, [corrected fact]: ApoE-mimetic nanoparticles, like PLGAApoE, mimic the structure of apoE and have indicated anti-inflammatory and atherosclerosis inhibitory effects."
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-7b-chat-hf_response": "SAMHD1 is a protein that plays a crucial role in regulating innate immune responses to viral infections. Recent studies have shown that there are sex differences in SAMHD1 activity, with females exhibiting higher levels of SAMHD1 activity compared to males.\nOne study found that female mice had higher levels of SAMHD1 protein expression in their livers compared to males, and that this difference was associated with increased resistance to viral infection. Another study found that human females had higher levels of SAMHD1 mRNA expression in their peripheral blood mononuclear cells compared to males, and that this difference was associated with better control of HIV replication.\nThese sex differences in SAMHD1 activity may contribute to the observed differences in susceptibility to viral infections between males and females. For example, the higher levels of SAMHD1 activity in females may help to protect them against viral infections, such as HIV, which disproportionately affects males.\nIt is important to note that these sex differences in SAMHD1 activity are not absolute and can vary depending on a variety of factors, including age, genetic background, and environmental factors. Further research is needed to fully understand the mechanisms underlying these sex differences and to identify potential therapeutic targets for improving immune function in both males and females.",
    "llama-2-7b-chat-hf_fact": [
      "SAMHD1 is a protein that plays a crucial role in regulating innate immune responses to viral infections.",
      "There are sex differences in SAMHD1 activity, with females generally exhibiting higher levels of SAMHD1 activity compared to males.",
      "One study found female mice had higher levels of SAMHD1 protein expression in their livers compared to males, which was associated with increased resistance to viral infection.",
      "Another study found that human females had higher levels of SAMHD1 mRNA expression in their peripheral blood mononuclear cells compared to males, a difference associated with better control of HIV replication.",
      "The differences in SAMHD1 activity may contribute to the different levels of susceptibility to viral infections between males and females."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3144,
    "user_query": "Is the protein Asporin related to disease?",
    "llama-2-7b-chat-hf_response": "Asporin is a protein that has been identified as a potential therapeutic target for various diseases, including cancer, inflammatory disorders, and neurodegenerative diseases. Here are some of the ways in which Asporin has been implicated in disease:\n1. Cancer: Asporin has been shown to promote the growth and migration of cancer cells, and high levels of Asporin have been detected in various types of cancer, including breast, lung, and colon cancer.\n2. Inflammatory disorders: Asporin has been implicated in the development and progression of inflammatory disorders, such as rheumatoid arthritis and multiple sclerosis.\n3. Neurodegenerative diseases: Asporin has been linked to the progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n4. Cardiovascular disease: Asporin has been shown to play a role in the development and progression of cardiovascular disease, including atherosclerosis and heart failure.\n5. Metabolic disorders: Asporin has been implicated in the development and progression of metabolic disorders, such as obesity and type 2 diabetes.\n6. Autoimmune disorders: Asporin has been linked to the development and progression of autoimmune disorders, such as lupus and rheumatoid arthritis.\n7. Neurological disorders: Asporin has been implicated in the development and progression of neurological disorders, such as epilepsy and multiple sclerosis.\n8. Fetal development: Asporin has been shown to play a role in the development and growth of the fetus, and high levels of Asporin have been detected in the umbilical cord blood of newborns.\n9. Immune system: Asporin has been linked to the immune system, and high levels of Asporin have been detected in the blood of individuals with autoimmune disorders.\n10. Cancer stem cells: Asporin has been shown to promote the growth and maintenance of cancer stem cells, which are thought to be responsible for the initiation and progression of",
    "llama-2-7b-chat-hf_fact": [
      "Asporin is a protein that can contribute to various diseases.",
      "High levels of Asporin have been detected in various types of cancer including breast, lung, and colon cancer.",
      "Asporin has been implicated in the development and progression of inflammatory disorders, such as rheumatoid arthritis and multiple sclerosis.",
      "Asporin has been linked to the progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.",
      "Asporin has a role in the development and progression of metabolic disorders like obesity and type 2 diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3147,
    "user_query": "Which cells secrete lactotransferrin?",
    "llama-2-7b-chat-hf_response": "Lactotransferrin is a protein that is secreted by cells in the body, including epithelial cells, endothelial cells, and immune cells. Some of the specific cell types that secrete lactotransferrin include:\n1. Epithelial cells: Lactotransferrin is secreted by epithelial cells in the small intestine, where it plays a role in the absorption of iron from dietary sources.\n2. Endothelial cells: Lactotransferrin is also secreted by endothelial cells that line blood vessels, where it helps to regulate the immune response and prevent inflammation.\n3. Immune cells: Lactotransferrin is secreted by immune cells, such as macrophages and neutrophils, where it helps to regulate the immune response and prevent infection.\n4. Mammary gland cells: Lactotransferrin is also secreted by mammary gland cells during lactation, where it helps to protect the newborn from infection and promote the development of the immune system.\nIn summary, lactotransferrin is secreted by a variety of cells in the body, including epithelial cells, endothelial cells, immune cells, and mammary gland cells.",
    "llama-2-7b-chat-hf_fact": [
      "Lactotransferrin is a protein that is secreted by cells in the body.",
      "This protein is secreted by epithelial cells in the small intestine where it aids in the absorption of iron from dietary sources.",
      "Endothelial cells that line blood vessels also secrete lactotransferrin, where it regulates the immune response and prevents inflammation.",
      "Some immune cells like macrophages and neutrophils secrete lactotransferrin to regulate the immune response and prevent infection.",
      "Mammary gland cells during lactation secrete lactotransferrin to protect the newborn from infection and promote the development of the immune system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Endothelial cells do not secrete lactotransferrin.",
      "true",
      "true"
    ]
  },
  {
    "id": 3150,
    "user_query": "What is the function of the protein Magt1?",
    "llama-2-7b-chat-hf_response": "Magt1 is a protein that plays a crucial role in the regulation of mitochondrial dynamics, particularly in the process of mitochondrial fission. Mitochondrial fission is the process by which mitochondria are broken down into smaller fragments, which can then be recycled or degraded. Magt1 is a key regulator of this process, and it has been shown to be involved in a variety of cellular processes, including cell proliferation, differentiation, and survival.\nIn addition to its role in mitochondrial fission, Magt1 has also been implicated in the regulation of other cellular processes, including cell adhesion, migration, and invasion. It has also been shown to play a role in the development and progression of certain diseases, including cancer and neurodegenerative disorders.\nOverall, the function of Magt1 is to regulate the dynamics of mitochondria in cells, particularly in the process of mitochondrial fission. Its dysregulation has been implicated in a variety of diseases, highlighting the importance of this protein in maintaining cellular homeostasis.",
    "llama-2-7b-chat-hf_fact": [
      "Magt1 is a protein that regulates mitochondrial dynamics.",
      "The protein Magt1 plays a key role in the process of mitochondrial fission.",
      "Magt1 is involved in various cellular processes including cell proliferation, differentiation, and survival.",
      "The protein Magt1 has also been linked to the regulation of cell adhesion, migration and invasion.",
      "Dysregulation of Magt1 has been implicated in the development and progression of certain diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3152,
    "user_query": "What is the function of the transcriptional co-activator p300?",
    "llama-2-7b-chat-hf_response": "p300 is a transcriptional co-activator that plays a crucial role in regulating gene expression by modulating the activity of transcription factors. p300 is a histone acetyltransferase (HAT) that catalyzes the acetylation of histone proteins, leading to the relaxation of chromatin structure and the activation of transcription. p300 also interacts with and activates other transcription factors, such as p53 and c-Myc, to modulate their transcriptional activity. Additionally, p300 has been implicated in a variety of cellular processes, including cell proliferation, differentiation, and survival. Dysregulation of p300 has been implicated in a number of diseases, including cancer and neurological disorders.",
    "llama-2-7b-chat-hf_fact": [
      "p300 is a transcriptional co-activator that regulates gene expression.",
      "p300 functions as a histone acetyltransferase (HAT) and catalyzes the acetylation of histone proteins.",
      "The activity of p300 leads to the relaxation of chromatin structure and activates transcription.",
      "p300 interacts with and activates other transcription factors, like p53 and c-Myc.",
      "Dysregulation of p300 has been linked to diseases, including cancer and neurological disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3158,
    "user_query": "What is a mitosome?",
    "llama-2-7b-chat-hf_response": "Mitosomes are membrane-bound organelles found in some eukaryotic cells that are involved in cell signaling and the regulation of cellular processes. They are similar to organelles like mitochondria and chloroplasts in that they have their own genetic material and are capable of producing their own proteins, but they are smaller and more specialized than these organelles.\nMitosomes are thought to have evolved from a type of bacterial organelle called a plasmid, and they are found in a wide range of eukaryotic organisms, including animals, plants, and fungi. They are involved in a variety of cellular processes, including cell signaling, metabolism, and the regulation of gene expression.\nOne of the key functions of mitosomes is to produce and transport signaling molecules, such as hormones and neurotransmitters, which are involved in cell-to-cell communication. They are also involved in the regulation of metabolic pathways, such as the breakdown of glucose and the synthesis of amino acids. Additionally, mitosomes play a role in the regulation of gene expression, by controlling the activity of transcription factors and other regulatory proteins.\nMitosomes are distinct from mitochondria, which are also membrane-bound organelles found in eukaryotic cells. While mitochondria are involved in energy production and metabolism, mitosomes are focused on cell signaling and the regulation of cellular processes.\nIn summary, mitosomes are membrane-bound organelles found in eukaryotic cells that are involved in cell signaling and the regulation of cellular processes. They are similar to organelles like mitochondria and chloroplasts in that they have their own genetic material and are capable of producing their own proteins, but they are smaller and more specialized than these organelles.",
    "llama-2-7b-chat-hf_fact": [
      "Mitosomes are membrane-bound organelles found in some eukaryotic cells that are involved in cell signaling and the regulation of cellular processes.",
      "Mitosomes have their own genetic material and are capable of producing their own proteins.",
      "Mitosomes are thought to have evolved from a type of bacterial organelle called a plasmid, and they are found in a wide range of eukaryotic organisms, including animals, plants, and fungi.",
      "Mitosomes produce and transport signaling molecules, such as hormones and neurotransmitters, which are involved in cell-to-cell communication.",
      "Mitosomes are involved in the regulation of metabolic pathways, such as the breakdown of glucose and the synthesis of amino acids."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Mitosomes are membrane-bound organelles found in some eukaryotic cells that are involved in processes related to the absence of mitochondria in cells.",
      "false, [corrected fact]: Mitosomes do not have their own genetic material and are not capable of producing their own proteins.",
      "false, [corrected fact]: Mitosomes are thought to have evolved from mitochondria, and they are typically found in protozoan parasites.",
      "false, [corrected fact]: Mitosomes do not produce and transport signaling molecules, such as hormones and neurotransmitters.",
      "true"
    ]
  },
  {
    "id": 3164,
    "user_query": "What is the effect of NFIA on astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "NFIA (Nuclear Factor (erythroid-derived 2)-like 2 or NFE2L2) is a transcription factor that plays a crucial role in regulating the differentiation of various cell types, including astrocytes. Astrocytes are a type of glial cell that play a crucial role in the central nervous system (CNS), providing support and maintenance functions for neurons.\nStudies have shown that NFIA regulates the differentiation of astrocytes by modulating the expression of genes involved in astrocyte differentiation and maturation. NFIA can bind to specific DNA sequences in the promoter regions of these genes and recruit other transcription factors to activate their transcription.\nFor example, NFIA has been shown to regulate the expression of the gene encoding the astrocyte-specific marker protein GFAP (Glial Fibrillary Acidic Protein). NFIA binds to the GFAP promoter and enhances its transcription, leading to increased GFAP expression and astrocyte differentiation.\nSimilarly, NFIA has been shown to regulate the expression of other genes involved in astrocyte differentiation, such as the gene encoding the neurotrophic factor receptor TrkB (Tropomyosin Receptor Kinase B). NFIA binds to the TrkB promoter and enhances its transcription, leading to increased TrkB expression and astrocyte differentiation.\nIn addition, NFIA has been shown to regulate the expression of genes involved in the maturation of astrocytes, such as the gene encoding the glutamate transporter GLT-1 (Glutamate Transporter 1). NFIA binds to the GLT-1 promoter and enhances its transcription, leading to increased GLT-1 expression and the maturation of astrocytes.\nOverall, NFIA plays a crucial role in regulating the differentiation and maturation of astrocytes, and its dysregulation has been implicated in various neurological disorders, including brain tumors and neurodegenerative diseases.",
    "llama-2-7b-chat-hf_fact": [
      "NFIA is a transcription factor involved in the differentiation of various cell types, including astrocytes.",
      "Astrocytes are a type of glial cell that support and maintain neurons in the central nervous system.",
      "NFIA regulates the differentiation of astrocytes by modulating the expression of genes related to astrocyte differentiation and maturation.",
      "NFIA has been shown to regulate the expression of the gene encoding the astrocyte-specific marker protein GFAP.",
      "Dysregulation of NFIA has been implicated in various neurological disorders, including brain tumors and neurodegenerative diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3165,
    "user_query": "What is the mode of action for Tocilizumab?",
    "llama-2-7b-chat-hf_response": "Tocilizumab is a monoclonal antibody that works by blocking the activity of a protein called interleukin-6 (IL-6). IL-6 is a cytokine that is involved in the immune system and plays a role in the inflammatory response. Tocilizumab binds to IL-6 and prevents it from interacting with its receptors on immune cells, thereby reducing the inflammatory response.\nTocilizumab is used to treat certain conditions, including:\n* Rheumatoid arthritis (RA): Tocilizumab is used to treat moderate-to-severe RA in adults who have had an inadequate response to other disease-modifying anti-rheumatic drugs (DMARDs) or biologic agents.\n* Giant cell arteritis (GCA): Tocilizumab is used to treat GCA in adults who have had an inadequate response to corticosteroids.\n* Castleman disease: Tocilizumab is used to treat Castleman disease in adults and children aged 12 years and older who have had an inadequate response to corticosteroids.\nThe mode of action of tocilizumab is to block the activity of IL-6, which is involved in the inflammatory response. By blocking the activity of IL-6, tocilizumab reduces the inflammatory response and can help to improve symptoms in conditions such as RA, GCA, and Castleman disease.",
    "llama-2-7b-chat-hf_fact": [
      "Tocilizumab is a monoclonal antibody that works by blocking the activity of a protein called interleukin-6 (IL-6).",
      "IL-6 is a cytokine that is involved in the immune system and plays a role in the inflammatory response.",
      "Tocilizumab is used to treat moderate-to-severe Rheumatoid Arthritis in adults who have had an inadequate response to other disease-modifying anti-rheumatic drugs.",
      "Tocilizumab is also used to treat Giant Cell Arteritis and Castleman disease in adults and children aged 12 years and older who have had an inadequate response to corticosteroids.",
      "The mode of action of Tocilizumab is to block the activity of IL-6, thereby reducing the inflammatory response."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3166,
    "user_query": "Where is the protein protamine 2 expressed?",
    "llama-2-7b-chat-hf_response": "Protamine 2 is a protein that is expressed in the male reproductive system, particularly in the testes. It is a type of protamine, which is a family of proteins that are involved in the regulation of chromatin structure and gene expression. Protamine 2 is specifically expressed in the cytoplasm of spermatids, which are immature sperm cells that are produced in the testes during spermatogenesis.\nProtamine 2 plays a crucial role in the process of spermatogenesis, as it helps to regulate the expression of genes involved in sperm maturation and fertility. It is also involved in the packaging of DNA into the sperm nucleus, and helps to protect the genetic material from damage during the process of meiosis.\nIn addition to its role in the male reproductive system, protamine 2 has also been implicated in the development and progression of certain cancers, including prostate cancer. Further research is needed to fully understand the role of protamine 2 in these processes and to identify potential therapeutic targets for the treatment of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Protamine 2 is a protein that expresses in the male reproductive system, specifically in the testes.",
      "Protamine 2 is expressed in the cytoplasm of spermatids.",
      "Spermatids are immature sperm cells that are produced in the testes during spermatogenesis.",
      "Protamine 2 helps regulate the expression of genes involved in sperm maturation and fertility.",
      "Protamine 2 has been implicated in the development and progression of certain cancers, including prostate cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3173,
    "user_query": "Can prevnar 13 be used in children?",
    "llama-2-7b-chat-hf_response": "Yes, PREVNAR 13 can be used in children. The vaccine has been studied in children as young as 6 months old, and it has been shown to be safe and effective in this age group. In fact, the Centers for Disease Control and Prevention (CDC) recommend that children receive the HPV vaccine at age 11-12 years old, before they become sexually active.\nHowever, it's important to note that the vaccine is most effective when given before a person becomes sexually active, as it can prevent HPV infections that can lead to cervical, vulvar, vaginal, penile, and anal cancers, as well as genital warts. If you have a child who is older than 11-12 years old, they may still benefit from getting the vaccine, but it may not be as effective in preventing HPV infections.\nIt's also important to talk to your child's doctor or healthcare provider about any concerns you may have about the vaccine, including its safety and effectiveness in children. They can provide you with more information and help you make an informed decision about whether the vaccine is right for your child.",
    "llama-2-7b-chat-hf_fact": [
      "PREVNAR 13 can be used in children.",
      "PREVNAR 13 has been studied in children as young as 6 months old.",
      "The vaccine has been shown to be safe and effective in children.",
      "The Centers for Disease Control and Prevention recommends that children receive the HPV vaccine at age 11-12 years old.",
      "The HPV vaccine can prevent HPV infections that can lead to cervical, vulvar, vaginal, penile, and anal cancers, as well as genital warts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3174,
    "user_query": "Was stelara developed by Amgen?",
    "llama-2-7b-chat-hf_response": "No, Stelara (ustekinumab) was developed by Janssen Pharmaceuticals, which is a subsidiary of Johnson & Johnson. Stelara was first approved by the US Food and Drug Administration (FDA) in 2009 for the treatment of moderate-to-severe plaque psoriasis, and has since been approved for the treatment of psoriatic arthritis, Crohn's disease, and ulcerative colitis. Amgen is a separate pharmaceutical company that specializes in developing and commercializing therapeutic drugs, but it is not involved in the development of Stelara.",
    "llama-2-7b-chat-hf_fact": [
      "Stelara (ustekinumab) was developed by Janssen Pharmaceuticals.",
      "Janssen Pharmaceuticals is a subsidiary of Johnson & Johnson.",
      "The US Food and Drug Administration approved Stelara in 2009 for the treatment of moderate-to-severe plaque psoriasis.",
      "Stelara has been approved for the treatment of psoriatic arthritis, Crohn's disease, and ulcerative colitis.",
      "Amgen is a pharmaceutical company that specializes in developing and commercializing therapeutic drugs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3178,
    "user_query": "What is the cause of Krabbe disease?",
    "llama-2-7b-chat-hf_response": "Krabbe disease is caused by a genetic mutation in the GALC gene, which codes for the enzyme galactocerebrosidase. This enzyme plays a crucial role in the breakdown and recycling of certain fats in the body, including galactocerebroside. When the GALC gene is mutated, the body is unable to produce functional galactocerebrosidase, leading to the accumulation of toxic substances in the brain and other tissues.\nThe mutation can occur spontaneously or be inherited from one or both parents. The inheritance pattern of Krabbe disease is autosomal recessive, which means that a child must inherit two copies of the mutated gene, one from each parent, in order to develop the disease.\nThere is currently no cure for Krabbe disease, and treatment is focused on managing the symptoms and slowing the progression of the disease. Bone marrow transplantation has been shown to be effective in some cases, but it is not a cure and is not available for all patients. Enzyme replacement therapy, which involves replacing the missing enzyme with a synthetic version, is also being studied as a potential treatment for Krabbe disease.",
    "llama-2-7b-chat-hf_fact": [
      "Krabbe disease is caused by a mutation in the GALC gene.",
      "The GALC gene codes for the enzyme galactocerebrosidase.",
      "The mutation in the GALC gene can either occur spontaneously or be inherited from one or both parents.",
      "The inheritance pattern of Krabbe disease is autosomal recessive.",
      "There is currently no cure for Krabbe disease and treatment focuses on symptom management and disease progression slowing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3182,
    "user_query": "What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome",
    "llama-2-7b-chat-hf_response": "?\nNoonan syndrome is an autosomal dominant developmental disorder that affects approximately 1 in 1,000 to 1 in 2,500 individuals worldwide. The disorder is characterized by a range of physical and developmental abnormalities, including:\n1. Short stature: Individuals with Noonan syndrome typically have short stature, with an average height of around 4 feet 6 inches (137 cm) in adults.\n2. Facial dysmorphism: Noonan syndrome is characterized by a distinctive facial appearance, including a broad forehead, widely spaced eyes, a short nose, and a small lower jaw.\n3. Heart defects: Many individuals with Noonan syndrome have heart defects, such as ventricular septal defect (VSD), atrial septal defect (ASD), or tetralogy of Fallot.\n4. Skeletal abnormalities: Noonan syndrome can cause a range of skeletal abnormalities, including scoliosis, kyphosis, and other spinal deformities.\n5. Neurological problems: Some individuals with Noonan syndrome may experience neurological problems, such as developmental delays, intellectual disability, and seizures.\n6. Eye abnormalities: Noonan syndrome can cause a range of eye abnormalities, including cataracts, glaucoma, and retinal detachment.\n7. Hearing loss: Some individuals with Noonan syndrome may experience hearing loss or deafness.\n8. Dental abnormalities: Noonan syndrome can cause a range of dental abnormalities, including small teeth, widely spaced teeth, and other dental defects.\n9. Increased risk of cancer: Individuals with Noonan syndrome have an increased risk of developing certain types of cancer, including leukemia, lymphoma, and Wilms tumor.\n10. Other abnormalities: Noonan syndrome can also cause a range of other abnormalities, including growth delays, delayed speech and language development, and social and emotional challenges.\nIt's important to note that",
    "llama-2-7b-chat-hf_fact": [
      "Noonan syndrome is an autosomal dominant developmental disorder that affects approximately 1 in 1,000 to 1 in 2,500 individuals worldwide.",
      "Individuals with Noonan syndrome often exhibit short stature, with an average adult height of around 4 feet 6 inches.",
      "Many individuals with Noonan syndrome have heart defects, such as ventricular septal defect, atrial septal defect, or tetralogy of Fallot.",
      "Noonan syndrome can cause various skeletal abnormalities, including scoliosis, kyphosis, and other spinal deformities.",
      "Individuals with Noonan syndrome have an increased risk of developing certain types of cancer, including leukemia, lymphoma, and Wilms tumor."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3186,
    "user_query": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "llama-2-7b-chat-hf_response": "There are several anti-amyloid antibodies that are currently being investigated as potential treatments for Alzheimer's disease. Some of these antibodies are in various stages of clinical trials, while others have already been approved for use in other conditions. Here are some examples:\n1. Aducanumab: Aducanumab is an anti-amyloid antibody that is being developed by Biogen and Eisai. It is currently in Phase 3 clinical trials for the treatment of early Alzheimer's disease.\n2. Gantenerumab: Gantenerumab is another anti-amyloid antibody that is being developed by Roche. It is currently in Phase 3 clinical trials for the treatment of early Alzheimer's disease.\n3. Immunotherapy with anti-amyloid antibodies: Immunotherapy with anti-amyloid antibodies is being investigated as a potential treatment for Alzheimer's disease. This approach involves using antibodies to target and remove amyloid-beta from the brain, with the goal of slowing or stopping the progression of the disease.\n4. Aducanumab: Aducanumab is an anti-amyloid antibody that is being developed by Biogen and Eisai. It is currently in Phase 3 clinical trials for the treatment of early Alzheimer's disease.\n5. BAN2401: BAN2401 is an anti-amyloid antibody that is being developed by Biogen and Ionis Pharmaceuticals. It is currently in Phase 3 clinical trials for the treatment of early Alzheimer's disease.\nIt's important to note that while these anti-amyloid antibodies have shown promise in clinical trials, they are not yet approved for use in Alzheimer's disease. More research is needed to fully understand their safety and effectiveness before they can be approved for use in patients.",
    "llama-2-7b-chat-hf_fact": [
      "Aducanumab is an anti-amyloid antibody being developed by Biogen and Eisai for the treatment of early Alzheimer's disease.",
      "Aducanumab is currently in Phase 3 clinical trials.",
      "Gantenerumab is another anti-amyloid antibody being developed by Roche for early Alzheimer's disease treatment.",
      "Gantenerumab is in Phase 3 clinical trials.",
      "BAN2401, an anti-amyloid antibody being developed by Biogen and Ionis Pharmaceuticals, is in Phase 3 clinical trials for early Alzheimer's disease treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: As of 2021, Aducanumab has received FDA approval for the treatment of Alzheimer's disease.",
      "true",
      "true",
      "false, [corrected fact]: BAN2401, an anti-amyloid antibody being developed by Biogen and Eisai, is in Phase 3 clinical trials for early Alzheimer's disease treatment."
    ]
  },
  {
    "id": 3192,
    "user_query": "List places in the body where somatostatin is produced.",
    "llama-2-7b-chat-hf_response": "Somatostatin is a hormone that is produced in several locations throughout the body. Here are some of the main places where somatostatin is produced:\n1. Pancreas: The pancreas is the primary site of somatostatin production. Somatostatin-producing cells in the pancreas, known as somatostatin-producing delta cells, are found in the islets of Langerhans.\n2. Brain: Somatostatin is also produced in the brain, particularly in the hypothalamus, cerebral cortex, and cerebellum.\n3. Gastrointestinal tract: Somatostatin is produced in the lining of the gastrointestinal tract, including the stomach, small intestine, and large intestine.\n4. Liver: Somatostatin-producing cells are found in the liver, particularly in the liver's parenchyma.\n5. Kidneys: Somatostatin is produced in the kidneys, particularly in the distal convoluted tubules and collecting ducts.\n6. Adrenal glands: Somatostatin is produced in the adrenal glands, particularly in the zona fasciculata.\n7. Thyroid gland: Somatostatin is produced in the thyroid gland, particularly in the follicular cells.\n8. Skin: Somatostatin is produced in the skin, particularly in the sweat glands and hair follicles.\n9. Muscles: Somatostatin is produced in skeletal muscles, particularly in the muscle fibers.\n10. Immune cells: Somatostatin is produced in some immune cells, such as T cells and B cells.\nIt's worth noting that while somatostatin is produced in these locations, its function can vary depending on the specific location and cell type.",
    "llama-2-7b-chat-hf_fact": [
      "Somatostatin is a hormone produced in several locations throughout the body.",
      "The pancreas, specifically the Islets of Langerhans, is a primary site of somatostatin production.",
      "Regions in the brain such as the hypothalamus, cerebral cortex, and cerebellum produce somatostatin.",
      "Somatostatin is produced in the lining of the gastrointestinal tract, including the stomach, small intestine, and large intestine.",
      "Somatostatin is also produced in the liver, kidneys, adrenal glands, thyroid gland, skin, muscles, and in some immune cells such as T cells and B cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: While somatostatin is indeed produced in the liver and the lining of the gastrointestinal tract, its production is not typically associated with kidneys, adrenal glands, thyroid gland, skin, muscles, T cells and B cells."
    ]
  },
  {
    "id": 3195,
    "user_query": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?",
    "llama-2-7b-chat-hf_response": "According to a study published in the Journal of Immunology, breast milk contains three types of immunoglobulin heavy chain (IgH) containing antibodies:\n1. IgH1: This is the most abundant type of IgH antibody in breast milk, accounting for approximately 70% of all IgH antibodies.\n2. IgH2: This type of IgH antibody is found in lower levels than IgH1, accounting for approximately 20% of all IgH antibodies.\n3. IgH3: This is the least abundant type of IgH antibody in breast milk, accounting for approximately 10% of all IgH antibodies.\nThese three types of IgH antibodies in breast milk are thought to play a role in protecting infants from infections and may also contribute to the development of the infant's immune system.",
    "llama-2-7b-chat-hf_fact": [
      "There are three types of immunoglobulin heavy chain containing antibodies found in human breast milk: IgH1, IgH2, and IgH3.",
      "IgH1 is the most abundant type of IgH antibody in breast milk, accounting for approximately 70% of all IgH antibodies.",
      "IgH2 accounts for approximately 20% of all IgH antibodies found in breast milk.",
      "IgH3 is the least abundant type of IgH antibody in breast milk, making up approximately 10% of all IgH antibodies.",
      "These IgH antibodies are believed to protect infants from infections and contribute to the development of the infant's immune system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: There are three types of immunoglobulin containing antibodies found in human breast milk: IgA, IgG, and IgM.",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3196,
    "user_query": "What is a exposome?",
    "llama-2-7b-chat-hf_response": "The exposome refers to the totality of all exposures that an individual experiences throughout their lifetime, including both environmental and social exposures. It encompasses a wide range of factors that can influence an individual's health, including:\n* Air pollution\n* Water quality\n* Food and diet\n* Lifestyle behaviors (e.g., physical activity, smoking)\n* Social and economic factors (e.g., income, education)\n* Noise exposure\n* Radiation exposure\n* Chemical exposures (e.g., pesticides, heavy metals)\nThe exposome is distinct from the genome, which refers to an individual's genetic makeup, and the microbiome, which refers to the collection of microorganisms that inhabit an individual's body. While the genome and microbiome can influence an individual's health, the exposome plays a critical role in determining an individual's exposure to environmental and social factors that can impact health.",
    "llama-2-7b-chat-hf_fact": [
      "The exposome includes all exposures an individual experiences throughout their lifetime, encompassing both environmental and social factors.",
      "Factors that make up the exposome include air pollution, water quality, food and diet, lifestyle behaviors, social and economic factors, noise exposure, radiation exposure and chemical exposures.",
      "The exposome, genome, and microbiome are distinct from each other.",
      "The genome refers to an individual's genetic makeup.",
      "The microbiome refers to the collection of microorganisms that inhabit an individual's body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3202,
    "user_query": "Which gene therapy treatment is FDA approved for retinal dystrophy?",
    "llama-2-7b-chat-hf_response": "The FDA has approved gene therapy treatments for several types of retinal dystrophy, including:\n1. Luxturna (voretigene neparvovec): This gene therapy is approved for the treatment of Leber congenital amaurosis (LCA), a rare and inherited form of blindness. Luxturna works by replacing the faulty RPE65 gene with a healthy copy of the gene, which helps to restore vision in people with LCA.\n2. Eylea (aflibercept): While not a gene therapy, Eylea is approved for the treatment of wet age-related macular degeneration (AMD), a leading cause of vision loss in older adults. Eylea works by blocking the growth of new blood vessels under the retina, which can cause vision loss in AMD.\n3. Spinraza (nusinersen): This gene therapy is approved for the treatment of spinal muscular atrophy (SMA), a genetic disorder that affects muscle strength and movement. Spinraza works by replacing the faulty survival motor neuron 1 (SMN1) gene with a healthy copy of the gene, which helps to restore muscle function in people with SMA.\n4. Zolgensma (onasemnogene abeparvovec): This gene therapy is approved for the treatment of spinal muscular atrophy (SMA), a genetic disorder that affects muscle strength and movement. Zolgensma works by replacing the faulty survival motor neuron 1 (SMN1) gene with a healthy copy of the gene, which helps to restore muscle function in people with SMA.\nIt's important to note that these treatments are not a cure for retinal dystrophy, but they can help to slow down or halt the progression of the disease, and in some cases, improve vision.",
    "llama-2-7b-chat-hf_fact": [
      "The FDA has approved a gene therapy treatment called Luxturna for the treatment of Leber congenital amaurosis.",
      "Luxturna works by replacing the faulty RPE65 gene with a healthy copy.",
      "Eylea, approved for the treatment of wet age-related macular degeneration, works by blocking the growth of new blood vessels under the retina.",
      "Spinraza and Zolgensma are FDA approved gene therapies for the treatment of spinal muscular atrophy.",
      "Both Spinraza and Zolgensma work by replacing the faulty survival motor neuron 1 gene with a healthy copy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Spinraza and Zolgensma work by increasing the production of the survival motor neuron protein, not by replacing a faulty gene. Specifically, Spinraza modifies the splicing of a secondary gene to increase the production of survival motor neuron protein, and Zolgensma delivers a fully functional copy of the SMN1 gene."
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "RUNX2 (Runt-related transcription factor 2) is a transcription factor that has been shown to play a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival. Recent studies have suggested that RUNX2 may also play a role in the regulation of astrocyte differentiation.\nAstrocytes are a type of glial cell that are found in the central nervous system (CNS) and play a crucial role in maintaining the homeostasis of the CNS. They are involved in various processes, including the regulation of the blood-brain barrier, the clearance of neurotransmitters, and the modulation of synaptic activity.\nStudies have shown that RUNX2 inhibits the differentiation of astrocytes in vitro and in vivo. For example, one study found that overexpression of RUNX2 inhibited the expression of astrocyte-specific genes, such as glial fibrillary acidic protein (GFAP), in mouse embryonic stem cells (ESCs) (1). Another study found that RUNX2 knockdown in human astrocytes led to an increase in GFAP expression and the formation of astrocyte-like cells (2).\nThe mechanisms by which RUNX2 inhibits astrocyte differentiation are not fully understood, but it is thought to involve the regulation of gene expression. RUNX2 has been shown to bind to specific DNA sequences and recruit other transcription factors to regulate the expression of target genes. In the context of astrocyte differentiation, RUNX2 may repress the expression of genes involved in astrocyte differentiation and promote the expression of genes involved in other cellular processes.\nIn conclusion, RUNX2 has been shown to inhibit astrocyte differentiation in vitro and in vivo. The mechanisms by which RUNX2 regulates astrocyte differentiation are complex and involve the regulation of gene expression. Further research is needed to fully understand the role of RUNX2 in the regulation of astrocyte differentiation and its implications for the development and function of the CNS.\nReferences:\n1. Kim, J. et al. (201",
    "llama-2-7b-chat-hf_fact": [
      "RUNX2 (Runt-related transcription factor 2) is a transcription factor involved in various cellular processes like cell proliferation, differentiation, and survival.",
      "Astrocytes are a type of glial cell found in the central nervous system involved in maintaining homeostasis of the CNS.",
      "RUNX2 has been shown to inhibit the differentiation of astrocytes in vitro and in vivo.",
      "Studies have shown that overexpression of RUNX2 can inhibit the expression of astrocyte-specific genes, such as glial fibrillary acidic protein (GFAP), in mouse embryonic stem cells.",
      "RUNX2 is thought to regulate gene expression by binding to specific DNA sequences and recruiting other transcription factors to regulate the expression of target genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-7b-chat-hf_response": "The Cobb-Stansby excision arthroplasty is a surgical procedure that involves the excision of a portion of bone from the distal end of the humerus (upper arm bone) and the proximal end of the radius (lower arm bone). This procedure is typically performed to treat advanced bone cancer that has spread to the bones of the upper or lower arm.\nThe Cobb-Stansby excision arthroplasty is usually performed under general anesthesia and involves the following steps:\n1. Preparation: The patient is given general anesthesia and is positioned on their back on the operating table.\n2. Incision: An incision is made in the skin over the affected arm, usually starting at the shoulder and extending down to the elbow.\n3. Dissection: The surgeon dissects the soft tissues to expose the bone.\n4. Excision: The surgeon removes a portion of bone from the distal end of the humerus and the proximal end of the radius.\n5. Reconstruction: The surgeon reconstructs the bone using a bone graft or a prosthetic implant.\n6. Closure: The incision is closed with sutures or staples, and the arm is immobilized in a splint to allow the bone to heal.\nIt is important to note that the Cobb-Stansby excision arthroplasty is a complex surgical procedure that requires a skilled and experienced orthopedic surgeon. The procedure is typically performed in a hospital setting, and the patient may require several weeks of recovery time before they can return to their normal activities.",
    "llama-2-7b-chat-hf_fact": [
      "The Cobb-Stansby excision arthroplasty is a surgical procedure involving the removal of a portion of bone from the humerus and the radius.",
      "This procedure is done to treat advanced bone cancer that has spread to the bones of the arm.",
      "The operation includes multiple steps such as preparation, incision, dissection, excision, reconstruction and final closure.",
      "The surgery typically requires the patient to be under general anesthesia.",
      "The procedure is usually performed by an experienced orthopedic surgeon in a hospital setting."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3213,
    "user_query": "What is a lipin 1 protein doing?",
    "llama-2-7b-chat-hf_response": "Lipin 1 is a protein that plays a crucial role in regulating lipid metabolism and energy homeostasis. It is a key component of the lipin protein family, which consists of three members: lipin 1, lipin 2, and lipin 3. Each member of the lipin protein family has distinct functions and overlapping roles in regulating lipid metabolism and energy homeostasis.\nLipin 1 is primarily involved in the regulation of lipid synthesis and storage, particularly in the liver and adipose tissue. It regulates the expression of genes involved in lipid metabolism, such as lipogenic enzymes and lipolytic enzymes, and also modulates the activity of these enzymes. Lipin 1 also plays a role in the regulation of glucose metabolism, as it interacts with the insulin signaling pathway and regulates the expression of genes involved in glucose uptake and storage.\nIn addition to its role in lipid and glucose metabolism, lipin 1 has been implicated in the regulation of inflammation and immune response. It has been shown to inhibit the activity of pro-inflammatory cytokines and promote the production of anti-inflammatory cytokines, suggesting that lipin 1 may play a role in regulating the immune response.\nDysregulation of lipin 1 has been implicated in a number of metabolic disorders, including obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). For example, studies have shown that lipin 1 knockout mice are more susceptible to diet-induced obesity and insulin resistance, and that lipin 1 overexpression in adipose tissue can improve insulin sensitivity and reduce liver inflammation in mice with NAFLD.\nOverall, lipin 1 plays a crucial role in regulating lipid and glucose metabolism, as well as inflammation and immune response. Dysregulation of lipin 1 has been implicated in a number of metabolic disorders, highlighting the importance of this protein in maintaining metabolic homeost",
    "llama-2-7b-chat-hf_fact": [
      "Lipin 1 is a protein that regulates lipid metabolism and energy homeostasis.",
      "The lipin protein family consists of three members: lipin 1, lipin 2, and lipin 3.",
      "Lipin 1 is involved in the regulation of lipid synthesis and storage in the liver and adipose tissue.",
      "Lipin 1 has a role in regulating glucose metabolism and interacts with the insulin signaling pathway.",
      "Dysregulation of lipin 1 has been implicated in metabolic disorders, including obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3215,
    "user_query": "What protein is recruited by Crumbs to regulate tracheal development?",
    "llama-2-7b-chat-hf_response": "Crumbs (Crbs) is a transcription factor that plays a crucial role in regulating tracheal development in Drosophila. Crbs recruits and regulates the expression of several proteins involved in tracheal development, including:\n1. E-cadherin: E-cadherin is a cell adhesion molecule that is involved in cell-cell adhesion and is required for proper tracheal development. Crbs regulates the expression of E-cadherin in the tracheal primordium, and E-cadherin is necessary for the proper formation of the tracheal primordium.\n2. N-cadherin: N-cadherin is another cell adhesion molecule that is involved in cell-cell adhesion and is required for proper tracheal development. Crbs regulates the expression of N-cadherin in the tracheal primordium, and N-cadherin is necessary for the proper formation of the tracheal primordium.\n3. Bone morphogenetic protein (BMP): BMP is a signaling molecule that is involved in the regulation of tracheal development. Crbs regulates the expression of BMP in the tracheal primordium, and BMP is necessary for the proper formation of the tracheal primordium.\n4. Twist: Twist is a transcription factor that is involved in the regulation of tracheal development. Crbs regulates the expression of Twist in the tracheal primordium, and Twist is necessary for the proper formation of the tracheal primordium.\n5. T-box proteins: T-box proteins are transcription factors that are involved in the regulation of tracheal development. Crbs regulates the expression of T-box proteins in the tracheal primordium, and T-box proteins are necessary for the proper formation of the tracheal primordium.\nIn summary, Crbs recruits and regulates the expression of several proteins involved in tracheal development, including E-cadherin, N-cadherin, BMP, Twist, and T-box proteins. These proteins are necessary for the proper formation of the tracheal prim",
    "llama-2-7b-chat-hf_fact": [
      "Crumbs (Crbs) is a transcription factor that regulates tracheal development in Drosophila.",
      "Crbs recruits and regulates the expression of protein E-cadherin which is involved in cell-cell adhesion and required for proper tracheal development.",
      "Protein N-cadherin, another cell adhesion molecule required for tracheal development, is also regulated by Crbs.",
      "The expression of Bone Morphogenetic Protein (BMP) in the tracheal primordium is regulated by Crbs.",
      "Crbs also recruits and regulates the expression of Twist, a transcription factor necessary for the proper formation of the tracheal primordium.",
      "The expression of T-box proteins, necessary for the proper formation of the tracheal primordium, is also regulated by Crbs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3223,
    "user_query": "Name three binding partners of cofilin 2.",
    "llama-2-7b-chat-hf_response": "Three binding partners of cofilin 2 are:\n1. Actin filaments: Cofilin 2 binds to actin filaments and regulates their dynamics by promoting depolymerization and inhibiting polymerization.\n2. Profilin: Cofilin 2 interacts with profilin, another actin-binding protein, to modulate actin dynamics and filament organization.\n3. GTPase activating proteins (GAPs): Cofilin 2 interacts with GAPs, which are enzymes that hydrolyze GTP to activate downstream signaling proteins, and regulates their activity to modulate actin dynamics.",
    "llama-2-7b-chat-hf_fact": [
      "Cofilin 2 binds to actin filaments and regulates their dynamics.",
      "Profilin is a binding partner of cofilin 2.",
      "Cofilin 2 interacts with profilin to modulate actin dynamics and filament organization.",
      "GTPase activating proteins (GAPs) are binding partners of cofilin 2.",
      "Cofilin 2 interacts with GAPs to modulate actin dynamics by regulating their activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Profilin is not a binding partner of cofilin 2, but it is involved in actin dynamics through its interaction with actin monomers.",
      "false, [corrected fact]: Cofilin 2 does not directly interact with profilin to modulate actin dynamics. Both have roles in regulating actin dynamics but their interaction is not direct.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3224,
    "user_query": "What is the function of GvpA?",
    "llama-2-7b-chat-hf_response": "GvpA is a protein found in the outer membrane of Gram-negative bacteria, including Escherichia coli. It plays a crucial role in the transport of virulence factors across the outer membrane and is involved in the pathogenesis of several bacterial infections. GvpA has been shown to be involved in the transport of toxins, adhesins, and other virulence factors, and its dysfunction has been implicated in the development of certain bacterial infections.",
    "llama-2-7b-chat-hf_fact": [
      "GvpA is a protein found in the outer membrane of Gram-negative bacteria.",
      "The protein is present in Escherichia coli.",
      "GvpA plays a role in the transport of virulence factors across the outer membrane.",
      "The protein is involved in the pathogenesis of several bacterial infections.",
      "GvpA aids in the transport of toxins, adhesins, and other virulence factors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3225,
    "user_query": "What is a SMR based BCI?",
    "llama-2-7b-chat-hf_response": "A SMR (Sensory Motor Rhythm) based BCI (Brain-Computer Interface) is a type of brain-computer interface that utilizes the sensory motor rhythm (SMR) to communicate with the brain. SMR is a neural oscillation that occurs at a frequency of approximately 13-15 Hz and is associated with the synchronized activity of sensory and motor cortices.\nIn an SMR-based BCI, electroencephalography (EEG) or other neuroimaging techniques are used to measure the SMR activity in the brain. The SMR signal is then analyzed and decoded using machine learning algorithms to extract information about the user's intentions or cognitive state. The decoded information is then used to control a device, such as a computer cursor or a robotic arm, or to communicate with other devices, such as a smart home system.\nSMR-based BCIs have several advantages over other types of BCIs, including:\n1. High spatial resolution: SMR-based BCIs can provide high spatial resolution, allowing for precise control of a device.\n2. Low latency: SMR-based BCIs can provide low latency, allowing for real-time communication between the brain and a device.\n3. Robustness to noise: SMR-based BCIs are robust to noise and interference, making them suitable for use in real-world environments.\n4. Non-invasive: SMR-based BCIs are non-invasive, meaning they do not require surgical implantation of electrodes or other devices.\n5. Low cost: SMR-based BCIs are relatively low cost compared to other types of BCIs, making them more accessible to a wider range of users.\nOverall, SMR-based BCIs offer a promising approach to brain-computer interfaces, with potential applications in a variety of fields, including gaming, communication, and rehabilitation.",
    "llama-2-7b-chat-hf_fact": [
      "A SMR (Sensory Motor Rhythm) based BCI (Brain-Computer Interface) utilizes neural oscillations that occur at a frequency of approximately 13-15 Hz.",
      "SMR is associated with the synchronized activity of sensory and motor cortices.",
      "SMR activity in the brain is usually measured with electroencephalography (EEG) or other neuroimaging techniques.",
      "SMR-based BCIs can be non-invasive, meaning they do not require surgical implantation of electrodes or other devices.",
      "SMR-based BCIs can have potential applications in various fields including gaming, communication, and rehabilitation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: A SMR (Sensory Motor Rhythm) based BCI (Brain-Computer Interface) utilizes neural oscillations that occur at a frequency of approximately 12-15 Hz.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3226,
    "user_query": "Is myc a tumour suppressor gene?",
    "llama-2-7b-chat-hf_response": "Yes, MYC (v-myc avian myelocytomatosis viral oncogene homolog) is a tumor suppressor gene. The MYC gene is a transcription factor that plays a crucial role in regulating cell growth, differentiation, and apoptosis (programmed cell death). Mutations in the MYC gene have been implicated in various types of cancer, including Burkitt lymphoma, breast cancer, and lung cancer.\nThe MYC gene is located on chromosome 8q12 in humans and consists of 12 exons that encode a protein of approximately 69 kDa. The MYC protein is a transcriptional activator that binds to specific DNA sequences and regulates the expression of target genes involved in cell growth, proliferation, and survival.\nMutations in the MYC gene can lead to the loss of its tumor suppressor function, resulting in uncontrolled cell growth and division, which can contribute to the development and progression of cancer. For example, point mutations in the MYC gene can result in the stabilization of the MYC protein, leading to its constitutive expression and promoting cell proliferation. Similarly, amplification or overexpression of the MYC gene can also contribute to cancer development by increasing the levels of the MYC protein and promoting cell growth and proliferation.\nIn summary, the MYC gene is a tumor suppressor gene that plays a critical role in regulating cell growth and differentiation. Mutations in the MYC gene can lead to the loss of its tumor suppressor function, contributing to the development and progression of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "MYC is a tumor suppressor gene.",
      "The MYC gene is a transcription factor that helps regulate cell growth, differentiation, and apoptosis.",
      "Mutations in the MYC gene have been linked to various types of cancer, including Burkitt lymphoma, breast cancer, and lung cancer.",
      "The MYC gene is located on chromosome 8q12 in humans.",
      "Point mutations in the MYC gene can lead to the stabilization of the MYC protein and promote cell proliferation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MYC is an oncogene, not a tumor suppressor gene.",
      "true",
      "true",
      "false, [corrected fact]: The MYC gene is located on chromosome 8q24.21 in humans.",
      "true"
    ]
  },
  {
    "id": 3227,
    "user_query": "Which syndrome is associated to SAMHD1 gene mutations?",
    "llama-2-7b-chat-hf_response": "SAMHD1 gene mutations have been associated with several syndromes, including:\n1. Aicardi-Goutieres syndrome: This is a rare genetic disorder that affects the brain and nervous system. It is characterized by delayed development, intellectual disability, seizures, and problems with movement and coordination.\n2. Myoclonic epilepsy with ragged red hair: This is a rare genetic disorder that affects the brain and nervous system. It is characterized by myoclonic seizures (muscle jerks), ragged red hair, and intellectual disability.\n3. Progressive encephalopathy with rigidity and myoclonus: This is a rare genetic disorder that affects the brain and nervous system. It is characterized by progressive loss of brain function, rigidity, and myoclonus (muscle jerks).\n4. Neuronal ceroid lipofuscinosis (NCL): This is a group of rare genetic disorders that affect the brain and nervous system. They are characterized by progressive loss of brain function, seizures, and vision loss.\n5. Batten disease: This is a rare genetic disorder that affects the brain and nervous system. It is characterized by progressive loss of brain function, seizures, and vision loss.\nIt's important to note that SAMHD1 gene mutations can cause a wide range of symptoms and syndromes, and not all individuals with a mutation in this gene will develop the same symptoms. A diagnosis of a syndrome associated with SAMHD1 gene mutations is typically made through a combination of clinical evaluation, genetic testing, and other diagnostic tests.",
    "llama-2-7b-chat-hf_fact": [
      "SAMHD1 gene mutations have been associated with Aicardi-Goutieres syndrome, a genetic disorder affecting the brain and nervous system.",
      "Myoclonic epilepsy with ragged red hair, characterized by myoclonic seizures and ragged red hair, is also associated with SAMHD1 gene mutations.",
      "Another condition linked to SAMHD1 gene mutations is Progressive encephalopathy with rigidity and myoclonus.",
      "Neuronal ceroid lipofuscinosis (NCL), a rare genetic disorder that affects the brain and nervous system, is associated with SAMHD1 gene mutations.",
      "Batten disease, characterized by progressive loss of brain function, seizures, and vision loss, is linked to SAMHD1 gene mutations."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Myoclonic epilepsy with ragged red fibers (MERRF) is associated with mutations in the mitochondrial DNA, not SAMHD1 gene mutations.",
      "unknown",
      "false, [corrected fact]: Neuronal ceroid lipofuscinosis (NCL) is associated with mutations in specific genes such as CLN1, CLN2, and CLN3, not SAMHD1 gene mutations.",
      "false, [corrected fact]: Batten disease occurs due to mutations in specific genes such as CLN1, CLN2, CLN3, etc., not SAMHD1 gene mutations."
    ]
  },
  {
    "id": 3228,
    "user_query": "List proteins with RING domain.",
    "llama-2-7b-chat-hf_response": "RING (RING finger) is a protein domain that is involved in various cellular processes, including protein-protein interactions, signal transduction, and ubiquitin ligase activity. RING domains are typically found in proteins that are involved in the regulation of gene expression, cell cycle progression, and cell signaling. Here are some examples of proteins with RING domains:\n1. E2F transcription factors: E2F transcription factors are a family of proteins that regulate the expression of genes involved in cell cycle progression and proliferation. They contain a RING domain that is involved in ubiquitin ligase activity, targeting other proteins for degradation.\n2. HDAC1 and HDAC2: Histone deacetylases (HDACs) are enzymes that remove acetyl groups from histones, leading to the condensation of chromatin and the repression of gene transcription. HDAC1 and HDAC2 contain RING domains that are involved in protein-protein interactions and ubiquitin ligase activity.\n3. p53 tumor suppressor protein: The p53 protein is a transcription factor that regulates the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair. It contains a RING domain that is involved in protein-protein interactions and ubiquitin ligase activity, targeting other proteins for degradation.\n4. mTOR complex: The mTOR (mechanistic target of rapamycin) complex is a protein complex that regulates cell growth and proliferation in response to nutrient availability. It contains a RING domain that is involved in protein-protein interactions and ubiquitin ligase activity, targeting other proteins for degradation.\n5. SCF (Skp1-Cul1-F-box) complex: The SCF complex is a ubiquitin ligase complex that regulates the degradation of proteins involved in the cell cycle, including cyclin-dependent kinases (CDKs) and pocket proteins. It contains a RING domain that is involved in protein-protein interactions and ubiquitin ligase activity.\n6. APC (adenomatous polyposis coli) protein: The APC protein is a",
    "llama-2-7b-chat-hf_fact": [
      "RING (RING finger) is a protein domain involved in numerous cellular processes, including protein-protein interactions, signal transduction, and ubiquitin ligase activity.",
      "E2F transcription factors, which regulate the expression of genes involved in cell cycle progression and proliferation, contain a RING domain.",
      "HDAC1 and HDAC2, enzymes that remove acetyl groups from histones, contain RING domains.",
      "The p53 protein, a transcription factor regulating the expression of genes involved in cell cycle arrest, apoptosis, and DNA repair, contains a RING domain.",
      "The mTOR complex, a protein complex that regulates cell growth and proliferation in response to nutrient availability, contains a RING domain.",
      "The SCF complex, a ubiquitin ligase complex regulating the degradation of proteins involved in the cell cycle, contains a RING domain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: E2F transcription factors, which regulate the expression of genes involved in cell cycle progression and proliferation, do not contain a RING domain.",
      "false, [corrected fact]: HDAC1 and HDAC2, enzymes that remove acetyl groups from histones, do not contain RING domains.",
      "true",
      "false, [corrected fact]: The mTOR complex, a protein complex that regulates cell growth and proliferation in response to nutrient availability, does not contain a RING domain.",
      "true"
    ]
  },
  {
    "id": 3230,
    "user_query": "What is the results of mutations in the gene autoimmune regulator?",
    "llama-2-7b-chat-hf_response": "Mutations in the autoimmune regulator (AIRE) gene have been associated with several autoimmune diseases, including:\n1. Autoimmune polyendocrinopathy-candidiasis-eosinophilia syndrome (APS-1): APS-1 is a rare genetic disorder characterized by the presence of autoantibodies against multiple endocrine organs, candidiasis, and eosinophilia. Mutations in the AIRE gene are the primary cause of APS-1.\n2. Autoimmune thyroid disease: Mutations in the AIRE gene have been identified in individuals with autoimmune thyroid disease, including Graves' disease and Hashimoto's thyroiditis.\n3. Type 1 diabetes: Some studies have suggested that mutations in the AIRE gene may contribute to the development of type 1 diabetes.\n4. Rheumatoid arthritis: Mutations in the AIRE gene have been identified in individuals with rheumatoid arthritis, an autoimmune disease that affects the joints.\n5. Systemic lupus erythematosus: Mutations in the AIRE gene have been identified in individuals with systemic lupus erythematosus, an autoimmune disease that affects multiple organ systems.\n6. Multiple sclerosis: Some studies have suggested that mutations in the AIRE gene may contribute to the development of multiple sclerosis, an autoimmune disease that affects the central nervous system.\n7. Primary biliary cirrhosis: Mutations in the AIRE gene have been identified in individuals with primary biliary cirrhosis, an autoimmune disease that affects the liver.\n8. Vitiligo: Mutations in the AIRE gene have been identified in individuals with vitiligo, an autoimmune disease that causes depigmentation of the skin.\n9. Alopecia areata: Mutations in the AIRE gene have been identified in individuals with alopecia areata, an autoimmune disease that causes hair loss.\n10. Psoriasis: Some studies have suggested that mutations in the AIRE gene may contribute to the development of psoriasis, an",
    "llama-2-7b-chat-hf_fact": [
      "Mutations in the autoimmune regulator (AIRE) gene are the primary cause of Autoimmune polyendocrinopathy-candidiasis-eosinophilia syndrome (APS-1).",
      "AIRE gene mutations have been identified in individuals with autoimmune thyroid diseases such as Graves' disease and Hashimoto's thyroiditis.",
      "Some studies suggest that mutations in the AIRE gene may contribute to the development of Type 1 diabetes.",
      "Mutations in the AIRE gene have been identified in individuals with Rheumatoid arthritis.",
      "Alterations in the AIRE gene have been discovered in individuals diagnosed with Vitiligo."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: No direct relationship between AIRE gene mutations and Rheumatoid arthritis has been established.",
      "true"
    ]
  },
  {
    "id": 3232,
    "user_query": "Is subdural empyema a complication of sinusitis?",
    "llama-2-7b-chat-hf_response": "Yes, subdural empyema is a possible complication of sinusitis. Subdural empyema is a type of infection that occurs in the space between the dura mater and the skull, which is the outermost protective covering of the brain. It can occur as a complication of sinusitis, which is an infection of the sinuses, when bacteria or other microorganisms enter the sinuses and spread to the surrounding tissues, including the brain.\nSubdural empyema can cause a range of symptoms, including headache, fever, nausea, and vomiting, as well as more severe symptoms such as confusion, seizures, and loss of consciousness. If left untreated, subdural empyema can lead to serious complications, including brain abscesses, meningitis, and even death.\nTreatment of subdural empyema typically involves antibiotics and surgical drainage of the infection. In some cases, surgical removal of the infected tissue may be necessary. Prompt treatment is essential to prevent serious complications and to improve outcomes for patients with subdural empyema.\nIt is important to note that subdural empyema is a rare complication of sinusitis, and the vast majority of patients with sinusitis will not develop this condition. However, if you have sinusitis and are experiencing any of the symptoms of subdural empyema, it is important to seek medical attention promptly to rule out this serious complication.",
    "llama-2-7b-chat-hf_fact": [
      "Subdural empyema is an infection occurring in the space between the dura mater and the skull.",
      "Subdural empyema can occur as a complication of sinusitis.",
      "Symptoms of subdural empyema can range from headache, fever, nausea and vomiting to severe symptoms such as confusion, seizures, and loss of consciousness.",
      "The treatment for subdural empyema typically involves antibiotics and surgical drainage of the infection.",
      "Subdural empyema is a rare complication of sinusitis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Subdural empyema is an infection occurring in the space between the dura mater and the arachnoid mater.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3237,
    "user_query": "Is the crystal structure of Pim-1 available?",
    "llama-2-7b-chat-hf_response": "Pim-1 (Protein Kinase Beta-1, also known as PI3K) is a member of the PI3K (Phosphatidylinositol 3-kinase) family of enzymes that play a key role in cell survival and signaling. Pim-1 is a serine/threonine kinase that is activated downstream of the PI3K signaling pathway and regulates various cellular processes, including cell survival, proliferation, and differentiation.\nThe crystal structure of Pim-1 has been resolved, providing insights into its mechanism of action and potential drug targeting strategies. The crystal structure of Pim-1 was determined using X-ray crystallography, revealing a homotetrameric structure composed of four identical subunits. Each subunit contains an N-terminal lobe that binds ATP and a C-terminal lobe that interacts with substrate proteins. The active site of Pim-1 is located at the interface of the two lobes, where ATP binding induces a conformational change that activates the enzyme.\nUnderstanding the crystal structure of Pim-1 can aid in the development of small molecule inhibitors that target the enzyme and modulate its activity. For example, drugs that bind to the ATP binding site or the substrate binding site could potentially inhibit Pim-1 activity, leading to a decrease in cell survival and proliferation.\nIn summary, the crystal structure of Pim-1 has been resolved, providing valuable insights into its mechanism of action and potential drug targeting strategies. Understanding the structure of Pim-1 can aid in the development of new drugs that target this key player in cell survival and signaling pathways.",
    "llama-2-7b-chat-hf_fact": [
      "Pim-1 (Protein Kinase Beta-1, also known as PI3K) is a member of the PI3K (Phosphatidylinositol 3-kinase) family of enzymes.",
      "Pim-1 is a serine/threonine kinase that is activated downstream of the PI3K signaling pathway.",
      "The crystal structure of Pim-1 has been resolved using X-ray crystallography, revealing a homotetrameric structure composed of four identical subunits.",
      "Each subunit of Pim-1 contains an N-terminal lobe that binds ATP and a C-terminal lobe that interacts with substrate proteins.",
      "Understanding the crystal structure of Pim-1 can aid in the development of small molecule inhibitors that target the enzyme and modulate its activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Pim-1 (Proviral Integration site for Moloney murine leukemia virus) is a serine/threonine kinase, not to be confused with PI3K, which is indeed a member of the PI3K family.",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3238,
    "user_query": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "llama-2-7b-chat-hf_response": "Yes, tumour-associated macrophages (TAMs) have been found to have a prognostic role in gliomas. Studies have shown that the presence of TAMs in gliomas is associated with poorer prognosis, including shorter overall survival and time to disease progression. This is thought to be due to the pro-tumourigenic functions of TAMs, such as promoting angiogenesis, suppressing immune responses, and contributing to the development of a tumour-promoting microenvironment.",
    "llama-2-7b-chat-hf_fact": [
      "Tumour-associated macrophages (TAMs) have been found to have a prognostic role in gliomas.",
      "Studies indicate that the presence of TAMs in gliomas is associated with poorer prognosis.",
      "The presence of TAMs in gliomas can lead to shorter overall survival and quicker time to disease progression.",
      "TAMs have pro-tumourigenic functions.",
      "Some of the functions of TAMs include promoting angiogenesis, suppressing immune responses, and contributing to the development of a tumour-promoting microenvironment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-7b-chat-hf_response": "Yes, over-expression of GRHL2 has been shown to promote epithelial-to-mesenchymal transition (EMT) in various cell types, including cancer cells. EMT is a process by which epithelial cells lose their cell-cell adhesion and polarity, and acquire mesenchymal characteristics, such as increased motility and invasiveness.\nGRHL2 is a basic helix-loop-helix (bHLH) transcription factor that regulates the expression of genes involved in cell adhesion, migration, and invasion. Over-expression of GRHL2 has been shown to promote EMT by repressing the expression of epithelial markers, such as E-cadherin, and activating the expression of mesenchymal markers, such as N-cadherin and vimentin.\nIn addition, GRHL2 over-expression has been shown to activate the PI3K/Akt signaling pathway, which is a key regulator of EMT. GRHL2 has been shown to phosphorylate and activate the PI3K/Akt pathway, leading to increased cell migration and invasion.\nFurthermore, GRHL2 over-expression has been implicated in cancer progression and metastasis. For example, GRHL2 has been shown to be over-expressed in various types of cancer, including breast, lung, and colon cancer, and to promote cancer cell migration and invasion.\nIn summary, over-expression of GRHL2 leads to EMT by repressing epithelial markers and activating mesenchymal markers, and by activating the PI3K/Akt signaling pathway. GRHL2 over-expression has been implicated in cancer progression and metastasis, highlighting its potential as a therapeutic target for cancer treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Over-expression of GRHL2 promotes epithelial-to-mesenchymal transition (EMT) in various cell types, including cancer cells.",
      "GRHL2 is a basic helix-loop-helix (bHLH) transcription factor that regulates the expression of genes involved in cell adhesion, migration, and invasion.",
      "GRHL2 over-expression represses the expression of epithelial markers like E-cadherin and activates the expression of mesenchymal markers such as N-cadherin and vimentin.",
      "GRHL2 over-expression has been shown to activate the PI3K/Akt signaling pathway, which is a key regulator of EMT.",
      "GRHL2 over-expression has been implicated in cancer progression and metastasis, including types of cancer such as breast, lung, and colon cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Over-expression of GRHL2 inhibits epithelial-to-mesenchymal transition (EMT) in various cell types, including cancer cells.",
      "true",
      "false, [corrected fact]: GRHL2 over-expression increases the expression of epithelial markers like E-cadherin and represses the expression of mesenchymal markers such as N-cadherin and vimentin.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3245,
    "user_query": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "llama-2-7b-chat-hf_response": "The Fluzone intradermal vaccine is produced by Sanofi Pasteur, while the Fluzone intradermal quadrivalent vaccine is produced by GlaxoSmithKline (GSK). Both vaccines are approved for use in the United States and are designed to protect against seasonal flu viruses. However, the Fluzone intradermal vaccine is only approved for use in people aged 18 to 64 years, while the Fluzone intradermal quadrivalent vaccine is approved for use in people aged 18 years and older.",
    "llama-2-7b-chat-hf_fact": [
      "The Fluzone intradermal vaccine is produced by Sanofi Pasteur.",
      "The Fluzone intradermal quadrivalent vaccine is produced by GlaxoSmithKline (GSK).",
      "Both these vaccines are approved for use in the United States.",
      "They are designed to protect against seasonal flu viruses.",
      "The Fluzone intradermal vaccine is approved for use in people aged 18 to 64 years, while the Fluzone intradermal quadrivalent vaccine is approved for use in people aged 18 years and older."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The Fluzone intradermal quadrivalent vaccine is produced by Sanofi Pasteur.",
      "true",
      "true",
      "false, [corrected fact]: Both the Fluzone intradermal vaccine and the Fluzone intradermal quadrivalent vaccine are approved for use in people aged 18 years and older."
    ]
  },
  {
    "id": 3251,
    "user_query": "List features of the Currarino triad.",
    "llama-2-7b-chat-hf_response": "The Currarino triad is a rare congenital anomaly that consists of three distinct abnormalities:\n1. Anal stenosis: A narrowing of the anus, which can cause difficulty passing stool.\n2. Imperforate anus: A condition where the anus is not properly formed, making it difficult for stool to pass through.\n3. Bladder exstrophy: A condition where the bladder is not properly formed and protrudes through the abdominal wall.\nThe Currarino triad is a rare congenital anomaly that affects approximately 1 in 40,000 to 1 in 100,000 newborns. It is more common in males than females, and the exact cause is not known.\nThe symptoms of the Currarino triad can vary in severity and may include:\n* Difficulty passing stool\n* Painful defecation\n* Rectal prolapse\n* Urinary incontinence\n* Difficulty controlling the flow of urine\n* Abnormal genitalia\nThe diagnosis of the Currarino triad is typically made through a combination of physical examination, imaging studies, and genetic testing. Treatment options for the Currarino triad depend on the severity of the symptoms and may include:\n* Surgery to repair the anus and rectum\n* Surgery to repair the bladder and urinary system\n* Physical therapy to help with bowel and bladder training\n* Medications to manage symptoms such as pain and constipation\nThe prognosis for individuals with the Currarino triad varies depending on the severity of the symptoms and the effectiveness of treatment. In some cases, individuals with the Currarino triad may have a normal life expectancy, while in other cases, they may experience ongoing health problems and disabilities.\nIt is important to note that the Currarino triad is a rare and complex condition, and individuals with this condition may require ongoing medical care and support throughout their lives. If you suspect that your child may have the Currarino triad, it is important to consult with a healthcare provider for proper diagnosis and treatment",
    "llama-2-7b-chat-hf_fact": [
      "The Currarino triad is a rare congenital anomaly consisting of three abnormalities: anal stenosis, imperforate anus, and bladder exstrophy.",
      "The Currarino triad affects approximately 1 in 40,000 to 1 in 100,000 newborns and is more common in males.",
      "The symptoms of the Currarino triad can include difficulty passing stool, rectal prolapse, urinary incontinence, and abnormal genitalia, among others.",
      "Diagnosis of the Currarino triad is made through physical examination, imaging studies, and genetic testing.",
      "Treatment options for Currarino triad depend on symptom severity and can include surgeries, physical therapy, and medications."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Currarino triad is a rare congenital anomaly consisting of three abnormalities: a presacral mass, anorectal malformation, and sacral bone defect.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3253,
    "user_query": "What are invasomes",
    "llama-2-7b-chat-hf_response": "?\nInvasomes are small, membrane-bound organelles that are found in the cytoplasm of many eukaryotic cells. They are involved in the regulation of intracellular signaling pathways and are thought to play a role in a variety of cellular processes, including cell growth, differentiation, and survival.\nInvasomes were first identified in the early 1990s, and since then, they have been found to be present in a wide range of cell types, including immune cells, nerve cells, and cancer cells. They are typically composed of a protein core surrounded by a lipid bilayer membrane, and they can be isolated from cells using a variety of techniques, including ultracentrifugation and fluorescence-activated cell sorting.\nInvasomes are thought to play a role in regulating the activity of intracellular signaling pathways by controlling the localization and activity of signaling molecules, such as protein kinases and phosphatases. They may also play a role in regulating the activity of other cellular structures, such as the endoplasmic reticulum and the Golgi apparatus.\nInvasomes have been implicated in a variety of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, alterations in invasome structure and function have been observed in cancer cells, and it is thought that these alterations may contribute to the development and progression of cancer. In addition, invasomes have been implicated in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, and they may play a role in the regulation of the immune response.\nOverall, invasomes are an important area of research, and further studies are needed to fully understand their structure, function, and role in cellular processes and disease.",
    "llama-2-7b-chat-hf_fact": [
      "Invasomes are small, membrane-bound organelles found in the cytoplasm of many eukaryotic cells.",
      "They were first identified in the early 1990s and are present in a range of cell types, including immune cells, nerve cells, and cancer cells.",
      "Invasomes are composed of a protein core surrounded by a lipid bilayer membrane, and can be isolated from cells using techniques such as ultracentrifugation and fluorescence-activated cell sorting.",
      "Invasomes regulate the activity of intracellular signaling pathways by controlling the localization and activity of signaling molecules.",
      "They have been implicated in diseases such as cancer, neurodegenerative disorders, and autoimmune diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Invasomes are not known organelles found in the cytoplasm of many eukaroyotic cells. The term \"invasomes\" often refers to a type of liposome used in drug delivery.",
      "false, [corrected fact]: The statement is false as invasomes are not identified cellular organelles.",
      "false, [corrected fact]: Invasomes, as used in the context of drug delivery, are composed of ethanol, terpenes and phospholipids, not a protein core surrounded by a lipid bilayer.",
      "false, [corrected fact]: As mentioned earlier, invasomes are not cellular organelles so they don't regulate signaling pathways.",
      "false, [corrected fact]: Invasomes as a type of liposome, may be used in the treatment of various diseases, including cancer and neurodegenerative disorders, but they are not implicated in causing these diseases."
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-7b-chat-hf_response": "Several T-UCRs have been implicated in lung cancer, including:\n1. T-bet: T-bet is a transcription factor that regulates the expression of genes involved in the immune response. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n2. Eomesodermin (Eomes): Eomes is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n3. T-box protein 1 (Tbx1): Tbx1 is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n4. T-box protein 2 (Tbx2): Tbx2 is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n5. T-box protein 4 (Tbx4): Tbx4 is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n6. T-box protein 5 (Tbx5): Tbx5 is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n7. T-box protein 6 (Tbx6): Tbx6 is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n8. T-box protein 7 (Tbx7): Tbx7 is a transcription factor that regulates the expression of genes involved in cell fate determination and differentiation. It has been shown to be overexpressed in many types of cancer, including lung cancer.\n9. T-box protein 8 (Tbx8): Tb",
    "llama-2-7b-chat-hf_fact": [
      "T-bet is a transcription factor that has been shown to be overexpressed in many types of cancer, including lung cancer.",
      "Eomesodermin (Eomes) is a transcription factor that is implicated in lung cancer.",
      "T-box protein 1 (Tbx1) has been shown to be overexpressed in many types of cancer, including lung cancer.",
      "T-box protein 2 (Tbx2) is involved in cell fate determination and differentiation and is overexpressed in lung cancer.",
      "T-box protein 4 (Tbx4) has been implicated in lung cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3255,
    "user_query": "Can Daptacel be used instead of IPOL?",
    "llama-2-7b-chat-hf_response": "Daptacel (Diphtheria, Tetanus, and Pertussis Vaccine Adsorbed) and IPOL (Inactivated Poliovirus Vaccine) are both vaccines used to protect against infectious diseases. While they share some similarities, they are not interchangeable, and it is not recommended to use Daptacel instead of IPOL or vice versa.\nHere are some reasons why:\n1. Composition: Daptacel contains a combination of diphtheria, tetanus, and pertussis antigens, while IPOL contains inactivated poliovirus antigens. These vaccines have different compositions, and using one instead of the other may not provide adequate protection against the respective diseases.\n2. Indications: Daptacel is primarily used to protect against diphtheria, tetanus, and pertussis, while IPOL is used to protect against polio. Using Daptacel instead of IPOL may not provide adequate protection against polio.\n3. Dosage and administration: The dosage and administration of Daptacel and IPOL may differ. For example, Daptacel is typically given as a single dose at 2, 4, 6, and 15-18 months of age, while IPOL is typically given in a series of 3-4 doses at 2, 4-6, 9-12, and 18-24 months of age. Using the wrong dosage or administration schedule may not provide adequate protection against the diseases.\n4. Age and risk groups: Daptacel and IPOL are approved for use in different age groups and risk categories. Daptacel is approved for use in infants and children from 2 months to 18 years of age, while IPOL is approved for use in infants and children from 2 months to 15 months of age. Using Daptacel instead of IPOL may not provide adequate protection against polio in younger infants.\nIn summary, while Daptacel and IPOL share some similarities, they are not interchangeable vaccines. It is important to follow the recommended vaccine schedule and use",
    "llama-2-7b-chat-hf_fact": [
      "Daptacel contains a combination of diphtheria, tetanus, and pertussis antigens.",
      "IPOL contains inactivated poliovirus antigens.",
      "Daptacel is primarily used to protect against diphtheria, tetanus, and pertussis.",
      "IPOL is used specifically to protect against polio.",
      "Daptacel and IPOL are approved for use in different age groups and have different dosing schedules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3256,
    "user_query": "Is ACE2 expressed on cell surfaces?",
    "llama-2-7b-chat-hf_response": "Yes, ACE2 is expressed on the surface of many cell types, including epithelial cells, endothelial cells, and immune cells. ACE2 is a transmembrane protein, meaning it spans the cell membrane and has both extracellular and intracellular domains. The extracellular domain of ACE2 is responsible for its enzymatic activity, while the intracellular domain interacts with other proteins and plays a role in cell signaling.\nStudies have shown that ACE2 is expressed on the surface of many different cell types, including:\n1. Epithelial cells: ACE2 is expressed on the surface of many epithelial cell types, including those in the lung, kidney, and gastrointestinal tract.\n2. Endothelial cells: ACE2 is also expressed on the surface of endothelial cells, which line blood vessels and play a role in regulating blood pressure and inflammation.\n3. Immune cells: ACE2 is expressed on the surface of some immune cells, including macrophages and dendritic cells, which play a role in the immune response.\n4. Cancer cells: ACE2 has been shown to be overexpressed on the surface of some cancer cells, including those in lung, breast, and colon cancer.\nOverall, the expression of ACE2 on cell surfaces can have important implications for cellular signaling and the immune response, and may play a role in the development and progression of certain diseases.",
    "llama-2-7b-chat-hf_fact": [
      "ACE2 is expressed on the surface of various cell types, including epithelial cells, endothelial cells, and immune cells.",
      "ACE2 is a transmembrane protein that spans the cell membrane.",
      "The extracellular domain of ACE2 is responsible for its enzymatic activity.",
      "The intracellular domain of ACE2 interacts with other proteins and plays a role in cell signaling.",
      "ACE2 has been found to be overexpressed on the surface of some cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3259,
    "user_query": "List the cancers that are associated with SBLA syndrome.",
    "llama-2-7b-chat-hf_response": "Sjogren's syndrome is an autoimmune disorder that affects the exocrine glands, particularly the salivary and lacrimal glands. Sjogren's syndrome is often associated with other autoimmune disorders, such as rheumatoid arthritis, lupus, and scleroderma. Sjogren's syndrome can also be associated with an increased risk of certain cancers, including:\n1. Lymphoma: Sjogren's syndrome is associated with an increased risk of non-Hodgkin's lymphoma, particularly of the B-cell type.\n2. Breast cancer: Women with Sjogren's syndrome have a higher risk of developing breast cancer, particularly if they are postmenopausal.\n3. Ovarian cancer: Women with Sjogren's syndrome have a higher risk of developing ovarian cancer, particularly if they are postmenopausal.\n4. Endometrial cancer: Women with Sjogren's syndrome have a higher risk of developing endometrial cancer, particularly if they are postmenopausal.\n5. Melanoma: People with Sjogren's syndrome have a higher risk of developing melanoma, particularly if they have a history of sun exposure.\n6. Kidney cancer: People with Sjogren's syndrome have a higher risk of developing kidney cancer, particularly if they have a history of smoking.\n7. Pancreatic cancer: People with Sjogren's syndrome have a higher risk of developing pancreatic cancer, particularly if they have a history of smoking.\n8. Thyroid cancer: People with Sjogren's syndrome have a higher risk of developing thyroid cancer, particularly if they have a history of radiation exposure.\nIt is important to note that the risk of cancer associated with Sjogren's syndrome is generally low, and many people with the condition will not develop cancer. However, it is important to be aware of the increased risk and to discuss any concerns with a healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Sjogren's syndrome is an autoimmune disorder that affects the exocrine glands.",
      "The syndrome is associated with an increased risk of certain cancers.",
      "Women with Sjogren's syndrome have a higher risk of developing breast, ovarian, and endometrial cancer, particularly if they are postmenopausal.",
      "Individuals with Sjogren's syndrome have a higher risk of developing melanoma, kidney, pancreatic, and thyroid cancer.",
      "The risk of cancer associated with Sjogren's syndrome is generally low."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Women with Sjogren's syndrome have a higher risk of developing lymphoma, not breast, ovarian, and endometrial cancer.",
      "false, [corrected fact]: Individuals with Sjogren's syndrome have a higher risk of developing lymphoma, not melanoma, kidney, pancreatic, and thyroid cancer.",
      "true"
    ]
  },
  {
    "id": 3264,
    "user_query": "What is Invaplex 50?",
    "llama-2-7b-chat-hf_response": "Invaplex 50 is a prescription medication used to treat various types of seizures in people with epilepsy. It is an anticonvulsant drug that works by reducing the abnormal electrical activity in the brain that causes seizures.\nInvaplex 50 is a combination of three active ingredients:\n1. Pregabalin: This is the primary active ingredient in Invaplex 50. It works by reducing the abnormal electrical activity in the brain that causes seizures.\n2. Lactate: This ingredient helps to stabilize the pH level of the solution, ensuring that the drug is effective and safe to use.\n3. Sodium chloride: This ingredient helps to maintain the proper balance of electrolytes in the body, which is important for the proper functioning of the nervous system.\nInvaplex 50 is available in a variety of strengths, including 50 mg, 75 mg, and 100 mg. It is usually taken two to three times a day, with or without food. It is important to follow the dosage instructions provided by your doctor carefully, as taking too much of this medication can increase the risk of side effects.\nCommon side effects of Invaplex 50 include:\n1. Dizziness\n2. Drowsiness\n3. Fatigue\n4. Headache\n5. Nausea\n6. Vomiting\n7. Diarrhea\n8. Constipation\n9. Muscle weakness\n10. Coordination problems\nThese side effects are usually mild and temporary, but if they persist or worsen over time, it is important to consult with your doctor.\nInvaplex 50 can interact with other medications, including:\n1. Opioids: Taking Invaplex 50 with opioids can increase the risk of drowsiness and respiratory depression.\n2. Benzodiazepines: Taking Invaplex 50 with benzodiazepines can increase the risk of drowsiness and respiratory depression.\n3. Antidepressants: Taking Invaplex 50 with antidepressants can increase the risk",
    "llama-2-7b-chat-hf_fact": [
      "Invaplex 50 is a prescription medication used to treat various types of seizures in people with epilepsy.",
      "Invaplex 50 is an anticonvulsant drug that works by reducing the abnormal electrical activity in the brain.",
      "Invaplex 50 is composed of three active ingredients: Pregabalin, Lactate, and Sodium chloride.",
      "Invaplex 50 is usually taken two to three times a day, with or without food.",
      "Some common side effects of Invaplex 50 include dizziness, drowsiness, fatigue, headache, and nausea."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3266,
    "user_query": "Which lncRNAS are regulated by SAM68?",
    "llama-2-7b-chat-hf_response": "SAM68 is a protein that has been shown to regulate the expression of several long non-coding RNAs (lncRNAs). Here are some of the lncRNAs that have been reported to be regulated by SAM68:\n1. MALAT1: SAM68 has been shown to bind to the 3' untranslated region (UTR) of the MALAT1 lncRNA and regulate its expression. MALAT1 is a metastasis-associated lncRNA that is involved in the regulation of cell migration and invasion.\n2. HOTAIR: SAM68 has been shown to bind to the 5' UTR of the HOTAIR lncRNA and regulate its expression. HOTAIR is a lncRNA that is involved in the regulation of cell proliferation and migration.\n3. XBP1: SAM68 has been shown to regulate the expression of the XBP1 lncRNA, which is involved in the regulation of cell proliferation and differentiation.\n4. TINCR: SAM68 has been shown to regulate the expression of the TINCR lncRNA, which is involved in the regulation of cell proliferation and migration.\n5. GAS5: SAM68 has been shown to regulate the expression of the GAS5 lncRNA, which is involved in the regulation of cell proliferation and differentiation.\nThese are some of the lncRNAs that have been reported to be regulated by SAM68, but it is important to note that this list is not exhaustive and there may be other lncRNAs that are also regulated by SAM68.",
    "llama-2-7b-chat-hf_fact": [
      "SAM68 is a protein that regulates the expression of several long non-coding RNAs (lncRNAs).",
      "SAM68 has been shown to bind to the 3' untranslated region (UTR) of the MALAT1 lncRNA and regulate its expression.",
      "SAM68 binds to the 5' UTR of the HOTAIR lncRNA and regulates its expression.",
      "The XBP1 lncRNA's expression is regulated by SAM68.",
      "SAM68 regulates the expression of the TINCR and GAS5 lncRNAs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: SAM68 has been shown to bind to the 3' untranslated region (UTR) of the HOTAIR lncRNA and regulate its expression.",
      "true",
      "true"
    ]
  },
  {
    "id": 3267,
    "user_query": "How many proteins have been queried for protein partners by the Drosophila protein interaction map (DPiM)?",
    "llama-2-7b-chat-hf_response": "The Drosophila protein interaction map (DPiM) is a comprehensive protein-protein interaction map for the fruit fly Drosophila melanogaster. As of 2019, DPiM has queried over 10,000 proteins for protein partners, including both known and predicted interactions. This number is constantly growing as new data becomes available and as DPiM continues to update and expand its map.",
    "llama-2-7b-chat-hf_fact": [
      "The Drosophila protein interaction map (DPiM) is a protein-protein interaction map for the fruit fly Drosophila melanogaster.",
      "DPiM maps out known and predicted interactions between proteins.",
      "As of 2019, over 10,000 proteins have been queried for protein partners by DPiM.",
      "The number of proteins queried by DPiM is constantly growing.",
      "DPiM continues to update and expand its map as new data becomes available."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-7b-chat-hf_response": "GPR151 (G protein-coupled receptor 151) is an orphan receptor, meaning that it does not have a well-defined endogenous ligand or a clear physiological function. The gene encoding GPR151 was first identified in the early 1990s and was initially named HA107 because it was cloned from a human brain cDNA library and its sequence was found to be homologous to that of the hamster orphan receptor HA107.\nGPR151 is a member of the G protein-coupled receptor (GPCR) superfamily, which includes more than 800 receptors involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPR151 is primarily expressed in the brain, specifically in regions involved in regulating feeding behavior, metabolism, and cardiovascular function, such as the hypothalamus, brainstem, and spinal cord.\nSeveral studies have shown that GPR151 is involved in the regulation of energy homeostasis and glucose metabolism. For example, GPR151 activation has been shown to decrease food intake and body weight in animal models of obesity, and GPR151 knockout mice are more susceptible to diet-induced obesity. GPR151 has also been implicated in the regulation of glucose metabolism, with GPR151 activation improving glucose tolerance and insulin sensitivity in animal models of type 2 diabetes.\nIn addition to its role in energy homeostasis and glucose metabolism, GPR151 has been implicated in the regulation of inflammation and immune responses. GPR151 activation has been shown to reduce inflammation in various animal models of inflammation, and GPR151 has been identified as a potential therapeutic target for the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.\nDespite its potential therapeutic applications, GPR151 remains an orphan receptor, meaning that",
    "llama-2-7b-chat-hf_fact": [
      "GPR151, first identified in the early 1990s, is an orphan receptor, which means it doesn't have a well-defined endogenous ligand or clear physiological function.",
      "The GPR151 gene was initially named HA107, having been cloned from a human brain cDNA library.",
      "GPR151 is a member of the G protein-coupled receptor superfamily, which includes over 800 receptors involved in various physiological processes.",
      "GPR151 is primarily expressed in the brain, particularly in regions such as the hypothalamus, brainstem, and spinal cord.",
      "Studies have suggested a role for GPR151 in the regulation of energy homeostasis, glucose metabolism, inflammation, and immune responses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3269,
    "user_query": "Is LiFraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "llama-2-7b-chat-hf_response": "Yes, Li-Fraumeni syndrome (LFS) is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development. LFS is caused by mutations in the TP53 gene, which is a tumor suppressor gene that plays a crucial role in maintaining genomic stability and preventing cancer.\nApproximately 1 in 50,000 to 1 in 100,000 individuals are born with a mutation in the TP53 gene, leading to LFS. The disorder is characterized by an increased risk of developing various types of cancer, including breast cancer, ovarian cancer, soft tissue sarcoma, and bone cancer, among others. The risk of developing cancer in individuals with LFS is estimated to be 40 to 60 times higher than the general population.\nLFS is usually inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated TP53 gene (one from each parent) to develop the disorder. However, some cases of LFS can also occur spontaneously due to a new mutation in the TP53 gene.\nThe diagnosis of LFS typically involves a combination of clinical evaluation, family history, and genetic testing. Genetic testing can identify the presence of a TP53 mutation, which can confirm the diagnosis of LFS. However, the absence of a mutation does not rule out the diagnosis, as some individuals with LFS may have a de novo mutation (a new mutation that occurs spontaneously) or a mutation in a different gene that affects the TP53 pathway.\nIndividuals with LFS require close monitoring and screening for cancer, particularly in high-risk sites such as the breast, ovaries, and soft tissue. Early detection and treatment of cancer can improve outcomes and reduce the risk of cancer-related death.\nIn summary, Li-Fraumeni syndrome is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development due to mutations in the TP53 gene. The disorder is characterized by an increased risk of developing various types of cancer, and early detection and treatment can",
    "llama-2-7b-chat-hf_fact": [
      "Li-Fraumeni syndrome is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development.",
      "The disorder is caused by mutations in the TP53 gene, a tumor suppressor gene that plays a crucial role in maintaining genomic stability and preventing cancer.",
      "Approximately 1 in 50,000 to 1 in 100,000 individuals are born with a mutation in the TP53 gene, leading to Li-Fraumeni syndrome.",
      "The syndrome is characterized by an increased risk of various types of cancer, such as breast cancer, ovarian cancer, soft tissue sarcoma, and bone cancer.",
      "Genetic testing can identify the presence of a TP53 mutation, which can confirm the diagnosis of Li-Fraumeni syndrome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Li-Fraumeni syndrome is a rare, autosomal dominant, hereditary disorder that predisposes carriers to cancer development.",
      "true",
      "false, [corrected fact]: The exact prevalence of Li-Fraumeni syndrome is not known but it is estimated that it occurs in 1 in 20,000 people.",
      "true",
      "true"
    ]
  },
  {
    "id": 3271,
    "user_query": "Salzburg EEG criteria are used to diagnose which disorder?",
    "llama-2-7b-chat-hf_response": "Salzburg EEG criteria are used to diagnose epilepsy. The Salzburg criteria are a set of criteria used to diagnose epilepsy based on the results of an electroencephalogram (EEG) test. The criteria were developed in Salzburg, Austria in the 1970s and have been widely used since then to diagnose epilepsy. The criteria are as follows:\n1. Spikes or sharp waves: The presence of spikes or sharp waves on the EEG indicates the presence of epilepsy.\n2. Interictal activity: Interictal activity refers to the abnormal electrical activity that occurs between seizures. The presence of interictal activity on the EEG is a criteria for diagnosing epilepsy.\n3. Ictal activity: Ictal activity refers to the abnormal electrical activity that occurs during a seizure. The presence of ictal activity on the EEG is a criteria for diagnosing epilepsy.\n4. Generalized spikes or sharp waves: Generalized spikes or sharp waves are abnormal electrical activity that occurs on both sides of the brain. The presence of generalized spikes or sharp waves on the EEG is a criteria for diagnosing epilepsy.\n5. Focal spikes or sharp waves: Focal spikes or sharp waves are abnormal electrical activity that occurs on one side of the brain. The presence of focal spikes or sharp waves on the EEG is a criteria for diagnosing epilepsy.\n6. Multifocal spikes or sharp waves: Multifocal spikes or sharp waves are abnormal electrical activity that occurs on multiple areas of the brain. The presence of multifocal spikes or sharp waves on the EEG is a criteria for diagnosing epilepsy.\n7. Occipital spikes or sharp waves: Occipital spikes or sharp waves are abnormal electrical activity that occurs in the occipital lobe of the brain. The presence of occipital spikes or sharp waves on the EEG is a criteria for diagnosing epilepsy.\n8. Frontal spikes or sharp waves: Frontal spikes or sharp waves are abnormal electrical activity that occurs in the frontal lobe of the brain. The presence of frontal spikes or sharp waves on the EEG is a",
    "llama-2-7b-chat-hf_fact": [
      "Salzburg EEG criteria are used to diagnose epilepsy.",
      "The Salzburg criteria were developed in Salzburg, Austria in the 1970s.",
      "The presence of spikes or sharp waves on the EEG is a criteria for diagnosing epilepsy.",
      "The presence of generalized spikes or sharp waves on both sides of the brain is a criteria for diagnosing epilepsy.",
      "The presence of frontal spikes or sharp waves occurring in the frontal lobe of the brain on the EEG is a criteria for diagnosing epilepsy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The Salzburg criteria for epilepsy was developed during a consensus workshop in Salzburg, Austria in 2015.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3272,
    "user_query": "List the components of the COMPASS complex",
    "llama-2-7b-chat-hf_response": "The COMPASS complex is a multi-subunit protein complex that plays a crucial role in the initiation of transcription in eukaryotic cells. The COMPASS complex is composed of several subunits, including:\n1. CCCTC-binding factor (CBF): CBF is the catalytic subunit of the COMPASS complex and is responsible for recognizing and binding to the initiator element of the gene.\n2. General transcription factor TFIIA: TFIIA is a general transcription factor that helps to recruit RNA polymerase to the promoter region of the gene.\n3. Transcriptional activator TFIIB: TFIIB is a transcriptional activator that helps to recruit RNA polymerase to the promoter region of the gene.\n4. RNA polymerase II (RNAPII): RNAPII is the enzyme responsible for transcribing DNA into RNA. The COMPASS complex helps to recruit RNAPII to the promoter region of the gene.\n5. Nucleosome: Nucleosomes are the building blocks of chromatin, and the COMPASS complex helps to recruit nucleosomes to the promoter region of the gene.\n6. Histone acetyltransferases (HATs): HATs are enzymes that help to acetylate histones, leading to the relaxation of chromatin structure and the activation of transcription. The COMPASS complex helps to recruit HATs to the promoter region of the gene.\n7. Histone deacetylases (HDACs): HDACs are enzymes that help to deacetylate histones, leading to the compacting of chromatin structure and the repression of transcription. The COMPASS complex helps to recruit HDACs to the promoter region of the gene.\nThe COMPASS complex plays a crucial role in the initiation of transcription by recruiting the necessary factors to the promoter region of the gene, including RNAPII, TFIIA, TFIIB, and nucleosomes. The COMPASS complex also helps to regulate the chromatin structure by recruiting HATs and HDACs",
    "llama-2-7b-chat-hf_fact": [
      "The COMPASS complex is a multi-subunit protein complex that facilitates the initiation of transcription in eukaryotic cells.",
      "CCCTC-binding factor (CBF) is a catalytic subunit of the COMPASS complex responsible for recognizing and binding to the initiator element of the gene.",
      "The COMPASS complex includes the Transcriptional activator TFIIB that helps to recruit RNA polymerase to the promoter region of the gene.",
      "The COMPASS complex contains the RNA polymerase II (RNAPII) enzyme which transcribes DNA into RNA.",
      "Histone acetyltransferases (HATs) and Histone deacetylases (HDACs), enzymes that regulate chromatin structure, are part of the COMPASS complex."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The COMPASS complex is a multi-subunit protein complex that facilitates methylation, specifically histone H3 lysine 4 methylation, not the initiation of transcription in eukaryotic cells.",
      "false, [corrected fact]: CCCTC-binding factor (CBF) is a nuclear protein involved in the organization of chromatin structure, not a subunit of the COMPASS complex.",
      "false, [corrected fact]: The COMPASS complex does not include the Transcriptional activator TFIIB. Its core components include SET domain-containing methyltransferase proteins.",
      "true",
      "false, [corrected fact]: Histone acetyltransferases (HATs) and Histone deacetylases (HDACs) are associated with transcription activation and repression, respectively, but they are not part of the COMPASS complex which is primarily a histone methylation complex."
    ]
  },
  {
    "id": 3274,
    "user_query": "Central Vein Sign is characteristic to which disease?",
    "llama-2-7b-chat-hf_response": "A. Deep vein thrombosis\nB. Pulmonary embolism\nC. Superficial vein thrombosis\nD. Varicose veins\nCorrect answer: B. Pulmonary embolism.\nExplanation: Central Vein Sign is a characteristic sign of pulmonary embolism, which is a blockage of a blood vessel in the lungs. It is caused by a blood clot that has traveled from another part of the body to the lungs. The sign is characterized by a prominent central vein in the chest radiograph, which is often accompanied by other signs such as consolidation or pleural effusion.\nDeep vein thrombosis is a condition in which a blood clot forms in the deep veins of the body, usually in the legs. It is not associated with the Central Vein Sign.\nSuperficial vein thrombosis is a condition in which a blood clot forms in the superficial veins, which are located closer to the skin. It is also not associated with the Central Vein Sign.\nVaricose veins are enlarged, twisted veins that can occur in any part of the body. They are not associated with the Central Vein Sign.",
    "llama-2-7b-chat-hf_fact": [
      "Central Vein Sign is a characteristic sign of pulmonary embolism.",
      "Pulmonary embolism is a blockage of a blood vessel in the lungs, typically caused by a blood clot that has traveled from another part of the body.",
      "The Central Vein Sign is characterized by a prominent central vein in the chest radiograph, often accompanied by other signs such as consolidation or pleural effusion.",
      "Deep vein thrombosis is a condition where a blood clot forms in the deep veins of the body, usually in the legs, and it is not associated with the Central Vein Sign.",
      "Varicose veins are enlarged, twisted veins that can occur in any part of the body and are not associated with the Central Vein Sign."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Central Vein Sign is a characteristic sign of Multiple Sclerosis, not pulmonary embolism.",
      "true",
      "false, [corrected fact]: Central Vein Sign is seen in magnetic resonance imaging (MRI) of the brain in the condition of Multiple Sclerosis, characterized by veins visible in the center of MS lesions. It is not characterized in a chest radiograph.",
      "true",
      "true"
    ]
  },
  {
    "id": 3284,
    "user_query": "Do de novo truncating mutations in WASF1 cause cancer?",
    "llama-2-7b-chat-hf_response": "WASF1 (Wiskott-Aldrich syndrome factor 1) is a protein that plays a crucial role in regulating the cytoskeleton and cell signaling. Mutations in the WASF1 gene have been associated with various cancers, including acute myeloid leukemia (AML) and non-Hodgkin lymphoma (NHL). However, the mechanisms by which WASF1 mutations contribute to cancer development and progression are not fully understood.\nRecently, a study published in the journal Cancer Research investigated the role of de novo truncating mutations in WASF1 in cancer development. The study found that de novo truncating mutations in WASF1 were present in a significant proportion of AML and NHL cases, and that these mutations were associated with poorer prognosis.\nThe study also found that de novo truncating mutations in WASF1 led to the loss of WASF1 protein function, which in turn disrupted the normal regulation of the cytoskeleton and cell signaling pathways. This disruption contributed to the development and progression of cancer by promoting cell proliferation, survival, and migration.\nOverall, the study suggests that de novo truncating mutations in WASF1 play a critical role in the development and progression of certain types of cancer, and that targeting these mutations may be a promising therapeutic strategy for cancer treatment.",
    "llama-2-7b-chat-hf_fact": [
      "WASF1 is a protein that regulates the cytoskeleton and cell signaling.",
      "Mutations in the WASF1 gene have been associated with various cancers, such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma (NHL).",
      "A study published in the journal Cancer Research found that de novo truncating mutations in WASF1 were present in a significant proportion of AML and NHL cases.",
      "The study found that de novo truncating mutations in WASF1 disrupt the normal regulation of the cytoskeleton and cell signaling pathways, contributing to the development and progression of cancer.",
      "The same study suggested that targeting these mutations may be a promising therapeutic strategy for cancer treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-7b-chat-hf_response": "Fluzone Intradermal Quadrivalent is a vaccine that protects against four different flu viruses: two influenza A viruses (H1N1 and H3N2) and two influenza B viruses (B/Victoria and B/Yamagata). The vaccine is administered as an intradermal injection, which means it is injected into the skin rather than the muscle.\nThe Fluzone Intradermal Quadrivalent vaccine contains the following attenuated live viruses:\n* Influenza A/H1N1 (A/California/7/2004-like virus)\n* Influenza A/H3N2 (A/Wisconsin/1/2019-like virus)\n* Influenza B/Victoria (B/Victoria/2019-like virus)\n* Influenza B/Yamagata (B/Yamagata/2019-like virus)",
    "llama-2-7b-chat-hf_fact": [
      "Fluzone Intradermal Quadrivalent is a vaccine that protects against four different flu viruses.",
      "The viruses it protects against include two influenza A viruses (H1N1 and H3N2) and two influenza B viruses (B/Victoria and B/Yamagata).",
      "The Fluzone Intradermal Quadrivalent vaccine contains the Influenza A/H1N1 (A/California/7/2004-like virus).",
      "It also contains Influenza A/H3N2 (A/Wisconsin/1/2019-like virus), Influenza B/Victoria (B/Victoria/2019-like virus), and Influenza B/Yamagata (B/Yamagata/2019-like virus).",
      "The vaccine is administered as an intradermal injection, which means it is injected into the skin rather than the muscle."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false, [corrected fact]: The Fluzone Intradermal Quadrivalent vaccine is administered as an intramuscular injection, which means it is injected into the muscle rather than the skin."
    ]
  },
  {
    "id": 3300,
    "user_query": "How is Slc22a3 imprinted?",
    "llama-2-7b-chat-hf_response": "Slc22a3, also known as the solute carrier family 22 member 3 (SLC22A3), is a gene that codes for a protein involved in the transport of dopamine and other catecholamines in the brain. The Slc22a3 gene is imprinted, meaning that it has a differentially methylated region (DMR) that determines whether the gene is expressed from the paternal or maternal allele.\nThe Slc22a3 DMR is located at the 5' end of the gene and is methylated in a parent-of-origin-specific manner. The methylation status of the DMR is established during early embryonic development and is maintained throughout life. Methylation of the DMR leads to the silencing of the paternal allele, while the maternal allele remains unmethylated and is expressed.\nThe imprinting of Slc22a3 is regulated by a complex interplay of epigenetic marks, including DNA methylation, histone modifications, and non-coding RNA molecules. The exact mechanisms underlying Slc22a3 imprinting are not fully understood, but it is thought to involve the action of non-coding RNA molecules, such as microRNAs and long non-coding RNAs, which bind to specific sequences in the DMR and regulate the methylation status of the region.\nAbnormal imprinting of Slc22a3 has been implicated in a number of neurological disorders, including Rett syndrome, which is caused by mutations in the MeCP2 gene, which is located nearby the Slc22a3 DMR. Other disorders that have been linked to Slc22a3 imprinting include autism, schizophrenia, and bipolar disorder.\nIn summary, Slc22a3 is imprinted through a complex interplay of epigenetic marks, including DNA methylation, histone modifications, and non-coding RNA molecules. The imprinting of Slc22a3 is established during early embryonic development and is maintained throughout life, and abnormal imprinting has been implicated in a number of neurological dis",
    "llama-2-7b-chat-hf_fact": [
      "Slc22a3, or the solute carrier family 22 member 3 (SLC22A3), is a gene that codes for a protein involved in the transport of dopamine and other catecholamines in the brain.",
      "The Slc22a3 gene has a differentially methylated region (DMR) that determines whether the gene is expressed from the paternal or maternal allele.",
      "The Slc22a3 DMR is located at the 5' end of the gene and is methylated in a parent-of-origin-specific manner, with methylation of the DMR leading to the silencing of the paternal allele.",
      "The imprinting of Slc22a3 is regulated by DNA methylation, histone modifications, and non-coding RNA molecules, including microRNAs and long non-coding RNAs.",
      "Abnormal imprinting of Slc22a3 has been implicated in a number of neurological disorders, including Rett syndrome, autism, schizophrenia, and bipolar disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3302,
    "user_query": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "llama-2-7b-chat-hf_response": "Yes, the tyrosine kinase Bruton's tyrosine kinase (BTK) has been implicated in autoimmunity. BTK is a key player in the B cell receptor (BCR) signaling pathway, which is critical for B cell activation, proliferation, and differentiation. In recent years, several studies have suggested that BTK may play a role in the development and progression of autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS).\nOne of the main mechanisms by which BTK contributes to autoimmunity is through its ability to regulate the activation and proliferation of autoreactive B cells. In autoimmune diseases, autoreactive B cells are thought to play a key role in the initiation and progression of disease, and BTK has been shown to promote their activation and proliferation. For example, studies have shown that BTK is required for the survival and proliferation of autoreactive B cells in the context of SLE, and that BTK inhibition can reduce the frequency of these cells in the periphery.\nIn addition to its role in regulating autoreactive B cells, BTK has also been implicated in the regulation of T cell responses in autoimmune diseases. For example, studies have shown that BTK is required for the activation and proliferation of T cells in the context of MS, and that BTK inhibition can reduce the frequency of these cells in the periphery.\nOverall, the evidence suggests that BTK is a key player in the development and progression of autoimmune diseases, and that targeting BTK may be a promising therapeutic strategy for the treatment of these diseases. However, further research is needed to fully understand the role of BTK in autoimmunity and to determine the efficacy and safety of BTK inhibitors in clinical settings.",
    "llama-2-7b-chat-hf_fact": [
      "Bruton's tyrosine kinase (BTK) plays a significant role in the B cell receptor signaling pathway, which is important for B cell activation, proliferation, and differentiation.",
      "BTK has been suggested to contribute to the development and progression of autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS).",
      "BTK is associated with regulating the activation and proliferation of autoreactive B cells, which are believed to be a key factor in starting and developing autoimmune diseases.",
      "Studies have suggested that BTK is necessary for the activation and proliferation of T cells in the context of multiple sclerosis.",
      "Further research is required to fully understand the role of BTK in autoimmunity and to assess the efficiency and safety of BTK inhibitors in a clinical setting."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no clear evidence to suggest that BTK is necessary for the activation and proliferation of T cells in the context of multiple sclerosis. More commonly, BTK is associated with the activation and proliferation of B cells.",
      "true"
    ]
  },
  {
    "id": 3303,
    "user_query": "What is the BioPlex network?",
    "llama-2-7b-chat-hf_response": "The BioPlex network is a collaborative research network that aims to advance the understanding of the biology of complex diseases, such as cancer, neurological disorders, and metabolic diseases. The network brings together researchers from academia, industry, and clinical settings to share data, resources, and expertise in order to accelerate the discovery of new biomarkers and therapies.",
    "llama-2-7b-chat-hf_fact": [
      "The BioPlex network is a collaborative research network.",
      "One of the goals of the BioPlex network is to advance the understanding of the biology of complex diseases.",
      "The BioPlex network focuses on diseases such as cancer, neurological disorders, and metabolic diseases.",
      "The network consists of researchers from academia, industry, and clinical settings.",
      "The BioPlex network aims to accelerate the discovery of new biomarkers and therapies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3304,
    "user_query": "Which algorithm has been developed for detecting expansions of tandem repeats?",
    "llama-2-7b-chat-hf_response": "Answer: There are several algorithms that have been developed for detecting expansions of tandem repeats, including:\n1. RepeatMasker: This is a widely used tool for identifying repetitive DNA elements in a genome, including tandem repeats. RepeatMasker uses a combination of algorithms to identify repeats and can be used to detect both short and long tandem repeats.\n2. Tandem Repeat Finder (TRF): This algorithm was developed specifically for detecting tandem repeats and can be used to identify both short and long repeats. TRF uses a hidden Markov model to identify repeats and can be used to analyze both DNA and RNA sequences.\n3. Repeat Scan: This algorithm is similar to RepeatMasker and can be used to identify both short and long tandem repeats. Repeat Scan uses a combination of algorithms to identify repeats and can be used to analyze both DNA and RNA sequences.\n4. Long Repeat Finder (LRF): This algorithm was developed specifically for identifying long tandem repeats (LTRs) and can be used to identify repeats that are longer than 100 base pairs. LRF uses a hidden Markov model to identify LTRs and can be used to analyze both DNA and RNA sequences.\n5. Iterative Repeat Finder (IRF): This algorithm is similar to RepeatMasker and can be used to identify both short and long tandem repeats. IRF uses an iterative approach to identify repeats and can be used to analyze both DNA and RNA sequences.\nThese are some of the commonly used algorithms for detecting expansions of tandem repeats, but there are many other algorithms available as well. The choice of algorithm will depend on the specific research question and the characteristics of the data being analyzed.",
    "llama-2-7b-chat-hf_fact": [
      "RepeatMasker is an algorithm used for detecting expansions of tandem repeats.",
      "Tandem Repeat Finder is another algorithm developed specifically for identifying both short and long tandem repeats.",
      "Repeat Scan is an algorithm similar to RepeatMasker, used for identifying both short and long tandem repeats.",
      "Long Repeat Finder was developed specifically for identifying long tandem repeats or LTRs longer than 100 base pairs.",
      "Iterative Repeat Finder is an algorithm similar to RepeatMasker used for identifying both short and long tandem repeats."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3305,
    "user_query": "Which clotting factor is in the Andexxa?",
    "llama-2-7b-chat-hf_response": "Andexxa is a clotting factor concentrate used to treat bleeding in patients with hemophilia A or B. It contains the clotting factor VIII in patients with hemophilia A or clotting factor IX in patients with hemophilia B.",
    "llama-2-7b-chat-hf_fact": [
      "Andexxa is a clotting factor concentrate.",
      "Andexxa is used to treat bleeding in patients with hemophilia A or B.",
      "Andexxa contains clotting factor VIII for patients with hemophilia A.",
      "Andexxa contains clotting factor IX for patients with hemophilia B."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Andexxa is used to treat severe bleeding in patients taking some types of anticoagulant medicines, not hemophilia A or B.",
      "false, [corrected fact]: Andexxa does not contain clotting factor VIII. It is used to reverse the effects of anticoagulant medicines.",
      "false, [corrected fact]: Andexxa does not contain clotting factor IX. It is used to reverse the effects of anticoagulant medicines."
    ]
  },
  {
    "id": 3315,
    "user_query": "What classes of drugs does Retapamulin belong to?",
    "llama-2-7b-chat-hf_response": "Retapamulin belongs to the class of drugs called aminoglycoside antibiotics. Aminoglycoside antibiotics are a class of antibiotics that work by interfering with the synthesis of proteins in bacteria, ultimately leading to the death of the bacterial cells. Retapamulin is specifically a cyclic aminoglycoside antibiotic, which means it has a cyclic structure and is related to other aminoglycoside antibiotics such as tobramycin and amikacin.",
    "llama-2-7b-chat-hf_fact": [
      "Retapamulin is a drug that belongs to the class of aminoglycoside antibiotics.",
      "Aminoglycoside antibiotics work by interfering with the synthesis of proteins in bacteria.",
      "This interference leads to the death of the bacterial cells.",
      "Retapamulin is a cyclic aminoglycoside antibiotic.",
      "Retapamulin is related to other aminoglycoside antibiotics such as tobramycin and amikacin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Retapamulin is a drug that belongs to the class of pleuromutilin antibiotics.",
      "true",
      "true",
      "false, [corrected fact]: Retapamulin is a pleuromutilin antibiotic, not a cyclic aminoglycoside antibiotic.",
      "false, [corrected fact]: Retapamulin is not related to aminoglycoside antibiotics such as tobramycin and amikacin; it is a pleuromutilin antibiotic."
    ]
  },
  {
    "id": 3322,
    "user_query": "Which T-UCR has been implicated in prostate cancer?",
    "llama-2-7b-chat-hf_response": "T-UCR stands for Tumor-associated CD4+ T cells, which are a subtype of T cell that are involved in the immune response to cancer. Prostate cancer is a common type of cancer that affects men, and research has shown that T-UCR play a role in the development and progression of this disease.\nSeveral studies have identified specific T-UCR subtypes that are associated with prostate cancer. For example, one study found that men with high-grade prostate cancer had higher levels of a subtype of T-UCR called T helper 17 (Th17) cells compared to men with low-grade prostate cancer. Another study found that men with metastatic prostate cancer had higher levels of T regulatory (Treg) cells compared to men with localized prostate cancer.\nOverall, the evidence suggests that T-UCR play a complex and multifaceted role in the development and progression of prostate cancer, and that different subtypes of T-UCR may be involved in different stages of the disease. Further research is needed to fully understand the mechanisms by which T-UCR contribute to prostate cancer and to identify potential therapeutic targets for this disease.",
    "llama-2-7b-chat-hf_fact": [
      "T-UCR stands for Tumor-associated CD4+ T cells, which are a subtype of T cell involved in the immune response to cancer.",
      "Research has shown that T-UCR play a role in the development and progression of prostate cancer.",
      "Men with high-grade prostate cancer have been found to have higher levels of a subtype of T-UCR called T helper 17 (Th17) cells compared to men with low-grade prostate cancer.",
      "Higher levels of T regulatory (Treg) cells have been found in men with metastatic prostate cancer compared to men with localized prostate cancer.",
      "The evidence suggests that T-UCR play a complex role in the development and progression of prostate cancer, with different subtypes of T-UCR involved in different stages of the disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: T-UCR stands for Transcribed Ultraconserved Regions, not Tumor-associated CD4+ T cells.",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3325,
    "user_query": "Which company sells the drug Afrezza since 2015?",
    "llama-2-7b-chat-hf_response": "Afrezza is a prescription medication that is used to treat type 1 and type 2 diabetes. It is an inhaled insulin product that is taken before meals to help manage blood sugar levels. The drug was first approved by the FDA in 2005, but it was removed from the market in 2014 due to poor sales. However, in 2015, the drug was reintroduced to the market by a new manufacturer, and it is now available by prescription in the United States.\nThe company that sells Afrezza since 2015 is MannKind Corporation. MannKind is a biopharmaceutical company that specializes in the development and commercialization of inhaled therapeutics. The company acquired the rights to Afrezza from Sanofi, the original manufacturer of the drug, in 2015. Since then, MannKind has been responsible for the marketing and distribution of Afrezza in the United States.",
    "llama-2-7b-chat-hf_fact": [
      "Afrezza is a prescription medication used to treat type 1 and type 2 diabetes.",
      "The drug Afrezza was first approved by the FDA in 2005.",
      "Afrezza was reintroduced to the market by MannKind Corporation in 2015.",
      "MannKind Corporation is a biopharmaceutical company that specializes in the development and commercialization of inhaled therapeutics.",
      "MannKind Corporation acquired the rights to Afrezza from Sanofi in 2015."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The drug Afrezza was first approved by the FDA in 2014.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3327,
    "user_query": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "llama-2-7b-chat-hf_response": "Yes, Uc63+ has been shown to promote sensitivity to treatment in prostate cancer. Uc63+ is a protein that is overexpressed in many types of cancer, including prostate cancer. Research has shown that Uc63+ can promote the development of resistance to chemotherapy and radiation therapy in prostate cancer cells.\nOne study published in the journal Cancer Research found that Uc63+ was overexpressed in prostate cancer cells that were resistant to chemotherapy. The researchers found that inhibiting the expression of Uc63+ in these cells made them more sensitive to chemotherapy.\nAnother study published in the journal Prostate found that Uc63+ was overexpressed in prostate cancer cells that were resistant to radiation therapy. The researchers found that inhibiting the expression of Uc63+ in these cells made them more sensitive to radiation therapy.\nOverall, these studies suggest that Uc63+ may play a role in the development of resistance to treatment in prostate cancer, and that targeting Uc63+ may be a promising strategy for improving the effectiveness of treatment in this disease.",
    "llama-2-7b-chat-hf_fact": [
      "Uc63+ is a protein that is overexpressed in many types of cancer including prostate cancer.",
      "Uc63+ promotes the development of resistance to chemotherapy and radiation therapy in prostate cancer cells.",
      "One study found that Uc63+ was overexpressed in prostate cancer cells resistant to chemotherapy and inhibiting its expression made them more sensitive to chemotherapy.",
      "Another study found that Uc63+ was overexpressed in prostate cancer cells resistant to radiation therapy and inhibiting its expression made them more sensitive to radiation therapy.",
      "These studies suggest that targeting Uc63+ may be a promising strategy for improving the effectiveness of treatment in prostate cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3332,
    "user_query": "What is OAC CHV?",
    "llama-2-7b-chat-hf_response": "OAC CHV stands for Ontario Association of Certified Home Visitors. The Ontario Association of Certified Home Visitors (OAC CHV) is a professional association that represents home visitors in Ontario, Canada. Home visitors are trained professionals who provide home visiting services to families with young children, pregnant women, and new mothers. The OAC CHV sets standards for home visiting practice, provides professional development opportunities, and advocates for home visiting services in Ontario.",
    "llama-2-7b-chat-hf_fact": [
      "OAC CHV stands for Ontario Association of Certified Home Visitors.",
      "Ontario Association of Certified Home Visitors is a professional association that represents home visitors in Ontario, Canada.",
      "Home visitors provide home visiting services to families with young children, pregnant women, and new mothers.",
      "The OAC CHV sets standards for home visiting practice in Ontario.",
      "The Ontario Association of Certified Home Visitors provides professional development opportunities and advocates for home visiting services in Ontario."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3338,
    "user_query": "What does MVA85A stand for?",
    "llama-2-7b-chat-hf_response": "MVA85A stands for \"Motor Vehicle Accident, 85th Percentile Speed\". It is a term used in traffic safety research to describe the speed at which a vehicle is traveling when it is involved in a collision. The 85th percentile speed is the speed at which 85% of vehicles travel at or below, and is often used as a measure of the prevailing speed of traffic.",
    "llama-2-7b-chat-hf_fact": [
      "MVA85A stands for \"Motor Vehicle Accident, 85th Percentile Speed\".",
      "MVA85A is a term used in traffic safety research.",
      "It refers to the speed at which a vehicle is traveling when it is involved in a collision.",
      "The 85th percentile speed is defined as the speed at which 85% of vehicles travel at or below.",
      "The 85th percentile speed is often used as a measure of the prevailing speed of traffic."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MVA85A does not stand for \"Motor Vehicle Accident, 85th Percentile Speed\". It is a vaccine candidate aiming to boost the efficacy of BCG, the established TB vaccine.",
      "false, [corrected fact]: MVA85A is not a term used in traffic safety research. It is involved in tuberculosis research.",
      "false, [corrected fact]: MVA85A does not refer to the speed at which a vehicle is traveling when it involved in a collision. It's a tuberculosis vaccine candidate.",
      "true",
      "true"
    ]
  },
  {
    "id": 3339,
    "user_query": "Can MVA85A confer immunity against smallpox?",
    "llama-2-7b-chat-hf_response": "No, MVA85A does not confer immunity against smallpox. MVA85A is a modified vaccinia virus Ankara (MVA) vaccine that is being developed as a potential vaccine against COVID-19. While MVA85A has been shown to be safe and immunogenic in clinical trials, it has not been tested for its ability to protect against smallpox.\nSmallpox is a highly contagious and potentially deadly disease that was eradicated in 1980 through a global vaccination campaign led by the World Health Organization (WHO). The last naturally occurring case of smallpox was reported in 1977, and the virus is now considered to be extinct in the wild. However, there is concern that smallpox could be used as a bioterrorism agent, and there is ongoing research into developing vaccines that could provide protection against this disease.\nCurrently, the only vaccine approved for use against smallpox is the smallpox vaccine, which is made from the smallpox virus itself. This vaccine has been shown to be highly effective in preventing smallpox, but it has some limitations, including the risk of adverse reactions and the need for multiple doses to provide full protection.\nIn summary, while MVA85A has shown promise as a COVID-19 vaccine, it has not been tested for its ability to protect against smallpox, and there is currently no vaccine available that provides immunity against this disease.",
    "llama-2-7b-chat-hf_fact": [
      "MVA85A is a modified vaccinia virus Ankara (MVA) vaccine that is being developed for COVID-19.",
      "Smallpox was eradicated in 1980 through a global vaccination campaign led by the World Health Organization (WHO).",
      "The last naturally occurring case of smallpox was reported in 1977.",
      "The only vaccine approved for use against smallpox is made from the smallpox virus itself.",
      "MVA85A vaccine has not been tested for its capacity to protect against smallpox."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: MVA85A is a modified vaccinia virus Ankara (MVA) vaccine that was primarily developed for tuberculosis, not COVID-19.",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3342,
    "user_query": "List cohesinopathies",
    "llama-2-7b-chat-hf_response": "Cohesinopathies are a group of rare genetic disorders caused by mutations in the SMC1 or SMC3 genes, which code for proteins involved in the cohesin complex. The cohesin complex plays a crucial role in the maintenance of chromosome stability and the proper segregation of chromosomes during cell division. Mutations in the SMC1 or SMC3 genes can lead to the loss of cohesin function, resulting in the breakdown of chromosomes and the development of various developmental delays, intellectual disability, and congenital anomalies.\nThere are several types of cohesinopathies, including:\n1. Cornelia de Lange syndrome (CdLS): This is a rare genetic disorder characterized by developmental delays, intellectual disability, and congenital anomalies such as craniofacial abnormalities, limb abnormalities, and heart defects. CdLS is caused by mutations in the SMC1 gene.\n2. Smith-Magenis syndrome (SMS): This is a rare genetic disorder characterized by developmental delays, intellectual disability, and congenital anomalies such as craniofacial abnormalities, ear abnormalities, and congenital heart defects. SMS is caused by mutations in the SMC3 gene.\n3. Bohring-Opitz syndrome (BOS): This is a rare genetic disorder characterized by developmental delays, intellectual disability, and congenital anomalies such as craniofacial abnormalities, limb abnormalities, and congenital heart defects. BOS is caused by mutations in the SMC1 gene.\n4. Cohesinopathy, type 1 (COH1): This is a rare genetic disorder characterized by developmental delays, intellectual disability, and congenital anomalies such as craniofacial abnormalities, limb abnormalities, and congenital heart defects. COH1 is caused by mutations in the SMC3 gene.\n5. Cohesinopathy, type 2 (COH2): This is a rare genetic disorder characterized by developmental delays, intellectual",
    "llama-2-7b-chat-hf_fact": [
      "Cohesinopathies are rare genetic disorders caused by mutations in the SMC1 or SMC3 genes.",
      "The SMC1 and SMC3 genes code for proteins involved in the cohesin complex.",
      "The cohesin complex plays a role in the maintenance of chromosome stability and the proper segregation of chromosomes during cell division.",
      "Cornelia de Lange syndrome (CdLS), a type of cohesinopathy, is caused by mutations in the SMC1 gene.",
      "Smith-Magenis syndrome (SMS), another type of cohesinopathy, is caused by mutations in the SMC3 gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Smith-Magenis syndrome (SMS) is not a type of cohesinopathy and it is not caused by mutations in the SMC3 gene. It is caused by mutations in the RAI1 gene or a deletion of genetic material from chromosome 17."
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-7b-chat-hf_response": "Systemic lupus erythematosus (SLE) is a complex and multifactorial autoimmune disease that affects various organs and tissues, including the skin, joints, kidneys, and nervous system. The Tumor Necrosis Factor Receptor 2 (TNFR2) gene has been implicated in the pathogenesis of SLE, and several studies have identified genetic variations in the TNFR2 gene that are associated with an increased risk of developing SLE.\nOne of the most well-established genetic associations with SLE is the presence of a single nucleotide polymorphism (SNP) in the TNFR2 gene, specifically the -308 G/C polymorphism. This SNP is located in the 5' untranslated region of the TNFR2 gene and has been shown to influence the expression of the TNFR2 protein. Studies have consistently found that individuals with the G allele at this locus have an increased risk of developing SLE compared to those with the C allele.\nOther genetic variations in the TNFR2 gene have also been associated with SLE, including insertion/deletion polymorphisms and copy number variations. However, the -308 G/C polymorphism is the most well-established and widely studied genetic association with SLE.\nIt is important to note that while genetic variations in the TNFR2 gene have been associated with an increased risk of developing SLE, the exact mechanisms by which these variations contribute to the development of the disease are not fully understood. Further research is needed to elucidate the complex interplay between genetic and environmental factors in the pathogenesis of SLE.",
    "llama-2-7b-chat-hf_fact": [
      "Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease that affects various organs and tissues.",
      "The Tumor Necrosis Factor Receptor 2 (TNFR2) gene has been implicated in the pathogenesis of SLE.",
      "Genetic variations in the TNFR2 gene, such as the -308 G/C polymorphism, have been associated with an increased risk of SLE.",
      "The -308 G/C single nucleotide polymorphism (SNP) is found in the 5' untranslated region of the TNFR2 gene.",
      "Individuals with the G allele at the -308 locus have an increased risk of developing SLE compared to those with the C allele."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The -308 G/A single nucleotide polymorphism (SNP) is found in the 5' untranslated region of the TNFR2 gene.",
      "unknown"
    ]
  },
  {
    "id": 3348,
    "user_query": "Is Figitumumab effective for non-small cell lung cancer?",
    "llama-2-7b-chat-hf_response": "Figitumumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFRvIII), which is a mutated form of the EGFR protein that is overexpressed in many types of cancer, including non-small cell lung cancer (NSCLC). In clinical trials, figitumumab has been shown to have antitumor activity in patients with NSCLC, particularly in those with EGFRvIII-positive tumors. However, the efficacy of figitumumab in NSCLC is still being studied and debated.\nSome studies have suggested that figitumumab may be effective in improving progression-free survival (PFS) and overall survival (OS) in patients with EGFRvIII-positive NSCLC. For example, a phase III clinical trial published in the New England Journal of Medicine in 2013 found that figitumumab plus first-line chemotherapy improved PFS by 2.5 months compared to chemotherapy alone in patients with EGFRvIII-positive NSCLC. Another study published in the Journal of Clinical Oncology in 2015 found that figitumumab plus chemotherapy improved OS by 6.7 months compared to chemotherapy alone in patients with EGFRvIII-positive NSCLC.\nHowever, other studies have found mixed results or no significant improvement in outcomes with figitumumab in NSCLC. For example, a phase II clinical trial published in the Journal of Thoracic Oncology in 2014 found that figitumumab plus chemotherapy had no significant improvement in PFS or OS compared to chemotherapy alone in patients with advanced NSCLC. Another study published in the Lancet Oncology in 2016 found that figitumumab plus chemotherapy had no significant improvement in OS compared to chemotherapy alone in patients with EGFRvIII-positive NSCLC.\nOverall, the evidence suggests that figitumumab may be effective in improving outcomes in patients with EGFRvIII-positive NSCLC, but more research is needed to confirm these findings and to determine the optimal use of figitumumab in the treatment of NSCLC.",
    "llama-2-7b-chat-hf_fact": [
      "Figitumumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFRvIII).",
      "EGFRvIII is a mutated form of the EGFR protein that is overexpressed in many types of cancer, including non-small cell lung cancer.",
      "A phase III clinical trial reported that figitumumab plus first-line chemotherapy improved progression-free survival in patients with EGFRvIII-positive non-small cell lung cancer.",
      "Another study found that figitumumab plus chemotherapy improved overall survival in EGFRvIII-positive non-small cell lung cancer patients.",
      "Some studies found no significant improvement in outcomes with figitumumab in non-small cell lung cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Figitumumab is a monoclonal antibody that targets the insulin growth factor 1 receptor (IGF-1R), not the epidermal growth factor receptor (EGFRvIII).",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3349,
    "user_query": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "llama-2-7b-chat-hf_response": "The LINCS L1000 data set contains gene expression data for drug-treated human cells. Therefore, the answer is yes.",
    "llama-2-7b-chat-hf_fact": [
      "The LINCS L1000 data set contains gene expression data.",
      "This gene expression data in the LINCS L1000 dataset is from drug-treated human cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3351,
    "user_query": "Which database exists that contains regulatory SNPs which affect predicted transcription factor binding site affinity?",
    "llama-2-7b-chat-hf_response": "There are several databases that contain information on regulatory SNPs that affect transcription factor binding site affinity. Here are a few examples:\n1. The Regulatory SNP (rs) Database: This database contains information on SNPs that affect the binding affinity of transcription factors to their target sites in the human genome. The database includes both experimentally validated and computationally predicted SNPs.\n2. The Transcription Factor Binding Site (TFBS) Database: This database contains information on the binding sites of transcription factors in the human genome, including the binding affinity of each site. The database also includes information on SNPs that affect the binding affinity of transcription factors to their target sites.\n3. The Chromatin Immunoprecipitation Sequencing (ChIP-seq) Database: This database contains information on the binding sites of transcription factors and other regulatory proteins in the human genome, including the binding affinity of each site. The database also includes information on SNPs that affect the binding affinity of transcription factors to their target sites.\n4. The Encyclopedia of DNA Elements (ENCODE): This database contains information on the functional elements in the human genome, including the binding sites of transcription factors and other regulatory proteins. The database also includes information on SNPs that affect the binding affinity of transcription factors to their target sites.\n5. The Genome-Wide Association Study (GWAS) Database: This database contains information on SNPs that have been associated with complex diseases and traits, including those that affect transcription factor binding site affinity.\nIt's worth noting that these databases are constantly being updated and expanded, so it's a good idea to check the latest version of the database you're interested in for the most up-to-date information.",
    "llama-2-7b-chat-hf_fact": [
      "The Regulatory SNP (rs) Database contains information on SNPs that affect the binding affinity of transcription factors to their target sites in the human genome.",
      "The Transcription Factor Binding Site (TFBS) Database includes information on SNPs that affect the binding affinity of transcription factors to their target sites.",
      "The Chromatin Immunoprecipitation Sequencing (ChIP-seq) Database contains information on the binding sites of transcription factors and other regulatory proteins in the human genome.",
      "The Encyclopedia of DNA Elements (ENCODE) is a database that contains information on the functional elements in the human genome.",
      "The Genome-Wide Association Study (GWAS) Database includes information on SNPs that have been associated with complex diseases and traits."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3352,
    "user_query": "Which R package has been developed for MS-based label-free phosphoproteomics?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for MS-based label-free phosphoproteomics, including:\n1. pphospho: This package provides tools for the analysis of label-free phosphoproteomics data, including phosphopeptide identification, phosphorylation site localization, and network analysis.\n2. PhosphoExplorer: This package provides a comprehensive set of tools for the analysis of label-free phosphoproteomics data, including phosphopeptide identification, phosphorylation site localization, and pathway analysis.\n3. PHOSPHOR: This package provides tools for the analysis of label-free phosphoproteomics data, including phosphopeptide identification, phosphorylation site localization, and network analysis.\n4. ProteinPhospho: This package provides tools for the analysis of label-free phosphoproteomics data, including phosphopeptide identification, phosphorylation site localization, and pathway analysis.\n5. PhosphoMass: This package provides tools for the analysis of label-free phosphoproteomics data, including phosphopeptide identification, phosphorylation site localization, and network analysis.\nThese packages can be used to analyze various types of MS-based label-free phosphoproteomics data, including data from mass spectrometry imaging (MSI) and data from data-independent acquisition (DIA) experiments.",
    "llama-2-7b-chat-hf_fact": [
      "The pphospho is an R package developed for MS-based label-free phosphoproteomics.",
      "PhosphoExplorer is an R package developed for the analysis of label-free phosphoproteomics data.",
      "PHOSPHOR is an R package that provides tools for the analysis of label-free phosphoproteomics data.",
      "ProteinPhospho is another R package designed for the analysis of label-free phosphoproteomics data.",
      "PhosphoMass is an R package that aids in the analysis of label-free phosphoproteomics data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-7b-chat-hf_response": "Researchers are working on developing a vaccine for peanut allergy, but it is still in the experimental stage and has not yet been approved for use in humans.\nPeanut allergy is one of the most common and severe food allergies, affecting an estimated 1% of children and 0.4% of adults in the United States. Currently, there is no cure for peanut allergy, and the only treatment is to avoid peanuts and peanut products entirely.\nSeveral approaches are being explored to develop a vaccine for peanut allergy, including:\n1. Oral immunotherapy: This involves gradually introducing small amounts of peanut protein to the body to build up tolerance.\n2. Epicutaneous immunotherapy: This involves applying a small amount of peanut protein to the skin, where it is absorbed and triggers an immune response.\n3. Sublingual immunotherapy: This involves placing a small amount of peanut protein under the tongue, where it is absorbed and triggers an immune response.\n4. mRNA vaccine: This involves using a piece of genetic material called messenger RNA (mRNA) to instruct cells to produce a specific protein. In the case of peanut allergy, the mRNA would instruct cells to produce a protein that is similar to the peanut allergen.\n5. Dendritic cell vaccine: This involves using dendritic cells, which are a type of immune cell, to present the peanut allergen to the immune system.\nIt is important to note that these vaccines are still in the experimental stage, and more research is needed to determine their safety and effectiveness in humans. Additionally, even if a vaccine is developed, it may not be effective for everyone with peanut allergy, and it may not completely eliminate the need for avoidance of peanuts and peanut products.\nIn summary, while researchers are working on developing a vaccine for peanut allergy, it is still in the experimental stage and has not yet been approved for use in humans. If you have peanut allergy, it is important to continue to avoid peanuts and peanut products to prevent an allergic reaction.",
    "llama-2-7b-chat-hf_fact": [
      "Researchers are currently working on developing a vaccine for peanut allergy.",
      "Peanut allergy is common, affecting around 1% of children and 0.4% of adults in the United States.",
      "There is currently no cure for peanut allergy, and prevention involves entirely avoiding peanuts and peanut products.",
      "Approaches being explored for a peanut allergy vaccine include oral immunotherapy, epicutaneous immunotherapy, sublingual immunotherapy, mRNA vaccines, and dendritic cell vaccines.",
      "Any potential vaccine for peanut allergy is still in the experimental stage and not yet approved for use in humans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3358,
    "user_query": "What is Soluvia?",
    "llama-2-7b-chat-hf_response": "Soluvia is a company that specializes in providing sustainable and eco-friendly solutions for various industries, including agriculture, horticulture, and landscaping. The company's mission is to help businesses and individuals reduce their environmental impact and promote sustainable practices through innovative products and services.\nWhat are some of the products and services offered by Soluvia?\nSoluvia offers a range of products and services that are designed to help businesses and individuals reduce their environmental impact. Some of the products and services offered by the company include:\n1. Eco-friendly fertilizers: Soluvia offers a range of fertilizers that are made from natural and organic materials, such as fish emulsion, bone meal, and alfalfa meal. These fertilizers are designed to provide essential nutrients to plants without harming the environment.\n2. Biodegradable pesticides: Soluvia's biodegradable pesticides are made from natural ingredients such as neem oil, pyrethrin, and rotenone. These pesticides are safe for the environment and can be used to control pests without harming beneficial insects.\n3. Composting solutions: Soluvia offers a range of composting solutions that are designed to help businesses and individuals reduce their food waste and create nutrient-rich compost. The company's composting solutions include turnkey composting systems, compost bins, and compost tea brewers.\n4. Irrigation systems: Soluvia's irrigation systems are designed to help businesses and individuals conserve water and reduce their water bills. The company's irrigation systems include drip irrigation systems, sprinkler systems, and rainwater harvesting systems.\n5. Landscaping services: Soluvia offers landscaping services that are designed to help businesses and individuals create beautiful and sustainable landscapes. The company's landscaping services include landscape design, installation, and maintenance.\n6. Education and consulting: Soluvia offers education and consulting services that are designed to help businesses and individuals understand the benefits of sustainable practices and how to implement them. The company's education and consulting services include workshops,",
    "llama-2-7b-chat-hf_fact": [
      "Soluvia is a company that specializes in providing eco-friendly solutions for industries such as agriculture, horticulture, and landscaping.",
      "Soluvia offers eco-friendly fertilizers made from natural and organic materials.",
      "Soluvia provides biodegradable pesticides made from natural ingredients like neem oil, pyrethrin and rotenone.",
      "The company offers composting solutions designed to reduce food waste and produce nutrient-rich compost.",
      "Soluvia offers landscaping services and its irrigation systems help conserve water."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3361,
    "user_query": "What is the main difference between nascent and mature chromatin?",
    "llama-2-7b-chat-hf_response": "Nascent chromatin refers to the newly synthesized DNA that is being transcribed into RNA and is still in the process of being compacted and organized into chromatin structures. Mature chromatin, on the other hand, refers to the fully compacted and organized chromatin that is ready for gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Nascent chromatin is the newly synthesized DNA being transcribed into RNA.",
      "Nascent chromatin is still in the process of being compacted and organized into chromatin structures.",
      "Mature chromatin is fully compacted and organized chromatin.",
      "Mature chromatin is ready for gene expression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Mature chromatin is not typically in a state suitable for gene expression. Gene expression usually occurs with less compacted, accessible chromatin."
    ]
  },
  {
    "id": 3362,
    "user_query": "Is CTCF bound at nucleosome free regions?",
    "llama-2-7b-chat-hf_response": "CTCF (CCCTC-binding factor) is a protein that plays a crucial role in regulating chromatin structure and gene expression. It is known to bind to specific DNA sequences and to be involved in the formation of topologically associating domains (TADs), which are regions of the genome that are physically associated with each other and are often involved in the regulation of gene expression.\nOne question that has been raised about CTCF is whether it is bound at nucleosome-free regions of the genome. Nucleosomes are the basic units of chromatin, consisting of a segment of DNA wrapped around a core of eight histone proteins. They are thought to play a role in compacting the chromatin and making it more inaccessible to the machinery of gene expression.\nStudies have shown that CTCF is indeed bound at nucleosome-free regions of the genome. For example, a study published in the journal Nature in 2010 found that CTCF is bound at the 5' ends of active genes, which are typically nucleosome-free. Another study published in the journal Cell in 2012 found that CTCF is bound at regions of the genome that are enriched in histone H3 lysine 4 trimethylation (H3K4me3), which is a mark of active gene expression and is often found at nucleosome-free regions.\nThese findings suggest that CTCF may play a role in maintaining the accessibility of the genome to the machinery of gene expression, by binding at regions that are free of nucleosomes. However, more research is needed to fully understand the relationship between CTCF and nucleosome-free regions of the genome.",
    "llama-2-7b-chat-hf_fact": [
      "CTCF (CCCTC-binding factor) is a protein known to bind to specific DNA sequences.",
      "CTCF is involved in the formation of topologically associating domains (TADs).",
      "Nucleosomes are the basic units of chromatin, consisting of DNA wrapped around a core of eight histone proteins.",
      "Studies have shown that CTCF is bound at nucleosome-free regions of the genome.",
      "A study found that CTCF is bound at regions of the genome enriched in histone H3 lysine 4 trimethylation (H3K4me3)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3364,
    "user_query": "Is PRDM9 essential for meiosis?",
    "llama-2-7b-chat-hf_response": "PRDM9 is a transcription factor that plays a crucial role in the regulation of meiosis, the process by which sex cells (sperm and egg cells) are produced in sexually reproducing organisms. In mammals, PRDM9 is specifically expressed in the germline cells, which are the cells that give rise to sperm and egg cells.\nStudies have shown that PRDM9 is essential for the proper progression of meiosis in mammals. Mice lacking PRDM9 have defects in meiosis, including abnormal chromosome segregation and reduced fertility. Similarly, studies in humans have shown that mutations in the PRDM9 gene are associated with infertility and recurrent pregnancy loss.\nPRDM9 regulates the expression of genes involved in meiosis, including genes involved in chromosome segregation, DNA repair, and the regulation of meiotic recombination. It also regulates the expression of genes involved in the development and maintenance of the germline cells.\nIn summary, PRDM9 is essential for the proper progression of meiosis in mammals, and its dysregulation can lead to defects in meiosis and infertility.",
    "llama-2-7b-chat-hf_fact": [
      "PRDM9 is a transcription factor that plays a role in the regulation of meiosis.",
      "PRDM9 is expressed in the germline cells that give rise to sperm and egg cells in mammals.",
      "Studies have indicated that PRDM9 is crucial for the proper progression of meiosis in mammals.",
      "Mutations in the PRDM9 gene are associated with infertility and recurrent pregnancy loss in humans.",
      "PRDM9 regulates the expression of genes involved in meiosis, including genes involved in chromosome segregation, DNA repair, development, and maintenance of the germline cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-7b-chat-hf_response": "The Fxy gene, which encodes the protein follistatin, is located on the X chromosome in mammals, including humans. The Fxy gene is located at Xp11.2, which is the long arm of the X chromosome at position 11.2. This location is specific to the X chromosome and is not found on any other chromosome in mammals. The Fxy gene is one of several genes located on the X chromosome that are involved in a variety of biological processes, including development, growth, and reproduction.",
    "llama-2-7b-chat-hf_fact": [
      "The Fxy gene encodes the protein follistatin.",
      "The Fxy gene is located on the X chromosome in mammals, including humans.",
      "Specifically, the Fxy gene is located at Xp11.2, the long arm of the X chromosome, at position 11.2.",
      "This particular location is exclusive to the X chromosome and is not found on any other chromosome in mammals.",
      "The Fxy gene is one of several genes located on the X chromosome that are involved in biological processes such as development, growth, and reproduction."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3367,
    "user_query": "What does a PET (Positron Excitation Tomography) measure?",
    "llama-2-7b-chat-hf_response": "PET (Positron Excitation Tomography) is a medical imaging technique that uses small amounts of radioactive tracers to visualize and measure various physiological and pathological processes in the body. PET measures the distribution and metabolism of these tracers in the body, which can provide information on a wide range of biological processes, including:\n1. Glucose metabolism: PET can measure glucose metabolism in the body, which can help diagnose and monitor conditions such as diabetes, cancer, and neurological disorders.\n2. Neurotransmitter function: PET can measure the activity of neurotransmitters such as dopamine, serotonin, and norepinephrine in the brain, which can help diagnose and monitor conditions such as Parkinson's disease, depression, and anxiety disorders.\n3. Cellular proliferation: PET can measure the growth and division of cells in the body, which can help diagnose and monitor conditions such as cancer.\n4. Inflammation: PET can measure inflammation in the body, which can help diagnose and monitor conditions such as infection, autoimmune disorders, and inflammatory diseases.\n5. Cardiovascular function: PET can measure blood flow, oxygen use, and metabolism in the heart and blood vessels, which can help diagnose and monitor conditions such as coronary artery disease, heart failure, and peripheral artery disease.\n6. Tumor physiology: PET can measure the metabolic activity of tumors, which can help diagnose and monitor cancer.\n7. Brain function: PET can measure the activity of various neurotransmitters and metabolic processes in the brain, which can help diagnose and monitor conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy.\n8. Bone metabolism: PET can measure bone metabolism, which can help diagnose and monitor conditions such as osteoporosis and bone cancer.\n9. Immune system function: PET can measure the activity of the immune system, which can help diagnose and monitor conditions such as autoimmune disorders and inflammatory diseases.\n10.",
    "llama-2-7b-chat-hf_fact": [
      "PET (Positron Excitation Tomography) is a medical imaging technique that uses small amounts of radioactive tracers.",
      "PET measures the distribution and metabolism of these tracers in the body.",
      "PET can measure glucose metabolism in the body to diagnose and monitor conditions as diabetes, cancer, and neurological disorders.",
      "PET is used to measure the activity of neurotransmitters in the brain for diagnosing conditions such as Parkinson's disease, depression, and anxiety disorders.",
      "One of PET's applications is the measurement of cellular proliferation to assist in diagnosing and monitoring conditions like cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: PET (Positron Emission Tomography) is a medical imaging technique that uses small amounts of radioactive tracers.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3371,
    "user_query": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Minocycline is an antibiotic that has been investigated for its potential therapeutic effects in amyotrophic lateral sclerosis (ALS). While there is limited clinical trial data available, some studies have suggested that minocycline may have a neuroprotective effect and slow disease progression in people with ALS.\nOne study published in the Journal of Neurology, Neurosurgery, and Psychiatry found that minocycline treatment was associated with a slower decline in muscle strength and function in people with ALS compared to those not receiving the drug. Another study published in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration found that minocycline may have a neuroprotective effect by reducing oxidative stress and inflammation in the brain and spinal cord of people with ALS.\nHowever, it is important to note that these studies were small and had limited sample sizes, so more research is needed to confirm these findings and establish the safety and efficacy of minocycline for ALS. Additionally, minocycline can have side effects, including gastrointestinal disturbances, and its long-term safety in people with ALS is not well understood.\nIn summary, while there is some evidence to suggest that minocycline may have a potential therapeutic effect in ALS, more research is needed to confirm these findings and establish the safety and efficacy of the drug for this indication.",
    "llama-2-7b-chat-hf_fact": [
      "Minocycline is an antibiotic which has been researched for its potential therapeutic effects in amyotrophic lateral sclerosis (ALS).",
      "Some studies have suggested that minocycline may slow disease progression in people with ALS.",
      "A study in the Journal of Neurology, Neurosurgery, and Psychiatry associated minocycline treatment with a slower decline in muscle strength and function in ALS patients.",
      "Another study published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration suggested that minocycline may reduce oxidative stress and inflammation in the brain and spinal cord of people with ALS.",
      "Minocycline has potential side effects, including gastrointestinal disturbances, with its long-term safety in people with ALS unknown."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3374,
    "user_query": "What is the function of the ISW1 and CHD1 remodellers in yeast chromatin?",
    "llama-2-7b-chat-hf_response": "The ISW1 and CHD1 remodellers are proteins that play important roles in regulating chromatin structure and gene expression in yeast. ISW1 is a chromatin remodeller that uses the energy from ATP hydrolysis to move nucleosomes along DNA strands, leading to changes in chromatin structure and accessibility to transcription factors. CHD1 is another chromatin remodeller that is involved in the regulation of chromatin structure and gene expression, particularly in the context of transcriptional elongation. Both ISW1 and CHD1 are required for proper gene expression and cellular function in yeast, and their dysregulation can lead to a variety of diseases, including cancer.",
    "llama-2-7b-chat-hf_fact": [
      "The ISW1 and CHD1 remodellers are proteins in yeast that regulate chromatin structure and gene expression.",
      "ISW1 uses the energy from ATP hydrolysis to move nucleosomes along DNA strands, changing chromatin structure and accessibility to transcription factors.",
      "CHD1 remodeller is involved in the regulation of chromatin structure and gene expression in the context of transcriptional elongation.",
      "Both ISW1 and CHD1 are required for proper gene expression and cellular function in yeast.",
      "Dysregulation of ISW1 and CHD1 can lead to a variety of diseases, including cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3382,
    "user_query": "What is the difference between Daptacel and Pentacel?",
    "llama-2-7b-chat-hf_response": "Daptacel and Pentacel are both vaccines used to protect infants against diphtheria, tetanus, and whooping cough (pertussis). However, there are some differences between the two vaccines:\n1. Composition: Daptacel contains inactivated toxoids of diphtheria and tetanus, as well as killed Bordetella pertussis bacteria. Pentacel, on the other hand, contains inactivated toxoids of diphtheria, tetanus, and pertussis, as well as killed Haemophilus influenzae type b (Hib) bacteria.\n2. Age indication: Daptacel is approved for use in infants and children from 2 months to 18 years of age, while Pentacel is approved for use in infants and children from 2 months to 4 years of age.\n3. Schedule: Daptacel is typically given in a 3-dose series, with the first dose given at 2 months, the second dose given at 4-6 months, and the third dose given at 15-18 months. Pentacel is also given in a 3-dose series, with the first dose given at 2 months, the second dose given at 4-6 months, and the third dose given at 15-18 months.\n4. Adjuvants: Daptacel contains aluminum hydroxide as an adjuvant, while Pentacel contains aluminum phosphate as an adjuvant.\n5. Manufacturer: Daptacel is manufactured by Sanofi Pasteur, while Pentacel is manufactured by GlaxoSmithKline (GSK).\nIt's important to note that both vaccines are effective in protecting against diphtheria, tetanus, and pertussis, and the choice between the two should be made in consultation with a healthcare provider, based on the individual child's needs and medical history.",
    "llama-2-7b-chat-hf_fact": [
      "Both Daptacel and Pentacel are vaccines used to protect infants against diphtheria, tetanus, and whooping cough.",
      "Daptacel contains inactivated toxoids of diphtheria and tetanus, and killed Bordetella pertussis bacteria, while Pentacel includes Haemophilus influenzae type b (Hib) bacteria in addition to the diphtheria, tetanus, and pertussis toxoids.",
      "Daptacel is approved for use in infants and children from 2 months to 18 years of age, while Pentacel is approved for use in infants and children from 2 months to 4 years of age.",
      "Daptacel uses aluminum hydroxide as an adjuvant, while Pentacel uses aluminum phosphate.",
      "Daptacel is manufactured by Sanofi Pasteur, and Pentacel is produced by GlaxoSmithKline (GSK)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Both Daptacel and Pentacel are approved for use in infants and children from 2 months to 4 years of age.",
      "true",
      "false, [corrected fact]: Both Daptacel and Pentacel are manufactured by Sanofi Pasteur."
    ]
  },
  {
    "id": 3389,
    "user_query": "What is herd immunity?",
    "llama-2-7b-chat-hf_response": "Herd immunity is a concept used in epidemiology to describe the protection of a community from infectious diseases when a sufficient percentage of the population is immune to the disease, either through vaccination or natural infection. When a sufficient percentage of the population is immune, it creates a barrier that prevents the disease from spreading easily from person to person, thus protecting those who are not immune.\nThe concept of herd immunity was first introduced in the 1930s by the British epidemiologist Alfred H. Hedrich, who observed that measles outbreaks in communities were less common when there were more children who had been vaccinated against the disease. The term \"herd immunity\" was coined by Hedrich to describe the phenomenon he observed.\nThe exact percentage of the population that needs to be immune to achieve herd immunity varies depending on the disease and the population being protected. For example, for measles, the World Health Organization recommends that at least 95% of the population be immune to maintain herd immunity. For other diseases, such as pertussis, the threshold may be lower, around 80-90% immunity.\nHerd immunity is important because it can prevent outbreaks of infectious diseases in communities, especially among those who are most vulnerable to serious illness, such as young children and the elderly. By protecting the entire community, herd immunity can help to prevent the spread of disease and protect those who are not immune.",
    "llama-2-7b-chat-hf_fact": [
      "Herd immunity is a concept in epidemiology that provides community protection from infectious diseases when a sufficient percentage of the population is immune.",
      "The immunity can be achieved through vaccination or natural infection.",
      "The concept of herd immunity was first introduced in the 1930s by the British epidemiologist Alfred H. Hedrich.",
      "The threshold percentage of the population that needs to be immune to achieve herd immunity varies depending on the disease and the population being protected.",
      "Herd immunity can help to prevent the spread of disease and protect those who are not immune, such as young children and the elderly."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The concept of herd immunity was first discussed in the 1920s by American veterinarian George Potter. However, it was further established by British epidemiologist Sir MacFarlane Burnet and seems the term 'herd immunity' was first used by Topley and Wilson in 1923.",
      "true",
      "true"
    ]
  },
  {
    "id": 3391,
    "user_query": "List the stages/types of Multiple Sclerosis.",
    "llama-2-7b-chat-hf_response": "Multiple sclerosis (MS) is a chronic and often disabling disease that affects the central nervous system (CNS), including the brain, spinal cord, and optic nerves. The disease is characterized by the immune system attacking the protective covering of nerve fibers, called myelin, leading to communication problems between the brain and the rest of the body. Here are the different stages and types of multiple sclerosis:\n1. Relapsing-Remitting MS (RRMS): This is the most common form of MS, accounting for about 85% of cases. People with RRMS experience relapses or attacks of new or worsening symptoms, followed by periods of remission.\n2. Secondary Progressive MS (SPMS): This type of MS follows RRMS and is characterized by a steady worsening of symptoms over time, with or without relapses.\n3. Primary Progressive MS (PPMS): This is the least common form of MS, accounting for about 10% of cases. People with PPMS experience a gradual worsening of symptoms from the beginning, with no periods of remission.\n4. Progressive-Relapsing MS (PRMS): This is a rare form of MS, accounting for about 5% of cases. People with PRMS experience a steady worsening of symptoms over time, with occasional relapses.\n5. Clinically Isolated Syndrome (CIS): This is a condition where a person experiences a single episode of symptoms that last for at least 24 hours, but the symptoms resolve completely. About 15% to 20% of people with CIS will go on to develop MS.\n6. Benign MS (BMS): This is a rare and benign form of MS that is characterized by a slow progression of symptoms over time, with no relapses or new symptoms.\n7. Acute-Onset MS (AOS): This is a rare form of MS that is characterized by a sudden onset of symptoms, often following a viral infection.\n8. Chronic Cerebrospinal Venous Insufficiency (CCSVI): This is a condition where the veins that drain blood from the brain and spinal cord",
    "llama-2-7b-chat-hf_fact": [
      "Multiple sclerosis (MS) is a chronic disease affecting the central nervous system, including the brain, spinal cord, and optic nerves.",
      "The most common form of Multiple Sclerosis is Relapsing-Remitting MS (RRMS), accounting for about 85% of cases.",
      "Secondary Progressive MS (SPMS) is characterized by a steady worsening of symptoms, typically following RRMS.",
      "Primary Progressive MS (PPMS), accounting for about 10% of cases, is characterized by a gradual worsening of symptoms from the start with no periods of remission.",
      "Clinically Isolated Syndrome (CIS) is a condition where a person experiences a single episode of symptoms that resolve completely, with around 15% to 20% of people with CIS going on to develop MS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Clinically Isolated Syndrome (CIS) is a condition where a person experiences a single episode of symptoms, but not everyone with CIS will go on to develop MS. Some research suggests that about 50% will develop MS within 2 decades while others will never have another MS-like attack."
    ]
  },
  {
    "id": 3395,
    "user_query": "List Mcl-1 inhibitors.",
    "llama-2-7b-chat-hf_response": "Mcl-1 (myeloid cell leukemia 1) is a protein that plays a crucial role in the regulation of apoptosis, or programmed cell death, in various cell types, including cancer cells. Inhibitors of Mcl-1 are being developed as potential anti-cancer drugs, as they can selectively induce apoptosis in cancer cells while sparing normal cells. Here are some Mcl-1 inhibitors that are currently being investigated:\n1. Azacitidine: Azacitidine is a DNA methyltransferase inhibitor that has been shown to inhibit Mcl-1 expression and induce apoptosis in myeloid leukemia cells.\n2. Vorinostat: Vorinostat is a histone deacetylase inhibitor that has been shown to inhibit Mcl-1 expression and induce apoptosis in various cancer cell types, including breast, lung, and ovarian cancer cells.\n3. Romidepsin: Romidepsin is a histone deacetylase inhibitor that has been shown to inhibit Mcl-1 expression and induce apoptosis in cutaneous T-cell lymphoma cells.\n4. Panobinostat: Panobinostat is a histone deacetylase inhibitor that has been shown to inhibit Mcl-1 expression and induce apoptosis in various cancer cell types, including breast, lung, and ovarian cancer cells.\n5. Entinostat: Entinostat is a histone deacetylase inhibitor that has been shown to inhibit Mcl-1 expression and induce apoptosis in various cancer cell types, including breast, lung, and ovarian cancer cells.\n6. MCC950: MCC950 is a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in various cancer cell types, including breast, lung, and ovarian cancer cells.\n7. GDC-0199: GDC-0199 is a small molecule inhibitor of Mcl-1 that has been shown to induce apoptosis in various cancer cell types, including breast, lung, and ovar",
    "llama-2-7b-chat-hf_fact": [
      "Mcl-1 is a protein that plays a crucial role in the regulation of apoptosis in various cell types, including cancer cells.",
      "Inhibitors of Mcl-1 are being developed as potential anticancer drugs.",
      "Azacitidine is a DNA methyltransferase inhibitor that has been shown to inhibit Mcl-1 expression in myeloid leukemia cells.",
      "Vorinostat, Romidepsin, Panobinostat, and Entinostat are all histone deacetylase inhibitors that have been shown to inhibit Mcl-1 expression in various cancer cell types.",
      "MCC950 and GDC-0199 are small molecule inhibitors of Mcl-1 that have been shown to induce apoptosis in various cancer cell types."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: MCC950 is a NLRP3 inflammasome inhibitor, not a Mcl-1 inhibitor. GDC-0199 (also known as Venetoclax) is a Bcl-2 inhibitor, not a specific inhibitor of Mcl-1."
    ]
  },
  {
    "id": 3396,
    "user_query": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "llama-2-7b-chat-hf_response": "No, autophagy is not the process where a virus obtains nutrients from its host. Autophagy is a cellular process where a cell breaks down and recycles damaged or dysfunctional cellular components, such as proteins and organelles, to maintain cellular homeostasis and promote cell survival.\nViruses, on the other hand, are obligate intracellular parasites that rely on the host cell's machinery to replicate and produce new virus particles. They do not have the ability to perform autophagy or obtain nutrients from their host cells. Instead, they hijack the host cell's metabolic pathways and use them to produce new virus particles, which can then be released from the host cell.",
    "llama-2-7b-chat-hf_fact": [
      "Autophagy is a cellular process where a cell breaks down and recycles damaged or dysfunctional cellular components.",
      "Autophagy is used to maintain cellular homeostasis and promote cell survival.",
      "Viruses are obligate intracellular parasites that rely on the host cell's machinery to replicate and produce new virus particles.",
      "Viruses do not have the ability to perform autophagy.",
      "Viruses hijack the host cell's metabolic pathways to produce new virus particles."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-7b-chat-hf_response": "Methidiumpropyl-EDTA (MPE) is a chemical modification that can be used to selectively label and capture RNA molecules in a sample. The MPE-seq method involves the following steps:\n1. Sample Preparation: The sample is first prepared by adding MPE to the sample, which reacts with the RNA molecules in the sample.\n2. Capture: The MPE-labelled RNA molecules are then captured using an oligonucleotide probe that is complementary to the MPE label.\n3. Library Preparation: The captured RNA molecules are then subjected to library preparation, which involves reverse transcription, adapter ligation, and size selection.\n4. Sequencing: The final step is to sequence the captured RNA molecules using Next-Generation Sequencing (NGS) technologies.\nThe basis of the MPE-seq method is the use of a chemical modification, MPE, to selectively label and capture RNA molecules in a sample. The MPE reaction selectively labels RNA molecules by reacting with the 2'-hydroxyl group of the ribose sugar, which is present in RNA but not in DNA. This allows for the selective capture of RNA molecules without affecting the DNA molecules in the sample. The captured RNA molecules are then subjected to library preparation and sequencing, which allows for the analysis of the RNA molecules in the sample.",
    "llama-2-7b-chat-hf_fact": [
      "Methidiumpropyl-EDTA (MPE) is a chemical modification used to selectively label and capture RNA molecules in a sample.",
      "The MPE-seq method enables the analysis of the RNA molecules in a sample.",
      "The process of MPE-seq involves steps like sample preparation, capture, library preparation, and sequencing.",
      "The MPE reacts with the 2'-hydroxyl group of the ribose sugar, only present in RNA and not DNA.",
      "The MPE-seq method uses Next-Generation Sequencing technologies for sequencing the captured RNA molecules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3399,
    "user_query": "Does CXorf21 escape X chromosome inactivation?",
    "llama-2-7b-chat-hf_response": "CXorf21 is a gene located on the X chromosome that is known to escape X chromosome inactivation (XCI) in some cells. XCI is a process that occurs in female mammals, in which one of the two X chromosomes is inactivated to avoid a doubling of gene expression due to the presence of two X chromosomes.\nCXorf21 is one of the few genes that have been identified to escape XCI in some cells. This means that the gene is expressed from both copies of the X chromosome, even in cells where XCI is normally occurring. The reasons why CXorf21 escapes XCI are not fully understood, but it is thought to be due to the location of the gene on the X chromosome and the presence of specific epigenetic marks that promote its expression.\nThe escape of CXorf21 from XCI has important implications for the study of X-linked genetic disorders, as it suggests that some X-linked genes may be more likely to be expressed in cells where XCI is occurring. This could have implications for the diagnosis and treatment of X-linked genetic disorders, as well as for our understanding of the mechanisms of XCI itself.\nIn summary, CXorf21 is a gene located on the X chromosome that escapes X chromosome inactivation in some cells, and its escape is thought to be due to the location of the gene on the X chromosome and the presence of specific epigenetic marks that promote its expression.",
    "llama-2-7b-chat-hf_fact": [
      "CXorf21 is a gene located on the X chromosome.",
      "CXorf21 is known to escape X chromosome inactivation (XCI) in some cells.",
      "X chromosome inactivation is a process in female mammals that inactivates one of the two X chromosomes to avoid a doubling of gene expression.",
      "The escape of CXorf21 from XCI has implications for the study of X-linked genetic disorders.",
      "The reasons for CXorf21's escape from XCI are not fully understood, but it is thought to be due to the gene's location on the X chromosome and the presence of specific epigenetic marks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-7b-chat-hf_response": "GWAR (GNU Wget Archiver) is a free and open-source software tool used for downloading and archiving files from the internet. GWAR is written in C programming language.",
    "llama-2-7b-chat-hf_fact": [
      "GWAR stands for GNU Wget Archiver.",
      "GWAR is a software tool used for downloading and archiving files from the internet.",
      "GWAR is free and open-source software.",
      "GWAR is written in the C programming language."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: GWAR does not stand for GNU Wget Archiver, GWAR is an American heavy metal band.",
      "false, [corrected fact]: GWAR is not a software tool used for downloading and archiving files from the internet, it's a music band.",
      "unknown",
      "false, [corrected fact]: GWAR is not written in the C programming language, it's not a software but a music band."
    ]
  },
  {
    "id": 3401,
    "user_query": "Describe f-scLVM",
    "llama-2-7b-chat-hf_response": "F-scLVM (Fast-Sparse Clustering with Locally Weighted Learning Vector Machines) is a machine learning algorithm that combines the strengths of both clustering and LVM (Learning Vector Machines) techniques. Clustering is a technique used to group similar objects together, while LVM is a type of supervised learning algorithm that can be used for classification or regression tasks.\nF-scLVM works by first applying clustering to the data to group similar objects together. Then, it uses LVM to learn a mapping between the input space and a lower-dimensional representation of the data. This mapping is learned using a locally weighted approach, which takes into account the similarity between nearby data points.\nThe main advantage of F-scLVM is its ability to handle high-dimensional data and to capture complex relationships between features. It is also robust to noise and outliers, and can be used for both classification and regression tasks.\nF-scLVM consists of the following steps:\n1. Clustering: Apply clustering to the data to group similar objects together.\n2. Dimensionality reduction: Use LVM to learn a mapping between the input space and a lower-dimensional representation of the data.\n3. Locally weighted learning: Use a locally weighted approach to learn the mapping between the input space and the lower-dimensional representation. This takes into account the similarity between nearby data points.\n4. Evaluation: Evaluate the performance of the algorithm using metrics such as accuracy, precision, recall, and F1-score.\nF-scLVM has been shown to be effective in a variety of applications, including image classification, text classification, and bioinformatics. It is a powerful tool for handling complex data sets and can be used in a variety of domains.\nIn summary, F-scLVM is a machine learning algorithm that combines the strengths of clustering and LVM techniques to handle high-dimensional data and capture complex relationships between features. It is robust to noise and outliers and can be used for both classification and regression tasks.",
    "llama-2-7b-chat-hf_fact": [
      "F-scLVM is a machine learning algorithm that combines clustering and Learning Vector Machines (LVM) techniques.",
      "Clustering groups similar objects together.",
      "Learning Vector Machines is a type of supervised learning algorithm used for classification or regression tasks.",
      "F-scLVM is designed to handle high-dimensional data and to capture complex relationships between features.",
      "F-scLVM has been employed in a variety of applications including image classification, text classification, and bioinformatics."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "false, [corrected fact]: Support Vector Machines is a type of supervised learning algorithm used for classification or regression tasks.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3403,
    "user_query": "How large is a lncRNAs?",
    "llama-2-7b-chat-hf_response": "Long non-coding RNAs (lncRNAs) are a class of RNA molecules that are longer than 200 nucleotides in length but do not encode proteins. The size of lncRNAs can vary greatly, ranging from a few hundred nucleotides to several kilobases (kb).\nThe size of lncRNAs can be measured in different ways, including:\n1. Sequence length: This is the most common way to measure the size of lncRNAs. It is calculated by counting the number of nucleotides in the RNA sequence.\n2. Transcript length: This is the length of the RNA transcript, including the untranslated region (UTR) and the coding region.\n3. Coding region length: This is the length of the coding region of the lncRNA, which is the part of the RNA that is translated into protein.\n4. Protein-coding potential: This is the length of the coding region of the lncRNA that has the potential to encode a protein.\n5. Intron length: This is the length of the introns (non-coding regions) in the lncRNA.\n6. Exon length: This is the length of the exons (coding regions) in the lncRNA.\n7. Total length: This is the sum of the length of all the exons and introns in the lncRNA.\n8. Average length: This is the average length of all the lncRNAs in a particular sample or population.\n9. Standard deviation: This is a measure of the variation in the length of the lncRNAs in a particular sample or population.\n10. Distribution: This is a graphical representation of the distribution of lncRNA lengths in a particular sample or population.\nIt is important to note that the size of lncRNAs can have important implications for their function, as different sizes of lncRNAs may be more or less effective at regulating gene expression or other cellular processes.",
    "llama-2-7b-chat-hf_fact": [
      "Long non-coding RNAs (lncRNAs) are a class of RNA molecules that are longer than 200 nucleotides in length.",
      "The size of lncRNAs can vary from a few hundred nucleotides to several kilobases (kb).",
      "lncRNAs do not encode proteins.",
      "The size of lncRNAs can be measured in various ways, including sequence length, transcript length, coding region length, protein-coding potential, intron length, exon length, total length, average length, standard deviation and distribution.",
      "The size of lncRNAs can influence their function in regulating gene expression or other cellular processes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually death. While there is currently no cure for ALS, there are various treatments available that can help manage the symptoms and improve the quality of life for patients. One such treatment is xaliproden, a drug that has shown promise in improving the prognosis of ALS patients.\nXaliproden is a small molecule inhibitor of the enzyme superoxide dismutase 1 (SOD1), which has been implicated in the pathogenesis of ALS. By inhibiting SOD1, xaliproden can reduce oxidative stress and inflammation in the nervous system, which are thought to contribute to the progression of ALS. In addition, xaliproden has been shown to promote the survival and differentiation of neural stem cells, which may help to replace damaged motor neurons in the spinal cord.\nSeveral studies have demonstrated the efficacy of xaliproden in improving the prognosis of ALS patients. For example, a phase II clinical trial published in the New England Journal of Medicine in 2017 found that xaliproden significantly slowed the progression of ALS compared to placebo, as measured by the rate of decline in the ALS Functional Rating Scale (ALSFRS). Additionally, a phase III clinical trial published in the Lancet in 2020 found that xaliproden improved the survival rate of ALS patients compared to placebo, with a median survival time of 30 months for xaliproden-treated patients versus 23 months for placebo-treated patients.\nWhile these results are promising, it is important to note that xaliproden is not a cure for ALS, and it does not reverse the damage that has already been done to the nervous system. However, it may help to slow the progression of the disease and improve the quality of life for patients, which can have a significant impact on their overall prognosis.\nIn conclusion, xaliproden is a promising treatment for A",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord.",
      "Xaliproden is a drug used for the treatment of ALS.",
      "Xaliproden is a small molecule inhibitor of the enzyme superoxide dismutase 1 (SOD1), which has been implicated in the pathogenesis of ALS.",
      "A phase II clinical trial published in the New England Journal of Medicine in 2017 found that xaliproden significantly slowed the progression of ALS compared to placebo.",
      "A phase III clinical trial published in the Lancet in 2020 found that xaliproden improved the survival rate of ALS patients compared to placebo."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Xaliproden is a neuroprotective agent that affects certain nerve receptors and is not an inhibitor of the enzyme superoxide dismutase 1 (SOD1).",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3407,
    "user_query": "What is Telangiectasia?",
    "llama-2-7b-chat-hf_response": "Telangiectasia is a medical condition characterized by the formation of dilated blood vessels, usually on the face, particularly around the nose, cheeks, and chin. The term \"telangiectasia\" comes from the Greek words \"telia,\" meaning \"blood vessels,\" and \"ectasia,\" meaning \"dilation.\"\nTelangiectasia can be caused by a variety of factors, including:\n1. Genetics: Telangiectasia can be inherited from one's parents.\n2. Sun exposure: Prolonged exposure to the sun can cause the blood vessels to dilate, leading to the formation of telangiectasia.\n3. Hormonal changes: Changes in hormone levels, such as those that occur during pregnancy or menopause, can cause telangiectasia to form.\n4. Skin conditions: Certain skin conditions, such as rosacea or eczema, can increase the risk of developing telangiectasia.\n5. Aging: Telangiectasia can occur as a result of the natural aging process, particularly on the face.\nThe symptoms of telangiectasia can vary depending on the location and severity of the condition. Common symptoms include:\n1. Redness and inflammation: The affected area may appear red and swollen, and may be tender to the touch.\n2. Dilated blood vessels: The blood vessels in the affected area may appear larger than normal, and may be visible to the naked eye.\n3. Itching or burning: Some people with telangiectasia may experience itching or burning sensations on the affected area.\n4. Skin thickening: In some cases, telangiectasia can cause the skin to thicken, leading to a rough or bumpy appearance.\nTreatment options for telangiectasia depend on the severity and location of the condition, as well as the underlying cause. Some common treatment options include:\n1. Topical creams or gels: Over-the-counter creams or gels containing ingredients such as salicylic acid or tea tree oil may be effective in reducing the appearance of telangiectasia.\n2. Laser therapy: Laser therapy can be used to",
    "llama-2-7b-chat-hf_fact": [
      "Telangiectasia is a medical condition characterized by the formation of dilated blood vessels.",
      "This condition is often observed on the face, particularly around the nose, cheeks, and chin.",
      "Various factors like genetics, sun exposure, hormonal changes, skin conditions, and aging can cause telangiectasia.",
      "Among the common symptoms of telangiectasia are redness and inflammation, dilated blood vessels, itching or burning sensations, and skin thickening.",
      "Treatment options for telangiectasia can include the application of topical creams or gels and laser therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3409,
    "user_query": "Which tissues express the ACE2 protein?",
    "llama-2-7b-chat-hf_response": "ACE2 (Angiotensin-converting enzyme 2) is an enzyme that plays a crucial role in the renin-angiotensin-aldosterone system (RAAS). The RAAS is a complex system that regulates blood pressure, fluid balance, and electrolyte homeostasis in the body. ACE2 is primarily expressed in the lung and is involved in the conversion of angiotensin I to angiotensin 1-7, a potent vasodilator.\nThe following tissues express the ACE2 protein:\n1. Lung: ACE2 is primarily expressed in the lung, where it plays a crucial role in the conversion of angiotensin I to angiotensin 1-7.\n2. Kidney: ACE2 is also expressed in the kidney, where it contributes to the regulation of blood pressure and fluid balance.\n3. Heart: ACE2 is expressed in the heart, where it helps to regulate cardiac function and blood pressure.\n4. Brain: ACE2 is also expressed in the brain, where it may play a role in the regulation of blood pressure and electrolyte homeostasis.\n5. Liver: ACE2 is expressed in the liver, where it may play a role in the regulation of glucose and lipid metabolism.\n6. Muscle: ACE2 is expressed in skeletal muscle, where it may play a role in the regulation of muscle contraction and relaxation.\n7. Adipose tissue: ACE2 is also expressed in adipose tissue, where it may play a role in the regulation of energy metabolism and glucose homeostasis.\n8. Immune cells: ACE2 is also expressed in immune cells, where it may play a role in the regulation of inflammation and immune response.",
    "llama-2-7b-chat-hf_fact": [
      "ACE2, also known as Angiotensin-converting enzyme 2, plays a crucial role in the renin-angiotensin-aldosterone system.",
      "ACE2 is primarily expressed in the lung and involves in the conversion of angiotensin I to angiotensin 1-7.",
      "The ACE2 enzyme is expressed in the kidney contributing to the regulation of blood pressure and fluid balance.",
      "ACE2 is expressed in the heart where it helps to regulate cardiac function and blood pressure.",
      "ACE2 is also found in the brain, where it may take part in the regulation of blood pressure and electrolyte homeostasis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-7b-chat-hf_response": "The LiPS-A3S line is a transgenic line of mice that expresses a humanized version of the apolipoprotein A-I (ApoA-I) gene under the control of the mouse albumin promoter. The ApoA-I gene is located on chromosome 19 in humans.\nTherefore, in the case of the LiPS-A3S line, transgenes are inserted into chromosome 19.",
    "llama-2-7b-chat-hf_fact": [
      "The LiPS-A3S line is a transgenic line of mice.",
      "This line expresses a humanized version of the apolipoprotein A-I (ApoA-I) gene.",
      "The expression of the ApoA-I gene in these mice is controlled by the mouse albumin promoter.",
      "In humans, the ApoA-I gene is located on chromosome 19.",
      "In the case of the LiPS-A3S line, transgenes are inserted into chromosome 19."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3411,
    "user_query": "What is a J pouch?",
    "llama-2-7b-chat-hf_response": "A J pouch, also known as a J-pouch or ileal pouch, is a type of artificial pouch that is created from the small intestine to replace the rectum and anus in individuals with inflammatory bowel disease (IBD), such as ulcerative colitis or Crohn's disease. The pouch is designed to collect stool and allow for normal bowel movements.\nThe J pouch is named after the shape of the pouch, which resembles the letter \"J.\" It is created by removing the diseased portion of the colon and attaching the healthy ends of the intestine to form a pouch. The pouch is then connected to the anus, allowing for normal bowel movements.\nA J pouch is typically recommended for individuals with IBD who have had extensive damage to their colon and rectum, and who have not responded to other treatments, such as medication or surgery. The procedure is usually performed laparoscopically, which involves making several small incisions in the abdomen and using a camera and specialized instruments to create the pouch.\nWhile a J pouch can provide relief from symptoms such as abdominal pain, diarrhea, and rectal bleeding, it is important to note that it is not a cure for IBD. Individuals with a J pouch will still need to take medication to manage their symptoms and prevent complications. Additionally, the pouch may need to be adjusted or replaced over time due to ongoing inflammation or other complications.",
    "llama-2-7b-chat-hf_fact": [
      "A J pouch, also known as a J-pouch or ileal pouch, is an artificial pouch created from the small intestine to replace the rectum and anus in individuals with inflammatory bowel disease.",
      "The J pouch is designed to collect stool and allow for normal bowel movements.",
      "This pouch is recommended for individuals with inflammatory bowel disease who have had extensive damage to their colon and rectum and have not responded well to other treatments.",
      "The procedure to create a J pouch is usually performed laparoscopically.",
      "Despite providing relief from inflammatory bowel disease symptoms, a J pouch is not a cure and may need to be adjusted or replaced over time due to complications."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3412,
    "user_query": "What is the function of the protein encoded by the gene NKCC2?",
    "llama-2-7b-chat-hf_response": "NKCC2 encodes a protein that functions as a cotransporter of sodium and chloride ions across the basolateral membrane of renal proximal tubular cells. The protein is responsible for reabsorbing sodium and chloride ions from the urine back into the bloodstream, which is essential for maintaining proper fluid balance and electrolyte homeostasis in the body. The NKCC2 protein is also involved in the regulation of pH in the body, as it helps to maintain the acid-base balance by reabsorbing hydrogen ions from the urine. Dysfunction of the NKCC2 protein has been implicated in various kidney diseases, including polycystic kidney disease and chronic kidney disease.",
    "llama-2-7b-chat-hf_fact": [
      "The gene NKCC2 encodes a protein that functions as a cotransporter of sodium and chloride ions.",
      "This protein is involved in the reabsorption of sodium and chloride ions from the urine back into the bloodstream.",
      "The protein encoded by the NKCC2 gene helps maintain fluid balance and electrolyte homeostasis in the body.",
      "The NKCC2 protein is also involved in the regulation of pH in the body by reabsorbing hydrogen ions from the urine.",
      "Dysfunction of the NKCC2 protein has been implicated in various kidney diseases such as polycystic kidney disease and chronic kidney disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The NKCC2 protein is not involved in the regulation of pH in the body by reabsorbing hydrogen ions from the urine.",
      "true"
    ]
  },
  {
    "id": 3414,
    "user_query": "Is the protein MCL-1 anti-apoptotic?",
    "llama-2-7b-chat-hf_response": "MCL-1 (Myeloid Cell Leukemia-1) is a protein that plays a crucial role in regulating programmed cell death (apoptosis) in various cell types, including hematopoietic cells. While MCL-1 can promote cell survival in some contexts, it can also inhibit apoptosis in others.\nMCL-1 functions as an anti-apoptotic protein by binding to and inhibiting the activity of pro-apoptotic proteins, such as BAX and BAK. By preventing the activation of these pro-apoptotic proteins, MCL-1 can inhibit the induction of apoptosis in response to various stimuli, including DNA damage, oxidative stress, and exposure to chemotherapeutic agents.\nHowever, MCL-1 can also promote cell survival by inhibiting the activity of caspases, which are enzymes that play a central role in the execution of apoptosis. By inhibiting caspase activity, MCL-1 can prevent the degradation of cellular proteins and the breakdown of cellular structures, leading to cell survival.\nIn summary, while MCL-1 can promote cell survival by inhibiting caspase activity, it can also inhibit apoptosis by binding to and inhibiting the activity of pro-apoptotic proteins. The balance between these two functions determines whether MCL-1 promotes or inhibits apoptosis in a given cellular context.",
    "llama-2-7b-chat-hf_fact": [
      "MCL-1 (Myeloid Cell Leukemia-1) is a protein that regulates apoptosis in various cell types, including hematopoietic cells.",
      "MCL-1 functions as an anti-apoptotic protein by binding to and inhibiting the activity of pro-apoptotic proteins like BAX and BAK.",
      "MCL-1 can inhibit the induction of apoptosis in response to various stimuli including DNA damage, oxidative stress, and exposure to chemotherapeutic agents.",
      "MCL-1 can promote cell survival by inhibiting the activity of caspases, which are enzymes central to the execution of apoptosis.",
      "The balance between its functions of inhibiting caspase activity and inhibiting pro-apoptotic proteins determines whether MCL-1 promotes or inhibits apoptosis in a specific cellular context."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3417,
    "user_query": "Which disease is ZP-PTH used for?",
    "llama-2-7b-chat-hf_response": "ZP-PTH is used for the treatment of X-linked hypophosphatemia (XLH), a rare genetic disorder that affects the body's ability to absorb phosphate from the diet. XLH is caused by mutations in the FGF23 gene, which codes for the fibroblast growth factor 23 protein. This protein plays a critical role in regulating phosphate metabolism in the body.\nZP-PTH is a synthetic form of parathyroid hormone (PTH) that is used to treat XLH by replacing the missing or deficient FGF23 protein. By replacing FGF23, ZP-PTH helps to restore normal phosphate metabolism in the body and improve the symptoms of XLH, such as weak bones, tooth decay, and short stature.\nZP-PTH is given by injection every 4-6 weeks, depending on the patient's response to the treatment. It is important to note that ZP-PTH is not a cure for XLH, but it can help to manage the symptoms and improve the quality of life for people with this condition.",
    "llama-2-7b-chat-hf_fact": [
      "ZP-PTH is used for the treatment of X-linked hypophosphatemia (XLH).",
      "XLH is a rare genetic disorder affecting the body's ability to absorb phosphate from the diet.",
      "XLH is caused by mutations in the FGF23 gene.",
      "ZP-PTH is a synthetic form of parathyroid hormone.",
      "ZP-PTH is given by injection every 4-6 weeks for the treatment of XLH."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: ZP-PTH is a synthetic form of parathyroid hormone, but it's commonly known as PTH 1-34, not ZP-PTH.",
      "false, [corrected fact]: ZP-PTH (Burosumab), is generally given by injection every 2-4 weeks for the treatment of XLH, not every 4-6 weeks. However, the exact dosage may vary per individual."
    ]
  },
  {
    "id": 3424,
    "user_query": "When was vaxchora first licensed by the FDA?",
    "llama-2-7b-chat-hf_response": "Vaxchora was first licensed by the FDA in 2018.",
    "llama-2-7b-chat-hf_fact": [
      "Vaxchora was first licensed by the FDA in 2018."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Vaxchora was first licensed by the FDA in 2016."
    ]
  },
  {
    "id": 3427,
    "user_query": "Which type of distance is used in the R-package XenofilteR?",
    "llama-2-7b-chat-hf_response": "I'm trying to use the R-package XenofilteR to perform phylogenetic distance calculations, but I'm not sure which type of distance is being used. The package documentation doesn't provide much information on this topic.\nDoes anyone know which type of distance is used in XenofilteR?\nAnswer: The `XenofilteR` package uses the [Jukes-Cantor distance](https://en.wikipedia.org/wiki/Jukes%E2%80%93Cantor_distance) as the default distance metric for phylogenetic distance calculations.\nThe Jukes-Cantor distance is a measure of the number of substitutions per site between two aligned sequences, taking into account the number of sites and the number of nucleotides in the alignment. It is a commonly used distance metric in phylogenetics, as it is easy to calculate and has been shown to be a good measure of evolutionary distance.\nIf you want to use a different distance metric, you can specify it when calling the `phylogenetic_distance()` function. For example, you can use the `hamming_distance()` function to calculate the Hamming distance between two vectors, or the `cosine_distance()` function to calculate the cosine similarity between two vectors.\nHere is an example of how to use the `XenofilteR` package to calculate phylogenetic distances using the Jukes-Cantor distance:\n\\begin{code}\n# Load the XenofilteR package\nlibrary(XenofilteR)\n# Define the alignment of the sequences\nalignment <- read.table(\"alignment.txt\", header=TRUE, row.names=1)\n# Calculate the phylogenetic distance using the Jukes-Cantor distance\ndistances <- phylogenetic_distance(alignment, method=\"jukes_cantor\")\n# Print the distances\nprint(distances)\n\\end{code\nThis will calculate the Jukes-Cantor distance between each pair of sequences in the alignment and print the distances to the console.",
    "llama-2-7b-chat-hf_fact": [
      "XenofilteR is an R-package used for phylogenetic distance calculations.",
      "By default, XenofilteR uses the Jukes-Cantor distance for phylogenetic distance calculations.",
      "Jukes-Cantor distance measures the number of substitutions per site between two aligned sequences, taking into account the number of sites and the number of nucleotides in the alignment.",
      "This distance metric is commonly used in phylogenetics due to its simplicity and efficacy in measuring evolutionary distance.",
      "XenofilteR allows users to specify different distance metrics, such as Hamming or cosine distance."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: XenofilteR is an R-package used for filtering of xenografted/host reads in sequencing data, not for phylogenetic distance calculations.",
      "false, [corrected fact]: By default, XenofilteR doesnt use the Jukes-Cantor distance or any other distance metrics as it is not meant for phylogenetic distance calculations.",
      "true",
      "true",
      "false, [corrected fact]: XenofilteR does not allow users to specify different distance metrics, such as Hamming or cosine distance, as it is not designed for this purpose."
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-7b-chat-hf_response": "There are several tools and techniques that have been developed for predicting drug synergy with deep learning, including:\n1. DeepSynth: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets.\n2. DrugSynth: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n3. SynergyNet: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n4. DrugCombinator: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n5. DeepDrug: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n6. Drug2Drug: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n7. SynergyPredictor: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n8. DrugSynergyNet: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n9. DeepSynergy: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\n10. DrugSynergyPredictor: This tool uses a deep learning model to predict drug synergy based on the chemical structures of the drugs and their targets, as well as their pharmacological properties.\nIt's worth noting that these tools are not mutually exclusive, and some of them may overlap in their functionality. Additionally, the accuracy of these tools may vary depending on the quality and quantity of the data used to train",
    "llama-2-7b-chat-hf_fact": [
      "DeepSynth is a tool that uses a deep learning model to predict drug synergy, focusing on the chemical structures of the drugs and their targets.",
      "DrugSynth employs a deep learning model to estimate drug synergy, considering chemical structures, drug targets, and pharmacological properties.",
      "SynergyNet uses deep learning to predict drug synergy, taking into account the chemical structures of the drugs and their targets as well as pharmacological properties.",
      "DrugCombinator is a tool that utilizes deep learning to anticipate drug synergy, based on chemical structures, drug targets, and pharmacological properties.",
      "DeepDrug applies a deep learning model for predicting drug synergy, concentrating on the chemical compositions of the drugs, their targets, and their pharmacological properties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3431,
    "user_query": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and death. While there is currently no cure for ALS, several experimental treatments are being investigated, including ozanezumab.\nOzanezumab is a monoclonal antibody that targets a protein called neurofilament light chain (NfL). NfL is a component of neurofilaments, which are proteins that provide structural support to nerve fibers. In ALS patients, NfL levels are elevated in the cerebrospinal fluid (CSF), and ozanezumab has been shown to reduce NfL levels in the CSF.\nSeveral clinical trials have been conducted to evaluate the safety and efficacy of ozanezumab in ALS patients. These trials have shown that ozanezumab can slow the progression of motor function decline in ALS patients, as measured by the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS). Additionally, ozanezumab has been shown to reduce the rate of cognitive decline in ALS patients.\nWhile the results of these trials are promising, it is important to note that ozanezumab has not yet been approved by regulatory authorities for the treatment of ALS. Further research is needed to confirm the efficacy and safety of ozanezumab in larger, longer-term studies.\nIn summary, ozanezumab is an experimental treatment for ALS that has shown promise in clinical trials. While it has not yet been approved by regulatory authorities, it has the potential to slow the progression of motor function decline and reduce the rate of cognitive decline in ALS patients.",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord.",
      "Ozanezumab is a monoclonal antibody that targets a protein called neurofilament light chain (NfL).",
      "In ALS patients, the level of NfL, which provides structural support to nerve fibers, is elevated in the cerebrospinal fluid (CSF).",
      "Ozanezumab has been shown to reduce the NfL levels and the progression of motor function decline in ALS patients.",
      "Ozanezumab is an experimental treatment for ALS and has not yet been approved by regulatory authorities for the treatment of ALS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3432,
    "user_query": "Is Dexmecamylamine effective for depression?",
    "llama-2-7b-chat-hf_response": "Dexmecamylamine is an antidepressant medication that is sometimes used to treat depression. It works by increasing the levels of certain neurotransmitters in the brain, such as norepinephrine and serotonin, which can help to improve mood and reduce symptoms of depression.\nStudies have shown that dexmecamylamine can be effective in reducing symptoms of depression, particularly in people who have not responded to other treatments. However, it is important to note that dexmecamylamine is not a first-line treatment for depression, and it is typically used as a last resort when other treatments have failed.\nOne study published in the Journal of Clinical Psychopharmacology found that dexmecamylamine was effective in reducing symptoms of depression in 60% of patients who had not responded to other treatments. Another study published in the Journal of Affective Disorders found that dexmecamylamine was effective in reducing symptoms of depression in 70% of patients with major depressive disorder.\nHowever, dexmecamylamine can have side effects, including drowsiness, dizziness, and weight gain. It can also interact with other medications, including sedatives and antidepressants, which can increase the risk of side effects. Therefore, it is important to use dexmecamylamine only under the close supervision of a healthcare provider.\nIn summary, dexmecamylamine can be effective in reducing symptoms of depression in some people, particularly those who have not responded to other treatments. However, it is important to use it with caution and under the close supervision of a healthcare provider due to its potential side effects and interactions with other medications.",
    "llama-2-7b-chat-hf_fact": [
      "Dexmecamylamine is a medication that is infrequently used to treat depression.",
      "This drug works by increasing the levels of certain neurotransmitters, such as norepinephrine and serotonin, in the brain.",
      "Dexmecamylamine is often used as a last resort when other depression treatments have failed.",
      "Studies have suggested that dexmecamylamine can reduce depression symptoms in certain patients who have not responded to other treatments.",
      "Side effects of dexmecamylamine can include drowsiness, dizziness, and weight gain, and it can interact with other medications, which has the potential to increase the risk of side effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-7b-chat-hf_response": "A) IBM Watson\nB) Amazon Web Services (AWS)\nC) Microsoft Azure\nD) Google Cloud Platform (GCP)\nAnswer: D) Google Cloud Platform (GCP)\nExplanation:\nGoogle Cloud Platform (GCP) has developed a cloud-based platform called \"Genomics Cloud\" for comparing Genome-Wide Association Studies (GWAS). Genomics Cloud is a cloud-based platform that enables researchers to analyze and interpret large-scale genomic data sets, including those generated from GWAS. The platform provides a range of tools and resources for analyzing genetic data, including machine learning algorithms, data visualization tools, and collaboration features. By using Genomics Cloud, researchers can more easily compare GWAS data and identify genetic variants associated with complex diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Google Cloud Platform (GCP) has developed a cloud-based platform called \"Genomics Cloud\" for comparing Genome-Wide Association Studies (GWAS).",
      "Genomics Cloud is used to analyze and interpret large-scale genomic data sets, including those from GWAS.",
      "The Genomics Cloud platform provides tools and resources for analyzing genetic data, including machine learning algorithms, data visualization tools, and collaboration features.",
      "Researchers can more easily compare GWAS data and identify genetic variants associated with complex diseases using Genomics Cloud."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-7b-chat-hf_response": "CMB305 is a bispecific antibody that targets both CD3 and CD20, which are proteins found on the surface of T cells and B cells, respectively. It has been shown to be effective in preclinical studies against various types of cancer, including sarcomas.\nSarcomas are a type of cancer that originates in the connective tissue of the body, such as bone, cartilage, and fat. They are relatively rare, accounting for about 1% of all adult cancers, and can be challenging to treat due to their aggressive nature and tendency to recur.\nCMB305 has been shown to be effective in preclinical studies against various types of sarcomas, including osteosarcoma, chondrosarcoma, and leiomyosarcoma. In these studies, CMB305 has been shown to induce antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), which are mechanisms of immune-mediated killing of cancer cells.\nIn addition, CMB305 has been shown to inhibit the growth of sarcoma cells and to induce apoptosis (programmed cell death) in these cells. These effects are thought to be mediated by the binding of CMB305 to CD3 and CD20, which activates the immune system to recognize and attack the cancer cells.\nWhile the results of these preclinical studies are promising, it is important to note that they were conducted in laboratory settings using cell cultures and animal models, and more research is needed to determine whether CMB305 is safe and effective in humans. Clinical trials are currently underway to evaluate the safety and efficacy of CMB305 in patients with various types of cancer, including sarcomas.",
    "llama-2-7b-chat-hf_fact": [
      "CMB305 is a bispecific antibody that targets proteins CD3 and CD20 on T cells and B cells respectively.",
      "Sarcomas are a type of cancer that originates in the connective tissue of the body.",
      "Sarcomas account for about 1% of all adult cancers.",
      "CMB305 has been effective against various types of sarcomas, including osteosarcoma, chondrosarcoma, and leiomyosarcoma in preclinical studies.",
      "Clinical trials are being conducted to evaluate the safety and efficacy of CMB305 in patients with different types of cancer, including sarcomas."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3435,
    "user_query": "What is Quadracel?",
    "llama-2-7b-chat-hf_response": "Quadracel is a vaccine used to protect against diphtheria, tetanus, pertussis (also known as whooping cough), and Haemophilus influenzae type b (Hib). It is given to children aged 18 months to 7 years as a booster dose to maintain their immunity against these diseases.\nQuadracel is a combination vaccine that contains four different antigens:\n1. Diphtheria toxoid: This protects against diphtheria, a bacterial infection that can cause severe respiratory and cardiac complications.\n2. Tetanus toxoid: This protects against tetanus, a bacterial infection that can cause muscle stiffness, spasms, and rigidity.\n3. Pertussis toxoid: This protects against pertussis, also known as whooping cough, a highly contagious respiratory infection that can cause severe coughing spells and difficulty breathing.\n4. Haemophilus influenzae type b (Hib) polysaccharide: This protects against Haemophilus influenzae type b, a bacterial infection that can cause meningitis, pneumonia, and other respiratory infections.\nQuadracel is given as an injection into the muscle of the upper arm. It is important to follow the recommended vaccination schedule to ensure that your child is fully protected against these diseases.\nCommon side effects of Quadracel include redness, swelling, or pain at the injection site, fever, and fatigue. In rare cases, more serious side effects can occur, such as an allergic reaction or a severe immune response. It is important to discuss any concerns or questions you have about Quadracel with your child's healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Quadracel is a vaccine used to protect against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b (Hib).",
      "Quadracel is given to children aged 18 months to 7 years as a booster dose.",
      "The Quadracel vaccine contains four different antigens: Diphtheria toxoid, Tetanus toxoid, Pertussis toxoid, and Haemophilus influenzae type b (Hib) polysaccharide.",
      "Quadracel is administered as an injection into the muscle of the upper arm.",
      "Common side effects of Quadracel include redness, swelling, or pain at the injection site, fever, and fatigue."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Quadracel is used to protect against diphtheria, tetanus, pertussis, and poliomyelitis.",
      "true",
      "false, [corrected fact]: The Quadracel vaccine contains four different types of antigens: Diphtheria toxoid, Tetanus toxoid, Pertussis toxoids (PT and FHA), and Inactivated Poliovirus.",
      "true",
      "true"
    ]
  },
  {
    "id": 3436,
    "user_query": "What delivery system is used for the Fluzone Intradermal vaccine?",
    "llama-2-7b-chat-hf_response": "The Fluzone Intradermal vaccine is administered via a intradermal delivery system, which involves injecting the vaccine into the skin rather than the muscle. This delivery system is designed to provide a more targeted and efficient immune response, as the vaccine is delivered directly to the immune cells in the skin.\nThe Fluzone Intradermal vaccine is available in a prefilled applicator that contains a single dose of the vaccine. The applicator is gently pressed against the skin, and the vaccine is injected through a small needle. The entire process typically takes about 15 seconds to complete.\nIt's important to follow the instructions provided by your healthcare provider or pharmacist when administering the Fluzone Intradermal vaccine. They can provide guidance on how to properly use the vaccine and help ensure that it is administered safely and effectively.",
    "llama-2-7b-chat-hf_fact": [
      "The Fluzone Intradermal vaccine is administered via an intradermal delivery system.",
      "This delivery system involves injecting the vaccine into the skin rather than the muscle.",
      "The Fluzone Intradermal vaccine is available in a prefilled applicator that contains a single dose of the vaccine.",
      "The entire process of injecting the Fluzone Intradermal vaccine typically takes about 15 seconds to complete.",
      "Healthcare providers or pharmacists provide guidance on how to properly use the Fluzone Intradermal vaccine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3450,
    "user_query": "How many genes belong to the KRAB-ZNF family in the human genome?",
    "llama-2-7b-chat-hf_response": "The KRAB-ZNF (Krppel-associated box Zinc finger) family is a group of transcription factors that play important roles in regulating gene expression during development and cell differentiation. In the human genome, there are approximately 150 genes that belong to the KRAB-ZNF family. These genes are scattered across different chromosomes, with the largest number of genes found on chromosomes 1, 6, and 12.",
    "llama-2-7b-chat-hf_fact": [
      "The KRAB-ZNF (Krppel-associated box Zinc finger) family is a group of transcription factors.",
      "KRAB-ZNF family plays important roles in regulating gene expression during development and cell differentiation.",
      "There are approximately 150 genes that belong to the KRAB-ZNF family in the human genome.",
      "The genes of the KRAB-ZNF family are scattered across different chromosomes within the human genome.",
      "The largest number of KRAB-ZNF genes are found on chromosomes 1, 6, and 12."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There are approximately 800 genes that belong to the KRAB-ZNF family in the human genome.",
      "true",
      "true"
    ]
  },
  {
    "id": 3451,
    "user_query": "Which molecule is targeted by Asciminib?",
    "llama-2-7b-chat-hf_response": "Asciminib is a drug that targets the enzyme Bcr-Abl, which is a constitutively active tyrosine kinase that is present in chronic myeloid leukemia (CML) cells. Bcr-Abl is a fusion protein that results from the translocation of the Abl and Bcr genes, leading to the expression of a chimeric protein that is constitutively active and promotes cell proliferation and survival. Asciminib is a small molecule inhibitor of Bcr-Abl, and it has shown promise in preclinical studies as a potential treatment for CML.",
    "llama-2-7b-chat-hf_fact": [
      "Asciminib is a drug that targets the enzyme Bcr-Abl.",
      "The enzyme Bcr-Abl is present in chronic myeloid leukemia (CML) cells.",
      "Bcr-Abl is a fusion protein that results from the translocation of the Abl and Bcr genes.",
      "The expression of Bcr-Abl promotes cell proliferation and survival.",
      "Asciminib has shown promise in preclinical studies as a potential treatment for CML."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3453,
    "user_query": "What is characteristic to Fitz-HughCurtis syndrome?",
    "llama-2-7b-chat-hf_response": "Fitz-HughCurtis syndrome is a rare condition that affects the female reproductive organs. It is characterized by the following symptoms:\n1. Pelvic pain: The most common symptom of Fitz-HughCurtis syndrome is pelvic pain, which can be severe and persistent. The pain may be located in the lower abdomen, pelvis, or lower back.\n2. Endometriosis: Fitz-HughCurtis syndrome is often associated with endometriosis, a condition in which tissue similar to the lining of the uterus grows outside of the uterus.\n3. Adhesions: The condition is also characterized by the formation of adhesions, which are bands of fibrous tissue that can bind organs together or to the pelvic wall.\n4. Infertility: Fitz-HughCurtis syndrome can cause infertility due to the presence of adhesions and endometriosis, which can distort the fallopian tubes and ovaries, making it difficult for an egg to travel through the reproductive system.\n5. Heavy menstrual bleeding: Women with Fitz-HughCurtis syndrome may experience heavy menstrual bleeding, which can be due to the presence of endometriosis and adhesions.\n6. Painful intercourse: The condition can also cause painful intercourse due to the presence of adhesions and endometriosis.\n7. Abnormal uterine bleeding: Women with Fitz-HughCurtis syndrome may experience abnormal uterine bleeding, which can be due to the presence of endometriosis and adhesions.\n8. Fertility problems: The condition can cause fertility problems due to the presence of adhesions and endometriosis, which can distort the fallopian tubes and ovaries, making it difficult for an egg to travel through the reproductive system.\n9. Increased risk of ectopic pregnancy: Women with Fitz-HughCurtis syndrome are at an increased risk of ectopic pregnancy, which occurs when a fertilized egg implants outside of the uterus.\n10. Chronic pelvic pain",
    "llama-2-7b-chat-hf_fact": [
      "Fitz-HughCurtis syndrome is a condition that affects the female reproductive organs.",
      "One of the common symptoms of Fitz-HughCurtis syndrome is severe and persistent pelvic pain.",
      "The condition is often associated with endometriosis.",
      "Fitz-HughCurtis syndrome is also characterized by the formation of adhesions, fibrous tissue that can bind organs together or to the pelvic wall.",
      "Women with Fitz-HughCurtis syndrome are at an increased risk of ectopic pregnancy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Fitz-Hugh-Curtis syndrome is often associated with pelvic inflammatory disease (PID), not endometriosis.",
      "true",
      "true"
    ]
  },
  {
    "id": 3454,
    "user_query": "What is the trade name of sildenafil?",
    "llama-2-7b-chat-hf_response": "Sildenafil is the active ingredient in the medication Viagra, which is used to treat erectile dysfunction (ED) in men. The trade name of sildenafil is Revatio, which is used to treat pulmonary arterial hypertension (PAH) and improve exercise capacity in patients with PAH.",
    "llama-2-7b-chat-hf_fact": [
      "Sildenafil is the active ingredient in the medication Viagra.",
      "Viagra is used to treat erectile dysfunction (ED) in men.",
      "The trade name of sildenafil is Revatio.",
      "Revatio is used to treat pulmonary arterial hypertension (PAH).",
      "Revatio can improve exercise capacity in patients with PAH."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3455,
    "user_query": "How large is the SARS-CoV  proteome?",
    "llama-2-7b-chat-hf_response": "The SARS-CoV proteome is relatively small compared to other viruses, with a total of 16 proteins encoded by the viral genome. These proteins include:\n1. Nucleocapsid (N) protein\n2. Phosphoprotein (P)\n3. Matrix (M) protein\n4. Non-structural protein 1 (NS1)\n5. Non-structural protein 2A (NS2A)\n6. Non-structural protein 2B (NS2B)\n7. Spike (S) protein\n8. Envelope (E) protein\n9. Glycoprotein (G)\n10. Membrane protein (M)\n11. RNA-dependent RNA polymerase (RdRp)\n12. Ribonuclease (RNase)\n13. Transcriptional activator (TAR)\n14. Transcriptional repressor (TR)\n15. Signal peptide-cleaving protease (SCP)\n16. Chaperone-like protein (HSP70)\nThe SARS-CoV proteome is relatively small compared to other viruses, with a total of 16 proteins encoded by the viral genome. This is likely due to the fact that SARS-CoV is an enveloped virus, which means that it has a lipid bilayer surrounding its genetic material, and therefore does not require as many structural proteins as other viruses. Additionally, SARS-CoV has a relatively low mutation rate compared to other viruses, which may also contribute to the small size of its proteome.",
    "llama-2-7b-chat-hf_fact": [
      "The SARS-CoV proteome consists of 16 proteins.",
      "The nucleocapsid (N) protein, phosphoprotein (P), and matrix (M) protein are part of the SARS-CoV proteome.",
      "Non-structural proteins 1, 2A, and 2B are encoded by the SARS-CoV genome.",
      "SARS-CoV is an enveloped virus, meaning it has a lipid bilayer surrounding its genetic material.",
      "SARS-CoV has a relatively low mutation rate compared to other viruses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The SARS-CoV proteome consists of 29 proteins.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3460,
    "user_query": "Can radiotherapy cause radiation induced osteosarcoma?",
    "llama-2-7b-chat-hf_response": "Radiotherapy, or radiation therapy, is a common treatment for cancer that uses high-energy radiation to kill cancer cells. However, there is a risk of radiation-induced osteosarcoma, a type of bone cancer, in patients who receive radiation therapy, particularly in children and young adults.\nThe risk of radiation-induced osteosarcoma depends on several factors, including the dose of radiation received, the location of the radiation field, and the age of the patient. Children and young adults are more susceptible to radiation-induced osteosarcoma because their bones are still growing and are more sensitive to radiation damage.\nThe risk of radiation-induced osteosarcoma is generally low, but it is estimated to occur in about 1 to 2% of patients who receive radiation therapy for cancer. However, the risk can be higher in certain groups of patients, such as those who receive high doses of radiation or who have a history of previous radiation exposure.\nTo minimize the risk of radiation-induced osteosarcoma, radiation oncologists take several precautions, including:\n1. Using the lowest dose of radiation necessary to treat the cancer.\n2. Limiting the area of the body that receives radiation.\n3. Spreading out the radiation treatments over a longer period of time.\n4. Monitoring patients for signs of radiation-induced osteosarcoma during and after treatment.\n5. Offering regular follow-up care to monitor patients for any signs of cancer.\nIt is important to note that while radiation-induced osteosarcoma is a risk associated with radiation therapy, it is still a relatively rare occurrence. With proper precautions and monitoring, the risk can be minimized, and the benefits of radiation therapy can be maximized.",
    "llama-2-7b-chat-hf_fact": [
      "Radiation therapy is a common treatment for cancer that uses high energy radiation to kill cancer cells.",
      "There is a risk of radiation-induced osteosarcoma in patients receiving radiation therapy, particularly in children and young adults.",
      "The risk of radiation-induced osteosarcoma is dependent on factors such as radiation dosage, the location of the radiation field, and the patient's age.",
      "It is estimated that about 1 to 2 percent of patients who receive radiation therapy for cancer may develop radiation-induced osteosarcoma.",
      "Precautions are taken by radiation oncologists to minimize the risk, including using the lowest necessary radiation dose, limiting the body area that receives radiation, and closely monitoring patients during and after treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-7b-chat-hf_response": "The Saint's Triad is a concept in Hinduism that refers to the three primary manifestations of the divine in the universe. These manifestations are:\n1. Brahma - the creator\n2. Vishnu - the preserver\n3. Shiva - the destroyer\nThese three deities are often referred to as the Hindu trinity and are considered to be the three primary aspects of the divine. They are believed to be eternal and inseparable, and their interactions and balancing of each other are seen as the driving force behind the creation and maintenance of the universe.\nThe Saint's Triad is a similar concept, but it is focused specifically on the manifestations of these three deities in the lives of saints and spiritual leaders. According to this concept, the three primary manifestations of the divine in a saint's life are:\n1. Bhakti - the path of devotion and love for God\n2. Jnana - the path of knowledge and self-realization\n3. Karma - the path of action and service to others\nThese three paths are seen as complementary and interconnected, and a true saint is believed to have mastered all three of them. Bhakti is the path of devotion and love for God, Jnana is the path of knowledge and self-realization, and Karma is the path of action and service to others.\nThe Saint's Triad is a useful concept for understanding the different aspects of a saint's life and teachings, and how they relate to the broader context of Hindu spirituality. By examining the manifestations of these three deities in the lives of saints, we can gain insights into the nature of the divine and the path to spiritual liberation.",
    "llama-2-7b-chat-hf_fact": [
      "The Saint's Triad in Hinduism refers to three primary manifestations of the divine in the universe: Brahma, Vishnu, and Shiva.",
      "Brahma is viewed as the creator in Hinduism.",
      "Vishnu is viewed as the preserver in Hinduism.",
      "Shiva is viewed as the destroyer in Hinduism.",
      "The three primary manifestations of the divine in a saint's life according to the concept of the Saint's Triad are Bhakti, Jnana, and Karma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Trimurti in Hinduism refers to three primary manifestations of the divine in the universe: Brahma, Vishnu, and Shiva.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Bhakti, Jnana, and Karma are not associated with the concept of the Trimurti or Saint's Triad. They are three paths in Hinduism, leading to spiritual liberation."
    ]
  },
  {
    "id": 3463,
    "user_query": "Are male or female persons more prone to autoimmunity?",
    "llama-2-7b-chat-hf_response": "Autoimmune diseases occur when the immune system mistakenly attacks healthy cells and tissues in the body. Both men and women can develop autoimmune diseases, but some conditions are more common in one gender than the other. Here are some examples of autoimmune diseases that are more common in men or women:\nAutoimmune diseases more common in men:\n1. Rheumatoid arthritis (RA): RA is more common in women than men, with a male-to-female ratio of approximately 1:3.\n2. Systemic lupus erythematosus (SLE): SLE is also more common in women than men, with a male-to-female ratio of approximately 1:2.\n3. Multiple sclerosis (MS): MS is more common in women than men, with a male-to-female ratio of approximately 1:2.\n4. Type 1 diabetes: Type 1 diabetes is more common in boys than girls, with a male-to-female ratio of approximately 1:1.5.\n5. Guillain-Barr syndrome: Guillain-Barr syndrome is more common in men than women, with a male-to-female ratio of approximately 1:2.\nAutoimmune diseases more common in women:\n1. Hashimoto's thyroiditis: Hashimoto's thyroiditis is more common in women than men, with a male-to-female ratio of approximately 1:4.\n2. Psoriasis: Psoriasis is more common in women than men, with a male-to-female ratio of approximately 1:2.\n3. Crohn's disease: Crohn's disease is more common in women than men, with a male-to-female ratio of approximately 1:2.\n4. Ulcerative colitis: Ulcerative colitis is more common in women than men, with a male-to-female ratio of approximately 1:2.\n5. Sjgren's syndrome: Sjgren's syndrome is more common in women than men, with a male-to-female ratio of approximately 1:3.\nIt's",
    "llama-2-7b-chat-hf_fact": [
      "Autoimmune diseases occur when the immune system mistakenly attacks healthy cells and tissues in the body.",
      "Rheumatoid arthritis is more common in women than men, with a male-to-female ratio of approximately 1:3.",
      "Type 1 diabetes is more common in boys than girls, with a male-to-female ratio of approximately 1:1.5.",
      "Hashimoto's thyroiditis is more common in women than men, with a male-to-female ratio of approximately 1:4.",
      "Sjgren's syndrome is more common in women than men, with a male-to-female ratio of approximately 1:3."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Type 1 diabetes occurs equally in boys and girls, with a male-to-female ratio of approximately 1:1.",
      "true",
      "true"
    ]
  },
  {
    "id": 3469,
    "user_query": "What is Fuchs' Uveitis?",
    "llama-2-7b-chat-hf_response": "Fuchs' uveitis is a type of uveitis, which is inflammation of the uvea, the middle layer of the eye. It is caused by a problem with the endothelium, the inner lining of the eye. The endothelium helps the aqueous humor, the fluid that fills the front part of the eye, to drain properly. When the endothelium becomes damaged or dysfunctional, it can cause inflammation in the uvea, leading to symptoms such as eye pain, redness, blurred vision, and sensitivity to light.\nFuchs' uveitis can occur at any age, but it is most common in people over the age of 40. It is more common in women than in men, and it can run in families. The symptoms of Fuchs' uveitis can come on suddenly or gradually, and they can vary in severity. In some cases, Fuchs' uveitis can lead to complications such as cataracts, glaucoma, or retinal detachment if left untreated.\nThe diagnosis of Fuchs' uveitis is made through a combination of physical examination, imaging tests such as ultrasound or MRI, and laboratory tests to check for signs of inflammation in the eye. Treatment for Fuchs' uveitis typically involves medications to reduce inflammation and prevent complications, such as corticosteroids, immunosuppressive drugs, or anti-inflammatory drops. In some cases, surgery may be necessary to remove the cataract or repair any damage to the retina. Early diagnosis and treatment are important to prevent long-term damage to the eye and to preserve vision.",
    "llama-2-7b-chat-hf_fact": [
      "Fuchs' uveitis is an inflammation of the uvea, the middle layer of the eye, caused by issues with the endothelium.",
      "Fuchs' uveitis usually affects people over the age of 40 and is more common in women.",
      "Fuchs' uveitis can lead to complications such as cataracts, glaucoma, and retinal detachment if left untreated.",
      "The diagnosis of Fuchs' uveitis is made through physical examination, imaging tests, and laboratory tests that check for inflammation in the eye.",
      "The treatment for Fuchs' uveitis often involves medications such as corticosteroids, immunosuppressive drugs or anti-inflammatory drops, and in some cases, surgery."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Fuchs' uveitis is an inflammation of the uvea, but it is not caused by issues with the endothelium. It is of unknown etiology, but it is believed to be related to an immune response to a prior viral infection.",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-7b-chat-hf_response": "LY6K (Lysozyme 6 kDa) is a protein that has been shown to play a role in the immune response and cancer progression. Recent studies have suggested that high levels of LY6K expression may be associated with better prognosis for non-small cell lung cancer (NSCLC) patients.\nOne study published in the journal Oncogene found that high levels of LY6K expression were associated with improved overall survival and disease-free survival in NSCLC patients. The study analyzed the expression of LY6K in 107 NSCLC tumors and found that patients with high levels of LY6K expression had a significantly longer overall survival and disease-free survival compared to those with low levels of expression.\nAnother study published in the journal Clinical Cancer Research found similar results, with high levels of LY6K expression associated with improved overall survival and reduced risk of disease recurrence in NSCLC patients.\nThese findings suggest that overexpression of LY6K may be a promising prognostic marker for NSCLC patients, and may also have implications for the development of new therapeutic strategies for this disease.",
    "llama-2-7b-chat-hf_fact": [
      "LY6K is a protein that plays a role in the immune response and cancer progression.",
      "Recent studies suggest high levels of LY6K expression may be associated with a better prognosis for non-small cell lung cancer patients.",
      "A study published in Oncogene found that high levels of LY6K expression were associated with improved overall survival and disease-free survival in NSCLC patients.",
      "Another study published in the journal Clinical Cancer Research found the same, that high levels of LY6K expression were associated with improved overall survival and reduced risk of disease recurrence in NSCLC patients.",
      "The overexpression of LY6K may be a promising prognostic marker for NSCLC patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-7b-chat-hf_response": "Cytokinesis is the process by which a cell divides into two daughter cells. During this process, the cell's membrane and cytoskeleton undergo significant changes to separate the daughter cells. CDKs (cyclin-dependent kinases) are important regulators of the cell cycle, including the process of cytokinesis. Here are some CDK targets that are dephosphorylated during cytokinesis:\n1. Cdc25A: Cdc25A is a phosphatase that dephosphorylates and activates Cdc2/CDK1, which is essential for the progression of the cell cycle, including cytokinesis. During cytokinesis, Cdc25A is dephosphorylated and inactivated, leading to the activation of Cdc2/CDK1 and the proper separation of the daughter cells.\n2. Aurora A: Aurora A is a serine/threonine kinase that plays a crucial role in the formation of the spindle and the separation of the daughter cells during cytokinesis. During cytokinesis, Aurora A is dephosphorylated, leading to its inactivation and the proper separation of the daughter cells.\n3. Polo-like kinase 1 (Plk1): Plk1 is a serine/threonine kinase that is involved in the regulation of the cell cycle, including cytokinesis. During cytokinesis, Plk1 is dephosphorylated, leading to its inactivation and the proper separation of the daughter cells.\n4. Bora: Bora is a serine/threonine kinase that is involved in the regulation of the cell cycle, including cytokinesis. During cytokinesis, Bora is dephosphorylated, leading to its inactivation and the proper separation of the daughter cells.\n5. APC/C: The anaphase-promoting complex/cyclosome (APC/C) is a large protein complex that regulates the metaphase-to-anaphase transition and the degradation of proteins involved in the cell cycle. During cytokinesis, the APC/C is inactivated, leading to the proper separation of the daughter cells.\n6.",
    "llama-2-7b-chat-hf_fact": [
      "Cytokinesis is the process by which a cell divides into two daughter cells.",
      "CDKs (cyclin-dependent kinases) are regulators of the cell cycle, including cytokinesis.",
      "Cdc25A, a phosphatase that activates Cdc2/CDK1, is a CDK target that is dephosphorylated during cytokinesis.",
      "During cytokinesis, Aurora A, a serine/threonine kinase, is dephosphorylated.",
      "Polo-like kinase 1 (Plk1), a serine/threonine kinase that regulates the cell cycle, is a CDK target that is also dephosphorylated during cytokinesis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Cdc25A, a phosphatase that activates Cdc2/CDK1, is a CDK target that is phosphorylated, not dephosphorylated, during cytokinesis.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3474,
    "user_query": "What is dystopia canthorum?",
    "llama-2-7b-chat-hf_response": "Dystopia canthorum is a rare eye condition that affects the canthi, which are the folds of skin where the eyelid meets the cheek. It is characterized by the formation of small, hard nodules or bumps on the canthi, which can be painful and cause discomfort.\nThe exact cause of dystopia canthorum is not known, but it is believed to be related to inflammation or infection of the canthi. It can occur in people of all ages, but it is more common in older adults.\nSymptoms of dystopia canthorum can include:\n* Small, hard nodules or bumps on the canthi\n* Pain or discomfort in the affected area\n* Redness or swelling of the eyelid or cheek\n* Difficulty moving the eyelid or cheek\n* Increased sensitivity to light\n* Blurred vision\nTreatment for dystopia canthorum typically involves antibiotics or anti-inflammatory medications to reduce inflammation and manage symptoms. In some cases, surgery may be necessary to remove the nodules or bumps. It is important to seek medical attention if you experience any symptoms of dystopia canthorum to receive proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Dystopia canthorum is a rare eye condition that affects the canthi.",
      "The condition is characterized by the formation of small, hard nodules or bumps on the canthi.",
      "Symptoms of dystopia canthorum can include redness or swelling of the eyelid or cheek, pain or discomfort, difficulty moving the eyelid or cheek, increased sensitivity to light and blurred vision.",
      "Treatment for dystopia canthorum typically involves antibiotics or anti-inflammatory medications.",
      "In some cases, surgery may be necessary to remove the nodules or bumps in dystopia canthorum."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Dystopia canthorum is a distinct facial feature and not an eye condition. It is characterized by a notable distance between the inner corner of the eyes.",
      "false, [corrected fact]: Dystopia canthorum does not involve the formation of hard nodules or bumps. It is marked by a larger distance between the inner eye corners.",
      "false, [corrected fact]: Dystopia canthorum is not associated with redness, swelling, pain, difficulty moving the eyelid or cheek, light sensitivity, or blurred vision. It simply refers to a wider nasal bridge.",
      "false, [corrected fact]: Treatment for dystopia canthorum does not involve medication as it is a physical characteristic rather than a disease.",
      "false, [corrected fact]: Surgery is not normally necessary for dystopia canthorum as it is not a health issue but a facial feature characterized by a wider space between the inner corners of the eyes."
    ]
  },
  {
    "id": 3476,
    "user_query": "What is Heterochromia Iridis?",
    "llama-2-7b-chat-hf_response": "Heterochromia iridis is a rare eye condition where there is a difference in the color of the iris (the colored part of the eye) between the left and right eyes. The condition is caused by an abnormality in the development of the iris during fetal development, and it can affect one or both eyes.\nTypes of Heterochromia Iridis\nThere are several types of heterochromia iridis, including:\n1. Complete heterochromia: This is the rarest and most severe form of the condition, where one eye has a completely different color from the other.\n2. Central heterochromia: In this form of the condition, there is a ring of color around the pupil in one eye, while the rest of the iris is a different color.\n3. Sectoral heterochromia: In this form of the condition, there is a sector or pie-shaped wedge of color in one eye that is different from the rest of the iris.\n4. Patchwork heterochromia: In this form of the condition, there are small patches of color in one eye that are different from the rest of the iris.\nCauses of Heterochromia Iridis\nThe exact cause of heterochromia iridis is not fully understood, but it is believed to be related to abnormalities in the development of the iris during fetal development. Some possible causes include:\n1. Genetic mutations: Heterochromia iridis can be inherited from one's parents.\n2. Infections: Certain infections during pregnancy or early childhood can increase the risk of developing heterochromia iridis.\n3. Trauma: Trauma to the eye during fetal development can lead to heterochromia iridis.\nSymptoms of Heterochromia Iridis\nThe symptoms of heterochromia iridis can vary depending on the type and severity of the condition. Some common symptoms include:\n1. Different colors in each eye: The most obvious symptom of heterochromia iridis is the presence of different colors in each eye.\n2. Blurred vision: In some cases, heterochromia iridis can cause blurred vision or distorted vision.\n3",
    "llama-2-7b-chat-hf_fact": [
      "Heterochromia iridis is a rare eye condition characterized by differences in the color of the iris between the left and right eyes.",
      "Complete heterochromia is a form of the condition where one eye has a completely different color from the other.",
      "Central heterochromia is a type in which there is a ring of color around the pupil in one eye, while the rest of the iris is different.",
      "Sectoral heterochromia is a type where there is a sector or pie-shaped wedge of color in one eye different from the rest of the iris.",
      "Patchwork heterochromia is characterized by small patches of different color in one eye that are different from the rest of the iris."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no recognized form of heterochromia called \"patchwork heterochromia.\""
    ]
  },
  {
    "id": 3483,
    "user_query": "Is Ubrogepant effective for migraine?",
    "llama-2-7b-chat-hf_response": "Ubrogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist that has been shown to be effective in reducing the frequency and severity of migraine attacks. CGRP is a molecule that is involved in the transmission of pain signals in the body, and it is believed to play a role in the development of migraine. Ubrogepant works by blocking the action of CGRP on its receptors, which can help to reduce the inflammation and pain associated with migraine.\nStudies have shown that ubrogepant is effective in reducing the frequency and severity of migraine attacks, as well as improving other symptoms such as sensitivity to light and sound. For example, a study published in the New England Journal of Medicine found that ubrogepant significantly reduced the frequency and severity of migraine attacks in patients compared to a placebo. Another study published in the Journal of Headache and Pain found that ubrogepant was effective in reducing the severity of migraine attacks and improving quality of life in patients.\nIt is important to note that ubrogepant is only approved for the acute treatment of migraine, and it is not intended for the prevention of migraine. It is also important to talk to your doctor before taking ubrogepant, as it may not be suitable for everyone and may have side effects.\nIn summary, ubrogepant is a CGRP receptor antagonist that has been shown to be effective in reducing the frequency and severity of migraine attacks. It works by blocking the action of CGRP on its receptors, which can help to reduce inflammation and pain associated with migraine. While it is effective, it is important to talk to your doctor before taking it and to only use it for the acute treatment of migraine.",
    "llama-2-7b-chat-hf_fact": [
      "Ubrogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist.",
      "Ubrogepant has been shown to reduce the frequency and severity of migraine attacks.",
      "CGRP is involved in the transmission of pain signals in the body and in the development of migraines.",
      "Ubrogepant is only approved for the acute treatment of migraines, not for prevention.",
      "A study published in the New England Journal of Medicine found that ubrogepant significantly reduced the frequency and severity of migraine attacks in patients compared to a placebo."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3485,
    "user_query": "What is the protein product of the gene GBA2?",
    "llama-2-7b-chat-hf_response": "The gene GBA2 encodes for the enzyme glucocerebrosidase, which is involved in the breakdown of glucocerebrosides, a type of glycolipid. Glucocerebrosidase is a lysosomal enzyme that hydrolyzes glucocerebrosides to ceramide and glucose. The protein product of the GBA2 gene is a key enzyme in the degradation of glycosphingolipids, which are important components of cell membranes and play a role in various cellular processes, including cell signaling and membrane trafficking.\nMutations in the GBA2 gene have been associated with several lysosomal storage disorders, including Gaucher disease, which is characterized by the accumulation of glucocerebrosides in the liver, spleen, and bone marrow. These mutations can lead to a deficiency in glucocerebrosidase activity, resulting in the accumulation of toxic intermediates and the progression of the disease.\nUnderstanding the structure and function of glucocerebrosidase and the GBA2 gene is important for the development of treatments for lysosomal storage disorders, including Gaucher disease.",
    "llama-2-7b-chat-hf_fact": [
      "The gene GBA2 encodes for the enzyme glucocerebrosidase.",
      "Glucocerebrosidase is a lysosomal enzyme involved in the breakdown of glucocerebrosides to ceramide and glucose.",
      "Glycosphingolipids, which are degraded by the protein product of GBA2, are important components of cell membranes.",
      "Mutations in the GBA2 gene have been associated with several lysosomal storage disorders, including Gaucher disease.",
      "Understanding the structure and function of glucocerebrosidase and the GBA2 gene is important for the development of treatments for lysosomal storage disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The gene GBA, not GBA2, encodes for the enzyme glucocerebrosidase.",
      "true",
      "true",
      "false, [corrected fact]: Mutations in the GBA gene, not GBA2, have been associated with several lysosomal storage disorders, including Gaucher disease.",
      "true"
    ]
  },
  {
    "id": 3498,
    "user_query": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "llama-2-7b-chat-hf_response": "No, ProSavin has not undergone phase IV clinical trials by 2018. According to the FDA, phase IV clinical trials are conducted after a drug has been approved and is being marketed to gather additional information on the drug's safety and effectiveness in real-world settings. As of 2018, ProSavin has not received FDA approval and therefore has not undergone phase IV clinical trials.",
    "llama-2-7b-chat-hf_fact": [
      "ProSavin had not undergone phase IV clinical trials by 2018.",
      "Phase IV clinical trials are conducted after a drug has been approved by FDA.",
      "Phase IV clinical trials gather additional information on a drug's safety and effectiveness in real-world settings.",
      "ProSavin had not received FDA approval by 2018."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3502,
    "user_query": "What is ProSavin?",
    "llama-2-7b-chat-hf_response": "ProSavin is a gene therapy product being developed by Bioverativ, a biotechnology company, for the treatment of hemophilia A, a genetic disorder that affects the blood's ability to clot and stop bleeding. ProSavin is designed to deliver a healthy copy of the Factor VIII gene to the liver, where it can produce functional Factor VIII protein to replace the missing or defective protein caused by the genetic mutation that causes hemophilia A.",
    "llama-2-7b-chat-hf_fact": [
      "ProSavin is a gene therapy product.",
      "ProSavin is being developed by Bioverativ, a biotechnology company.",
      "The therapy product, ProSavin, is intended for the treatment of hemophilia A.",
      "Hemophilia A is a genetic disorder that affects the blood's ability to clot.",
      "ProSavin is designed to deliver a healthy copy of the Factor VIII gene to replace the missing or defective protein caused by hemophilia A."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: ProSavin is being developed by Oxford Biomedica, not Bioverativ.",
      "false, [corrected fact]: ProSavin is intended for the treatment of Parkinsons disease, not hemophilia A.",
      "true",
      "false, [corrected fact]: ProSavin is designed to deliver three genes that together encode for dopamine, to help in the treatment of Parkinson's disease, not hemophilia A."
    ]
  },
  {
    "id": 3503,
    "user_query": "Are stretch enhancers transcribed more than super-enhancers?",
    "llama-2-7b-chat-hf_response": "Stretch enhancers are a type of enhancer element that are located far away from their target genes, typically on the opposite strand of the gene. Super-enhancers, on the other hand, are clusters of enhancers that are located close to their target genes.\nWhile both stretch enhancers and super-enhancers play important roles in regulating gene expression, it is not clear whether stretch enhancers are transcribed more than super-enhancers.\nSome studies have suggested that stretch enhancers may be more active than super-enhancers. For example, one study found that stretch enhancers were more frequently bound by transcription factors than super-enhancers. Another study found that stretch enhancers were more active in regulating gene expression than super-enhancers.\nHowever, other studies have suggested that super-enhancers may be more active than stretch enhancers. For example, one study found that super-enhancers were more efficient at recruiting RNA polymerase II, the enzyme responsible for transcribing DNA into RNA, than stretch enhancers. Another study found that super-enhancers were more effective at regulating gene expression than stretch enhancers.\nOverall, the literature suggests that both stretch enhancers and super-enhancers play important roles in regulating gene expression, and that the relative activity of these elements may depend on the specific context in which they are found. Further research is needed to fully understand the mechanisms by which stretch enhancers and super-enhancers regulate gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Stretch enhancers are a type of enhancer element located far away from their target genes, typically on the opposite strand of the gene.",
      "Super-enhancers are clusters of enhancers that are located close to their target genes.",
      "Both stretch enhancers and super-enhancers play important roles in regulating gene expression.",
      "Some studies suggest that stretch enhancers may be more active than super-enhancers.",
      "Other studies suggest that super-enhancers may be more active than stretch enhancers, being more efficient at recruiting RNA polymerase II."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3507,
    "user_query": "Which diagnostic test is approved for coronavirus infection screening?",
    "llama-2-7b-chat-hf_response": "The U.S. Food and Drug Administration (FDA) has approved several diagnostic tests for coronavirus infection screening. These tests are designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19, in a patient's respiratory or nasal secretions. Some of the FDA-approved tests for COVID-19 screening include:\n1. Rapid antigen tests: These tests detect the presence of SARS-CoV-2 antigens in a patient's respiratory or nasal secretions. They are quick and easy to use, providing results within 15-30 minutes.\n2. Reverse transcription polymerase chain reaction (RT-PCR) tests: These tests detect the genetic material of SARS-CoV-2 in a patient's respiratory or nasal secretions. They are more sensitive than rapid antigen tests and can detect very small amounts of the virus.\n3. Loop-mediated isothermal amplification (LAMP) tests: These tests detect the genetic material of SARS-CoV-2 in a patient's respiratory or nasal secretions. They are simpler and faster than RT-PCR tests, providing results within 30-60 minutes.\n4. Digital PCR (dPCR) tests: These tests detect the genetic material of SARS-CoV-2 in a patient's respiratory or nasal secretions. They are highly sensitive and can detect very small amounts of the virus.\n5. Next-generation sequencing (NGS) tests: These tests detect the genetic material of SARS-CoV-2 in a patient's respiratory or nasal secretions. They are highly sensitive and can detect very small amounts of the virus, but they are also more complex and time-consuming than other tests.\nIt's important to note that these tests are not 100% accurate and may produce false negative or false positive results. Therefore, it's important to follow up with a healthcare professional for proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact": [
      "The U.S. Food and Drug Administration (FDA) has approved several diagnostic tests for coronavirus infection screening.",
      "The diagnostic tests are designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19.",
      "Rapid antigen tests provide results within 15-30 minutes.",
      "Reverse transcription polymerase chain reaction (RT-PCR) tests are more sensitive than rapid antigen tests and can detect very small amounts of the virus.",
      "The diagnostic tests are not 100% accurate and may produce false negative or false positive results."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-7b-chat-hf_response": "Xanamem is a prescription medication used to treat anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder. It belongs to a class of drugs called benzodiazepines, which work by slowing down the activity of the nervous system to produce a calming effect.\nXanamem is available in immediate-release and extended-release formulations. The immediate-release formulation is designed to provide rapid relief of anxiety symptoms, while the extended-release formulation is designed to provide longer-lasting relief of anxiety symptoms over a 24-hour period.\nXanamem is typically taken orally, once or twice a day, as directed by your doctor. It may take several weeks to see the full effects of Xanamem. It's important to follow your doctor's instructions carefully and not take more Xanamem than prescribed, as it can be habit-forming and may cause withdrawal symptoms if stopped suddenly.\nCommon side effects of Xanamem include drowsiness, dizziness, confusion, and difficulty concentrating. Less common side effects can include memory problems, difficulty with coordination and balance, and changes in mood.\nXanamem can interact with other medications, including other benzodiazepines, opioids, and certain antidepressants. It's important to inform your doctor of all medications you are taking, including over-the-counter medications and supplements, to avoid potential interactions.\nIn summary, Xanamem is a benzodiazepine medication used to treat anxiety disorders, including GAD, panic disorder, and social anxiety disorder. It works by slowing down the activity of the nervous system to produce a calming effect, but it can be habit-forming and may cause withdrawal symptoms if stopped suddenly. It's important to follow your doctor's instructions carefully and be aware of potential side effects and interactions.",
    "llama-2-7b-chat-hf_fact": [
      "Xanamem is a prescription medication used to treat anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder.",
      "Xanamem belongs to a class of drugs called benzodiazepines.",
      "Xanamem is available in immediate-release and extended-release formulations.",
      "Common side effects of Xanamem include drowsiness, dizziness, confusion, and difficulty concentrating.",
      "Xanamem can interact with other medications, including other benzodiazepines, opioids, and certain antidepressants."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3509,
    "user_query": "Can nrf2 activation lead to resistance to radiotherapy?",
    "llama-2-7b-chat-hf_response": "Yes, activation of the nuclear factor erythroid 2-related factor 2 (NFE2L2 or NRF2) has been shown to confer resistance to radiation therapy in various cancer types, including breast, lung, and ovarian cancer. NRF2 is a transcription factor that plays a critical role in protecting cells against oxidative stress and inflammation by activating antioxidant and detoxification pathways. However, in cancer cells, NRF2 can also promote resistance to radiation therapy by activating genes involved in DNA repair, cell cycle regulation, and angiogenesis.\nSeveral mechanisms have been proposed by which NRF2 activation can lead to resistance to radiotherapy, including:\n1. Enhanced DNA repair: NRF2 can activate genes involved in DNA repair, such as O6-methylguanine-DNA methyltransferase (MGMT), which can repair DNA damage induced by radiation therapy, leading to increased resistance to treatment.\n2. Increased angiogenesis: NRF2 can activate genes involved in angiogenesis, such as vascular endothelial growth factor (VEGF), which can promote the formation of new blood vessels that supply the tumor with oxygen and nutrients, making it more resistant to radiation therapy.\n3. Enhanced cell cycle regulation: NRF2 can activate genes involved in cell cycle regulation, such as cyclin-dependent kinase inhibitors (CKIs), which can inhibit radiation-induced cell cycle arrest and apoptosis, leading to increased resistance to treatment.\n4. Induction of cancer stem cells: NRF2 can activate genes involved in the maintenance of cancer stem cells, which are thought to be responsible for the initiation and progression of cancer. These stem cells are often more resistant to radiation therapy than other cancer cells, leading to increased resistance to treatment.\n5. Inhibition of radiation-induced apoptosis: NRF2 can activate genes involved in inhibiting radiation-induced apoptosis, such as BCL-2, which can prevent radiation-induced cell death, leading to increased resistance to treatment.\nOverall, the activation of NRF2 can lead to increased resistance to radiation therapy by prom",
    "llama-2-7b-chat-hf_fact": [
      "Nuclear factor erythroid 2-related factor 2 (NFE2L2 or NRF2) is a transcription factor that plays a crucial role in protecting cells against oxidative stress and inflammation.",
      "Activation of NRF2 can confer resistance to radiation therapy in various cancer types, such as breast, lung, and ovarian cancer.",
      "NRF2 can activate genes that enhance DNA repair, promote angiogenesis, regulate cell cycles, maintain cancer stem cells, and inhibit radiation-induced apoptosis.",
      "The activation of genes, such as O6-methylguanine-DNA methyltransferase (MGMT) by NRF2, can repair DNA damage induced by radiation therapy, leading to increased resistance to the treatment.",
      "Activation of BCL-2 gene by NRF2 prevents radiation-induced cell death, enhancing resistance to radiation therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3513,
    "user_query": "What is the role of Scc2/Nipbl?",
    "llama-2-7b-chat-hf_response": "Scc2/Nipbl is a protein that plays a crucial role in the regulation of cellular processes, including cell adhesion, migration, and signaling. Here are some of the key functions of Scc2/Nipbl:\n1. Cell adhesion: Scc2/Nipbl is involved in the regulation of cell adhesion molecules, such as cadherins and integrins, which are important for maintaining cell-cell and cell-matrix interactions.\n2. Cell migration: Scc2/Nipbl regulates the movement of cells during development and tissue repair. It helps to maintain the integrity of the actin cytoskeleton, which is essential for cell migration.\n3. Signaling: Scc2/Nipbl is involved in the regulation of signaling pathways, including the PI3K/Akt and MAPK pathways, which are important for cell survival and proliferation.\n4. Cytoskeleton organization: Scc2/Nipbl helps to maintain the organization of the actin cytoskeleton, which is essential for cell shape and movement.\n5. Cancer: Scc2/Nipbl has been implicated in cancer development and progression. It is overexpressed in many types of cancer, including breast, lung, and colon cancer.\nIn summary, Scc2/Nipbl is a multifunctional protein that plays a crucial role in the regulation of cellular processes, including cell adhesion, migration, signaling, cytoskeleton organization, and cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Scc2/Nipbl is a protein that regulates cellular processes, including cell adhesion, migration, and signaling.",
      "Scc2/Nipbl plays a role in regulating cell adhesion molecules, such as cadherins and integrins.",
      "The protein also participates in the regulation of cell migration during development and tissue repair.",
      "Scc2/Nipbl is involved in the regulation of signaling pathways, including the PI3K/Akt and MAPK pathways.",
      "It has been found that Scc2/Nipbl is often overexpressed in many types of cancer, including breast, lung, and colon cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3515,
    "user_query": "Can brain derived exosomes carry APP molecules?",
    "llama-2-7b-chat-hf_response": "Yes, brain-derived exosomes can carry APP (amyloid precursor protein) molecules. Exosomes are small, membrane-bound vesicles that are released by cells and can carry a variety of biomolecules, including proteins, lipids, and RNA. The brain is a rich source of exosomes, and brain-derived exosomes have been shown to carry a variety of molecules, including APP, which is a key component of amyloid plaques in Alzheimer's disease.\nStudies have shown that brain-derived exosomes can take up APP from the extracellular space and transport it to other cells, where it can be processed and incorporated into amyloid plaques. For example, one study found that brain-derived exosomes isolated from the cerebrospinal fluid of Alzheimer's disease patients contained higher levels of APP than exosomes from healthy controls.\nThe ability of brain-derived exosomes to carry APP molecules has important implications for the development of new therapies for Alzheimer's disease. For example, exosomes could be used as a delivery vehicle to target APP to specific cells or tissues in the brain, such as astrocytes or microglia, where it can be processed and incorporated into amyloid plaques. Alternatively, exosomes could be used to deliver APP to other cells, such as immune cells, where it can be degraded and prevented from accumulating in the brain.\nOverall, the ability of brain-derived exosomes to carry APP molecules highlights the complex interplay between cells in the brain and the potential for exosomes to play a role in the development and progression of Alzheimer's disease.",
    "llama-2-7b-chat-hf_fact": [
      "Exosomes are small, membrane-bound vesicles released by cells that can carry a variety of biomolecules.",
      "Brain-derived exosomes can carry APP (amyloid precursor protein) molecules, a key component of amyloid plaques in Alzheimer's disease.",
      "Studies have indicated that brain-derived exosomes can take APP from the extracellular space and transport it to other cells.",
      "It has been found that brain-derived exosomes isolated from the cerebrospinal fluid of Alzheimer's disease patients contained higher levels of APP than exosomes from healthy controls.",
      "The ability of brain-derived exosomes to carry APP molecules may have implications for the development of new therapies for Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3517,
    "user_query": "Which are the main G1/S transcription factors in yeast?",
    "llama-2-7b-chat-hf_response": "The G1/S transition is a critical checkpoint in the cell cycle that regulates progression from the G1 phase to the S phase. In yeast, there are several G1/S transcription factors that play important roles in regulating this transition. Here are some of the main G1/S transcription factors in yeast:\n1. SBF (SBF1/2): SBF is a transcriptional activator that is composed of two subunits, SBF1 and SBF2. SBF is a key regulator of the G1/S transition and is required for the expression of genes involved in DNA replication and cell cycle progression.\n2. MBF (MBF1/2): MBF is another transcriptional activator that is composed of two subunits, MBF1 and MBF2. MBF is also involved in the regulation of the G1/S transition and is required for the expression of genes involved in DNA replication and cell cycle progression.\n3. CDK7 (Cyclin-Dependent Kinase 7): CDK7 is a cyclin-dependent kinase that is involved in the regulation of the G1/S transition. CDK7 phosphorylates and activates the transcriptional activators SBF and MBF, which leads to the expression of genes involved in DNA replication and cell cycle progression.\n4. MCM1 (Minichromosome Maintenance Complex Subunit 1): MCM1 is a subunit of the minichromosome maintenance complex, which is involved in the initiation of DNA replication. MCM1 is required for the expression of genes involved in DNA replication and cell cycle progression during the G1/S transition.\n5. ORC1 (Origin Recognition Complex Subunit 1): ORC1 is a subunit of the origin recognition complex, which is involved in the initiation of DNA replication. ORC1 is required for the expression of genes involved in DNA replication and cell cycle progression during the G1/S transition.\nThese transcription factors work together to regulate the expression of genes involved in DNA replication and cell cycle progression during the G1/S transition. Dysregulation of these transcription factors has been implicated in various diseases, including cancer.",
    "llama-2-7b-chat-hf_fact": [
      "In yeast, SBF (SBF1/2) is a G1/S transcription factor that contributes to the regulation of the G1 to S phase transition in the cell cycle.",
      "MBF (MBF1/2) is another G1/S transcriptional activator in yeast involved in progression from the G1 phase to the S phase.",
      "Cyclin-Dependent Kinase 7 (CDK7) in yeast is involved in the regulation of the G1/S transition and activates SBF and MBF.",
      "MCM1 is a subunit of the minichromosome maintenance complex in yeast and contributes to DNA replication and cell cycle progression during the G1/S transition.",
      "ORC1 is a subunit of the origin recognition complex in yeast and plays a role in DNA replication and cell cycle progression during the G1/S transition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Cyclin Dependent Kinase 1 (CDK1), not CDK7, in yeast is involved in the regulation of the G1/S transition and activates SBF and MBF.",
      "true",
      "true"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-7b-chat-hf_response": "The Hof1-Cyk3 interaction plays a crucial role in regulating the cellular response to oxidative stress in yeast. Hof1 is a transcription factor that regulates the expression of genes involved in the response to oxidative stress, while Cyk3 is a protein kinase that phosphorylates and activates Hof1. The interaction between Hof1 and Cyk3 is necessary for Hof1 to be activated and to regulate the expression of genes involved in the response to oxidative stress.\nIn the absence of oxidative stress, Hof1 is in an inactive state due to the presence of a repressive chromatin structure. When oxidative stress is detected, Cyk3 is activated and phosphorylates Hof1, leading to its activation and the relaxation of the repressive chromatin structure. Activated Hof1 then regulates the expression of genes involved in the response to oxidative stress, such as those involved in the production of antioxidants and the repair of damaged cellular components.\nIn summary, the Hof1-Cyk3 interaction plays a crucial role in regulating the cellular response to oxidative stress in yeast by activating Hof1 and allowing it to regulate the expression of genes involved in the response to oxidative stress.",
    "llama-2-7b-chat-hf_fact": [
      "Hof1-Cyk3 interaction plays a vital role in regulating the cellular response to oxidative stress in yeast.",
      "Hof1 is a transcription factor that regulates the expression of genes involved in the response to oxidative stress.",
      "Cyk3 is a protein kinase that phosphorylates and activates Hof1.",
      "Interaction between Hof1 and Cyk3 is necessary for Hof1 to be activated.",
      "Activated Hof1 regulates the expression of genes involved in the response to oxidative stress in yeast, such as those involved in the production of antioxidants and the repair of damaged cellular components."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3523,
    "user_query": "Is SATB1 positioned close to AT-rich sequences?",
    "llama-2-7b-chat-hf_response": "Yes, SATB1 is often positioned close to AT-rich sequences in the genome. SATB1 is a transcription factor that plays a crucial role in regulating the expression of genes involved in cell fate determination, differentiation, and tissue development. It has been shown to be enriched in regions of the genome that are rich in AT-rich sequences, such as gene bodies and enhancers.\nAT-rich sequences are characterized by a high content of adenine (A) bases and are typically found in regions of the genome that are involved in gene regulation. These sequences are thought to play a role in the recruitment of transcription factors and other regulatory proteins to specific genomic regions, where they can modulate gene expression.\nSATB1 has been shown to bind to AT-rich sequences in vitro and in vivo, and it is thought to play a role in recruiting other transcription factors and regulatory proteins to these regions. For example, SATB1 has been shown to bind to the AT-rich sequences in the promoter region of the human retinoblastoma gene, where it regulates the expression of this tumor suppressor gene.\nIn summary, SATB1 is often positioned close to AT-rich sequences in the genome, where it plays a role in regulating the expression of genes involved in cell fate determination, differentiation, and tissue development.",
    "llama-2-7b-chat-hf_fact": [
      "SATB1 is a transcription factor that regulates the expression of genes involved in cell fate determination, differentiation, and tissue development.",
      "SATB1 is often positioned close to AT-rich sequences in the genome.",
      "AT-rich sequences are characterized by a high content of adenine (A) bases and are typically found in regions of the genome that are involved in gene regulation.",
      "SATB1 has been shown to bind to AT-rich sequences in vitro and in vivo.",
      "SATB1 binds to the AT-rich sequences in the promoter region of the human retinoblastoma gene, where it regulates the expression of this tumor suppressor gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3526,
    "user_query": "What is known about PAI-1 in longevity in humans?",
    "llama-2-7b-chat-hf_response": "PAI-1 (plasminogen activator inhibitor-1) is a protein that plays a crucial role in the regulation of the fibrinolytic system, which is responsible for breaking down blood clots. Elevated levels of PAI-1 have been associated with an increased risk of cardiovascular disease (CVD) and mortality in humans.\nSeveral studies have investigated the relationship between PAI-1 and longevity in humans. One study found that higher levels of PAI-1 were associated with a shorter lifespan in a cohort of older adults. Another study found that lower levels of PAI-1 were associated with a longer lifespan in a cohort of centenarians (individuals aged 100 years or older).\nAdditionally, PAI-1 has been shown to play a role in the regulation of cellular senescence, which is a state of permanent cell cycle arrest that can contribute to aging and age-related diseases. Elevated levels of PAI-1 have been shown to promote cellular senescence, while lower levels of PAI-1 have been shown to inhibit cellular senescence.\nOverall, the evidence suggests that PAI-1 may play a role in the regulation of longevity in humans, with higher levels of PAI-1 associated with a shorter lifespan and lower levels of PAI-1 associated with a longer lifespan. However, further research is needed to fully understand the relationship between PAI-1 and longevity in humans.",
    "llama-2-7b-chat-hf_fact": [
      "PAI-1 (plasminogen activator inhibitor-1) is a protein that is involved in the regulation of the fibrinolytic system.",
      "The fibrinolytic system is responsible for breaking down blood clots.",
      "Elevated levels of PAI-1 have been associated with an increased risk of cardiovascular disease and mortality in humans.",
      "PAI-1 also plays a role in the regulation of cellular senescence, which is a state of permanent cell cycle arrest that can contribute to aging and age-related diseases.",
      "Studies suggest that PAI-1 levels may have an influence on human longevity, with higher levels associated with a shorter lifespan and lower levels associated with a longer lifespan."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3530,
    "user_query": "What bacteria is associated with Gastric cancer and peptic ulcers?",
    "llama-2-7b-chat-hf_response": "Helicobacter pylori (H. pylori) is a type of bacteria that is commonly associated with gastric cancer and peptic ulcers. H. pylori infection is a major risk factor for the development of gastric cancer, and it is estimated that up to 70% of gastric cancers worldwide are caused by H. pylori infection. H. pylori infection can also cause peptic ulcers, which are open sores in the lining of the stomach or duodenum (the first part of the small intestine).\nH. pylori infection is caused by the ingestion of contaminated food or water, and it can persist in the stomach for many years if left untreated. Symptoms of H. pylori infection may include abdominal pain, nausea, vomiting, and loss of appetite. Treatment for H. pylori infection typically involves the use of antibiotics, and it is important to seek medical attention if symptoms persist or worsen over time.\nIn addition to H. pylori, other types of bacteria may also be associated with gastric cancer and peptic ulcers, including:\n* Streptococcus: This type of bacteria can cause infections in the stomach and duodenum, including peptic ulcers.\n* Enterococcus: This type of bacteria can also cause infections in the stomach and duodenum, including peptic ulcers.\n* Bacteroides: This type of bacteria can cause infections in the stomach and small intestine, including peptic ulcers.\n* Clostridium: This type of bacteria can cause infections in the stomach and small intestine, including peptic ulcers.\nIt is important to note that the exact mechanisms by which these bacteria contribute to the development of gastric cancer and peptic ulcers are not yet fully understood, and further research is needed to determine the specific roles of these bacteria in these conditions.",
    "llama-2-7b-chat-hf_fact": [
      "Helicobacter pylori (H. pylori) is a type of bacteria commonly associated with gastric cancer and peptic ulcers.",
      "An estimated 70% of gastric cancers globally are linked to H. pylori infection.",
      "H. pylori infection can cause peptic ulcers, open sores in the lining of the stomach or the duodenum.",
      "Symptoms of H. pylori infection can include abdominal pain, nausea, vomiting, and loss of appetite, among others.",
      "Besides H. pylori, bacteria such as Streptococcus, Enterococcus, Bacteroides, and Clostridium can also cause infections in the stomach and duodenum, including peptic ulcers."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3532,
    "user_query": "What is the purpose of the 123 dihydrorhodamine assay?",
    "llama-2-7b-chat-hf_response": "The 123 dihydrorhodamine (DHR) assay is a fluorescence-based assay used to measure the activity of cytochrome P450 enzymes, particularly CYP3A4, in liver microsomes or recombinant enzymes. The assay is based on the conversion of the fluorescent dye dihydrorhodamine (DHR) by cytochrome P450 enzymes into a fluorescent product, 123-DHR, which can be measured spectrophotometrically.\nThe purpose of the 123-DHR assay is to:\n1. Measure the activity of specific cytochrome P450 enzymes, such as CYP3A4, in liver microsomes or recombinant enzymes.\n2. Determine the effect of drugs or other compounds on the activity of cytochrome P450 enzymes.\n3. Investigate the role of cytochrome P450 enzymes in drug metabolism and toxicity.\n4. Develop new drugs or drug metabolizing enzymes.\n5. Evaluate the potential side effects of drugs on cytochrome P450 enzymes and drug metabolism.\nThe 123-DHR assay is a useful tool for studying cytochrome P450 enzymes and their role in drug metabolism, as it provides a sensitive and specific method for measuring enzyme activity.",
    "llama-2-7b-chat-hf_fact": [
      "The 123 dihydrorhodamine (DHR) assay is a fluorescence-based assay used to measure the activity of cytochrome P450 enzymes.",
      "The 123-DHR assay is used to measure the activity of specific cytochrome P450 enzymes, such as CYP3A4, in liver microsomes or recombinant enzymes.",
      "The assay can help determine the effect of drugs or other compounds on the activity of cytochrome P450 enzymes.",
      "The assay is used to investigate the role of cytochrome P450 enzymes in drug metabolism and toxicity.",
      "The 123-DHR assay is used to develop new drugs or drug metabolizing enzymes and evaluate possible side effects of drugs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The dihydrorhodamine (DHR) assay is a flow cytometry-based assay used to test the function of phagocytes.",
      "false, [corrected fact]: The DHR assay is used to measure the function of phagocytes, not cytochrome P450 enzymes.",
      "false, [corrected fact]: The assay can help determine the effect of stimuli on the phagocytic activity, not on the activity of cytochrome P450 enzymes.",
      "false, [corrected fact]: The assay is used to investigate the function of phagocytes in immune response, not the role of cytochrome P450 enzymes in drug metabolism and toxicity.",
      "false, [corrected fact]: The DHR assay is used in diagnosing certain immunodeficiency diseases, not in drug development or testing."
    ]
  },
  {
    "id": 3533,
    "user_query": "What is the mode of action of filgotinib?",
    "llama-2-7b-chat-hf_response": "Filgotinib is a JAK1 inhibitor, which means it works by blocking the activity of the enzyme Janus kinase 1 (JAK1). JAK1 is involved in signaling pathways that are important for the immune system and inflammation. By blocking JAK1, filgotinib can reduce the activity of immune cells that are involved in the inflammatory response, such as T cells and macrophages. This can help to reduce the symptoms of conditions such as rheumatoid arthritis and ulcerative colitis.\nFilgotinib also has anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines, which are signaling molecules that promote inflammation. By reducing the production of these cytokines, filgotinib can help to reduce the inflammation that is associated with conditions such as rheumatoid arthritis and ulcerative colitis.\nIn addition, filgotinib has been shown to have anti-tumor effects by inhibiting the growth and spread of cancer cells. It is thought to do this by blocking the activity of JAK1, which is involved in the signaling pathways that promote cell growth and division. By blocking these pathways, filgotinib can help to slow the growth of cancer cells and reduce the risk of tumor growth and metastasis.\nOverall, the mode of action of filgotinib is to reduce the activity of immune cells and inflammatory signaling pathways, which can help to reduce the symptoms of conditions such as rheumatoid arthritis and ulcerative colitis. It also has anti-tumor effects by blocking the growth and spread of cancer cells.",
    "llama-2-7b-chat-hf_fact": [
      "Filgotinib is a JAK1 inhibitor.",
      "The drug Filgotinib blocks the enzyme Janus kinase 1 (JAK1) which is involved in important immune system and inflammation signaling pathways.",
      "Filgotinib can reduce the activity of immune cells involved in the inflammatory response such as T cells and macrophages.",
      "Filgotinib inhibits the production of pro-inflammatory cytokines, which reduces inflammation.",
      "Filgotinib has been shown to inhibit the growth and spread of cancer cells by blocking the activity of JAK1."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3535,
    "user_query": "What is RiboTag profiling?",
    "llama-2-7b-chat-hf_response": "RiboTag profiling is a method used to measure the abundance of ribosomes in a cell or tissue. Ribosomes are the site of protein synthesis in the cell, and their abundance can be an indicator of cellular stress, growth, or disease. RiboTag profiling involves labeling ribosomes with a small molecule tag, such as a fluorescent dye or a radioactive label, and then isolating and analyzing the labeled ribosomes using techniques such as fluorescence microscopy or mass spectrometry.\nThe advantages of RiboTag profiling include:\n1. High sensitivity and specificity: RiboTag profiling can detect changes in ribosome abundance at the single-cell level, allowing for the detection of subtle changes in cellular behavior.\n2. Non-invasive: RiboTag profiling can be performed using cells or tissues that are easily accessible, such as those from blood or tissue biopsies.\n3. Reduced background: The use of a small molecule tag can reduce background signal and increase the signal-to-noise ratio, allowing for more accurate measurements of ribosome abundance.\n4. Improved resolution: The high sensitivity and specificity of RiboTag profiling can provide detailed information about the distribution and abundance of ribosomes within cells and tissues.\n5. Combination with other techniques: RiboTag profiling can be combined with other techniques, such as RNA sequencing or mass spectrometry, to provide a more comprehensive understanding of cellular processes.\nThe applications of RiboTag profiling include:\n1. Cancer research: RiboTag profiling can be used to study the changes in ribosome abundance and distribution in cancer cells, which can provide insights into the mechanisms of cancer development and progression.\n2. Stem cell biology: RiboTag profiling can be used to study the changes in ribosome abundance and distribution in stem cells, which can provide insights into the mechanisms of stem cell maintenance and differentiation.\n3. Neurodegenerative diseases: RiboTag profiling can be used to study the changes in ribosome abundance and distribution in neurons and other cells in the brain, which can provide insights into the mechanisms of",
    "llama-2-7b-chat-hf_fact": [
      "RiboTag profiling is a method used to measure the abundance of ribosomes in a cell or tissue.",
      "Ribosomes are the site of protein synthesis in the cell.",
      "The abundance of ribosomes can indicate cellular stress, growth, or disease.",
      "RiboTag profiling involves labeling ribosomes with a small molecule tag, such as a fluorescent dye or a radioactive label.",
      "RiboTag profiling can be combined with other techniques, such as RNA sequencing or mass spectrometry, to provide a more comprehensive understanding of cellular processes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: RiboTag profiling is a method used to measure the abundance and identity of mRNAs in a specific cell type or tissue, not the abundance of ribosomes.",
      "true",
      "true",
      "false, [corrected fact]: RiboTag profiling involves equipping a ribosomal protein with an epitope tag, not labeling ribosomes with a small molecule tag.",
      "true"
    ]
  },
  {
    "id": 3537,
    "user_query": "What is foliglurax?",
    "llama-2-7b-chat-hf_response": "Foliglurax is a medication used to treat glaucoma, a group of eye conditions that can damage the optic nerve and lead to vision loss. It belongs to a class of drugs called cholinergic agents, which work by increasing the amount of a chemical called acetylcholine in the eye. Acetylcholine helps to reduce pressure inside the eye, which can help to slow or stop the progression of glaucoma.\nFoliglurax is available in the form of eye drops and is typically used in combination with other medications to treat glaucoma. It is important to use foliglurax exactly as directed by your doctor and to continue using it regularly to control your glaucoma.\nCommon side effects of foliglurax include:\n* Redness of the eye\n* Itching or burning of the eye\n* Discharge or crusting of the eye\n* Blurred vision\n* Eye pain\n* Difficulty seeing at night\nThese side effects are usually mild and temporary, but if they persist or worsen, you should contact your doctor.\nFoliglurax can also cause more serious side effects, including:\n* Allergic reactions, including rash, hives, or swelling of the face, lips, tongue, or throat\n* Eye inflammation or infection\n* Changes in vision\n* Seizures\n* Abnormal liver function tests\nIf you experience any of these serious side effects, you should seek medical attention immediately.\nIt is important to inform your doctor of any medications you are taking, including over-the-counter medications and supplements, as they may interact with foliglurax. Foliglurax may also cause dizziness or drowsiness, so you should avoid driving or operating heavy machinery until you know how it affects you.\nIn summary, foliglurax is a medication used to treat glaucoma by increasing the amount of acetylcholine in the eye. It can cause side effects such as redness, itching, and blurred vision, but serious side effects are rare. It is important to use foliglurax exactly as directed by your doctor and to inform them of any medications you are taking.",
    "llama-2-7b-chat-hf_fact": [
      "Foliglurax is a medication used to treat glaucoma, a condition that can damage the optic nerve and lead to vision loss.",
      "Foliglurax belongs to a class of drugs called cholinergic agents, which function by increasing the amount of a chemical called acetylcholine in the eye.",
      "Acetylcholine, increased by foliglurax, helps to reduce pressure inside the eye to slow or stop the progression of glaucoma.",
      "Foliglurax is typically used in combination with other medications to treat glaucoma, and the medication is in the form of eye drops.",
      "Common side effects of foliglurax include redness of the eye, itching or burning of the eye, discharge or crusting of the eye, blurred vision, eye pain, and difficulty in seeing at night."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3549,
    "user_query": "List symptoms of Allgrove syndrome.",
    "llama-2-7b-chat-hf_response": "Allgrove syndrome is a rare genetic disorder characterized by intellectual disability, seizures, and distinctive facial features. Here are some common symptoms associated with Allgrove syndrome:\n1. Intellectual disability: Individuals with Allgrove syndrome typically have mild to moderate intellectual disability, which can affect their ability to learn and adapt to new situations.\n2. Seizures: Allgrove syndrome can cause various types of seizures, including tonic-clonic, atonic, and myoclonic seizures. These seizures can occur at any age and can be a significant source of concern for individuals and their families.\n3. Distinctive facial features: People with Allgrove syndrome often have distinctive facial features, including a small head, narrow eyes, a short nose, and a thin upper lip. These features can vary in severity and may not be present in all individuals with the disorder.\n4. Delayed speech and language development: Individuals with Allgrove syndrome may experience delayed speech and language development, which can make it difficult for them to communicate effectively.\n5. Autism spectrum disorder: Some individuals with Allgrove syndrome may also have autism spectrum disorder (ASD), which can affect their social interaction and communication skills.\n6. Skeletal abnormalities: Allgrove syndrome can cause various skeletal abnormalities, including short stature, scoliosis, and joint deformities. These abnormalities can vary in severity and may not be present in all individuals with the disorder.\n7. Vision problems: Some individuals with Allgrove syndrome may experience vision problems, including strabismus (crossed eyes) and cataracts.\n8. Hearing loss: Allgrove syndrome can also cause hearing loss, which can affect an individual's ability to communicate and understand speech.\n9. Respiratory problems: Some individuals with Allgrove syndrome may experience respiratory problems, including respiratory infections and sleep apnea.\n10. Increased risk of infections: Individuals with Allgrove syndrome may be at increased risk of infections, particularly respiratory infections, due to",
    "llama-2-7b-chat-hf_fact": [
      "Allgrove syndrome is a rare genetic disorder characterized by intellectual disability, seizures, and distinctive facial features.",
      "Seizures, including tonic-clonic, atonic, and myoclonic seizures, can occur in individuals with Allgrove syndrome.",
      "People with Allgrove syndrome can have distinctive facial features, including a small head, narrow eyes, a short nose, and a thin upper lip.",
      "Allgrove syndrome can cause various skeletal abnormalities, including short stature, scoliosis, and joint deformities.",
      "Some individuals with Allgrove syndrome may experience vision problems, including strabismus (crossed eyes) and cataracts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Allgrove syndrome, also known as Triple A syndrome, is a rare genetic disorder characterized by alacrima (a reduced or absent ability to secrete or produce tears), achalasia (a disorder of the esophagus where it's hard for foods and liquids to pass into the stomach), and adrenal gland insufficiency (where the adrenal gland produces insufficient amounts of certain hormones). It does not primarily involve intellectual disabilities, seizures, or distinctive facial features.",
      "false, [corrected fact]: Seizures are not a primary symptom of Allgrove syndrome. The main symptoms involve alacrima, achalasia, and adrenal gland insufficiency.",
      "false, [corrected fact]: Allgrove syndrome does not typically cause distinctive facial features like a small head, narrow eyes, a short nose, and a thin upper lip.",
      "true",
      "true"
    ]
  },
  {
    "id": 3551,
    "user_query": "How do the plasma concentrations of amantadine extended release and amantadine immediate release compare?",
    "llama-2-7b-chat-hf_response": "Amantadine is an antiviral drug that is used to treat Parkinson's disease and other movement disorders. It is available in two formulations: immediate release (IR) and extended release (ER). The ER formulation is designed to release the drug more slowly over a longer period of time, which can provide more consistent levels of the drug in the body and potentially reduce side effects.\nStudies have shown that the plasma concentrations of amantadine ER and IR are different. For example, a study published in the Journal of Clinical Pharmacology found that the mean peak plasma concentration (Cmax) of amantadine ER was significantly lower than that of IR (31% lower). The study also found that the mean area under the plasma concentration-time curve (AUC) of amantadine ER was significantly higher than that of IR (23% higher).\nAnother study published in the European Journal of Clinical Pharmacology found similar results. The study found that the Cmax of amantadine ER was 37% lower than that of IR, and the AUC was 19% higher.\nThese studies suggest that the plasma concentrations of amantadine ER and IR are different, with the ER formulation resulting in lower peak concentrations and higher overall exposure. However, more research is needed to fully understand the differences in pharmacokinetics between these two formulations.",
    "llama-2-7b-chat-hf_fact": [
      "Amantadine is an antiviral drug used to treat Parkinson's disease and other movement disorders.",
      "Amantadine is available in two formulations: immediate release and extended release.",
      "The extended release formulation of amantadine is designed to release the drug more slowly over a longer period of time.",
      "Studies have indicated that the plasma concentration of amantadine extended release and immediate release are different with the former typically having a lower peak concentration and higher overall exposure.",
      "Findings published in both the Journal of Clinical Pharmacology and the European Journal of Clinical Pharmacology confirmed differences in the concentration peaks and exposure of amantadine in its immediate and extended-release forms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3554,
    "user_query": "Which drugs are included in GI cocktail?",
    "llama-2-7b-chat-hf_response": "A GI cocktail is a combination of medications used to treat gastrointestinal (GI) disorders, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD). The specific drugs included in a GI cocktail may vary depending on the individual patient and their condition, but common medications used in GI cocktails include:\n1. Aminosalicylates: These medications, such as sulfasalazine or mesalamine, help to reduce inflammation in the GI tract.\n2. Corticosteroids: Corticosteroids, such as prednisone, can help to reduce inflammation and swelling in the GI tract.\n3. Immunomodulators: Immunomodulators, such as azathioprine or mercaptopurine, help to suppress the immune system and reduce inflammation in the GI tract.\n4. Proton pump inhibitors (PPIs): PPIs, such as omeprazole or lansoprazole, help to reduce acid production in the stomach, which can help to relieve symptoms of GERD.\n5. H2 blockers: H2 blockers, such as ranitidine or famotidine, help to reduce acid production in the stomach, which can help to relieve symptoms of GERD.\n6. Antibiotics: Antibiotics, such as ciprofloxacin or metronidazole, may be used to treat bacterial infections in the GI tract.\n7. Anti-diarrheal medications: Anti-diarrheal medications, such as loperamide or diphenoxylate, can help to slow down bowel movements and relieve diarrhea.\n8. Laxatives: Laxatives, such as bisacodyl or senna, can help to stimulate bowel movements and relieve constipation.\nIt's important to note that GI cocktails may also include other medications, such as antacids or anti-seizure medications, depending on the individual patient's",
    "llama-2-7b-chat-hf_fact": [
      "A GI cocktail is a combination of medications used to treat gastrointestinal disorders like inflammatory bowel disease, irritable bowel syndrome, and gastroesophageal reflux disease.",
      "Aminosalicylates, such as sulfasalazine or mesalamine, are medications that can be included in a GI cocktail to reduce inflammation in the GI tract.",
      "Corticosteroids, such as prednisone, can also be used in a GI cocktail to reduce inflammation and swelling in the GI tract.",
      "The medication loperamide or diphenoxylate can be included in a GI cocktail as anti-diarrheal medications.",
      "Laxatives like bisacodyl or senna can be included in a GI cocktail to stimulate bowel movements and relieve constipation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: A GI cocktail, also known as Green Goddess or a gastric cocktail, is a generic term for a mixture of liquid antacid, viscous lidocaine, and an anticholinergic primarily used to treat dyspepsia.",
      "false, [corrected fact]: Aminosalicylates, such as sulfasalazine or mesalamine, are medications used in the treatment of inflammatory bowel disorders, but they are not typically part of a GI cocktail.",
      "false, [corrected fact]: Corticosteroids, such as prednisone, can be used to reduce inflammation and swelling in the GI tract in certain conditions, but they are not a standard constituent of a GI cocktail.",
      "false, [corrected fact]: Loperamide or diphenoxylate are anti-diarrheal medications and are not typically included in a GI cocktail which is mainly used for dyspepsia relief.",
      "false, [corrected fact]: Laxatives like bisacodyl or senna are not typically included in a GI cocktail. Their primary uses are to relieve constipation and stimulate bowel movements."
    ]
  },
  {
    "id": 3555,
    "user_query": "Is AZD5153 active in prostate cancer?",
    "llama-2-7b-chat-hf_response": "Yes, AZD5153 is active in prostate cancer. AZD5153 is a potent and selective inhibitor of the enzyme PI3K-delta, which is overexpressed in many types of cancer, including prostate cancer. Studies have shown that AZD5153 can inhibit the growth of prostate cancer cells both in vitro and in vivo, and can also induce apoptosis (cell death) in these cells.\nFor example, a study published in the journal Cancer Research in 2013 found that AZD5153 inhibited the growth of prostate cancer cells and induced apoptosis in these cells, both in vitro and in vivo. The study also found that AZD5153 was more effective at inhibiting the growth of prostate cancer cells than other PI3K-delta inhibitors that were tested.\nAnother study published in the journal Prostate in 2016 found that AZD5153 inhibited the growth of prostate cancer cells and reduced the expression of the PI3K-delta protein in these cells. The study also found that AZD5153 was effective at inhibiting the growth of prostate cancer cells that were resistant to other treatments.\nOverall, these studies suggest that AZD5153 is a promising agent for the treatment of prostate cancer, and may be effective at inhibiting the growth of cancer cells and inducing apoptosis in these cells. However, further research is needed to fully understand the activity of AZD5153 in prostate cancer and to determine its potential as a therapeutic agent.",
    "llama-2-7b-chat-hf_fact": [
      "AZD5153 is active in prostate cancer.",
      "AZD5153 is a potent and selective inhibitor of the enzyme PI3K-delta.",
      "AZD5153 can inhibit the growth of prostate cancer cells both in vitro and in vivo, and can also induce apoptosis in these cells.",
      "A study published in 2013 showed AZD5153 was more effective at inhibiting the growth of prostate cancer cells than other PI3K-delta inhibitors.",
      "Another study published in 2016 found that AZD5153 was effective at inhibiting the growth of prostate cancer cells that were resistant to other treatments."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false, [corrected fact]: AZD5153 is a potent and selective inhibitor of the Bromodomain and Extra-Terminal motif (BET) family of proteins.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3556,
    "user_query": "Is GRG5 involved only in late embryonic mouse development?",
    "llama-2-7b-chat-hf_response": "No, GRG5 is not only involved in late embryonic mouse development. While it is true that GRG5 is expressed at high levels during late embryonic development, particularly during gastrulation and neurulation, it is also expressed in earlier embryonic stages and throughout embryonic development.\nIn fact, GRG5 has been shown to be involved in a variety of developmental processes, including:\n1. Cell fate determination: GRG5 has been shown to regulate the fate of cells during embryonic development, particularly in the neural tube and limb buds.\n2. Cell migration: GRG5 has been implicated in the migration of cells during embryonic development, including the migration of neurons and immune cells.\n3. Cell proliferation: GRG5 has been shown to regulate cell proliferation during embryonic development, particularly in the neural tube and limb buds.\n4. Differentiation: GRG5 has been implicated in the differentiation of cells during embryonic development, particularly in the neural tube and limb buds.\n5. Organogenesis: GRG5 has been shown to be involved in the formation of various organs during embryonic development, including the neural tube, limb buds, and gut.\nIn summary, while GRG5 is expressed at high levels during late embryonic development, it is also involved in earlier embryonic stages and throughout embryonic development in a variety of developmental processes.",
    "llama-2-7b-chat-hf_fact": [
      "GRG5 is expressed at high levels during late embryonic mouse development.",
      "GRG5 is also expressed in earlier embryonic stages and throughout embryonic development.",
      "GRG5 has been shown to regulate cell fate determination during embryonic development.",
      "GRG5 has been implicated in the migration of cells during embryonic development.",
      "GRG5 has been shown to interact with the differentiation of cells during embryonic development."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3558,
    "user_query": "Describe the mechanism of action of a drug Elagolix.",
    "llama-2-7b-chat-hf_response": "Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the action of GnRH on the pituitary gland. GnRH is a hormone produced by the hypothalamus that stimulates the pituitary gland to produce follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH and LH are important for the development and maturation of ovarian follicles in women and the production of testosterone in men.\nWhen elagolix binds to the GnRH receptor, it prevents GnRH from activating the pituitary gland to produce FSH and LH. This results in a decrease in the levels of these hormones in the bloodstream, leading to a reduction in the growth and maturation of ovarian follicles in women and a decrease in testosterone production in men.\nElagolix also has a direct effect on the ovarian follicles, causing them to degenerate and die. This can lead to a decrease in the size of the ovaries and a reduction in the number of follicles available for ovulation.\nOverall, elagolix works by blocking the action of GnRH on the pituitary gland and directly affecting the ovarian follicles, leading to a reduction in the levels of FSH and LH and a decrease in the growth and maturation of ovarian follicles.",
    "llama-2-7b-chat-hf_fact": [
      "Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist.",
      "GnRH stimulates the pituitary gland to produce follicle-stimulating hormone (FSH) and luteinizing hormone (LH).",
      "FSH and LH are critical for the development and maturation of ovarian follicles in women and the production of testosterone in men.",
      "Elagolix works by blocking the action of GnRH on the pituitary gland, preventing the production of FSH and LH.",
      "Elagolix also has a direct effect on the ovarian follicles, causing them to degenerate and die."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Elagolix does not have a direct effect on the ovarian follicles. It works by blocking the action of GnRH on the pituitary gland, which subsequently decreases the production of FSH and LH, affecting the development and maturation of ovarian follicles."
    ]
  },
  {
    "id": 3567,
    "user_query": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?",
    "llama-2-7b-chat-hf_response": "CRISPR/Cas9 knockout screens are a powerful tool for identifying genes that are essential for cell viability or specific biological processes. However, analyzing the large amounts of data generated by these screens can be challenging. Several algorithms have been developed to help analyze CRISPR/Cas9 knockout screen data, including:\n1. Cluster-based methods: These algorithms group genes into clusters based on their knockout phenotypes, allowing researchers to identify groups of genes that have similar functions or are involved in the same biological pathways.\n2. Machine learning methods: These algorithms use statistical models to identify genes that are most strongly associated with specific phenotypes or biological processes, based on the knockout data.\n3. Network-based methods: These algorithms use computational models of biological networks to identify genes that are connected to genes with specific phenotypes or biological processes, based on the knockout data.\n4. Pathway analysis methods: These algorithms identify genes that are involved in specific biological pathways or networks, based on the knockout data.\n5. Functional enrichment analysis methods: These algorithms identify genes that are enriched for specific functional categories, such as gene ontology terms or Kyoto encyclopedia of genes and genomes (KEGG) pathways, based on the knockout data.\n6. Network-based methods: These algorithms use computational models of biological networks to identify genes that are connected to genes with specific phenotypes or biological processes, based on the knockout data.\n7. Machine learning methods: These algorithms use statistical models to identify genes that are most strongly associated with specific phenotypes or biological processes, based on the knockout data.\n8. Cluster-based methods: These algorithms group genes into clusters based on their knockout phenotypes, allowing researchers to identify groups of genes that have similar functions or are involved in the same biological pathways.\nEach of these algorithms has its own strengths and limitations, and the choice of algorithm will depend on the specific research question and the characteristics of the knockout data.",
    "llama-2-7b-chat-hf_fact": [
      "CRISPR/Cas9 knockout screens are used for identifying genes essential for cell viability or specific biological processes.",
      "Cluster-based methods are algorithms that group genes based on their knockout phenotypes.",
      "Machine learning methods use statistical models to identify genes associated with specific phenotypes or biological processes from the knockout data.",
      "Network-based methods use computational models of biological networks to identify genes connected to genes with specific phenotypes or biological processes.",
      "Functional enrichment analysis methods are algorithms that identify genes enriched for specific functional categories such as gene ontology terms or KEGG pathways, based on the knockout data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3569,
    "user_query": "PDQ39 questionnaires is design for which disease?",
    "llama-2-7b-chat-hf_response": "A) Rheumatoid Arthritis\nB) Osteoarthritis\nC) Systemic Lupus Erythematosus\nD) Fibromyalgia\nAnswer: A) Rheumatoid Arthritis.\nThe PDQ39 questionnaire is a widely used tool for assessing the quality of life (QoL) in patients with rheumatoid arthritis (RA). It is a 39-item questionnaire that assesses various aspects of QoL, including physical functioning, pain, and emotional well-being. The PDQ39 has been shown to be a reliable and valid measure of QoL in patients with RA, and has been used in clinical trials and research studies to evaluate the effectiveness of treatments for this condition.",
    "llama-2-7b-chat-hf_fact": [
      "The PDQ39 questionnaire is used to assess the quality of life in patients with rheumatoid arthritis.",
      "The PDQ39 questionnaire includes 39 items.",
      "Components covered in the PDQ39 questionnaire include physical functioning, pain, and emotional well-being.",
      "The PDQ39 questionnaire has been proven to be a reliable measure of quality of life for patients with rheumatoid arthritis.",
      "The PDQ39 questionnaire has been used in clinical trials and research studies to evaluate the effectiveness of treatments for rheumatoid arthritis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The PDQ39 questionnaire is used to assess the quality of life in patients with Parkinson's Disease, not rheumatoid arthritis.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The PDQ39 questionnaire has been used in clinical trials and research studies to evaluate the effectiveness of treatments for Parkinson's Disease, not rheumatoid arthritis."
    ]
  },
  {
    "id": 3570,
    "user_query": "Is palbociclib effective for glioblastoma?",
    "llama-2-7b-chat-hf_response": "Palbociclib, a CDK4/6 inhibitor, has shown promise in treating various types of cancer, including breast cancer. However, its effectiveness in treating glioblastoma, an aggressive form of brain cancer, is still unknown.\nGlioblastoma is a highly malignant brain tumor that is resistant to conventional treatments, including surgery, radiation therapy, and chemotherapy. The prognosis for patients with glioblastoma is poor, with a median survival time of around 15 months.\nSeveral studies have investigated the use of CDK4/6 inhibitors, including palbociclib, in glioblastoma. These studies have shown that CDK4/6 inhibitors can inhibit the growth of glioblastoma cells and increase the expression of pro-apoptotic genes, leading to increased cell death.\nOne study published in the journal Cancer Research in 2018 found that palbociclib increased the expression of the pro-apoptotic gene BAX in glioblastoma cells, leading to increased cell death. Another study published in the journal Neuro-Oncology in 2019 found that palbociclib inhibited the growth of glioblastoma cells and increased the expression of the pro-apoptotic gene PUMA.\nWhile these studies suggest that CDK4/6 inhibitors, including palbociclib, may be effective in treating glioblastoma, further research is needed to confirm these findings and to determine the optimal dosing and combination regimens for clinical use.\nIn summary, while the effectiveness of palbociclib in treating glioblastoma is still unknown, preclinical studies suggest that CDK4/6 inhibitors may be effective in inhibiting the growth of glioblastoma cells and increasing cell death. Further research is needed to confirm these findings and to determine the potential of CDK4/6 inhibitors as a treatment for glioblastoma.",
    "llama-2-7b-chat-hf_fact": [
      "Palbociclib is a CDK4/6 inhibitor that has shown promise in treating various types of cancer, including breast cancer.",
      "Glioblastoma is a highly malignant brain tumor resistant to conventional treatments, including surgery, radiation therapy, and chemotherapy.",
      "Studies have shown that CDK4/6 inhibitors, including palbociclib, can inhibit the growth of glioblastoma cells.",
      "One research study found that palbociclib increased the expression of the pro-apoptotic gene BAX in glioblastoma cells.",
      "Another study found that palbociclib inhibited the growth of glioblastoma cells and increased the expression of the pro-apoptotic gene PUMA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3572,
    "user_query": "Does the Mcm2-Ctf4-Pol axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "llama-2-7b-chat-hf_response": "Yes, the Mcm2-Ctf4-Pol axis plays a crucial role in the transfer of histones to leading strand DNA at the replication forks. The Mcm2-Ctf4-Pol complex is a key player in the initiation of DNA replication, and it is involved in the transfer of histones from the template to the leading strand DNA.\nThe Mcm2-Ctf4-Pol complex is composed of three subunits: Mcm2, Ctf4, and Pol. Mcm2 is a minichromosome maintenance (MCM) protein that is essential for the initiation of DNA replication. Ctf4 is a C-terminal fragment of the Mcm2 protein that is required for the binding of the Mcm2-Ctf4-Pol complex to the template DNA. Pol is a DNA polymerase that is responsible for the synthesis of new DNA strands during replication.\nStudies have shown that the Mcm2-Ctf4-Pol complex plays a crucial role in the transfer of histones from the template to the leading strand DNA. During the initiation of DNA replication, the Mcm2-Ctf4-Pol complex binds to the template DNA and unwinds the double helix. As the replication fork moves along the template, the Mcm2-Ctf4-Pol complex helps to transfer histones from the template to the leading strand DNA. This process is essential for the proper synthesis of new DNA strands during replication.\nIn addition to its role in histone transfer, the Mcm2-Ctf4-Pol complex also plays a role in the regulation of DNA replication initiation. The complex helps to recruit other proteins that are necessary for the initiation of DNA replication, such as the origin recognition complex (ORC) and the Cdc6 protein.\nIn summary, the Mcm2-Ctf4-Pol axis plays a crucial role in the transfer of histones to leading strand DNA at the replication forks, and it is essential for the proper synthesis of new DNA strands during replication.",
    "llama-2-7b-chat-hf_fact": [
      "The Mcm2-Ctf4-Pol axis is involved in the transfer of histones to leading strand DNA at the replication forks.",
      "The Mcm2-Ctf4-Pol complex is made up of three subunits: Mcm2, Ctf4, and Pol.",
      "Mcm2 is a minichromosome maintenance (MCM) protein essential for the initiation of DNA replication.",
      "Pol is a DNA polymerase responsible for the synthesis of new DNA strands during replication.",
      "The Mcm2-Ctf4-Pol complex helps to recruit other proteins for the initiation of DNA replication, such as the origin recognition complex (ORC) and the Cdc6 protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The Mcm2-Ctf4-Pol complex is involved in the elongation, not initiation of DNA replication. The origin recognition complex (ORC) and Cdc6 protein are involved in the initiation of DNA replication but they are not directly recruited by the Mcm2-Ctf4-Pol complex."
    ]
  },
  {
    "id": 3574,
    "user_query": "Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?",
    "llama-2-7b-chat-hf_response": "Autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is a rare genetic disorder that affects the brain and spinal cord. It is characterized by progressive loss of myelin, the fatty insulating layer that surrounds nerve fibers, leading to a range of neurological symptoms including muscle weakness, coordination problems, and cognitive decline.\nThere are several genes that have been identified as being frequently involved in ADLD. These include:\n1. ARSA gene: The ARSA gene provides instructions for making an enzyme called arylsulfatase A, which is involved in the breakdown of sulfatides, a type of lipid molecule found in myelin. Mutations in the ARSA gene can lead to the accumulation of sulfatides in the brain, which is thought to contribute to the development of ADLD.\n2. ASMD gene: The ASMD gene provides instructions for making an enzyme called acid sphingomyelinase, which is involved in the breakdown of sphingomyelin, a type of lipid molecule found in myelin. Mutations in the ASMD gene can lead to the accumulation of sphingomyelin in the brain, which is thought to contribute to the development of ADLD.\n3. CLN1 gene: The CLN1 gene provides instructions for making a protein called claudin-1, which is involved in the structure and function of the blood-brain barrier. Mutations in the CLN1 gene can lead to the accumulation of toxic substances in the brain, which is thought to contribute to the development of ADLD.\n4. GALC gene: The GALC gene provides instructions for making an enzyme called galactocerebrosidase, which is involved in the breakdown of galactocerebroside, a type of lipid molecule found in myelin. Mutations in the GALC gene can lead to the accumulation of galactocerebroside in the brain, which is thought to contribute to the development of ADLD.\n5. GCase gene: The GCase gene provides instructions for making an enzyme called glucocerebrosidase, which is involved in the breakdown of glucocereb",
    "llama-2-7b-chat-hf_fact": [
      "Autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is a rare genetic disorder that affects the brain and spinal cord.",
      "The ARSA gene, involved in the breakdown of sulfatides, has been identified as frequently associated with ADLD.",
      "The ASMD gene, associated with the breakdown of sphingomyelin, has been identified as frequently associated with ADLD.",
      "The CLN1 gene, involved with the structure and function of the blood-brain barrier, is frequently associated with ADLD.",
      "The GALC gene, associated with the breakdown of galactocerebroside, has been identified as frequently associated with ADLD."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The ARSA gene is associated with Metachromatic Leukodystrophy, not ADLD.",
      "false, [corrected fact]: The ASMD gene is not known to be frequently associated with ADLD.",
      "false, [corrected fact]: The CLN1 gene is not known to be associated with ADLD but with Infantile Neuronal Ceroid Lipofuscinosis.",
      "false, [corrected fact]: The GALC gene is associated with Krabbe disease, not ADLD."
    ]
  },
  {
    "id": 3577,
    "user_query": "Which is the main epigenetic difference between poised and constitutive enhancers?",
    "llama-2-7b-chat-hf_response": "Poised enhancers are enhancers that are active only in specific cell types or developmental stages, whereas constitutive enhancers are active in all cell types and developmental stages. One of the main epigenetic differences between these two types of enhancers is the pattern of histone modifications. Poised enhancers typically have a different histone modification profile than constitutive enhancers. For example, poised enhancers may have higher levels of histone 3 lysine 4 trimethylation (H3K4me3) and lower levels of histone 3 lysine 27 trimethylation (H3K27me3) compared to constitutive enhancers. These differences in histone modifications can lead to differences in the recruitment of transcription factors and other regulatory proteins to the enhancer, which in turn can affect the level of enhancer activity.",
    "llama-2-7b-chat-hf_fact": [
      "Poised enhancers are active only in specific cell types or developmental stages.",
      "Constitutive enhancers are active in all cell types and developmental stages.",
      "One of the main epigenetic differences between poised and constitutive enhancers is the pattern of histone modifications.",
      "Poised enhancers typically have a different histone modification profile than constitutive enhancers.",
      "These differences in histone modifications can lead to differences in the recruitment of transcription factors and other regulatory proteins to the enhancer, affecting the level of enhancer activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3586,
    "user_query": "What is gamma sterilization used for?",
    "llama-2-7b-chat-hf_response": "Gamma sterilization is a type of radiation sterilization that uses ionizing radiation to kill microorganisms and sterilize medical instruments and supplies. It is commonly used to sterilize heat-sensitive medical instruments, such as surgical instruments, implantable devices, and pharmaceuticals.\nGamma sterilization works by exposing the items to a dose of ionizing radiation, typically in the form of gamma rays, which are produced by a radioisotope. The radiation damages the DNA of the microorganisms, making it impossible for them to reproduce and cause contamination. The process is effective against a wide range of microorganisms, including bacteria, viruses, and fungi.\nGamma sterilization is used in a variety of applications, including:\n1. Medical instrument sterilization: Gamma sterilization is commonly used to sterilize heat-sensitive medical instruments, such as surgical instruments, endoscopes, and implantable devices.\n2. Pharmaceutical sterilization: Gamma sterilization is used to sterilize pharmaceuticals, including vaccines, blood products, and other injectable drugs.\n3. Food irradiation: Gamma sterilization is used to sterilize food products, such as meat, poultry, and produce, to kill bacteria and extend shelf life.\n4. Water treatment: Gamma sterilization can be used to sterilize water by killing bacteria and other microorganisms.\n5. Waste treatment: Gamma sterilization can be used to sterilize hazardous waste, such as medical waste, to reduce the risk of infection and contamination.\n6. Radiation sterilization of medical devices: Gamma sterilization is used to sterilize a wide range of medical devices, including implantable devices, surgical instruments, and diagnostic equipment.\n7. Radiation sterilization of pharmaceuticals: Gamma sterilization is used to sterilize pharmaceuticals, including vaccines, blood products, and other injectable drugs.\n8. Radiation sterilization of food: Gamma sterilization is used to sterilize food products, such as meat, poultry, and produce, to kill bacter",
    "llama-2-7b-chat-hf_fact": [
      "Gamma sterilization uses ionizing radiation to kill microorganisms and sterilize medical instruments and supplies.",
      "This process of sterilization works by damaging the DNA of the microorganisms, making it impossible for them to reproduce.",
      "Gamma sterilization is used to sterilize heat-sensitive medical instruments, implantable devices, and pharmaceuticals.",
      "Gamma sterilization is also used to sterilize food products to kill bacteria and extend shelf life.",
      "It can be used to sterilize water and hazardous waste, such as medical waste."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3589,
    "user_query": "What is the current regulation of eye lens radiation exposure?",
    "llama-2-7b-chat-hf_response": "The current regulation of eye lens radiation exposure is primarily governed by the International Commission on Radiological Protection (ICRP) and the National Institute of Occupational Safety and Health (NIOSH) in the United States. Here are some of the key regulations and guidelines related to eye lens radiation exposure:\n1. ICRP Publication 60: This publication provides recommendations for the protection of people from the effects of ionizing radiation. It includes guidelines for assessing and controlling radiation exposure to the eye lens.\n2. NIOSH Recommendations: NIOSH has developed recommendations for the protection of workers from eye lens radiation exposure. These recommendations include limits on the maximum allowable eye lens dose, as well as guidelines for monitoring and controlling radiation exposure.\n3. Occupational Safety and Health Standards (OSHA): OSHA has established standards for protecting workers from radiation exposure in the workplace. These standards include limits on the maximum allowable eye lens dose, as well as requirements for monitoring and controlling radiation exposure.\n4. American National Standards Institute (ANSI): ANSI has established standards for the protection of workers from radiation exposure. These standards include guidelines for assessing and controlling radiation exposure to the eye lens.\n5. International Electrotechnical Commission (IEC): IEC has established standards for the protection of workers from radiation exposure in the workplace. These standards include guidelines for assessing and controlling radiation exposure to the eye lens.\n6. National Council on Radiation Protection and Measurements (NCRP): NCRP has developed recommendations for the protection of people from the effects of ionizing radiation. These recommendations include guidelines for assessing and controlling radiation exposure to the eye lens.\n7. World Health Organization (WHO): WHO has established guidelines for the protection of workers from radiation exposure in the workplace. These guidelines include limits on the maximum allowable eye lens dose, as well as recommendations for monitoring and controlling radiation exposure.\nIt is important to note that these regulations and guidelines are subject to change, and it is recommended to consult the most recent versions of these documents for the most up-",
    "llama-2-7b-chat-hf_fact": [
      "The regulation of eye lens radiation exposure is governed by the International Commission on Radiological Protection (ICRP) and the National Institute of Occupational Safety and Health (NIOSH) in the United States.",
      "ICRP Publication 60 provides recommendations for the protection of people from the effects of ionizing radiation, including guidelines for assessing and controlling eye lens radiation exposure.",
      "NIOSH has developed recommendations for the protection of workers from eye lens radiation exposure, which include limits on the maximum allowable dose and guidelines for monitoring and controlling exposure.",
      "The Occupational Safety and Health Standards (OSHA) has specific standards for protecting workers from radiation exposure in the workplace, including limits on the maximum allowable eye lens dose and requirements for monitoring and controlling radiation exposure.",
      "The American National Standards Institute (ANSI) has established standards for the protection of workers from radiation exposure, including guidelines for assessing and controlling radiation exposure to the eye lens."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3593,
    "user_query": "What is the cause of the disease Xeroderma Pigmentosum?",
    "llama-2-7b-chat-hf_response": "Xeroderma pigmentosum (XP) is a rare genetic disorder that affects the skin and increases the risk of developing skin cancer. People with XP have a defect in the DNA repair system, which makes them more susceptible to the harmful effects of ultraviolet (UV) radiation from the sun or tanning beds.\nThe cause of XP is a mutation in one of several genes that are involved in the DNA repair process. These genes are responsible for fixing damaged DNA molecules, which can occur as a result of exposure to UV radiation. When these genes are mutated, the DNA repair process is impaired, leading to the development of XP.\nThere are several different genes that can be mutated in XP, including the ERCC2 gene, the ERCC3 gene, and the XPA gene. Each of these genes plays a different role in the DNA repair process, and mutations in any of them can lead to the development of XP.\nXP is usually inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. However, some cases of XP can occur spontaneously, without a known family history of the disorder.\nOverall, the cause of XP is a defect in the DNA repair system, which makes people with the disorder more susceptible to the harmful effects of UV radiation. This defect can lead to an increased risk of developing skin cancer, as well as other health problems.",
    "llama-2-7b-chat-hf_fact": [
      "Xeroderma pigmentosum (XP) is a rare genetic disorder that increases the risk of developing skin cancer.",
      "XP causes a defect in the DNA repair system, making those with the disorder more susceptible to harmful effects of UV radiation.",
      "The cause of XP is a mutation in one of several genes involved in DNA repair, including the ERCC2 gene, the ERCC3 gene, and the XPA gene.",
      "XP is usually inherited in an autosomal recessive pattern, requiring a person to inherit two copies of the mutated gene from each parent to develop the disorder.",
      "In some cases, XP can occur without a known family history of the disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: XP is usually inherited in an autosomal recessive pattern, requiring a person to inherit one copy of the mutated gene from each parent to develop the disorder.",
      "true"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-7b-chat-hf_response": "Gastric cancer is a leading cause of cancer-related deaths worldwide, and understanding the molecular mechanisms underlying its development and progression is crucial for the development of effective diagnostic and therapeutic strategies. Tumor-associated circular RNAs (T-UCRs) are a novel class of non-coding RNAs that have been implicated in various types of cancer, including gastric cancer. In this answer, we will discuss which T-UCRs have been implicated in gastric cancer and their potential roles in cancer development and progression.\nSeveral T-UCRs have been identified as potential biomarkers or therapeutic targets in gastric cancer. For example:\n1. TUCR-1: TUCR-1 is a T-UCR that has been shown to be upregulated in gastric cancer tissues and cell lines. It has been suggested as a potential biomarker for early detection of gastric cancer.\n2. TUCR-2: TUCR-2 is another T-UCR that has been implicated in gastric cancer. It has been shown to promote the proliferation and migration of gastric cancer cells.\n3. TUCR-3: TUCR-3 is a T-UCR that has been shown to be downregulated in gastric cancer tissues. It has been suggested as a potential therapeutic target for the treatment of gastric cancer.\n4. TUCR-4: TUCR-4 is a T-UCR that has been implicated in the development and progression of gastric cancer. It has been shown to promote the epithelial-to-mesenchymal transition (EMT) in gastric cancer cells.\n5. TUCR-5: TUCR-5 is a T-UCR that has been shown to be upregulated in gastric cancer tissues and cell lines. It has been suggested as a potential biomarker for the diagnosis and prognosis of gastric cancer.\nIn summary, several T-UCRs have been implicated in gastric cancer, including TUCR-1, TUCR-2, TUCR-3, TUCR-4,",
    "llama-2-7b-chat-hf_fact": [
      "TUCR-1 is a T-UCR that has been shown to be upregulated in gastric cancer tissues and cell lines.",
      "TUCR-2, another T-UCR has been implicated in gastric cancer.",
      "TUCR-3, a T-UCR, has been identified as notably less present in gastric cancer tissues.",
      "TUCR-4 is a T-UCR that has been implicated in the development and progression of gastric cancer.",
      "TUCR-5 is a T-UCR that has been shown to be increased in presence in gastric cancer tissues and cell lines."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3600,
    "user_query": "Which de novo mutation in FGFR cause achondroplasia?",
    "llama-2-7b-chat-hf_response": "Achondroplasia is a genetic disorder that affects the development of cartilage and bone, leading to short stature, bowed legs, and other skeletal abnormalities. The majority of cases of achondroplasia are caused by mutations in the FGFR3 gene, which encodes a fibroblast growth factor receptor. However, some cases of achondroplasia have been linked to mutations in other genes, including FGFR1 and FGFR2.\nOne example of a de novo mutation in FGFR that has been associated with achondroplasia is a point mutation in the FGFR1 gene. This mutation, known as R206H, occurs when a glutamine at position 206 in the FGFR1 protein is replaced with a histidine. This mutation can lead to constitutive activation of the FGFR1 signaling pathway, which can disrupt the normal development of cartilage and bone and lead to the characteristic skeletal abnormalities of achondroplasia.\nOther de novo mutations in FGFR genes that have been linked to achondroplasia include a missense mutation in the FGFR2 gene (E83K) and a nonsense mutation in the FGFR3 gene (R463W). These mutations can also lead to constitutive activation of the FGFR signaling pathway and disruption of cartilage and bone development, resulting in the characteristic skeletal abnormalities of achondroplasia.\nIt is important to note that achondroplasia is a rare genetic disorder, and the majority of cases are caused by mutations in the FGFR3 gene. However, de novo mutations in other FGFR genes, including FGFR1 and FGFR2, can also cause the disorder.",
    "llama-2-7b-chat-hf_fact": [
      "Achondroplasia is a genetic disorder that affects the development of cartilage and bone.",
      "The majority of cases of achondroplasia are caused by mutations in the FGFR3 gene.",
      "A specific point mutation in the FGFR1 gene, known as R206H, has been associated with achondroplasia.",
      "There has been a documented case of a missense mutation in the FGFR2 gene (E83K) and a nonsense mutation in the FGFR3 gene (R463W) that have been linked to achondroplasia.",
      "Although rare, de novo mutations in other FGFR genes, including FGFR1 and FGFR2, can cause achondroplasia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: A specific point mutation in the FGFR3 gene, known as G380R, has been associated with achondroplasia.",
      "unknown",
      "false, [corrected fact]: Achondroplasia is specifically associated with mutations in the FGFR3 gene, not FGFR1 or FGFR2."
    ]
  },
  {
    "id": 3601,
    "user_query": "List types of DNA lesions caused by UV light.",
    "llama-2-7b-chat-hf_response": "DNA lesions are changes in the DNA molecule that can occur as a result of exposure to UV light. UV light can cause a variety of DNA lesions, including:\n1. Thymine dimers: These are the most common type of DNA lesion caused by UV light. They occur when two adjacent thymine bases on the DNA molecule are linked together by a covalent bond.\n2. Pyrimidine dimers: These are similar to thymine dimers, but they occur between two adjacent pyrimidine bases (cytosine or uracil) instead of thymine.\n3. Cyclobutane pyrimidine dimers: These are a type of pyrimidine dimer that forms when two adjacent pyrimidine bases are linked together by a six-membered ring.\n4. Oxidized bases: UV light can also cause the formation of oxidized bases in DNA, such as 8-oxoguanine (8-oxoG) and 2,6-diaminopurine (2,6-dA). These bases are mutagenic and can lead to genetic mutations if they are not repaired properly.\n5. DNA-protein crosslinks: UV light can also cause the formation of DNA-protein crosslinks, which are complexes between DNA and proteins. These crosslinks can be repaired by the cell's repair machinery, but if they are not repaired properly, they can lead to genetic mutations.\n6. Strand breaks: UV light can also cause strand breaks in DNA, which are breaks in one of the two strands of the DNA molecule. These breaks can be repaired by the cell's repair machinery, but if they are not repaired properly, they can lead to genetic mutations.\n7. Chromatin modifications: UV light can also cause changes in the chromatin structure of DNA, such as histone modifications and DNA methylation. These changes can affect the expression of genes and can lead to genetic mutations if they are not properly maintained.\n8. Mismatch repair defects: UV light can also cause defects in the mismatch repair system, which is responsible for repairing errors in DNA",
    "llama-2-7b-chat-hf_fact": [
      "DNA lesions are changes in the DNA molecule that can occur as a result of exposure to UV light.",
      "Thymine dimers, a type of DNA lesion, occur when two adjacent thymine bases on the DNA molecule are linked together by a covalent bond.",
      "Pyrimidine dimers occur between two adjacent pyrimidine bases (cytosine or uracil) instead of thymine.",
      "Cyclobutane pyrimidine dimers are a type of pyrimidine dimer that forms when two adjacent pyrimidine bases are linked together by a six-membered ring.",
      "UV light can cause the formation of oxidized bases in DNA, such as 8-oxoguanine and 2,6-diaminopurine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Pyrimidine dimers occur between two adjacent pyrimidine bases, which can be thymine-thymine, cytosine-cytosine, or cytosine-thymine, not uracil.",
      "false, [corrected fact]: Cyclobutane pyrimidine dimers are a type of pyrimidine dimer that forms when two adjacent pyrimidine bases are linked together by a four-membered ring, not a six-membered.",
      "true"
    ]
  },
  {
    "id": 3604,
    "user_query": "Which software are used for the detection of selective sweeps?",
    "llama-2-7b-chat-hf_response": "Selective sweeps are a type of evolutionary event that occurs when a specific allele or genetic variant becomes fixed in a population due to positive selection. Detecting selective sweeps can provide important insights into the evolutionary history of a species, including the genetic basis of adaptation and the role of natural selection in shaping the genome.\nThere are several software programs and methods that can be used for the detection of selective sweeps, including:\n1. SweepFinder: This is a widely used software package for detecting selective sweeps in genome-wide data. It uses a Bayesian approach to identify regions of the genome that have undergone a selective sweep, based on the distribution of allele frequencies and the presence of associated genetic markers.\n2. HYPHY: This is another popular software package for detecting selective sweeps, which uses a likelihood-based approach to identify regions of the genome that have undergone a selective sweep. HYPHY takes into account the demographic history of the population, as well as the distribution of allele frequencies and the presence of associated genetic markers.\n3. SEEK: This is a software package for detecting selective sweeps in genomic data, which uses a Bayesian approach to identify regions of the genome that have undergone a selective sweep. SEEK takes into account the demographic history of the population, as well as the distribution of allele frequencies and the presence of associated genetic markers.\n4. GERMLINE: This is a software package for detecting selective sweeps in genomic data, which uses a likelihood-based approach to identify regions of the genome that have undergone a selective sweep. GERMLINE takes into account the demographic history of the population, as well as the distribution of allele frequencies and the presence of associated genetic markers.\n5. PAML: This is a software package for detecting selective sweeps in genomic data, which uses a likelihood-based approach to identify regions of the genome that have undergone a selective sweep. PAML takes into account the demographic history of the population, as well as the distribution of allele frequencies and the presence of associated genetic markers.\n6. SLiM: This is a software package for detecting selective swe",
    "llama-2-7b-chat-hf_fact": [
      "Selective sweeps are evolutionary events where a specific genetic variant becomes common in a population due to positive selection.",
      "SweepFinder is a software used for detecting selective sweeps in genome-wide data.",
      "HYPHY is a software used for detecting selective sweeps, with its method focusing on the likelihood-based approach, and considers the population's demographic history.",
      "SEEK is another software used for detecting selective sweeps in genomic data.",
      "GERMLINE is a software that uses a likelihood-based approach for detecting selective sweeps in genomic data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: SEEK is a computational gene co-expression network tool and not used specifically for detecting selective sweeps in genomic data.",
      "false, [corrected fact]: GERMLINE is a software that enables fast and accurate detection of long shared segments of identity by descent, not selective sweeps."
    ]
  },
  {
    "id": 3606,
    "user_query": "What is Amyand hernia?",
    "llama-2-7b-chat-hf_response": "Amyand's hernia is a rare congenital abnormality that occurs when a portion of the small intestine protrudes through a weakened area in the abdominal wall. It is also known as intestinal hernia or hernia of the small intestine.\nAmyand's hernia is caused by a failure of the abdominal wall to close properly during fetal development, resulting in a defect in the muscle and connective tissue that surrounds the small intestine. This defect allows the small intestine to bulge through the abdominal wall and create a hernia.\nAmyand's hernia can occur at any age, but it is most commonly diagnosed in infants and young children. It is estimated to occur in about 1 in 10,000 to 1 in 20,000 births.\nSymptoms of Amyand's hernia may include:\n* A bulge or lump in the abdomen\n* Abdominal pain or discomfort\n* Diarrhea or constipation\n* Vomiting\n* Failure to gain weight or grow at the expected rate in infants\n* Abdominal distension (swelling)\nIf left untreated, Amyand's hernia can lead to complications such as:\n* Obstruction of the intestine\n* Intestinal ischemia (reduced blood flow to the intestine)\n* Intestinal perforation (a hole in the intestine)\n* Abscess formation\n* Increased risk of bowel obstruction or perforation in adulthood\nTreatment for Amyand's hernia usually involves surgery to repair the defect in the abdominal wall and push the protruding intestine back into its proper place. In some cases, the hernia may be too large or complex to be repaired with surgery, and a portion of the intestine may need to be removed.\nIn summary, Amyand's hernia is a rare congenital abnormality that occurs when a portion of the small intestine protrudes through a weakened area in the abdominal wall. It can occur at any age but is most commonly diagnosed",
    "llama-2-7b-chat-hf_fact": [
      "Amyand's hernia occurs when a portion of the small intestine protrudes through a weakened area in the abdominal wall.",
      "The cause of Amyand's hernia is the failure of the abdominal wall to close properly during fetal development.",
      "Amyand's hernia is most commonly diagnosed in infants and young children.",
      "Common symptoms of Amyand's hernia can include abdominal pain, a visible bulge, and problems with bowel movements.",
      "The primary treatment for Amyand's hernia is surgery to repair the abdominal wall and reposition the intestine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Amyand's hernia occurs when the appendix protrudes through a weakened area in the abdominal wall.",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-7b-chat-hf_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that affects various parts of the body, including the skin, joints, kidneys, and nervous system. The LSI is a standardized measure that takes into account the patient's symptoms, laboratory test results, and organ damage to provide a comprehensive assessment of the disease severity.\nThe LSI was developed by a team of researchers led by Dr. Daniel J. Wallace, a rheumatologist at the University of California, Los Angeles (UCLA). It is based on a combination of 11 variables, including:\n1. Skin involvement\n2. Joint involvement\n3. Renal involvement\n4. Neurological involvement\n5. Haemolytic anaemia\n6. Thrombocytopenia\n7. Leukopenia\n8. Inflammatory markers (such as erythrocyte sedimentation rate and C-reactive protein)\n9. Anti-nuclear antibody (ANA) titer\n10. Anti-double-stranded DNA (anti-dsDNA) antibody titer\n11. Organ damage (based on the patient's medical history and physical examination)\nThe LSI scores range from 0 to 100, with higher scores indicating greater disease severity. A score of 0-19 indicates mild disease, 20-39 indicates moderate disease, 40-59 indicates severe disease, and 60-100 indicates very severe disease.\nThe LSI has been shown to be a reliable and valid measure of SLE severity in various studies, and it has been used in clinical trials to evaluate the effectiveness of new treatments for the disease. However, it is important to note that the LSI is not a perfect measure of disease severity, and other factors, such as the patient's quality of life and functional status, should also be taken into account when assessing the overall severity of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI was developed by Dr. Daniel J. Wallace, a rheumatologist at the University of California, Los Angeles (UCLA).",
      "The LSI is a standardized measure that takes into account a patient's symptoms, test results, and organ damage to assess the disease severity.",
      "The LSI scores range from 0 to 100, with higher scores indicating greater disease severity.",
      "The LSI has been used in clinical trials to evaluate the effectiveness of new treatments for SLE."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3610,
    "user_query": "Is g-H2AX a marker for double strand breaks?",
    "llama-2-7b-chat-hf_response": "Yes, g-H2AX is a marker for double-strand breaks (DSBs). H2AX is a histone variant that is rapidly phosphorylated at serine 139 (-H2AX) in response to DSBs. The phosphorylation of H2AX at this site is a reliable marker for the presence of DSBs, as it is rapidly induced within minutes of DSB formation and remains elevated for several hours.\nThe g-H2AX foci formation is a sensitive and specific marker for DSBs, as it is not affected by other types of DNA damage, such as single-strand breaks or oxidative damage. The g-H2AX foci are also specific to the site of DSB formation, allowing researchers to identify the location of DSBs in the genome.\nThe use of g-H2AX as a marker for DSBs has several advantages, including its high sensitivity and specificity, as well as its ability to detect DSBs in a wide range of cell types, including primary cells and stem cells. Additionally, g-H2AX can be used to monitor DSB repair in real-time, allowing researchers to study the kinetics of DSB repair and the role of different repair pathways in maintaining genome stability.\nIn summary, g-H2AX is a reliable and sensitive marker for double-strand breaks, allowing researchers to detect and study DSBs in a wide range of cell types and contexts.",
    "llama-2-7b-chat-hf_fact": [
      "g-H2AX is a marker for double-strand breaks (DSBs).",
      "H2AX is a histone variant that is rapidly phosphorylated at serine 139 (-H2AX) in response to DSBs.",
      "The phosphorylation of H2AX at this site is rapidly induced within minutes of DSB formation and remains elevated for several hours.",
      "g-H2AX foci formation is not affected by other types of DNA damage, such as single-strand breaks or oxidative damage.",
      "g-H2AX can be used to monitor DSB repair in real-time."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: g-H2AX foci formation can also be affected by other types of DNA damage, not solely double-strand breaks.",
      "true"
    ]
  },
  {
    "id": 3611,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs)?",
    "llama-2-7b-chat-hf_response": "Conserved non-coding elements (CNEs) are regions of non-coding DNA that are evolutionarily conserved across different species. These regions are thought to play important roles in regulating gene expression and other cellular processes, but their exact functions are not yet fully understood.\nSeveral algorithms have been developed for identifying CNEs in genomic data. These algorithms typically use a combination of sequence alignment and statistical analysis to identify regions of the genome that are conserved across different species or samples. Some common algorithms used for identifying CNEs include:\n1. MEME (Multiple Em for Motif Elicitation): This algorithm uses a combination of sequence alignment and statistical analysis to identify conserved regions of the genome. MEME can be used to identify both short and long-range conserved elements.\n2. HMMER: This algorithm uses a hidden Markov model (HMM) to identify conserved regions of the genome. HMMER can be used to identify both short and long-range conserved elements, and it can also be used to predict the function of conserved elements.\n3. GLIMMER: This algorithm uses a combination of sequence alignment and statistical analysis to identify conserved regions of the genome. GLIMMER can be used to identify both short and long-range conserved elements, and it can also be used to predict the function of conserved elements.\n4. PILER: This algorithm uses a combination of sequence alignment and statistical analysis to identify conserved regions of the genome. PILER can be used to identify both short and long-range conserved elements, and it can also be used to predict the function of conserved elements.\n5. CNEFinder: This algorithm uses a combination of sequence alignment and statistical analysis to identify conserved regions of the genome. CNEFinder can be used to identify both short and long-range conserved elements, and it can also be used to predict the function of conserved elements.\n6. DeepSEA: This algorithm uses a deep learning approach to identify conserved regions of the genome. DeepSEA can be used to identify both short and long-range conserved elements, and it can also be used to predict the function of conserved elements.\nThese algorithms have been used to identify CNEs in a variety of organisms, including humans, mice, and fruit flies.",
    "llama-2-7b-chat-hf_fact": [
      "Conserved non-coding elements (CNEs) are regions of non-coding DNA conserved across different species.",
      "CNEs are believed to play significant roles in gene regulation and other cellular processes.",
      "Multiple algorithms have been developed for identifying CNEs in genomic data, using a combination of sequence alignment and statistical analysis.",
      "Some common algorithms for identifying CNEs include MEME, HMMER, GLIMMER, PILER, CNEFinder, and DeepSEA.",
      "These algorithms have been used to identify CNEs in various organisms including humans, mice, and fruit flies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: While MEME, HMMER, GLIMMER, and PILER are bioinformatics tools, they are not specifically designed for identifying CNEs. Tools like PhyloP and PhastCons are commonly used for this purpose. CNEFinder and DeepSEA does relate to the identification and functional annotation of CNEs.",
      "true"
    ]
  },
  {
    "id": 3612,
    "user_query": "What type of antagonist is istradefylline?",
    "llama-2-7b-chat-hf_response": "Istradefylline is a dopamine D2 receptor antagonist.",
    "llama-2-7b-chat-hf_fact": [
      "Istradefylline is a dopamine D2 receptor antagonist."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Istradefylline is an adenosine A2A receptor antagonist."
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-7b-chat-hf_response": "ZSWIM6 is a gene that has been associated with several neurodevelopmental disorders, including intellectual disability, autism spectrum disorder, and epilepsy. De novo mutations in ZSWIM6 have been identified as a cause of some of these disorders. Here are some of the disorders that have been linked to de novo mutations in ZSWIM6:\n1. Intellectual disability: De novo mutations in ZSWIM6 have been identified in individuals with intellectual disability, including those with mild, moderate, and severe forms of the disorder.\n2. Autism spectrum disorder: De novo mutations in ZSWIM6 have been identified in individuals with autism spectrum disorder (ASD), including those with classic autism, Asperger syndrome, and other subtypes of ASD.\n3. Epilepsy: De novo mutations in ZSWIM6 have been identified in individuals with epilepsy, including those with generalized epilepsy, focal epilepsy, and other forms of the disorder.\n4. Neurodevelopmental disorders: De novo mutations in ZSWIM6 have been identified in individuals with other neurodevelopmental disorders, including ADHD, Tourette syndrome, and Rett syndrome.\nIt is important to note that the frequency and distribution of de novo mutations in ZSWIM6 may vary depending on the population being studied and the specific disorder being investigated. Further research is needed to fully understand the role of de novo mutations in ZSWIM6 in the development of these disorders.",
    "llama-2-7b-chat-hf_fact": [
      "ZSWIM6 is a gene that is associated with several neurodevelopmental disorders.",
      "De novo mutations in ZSWIM6 have been identified as a cause of some neurodevelopmental disorders.",
      "Intellectual disability has been linked to de novo mutations in ZSWIM6.",
      "Autism spectrum disorder has been linked to de novo mutations in ZSWIM6.",
      "Epilepsy has been linked to de novo mutations in ZSWIM6."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3625,
    "user_query": "Which disease category is LB-100 mostly assessed for?",
    "llama-2-7b-chat-hf_response": "LB-100 is mostly assessed for the treatment of which disease category?\nA. Cancer\nB. Neurological disorders\nC. Autoimmune diseases\nD. Infectious diseases\nCorrect answer: C. Autoimmune diseases.\nLB-100 is a drug that has been investigated for the treatment of various autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. While it has also shown promise in the treatment of other disease categories, such as cancer and neurological disorders, its primary focus of research and development has been in the area of autoimmune diseases.",
    "llama-2-7b-chat-hf_fact": [
      "LB-100 is a drug that is primarily assessed for treatment of autoimmune diseases.",
      "Multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease are among the autoimmune diseases that LB-100 is investigated for.",
      "Research and development of LB-100 primarily focuses on autoimmune diseases.",
      "LB-100 has also been investigated for the treatment of cancer.",
      "LB-100 has also been examined in relation to neurological disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: LB-100 is a drug that is primarily assessed for treatment of cancer.",
      "false, [corrected fact]: Multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease are not the primary autoimmune diseases that LB-100 is investigated for, it is mainly evaluated for cancer treatment.",
      "false, [corrected fact]: Research and development of LB-100 primarily focuses on cancer.",
      "true",
      "true"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-7b-chat-hf_response": "The Koos Classification is a system used to classify diseases based on their etiology, or cause. The classification system was developed by Dr. H.P. Koos in the early 20th century and is still widely used today. The Koos Classification divides diseases into four main categories:\n1. Infectious diseases: These are diseases caused by the presence of microorganisms such as bacteria, viruses, fungi, or parasites. Examples of infectious diseases include pneumonia, tuberculosis, and malaria.\n2. Genetic diseases: These are diseases caused by abnormalities in an individual's genetic material. Examples of genetic diseases include sickle cell anemia, cystic fibrosis, and Huntington's disease.\n3. Autoimmune diseases: These are diseases caused by the immune system attacking the body's own tissues. Examples of autoimmune diseases include rheumatoid arthritis, lupus, and multiple sclerosis.\n4. Neoplastic diseases: These are diseases caused by the growth of abnormal cells. Examples of neoplastic diseases include cancer, leukemia, and lymphoma.\nThe Koos Classification is a useful tool for healthcare providers because it helps them quickly identify the underlying cause of a patient's illness and develop an appropriate treatment plan.",
    "llama-2-7b-chat-hf_fact": [
      "The Koos Classification is a system used to classify diseases based on their etiology.",
      "Dr. H.P. Koos developed the Koos Classification in the early 20th century.",
      "The Koos Classification divides diseases into four main categories: Infectious diseases, genetic diseases, autoimmune diseases, and neoplastic diseases.",
      "Infectious diseases are diseases caused by the presence of microorganisms.",
      "Genetic diseases are caused by abnormalities in an individual's genetic material."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Koos Classification is a system used to classify intracranial arachnoid cysts, not diseases based on their etiology.",
      "false, [corrected fact]: Dr. H.P. Koos did not develop the Koos Classification in the early 20th century; instead, it was developed towards the end of the 20th century.",
      "false, [corrected fact]: The Koos Classification divides intracranial arachnoid cysts into four grades, not diseases into these categories.",
      "true",
      "true"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is a potent and selective inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1), which plays a key role in the regulation of triacylglycerol (TG) metabolism. The in vivo effects of AZD8601 have been studied in various animal models of obesity and related metabolic disorders. Here are some of the key in vivo effects of AZD8601:\n1. Reduction of body weight: AZD8601 has been shown to reduce body weight in both high-fat diet-induced obese mice and diabetic mice.\n2. Improved glucose tolerance: AZD8601 has been shown to improve glucose tolerance in both obese mice and diabetic rats.\n3. Reduction of TG levels: AZD8601 has been shown to reduce TG levels in the liver, muscle, and adipose tissue of obese mice and rats.\n4. Increased fatty acid oxidation: AZD8601 has been shown to increase the oxidation of fatty acids in the liver, muscle, and adipose tissue of obese mice and rats.\n5. Improved insulin sensitivity: AZD8601 has been shown to improve insulin sensitivity in obese mice and rats.\n6. Reduction of inflammation: AZD8601 has been shown to reduce inflammation in obese mice and rats.\n7. Improved cardiovascular function: AZD8601 has been shown to improve cardiovascular function in obese mice and rats.\nOverall, the in vivo effects of AZD8601 suggest that it may be a useful therapeutic agent for the treatment of obesity and related metabolic disorders, including insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD).",
    "llama-2-7b-chat-hf_fact": [
      "AZD8601 is a potent and selective inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1).",
      "The enzyme DGAT1 plays a key role in triacylglycerol (TG) metabolism.",
      "AZD8601 has been shown to reduce body weight in both high-fat diet-induced obese mice and diabetic mice.",
      "AZD8601 has been shown to improve glucose tolerance in both obese mice and diabetic rats.",
      "AZD8601 may be a useful therapeutic agent for the treatment of obesity and related metabolic disorders, including insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: AZD8601 is not an inhibitor of the enzyme diacylglycerol acyltransferase 1 (DGAT1). It is a drug candidate that codes for the vascular endothelial growth factor-A (VEGF-A).",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3630,
    "user_query": "Which characteristics are used in the SLEDAI index for SLE patients?",
    "llama-2-7b-chat-hf_response": "The SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) is a tool used to assess the severity of systemic lupus erythematosus (SLE) disease activity. The SLEDAI index includes the following characteristics:\n1. Physical examination findings: This includes assessment of joint inflammation, skin rashes, and other organ involvement.\n2. Laboratory tests: This includes measurement of inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), as well as blood counts and liver function tests.\n3. Patient-reported symptoms: This includes assessment of fatigue, joint pain, and other symptoms experienced by the patient.\n4. Medication use: This includes assessment of medications used to treat SLE, such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and immunosuppressive drugs.\n5. Organ involvement: This includes assessment of involvement of various organs, such as the kidneys, lungs, and nervous system.\n6. Infections: This includes assessment of infections such as urinary tract infections, respiratory infections, and opportunistic infections.\n7. Serologic tests: This includes measurement of antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), and other autoantibodies.\nThe SLEDAI score is calculated by assigning weights to each of these characteristics based on their relative importance in assessing SLE disease activity. The score can range from 0 to 100, with higher scores indicating greater disease activity.",
    "llama-2-7b-chat-hf_fact": [
      "The SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) is a tool used to measure the severity of systemic lupus erythematosus disease activity.",
      "The SLEDAI index uses physical examination findings as one of its characteristics for assessment.",
      "Laboratory tests, which involve the measurement of inflammatory markers such as ESR and CRP, are also included in the SLEDAI index.",
      "The SLEDAI index includes patient-reported symptoms as part of the evaluation.",
      "Medication use, organ involvement, infections, and serologic tests are also evaluated in the SLEDAI index.",
      "The SLEDAI score can range from 0 to 100, with higher scores indicating greater disease activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The SLEDAI score can range from 0 to 105, with higher scores indicating greater disease activity."
    ]
  },
  {
    "id": 3632,
    "user_query": "Describe the mechanism of action of Luspatercept.",
    "llama-2-7b-chat-hf_response": "Luspatercept is a first-in-class, oral, selective inhibitor of the tyrosine kinase receptor (TKR) BCR-ABL1, which is a constitutively active tyrosine kinase that is present in chronic myeloid leukemia (CML) cells. The mechanism of action of luspatercept is based on its ability to bind to and inhibit the activity of BCR-ABL1, thereby preventing the activation of downstream signaling pathways that promote cell proliferation and survival in CML cells.\nLuspatercept works by binding to the BCR-ABL1 receptor with high affinity and specificity, thereby preventing the activation of the receptor's tyrosine kinase activity. This results in the inhibition of downstream signaling pathways, including the PI3K/Akt and MAPK/ERK pathways, which are involved in cell proliferation and survival. By inhibiting these pathways, luspatercept reduces the proliferation and survival of CML cells, leading to a decrease in the number of cancer cells in the body.\nIn addition, luspatercept has been shown to induce apoptosis (programmed cell death) in CML cells, which can further contribute to the reduction of cancer cells. Overall, the mechanism of action of luspatercept is based on its ability to selectively target and inhibit the activity of the BCR-ABL1 receptor, leading to the inhibition of downstream signaling pathways and the reduction of CML cell proliferation and survival.",
    "llama-2-7b-chat-hf_fact": [
      "Luspatercept is a first-in-class, oral, selective inhibitor of the tyrosine kinase receptor (TKR) BCR-ABL1.",
      "The BCR-ABL1 receptor is a constitutively active tyrosine kinase that is present in chronic myeloid leukemia (CML) cells.",
      "Luspatercept works by binding to and inhibiting the activity of BCR-ABL1, thereby disrupting cell proliferation and survival in CML cells.",
      "Luspatercept's mechanism of action includes the inhibition of downstream signaling pathways, such as PI3K/Akt and MAPK/ERK pathways, involved in cell proliferation and survival.",
      "Luspatercept has been demonstrated to induce apoptosis (programmed cell death) in CML cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Luspatercept is not an inhibitor of the tyrosine kinase receptor (TKR) BCR-ABL1. It is an erythroid maturation agent.",
      "true",
      "false, [corrected fact]: Luspatercept does not work by binding to and inhibiting the activity of BCR-ABL1. It is designed to treat anemia by helping the bone marrow to produce more mature red blood cells.",
      "false, [corrected fact]: Luspatercept's mechanism of action does not include inhibition of downstream signaling pathways such as PI3K/Akt and MAPK/ERK, rather it is believed to work by reducing SMAD2/SMAD3 transcriptional activity.",
      "false, [corrected fact]: There is no evidence that Luspatercept induces apoptosis in CML cells, its primary role is in facilitating the maturation of red blood cells."
    ]
  },
  {
    "id": 3633,
    "user_query": "Which method has been developed for mapping of Transcription Start Sites (TSS) starting from nanograms of RNA?",
    "llama-2-7b-chat-hf_response": "Answer: A method called \"RNA-seq\" has been developed for mapping Transcription Start Sites (TSS) starting from nanograms of RNA.\nRNA-seq is a powerful tool for transcriptome analysis that involves the following steps:\n1. RNA isolation: Nanogram amounts of RNA are isolated from cells or tissues using various methods.\n2. Library preparation: The isolated RNA is then converted into a library of complementary DNA (cDNA) using reverse transcription.\n3. Sequencing: The cDNA library is then sequenced using next-generation sequencing (NGS) technologies, such as Illumina or PacBio.\n4. Data analysis: The generated sequencing data is then analyzed using bioinformatic tools to map the TSSs.\nThe advantages of RNA-seq are:\n1. Sensitivity: RNA-seq can detect low-abundance transcripts that are not detectable by microarray analysis.\n2. Specificity: RNA-seq can identify novel transcripts and splice variants that are not present in the reference genome.\n3. Flexibility: RNA-seq can be used to analyze any organism, including non-model organisms and organisms with non-reference genomes.\nThe limitations of RNA-seq are:\n1. Cost: RNA-seq is more expensive than microarray analysis, especially for large-scale studies.\n2. Sequence quality: RNA-seq requires high-quality RNA samples, which can be challenging to obtain, especially for certain tissues or cell types.\n3. Data analysis: RNA-seq generates large amounts of data, which can be computationally challenging to analyze.\nIn summary, RNA-seq is a powerful tool for mapping TSSs starting from nanogram amounts of RNA, offering high sensitivity, specificity, and flexibility. However, it also has some limitations, including cost and data analysis challenges.",
    "llama-2-7b-chat-hf_fact": [
      "RNA-seq is a method developed for mapping Transcription Start Sites (TSS) starting from nanograms of RNA.",
      "The process of RNA-seq involves steps of RNA isolation, library preparation, sequencing, and data analysis.",
      "RNA-seq can detect low-abundance transcripts, identify novel transcripts and splice variants, and can be used to analyze any organism.",
      "RNA-seq, compared to microarray analysis, is more expensive, notably for large-scale studies.",
      "RNA-seq requires high-quality RNA samples, which can be challenging to obtain, especially for certain tissues or cell types."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: RNA-seq is a method developed for sequencing and profiling RNA, not specifically for mapping Transcription Start Sites (TSS).",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3637,
    "user_query": "Which mRNAs are sequestered in stress granules?",
    "llama-2-7b-chat-hf_response": "Stress granules are RNA-protein complexes that form in response to cellular stress, such as heat shock, oxidative stress, or exposure to toxins. These complexes are thought to play a role in protecting cells from stress by sequestering mRNAs and preventing their translation.\nSeveral mRNAs have been identified as being sequestered in stress granules, including:\n1. HSP70: The heat shock protein 70 (HSP70) mRNA is one of the most well-studied mRNAs associated with stress granules. HSP70 is a chaperone protein that helps protect cells from stress by preventing protein misfolding and promoting protein degradation.\n2. HSP90: The heat shock protein 90 (HSP90) mRNA is another well-studied mRNA associated with stress granules. HSP90 is a chaperone protein that helps protect cells from stress by preventing protein misfolding and promoting protein degradation.\n3. GRP78: The glucose-regulated protein 78 (GRP78) mRNA is also associated with stress granules. GRP78 is a chaperone protein that helps protect cells from stress by preventing protein misfolding and promoting protein degradation.\n4. GADD45A: The growth arrest and DNA damage-inducible gene 45 alpha (GADD45A) mRNA is another mRNA associated with stress granules. GADD45A is a protein that helps protect cells from stress by inducing cell cycle arrest and promoting DNA repair.\n5. EIF2AK2: The eukaryotic translation initiation factor 2 alpha subunit kinase 2 (EIF2AK2) mRNA is also associated with stress granules. EIF2AK2 is a protein that helps regulate protein synthesis in response to cellular stress.\n6. XBP1: The X-box binding protein 1 (XBP1) mRNA is another mRNA associated with stress granules. XBP1 is a transcription factor that helps regulate gene expression in response to cellular stress.\n7. ATF4: The activating transcription factor",
    "llama-2-7b-chat-hf_fact": [
      "Stress granules are RNA-protein complexes that form in response to cellular stress.",
      "The heat shock protein 70 (HSP70) mRNA is associated with stress granules.",
      "The heat shock protein 90 (HSP90) mRNA is also found in stress granules.",
      "The glucose-regulated protein 78 (GRP78) mRNA is another molecule sequestered in stress granules.",
      "The growth arrest and DNA damage-inducible gene 45 alpha (GADD45A) mRNA and the eukaryotic translation initiation factor 2 alpha subunit kinase 2 (EIF2AK2) mRNA are other examples of transcripts housed in stress granules.",
      "The X-box binding protein 1 (XBP1) mRNA is associated with stress granules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3638,
    "user_query": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?",
    "llama-2-7b-chat-hf_response": "The use of PD-L1 as an immunotherapy biomarker has been associated with several challenges and limitations, including:\n1. Lack of specificity: PD-L1 is expressed on a wide range of cell types, including normal tissue cells, making it difficult to interpret the results of PD-L1 testing.\n2. Variability in expression levels: PD-L1 expression levels can vary significantly between different tumors and even within the same tumor, which can make it difficult to identify patients who are most likely to benefit from PD-L1-targeted therapies.\n3. Limited sensitivity: PD-L1 testing may not be sensitive enough to detect low levels of PD-L1 expression, which can lead to false-negative results.\n4. Clinical heterogeneity: PD-L1 expression levels can vary significantly between different types of cancer, and even within the same tumor, which can make it difficult to identify patients who are most likely to benefit from PD-L1-targeted therapies.\n5. Cost and availability: PD-L1 testing can be expensive and may not be widely available, which can limit access to PD-L1-targeted therapies.\n6. Lack of standardization: There is currently no standardized approach to PD-L1 testing, which can make it difficult to interpret the results of PD-L1 testing and to compare results across different studies.\n7. Limited understanding of the biology: There is still limited understanding of the biology of PD-L1 and its role in immune evasion, which can make it difficult to interpret the results of PD-L1 testing and to develop effective PD-L1-targeted therapies.\n8. Off-target effects: PD-L1-targeted therapies can have off-target effects on normal tissues, which can limit their efficacy and increase the risk of toxicities.\n9. Resistance: Cancer cells can develop resistance to PD-L1-targeted therapies, which can limit their efficacy over time.\n10. Combination with other therapies: PD-L1-targeted therapies are most effective when used in combination with other therapies, such as chemotherapy",
    "llama-2-7b-chat-hf_fact": [
      "PD-L1 is expressed on a wide range of cell types, including normal tissue cells.",
      "There is a variability in PD-L1 expression levels between different tumors and even within the same tumor.",
      "PD-L1 testing may not be sensitive enough to detect low levels of PD-L1 expression, which can lead to false-negative results.",
      "PD-L1 testing can be expensive and may not be widely available.",
      "PD-L1-targeted therapies can have off-target effects on normal tissues."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3639,
    "user_query": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "llama-2-7b-chat-hf_response": "Poliosis circumscripta is a rare condition characterized by the presence of white or unpigmented patches of hair or skin. The patches are usually round or oval in shape and can occur anywhere on the body, including the scalp, face, and limbs. The condition is usually inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition.\nPoliosis circumscripta can be confused with other conditions that also cause white or unpigmented patches of hair or skin, such as vitiligo, albinism, and depigmentation. However, there are some key differences between these conditions that can help distinguish them. For example, vitiligo is an autoimmune disorder that causes the destruction of pigment-producing cells in the skin, while albinism is a genetic condition that affects the production of melanin, the pigment responsible for skin and hair color. Depigmentation, on the other hand, is a condition that occurs when the melanin-producing cells in the skin are damaged or destroyed, leading to a loss of pigmentation.\nIn conclusion, poliosis circumscripta is a rare condition characterized by the presence of white or unpigmented patches of hair or skin. While it can be confused with other conditions that cause similar symptoms, there are some key differences that can help distinguish it. If you suspect you or someone you know may have poliosis circumscripta, it is important to consult with a dermatologist or other healthcare professional for an accurate diagnosis and appropriate treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Poliosis circumscripta is characterized by white or unpigmented patches of hair or skin.",
      "Patches of Poliosis circumscripta can occur anywhere on the body.",
      "Poliosis circumscripta is usually inherited in an autosomal dominant pattern.",
      "Vitiligo is an autoimmune disorder that causes the destruction of pigment-producing cells in the skin.",
      "Albinism is a genetic condition that affects the production of melanin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Poliosis circumscripta is not usually inherited; it often results from a variety of other conditions including vitiligo, halo nevi, and inflammatory diseases, or can be idiopathic.",
      "true",
      "true"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-7b-chat-hf_response": "SAHFS are created through a process called \"self-assembly,\" which means that the molecules spontaneously come together to form the desired structure without the need for external guidance or direction. This process is driven by the chemical properties of the molecules and the interactions between them, such as hydrogen bonding, ionic interactions, and van der Waals forces.\nIn the case of SAHFS, the molecules are designed to have specific functional groups that allow them to interact with each other in a particular way. For example, the molecules might have a hydrophobic (water-repelling) region and a hydrophilic (water-attracting) region, which allows them to form a stable structure in water.\nOnce the molecules are mixed together in a solution, they begin to interact with each other and form the desired structure through a process of self-assembly. This process can be influenced by factors such as the concentration of the molecules, the temperature of the solution, and the presence of other molecules or ions.\nOverall, the creation of SAHFS involves the careful design and synthesis of molecules with specific properties, followed by the spontaneous self-assembly of these molecules into the desired structure. This approach has the potential to create a wide range of complex structures and materials with unique properties, and it is an active area of research in the field of supramolecular chemistry.",
    "llama-2-7b-chat-hf_fact": [
      "SAHFS are created through a process called \"self-assembly.\"",
      "The process of self-assembly is driven by the chemical properties of the molecules and the interactions between them, such as hydrogen bonding, ionic interactions, and van der Waals forces.",
      "The molecules used in SAHFS self-assembly are designed to have specific functional groups that interact in specific ways.",
      "The process of self-assembly can be influenced by factors such as the concentration of the molecules, the temperature of the solution, and the presence of other molecules or ions.",
      "The creation of SAHFS involves the careful design and synthesis of molecules with specific properties, followed by the spontaneous self-assembly of these molecules into the desired structure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3641,
    "user_query": "What is another name for AZD0530?",
    "llama-2-7b-chat-hf_response": "AZD0530 is also known as:\n* RX-0201\n* BMS-986177\nWhat is AZD0530?\nAZD0530 is a small molecule inhibitor of the enzyme Bruton's tyrosine kinase (BTK). It is being developed by AstraZeneca for the treatment of various B-cell malignancies, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).",
    "llama-2-7b-chat-hf_fact": [
      "AZD0530 is also known as RX-0201 and BMS-986177.",
      "AZD0530 is a small molecule inhibitor of the enzyme Bruton's tyrosine kinase (BTK).",
      "The drug AZD0530 is being developed by AstraZeneca.",
      "AZD0530 is being developed for the treatment of various B-cell malignancies.",
      "The drugs targets for treatment include chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: AZD0530 is also known as saracatinib not RX-0201 or BMS-986177.",
      "false, [corrected fact]: AZD0530 is a small molecule inhibitor of the Src family kinases (SFKs), not Bruton's tyrosine kinase (BTK).",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3647,
    "user_query": "What is the Match BAM to VCF method?",
    "llama-2-7b-chat-hf_response": "The Match BAM to VCF method is a computational method used to identify genetic variants associated with a trait or disease. It involves comparing a set of genetic variants (called a genotype array or BAM) to a reference set of genetic variants (called a variant call format or VCF) to identify variants that are associated with the trait or disease of interest.\nThe Match BAM to VCF method typically involves the following steps:\n1. Alignment of the BAM to the reference genome: The BAM is aligned to the reference genome to identify the genomic positions of the genetic variants.\n2. Filtering of the VCF: The VCF is filtered to remove variants that are not suitable for analysis, such as those with low quality scores or those that are not in the reference genome.\n3. Comparison of the BAM to the filtered VCF: The BAM is compared to the filtered VCF to identify variants that are present in both the BAM and the VCF.\n4. Statistical analysis of the identified variants: The identified variants are subjected to statistical analysis to determine whether they are associated with the trait or disease of interest.\nThe Match BAM to VCF method can be used to identify genetic variants associated with a wide range of traits and diseases, including common complex diseases such as heart disease, diabetes, and mental health disorders. It is a powerful tool for identifying genetic variants that are associated with a trait or disease, and can be used in conjunction with other methods, such as genome-wide association studies (GWAS), to increase the accuracy of the results.",
    "llama-2-7b-chat-hf_fact": [
      "The Match BAM to VCF is a computational method used to identify genetic variants associated with a trait or disease.",
      "This method requires comparing a genotype array (BAM) to a reference set of genetic variants (VCF).",
      "The Match BAM to VCF method includes aligning the BAM to the reference genome, filtering the VCF, comparing BAM to the filtered VCF, and statistical analysis of the identified variants.",
      "The method can help to identify genetic variants associated with a wide range of traits and diseases.",
      "The Match BAM to VCF can be used in conjunction with genome-wide association studies (GWAS) to enhance the accuracy of results."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3649,
    "user_query": "Is SATB1 expressed in thymocytes?",
    "llama-2-7b-chat-hf_response": "Yes, SATB1 (Sex Determining Region Y-Absent, Testis-Specific B1) is expressed in thymocytes. SATB1 is a transcription factor that plays a crucial role in the development and differentiation of various cell types, including hematopoietic cells in the bone marrow and lymphoid cells in the thymus.\nStudies have shown that SATB1 is expressed in thymocytes at different stages of development, including early double-negative (DN) thymocytes, double-positive (DP) thymocytes, and mature single-positive (SP) T cells. The expression of SATB1 in thymocytes is important for the proper differentiation and maturation of T cells, and it has been implicated in the regulation of T cell function and autoimmune diseases.\nFor example, one study found that SATB1-deficient mice had a reduced number of T cells in the thymus and peripheral blood, and they were more susceptible to autoimmune diseases such as type 1 diabetes and multiple sclerosis. Another study found that SATB1 was required for the proper differentiation of T cells in the thymus and that it regulated the expression of genes involved in T cell development and function.\nOverall, the expression of SATB1 in thymocytes is an important aspect of T cell development and differentiation, and it has important implications for the regulation of T cell function and autoimmune diseases.",
    "llama-2-7b-chat-hf_fact": [
      "SATB1 is a transcription factor expressed in thymocytes.",
      "This transcription factor plays a crucial role in the development and differentiation of various cell types, including hematopoietic cells in the bone marrow and lymphoid cells in the thymus.",
      "SATB1 is expressed in thymocytes at different stages of development, including early double-negative thymocytes, double-positive thymocytes, and mature single-positive T cells.",
      "SATB1-deficient mice have a reduced number of T cells in the thymus and peripheral blood, and are more susceptible to autoimmune diseases such as type 1 diabetes and multiple sclerosis.",
      "SATB1 is required for the proper differentiation of T cells in the thymus and regulates the expression of genes involved in T cell development and function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3652,
    "user_query": "Describe Twiddler Syndrome.",
    "llama-2-7b-chat-hf_response": "Twiddler Syndrome, also known as Fidgeter's Syndrome, is a neurological disorder characterized by excessive fidgeting or twiddling of the fingers, toes, or other body parts. People with Twiddler Syndrome may have difficulty sitting still or engaging in quiet activities, and may exhibit repetitive movements such as tapping their feet, drumming their fingers, or biting their nails.\nThe exact cause of Twiddler Syndrome is not yet fully understood, but it is believed to be related to abnormalities in the brain's basal ganglia, which are responsible for regulating movement and motor control. Some research suggests that Twiddler Syndrome may be associated with other neurological disorders, such as attention deficit hyperactivity disorder (ADHD) or obsessive-compulsive disorder (OCD).\nThere is no cure for Twiddler Syndrome, but various treatments can help manage the symptoms. These may include medications such as dopamine agonists or selective serotonin reuptake inhibitors, as well as behavioral therapies such as habit reversal training or exposure and response prevention. In some cases, deep brain stimulation may be recommended.\nIt is important to note that Twiddler Syndrome is a relatively rare condition, and many people who exhibit excessive fidgeting or twiddling may not have the disorder. If you are concerned about your own or someone else's symptoms, it is important to consult with a qualified healthcare professional for an accurate diagnosis and appropriate treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Twiddler Syndrome, also known as Fidgeter's Syndrome, is a neurological disorder characterized by excessive fidgeting or twiddling of the fingers, toes, or other body parts.",
      "The cause of Twiddler Syndrome is not fully understood, but may be related to abnormalities in the brain's basal ganglia, which regulate movement and motor control.",
      "Research suggests that Twiddler Syndrome may be associated with other neurological disorders, such as attention deficit hyperactivity disorder (ADHD) or obsessive-compulsive disorder (OCD).",
      "There is no cure for Twiddler Syndrome, but symptoms can be managed with medications and behavioral therapies, and in some cases, deep brain stimulation may be recommended.",
      "Twiddler Syndrome is a relatively rare condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Twiddler's Syndrome is a condition in which patients manipulate medical devices implanted in their bodies leading to malfunction, not a neurological disorder characterized by excessive fidgeting or twiddling of the fingers, toes, or other body parts.",
      "false, [corrected fact]: The cause of Twiddler's Syndrome is not related to abnormalities in the brain's basal ganglia. It is more related to the manipulation of implanted medical devices, usually by elderly or mentally impaired patients.",
      "false, [corrected fact]: Twiddler's Syndrome is not associated with other neurological disorders like ADHD or OCD, but instead could be seen in patients with implanted medical devices who are either elderly or have impaired mental status.",
      "false, [corrected fact]: Managing Twiddler's Syndrome involves repositioning or securing the medical implant better, not necessarily with medications, behavioral therapies and deep brain stimulation.",
      "true"
    ]
  },
  {
    "id": 3653,
    "user_query": "What are Drosophila's balancer chromosomes?",
    "llama-2-7b-chat-hf_response": "Drosophila melanogaster, the fruit fly, has seven pairs of chromosomes. In addition to these autosomal chromosomes, Drosophila also has three pairs of balancer chromosomes. These balancer chromosomes are specialized chromosomes that are used to maintain the proper number of chromosomes in the genome during meiosis.\nThe three pairs of balancer chromosomes in Drosophila are:\n1. The lethal (L) chromosomes: These chromosomes are responsible for causing lethal mutations in the offspring when they are inherited in certain combinations.\n2. The white (W) chromosomes: These chromosomes are used to balance the number of chromosomes in the genome during meiosis.\n3. The yellow (Y) chromosomes: These chromosomes are also used to balance the number of chromosomes in the genome during meiosis.\nThe balancer chromosomes are essential for maintaining the proper number of chromosomes in the genome and preventing genetic abnormalities in the offspring. They play a critical role in ensuring the genetic diversity of the population and are an important tool for geneticists studying the genetics of Drosophila.",
    "llama-2-7b-chat-hf_fact": [
      "Drosophila melanogaster, the fruit fly, has seven pairs of chromosomes.",
      "In addition to these autosomal chromosomes, Drosophila also has three pairs of balancer chromosomes.",
      "The lethal (L) chromosomes in Drosophila are responsible for causing lethal mutations in the offspring when they are inherited in certain combinations.",
      "The white (W) chromosomes in Drosophila are used to balance the number of chromosomes in the genome during meiosis.",
      "The yellow (Y) chromosomes in Drosophila are also used to balance the number of chromosomes in the genome during meiosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Drosophila melanogaster, the fruit fly, has four pairs of chromosomes.",
      "false, [corrected fact]: In addition to these autosomal chromosomes, Drosophila does not have balancer chromosomes. The term \"balancer chromosomes\" refers to mutated chromosomes in Drosophila that prevent crossing over between homologous chromosomes during meiosis.",
      "true",
      "false, [corrected fact]: The white (W) chromosomes in Drosophila do not exist. The white gene in Drosophila is associated with eye color not with balancing the number of chromosomes during meiosis.",
      "false, [corrected fact]: The yellow (Y) chromosomes in Drosophila do not exist. There's a Sex-determination system in Drosophila where X and Y chromosomes play a role, Y chromosome doesn't balance the number of chromosomes during meiosis, it's involved in male determination. The \"yellow\" gene in Drosophila is associated with body and wing color, and not with balancing the number of chromosomes."
    ]
  },
  {
    "id": 3654,
    "user_query": "What is iodine thyroid blocking?",
    "llama-2-7b-chat-hf_response": "Iodine is an essential nutrient that is necessary for the production of thyroid hormones. However, excessive intake of iodine can block the production of these hormones, leading to hypothyroidism.\nHypothyroidism is a condition in which the thyroid gland does not produce enough thyroid hormones, leading to a range of symptoms including fatigue, weight gain, cold intolerance, dry skin, and depression.\nIodine thyroid blocking occurs when the body takes in too much iodine, which can overwhelm the thyroid gland and prevent it from producing enough thyroid hormones. This can happen through a variety of means, including:\n1. Consuming too much iodized salt: Iodized salt is fortified with iodine to prevent goiter, a condition in which the thyroid gland becomes enlarged due to a lack of iodine. However, consuming too much iodized salt can lead to iodine thyroid blocking.\n2. Taking too much iodine supplements: Taking high doses of iodine supplements can also lead to iodine thyroid blocking.\n3. Consuming foods high in iodine: Some foods, such as seaweed and seafood, are high in iodine. Consuming large amounts of these foods can also lead to iodine thyroid blocking.\nIt is important to note that iodine thyroid blocking is rare in developed countries where iodized salt is widely available. However, it can be a concern in areas where iodine deficiency is common.\nIf you suspect that you have iodine thyroid blocking, it is important to speak with your healthcare provider. They can perform tests to determine the cause of your hypothyroidism and recommend appropriate treatment. Treatment may involve reducing iodine intake, taking thyroid hormone replacement medication, or other therapies.",
    "llama-2-7b-chat-hf_fact": [
      "Iodine is a nutrient required for the production of thyroid hormones.",
      "Excessive iodine intake can block hormone production, leading to hypothyroidism, a condition where not enough thyroid hormones are produced.",
      "Iodine thyroid blocking can occur when large amounts of iodized salt, iodine supplements or high-iodine foods are consumed.",
      "Iodine thyroid blocking is generally rare in developed countries where iodized salt is widely available.",
      "If suspected, iodine thyroid blocking can be diagnosed and treated by a healthcare provider, with treatments potentially including reducing iodine intake or taking thyroid hormone replacement medication."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Iodine thyroid blocking is often more prevalent in developed countries where iodized salt and high-iodine foods are widely available.",
      "true"
    ]
  },
  {
    "id": 3658,
    "user_query": "What is the mechanism of action of rogaratinib?",
    "llama-2-7b-chat-hf_response": "Rogaratinib is a potent and selective inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH), which is involved in the de novo synthesis of pyrimidines, including thymidine and uracil, in cancer cells. By inhibiting DHODH, rogaratinib reduces the availability of these building blocks for DNA synthesis and replication, leading to cell cycle arrest and apoptosis in cancer cells. Additionally, rogaratinib also inhibits the activity of the enzyme orotate phosphoribosyltransferase (OPRT), which is involved in the salvage pathway of pyrimidine synthesis, further reducing the availability of pyrimidines for DNA synthesis.\nRogaratinib has been shown to be effective in preclinical models of various cancers, including breast, lung, and ovarian cancer, and is currently being investigated in clinical trials as a potential treatment for these and other types of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Rogaratinib is an inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH).",
      "Dihydroorotate dehydrogenase (DHODH) is involved in the de novo synthesis of pyrimidines in cancer cells.",
      "Rogaratinib reduces the availability of pyrimidines for DNA synthesis and replication in cancer cells.",
      "Rogaratinib also inhibits the enzyme orotate phosphoribosyltransferase (OPRT), involved in the salvage pathway of pyrimidine synthesis.",
      "Rogaratinib is being investigated in clinical trials as a potential treatment for various types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3661,
    "user_query": "List diseases that are caused by the Meningococcus B?",
    "llama-2-7b-chat-hf_response": "Meningococcus B is a type of bacteria that can cause meningitis, a serious infection of the protective membranes (meninges) that cover the brain and spinal cord. Meningococcus B is one of the most common causes of meningitis in the United States, and it can also cause other serious infections, such as bloodstream infections (sepsis) and pneumonia.\nSome of the diseases caused by Meningococcus B include:\n1. Meningitis: This is the most common disease caused by Meningococcus B, and it occurs when the bacteria infect the meninges, which are the protective membranes that cover the brain and spinal cord. Meningitis can cause a range of symptoms, including fever, headache, stiff neck, confusion, and loss of consciousness.\n2. Sepsis: This is a serious infection that occurs when Meningococcus B bacteria enter the bloodstream and cause inflammation throughout the body. Sepsis can lead to organ failure and death if left untreated.\n3. Pneumonia: Meningococcus B can also cause pneumonia, which occurs when the bacteria infect the lungs. Pneumonia can cause symptoms such as cough, fever, chills, and difficulty breathing.\n4. Meningococcal arthritis: This is an inflammatory condition that occurs when Meningococcus B bacteria infect the joints, causing pain, swelling, and stiffness.\n5. Meningococcal conjunctivitis: This is an infection of the eyes that occurs when Meningococcus B bacteria infect the conjunctiva, which is the thin membrane that covers the white part of the eye. Meningococcal conjunctivitis can cause symptoms such as redness, swelling, and discharge in the eyes.\n6. Meningococcal sinusitis: This is an infection of the sinuses that occurs when Meningococcus B bacteria infect the sinuses, which are air-filled cavities in the skull. Meningococcal sinusitis can cause symptoms such as facial pain, headache,",
    "llama-2-7b-chat-hf_fact": [
      "Meningococcus B is a type of bacteria that can cause meningitis.",
      "Meningitis occurs when Meningococcus B infects the meninges, the protective membranes that cover the brain and spinal cord.",
      "Meningococcus B may also cause sepsis, a serious disease resulting from the bacteria entering the bloodstream.",
      "Pneumonia too can be caused by Meningococcus B, occurring when the bacteria infects the lungs.",
      "Meningococcus B can also cause Meningococcal arthritis, an infection of the joints, and Meningococcal conjunctivitis, an infection of the eyes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3664,
    "user_query": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved",
    "llama-2-7b-chat-hf_response": "in cancer development and progression\nTBC1D16 is a protein that plays a crucial role in regulating various cellular processes, including cell signaling, cytoskeleton organization, and protein degradation. In cancer, TBC1D16 has been found to be involved in cancer development and progression in several ways. Here are some of the types of cancer where TBC1D16 has been implicated:\n1. Breast Cancer: TBC1D16 has been shown to be overexpressed in various types of breast cancer, including hormone-sensitive and HER2-positive breast cancer. Overexpression of TBC1D16 has been linked to increased cancer cell proliferation, migration, and invasion, as well as poorer prognosis.\n2. Lung Cancer: TBC1D16 has been found to be overexpressed in non-small cell lung cancer (NSCLC), which is the most common type of lung cancer. Overexpression of TBC1D16 has been linked to increased cancer cell proliferation, migration, and invasion, as well as poorer prognosis.\n3. Colorectal Cancer: TBC1D16 has been overexpressed in some cases of colorectal cancer, particularly in those with microsatellite instability (MSI). Overexpression of TBC1D16 has been linked to increased cancer cell proliferation, migration, and invasion, as well as poorer prognosis.\n4. Pancreatic Cancer: TBC1D16 has been found to be overexpressed in some cases of pancreatic cancer. Overexpression of TBC1D16 has been linked to increased cancer cell proliferation, migration, and invasion, as well as poorer prognosis.\n5. Prostate Cancer: TBC1D16 has been overexpressed in some cases of prostate cancer. Overexpression of TBC1D16 has been linked to increased cancer cell proliferation, migration, and invasion, as well as poorer prognosis.\n6. Ovarian Cancer: TBC1D16 has been found to be overexpressed in some cases of ovarian cancer. Overexpression of TBC1D16 has been linked to increased cancer cell prol",
    "llama-2-7b-chat-hf_fact": [
      "TBC1D16 is a protein that plays a role in regulating various cellular processes.",
      "TBC1D16 is involved in cancer development and progression.",
      "TBC1D16 has been found to be overexpressed in various types of breast cancer.",
      "TBC1D16 has been found to be overexpressed in non-small cell lung cancer.",
      "TBC1D16 has been overexpressed in some cases of colorectal cancer, particularly in those with microsatellite instability (MSI)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3665,
    "user_query": "What does osanetant and talnetant have in common?",
    "llama-2-7b-chat-hf_response": "Both osanetant and talnetant are drugs that have been investigated for the treatment of chronic pain. Both drugs work by activating kappa opioid receptors in the brain, which can help to reduce pain perception. However, there are some key differences between the two drugs.\nOsanetant is a selective kappa opioid receptor agonist, which means that it only activates kappa opioid receptors and does not activate other types of opioid receptors. Talnetant, on the other hand, is a mixed opioid receptor agonist, which means that it activates both kappa and delta opioid receptors.\nStudies have shown that osanetant may be more effective than talnetant in reducing chronic pain, possibly due to its selective action on kappa opioid receptors. However, talnetant may have a more rapid onset of action compared to osanetant.\nIt is important to note that both osanetant and talnetant are investigational drugs and have not yet been approved by the FDA for the treatment of chronic pain. More research is needed to fully understand the safety and efficacy of these drugs, as well as their potential benefits and risks.",
    "llama-2-7b-chat-hf_fact": [
      "Osanetant and talnetant are drugs that have been investigated for the treatment of chronic pain.",
      "Both drugs work by activating kappa opioid receptors in the brain to reduce pain perception.",
      "Osanetant is a selective kappa opioid receptor agonist.",
      "Talnetant is a mixed opioid receptor agonist that activates both kappa and delta opioid receptors.",
      "Neither osanetant nor talnetant have been approved by the FDA for the treatment of chronic pain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Both drugs work by blocking neurokinin-1 (NK-1) receptors in the brain to reduce pain perception.",
      "false, [corrected fact]: Osanetant is a selective NK1 receptor antagonist.",
      "false, [corrected fact]: Talnetant is a selective NK1 receptor antagonist.",
      "true"
    ]
  },
  {
    "id": 3666,
    "user_query": "List SLC25A46-related pathologies",
    "llama-2-7b-chat-hf_response": "SLC25A46-related pathologies are rare genetic disorders caused by mutations in the SLC25A46 gene. Here are some of the known pathologies associated with SLC25A46 mutations:\n1. Progressive supranuclear palsy (PSP): PSP is a rare, degenerative brain disorder that affects movement, balance, and eye movements. SLC25A46 mutations have been identified in approximately 10% of PSP cases.\n2. Multiple system atrophy (MSA): MSA is a rare, progressive neurodegenerative disorder that affects the autonomic nervous system, cerebellum, and brainstem. SLC25A46 mutations have been identified in approximately 10% of MSA cases.\n3. Parkinson's disease: Parkinson's disease is a neurodegenerative disorder that affects movement, balance, and coordination. While SLC25A46 mutations are rare in Parkinson's disease, they have been identified in some cases.\n4. Dementia with Lewy bodies (DLB): DLB is a progressive neurodegenerative disorder that affects cognition, movement, and behavior. SLC25A46 mutations have been identified in approximately 10% of DLB cases.\n5. Corticobasal degeneration (CBD): CBD is a rare, progressive neurodegenerative disorder that affects movement, balance, and cognition. SLC25A46 mutations have been identified in approximately 10% of CBD cases.\n6. Frontotemporal dementia (FTD): FTD is a group of rare, progressive neurodegenerative disorders that affect personality, behavior, and language. SLC25A46 mutations have been identified in approximately 10% of FTD cases.\n7. Amyotrophic lateral sclerosis (ALS): ALS is a progressive neurodegenerative disorder that affects movement, balance, and coordination. While SLC25A46 mutations are rare in ALS, they have been identified in some cases.\n8. Charcot-Marie",
    "llama-2-7b-chat-hf_fact": [
      "SLC25A46-related pathologies are rare genetic disorders caused by mutations in the SLC25A46 gene.",
      "Progressive supranuclear palsy, a rare degenerative brain disorder is associated with SLC25A46 mutations.",
      "Multiple system atrophy, a neurodegenerative disorder, is one of the known pathologies associated with SLC25A46 mutations.",
      "SLC25A46 mutations have been identified in some cases of Parkinson's disease.",
      "Amyotrophic lateral sclerosis, a progressive neurodegenerative disorder, is associated with SLC25A46 gene mutations in some cases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-7b-chat-hf_response": "SATB1 is a transcription factor that plays a crucial role in the regulation of cell fate decisions, including cell proliferation, differentiation, and survival. The PDZ domain is a structural motif found in many proteins, including SATB1, that is involved in protein-protein interactions. In SATB1, the PDZ domain is located at the N-terminal region of the protein and is responsible for binding to phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2). The binding of PIP3 and PIP2 to the PDZ domain of SATB1 leads to the recruitment of the protein to the plasma membrane, where it can interact with other proteins and modulate signaling pathways involved in cell fate decisions.\nThe PDZ domain of SATB1 also plays a role in regulating the stability and localization of the protein. Studies have shown that the PDZ domain of SATB1 can interact with the ubiquitin-proteasome pathway, leading to the degradation of the protein. Additionally, the PDZ domain can also regulate the localization of SATB1 to specific subcellular regions, such as the nucleus or the cytoplasm, which can impact its ability to interact with other proteins and modulate signaling pathways.\nIn summary, the function of the PDZ domain in SATB1 is to regulate protein-protein interactions, modulate signaling pathways involved in cell fate decisions, and regulate the stability and localization of the protein.",
    "llama-2-7b-chat-hf_fact": [
      "SATB1 is a transcription factor that regulates cell fate decisions, including cell proliferation, differentiation, and survival.",
      "The PDZ domain is a structural motif in SATB1 that is responsible for protein-protein interactions.",
      "The PDZ domain in SATB1 is located at the N-terminal region of the protein and binds to phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2).",
      "Once PIP3 and PIP2 bind to the PDZ domain of SATB1, this contributes to the recruitment of SATB1 to the plasma membrane.",
      "The PDZ domain plays a role in regulating the stability and localization of SATB1, with capability to interact with the ubiquitin-proteasome pathway for protein degradation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3675,
    "user_query": "Which are the databases for intrinsic protein disorders?",
    "llama-2-7b-chat-hf_response": "There are several databases that provide information on intrinsic protein disorders, including:\n1. The Protein Data Bank (PDB): The PDB is a comprehensive database of 3D structures of proteins, nucleic acids, and other biological molecules. It includes structures of intrinsically disordered proteins, as well as their complexes with other molecules.\n2. DisProt: DisProt is a database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n3. Intrinsically Disordered Proteins Database (IDPdb): IDPdb is a comprehensive database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n4. Disordered Protein Database (DDB): DDB is a database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n5. Protein Folding and Misfolding Database (PFMD): PFMD is a database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n6. Intrinsically Disordered Protein Research Database (IDPRD): IDPRD is a comprehensive database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n7. Disordered Protein Interaction Database (DPI): DPI is a database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n8. Protein Misfolding and Aggregation Database (PMAD): PMAD is a database of intrinsically disordered proteins, including their structures, functions, and interactions. It also includes information on the mechanisms of protein misfolding and aggregation.\n9. Intrinsically Disordered Protein Disease Database (IDPD): IDPD is a database of intrinsically disordered proteins, including their",
    "llama-2-7b-chat-hf_fact": [
      "The Protein Data Bank (PDB) is a database of 3D structures of proteins, nucleic acids, and other biological molecules.",
      "DisProt is a database specifically for intrinsically disordered proteins.",
      "Intrinsically Disordered Proteins Database (IDPdb) provides information on intrinsically disordered proteins.",
      "Disordered Protein Database (DDB) is a database of intrinsically disordered proteins.",
      "Protein Folding and Misfolding Database (PFMD) is another database providing resources about intrinsically disordered proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no such database as \"Disordered Protein Database (DDB)\" for intrinsically disordered proteins.",
      "unknown"
    ]
  },
  {
    "id": 3676,
    "user_query": "List the 5 different human immunoglobulin heavy chains.",
    "llama-2-7b-chat-hf_response": "There are five different human immunoglobulin heavy chains (IgH) that are encoded by distinct genes on chromosome 14. These heavy chains are the main structural components of antibodies and play a crucial role in the immune response. Here are the five different human IgH heavy chains:\n1. IgH1: Also known as IgA1, this heavy chain is expressed on mucosal surfaces, such as the respiratory, gastrointestinal, and genitourinary tracts, as well as on the surface of B cells.\n2. IgH2: Also known as IgD, this heavy chain is expressed on the surface of mature B cells and plays a role in the activation of B cells by antigens.\n3. IgH3: Also known as IgE, this heavy chain is involved in allergic reactions and is responsible for triggering the release of histamine from mast cells.\n4. IgH4: Also known as IgG3, this heavy chain is expressed on the surface of mature B cells and plays a role in the activation of B cells by antigens.\n5. IgH5: Also known as IgG4, this heavy chain is expressed on the surface of mature B cells and plays a role in the activation of B cells by antigens.",
    "llama-2-7b-chat-hf_fact": [
      "There are five different human immunoglobulin heavy chains (IgH).",
      "These five different IgH are encoded by distinct genes on chromosome 14.",
      "IgH1, or IgA1, is expressed on mucosal surfaces and the surface of B cells.",
      "IgH3, or IgE, is involved in allergic reactions and triggers the release of histamine from mast cells.",
      "IgH5, also known as IgG4, is expressed on the surface of mature B cells and plays a role in the activation of B cells by antigens."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: IgA1, not IgH1, is expressed on mucosal surfaces and the surface of B cells.",
      "false, [corrected fact]: IgE, not IgH3, is involved in allergic reactions and triggers the release of histamine from mast cells.",
      "false, [corrected fact]: IgG4, not IgH5, is expressed on the surface of mature B cells and plays a role in the activation of B cells by antigens."
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-7b-chat-hf_response": "The BLISS technique is based on the principles of cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT). CBT focuses on identifying and changing negative thought patterns and behaviors, while ACT aims to help individuals develop psychological flexibility and acceptance of difficult emotions and experiences. The BLISS technique combines these two approaches to help individuals manage their emotions and behaviors in a more adaptive way.\nThe acronym BLISS stands for:",
    "llama-2-7b-chat-hf_fact": [
      "The BLISS technique is based on the principles of cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT).",
      "Cognitive-behavioral therapy focuses on identifying and changing negative thought patterns and behaviors.",
      "Acceptance and commitment therapy aims to help individuals develop psychological flexibility and acceptance of difficult emotions and experiences.",
      "The BLISS technique combines cognitive-behavioral therapy and acceptance and commitment therapy.",
      "The BLISS technique aims to help individuals manage their emotions and behaviors in a more adaptive way."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-7b-chat-hf_response": "NK3R (N-methyl-D-aspartate receptor subtype 3) antagonists are a class of drugs that act on the NK3 receptor, which is involved in the regulation of various physiological processes, including nausea and vomiting, appetite, and pain. Here are three examples of NK3R antagonists:\n1. Aprepitant: Aprepitant is an NK3R antagonist that is FDA-approved for the prevention of chemotherapy-induced nausea and vomiting. It works by blocking the action of NK3 receptors in the gut, thereby reducing the nausea and vomiting associated with chemotherapy.\n2. Granisetron: Granisetron is an NK3R antagonist that is FDA-approved for the prevention of chemotherapy-induced nausea and vomiting. It works by blocking the action of NK3 receptors in the gut, thereby reducing the nausea and vomiting associated with chemotherapy.\n3. Ondansetron: Ondansetron is an NK3R antagonist that is FDA-approved for the prevention of nausea and vomiting associated with chemotherapy, as well as for the treatment of postoperative nausea and vomiting. It works by blocking the action of NK3 receptors in the gut, thereby reducing the nausea and vomiting associated with chemotherapy or surgery.",
    "llama-2-7b-chat-hf_fact": [
      "NK3R (N-methyl-D-aspartate receptor subtype 3) antagonists are a class of drugs that act on the NK3 receptor.",
      "The NK3 receptor is involved in the regulation of various physiological processes, including nausea and vomiting, appetite, and pain.",
      "Aprepitant is an NK3R antagonist that is FDA-approved for the prevention of chemotherapy-induced nausea and vomiting.",
      "Granisetron is an NK3R antagonist that is FDA-approved for the prevention of chemotherapy-induced nausea and vomiting.",
      "Ondansetron is an NK3R antagonist that is FDA-approved for the prevention of nausea and vomiting associated with chemotherapy, as well as for the treatment of postoperative nausea and vomiting."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Aprepitant is an NK1R antagonist that is FDA-approved for the prevention of chemotherapy-induced nausea and vomiting.",
      "false, [corrected fact]: Granisetron is a 5-HT3 receptor antagonist that is FDA-approved for the prevention of chemotherapy-induced nausea and vomiting.",
      "false, [corrected fact]: Ondansetron is a 5-HT3 receptor antagonist that is FDA-approved for the prevention of nausea and vomiting associated with chemotherapy, as well as for the treatment of postoperative nausea and vomiting."
    ]
  },
  {
    "id": 3682,
    "user_query": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, atrophy, and paralysis. While there is currently no cure for ALS, various treatments are available to manage symptoms and slow disease progression. Indinavir, an antiretroviral drug used to treat HIV infection, has been investigated for its potential therapeutic effects on ALS. Here is a summary of the available evidence:\nStudies on indinavir for ALS:\n1. A small pilot study published in 2003 investigated the safety and efficacy of indinavir in 10 patients with ALS. The study found that indinavir was well-tolerated and appeared to slow disease progression, as measured by the rate of decline in forced vital capacity (FVC) over 12 months.\n2. A larger, multi-center study published in 2010 enrolled 150 patients with ALS to evaluate the efficacy and safety of indinavir. The study found that indinavir treatment resulted in a slower decline in FVC compared to placebo over a 24-month period. However, the study also found that indinavir was associated with an increased risk of adverse events, including gastrointestinal disturbances and liver enzyme elevations.\n3. A systematic review and meta-analysis published in 2017 pooled data from these and other studies to assess the overall effectiveness of indinavir for ALS. The review found that indinavir was associated with a modest but statistically significant slowing of disease progression, as measured by FVC decline, compared to placebo or no treatment. However, the review also noted that the quality of evidence was generally low and that further research is needed to confirm these findings.\nMechanisms of indinavir in ALS:\nThe exact mechanisms by which indinavir may exert its therapeutic effects in ALS are not fully understood. However, it is thought that indinavir may act by reducing oxidative stress and inflammation in the nervous system, which are",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord.",
      "Indinavir is an antiretroviral drug used to treat HIV infection.",
      "Indinavir has been studied for potential therapeutic effects on ALS.",
      "A small pilot study published in 2003 found indinavir to be well-tolerated and appear to slow ALS progression in 10 patients.",
      "A multi-center study from 2010, involving 150 patients with ALS, found that indinavir treatment resulted in a slower decline in FVC but it was also associated with an increased risk of adverse events."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3685,
    "user_query": "What is ORMD-0801?",
    "llama-2-7b-chat-hf_response": "ORMD-0801 is a small molecule inhibitor of the enzyme bromodomain-containing protein 1 (BRD1). BRD1 is a member of the bromodomain and extraterminal (BET) protein family, which are involved in regulating gene expression by binding to acetylated histone proteins. ORMD-0801 was developed as a potential therapeutic agent for the treatment of various cancers, including breast, lung, and colon cancer, as well as for the treatment of hematologic malignancies such as acute myeloid leukemia (AML) and multiple myeloma.\nORMD-0801 works by binding to the bromodomain of BRD1 and preventing it from interacting with acetylated histone proteins, which are known to play a role in the regulation of gene expression. By inhibiting the activity of BRD1, ORMD-0801 can alter the expression of genes involved in cell growth, proliferation, and survival, leading to the death of cancer cells.\nORMD-0801 has shown promise in preclinical studies as a potential cancer therapy, and it is currently being evaluated in clinical trials for the treatment of various types of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "ORMD-0801 is a small molecule inhibitor of the enzyme bromodomain-containing protein 1 (BRD1).",
      "BRD1 is a part of the bromodomain and extraterminal (BET) protein family, which regulates gene expression by binding to acetylated histone proteins.",
      "ORMD-0801 was developed as a potential therapeutic agent for various cancers, which include breast, lung, and colon cancer, as well as hematologic malignancies such as acute myeloid leukemia (AML) and multiple myeloma.",
      "ORMD-0801 functions by binding to the bromodomain of BRD1 and preventing its interaction with acetylated histone proteins, subsequently leading to the death of cancer cells.",
      "ORMD-0801 is being assessed in clinical trials for the treatment of different types of cancer after showing promise in preclinical studies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3686,
    "user_query": "Does saracatinib promote oncogenesis?",
    "llama-2-7b-chat-hf_response": "Saracatinib is a tyrosine kinase inhibitor that has been investigated as a potential treatment for various types of cancer, including breast, lung, and ovarian cancer. However, recent studies have suggested that saracatinib may also promote oncogenesis, or the development of cancer, in certain contexts.\nOne study published in the journal Cancer Research found that saracatinib can induce the expression of genes involved in cell proliferation and survival in breast cancer cells, leading to increased tumor growth and proliferation. Another study published in the journal Oncogene found that saracatinib can activate the PI3K/Akt signaling pathway in lung cancer cells, leading to increased cell survival and proliferation.\nThe mechanisms by which saracatinib promotes oncogenesis are not fully understood, but it is thought to involve the inhibition of tumor suppressor proteins and the activation of oncogenic signaling pathways. For example, saracatinib has been shown to inhibit the activity of the tumor suppressor protein PTEN in some contexts, leading to increased activation of the PI3K/Akt signaling pathway.\nOverall, these findings suggest that saracatinib may have both anti-tumor and pro-tumor effects depending on the context in which it is used, and further research is needed to fully understand its mechanisms of action in cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Saracatinib is a tyrosine kinase inhibitor.",
      "Saracatinib has been investigated as a potential treatment for various types of cancer, including breast, lung, and ovarian cancer.",
      "Some studies suggest saracatinib can promote oncogenesis or the development of cancer in certain contexts.",
      "Saracatinib has been shown to inhibit the activity of the tumor suppressor protein PTEN in some contexts.",
      "The mechanisms by which saracatinib promotes oncogenesis are not fully understood."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Saracatinib has been investigated as a potential treatment for various types of cancer because of its anti-oncogenic or anti-cancer properties, not because it would promote oncogenesis.",
      "false, [corrected fact]: Saracatinib inhibits Src family kinases, and not the tumor suppressor protein PTEN.",
      "false, [corrected fact]: The mechanisms by which saracatinib inhibits oncogenesis or cancer development, not promotes, are not fully understood."
    ]
  },
  {
    "id": 3687,
    "user_query": "Is BCL11B involved in schizophrenia?",
    "llama-2-7b-chat-hf_response": "Yes, BCL11B has been implicated in the pathophysiology of schizophrenia. BCL11B is a transcription factor that plays a critical role in regulating the expression of genes involved in neural development and function. Studies have shown that individuals with schizophrenia have altered expression of BCL11B in their brains, which may contribute to the development of the disorder.\nOne study published in the journal Nature Medicine found that individuals with schizophrenia had reduced expression of BCL11B in the prefrontal cortex, a region of the brain involved in cognitive function and decision-making. The study suggested that this reduction in BCL11B expression may contribute to the cognitive impairments seen in schizophrenia.\nAnother study published in the journal Molecular Psychiatry found that BCL11B mutations were more common in individuals with schizophrenia than in healthy controls. The study suggested that these mutations may disrupt the normal function of BCL11B and contribute to the development of the disorder.\nOverall, these studies suggest that BCL11B may play a role in the pathophysiology of schizophrenia, and that further research is needed to fully understand its involvement in the disorder.",
    "llama-2-7b-chat-hf_fact": [
      "BCL11B is a transcription factor involved in regulating the expression of genes related to neural development and function.",
      "Some studies have found altered expression of BCL11B in the brains of individuals with schizophrenia.",
      "A study in Nature Medicine reported reduced BCL11B expression in the prefrontal cortex of schizophrenic individuals, which is suggested to contribute to cognitive impairments in the disorder.",
      "Another study in Molecular Psychiatry found BCL11B mutations more frequently among schizophrenic individuals than in healthy controls.",
      "There is a hypothesis suggesting that BCL11B plays a role in the pathophysiology of schizophrenia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3690,
    "user_query": "What is a zoonotic virus?",
    "llama-2-7b-chat-hf_response": "A zoonotic virus is a virus that can be transmitted between animals and humans. Zoonotic viruses can be found in a wide range of animals, including mammals, birds, reptiles, and insects. These viruses can cause a variety of diseases in humans, ranging from mild to severe and even life-threatening.\nExamples of zoonotic viruses include:\n1. Ebola virus: This virus is transmitted through contact with infected animals, such as bats and nonhuman primates. It can cause a severe and often deadly hemorrhagic fever in humans.\n2. Avian influenza (bird flu): This virus is transmitted through contact with infected birds, such as poultry and wild birds. It can cause respiratory illness in humans, ranging from mild to severe.\n3. Rabies virus: This virus is transmitted through the bite of infected animals, such as dogs, bats, and raccoons. It can cause inflammation of the brain and central nervous system in humans.\n4. Lassa fever: This virus is transmitted through contact with infected rodents, such as rats and mice. It can cause a severe hemorrhagic fever in humans.\n5. SARS-CoV-2: This virus is transmitted through close contact with an infected person, such as through respiratory droplets. It can cause a severe respiratory illness in humans, known as COVID-19.\nZoonotic viruses can be transmitted to humans through a variety of routes, including:\n1. Direct contact with an infected animal, such as through a bite or scratch.\n2. Indirect contact with an infected animal, such as through contaminated food or water.\n3. Contact with an infected person, such as through respiratory droplets.\n4. Insect vectors, such as mosquitoes and ticks, can also transmit zoonotic viruses from animals to humans.\nPrevention and control of zoonotic viruses involves a combination of measures, including:\n1. Vaccination of animals and humans to prevent infection.\n2. Improved hygiene and sanitation practices, such as proper handwashing and food preparation.",
    "llama-2-7b-chat-hf_fact": [
      "A zoonotic virus is a virus that can be transmitted between animals and humans.",
      "Zoonotic viruses can cause a variety of diseases in humans, from mild to severe and potentially life-threatening.",
      "Examples of zoonotic viruses include the Ebola virus, Avian influenza, the Rabies virus, Lassa fever, and SARS-CoV-2.",
      "Zoonotic viruses can be transmitted to humans through direct contact with an infected animal, indirect contact with an infected animal, contact with an infected person, and insect vectors.",
      "Prevention and control of zoonotic viruses involve measures such as vaccination of animals and humans, and improved hygiene and sanitation practices."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-7b-chat-hf_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called BMS-986177. BMS-986177 is a potent and selective inverse agonist of the ghrelin receptor that has been shown to decrease ghrelin-stimulated growth hormone (GH) secretion in vitro and in vivo. In a Phase I clinical trial, BMS-986177 was evaluated in healthy subjects to assess its safety, pharmacokinetics, and pharmacodynamics. The results of this trial demonstrated that BMS-986177 was well-tolerated and showed dose-dependent inhibition of ghrelin-stimulated GH secretion. These findings support the further development of BMS-986177 as a potential treatment for growth hormone-related disorders, such as growth hormone deficiency and acromegaly.",
    "llama-2-7b-chat-hf_fact": [
      "BMS-986177 is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "BMS-986177 has been shown to decrease ghrelin-stimulated growth hormone secretion in vitro and in vivo.",
      "A Phase I clinical trial was conducted to evaluate the safety, pharmacokinetics, and pharmacodynamics of BMS-986177 in healthy subjects.",
      "The results from the trial showed that BMS-986177 was well-tolerated and displayed dose-dependent inhibition of ghrelin-stimulated growth hormone secretion.",
      "BMS-986177 is being further developed as a potential treatment for growth hormone-related disorders, such as growth hormone deficiency and acromegaly."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-7b-chat-hf_response": "Vaxchora is a cholera vaccine that has been shown to provide protection against moderate to severe cholera in clinical trials. The protective efficacy of Vaxchora against moderate to severe cholera was evaluated in a phase 3 clinical trial conducted in Bangladesh, where cholera is a major public health problem.\nThe trial enrolled 24,000 participants, aged 1 year to 60 years, who were randomly assigned to receive either two doses of Vaxchora or a placebo. The participants were then monitored for 12 months for the development of cholera. The primary endpoint of the trial was the incidence of cholera in the two groups.\nThe results of the trial showed that the incidence of cholera was significantly lower in the Vaxchora group compared to the placebo group. Specifically, the incidence of cholera was 1.3% in the Vaxchora group and 3.7% in the placebo group, representing a 64% reduction in the risk of developing cholera.\nThe protective efficacy of Vaxchora against moderate to severe cholera was also evaluated in a subset of participants who developed cholera despite being vaccinated. In this subset, the vaccine was found to reduce the severity of cholera symptoms and the duration of diarrhea.\nOverall, the results of the clinical trial suggest that Vaxchora is effective in preventing moderate to severe cholera in individuals, particularly in areas where cholera is a significant public health problem. However, the vaccine may not provide complete protection against mild or asymptomatic cases of cholera.",
    "llama-2-7b-chat-hf_fact": [
      "Vaxchora is a vaccine developed to protect against moderate to severe cholera.",
      "A phase 3 clinical trial for Vaxchora was conducted in Bangladesh involving 24,000 participants aged between 1 and 60 years.",
      "The trial had a primary endpoint of the incidence of cholera in the Vaxchora group and the placebo group.",
      "The incidence of cholera was found to be 1.3% in the Vaxchora group and 3.7% in the placebo group, translating to a 64% reduction in the risk of developing cholera for the individuals who were administered Vaxchora.",
      "The vaccine was observed to reduce the severity of cholera symptoms and the duration of diarrhea in a subset of participants who developed cholera despite being vaccinated."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3694,
    "user_query": "What is minodixil approved for?",
    "llama-2-7b-chat-hf_response": "Minoxidil is FDA-approved for the treatment of male pattern baldness (androgenetic alopecia) and female pattern baldness (female pattern hair loss). It is available over-the-counter (OTC) and is applied directly to the scalp as a solution or foam.\nMinoxidil works by increasing blood flow to the hair follicles, which can help to stimulate hair growth and slow down hair loss. It is important to note that minoxidil is not a cure for baldness, but it can help to slow down the progression of hair loss and promote new hair growth.\nMinoxidil is also sometimes used off-label to treat other types of hair loss, such as alopecia areata and telogen effluvium. However, it is important to talk to a healthcare provider before using minoxidil for these conditions, as it may not be effective and could potentially cause side effects.",
    "llama-2-7b-chat-hf_fact": [
      "Minoxidil is FDA-approved for the treatment of male pattern baldness (androgenetic alopecia) and female pattern baldness (female pattern hair loss).",
      "Minoxidil is available over-the-counter and applied directly to the scalp as a solution or foam.",
      "Minoxidil increases blood flow to the hair follicles, which can stimulate hair growth and slow down hair loss.",
      "Minoxidil isn't a cure for baldness but can slow down the progression of hair loss and promote new hair growth.",
      "Minoxidil is sometimes used off-label to treat other types of hair loss, such as alopecia areata and telogen effluvium."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3697,
    "user_query": "Is SATB1 necessary for T-cell maturation?",
    "llama-2-7b-chat-hf_response": "Yes, SATB1 is necessary for T-cell maturation. SATB1 is a transcription factor that plays a crucial role in the regulation of T-cell development and differentiation. It is expressed in early T-cell precursors and remains expressed throughout T-cell maturation, where it regulates the expression of genes involved in T-cell activation, proliferation, and differentiation.\nStudies have shown that SATB1-deficient mice have impaired T-cell development and maturation, leading to defects in T-cell function and immune responses. For example, SATB1-deficient mice are more susceptible to infection and have impaired immune responses to viral infections.\nSATB1 regulates the expression of genes involved in T-cell activation, proliferation, and differentiation, including the T-cell receptor (TCR), CD4 and CD8 coreceptors, and genes involved in cytokine production. It also regulates the expression of genes involved in T-cell adhesion and migration, such as CD44 and CD62L.\nIn addition, SATB1 has been shown to regulate the expression of genes involved in T-cell exhaustion, a state of T-cell dysfunction that can occur in response to chronic antigen exposure.\nOverall, SATB1 is essential for T-cell maturation and function, and its dysregulation can lead to impaired immune responses and increased susceptibility to infection.",
    "llama-2-7b-chat-hf_fact": [
      "SATB1 is a transcription factor that plays a key role in the regulation of T-cell development and differentiation.",
      "SATB1 is expressed in early T-cell precursors and remains expressed throughout T-cell maturation.",
      "Studies suggest that SATB1-deficient mice have diminished T-cell development and maturation, leading to defects in T-cell function and immune responses.",
      "SATB1 regulates the expression of genes involved in T-cell activation, proliferation, differentiation, adhesion, migration, and cytokine production.",
      "SATB1 has been observed to regulate the expression of genes associated with T-cell exhaustion, a state of T-cell dysfunction that can occur in response to chronic antigen exposure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3700,
    "user_query": "What is the function of a viral peplomer?",
    "llama-2-7b-chat-hf_response": "A viral peplomer is a protein found on the surface of some viruses that helps the virus to attach to and enter host cells. The peplomer is usually made up of multiple subunits, each of which has a specific function in the attachment and entry process.",
    "llama-2-7b-chat-hf_fact": [
      "A viral peplomer is a protein found on the surface of some viruses.",
      "The function of a viral peplomer is to help the virus attach to and enter host cells.",
      "The peplomer is usually made up of multiple subunits.",
      "Each subunit of a peplomer has a specific function in the attachment and entry process of the virus to the host cell."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3704,
    "user_query": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "llama-2-7b-chat-hf_response": "Yes, radiotherapy for prostate cancer can increase the risk of developing bladder cancer. Radiotherapy, also known as radiation therapy, is a common treatment for prostate cancer. However, it can also damage the cells in the bladder, which can increase the risk of developing bladder cancer.\nThe risk of developing bladder cancer after radiotherapy for prostate cancer varies depending on several factors, including the dose of radiation used, the location of the prostate cancer, and the individual's overall health. Studies have shown that men who receive higher doses of radiation to the pelvic area are at a higher risk of developing bladder cancer.\nIt's important to note that the risk of developing bladder cancer after radiotherapy for prostate cancer is generally low, and most men who receive radiotherapy will not develop bladder cancer. However, it's important to be aware of the potential risk and to discuss any concerns with your doctor.\nIf you have been treated for prostate cancer with radiotherapy and are concerned about the risk of bladder cancer, there are several things you can do to reduce your risk:\n1. Get regular check-ups: Regular check-ups with your doctor can help detect any changes in your bladder or any signs of bladder cancer early on.\n2. Practice bladder-sparing techniques: There are several techniques that can help reduce the risk of bladder damage during radiotherapy, such as using a smaller radiation field or delivering the radiation in smaller doses over a longer period of time.\n3. Consider alternative treatments: If you are concerned about the risk of bladder cancer, you may want to consider alternative treatments for prostate cancer, such as active surveillance or hormone therapy.\n4. Quit smoking: Smoking can increase the risk of bladder cancer, so quitting smoking can help reduce your overall risk.\nIt's important to remember that the risk of bladder cancer after radiotherapy for prostate cancer is generally low, and most men who receive radiotherapy will not develop bladder cancer. However, it's important to be aware of the potential risk and to discuss any concerns with your doctor.",
    "llama-2-7b-chat-hf_fact": [
      "Radiotherapy for prostate cancer can increase the risk of developing bladder cancer.",
      "The risk of getting bladder cancer after radiotherapy for prostate cancer is influenced by several factors, including the dose of radiation, the location of the prostate cancer, and an individual's overall health.",
      "Regular check-ups can help detect early signs of bladder cancer in patients treated for prostate cancer with radiotherapy.",
      "Smoking can increase the risk of bladder cancer.",
      "Alternative treatments for prostate cancer such as active surveillance or hormone therapy exist."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3705,
    "user_query": "What is ESN364?",
    "llama-2-7b-chat-hf_response": "ESN364 is a non-invasive, wearable device that uses electroencephalography (EEG) technology to measure brain activity in real-time. It is designed to provide insights into an individual's cognitive state, including their level of focus, attention, and mental workload.\nHow does ESN364 work?\nESN364 works by placing electrodes on the scalp, which measure the electrical activity of the brain. This activity is then translated into a digital signal that can be analyzed using machine learning algorithms. The device can detect changes in brain activity in real-time, allowing it to provide insights into an individual's cognitive state.\nWhat are the benefits of using ESN364?\nESN364 can be used in a variety of settings, including education, workplace productivity, and mental health. Some of the benefits of using ESN364 include:\n* Improved focus and attention: ESN364 can help individuals improve their focus and attention by providing real-time feedback on their cognitive state.\n* Enhanced mental workload management: ESN364 can help individuals manage their mental workload by providing insights into their cognitive state and alerting them when they may be experiencing cognitive overload.\n* Better decision-making: ESN364 can help individuals make better decisions by providing insights into their cognitive state and alerting them when they may be experiencing cognitive biases.\n* Improved mental health: ESN364 can help individuals monitor their mental health by providing insights into their cognitive state and alerting them when they may be experiencing symptoms of mental health disorders.",
    "llama-2-7b-chat-hf_fact": [
      "ESN364 is a non-invasive, wearable device.",
      "The device ESN364 uses electroencephalography (EEG) technology to measure brain activity in real-time.",
      "The operation of ESN364 involves placing electrodes on the scalp to measure electrical activity of the brain, which is then translated into a digital signal.",
      "This digital signal from ESN364 device can be analysed using machine learning algorithms to provide insights into an individual's cognitive state.",
      "The ESN364 device can be used in education, workplace productivity, and mental health settings."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3707,
    "user_query": "Has MLE4901 been tested in phase III clinical trials?",
    "llama-2-7b-chat-hf_response": "No, MLE4901 has not been tested in phase III clinical trials. MLE4901 is an investigational drug that is currently being studied in phase II clinical trials for the treatment of various types of cancer, including non-small cell lung cancer (NSCLC), pancreatic cancer, and ovarian cancer. These trials are evaluating the safety and efficacy of MLE4901 in combination with other therapies, including chemotherapy and immunotherapy.\nPhase III clinical trials are typically conducted after a drug has shown promising results in earlier-stage clinical trials, and are designed to confirm the efficacy and safety of the drug in a larger, more diverse population of patients. While MLE4901 has shown promise in early-stage clinical trials, it has not yet been tested in a phase III clinical trial.",
    "llama-2-7b-chat-hf_fact": [
      "MLE4901 has not been tested in phase III clinical trials.",
      "MLE4901 is currently being studied in phase II clinical trials.",
      "Phase III clinical trials are conducted to confirm the efficacy and safety of a drug in a larger, diverse population of patients.",
      "MLE4901 is being studied for the treatment of various types of cancers, including non-small cell lung cancer (NSCLC), pancreatic cancer, and ovarian cancer.",
      "The phase II clinical trials of MLE4901 are evaluating its safety and efficacy in combination with other therapies, including chemotherapy and immunotherapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3713,
    "user_query": "What is the interaction between WAPL and PDS5 proteins?",
    "llama-2-7b-chat-hf_response": "WAPL (WASP-Adaptor Protein-Like) and PDS5 (Protein Disulfide Isomerase 5) are two proteins that play important roles in the regulation of protein folding and degradation. WAPL is a scaffold protein that interacts with various signaling molecules and regulates their activity, while PDS5 is an enzyme that catalyzes the isomerization of disulfide bonds in proteins.\nStudies have shown that WAPL and PDS5 interact with each other and cooperate to regulate protein folding and degradation. WAPL can recruit PDS5 to specific protein substrates, and PDS5 can then catalyze the isomerization of disulfide bonds in these proteins, leading to their proper folding and stability. Conversely, PDS5 can also promote the degradation of misfolded proteins by interacting with the ubiquitin-proteasome system.\nOverall, the interaction between WAPL and PDS5 is important for ensuring proper protein folding and degradation, and dysregulation of this interaction has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "WAPL (WASP-Adaptor Protein-Like) is a scaffold protein that interacts with various signaling molecules and regulates their activity.",
      "PDS5 (Protein Disulfide Isomerase 5) is an enzyme that catalyzes the isomerization of disulfide bonds in proteins.",
      "Studies have shown that WAPL and PDS5 interact to regulate protein folding and degradation.",
      "PDS5 promotes the degradation of misfolded proteins by interacting with the ubiquitin-proteasome system.",
      "Dysregulation of the interaction between WAPL and PDS5 has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-7b-chat-hf_response": "The first cholera vaccine approved in the US was the Shanchol vaccine, which was approved by the Food and Drug Administration (FDA) in 2007. Shanchol is a killed, oral cholera vaccine that provides protection against cholera caused by the Vibrio cholerae bacteria. It is recommended for adults aged 18 through 64 years who are traveling to areas where cholera is common.",
    "llama-2-7b-chat-hf_fact": [
      "The first cholera vaccine approved in the US was the Shanchol vaccine.",
      "The Shanchol vaccine was approved by the Food and Drug Administration (FDA) in 2007.",
      "Shanchol is a killed, oral cholera vaccine.",
      "This vaccine provides protection against cholera caused by the Vibrio cholerae bacteria.",
      "It is recommended for adults aged 18 through 64 years who are traveling to areas where cholera is common."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The first cholera vaccine approved in the US was the Vaxchora vaccine.",
      "false, [corrected fact]: The Shanchol vaccine was approved by the World Health Organization, not the FDA, in 2011.",
      "true",
      "true",
      "false, [corrected fact]: The vaccine is recommended for people aged two years and above who are traveling to an area of active cholera transmission."
    ]
  },
  {
    "id": 3718,
    "user_query": "Are there negative enhancers?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-acting DNA elements that can increase the expression of a gene by binding to transcription factors and recruiting RNA polymerase to the promoter region of the gene. Enhancers can be located far away from the promoter and gene they regulate, and they can have a profound impact on the expression of the gene.\nHowever, there are also negative enhancers, which can decrease the expression of a gene by binding to transcription factors and blocking the recruitment of RNA polymerase to the promoter region of the gene. Negative enhancers can be located far away from the promoter and gene they regulate, and they can have a profound impact on the expression of the gene.\nNegative enhancers can be achieved through several mechanisms, including:\n1. Competitive binding: Negative enhancers can compete with positive enhancers for the binding of transcription factors, thereby reducing the recruitment of RNA polymerase to the promoter region of the gene.\n2. Sequestration: Negative enhancers can sequester transcription factors, preventing them from binding to the promoter region of the gene and recruiting RNA polymerase.\n3. Chromatin modification: Negative enhancers can alter the chromatin structure around the promoter region of the gene, making it more difficult for RNA polymerase to access the gene.\n4. RNA interference: Negative enhancers can induce the production of small RNAs, such as siRNAs or miRNAs, that can bind to the messenger RNA (mRNA) of the gene and prevent its translation.\nThe discovery of negative enhancers has expanded our understanding of the complex regulatory networks that control gene expression and has implications for the development of new therapeutic strategies for diseases caused by dysregulation of gene expression.\nIn summary, negative enhancers are cis-acting DNA elements that can decrease the expression of a gene by binding to transcription factors and blocking the recruitment of RNA polymerase to the promoter region of the gene. They can be achieved through several mechanisms, including competitive binding, sequestration, chromatin modification, and RNA interference. The discovery of negative enhancers has expanded",
    "llama-2-7b-chat-hf_fact": [
      "Enhancers are cis-acting DNA elements that increase the expression of a gene.",
      "Negative enhancers are cis-acting DNA elements that can decrease the expression of a gene.",
      "Negative enhancers can function via mechanisms of competitive binding, sequestration, chromatin modification, and RNA interference.",
      "One function of negative enhancers is to compete with positive enhancers for the binding of transcription factors, reducing the recruitment of RNA polymerase.",
      "The discovery of negative enhancers expanded our understanding of gene expression regulatory networks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: There is no consensually recognized term called \"negative enhancer\". Instead, cis-acting elements that negatively regulate gene expression are generally termed \"silencers\".",
      "false, [corrected fact]: Silencers, not \"negative enhancers\", can function via mechanisms of competitive binding, sequestration, chromatin modification, and RNA interference.",
      "false, [corrected fact]: It is silencers, not \"negative enhancers\", that compete with enhancers for the binding of transcription factors, reducing the recruitment of RNA polymerase.",
      "unknown"
    ]
  },
  {
    "id": 3719,
    "user_query": "What is the function of WAPL protein on cohesin?",
    "llama-2-7b-chat-hf_response": "WAPL (WASP-associated protein-like) is a protein that is involved in the regulation of cohesin, a protein complex that plays a crucial role in the maintenance of chromosomal stability. WAPL protein is known to interact with the cohesin complex and regulate its activity, particularly during the process of DNA replication and repair.\nWAPL protein functions as a negative regulator of cohesin, meaning that it inhibits the activity of cohesin and prevents it from unwinding DNA. This is important for maintaining the stability of chromosomes during DNA replication and repair, as uncontrolled unwinding of DNA can lead to genetic instability and the formation of chromosomal abnormalities.\nIn addition to its role in regulating cohesin, WAPL protein has also been implicated in the regulation of other cellular processes, including cell adhesion, migration, and signaling.\nOverall, the function of WAPL protein on cohesin is to regulate its activity and prevent unwinding of DNA, thereby maintaining the stability of chromosomes and ensuring proper cellular function.",
    "llama-2-7b-chat-hf_fact": [
      "WAPL (WASP-associated protein-like) protein is involved in the regulation of cohesin.",
      "Cohesin is a protein complex that helps maintain chromosomal stability.",
      "WAPL protein interacts with the cohesin complex during DNA replication and repair.",
      "As a negative regulator of cohesin, WAPL protein prevents cohesin from unwinding DNA.",
      "WAPL protein also plays a role in regulating other cellular processes, such as cell adhesion, migration, and signaling."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: As a negative regulator of cohesin, WAPL protein promotes the removal of cohesin from DNA, not preventing it from unwinding DNA.",
      "unknown"
    ]
  },
  {
    "id": 3728,
    "user_query": "Which cells mature in the human thymus?",
    "llama-2-7b-chat-hf_response": "The human thymus is a gland located in the chest, just behind the sternum. It is responsible for the maturation and selection of T-lymphocytes (T-cells), which are a type of immune cell that plays a central role in cell-mediated immunity. The thymus is present throughout life, but it is largest and most active during childhood and adolescence.\nThere are several types of cells that mature in the human thymus, including:\n1. Thymocytes: These are immature T-cells that are produced in the bone marrow and migrate to the thymus for maturation. In the thymus, thymocytes undergo a process called positive and negative selection, in which they are either eliminated or mature into functional T-cells.\n2. Mature T-cells: Once thymocytes have undergone selection, they mature into functional T-cells. There are several subtypes of mature T-cells, including CD4+ T-cells (also known as T-helpers) and CD8+ T-cells (also known as cytotoxic T-cells).\n3. T-regulatory cells (Tregs): These are a subtype of T-cells that play a regulatory role in the immune system. Tregs help to prevent autoimmune diseases by suppressing the activity of other immune cells.\n4. Mucosal associated invariant T (MAIT) cells: These are a type of T-cell that are found in the mucosal surfaces of the body, such as the respiratory, gastrointestinal, and genitourinary tracts. MAIT cells play a role in the immune response to microorganisms in these areas.\n5. Natural killer (NK) cells: These are a type of immune cell that can recognize and kill infected cells or tumor cells without the need for antigen presentation. NK cells are produced in the bone marrow and can also be found in the thymus.",
    "llama-2-7b-chat-hf_fact": [
      "The human thymus is a gland located in the chest, responsible for the maturation and selection of T-lymphocytes (T-cells).",
      "Thymocytes, which are immature T-cells, are produced in the bone marrow and migrate to the thymus for maturation.",
      "Mature T-cells, including CD4+ T-cells (T-helpers) and CD8+ T-cells (cytotoxic T-cells), are developed from thymocytes.",
      "T-regulatory cells (Tregs), a subtype of T-cells, play a regulatory role in the immune system and aim to prevent autoimmune diseases.",
      "The human thymus also accommodates the maturation of Mucosal associated invariant T (MAIT) cells, which play a role in the immune response to microorganisms on mucosal surfaces, and Natural killer (NK) cells, which can recognize and kill infected cells or tumor cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: The human thymus accommodates the maturation of Mucosal associated invariant T (MAIT) cells, which play a role in the immune response to microorganisms on mucosal surfaces. However, Natural killer (NK) cells are not matured in the thymus, they develop and mature in the bone marrow."
    ]
  },
  {
    "id": 3729,
    "user_query": "What are the eRNA-producing centers (EPCs)?",
    "llama-2-7b-chat-hf_response": "EPCs (eRNA-producing centers) are specialized subcellular structures that are responsible for the production of extracellular RNA (eRNA) in cells. EPCs are found in various cell types, including immune cells, neurons, and cancer cells, and play a crucial role in the regulation of cellular processes such as inflammation, immune response, and cancer progression.\nEPCs are characterized by the presence of specific protein markers, such as TAR RNA-binding protein 1 (TRBP1), which is a key component of the eRNA-producing machinery. EPCs can produce a wide range of eRNAs, including microRNAs (miRNAs), small interfering RNAs (siRNAs), and long non-coding RNAs (lncRNAs), which can be secreted into the extracellular space and play a role in intercellular communication.\nEPCs have been implicated in various diseases, including cancer, neurodegenerative disorders, and infectious diseases. For example, EPCs have been shown to play a role in the progression of cancer by producing eRNAs that promote tumor growth and metastasis. In addition, EPCs have been implicated in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease, where they may contribute to the production of pro-inflammatory eRNAs.\nOverall, EPCs are an important aspect of cellular biology, and further research is needed to fully understand their mechanisms of action and their role in various diseases.",
    "llama-2-7b-chat-hf_fact": [
      "EPCs are subcellular structures responsible for the production of extracellular RNA (eRNA) in cells.",
      "EPCs occur in various cell types including immune cells, neurons, and cancer cells, and they are involved in regulating different cellular processes.",
      "TAR RNA-binding protein 1 (TRBP1) is a specific protein marker characteristic of EPCs.",
      "EPCs can produce a wide range of eRNAs, including microRNAs, small interfering RNAs, and long non-coding RNAs.",
      "EPCs have been implicated in numerous diseases, such as cancer, neurodegenerative disorders, and infectious diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3731,
    "user_query": "When was vivotif first licenced in Europe?",
    "llama-2-7b-chat-hf_response": "Vivotif was first licensed in Europe in 2002. It was approved by the European Medicines Agency (EMA) in June 2002 and became available in pharmacies across the European Union (EU) in July 2002.",
    "llama-2-7b-chat-hf_fact": [
      "Vivotif was first licensed in Europe in 2002.",
      "The European Medicines Agency (EMA) approved Vivotif in June 2002.",
      "Vivotif became available in pharmacies across the European Union in July 2002."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3735,
    "user_query": "Which molecules are inhibited by Gilteritinib?",
    "llama-2-7b-chat-hf_response": "Gilteritinib is a drug that inhibits the enzyme FLT3, which is overexpressed in many types of cancer, including acute myeloid leukemia (AML). By inhibiting FLT3, Gilteritinib can reduce the growth and survival of cancer cells. Here are some examples of molecules that are inhibited by Gilteritinib:\n1. FLT3: As mentioned earlier, Gilteritinib is a selective inhibitor of FLT3, which is overexpressed in many types of cancer, including AML. By inhibiting FLT3, Gilteritinib can reduce the growth and survival of cancer cells.\n2. PI3K/Akt/mTOR signaling pathway: Gilteritinib has been shown to inhibit the PI3K/Akt/mTOR signaling pathway in cancer cells, which is involved in cell survival and proliferation. By inhibiting this pathway, Gilteritinib can reduce the growth and survival of cancer cells.\n3. NF-B signaling pathway: Gilteritinib has also been shown to inhibit the NF-B signaling pathway in cancer cells, which is involved in cell survival and proliferation. By inhibiting this pathway, Gilteritinib can reduce the growth and survival of cancer cells.\n4. VEGF signaling pathway: Gilteritinib has been shown to inhibit the VEGF signaling pathway in cancer cells, which is involved in angiogenesis and tumor growth. By inhibiting this pathway, Gilteritinib can reduce the growth and survival of cancer cells.\n5. Cyclin-dependent kinases (CDKs): Gilteritinib has been shown to inhibit CDKs in cancer cells, which are involved in cell cycle progression and proliferation. By inhibiting CDKs, Gilteritinib can reduce the growth and survival of cancer cells.\n6. Topoisomerase II: Gilteritinib has been shown to inhibit topoisomerase II in cancer cells, which is involved in DNA replication and repair. By inhibiting topoisomer",
    "llama-2-7b-chat-hf_fact": [
      "Gilteritinib inhibits the enzyme FLT3 which is overexpressed in many types of cancer, including acute myeloid leukemia (AML).",
      "Gilteritinib is known to inhibit the PI3K/Akt/mTOR signaling pathway in cancer cells.",
      "The drug Gilteritinib can inhibit the NF-B signaling pathway in cancer cells.",
      "Gilteritinib has been found to inhibit the VEGF signaling pathway in cancer cells.",
      "Gilteritinib has been shown to inhibit cyclin-dependent kinases (CDKs) and topoisomerase II in cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3738,
    "user_query": "List 3 human diseases caused by  viruses in the family Paramyxoviridae.",
    "llama-2-7b-chat-hf_response": "1. Measles\n2. Mumps\n3. Respiratory syncytial virus (RSV)\nThe Paramyxoviridae family includes viruses that cause a range of diseases in humans, including:\n* Measles (caused by Measles virus)\n* Mumps (caused by Mumps virus)\n* Respiratory syncytial virus (RSV) (caused by Respiratory syncytial virus)\nThese viruses are known to cause significant morbidity and mortality worldwide, particularly in young children and immunocompromised individuals.",
    "llama-2-7b-chat-hf_fact": [
      "Measles is a disease caused by a virus in the Paramyxoviridae family.",
      "Mumps is another disease caused by a virus from the same family, Paramyxoviridae.",
      "Respiratory syncytial virus (RSV) can be caused by a virus within the family Paramyxoviridae.",
      "The Paramyxoviridae family includes viruses that cause illnesses across the globe.",
      "These viruses can lead to significant morbidity and mortality, particularly in young children and immunocompromised individuals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Respiratory syncytial virus (RSV) is caused by a virus in the family Pneumoviridae, not Paramyxoviridae.",
      "true",
      "true"
    ]
  },
  {
    "id": 3740,
    "user_query": "What is the target of a drug pidilizumab?",
    "llama-2-7b-chat-hf_response": "Pidilizumab is a drug that is being studied for the treatment of various types of cancer, including breast cancer, lung cancer, and multiple myeloma. It works by blocking a protein called CD276, which is found on the surface of many cancer cells. By blocking CD276, pidilizumab can help to prevent cancer cells from growing and dividing, and can also help the immune system to recognize and attack cancer cells more effectively.\nPidilizumab is being studied in clinical trials as a potential treatment for several types of cancer, including:\n* Breast cancer: Pidilizumab is being studied as a potential treatment for hormone-receptor-positive breast cancer, which is a type of breast cancer that is fueled by the hormone estrogen.\n* Lung cancer: Pidilizumab is being studied as a potential treatment for non-small cell lung cancer, which is the most common type of lung cancer.\n* Multiple myeloma: Pidilizumab is being studied as a potential treatment for multiple myeloma, which is a type of cancer that affects the plasma cells in the bone marrow.\nOverall, the target of pidilizumab is to help the immune system recognize and attack cancer cells more effectively, and to slow or stop the growth of cancer cells.",
    "llama-2-7b-chat-hf_fact": [
      "Pidilizumab is a drug being studied for treatment of various types of cancer.",
      "Pidilizumab works by blocking a protein called CD276 found on the surface of many cancer cells.",
      "CD276-blocking action by pidilizumab can prevent cancer cells from growing and dividing.",
      "Pidilizumab is being studied as a potential treatment for hormone-receptor-positive breast cancer.",
      "Pidilizumab is being studied for its potential in treating non-small cell lung cancer and multiple myeloma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Pidilizumab works by blocking a protein called PD-1 found on the surface of many cancer cells.",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3742,
    "user_query": "Han Wistar and Sprague Dawley are breeds of what laboratory animal?",
    "llama-2-7b-chat-hf_response": "Answer: Han Wistar and Sprague Dawley are breeds of rats.",
    "llama-2-7b-chat-hf_fact": [
      "Han Wistar is a breed of rat.",
      "Sprague Dawley is a breed of rat."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Han Wistar is a strain of rat, not a breed.",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-7b-chat-hf_response": "The IFIT1 gene has been shown to play a crucial role in the pathogenesis of Systemic Lupus Erythematosus (SLE). SLE is a chronic autoimmune disease that affects multiple organs and tissues, including the skin, joints, kidneys, and nervous system. The IFIT1 gene encodes for a protein called interferon-induced protein with tetratricopeptide repeats 1 (IFIT1), which is involved in the antiviral response and the regulation of immune cell function.\nStudies have shown that IFIT1 gene variants are associated with an increased risk of developing SLE, and that these variants may contribute to the development of the disease by disrupting the regulation of immune cell function. For example, one study found that IFIT1 gene variants were more common in SLE patients than in healthy controls, and that these variants were associated with increased levels of pro-inflammatory cytokines and autoantibodies. Another study found that IFIT1 gene variants were associated with a higher risk of renal involvement in SLE patients.\nIn addition to its role in the pathogenesis of SLE, the IFIT1 gene has also been implicated in the development of other autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.\nIn summary, the IFIT1 gene plays a crucial role in the pathogenesis of Systemic Lupus Erythematosus (SLE) by disrupting the regulation of immune cell function and contributing to the development of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "The IFIT1 gene plays a crucial role in the development of Systemic Lupus Erythematosus (SLE).",
      "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs and tissues.",
      "The IFIT1 gene encodes for a protein involved in the antiviral response and the regulation of immune cell function.",
      "Studies have shown that IFIT1 gene variants are associated with an increased risk of developing SLE.",
      "The IFIT1 gene has also been implicated in the development of other autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3744,
    "user_query": "Has tocilizumab been assessed against Covid-19?",
    "llama-2-7b-chat-hf_response": "Yes, tocilizumab has been assessed in clinical trials for the treatment of COVID-19. Tocilizumab is a monoclonal antibody that targets the interleukin-6 (IL-6) receptor, which is involved in the inflammatory response. IL-6 is a cytokine that is elevated in response to COVID-19 infection and can contribute to the severity of the disease.\nSeveral clinical trials have been conducted to evaluate the safety and efficacy of tocilizumab in patients with COVID-19. These trials have been conducted in various countries and have included patients with mild, moderate, and severe COVID-19.\nSome of the key findings from these trials include:\n1. Reduced inflammation: Tocilizumab has been shown to reduce inflammation in patients with COVID-19, as measured by levels of IL-6 and other inflammatory markers.\n2. Improved lung function: Tocilizumab has been shown to improve lung function in patients with COVID-19, as measured by forced vital capacity (FVC) and other markers of lung function.\n3. Reduced risk of mechanical ventilation: Tocilizumab has been shown to reduce the risk of mechanical ventilation in patients with COVID-19, particularly in those with severe disease.\n4. Reduced risk of hospitalization: Tocilizumab has been shown to reduce the risk of hospitalization in patients with COVID-19, particularly in those with mild or moderate disease.\n5. Safety profile: Tocilizumab has been shown to have a generally safe and well-tolerated profile in patients with COVID-19, with the most common adverse events being mild to moderate in severity.\nOverall, the results of these clinical trials suggest that tocilizumab may be a useful treatment option for patients with COVID-19, particularly those with severe disease. However, more research is needed to confirm these findings and to determine the optimal dosing and duration of treatment with tocilizumab for COVID-19.",
    "llama-2-7b-chat-hf_fact": [
      "Tocilizumab, a monoclonal antibody, has been assessed in multiple clinical trials for the treatment of COVID-19.",
      "Tocilizumab targets the interleukin-6 (IL-6) receptor that is involved in the inflammatory response.",
      "The clinical trials have included patients with mild, moderate, and severe COVID-19 from various countries.",
      "Key findings from these trials show that tocilizumab can reduce inflammation, improve lung function, and decrease the risk of mechanical ventilation and hospitalization in COVID-19 patients.",
      "Additional research is required to confirm these findings and determine the optimal dosing and treatment duration with tocilizumab for COVID-19 patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3745,
    "user_query": "Variants in which genes cause nonsyndromic retinal degeneration?",
    "llama-2-7b-chat-hf_response": "Nonsyndromic retinal degeneration refers to a group of inherited retinal disorders that do not occur as part of a larger syndrome or condition. These disorders are often caused by mutations in single genes that are responsible for the development and maintenance of the retina. Here are some examples of genes that can cause nonsyndromic retinal degeneration:\n1. Retinitis pigmentosa (RP) genes: RP is a group of inherited disorders characterized by progressive degeneration of the retina, leading to night blindness, tunnel vision, and eventual blindness. Mutations in genes such as RPE65, CRB1, and RHO are associated with RP.\n2. Leber congenital amaurosis (LCA) genes: LCA is a rare inherited disorder characterized by severe visual impairment or blindness at birth or in early childhood. Mutations in genes such as CEP290, CNGA3, and RPE65 are associated with LCA.\n3. Stargardt disease genes: Stargardt disease is a rare inherited disorder characterized by progressive vision loss, usually starting in childhood or adolescence. Mutations in genes such as ABCA4, ELOVL4, and PDE6A are associated with Stargardt disease.\n4. Choroideremia genes: Choroideremia is a rare inherited disorder characterized by progressive vision loss, usually starting in childhood or adolescence. Mutations in the CHM gene are associated with choroideremia.\n5. Fundus flavimaculatus genes: Fundus flavimaculatus is a rare inherited disorder characterized by progressive vision loss, usually starting in childhood or adolescence. Mutations in the RPE65 gene are associated with fundus flavimaculatus.\n6. cone-rod dystrophy genes: Cone-rod dystrophy is a group of inherited disorders characterized by progressive vision loss due to degeneration of the cone and rod photoreceptors in the retina. Mutations in genes such as CRB1, CNGA3, and CNGB3 are associated with cone-rod d",
    "llama-2-7b-chat-hf_fact": [
      "Nonsyndromic retinal degeneration is caused by mutations in genes responsible for the development and maintenance of the retina.",
      "Retinitis pigmentosa, a disorder characterized by progressive degeneration of the retina, is associated with mutations in genes such as RPE65, CRB1, and RHO.",
      "Leber congenital amaurosis, a severe visual impairment disorder, is associated with mutations in genes such as CEP290, CNGA3, and RPE65.",
      "Stargardt disease, characterized by progressive vision loss, is associated with mutations in genes such as ABCA4, ELOVL4, and PDE6A.",
      "Choroideremia, a progressive vision loss disorder, is associated with mutations in the CHM gene."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-7b-chat-hf_response": "The Liverpool Elbow Score (LES) is a patient-reported outcome measure (PROM) used to assess the severity of elbow pain and disability in patients with elbow conditions, such as tennis elbow (lateral epicondylitis) and golfer's elbow (medial epicondylitis). The LES is a self-administered questionnaire that assesses the patient's level of agreement with a series of statements related to their elbow symptoms and function. The score ranges from 0 to 100, with higher scores indicating greater severity of symptoms and disability. The LES has been found to be reliable and valid in measuring elbow symptoms and disability in various populations, including athletes and non-athletes. It is commonly used in clinical practice and research studies to evaluate the effectiveness of treatments for elbow conditions.",
    "llama-2-7b-chat-hf_fact": [
      "The Liverpool Elbow Score (LES) is a patient-reported outcome measure used to assess the severity of elbow pain and disability in patients with elbow conditions.",
      "LES is used for patients with conditions such as tennis elbow (lateral epicondylitis) and golfer's elbow (medial epicondylitis).",
      "LES is a self-administered questionnaire that assesses the patient's level of agreement with statements related to their elbow symptoms and function.",
      "The score of the LES ranges from 0 to 100, with higher scores indicating greater severity of symptoms and disability.",
      "The LES is used in both clinical practice and research studies to evaluate the effectiveness of treatments for elbow conditions."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The score of the LES ranges from 0 to 100, with higher scores indicating less severity of symptoms and disability.",
      "true"
    ]
  },
  {
    "id": 3755,
    "user_query": "What is the function of the zelda transcription factor in D. melanogaster?",
    "llama-2-7b-chat-hf_response": "The zelda transcription factor is a key regulator of the circadian clock in Drosophila melanogaster. It is a basic leucine zipper (bZIP) transcription factor that is expressed in the brain and other tissues and plays a crucial role in regulating the expression of clock genes and other genes involved in the circadian rhythm.",
    "llama-2-7b-chat-hf_fact": [
      "The zelda transcription factor is a regulator of the circadian clock in Drosophila melanogaster.",
      "Zelda transcription factor is a basic leucine zipper (bZIP) transcription factor.",
      "Zelda transcription factor is expressed in the brain and other tissues of Drosophila melanogaster.",
      "It plays a crucial role in regulating the expression of clock genes.",
      "The zelda transcription factor is involved in regulating other genes of the circadian rhythm."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3757,
    "user_query": "Which conditions are manifested by TRIM8 mutations?",
    "llama-2-7b-chat-hf_response": "TRIM8 mutations have been associated with a variety of conditions, including:\n1. Intellectual disability: TRIM8 mutations have been identified as a cause of intellectual disability in several individuals and families.\n2. Autism spectrum disorder: Some studies have found an increased frequency of TRIM8 mutations in individuals with autism spectrum disorder (ASD).\n3. Congenital anomalies: TRIM8 mutations have been identified in individuals with congenital anomalies, such as heart defects and facial dysmorphism.\n4. Cancer: TRIM8 mutations have been identified in various types of cancer, including breast, ovarian, and colorectal cancer.\n5. Immunodeficiency: TRIM8 mutations have been identified in individuals with primary immunodeficiency disorders, such as X-linked agammaglobulinemia.\n6. Neurodegenerative disorders: TRIM8 mutations have been identified in individuals with neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).\n7. Metabolic disorders: TRIM8 mutations have been identified in individuals with metabolic disorders, such as methylmalonic acidemia and propionic acidemia.\n8. Eye disorders: TRIM8 mutations have been identified in individuals with eye disorders, such as retinitis pigmentosa and Leber congenital amaurosis.\n9. Hearing loss: TRIM8 mutations have been identified in individuals with hearing loss, including profound sensorineural hearing loss.\n10. Cardiovascular disease: TRIM8 mutations have been identified in individuals with cardiovascular disease, including hypertension and atherosclerosis.\nIt is important to note that the full spectrum of conditions associated with TRIM8 mutations is not yet fully understood and may expand as more research is conducted.",
    "llama-2-7b-chat-hf_fact": [
      "TRIM8 mutations have been identified as a cause of intellectual disability.",
      "Some studies have found an increased frequency of TRIM8 mutations in individuals with autism spectrum disorder.",
      "TRIM8 mutations have been identified in individuals with congenital anomalies, such as heart defects and facial dysmorphism.",
      "TRIM8 mutations have been identified in various types of cancer, including breast, ovarian, and colorectal cancer.",
      "TRIM8 mutations have been identified in individuals with primary immunodeficiency disorders, such as X-linked agammaglobulinemia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3758,
    "user_query": "What is LY-CoV555?",
    "llama-2-7b-chat-hf_response": "LY-CoV555 is an investigational antiviral drug being developed by Lyell Immunopharma to treat COVID-19. It is an oral small molecule inhibitor of the SARS-CoV-2 protease, which is an enzyme that plays a crucial role in the replication of the virus. By inhibiting the protease, LY-CoV555 is thought to reduce the ability of the virus to replicate and cause disease.\nLY-CoV555 has been shown to be effective in reducing viral load and improving clinical outcomes in patients with mild to moderate COVID-19 in clinical trials. It has also been shown to be well-tolerated and safe, with the most common adverse events being mild and transient.\nLY-CoV555 is being developed as a potential treatment for COVID-19, both for patients who are hospitalized with severe disease and for those who are not hospitalized but are at high risk of developing severe disease. It is being studied in a number of clinical trials, including a phase 3 trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and a phase 2 trial sponsored by Lyell Immunopharma.\nIt is important to note that LY-CoV555 is still an investigational drug and has not yet been approved by regulatory authorities for the treatment of COVID-19.",
    "llama-2-7b-chat-hf_fact": [
      "LY-CoV555 is an investigational antiviral drug being developed to treat COVID-19.",
      "The pharmaceutical company Lyell Immunopharma is developing LY-CoV555.",
      "The drug LY-CoV555 inhibits the SARS-CoV-2 protease, an enzyme crucial for virus replication.",
      "LY-CoV555 has shown effectiveness in reducing viral load and improving clinical outcomes in patients with mild to moderate COVID-19 based on clinical trials.",
      "A phase 3 trial of LY-CoV555 is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The pharmaceutical company Eli Lilly and Company is developing LY-CoV555.",
      "false, [corrected fact]: The drug LY-CoV555 is a neutralizing antibody designed to bind to the Spike protein of the SARS-CoV-2 virus, not its protease.",
      "true",
      "true"
    ]
  },
  {
    "id": 3760,
    "user_query": "Are bacteria in the genus Clostridium facultative anaerobes?",
    "llama-2-7b-chat-hf_response": "Yes, bacteria in the genus Clostridium are facultative anaerobes. Facultative anaerobes are microorganisms that can grow in the presence or absence of oxygen. While some species of Clostridium are obligate anaerobes, meaning they can only grow in the absence of oxygen, many others are facultative anaerobes and can grow in both aerobic (oxygen-rich) and anaerobic (oxygen-free) environments.\nClostridium species are commonly found in a variety of environments, including soil, water, and the gastrointestinal tracts of animals. They play important roles in decomposing organic matter, producing biogas (a mixture of methane and carbon dioxide), and influencing the structure and function of ecosystems.\nSome examples of facultative anaerobic Clostridium species include:\n1. Clostridium perfringens: This species is commonly found in the gastrointestinal tracts of animals and can cause food poisoning in humans.\n2. Clostridium difficile: This species is also found in the gastrointestinal tracts of animals and can cause diarrhea and other gastrointestinal problems in humans.\n3. Clostridium tetani: This species is found in soil and can cause tetanus in animals and humans.\n4. Clostridium botulinum: This species is found in soil and can cause botulism in animals and humans.\nOverall, the ability of Clostridium species to grow in both aerobic and anaerobic environments makes them important players in a variety of ecosystems.",
    "llama-2-7b-chat-hf_fact": [
      "Bacteria in the genus Clostridium are facultative anaerobes, meaning they can grow in the presence or absence of oxygen.",
      "Clostridium species are found in environments including soil, water, and the gastrointestinal tracts of animals.",
      "Clostridium species play roles in decomposing organic matter, producing biogas, and influencing the structure and function of ecosystems.",
      "Clostridium perfringens can cause food poisoning in humans.",
      "Clostridium botulinum, found in soil, can cause botulism in animals and humans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Bacteria in the genus Clostridium are obligate anaerobes, meaning they can only grow in the absence of oxygen.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-7b-chat-hf_response": "The 100,000 Genomes Project is a large-scale genomics initiative launched in 2015 by the National Health Service (NHS) in the United Kingdom. The project aims to analyze the genomes of 100,000 individuals, including those with rare and aggressive cancers such as sarcoma. Here are some efforts on sarcoma from the 100,000 Genomes Project:\n1. Whole-genome sequencing: The 100,000 Genomes Project is using whole-genome sequencing to identify genetic mutations in sarcoma tumors. This involves analyzing the entire DNA sequence of the tumor to identify mutations that may be driving its growth and progression.\n2. Transcriptome analysis: In addition to whole-genome sequencing, the project is also analyzing the transcriptome of sarcoma tumors. The transcriptome is the set of RNA molecules present in a cell, and analyzing it can provide insights into the genes that are actively being expressed in the tumor.\n3. Epigenetic analysis: Epigenetic modifications, such as DNA methylation and histone modification, can also play a role in the development and progression of sarcoma. The 100,000 Genomes Project is analyzing the epigenetic landscape of sarcoma tumors to identify potential epigenetic targets for therapy.\n4. Integrative analysis: The 100,000 Genomes Project is integrating data from whole-genome sequencing, transcriptome analysis, and epigenetic analysis to gain a comprehensive understanding of the genetic and epigenetic changes that occur in sarcoma. This integrative approach can help identify potential therapeutic targets and improve our understanding of the biology of sarcoma.\n5. Collaboration with clinicians: The 100,000 Genomes Project is working closely with clinicians to ensure that the insights gained from genomic analysis are translated into clinical practice. This collaboration will help identify potential therapeutic targets and improve patient outcomes.\n6. Development of new diagnostic tests: The 100,000 Genom",
    "llama-2-7b-chat-hf_fact": [
      "The 100,000 Genomes Project was initiated by the National Health Service in the United Kingdom in 2015.",
      "The 100,000 Genomes Project aims to analyze the genomes of 100,000 individuals, including those with sarcoma.",
      "As part of its study on sarcoma, the project uses whole-genome sequencing to identify mutations in sarcoma tumors.",
      "The 100,000 Genomes Project is also conducting transcriptome analysis of sarcoma tumors to understand the genes being expressed in the tumor.",
      "The project analyzes the epigenetic landscape of sarcoma tumors to identify potential epigenetic targets for therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3770,
    "user_query": "Describe the mechanism of action of pitolisant.",
    "llama-2-7b-chat-hf_response": "Pitolisant is a drug that acts on the alpha-2 adrenergic receptor. It is used to treat excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. The mechanism of action of pitolisant is not fully understood, but it is believed to work by increasing the activity of certain neurotransmitters in the brain, such as acetylcholine and norepinephrine, which help regulate sleep and wakefulness. Pitolisant may also have a direct effect on the brain's sleep-wake cycle, increasing the amount of time spent in the wakeful state and reducing the amount of time spent in the sleep state. Additionally, pitolisant may help reduce the symptoms of narcolepsy, such as excessive daytime sleepiness, by increasing the amount of time spent in the wakeful state and reducing the amount of time spent in the sleep state.",
    "llama-2-7b-chat-hf_fact": [
      "Pitolisant is a drug that acts on the alpha-2 adrenergic receptor.",
      "Pitolisant is used to treat excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder.",
      "The mechanism of action of pitolisant is believed to increase the activity of certain neurotransmitters in the brain, such as acetylcholine and norepinephrine.",
      "Pitolisant may have a direct effect on the brain's sleep-wake cycle.",
      "Pitolisant may help reduce the symptoms of narcolepsy by altering the amount of time spent in different sleep states."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Pitolisant is a drug that acts on the histamine H3 receptor, not the alpha-2 adrenergic receptor.",
      "true",
      "false, [corrected fact]: The mechanism of action of pitolisant is believed to increase the activity of histamine, not acetylcholine and norepinephrine.",
      "true",
      "true"
    ]
  },
  {
    "id": 3773,
    "user_query": "Do circular exons increase gene expression?",
    "llama-2-7b-chat-hf_response": "Circular exons are a type of exon structure that has gained attention in recent years due to their potential to enhance gene expression. Unlike traditional exons, which have a 5' cap and a 3' tail, circular exons have a continuous loop of coding sequence with no 5' cap or 3' tail. This unique structure allows circular exons to behave differently than traditional exons in terms of splicing and translation.\nStudies have shown that circular exons can increase gene expression in several ways:\n1. Improved splicing efficiency: Circular exons can enhance splicing efficiency by reducing the distance between the splice sites, which can lead to more accurate splicing and increased gene expression.\n2. Enhanced translation: Circular exons can increase translation efficiency by providing a continuous loop of coding sequence that can be translated more quickly and efficiently than traditional exons.\n3. Increased stability: Circular exons can increase gene expression by providing a more stable structure for the mRNA molecule, which can reduce degradation and increase the half-life of the mRNA.\n4. Improved localization: Circular exons can increase gene expression by improving the localization of the mRNA molecule within the cell, which can increase the likelihood of translation and gene expression.\n5. Reduced degradation: Circular exons can reduce degradation of the mRNA molecule by providing a more stable structure, which can increase the half-life of the mRNA and enhance gene expression.\nOverall, circular exons have the potential to increase gene expression by improving splicing efficiency, enhancing translation, increasing stability, improving localization, and reducing degradation. However, more research is needed to fully understand the mechanisms by which circular exons function and their potential applications in gene therapy and gene editing.",
    "llama-2-7b-chat-hf_fact": [
      "Circular exons have a continuous loop of coding sequence with no 5' cap or 3' tail.",
      "Circular exons can enhance splicing efficiency by reducing the distance between the splice sites.",
      "Circular exons can increase translation efficiency by providing a continuous loop of coding sequence that can be translated more quickly and efficiently than traditional exons.",
      "Circular exons can increase gene expression by providing a more stable structure for the mRNA molecule.",
      "Circular exons can improve the localization of the mRNA molecule within the cell."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false, [corrected fact]: Circular RNA, not exons, can increase translation efficiency by providing a continuous loop of coding sequence that can be translated more quickly and efficiently than linear RNAs.",
      "true",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-7b-chat-hf_response": "Protein ALEX1 is a transcriptional regulator that plays a crucial role in the development and progression of various cancers, including breast, lung, and colon cancer. It has been shown to be overexpressed in many types of cancer and has been implicated in the epithelial-to-mesenchymal transition (EMT), a process that is associated with cancer progression and metastasis.\nOne of the structural features of ALEX1 is the presence of armadillo repeats, which are short, repetitive sequences of amino acids that are found in the protein's structure. These repeats are thought to play a role in the protein's ability to interact with DNA and regulate gene expression.\nIn summary, yes, protein ALEX1 does contain armadillo repeats.",
    "llama-2-7b-chat-hf_fact": [
      "Protein ALEX1 is a transcriptional regulator.",
      "ALEX1 plays a crucial role in the development and progression of various cancers, including breast, lung, and colon cancer.",
      "ALEX1 has been shown to be overexpressed in many types of cancer.",
      "ALEX1 plays a role in the epithelial-to-mesenchymal transition (EMT).",
      "Protein ALEX1 contains armadillo repeats."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3782,
    "user_query": "Does radiotherapy for cervical cancer increases risk of colon cancer?",
    "llama-2-7b-chat-hf_response": "Cervical cancer is cancer that develops in the cervix, which is the lower part of the uterus in the female reproductive system. Radiotherapy, also known as radiation therapy, is a common treatment for cervical cancer. However, there is some evidence to suggest that radiotherapy may increase the risk of developing colon cancer.\nOne study published in the Journal of Clinical Oncology found that women who received radiotherapy for cervical cancer had a higher risk of developing colon cancer compared to those who did not receive radiotherapy. The study found that the risk of colon cancer was highest in women who received both radiotherapy and chemotherapy for their cervical cancer.\nAnother study published in the International Journal of Radiation Oncology, Biology, Physics found that the risk of colon cancer was significantly higher in women who received radiotherapy for cervical cancer compared to those who did not receive radiotherapy. The study found that the risk of colon cancer was highest in women who received high doses of radiotherapy.\nIt is important to note that these studies were observational, meaning they looked at data that was already collected rather than conducting a controlled study. As a result, the findings may not be due to the radiotherapy itself, but rather to other factors that were not accounted for in the study.\nThe exact mechanism by which radiotherapy may increase the risk of colon cancer is not fully understood. However, it is thought that the radiation may damage the DNA in the cells of the colon, leading to genetic mutations that can increase the risk of cancer.\nIt is important to note that the overall risk of developing colon cancer after radiotherapy for cervical cancer is still relatively low. According to the American Cancer Society, the risk of developing colon cancer in women who have had cervical cancer is about 1 in 20.\nIf you have had radiotherapy for cervical cancer, it is important to talk to your doctor about your individual risk of developing colon cancer. Your doctor can help you understand your risk and monitor you for any signs of colon cancer.\nIn summary, while there is some evidence to suggest that radiotherapy may increase the risk of colon cancer in women who have had cervical cancer, the overall risk is still relatively low. If you have had radiotherapy for cervical cancer, it is important to",
    "llama-2-7b-chat-hf_fact": [
      "Cervical cancer is a type of cancer that develops in the lower part of the uterus in the female reproductive system.",
      "There's evidence that suggests radiotherapy for cervical cancer could increase the risk of colon cancer.",
      "Studies published in the Journal of Clinical Oncology and the International Journal of Radiation Oncology, Biology, Physics indicate a higher risk of colon cancer in women who had radiotherapy for cervical cancer.",
      "The mechanism by which radiotherapy may increase colon cancer risk relates to potential DNA damage in the cells of the colon, leading to mutations that can increase cancer risk.",
      "The American Cancer Society reports that the risk of developing colon cancer for women who have had cervical cancer is about 1 in 20."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3785,
    "user_query": "Is yeast fbp1 affected by glucose starvation stress?",
    "llama-2-7b-chat-hf_response": "Yeast Fbp1 is a protein that plays a crucial role in the regulation of protein synthesis and degradation in yeast. It is a member of the F-box protein family and is involved in the ubiquitination and degradation of target proteins. Yeast Fbp1 has been shown to be affected by glucose starvation stress, which can lead to changes in protein synthesis and degradation.\nGlucose starvation stress can activate the unfolded protein response (UPR) pathway in yeast, which can lead to changes in protein synthesis and degradation. The UPR pathway is a cellular response to stress that helps to maintain protein homeostasis in the cell. When yeast cells are exposed to glucose starvation stress, the UPR pathway is activated, leading to changes in protein synthesis and degradation.\nFbp1 is a key regulator of protein synthesis and degradation in yeast, and it has been shown to be involved in the UPR pathway. When yeast cells are exposed to glucose starvation stress, Fbp1 is activated and plays a role in the regulation of protein synthesis and degradation.\nStudies have shown that glucose starvation stress can lead to changes in the localization and activity of Fbp1 in yeast. For example, one study found that glucose starvation stress can cause Fbp1 to be relocalized from the cytoplasm to the nucleus, where it can interact with other proteins involved in the UPR pathway. Another study found that glucose starvation stress can increase the activity of Fbp1, leading to changes in protein synthesis and degradation.\nOverall, yeast Fbp1 is affected by glucose starvation stress, and it plays a key role in the regulation of protein synthesis and degradation in response to this stress. Understanding the mechanisms by which Fbp1 is involved in the UPR pathway can provide insights into the development of new therapeutic strategies for the treatment of diseases caused by protein misfolding and aggregation.",
    "llama-2-7b-chat-hf_fact": [
      "Yeast Fbp1 is a protein that plays a role in the regulation of protein synthesis and degradation in yeast.",
      "Fbp1 is a member of the F-box protein family and is involved in the ubiquitination and degradation of target proteins.",
      "Yeast Fbp1 is affected by glucose starvation stress.",
      "Glucose starvation stress can activate the unfolded protein response (UPR) pathway in yeast.",
      "Glucose starvation stress can lead to changes in the localization and activity of Fbp1 in yeast."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3786,
    "user_query": "What does csDMARD stand for?",
    "llama-2-7b-chat-hf_response": "CsDMARD stands for:\nCsDMARD stands for \"Clinical Disease Modifying Anti-Rheumatic Drug\". It is a term used to describe a class of drugs that are used to treat rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. These drugs are designed to slow or stop the progression of the disease, and can help to reduce symptoms and improve quality of life.",
    "llama-2-7b-chat-hf_fact": [
      "CsDMARD stands for \"Clinical Disease Modifying Anti-Rheumatic Drug\".",
      "CsDMARDs are used to treat rheumatic diseases.",
      "Rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis are types of rheumatic diseases treatable with CsDMARD.",
      "CsDMARDs are designed to slow or stop the disease progression.",
      "CsDMARDs can help reduce symptoms and improve quality of life for patients with rheumatic diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: CsDMARD stands for \"Conventional Synthetic Disease Modifying Anti-Rheumatic Drug\".",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3788,
    "user_query": "Is Semagacestat effective for Alzheimer's Disease?",
    "llama-2-7b-chat-hf_response": "Semagacestat is an experimental drug that has shown promise in slowing down the progression of Alzheimer's disease. It works by inhibiting the activity of an enzyme called acetyl-CoA carboxylase (ACC), which is involved in the production of beta-amyloid, a protein that accumulates in the brains of people with Alzheimer's disease and contributes to the progression of the disease.\nStudies have shown that semagacestat can reduce the levels of beta-amyloid in the brain and improve cognitive function in people with mild to moderate Alzheimer's disease. However, it is important to note that semagacestat has not yet been approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer's disease, and more research is needed to determine its long-term safety and effectiveness.\nSome of the potential benefits of semagacestat for Alzheimer's disease include:\n1. Reduced beta-amyloid levels: Semagacestat has been shown to reduce the levels of beta-amyloid in the brain, which is a hallmark of Alzheimer's disease.\n2. Improved cognitive function: Semagacestat has been shown to improve cognitive function in people with mild to moderate Alzheimer's disease.\n3. Potential to slow down disease progression: By reducing beta-amyloid levels and improving cognitive function, semagacestat may have the potential to slow down the progression of Alzheimer's disease.\nHowever, there are also potential risks and side effects associated with semagacestat, including:\n1. Increased risk of seizures: Semagacestat has been shown to increase the risk of seizures in some people, particularly those with a history of seizure disorders.\n2. Nausea and vomiting: Semagacestat can cause nausea and vomiting in some people.\n3. Headache: Semagacestat can cause headaches in some people.\n4. Dizziness and drowsiness: Semagacestat can cause dizziness and drowsiness in some people.\nIt is important to note that semagacest",
    "llama-2-7b-chat-hf_fact": [
      "Semagacestat is an experimental drug that has shown promise for slowing down the progression of Alzheimer's disease.",
      "Semagacestat works by inhibiting the activity of an enzyme called acetyl-CoA carboxylase (ACC), which is involved in the production of beta-amyloid.",
      "Beta-amyloid is a protein that accumulates in the brains of people with Alzheimer's disease and contributes to the progression of the disease.",
      "Studies have shown that semagacestat can reduce the levels of beta-amyloid in the brain.",
      "Semagacestat has not yet been approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer's disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Semagacestat works by inhibiting the activity of an enzyme called gamma-secretase, which is involved in the production of beta-amyloid.",
      "true",
      "false, [corrected fact]: Studies have shown that semagacestat failed in reducing the levels of beta-amyloid in the brain, and further, it worsened the cognitive ability of Alzheimer's patients.",
      "true"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-7b-chat-hf_response": "Enzymes that remove histone modifications include:\n1. Histone demethylases: These enzymes remove methyl groups from histone proteins, leading to changes in gene expression.\n2. Histone acetyltransferases: These enzymes add acetyl groups to histone proteins, leading to changes in gene expression.\n3. Histone deacetylases: These enzymes remove acetyl groups from histone proteins, leading to changes in gene expression.\n4. Histone ubiquitin ligases: These enzymes remove histone proteins from chromatin, leading to changes in gene expression.\n5. Histone-lysine N-methyltransferases: These enzymes methylate lysine residues on histone proteins, leading to changes in gene expression.\n6. Histone-arginine methyltransferases: These enzymes methylate arginine residues on histone proteins, leading to changes in gene expression.\n7. Histone-glycine N-methyltransferases: These enzymes methylate glycine residues on histone proteins, leading to changes in gene expression.\n8. Histone-proline N-methyltransferases: These enzymes methylate proline residues on histone proteins, leading to changes in gene expression.\n9. Histone-glutamine N-methyltransferases: These enzymes methylate glutamine residues on histone proteins, leading to changes in gene expression.\n10. Histone-asparagine N-methyltransferases: These enzymes methylate asparagine residues on histone proteins, leading to changes in gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "Histone demethylases are enzymes that remove methyl groups from histone proteins.",
      "Histone acetyltransferases add acetyl groups to histone proteins.",
      "Histone deacetylases remove acetyl groups from histone proteins.",
      "Histone ubiquitin ligases remove histone proteins from chromatin.",
      "Histone-lysine N-methyltransferases methylate lysine residues on histone proteins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Histone ubiquitin ligases add ubiquitin molecules to histone proteins; they do not remove histone proteins from chromatin.",
      "true"
    ]
  },
  {
    "id": 3790,
    "user_query": "Roughly how many base pairs are in the human mitochondrial genome or mtDNA?",
    "llama-2-7b-chat-hf_response": "The human mitochondrial genome, also known as mtDNA, contains approximately 16,569 base pairs.",
    "llama-2-7b-chat-hf_fact": [
      "The human mitochondrial genome is also known as mtDNA.",
      "The human mitochondrial genome contains approximately 16,569 base pairs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3791,
    "user_query": "Do nematodes contain a CTCF gene?",
    "llama-2-7b-chat-hf_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in regulating gene expression and chromatin organization. CTCF is known to be present in various organisms, including animals, plants, and fungi. However, there is limited information available on the presence of CTCF in nematodes, which are a group of microscopic worms that include parasitic and free-living species.\nRecent studies have shown that nematodes do contain a CTCF gene, which is highly conserved across different species. The CTCF gene in nematodes is similar in structure and function to the CTCF gene found in other organisms, and it plays a crucial role in regulating gene expression and chromatin organization.\nOne study published in the journal Nature Communications in 2017 reported the identification of a CTCF gene in the parasitic nematode Caenorhabditis elegans. The study found that the CTCF gene in C. elegans is highly conserved with its counterparts in other organisms and plays a crucial role in regulating gene expression and chromatin organization in the parasite.\nAnother study published in the journal PLOS ONE in 2018 reported the identification of a CTCF gene in the free-living nematode Pristionchus pacificus. The study found that the CTCF gene in P. pacificus is also highly conserved with its counterparts in other organisms and plays a crucial role in regulating gene expression and chromatin organization in the nematode.\nOverall, these studies suggest that nematodes do contain a CTCF gene, which is highly conserved across different species and plays a crucial role in regulating gene expression and chromatin organization in these microscopic worms.",
    "llama-2-7b-chat-hf_fact": [
      "CTCF is a transcription factor that regulates gene expression and chromatin organization.",
      "The CTCF gene is present in various organisms, including animals, plants, and fungi.",
      "Current research evidences the presence of a CTCF gene in nematodes, a group of microscopic worms.",
      "A 2017 study in Nature Communications identified a CTCF gene in the parasitic nematode Caenorhabditis elegans.",
      "A 2018 study in PLOS ONE identified a CTCF gene in the free-living nematode Pristionchus pacificus."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3796,
    "user_query": "What does Retapamulin treat?",
    "llama-2-7b-chat-hf_response": "Retapamulin is an antibiotic that is used to treat bacterial infections, including:\n1. Community-acquired pneumonia (CAP): Retapamulin is used to treat mild to moderate CAP caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.\n2. Acute bacterial sinusitis: Retapamulin is used to treat acute bacterial sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.\n3. Otitis media: Retapamulin is used to treat acute otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.\n4. Bronchitis: Retapamulin is used to treat acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.\n5. Skin and skin structure infections: Retapamulin is used to treat mild to moderate skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes.\nIt is important to note that retapamulin is not effective against viral infections, and it is not recommended for use in children under 6 months of age.",
    "llama-2-7b-chat-hf_fact": [
      "Retapamulin is an antibiotic that is used to treat bacterial infections.",
      "Retapamulin is used to treat community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.",
      "It is also used in the treatment of acute bacterial sinusitis caused by similar bacteria.",
      "Retapamulin can be used to treat skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes.",
      "Retapamulin is not recommended for use in children under 6 months of age."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Retapamulin is not typically used to treat community-acquired pneumonia. It is mostly used for skin infections.",
      "false, [corrected fact]: Retapamulin is not typically used in the treatment of acute bacterial sinusitis. It is used to treat skin infections.",
      "true",
      "true"
    ]
  },
  {
    "id": 3797,
    "user_query": "Which histone mark distinguishes active from inactive enhancers?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-acting DNA elements that can increase the recruitment of RNA polymerase II (RNAPII) and other transcription factors to specific gene promoters, leading to increased gene expression. Enhancers can be located far away from their target genes, and their activity can be influenced by various epigenetic marks, including histone modifications.\nOne of the most well-known histone marks associated with enhancer activity is histone 3 lysine 4 trimethylation (H3K4me3). H3K4me3 is known to be enriched at active enhancers and is thought to play a role in recruiting RNAPII and other transcription factors to the promoter region. However, not all active enhancers are marked with H3K4me3, and some inactive enhancers can also be H3K4me3-positive.\nAnother histone mark that has been implicated in enhancer function is histone 3 lysine 27 trimethylation (H3K27me3). H3K27me3 is known to be enriched at inactive enhancers and is thought to play a role in repressing enhancer activity by blocking the recruitment of RNAPII and other transcription factors.\nOther histone marks, such as histone 3 lysine 9 trimethylation (H3K9me3) and histone 4 lysine 20 trimethylation (H4K20me3), have also been implicated in enhancer function, although the exact role of these marks is not yet fully understood.\nIn summary, while H3K4me3 is a well-established mark of active enhancers, other histone marks, such as H3K27me3, H3K9me3, and H4K20me3, can also play a role in distinguishing active from inactive enhancers.",
    "llama-2-7b-chat-hf_fact": [
      "Enhancers are cis-acting DNA elements that can increase the recruitment of RNA polymerase II and other transcription factors to specific gene promoters.",
      "Histone 3 lysine 4 trimethylation (H3K4me3) is a histone mark associated with enhancer activity and is known to be enriched at active enhancers.",
      "Not all active enhancers are marked with H3K4me3, and some inactive enhancers can also be H3K4me3-positive.",
      "Histone 3 lysine 27 trimethylation (H3K27me3) is a histone mark that is known to be enriched at inactive enhancers and it is thought to play a role in repressing enhancer activity.",
      "Other histone marks, such as histone 3 lysine 9 trimethylation (H3K9me3) and histone 4 lysine 20 trimethylation (H4K20me3), have also been implicated in enhancer function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Histone 3 lysine 4 trimethylation (H3K4me3) is a histone mark associated with promoter activity, not enhancer activity.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3800,
    "user_query": "What is targeted by Pexidartinib?",
    "llama-2-7b-chat-hf_response": "Pexidartinib is a drug that targets the enzyme CSF1R (colony-stimulating factor 1 receptor), which is involved in the growth and survival of myeloid-derived suppressor cells (MDSCs) and other immune cells. MDSCs are a type of immune cell that can suppress the activity of other immune cells, such as T cells and natural killer cells, and promote tumor growth and progression. By inhibiting the activity of CSF1R, pexidartinib can reduce the number of MDSCs in the tumor microenvironment and enhance the activity of anti-tumor immune cells.\nPexidartinib is being developed as a potential treatment for various types of cancer, including breast, lung, and gastrointestinal cancers, as well as multiple myeloma. It is typically administered orally and has been shown to be well-tolerated in clinical trials, with common side effects including diarrhea, nausea, and fatigue.",
    "llama-2-7b-chat-hf_fact": [
      "Pexidartinib is a drug that targets the enzyme CSF1R (colony-stimulating factor 1 receptor).",
      "CSF1R is involved in the growth and survival of myeloid-derived suppressor cells (MDSCs) and other immune cells.",
      "MDSCs can suppress the activity of other immune cells, such as T cells and natural killer cells, and promote tumor growth and progression.",
      "Pexidartinib is being developed as a potential treatment for various types of cancer, including breast, lung, and gastrointestinal cancers, as well as multiple myeloma.",
      "The drug is typically administered orally and common side effects include diarrhea, nausea, and fatigue."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-7b-chat-hf_response": "Head CT scans are commonly used to diagnose and monitor various conditions, including brain tumors. However, there is some concern that repeated exposure to CT radiation may increase the risk of developing a brain tumor.",
    "llama-2-7b-chat-hf_fact": [
      "Head CT scans are used to diagnose and monitor various conditions, including brain tumors.",
      "Repeated exposure to CT radiation may increase the risk of developing a brain tumor."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3807,
    "user_query": "Which main viral protein is targeted by the drug remdesivir?",
    "llama-2-7b-chat-hf_response": "Remdesivir is a drug that has been shown to be effective in treating COVID-19. It works by targeting the main viral protein, which is:\nA) Spike protein\nB) Envelope protein\nC) Nucleocapsid protein\nD) Matrix protein\nThe correct answer is (A) Spike protein. Remdesivir targets the spike protein of SARS-CoV-2, which is responsible for binding to and entering host cells. By inhibiting the spike protein, remdesivir prevents the virus from infecting cells and spreading in the body.",
    "llama-2-7b-chat-hf_fact": [
      "Remdesivir is a drug used to treat COVID-19.",
      "Remdesivir targets the spike protein of SARS-CoV-2.",
      "The spike protein of SARS-CoV-2 is responsible for binding to and entering host cells.",
      "By inhibiting the spike protein, remdesivir prevents the virus from infecting cells and spreading in the body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Remdesivir targets the RNA polymerase of SARS-CoV-2, not the spike protein.",
      "true",
      "false, [corrected fact]: By inhibiting the RNA polymerase, remdesivir prevents the virus from replicating within cells."
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-7b-chat-hf_response": "Otx2 is associated with neural pluripotency.",
    "llama-2-7b-chat-hf_fact": [
      "Otx2 is associated with neural pluripotency."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3813,
    "user_query": "Is aggrephagy a variant of autophagy?",
    "llama-2-7b-chat-hf_response": "Aggrephagy is a process by which cells engulf and degrade extracellular matrix (ECM) components, such as collagen, fibronectin, and laminin. While aggrephagy shares some similarities with autophagy, the two processes are distinct and have different mechanisms and functions.\nAutophagy is a catabolic process that involves the degradation of cellular components, such as proteins and organelles, by the lysosome. Autophagy is an important mechanism for maintaining cellular homeostasis and responding to stress, and it has been implicated in a variety of diseases, including cancer and neurodegeneration.\nAggrephagy, on the other hand, is a process that is specifically focused on the degradation of ECM components. ECM components are important for maintaining tissue structure and function, and alterations in ECM composition can contribute to a variety of diseases, including fibrosis and cancer. Aggrephagy is thought to play a role in maintaining tissue homeostasis by removing excess or damaged ECM components and promoting tissue remodeling.\nWhile aggrephagy shares some similarities with autophagy, such as the involvement of the lysosome and the degradation of cellular components, there are several key differences between the two processes. For example, aggrephagy is specifically focused on the degradation of ECM components, whereas autophagy can degrade a wide range of cellular components. Additionally, aggrephagy is thought to be more highly regulated than autophagy, with specific signaling pathways and molecular mechanisms controlling its initiation and progression.\nIn summary, while aggrephagy shares some similarities with autophagy, it is a distinct process that is specifically focused on the degradation of ECM components and has different mechanisms and functions.",
    "llama-2-7b-chat-hf_fact": [
      "Aggrephagy and autophagy are distinct processes with different mechanisms and functions.",
      "Autophagy is a catabolic process that involves the degradation of cellular components by the lysosome.",
      "Autophagy plays crucial role in maintaining cellular homeostasis and responding to stress.",
      "Aggrephagy is a process that focuses on the degradation of extracellular matrix (ECM) components.",
      "Alterations in ECM composition can contribute to various diseases including fibrosis and cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Aggrephagy is a selective type of autophagy that focuses on the degradation of protein aggregates, not extracellular matrix (ECM) components.",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-7b-chat-hf_response": "The number of DNaseI hypersensitive sites (DHS) marking the murine beta globin locus region can vary depending on the specific cell type and experimental conditions. However, in general, there are several DHS sites scattered throughout the beta globin locus region.\nAccording to a study published in the journal Genomics, there are approximately 30-40 DHS sites located along the beta globin locus in mouse cells (1). Another study published in the journal Nucleic Acids Research found that there are around 20-30 DHS sites in the beta globin locus region of mouse cells (2).\nIt's worth noting that the number of DHS sites can vary depending on the specific cell type and experimental conditions. For example, some studies have found that there are more DHS sites in certain cell types, such as embryonic stem cells or hematopoietic cells, compared to other cell types (3, 4). Additionally, the number of DHS sites can change depending on the experimental conditions, such as the presence of certain transcription factors or the level of DNA methylation (5, 6).\nIn summary, the number of DHS sites marking the murine beta globin locus region can vary depending on the specific cell type and experimental conditions, but there are generally around 30-40 DHS sites located along the beta globin locus in mouse cells.\nReferences:\n1. Kim, J. et al. (2013). Genome-wide mapping of DNase I hypersensitive sites in mouse cells. Genomics, 10.1016/j.ygeno.2013.07.004.\n2. Zhang, Y. et al. (2015). Genome-wide mapping of DNase I hypersensitive sites in mouse embryonic stem cells. Nucleic Acids Research, 43(19), 8343-8357.\n3. Liu, T. et al. (2013). Genome-wide mapping of DNase I hypersensitive sites in human cells. Nucleic Acids Research, 41(19), 8343-8357.",
    "llama-2-7b-chat-hf_fact": [
      "DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region.",
      "The number of DHS sites in the murine beta globin locus region can range from 20 to 40, depending on the specific cell type and experimental conditions.",
      "Kim, J. et al. published a 2013 study in the journal \"Genomics\" documenting approximately 30-40 DHS sites in the beta globin locus of mouse cells.",
      "Zhang, Y. et al. published a 2015 study in \"Nucleic Acids Research\" estimating around 20-30 DHS sites in the same region of mouse cells.",
      "Some studies have found that there are more DHS sites in certain cell types, such as embryonic stem cells or hematopoietic cells, compared to other cell types."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3817,
    "user_query": "Which loss-of-function ABCC8 mutation is associated with Pulmonary Arterial Hypertension (PAH)?",
    "llama-2-7b-chat-hf_response": "Answer: The ABCC8 mutation associated with Pulmonary Arterial Hypertension (PAH) is the R102H mutation.\nThe ABCC8 gene encodes the solute carrier family 12 member 1 (SLC12A1) protein, which is a member of the ATP-binding cassette (ABC) transporter superfamily. The R102H mutation is a missense mutation that results in the substitution of histidine for arginine at position 102 in the ABCC8 protein. This mutation has been identified in several studies as a risk factor for the development of PAH, particularly in individuals with a family history of the disease. The R102H mutation is thought to disrupt the normal function of the ABCC8 protein, leading to impaired pulmonary vascular tone and vascular remodeling, which are hallmarks of PAH.",
    "llama-2-7b-chat-hf_fact": [
      "The ABCC8 mutation associated with Pulmonary Arterial Hypertension is the R102H mutation.",
      "The ABCC8 gene encodes the solute carrier family 12 member 1 (SLC12A1) protein.",
      "The R102H mutation results in the substitution of histidine for arginine at position 102 in the ABCC8 protein.",
      "The R102H mutation has been identified as a risk factor for the development of PAH, especially in individuals with a family history of the disease.",
      "The R102H mutation disrupts the normal function of the ABCC8 protein, leading to impaired pulmonary vascular tone and vascular remodeling, which are hallmarks of PAH."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false, [corrected fact]: The ABCC8 gene encodes the sulfonylurea receptor 1 (SUR1) protein.",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3819,
    "user_query": "List the core SNARE complex proteins.",
    "llama-2-7b-chat-hf_response": "The core SNARE complex proteins are:\n1. Vesicle-associated membrane protein 2 (VAMP2)\n2. Vesicle-associated membrane protein 8 (VAMP8)\n3. Synaptosomal-associated protein 10 (SNAP10)\n4. Synaptosomal-associated protein 25 (SNAP25)\n5. Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)\nThese proteins work together to mediate the fusion of vesicles with the plasma membrane during exocytosis.",
    "llama-2-7b-chat-hf_fact": [
      "Vesicle-associated membrane protein 2 (VAMP2) is a core SNARE complex protein.",
      "Vesicle-associated membrane protein 8 (VAMP8) is also a core SNARE complex protein.",
      "Synaptosomal-associated protein 10 (SNAP10) is part of the core SNARE complex proteins.",
      "Synaptosomal-associated protein 25 (SNAP25) is a core SNARE complex protein.",
      "Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) is a core SNARE complex protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Synaptosomal-associated protein 10 (SNAP10) is not part of the core SNARE complex proteins.",
      "true",
      "false, [corrected fact]: Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) is not a core SNARE complex protein, but a type of protein that the SNARE complex proteins (like VAMP2, VAMP8, etc.) belong to."
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-7b-chat-hf_response": "Influenza, commonly known as the flu, is a contagious respiratory illness caused by the influenza virus. The virus infects the nose, throat, and lungs, causing symptoms such as fever, cough, sore throat, runny or stuffy nose, body aches, headache, and fatigue. Influenza is a serious disease that can lead to complications such as pneumonia, bronchitis, and sinus and ear infections, which can be life-threatening, especially in high-risk groups such as older adults, young children, pregnant women, and people with certain health conditions.\nThere are several types of influenza vaccines available in Europe, including:\n1. Trivalent influenza vaccine (TIV): This vaccine protects against three strains of the influenza virus: two A strains and one B strain.\n2. Quadrivalent influenza vaccine (QIV): This vaccine protects against four strains of the influenza virus: two A strains and two B strains.\n3. Cell-based influenza vaccine: This vaccine is made using animal cells rather than chicken eggs, which is the traditional method of producing influenza vaccines.\n4. Recombinant influenza vaccine: This vaccine is made using genetic engineering techniques to produce a protein that stimulates an immune response to the influenza virus.\n5. Adjuvanted influenza vaccine: This vaccine contains an adjuvant, which is a substance that helps to stimulate an immune response to the vaccine.\n6. High-dose influenza vaccine: This vaccine contains four times the amount of antigen as a standard dose vaccine, which may provide better protection against the influenza virus for older adults.\n7. Live, attenuated influenza vaccine: This vaccine contains a weakened form of the influenza virus, which can cause a mild infection in the body and stimulate an immune response.\n8. Intranasal influenza vaccine: This vaccine is administered through the nose, rather than by injection, and can provide protection against the influenza virus.",
    "llama-2-7b-chat-hf_fact": [
      "The Trivalent influenza vaccine (TIV) protects against three strains of the influenza virus: two A strains and one B strain.",
      "The Quadrivalent influenza vaccine (QIV) protects against four strains of the influenza virus: two A strains and two B strains.",
      "A Cell-based influenza vaccine is produced using animal cells rather than the conventional chicken eggs method.",
      "The Recombinant influenza vaccine is made utilizing genetic engineering to generate a protein that initiates an immune response to the influenza virus.",
      "The Intranasal influenza vaccine is administered via the nose rather than an injection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3823,
    "user_query": "What is canSAR?",
    "llama-2-7b-chat-hf_response": "canSAR is a software tool for processing and analyzing SAR (Synthetic Aperture Radar) data. SAR is a powerful remote sensing technique that uses radar waves to gather information about the surface of the Earth, even in adverse weather conditions. canSAR is designed to be user-friendly and accessible, making it easier for researchers and practitioners to work with SAR data.\nSome of the key features of canSAR include:\n1. Data processing: canSAR can process SAR data from a variety of sources, including airborne and spaceborne sensors. It can perform a range of processing tasks, including speckle filtering, coherence analysis, and interferometric processing.\n2. Data visualization: canSAR includes a range of tools for visualizing SAR data, including 2D and 3D visualization, and the ability to overlay different types of data.\n3. Feature extraction: canSAR includes a range of tools for extracting features from SAR data, including the ability to detect and classify different types of features, such as buildings, roads, and vegetation.\n4. Change detection: canSAR can be used to detect changes between different SAR datasets, allowing users to monitor changes over time.\n5. Data fusion: canSAR can fuse SAR data with other types of data, such as optical or LiDAR data, to create more comprehensive and accurate maps.\ncanSAR is widely used in a variety of applications, including:\n1. Land cover classification: canSAR can be used to classify different types of land cover, such as forests, grasslands, and urban areas.\n2. Crop monitoring: canSAR can be used to monitor crop health and growth, and to detect crop stress.\n3. Disaster response: canSAR can be used to assess damage after natural disasters, such as floods, hurricanes, and earthquakes.\n4. Environmental monitoring: canSAR can be used to monitor environmental changes, such as deforestation, soil moisture, and ocean currents.\n5. Infrastructure planning: canSAR can be used to map and monitor infrastructure, such as roads, bridges, and buildings.\nOverall, canSAR is a powerful tool for working with",
    "llama-2-7b-chat-hf_fact": [
      "canSAR is a software tool for processing and analyzing Synthetic Aperture Radar (SAR) data.",
      "Synthetic Aperture Radar (SAR) is a remote sensing technique that uses radar waves to gather information about the Earth's surface.",
      "canSAR can process SAR data from various sources and perform processing tasks such as speckle filtering, coherence analysis, and interferometric processing.",
      "canSAR includes tools for visualizing SAR data, including 2D and 3D visualization.",
      "canSAR has applications in land cover classification, crop monitoring, disaster response, environmental monitoring, and infrastructure planning."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: canSAR is not a software for processing and analyzing Synthetic Aperture Radar (SAR) data. It is an integrated knowledge-based system in support of cancer translational research and drug discovery.",
      "true",
      "false, [corrected fact]: canSAR does not process SAR data. It provides data and analytical tools to aid cancer research.",
      "false, [corrected fact]: canSAR does not include tools for visualizing SAR data as it primarily supports cancer translational research and drug discovery.",
      "false, [corrected fact]: canSAR does not have applications in land cover classification, crop monitoring, disaster response, environmental monitoring, and infrastructure planning. Its primary usage is in cancer research and drug discovery."
    ]
  },
  {
    "id": 3824,
    "user_query": "What is the mechanism of action of magrolimab?",
    "llama-2-7b-chat-hf_response": "Magrolimab is an investigational drug being studied for the treatment of COVID-19. It works by targeting the SARS-CoV-2 virus and preventing it from entering host cells. Specifically, magrolimab binds to the spike protein of the virus, which is responsible for attaching to and entering host cells. By blocking the spike protein, magrolimab prevents the virus from entering host cells and replicating, which can help to reduce the severity of COVID-19 symptoms.\nMagrolimab is being studied in clinical trials as a potential treatment for COVID-19, and early results suggest that it may be effective in reducing the severity of symptoms and improving outcomes for patients with mild to moderate COVID-19. However, more research is needed to fully understand the mechanism of action of magrolimab and to determine its safety and efficacy as a treatment for COVID-19.",
    "llama-2-7b-chat-hf_fact": [
      "Magrolimab is an investigational drug being studied for the treatment of COVID-19.",
      "Magrolimab works by targeting the SARS-CoV-2 virus and preventing it from entering host cells.",
      "It binds to the spike protein of the SARS-CoV-2 virus, which attaches to and enters host cells.",
      "Blocking the spike protein with magrolimab prevents the virus from entering host cells and replicating.",
      "Early results from clinical trials suggest that magrolimab may be effective in reducing the severity of symptoms and improving outcomes for patients with mild to moderate COVID-19."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3830,
    "user_query": "Should tirilazad be used for treatment of ischemic stroke?",
    "llama-2-7b-chat-hf_response": "Tirilazad is a drug that has been shown to have neuroprotective effects in preclinical studies, and it is being investigated as a potential treatment for ischemic stroke. Ischemic stroke occurs when a blood vessel in the brain becomes blocked, leading to a lack of oxygen and nutrients to the brain tissue. This can result in brain cell death and long-term disability.\nTirilazad works by inhibiting the activity of an enzyme called caspase-3, which is involved in the process of programmed cell death (apoptosis). By inhibiting caspase-3, tirilazad can help to protect brain cells from damage caused by ischemic stroke.\nThere have been several clinical trials conducted to evaluate the safety and efficacy of tirilazad for the treatment of ischemic stroke. These trials have shown that tirilazad can improve functional outcomes in patients with acute ischemic stroke, including those who receive treatment within 4.5 hours of the onset of stroke symptoms.\nHowever, it is important to note that tirilazad is not a cure for ischemic stroke, and it is not a substitute for standard treatments such as tissue plasminogen activator (tPA) or endovascular thrombectomy. These treatments are most effective when started promptly after the onset of stroke symptoms, and they can help to restore blood flow to the affected area of the brain.\nIn summary, tirilazad is a promising drug that is being investigated as a potential treatment for ischemic stroke. While it has shown promise in clinical trials, it is not a substitute for standard treatments and should only be used under the guidance of a healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "Tirilazad is a drug that has been shown to have neuroprotective effects.",
      "Ischemic stroke occurs when a blood vessel in the brain becomes blocked, leading to a lack of oxygen and nutrients to the brain tissue.",
      "Tirilazad works by inhibiting the activity of an enzyme called caspase-3.",
      "Clinical trials have shown that tirilazad can improve functional outcomes in patients with acute ischemic stroke, including those who receive treatment within 4.5 hours of the onset of stroke symptoms.",
      "Tissue plasminogen activator (tPA) and endovascular thrombectomy are standard treatments for ischemic stroke."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3831,
    "user_query": "List the major families of Histones.",
    "llama-2-7b-chat-hf_response": "1. Histone H1\n2. Histone H2A\n3. Histone H2B\n4. Histone H3\n5. Histone H4\n6. Histone H5\n7. Histone H6\n8. Histone H7\n9. Histone H8\n10. Histone H9\n11. Histone H10\n12. Histone H11\n13. Histone H12\n14. Histone H13\n15. Histone H14\n16. Histone H15\n17. Histone H16\n18. Histone H17\n19. Histone H18\n20. Histone H19",
    "llama-2-7b-chat-hf_fact": [
      "Histone H1 is a family of histones.",
      "Histone H2A is a family of histones.",
      "Histone H2B is a family of histones.",
      "Histone H3 is a family of histones.",
      "Histone H4 is a family of histones."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-7b-chat-hf_response": "Yes, the Paramyxovirus geneome is segmented, negative-sense RNA. Paramyxoviruses are a family of viruses that include the measles virus, mumps virus, and Nipah virus, among others. These viruses have a single-stranded, negative-sense RNA genome that is segmented into several smaller segments, each of which encodes a different protein. The segments are named according to their position in the genome, with the largest segment (called the L segment) encoding the viral RNA-dependent RNA polymerase and the smallest segment (called the U segment) encoding a small non-structural protein.\nThe negative-sense RNA genome of Paramyxoviruses is complementary to the messenger RNA (mRNA) transcripts that are produced from the genome during transcription. This means that the RNA sequence of the genome is the reverse of the sequence of the mRNA transcripts. The negative-sense RNA genome is then used as a template for the synthesis of new mRNA transcripts, which are then translated into proteins.\nThe segmented nature of the Paramyxovirus genome is thought to provide a mechanism for the virus to regulate the expression of its genes in response to changes in its environment. By controlling the expression of different segments of the genome, the virus can produce different proteins and respond to different stimuli, allowing it to adapt to different situations and evade the host immune system.",
    "llama-2-7b-chat-hf_fact": [
      "The Paramyxovirus geneome is a segmented, negative-sense RNA.",
      "The Paramyxoviruses family includes the measles virus, mumps virus, and Nipah virus, among others.",
      "Each segment of the Paramyxoviruses genome encodes a different protein.",
      "The largest segment of the Paramyxovirus genome, the L segment, encodes the viral RNA-dependent RNA polymerase.",
      "The smallest segment of the Paramyxovirus genome, the U segment, encodes a small non-structural protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Paramyxovirus genome is non-segmented, negative-sense RNA.",
      "true",
      "false, [corrected fact]: The Paramyxovirus genome is not segmented, so it does not have different sections encoding for different proteins.",
      "true",
      "false, [corrected fact]: Since the Paramyxovirus genome is non-segmented, it does not have a smallest \"U segment\"."
    ]
  },
  {
    "id": 3835,
    "user_query": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?",
    "llama-2-7b-chat-hf_response": "Kabuki syndrome type 1 (KS1) is a rare genetic disorder that affects approximately 1 in 40,000 to 1 in 100,000 individuals worldwide. The disorder is caused by mutations in the KMT2D gene, which encodes a protein involved in the regulation of gene expression.\nExons 38 and 39 of the KMT2D gene are particularly important for the function of the protein, and mutations in these regions have been identified as a common cause of KS1. Missense variants, which are point mutations that result in a change in the amino acid sequence of the protein, have been identified in exons 38 and 39 of the KMT2D gene in individuals with KS1.\nIt is important to note that not all missense variants in exons 38 and 39 of the KMT2D gene will cause KS1, and the severity of the disorder can vary depending on the specific mutation and the individual affected. However, mutations in these regions are a common cause of KS1 and are often associated with more severe symptoms.\nDiagnosis of KS1 typically involves a combination of clinical evaluation, genetic testing, and imaging studies. Genetic testing can identify mutations in the KMT2D gene, including missense variants in exons 38 and 39, and can help confirm the diagnosis of KS1.\nTreatment for KS1 is focused on managing the symptoms and can include a variety of therapies, such as speech and language therapy, occupational therapy, and physical therapy. In some cases, medications may also be prescribed to help manage symptoms.\nIn summary, missense variants in exons 38 and 39 of the KMT2D gene are a common cause of Kabuki syndrome type 1 (KS1), a rare genetic disorder that affects approximately 1 in 40,000 to 1 in 100,000 individuals worldwide. While not all missense variants in these regions will cause KS1, mutations in these areas are a common cause of the disorder and are often associated with more severe symptoms. Genetic testing can help confirm the diagnosis of",
    "llama-2-7b-chat-hf_fact": [
      "Kabuki syndrome type 1 (KS1) is a rare genetic disorder that affects approximately 1 in 40,000 to 1 in 100,000 individuals worldwide.",
      "Mutations in the KMT2D gene, specifically in exons 38 and 39, are a common cause of KS1.",
      "Not all missense variants in exons 38 and 39 of the KMT2D gene will cause KS1, and the severity of the disorder can vary depending on the specific mutation and the individual affected.",
      "Diagnosis of KS1 typically involves a combination of clinical evaluation, genetic testing, and imaging studies.",
      "The treatment for KS1 is symptom-management-focused and can include therapies such as speech and language therapy, occupational therapy, and physical therapy. In some cases, medications may also be prescribed to help manage symptoms."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3836,
    "user_query": "The NoSAS Score can be used for screening of which disorders?",
    "llama-2-7b-chat-hf_response": "The NoSAS Score can be used for screening of the following disorders:\n1. Substance Use Disorders (SUDs): The NoSAS Score can be used to screen for alcohol use disorder (AUD), drug use disorder (DUD), and polysubstance use disorder (PSUD).\n2. Mental Health Disorders: The NoSAS Score can be used to screen for major depressive disorder (MDD), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD).\n3. Eating Disorders: The NoSAS Score can be used to screen for anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED).\n4. Personality Disorders: The NoSAS Score can be used to screen for borderline personality disorder (BPD), antisocial personality disorder (ASPD), and narcissistic personality disorder (NPD).\n5. Psychotic Disorders: The NoSAS Score can be used to screen for schizophrenia spectrum disorders, including schizophrenia, schizoaffective disorder, and brief psychotic disorder.\n6. Neurodevelopmental Disorders: The NoSAS Score can be used to screen for attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).\n7. Somatic Symptom Disorders: The NoSAS Score can be used to screen for somatic symptom disorder (SSD), which is characterized by excessive thoughts or concerns about one's physical symptoms.\n8. Feeding and Eating Disorders: The NoSAS Score can be used to screen for feeding and eating disorders, such as avoidant/restrictive food intake disorder (ARFID) and binge eating disorder (BED).\n9. Elimination Disorders: The NoSAS Score can be used to screen for elimination disorders, such as encopresis and enuresis.\n10. Sleep Disorders: The NoSAS Score can be used to screen for",
    "llama-2-7b-chat-hf_fact": [
      "The NoSAS Score can be used to screen for Substance Use Disorders, including alcohol use disorder, drug use disorder, and polysubstance use disorder.",
      "The NoSAS Score can be used to screen for Mental Health Disorders, such as major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, and obsessive-compulsive disorder.",
      "The NoSAS Score can screen for Eating Disorders like anorexia nervosa, bulimia nervosa, and binge eating disorder.",
      "The NoSAS Score is used to screen for various Personality Disorders, including borderline personality disorder, antisocial personality disorder, and narcissistic personality disorder.",
      "The NoSAS Score can be used to screen for Neurodevelopmental Disorders, including attention-deficit/hyperactivity disorder and autism spectrum disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The NoSAS Score is used to screen for sleep apnea, not Substance Use Disorders.",
      "false, [corrected fact]: The NoSAS Score is not used to screen for Mental Health Disorders.",
      "false, [corrected fact]: The NoSAS Score does not screen for Eating Disorders.",
      "false, [corrected fact]: The NoSAS Score is not used to screen for various Personality Disorders.",
      "false, [corrected fact]: The NoSAS Score is not used to screen for Neurodevelopmental Disorders."
    ]
  },
  {
    "id": 3837,
    "user_query": "What is the chromosomal abnormality associated with Klinefelter Syndrome",
    "llama-2-7b-chat-hf_response": "?\nKlinefelter Syndrome is a genetic disorder that affects males and is caused by an extra X chromosome. The chromosomal abnormality associated with Klinefelter Syndrome is 47,XXY or 47,XYY. This means that instead of the typical 46 chromosomes found in most males (46,XY), individuals with Klinefelter Syndrome have an extra X chromosome (47,XXY) or an extra Y chromosome (47,XYY). This extra genetic material can lead to a variety of developmental and reproductive problems.",
    "llama-2-7b-chat-hf_fact": [
      "Klinefelter Syndrome is a genetic disorder that affects males.",
      "Klinefelter Syndrome is caused by an extra X chromosome.",
      "The chromosomal abnormality associated with Klinefelter Syndrome is 47,XXY or 47,XYY.",
      "Typically, males have 46 chromosomes (46,XY).",
      "The extra genetic material from Klinefelter Syndrome can lead to developmental and reproductive problems."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The chromosomal abnormality associated with Klinefelter Syndrome is 47,XXY, not 47,XYY.",
      "true",
      "true"
    ]
  },
  {
    "id": 3838,
    "user_query": "What distinguishes RIDLs from other transpozable elements?",
    "llama-2-7b-chat-hf_response": "RIDLs (Retrotransposable elements in Drosophila) are a type of transposable element that are found in the genomes of Drosophila species. They are characterized by the presence of a reverse transcriptase gene, which is used to generate a complementary RNA (cRNA) copy of the element. This cRNA is then used as a template for the synthesis of DNA, which is integrated into the host genome.\nThere are several features that distinguish RIDLs from other types of transposable elements:\n1. Reverse transcriptase: RIDLs have a reverse transcriptase gene, which is used to generate a cRNA copy of the element. This is distinct from other types of transposable elements, such as retrotransposons, which do not have a reverse transcriptase gene.\n2. Targeted integration: RIDLs are targeted to specific genomic locations, where they integrate into the host genome. This is in contrast to other types of transposable elements, such as transposons, which can integrate randomly into the genome.\n3. Regulation of expression: RIDLs are regulated by a complex system of transcriptional and post-transcriptional mechanisms, which control the expression of the reverse transcriptase gene. This is distinct from other types of transposable elements, which are often constitutively expressed.\n4. Genomic context: RIDLs are found in the genomes of Drosophila species, and are particularly abundant in the genomes of D. melanogaster and D. pseudoobscura. This is distinct from other types of transposable elements, which can be found in a wide range of organisms.\n5. Evolutionary history: RIDLs have a complex evolutionary history, with evidence suggesting that they have undergone multiple rounds of duplication and divergence. This is distinct from other types of transposable elements, which may have a more simple evolutionary history.",
    "llama-2-7b-chat-hf_fact": [
      "RIDLs (Retrotransposable elements in Drosophila) are a type of transposable element found in the genomes of Drosophila species.",
      "RIDLs possess a reverse transcriptase gene, utilized to generate a complementary RNA (cRNA) copy of the element for the synthesis of DNA.",
      "Unlike other types of transposable elements like retrotransposons, RIDLs have a reverse transcriptase gene.",
      "RIDLs uniquely integrate into specific genomic locations, differing from other transposons that can randomly integrate into the genome.",
      "RIDLs are regulated by transcriptional and post-transcriptional mechanisms which control the expression of the reverse transcriptase gene. This is distinct from other transposable elements that are often constitutively expressed."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: RIDLs possess a reverse transcriptase gene, utilized to generate a complementary DNA (cDNA) copy of the element for the synthesis of DNA.",
      "false, [corrected fact]: Just like other types of transposable elements like retrotransposons, RIDLs have a reverse transcriptase gene.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3839,
    "user_query": "What indication has FTY720 been approved for by the FDA?",
    "llama-2-7b-chat-hf_response": "FTY720 (fingolimod) has been approved by the US Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.",
    "llama-2-7b-chat-hf_fact": [
      "FTY720, also known as fingolimod, is a medication.",
      "The US Food and Drug Administration (FDA) has approved FTY720.",
      "FTY720 has been approved for the treatment of relapsing forms of multiple sclerosis (MS).",
      "The approved indications for FTY720 include clinically isolated syndrome, relapsing-remitting disease.",
      "FTY720 has also been approved for treating active secondary progressive disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3846,
    "user_query": "Which type of analysis does DeSeq2 perform?",
    "llama-2-7b-chat-hf_response": "DeSeq2 is a popular R package for detecting differentially expressed genes in RNA-seq data. It performs a statistical analysis to identify genes that are differentially expressed between two or more sample groups. Specifically, DeSeq2 uses a negative binomial model to account for the variation in read counts across the transcriptome and to test for differences in gene expression between the sample groups.\nDeSeq2 performs the following types of analysis:\n1. Differential expression analysis: DeSeq2 identifies genes that are differentially expressed between two or more sample groups. It uses a negative binomial model to account for the variation in read counts across the transcriptome and to test for differences in gene expression between the sample groups.\n2. Multiple testing correction: DeSeq2 uses the Benjamini-Hochberg procedure to perform multiple testing correction, which is a conservative method for controlling the false discovery rate (FDR). This ensures that the results are not overly influenced by the large number of tests performed.\n3. Gene ontology (GO) enrichment analysis: DeSeq2 can perform GO enrichment analysis to identify pathways or biological processes that are overrepresented among the differentially expressed genes. This can provide insights into the biological mechanisms underlying the observed differences in gene expression.\n4. Visualization and interpretation: DeSeq2 provides several visualization tools, such as volcano plots and heatmaps, to help interpret the results of the differential expression analysis. These visualizations can help identify patterns of gene expression that are associated with specific biological processes or pathways.\nIn summary, DeSeq2 performs differential expression analysis, multiple testing correction, GO enrichment analysis, and visualization and interpretation of the results.",
    "llama-2-7b-chat-hf_fact": [
      "DeSeq2 is an R package used for detecting differentially expressed genes in RNA-seq data.",
      "DeSeq2 performs a statistical analysis to identify genes that are differentially expressed between two or more sample groups.",
      "The DeSeq2 uses a negative binomial model to account for the variation in read counts across the transcriptome.",
      "DeSeq2 uses the Benjamini-Hochberg procedure for multiple testing correction.",
      "DeSeq2 can perform Gene Ontology (GO) enrichment analysis to identify overrepresented pathways or biological processes among differentially expressed genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: DeSeq2 does not directly perform Gene Ontology (GO) enrichment analysis. This would require additional software or packages such as topGO or clusterProfiler."
    ]
  },
  {
    "id": 3848,
    "user_query": "Which computational methods are used for the definition of synteny?",
    "llama-2-7b-chat-hf_response": "Synteny is a term used in genomics to describe the similarity in gene order and orientation between two or more genomes. Computational methods are essential for the definition of synteny, as they allow researchers to identify and analyze the similarities and differences between genomes. Here are some of the most commonly used computational methods for defining synteny:\n1. Genome alignment: This method involves aligning two or more genomes along their entire length to identify regions of similarity. Genome alignment can be performed using a variety of algorithms, including progressive alignment, iterative alignment, and dynamic programming.\n2. Synteny map construction: This method involves constructing a map of syntenic regions between two or more genomes. Synteny maps can be constructed using a variety of algorithms, including graph-based methods, k-mer-based methods, and machine learning-based methods.\n3. OrthoMCL: This method uses a Markov Cluster Algorithm (MCL) to identify and cluster orthologous genes between two or more genomes. OrthoMCL can be used to identify syntenic regions and to infer evolutionary relationships between genomes.\n4. HMMER: This method uses a hidden Markov model (HMM) to identify and classify orthologous genes between two or more genomes. HMMER can be used to identify syntenic regions and to infer evolutionary relationships between genomes.\n5. MUSCLE: This method uses a multiple sequence alignment algorithm to identify and align orthologous genes between two or more genomes. MUSCLE can be used to identify syntenic regions and to infer evolutionary relationships between genomes.\n6. BLASTZ: This method uses a BLAST algorithm to identify and align orthologous genes between two or more genomes. BLASTZ can be used to identify syntenic regions and to infer evolutionary relationships between genomes.\n7. Dotter: This method uses a dot-product algorithm to identify and align orthologous genes between two or more genomes. Dotter can be used to identify syntenic regions and to infer evolutionary relationships between genomes.\n8. Prodigal: This method uses a probabilistic algorithm to identify and align orthologous genes between two or more genomes. Prodigal can be used to",
    "llama-2-7b-chat-hf_fact": [
      "Synteny is a term used in genomics to describe the similarity in gene order and orientation between two or more genomes.",
      "Computational methods are essential for the definition of synteny.",
      "Genome alignment and synteny map construction are computational methods for defining synteny.",
      "OrthoMCL is a computational method that uses a Markov Cluster Algorithm (MCL) to identify and cluster orthologous genes between two or more genomes.",
      "HMMER, MUSCLE, BLASTZ, Dotter, and Prodigal are computational methods that are used to identify and classify orthologous genes between two or more genomes for the definition of synteny."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3850,
    "user_query": "How can B-cells transdifferentiate into macrophages?",
    "llama-2-7b-chat-hf_response": "B cells are a type of immune cell that plays a crucial role in the adaptive immune response. They are responsible for producing antibodies, which are proteins that recognize and neutralize pathogens. However, recent studies have shown that B cells can also transdifferentiate into macrophages, a type of immune cell that plays a crucial role in the innate immune response.\nTransdifferentiation is the process by which a cell changes its identity to become a different type of cell. In the case of B-cell transdifferentiation into macrophages, this process involves a complex series of molecular events that allow the B cell to acquire the characteristics of a macrophage.\nOne of the key molecules involved in B-cell transdifferentiation is a protein called Bcl-6. Bcl-6 is a transcription factor that regulates the expression of genes involved in the differentiation of B cells into antibody-secreting plasma cells. However, Bcl-6 can also promote the transdifferentiation of B cells into macrophages by repressing the expression of genes involved in plasma cell differentiation and activating the expression of genes involved in macrophage differentiation.\nAnother key molecule involved in B-cell transdifferentiation is a protein called IRF4. IRF4 is a transcription factor that regulates the expression of genes involved in the differentiation of B cells into antibody-secreting plasma cells. However, IRF4 can also promote the transdifferentiation of B cells into macrophages by repressing the expression of genes involved in plasma cell differentiation and activating the expression of genes involved in macrophage differentiation.\nIn addition to Bcl-6 and IRF4, other molecules involved in B-cell transdifferentiation include the Notch signaling pathway, which regulates the expression of genes involved in cell fate decisions, and the Wnt signaling pathway, which regulates the expression of genes involved in cell proliferation and differentiation.\nOverall, the transdifferentiation of B cells into macrophages is a complex process that involves the coordinated action of multiple molecules and signaling pathways. Understanding the mechanisms of B-cell trans",
    "llama-2-7b-chat-hf_fact": [
      "B cells are a type of immune cell that plays a crucial role in the adaptive immune response and are responsible for producing antibodies.",
      "B cells can transdifferentiate into macrophages, a type of immune cell crucial in the innate immune response.",
      "Transdifferentiation is the process by which a cell changes its identity to become a different type of cell.",
      "Bcl-6 and IRF4 are proteins that can promote the transdifferentiation of B cells into macrophages.",
      "The Notch and the Wnt signaling pathways are other molecules that are involved in B-cell transdifferentiation."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: B cells do not transdifferentiate into macrophages. B cells can differentiate into plasma cells and memory B cells.",
      "true",
      "false, [corrected fact]: Bcl-6 and IRF4 are proteins involved in the differentiating processes of B cells, but not in their transdifferentiation into macrophages.",
      "unknown"
    ]
  },
  {
    "id": 3852,
    "user_query": "What is FeatureCounts used for?",
    "llama-2-7b-chat-hf_response": "FeatureCounts is a Python library used for counting the number of features in a dataset. It provides a simple and efficient way to count the number of features in a dataset, including categorical and numerical features.\nHere are some common use cases for FeatureCounts:\n1. **Data exploration**: FeatureCounts can be used to quickly get an overview of the number of features in a dataset, including the number of categorical and numerical features.\n2. **Data preprocessing**: FeatureCounts can be used to reduce the dimensionality of a dataset by removing unimportant features. By counting the number of features in a dataset, FeatureCounts can help identify which features are most important and which can be safely removed.\n3. **Model selection**: FeatureCounts can be used to compare the number of features in different datasets and select the dataset with the most relevant features for a particular task.\n4. **Data visualization**: FeatureCounts can be used to create visualizations of the number of features in a dataset, which can help identify trends and patterns in the data.\n5. **Evaluation**: FeatureCounts can be used to evaluate the performance of a machine learning model by comparing the number of features in the training and testing datasets.\nIn summary, FeatureCounts is a useful library for quickly and easily counting the number of features in a dataset, which can be useful for a variety of data exploration, preprocessing, and evaluation tasks.",
    "llama-2-7b-chat-hf_fact": [
      "FeatureCounts is a Python library used for counting the number of features in a dataset.",
      "FeatureCounts can be used for data exploration by providing an overview of the number of features in a dataset.",
      "FeatureCounts can help in data preprocessing by aiding in the reduction of dimensionality of a dataset.",
      "The Python library can be utilized for model selection; it aids in comparing the number of features in different datasets.",
      "FeatureCounts can be used to generate visualizations of the number of features in a dataset."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: FeatureCounts is not a Python library, it is a bioinformatics software for counting reads associated with genomic features such as genes, exons, promoters, etc in RNA sequencing data.",
      "false, [corrected fact]: FeatureCounts is not typically used for data exploration in the manner described, it is more specifically used in genomics for counting sequencing reads.",
      "false, [corrected fact]: FeatureCounts, as a genomic feature counting tool, does not aid in dimensionality reduction of a dataset.",
      "false, [corrected fact]: The use of FeatureCounts is not for model selection or comparing the number of features in different datasets; rather, it is used in genomic analyses.",
      "false, [corrected fact]: FeatureCounts does not generate visualizations of features, it outputs count data that can be used in further analysis."
    ]
  },
  {
    "id": 3854,
    "user_query": "Are super enhancers structurally insulated in chromatin loops?",
    "llama-2-7b-chat-hf_response": "Super enhancers are cis-acting DNA elements that are responsible for the regulation of gene expression by recruiting RNA polymerase II (RNAPII) and other transcription factors to specific genomic loci. While the mechanisms underlying super enhancer function are not fully understood, recent studies have suggested that super enhancers may be structurally insulated in chromatin loops.\nChromatin loops are higher-order chromatin structures that are formed by the interaction of distant regulatory elements and gene promoters. These loops can bring distant regulatory elements into close proximity with their target genes, allowing for the coordinated regulation of gene expression. Recent studies have shown that super enhancers are often located at the termini of chromatin loops, where they can interact with other regulatory elements and RNAPII to enhance gene expression.\nOne study published in the journal Nature found that super enhancers in the human genome are often located at the termini of chromatin loops that are formed by the interaction of distant regulatory elements and gene promoters. The authors of the study used a combination of chromatin conformation capture (3C) and RNA sequencing (RNA-seq) to identify super enhancers and their associated chromatin loops in human cells. They found that super enhancers were enriched at the termini of chromatin loops, and that these loops were more likely to be associated with active gene expression.\nAnother study published in the journal Cell found that super enhancers in the mouse genome are structurally insulated in chromatin loops. The authors of the study used a combination of chromatin conformation capture (4C) and RNA sequencing (RNA-seq) to identify super enhancers and their associated chromatin loops in mouse cells. They found that super enhancers were enriched at the termini of chromatin loops, and that these loops were more likely to be associated with active gene expression.\nThese studies suggest that super enhancers may be structurally insulated in chromatin loops, which could provide a mechanism for the coordinated regulation of gene expression. Chromatin loops can bring distant regulatory elements into close proximity with their target genes, allowing for the coordinated regulation of gene expression. By being located at the termini of these loops, super enhancers may be able",
    "llama-2-7b-chat-hf_fact": [
      "Super enhancers are cis-acting DNA elements that regulate gene expression by recruiting RNA polymerase II and other transcription factors to specific genomic loci.",
      "Chromatin loops are higher-order chromatin structures formed by distant regulatory elements and gene promoters' interaction.",
      "Recent studies suggest that super enhancers are often located at the termini of chromatin loops.",
      "A study published in the journal Nature found that super enhancers in the human genome are often located at the termini of chromatin loops formed by the interaction of distant regulatory elements and gene promoters.",
      "Another study published in the journal Cell found that in the mouse genome, super enhancers are structurally insulated in chromatin loops."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3858,
    "user_query": "Which deep learning framework has been developed for cancer molecular subtype classification?",
    "llama-2-7b-chat-hf_response": "Answer: Several deep learning frameworks have been developed for cancer molecular subtype classification. Some of the popular ones include:\n1. TensorFlow: TensorFlow is an open-source deep learning framework developed by Google. It has been widely used for cancer molecular subtype classification tasks, including the classification of breast cancer subtypes based on gene expression data.\n2. PyTorch: PyTorch is another popular open-source deep learning framework that has been used for cancer molecular subtype classification. For example, researchers have used PyTorch to classify lung adenocarcinoma subtypes based on genomic features.\n3. Keras: Keras is a high-level deep learning framework that can run on top of TensorFlow or PyTorch. It has been used for cancer molecular subtype classification tasks, including the classification of colorectal cancer subtypes based on DNA methylation data.\n4. Caffe: Caffe is a deep learning framework that has been used for cancer molecular subtype classification tasks, including the classification of breast cancer subtypes based on histopathology images.\n5. Deepar: Deepar is a deep learning framework specifically designed for cancer genomics. It has been used for cancer molecular subtype classification tasks, including the classification of breast cancer subtypes based on RNA sequencing data.\nThese are just a few examples of the deep learning frameworks that have been developed for cancer molecular subtype classification. The choice of framework will depend on the specific research question, the type of data available, and the computational resources available.",
    "llama-2-7b-chat-hf_fact": [
      "TensorFlow is an open-source deep learning framework developed by Google.",
      "TensorFlow has been used for cancer molecular subtype classification, including the classification of breast cancer subtypes based on gene expression data.",
      "PyTorch is a popular open-source deep learning framework that has been used for cancer molecular subtype classification such as classifying lung adenocarcinoma subtypes based on genomic features.",
      "Keras can run on top of TensorFlow or PyTorch and has been used for cancer molecular subtype classification, like the classification of colorectal cancer subtypes based on DNA methylation data.",
      "Deepar is a deep learning framework specifically designed for cancer genomics and has been used for cancer molecular subtype classification tasks, including the classification of breast cancer subtypes based on RNA sequencing data."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Deepar is a deep learning method for forecasting time series, not specifically designed for cancer genomics. The application of Deepar for cancer molecular subtype classification is unknown."
    ]
  },
  {
    "id": 3861,
    "user_query": "What drug, used to treat rheumatoid arthritis, is an interleukin-1 receptor antagonist?",
    "llama-2-7b-chat-hf_response": "Answer:\nHumira (adalimumab) is an interleukin-1 receptor antagonist used to treat rheumatoid arthritis.",
    "llama-2-7b-chat-hf_fact": [
      "Humira is also known as adalimumab.",
      "Adalimumab is an interleukin-1 receptor antagonist.",
      "Humira is used to treat rheumatoid arthritis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Adalimumab is a TNF (tumor necrosis factor) inhibitor, not an interleukin-1 receptor antagonist.",
      "true"
    ]
  },
  {
    "id": 3863,
    "user_query": "Is liraglutide effective for weight reduction?",
    "llama-2-7b-chat-hf_response": "Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been shown to be effective for weight reduction in individuals with obesity. GLP-1 receptor agonists work by mimicking the action of the natural hormone GLP-1, which helps to regulate appetite and food intake.\nStudies have shown that liraglutide can lead to significant weight loss, particularly in individuals with a body mass index (BMI) of 30 or higher. For example, a randomized controlled trial published in The New England Journal of Medicine found that liraglutide resulted in an average weight loss of 6.4 kg (14.1 lbs) over a period of 56 weeks, compared to a weight gain of 0.5 kg (1.1 lbs) in the placebo group.\nLiraglutide has also been shown to improve other cardiovascular risk factors, such as blood pressure, triglycerides, and HDL cholesterol. Additionally, it has been shown to reduce the risk of major adverse cardiovascular events, such as non-fatal myocardial infarction, non-fatal stroke, and death from cardiovascular causes.\nHowever, it is important to note that liraglutide is not a quick fix for weight loss, and it may take several months to see significant results. Additionally, it is important to follow a healthy diet and exercise program in conjunction with liraglutide to maximize its weight loss effects.\nIn summary, liraglutide is an effective medication for weight reduction in individuals with obesity, particularly those with a BMI of 30 or higher. It can lead to significant weight loss, improve other cardiovascular risk factors, and reduce the risk of major adverse cardiovascular events. However, it is important to use it as part of a comprehensive weight loss plan that includes a healthy diet and exercise program.",
    "llama-2-7b-chat-hf_fact": [
      "Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist.",
      "Liraglutide has been shown to be effective for weight reduction in individuals with obesity.",
      "A randomized controlled trial published in The New England Journal of Medicine found that liraglutide resulted in an average weight loss of 6.4 kg (14.1 lbs) over 56 weeks.",
      "Apart from weight loss, liraglutide has also been shown to improve cardiovascular risk factors such as blood pressure, triglycerides, and HDL cholesterol.",
      "It has been shown to reduce the risk of major adverse cardiovascular events, including non-fatal myocardial infarction, non-fatal stroke, and death from cardiovascular causes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3865,
    "user_query": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?",
    "llama-2-7b-chat-hf_response": "Familial adenomatous polyposis (FAP) is a rare inherited disorder characterized by the development of hundreds or thousands of adenomatous polyps in the colon and rectum. These polyps are precancerous and can eventually become malignant if left untreated. Eflornithine and sulindac are two drugs that have been studied for their potential to prevent the progression of FAP.\nEflornithine is a drug that inhibits the enzyme ornithine decarboxylase (ODC), which is involved in the production of polyamines, a class of compounds that promote cell growth and proliferation. By inhibiting ODC, eflornithine reduces the amount of polyamines available for cell growth and proliferation, which may slow the growth of polyps in FAP.\nSulindac is a nonsteroidal anti-inflammatory drug (NSAID) that has been shown to inhibit the production of cyclooxygenase (COX) enzymes, which are involved in the production of prostaglandins, prostacyclin, and thromboxane. Prostaglandins and prostacyclin are involved in the regulation of inflammation and immune responses, while thromboxane is involved in the formation of blood clots. By inhibiting COX enzymes, sulindac may reduce the inflammation and immune responses that contribute to the growth and progression of FAP polyps.\nSeveral studies have investigated the efficacy of eflornithine and sulindac in preventing the progression of FAP. A phase II clinical trial published in the Journal of Clinical Oncology in 2003 found that eflornithine therapy significantly reduced the number of new adenomas in patients with FAP. Another study published in the Journal of Gastrointestinal Surgery in 2010 found that sulindac therapy reduced the number of new adenomas in patients with FAP.\nWhile these studies suggest that eflornithine and sulindac may be effective in preventing the progression of FAP, more research is needed to confirm these findings and to determine the optimal dosage and duration of treatment. Additionally, these",
    "llama-2-7b-chat-hf_fact": [
      "Familial adenomatous polyposis (FAP) is a rare inherited disorder characterized by the development of hundreds or thousands of adenomatous polyps in the colon and rectum.",
      "Eflornithine is a drug that inhibits the enzyme ornithine decarboxylase (ODC), which is involved in the production of polyamines.",
      "Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits the production of cyclooxygenase (COX) enzymes.",
      "A phase II clinical trial published in the Journal of Clinical Oncology in 2003 found that eflornithine therapy reduced the number of new adenomas in patients with FAP.",
      "A study published in the Journal of Gastrointestinal Surgery in 2010 found that sulindac therapy reduced the number of new adenomas in patients with FAP."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3867,
    "user_query": "Which cancers can be treated with Selpercatinib?",
    "llama-2-7b-chat-hf_response": "Selpercatinib is a drug used to treat various types of cancer, including:\n1. Lung cancer: Selpercatinib has been shown to be effective in treating non-small cell lung cancer (NSCLC), including adenocarcinoma and squamous cell carcinoma.\n2. Breast cancer: Selpercatinib has been investigated as a potential treatment for hormone receptor-positive breast cancer, including estrogen receptor (ER)-positive and progesterone receptor (PR)-positive breast cancer.\n3. Urothelial cancer: Selpercatinib has been studied as a potential treatment for urothelial cancer, including bladder cancer and urethral cancer.\n4. Colorectal cancer: Selpercatinib has been investigated as a potential treatment for colorectal cancer, including microsatellite instability-high (MSI-H) colorectal cancer.\n5. Pancreatic cancer: Selpercatinib has been studied as a potential treatment for pancreatic cancer, including pancreatic ductal adenocarcinoma (PDAC).\nIt is important to note that the use of selpercatinib for the treatment of these cancers is still experimental and has not yet been approved by regulatory authorities. Further clinical trials are needed to confirm the safety and efficacy of selpercatinib for these indications.",
    "llama-2-7b-chat-hf_fact": [
      "Selpercatinib is a drug used to treat various types of cancer.",
      "Selpercatinib has been shown to be effective in treating non-small cell lung cancer (NSCLC).",
      "Selpercatinib has been investigated as a potential treatment for hormone receptor-positive breast cancer.",
      "Selpercatinib has been studied as a potential treatment for urothelial cancer, including bladder cancer and urethral cancer.",
      "Selpercatinib has been studied as a potential treatment for pancreatic cancer, including pancreatic ductal adenocarcinoma (PDAC)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3868,
    "user_query": "What is the target of Volanesorsen?",
    "llama-2-7b-chat-hf_response": "Volanesorsen is a drug used to treat familial chylomicronemia syndrome (FCS), a rare genetic disorder that affects the body's ability to break down triglycerides. The target of Volanesorsen is the enzyme lipoprotein lipase (LPL), which is responsible for breaking down triglycerides in the blood. Volanesorsen works by increasing the activity of LPL, allowing the body to break down triglycerides more efficiently and reducing the risk of pancreatitis and other complications associated with FCS.",
    "llama-2-7b-chat-hf_fact": [
      "Volanesorsen is a drug used to treat familial chylomicronemia syndrome (FCS).",
      "Familial chylomicronemia syndrome is a rare genetic disorder that affects the body's ability to break down triglycerides.",
      "The target of Volanesorsen is the enzyme lipoprotein lipase (LPL).",
      "Lipoprotein lipase (LPL) is responsible for breaking down triglycerides in the blood.",
      "Volanesorsen works by increasing the activity of LPL, which reduces the risk of pancreatitis and other complications associated with FCS."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The target of Volanesorsen is the messenger RNA produced by the gene encoding apolipoprotein C-III, not lipoprotein lipase (LPL).",
      "true",
      "true"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-7b-chat-hf_response": "A. Psoriasis\nB. Eczema\nC. Atopic dermatitis\nD. Vitiligo\nAnswer: C. Atopic dermatitis\nRoflumilast cream is a topical phosphodiesterase 4 (PDE4) inhibitor that has been shown to be effective in treating atopic dermatitis, a chronic inflammatory skin condition characterized by dry, itchy, and scaly skin. Roflumilast cream has been shown to reduce inflammation and improve symptoms of atopic dermatitis, including itching, redness, and dryness, in clinical trials. Therefore, the correct answer is (C) Atopic dermatitis.",
    "llama-2-7b-chat-hf_fact": [
      "Roflumilast cream is a topical phosphodiesterase 4 (PDE4) inhibitor.",
      "Roflumilast cream is effective in treating atopic dermatitis.",
      "Atopic dermatitis is a chronic inflammatory skin condition characterized by dry, itchy, and scaly skin.",
      "Roflumilast cream has been shown to reduce inflammation and improve symptoms of atopic dermatitis in clinical trials.",
      "Symptoms of atopic dermatitis include itching, redness, and dryness."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Roflumilast is an oral drug, not a cream.",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3870,
    "user_query": "Describe the mechanism of action of Givosiran.",
    "llama-2-7b-chat-hf_response": "Givosiran is an investigational RNA interference (RNAi) therapy being developed by Alnylam Pharmaceuticals for the treatment of acute hepatitis B virus (HBV) infection. The mechanism of action of givosiran is based on the principle of RNA interference, which is a natural process by which cells regulate the expression of their genes.\nRNAi works by degrading specific messenger RNA (mRNA) molecules, which carry genetic information from DNA to the ribosome for protein synthesis. By targeting specific mRNAs with RNAi, cells can reduce the production of specific proteins, leading to a decrease in the activity of the corresponding enzyme or protein.\nGivosiran is designed to target and degrade the mRNA of the HBV polymerase enzyme, which is essential for the replication of the virus. By reducing the production of the HBV polymerase enzyme, givosiran inhibits the replication of the virus, leading to a decrease in the levels of HBV DNA in the liver.\nThe mechanism of action of givosiran is complex and involves several steps, including:\n1. Target recognition: Givosiran recognizes and binds to the mRNA of the HBV polymerase enzyme.\n2. RNAi-mediated degradation: Once bound, givosiran triggers the RNAi machinery in the cell, leading to the degradation of the HBV polymerase mRNA.\n3. Reduction of HBV DNA: As a result of the degradation of the HBV polymerase mRNA, the production of new HBV DNA is reduced, leading to a decrease in the levels of HBV DNA in the liver.\n4. Inhibition of viral replication: By reducing the levels of HBV DNA, givosiran inhibits the replication of the virus, leading to a decrease in the levels of HBV DNA in the liver.\nOverall, the mechanism of action of givosiran is a complex process that involves the targeting and degradation of specific mRNAs, leading to a decrease in the production of viral proteins",
    "llama-2-7b-chat-hf_fact": [
      "Givosiran is an investigational RNA interference (RNAi) therapy being developed by Alnylam Pharmaceuticals for treatment of acute hepatitis B virus (HBV) infection.",
      "The mechanism of action of givosiran is based on the principle of RNA interference, a process by which cells regulate gene expression.",
      "It mechanism involves degrading specific mRNA molecules related to the HBV polymerase enzyme, reducing its production.",
      "Givosiran is designed to target and degrade the mRNA of the HBV polymerase enzyme - a key enzyme for the replication of hepatitis B virus.",
      "As a result of the degradation of the HBV polymerase mRNA, the production of new HBV DNA is reduced, leading to a decrease in the levels of HBV DNA in the liver."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Givosiran is an investigational RNA interference (RNAi) therapy being developed by Alnylam Pharmaceuticals for the treatment of acute hepatic porphyria, not hepatitis B virus (HBV) infection.",
      "true",
      "unknown",
      "false, [corrected fact]: Givosiran is designed to target and degrade the mRNA of the delta-aminolevulinate synthase 1 (ALAS1) enzyme, not the HBV polymerase enzyme.",
      "false, [corrected fact]: As a result of the degradation of the ALAS1 mRNA, the production of aminolevulinic acid is reduced, not the production of new HBV DNA."
    ]
  },
  {
    "id": 3871,
    "user_query": "Is Olaparib effective for prostate cancer?",
    "llama-2-7b-chat-hf_response": "Olaparib is a PARP inhibitor that has shown promise in the treatment of various types of cancer, including prostate cancer. PARP (poly ADP-ribose polymerase) is an enzyme that plays a role in DNA repair, and cancer cells often rely on PARP-mediated repair to survive and grow. By inhibiting PARP, olaparib can increase the sensitivity of cancer cells to chemotherapy and radiation therapy, leading to improved treatment outcomes.\nStudies have shown that olaparib can be effective in treating castration-resistant prostate cancer (CRPC), which is a type of prostate cancer that has progressed despite hormone therapy. In clinical trials, olaparib has been shown to slow the growth of CRPC tumors and improve progression-free survival (PFS), which is the length of time during which a patient's cancer does not grow or spread.\nOne study published in the New England Journal of Medicine in 2018 found that olaparib significantly improved PFS in patients with BRCA1 or BRCA2 mutations and CRPC. The study included 199 patients who were randomized to receive either olaparib or placebo, and the results showed that the median PFS was 7.4 months in the olaparib group compared to 3.6 months in the placebo group.\nAnother study published in the Journal of Clinical Oncology in 2020 found that olaparib was effective in treating patients with metastatic castrate-resistant prostate cancer (mCRPC) regardless of their BRCA status. The study included 160 patients who were randomized to receive either olaparib or placebo, and the results showed that the median PFS was 4.8 months in the olaparib group compared to 2.8 months in the placebo group.\nWhile these studies suggest that olaparib can be effective in treating certain types of prostate cancer, it is important to note that not all prostate cancers are the same, and the effectiveness of olaparib may vary depending on the specific characteristics of the cancer. Additionally, olaparib can have side effects, including nausea, fatigue, and",
    "llama-2-7b-chat-hf_fact": [
      "Olaparib is a PARP inhibitor that has shown promise in the treatment of various types of cancer, including prostate cancer.",
      "PARP (poly ADP-ribose polymerase) is an enzyme that plays a role in DNA repair.",
      "Olaparib has been shown in clinical trials to slow the growth of CRPC tumors and improve progression-free survival.",
      "A study published in the New England Journal of Medicine in 2018 found that olaparib improved progression-free survival in patients with BRCA1 or BRCA2 mutations and castration-resistant prostate cancer.",
      "A study published in the Journal of Clinical Oncology in 2020 found that olaparib was effective in treating patients with metastatic castrate-resistant prostate cancer regardless of their BRCA status."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3876,
    "user_query": "Which company developed eptinezumab?",
    "llama-2-7b-chat-hf_response": "Eptinezumab is a monoclonal antibody drug developed by the biotechnology company, Lilly.",
    "llama-2-7b-chat-hf_fact": [
      "Eptinezumab is a monoclonal antibody drug.",
      "The biotechnology company Lilly developed Eptinezumab."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The biotechnology company Alder Biopharmaceuticals developed Eptinezumab."
    ]
  },
  {
    "id": 3878,
    "user_query": "Which drugs are included in the VIFUP regimen for breast cancer?",
    "llama-2-7b-chat-hf_response": "VIFUP (Vincristine, Ifosfamide, 5-Fluorouracil, and Prednisone) is a chemotherapy regimen commonly used to treat various types of cancer, including breast cancer. The specific drugs included in the VIFUP regimen for breast cancer are:\n1. Vincristine (Oncovin): This drug is a vinca alkaloid that works by interfering with the ability of cancer cells to divide and grow.\n2. Ifosfamide (Ifex): This drug is an alkylating agent that works by damaging the DNA of cancer cells, preventing them from reproducing.\n3. 5-Fluorouracil (5-FU): This drug is a fluoropyrimidine that works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA replication.\n4. Prednisone: This drug is a corticosteroid that is used to reduce inflammation and swelling associated with cancer treatment.\nThe VIFUP regimen is typically used for the treatment of metastatic breast cancer, which is cancer that has spread to other parts of the body beyond the original tumor site. It may also be used in combination with other chemotherapy drugs or hormone therapy for the treatment of early-stage breast cancer.",
    "llama-2-7b-chat-hf_fact": [
      "VIFUP is a chemotherapy regimen used to treat different types of cancer such as breast cancer.",
      "The VIFUP regimen for treating breast cancer includes Vincristine, Ifosfamide, 5-Fluorouracil, and Prednisone.",
      "Vincristine works by interfering with the growth and division of cancer cells.",
      "Ifosfamide prevents cancer cell reproduction by damaging their DNA.",
      "The drug 5-Fluorouracil inhibits the enzyme thymidylate synthase, which is necessary for DNA replication."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3881,
    "user_query": "Which network analysis method can you use for prioritization of metabolic disease genes?",
    "llama-2-7b-chat-hf_response": "There are several network analysis methods that can be used for prioritization of metabolic disease genes, including:\n1. Degree-based prioritization: This method prioritizes genes based on their connectivity to other genes in the network. Genes with a higher degree (i.e., more connections) are considered more important.\n2. Betweenness centrality-based prioritization: This method prioritizes genes based on their betweenness centrality, which is a measure of the extent to which a gene lies on the shortest paths between other genes in the network. Genes with a higher betweenness centrality are considered more important.\n3. Eigenvector centrality-based prioritization: This method prioritizes genes based on their eigenvector centrality, which is a measure of the extent to which a gene is connected to other highly connected genes in the network. Genes with a higher eigenvector centrality are considered more important.\n4. Clustering coefficient-based prioritization: This method prioritizes genes based on their clustering coefficient, which is a measure of the degree to which genes in a network tend to cluster together. Genes with a higher clustering coefficient are considered more important.\n5. Modularity maximization-based prioritization: This method prioritizes genes based on their contribution to the modularity of the network, which is a measure of the degree to which the network can be divided into distinct communities or modules. Genes with a higher modularity are considered more important.\n6. Network diffusion-based prioritization: This method prioritizes genes based on their ability to diffuse information or molecules through the network. Genes with a higher network diffusion are considered more important.\n7. Network robustness-based prioritization: This method prioritizes genes based on their ability to maintain the robustness of the network under perturbations. Genes with a higher network robustness are considered more important.\n8. Network flexibility-based prioritization: This method prioritizes genes based on their ability to adapt the network to changing conditions. Genes with a higher network flexibility are considered more important.\nEach of these methods has its own strengths and limitations, and the choice of method will depend on the specific research question and data available.",
    "llama-2-7b-chat-hf_fact": [
      "Degree-based prioritization is a network analysis method that prioritizes genes based on their connectivity to other genes in the network.",
      "Betweenness centrality-based prioritization is a network analysis method that prioritizes genes based on their betweenness centrality.",
      "Eigenvector centrality-based prioritization is a network analysis method that prioritizes genes based on how they are connected to other highly connected genes in a network.",
      "Clustering coefficient-based prioritization is a network analysis method that prioritizes genes based the degree of cluster formation in a network.",
      "Modularity maximization-based prioritization is a network analysis method that prioritizes genes based on their contribution to network modularity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3883,
    "user_query": "What are the targets of pemigatinib?",
    "llama-2-7b-chat-hf_response": "Pemigatinib is a drug used to treat various types of cancer, including breast cancer and cholangiocarcinoma. It works by inhibiting the activity of a protein called FGFR1, which is often overexpressed in these types of cancer. By blocking the activity of FGFR1, pemigatinib can help slow the growth and spread of cancer cells.\nThere are several different targets of pemigatinib, including:\n1. FGFR1: Pemigatinib is a potent and selective inhibitor of FGFR1, which is overexpressed in many types of cancer, including breast cancer and cholangiocarcinoma. By blocking the activity of FGFR1, pemigatinib can help slow the growth and spread of cancer cells.\n2. PI3K/Akt/mTOR signaling pathway: Pemigatinib has been shown to inhibit the PI3K/Akt/mTOR signaling pathway in cancer cells, which is involved in cell survival and proliferation. By inhibiting this pathway, pemigatinib can help induce cell death in cancer cells.\n3. Angiogenesis: Pemigatinib has been shown to inhibit angiogenesis, the formation of new blood vessels that supply oxygen and nutrients to cancer cells. By inhibiting angiogenesis, pemigatinib can help starve cancer cells of the resources they need to grow and spread.\n4. Immune evasion: Pemigatinib has been shown to inhibit the immune evasion mechanisms used by cancer cells to evade the immune system. By blocking these mechanisms, pemigatinib can help the immune system recognize and attack cancer cells more effectively.\n5. Stem cell factor signaling pathway: Pemigatinib has been shown to inhibit the stem cell factor signaling pathway in cancer cells, which is involved in the maintenance of cancer stem cells. By inhibiting this pathway, pemigatinib can help reduce the number of cancer stem cells and slow the growth of cancer.\nOverall, pemigatinib is a targeted therapy that works by inhibiting multiple pathways involved in the growth, surv",
    "llama-2-7b-chat-hf_fact": [
      "Pemigatinib is a drug used to treat various types of cancer, including breast cancer and cholangiocarcinoma.",
      "Pemigatinib works by inhibiting the activity of a protein called FGFR1.",
      "Pemigatinib has been shown to inhibit the PI3K/Akt/mTOR signaling pathway in cancer cells.",
      "Pemigatinib has been shown to inhibit angiogenesis.",
      "Pemigatinib has been shown to inhibit the immune evasion mechanisms used by cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-7b-chat-hf_response": "Several tools have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters. Here are some of the commonly used tools:\n1. CpG Island Finder: This tool identifies regions of the genome that are enriched in the dinucleotide CpG, which is a common feature of ncRNA promoters.\n2. ProbeFinder: This tool identifies potential probes for ChIP-seq experiments that can be used to identify ncRNA promoters.\n3. RNA polymerase II (RNAPII) ChIP-seq: This tool uses ChIP-seq data to identify regions of the genome that are bound by RNA polymerase II (RNAPII), which is the primary enzyme responsible for transcribing ncRNAs.\n4. HISAT2: This tool uses ChIP-seq data to identify regions of the genome that are bound by histone-modifying enzymes, which can be used to identify ncRNA promoters.\n5. STAR: This tool uses RNA-seq data to identify regions of the genome that are actively transcribed, which can be used to identify ncRNA promoters.\n6. TopHat2: This tool uses RNA-seq data to identify regions of the genome that are actively transcribed, which can be used to identify ncRNA promoters.\n7. Cufflinks: This tool uses RNA-seq data to identify regions of the genome that are actively transcribed, which can be used to identify ncRNA promoters.\n8. HISAT: This tool uses ChIP-seq data to identify regions of the genome that are bound by histone-modifying enzymes, which can be used to identify ncRNA promoters.\n9. MACS2: This tool uses ChIP-seq data to identify regions of the genome that are bound by histone-modifying enzymes, which can be used to identify ncRNA promoters.\n10. ChIPseek: This tool uses ChIP-seq data to identify regions of the genome that are bound by histone-modifying",
    "llama-2-7b-chat-hf_fact": [
      "CpG Island Finder is a tool that identifies regions of the genome enriched in the dinucleotide CpG.",
      "ProbeFinder is a tool designed for identifying potential probes for ChIP-seq experiments to spot ncRNA promoters.",
      "RNA polymerase II (RNAPII) ChIP-seq uses ChIP-seq data to identify regions of the genome bound by RNA polymerase II, an enzyme responsible for transcribing ncRNAs.",
      "HISAT2 is a tool that identifies regions of the genome bound by histone-modifying enzymes using ChIP-seq data.",
      "STAR is a tool which uses RNA-seq data to identify actively transcribed regions of the genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "false, [corrected fact]: HISAT2 is a tool for fast and sensitive alignment of next generation sequencing reads, not for identifying regions of the genome bound by histone-modifying enzymes.",
      "true"
    ]
  },
  {
    "id": 3889,
    "user_query": "Is Hunter's disease is associated with the X Chromosome?",
    "llama-2-7b-chat-hf_response": "Hunter's disease, also known as Huntington's disease, is a rare genetic disorder that affects the brain and causes progressive damage to nerve cells. The disease is caused by an expansion of a CAG repeat in the Huntingtin gene, which is located on the long arm of chromosome 4.",
    "llama-2-7b-chat-hf_fact": [
      "Hunter's disease, also known as Huntington's disease, is a genetic disorder.",
      "Huntington's disease affects the brain and causes progressive damage to nerve cells.",
      "The disease is caused by an expansion of a CAG repeat in the Huntingtin gene.",
      "The Huntingtin gene is located on the long arm of chromosome 4.",
      "Huntington's disease is a rare condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Hunter's disease, also known as Mucopolysaccharidosis II, is a genetic disorder. It should not be confused with Huntington's disease.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3893,
    "user_query": "What is Aortitis?",
    "llama-2-7b-chat-hf_response": "Aortitis is inflammation of the aorta, the main artery that carries oxygenated blood from the heart to the rest of the body. It can be caused by a variety of factors, including infections, autoimmune disorders, and certain medications.\nSymptoms of Aortitis\nThe symptoms of aortitis can vary depending on the cause and severity of the condition. Common symptoms include:\n* Chest pain or tenderness\n* Fever\n* Fatigue\n* Shortness of breath\n* Swelling in the legs, ankles, and feet\n* Pain in the abdomen, back, or joints\n* Numbness or tingling in the arms or legs\nDiagnosis of Aortitis\nDiagnosis of aortitis typically involves a combination of physical examination, medical history, and diagnostic tests. These tests may include:\n* Chest X-ray or CT scan to visualize the aorta and detect any abnormalities\n* Blood tests to check for signs of infection or inflammation\n* Echocardiogram to evaluate the heart and aorta\n* Magnetic resonance angiography (MRA) or computed tomography angiography (CTA) to visualize the aorta and its branches\nTreatment of Aortitis\nTreatment of aortitis depends on the underlying cause of the condition. Infections can be treated with antibiotics, while autoimmune disorders may require immunosuppressive medications. In some cases, surgery may be necessary to repair or replace the affected portion of the aorta.\nComplications of Aortitis\nComplications of aortitis can include:\n* Aortic dissection: a tear in the inner lining of the aorta that can lead to bleeding or rupture\n* Aortic aneurysm: an enlargement of the aorta that can lead to rupture or dissection\n* Heart failure: decreased heart function that can lead to fatigue, shortness of breath, and swelling in the legs and feet\n* Kidney failure: decreased function of the kidneys that can lead to fluid buildup and electrolyte imbalances",
    "llama-2-7b-chat-hf_fact": [
      "Aortitis is characterized as inflammation of the aorta which carries oxygenated blood from the heart to the rest of the body.",
      "Symptoms of aortitis can include chest pain, fever, fatigue, shortness of breath, and swelling in the legs, ankles, and feet among others.",
      "Diagnosis of aortitis commonly involves physical examination, medical history, and diagnostic tests such as chest X-ray, blood tests, echocardiogram, and Magnetic resonance angiography (MRA) or computed tomography angiography (CTA).",
      "Treatment of aortitis is contingent on the underlying cause of the condition and can range from antibiotics in case of infections to potentially surgery depending on the seriousness.",
      "Complications of aortitis can lead to aortic dissection, aortic aneurysm, heart failure, and kidney failure."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3894,
    "user_query": "Please list the syndromes that are part of Castleman's disease AKA TAFRO",
    "llama-2-7b-chat-hf_response": "syndrome.\nCastleman's disease, also known as TAFRO syndrome, is a rare lymphoproliferative disorder characterized by the presence of lymphoid follicles in various organs, including the lymph nodes, spleen, liver, and bone marrow. The following are some of the syndromes that are part of Castleman's disease:\n1. TAFRO syndrome: This is the most common form of Castleman's disease, accounting for about 70% of cases. It is characterized by the presence of lymphoid follicles in the liver, spleen, lymph nodes, and bone marrow.\n2. HIV-associated Castleman's disease: This is a rare form of Castleman's disease that occurs in people with HIV infection. It is characterized by the presence of lymphoid follicles in the lymph nodes, spleen, and bone marrow.\n3. Hypersplenism-associated Castleman's disease: This is a rare form of Castleman's disease that occurs in people with hypersplenism, a condition in which the spleen is enlarged. It is characterized by the presence of lymphoid follicles in the spleen, lymph nodes, and bone marrow.\n4. Familial Castleman's disease: This is a rare form of Castleman's disease that occurs in families. It is characterized by the presence of lymphoid follicles in various organs, including the lymph nodes, spleen, and bone marrow.\n5. Castleman's disease associated with myeloproliferative neoplasms: This is a rare form of Castleman's disease that occurs in people with myeloproliferative neoplasms, such as polycythemia vera, essential thrombocythemia, or primary myelofibrosis. It is characterized by the presence of lymphoid follicles in the bone marrow, spleen, and lymph nodes.\n6. Castleman's disease associated with lymphoproliferative disorders: This is a rare form of Castleman's disease that occurs",
    "llama-2-7b-chat-hf_fact": [
      "Castleman's disease, also known as TAFRO syndrome, is a rare lymphoproliferative disorder characterized by the presence of lymphoid follicles in various organs.",
      "TAFRO syndrome accounts for about 70% of Castleman's disease cases.",
      "There is a form of Castleman's disease that occurs in people with HIV infection, known as HIV-associated Castleman's disease.",
      "Hypersplenism-associated Castleman's disease occurs in people with hypersplenism, where the spleen is enlarged.",
      "Familial Castleman's disease is a variant of Castleman's disease that is hereditary and occurs in families."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3904,
    "user_query": "Is Ixodes a species of tick?",
    "llama-2-7b-chat-hf_response": "Yes, Ixodes is a genus of ticks, which are small, blood-sucking arachnids that feed on the blood of mammals and birds. The genus Ixodes includes several species of ticks that are known to transmit diseases to humans and animals, such as Lyme disease, anaplasmosis, and ehrlichiosis. Some of the most common species of ticks in the genus Ixodes include Ixodes scapularis (the blacklegged tick), Ixodes pacificus (the western blacklegged tick), and Ixodes ricinus (the castor bean tick).",
    "llama-2-7b-chat-hf_fact": [
      "Ixodes is a genus of ticks.",
      "Ticks are small, blood-sucking arachnids that feed on the blood of mammals and birds.",
      "Ixodes ticks are known to transmit diseases to humans and animals, such as Lyme disease, anaplasmosis, and ehrlichiosis.",
      "Ixodes scapularis is also known as the blacklegged tick.",
      "Ixodes pacificus and Ixodes ricinus are known as the western blacklegged tick and the castor bean tick respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3906,
    "user_query": "Which was  the first oral drug for the treatment of multiple sclerosis by the US Food and Drug Administration (FDA)?",
    "llama-2-7b-chat-hf_response": "A) Avonex\nB) Betaseron\nC) Copaxone\nD) Tysabri\nAnswer: A) Avonex.\nAvonex (interferon beta-1a) was the first oral drug approved by the US Food and Drug Administration (FDA) for the treatment of multiple sclerosis (MS) in 1995. Betaseron (interferon beta-1b), Copaxone (glatiramer acetate), and Tysabri (natalizumab) are also FDA-approved for the treatment of MS, but Avonex was the first to be approved.",
    "llama-2-7b-chat-hf_fact": [
      "Avonex is an oral drug used to treat multiple sclerosis.",
      "The US Food and Drug Administration approved Avonex for treatment of multiple sclerosis in 1995.",
      "Avonex was the first oral drug approved by the FDA for the treatment of multiple sclerosis.",
      "Betaseron, Copaxone, and Tysabri are also FDA-approved for the treatment of multiple sclerosis.",
      "Avonex contains interferon beta-1a."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Avonex is not an oral drug, it's an injectable drug used to treat multiple sclerosis.",
      "true",
      "false, [corrected fact]: Avonex was not the first oral drug approved by the FDA for the treatment of multiple sclerosis, it's an injectable drug.",
      "true",
      "true"
    ]
  },
  {
    "id": 3909,
    "user_query": "What does fingolimod do to the grey matter of the brain?",
    "llama-2-7b-chat-hf_response": "Fingolimod, a drug used to treat multiple sclerosis, has been shown to have a significant impact on the grey matter of the brain. Studies have found that fingolimod can reduce the volume of grey matter in various regions of the brain, including the cortex, hippocampus, and cerebellum. This reduction in grey matter can lead to cognitive impairments, such as difficulties with memory, attention, and processing speed. Additionally, fingolimod has been shown to affect the integrity of neural connections within the brain, which can further contribute to cognitive decline. While the exact mechanisms by which fingolimod affects grey matter are not yet fully understood, these findings highlight the importance of monitoring cognitive function in patients treated with this drug.",
    "llama-2-7b-chat-hf_fact": [
      "Fingolimod is a drug used to treat multiple sclerosis.",
      "Studies indicate that fingolimod can reduce the volume of grey matter in various regions of the brain, including the cortex, hippocampus, and cerebellum.",
      "The reduction in grey matter due to fingolimod can lead to cognitive impairments, such as difficulties with memory, attention, and processing speed.",
      "Fingolimod affects the integrity of neural connections within the brain.",
      "The ways in which fingolimod affects grey matter are not yet fully understood."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3913,
    "user_query": "Explain the action of Balovaptan.",
    "llama-2-7b-chat-hf_response": "Balovaptan is a medication used to treat excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea/hypopnea syndrome (OSAHS). It works by increasing the activity of a neurotransmitter called orexin, which helps regulate the sleep-wake cycle. By increasing orexin activity, balovaptan helps to reduce excessive daytime sleepiness and improve alertness.",
    "llama-2-7b-chat-hf_fact": [
      "Balovaptan is a medication used to treat excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea/hypopnea syndrome (OSAHS).",
      "The drug works by increasing the activity of a neurotransmitter called orexin.",
      "Orexin is a neurotransmitter that helps regulate the sleep-wake cycle.",
      "By increasing orexin activity, balovaptan can improve alertness.",
      "Balovaptan helps to reduce excessive daytime sleepiness."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Balovaptan is being investigated for potential use in the treatment of Autism Spectrum Disorder, not excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.",
      "false, [corrected fact]: Balovaptan works by inhibiting the vasopressin V1a receptor, not by increasing the activity of the neurotransmitter orexin.",
      "true",
      "false, [corrected fact]: Balovaptan doesn't work by increasing orexin activity. Its mechanism of action involves the vasopressin V1a receptor.",
      "false, [corrected fact]: Balovaptan is not used to reduce excessive daytime sleepiness. It's being studied for potential use in treating Autism Spectrum Disorder."
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-7b-chat-hf_response": "SWIM tool is a bioinformatics tool that can identify genes that are down-regulated in glioblastoma compared to normal brain tissue. Here are some examples of genes that SWIM tool has identified as down-regulated in glioblastoma:\n1. TP53: TP53 is a tumor suppressor gene that is commonly mutated in glioblastoma. SWIM tool has identified TP53 as one of the most down-regulated genes in glioblastoma.\n2. PTEN: PTEN is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma. SWIM tool has identified PTEN as one of the most down-regulated genes in glioblastoma.\n3. CDKN2A: CDKN2A is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma. SWIM tool has identified CDKN2A as one of the most down-regulated genes in glioblastoma.\n4. STK11: STK11 is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma. SWIM tool has identified STK11 as one of the most down-regulated genes in glioblastoma.\n5. BRCA1: BRCA1 is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma. SWIM tool has identified BRCA1 as one of the most down-regulated genes in glioblastoma.\n6. BRCA2: BRCA2 is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma. SWIM tool has identified BRCA2 as one of the most down-regulated genes in glioblastoma.\n7. MLH1: MLH1 is a tumor suppressor gene that is down-regulated in many types of cancer, including glioblastoma. SWIM tool has identified MLH1 as one of the most down-regulated genes in glioblastoma.\n8. MSH2: MSH2 is a tumor suppressor gene that is down-regulated in many types of cancer",
    "llama-2-7b-chat-hf_fact": [
      "SWIM is a bioinformatics tool that identifies down-regulated genes in glioblastoma compared to normal brain tissue.",
      "TP53 is a tumor suppressor gene that SWIM tool has identified as down-regulated in glioblastoma.",
      "PTEN is another tumor suppressor gene that the SWIM tool has identified as down-regulated in glioblastoma.",
      "CDKN2A, a tumor suppressor gene, is identified by the SWIM tool as one of the most down-regulated genes in glioblastoma.",
      "The SWIM tool has identified STK11, a tumor suppressor gene, as down-regulated in glioblastoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3921,
    "user_query": "Which method has been developed for detection of ATAC-seq or ChIP-seq signals with DNA methylation?",
    "llama-2-7b-chat-hf_response": "ATAC-seq (Assay for Transposase-Accessible Chromatin) and ChIP-seq (Chromatin Immunoprecipitation sequencing) are both powerful tools for understanding the epigenetic landscape of cells. However, the signals detected by these methods can be challenging to interpret, particularly in the context of DNA methylation. To address this challenge, several methods have been developed for detecting ATAC-seq or ChIP-seq signals with DNA methylation. Here are some of the commonly used methods:\n1. MethylC-seq: This method combines ATAC-seq and DNA methylation profiling to identify regions of open chromatin that are also methylated. MethylC-seq involves treating cells with the demethylating agent 5-aza-2'-deoxycytidine, which removes methyl groups from cytosine residues in DNA. The resulting changes in chromatin accessibility are then profiled using ATAC-seq.\n2. ChIP-seq with methylation-specific antibodies: This method involves using antibodies that specifically bind to methylated cytosine residues in DNA. The immunoprecipitated DNA is then sequenced using ChIP-seq, allowing researchers to identify regions of the genome that are enriched for methylated cytosine residues.\n3. Methylation-specific PCR (MSP): This method involves using primers that specifically bind to methylated or unmethylated cytosine residues in DNA. The resulting PCR products are then analyzed using agarose gel electrophoresis or high-resolution melting analysis.\n4. Reduced representation bisulfite sequencing (RRBS): This method involves treating cells with bisulfite, which deaminates unmethylated cytosine residues but not methylated cytosine residues. The resulting DNA is then sequenced using RRBS, allowing researchers to identify regions of the genome that are methylated or unmethylated.\n5. Whole-genome bisulfite sequencing (WGBS): This method involves sequencing the entire genome using bisulfite-treated DNA. WGB",
    "llama-2-7b-chat-hf_fact": [
      "ATAC-seq (Assay for Transposase-Accessible Chromatin) and ChIP-seq (Chromatin Immunoprecipitation sequencing) are tools used to understand the epigenetic landscape of cells.",
      "MethylC-seq is a method that combines ATAC-seq and DNA methylation profiling to identify regions of open chromatin that are also methylated.",
      "ChIP-seq with methylation-specific antibodies involves usage of antibodies that specifically bind to methylated cytosine residues in DNA to identify the methylated regions.",
      "Methylation-specific PCR (MSP) is a method that involves the use of primers designed to specifically bind to methylated or unmethylated cytosine residues in DNA.",
      "Reduced representation bisulfite sequencing (RRBS) is a method where cells are treated with bisulfite, leading to deamination of unmethylated cytosine residues but not methylated cytosine residues. This allows researchers to identify regions of the genome that are methylated or unmethylated."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: MethylC-seq is a method that combines whole-genome bisulfite sequencing with high-throughput sequencing for DNA methylation analysis, not ATAC-seq.",
      "false, [corrected fact]: ChIP-seq uses precipitation with antibodies specific to proteins that bind DNA, not methylation-specific antibodies.",
      "true",
      "true"
    ]
  },
  {
    "id": 3922,
    "user_query": "Which protein is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks?",
    "llama-2-7b-chat-hf_response": "Answer: The protein involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks is called PRDM14. PRDM14 is a transcription factor that plays a crucial role in maintaining the pluripotency of embryonic stem cells by regulating the expression of key pluripotency genes and the three-dimensional organization of enhancer-promoter interactions.\nIn embryonic stem cells, PRDM14 is required for the maintenance of pluripotency by regulating the expression of key pluripotency genes, such as OCT4, SOX2, and NANOG. PRDM14 also plays a role in the regulation of the three-dimensional organization of enhancer-promoter interactions, which is important for the maintenance of pluripotency.\nStudies have shown that PRDM14 is required for the formation of three-dimensional enhancer-promoter interactions in embryonic stem cells, and that these interactions are important for the maintenance of pluripotency. For example, one study found that PRDM14 regulates the formation of a three-dimensional enhancer-promoter interaction between the OCT4 locus and a distant enhancer element, which is important for the maintenance of OCT4 expression and pluripotency.\nIn addition to its role in embryonic stem cells, PRDM14 has also been implicated in the regulation of pluripotency in other cell types, including cancer cells. For example, one study found that PRDM14 is required for the maintenance of pluripotency in cancer stem cells, and that PRDM14 regulates the expression of key pluripotency genes in these cells.\nOverall, PRDM14 is a key protein involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks, and its dysregulation has been implicated in a variety of diseases, including cancer.",
    "llama-2-7b-chat-hf_fact": [
      "PRDM14 is a protein involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks.",
      "PRDM14 is a transcription factor that maintains the pluripotency of embryonic stem cells by regulating the expression of key pluripotency genes and the three-dimensional organization of enhancer-promoter interactions.",
      "PRDM14 regulates the expression of key pluripotency genes in embryonic stem cells, such as OCT4, SOX2, and NANOG.",
      "PRDM14 is also implicated in the regulation of pluripotency in cancer stem cells.",
      "Dysregulation of PRDM14 has been implicated in a variety of diseases, including cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3923,
    "user_query": "Where is the agouti-related peptide expressed?",
    "llama-2-7b-chat-hf_response": "The agouti-related peptide (AgRP) is expressed in several tissues throughout the body, including:\n1. Brain: AgRP is expressed in several brain regions, including the hypothalamus, brainstem, and spinal cord.\n2. Pancreas: AgRP is expressed in pancreatic beta cells, where it plays a role in regulating glucose secretion and insulin secretion.\n3. Adipose tissue: AgRP is expressed in adipose tissue, where it regulates lipolysis and glucose metabolism.\n4. Liver: AgRP is expressed in the liver, where it regulates glucose metabolism and insulin sensitivity.\n5. Muscle: AgRP is expressed in skeletal muscle, where it regulates glucose uptake and metabolism.\n6. Immune cells: AgRP is also expressed in immune cells, such as macrophages and T cells, where it regulates inflammation and immune function.\nOverall, AgRP is expressed in a wide range of tissues, and its expression is involved in a variety of physiological processes, including energy homeostasis, glucose metabolism, and immune function.",
    "llama-2-7b-chat-hf_fact": [
      "The agouti-related peptide (AgRP) is expressed in several tissues throughout the body.",
      "In the brain - hypothalamus, brainstem, and spinal cord - AgRP is expressed.",
      "AgRP is also expressed in pancreatic beta cells, where it plays a role in regulating glucose secretion and insulin secretion.",
      "In adipose tissue, AgRP regulates lipolysis and glucose metabolism.",
      "AgRP's presence in skeletal muscles helps regulate glucose uptake and metabolism.",
      "AgRP is additionally expressed in immune cells such as macrophages and T cells, where it regulates inflammation and immune function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3924,
    "user_query": "What is the function of ketohexokinase-A?",
    "llama-2-7b-chat-hf_response": "Ketohexokinase-A is an enzyme that plays a crucial role in the metabolism of glucose and lipids in the body. It is responsible for phosphorylating ketone bodies, such as beta-hydroxybutyrate (BHB), and converting them into usable energy for the body.\nKetohexokinase-A is the first enzyme in the ketogenic pathway, which is activated when the body is in a state of ketosis. When glucose is in short supply, the body begins to break down fat for energy, producing ketone bodies as a byproduct. Ketohexokinase-A converts these ketone bodies into acetyl-CoA, which can then be used to produce energy in the form of ATP.\nIn addition to its role in ketogenesis, ketohexokinase-A has been shown to have anti-inflammatory and anti-oxidant effects, and may play a role in the prevention and treatment of various diseases, including cancer, neurodegenerative disorders, and metabolic disorders.\nOverall, ketohexokinase-A is a crucial enzyme that plays a central role in the metabolism of glucose and lipids in the body, and its dysregulation has been implicated in a variety of diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Ketohexokinase-A is an enzyme that plays a role in the metabolism of glucose and lipids in the body.",
      "The enzyme ketohexokinase-A phosphorylates ketone bodies, such as beta-hydroxybutyrate (BHB), and converts them into usable energy.",
      "Ketohexokinase-A is the first enzyme in the ketogenic pathway.",
      "Ketone bodies are produced as a byproduct when the body breaks down fat for energy in a state of ketosis.",
      "Dysregulation of ketohexokinase-A has been implicated in a variety of diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The enzyme ketohexokinase-A phosphorylates fructose, not ketone bodies, and does not convert them into usable energy directly.",
      "false, [corrected fact]: Ketohexokinase-A is actually an enzyme in the fructose metabolism pathway, not in the ketogenic pathway.",
      "true",
      "true"
    ]
  },
  {
    "id": 3925,
    "user_query": "Are the major royal jelly proteins similar to the yellow proteins?",
    "llama-2-7b-chat-hf_response": "Royal jelly is a complex mixture of proteins, carbohydrates, and other compounds produced by honey bees (Apis mellifera) to feed their larvae. The major royal jelly proteins (MRJPs) are a group of proteins that have been isolated and characterized from royal jelly. These proteins are similar in size and structure to the yellow proteins (YPs) found in honey bee venom.",
    "llama-2-7b-chat-hf_fact": [
      "Royal jelly is produced by honey bees (Apis mellifera) to feed their larvae.",
      "Royal jelly is a complex mixture of proteins, carbohydrates, and other compounds.",
      "The major royal jelly proteins (MRJPs) are a group of proteins that have been isolated and characterized from royal jelly.",
      "MRJPs are similar in size and structure to the yellow proteins (YPs).",
      "Yellow proteins (YPs) are found in honey bee venom."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for studying TADs, including:\n1. TADbit: This package provides a comprehensive set of tools for the analysis of TADs, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n2. TADtrack: This package provides a set of tools for the analysis of TADs, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n3. TADeep: This package provides a set of tools for the analysis of TADs, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n4. ChromHMM: This package provides a set of tools for the analysis of chromatin structure and TADs, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n5. ChromTAD: This package provides a set of tools for the analysis of TADs, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n6. TAD-seq: This package provides a set of tools for the analysis of TADs from ChIP-seq data, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n7. TAD-caller: This package provides a set of tools for the identification of TADs from ChIP-seq data, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n8. TAD-profile: This package provides a set of tools for the analysis of TADs from ChIP-seq data, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n9. TAD-diff: This package provides a set of tools for the analysis of TADs from ChIP-seq data, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\n10. TAD-track: This package provides a set of tools for the analysis of TADs from ChIP-seq data, including the ability to identify TADs, analyze their chromatin structure, and study their functional implications.\nThese packages provide a",
    "llama-2-7b-chat-hf_fact": [
      "TADbit is an R package developed for studying TADs.",
      "TADtrack is an R package developed for studying TADs.",
      "TADeep is an R package developed for studying TADs.",
      "ChromHMM is an R package developed for studying chromatin structure and TADs.",
      "ChromTAD is an R package developed for studying TADs."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "false, [corrected fact]: ChromHMM is a Java tool developed for studying chromatin state and structure, not specifically for TADs.",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-7b-chat-hf_response": "Answer: There are several bioconductor tools that have been developed for accessing bacterial regulatory networks. Some of the popular ones include:\n1. BIOCARTA: BIOCARTA is a bioconductor package that provides a comprehensive framework for the analysis of bacterial regulatory networks. It includes tools for the analysis of transcriptional regulation, protein-DNA interactions, and gene expression data.\n2. RegulonDB: RegulonDB is a bioconductor package that provides a comprehensive database of bacterial regulatory networks. It includes tools for the analysis of transcriptional regulation, protein-DNA interactions, and gene expression data.\n3. BactoCyc: BactoCyc is a bioconductor package that provides a comprehensive database of bacterial metabolic pathways and regulatory networks. It includes tools for the analysis of gene expression data, protein-DNA interactions, and metabolic pathways.\n4. BioCyc: BioCyc is a bioconductor package that provides a comprehensive database of bacterial metabolic pathways and regulatory networks. It includes tools for the analysis of gene expression data, protein-DNA interactions, and metabolic pathways.\n5. KEGG: KEGG is a bioconductor package that provides a comprehensive database of bacterial metabolic pathways and regulatory networks. It includes tools for the analysis of gene expression data, protein-DNA interactions, and metabolic pathways.\nThese are some of the popular bioconductor tools that have been developed for accessing bacterial regulatory networks. Each of these tools has its own strengths and limitations, and the choice of tool will depend on the specific research question and experimental design.",
    "llama-2-7b-chat-hf_fact": [
      "BIOCARTA is a bioconductor package designed for the analysis of bacterial regulatory networks.",
      "RegulonDB is another bioconductor package that provides a comprehensive database of bacterial regulatory networks.",
      "BactoCyc is a bioconductor package that provides a database of bacterial metabolic pathways and regulatory networks.",
      "BioCyc is a bioconductor package which includes tools for the analysis of gene expression data, protein-DNA interactions, and metabolic pathways.",
      "KEGG is a bioconductor package offering a comprehensive database of bacterial metabolic pathways and regulatory networks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: BIOCARTA is not a bioconductor package. It is a database of biological pathways, including regulatory networks, in human.",
      "false, [corrected fact]: RegulonDB is not a bioconductor package. It is a database that captures knowledge of the regulation of gene expression in the bacterium Escherichia coli.",
      "false, [corrected fact]: BactoCyc is not a bioconductor package. It is an integrated database system collecting curated data on bacterial metabolic and regulatory networks.",
      "true",
      "false, [corrected fact]: KEGG is not a bioconductor package. It is a database resource that integrates genomic, chemical, and systemic functional information."
    ]
  },
  {
    "id": 3928,
    "user_query": "Is the Apis mellifera genome available?",
    "llama-2-7b-chat-hf_response": "Yes, the genome of the Western honey bee (Apis mellifera) was sequenced in 2006 and the data was released to the public in 2007. The genome consists of approximately 300 million base pairs of DNA and contains around 30,000 protein-coding genes.",
    "llama-2-7b-chat-hf_fact": [
      "The genome of the Western honey bee, also known as Apis mellifera, was sequenced in 2006.",
      "The data of the Apis mellifera's genome was released to the public in 2007.",
      "The genome of the Apis mellifera consists of approximately 300 million base pairs of DNA.",
      "The genome of the Apis mellifera contains around 30,000 protein-coding genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "false, [corrected fact]: The genome of the Apis mellifera contains around 10,000 to 15,000 protein-coding genes."
    ]
  },
  {
    "id": 3929,
    "user_query": "What genes is implicated in myotonic goats and other  nondystrophic myotonias?",
    "llama-2-7b-chat-hf_response": "Myotonic goats are a breed of goat that is characterized by muscle stiffness and weakness. This condition is caused by mutations in the MH1 gene, which codes for a protein called myotonic dystrophy protein kinase (MyoD). MyoD is involved in regulating muscle contraction and relaxation, and mutations in the MH1 gene disrupt this process, leading to muscle stiffness and weakness.\nOther nondystrophic myotonias, such as myotonic dystrophy type 2 (DM2), are also caused by mutations in genes that code for proteins involved in muscle contraction and relaxation. These genes include:\n* MH2 gene: This gene codes for a protein called myotonic dystrophy protein kinase (MyoD2), which is similar to MyoD and is also involved in regulating muscle contraction and relaxation. Mutations in the MH2 gene can cause DM2.\n* CNBP gene: This gene codes for a protein called CNBP, which is involved in regulating the expression of genes involved in muscle contraction and relaxation. Mutations in the CNBP gene can cause a form of myotonia called congenital myotonic dystrophy (CMD).\n* PPAR gene: This gene codes for a protein called peroxisome proliferator-activated receptor gamma (PPAR), which is involved in regulating glucose and lipid metabolism. Mutations in the PPAR gene can cause a form of myotonia called PPAR-related myotonia.\n* KCNQ2 and KCNQ3 genes: These genes code for proteins called potassium channels, which are involved in regulating muscle contraction and relaxation. Mutations in these genes can cause a form of myotonia called hypokalemic periodic paralysis (HPP).\n* SCN4A gene: This gene codes for a protein called sodium channel alpha subunit (SCN4A), which is involved in regulating muscle contraction and relaxation. Mutations in the SCN4A gene can cause a form of myotonia called sodium channelopathy.\nIt is important to note",
    "llama-2-7b-chat-hf_fact": [
      "Myotonic goats suffer from muscle stiffness and weakness due to mutations in the MH1 gene which codes for myotonic dystrophy protein kinase (MyoD).",
      "Myotonic dystrophy type 2 (DM2) is caused by mutations in the MH2 gene that codes for myotonic dystrophy protein kinase (MyoD2).",
      "Mutations in the CNBP gene can cause congenital myotonic dystrophy (CMD).",
      "A form of myotonia called PPAR-related myotonia is caused by mutations in the PPAR gene.",
      "Hypokalemic periodic paralysis (HPP) is a form of myotonia caused by mutations in the KCNQ2 and KCNQ3 genes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Myotonic goats, also known as fainting goats, suffer from muscle stiffness due to mutations in the CLCN1 gene, not the MH1 gene.",
      "false, [corrected fact]: Myotonic dystrophy type 2 (DM2) is caused by mutations in the CNBP gene (formerly known as ZNF9), not the MH2 gene.",
      "true",
      "unknown",
      "false, [corrected fact]: Hypokalemic periodic paralysis is caused by mutations in the CACNA1S and SCN4A genes, not the KCNQ2 and KCNQ3 genes."
    ]
  },
  {
    "id": 3931,
    "user_query": "Is cadherin a plasma membrane marker?",
    "llama-2-7b-chat-hf_response": "Cadherin is a transmembrane protein that is primarily localized to the plasma membrane. It plays a crucial role in cell-cell adhesion and communication, and is involved in various cellular processes such as cell migration, differentiation, and survival. As a plasma membrane marker, cadherin can be used to identify and isolate specific cell types or to study the dynamics of cell-cell adhesion.",
    "llama-2-7b-chat-hf_fact": [
      "Cadherin is a transmembrane protein.",
      "Cadherin is primarily localized to the plasma membrane.",
      "Cadherin plays a role in cell-cell adhesion and communication.",
      "Cadherin is involved in cell migration, differentiation, and survival.",
      "Cadherin can be used as a plasma membrane marker to identify and isolate specific cell types."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-7b-chat-hf_response": "The shikimate pathway is a metabolic pathway found in bacteria, fungi, and some plants. It is involved in the biosynthesis of aromatic amino acids, such as phenylalanine, tyrosine, and tryptophan, as well as other compounds like quinates and polyketides. The end products of the shikimate pathway are:",
    "llama-2-7b-chat-hf_fact": [
      "The shikimate pathway is a metabolic pathway found in bacteria, fungi, and some plants.",
      "The shikimate pathway is involved in the biosynthesis of aromatic amino acids.",
      "Phenylalanine, tyrosine, and tryptophan are some of the aromatic amino acids produced through the shikimate pathway.",
      "The shikimate pathway also contributes to the production of compounds like quinates and polyketides.",
      "The end products of the shikimate pathway include aromatic amino acids and other compounds."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3934,
    "user_query": "What are the uber-operons?",
    "llama-2-7b-chat-hf_response": "The uber-operons are a set of operons that are thought to play a key role in the regulation of gene expression in bacteria. The term \"uber-operon\" was coined to describe these operons because they are larger and more complex than the typical operons found in bacteria.",
    "llama-2-7b-chat-hf_fact": [
      "Uber-operons are a set of operons.",
      "Uber-operons play a key role in the regulation of gene expression in bacteria.",
      "The term \"uber-operon\" was specifically coined to describe these particular operons.",
      "Uber-operons are larger and more complex than the typical operons found in bacteria."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-7b-chat-hf_response": "Cabergoline is a dopamine receptor agonist that is FDA-approved for the treatment of hyperprolactinemia (elevated prolactin levels) and is sometimes used off-label for the treatment of Nelson's syndrome. Nelson's syndrome is a rare condition that occurs after surgical removal of a pituitary tumor and is characterized by excessive growth of the remaining pituitary tissue, leading to hyperpituitarism (elevated levels of multiple hormones). Cabergoline has been shown to be effective in reducing the levels of prolactin and other hormones in patients with hyperpituitarism, including those with Nelson's syndrome. However, it is important to note that cabergoline is not FDA-approved for the treatment of Nelson's syndrome, and its use for this condition is considered off-label.",
    "llama-2-7b-chat-hf_fact": [
      "Cabergoline is a dopamine receptor agonist.",
      "The FDA has approved cabergoline for the treatment of hyperprolactinemia.",
      "Nelson's syndrome is a rare condition that occurs after the surgical removal of a pituitary tumor.",
      "Cabergoline has been used off-label to treat Nelson's syndrome.",
      "Cabergoline can reduce the levels of prolactin and other hormones in patients with hyperpituitarism."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false, [corrected fact]: Cabergoline can reduce the levels of prolactin in patients with hyperprolactinemia, not hyperpituitarism."
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-7b-chat-hf_response": "Liebenberg syndrome is a rare autoimmune disorder that affects the nervous system. The main manifestation of Liebenberg syndrome is progressive weakness and wasting of the muscles, particularly in the face, arms, and legs. Other symptoms may include:\n* Weakness in the muscles of the face, leading to drooping eyelids, weakness of the facial muscles, and difficulty closing the eyes.\n* Weakness in the muscles of the arms and legs, leading to difficulty walking, balance problems, and muscle wasting.\n* Numbness or tingling sensations in the hands and feet.\n* Difficulty with speech and swallowing.\n* Vision problems, including blurred vision, double vision, and loss of peripheral vision.\n* Seizures and other neurological problems.\nIt is important to note that the symptoms of Liebenberg syndrome can vary in severity and may progress over time. A diagnosis of Liebenberg syndrome is typically made through a combination of clinical evaluation, laboratory tests, and imaging studies. Treatment for Liebenberg syndrome typically involves a combination of medications and physical therapy to manage symptoms and slow the progression of the disease.",
    "llama-2-7b-chat-hf_fact": [
      "Liebenberg syndrome is a rare autoimmune disorder that affects the nervous system.",
      "The main manifestation of Liebenberg syndrome is progressive weakness and wasting of the muscles particularly in the face, arms, and legs.",
      "Numbness or tingling sensations in the hands and feet can be a symptom of Liebenberg syndrome.",
      "Difficulty with speech and swallowing, as well as vision problems including blurred vision, double vision, and loss of peripheral vision, can be symptoms of Liebenberg syndrome.",
      "The diagnosis and treatment for Liebenberg syndrome involve clinical evaluation, laboratory tests, imaging studies, medications, and physical therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Liebenberg syndrome is not an autoimmune disorder affecting the nervous system. It is a condition characterized by the development of excess muscular tissue in the forearm, leading to limited movement in the wrists and elbows.",
      "false, [corrected fact]: The main manifestation of Liebenberg syndrome is not progressive muscle wasting and weakness, but instead, the development of excess muscle mass in the forearm.",
      "false, [corrected fact]: Numbness or tingling sensations in the hands and feet are not typically associated with Liebenberg syndrome.",
      "false, [corrected fact]: Difficulty with speech, swallowing, and vision problems are not generally symptoms of Liebenberg syndrome.",
      "true"
    ]
  },
  {
    "id": 3940,
    "user_query": "Which IDH inhibitors by Agios Pharmaceuticals have been approved by the FDA?",
    "llama-2-7b-chat-hf_response": "None of the IDH inhibitors developed by Agios Pharmaceuticals have been approved by the FDA.\nAnswer: None of the IDH inhibitors developed by Agios Pharmaceuticals have been approved by the FDA.\nExplanation: Agios Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for cancer and rare genetic disorders. They have developed several IDH inhibitors, which are a class of drugs that target the enzyme isocitrate dehydrogenase (IDH). However, none of these inhibitors have been approved by the US Food and Drug Administration (FDA) for any indication.",
    "llama-2-7b-chat-hf_fact": [
      "Agios Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for cancer and rare genetic disorders.",
      "Agios Pharmaceuticals has developed several IDH inhibitors.",
      "IDH inhibitors are a class of drugs that target the enzyme isocitrate dehydrogenase (IDH).",
      "None of the IDH inhibitors developed by Agios Pharmaceuticals have been approved by the US Food and Drug Administration (FDA)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Some of the IDH inhibitors developed by Agios Pharmaceuticals have been approved by the US Food and Drug Administration (FDA)."
    ]
  },
  {
    "id": 3941,
    "user_query": "What is RADICL-seq?",
    "llama-2-7b-chat-hf_response": "RADICL-seq is a method for single-cell transcriptomics that allows for the simultaneous analysis of gene expression and DNA methylation at the single-cell level. It combines the advantages of both RNA sequencing (RNA-seq) and reduced representation bisulfite sequencing (RRBS) to provide a more comprehensive understanding of cellular heterogeneity and epigenetic regulation.\nIn RADICL-seq, single cells are first isolated using microfluidics or other methods, and then subjected to RNA sequencing and reduced representation bisulfite sequencing. The resulting data are then integrated to provide a comprehensive view of gene expression and DNA methylation at the single-cell level.\nThe advantages of RADICL-seq include:\n1. High resolution: RADICL-seq allows for the analysis of gene expression and DNA methylation at the single-cell level, providing a high resolution view of cellular heterogeneity.\n2. Comprehensive view: By integrating RNA sequencing and reduced representation bisulfite sequencing data, RADICL-seq provides a comprehensive view of cellular regulation, including both gene expression and epigenetic marks.\n3. Minimizes bias: RADICL-seq minimizes bias by using a combination of RNA sequencing and reduced representation bisulfite sequencing, which provides a more accurate representation of cellular heterogeneity.\n4. Scalability: RADICL-seq can be used to analyze large numbers of cells, making it a powerful tool for studying complex tissues and systems.\n5. Cost-effective: RADICL-seq is a cost-effective method compared to other single-cell transcriptomics methods, making it more accessible to researchers.\nIn summary, RADICL-seq is a powerful tool for single-cell transcriptomics that allows for the simultaneous analysis of gene expression and DNA methylation at the single-cell level. Its high resolution, comprehensive view, minimization of bias, scalability, and cost-effectiveness make it a valuable tool for understanding cellular heterogeneity and epigenetic regulation.",
    "llama-2-7b-chat-hf_fact": [
      "RADICL-seq is a method for single-cell transcriptomics that enables simultaneous analysis of gene expression and DNA methylation.",
      "The RADICL-seq process integrates RNA sequencing (RNA-seq) and reduced representation bisulfite sequencing (RRBS).",
      "Single cells are isolated using microfluidics or other methods in the RADICL-seq procedure.",
      "RADICL-seq allows for the study of gene expression and DNA methylation at the single-cell level, offering a detailed view of cellular heterogeneity.",
      "RADICL-seq can be used to analyze a large number of cells, which makes it a useful tool for studying complex tissues and systems."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3942,
    "user_query": "Which disease is treated with AntiSiglec-8 Antibody?",
    "llama-2-7b-chat-hf_response": "Anti-Siglec-8 antibody is used to treat a variety of diseases, including:\n1. Cancer: Anti-Siglec-8 antibody has been shown to have anti-tumor effects in various types of cancer, including breast, lung, and colon cancer.\n2. Autoimmune diseases: Anti-Siglec-8 antibody has been investigated as a potential treatment for autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.\n3. Neurodegenerative diseases: Anti-Siglec-8 antibody has been studied as a potential treatment for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.\n4. Cardiovascular diseases: Anti-Siglec-8 antibody has been investigated as a potential treatment for cardiovascular diseases such as atherosclerosis and heart failure.\n5. Inflammatory diseases: Anti-Siglec-8 antibody has been studied as a potential treatment for inflammatory diseases such as asthma and chronic obstructive pulmonary disease (COPD).\nIt is important to note that while Anti-Siglec-8 antibody has shown promise in preclinical studies, its efficacy and safety in humans have not yet been fully evaluated in clinical trials.",
    "llama-2-7b-chat-hf_fact": [
      "Anti-Siglec-8 antibody is under investigation for treating various types of cancer, including breast, lung, and colon.",
      "Multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease are autoimmune diseases potentiality treated with Anti-Siglec-8 antibody.",
      "Anti-Siglec-8 antibody has been studied as a potential treatment for neurodegenerative diseases like Alzheimer's disease and Parkinson's disease.",
      "It has been investigated as a potential treatment for cardiovascular diseases such as atherosclerosis and heart failure.",
      "Anti-Siglec-8 antibody is under investigation for treating inflammatory diseases like asthma and chronic obstructive pulmonary disease (COPD)."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3945,
    "user_query": "What is the effect of notch in the division of neural progenitor cells in Drosophila?",
    "llama-2-7b-chat-hf_response": "Notch signaling is known to play a crucial role in the regulation of neural progenitor cell (NPC) division in Drosophila. Notch signaling can either promote or inhibit NPC division, depending on the stage of development and the specific context.\nDuring early embryogenesis, Notch signaling promotes NPC division by maintaining the proliferative state of these cells. This is achieved through the activation of the transcription factor E2F, which promotes cell cycle progression. In addition, Notch signaling can also regulate the expression of genes involved in cell cycle progression, such as Cyclin D.\nLater in development, Notch signaling can also inhibit NPC division by repressing the expression of genes involved in cell cycle progression. This is achieved through the inhibition of the transcription factor E2F, which is a key regulator of cell cycle progression. In addition, Notch signaling can also regulate the expression of genes involved in cell cycle arrest, such as p21.\nOverall, the effect of Notch signaling on NPC division in Drosophila is complex and context-dependent, and can vary depending on the stage of development and the specific cellular context.",
    "llama-2-7b-chat-hf_fact": [
      "Notch signaling plays a role in the regulation of neural progenitor cell (NPC) division in Drosophila.",
      "During early embryogenesis, Notch signaling promotes NPC division by maintaining the proliferative state of these cells.",
      "This promotion of NPC division is achieved through the activation of the transcription factor E2F.",
      "Later in development, Notch signaling can inhibit NPC division by repressing the expression of genes involved in cell cycle progression.",
      "This inhibition of NPC division is achieved through the inhibition of the transcription factor E2F."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3950,
    "user_query": "What syndrome is associated with mutations in lysine methyltransferase 2D KMT2D?",
    "llama-2-7b-chat-hf_response": "Lysine methyltransferase 2D (KMT2D) is a protein that plays a crucial role in regulating gene expression by adding a methyl group to specific lysine residues on histone proteins. Mutations in KMT2D have been associated with a variety of human diseases, including:\n1. Beckwith-Wiedemann syndrome (BWS): BWS is a rare genetic disorder characterized by overgrowth, abdominal wall defects, and an increased risk of developing certain cancers. Mutations in KMT2D are a common cause of BWS.\n2. Silver-Russell syndrome (SRS): SRS is a rare genetic disorder characterized by growth restriction, feeding difficulties, and developmental delays. Mutations in KMT2D have been identified in some cases of SRS.\n3. Neurodevelopmental disorders: Mutations in KMT2D have been associated with a range of neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and epilepsy.\n4. Cancer: Mutations in KMT2D have been identified in various types of cancer, including lung, breast, and colon cancer.\n5. Immunological disorders: Mutations in KMT2D have been associated with immunological disorders, including autoimmune diseases such as type 1 diabetes and rheumatoid arthritis.\nOverall, mutations in KMT2D can have significant consequences for human health, and further research is needed to fully understand the mechanisms underlying these disorders.",
    "llama-2-7b-chat-hf_fact": [
      "KMT2D is a protein that adds a methyl group to specific lysine residues on histone proteins.",
      "Mutations in KMT2D have been linked to human diseases including Beckwith-Wiedemann syndrome, Silver-Russell syndrome, neurodevelopmental disorders, cancer, and immunological disorders.",
      "Beckwith-Wiedemann syndrome, characterized by overgrowth, abdominal wall defects, and an increased risk of certain cancers, is often caused by mutations in KMT2D.",
      "Silver-Russell syndrome, a condition characterized by growth restriction, feeding difficulties, and developmental delays, can potentially result from mutations in KMT2D.",
      "KMT2D mutations have been found in some types of cancer, including lung, breast, and colon cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Beckwith-Wiedemann syndrome is often caused by mutations in genes like CDKN1C, not KMT2D.",
      "false, [corrected fact]: Silver-Russell syndrome is typically associated with mutations in genes like IGF2 and H19, not KMT2D.",
      "true"
    ]
  },
  {
    "id": 3951,
    "user_query": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?",
    "llama-2-7b-chat-hf_response": "Steroid 5-alpha-reductase (5AR) is an enzyme that plays a crucial role in the biosynthesis of steroid hormones, including testosterone and estrogen. Mutations in the 5AR gene can lead to a deficiency in 5AR enzyme activity, which can result in various clinical manifestations, including hermaphroditism.\nHermaphroditism, also known as intersex, is a congenital condition in which an individual has reproductive or sexual anatomy that doesn't fit typical male or female classifications. In individuals with 5AR deficiency, the genitalia may not develop typically, leading to a mix of male and female characteristics.\nThe exact mechanism by which 5AR deficiency leads to hermaphroditism is not fully understood, but it is thought to involve disruptions in the normal development of the reproductive system during fetal development. The 5AR enzyme is essential for the conversion of testosterone to 5-alpha-dihydrotestosterone (5-alpha-DHT), which is a potent androgen that plays a critical role in the development of male reproductive structures. Without sufficient 5AR enzyme activity, the development of male genitalia may be disrupted, leading to a mix of male and female characteristics.\nIt's worth noting that 5AR deficiency is a rare condition, and the vast majority of individuals with hermaphroditism have other underlying causes, such as genetic mutations or exposure to certain hormones during fetal development. However, 5AR deficiency is one potential cause of hermaphroditism, and it's important to consider this diagnosis in individuals with atypical reproductive anatomy.",
    "llama-2-7b-chat-hf_fact": [
      "Steroid 5-alpha-reductase (5AR) is an enzyme which is involved in the biosynthesis of steroid hormones such as testosterone and estrogen.",
      "Mutations in the 5AR gene can lead to a deficiency of the 5AR enzyme activity, which can cause various clinical manifestations including hermaphroditism.",
      "Hermaphroditism, also referred to as intersex, is a condition in which an individual has reproductive or sexual anatomy that doesn't fit the typical classifications of male or female.",
      "The 5AR enzyme converts testosterone to 5-alpha-dihydrotestosterone (5-alpha-DHT), a potent androgen that is critical in the development of male reproductive structures.",
      "5AR deficiency is a rare condition and one potential cause of hermaphroditism. However, most people with hermaphroditism have other underlying causes such as genetic mutations or exposure to certain hormones during fetal development."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3955,
    "user_query": "What is the function of osteolectin?",
    "llama-2-7b-chat-hf_response": "Osteolectin is a protein that is produced by osteoblasts, which are cells that are responsible for bone formation. Osteolectin plays a crucial role in the regulation of bone metabolism and homeostasis. Here are some of the functions of osteolectin:\n1. Bone formation: Osteolectin is involved in the formation of new bone tissue during the process of bone modeling and remodeling. It helps to regulate the proliferation and differentiation of osteoblasts, which are the cells that produce bone tissue.\n2. Bone remodeling: Osteolectin also plays a role in the process of bone remodeling, which is the process by which bone tissue is broken down and replaced with new tissue. Osteolectin helps to regulate the activity of osteoclasts, which are the cells that break down bone tissue.\n3. Hormone regulation: Osteolectin can regulate the activity of hormones that are involved in bone metabolism, such as parathyroid hormone and vitamin D.\n4. Cell signaling: Osteolectin can also act as a signaling molecule, helping to regulate the communication between osteoblasts and other cells in the bone.\n5. Cancer: Osteolectin has been implicated in the development and progression of bone cancer, such as osteosarcoma.\nOverall, osteolectin plays a crucial role in the regulation of bone metabolism and homeostasis, and its dysregulation can lead to a range of bone-related disorders.",
    "llama-2-7b-chat-hf_fact": [
      "Osteolectin is a protein produced by osteoblasts, cells that are responsible for bone formation.",
      "Osteolectin helps regulate the proliferation and differentiation of osteoblasts.",
      "It plays a role in the process of bone remodeling, helping to regulate the activity of osteoclasts, the cells that break down bone tissue.",
      "Osteolectin can act as a signaling molecule, aiding communication between osteoblasts and other cells in the bone.",
      "Osteolectin has been implicated in the development and progression of bone diseases like osteosarcoma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3959,
    "user_query": "Are PDXK mutations linked to polyneuropathy?",
    "llama-2-7b-chat-hf_response": "Yes, PDXK mutations have been found to be associated with a rare genetic disorder called Charcot-Marie-Tooth disease (CMT), which is a group of inherited disorders that affect the peripheral nervous system (PNS). CMT is characterized by progressive damage to the nerves that control muscles and sensation in the hands and feet, leading to muscle weakness, numbness, and loss of coordination.\nPDXK mutations are specifically associated with CMT type 1A, which is the most common form of the disorder. CMT type 1A is caused by mutations in the PMP22 gene, which codes for the protein peripherin, which is important for maintaining the structure and function of the nerve fibers in the PNS.\nStudies have shown that individuals with CMT type 1A have a higher frequency of PDXK mutations compared to the general population, suggesting that these mutations may play a role in the pathogenesis of the disorder. However, it is important to note that not all individuals with CMT type 1A have PDXK mutations, and not all individuals with PDXK mutations have CMT type 1A.\nIn summary, PDXK mutations are associated with CMT type 1A, a rare genetic disorder that affects the peripheral nervous system. While not all individuals with CMT type 1A have PDXK mutations, these mutations may play a role in the pathogenesis of the disorder.",
    "llama-2-7b-chat-hf_fact": [
      "PDXK mutations are linked with a genetic disorder called Charcot-Marie-Tooth disease (CMT).",
      "Charcot-Marie-Tooth disease is a group of inherited disorders affecting the peripheral nervous system.",
      "CMT type 1A, which is associated with PDXK mutations, is the most common form of Charcot-Marie-Tooth disease.",
      "CMT type 1A is caused by mutations in the PMP22 gene which codes for the protein peripherin.",
      "PDXK mutations are found more frequently in individuals with CMT type 1A than in the general population."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: PDXK mutations are not known to be linked with Charcot-Marie-Tooth disease (CMT). They are associated with a type of anemia.",
      "true",
      "false, [corrected fact]: CMT type 1A is the most common form of Charcot-Marie-Tooth disease, but it is not associated with PDXK mutations.",
      "true",
      "false, [corrected fact]: PDXK mutations are not associated with CMT type 1A or any form of CMT, therefore they are not found more frequently in individuals with CMT type 1A than in the general population."
    ]
  },
  {
    "id": 3963,
    "user_query": "Which RNA polymerase transcribes enhancer RNAs?",
    "llama-2-7b-chat-hf_response": "Enhancer RNAs (eRNAs) are non-coding RNAs that play a crucial role in regulating gene expression by enhancing the transcription of target genes. The process of eRNA transcription is mediated by RNA polymerase II (RNAPII), which is the primary enzyme responsible for transcribing messenger RNAs (mRNAs) in eukaryotic cells. However, recent studies have shown that RNAPII can also transcribe eRNAs in a process that is distinct from mRNA transcription.\nOne of the key differences between eRNA transcription and mRNA transcription is the presence of an enhancer element in the eRNA transcriptional start site. Enhancers are cis-acting elements that can be located far away from the promoter and gene they regulate, and they work by looping back to the promoter to increase the recruitment of RNAPII. The presence of an enhancer element in the eRNA transcriptional start site is essential for the recruitment of RNAPII and the initiation of eRNA transcription.\nIn summary, RNA polymerase II (RNAPII) transcribes enhancer RNAs (eRNAs) in a process that is distinct from mRNA transcription, and the presence of an enhancer element in the eRNA transcriptional start site is essential for the recruitment of RNAPII.",
    "llama-2-7b-chat-hf_fact": [
      "Enhancer RNAs (eRNAs) are non-coding RNAs that play a role in regulating gene expression by enhancing the transcription of target genes.",
      "RNA polymerase II (RNAPII) mediates the process of eRNA transcription.",
      "RNA polymerase II is also the primary enzyme responsible for transcribing messenger RNAs (mRNAs) in eukaryotic cells.",
      "The process of transcribing eRNAs by RNAPII is distinct from mRNA transcription.",
      "The presence of an enhancer element in the eRNA transcriptional start site is vital for the recruitment of RNAPII and the initiation of eRNA transcription."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3965,
    "user_query": "Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?",
    "llama-2-7b-chat-hf_response": "According to a recent study published in the journal Cancer Research, co-loss of BRCA2-RB1 may be associated with a better prognosis for prostate cancer patients. The study found that among prostate cancer patients who had co-loss of BRCA2-RB1, the cancer was more likely to be confined to the prostate at the time of diagnosis, and the patients were less likely to experience disease progression or death compared to those who did not have co-loss of BRCA2-RB1.\nThe BRCA2-RB1 gene is a tumor suppressor gene that helps to regulate cell growth and division. Mutations in this gene have been linked to an increased risk of breast and ovarian cancer, as well as prostate cancer. The study suggests that co-loss of BRCA2-RB1 may play a role in the development and progression of prostate cancer, and that it may be a useful biomarker for predicting prognosis in prostate cancer patients.\nIt is important to note that this study only found an association between co-loss of BRCA2-RB1 and better prognosis, and did not prove cause and effect. Further research is needed to confirm these findings and to better understand the role of BRCA2-RB1 in prostate cancer.\nIn summary, the study suggests that co-loss of BRCA2-RB1 may be associated with a better prognosis for prostate cancer patients, but more research is needed to confirm these findings.",
    "llama-2-7b-chat-hf_fact": [
      "The Cancer Research journal published a study that suggested co-loss of BRCA2-RB1 could be associated with a better prognosis for prostate cancer patients.",
      "The study observed that among prostate cancer patients with co-loss of BRCA2-RB1, the cancer was often still confined to the prostate at the time of diagnosis.",
      "Patients with co-loss of BRCA2-RB1 were less likely to experience disease progression or death as compared to those without this co-loss, according to the study.",
      "The BRCA2-RB1 gene is a tumor suppressor gene that helps regulate cell growth and division.",
      "Mutations in the BRCA2-RB1 gene have been linked to an increased risk of breast and ovarian cancer, as well as prostate cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false, [corrected fact]: BRCA2 and RB1 are two separate tumor suppressor genes that help regulate cell growth and division.",
      "true"
    ]
  },
  {
    "id": 3967,
    "user_query": "Which cell secretes the enzyme tryptase?",
    "llama-2-7b-chat-hf_response": "Tryptase is an enzyme that is secreted by a variety of cells in the body, including:\n1. Mast cells: Mast cells are a type of immune system cell that play a role in allergic reactions and inflammation. They release histamine and other chemical mediators, including tryptase, in response to allergens or other stimuli.\n2. Basophils: Basophils are another type of immune system cell that play a role in allergic reactions and inflammation. They also release histamine and other chemical mediators, including tryptase, in response to allergens or other stimuli.\n3. Neutrophils: Neutrophils are a type of white blood cell that play a role in fighting bacterial infections. They can also release tryptase in response to certain stimuli.\n4. Eosinophils: Eosinophils are a type of white blood cell that play a role in fighting parasitic infections and in allergic reactions. They can also release tryptase in response to certain stimuli.",
    "llama-2-7b-chat-hf_fact": [
      "Tryptase is an enzyme secreted by several types of cells in the body.",
      "Mast cells, a type of immune system cell, secrete tryptase.",
      "Basophils, another type of immune system cell, also secrete tryptase.",
      "Neutrophils, a type of white blood cell, can release tryptase in response to certain stimuli.",
      "Eosinophils, another type of white blood cell, can release tryptase in response to certain stimuli."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Neutrophils, a type of white blood cell, cannot release tryptase in response to certain stimuli.",
      "false, [corrected fact]: Eosinophils, another type of white blood cell, cannot release tryptase in response to certain stimuli."
    ]
  },
  {
    "id": 3974,
    "user_query": "How many groups of viruses exist  in the Baltimore Classification?",
    "llama-2-7b-chat-hf_response": "According to the Baltimore Classification, there are 5 groups of viruses:\n1. Double-stranded DNA viruses\n2. Single-stranded DNA viruses\n3. Double-stranded RNA viruses\n4. Single-stranded RNA viruses\n5. Reverse transcribing viruses\nEach group is further divided into families, genera, and species, based on the characteristics of the viruses within that group.",
    "llama-2-7b-chat-hf_fact": [
      "The Baltimore Classification categorizes viruses into five groups.",
      "These groups are double-stranded DNA viruses, single-stranded DNA viruses, double-stranded RNA viruses, single-stranded RNA viruses, and reverse transcribing viruses.",
      "Each of these groups in the Baltimore Classification is further divided into families, genera, and species.",
      "The division within each group is based on the characteristics of the viruses."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Baltimore Classification categorizes viruses into seven groups.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-7b-chat-hf_response": "MPS1 (Microtubule-associated protein 1) kinase is an enzyme that plays a crucial role in regulating various cellular processes, including cell division, intracellular transport, and signaling pathways. Inhibition of MPS1 kinase has been shown to have potential therapeutic applications in various diseases, including cancer and neurodegenerative disorders. Here are some orally bioavailable MPS1 kinase inhibitors that have been identified or developed:\n1. AZD-8055: AZD-8055 is a potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer. It is being developed by AstraZeneca.\n2. BAY-1000394: BAY-1000394 is a small molecule inhibitor of MPS1 kinase that has been shown to have antitumor activity in preclinical studies. It is being developed by Baylor College of Medicine.\n3. GSK-860628: GSK-860628 is a potent and selective MPS1 kinase inhibitor that has shown potential in preclinical studies for the treatment of various cancers, including pancreatic and prostate cancer. It is being developed by GlaxoSmithKline.\n4. LB-100: LB-100 is a small molecule inhibitor of MPS1 kinase that has shown potential in preclinical studies for the treatment of various cancers, including breast and lung cancer. It is being developed by Ligand Pharmaceuticals.\n5. MLN0128: MLN0128 is a potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer. It is being developed by Millennium Pharmaceuticals.\n6. RX-0201: RX-0201 is a small molecule inhibitor of MPS1 kinase that has shown",
    "llama-2-7b-chat-hf_fact": [
      "MPS1 kinase is an enzyme that plays a crucial role in regulating various cellular processes, including cell division, intracellular transport, and signaling pathways.",
      "AZD-8055 is an orally bioavailable MPS1 kinase inhibitor being developed by AstraZeneca.",
      "BAY-1000394, an inhibitor of MPS1 kinase being developed by Baylor College of Medicine, has been shown to have antitumor activity in preclinical studies.",
      "GSK-860628 is an MPS1 kinase inhibitor being developed by GlaxoSmithKline.",
      "LB-100 and MLN0128 are both orally bioavailable MPS1 kinase inhibitors, being developed by Ligand Pharmaceuticals and Millennium Pharmaceuticals respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: AZD-8055 is an orally bioavailable mTOR kinase inhibitor being developed by AstraZeneca.",
      "false, [corrected fact]: BAY-1000394, also known as Rigosertib, an inhibitor of PI3K and PLK1 pathways being developed by Onconova Therapeutics, has been shown to have antitumor activity in preclinical studies.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3982,
    "user_query": "When did eptinezumab get its first FDA approval?",
    "llama-2-7b-chat-hf_response": "Eptinezumab, also known as Vyepti, is a monoclonal antibody drug used to treat migraines. It was first approved by the US Food and Drug Administration (FDA) in January 2020.\nWhat is the mechanism of action of eptinezumab?\nEptinezumab is a monoclonal antibody drug that works by blocking the action of calcitonin gene-related peptide (CGRP), a molecule involved in the transmission of pain signals in the body. By blocking CGRP, eptinezumab can help to reduce the frequency and severity of migraines.\nWhat are the side effects of eptinezumab?\nCommon side effects of eptinezumab include injection site reactions, such as redness, swelling, or itching, as well as muscle weakness, fatigue, and nausea. Less common side effects can include allergic reactions, such as hives or difficulty breathing, and changes in mood or behavior, such as depression or anxiety.\nIs eptinezumab a new drug?\nNo, eptinezumab is not a new drug. It was first approved by the US Food and Drug Administration (FDA) in January 2020.\nWhat is the dosage of eptinezumab?\nThe recommended dosage of eptinezumab for the treatment of migraines is 100 mg administered as an injection every 12 weeks.\nWhat is the cost of eptinezumab?\nThe cost of eptinezumab can vary depending on factors such as the dosage, frequency of use, and location. It is important to consult with a healthcare provider or pharmacist to determine the actual cost of the drug.\nIs eptinezumab available in generic form?\nNo, eptinezumab is not available in generic form. It is a brand-name drug that is manufactured and marketed by the company Amgen.\nWhat are the contraindications of eptinezumab?\nEptinezumab is contraindicated in patients with a history of hypersensitivity reactions to the drug or any of",
    "llama-2-7b-chat-hf_fact": [
      "Eptinezumab, also known as Vyepti, is a monoclonal antibody drug used to treat migraines.",
      "The FDA first approved Eptinezumab in January 2020.",
      "Eptinezumab works by blocking the action of the calcitonin gene-related peptide (CGRP).",
      "The recommended dosage of eptinezumab for the treatment of migraines is 100 mg administered as an injection every 12 weeks.",
      "Eptinezumab is manufactured and marketed by Amgen."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The recommended dosage of eptinezumab for the treatment of migraines is 100 mg or 300 mg administered as an infusion every 12 weeks.",
      "false, [corrected fact]: Eptinezumab is manufactured and marketed by Lundbeck."
    ]
  },
  {
    "id": 3983,
    "user_query": "Which database exists that contains regulatory sites for splicing in human basal ganglia?",
    "llama-2-7b-chat-hf_response": "There are several databases that contain information on regulatory sites for splicing in human basal ganglia, including:\n1. The Basal Ganglia Splicing Database (BGSD): This database contains a comprehensive collection of splicing events in the human basal ganglia, including their genomic coordinates, splicing patterns, and functional implications.\n2. The Human Splicing Finder (HSF): This database contains a large collection of splicing events in human tissues, including the basal ganglia, and provides information on the genomic coordinates, splicing patterns, and functional implications of each event.\n3. The Splicing Code (SC): This database contains a comprehensive collection of splicing events in human tissues, including the basal ganglia, and provides information on the genomic coordinates, splicing patterns, and functional implications of each event.\n4. The RNA Splicing Database (RSD): This database contains a comprehensive collection of splicing events in human tissues, including the basal ganglia, and provides information on the genomic coordinates, splicing patterns, and functional implications of each event.\n5. The University of California, San Diego (UCSD) Splicing Database: This database contains a comprehensive collection of splicing events in human tissues, including the basal ganglia, and provides information on the genomic coordinates, splicing patterns, and functional implications of each event.\nThese databases are valuable resources for researchers studying the regulation of splicing in the human basal ganglia and its role in neurological disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The Basal Ganglia Splicing Database contains a collection of splicing events in the human basal ganglia, including their genomic coordinates, splicing patterns, and functional implications.",
      "The Human Splicing Finder is a database that includes splicing events in human tissues, like the basal ganglia.",
      "The Splicing Code is a database that provides information about splicing events in human tissues, including the basal ganglia.",
      "The RNA Splicing Database includes splicing events in human tissues, and offers information on the genomic coordinates, splicing patterns, and functional implications in the basal ganglia.",
      "The University of California, San Diego Splicing Database contains a comprehensive collection of splicing events in human tissues, including the basal ganglia."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3985,
    "user_query": "What is pyroptosis?",
    "llama-2-7b-chat-hf_response": "Pyroptosis is a type of programmed cell death that is characterized by the release of inflammatory cytokines and the activation of caspase-1, which leads to the formation of the pro-inflammatory cytokine interleukin-1 (IL-1). Pyroptosis is a highly regulated process that plays a crucial role in the immune system, particularly in the defense against invading pathogens.",
    "llama-2-7b-chat-hf_fact": [
      "Pyroptosis is a type of programmed cell death.",
      "Pyroptosis is characterized by the release of inflammatory cytokines and the activation of caspase-1.",
      "Caspase-1 activation during pyroptosis leads to the formation of the pro-inflammatory cytokine interleukin-1 (IL-1).",
      "Pyroptosis is a highly regulated process.",
      "Pyroptosis plays a crucial role in the defense against invading pathogens in the immune system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3986,
    "user_query": "What is a HapMap",
    "llama-2-7b-chat-hf_response": "?\nA HapMap is a genetic map that shows the location of genetic variants, such as single nucleotide polymorphisms (SNPs), in a population. The term \"hap\" refers to the genetic variation at a particular locus, and \"map\" refers to the location of that variation on a chromosome.\nHapMaps are created by analyzing the genetic data of a large number of individuals in a population, typically using techniques such as DNA sequencing or genotyping. The resulting data is then used to create a map of the genetic variation at a particular locus, which can be used to identify genetic variants that are associated with specific traits or diseases.\nHapMaps can be used for a variety of purposes, including:\n1. Genetic association studies: HapMaps can be used to identify genetic variants that are associated with specific traits or diseases.\n2. Genetic linkage analysis: HapMaps can be used to identify genetic variants that are linked to a particular gene or genetic region.\n3. Genetic variation analysis: HapMaps can be used to identify genetic variants that are present in a population, and to study the distribution and frequency of those variants.\n4. Forensic analysis: HapMaps can be used in forensic science to identify the genetic ancestry of an individual.\n5. Personalized medicine: HapMaps can be used to identify genetic variants that are associated with an individual's response to particular drugs or treatments.\n6. Population genetics: HapMaps can be used to study the genetic structure of a population, including the distribution of genetic variants and the relationships between different populations.\n7. Evolutionary studies: HapMaps can be used to study the evolutionary history of a species, including the distribution of genetic variants and the relationships between different species.\n8. Medical genetics: HapMaps can be used to identify genetic variants that are associated with specific diseases or conditions, and to study the genetic basis of those diseases.\n9. Pharmacogenomics: HapMaps can be used to identify genetic variants that are associated with an individual's response to particular drugs or treatments.\n10. Reproductive genetics: HapMaps can",
    "llama-2-7b-chat-hf_fact": [
      "A HapMap is a genetic map that shows the location of genetic variants in a population.",
      "The process of creating HapMaps involves analyzing the genetic data of a large number of individuals in a population, using techniques such as DNA sequencing or genotyping.",
      "HapMaps can be used to identify genetic variants that are linked to specific traits or diseases.",
      "HapMaps are applicable in forensic science to identify the genetic ancestry of an individual.",
      "HapMaps can be used in studying the genetic structure of a population."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: HapMaps are used in genetic research to study the genetic variations in different populations, they are not typically used in forensic science to identify an individual's genetic ancestry.",
      "true"
    ]
  },
  {
    "id": 3987,
    "user_query": "Which cancer types are associated with mutations in the TWIST1 gene?",
    "llama-2-7b-chat-hf_response": "The TWIST1 gene provides instructions for making a protein called Twist family bHLH transcription factor 1 (Twist1). This protein plays a critical role in regulating the expression of genes involved in cell growth, differentiation, and survival. Mutations in the TWIST1 gene have been identified in various types of cancer, including:\n1. Leukemia: Twist1 mutations are found in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). These mutations can lead to the overexpression of Twist1, which can promote the proliferation and survival of leukemic cells.\n2. Lung cancer: Twist1 mutations are found in non-small cell lung cancer (NSCLC) and adenocarcinoma. These mutations can lead to the overexpression of Twist1, which can promote the proliferation and survival of cancer cells.\n3. Breast cancer: Twist1 mutations are found in triple-negative breast cancer (TNBC). These mutations can lead to the overexpression of Twist1, which can promote the proliferation and survival of cancer cells.\n4. Colorectal cancer: Twist1 mutations are found in colorectal cancer, particularly in microsatellite instability-high (MSI-H) tumors. These mutations can lead to the overexpression of Twist1, which can promote the proliferation and survival of cancer cells.\n5. Pancreatic cancer: Twist1 mutations are found in pancreatic ductal adenocarcinoma (PDA). These mutations can lead to the overexpression of Twist1, which can promote the proliferation and survival of cancer cells.\nIt is important to note that the frequency and distribution of TWIST1 mutations may vary depending on the specific type of cancer and the patient population being studied.",
    "llama-2-7b-chat-hf_fact": [
      "The TWIST1 gene provides instructions for making a protein called Twist family bHLH transcription factor 1.",
      "Mutations in the TWIST1 gene have been identified in various types of cancer, including Leukemia, Lung cancer, Breast cancer, Colorectal cancer, and Pancreatic cancer.",
      "In Leukemia, specifically acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), Twist1 mutations can lead to overexpression of Twist1.",
      "Lung cancers such as non-small cell lung cancer (NSCLC) and adenocarcinoma have also been associated with Twist1 mutations.",
      "Mutations in the TWIST1 gene can be found in colorectal cancer, particularly in microsatellite instability-high (MSI-H) tumors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3991,
    "user_query": "List 3 therapeutic uses for botulism toxin.",
    "llama-2-7b-chat-hf_response": "Botulism toxin is a powerful neurotoxin that can cause botulism, a potentially life-threatening illness. However, it has also been found to have therapeutic uses in certain medical conditions. Here are three therapeutic uses for botulism toxin:\n1. Blepharospasm: Botulism toxin has been used to treat blepharospasm, a condition characterized by involuntary closure of the eyelids. Injecting botulism toxin into the affected muscles can help relax them and reduce spasms.\n2. Strabismus: Botulism toxin has been used to treat strabismus, a condition in which the eyes are misaligned. Injecting botulism toxin into the affected muscles can help realign the eyes and improve vision.\n3. Hyperhidrosis: Botulism toxin has been used to treat severe hyperhidrosis (excessive sweating). Injecting botulism toxin into the affected areas can help reduce sweating and improve quality of life for people with this condition.\nIt is important to note that botulism toxin is a powerful substance that should only be used under the guidance of a medical professional. While it can be effective in treating certain medical conditions, it can also have serious side effects if used improperly.",
    "llama-2-7b-chat-hf_fact": [
      "Botulism toxin is a neurotoxin that can cause a potentially life-threatening illness.",
      "Botulism toxin is used in the treatment of blepharospasm, a condition wherein the eyelids close involuntarily.",
      "Botulism toxin plays a therapeutic role in the treatment of strabismus, a disorder characterized by misaligned eyes.",
      "Botulism toxin can be used to treat severe hyperhidrosis or excessive sweating.",
      "Botulism toxin should be used under the guidance of a medical professional due to its potential for serious side effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3997,
    "user_query": "What are the 4 types of holoprosencephaly?",
    "llama-2-7b-chat-hf_response": "Holoprosencephaly is a congenital brain abnormality that occurs when the brain does not properly divide into two hemispheres. There are four types of holoprosencephaly, each with different symptoms and outcomes:\n1. Severe holoprosencephaly: This is the most severe form of the condition, where the brain does not properly divide into two hemispheres. Children with this type of holoprosencephaly often have significant developmental delays, intellectual disability, and seizures.\n2. Moderate holoprosencephaly: In this type of holoprosencephaly, the brain is partially divided into two hemispheres, but there is still significant abnormality in the structure and function of the brain. Children with this type of holoprosencephaly may have mild to moderate developmental delays, intellectual disability, and seizures.\n3. Mild holoprosencephaly: In this type of holoprosencephaly, the brain is mostly divided into two hemispheres, but there may be some abnormalities in the structure and function of the brain. Children with this type of holoprosencephaly may have mild developmental delays and intellectual disability, but they typically do not have seizures.\n4. Embryonal holoprosencephaly: This is the mildest form of holoprosencephaly, where the brain is almost completely divided into two hemispheres. Children with this type of holoprosencephaly typically do not have any significant developmental delays or intellectual disability, and they rarely have seizures.\nIt is important to note that each type of holoprosencephaly can have a wide range of symptoms and outcomes, and the severity of the condition can vary greatly from one individual to another.",
    "llama-2-7b-chat-hf_fact": [
      "Holoprosencephaly is a congenital brain abnormality that occurs when the brain does not properly divide into two hemispheres.",
      "Severe holoprosencephaly is the most severe form and children with this type often have significant developmental delays, intellectual disability, and seizures.",
      "Moderate holoprosencephaly results in a partially divided brain and may lead to mild to moderate developmental delays, and seizures.",
      "Mild holoprosencephaly results in a mostly divided brain and may lead to mild developmental delays, but typically no seizures.",
      "Embryonal holoprosencephaly is the mildest form, where the brain is almost completely divided and children typically do not have any significant developmental delays or intellectual disability, and they rarely have seizures."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: There is no form of holoprosencephaly called 'Embryonal holoprosencephaly'. The mildest form of the condition, often referred to as lobar holoprosencephaly, results in a mostly divided brain and may lead to mild developmental delays, but typically no seizures."
    ]
  },
  {
    "id": 3998,
    "user_query": "Which yeast genes encode for condensin?",
    "llama-2-7b-chat-hf_response": "Condensin is a protein complex that plays a crucial role in chromosome condensation, the process by which chromosomes are compacted and prepared for cell division. In yeast, the condensin complex is composed of four subunits: Condensin I, II, III, and IV. These subunits are encoded by the genes CDC5, CDC6, CDC11, and CDC12, respectively.",
    "llama-2-7b-chat-hf_fact": [
      "Condensin is a protein complex that plays a role in chromosome condensation.",
      "Chromosome condensation is the process by which chromosomes are prepared for cell division.",
      "In yeast, the condensin complex is made up of four subunits: Condensin I, II, III, and IV.",
      "The gene CDC5 encodes for the Condensin I subunit.",
      "The genes CDC6, CDC11, and CDC12 encode for the Condensin II, III, and IV subunits respectively."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: In yeast, the condensin complex is made up of five subunits: Smc2p, Smc4p, Brn1p, Ycs4p, and Ycg1p.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3999,
    "user_query": "What is another name for the drug AMG334?",
    "llama-2-7b-chat-hf_response": "AMG334 is also known as omburtamab.",
    "llama-2-7b-chat-hf_fact": [
      "The drug AMG334 is also known as omburtamab."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The drug AMG334 is also known as erenumab, not omburtamab."
    ]
  },
  {
    "id": 4004,
    "user_query": "Which gene is primarily associated with the Saethre-Chotzen syndrome?",
    "llama-2-7b-chat-hf_response": "A. PTCH1\nB. PTCH2\nC. SMO\nD. Hedgehog signaling pathway\nCorrect answer: A. PTCH1.\nExplanation: Saethre-Chotzen syndrome is a rare genetic disorder caused by mutations in the PTCH1 gene. The PTCH1 gene provides instructions for making a protein called patched 1, which plays a critical role in the Hedgehog signaling pathway. The Hedgehog signaling pathway is important for regulating the growth and development of cells, and mutations in the PTCH1 gene can lead to the characteristic features of Saethre-Chotzen syndrome, including craniofacial abnormalities, limb abnormalities, and intellectual disability.",
    "llama-2-7b-chat-hf_fact": [
      "Saethre-Chotzen syndrome is a genetic disorder caused by mutations in the PTCH1 gene.",
      "The PTCH1 gene provides instructions for making a protein called patched 1.",
      "Patched 1 plays a key role in the Hedgehog signaling pathway.",
      "The Hedgehog signaling pathway regulates the growth and development of cells.",
      "Mutations in the PTCH1 gene can lead to the characteristic features of Saethre-Chotzen syndrome, such as craniofacial abnormalities, limb abnormalities, and intellectual disability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Saethre-Chotzen syndrome is a genetic disorder caused by mutations in the TWIST1 gene.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Mutations in the TWIST1 gene can lead to the characteristic features of Saethre-Chotzen syndrome, such as craniofacial abnormalities, limb abnormalities, and intellectual disability."
    ]
  },
  {
    "id": 4008,
    "user_query": "Which are the parts of a flaggelum?",
    "llama-2-7b-chat-hf_response": "A flagellum is a whip-like structure that is found in some bacteria and archaea. It is composed of a long, thin filament that is attached to the cell body at one end and has a small hook or ring at the other end. The parts of a flagellum include:\n1. Filament: The long, thin filament that makes up the majority of the flagellum.\n2. Hook or ring: The small hook or ring at the end of the filament that attaches to the cell body.\n3. Cell body: The part of the flagellum that is attached to the cell body and provides support and anchorage for the filament.\n4. Basal body: The part of the flagellum that is attached to the cell body and provides support and anchorage for the filament.\n5. Motor proteins: The proteins that drive the movement of the flagellum by rotating the filament.\n6. Stator proteins: The proteins that provide structural support for the flagellum and help to maintain its shape.\n7. Transmembrane proteins: The proteins that span the cell membrane and help to anchor the flagellum to the cell body.",
    "llama-2-7b-chat-hf_fact": [
      "A flagellum is a whip-like structure found in some bacteria and archaea.",
      "The filament is a long, thin part that makes up most of the flagellum.",
      "The hook or ring at the end of the filament attaches to the cell body.",
      "The basal body attaches the flagellum to the cell body to provide support and anchorage.",
      "Motor proteins drive the movement of the flagellum.",
      "Stator proteins provide structural support for the flagellum.",
      "Transmembrane proteins span the cell membrane to anchor the flagellum to the cell body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The hook, located at the base of the filament, connects the flagellum to the basal body, not to the cell body directly.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4013,
    "user_query": "Givosiran is used for treatment of which disease?",
    "llama-2-7b-chat-hf_response": "Givosiran is used for the treatment of primary hyperoxaluria type 1 (PH1), a rare genetic disorder caused by a deficiency of the enzyme alanine aminotransferase (ALT). Givosiran works by reducing the production of oxalate in the liver, which can help to reduce the risk of kidney damage and other complications associated with PH1.",
    "llama-2-7b-chat-hf_fact": [
      "Givosiran is used for the treatment of primary hyperoxaluria type 1 (PH1).",
      "PH1 is a rare genetic disorder caused by a deficiency of the enzyme alanine aminotransferase (ALT).",
      "Givosiran works by reducing the production of oxalate in the liver.",
      "Reducing the production of oxalate can help to reduce the risk of kidney damage and other complications.",
      "Kidney damage and other complications are associated with PH1."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: PH1 is a rare genetic disorder caused by a deficiency of the enzyme alanine-glyoxylate aminotransferase (AGT).",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4019,
    "user_query": "Inhaled Molgramostim can be used for treatment of which disease?",
    "llama-2-7b-chat-hf_response": "A. Cystic fibrosis\nB. Chronic obstructive pulmonary disease (COPD)\nC. Idiopathic pulmonary fibrosis (IPF)\nD. Asthma\nAnswer: A. Cystic fibrosis\nExplanation: Molgramostim is a granulocyte-macrophage colony-stimulating factor (GM-CSF) that is used to treat cystic fibrosis, a genetic disorder that affects the respiratory, digestive, and reproductive systems. Inhaled Molgramostim can help to improve lung function and reduce the frequency of lung infections in people with cystic fibrosis. It is not approved for the treatment of COPD, IPF, or asthma.",
    "llama-2-7b-chat-hf_fact": [
      "Molgramostim is a granulocyte-macrophage colony-stimulating factor (GM-CSF).",
      "Molgramostim can be used to treat cystic fibrosis.",
      "Cystic fibrosis is a genetic disorder that affects the respiratory, digestive, and reproductive systems.",
      "Inhaled Molgramostim can help improve lung function and reduce the frequency of lung infections in people with cystic fibrosis.",
      "Molgramostim is not approved for the treatment of Chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), or asthma."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4021,
    "user_query": "Please list the 2 vaccines for herpes zoster(shingles)",
    "llama-2-7b-chat-hf_response": "that are available in the US.\nThere are two vaccines available in the US to protect against herpes zoster, or shingles:\n1. Zostavax (zoster vaccine live, attenuated): This vaccine is approved for use in adults aged 50 years and older and provides protection against both herpes zoster and postherpetic neuralgia (PHN), a common complication of shingles. Zostavax is given as a single dose and is generally well-tolerated, with common side effects including redness, swelling, and pain at the injection site.\n2. Shingrix (zoster vaccine recombinant, adsorbed): This vaccine is approved for use in adults aged 50 years and older and provides longer-lasting protection against herpes zoster than Zostavax. Shingrix is given in two doses, spaced 2 to 6 months apart, and is generally well-tolerated, with common side effects including redness, swelling, and pain at the injection site.\nIt's important to note that while these vaccines can help reduce the risk of developing shingles and PHN, they are not 100% effective and may not prevent all cases of shingles. It's also important to talk to your healthcare provider about your individual risk factors and whether the shingles vaccine is right for you.",
    "llama-2-7b-chat-hf_fact": [
      "Zostavax and Shingrix are two vaccines available in the US to protect against herpes zoster, or shingles.",
      "Zostavax is approved for use in adults aged 50 years and older, providing protection against both herpes zoster and postherpetic neuralgia (PHN).",
      "Shingrix is also approved for use in adults aged 50 years and older and provides longer-lasting protection against herpes zoster than Zostavax.",
      "Shingrix is given in two doses, spaced 2 to 6 months apart.",
      "Both vaccines can help reduce the risk of developing shingles and PHN but are not 100% effective."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4028,
    "user_query": "What does \"28\" stand for in the Disease Activity Score DAS28?",
    "llama-2-7b-chat-hf_response": "The Disease Activity Score (DAS) is a measure of disease activity in rheumatoid arthritis (RA) that takes into account both clinical and laboratory measures of disease activity. The DAS28 is a specific version of the DAS that uses 28 tender joints and 28 swollen joints to calculate the score.\nThe \"28\" in DAS28 refers to the number of joints that are assessed in the calculation of the score. Specifically, the DAS28 calculates the disease activity by counting the number of tender and swollen joints a patient has, and then using those numbers to calculate a score that reflects the overall level of disease activity. The tender joints are those that are painful to the touch, and the swollen joints are those that are visibly larger than normal.\nThe DAS28 is widely used in clinical practice and research to evaluate the effectiveness of treatments for RA and to monitor disease activity over time. A lower DAS28 score indicates lower disease activity, while a higher score indicates higher disease activity.",
    "llama-2-7b-chat-hf_fact": [
      "The Disease Activity Score (DAS) is a measure used to evaluate disease activity in rheumatoid arthritis (RA).",
      "The DAS28 is a variation of DAS, where the \"28\" denotes the number of joints assessed in the scores calculation.",
      "The calculation of the DAS28 score involves assessment of 28 tender and 28 swollen joints.",
      "The DAS28 is utilized in both clinical practice and research for the evaluation of RA treatments and monitoring of disease progression.",
      "A lower DAS28 score signifies lower disease activity, while a higher score indicates greater disease activity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-7b-chat-hf_response": "Golimumab is a medication used to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is also being studied for the treatment of other conditions, such as ulcerative colitis and Crohn's disease. However, there is no evidence to suggest that golimumab has been tested for the treatment of diabetes.",
    "llama-2-7b-chat-hf_fact": [
      "Golimumab is a medication used to treat certain autoimmune diseases.",
      "Rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis can be treated with golimumab.",
      "Golimumab is being studied for the treatment of ulcerative colitis and Crohn's disease.",
      "There is no evidence to suggest that golimumab has been tested for the treatment of diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4032,
    "user_query": "Is G3BP1 found in stress granules?",
    "llama-2-7b-chat-hf_response": "G3BP1 (GTPase-activating protein 3-binding protein 1) is a protein that has been implicated in various cellular processes, including the regulation of mRNA translation and the formation of stress granules. Stress granules are RNA-protein complexes that form in response to cellular stress and play a role in the regulation of mRNA translation and the maintenance of cellular homeostasis.\nStudies have shown that G3BP1 is found in stress granules and plays a role in their formation and function. For example, one study found that G3BP1 is required for the formation of stress granules in response to oxidative stress, and that G3BP1-deficient cells have impaired stress granule formation and mRNA translation (1). Another study found that G3BP1 interacts with the RNA-binding protein TIA-1 and is required for the localization of TIA-1 to stress granules (2).\nOverall, the evidence suggests that G3BP1 is found in stress granules and plays a role in their formation and function, particularly in response to oxidative stress.\nReferences:\n1. Kim et al. (2010). G3BP1 is required for stress granule formation and mRNA translation in response to oxidative stress. Molecular Biology of the Cell, 21(10), 1747-1757.\n2. Zhang et al. (2013). G3BP1 interacts with TIA-1 and is required for localization of TIA-1 to stress granules. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1829(11), 870-878.",
    "llama-2-7b-chat-hf_fact": [
      "G3BP1 (GTPase-activating protein 3-binding protein 1) is a protein implicated in various cellular processes, including the regulation of mRNA translation and the formation of stress granules.",
      "Stress granules are RNA-protein complexes that form in response to cellular stress.",
      "G3BP1 is found in stress granules and plays a role in their formation and function.",
      "G3BP1 is required for the formation of stress granules in response to oxidative stress.",
      "The RNA-binding protein TIA-1 interacts with G3BP1 and G3BP1 is required for the localization of TIA-1 to stress granules."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4036,
    "user_query": "Is colistin an antibiotic?",
    "llama-2-7b-chat-hf_response": "Colistin is a polymyxin antibiotic that is used to treat a variety of bacterial infections, including those caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria. While colistin is not a broad-spectrum antibiotic, it has been shown to be effective against a wide range of Gram-negative bacteria, including many strains that are resistant to other antibiotics.",
    "llama-2-7b-chat-hf_fact": [
      "Colistin is a polymyxin antibiotic.",
      "Colistin is used to treat a variety of bacterial infections.",
      "Colistin can be used to treat infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria.",
      "Colistin is not a broad-spectrum antibiotic.",
      "Colistin has been shown to be effective against a wide range of Gram-negative bacteria, including many strains that are resistant to other antibiotics."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Colistin is considered a broad-spectrum antibiotic because it is effective against a wide range of bacterial species.",
      "true"
    ]
  },
  {
    "id": 4038,
    "user_query": "Is the process of DNA loop-extrusion independent of ATP?",
    "llama-2-7b-chat-hf_response": "DNA loop-extrusion is a process that involves the unwinding of DNA and the formation of a loop structure. This process is important for a variety of cellular functions, including DNA replication, repair, and transcription. While the process of DNA loop-extrusion is typically associated with the hydrolysis of ATP, recent studies have suggested that the process may be independent of ATP in some cases.\nOne study published in the journal Nature found that the enzyme topoisomerase II, which is involved in DNA loop-extrusion, can catalyze the process in the absence of ATP. The researchers used a combination of biochemical and biophysical techniques to show that topoisomerase II can unwind DNA and form loops without the need for ATP hydrolysis.\nAnother study published in the journal Cell found that the DNA loop-extrusion process can be driven by a variety of energy sources, including ATP, GTP, and even mechanical forces. The researchers used a combination of live-cell imaging and biochemical assays to show that the process of DNA loop-extrusion can be driven by a variety of energy sources, and that the choice of energy source can depend on the specific context in which the process is occurring.\nWhile these studies suggest that the process of DNA loop-extrusion may be independent of ATP in some cases, it is important to note that ATP hydrolysis is still thought to play a role in many aspects of DNA loop-extrusion. For example, ATP hydrolysis is thought to provide the energy necessary for the unwinding of DNA, and the formation of the loop structure.\nIn summary, while the process of DNA loop-extrusion may be independent of ATP in some cases, the majority of studies suggest that ATP hydrolysis plays a critical role in the process. Further research is needed to fully understand the mechanisms underlying DNA loop-extrusion and the role of ATP in these processes.",
    "llama-2-7b-chat-hf_fact": [
      "DNA loop-extrusion is a process that involves the unwinding of DNA and the formation of a loop structure.",
      "DNA loop-extrusion is typically associated with the hydrolysis of ATP.",
      "According to a study in the journal Nature, the enzyme topoisomerase II can catalyze DNA loop-extrusion in the absence of ATP.",
      "Another study published in the journal Cell, suggests that DNA loop-extrusion process can be driven by a variety of energy sources, including ATP, GTP, and even mechanical forces.",
      "Although some cases suggest DNA loop-extrusion may be independent of ATP, it is regarded that ATP hydrolysis plays a critical role in the process."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4048,
    "user_query": "Where is the organ of Corti located?",
    "llama-2-7b-chat-hf_response": "The organ of Corti is located in the cochlea of the inner ear. The cochlea is a spiral-shaped structure in the inner ear that is responsible for hearing. The organ of Corti is a complex structure of sensory cells and supporting cells that are arranged along the basement membrane of the cochlea. It is here that sound waves are converted into electrical signals that are transmitted to the brain.",
    "llama-2-7b-chat-hf_fact": [
      "The organ of Corti is located in the cochlea of the inner ear.",
      "The cochlea is a spiral-shaped structure in the inner ear responsible for hearing.",
      "The organ of Corti is composed of sensory cells and supporting cells.",
      "These cells are arranged along the basement membrane of the cochlea.",
      "The organ of Corti converts sound waves into electrical signals for transmission to the brain."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-7b-chat-hf_response": "Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare genetic disorder that causes accelerated aging in children. While the exact cause of progeria is still not fully understood, research suggests that it is caused by an autosomal recessive mutation in the LMNA gene.\nThe LMNA gene provides instructions for making a protein called lamin A, which is involved in the structure and function of chromosomes. In people with progeria, the LMNA gene carries a mutation that leads to the production of a misshapen form of lamin A, known as progerin. Progerin accumulates in the cells and disrupts the normal aging process, leading to the rapid aging and degeneration characteristic of progeria.\nThe autosomal recessive inheritance pattern of progeria means that a child must inherit two copies of the mutated LMNA gene, one from each parent, in order to develop the disorder. If a child inherits only one mutated copy of the gene, they will be a carrier of the disorder but are unlikely to develop symptoms themselves.\nWhile the genetic basis of progeria has been identified, much remains to be learned about the disorder and how it affects the aging process. Ongoing research is focused on understanding the molecular mechanisms underlying progeria and developing potential treatments to slow or halt the progression of the disorder.",
    "llama-2-7b-chat-hf_fact": [
      "Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare genetic disorder that causes accelerated aging in children.",
      "Research suggests that progeria is caused by an autosomal recessive mutation in the LMNA gene.",
      "The LMNA gene provides instructions for making a protein called lamin A, which is involved in the structure and function of chromosomes.",
      "In people with progeria, the LMNA gene carries a mutation that leads to the production of a misshapen form of lamin A, known as progerin.",
      "The autosomal recessive inheritance pattern of progeria means that a child must inherit two copies of the mutated LMNA gene, one from each parent, in order to develop the disorder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Progeria is caused by an autosomal dominant mutation in the LMNA gene.",
      "true",
      "true",
      "false, [corrected fact]: The autosomal dominant inheritance pattern of progeria means that a child can inherit a copy of the mutated LMNA gene from just one parent and develop the disorder."
    ]
  },
  {
    "id": 4060,
    "user_query": "What is the cause of the Kleefstra syndrome?",
    "llama-2-7b-chat-hf_response": "Kleefstra syndrome is a rare genetic disorder that affects the brain and nervous system. It is caused by mutations in the NLGN4A gene, which is responsible for producing a protein called neuroligin-4. This protein plays a critical role in the formation and maintenance of synapses, the connections between neurons that allow them to communicate with each other.\nMutations in the NLGN4A gene can lead to changes in the structure and function of synapses, which can disrupt the normal functioning of the brain and nervous system. This can result in a range of symptoms, including intellectual disability, seizures, and problems with movement and coordination.\nKleefstra syndrome is inherited in an autosomal dominant pattern, which means that a single copy of the mutated gene is enough to cause the condition. It is a rare disorder, and the prevalence is estimated to be around 1 in 100,000 to 1 in 50,000 births.\nThere is currently no cure for Kleefstra syndrome, but researchers are working to develop new treatments and therapies to help manage the symptoms and improve the quality of life for people with the condition.",
    "llama-2-7b-chat-hf_fact": [
      "Kleefstra syndrome is a rare genetic disorder that affects the brain and nervous system.",
      "The Kleefstra syndrome is caused by mutations in the NLGN4A gene.",
      "The NLGN4A gene is responsible for producing a protein called neuroligin-4, which is critical in the formation and maintenance of synapses.",
      "Kleefstra syndrome is inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene can cause the condition.",
      "The estimated prevalence of Kleefstra syndrome is around 1 in 100,000 to 1 in 50,000 births."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Kleefstra syndrome is caused by mutations in the EHMT1 gene.",
      "false, [corrected fact]: The gene responsible for producing a protein called neuroligin-4 is NLGN4, not NLGN4A.",
      "false, [corrected fact]: Kleefstra syndrome is inherited in an autosomal dominant pattern, meaning two copies of the mutated gene are needed to cause the condition.",
      "true"
    ]
  },
  {
    "id": 4066,
    "user_query": "List proteins that promotes calcification.",
    "llama-2-7b-chat-hf_response": "There are several proteins that have been shown to promote calcification in various biological systems. Here are some examples:\n1. Matrix Gla protein (MGP): MGP is a secreted protein that inhibits calcium carbonate (CaCO3) crystal formation by binding to the crystal surface and preventing the formation of new crystals. However, under certain conditions, MGP can also promote the formation of hydroxyapatite (HA) crystals, which are the main component of bone tissue.\n2. Bone sialoprotein (BSP): BSP is a protein that is expressed in bone tissue and plays a role in the regulation of mineral metabolism. It has been shown to promote the formation of HA crystals in vitro and in vivo.\n3. Osteopontin (OPN): OPN is a protein that is expressed in bone tissue and plays a role in the regulation of mineral metabolism. It has been shown to promote the formation of HA crystals in vitro and in vivo.\n4. Fibronectin (FN): FN is a protein that is expressed in many tissues, including bone, and plays a role in cell adhesion and migration. It has been shown to promote the formation of HA crystals in vitro and in vivo.\n5. Vitronectin (VN): VN is a protein that is expressed in many tissues, including bone, and plays a role in cell adhesion and migration. It has been shown to promote the formation of HA crystals in vitro and in vivo.\n6. Osteocalcin (OC): OC is a protein that is expressed in bone tissue and plays a role in the regulation of mineral metabolism. It has been shown to promote the formation of HA crystals in vitro and in vivo.\n7. Tissue non-specific alkaline phosphatase (TNAP): TNAP is an enzyme that is expressed in many tissues, including bone, and plays a role in the regulation of mineral metabolism. It has been shown to promote the formation of HA crystals in vitro and in vivo.\n8. Bone morphogenetic protein (",
    "llama-2-7b-chat-hf_fact": [
      "Matrix Gla protein (MGP) is a secreted protein that can promote the formation of hydroxyapatite (HA) crystals under certain conditions.",
      "Bone sialoprotein (BSP) is expressed in bone tissue and promotes the formation of HA crystals.",
      "Osteopontin (OPN) is a protein expressed in bone tissue and promotes the formation of HA crystals.",
      "Fibronectin (FN) is expressed in many tissues and it promotes the formation of HA crystals.",
      "Vitronectin (VN) is a protein expressed in many tissues and it promotes the formation of HA crystals."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Matrix Gla protein (MGP) is a secreted protein that inhibits the formation of hydroxyapatite (HA) crystals under certain conditions.",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Vitronectin (VN) is a protein expressed in many tissues but it does not promote the formation of HA crystals."
    ]
  },
  {
    "id": 4067,
    "user_query": "Please list 3 small molecule CGRP-Receptor antagonists for migraine",
    "llama-2-7b-chat-hf_response": "prevention\nHere are three small molecule CGRP-Receptor antagonists that have been investigated for migraine prevention:\n1. Eptinezumab: Eptinezumab is a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor. It has been shown to be effective in reducing the frequency and severity of migraine attacks in clinical trials.\n2. Fremanezumab: Fremanezumab is another monoclonal antibody that targets the CGRP receptor. It has been shown to be effective in reducing the frequency and severity of migraine attacks in clinical trials.\n3. Galcanezumab: Galcanezumab is a small molecule CGRP-Receptor antagonist that has been investigated for migraine prevention. It has been shown to be effective in reducing the frequency and severity of migraine attacks in clinical trials.\nPlease note that this list is not exhaustive and there may be other small molecule CGRP-Receptor antagonists in development for migraine prevention.",
    "llama-2-7b-chat-hf_fact": [
      "Eptinezumab is a monoclonal antibody that targets the CGRP receptor and is used for migraine prevention.",
      "Fremanezumab is another monoclonal antibody that targets the CGRP receptor and is used for migraine prevention.",
      "Galcanezumab is a small molecule CGRP-Receptor antagonist that has been used for migraine prevention.",
      "Eptinezumab, Fremanezumab, and Galcanezumab have been shown to reduce the frequency and severity of migraine attacks in clinical trials.",
      "There may be other small molecule CGRP-Receptor antagonists in development for migraine prevention."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Galcanezumab is a monoclonal antibody that targets CGRP ligand, not a small molecule CGRP-Receptor antagonist, used for migraine prevention.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4069,
    "user_query": "Why is fingolimod considered a prodrug?",
    "llama-2-7b-chat-hf_response": "Fingolimod is considered a prodrug because it is rapidly metabolized to its active metabolite, fingolimod phosphate, which is responsible for its therapeutic effects. The term \"prodrug\" refers to a drug that is inactive when administered but is converted to an active form in the body. In the case of fingolimod, the drug is converted to its active metabolite through a series of phosphorylation reactions, which are catalyzed by enzymes in the liver and other tissues. Once the active metabolite is formed, it can bind to the sphingosine 1-phosphate receptor 1 (S1PR1) on immune cells, leading to the inhibition of lymphocyte trafficking and the reduction of inflammation in the central nervous system.",
    "llama-2-7b-chat-hf_fact": [
      "Fingolimod is considered a prodrug because it metabolizes into an active metabolite, fingolimod phosphate.",
      "A prodrug is a substance that is inactive when administered but is converted to an active form in the body.",
      "Fingolimod is activated through a series of phosphorylation reactions.",
      "These reactions are catalyzed by enzymes in the liver and other tissues.",
      "The active metabolite of fingolimod binds to the S1PR1 on immune cells, reducing inflammation in the central nervous system."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4081,
    "user_query": "What is the Oncomine Dx Target test?",
    "llama-2-7b-chat-hf_response": "The Oncomine Dx Target test is a liquid biopsy test that analyzes circulating tumor DNA (ctDNA) in a patient's blood or other bodily fluids to identify genetic alterations in cancer cells. The test is used to help diagnose, monitor, and guide treatment for various types of cancer, including breast, lung, colon, and other solid tumors.\nThe Oncomine Dx Target test is based on next-generation sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes and mutations in a single test. The test can detect a wide range of genetic alterations, including single nucleotide variations, insertions, deletions, and copy number variations.\nThe Oncomine Dx Target test is designed to be highly sensitive and specific, with the ability to detect even small amounts of ctDNA in the blood or other bodily fluids. This makes it a valuable tool for detecting cancer at an early stage, when it is more treatable, and for monitoring the effectiveness of cancer therapies.\nSome of the key benefits of the Oncomine Dx Target test include:\n1. Non-invasive: The test requires only a simple blood or other bodily fluid sample, making it a more patient-friendly option than traditional tissue biopsies.\n2. Early detection: The test can detect cancer at an early stage, when it is more treatable.\n3. Personalized medicine: The test can help identify specific genetic alterations in a patient's cancer, which can be used to guide targeted therapies and improve treatment outcomes.\n4. Monitoring: The test can be used to monitor the effectiveness of cancer therapies and detect recurrences earlier than traditional imaging methods.\n5. Minimally invasive: The test requires only a simple blood or other bodily fluid sample, making it a more patient-friendly option than traditional tissue biopsies.\n6. Cost-effective: The test is relatively inexpensive compared to other liquid biopsy tests on the market.\n7. Fast turnaround time: The test can provide results in as little as 3-5 days, allowing for quicker treatment decisions.\n8. Comprehensive: The test can detect a wide range of genetic alterations, including those that are",
    "llama-2-7b-chat-hf_fact": [
      "The Oncomine Dx Target test is a liquid biopsy test that analyses circulating tumor DNA to identify genetic alterations in cancer cells.",
      "The Oncomine Dx Target test is used to diagnose, monitor, and guide treatment for various types of cancer, including breast, lung, colon, and other solid tumors.",
      "The Oncomine Dx Target test uses next-generation sequencing technology which allows for the simultaneous analysis of multiple genes and mutations in a single test.",
      "The Oncomine Dx Target test can detect various genetic alterations, including single nucleotide variations, insertions, deletions, and copy number variations.",
      "The Oncomine Dx Target test can provide results in 3-5 days."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The Oncomine Dx Target Test is a tissue-based test, not a liquid biopsy test. It analyses tumor tissue DNA to identify genetic alterations in cancer cells, not circulating tumor DNA.",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-7b-chat-hf_response": "Common variants at 12q14 and 12q24 have been associated with a variety of diseases and conditions, including:\n1. Cardiovascular disease: Variants in the 12q14 region have been associated with increased risk of coronary artery disease, heart failure, and atrial fibrillation.\n2. Cancer: Variants in the 12q14 region have been associated with increased risk of breast, ovarian, and colorectal cancer.\n3. Neurological disorders: Variants in the 12q14 region have been associated with increased risk of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).\n4. Autoimmune disorders: Variants in the 12q14 region have been associated with increased risk of autoimmune disorders such as rheumatoid arthritis and lupus.\n5. Metabolic disorders: Variants in the 12q14 region have been associated with increased risk of metabolic disorders such as type 2 diabetes and obesity.\n6. Psychiatric disorders: Variants in the 12q14 region have been associated with increased risk of psychiatric disorders such as schizophrenia and bipolar disorder.\n7. Eye disorders: Variants in the 12q14 region have been associated with increased risk of eye disorders such as age-related macular degeneration and cataracts.\n8. Kidney disorders: Variants in the 12q14 region have been associated with increased risk of kidney disorders such as chronic kidney disease and kidney failure.\n9. Immune system disorders: Variants in the 12q14 region have been associated with increased risk of immune system disorders such as multiple sclerosis and Guillain-Barr syndrome.\n10. Reproductive disorders: Variants in the 12q14 region have been associated with increased risk of reproductive disorders such as polycystic ovary syndrome (PCOS) and endometriosis.",
    "llama-2-7b-chat-hf_fact": [
      "Variants at 12q14 have been linked to an increased risk of cardiovascular diseases such as coronary artery disease, heart failure, and atrial fibrillation.",
      "12q14 variants have been associated with an increased risk of cancers like breast, ovarian, and colorectal cancer.",
      "Neurological disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) have been linked to 12q14 variants.",
      "Autoimmune disorders such as rheumatoid arthritis and lupus have been associated with variants at 12q14.",
      "Variants in the 12q14 region have been linked to an increased risk of metabolic disorders like type 2 diabetes and obesity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4087,
    "user_query": "What is AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is a small molecule inhibitor of the enzyme protease, which is involved in the replication of certain viruses, including HIV. AZD8601 is being developed as a potential antiviral drug for the treatment of HIV infection.\nHow does AZD8601 work?\nAZD8601 works by inhibiting the protease enzyme, which is essential for the replication of HIV. Protease is a key enzyme in the viral replication cycle, and it helps to cleave viral polyproteins into individual proteins that are necessary for virus production. By inhibiting protease, AZD8601 reduces the ability of HIV to replicate and produce new viral particles, which can help to slow the progression of the infection.\nWhat are the advantages of AZD8601?\nAZD8601 has several potential advantages as an antiviral drug for HIV. These include:\n1. Broad-spectrum activity: AZD8601 has been shown to be effective against a wide range of HIV strains, including those that are resistant to other protease inhibitors.\n2. High potency: AZD8601 has been shown to be highly potent against HIV, with EC50 values (the concentration of drug required to inhibit the enzyme by 50%) in the low nanomolar range.\n3. Low toxicity: AZD8601 has been shown to be well-tolerated in preclinical studies, with low levels of toxicity observed.\n4. Oral bioavailability: AZD8601 has been shown to have good oral bioavailability, which could make it easier to administer than some other antiviral drugs.\n5. Potential for use in combination therapy: AZD8601 may be effective when used in combination with other antiviral drugs, which could help to improve treatment outcomes for HIV-infected patients.\nWhat are the challenges of developing AZD8601?\nDespite its potential advantages, there are several challenges associated with the development of AZD86",
    "llama-2-7b-chat-hf_fact": [
      "AZD8601 is a small molecule inhibitor of the protease enzyme.",
      "The protease enzyme helps the replication of certain viruses, including HIV.",
      "AZD8601 is being developed as an antiviral drug for the treatment of HIV infection.",
      "AZD8601 works by reducing the ability of HIV to replicate and produce new viral particles.",
      "AZD8601 has demonstrated broad-spectrum activity and high potency against HIV in studies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: AZD8601 is not a small molecule inhibitor of the protease enzyme. It is an mRNA-based drug.",
      "true",
      "false, [corrected fact]: AZD8601 is being developed for the treatment of cardiovascular disease, not HIV infection.",
      "false, [corrected fact]: AZD8601 does not work by reducing the ability of HIV to replicate, as it is intended for the treatment of cardiovascular disease.",
      "false, [corrected fact]: AZD8601 has not demonstrated broad-spectrum activity and high potency against HIV, as this is not its intended application."
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-7b-chat-hf_response": "Roundabout (Robo) receptors are members of the Robo family of receptors, which are involved in the regulation of cell migration and axon guidance during embryonic development and tissue repair. There are four known Robo receptors (Robo1, Robo2, Robo3, and Robo4) that are expressed in various tissues and cells, including neurons, muscle cells, and epithelial cells.\nSeveral ligands have been identified as binding to Robo receptors and modulating their activity. These ligands include:\n1. Roundabout ligand (RoboL): RoboL is a secreted protein that functions as a ligand for Robo1 and Robo2 receptors. RoboL binding to Robo1 and Robo2 triggers the activation of downstream signaling pathways that regulate cell migration and axon guidance.\n2. Delta-like ligand (Dll): Dll is a secreted protein that functions as a ligand for Robo2 and Robo3 receptors. Dll binding to Robo2 and Robo3 triggers the activation of downstream signaling pathways that regulate cell migration and axon guidance.\n3. Jagged ligand (Jagged): Jagged is a secreted protein that functions as a ligand for Robo1 and Robo4 receptors. Jagged binding to Robo1 and Robo4 triggers the activation of downstream signaling pathways that regulate cell migration and axon guidance.\n4. Notch ligand (Notch): Notch is a secreted protein that functions as a ligand for Robo1 and Robo4 receptors. Notch binding to Robo1 and Robo4 triggers the activation of downstream signaling pathways that regulate cell migration and axon guidance.\nOverall, these ligands play important roles in regulating the activity of Robo receptors and modulating cellular behavior, including cell migration and axon guidance, during embryonic development and tissue repair.",
    "llama-2-7b-chat-hf_fact": [
      "Roundabout (Robo) receptors are members of the Robo family of receptors which regulate cell migration and axon guidance during embryonic development and tissue repair.",
      "There are four known Robo receptors (Robo1, Robo2, Robo3, and Robo4) that are expressed in various tissues and cells.",
      "Roundabout ligand (RoboL) is a secreted protein that functions as a ligand for Robo1 and Robo2 receptors.",
      "Delta-like ligand (Dll) functions as a ligand for Robo2 and Robo3 receptors.",
      "Notch ligand (Notch) functions as a ligand for Robo1 and Robo4 receptors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false, [corrected fact]: Notch ligands are involved in the Notch signaling pathway, and interact with Notch receptors, not Roundabout (Robo) receptors."
    ]
  },
  {
    "id": 4111,
    "user_query": "Which proteins does RG-7992 target?",
    "llama-2-7b-chat-hf_response": "RG-7992 is a small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4). BRD4 is a member of the bromodomain and extraterminal (BET) protein family, which are involved in regulating gene expression by binding to acetylated histone proteins. RG-7992 binds to the bromodomain of BRD4, preventing it from interacting with acetylated histones and thereby inhibiting its ability to regulate gene expression.\nRG-7992 has been shown to inhibit the proliferation of various cancer cell lines, including those derived from breast, lung, and colon cancers. It has also been shown to induce apoptosis (programmed cell death) in cancer cells and to inhibit the formation of new blood vessels in tumors, which are processes that are important for cancer growth and progression.\nIn summary, RG-7992 targets the bromodomain-containing protein 4 (BRD4), which is involved in regulating gene expression by binding to acetylated histone proteins. By inhibiting BRD4, RG-7992 can inhibit the proliferation of cancer cells and induce apoptosis, as well as inhibit the formation of new blood vessels in tumors.",
    "llama-2-7b-chat-hf_fact": [
      "RG-7992 is a small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4).",
      "BRD4 is a member of the bromodomain and extraterminal (BET) protein family.",
      "The BET protein family is involved in regulating gene expression by binding to acetylated histone proteins.",
      "RG-7992 has been shown to inhibit the proliferation of various cancer cell lines, including those derived from breast, lung, and colon cancers.",
      "RG-7992 can induce apoptosis in cancer cells and inhibit the formation of new blood vessels in tumors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-7b-chat-hf_response": "Megakaryocytes are the precursors of platelets, which are essential for blood clotting. The regulation of megakaryocyte development and platelet production is complex and involves multiple transcription factors. TFII-I is a transcription factor that has been shown to play a role in the regulation of gene expression during cellular differentiation, including megakaryocyte development.\nStudies have shown that TFII-I is expressed in megakaryocytes and platelets, and its expression increases during megakaryocyte differentiation. TFII-I has been shown to bind to specific DNA sequences in the promoter region of genes involved in megakaryocyte differentiation, such as the gene encoding the platelet-derived growth factor receptor alpha (PDGFR). Overexpression of TFII-I has been shown to enhance the expression of PDGFR in megakaryocytes, leading to increased platelet production.\nIn addition, TFII-I has been shown to regulate the expression of genes involved in the maintenance of platelet function, such as the gene encoding the platelet-activating factor acetylhydrolase (PAF-AH). TFII-I has been shown to bind to the promoter region of the PAF-AH gene and enhance its expression, leading to increased PAF-AH activity and improved platelet function.\nTFII-I has also been shown to play a role in the regulation of megakaryocyte survival. TFII-I has been shown to bind to the promoter region of the bcl-xL gene, a pro-survival gene that is important for megakaryocyte survival. Overexpression of TFII-I has been shown to increase the expression of bcl-xL, leading to increased megakaryocyte survival.\nIn summary, TFII-I plays a role in the regulation of megakaryocyte differentiation, platelet production, and megakaryocyte survival. Its expression increases during megakaryocyte differentiation, and it regulates the expression of genes involved in these processes, including PDGFR, PAF-AH, and bcl-xL. These findings suggest that TFII-I may be",
    "llama-2-7b-chat-hf_fact": [
      "Megakaryocytes are the precursors of platelets, which are essential for blood clotting.",
      "TFII-I is a transcription factor that is involved in the regulation of gene expression during cellular differentiation, including megakaryocyte development.",
      "TFII-I is expressed in megakaryocytes and its expression increases during their differentiation.",
      "TFII-I has been shown to regulate the expression of genes involved in the maintenance of platelet function.",
      "The transcription factor TFII-I has a role in the regulation of megakaryocyte survival."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4118,
    "user_query": "Which R/Bioconductor package has been developed for network-based differential expression analysis?",
    "llama-2-7b-chat-hf_response": "Answer: There are several R/Bioconductor packages that have been developed for network-based differential expression analysis. Some of the popular packages include:\n1. NetworkAnalyst: This package provides a comprehensive framework for network-based differential expression analysis, including the construction of gene regulatory networks, identification of differentially expressed genes, and functional enrichment analysis.\n2. DAVID: DAVID (Database for Annotation, Visualization, and Integrated Discovery) is a popular Bioconductor package that provides a wide range of tools for network-based differential expression analysis, including gene set enrichment analysis, pathway analysis, and network analysis.\n3. ReactomePA: ReactomePA is a Bioconductor package that provides a comprehensive framework for network-based differential expression analysis, including the construction of gene regulatory networks, identification of differentially expressed genes, and functional enrichment analysis.\n4. GSEA: Gene Set Enrichment Analysis (GSEA) is a Bioconductor package that provides a comprehensive framework for network-based differential expression analysis, including the construction of gene regulatory networks, identification of differentially expressed genes, and functional enrichment analysis.\n5. ARACNe: ARACNe (Algorithm for the Reconstruction of Accurate Networks) is a Bioconductor package that provides a comprehensive framework for network-based differential expression analysis, including the construction of gene regulatory networks, identification of differentially expressed genes, and functional enrichment analysis.",
    "llama-2-7b-chat-hf_fact": [
      "NetworkAnalyst is an R/Bioconductor package used for network-based differential expression analysis.",
      "DAVID is an R/Bioconductor package that provides tools for network-based differential expression analysis.",
      "ReactomePA is an R/Bioconductor package used for network-based differential expression analysis.",
      "Gene Set Enrichment Analysis (GSEA) is an R/Bioconductor package for network-based differential expression analysis.",
      "ARACNe is an R/Bioconductor package designed for network-based differential expression analysis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: DAVID is a bioinformatics resource that provides a comprehensive set of functional annotation tools for investigators to understand biological meaning behind large list of genes.",
      "false, [corrected fact]: ReactomePA is an R/Bioconductor package used for pathway analysis based on Reactome pathway data.",
      "false, [corrected fact]: Gene Set Enrichment Analysis (GSEA) is a computational method that determines whether a predefined set of genes shows statistically significant, concordant differences between two biological states.",
      "false, [corrected fact]: ARACNe is an algorithm specifically designed to reverse engineer the underlying gene regulatory network from gene expression profiles of cancer samples."
    ]
  },
  {
    "id": 4119,
    "user_query": "Can propofol cause green urine?",
    "llama-2-7b-chat-hf_response": "Yes, propofol can cause green urine as a side effect. This is due to the drug's metabolism, which can lead to the formation of a pigment called pyridinium. This pigment can give the urine a greenish tint.\nOther side effects of propofol that can cause changes in urine color include:\n1. Yellowing of the skin and eyes: Propofol can cause an increase in bilirubin levels in the blood, which can lead to a yellowish tint to the skin and eyes.\n2. Darkening of the urine: Propofol can also cause a darkening of the urine, which can be due to the drug's metabolism or the accumulation of certain metabolites in the body.\nIt's important to note that these side effects are generally mild and temporary, and they typically resolve on their own within a few days of stopping the drug. However, if you experience any persistent or severe changes in urine color or any other symptoms while taking propofol, you should speak with your healthcare provider.",
    "llama-2-7b-chat-hf_fact": [
      "Propofol can cause green urine as a side effect.",
      "This effect is due to the drug's metabolism forming a pigment called pyridinium.",
      "Propofol can lead to an increase in bilirubin levels in the blood.",
      "Increased bilirubin from propofol can cause a yellowish tint to the skin and eyes.",
      "Another side effect is that propofol can cause darkening of the urine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: This effect is due to the drug's metabolism forming a pigment called phenol.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4125,
    "user_query": "Is vocimagene amiretrorepvec effective for glioblastoma?",
    "llama-2-7b-chat-hf_response": "Vocimagene amiretrorepvec is an investigational gene therapy that is being studied for the treatment of glioblastoma, an aggressive form of brain cancer. In clinical trials, vocimagene amiretrorepvec has shown promise in reducing the size of glioblastoma tumors and improving survival rates compared to standard of care treatments. However, it is important to note that vocimagene amiretrorepvec is still in the experimental stage and has not yet been approved by regulatory authorities for use in humans. More research is needed to fully understand its safety and effectiveness in treating glioblastoma.",
    "llama-2-7b-chat-hf_fact": [
      "Vocimagene amiretrorepvec is an investigational gene therapy.",
      "Vocimagene amiretrorepvec is being studied for the treatment of glioblastoma.",
      "In clinical trials, vocimagene amiretrorepvec has shown promise in reducing tumor size and improving survival rates for glioblastoma.",
      "Vocimagene amiretrorepvec is still in the experimental stage.",
      "Vocimagene amiretrorepvec has not yet been approved by regulatory authorities for use in humans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4131,
    "user_query": "Can Panitumumab cause trichomegaly?",
    "llama-2-7b-chat-hf_response": "Yes, panitumumab can cause trichomegaly, which is a condition characterized by an abnormal increase in the size of the hair follicles. This side effect is not uncommon with panitumumab and has been reported in clinical trials. The exact mechanism by which panitumumab causes trichomegaly is not fully understood, but it is thought to be related to the drug's ability to inhibit the activity of the epidermal growth factor receptor (EGFR), which is involved in the growth and maintenance of hair follicles.\nTrichomegaly caused by panitumumab can range from mild to severe and may be accompanied by other symptoms such as itching, redness, and swelling of the skin. In some cases, the condition may resolve on its own once the drug is discontinued, but in other cases, it may persist even after treatment is stopped.\nIf you are taking panitumumab and experiencing trichomegaly or any other side effects, it is important to speak with your healthcare provider. They can provide guidance on how to manage the side effects and determine whether the drug is still appropriate for your treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Panitumumab can cause trichomegaly, a condition characterized by an abnormal increase in the size of the hair follicles.",
      "Trichomegaly as a side effect of panitumumab use has been reported in clinical trials.",
      "The exact mechanism by which panitumumab causes trichomegaly is thought to be related to the drug's ability to inhibit the activity of the epidermal growth factor receptor (EGFR).",
      "Trichomegaly caused by panitumumab can vary from mild to severe and may be accompanied by symptoms such as itching, redness and swelling of the skin.",
      "The trichomegaly condition may resolve on its own after panitumumab is discontinued, or it may persist even after the treatment is stopped."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4135,
    "user_query": "What is the mechanism of action of vosoritide?",
    "llama-2-7b-chat-hf_response": "Vosoritide is a drug that is being developed to treat Duchenne muscular dystrophy (DMD), a genetic disorder that affects muscle strength and function. The mechanism of action of vosoritide is not fully understood, but it is believed to work by increasing the production of dystrophin, a protein that is deficient in DMD patients. Dystrophin is important for maintaining muscle structure and function, and its deficiency leads to the muscle weakness and wasting that characterizes DMD.\nVosoritide is a small molecule that is administered by injection. It is thought to work by binding to the messenger RNA (mRNA) of the dystrophin gene, which is the molecule that carries genetic information from DNA to the ribosome, where proteins are made. By binding to the dystrophin mRNA, vosoritide may help to increase the production of dystrophin protein in muscle cells, which could help to restore muscle function in DMD patients.\nVosoritide has been shown to increase dystrophin protein levels in muscle biopsies from DMD patients, and it has also been shown to improve muscle function in animal models of DMD. However, more research is needed to fully understand the mechanism of action of vosoritide and to determine its potential as a treatment for DMD.",
    "llama-2-7b-chat-hf_fact": [
      "Vosoritide is a drug being developed to treat Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy is a genetic disorder affecting muscle strength and function.",
      "Vosoritide is theorized to work by increasing the production of dystrophin, a protein deficient in DMD patients.",
      "Dystrophin is critical for maintaining muscle structure and function.",
      "Vosoritide is administered by injection and it is suggested to increase dystrophin levels in muscle biopsies from DMD patients."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Vosoritide is a drug being developed to treat achondroplasia, not Duchenne muscular dystrophy (DMD).",
      "true",
      "false, [corrected fact]: Vosoritide is theorized to work by increasing the production of growth plates, not dystrophin.",
      "true",
      "false, [corrected fact]: Vosoritide is administered by injection and it is suggested to stimulate bone growth in patients with achondroplasia, not increase dystrophin levels in DMD patients."
    ]
  },
  {
    "id": 4141,
    "user_query": "What is the mechanism of action of idasanutlin?",
    "llama-2-7b-chat-hf_response": "Idasanutlin is a small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4). BRD4 is a member of the bromodomain and extraterminal (BET) protein family, which are involved in regulating gene expression by recognizing and binding to acetylated lysine residues on histone proteins.\nIdasanutlin works by binding to the bromodomain of BRD4, thereby preventing it from recognizing and binding to acetylated histone proteins. This leads to a decrease in the expression of genes involved in cell proliferation, survival, and angiogenesis, ultimately inhibiting the growth of cancer cells.\nIdasanutlin has been shown to be effective in preclinical models of various types of cancer, including breast, lung, and ovarian cancer. It is currently being investigated in clinical trials as a potential treatment for various types of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Idasanutlin is a small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4).",
      "BRD4 is a member of the bromodomain and extraterminal (BET) protein family which regulates gene expression.",
      "Idasanutlin works by preventing BRD4 from recognizing and binding to acetylated histone proteins.",
      "The mechanism of action of idasanutlin can lead to a decrease in the expression of genes involved in cell proliferation, survival, and angiogenesis, ultimately inhibiting the growth of cancer cells.",
      "Idasanutlin is currently being investigated in clinical trials as a potential treatment for various types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Idasanutlin is a small molecule inhibitor of the MDM2 (mouse double minute 2 homolog) protein, not BRD4.",
      "true",
      "false, [corrected fact]: Idasanutlin works by blocking MDM2 from inhibiting p53, a protein that regulates the cell cycle, not by preventing BRD4 from recognizing and binding to acetylated histone proteins.",
      "true",
      "true"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-7b-chat-hf_response": "Atenolol, a beta-blocker medication, is metabolized by the cytochrome P450 (CYP) enzyme CYP2D6. CYP2D6 is one of the most important enzymes involved in the metabolism of atenolol, and it accounts for approximately 30-40% of the drug's metabolism in most individuals.\nOther CYP enzymes, such as CYP1A2, CYP2C9, and CYP3A4, may also contribute to the metabolism of atenolol to a lesser extent. However, the major pathway of atenolol metabolism is through CYP2D6, and this enzyme is responsible for the formation of the major metabolites of atenolol, including carbamylated atenolol and the glucuronide conjugate of atenolol.\nIndividuals with genetic variations in the CYP2D6 gene may have altered levels of atenolol metabolism, which can affect the drug's efficacy and side effect profile. For example, individuals with reduced function of CYP2D6 may have lower levels of atenolol metabolism, which can result in reduced drug efficacy. Conversely, individuals with increased function of CYP2D6 may have higher levels of atenolol metabolism, which can result in increased side effects.\nOverall, the metabolism of atenolol by CYP2D6 is an important factor to consider when prescribing this medication, particularly in individuals with genetic variations in the CYP2D6 gene.",
    "llama-2-7b-chat-hf_fact": [
      "Atenolol is metabolized by the cytochrome P450 (CYP) enzyme CYP2D6.",
      "CYP2D6 is one of the most important enzymes involved in the metabolism of Atenolol.",
      "CYP enzymes such as CYP1A2, CYP2C9, and CYP3A4 may also contribute to the metabolism of atenolol.",
      "Genetic variations in the CYP2D6 gene can affect the levels of atenolol metabolism.",
      "The metabolism of atenolol by CYP2D6 can affect the drug's efficacy and side effect profile."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Atenolol is not metabolized by the cytochrome P450 (CYP) enzyme CYP2D6, it is primarily eliminated by renal excretion.",
      "false, [corrected fact]: CYP2D6 does not play a significant role in the metabolism of Atenolol.",
      "false, [corrected fact]: CYP enzymes such as CYP1A2, CYP2C9, and CYP3A4 do not necessarily contribute significantly to the metabolism of atenolol as it is not typically processed through the CYP enzyme system.",
      "false, [corrected fact]: Genetic variations in the CYP2D6 gene does not affect the levels of atenolol metabolism as it is not primarily processed by the CYP2D6 enzyme.",
      "false, [corrected fact]: The metabolism of atenolol is not significantly affected by CYP2D6, thus it would not notably alter the drug's efficacy and side effect profile."
    ]
  },
  {
    "id": 4151,
    "user_query": "Which pharmacogenetic test is recommended prior to administering carbamazepine and why?",
    "llama-2-7b-chat-hf_response": "Carbamazepine is an anticonvulsant medication that is commonly used to treat seizures, bipolar disorder, and neuropathic pain. However, its efficacy and safety can vary significantly among individuals due to genetic differences in the CYP3A4 enzyme, which is responsible for metabolizing carbamazepine. Therefore, it is recommended to perform a pharmacogenetic test prior to administering carbamazepine to determine an individual's CYP3A4 genotype.\nThe CYP3A4 enzyme is responsible for metabolizing carbamazepine into its active metabolite, carbamazepine-10,11-epoxide. Individuals with certain genetic variations in the CYP3A4 gene may have reduced enzyme activity, leading to reduced metabolism of carbamazepine and increased risk of adverse effects, such as drowsiness, dizziness, and cognitive impairment. Conversely, individuals with other genetic variations may have increased enzyme activity, leading to increased metabolism of carbamazepine and reduced efficacy.\nBy performing a pharmacogenetic test prior to administering carbamazepine, healthcare providers can identify an individual's CYP3A4 genotype and adjust the dosage of the medication accordingly. For example, individuals with reduced CYP3A4 activity may require lower doses of carbamazepine to minimize the risk of adverse effects, while individuals with increased activity may require higher doses to achieve optimal efficacy.\nIn summary, a pharmacogenetic test is recommended prior to administering carbamazepine to determine an individual's CYP3A4 genotype and adjust the dosage of the medication accordingly to minimize the risk of adverse effects and optimize efficacy.",
    "llama-2-7b-chat-hf_fact": [
      "Carbamazepine is used to treat seizures, bipolar disorder, and neuropathic pain.",
      "The CYP3A4 enzyme is responsible for metabolizing carbamazepine.",
      "Certain genetic variations in the CYP3A4 gene can affect an individual's response to carbamazepine.",
      "A pharmacogenetic test can identify an individual's CYP3A4 genotype.",
      "Knowing an individual's CYP3A4 genotype allows for dosage adjustments of carbamazepine, optimizing efficacy and minimizing adverse effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4153,
    "user_query": "Which drugs are included in the MAID chemotherapy regimen for sarcoma?",
    "llama-2-7b-chat-hf_response": "The MAID chemotherapy regimen for sarcoma typically includes the following drugs:\n1. Methotrexate: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n2. Doxorubicin: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n3. Ifosfamide: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n4. Etoposide: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n5. Cisplatin: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n6. Paclitaxel: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n7. Docetaxel: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n8. Vinorelbine: This drug is used to treat soft tissue sarcoma and osteosarcoma.\n9. Gemcitabine: This drug is used to treat soft tissue sarcoma and osteosarcoma.\nIt's important to note that the specific drugs and their dosages may vary depending on the individual patient and the specific type of sarcoma they have. Additionally, the MAID regimen may be used in combination with other treatments, such as surgery or radiation therapy, to achieve the best possible outcome.",
    "llama-2-7b-chat-hf_fact": [
      "The MAID chemotherapy regimen for sarcoma includes the drug Methotrexate.",
      "Doxorubicin is another drug included in the MAID regimen for sarcoma treatment.",
      "Ifosfamide is used in the MAID chemotherapy regimen for sarcoma.",
      "Etoposide and Cisplatin are also part of the MAID regimen for sarcoma treatment.",
      "The MAID regimen for sarcoma may be used in combination with other treatments, such as surgery or radiation therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The MAID chemotherapy regimen for sarcoma does not include the drug Methotrexate. It includes Mesna, Doxorubicin, Ifosfamide, and Dacarbazine.",
      "true",
      "true",
      "false, [corrected fact]: Etoposide and Cisplatin are not part of the MAID regimen for sarcoma treatment. It includes Mesna, Doxorubicin, Ifosfamide, and Dacarbazine.",
      "true"
    ]
  },
  {
    "id": 4155,
    "user_query": "Who received the Nobel prize for development of CRISPR?",
    "llama-2-7b-chat-hf_response": "The Nobel Prize in Physiology or Medicine 2020 was awarded to Jennifer Doudna and Emmanuelle Charpentier for the discovery of the CRISPR-Cas9 gene editing tool.",
    "llama-2-7b-chat-hf_fact": [
      "The Nobel Prize in Physiology or Medicine 2020 was given for the discovery of the CRISPR-Cas9 gene editing tool.",
      "Jennifer Doudna was a recipient of the Nobel Prize in Physiology or Medicine 2020.",
      "Emmanuelle Charpentier was a recipient of the Nobel Prize in Physiology or Medicine 2020.",
      "The Nobel Prize was awarded to Jennifer Doudna and Emmanuelle Charpentier for their work related to CRISPR."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4156,
    "user_query": "How are super enhancers defined?",
    "llama-2-7b-chat-hf_response": "Super enhancers are cis-acting elements that are located far away from the promoter and gene they regulate, and they play a crucial role in regulating gene expression by enhancing the activity of nearby genes. Super enhancers are characterized by their ability to bind to specific proteins, such as transcription factors, and to recruit RNA polymerase II, the enzyme responsible for transcribing DNA into RNA, to the promoter region of the gene.",
    "llama-2-7b-chat-hf_fact": [
      "Super enhancers are cis-acting elements that are located far from the promoter and gene they regulate.",
      "Super enhancers play a crucial role in enhancing the activity of nearby genes.",
      "Super enhancers are characterized by their ability to bind to specific proteins, such as transcription factors.",
      "Super enhancers are capable of recruiting RNA polymerase II to the promoter region of the gene.",
      "RNA polymerase II is the enzyme responsible for transcribing DNA into RNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-7b-chat-hf_response": "Here are some versions of ExpansionHunter that you can use:\n1. **ExpansionHunter 1.0**: This is the initial version of ExpansionHunter, which includes basic features such as keyword research, competitor analysis, and content optimization.\n2. **ExpansionHunter 2.0**: This version includes additional features such as backlink analysis, technical SEO audits, and content creation templates.\n3. **ExpansionHunter Pro**: This is an upgraded version of ExpansionHunter that includes advanced features such as AI-powered keyword research, competitor tracking, and custom reporting.\n4. **ExpansionHunter Enterprise**: This is a customized version of ExpansionHunter that is designed for large businesses and agencies. It includes additional features such as team collaboration, custom workflows, and enterprise-level support.\n5. **ExpansionHunter Agency**: This is a version of ExpansionHunter that is specifically designed for digital marketing agencies. It includes features such as client management, project tracking, and agency-level reporting.\n6. **ExpansionHunter eCommerce**: This is a version of ExpansionHunter that is specifically designed for eCommerce businesses. It includes features such as product research, competitor analysis, and optimization for eCommerce SEO.\n7. **ExpansionHunter Local**: This is a version of ExpansionHunter that is specifically designed for local SEO. It includes features such as local keyword research, competitor analysis, and optimization for local SEO.\n8. **ExpansionHunter Voice**: This is a version of ExpansionHunter that is specifically designed for voice search optimization. It includes features such as voice search keyword research, competitor analysis, and optimization for voice search SEO.\n9. **ExpansionHunter Content**: This is a version of ExpansionHunter that is specifically designed for content marketing. It includes features such as content research, competitor analysis, and optimization for content marketing.\n10. **ExpansionHunter Social**: This is a version of ExpansionHunter that is specifically designed for social media marketing. It includes features such as social media keyword research, competitor analysis, and optimization for social media SEO.\nThese are some of the versions of ExpansionHunter that",
    "llama-2-7b-chat-hf_fact": [
      "ExpansionHunter 1.0 is the initial version of ExpansionHunter which includes basic features for keyword research, competitor analysis, and content optimization.",
      "ExpansionHunter 2.0 includes additional features like backlink analysis, technical SEO audits, and content creation templates.",
      "ExpansionHunter Pro is an upgraded version of ExpansionHunter that includes AI-powered keyword research, competitor tracking, and custom reporting.",
      "ExpansionHunter Enterprise is a version of ExpansionHunter designed for large businesses and agencies, with features such as team collaboration, custom workflows, and enterprise-level support.",
      "ExpansionHunter Agency is a version of ExpansionHunter designed for digital marketing agencies, with features like client management, project tracking, and agency-level reporting."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4160,
    "user_query": "What is the proteoglycan Tsukushi?",
    "llama-2-7b-chat-hf_response": "Tsukushi is a proteoglycan that is found in the extracellular matrix (ECM) of various tissues, including cartilage, bone, and connective tissue. It is composed of a core protein (aggrecan) and one or more covalently attached glycosaminoglycan (GAG) chains (e.g., keratan sulfate and chondroitin sulfate). Tsukushi plays a crucial role in maintaining tissue structure and function by providing mechanical support, regulating cell signaling and adhesion, and modulating the activity of growth factors and enzymes.\nTsukushi is also known as cartilage oligomeric matrix protein (COMP) and is a major component of the ECM in cartilage. It is involved in the maintenance of cartilage structure and function, and its dysregulation has been implicated in various cartilage-related diseases, such as osteoarthritis.\nIn summary, Tsukushi is a proteoglycan that plays a critical role in maintaining tissue structure and function by providing mechanical support, regulating cell signaling and adhesion, and modulating the activity of growth factors and enzymes. Its dysregulation has been implicated in various diseases, including osteoarthritis.",
    "llama-2-7b-chat-hf_fact": [
      "Tsukushi is a proteoglycan found in the extracellular matrix of various tissues such as cartilage, bone, and connective tissue.",
      "Tsukushi is composed of a core protein, aggrecan, and one or more covalently attached glycosaminoglycan chains.",
      "Tsukushi is essential in maintaining tissue structure and function by providing mechanical support, regulating cell signaling and adhesion, and modulating the activity of growth factors and enzymes.",
      "Tsukushi is also known as cartilage oligomeric matrix protein.",
      "Dysregulation of Tsukushi has been implicated in various diseases, including osteoarthritis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Tsukushi is composed of a core protein and heparan sulfate chains. Aggrecan is a different proteoglycan.",
      "true",
      "false, [corrected fact]: Tsukushi is not the same as cartilage oligomeric matrix protein. They are separate entities.",
      "true"
    ]
  },
  {
    "id": 4163,
    "user_query": "Which biological drugs are EMA approved for pediatric psoriasis?",
    "llama-2-7b-chat-hf_response": "The European Medicines Agency (EMA) has approved several biological drugs for the treatment of pediatric psoriasis. These include:\n1. Adalimumab (Humira): Adalimumab is a tumor necrosis factor-alpha (TNF-alpha) inhibitor that is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 4 years and older.\n2. Etanercept (Enbrel): Etanercept is also a TNF-alpha inhibitor that is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 4 years and older.\n3. Infliximab (Remicade): Infliximab is a TNF-alpha inhibitor that is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 years and older.\n4. Secukinumab (Cosentyx): Secukinumab is an interleukin-17A (IL-17A) inhibitor that is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 4 years and older.\n5. Ixekizumab (Taltz): Ixekizumab is an IL-17A inhibitor that is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 years and older.\n6. Ustekinumab (Stelara): Ustekinumab is an IL-12 and IL-23 inhibitor that is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 years and older.",
    "llama-2-7b-chat-hf_fact": [
      "The European Medicines Agency (EMA) has approved several biological drugs for pediatric psoriasis.",
      "Adalimumab (Humira), a tumor necrosis factor-alpha (TNF-alpha) inhibitor, is approved for treating moderate-to-severe plaque psoriasis in children and adolescents aged 4 years and older.",
      "Ixekizumab (Taltz), an interleukin-17A (IL-17A) inhibitor, is approved for treating moderate-to-severe plaque psoriasis in children and adolescents aged 6 years and older.",
      "Ustekinumab (Stelara), an IL-12 and IL-23 inhibitor, is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 6 years and older.",
      "Secukinumab (Cosentyx), an interleukin-17A (IL-17A) inhibitor, is approved for the treatment of moderate-to-severe plaque psoriasis in children and adolescents aged 4 years and older."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-7b-chat-hf_response": "Adamts18 is a protease that has been shown to play a role in the regulation of hormone receptor signaling. Specifically, Adamts18 has been shown to cleave and activate the estrogen receptor alpha (ER), leading to increased ER activity and downstream signaling. Adamts18 has also been shown to cleave and activate other hormone receptors, including the progesterone receptor (PR) and the retinoic acid receptor alpha (RAR).\nAdamts18 is a member of the a disintegrin and metalloproteinase (ADAM) family of proteases, which are involved in a variety of cellular processes, including cell adhesion, migration, and signaling. In addition to its role in hormone receptor signaling, Adamts18 has been implicated in the development and progression of various cancers, including breast, ovarian, and prostate cancer.\nOverall, the role of Adamts18 in hormone receptor signaling is complex and multifaceted, and further research is needed to fully understand its mechanisms of action and its potential as a therapeutic target for hormone-sensitive cancers.",
    "llama-2-7b-chat-hf_fact": [
      "Adamts18 is a protease that regulates hormone receptor signaling.",
      "Adamts18 has been shown to cleave and activate the estrogen receptor alpha (ER).",
      "Adamts18 also can cleave and activate other hormone receptors like the progesterone receptor (PR) and the retinoic acid receptor alpha (RAR).",
      "Adamts18 is a member of the a disintegrin and metalloproteinase (ADAM) family of proteases.",
      "Adamts18 has been implicated in the development and progression of various cancers, including breast, ovarian, and prostate cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Adamts18 is a member of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family of proteases.",
      "true"
    ]
  },
  {
    "id": 4166,
    "user_query": "Which are the lactate isomers?",
    "llama-2-7b-chat-hf_response": "Lactate isomers are compounds that have the same molecular formula but differ in their molecular structure. There are two isomers of lactate:\n1. L-lactate: This is the natural isomer of lactate, which is found in many living organisms, including humans. L-lactate is also known as D-lactate.\n2. D-lactate: This is the artificial isomer of lactate, which is not found in nature. D-lactate is also known as L-lactate.\nBoth L-lactate and D-lactate have the same molecular formula, C3H6O3, but they differ in their stereochemistry. L-lactate has a \"L\"-configuration, while D-lactate has a \"D\"-configuration.\nLactate isomers have different physical and chemical properties, such as melting and boiling points, solubility, and reactivity. For example, L-lactate has a higher melting point than D-lactate, and it is more soluble in water. D-lactate, on the other hand, is more reactive than L-lactate and can undergo certain chemical reactions more easily.\nLactate isomers have important applications in various fields, including pharmaceuticals, food science, and biotechnology. For example, L-lactate is used in the production of certain drugs and nutritional supplements, while D-lactate is used in the production of some food additives and flavorings.\nIn summary, the two isomers of lactate are L-lactate and D-lactate, which differ in their stereochemistry and have different physical and chemical properties.",
    "llama-2-7b-chat-hf_fact": [
      "Lactate has two isomers: L-lactate and D-lactate.",
      "Both L-lactate and D-lactate have the same molecular formula, C3H6O3, but different stereochemistry.",
      "L-lactate and D-lactate have different physical and chemical properties, including melting and boiling points, solubility, and reactivity.",
      "L-lactate is used in the production of certain drugs and nutritional supplements.",
      "D-lactate is used in the production of some food additives and flavorings."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4168,
    "user_query": "Are enhancers directional in their targeting of gene promoters?",
    "llama-2-7b-chat-hf_response": "Enhancers are cis-acting elements that can increase the expression of a gene by binding to proteins that recruit RNA polymerase, the enzyme responsible for transcribing DNA into RNA, to the promoter region of the gene. The question of whether enhancers are directional in their targeting of gene promoters is a topic of ongoing research and debate.\nSome studies have suggested that enhancers can be directional in their targeting of gene promoters, meaning that they preferentially bind to promoters in a specific direction relative to the enhancer. For example, one study found that in the Drosophila melanogaster genome, enhancers tend to bind to promoters that are located upstream of the enhancer, rather than downstream. Another study found that in the mouse genome, enhancers tend to target promoters that are located in the same orientation as the enhancer, rather than in the opposite orientation.\nHowever, other studies have suggested that enhancers may not be directional in their targeting of gene promoters. For example, one study found that in the human genome, enhancers can bind to promoters located in either the same or opposite orientation relative to the enhancer, and that the orientation of the enhancer does not significantly affect its ability to recruit RNA polymerase to the promoter. Another study found that in the zebrafish genome, enhancers can bind to promoters located in any direction relative to the enhancer, and that the orientation of the enhancer does not significantly affect its ability to regulate gene expression.\nOverall, the question of whether enhancers are directional in their targeting of gene promoters is still an open one, and more research is needed to fully understand the mechanisms by which enhancers regulate gene expression. However, it is clear that the orientation of the enhancer relative to the promoter is not the only factor that determines its ability to recruit RNA polymerase and regulate gene expression, and that other factors, such as the distance between the enhancer and promoter, may also play a role.",
    "llama-2-7b-chat-hf_fact": [
      "Enhancers are cis-acting elements that can increase the expression of a gene.",
      "RNA polymerase is the enzyme responsible for transcribing DNA into RNA.",
      "Some studies have suggested that enhancers preferentially bind to promoters in a specific direction relative to the enhancer.",
      "One study suggested that in the Drosophila melanogaster genome, enhancers tend to bind to promoters that are located upstream of the enhancer.",
      "Another study suggested that in the human genome, the orientation of the enhancer does not significantly affect its ability to recruit RNA polymerase to the promoter."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4171,
    "user_query": "What is the role of phenylbutyratetaurursodiol for amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that affects the motor neurons in the brain and spinal cord, leading to muscle weakness, atrophy, and paralysis. While there is currently no cure for ALS, various treatments are being investigated to slow disease progression and improve quality of life for patients. One such treatment is phenylbutyratetaurursodiol, a combination of two compounds that have been shown to have neuroprotective effects in preclinical studies.\nPhenylbutyrate is a potent inhibitor of the enzyme butyrylcholinesterase, which is involved in the breakdown of the neurotransmitter acetylcholine. Acetylcholine plays a key role in the transmission of nerve impulses, and its degradation is thought to contribute to the degeneration of motor neurons in ALS. By inhibiting butyrylcholinesterase, phenylbutyrate increases the levels of acetylcholine in the brain and spinal cord, which may help to slow disease progression.\nTaurursodiol, on the other hand, is a naturally occurring compound that is derived from the amino acid taurine. It has been shown to have antioxidant and anti-inflammatory effects, which may help to protect motor neurons from damage. Taurursodiol has also been shown to increase the levels of the neurotrophic factor brain-derived neurotrophic factor (BDNF), which is important for the survival and function of motor neurons.\nThe combination of phenylbutyrate and taurursodiol has been shown to have synergistic effects in preclinical studies, with greater neuroprotective effects than either compound alone. For example, a study published in the journal Neuropharmacology found that mice treated with a combination of phenylbutyrate and taurursodiol had improved motor function and reduced muscle atrophy compared to mice treated with either compound alone.\nWhile these findings are promising, it is important to note that the current evidence for the use of phenylbutyratetaurursodiol in",
    "llama-2-7b-chat-hf_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects the motor neurons in the brain and spinal cord.",
      "Phenylbutyratetaurursodiol is being examined as a treatment for ALS.",
      "Phenylbutyrate is an inhibitor of the enzyme butyrylcholinesterase, which is involved in the degradation of the neurotransmitter acetylcholine.",
      "Taurursodiol, derived from the amino acid taurine, possesses antioxidant and anti-inflammatory properties that potentially aid in protecting motor neurons.",
      "A preclinical study in the journal Neuropharmacology revealed that a combination of phenylbutyrate and taurursodiol improved motor function and reduced muscle atrophy in mice."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Phenylbutyrate is a histone deacetylase inhibitor and does not specifically inhibit butyrylcholinesterase.",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4172,
    "user_query": "What is known about growth arrest-specific 6 protein?",
    "llama-2-7b-chat-hf_response": "Growth arrest-specific 6 (GAS6) is a protein that plays a crucial role in regulating cellular processes such as cell growth, differentiation, and survival. Here are some key points to know about GAS6:\n1. Structure: GAS6 is a member of the growth arrest-specific family of proteins, which are characterized by the presence of a conserved GAS domain. The GAS domain is responsible for the protein's ability to interact with and regulate the activity of other proteins.\n2. Cellular functions: GAS6 has been shown to play a role in regulating cellular processes such as cell growth, differentiation, and survival. It has been implicated in the regulation of cell cycle progression, apoptosis, and angiogenesis.\n3. Regulation of signaling pathways: GAS6 has been shown to regulate a variety of signaling pathways, including the PI3K/Akt, MAPK/ERK, and JNK pathways. These pathways are involved in a wide range of cellular processes, including cell growth, differentiation, and survival.\n4. Role in cancer: GAS6 has been implicated in the development and progression of cancer. It has been shown to promote the growth and survival of cancer cells, and to inhibit the activity of anti-cancer drugs.\n5. Role in inflammation: GAS6 has been shown to play a role in the regulation of inflammation. It has been implicated in the regulation of the production of pro-inflammatory cytokines, and has been shown to inhibit the activity of inflammatory cells.\n6. Therapeutic potential: GAS6 has been identified as a potential therapeutic target for a variety of diseases, including cancer and inflammatory disorders. Agents that target GAS6 have been shown to be effective in inhibiting the growth and survival of cancer cells, and in reducing inflammation.\n7. Interactions with other proteins: GAS6 has been shown to interact with a variety of other proteins, including the PI3K/Akt signaling pathway, the MAPK/ERK signaling pathway, and",
    "llama-2-7b-chat-hf_fact": [
      "Growth arrest-specific 6 (GAS6) is a protein that plays a crucial role in regulating cellular processes such as cell growth, differentiation, and survival.",
      "GAS6 is a member of the growth arrest-specific family of proteins, which are characterized by a conserved GAS domain.",
      "GAS6 regulates a variety of signaling pathways, including the PI3K/Akt, MAPK/ERK, and JNK pathways.",
      "GAS6 has been implicated in the development and progression of cancer, promoting the growth and survival of cancer cells, and inhibiting the activity of anti-cancer drugs.",
      "GAS6 has been identified as a potential therapeutic target for a variety of diseases, including cancer and inflammatory disorders."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4174,
    "user_query": "What percent of Rheumatoid Arthritis (RA) patients are not responding to anti-TNF therapy?",
    "llama-2-7b-chat-hf_response": "According to the American College of Rheumatology (ACR), approximately 40-50% of patients with Rheumatoid Arthritis (RA) do not respond to anti-Tumor Necrosis Factor (TNF) therapy, which is a common treatment for RA. This means that about half of RA patients do not experience significant improvement in their symptoms or joint damage after receiving anti-TNF therapy.\nThere are several factors that may contribute to a patient's lack of response to anti-TNF therapy, including:\n1. Disease duration: Patients with longer disease duration may be less likely to respond to anti-TNF therapy.\n2. Severity of disease: Patients with more severe disease may be less likely to respond to anti-TNF therapy.\n3. Presence of comorbidities: Patients with certain comorbidities, such as cardiovascular disease or lung disease, may be less likely to respond to anti-TNF therapy.\n4. Genetic factors: Some patients may have genetic variations that affect their response to anti-TNF therapy.\n5. Inadequate dosing or duration of treatment: Patients who do not receive adequate doses of anti-TNF therapy or who do not receive it for long enough may be less likely to respond to treatment.\nIt is important to note that not all patients with RA will respond to anti-TNF therapy, and there are other treatment options available for those who do not respond.",
    "llama-2-7b-chat-hf_fact": [
      "The American College of Rheumatology states that around 40-50% of Rheumatoid Arthritis (RA) patients do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy.",
      "Anti-Tumor Necrosis Factor (anti-TNF) therapy is a common treatment for Rheumatoid Arthritis.",
      "Factors such as disease duration, disease severity, presence of comorbidities, genetic variations, and inadequate dosing or duration of treatment can impact a patient's response to anti-TNF therapy.",
      "Not all patients with Rheumatoid Arthritis respond to anti-TNF therapy.",
      "There are alternative treatment options available for Rheumatoid Arthritis patients who do not respond to anti-TNF therapy."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4178,
    "user_query": "Do bacteria release extracellular vesicles?",
    "llama-2-7b-chat-hf_response": "Yes, bacteria do release extracellular vesicles (EVs). EVs are small, membrane-bound vesicles that are released from the cytoplasm of cells and can carry a variety of biomolecules, including proteins, lipids, and nucleic acids. In bacteria, EVs are called outer membrane vesicles (OMVs) and are formed by the outer membrane of the bacterial cell.\nOMVs are released from the bacterial cell through a process called exocytosis, in which the vesicles are budded off from the outer membrane and then released into the extracellular space. OMVs can carry a wide range of molecules, including lipopolysaccharides, proteins, and small molecules, and can play important roles in bacterial communication, immune evasion, and pathogenesis.\nOMVs have been studied extensively in Gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa, but they have also been observed in Gram-positive bacteria, such as Staphylococcus aureus. The composition and function of OMVs can vary depending on the bacterial species and the conditions under which they are formed.\nSome of the functions of OMVs in bacteria include:\n1. Immune evasion: OMVs can carry immunogenic molecules, such as lipopolysaccharides, that can activate the host immune system and contribute to bacterial immune evasion.\n2. Communication: OMVs can carry signaling molecules, such as autoinducers, that can communicate with other bacteria and coordinate their behavior.\n3. Pathogenesis: OMVs can carry virulence factors, such as toxins and adhesins, that can contribute to the pathogenesis of bacterial infections.\n4. Antibiotic resistance: OMVs can carry genes that confer antibiotic resistance to the bacteria, making them more difficult to kill with antibiotics.\n5. Nutrient acquisition: OMVs can carry nutrients, such as amino acids and sugars, that can be used by the",
    "llama-2-7b-chat-hf_fact": [
      "Bacteria release extracellular vesicles (EVs), also known as outer membrane vesicles (OMVs), from their cytoplasm.",
      "These vesicles can carry a variety of biomolecules including proteins, lipids, and nucleic acids.",
      "OMVs have been extensively studied in Gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa, but have also been observed in Gram-positive bacteria, such as Staphylococcus aureus.",
      "The functions of OMVs in bacteria can include immune evasion, communication, pathogenesis, antibiotic resistance, and nutrient acquisition.",
      "The composition and function of OMVs can vary depending on the bacterial species and the conditions under which they are formed."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Bacteria release extracellular vesicles (EVs), also known as outer membrane vesicles (OMVs), from their outer membrane, not their cytoplasm.",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4179,
    "user_query": "What is the effect of the venom of the cone snail, Conus tulipa?",
    "llama-2-7b-chat-hf_response": "The venom of the cone snail, Conus tulipa, has been found to have a variety of effects on different organisms, including:\n1. Pain relief: The venom of Conus tulipa has been shown to have analgesic and anti-inflammatory effects, making it a potential candidate for the development of new painkillers.\n2. Neuroprotection: The venom of Conus tulipa has been found to have neuroprotective effects, and may be useful in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.\n3. Antimicrobial activity: The venom of Conus tulipa has been shown to have antibacterial and antifungal activity, making it a potential candidate for the development of new antimicrobial drugs.\n4. Cardiovascular effects: The venom of Conus tulipa has been found to have cardiovascular effects, including the ability to relax blood vessels and reduce blood pressure.\n5. Immune system modulation: The venom of Conus tulipa has been found to have immunomodulatory effects, and may be useful in the treatment of autoimmune diseases.\nOverall, the venom of Conus tulipa is a complex mixture of compounds with a wide range of biological activities, and further research is needed to fully understand its potential as a source of new drugs and therapies.",
    "llama-2-7b-chat-hf_fact": [
      "The venom of Conus tulipa, a species of cone snail, has analgesic and anti-inflammatory effects.",
      "This venom also exhibits neuroprotective effects, making it a potential area of research for the treatment of neurodegenerative diseases.",
      "Conus tulipa's venom has antibacterial and antifungal activities.",
      "The venom of Conus tulipa has been found to have effects on the cardiovascular system, including the relaxation of blood vessels and blood pressure reduction.",
      "The venom of Conus tulipa has immunomodulatory effects, which may be helpful in treating autoimmune diseases."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4180,
    "user_query": "Which component of the Influenza A Virus affects mRNA transcription termination?",
    "llama-2-7b-chat-hf_response": "Influenza A Virus (IAV) is a member of the Orthomyxoviridae family and is known to cause seasonal outbreaks of respiratory illness in humans. The virus has a single-stranded RNA genome that is approximately 13,000 nucleotides in length. The genome is divided into eight segments, each of which encodes a different protein.\nOne of the key steps in the replication of IAV is the transcription of the viral RNA genome into messenger RNA (mRNA). This process occurs in the cytoplasm of infected cells and is mediated by the viral RNA-dependent RNA polymerase (RdRp). The RdRp enzyme reads the viral RNA genome and synthesizes a complementary RNA strand, which is then used as a template for the transcription of the mRNA.\nOnce the mRNA is synthesized, it undergoes several processing steps before it is ready to be translated into protein. One of the key components of the IAV that affects mRNA transcription termination is the NS1 protein.\nThe NS1 protein is a non-structural protein that is encoded by segment 1 of the IAV genome. It plays a multifaceted role in the replication of the virus, including the regulation of mRNA transcription termination. The NS1 protein binds to the 3' untranslated region (3' UTR) of the mRNA and inhibits the activity of the RNA polymerase, thereby preventing the transcription of the mRNA from terminating. This results in the synthesis of longer mRNA transcripts, which are then translated into protein.\nIn summary, the NS1 protein of the Influenza A Virus affects mRNA transcription termination by inhibiting the activity of the RNA polymerase and preventing the transcription of the mRNA from terminating. This results in the synthesis of longer mRNA transcripts, which are then translated into protein.",
    "llama-2-7b-chat-hf_fact": [
      "Influenza A Virus (IAV) is a member of the Orthomyxoviridae family and causes seasonal outbreaks of respiratory illness in humans.",
      "The RNA-dependent RNA polymerase (RdRp) enzyme mediates the transcription of the viral RNA genome into messenger RNA (mRNA) in the cytoplasm of infected cells.",
      "The NS1 protein of the Influenza A Virus affects mRNA transcription termination.",
      "The NS1 protein binds to the 3' untranslated region (3' UTR) of the mRNA and inhibits the activity of the RNA polymerase, preventing mRNA transcription from terminating.",
      "Inhibition by the NS1 protein results in the synthesis of longer mRNA transcripts that are then translated into protein."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4183,
    "user_query": "Is Tranexamic acid effective for intracerebral haemorrhage?",
    "llama-2-7b-chat-hf_response": "Tranexamic acid is an antifibrinolytic drug that has been shown to be effective in reducing the risk of death and disability in patients with intracerebral haemorrhage (ICH). It works by inhibiting the breakdown of blood clots and reducing the amount of bleeding in the brain.\nStudies have consistently shown that tranexamic acid can improve outcomes in patients with ICH, including reducing the risk of death or disability at 90 days, improving cognitive function, and reducing the need for surgical intervention.\nHowever, it is important to note that tranexamic acid is not a cure for ICH, and it is not a substitute for prompt medical treatment. Patients with ICH should still receive prompt medical attention, including CT scans, blood transfusions, and other interventions as needed.\nOverall, tranexamic acid is a valuable addition to the treatment of intracerebral haemorrhage, and it has the potential to improve outcomes for patients with this devastating condition.",
    "llama-2-7b-chat-hf_fact": [
      "Tranexamic acid is used to reduce the risk of death and disability in patients with intracerebral haemorrhage (ICH).",
      "Tranexamic acid functions by inhibiting the breakdown of blood clots and reducing bleeding in the brain.",
      "Studies have shown that tranexamic acid can decrease the need for surgical intervention in ICH patients.",
      "Despite its effective role, tranexamic acid is not a cure for ICH.",
      "CT scans, blood transfusions, and other interventions as needed still have important roles in ICH treatment."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4186,
    "user_query": "What is particular about the 3D structure of the inactive X chromosome?",
    "llama-2-7b-chat-hf_response": "The inactive X chromosome, also known as the Barr body, is a unique 3D structure that is present in female mammals. Unlike the active X chromosome, which is predominantly composed of gene-rich regions, the inactive X chromosome is characterized by the presence of repetitive DNA elements, such as satellite repeats and transposons. These repetitive elements are thought to play a role in the formation of the 3D structure of the inactive X chromosome.\nThe 3D structure of the inactive X chromosome is characterized by a number of distinct features, including:\n1. Highly condensed chromatin: The inactive X chromosome is much more condensed than the active X chromosome, with a higher density of chromatin fibers.\n2. Nucleolus organizer region (NOR): The inactive X chromosome has a well-defined NOR, which is a region of highly condensed chromatin that is involved in the formation of the 3D structure of the chromosome.\n3. Centromere-like regions: The inactive X chromosome has centromere-like regions, which are regions of highly condensed chromatin that are involved in the formation of the 3D structure of the chromosome.\n4. Satellite repeats: The inactive X chromosome is characterized by the presence of satellite repeats, which are repetitive DNA elements that are found throughout the chromosome. These repeats are thought to play a role in the formation of the 3D structure of the inactive X chromosome.\n5. Transposons: The inactive X chromosome is also characterized by the presence of transposons, which are mobile genetic elements that can move around the genome. These transposons are thought to play a role in the formation of the 3D structure of the inactive X chromosome.\n6. Heterochromatin: The inactive X chromosome is characterized by the presence of heterochromatin, which is a type of chromatin that is highly condensed and gene-poor. Heterochromatin is thought to play a role in the formation of the 3D structure of the inactive X chromosome.\n7. Chromosome territory: The inactive X",
    "llama-2-7b-chat-hf_fact": [
      "The inactive X chromosome, also known as the Barr body, is present in female mammals.",
      "The inactive X chromosome is characterized by the presence of repetitive DNA elements, such as satellite repeats and transposons.",
      "The 3D structure of the inactive X chromosome is more condensed than the active X chromosome, with a higher density of chromatin fibers.",
      "The inactive X chromosome has a specific region known as the Nucleolus organizer region (NOR), which is involved in the formation of its 3D structure.",
      "The inactive X chromosome has centromere-like regions and is characterized by the presence of heterochromatin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: The Nucleolus organizer region (NOR) is not specific to the inactive X chromosome. NORs are related to the synthesis of ribosomal RNA and not directly to the formation of the 3D structure of the inactive X chromosome.",
      "true"
    ]
  },
  {
    "id": 4187,
    "user_query": "Why mothers with a CYP2D6 ultrarapid metabolizer phenotype may expose their infants to risk of adverse events when taking codeine while breastfeeding?",
    "llama-2-7b-chat-hf_response": "Mothers with a CYP2D6 ultrarapid metabolizer phenotype may expose their infants to a higher risk of adverse events when taking codeine while breastfeeding due to the increased metabolism of codeine to morphine. This can lead to higher levels of morphine in the infant's system, which can cause respiratory depression, sedation, and other adverse effects. Additionally, the ultrarapid metabolism of codeine may reduce the efficacy of the drug in the mother, leading to inadequate pain relief.",
    "llama-2-7b-chat-hf_fact": [
      "Mothers with a CYP2D6 ultrarapid metabolizer phenotype have an increased metabolism of codeine to morphine.",
      "High levels of morphine can cause respiratory depression, sedation, and other adverse effects in infants.",
      "Codeine is used for pain relief.",
      "In mothers with a CYP2D6 ultrarapid metabolizer phenotype, the ultrarapid metabolism of codeine can reduce the drug's efficacy.",
      "Codeine can be transferred to infants through breastfeeding."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: In mothers with a CYP2D6 ultrarapid metabolizer phenotype, the ultrarapid metabolism of codeine can increase the levels of morphine, not reduce the drug's efficacy.",
      "true"
    ]
  },
  {
    "id": 4188,
    "user_query": "Which R package can infer protein-protein interactions via thermal proximity coaggregation (TPCA)?",
    "llama-2-7b-chat-hf_response": "I am looking for an R package that can infer protein-protein interactions using thermal proximity coaggregation (TPCA) method. Can you please suggest some packages?\nAnswer: Yes, there are several R packages that can be used to infer protein-protein interactions using the thermal proximity coaggregation (TPCA) method. Here are a few options:\n1. `TPCA`: This is an R package specifically designed for TPCA-based protein-protein interaction inference. It provides a comprehensive workflow for TPCA data analysis, including data preprocessing, clustering, and network construction.\n2. `ProteinInteractome`: This package provides a comprehensive framework for protein-protein interaction inference using a variety of methods, including TPCA. It includes tools for data preprocessing, clustering, and network construction, as well as methods for evaluating the quality of the inferred interactions.\n3. `InteractomeWalker`: This package provides a modular framework for protein-protein interaction inference using a variety of methods, including TPCA. It includes tools for data preprocessing, clustering, and network construction, as well as methods for evaluating the quality of the inferred interactions.\n4. `PPInteractome`: This package provides a comprehensive framework for protein-protein interaction inference using a variety of methods, including TPCA. It includes tools for data preprocessing, clustering, and network construction, as well as methods for evaluating the quality of the inferred interactions.\n5. `ProteinConnect`: This package provides a comprehensive framework for protein-protein interaction inference using a variety of methods, including TPCA. It includes tools for data preprocessing, clustering, and network construction, as well as methods for evaluating the quality of the inferred interactions.\nPlease note that these packages may have different levels of complexity and functionality, so you may want to try out a few of them to see which one best suits your needs.",
    "llama-2-7b-chat-hf_fact": [
      "The `TPCA` R package is designed for TPCA-based protein-protein interaction inference and provides a comprehensive workflow for TPCA data analysis.",
      "`ProteinInteractome` is an R package providing a comprehensive framework for protein-protein interaction inference using various methods including TPCA.",
      "`InteractomeWalker` is an R package that includes a modular framework for protein-protein interaction inference using various methods, one of them being TPCA.",
      "The R package `PPInteractome` can infer protein-protein interactions using various methods, including TPCA.",
      "`ProteinConnect` is an R package that allows for protein-protein interaction inference using a variety of methods, among them TPCA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4189,
    "user_query": "What is the mechanisms of action of Evinacumab?",
    "llama-2-7b-chat-hf_response": "Evinacumab is a monoclonal antibody that targets and neutralizes Tumor Necrosis Factor-alpha (TNF-alpha). TNF-alpha is a cytokine that plays a central role in the inflammatory response. Evinacumab works by binding to TNF-alpha and preventing it from interacting with its receptors on immune cells, thereby reducing the production of pro-inflammatory cytokines and chemokines. This can help to reduce inflammation and promote healing in conditions such as Crohn's disease and ulcerative colitis.",
    "llama-2-7b-chat-hf_fact": [
      "Evinacumab is a monoclonal antibody.",
      "Evinacumab targets and neutralizes Tumor Necrosis Factor-alpha (TNF-alpha).",
      "TNF-alpha is a cytokine that plays a central role in the inflammatory response.",
      "The mechanism of action of Evinacumab involves preventing TNF-alpha from interacting with its receptors on immune cells.",
      "Evinacumab is used in the treatment of conditions such as Crohn's disease and ulcerative colitis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Evinacumab targets and neutralizes angiopoietin-like 3 (ANGPTL3).",
      "true",
      "false, [corrected fact]: The mechanism of action of Evinacumab involves preventing ANGPTL3 from interacting with lipoprotein lipase and endothelial lipase.",
      "false, [corrected fact]: Evinacumab is used in the treatment of homozygous familial hypercholesterolemia."
    ]
  },
  {
    "id": 4191,
    "user_query": "What year was the first successful human heart transplant performed?",
    "llama-2-7b-chat-hf_response": "The first successful human heart transplant was performed in 1967 by Dr. Christiaan Barnard at Groote Schuur Hospital in Cape Town, South Africa. The recipient of the transplant was a 55-year-old man named Louis Washkansky, who lived for 18 days after the surgery.",
    "llama-2-7b-chat-hf_fact": [
      "The first successful human heart transplant was performed in 1967.",
      "Dr. Christiaan Barnard performed the first successful human heart transplant.",
      "The first successful human heart transplant took place at Groote Schuur Hospital in Cape Town, South Africa.",
      "The recipient of the first successful human heart transplant was a man named Louis Washkansky.",
      "Louis Washkansky lived for 18 days after receiving the heart transplant."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4196,
    "user_query": "Which human tissue synthesize CRP?",
    "llama-2-7b-chat-hf_response": "CRP (C-reactive protein) is a protein that is produced by the liver in response to inflammation. It is commonly used as a marker of inflammation in the body.",
    "llama-2-7b-chat-hf_fact": [
      "CRP, or C-reactive protein, is a protein.",
      "CRP is produced by the liver.",
      "CRP is synthesized in response to inflammation.",
      "C-reactive protein is commonly used as a marker of inflammation in the body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4197,
    "user_query": "What is the relationship between the X chromosome and a  neutrophil drumstick?",
    "llama-2-7b-chat-hf_response": "The X chromosome is a sex chromosome that is present in both males and females, but it is more highly represented in females due to a process called X-inactivation. Neutrophil drumsticks, on the other hand, are a type of white blood cell that plays a crucial role in the immune system.\nThere is no direct relationship between the X chromosome and neutrophil drumsticks. The X chromosome is involved in the development and function of various tissues and organs in the body, including the immune system, but it does not directly affect the structure or function of neutrophil drumsticks.\nIn summary, the X chromosome is a sex chromosome that plays a role in the development and function of various tissues and organs in the body, while neutrophil drumsticks are a type of white blood cell that plays a crucial role in the immune system. There is no direct relationship between the two.",
    "llama-2-7b-chat-hf_fact": [
      "The X chromosome is a sex chromosome that is present in both males and females.",
      "The X chromosome is more highly represented in females due to a process called X-inactivation.",
      "Neutrophil drumsticks are a type of white blood cell that plays a crucial role in the immune system.",
      "The X chromosome is involved in the development and function of various tissues and organs in the body, including the immune system.",
      "There is no direct relationship between the X chromosome and neutrophil drumsticks."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Neutrophil drumsticks are a cellular feature seen in neutrophils, a type of white blood cell, but they do not themselves play a role in the immune system.",
      "true",
      "false, [corrected fact]: The presence of neutrophil drumsticks is directly linked to the X chromosome, as they are a manifestation of X-chromosome inactivation in females."
    ]
  },
  {
    "id": 4201,
    "user_query": "Which molecule is targeted by Teprotumumab?",
    "llama-2-7b-chat-hf_response": "Teprotumumab is a monoclonal antibody that targets a specific molecule in the body. The molecule that Teprotumumab targets is called insulin-like growth factor 2 (IGF2). IGF2 is a protein that is involved in cell growth and division, and it is overexpressed in some types of cancer, including breast cancer. Teprotumumab works by binding to IGF2 and preventing it from interacting with its receptors on cancer cells, which can slow down or stop the growth of cancer cells.",
    "llama-2-7b-chat-hf_fact": [
      "Teprotumumab is a monoclonal antibody.",
      "Teprotumumab targets the insulin-like growth factor 2 (IGF2) molecule.",
      "IGF2 is a protein involved in cell growth and division.",
      "IGF2 is overexpressed in some types of cancer, including breast cancer.",
      "Teprotumumab binds to IGF2 and prevents it from interacting with its receptors on cancer cells."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Teprotumumab targets the insulin-like growth factor 1 (IGF1) receptor molecule.",
      "true",
      "true",
      "false, [corrected fact]: Teprotumumab binds to IGF1 receptor and prevents it from interacting with its receptors on cells."
    ]
  },
  {
    "id": 4204,
    "user_query": "What is the major sequence determinant for nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "Nucleosomes are the basic units of DNA packaging in eukaryotic cells, consisting of a segment of DNA wrapped around a core of eight histone proteins (two copies each of histones H2A, H2B, H3, and H4). The positioning of nucleosomes along DNA is crucial for regulating gene expression, as it affects the accessibility of transcription factors and other regulatory proteins to the DNA. The major sequence determinants for nucleosome positioning are:\n1. Nucleosome-binding sites: These are specific sequences in the DNA that are recognized by the histone chaperone complex, which facilitates the assembly and disassembly of nucleosomes.\n2. Chromatin structure: The higher-order structure of chromatin, including the arrangement of nucleosomes and the interactions between them, can also influence nucleosome positioning.\n3. Histone modifications: The post-translational modifications of histones, such as acetylation, methylation, and phosphorylation, can alter the interaction between histones and DNA, leading to changes in nucleosome positioning.\n4. Non-coding RNAs: Non-coding RNAs, such as small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs), can also influence nucleosome positioning by base-pairing with specific sequences in the DNA.\n5. Chromatin-modifying enzymes: Enzymes that modify histones, such as histone acetyltransferases (HATs) and histone deacetylases (HDACs), can also influence nucleosome positioning by altering the interaction between histones and DNA.",
    "llama-2-7b-chat-hf_fact": [
      "Nucleosomes are the basic units of DNA packaging in eukaryotic cells.",
      "A nucleosome consists of a segment of DNA wrapped around two copies each of histones H2A, H2B, H3, and H4.",
      "The positioning of nucleosomes on DNA affects gene expression and the accessibility of transcription factors and other regulatory proteins to the DNA.",
      "The post-translational modifications of histones - such as acetylation, methylation, and phosphorylation - can alter the interaction between histones and DNA, leading to changes in nucleosome positioning.",
      "Non-coding RNAs, such as small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs), can influence nucleosome positioning by base-pairing with specific sequences in the DNA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4205,
    "user_query": "Which is the primary enzyme metabolizing esomeprazole?",
    "llama-2-7b-chat-hf_response": "A. CYP3A4\nB. CYP2C9\nC. CYP2C19\nD. CYP1A2\nAnswer: A. CYP3A4\nExplanation: Esomeprazole is a proton pump inhibitor (PPI) that is metabolized by the cytochrome P450 (CYP) enzyme system. The primary enzyme responsible for metabolizing esomeprazole is CYP3A4. This enzyme is responsible for converting esomeprazole into its active metabolite, which is further metabolized by other CYP enzymes, such as CYP2C9 and CYP2C19. CYP1A2 is not involved in the metabolism of esomeprazole.",
    "llama-2-7b-chat-hf_fact": [
      "Esomeprazole is a proton pump inhibitor.",
      "Esomeprazole is metabolized by the cytochrome P450 (CYP) enzyme system.",
      "The primary enzyme responsible for metabolizing esomeprazole is CYP3A4.",
      "CYP3A4 converts esomeprazole into its active metabolite.",
      "Other CYP enzymes, such as CYP2C9 and CYP2C19, further metabolize the active metabolite of esomeprazole."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: The primary enzyme responsible for metabolizing esomeprazole is CYP2C19.",
      "false, [corrected fact]: CYP2C19 converts esomeprazole into its active metabolite.",
      "false, [corrected fact]: Other CYP enzymes, such as CYP3A4, can also metabolize esomeprazole."
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-7b-chat-hf_response": "Thiazovivin is a synthetic compound that has been shown to have a variety of biological activities, including anti-inflammatory, anti-cancer, and neuroprotective effects. The exact mechanism of action of thiazovivin is not fully understood, but it is believed to act through a number of different pathways, including:\n1. Inhibition of NF-B signaling: Thiazovivin has been shown to inhibit the activation of NF-B, a transcription factor that plays a key role in the regulation of inflammation and immune responses.\n2. Induction of apoptosis: Thiazovivin has been shown to induce programmed cell death (apoptosis) in a number of different cell types, including cancer cells.\n3. Inhibition of angiogenesis: Thiazovivin has been shown to inhibit the formation of new blood vessels, a process known as angiogenesis, which is important for the growth and spread of solid tumors.\n4. Modulation of the immune response: Thiazovivin has been shown to modulate the immune response by inhibiting the activity of certain immune cells, such as macrophages and T cells.\n5. Antioxidant effects: Thiazovivin has been shown to have antioxidant effects, which may contribute to its anti-inflammatory and anti-cancer activities.\nOverall, the mode of action of thiazovivin is complex and involves the interaction of multiple cellular pathways and processes. Further research is needed to fully understand the mechanisms of action of this compound and to determine its potential as a therapeutic agent.",
    "llama-2-7b-chat-hf_fact": [
      "Thiazovivin is a synthetic compound with biological activities such as anti-inflammatory, anti-cancer, and neuroprotective effects.",
      "Thiazovivin has displayed an ability to inhibit NF-B signaling which is involved in regulation of inflammation and immune responses.",
      "Thiazovivin can induce apoptosis in various cell types including cancer cells.",
      "The compound Thiazovivin can inhibit the formation of new blood vessels, a process known as angiogenesis.",
      "Thiazovivin has shown antioxidant effects, which could support its anti-inflammatory and anti-cancer activities."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4216,
    "user_query": "Which methods infer 3D genome structure without proximity ligation?",
    "llama-2-7b-chat-hf_response": "There are several methods that can be used to infer 3D genome structure without using proximity ligation:\n1. Hi-C: This method uses chromosome conformation capture (CCC) to measure the proximity of different regions of the genome. By analyzing the patterns of interaction between different regions, researchers can infer the 3D structure of the genome.\n2. 4C: This method is similar to Hi-C, but it uses crosslinking and immunoprecipitation to capture the interactions between different regions of the genome.\n3. FAIRE-seq: This method uses formaldehyde fixation and immunoprecipitation to capture the interactions between different regions of the genome.\n4. DNase-seq: This method uses DNase I to digest the DNA in a sample, and then analyzes the patterns of cleavage to infer the 3D structure of the genome.\n5. Chromatin immunoprecipitation sequencing (ChIP-seq): This method uses antibodies to immunoprecipitate specific regions of the genome, and then analyzes the patterns of binding to infer the 3D structure of the genome.\n6. Single-molecule FISH (smFISH): This method uses fluorescently labeled probes to visualize the 3D structure of the genome at the single-molecule level.\n7. Fluorescence in situ hybridization (FISH): This method uses fluorescently labeled probes to visualize the 3D structure of the genome.\n8. Electron microscopy (EM): This method uses a transmission electron microscope to image the 3D structure of the genome.\n9. Cryo-electron microscopy (cryo-EM): This method uses a transmission electron microscope to image the 3D structure of the genome at very high resolution.\n10. X-ray crystallography: This method uses X-rays to determine the 3D structure of specific regions of the genome.\nEach of these methods has its own strengths and limitations, and the choice of method will depend on the specific research question and experimental system being studied.",
    "llama-2-7b-chat-hf_fact": [
      "Hi-C is a method that uses chromosome conformation capture to measure the proximity of different regions of the genome.",
      "4C is a method that uses cross-linking and immunoprecipitation to capture the interactions between different regions of the genome.",
      "FAIRE-seq is a method that uses formaldehyde fixation and immunoprecipitation to capture the interactions between different regions of the genome.",
      "DNase-seq is a method that uses DNase I to digest the DNA in a sample and then analyzes the patterns of cleavage to infer the 3D structure of the genome.",
      "Chromatin immunoprecipitation sequencing uses antibodies to immunoprecipitate specific regions of the genome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: 4C (Circular Chromosome Conformation Capture) is a method that uses restriction digestion and ligation to capture the interactions between different regions of the genome.",
      "false, [corrected fact]: FAIRE-seq (Formaldehyde Assisted Isolation of Regulatory Elements) is a method that uses formaldehyde fixation and phenol-chloroform extraction to isolate and sequence open or nucleosome-depleted regions of the genome.",
      "true",
      "true"
    ]
  },
  {
    "id": 4219,
    "user_query": "Can thiotepa be recommended for treatment of osteosarcoma?",
    "llama-2-7b-chat-hf_response": "Thiotepa is an alkylating agent that has been used to treat various types of cancer, including osteosarcoma. While there is limited research on the use of thiotepa specifically for osteosarcoma, it has been shown to be effective in treating other types of bone cancer, such as chondrosarcoma.\nOne study published in the Journal of Clinical Oncology found that thiotepa was effective in achieving a complete response in patients with advanced chondrosarcoma. Another study published in the International Journal of Radiation Oncology Biology Physics found that thiotepa was effective in improving survival outcomes in patients with osteosarcoma.\nHowever, it's important to note that thiotepa is typically used in combination with other treatments, such as surgery, chemotherapy, and radiation therapy, for the treatment of osteosarcoma. The specific treatment plan for osteosarcoma will depend on the stage and location of the cancer, as well as the patient's overall health and medical history.\nIn summary, while there is limited research specifically on the use of thiotepa for the treatment of osteosarcoma, it has been shown to be effective in treating other types of bone cancer and may be recommended as part of a comprehensive treatment plan for osteosarcoma. It's important to discuss the potential benefits and risks of thiotepa with a qualified healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "Thiotepa is an alkylating agent used to treat various types of cancer, including osteosarcoma.",
      "According to one study in the Journal of Clinical Oncology, thiotepa was shown to be effective in treating advanced chondrosarcoma.",
      "Another study in the International Journal of Radiation Oncology Biology Physics found thiotepa effective in improving survival outcomes for patients with osteosarcoma.",
      "Thiotepa is often used in conjunction with other treatments like surgery, chemotherapy, and radiation therapy for osteosarcoma.",
      "The specific treatment plan for osteosarcoma depends on the cancer's stage and location, and the patient's overall health and medical history."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4223,
    "user_query": "Has the companion diagnostic HercepTest received FDA approval?",
    "llama-2-7b-chat-hf_response": "HercepTest is a companion diagnostic test used to help identify patients with breast cancer who are likely to benefit from the targeted therapy trastuzumab (Herceptin). The test measures the levels of a protein called HER2 in breast cancer cells.\nYes, HercepTest has received FDA approval. It was approved in 1998 as a companion diagnostic test for the breast cancer drug Herceptin (trastuzumab). The test is used to determine which breast cancer patients are likely to benefit from treatment with Herceptin, which is a targeted therapy that works by blocking the HER2 protein.\nThe FDA approval of HercepTest was based on data from clinical trials that showed the test could accurately identify patients with HER2-positive breast cancer, which is a subtype of breast cancer that accounts for about 20% of all breast cancer cases.\nSince its approval, HercepTest has become a standard tool in the diagnosis and treatment of breast cancer. It is used in conjunction with other diagnostic tests, such as biopsies and imaging studies, to help doctors determine the best course of treatment for each patient.",
    "llama-2-7b-chat-hf_fact": [
      "HercepTest is a companion diagnostic test used to identify patients with breast cancer who are likely to benefit from the therapy trastuzumab (Herceptin).",
      "HercepTest measures the levels of a protein called HER2 in breast cancer cells.",
      "The FDA approved HercepTest in 1998 as a companion diagnostic test for the breast cancer drug Herceptin (trastuzumab).",
      "HER2-positive breast cancer, which can be detected by HercepTest, is a subtype of breast cancer that accounts for about 20% of all breast cancer cases.",
      "HercepTest is used along with other diagnostic tests such as biopsies and imaging studies in the diagnosis and treatment of breast cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4224,
    "user_query": "Which R/Bioconductor package has been developed for visualizing differential amino acid group usage in proteomics?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4226,
    "user_query": "Is phosphoenolpyruvate carboxykinase 1 (PCK1) the rate-limiting enzyme in gluconeogenesis?",
    "llama-2-7b-chat-hf_response": "Gluconeogenesis is the process by which the liver and kidneys generate glucose from non-carbohydrate precursors, such as lactate, glycerol, and the amino acids. Phosphoenolpyruvate carboxykinase 1 (PCK1) is one of the key enzymes involved in gluconeogenesis. PCK1 is responsible for the conversion of phosphoenolpyruvate (PEP) to oxaloacetate and inorganic pyrophosphate (PPi). This reaction is the first committed step in gluconeogenesis, and it is the rate-limiting step in the synthesis of glucose from non-carbohydrate precursors.",
    "llama-2-7b-chat-hf_fact": [
      "Gluconeogenesis is a process by which the liver and kidneys generate glucose from non-carbohydrate precursors.",
      "Phosphoenolpyruvate carboxykinase 1 (PCK1) is a key enzyme involved in gluconeogenesis.",
      "PCK1 is responsible for the conversion of phosphoenolpyruvate (PEP) to oxaloacetate and inorganic pyrophosphate (PPi).",
      "The reaction catalyzed by PCK1 is the first committed step in gluconeogenesis.",
      "The conversion of phosphoenolpyruvate (PEP) to oxaloacetate and inorganic pyrophosphate (PPi) is the rate-limiting step in the synthesis of glucose from non-carbohydrate precursors."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: PCK1 is responsible for the conversion of oxaloacetate to phosphoenolpyruvate (PEP) and carbon dioxide (CO2).",
      "false, [corrected fact]: The reaction catalyzed by PCK1 is not the first committed step in gluconeogenesis. The conversion of pyruvate to phosphoenolpyruvate by pyruvate carboxylase and PCK1 is the first committed step in gluconeogenesis.",
      "true"
    ]
  },
  {
    "id": 4227,
    "user_query": "What conditions are diagnosed using the scratch collapse test?",
    "llama-2-7b-chat-hf_response": "The scratch collapse test is a clinical test used to diagnose various neurological conditions, including:\n1. Brain tumors: The test can help identify tumors that are pressing on the brain stem, which can cause symptoms such as sudden weakness or paralysis of the face, arm, or leg.\n2. Stroke or cerebral vasculature disorders: The test can help identify blockages or bleeding in the blood vessels of the brain, which can cause sudden weakness or paralysis of the face, arm, or leg.\n3. Multiple sclerosis: The test can help diagnose multiple sclerosis, an autoimmune disease that affects the protective covering of nerve fibers in the brain and spinal cord.\n4. Myasthenia gravis: The test can help diagnose myasthenia gravis, an autoimmune disorder that affects the nerve-muscle connection.\n5. Traumatic brain injury: The test can help diagnose traumatic brain injury, which can cause sudden weakness or paralysis of the face, arm, or leg.\n6. Spinal cord injury: The test can help diagnose spinal cord injury, which can cause sudden weakness or paralysis of the face, arm, or leg.\n7. Guillain-Barr syndrome: The test can help diagnose Guillain-Barr syndrome, an autoimmune disorder that affects the nerve-muscle connection.\n8. Chronic inflammatory demyelinating polyneuropathy: The test can help diagnose chronic inflammatory demyelinating polyneuropathy, an autoimmune disorder that affects the protective covering of nerve fibers in the brain and spinal cord.\nIt is important to note that the scratch collapse test is not a definitive diagnostic test, and other tests such as MRI, CT scan, or electromyography may be needed to confirm the diagnosis.",
    "llama-2-7b-chat-hf_fact": [
      "The scratch collapse test is a clinical test used to diagnose various neurological conditions.",
      "The scratch collapse test can help identify brain tumors that are pressing on the brain stem.",
      "The scratch collapse test can be used to identify blockages or bleeding in the blood vessels of the brain associated with stroke or cerebral vasculature disorders.",
      "The scratch collapse test can help diagnose multiple sclerosis, an autoimmune disease that affects the protective covering of nerve fibers in the brain and spinal cord.",
      "The scratch collapse test can help diagnose traumatic brain injury, characterized by sudden weakness or paralysis of the face, arm, or leg."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The scratch collapse test is not used to identify brain tumors. Imaging techniques like MRI and CT scans are typically used for that purpose.",
      "false, [corrected fact]: The scratch collapse test is not used to identify blockages or bleeding in the blood vessels of the brain associated with stroke or cerebral vasculature disorders. These are typically identified with imaging techniques such as CT and MRI scans, or through a procedure called an angiogram.",
      "false, [corrected fact]: Multiple sclerosis cannot be diagnosed with the scratch collapse test. It is typically diagnosed with a combination of physical exams, medical history, an MRI, and other tests that evaluate the function of the nervous system.",
      "false, [corrected fact]: The scratch collapse test is not used to diagnose traumatic brain injury. Diagnostic tools for traumatic brain injury usually include a neurological exam, imaging tests, and neuropsychological tests."
    ]
  },
  {
    "id": 4231,
    "user_query": "Which disease can be treated with Relugolix.",
    "llama-2-7b-chat-hf_response": "Relugolix is a drug used to treat:\nA) Endometriosis\nB) Uterine fibroids\nC) Premenstrual dysphoric disorder (PMDD)\nD) Neuroendocrine tumors\nAnswer: C) Premenstrual dysphoric disorder (PMDD)",
    "llama-2-7b-chat-hf_fact": [
      "Relugolix is a drug.",
      "Relugolix can be used to treat Endometriosis.",
      "Uterine fibroids can be treated with Relugolix.",
      "Premenstrual dysphoric disorder (PMDD) can be treated using Relugolix.",
      "Neuroendocrine tumors can be treated with the drug Relugolix."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: As of now, there's no established evidence suggesting that Relugolix can be used to treat Premenstrual dysphoric disorder (PMDD).",
      "false, [corrected fact]: Relugolix is not typically used in the treatment of Neuroendocrine tumors. It is primarily used in the management of conditions like Endometriosis and Uterine fibroids."
    ]
  },
  {
    "id": 4233,
    "user_query": "What 3 organs are the sphincter of Oddi associated with?",
    "llama-2-7b-chat-hf_response": "The sphincter of Oddi is a circular muscle that controls the flow of fluids between the stomach and small intestine. It is associated with the following three organs:\n1. Stomach: The sphincter of Oddi is located at the junction of the stomach and small intestine, and it controls the flow of digestive juices from the stomach into the small intestine.\n2. Small intestine: The sphincter of Oddi regulates the flow of digestive juices from the small intestine into the large intestine.\n3. Liver: The sphincter of Oddi is also associated with the liver, as it helps to regulate the flow of bile from the liver into the small intestine.\nTherefore, the sphincter of Oddi is associated with the stomach, small intestine, and liver.",
    "llama-2-7b-chat-hf_fact": [
      "The sphincter of Oddi is a circular muscle that controls the flow of fluids between the stomach and small intestine.",
      "It is located at the junction of the stomach and small intestine.",
      "The sphincter of Oddi controls the flow of digestive juices from the stomach into the small intestine.",
      "This sphincter also regulates the flow of digestive juices from the small intestine into the large intestine.",
      "The sphincter of Oddi is associated with the liver as it aids in the regulation of bile flow from the liver into the small intestine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: The sphincter of Oddi is a circular muscle that controls the flow of digestive juices from the pancreas and bile from the liver into the small intestine.",
      "false, [corrected fact]: The sphincter of Oddi is located at the junction of the bile duct and the pancreatic duct into the small intestine.",
      "false, [corrected fact]: The sphincter of Oddi controls the flow of digestive juices from the pancreas and bile from the liver into the small intestine.",
      "false, [corrected fact]: The sphincter of Oddi does not regulate the flow of digestive juices from the small intestine into large intestine.",
      "true"
    ]
  },
  {
    "id": 4245,
    "user_query": "why are eggs linked to cancer progression ?",
    "llama-2-7b-chat-hf_response": "Eggs are a nutritious food that provides many essential nutrients, including protein, vitamins, and minerals. However, some studies have suggested that eggs may also play a role in cancer progression. Here are some reasons why eggs might be linked to cancer progression:\n1. Choline and TMAO: Eggs are a rich source of choline, a nutrient that is converted into a compound called trimethylamine-N-oxide (TMAO) in the body. TMAO has been shown to promote the growth of cancer cells and increase the risk of cancer progression.\n2. Arachidonic acid: Eggs are also a source of arachidonic acid, an omega-6 fatty acid that has been linked to cancer progression. Arachidonic acid can be converted into pro-inflammatory eicosanoids, which can promote the growth and spread of cancer cells.\n3. Hormones: Eggs contain hormones such as estrogen and progesterone, which can affect the growth and development of cancer cells. For example, high levels of estrogen have been linked to an increased risk of breast cancer, while high levels of progesterone have been linked to an increased risk of endometrial cancer.\n4. Oxidative stress: Eggs contain high levels of oxidized cholesterol, which can contribute to oxidative stress in the body. Oxidative stress can damage cellular components and increase the risk of cancer progression.\n5. Nutrient imbalance: Eating too many eggs can lead to an imbalance of certain nutrients in the body, such as an excess of choline and a deficiency of other nutrients. This imbalance can disrupt cellular function and increase the risk of cancer progression.\nIt's important to note that the relationship between eggs and cancer progression is complex and not fully understood. While some studies have suggested a link between eggs and cancer, other studies have found no association. Further research is needed to clarify the role of eggs in cancer development and progression.\nIn summary, eggs are a nutritious food that provides many essential nutrients, but they may also play a role in cancer progression through various mechanisms, including choline and TMAO, arachid",
    "llama-2-7b-chat-hf_fact": [
      "Eggs are a rich source of choline, a nutrient that the body converts into the compound trimethylamine-N-oxide (TMAO).",
      "TMAO has been shown to promote the growth of cancer cells and increase the risk of cancer progression.",
      "Eggs are a source of arachidonic acid, an omega-6 fatty acid that has been linked to cancer progression.",
      "Eggs contain hormones such as estrogen and progesterone, which can affect the growth and development of cancer cells.",
      "Eggs contain high levels of oxidized cholesterol, which can contribute to oxidative stress in the body, potentially increasing the risk of cancer progression."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Eggs do not contain hormones such as estrogen and progesterone.",
      "true"
    ]
  },
  {
    "id": 4246,
    "user_query": "tarragon toxicity ?",
    "llama-2-7b-chat-hf_response": "Tarragon (Artemisia dracunculus) is a perennial herb that is commonly used in cooking and herbal medicine. While it is generally considered safe to consume in small amounts, there have been some reports of tarragon toxicity.",
    "llama-2-7b-chat-hf_fact": [
      "Tarragon is also known as Artemisia dracunculus.",
      "Tarragon is a perennial herb.",
      "Tarragon is used in cooking and herbal medicine.",
      "Generally, Tarragon is considered safe to consume in small amounts.",
      "There have been reports of tarragon toxicity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4277,
    "user_query": "which parts of the mediterranean diet extended life ?",
    "llama-2-7b-chat-hf_response": "The Mediterranean diet has been associated with a number of health benefits, including a reduced risk of chronic diseases such as heart disease, stroke, and cancer. Some of the specific components of the Mediterranean diet that have been linked to a longer lifespan include:\n1. High consumption of fruits, vegetables, and legumes: These foods are rich in vitamins, minerals, and antioxidants, which can help protect against cell damage and reduce the risk of chronic diseases.\n2. Moderate consumption of dairy products: Dairy products, such as cheese and yogurt, are a good source of protein and calcium, which are important for bone health.\n3. High consumption of nuts and seeds: Nuts and seeds are rich in healthy fats, protein, and fiber, which can help lower cholesterol levels and improve insulin sensitivity.\n4. Moderate consumption of red wine: Red wine contains antioxidants and polyphenols, which may help protect against heart disease and certain types of cancer.\n5. High consumption of olive oil: Olive oil is rich in healthy fats, such as monounsaturated fats, which can help lower cholesterol levels and improve insulin sensitivity.\n6. Low consumption of processed meats: Processed meats, such as bacon and sausage, are high in saturated fats and sodium, which can increase the risk of chronic diseases.\n7. High consumption of whole grains: Whole grains, such as brown rice and whole wheat bread, are rich in fiber, vitamins, and minerals, which can help lower cholesterol levels and improve insulin sensitivity.\n8. Low consumption of added sugars: Added sugars, such as those found in sweets and sugary drinks, can increase the risk of chronic diseases.\n9. High consumption of fish and seafood: Fish and seafood are rich in omega-3 fatty acids, which can help reduce inflammation and improve heart health.\n10. Low consumption of saturated fats: Saturated fats, such as those found in red meat and full-",
    "llama-2-7b-chat-hf_fact": [
      "High consumption of fruits, vegetables, and legumes are a part of the Mediterranean diet.",
      "Moderate consumption of dairy products is recommended in the Mediterranean diet.",
      "Nuts and seeds are high in healthy fats, protein, and fiber.",
      "Moderate consumption of red wine is included in the Mediterranean diet.",
      "Olive oil, rich in healthy fats, is consumed in high amounts in the Mediterranean diet."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4278,
    "user_query": "predimed : does eating nuts prevent strokes ?",
    "llama-2-7b-chat-hf_response": "Nuts are a nutritious snack that can provide a range of health benefits, including reducing the risk of stroke. Here are some of the ways that eating nuts may help prevent strokes:\n1. Lowering cholesterol levels: Nuts are high in healthy fats, including monounsaturated and polyunsaturated fats, which can help lower cholesterol levels and reduce the risk of stroke.\n2. Reducing inflammation: Nuts are rich in anti-inflammatory compounds, such as omega-3 fatty acids and polyphenols, which can help reduce inflammation in the body and lower the risk of stroke.\n3. Improving blood vessel function: Nuts are rich in potassium, magnesium, and other minerals that can help improve blood vessel function and reduce the risk of stroke.\n4. Lowering blood pressure: Nuts are rich in potassium, which can help lower blood pressure and reduce the risk of stroke.\n5. Improving blood sugar control: Nuts are rich in healthy fats and fiber, which can help improve blood sugar control and reduce the risk of stroke.\n6. Reducing oxidative stress: Nuts are rich in antioxidants, which can help reduce oxidative stress and lower the risk of stroke.\n7. Improving cognitive function: Nuts are rich in vitamin E, which can help improve cognitive function and reduce the risk of stroke.\n8. Lowering homocysteine levels: Nuts are rich in folate, which can help lower homocysteine levels and reduce the risk of stroke.\n9. Improving lipid profiles: Nuts are rich in healthy fats, which can help improve lipid profiles and reduce the risk of stroke.\n10. Reducing the risk of cardiovascular disease: Nuts are rich in a range of nutrients that can help reduce the risk of cardiovascular disease, including stroke.\nIt is important to note that while nuts may help prevent stroke, they are not a replacement for a healthy diet and lifestyle. A diet rich in fruits, vegetables, whole grains, and lean protein sources, along with regular physical activity and a healthy weight, can help reduce the",
    "llama-2-7b-chat-hf_fact": [
      "Nuts are high in monounsaturated and polyunsaturated fats, which can lower cholesterol levels.",
      "Nuts are rich in anti-inflammatory compounds such as omega-3 fatty acids and polyphenols.",
      "Nuts contain potassium, magnesium, and other minerals that can improve blood vessel function.",
      "Potassium in nuts can help lower blood pressure.",
      "Nuts are rich in healthy fats and fiber, aiding in blood sugar control."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4285,
    "user_query": "why do vegan women have 5x fewer twins ?",
    "llama-2-7b-chat-hf_response": "Research has shown that vegan women are less likely to have twins than non-vegan women. According to a study published in the journal Fertility and Sterility, vegan women are 5 times less likely to have twins than non-vegan women.\nThere are several reasons why this might be the case:\n1. Hormone levels: Vegan women tend to have lower levels of hormones such as estrogen and progesterone, which are important for fertility and twinning. These hormones play a role in regulating ovulation and the thickness of the uterine lining, which can affect the likelihood of twinning.\n2. Nutrient deficiencies: A vegan diet can be low in certain nutrients that are important for fertility and twinning, such as vitamin D, calcium, and omega-3 fatty acids. These nutrients are important for the health of the reproductive system and the development of the fetus.\n3. Lower body mass index (BMI): Vegan women tend to have lower BMIs than non-vegan women, which can also affect the likelihood of twinning. Women with higher BMIs are more likely to experience twin pregnancies.\n4. Different reproductive physiology: Vegan women may have different reproductive physiology than non-vegan women, which can affect the likelihood of twinning. For example, vegan women may have a shorter luteal phase (the time between ovulation and menstruation), which can make it more difficult to conceive and carry twins.\nIt's important to note that these are general trends and that many vegan women will still have twins. However, if you are a vegan woman trying to conceive, it's important to be aware of these factors and to make sure you are getting enough of the nutrients that are important for fertility and twinning. Consulting with a healthcare provider or a registered dietitian can help you make sure you are getting the nutrients you need.",
    "llama-2-7b-chat-hf_fact": [
      "Research indicates that vegan women are 5 times less likely to have twins than non-vegan women, according to a study published in the journal Fertility and Sterility.",
      "Vegan women tend to have lower levels of hormones such as estrogen and progesterone, which are important for fertility and twinning.",
      "Certain nutrients important for fertility and twinning, such as vitamin D, calcium, and omega-3 fatty acids, can be low in a vegan diet.",
      "Vegan women generally have lower BMIs than non-vegan women.",
      "Vegan women could have a shorter luteal phase (the time between ovulation and menstruation), which can make it more difficult to conceive and carry twins."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4292,
    "user_query": "is there too much aluminum in tea ?",
    "llama-2-7b-chat-hf_response": "Aluminum is a naturally occurring element that can be found in small amounts in some types of tea, particularly in black tea. However, the amount of aluminum in tea is generally considered to be safe for most people.",
    "llama-2-7b-chat-hf_fact": [
      "Aluminum is a naturally occurring element.",
      "Aluminum can be found in small amounts in some types of tea.",
      "Black tea particularly contains small amounts of aluminum.",
      "The amount of aluminum in tea is generally considered to be safe for most people."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4293,
    "user_query": "does meditation affect cellular aging ?",
    "llama-2-7b-chat-hf_response": "Meditation has been shown to have a positive impact on cellular aging by reducing oxidative stress and inflammation, improving telomere length, and activating cellular pathways that promote longevity.",
    "llama-2-7b-chat-hf_fact": [
      "Meditation has been shown to have a positive impact on cellular aging.",
      "Meditation can reduce oxidative stress and inflammation.",
      "Meditation is capable of improving telomere length.",
      "Meditation can activate cellular pathways that promote longevity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4294,
    "user_query": "is gluten sensitivity real ?",
    "llama-2-7b-chat-hf_response": "Gluten sensitivity, also known as non-celiac gluten sensitivity (NCGS), is a condition in which individuals experience symptoms after consuming gluten, a protein found in wheat, barley, and rye. While the exact cause of gluten sensitivity is not fully understood, research suggests that it is a real condition that affects a significant number of people. Here are some reasons why gluten sensitivity is real:\n1. Increased prevalence: The prevalence of gluten sensitivity has increased significantly over the past decade, with some studies suggesting that it affects up to 15% of the population.\n2. Symptoms: Individuals with gluten sensitivity often experience a range of symptoms, including abdominal pain, bloating, diarrhea, fatigue, and brain fog. These symptoms are similar to those experienced by people with celiac disease, an autoimmune disorder that causes an adverse reaction to gluten.\n3. Immune system response: Studies have shown that individuals with gluten sensitivity have an immune system response to gluten, similar to that seen in people with celiac disease. This suggests that gluten sensitivity is an immune-mediated response, rather than a psychological or imaginary condition.\n4. Genetic markers: Research has identified genetic markers associated with gluten sensitivity, which suggests that there may be a genetic component to the condition.\n5. Neurological symptoms: Some studies have found that individuals with gluten sensitivity may experience neurological symptoms, such as headaches, migraines, and cognitive impairment.\n6. Improved symptoms on gluten-free diet: Many individuals with gluten sensitivity report improved symptoms when they follow a gluten-free diet. This suggests that gluten may be contributing to their symptoms, rather than being a psychological or imaginary condition.\n7. Mechanistic studies: Mechanistic studies have shown that gluten can cause inflammation and damage to the gut lining, which may contribute to the development of symptoms in individuals with gluten sensitivity.\n8. Clinical trials: Clinical trials have shown that individuals with gluten sensitivity experience significant improvements in symptoms when they are placed on a gluten-free diet.",
    "llama-2-7b-chat-hf_fact": [
      "Gluten sensitivity, also known as non-celiac gluten sensitivity (NCGS), is a condition where individuals experience symptoms after consuming gluten, a protein found in wheat, barley, and rye.",
      "The prevalence of gluten sensitivity has increased significantly over the past decade, affecting up to 15% of the population according to some studies.",
      "Individuals with gluten sensitivity may experience symptoms such as abdominal pain, bloating, diarrhea, fatigue, and brain fog.",
      "Genetic markers associated with gluten sensitivity have been identified through research.",
      "Clinical trials have demonstrated that individuals with gluten sensitivity experience significant improvements in symptoms when they are placed on a gluten-free diet."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4300,
    "user_query": "fruits , veggies , and longevity : how many minutes per mouthful ?",
    "llama-2-7b-chat-hf_response": "According to a study published in the Journal of the Academy of Nutrition and Dietetics, eating 3-5 servings of fruits and vegetables per day can increase life expectancy by 1-2 years.",
    "llama-2-7b-chat-hf_fact": [
      "A study published in the Journal of the Academy of Nutrition and Dietetics linked fruit and vegetable consumption with increased life expectancy.",
      "According to that study, eating 3-5 servings of fruits and vegetables per day could potentially increase life expectancy by 1-2 years."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown"
    ]
  },
  {
    "id": 4310,
    "user_query": "should we take a multivitamin ?",
    "llama-2-7b-chat-hf_response": "A multivitamin is a dietary supplement that contains a combination of vitamins, minerals, and other nutrients that are intended to provide a broad range of health benefits. While multivitamins can be helpful in filling in any nutritional gaps in your diet, it's important to understand that they are not a substitute for a healthy diet and lifestyle.\nHere are some pros and cons to consider when deciding whether or not to take a multivitamin:\nPros:\n1. Helps fill in nutritional gaps: A multivitamin can help fill in any nutritional gaps in your diet, ensuring that you are getting all the essential vitamins and minerals your body needs.\n2. Boosts energy levels: Many multivitamins contain B vitamins, which are important for energy production and can help boost energy levels.\n3. Supports immune function: A multivitamin can help support immune function by providing vitamins and minerals that are important for immune system function.\n4. May reduce the risk of chronic diseases: Some studies have suggested that taking a multivitamin may reduce the risk of chronic diseases such as heart disease, stroke, and certain types of cancer.\nCons:\n1. May not be necessary: If you are eating a balanced diet that includes a variety of whole foods, you may not need to take a multivitamin.\n2. Can be expensive: Multivitamins can be expensive, especially if you are taking them regularly.\n3. May interact with medications: Some multivitamins can interact with medications, so it's important to talk to your doctor before taking one.\n4. May not be effective: Some studies have suggested that multivitamins may not be effective in preventing chronic diseases, and may even be harmful in some cases.\nIn conclusion, while a multivitamin can be helpful in filling in any nutritional gaps in your diet, it's important to understand that they are not a substitute for a healthy diet and lifestyle. If you are considering taking a multivitamin, it's important to talk to your doctor first to determine if it's right for you.",
    "llama-2-7b-chat-hf_fact": [
      "A multivitamin is a dietary supplement that contains a combination of vitamins, minerals, and other nutrients.",
      "Many multivitamins contain B vitamins, which are important for energy production.",
      "Some studies have suggested that taking a multivitamin may reduce the risk of chronic diseases such as heart disease, stroke, and certain types of cancer.",
      "Some multivitamins are known to interact with medications.",
      "Multivitamins may not be necessary if one is eating a balanced diet that includes a variety of whole foods."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4315,
    "user_query": "canned beans or cooked beans ?",
    "llama-2-7b-chat-hf_response": "Canned beans have several advantages over cooked beans, including:\n1. Convenience: Canned beans are already cooked and ready to eat, making them a convenient option for busy people.\n2. Shelf life: Canned beans have a longer shelf life than cooked beans, which can spoil quickly if not stored properly.\n3. Cost: Canned beans are generally cheaper than cooked beans, especially if you buy them in bulk.\n4. Nutrition: Canned beans are often higher in sodium than cooked beans, but they are still a good source of protein, fiber, and other nutrients.\nOn the other hand, cooked beans have some advantages over canned beans, including:\n1. Freshness: Cooked beans are fresher and more flavorful than canned beans, which can lose their flavor over time.\n2. Customization: Cooked beans can be customized to your taste by adding spices, herbs, and other seasonings.\n3. Lower sodium: Cooked beans generally have lower sodium content than canned beans, which can be beneficial for people with high blood pressure or other health conditions.\n4. Texture: Cooked beans have a softer, more tender texture than canned beans, which can be appealing to some people.\nUltimately, the choice between canned beans and cooked beans depends on your personal preferences, lifestyle, and dietary needs. Both options have their advantages and disadvantages, and it's important to consider these factors when deciding which option to choose.",
    "llama-2-7b-chat-hf_fact": [
      "Canned beans have a longer shelf life compared to cooked beans.",
      "Canned beans are typically higher in sodium content than cooked beans.",
      "Canned beans are considered a good source of protein, fiber, and other nutrients.",
      "Cooked beans generally have a lower sodium content than canned beans.",
      "The texture of cooked beans is softer and more tender compared to canned beans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4316,
    "user_query": "how many poppy seeds are too many ?",
    "llama-2-7b-chat-hf_response": "Poppy seeds are a nutritious and versatile ingredient that can be used in a variety of dishes, but consuming too many can have negative effects. Here are some guidelines on how many poppy seeds are too many:\n1. Overdose symptoms: Consuming too many poppy seeds can cause an overdose, which can lead to symptoms such as drowsiness, confusion, slowed breathing, and difficulty staying awake. In severe cases, an overdose can cause respiratory depression, coma, and even death.\n2. Safe amount: The safe amount of poppy seeds to consume varies depending on several factors, including age, weight, and individual tolerance. Generally, consuming up to 1 teaspoon (5 grams) of poppy seeds per day is considered safe for most adults. However, it's important to note that even this amount can cause drowsiness and other side effects in some people.\n3. Interaction with medications: Poppy seeds can interact with certain medications, including opioids, benzodiazepines, and alcohol. Consuming too many poppy seeds can enhance the effects of these medications, leading to increased drowsiness, confusion, and respiratory depression.\n4. Pregnancy and breastfeeding: Pregnant or breastfeeding women should avoid consuming poppy seeds altogether, as they can pass through the placenta or breast milk and cause drowsiness or respiratory depression in the baby.\n5. Allergic reactions: Some people may be allergic to poppy seeds, which can cause an allergic reaction when consumed. Symptoms of an allergic reaction may include hives, itching, swelling, and difficulty breathing.\nIn summary, consuming too many poppy seeds can cause negative effects, including drowsiness, confusion, and respiratory depression. The safe amount of poppy seeds to consume varies depending on several factors, and it's important to be aware of the potential interactions with medications and the risks for pregnant or breastfeeding women. If you experience any adverse effects after consuming poppy seeds, seek medical attention immediately.",
    "llama-2-7b-chat-hf_fact": [
      "Consuming too many poppy seeds can cause an overdose, exhibited by symptoms such as drowsiness, confusion, slowed breathing, and difficulty staying awake.",
      "Generally, up to 1 teaspoon (5 grams) of poppy seeds per day is considered safe for most adults.",
      "Poppy seeds can interact with certain medications, including opioids, benzodiazepines, and alcohol, leading to increased side effects.",
      "Pregnant or breastfeeding women are recommended to avoid consuming poppy seeds altogether.",
      "Some individuals may have an allergic reaction to poppy seeds, with symptoms including hives, itching, swelling, and difficulty breathing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "false, [corrected fact]: Pregnant or breastfeeding women can consume poppy seeds but in moderation.",
      "true"
    ]
  },
  {
    "id": 4326,
    "user_query": "which fruit fights cancer better ?",
    "llama-2-7b-chat-hf_response": "Which fruit fights cancer better?\nFruits are a rich source of vitamins, minerals, and antioxidants that have been shown to have anti-cancer properties. While all fruits have some anti-cancer properties, some have been found to be more effective than others in fighting cancer. Here are some of the top fruits that have been shown to have anti-cancer properties:\n1. Berries: Berries such as blueberries, raspberries, and strawberries are packed with antioxidants and phytochemicals that have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n2. Citrus fruits: Citrus fruits like oranges, lemons, and grapefruits are rich in vitamin C and flavonoids, which have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n3. Apples: Apples are a good source of quercetin, a flavonoid that has been shown to have anti-cancer properties. Quercetin can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n4. Pineapples: Pineapples are rich in an enzyme called bromelain, which has been shown to have anti-cancer properties. Bromelain can help reduce inflammation and inhibit the growth of cancer cells.\n5. Pomegranates: Pomegranates are a rich source of antioxidants and phytochemicals that have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n6. Acai berries: Acai berries are a rich source of antioxidants and phytochemicals that have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n7. Goji berries: Goji berries are a rich source of antioxid",
    "llama-2-7b-chat-hf_fact": [
      "Berries such as blueberries, raspberries, and strawberries contain antioxidants and phytochemicals which have anti-cancer properties.",
      "Citrus fruits like oranges, lemons, and grapefruits are rich in vitamin C and flavonoids that have anti-cancer properties.",
      "Apples contain quercetin, a flavonoid that has been shown to have anti-cancer properties.",
      "Pineapples are rich in an enzyme called bromelain, which has been shown to have anti-cancer properties.",
      "Pomegranates and Acai berries are a rich source of antioxidants and phytochemicals that have anti-cancer properties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4333,
    "user_query": "can gargling prevent the common cold ?",
    "llama-2-7b-chat-hf_response": "Gargling with salt water has been suggested as a way to help prevent the common cold, but there is limited scientific evidence to support this claim. Here are some reasons why gargling may not be effective in preventing the common cold:\n1. The common cold is caused by viruses: The common cold is caused by viruses, such as rhinoviruses, coronaviruses, and adenoviruses. These viruses are highly contagious and can easily spread through the air when an infected person talks, coughs, or sneezes. Gargling with salt water may not be able to kill or remove these viruses from the throat and nasal passages.\n2. Gargling may not reach the nasal passages: The nasal passages are the primary site where the common cold virus enters the body. Gargling with salt water may not be able to reach the nasal passages, where the virus is most likely to enter the body.\n3. Gargling may not reduce inflammation: The common cold can cause inflammation in the throat and nasal passages, which can lead to symptoms such as a sore throat, cough, and congestion. Gargling with salt water may not be able to reduce inflammation in these areas.\n4. There are other factors that contribute to the common cold: The common cold is caused by a combination of factors, including exposure to viruses, weakened immune systems, and environmental factors such as lack of sleep, stress, and exposure to allergens. Gargling with salt water may not be able to address these underlying factors.\n5. There are other, more effective ways to prevent the common cold: While gargling with salt water may not be effective in preventing the common cold, there are other ways to reduce your risk of getting sick. These include:\n* Washing your hands frequently with soap and water\n* Avoiding close contact with people who are sick\n* Avoiding touching your eyes, nose, and mouth\n* Staying hydrated by drinking plenty of fluids\n* Getting enough sleep and managing stress\n* Exercising regularly to boost your immune system\nIn conclusion, while gargling with salt water may have some benefits for throat health, there is limited scientific evidence to support its effect",
    "llama-2-7b-chat-hf_fact": [
      "The common cold is caused by viruses, such as rhinoviruses, coronaviruses, and adenoviruses.",
      "The common cold can cause inflammation in the throat and nasal passages, leading to symptoms such as a sore throat, cough, and congestion.",
      "The common cold is influenced by a variety of factors, including a weakened immune system, lack of sleep, stress, and exposure to allergens.",
      "Frequent hand washing, avoiding close contact with sick people, not touching your eyes, nose, and mouth, staying hydrated, getting enough sleep, managing stress, and regular exercising can potentially reduce the risk of getting the common cold.",
      "Gargling with salt water has limited scientific evidence to support its effectiveness in preventing the common cold."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4334,
    "user_query": "are cats or dogs more protective for children 's health ?",
    "llama-2-7b-chat-hf_response": "Cats and dogs are both popular pets that can provide companionship and affection to children. However, when it comes to protecting children's health, both cats and dogs can play a role, but in different ways.\nCats are known for their cleanliness and can help reduce the risk of allergies in children. According to a study published in the Journal of Allergy and Clinical Immunology, children who grow up in households with cats have a lower risk of developing allergies compared to those who grow up in households without cats. Additionally, cats can help reduce stress and anxiety in children, which can have a positive impact on their overall health and well-being.\nDogs, on the other hand, are often considered to be more protective of children's health than cats. Dogs are social animals that are naturally inclined to watch over and protect their human family members, including children. According to a study published in the Journal of Pediatrics, children who have dogs in their household have a lower risk of developing asthma compared to those who do not have dogs. Dogs can also provide emotional support and comfort to children, which can help reduce stress and anxiety.\nHowever, it's important to note that both cats and dogs can also pose health risks to children if they are not properly supervised and cared for. For example, cats can scratch or bite if they feel threatened or scared, while dogs can bite or knock over children if they are not properly trained or supervised.\nIn conclusion, both cats and dogs can provide health benefits to children, but in different ways. Cats can help reduce the risk of allergies, while dogs can provide emotional support and protection. However, it's important to properly supervise and care for both cats and dogs to ensure the safety and well-being of children.",
    "llama-2-7b-chat-hf_fact": [
      "Cats can help reduce the risk of allergies in children.",
      "A study published in the Journal of Allergy and Clinical Immunology found that children who grow up in households with cats have a lower risk of developing allergies.",
      "Cats can help reduce stress and anxiety in children.",
      "A study published in the Journal of Pediatrics found that children who have dogs in their household have a lower risk of developing asthma.",
      "Dogs can provide emotional support and comfort to children, which can reportedly help reduce stress and anxiety."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4342,
    "user_query": "do eden beans have too much iodine ?",
    "llama-2-7b-chat-hf_response": "Eden beans, also known as adzuki beans, are a type of legume that is commonly consumed in many parts of the world. While they are a nutritious and healthy food, there is some concern that they may contain too much iodine.\nIodine is an essential nutrient that is important for the proper functioning of the thyroid gland, which produces hormones that regulate metabolism and growth. However, excessive intake of iodine can be harmful, and it is important to be aware of the iodine content of foods like Eden beans.\nAccording to the United States Department of Agriculture (USDA), one cup of cooked Eden beans contains approximately 100 micrograms of iodine. This is significantly higher than the recommended daily intake of iodine, which is typically around 150 micrograms for adults.\nWhile the high iodine content of Eden beans may be a concern for some people, it is worth noting that the body has a built-in mechanism for regulating iodine levels. The thyroid gland can convert excess iodine into a form that is not harmful, and the kidneys can excrete excess iodine in the urine.\nHowever, it is still important to be aware of the iodine content of foods and to consume them in moderation. If you have any concerns about your iodine intake or have questions about how to reduce your exposure to excessive iodine, it is best to speak with a healthcare professional.\nIn summary, while Eden beans do contain a relatively high amount of iodine, the body has mechanisms in place to regulate iodine levels and excessive intake is unlikely to cause harm. However, it is still important to be aware of the iodine content of foods and to consume them in moderation.",
    "llama-2-7b-chat-hf_fact": [
      "Eden beans, also known as adzuki beans, are a type of legume that is commonly consumed in many parts of the world.",
      "One cup of cooked Eden beans contains approximately 100 micrograms of iodine according to the United States Department of Agriculture (USDA).",
      "The recommended daily intake of iodine for adults is typically around 150 micrograms.",
      "The thyroid gland can convert excess iodine into a form that is not harmful and the kidneys can excrete excess iodine in the urine.",
      "Excessive intake of iodine can be harmful to the body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Eden beans are different from adzuki beans. Both are commonly consumed legumes in many parts of the world but they are not the same.",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4360,
    "user_query": "better than green tea ?",
    "llama-2-7b-chat-hf_response": "While both green and black tea have their own unique health benefits, black tea may have a slight edge over green tea in certain areas. Here are some reasons why:\n1. Antioxidant content: Black tea contains more antioxidants than green tea, particularly a compound called theaflavins, which has been shown to have anti-inflammatory and anti-cancer properties.\n2. Catechins: Black tea contains more catechins than green tea, which are a type of antioxidant that has been linked to improved heart health and reduced risk of certain diseases.\n3. Theanine content: Black tea contains more theanine than green tea, which is an amino acid that has been shown to promote relaxation and reduce stress levels.\n4. Caffeine content: Black tea generally contains more caffeine than green tea, which can provide a boost of energy and alertness.\n5. Flavonoids: Black tea contains more flavonoids than green tea, which are a type of antioxidant that has been linked to improved cardiovascular health and reduced risk of certain diseases.\n6. Anti-inflammatory properties: Black tea has been shown to have stronger anti-inflammatory properties than green tea, which may help reduce the risk of chronic diseases such as arthritis and cardiovascular disease.\n7. Cardiovascular health: Black tea has been shown to have a positive impact on cardiovascular health, particularly in reducing the risk of heart disease and stroke.\n8. Anti-cancer properties: Black tea has been shown to have anti-cancer properties, particularly in reducing the risk of certain types of cancer such as colon, breast, and prostate cancer.\n9. Immune system support: Black tea has been shown to have immune-boosting properties, which may help support the immune system and reduce the risk of illnesses such as the common cold and flu.\n10. Anti-aging properties: Black tea contains antioxidants that may help reduce the signs of aging, such as wrinkles and age spots, and improve overall skin health.\nIt's important to note that both green and black tea have their own unique health benefits, and the best choice for you will depend on your individual needs",
    "llama-2-7b-chat-hf_fact": [
      "Black tea contains more antioxidants than green tea, particularly a compound called theaflavins.",
      "Black tea contains more catechins than green tea, a type of antioxidant linked to improved heart health.",
      "Black tea contains more theanine, an amino acid that promotes relaxation and reduces stress levels, than green tea.",
      "Black tea generally has a higher caffeine content than green tea.",
      "Black tea is noted for its immune-boosting properties that help in reducing the risk of illnesses such as the common cold and flu."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Green tea contains more antioxidants than black tea.",
      "false, [corrected fact]: Green tea contains more catechins than black tea, a type of antioxidant linked to improved heart health.",
      "false, [corrected fact]: Green tea contains more theanine, an amino acid that promotes relaxation and reduces stress levels, than black tea.",
      "true",
      "true"
    ]
  },
  {
    "id": 4361,
    "user_query": "fast food : do you want fries with that lipitor ?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4375,
    "user_query": "are dates good for you ?",
    "llama-2-7b-chat-hf_response": "Dates are a nutritious fruit that provides several health benefits when consumed as part of a balanced diet. Here are some of the key benefits of dates:\n1. Rich in Fiber: Dates are a good source of dietary fiber, which can help promote digestive health and prevent constipation.\n2. Natural Energy Boost: Dates are a good source of natural sugars like glucose, fructose, and sucrose, which can provide a quick energy boost when consumed.\n3. Good Source of Antioxidants: Dates are rich in antioxidants like vitamin C, vitamin E, and beta-carotene, which can help protect the body against free radicals and oxidative stress.\n4. Supports Bone Health: Dates are a good source of several minerals like calcium, magnesium, and potassium, which are essential for bone health.\n5. May Help Manage Blood Sugar: Dates have been shown to have a beneficial effect on blood sugar levels in people with type 2 diabetes.\n6. Supports Brain Health: Dates contain antioxidants and other nutrients that may help support brain health and reduce the risk of age-related cognitive decline.\n7. May Help Lower Cholesterol: The fiber and potassium in dates may help lower cholesterol levels and reduce the risk of heart disease.\n8. Supports Healthy Gut Bacteria: Dates contain prebiotic fiber that can help feed the good bacteria in the gut, promoting a healthy gut microbiome.\n9. May Help Reduce Inflammation: Dates contain anti-inflammatory compounds that may help reduce inflammation in the body and reduce the risk of chronic diseases.\n10. Supports Eye Health: Dates are a good source of vitamin A, which is essential for healthy vision and can help reduce the risk of age-related macular degeneration.\nOverall, dates are a nutritious fruit that can provide several health benefits when consumed as part of a balanced diet. They are a good source of fiber, antioxidants, minerals, and",
    "llama-2-7b-chat-hf_fact": [
      "Dates are a source of dietary fiber.",
      "Dates contain natural sugars like glucose, fructose, and sucrose.",
      "Dates contain antioxidants including vitamin C, vitamin E, and beta-carotene.",
      "They are also a source of minerals like calcium, magnesium, and potassium, essential for bone health.",
      "Dates are a good source of vitamin A, which is essential for healthy vision."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Dates contain antioxidants including flavonoids, carotenoids and phenolic acid, not vitamin C, vitamin E, or beta-carotene.",
      "true",
      "false, [corrected fact]: Dates contain small amounts of vitamin A, but are not considered a good source for it."
    ]
  },
  {
    "id": 4376,
    "user_query": "are chili peppers good for you ?",
    "llama-2-7b-chat-hf_response": "Chili peppers are a nutritious and versatile ingredient that can provide numerous health benefits when consumed as part of a balanced diet. Here are some of the potential health benefits of chili peppers:\n1. Pain relief: Chili peppers contain a compound called capsaicin, which has been shown to have analgesic and anti-inflammatory properties. This means that chili peppers can help to relieve pain and reduce inflammation.\n2. Improved heart health: Chili peppers are a good source of potassium, which can help to lower blood pressure and reduce the risk of heart disease. They also contain antioxidants and other nutrients that can help to protect against heart disease.\n3. Anti-cancer properties: Chili peppers contain a variety of antioxidants and other compounds that have been shown to have anti-cancer properties. For example, capsaicin has been shown to inhibit the growth of cancer cells and induce apoptosis (cell death).\n4. Improved digestion: Chili peppers contain fiber and other nutrients that can help to promote digestive health. They can also help to stimulate digestive enzymes and improve gut motility.\n5. Anti-bacterial properties: Chili peppers contain compounds that have been shown to have anti-bacterial properties, which can help to protect against infections and promote overall health.\n6. Improved immune function: Chili peppers contain a variety of nutrients and compounds that can help to support immune function, including vitamin C, vitamin A, and beta-carotene.\n7. Anti-inflammatory properties: Chili peppers contain compounds that have been shown to have anti-inflammatory properties, which can help to reduce inflammation and promote overall health.\n8. Weight loss: Chili peppers contain capsaicin, which can help to increase metabolism and promote weight loss.\n9. Anti-diabetic properties: Chili peppers have been shown to have anti-diabetic properties, which can help to reduce the risk of developing type 2 diabetes.\n10. Anti-aging properties: Chili peppers contain a variety of antio",
    "llama-2-7b-chat-hf_fact": [
      "Chili peppers contain a compound called capsaicin, which has analgesic and anti-inflammatory properties.",
      "Chili peppers are a source of potassium, which can help to lower blood pressure and reduce the risk of heart disease.",
      "Capsaicin found in chili peppers has been shown to inhibit the growth of cancer cells and induce apoptosis.",
      "Chili peppers contain fiber and other nutrients that promote digestive health.",
      "Chili peppers contain compounds with anti-bacterial properties, which can protect against infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4383,
    "user_query": "can cholesterol be too low ?",
    "llama-2-7b-chat-hf_response": "Can cholesterol be too low? Yes, it is possible for cholesterol levels to be too low, a condition known as hypolipidemia or low cholesterol.\nHypolipidemia can be caused by a variety of factors, including:\n1. Genetics: Some people may have a genetic predisposition to low cholesterol levels.\n2. Malabsorption: Certain medical conditions, such as celiac disease or pancreatic insufficiency, can lead to malabsorption of fats and cholesterol, resulting in low levels.\n3. Medications: Certain medications, such as statins, can lower cholesterol levels by inhibiting the production of cholesterol in the liver.\n4. Diet: A very low-fat diet can lead to low cholesterol levels.\n5. Other medical conditions: Certain medical conditions, such as hypothyroidism or liver disease, can also lead to low cholesterol levels.\nWhile low cholesterol levels may not be harmful in and of themselves, they can sometimes be a sign of an underlying medical condition that needs to be addressed. For example, low cholesterol levels can increase the risk of gallstones, and low levels of HDL (good) cholesterol can increase the risk of heart disease.\nIf you have low cholesterol levels, your healthcare provider may recommend dietary changes, such as increasing your intake of healthy fats, or medication to help raise your cholesterol levels to a healthy range. In some cases, they may also recommend further testing to determine the underlying cause of your low cholesterol levels.\nIn summary, while low cholesterol levels are generally not a cause for concern, they can be a sign of an underlying medical condition that needs to be addressed. If you have low cholesterol levels, it is important to speak with your healthcare provider to determine the cause and develop a plan to raise your cholesterol levels to a healthy range.",
    "llama-2-7b-chat-hf_fact": [
      "Hypolipidemia is a condition characterized by low cholesterol levels.",
      "Certain genetic factors may predispose some people to low cholesterol levels.",
      "Medical conditions such as celiac disease or pancreatic insufficiency can lead to malabsorption of fats and cholesterol causing low cholesterol levels.",
      "Medications like statins can lower cholesterol levels by inhibiting the production of cholesterol in the liver.",
      "Low cholesterol levels could be a sign of an underlying medical condition like hypothyroidism or liver disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4385,
    "user_query": "how much pus is there in milk ?",
    "llama-2-7b-chat-hf_response": "Answer: Pus is not typically found in milk. Milk is a nutrient-rich fluid produced by mammary glands in female mammals, primarily for the purpose of nourishing their young. It is composed of water, carbohydrates, proteins, fats, and other nutrients.\nPus, on the other hand, is a type of fluid that forms in the body as a result of an infection or inflammation. It is typically yellowish or greenish in color and may have a foul odor. Pus is produced by the body's immune system as it tries to fight off an infection, and it can be found in various parts of the body, including the skin, lungs, and urinary tract.\nWhile it is possible for milk to become contaminated with bacteria or other microorganisms that can cause infection, there is no reason to believe that milk would naturally contain pus. If you have concerns about the safety or quality of milk, it is best to consult with a healthcare professional or a trusted source of information.",
    "llama-2-7b-chat-hf_fact": [
      "Milk is a nutrient-rich fluid produced by mammary glands in female mammals, primarily for the purpose of nourishing their young.",
      "Milk is composed of water, carbohydrates, proteins, fats, and other nutrients.",
      "Pus is a type of fluid that forms in the body as a result of an infection or inflammation.",
      "Pus is typically yellowish or greenish in color and may have a foul odor.",
      "Pus is produced by the body's immune system as it tries to fight off an infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4391,
    "user_query": "toxins in cooked potatoes ?",
    "llama-2-7b-chat-hf_response": "Toxins in cooked potatoes are relatively rare, but they can occur under certain conditions. Here are some of the toxins that can form in cooked potatoes:\n1. Solanine: Solanine is a glycoalkaloid toxin that can form in potatoes that have been exposed to light, heat, or water. It can cause nausea, diarrhea, and stomach cramps if consumed in large amounts.\n2. Chaconine: Chaconine is another glycoalkaloid toxin that can form in potatoes. It can cause similar symptoms to solanine, including nausea, diarrhea, and stomach cramps.\n3. Agatoxin: Agatoxin is a toxin that can form in potatoes that have been exposed to light, heat, or water. It can cause symptoms such as nausea, vomiting, and diarrhea.\n4. T-2 toxin: T-2 toxin is a mycotoxin that can form in potatoes that have been infected with a fungus. It can cause symptoms such as vomiting, diarrhea, and stomach cramps.\n5. Aflatoxin: Aflatoxin is a mycotoxin that can form in potatoes that have been infected with a fungus. It can cause symptoms such as vomiting, diarrhea, and stomach cramps.\nIt's worth noting that these toxins are relatively rare and are more likely to occur in potatoes that have been improperly stored or handled. To minimize the risk of exposure to these toxins, it's important to store potatoes in a cool, dark place and to cook them thoroughly before eating.",
    "llama-2-7b-chat-hf_fact": [
      "Solanine is a glycoalkaloid toxin that can form in potatoes exposed to light, heat, or water, causing symptoms like nausea, diarrhea, and stomach cramps.",
      "Chaconine is another glycoalkaloid toxin that can develop in potatoes, potentially causing symptoms similar to solanine.",
      "Agatoxin can form in potatoes exposed to light, heat, or water and lead to symptoms like nausea, vomiting, and diarrhea.",
      "T-2 toxin, a mycotoxin, can develop in potatoes infected with fungus, potentially causing symptoms such as vomiting, diarrhea, and stomach cramps.",
      "Aflatoxin is another type of mycotoxin that can develop in fungus-infected potatoes and can cause symptoms similar to the T-2 toxin."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Agatoxin is a toxin found in spider venom, not in potatoes.",
      "false, [corrected fact]: T-2 toxin is a mycotoxin that can develop in moldy grains and feed, not in potatoes.",
      "false, [corrected fact]: Aflatoxin is a mycotoxin that can develop in certain crops like peanuts and corn, not in potatoes."
    ]
  },
  {
    "id": 4408,
    "user_query": "is chlorella good for you ?",
    "llama-2-7b-chat-hf_response": "Chlorella is a type of algae that has been used for centuries in traditional medicine. It is rich in nutrients, including protein, vitamins, and minerals, and has been shown to have a range of potential health benefits. Here are some of the ways that chlorella may be good for you:\n1. Boosts immune system: Chlorella contains beta-glucans, which are known to stimulate the immune system and increase its ability to fight off infection.\n2. Detoxifies the body: Chlorella has been shown to bind to heavy metals and other toxins in the body, helping to remove them and promote detoxification.\n3. Supports digestive health: Chlorella contains fiber and other nutrients that can help support digestive health and promote regular bowel movements.\n4. May help lower cholesterol: Some studies have suggested that chlorella may help lower cholesterol levels by binding to bile acids and removing them from the body.\n5. May help manage blood sugar: Chlorella has been shown to improve insulin sensitivity and may help manage blood sugar levels in people with type 2 diabetes.\n6. May help reduce inflammation: Chlorella contains anti-inflammatory compounds that may help reduce inflammation in the body.\n7. May help improve cognitive function: Chlorella contains chlorella growth factor (CGF), which has been shown to improve cognitive function and memory in some studies.\n8. May help support skin health: Chlorella contains antioxidants and other nutrients that may help protect the skin from damage and promote healthy aging.\n9. May help support eye health: Chlorella contains lutein and zeaxanthin, which are antioxidants that may help protect the eyes from damage and reduce the risk of age-related macular degeneration.\n10. May help support bone health: Chlorella contains calcium and other minerals that are important for bone health, and may help reduce the risk of osteoporosis.\nIt is important to note that while chlorella may have a range of potential health benefits, more research is needed to confirm the effectiveness of chlorella for many of these uses. Additionally, chlorella",
    "llama-2-7b-chat-hf_fact": [
      "Chlorella is a type of algae used in traditional medicine.",
      "Chlorella is rich in protein, vitamins, and minerals.",
      "Chlorella contains beta-glucans, which can stimulate the immune system.",
      "Chlorella has been shown to bind to heavy metals and other toxins in the body, aiding in detoxification.",
      "Chlorella contains compounds that may help reduce inflammation in the body."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4420,
    "user_query": "what do eggs do to our arteries ?",
    "llama-2-7b-chat-hf_response": "Eggs are a nutritious food that provides many essential nutrients, including protein, vitamins, and minerals. However, some people have raised concerns about the potential negative effects of eggs on our arteries. In this article, we will explore what eggs do to our arteries and whether these effects are cause for concern.",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4427,
    "user_query": "is msg bad for you ?",
    "llama-2-7b-chat-hf_response": "MSG (monosodium glutamate) is a flavor enhancer commonly used in many food products, including soups, sauces, and processed meats. While some people may be sensitive to MSG and experience adverse effects, the scientific consensus is that MSG is generally safe for most people in small amounts.\nThe U.S. Food and Drug Administration (FDA) has classified MSG as generally recognized as safe (GRAS) for use in food, and the European Food Safety Authority (EFSA) has also concluded that MSG is safe for human consumption.\nHowever, some people may experience adverse effects after consuming MSG, including:\n1. Headaches and migraines: Some people may experience headaches or migraines after consuming MSG.\n2. Flushing and sweating: MSG can cause flushing and sweating in some individuals.\n3. Digestive problems: Some people may experience nausea, diarrhea, or abdominal pain after consuming MSG.\n4. Allergic reactions: While rare, some people may be allergic to MSG and experience an allergic reaction after consuming it.\nIt's important to note that the amount of MSG used in food products can vary widely, and some people may be more sensitive to smaller amounts than others. If you experience any adverse effects after consuming MSG, it's a good idea to speak with a healthcare professional.\nIn summary, while MSG is generally safe for most people in small amounts, some people may experience adverse effects. If you're concerned about MSG, it's a good idea to speak with a healthcare professional or a registered dietitian for more information.",
    "llama-2-7b-chat-hf_fact": [
      "Monosodium glutamate (MSG) is a flavor enhancer used in various food products like soups, sauces, and processed meats.",
      "The U.S. Food and Drug Administration has classified MSG as generally recognized as safe (GRAS) for use in food.",
      "The European Food Safety Authority (EFSA) has also concluded that MSG is safe for human consumption.",
      "Some people may experience adverse effects like headaches, migraines, flushing, sweating, digestive problems, and allergic reactions after consuming MSG.",
      "Wide variance exists in the amount of MSG used in food products."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4431,
    "user_query": "why would eating fish increase diabetes risk ?",
    "llama-2-7b-chat-hf_response": "Eating fish may increase the risk of developing type 2 diabetes, according to a study published in the Journal of Clinical Endocrinology and Metabolism. The study found that people who ate fish more than twice a week had a higher risk of developing type 2 diabetes compared to those who ate fish less than once a week.\nThere are several reasons why eating fish may increase the risk of developing type 2 diabetes:\n1. Mercury content: Fish can contain high levels of mercury, a toxic substance that can damage the pancreas and increase insulin resistance. Insulin resistance is a key factor in the development of type 2 diabetes.\n2. Omega-3 fatty acids: While omega-3 fatty acids found in fish have been shown to have numerous health benefits, they can also increase inflammation in the body. Chronic inflammation is a known risk factor for type 2 diabetes.\n3. Protein content: Fish can be high in protein, which can increase glucose levels in the blood and increase the risk of developing type 2 diabetes.\n4. Cooking methods: Cooking fish at high temperatures, such as grilling or frying, can produce toxic compounds that may increase the risk of type 2 diabetes.\n5. Nutrient imbalance: Eating fish regularly may lead to an imbalance of certain nutrients in the body, such as an excess of omega-3 fatty acids and a deficiency of certain minerals like zinc and magnesium, which are important for insulin function and glucose metabolism.\nIt is important to note that not all fish are created equal when it comes to type 2 diabetes risk. Some fish, such as salmon and sardines, are lower in mercury and higher in omega-3 fatty acids than others, such as shark, swordfish, and king mackerel, which are higher in mercury and lower in omega-3s.\nIn conclusion, while fish can be a healthy addition to a balanced diet, it is important to be aware of the potential risks associated with eating fish and to consume it in moderation. It is also important to choose fish",
    "llama-2-7b-chat-hf_fact": [
      "Eating fish more than twice a week is associated with a higher risk of developing type 2 diabetes according to a study in the Journal of Clinical Endocrinology and Metabolism.",
      "Fish can contain high levels of mercury, which can damage the pancreas and increase insulin resistance, a factor in the development of type 2 diabetes.",
      "Omega-3 fatty acids, found in fish, can increase inflammation in the body, a known risk factor for type 2 diabetes.",
      "The manner of cooking fish, specifically at high temperatures, can produce toxic compounds that may increase the risk of type 2 diabetes.",
      "Consuming fish regularly can lead to an imbalance in certain nutrients, such as a surplus of omega-3 fatty acids and a deficiency of minerals like zinc and magnesium, that are important for glucose metabolism and insulin function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "false, [corrected fact]: Omega-3 fatty acids, found in fish, are known to decrease inflammation in the body, which is beneficial in reducing the risk factors for type 2 diabetes.",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4440,
    "user_query": "should i stay away from soy if i have breast cancer ?",
    "llama-2-7b-chat-hf_response": "Soy is a controversial topic when it comes to breast cancer, and the answer to whether you should stay away from it depends on several factors. Here are some things to consider:\n1. Soy contains isoflavones: Soy contains a group of compounds called isoflavones, which have been shown to have both positive and negative effects on breast cancer. Isoflavones can act like estrogen in the body, which can help slow the growth of some types of breast cancer. However, they can also increase the risk of certain types of breast cancer in some people.\n2. Breast cancer type: The type of breast cancer you have can play a role in how soy affects you. For example, if you have hormone-receptor-positive breast cancer (HR+), soy isoflavones may help slow the growth of the cancer. However, if you have hormone-receptor-negative breast cancer (HR-), soy isoflavones may actually increase the risk of the cancer growing.\n3. Individual variability: Everyone's body is different, and how soy affects you can depend on a variety of factors, including your genetics, diet, and overall health. Some people may be more sensitive to the effects of soy isoflavones than others.\n4. Moderation is key: If you do choose to include soy in your diet, it's important to do so in moderation. Soy products can be high in calories and fat, so it's important to consume them in moderation as part of a balanced diet.",
    "llama-2-7b-chat-hf_fact": [
      "Soy contains a group of compounds called isoflavones.",
      "Isoflavones can have both positive and negative effects on breast cancer.",
      "The type of breast cancer one has can influence how soy affects it.",
      "Soy isoflavones may help slow the growth of hormone-receptor-positive breast cancer (HR+).",
      "Soy isoflavones may increase the risk of hormone-receptor-negative breast cancer (HR-) growing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4442,
    "user_query": "have you seen the very recent web blitz on heavy metals ( particularly thallium ) in cruciferous vegetables ( particularly kale ) ... ?",
    "llama-2-7b-chat-hf_response": "Comment: Yes, I'm aware of the recent web blitz on heavy metals in cruciferous vegetables, particularly kale. There have been some studies that have detected trace amounts of heavy metals, including thallium, in kale and other cruciferous vegetables. However, it's important to note that the levels of heavy metals in these vegetables are generally very low and are not considered to be a significant health risk.\nComment: Additionally, it's worth noting that the benefits of eating cruciferous vegetables, including kale, far outweigh any potential risks associated with heavy metal exposure. These vegetables are rich in vitamins, minerals, and antioxidants, and have been shown to have numerous health benefits, including reducing the risk of certain cancers, improving cardiovascular health, and supporting immune function.\nComment: So, while it's important to be aware of the potential risks associated with heavy metals in cruciferous vegetables, it's also important to keep things in perspective and continue to enjoy these nutritious foods as part of a balanced diet.",
    "llama-2-7b-chat-hf_fact": [
      "Trace amounts of heavy metals, including thallium, have been detected in kale and other cruciferous vegetables.",
      "The levels of heavy metals in cruciferous vegetables are generally very low.",
      "Cruciferous vegetables, including kale, are rich in vitamins, minerals, and antioxidants.",
      "Cruciferous vegetables have been shown to reduce the risk of certain cancers, improve cardiovascular health, and support immune function.",
      "It's recommended to continue to eat cruciferous vegetables as part of a balanced diet."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4444,
    "user_query": "might too many antioxidants cause cancer ?",
    "llama-2-7b-chat-hf_response": "While antioxidants have been shown to have numerous health benefits, there is some evidence to suggest that excessive intake of certain antioxidants may increase the risk of certain types of cancer. Here are some of the potential risks associated with excessive antioxidant intake:\n1. Vitamin E: High levels of vitamin E intake have been linked to an increased risk of prostate cancer in some studies.\n2. Beta-carotene: Some studies have suggested that high levels of beta-carotene intake may increase the risk of lung cancer in smokers.\n3. Vitamin A: High levels of vitamin A intake have been linked to an increased risk of ovarian cancer in some studies.\n4. Selenium: While selenium is an essential antioxidant, high levels of intake have been linked to an increased risk of prostate cancer in some studies.\n5. Garlic: Some studies have suggested that high levels of garlic intake may increase the risk of certain types of cancer, such as stomach cancer.\nIt's important to note that the potential risks associated with excessive antioxidant intake are still being studied and debated, and more research is needed to fully understand the relationship between antioxidants and cancer risk. Additionally, it's important to consume antioxidants in moderation and as part of a balanced diet that includes a variety of whole foods.\nIn summary, while antioxidants have been shown to have numerous health benefits, excessive intake of certain antioxidants may increase the risk of certain types of cancer. It's important to consume antioxidants in moderation and as part of a balanced diet that includes a variety of whole foods.",
    "llama-2-7b-chat-hf_fact": [
      "Some evidence suggests that excessive intake of certain antioxidants may increase the risk of certain types of cancer.",
      "High levels of vitamin E intake have been linked to an increased risk of prostate cancer in some studies.",
      "Some studies have suggested that high levels of beta-carotene intake may increase the risk of lung cancer in smokers.",
      "High levels of vitamin A intake have been linked to an increased risk of ovarian cancer in some studies.",
      "High levels of selenium intake have been linked to an increased risk of prostate cancer in some studies."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4449,
    "user_query": "what is the best way to get vitamin b12 ?",
    "llama-2-7b-chat-hf_response": "Vitamin B12 is an essential nutrient that plays a crucial role in the body's functioning, particularly in the production of red blood cells and the maintenance of the nervous system. Here are some of the best ways to get enough vitamin B12:\n1. Food: Vitamin B12 is found primarily in animal-derived foods, such as meat, poultry, fish, eggs, and dairy products. Fortified plant-based milk and cereals also contain vitamin B12.\n2. Supplements: Vitamin B12 supplements are available in various forms, including tablets, capsules, and lozenges. They can be found in most health food stores and pharmacies.\n3. Injections: Vitamin B12 injections are also available and can be administered by a healthcare professional.\n4. Methylcobalamin: Methylcobalamin is the active form of vitamin B12 and is more easily absorbed by the body than other forms.\n5. Adenosylcobalamin: Adenosylcobalamin is another form of vitamin B12 that is involved in the methylation process in the body.\n6. Hydroxocobalamin: Hydroxocobalamin is a form of vitamin B12 that is used in intramuscular injections.\n7. Cyanocobalamin: Cyanocobalamin is the most common form of vitamin B12 found in supplements and is converted to the active form in the body.\n8. Vitamin B12-rich foods: In addition to animal-derived foods, some plant-based foods are rich in vitamin B12, such as tempeh, seaweed, and nutritional yeast.\n9. Fortified foods: Many processed foods, such as breakfast cereals and energy bars, are fortified with vitamin B12.\n10. Breast milk: Breast milk is a good source of vitamin B12 for infants.\nIt's important to note that vitamin B12 deficiency is common, especially in vegetarians and vegans, older adults, and people with certain medical conditions. If you",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin B12 plays a crucial role in the production of red blood cells and the maintenance of the nervous system.",
      "Animal-derived foods such as meat, poultry, fish, eggs, and dairy products are primary sources of vitamin B12.",
      "Fortified plant-based milk, cereals, tempeh, seaweed, and nutritional yeast can also provide vitamin B12.",
      "Vitamin B12 supplements in forms of tablets, capsules, and lozenges are available in health food stores and pharmacies.",
      "Methylcobalamin, Adenosylcobalamin, Hydroxocobalamin, and Cyanocobalamin are different forms of vitamin B12."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4451,
    "user_query": "might flax seeds ( ala ) increase prostate cancer risk ?",
    "llama-2-7b-chat-hf_response": "Flaxseeds are a rich source of omega-3 fatty acids, fiber, and other nutrients, and have been associated with several potential health benefits, including reducing inflammation and improving digestive health. However, there is some evidence to suggest that consuming flaxseeds may increase the risk of prostate cancer in certain individuals.\nOne study published in the Journal of Nutrition found that mice fed a diet supplemented with flaxseeds had increased levels of prostate cancer compared to mice not fed the supplemented diet. The researchers suggested that the increased risk may be due to the high levels of lignans in flaxseeds, which can be metabolized into estrogen-like compounds in the body. Elevated levels of estrogen have been linked to an increased risk of prostate cancer in some studies.\nAnother study published in the journal Cancer Epidemiology, Biomarkers & Prevention found that men who consumed the highest amounts of flaxseeds had a higher risk of high-grade prostate cancer compared to men who consumed lower amounts. High-grade prostate cancer is a more aggressive form of the disease.\nIt's important to note that these studies were conducted in animal models and in human populations, and the evidence is not yet conclusive. More research is needed to fully understand the potential effects of flaxseeds on prostate cancer risk.\nIf you are concerned about the potential risks of flaxseeds and prostate cancer, you may want to consider the following:\n1. Consult with a healthcare professional: If you have a history of prostate cancer or are at high risk for the disease, you may want to consult with a healthcare professional before consuming flaxseeds. They can help you weigh the potential benefits and risks and make an informed decision.\n2. Start with small amounts: If you do decide to consume flaxseeds, start with small amounts (about 1-2 tablespoons per day) and monitor your body's response. Gradually increase the amount if you tolerate it well.\n3. Consider alternative sources of omega-3 fatty acids: While flaxseeds are a rich source of omega-3 fatty acids, there are other sources that may be less likely to increase prostate",
    "llama-2-7b-chat-hf_fact": [
      "Flaxseeds are a source of omega-3 fatty acids, fiber, and other nutrients.",
      "A study in the Journal of Nutrition found that mice fed a diet with flaxseeds had increased levels of prostate cancer.",
      "Lignans in flaxseeds can be metabolized into estrogen-like compounds in the body.",
      "Another study in Cancer Epidemiology, Biomarkers & Prevention found that men who consumed the highest amounts of flaxseeds had a higher risk of high-grade prostate cancer.",
      "High-grade prostate cancer is a more aggressive form of the disease."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Various studies, including one in the Journal of Nutrition, found that diet with flaxseeds could potentially reduce the risk of prostate cancer.",
      "true",
      "false, [corrected fact]: Studies, including one in Cancer Epidemiology, Biomarkers & Prevention, suggest that men who consumed greater amounts of flaxseeds might have a lower risk of developing prostate cancer.",
      "true"
    ]
  },
  {
    "id": 4452,
    "user_query": "viral food poisoning from pesticides ?",
    "llama-2-7b-chat-hf_response": "Pesticides are chemicals used to control pests, including insects, rodents, and weeds. While they can be effective in protecting crops, they can also have negative effects on human health, including the potential to cause viral food poisoning.\nViral food poisoning occurs when a person ingests food or water that has been contaminated with a virus. This can happen through a variety of means, including:\n1. Contaminated produce: Pesticides can be used on produce to control pests, but they can also contaminate the produce. If the produce is not properly washed or handled, the pesticides can remain on the produce and cause illness.\n2. Contaminated water: Pesticides can also contaminate water sources, including wells and rivers. If a person drinks contaminated water, they can become ill with a viral infection.\n3. Contaminated food products: Pesticides can also be used in food products, such as meats and dairy products. If these products are not properly handled or stored, the pesticides can contaminate the food and cause illness.\nThe symptoms of viral food poisoning from pesticides can vary depending on the type of virus and the individual affected. Common symptoms include:\n1. Nausea and vomiting\n2. Diarrhea\n3. Abdominal cramps\n4. Fever\n5. Headache\n6. Fatigue\n7. Muscle weakness\nIn severe cases, viral food poisoning from pesticides can lead to more serious complications, including:\n1. Dehydration\n2. Electrolyte imbalances\n3. Kidney damage\n4. Liver damage\n5. Respiratory failure\nTo reduce the risk of viral food poisoning from pesticides, it is important to take the following precautions:\n1. Buy organic produce: Organic produce is grown without the use of pesticides, reducing the risk of contamination.\n2. Wash produce thoroughly: Washing produce thoroughly can help remove any pesticides that may be present.\n3. Use filtered water: Using filtered water can help reduce the risk of contamination from pesticides in water sources.\n4. Avoid cross-contamination: Cross-",
    "llama-2-7b-chat-hf_fact": [
      "Pesticides are chemicals used to control pests, including insects, rodents, and weeds.",
      "Viral food poisoning occurs when a person ingests food or water that has been contaminated with a virus.",
      "Pesticides used in agriculture can contaminate produce if not properly washed or handled.",
      "Pesticides can also contaminate water sources, causing illness if consumed by a person.",
      "Symptoms of viral food poisoning from pesticides can vary and common symptoms include nausea, vomiting, diarrhea, abdominal cramps, fever, headache, fatigue, and muscle weakness."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Symptoms mentioned are common for viral food poisoning, not specifically from pesticides. Pesticides can cause these symptoms, but they are not exclusively associated with them."
    ]
  },
  {
    "id": 4455,
    "user_query": "are neurotoxins only present in blue-green algae ?",
    "llama-2-7b-chat-hf_response": "No, neurotoxins are not only present in blue-green algae. Neurotoxins can be found in a variety of organisms, including:\n1. Cyanobacteria: Like blue-green algae, cyanobacteria are also photosynthetic bacteria that can produce neurotoxins. In fact, some of the most well-known neurotoxins, such as saxitoxin and brevetoxin, are produced by cyanobacteria.\n2. Fungi: Some species of fungi, such as the mushroom Amanita muscaria, can produce neurotoxins. These toxins can cause a range of symptoms, including muscle weakness, confusion, and hallucinations.\n3. Insects: Some insects, such as certain species of ants and bees, can produce neurotoxins. For example, the venom of the bullet ant (Paraponera clavata) contains a neurotoxin that can cause intense pain and muscle spasms.\n4. Jellyfish: Jellyfish are known to produce a variety of neurotoxins, including stinging cells called nematocysts. These toxins can cause pain, numbness, and muscle paralysis in humans.\n5. Plants: While not as well-known as neurotoxins produced by animals, some plants can also produce compounds that can affect the nervous system. For example, the poisonous hemlock plant (Conium maculatum) contains a neurotoxin called coniine that can cause muscle weakness, paralysis, and respiratory failure.\nIt's worth noting that the term \"neurotoxin\" can be somewhat misleading, as it implies that the toxin only affects the nervous system. In reality, many neurotoxins can have a wide range of effects on the body, including muscle weakness, respiratory problems, and even death.",
    "llama-2-7b-chat-hf_fact": [
      "Neurotoxins are found in more organisms than just blue-green algae.",
      "Cyanobacteria, similar to blue-green algae, produce well-known neurotoxins like saxitoxin and brevetoxin.",
      "Some species of fungi, like Amanita muscaria, can produce neurotoxins.",
      "Insects, such as certain ants and bees, can also produce neurotoxins, including the venom of the bullet ant.",
      "Jellyfish produce a variety of neurotoxins, including stinging cells called nematocysts.",
      "The poisonous hemlock plant contains a neurotoxin called coniine."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4458,
    "user_query": "what about gurmar , jamun , bitter melon , and fenugreek ?",
    "llama-2-7b-chat-hf_response": "Comment: Thank you for your question! Gurmar, jamun, bitter melon, and fenugreek are all plants that have been used in traditional medicine for various purposes. Here are some of their potential health benefits:\n1. Gurmar (Gymnema sylvestre): Gurmar is a plant that has been used in traditional medicine for centuries to control blood sugar levels and improve insulin sensitivity. Some studies have shown that gurmar can help reduce blood sugar levels and improve glucose tolerance in people with type 2 diabetes.\n2. Jamun (Syzygium cumini): Jamun is a fruit that has been used in traditional medicine to treat various conditions, including diabetes, digestive problems, and respiratory issues. Some studies have shown that jamun can help reduce blood sugar levels and improve insulin sensitivity in people with type 2 diabetes.\n3. Bitter melon (Momordica charantia): Bitter melon is a plant that has been used in traditional medicine for centuries to treat various conditions, including diabetes, digestive problems, and respiratory issues. Some studies have shown that bitter melon can help reduce blood sugar levels and improve insulin sensitivity in people with type 2 diabetes.\n4. Fenugreek (Trigonella foenum-graecum): Fenugreek is a plant that has been used in traditional medicine for centuries to treat various conditions, including diabetes, digestive problems, and respiratory issues. Some studies have shown that fenugreek can help reduce blood sugar levels and improve insulin sensitivity in people with type 2 diabetes.\nIt's important to note that while these plants may have potential health benefits, they should not be used as a replacement for conventional diabetes treatment. It's always best to consult with a healthcare professional before using any herbal remedies.",
    "llama-2-7b-chat-hf_fact": [
      "Gurmar (Gymnema sylvestre) has been traditionally used to control blood sugar levels and improve insulin sensitivity.",
      "Some studies suggest that Gurmar might help improve glucose tolerance in people with type 2 diabetes.",
      "Jamun (Syzygium cumini) has been used in traditional medicine to treat various conditions such as diabetes, digestive problems, and respiratory issues.",
      "Bitter melon (Momordica charantia) and Fenugreek (Trigonella foenum-graecum) have been used in traditional medicine for conditions including diabetes.",
      "Some studies suggest that bitter melon, fenugreek, and jamun may help reduce blood sugar levels and improve insulin sensitivity in people with type 2 diabetes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4462,
    "user_query": "my skin is turning orange ( carotenoderma ) --too many carrots ?",
    "llama-2-7b-chat-hf_response": "Carotenoderma is a condition where the skin takes on an orange hue due to an excessive intake of beta-carotene, which is found in foods such as carrots, sweet potatoes, and leafy greens. This condition is usually temporary and reversible, but in rare cases, it can be a sign of an underlying medical condition.\nCauses of Carotenoderma:\n1. Excessive intake of beta-carotene: The most common cause of carotenoderma is consuming too many foods that are high in beta-carotene, such as carrots, sweet potatoes, and leafy greens.\n2. Vitamin A toxicity: Taking too much vitamin A can also cause carotenoderma. Vitamin A is a fat-soluble vitamin that can accumulate in the body and cause toxicity if taken in excessive amounts.\n3. Certain medications: Some medications, such as isotretinoin, can cause carotenoderma as a side effect.\n4. Genetic disorders: In rare cases, carotenoderma can be a sign of an underlying genetic disorder, such as erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP).\nSymptoms of Carotenoderma:\n1. Orange discoloration of the skin: The most obvious symptom of carotenoderma is an orange discoloration of the skin, particularly on the palms of the hands and soles of the feet.\n2. Itching: Some people with carotenoderma may experience itching or burning sensations on the skin.\n3. Skin thickening: In some cases, carotenoderma can cause the skin to thicken, leading to a leathery texture.\n4. Blistering: In rare cases, carotenoderma can cause blistering or peeling of the skin.\nTreatment of Carotenoderma:\n1. Stopping the offending food: If carotenoderma is caused by an excessive intake of beta-carotene, the best course of action is to stop consuming foods that are high in beta-carotene until the condition resolves.\n2. Vitamin A supp",
    "llama-2-7b-chat-hf_fact": [
      "Carotenoderma is a condition causing an orange hue to the skin due to excessive intake of beta-carotene.",
      "Foods high in beta-carotene include carrots, sweet potatoes, and leafy greens.",
      "In rare instances, Carotenoderma can signify an underlying genetic disorder, such as erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP).",
      "Symptoms of Carotenoderma may include orange discoloration of the skin, itching, skin thickening, and in rare cases, blistering or peeling of the skin.",
      "To treat carotenoderma caused by an excessive intake of beta-carotene, one should stop consuming foods high in beta-carotene until the condition resolves."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Carotenoderma does not signify an underlying genetic disorder, such as erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP). It is typically a benign, self-reversible condition associated with chronic or excessive consumption of carotenoid-rich food.",
      "false, [corrected fact]: Symptoms of Carotenoderma mainly include an orange discoloration of the skin, making palms, soles, knees, and nasolabial folds more noticeably colored. Itching, skin thickening, blistering or peeling of the skin are not typically symptoms of this condition.",
      "true"
    ]
  },
  {
    "id": 4463,
    "user_query": "does caffeine impair endothelial function in our arteries ?",
    "llama-2-7b-chat-hf_response": "Caffeine is a widely consumed stimulant that can have both positive and negative effects on the body. While caffeine can improve alertness and cognitive function, it can also impair endothelial function in our arteries.\nEndothelial function refers to the ability of the inner lining of our blood vessels, known as the endothelium, to regulate blood flow, blood pressure, and inflammation. The endothelium plays a crucial role in maintaining the health of our arteries by producing nitric oxide, a molecule that helps to relax and dilate blood vessels, improving blood flow and reducing blood pressure.\nResearch has shown that caffeine can impair endothelial function by reducing the production of nitric oxide in the endothelium. This can lead to decreased blood flow, increased blood pressure, and increased risk of cardiovascular disease.\nOne study published in the Journal of the American College of Cardiology found that caffeine consumption was associated with reduced endothelial-dependent vasodilation in healthy adults. Another study published in the European Journal of Clinical Nutrition found that caffeine consumption was associated with decreased nitric oxide production in the endothelium.\nHowever, it's important to note that the impact of caffeine on endothelial function can vary depending on the individual and the amount of caffeine consumed. Moderate caffeine consumption, defined as up to 400 milligrams per day, is generally considered safe for most adults. However, excessive caffeine consumption, defined as more than 400 milligrams per day, may have negative effects on endothelial function and overall cardiovascular health.\nIn conclusion, caffeine can impair endothelial function in our arteries by reducing the production of nitric oxide in the endothelium. While moderate caffeine consumption is generally considered safe, excessive consumption may have negative effects on cardiovascular health. It's important to be mindful of caffeine intake and to consult with a healthcare professional if you have concerns about its impact on your endothelial function or overall health.",
    "llama-2-7b-chat-hf_fact": [
      "Caffeine is a widely consumed stimulant that can both improve alertness and cognitive function and impair endothelial function in our arteries.",
      "Endothelial function refers to the ability of the inner lining of our blood vessels, the endothelium, to regulate blood flow, blood pressure, and inflammation.",
      "The endothelium produces nitric oxide which aids in relaxing and dilating blood vessels, improving blood flow and reducing blood pressure.",
      "Studies have associated caffeine consumption with reduced endothelial-dependent vasodilation in healthy adults and decreased nitric oxide production in the endothelium.",
      "Moderate caffeine consumption, defined as up to 400 milligrams per day, is generally regarded as safe for most adults, while excessive caffeine consumption, more than 400 milligrams per day, may have negative effects on endothelial function and overall cardiovascular health."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4464,
    "user_query": "what about the oxalic acid in beets ?",
    "llama-2-7b-chat-hf_response": "Beets contain a compound called oxalic acid, which can bind to minerals like calcium, magnesium, and iron, making them less available for absorption. This can be a concern for people with mineral deficiencies or those who have difficulty absorbing these minerals.\nHowever, it's worth noting that the oxalic acid in beets is not necessarily a bad thing. Beets are also a good source of fiber, vitamins, and antioxidants, and the oxalic acid can help to protect these nutrients from being broken down in the digestive system.\nIf you have a mineral deficiency or are concerned about the oxalic acid in beets, there are a few things you can do:\n1. Cook beets thoroughly: Cooking beets can help to break down some of the oxalic acid, making the minerals more available for absorption.\n2. Soak beets: Soaking beets in water can help to break down some of the oxalic acid, making the minerals more available for absorption.\n3. Eat beets in moderation: If you have a mineral deficiency or are concerned about the oxalic acid in beets, it's a good idea to eat beets in moderation. You can still enjoy beets as part of a balanced diet, but don't rely on them as your primary source of minerals.\n4. Consider supplements: If you have a mineral deficiency or are concerned about the oxalic acid in beets, you may want to consider taking a mineral supplement. This can help to ensure that you are getting enough of the minerals you need, without the potential negative effects of the oxalic acid.\nIn summary, while beets do contain oxalic acid, which can bind to minerals and make them less available for absorption, they are also a good source of fiber, vitamins, and antioxidants. If you have a mineral deficiency or are concerned about the oxalic acid in beets, there are a few things you can do to minimize the potential negative effects.",
    "llama-2-7b-chat-hf_fact": [
      "Beets contain a compound called oxalic acid, which can bind to minerals like calcium, magnesium, and iron.",
      "Oxalic acid in beets can make these minerals less available for absorption.",
      "Oxalic acid in beets can help protect nutrients like fiber, vitamins, and antioxidants, from being broken down in the digestive system.",
      "Cooking or soaking beets can help break down some of the oxalic acid, making minerals more available for absorption.",
      "Beets are a good source of fiber, vitamins, and antioxidants."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Oxalic acid in beets does not help to protect nutrients like fiber, vitamins, and antioxidants from being broken down in the digestive system. Instead, it can interfere with the absorption of certain nutrients.",
      "true",
      "true"
    ]
  },
  {
    "id": 4466,
    "user_query": "what is the healthiest potato ?",
    "llama-2-7b-chat-hf_response": "The healthiest potato is the sweet potato. Sweet potatoes are rich in vitamins, minerals, and antioxidants, and are lower in calories and sugar than white potatoes. They are also higher in fiber and have a lower glycemic index, which means they are less likely to cause a spike in blood sugar levels.\nSome of the key nutrients found in sweet potatoes include:\n* Vitamin A: Sweet potatoes are a good source of vitamin A, which is important for healthy vision, immune function, and skin health.\n* Vitamin C: Sweet potatoes are a good source of vitamin C, which is important for immune function and overall health.\n* Fiber: Sweet potatoes are high in fiber, which can help promote digestive health and support healthy blood sugar levels.\n* Antioxidants: Sweet potatoes contain a variety of antioxidants, including beta-carotene, lutein, and zeaxanthin, which can help protect cells from damage and reduce the risk of chronic diseases such as heart disease and cancer.\n* Minerals: Sweet potatoes are a good source of minerals such as potassium, magnesium, and iron, which are important for maintaining healthy blood pressure, bone health, and immune function.\nSome of the key differences between sweet potatoes and white potatoes include:\n* Nutrient content: Sweet potatoes are higher in vitamins, minerals, and antioxidants than white potatoes.\n* Glycemic index: Sweet potatoes have a lower glycemic index than white potatoes, which means they are less likely to cause a spike in blood sugar levels.\n* Calories: Sweet potatoes are lower in calories than white potatoes, making them a better choice for those looking to manage their weight.\n* Sugar content: Sweet potatoes are lower in sugar than white potatoes, making them a better choice for those looking to reduce their sugar intake.\nOverall, sweet potatoes are considered the healthiest potato due to their higher nutrient content, lower glycemic index, and lower calorie and sugar content compared to white potatoes.",
    "llama-2-7b-chat-hf_fact": [
      "Sweet potatoes are rich in vitamins, minerals, and antioxidants and are lower in calories and sugar than white potatoes.",
      "Sweet potatoes have a lower glycemic index than white potatoes, meaning they are less likely to cause a spike in blood sugar levels.",
      "Sweet potatoes contain Vitamin A, which is important for healthy vision, immune function, and skin health.",
      "Sweet potatoes also contain Vitamin C, which is essential for immune function and overall health.",
      "Sweet potatoes are a good source of minerals such as potassium, magnesium, and iron, which are important for maintaining healthy blood pressure, bone health, and immune function."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4468,
    "user_query": "should we avoid canned tomatoes and non-organic root vegetables ?",
    "llama-2-7b-chat-hf_response": "Canned tomatoes and non-organic root vegetables may contain high levels of heavy metals, pesticides, and other toxins that can be harmful to your health. Here are some reasons why you may want to limit or avoid these foods:\nCanned Tomatoes:\n1. Heavy Metals: Canned tomatoes can contain high levels of heavy metals like lead, mercury, and cadmium, which can accumulate in the body over time and cause health problems.\n2. BPA Exposure: Many canned tomatoes are lined with a chemical called bisphenol A (BPA), which can leach into the food and cause hormonal imbalances and other health issues.\n3. Lack of Nutrients: Canned tomatoes are often stripped of their nutrients during the canning process, including vitamins, minerals, and antioxidants.\nNon-Organic Root Vegetables:\n1. Pesticide Residues: Non-organic root vegetables may contain high levels of pesticide residues, which can be harmful to your health.\n2. GMOs: Many non-organic root vegetables are genetically modified, which can cause unintended health effects.\n3. Lower Nutrient Content: Non-organic root vegetables may have lower levels of nutrients compared to organic varieties, including vitamins, minerals, and antioxidants.\nHowever, it's important to note that not all canned tomatoes and non-organic root vegetables are created equal. Look for options that are labeled as \"low-heavy metal\" or \"BPA-free,\" and choose non-GMO varieties whenever possible. Additionally, consider purchasing organic or locally grown options to minimize exposure to pesticides and other toxins.\nIn summary, while canned tomatoes and non-organic root vegetables may contain higher levels of toxins and lower levels of nutrients compared to their organic counterparts, it's not necessary to completely avoid them. By making informed choices and taking steps to minimize exposure to toxins, you can still enjoy these foods as part of a healthy diet.",
    "llama-2-7b-chat-hf_fact": [
      "Canned tomatoes can contain high levels of heavy metals such as lead, mercury, and cadmium.",
      "Many canned tomatoes are lined with a chemical called bisphenol A (BPA), which can cause hormonal imbalances and other health issues.",
      "The canning process can strip tomatoes of their nutrients, including vitamins, minerals, and antioxidants.",
      "Non-organic root vegetables may contain high levels of pesticide residues.",
      "Non-organic root vegetables may have lower levels of nutrients compared to organic varieties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "false, [corrected fact]: The canning process may decrease the levels of some vitamins in tomatoes but it also can increase the availability of others, like lycopene, an antioxidant.",
      "true",
      "true"
    ]
  },
  {
    "id": 4470,
    "user_query": "sulfite sensitivity from sulphur dioxide in dried fruits ?",
    "llama-2-7b-chat-hf_response": "Sulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits?\nSulfite sensitivity from sulphur dioxide in dried fruits",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4471,
    "user_query": "are multivitamins just a waste of money ?",
    "llama-2-7b-chat-hf_response": "Multivitamins are dietary supplements that contain a combination of vitamins, minerals, and other nutrients. They are marketed as a way to fill in any nutritional gaps in a person's diet, but some experts argue that they are not as effective as they are made out to be. Here are some reasons why some experts believe that multivitamins may be a waste of money:\n1. Most people don't need them: According to a study published in the Journal of the American Medical Association, the majority of healthy adults do not need to take a multivitamin. The study found that only about 10% of adults had a vitamin deficiency that could be improved by taking a multivitamin.\n2. They may not be absorbed properly: Even if you do need a particular vitamin or mineral, it may not be absorbed properly if you are taking it in a supplement form. The body has a complex system for absorbing nutrients from food, and this system may not be able to fully utilize the nutrients in a multivitamin.\n3. They can interact with medications: Multivitamins can interact with certain medications, such as blood thinners, and can increase the risk of bleeding. They can also interact with other supplements, such as St. John's Wort, and can reduce the effectiveness of certain medications.\n4. They may not be regulated: The supplement industry is not as heavily regulated as the pharmaceutical industry, which means that the quality and purity of multivitamins can vary widely. Some multivitamins may contain impurities or contaminants that can be harmful to your health.\n5. They can be expensive: Multivitamins can be expensive, especially if you are taking them regularly. According to a study published in the Journal of the American Board of Family Medicine, the cost of multivitamins can add up quickly, especially if you are taking them for an extended period of time.\nIn conclusion, while multivitamins may be marketed as a convenient way to ensure that you are getting all the nutrients you need, they may not be as effective as they are made out to be. Before taking a multivitamin,",
    "llama-2-7b-chat-hf_fact": [
      "Multivitamins are dietary supplements that contain a combination of vitamins, minerals, and other nutrients.",
      "Multivitamins can interact with medications, including blood thinners, and can increase the risk of bleeding.",
      "The supplement industry is not as heavily regulated as the pharmaceutical industry, suggesting the quality and purity of multivitamins can vary.",
      "A study from the Journal of the American Medical Association found that approximately just 10% of healthy adults have a vitamin deficiency that could be improved by taking a multivitamin.",
      "A study from the Journal of the American Board of Family Medicine highlighted the cost implications of taking multivitamins regularly over an extended period."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4473,
    "user_query": "what are the best sources of vitamin k ?",
    "llama-2-7b-chat-hf_response": "Vitamin K is an essential nutrient that plays a role in blood clotting, bone health, and heart health. Here are some of the best sources of vitamin K:\n1. Leafy green vegetables: These include foods like spinach, kale, collard greens, and broccoli. These vegetables are some of the richest sources of vitamin K.\n2. Fermented foods: Fermented foods like sauerkraut, kimchi, and miso contain vitamin K.\n3. Fatty fish: Fatty fish like salmon, mackerel, and sardines are good sources of vitamin K.\n4. Egg yolks: Egg yolks are a good source of vitamin K.\n5. Grass-fed beef: Grass-fed beef is a good source of vitamin K.\n6. Natto: Natto is a fermented soybean dish that is high in vitamin K.\n7. Chicken liver: Chicken liver is a good source of vitamin K.\n8. Brussels sprouts: Brussels sprouts are a cruciferous vegetable that is high in vitamin K.\n9. Cabbage: Cabbage is a cruciferous vegetable that is high in vitamin K.\n10. Avocado: Avocados are a good source of vitamin K.\nIt's important to note that vitamin K is a fat-soluble vitamin, so it's best absorbed when consumed with a source of fat. Also, some antibiotics and cholesterol-lowering medications can interfere with vitamin K absorption, so it's important to speak with a healthcare provider before taking any supplements.",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin K is an essential nutrient involved in blood clotting, bone health, and heart health.",
      "Leafy green vegetables, such as spinach, kale, and broccoli, are rich sources of vitamin K.",
      "Fermented foods like sauerkraut, miso, and natto are sources of vitamin K.",
      "Fatty fishes like salmon and mackerel, and egg yolks, are good sources of vitamin K.",
      "Grass-fed beef, chicken liver, brussels sprouts, cabbage and avocado are also sources of vitamin K."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Fatty fishes like salmon and mackerel, and egg yolks, are good sources of vitamin D, not K.",
      "true"
    ]
  },
  {
    "id": 4477,
    "user_query": "is raw milk healthy ?",
    "llama-2-7b-chat-hf_response": "Raw milk is a type of milk that has not been pasteurized or homogenized, meaning that it has not been heated to a high temperature to kill bacteria and extend its shelf life. Proponents of raw milk argue that it contains more nutrients and beneficial bacteria than pasteurized milk, while opponents argue that it can pose a risk of foodborne illness.\nHere are some potential health benefits of raw milk:\n1. Nutrient content: Raw milk contains more nutrients, such as vitamins, minerals, and fatty acids, than pasteurized milk. These nutrients can include:\n* Calcium: Raw milk contains more calcium than pasteurized milk.\n* Vitamin B12: Raw milk is a better source of vitamin B12 than pasteurized milk.\n* Conjugated linoleic acid (CLA): Raw milk contains more CLA than pasteurized milk.\n* Omega-3 fatty acids: Raw milk contains more omega-3 fatty acids than pasteurized milk.\n2. Beneficial bacteria: Raw milk contains beneficial bacteria, such as Lactobacillus and Bifidobacterium, which can help support gut health.\n3. Immune system support: Raw milk contains immunoglobulins, which are proteins that can help support the immune system.\n4. Anti-inflammatory effects: Raw milk has been shown to have anti-inflammatory effects, which may help reduce the risk of chronic diseases such as heart disease and cancer.\n5. Better taste: Many people prefer the taste of raw milk to pasteurized milk.\nHowever, there are also potential risks associated with consuming raw milk, including:\n1. Foodborne illness: Raw milk can pose a risk of foodborne illness, as it can contain harmful bacteria such as E. coli and Salmonella.\n2. Allergies and intolerances: Some people may be allergic or intolerant to the proteins in raw milk, which can cause symptoms such as digestive problems and skin rashes.\n3. Risk of contamination: Raw milk can be contaminated with harmful bacteria",
    "llama-2-7b-chat-hf_fact": [
      "Raw milk is a type of milk that has not been pasteurized or homogenized.",
      "Raw milk reportedly contains more nutrients, such as vitamins, minerals, and fatty acids, than pasteurized milk.",
      "Raw milk contains beneficial bacteria, such as Lactobacillus and Bifidobacterium, which can help support gut health.",
      "Consumption of raw milk can pose a risk of foodborne illness, as it can contain harmful bacteria such as E. coli and Salmonella.",
      "Some people may be allergic or intolerant to the proteins in raw milk, causing symptoms such as digestive problems and skin rashes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4479,
    "user_query": "is the new vitamin d3 spray a waste of money ?",
    "llama-2-7b-chat-hf_response": "Vitamin D3 is an essential nutrient that plays a role in maintaining strong bones, immune function, and overall health. While some people may benefit from taking vitamin D3 supplements, others may not experience any noticeable benefits or may even experience negative side effects.\nHere are some reasons why taking vitamin D3 supplements may be a waste of money:\n1. You're not deficient: If you're not deficient in vitamin D, taking supplements won't provide any benefits. Vitamin D deficiency is relatively rare in healthy adults, and most people get enough vitamin D from their diet and sun exposure.\n2. You're getting enough from your diet: If you're eating a balanced diet that includes foods rich in vitamin D, such as fatty fish, egg yolks, and fortified dairy products, you may not need to take supplements.\n3. You're experiencing negative side effects: Some people may experience negative side effects from taking vitamin D supplements, such as nausea, vomiting, and kidney problems. If you're experiencing these side effects, it may be a sign that you're taking too much vitamin D.\n4. You're not absorbing the supplement: If you're not absorbing the vitamin D from your supplements, they may not be providing any benefits. Factors that can affect absorption include age, kidney function, and the type of supplement you're taking.\n5. You're not following the recommended dosage: Taking too much vitamin D can be harmful, so it's important to follow the recommended dosage on the supplement label. Taking more than 4,000 IU of vitamin D per day may increase the risk of side effects.\n6. You're not monitoring your vitamin D levels: If you're not monitoring your vitamin D levels, you may not know if you're deficient or if your supplements are working. Having your vitamin D levels checked by a healthcare provider can help you determine if you need to adjust your supplement dosage.\n7. You're taking other supplements that provide similar benefits: If you're taking other supplements that provide similar",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin D3 plays a role in maintaining strong bones, immune function, and overall health.",
      "Vitamin D deficiency is relatively rare in healthy adults, with most people receiving enough vitamin D from their diet and sun exposure.",
      "Some people may experience negative side effects from taking vitamin D supplements, such as nausea, vomiting, and kidney problems.",
      "The absorption of vitamin D from supplements can be influenced by factors like age, kidney function, and the type of supplement taken.",
      "Taking more than 4,000 IU of vitamin D per day may increase the risk of side effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Vitamin D deficiency is increasingly common in adults, with many people failing to receive enough vitamin D from their diet and sun exposure alone.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4481,
    "user_query": "how can i preserve the anti-cancer effects of cooked garlic ?",
    "llama-2-7b-chat-hf_response": "Cooked garlic has been shown to have anti-cancer properties, but its effectiveness can be reduced over time due to the degradation of its bioactive compounds. Here are some ways to preserve the anti-cancer effects of cooked garlic:\n1. Refrigerate or freeze it: Cooked garlic can be stored in the refrigerator for up to 3 days or frozen for up to 6 months. This will slow down the degradation of its bioactive compounds, allowing you to enjoy its anti-cancer benefits for a longer period.\n2. Use it fresh: If you plan to use cooked garlic within a day or two, it's best to use it fresh. This will ensure that its bioactive compounds are at their peak and most effective.\n3. Make a garlic paste: Mixing cooked garlic with other ingredients, such as olive oil, lemon juice, or vinegar, can help preserve its anti-cancer properties. This can be stored in an airtight container in the refrigerator for up to a week.\n4. Take supplements: If you want to enjoy the anti-cancer benefits of cooked garlic for a longer period, you can take supplements. Look for supplements that contain allicin, the bioactive compound responsible for garlic's anti-cancer properties.\n5. Use it in cooking: Cooked garlic can be used in a variety of dishes, such as soups, stews, and stir-fries. This will help to distribute its anti-cancer compounds throughout the dish, making it more effective.\n6. Add it to sauces and marinades: Mixing cooked garlic with sauces and marinades can help to preserve its anti-cancer properties. This can be stored in an airtight container in the refrigerator for up to a week.\n7. Use it in baked goods: Cooked garlic can be used in baked goods, such as bread, muffins, and cakes. This can help to distribute its anti-cancer compounds throughout the dish, making it more effective.\n8. Make a garlic-based tea: Cooked garlic can be made into a tea by steeping it in hot",
    "llama-2-7b-chat-hf_fact": [
      "Cooked garlic is known for its anti-cancer properties.",
      "Cooked garlic can be stored in the refrigerator for up to 3 days or frozen for up to 6 months.",
      "Making a garlic paste with cooked garlic and other ingredients and storing it in an airtight container in the fridge can help preserve its anti-cancer properties for up to a week.",
      "Using cooked garlic in cooking recipes can help distribute its anti-cancer compounds throughout the dish.",
      "Allicin is the bioactive compound in garlic responsible for its anti-cancer properties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4482,
    "user_query": "given the  brain-eating amoeba  ( naegleria fowleri ) in tap water should i sterilize my neti pot water ?",
    "llama-2-7b-chat-hf_response": "Yes, it is recommended to sterilize your neti pot water to prevent the growth of Naegleria fowleri, the brain-eating amoeba. Naegleria fowleri is a free-living amoeba that can be found in freshwater environments, including tap water.\nWhile the risk of infection from Naegleria fowleri in tap water is low, it is still important to take precautions to minimize your exposure. Sterilizing your neti pot water is a simple and effective way to reduce the risk of infection.\nHere are some tips for sterilizing your neti pot water:\n1. Use distilled or sterile water: Use distilled or sterile water to fill your neti pot, as this will reduce the risk of contamination.\n2. Boil the water: Boil the water for 5-10 minutes to kill any Naegleria fowleri amoebae that may be present.\n3. Use a sterilizing solution: Mix 1/4 teaspoon of unscented household bleach with 8 ounces of water and use it to sterilize your neti pot. Let the solution sit in the pot for 5-10 minutes before rinsing it out with clean water.\n4. Use a microwave sterilizer: You can also use a microwave sterilizer to kill any Naegleria fowleri amoebae in your neti pot water. Follow the manufacturer's instructions for using the sterilizer.\n5. Replace your neti pot regularly: If you use your neti pot frequently, consider replacing it every 3-6 months to reduce the risk of infection.\nBy following these tips, you can help ensure that your neti pot water is safe and free from Naegleria fowleri.",
    "llama-2-7b-chat-hf_fact": [
      "Sterilizing neti pot water can help prevent the growth of Naegleria fowleri, commonly known as the brain-eating amoeba.",
      "Naegleria fowleri is a free-living amoeba found in freshwater environments, including tap water.",
      "The risk of infection from Naegleria fowleri in tap water is low, but sterilizing neti pot water can further minimize exposure.",
      "Tips for sterilizing neti pot water include using distilled or sterile water and boiling the water for 5-10 minutes.",
      "It's suggested to replace a frequently used neti pot every 3-6 months to reduce the risk of infection."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4483,
    "user_query": "does adding baking soda to soaking beans reduce gas ?",
    "llama-2-7b-chat-hf_response": "Adding baking soda to soaking beans can help reduce gas in several ways:\n1. Neutralizes acidic environment: Baking soda (sodium bicarbonate) is a base that can neutralize the acidic environment in the digestive system, which can help reduce gas and bloating.\n2. Increases digestive enzymes: Baking soda can increase the production of digestive enzymes in the gut, which can help break down proteins and carbohydrates more efficiently, reducing the amount of undigested material that can lead to gas.\n3. Reduces pH: Baking soda can help reduce the pH of the digestive system, making it more alkaline. This can help reduce gas and bloating by creating an environment that is less favorable for the growth of gas-producing bacteria.\n4. Inhibits gas-producing bacteria: Baking soda can inhibit the growth of gas-producing bacteria in the digestive system, such as Streptococcus and Lactobacillus, which can help reduce gas and bloating.\n5. Improves gut health: Baking soda can help improve gut health by reducing inflammation and promoting the growth of beneficial gut bacteria, which can help reduce gas and bloating.\nIt's important to note that while adding baking soda to soaking beans can help reduce gas, it's not a foolproof solution. Other factors, such as the type of bean, cooking method, and individual tolerance, can also play a role in gas production. Additionally, excessive consumption of baking soda can have negative health effects, so it's important to consume it in moderation.",
    "llama-2-7b-chat-hf_fact": [
      "Baking soda, or sodium bicarbonate, is a base that can neutralize acidity.",
      "Baking soda can increase the production of digestive enzymes in the gut.",
      "Baking soda can reduce the pH of the digestive system, making it more alkaline.",
      "Baking soda can inhibit the growth of gas-producing bacteria in the digestive system, such as Streptococcus and Lactobacillus.",
      "Excessive consumption of baking soda can lead to negative health effects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Baking soda can increase the pH of the digestive system, making it more alkaline.",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4487,
    "user_query": "can vitamin d supplements help prevent respiratory infections ?",
    "llama-2-7b-chat-hf_response": "Vitamin D is an essential nutrient that plays a role in maintaining overall health, including the immune system. Some research suggests that vitamin D supplements may help prevent respiratory infections, such as the common cold and flu.\nOne study published in the Journal of Clinical Immunology found that vitamin D supplementation reduced the incidence of respiratory infections in healthy adults during the winter months. Another study published in the American Journal of Respiratory and Critical Care Medicine found that vitamin D supplementation reduced the severity of respiratory infections in children with asthma.\nThe exact mechanisms by which vitamin D may help prevent respiratory infections are not fully understood, but it is thought that vitamin D may help to regulate the immune system and reduce inflammation. Vitamin D also helps to maintain the health of the mucous membranes in the respiratory tract, which can help to prevent infections from entering the body.\nIt's important to note that while some studies suggest that vitamin D supplements may help prevent respiratory infections, more research is needed to confirm these findings. Additionally, it's important to talk to a healthcare provider before starting any new supplements, as they can interact with other medications or have side effects in certain individuals.\nIn summary, while the evidence is not yet conclusive, some studies suggest that vitamin D supplements may help prevent respiratory infections. If you're considering taking vitamin D supplements, talk to a healthcare provider to discuss the potential benefits and risks and to determine the appropriate dosage for you.",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin D is an essential nutrient that contributes to the maintenance of overall health and the immune system.",
      "Some research suggests that vitamin D supplements may help prevent respiratory infections including cold and flu.",
      "One study in the Journal of Clinical Immunology found that vitamin D supplementation reduced the incidence of respiratory infections in healthy adults during winter.",
      "Another study in the American Journal of Respiratory and Critical Care Medicine found that vitamin D supplementation reduced the severity of respiratory infections in children with asthma.",
      "Vitamin D helps to maintain the health of mucous membranes in the respiratory tract which could help to prevent infections."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4489,
    "user_query": "what about getting gas from beans ?",
    "llama-2-7b-chat-hf_response": "Gas can be produced from beans through a process called gasification. Gasification is a thermochemical process that converts organic materials, such as beans, into a mixture of gases, including carbon monoxide, hydrogen, and methane. The gasification process involves heating the beans in the absence of air to produce a gas that can be used as a fuel.\nThere are several ways to gasify beans, including:\n1. Pyrolysis: This involves heating the beans in a pyrolysis reactor to produce a gas that can be used as a fuel.\n2. Gasification: This involves heating the beans in a gasification reactor to produce a gas that can be used as a fuel.\n3. Anaerobic digestion: This involves heating the beans in an anaerobic digester to produce biogas, which is a mixture of methane and carbon dioxide.\n4. Fermentation: This involves heating the beans in a fermentation tank to produce biogas, which is a mixture of methane and carbon dioxide.\n5. Plasma gasification: This involves heating the beans in a plasma reactor to produce a gas that can be used as a fuel.\n6. Torrefaction: This involves heating the beans in a torrefaction reactor to produce a gas that can be used as a fuel.\n7. Fast pyrolysis: This involves heating the beans in a fast pyrolysis reactor to produce a gas that can be used as a fuel.\n8. Slow pyrolysis: This involves heating the beans in a slow pyrolysis reactor to produce a gas that can be used as a fuel.\n9. Bio-oil: This involves heating the beans in a bio-oil reactor to produce a liquid fuel that can be used as a substitute for fossil fuels.\n10. Biogas: This involves heating the beans in a biogas reactor to produce a mixture of methane and carbon dioxide that can be used as a fuel.\nIt is important to note that the specific process used to gasify beans will depend on the type of beans being used, as well as the",
    "llama-2-7b-chat-hf_fact": [
      "Gas can be produced from beans through a process called gasification.",
      "Gasification is a thermochemical process that converts organic materials into a mixture of gases including carbon monoxide, hydrogen, and methane.",
      "Pyrolysis is a method of gasification which involves heating the beans in a pyrolysis reactor to produce gas as fuel.",
      "Anaerobic digestion is another method of gasification where beans are heated in an anaerobic digester to produce a mixture of methane and carbon dioxide.",
      "Bio-oil is a method of gasification where beans are heated in a bio-oil reactor to produce a liquid fuel that can act as a substitute for fossil fuels."
    ],
    "llama-2-7b-chat-hf_judge": [
      "false, [corrected fact]: Gas can be produced from beans through a process called fermentation, not gasification.",
      "true",
      "false, [corrected fact]: Pyrolysis is a thermochemical process that converts organic materials into charcoal, gas, and bio-oil through high temperature heating in the absence of oxygen. It's not specifically associated with beans.",
      "false, [corrected fact]: Anaerobic digestion is a biochemical process where microorganisms break down organic materials in the absence of oxygen to produce a mixture of gases including methane and carbon dioxide, not a method of gasification.",
      "false, [corrected fact]: Bio-oil is a product of a process called pyrolysis, not a method itself. During pyrolysis, biomass like wood chips, not beans, are rapidly heated in the absence of oxygen to produce bio-oil, gas, and biochar."
    ]
  },
  {
    "id": 4493,
    "user_query": "where does the fat come from in a skinless chicken breast ?",
    "llama-2-7b-chat-hf_response": "A skinless chicken breast is a lean protein that contains very little fat. According to the United States Department of Agriculture (USDA), a 3-ounce serving of boneless, skinless chicken breast contains approximately 3 grams of fat.",
    "llama-2-7b-chat-hf_fact": [
      "A skinless chicken breast is a lean protein that contains very little fat.",
      "The United States Department of Agriculture (USDA) provides information about the chicken breast's fat content.",
      "A 3-ounce serving of boneless, skinless chicken breast contains approximately 3 grams of fat according to USDA."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: A 3-ounce serving of boneless, skinless chicken breast contains approximately 2.5 grams of fat according to USDA."
    ]
  },
  {
    "id": 4494,
    "user_query": "what is the recommended child requirement for vitamin d ?",
    "llama-2-7b-chat-hf_response": "The recommended dietary allowance (RDA) for vitamin D varies by age:\n* Infants 0-12 months: 400 IU (International Units) per day\n* Children 1-18 years: 600 IU per day\n* Adults 19-70 years: 600 IU per day\n* Adults 71 years and older: 800 IU per day\nIt's worth noting that some organizations, such as the Institute of Medicine (now known as the National Academy of Medicine), recommend higher levels of vitamin D for children and adolescents than the RDA. For example, they recommend 600-1000 IU per day for children 1-18 years, and 1000-2000 IU per day for adolescents 14-18 years.\nIt's also important to note that excessive intake of vitamin D can be harmful, so it's important to consult with a healthcare professional to determine the appropriate dosage for your child.",
    "llama-2-7b-chat-hf_fact": [
      "The recommended dietary allowance (RDA) for vitamin D for infants 0-12 months is 400 IU per day.",
      "The RDA for vitamin D for children 1-18 years is 600 IU per day.",
      "Adults 19-70 years are recommended to intake 600 IU of Vitamin D per day.",
      "Adults 71 years and older should intake 800 IU of Vitamin D per day.",
      "Excessive intake of vitamin D can be harmful."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4495,
    "user_query": "what is the definition of a \" handful \" serving of nuts ?",
    "llama-2-7b-chat-hf_response": "Answer: The definition of a \"handful\" serving of nuts can vary depending on the source, but here are some general guidelines:\nThe National Institutes of Health (NIH) recommends the following serving sizes for nuts:\n* Almonds: 1 ounce (28 grams) or about 1/4 cup\n* Cashews: 1 ounce (28 grams) or about 1/4 cup\n* Hazelnuts: 1 ounce (28 grams) or about 1/4 cup\n* Macadamia nuts: 1 ounce (28 grams) or about 1/4 cup\n* Peanuts: 1 ounce (28 grams) or about 1/4 cup\n* Pistachios: 1 ounce (28 grams) or about 1/4 cup\n* Walnuts: 1 ounce (28 grams) or about 1/4 cup\nSo, a \"handful\" of nuts is generally considered to be about 1/4 cup or 2-3 ounces (57-85 grams) of nuts. However, it's important to note that the serving size can vary depending on the individual and their nutritional needs, so it's always a good idea to consult with a healthcare professional or registered dietitian for personalized recommendations.",
    "llama-2-7b-chat-hf_fact": [
      "The National Institutes of Health (NIH) recommends a serving size of 1 ounce (28 grams) or about 1/4 cup for almonds, cashews, hazelnuts, macadamia nuts, peanuts, pistachios, and walnuts.",
      "A \"handful\" of nuts is generally considered to be about 1/4 cup or 2-3 ounces (57-85 grams) of nuts.",
      "The serving size of nuts can vary depending on the individual and their nutritional needs.",
      "It's recommended to consult with a healthcare professional or registered dietitian for personalized recommendations regarding serving sizes of nuts."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4511,
    "user_query": "can hot peppers ( capsaicin ) cause cancer ?",
    "llama-2-7b-chat-hf_response": "Capsaicin, the active ingredient in hot peppers, has been shown to have both anti-cancer and pro-cancer effects, depending on the type of cancer and the dose used.\nAnti-cancer effects:\n1. Inhibition of tumor growth: Capsaicin has been shown to inhibit the growth of various types of tumors, including breast, lung, and prostate cancer cells.\n2. Induction of apoptosis: Capsaicin can induce programmed cell death (apoptosis) in cancer cells, which can help to reduce the size of tumors.\n3. Inhibition of angiogenesis: Capsaicin can inhibit the formation of new blood vessels, which are necessary for the growth and spread of tumors.\nPro-cancer effects:\n1. Irritation and inflammation: Capsaicin can cause irritation and inflammation in the digestive tract, which can increase the risk of cancer.\n2. Oxidative stress: Capsaicin can increase the production of reactive oxygen species (ROS), which can damage cellular components and increase the risk of cancer.\n3. Interaction with chemotherapy: Capsaicin can interact with chemotherapy drugs, reducing their effectiveness and increasing the risk of cancer recurrence.\nIt is important to note that the anti-cancer effects of capsaicin are generally observed at high doses, while the pro-cancer effects are observed at lower doses. Therefore, it is important to consume hot peppers in moderation and to consult with a healthcare professional before using them as a cancer treatment.\nIn summary, while capsaicin has shown promise as an anti-cancer agent, it is important to be aware of its potential pro-cancer effects and to consume it in moderation. Further research is needed to fully understand the effects of capsaicin on cancer and to determine its potential as a cancer treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Capsaicin is the active ingredient in hot peppers.",
      "High doses of capsaicin have been shown to inhibit the growth of various types of tumors, including breast, lung, and prostate cancer cells.",
      "Capsaicin can induce programmed cell death (apoptosis) in cancer cells.",
      "Low doses of capsaicin can cause irritation and inflammation in the digestive tract, increasing the risk of cancer.",
      "Capsaicin can interact with chemotherapy drugs, potentially reducing their effectiveness and increasing the risk of cancer recurrence."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4513,
    "user_query": "is thermography better than mammograms for early breast cancer detection ?",
    "llama-2-7b-chat-hf_response": "Thermography is a non-invasive imaging technique that measures the temperature of the breast tissue. It has gained popularity as an alternative to mammography for early breast cancer detection. However, the scientific evidence on its effectiveness is mixed. Here are some points to consider:\nAdvantages of thermography:\n1. Non-invasive: Thermography does not require any compression or radiation, making it a more comfortable option for some women.\n2. Early detection: Thermography can detect temperature changes in the breast tissue up to 10 years before a mammogram can. This could potentially allow for earlier detection and treatment of breast cancer.\n3. Cost-effective: Thermography is generally less expensive than mammography, making it a more accessible option for some women.\nDisadvantages of thermography:\n1. Limited accuracy: Thermography is not as accurate as mammography in detecting breast cancer. Studies have shown that thermography has a lower sensitivity and specificity than mammography.\n2. Lack of standardization: There is currently no standardized protocol for thermography, which can make it difficult to interpret and compare results.\n3. Limited availability: Thermography is not widely available and may not be covered by insurance in all areas.\nAdvantages of mammography:\n1. High accuracy: Mammography is highly accurate in detecting breast cancer, with a sensitivity and specificity of around 80-90%.\n2. Standardized protocol: There is a standardized protocol for mammography, which ensures consistency and accuracy in the imaging process.\n3. Wide availability: Mammography is widely available and covered by insurance in most areas.\nDisadvantages of mammography:\n1. Invasive: Mammography requires compression of the breast tissue, which can be uncomfortable for some women.\n2. Radiation exposure: Mammography involves exposure to low levels of radiation, which may be a concern for some women.\n3. Cost: Mammography is generally more expensive than thermography.\nIn conclusion, while thermography has some advantages over mammography, the scientific evidence on its effectiveness is mixed. Mammography remains the gold standard for early breast cancer detection due to its high accuracy and wide availability.",
    "llama-2-7b-chat-hf_fact": [
      "Thermography is a non-invasive imaging technique that measures the temperature of breast tissue.",
      "Thermography can detect temperature changes in breast tissue up to 10 years before a mammogram can.",
      "Mammography has a sensitivity and specificity of around 80-90% for detecting breast cancer.",
      "Mammography requires compression of the breast tissue and involves exposure to low levels of radiation.",
      "Mammography is the gold standard for early breast cancer detection due to its high accuracy and availability."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Thermography cannot reliably detect temperature changes in breast tissue up to 10 years before a mammogram can. The technology may show changes in skin temperature, but it's not proven to be an effective standalone tool for detecting breast cancer.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4514,
    "user_query": "does  organic  chicken contain less arsenic ?",
    "llama-2-7b-chat-hf_response": "According to a study published in the journal Environmental Health Perspectives, organic chicken may contain less arsenic than conventionally raised chicken. The study found that organic chicken had lower levels of inorganic arsenic, which is the form of arsenic that is most toxic to humans, compared to conventionally raised chicken.\nThe study analyzed samples of chicken meat from both organic and conventionally raised chickens and found that the organic chicken had an average of 36% lower levels of inorganic arsenic compared to the conventionally raised chicken. The study also found that the levels of organic arsenic, which is less toxic than inorganic arsenic, were similar in both types of chicken.\nIt's worth noting that the levels of arsenic found in both types of chicken were still within the safety limits set by the U.S. Food and Drug Administration (FDA). However, the study suggests that organic chicken may be a safer choice for consumers who are concerned about exposure to arsenic.\nIt's important to note that this study only looked at the levels of arsenic in chicken meat and did not examine the potential health effects of consuming chicken with lower levels of arsenic. Further research is needed to fully understand the implications of these findings.",
    "llama-2-7b-chat-hf_fact": [
      "Organic chicken may contain less arsenic than conventionally raised chicken, according to a study.",
      "The study found that organic chicken had lower levels of inorganic arsenic, which is most toxic to humans.",
      "In the study, organic chicken had an average of 36% lower levels of inorganic arsenic compared to conventionally raised chicken.",
      "The U.S. Food and Drug Administration sets safety limits for the levels of arsenic in chicken.",
      "Inorganic arsenic is more toxic than organic arsenic."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4515,
    "user_query": "are there any risks of excess vitamin b12 consumption ?",
    "llama-2-7b-chat-hf_response": "Vitamin B12 is an essential nutrient that plays a crucial role in the body's functioning, particularly in the production of red blood cells and the maintenance of the nervous system. However, like any other nutrient, excessive consumption of vitamin B12 can have negative effects on the body. Here are some of the risks associated with excessive vitamin B12 consumption:\n1. Vitamin B12 toxicity: Taking too much vitamin B12 can lead to toxicity, which can cause a range of symptoms including joint pain, muscle weakness, and mood changes. The risk of toxicity increases with high doses, and it is estimated that taking more than 1000 mcg of vitamin B12 per day can lead to toxicity in some individuals.\n2. Interaction with medications: Vitamin B12 can interact with certain medications, including metformin, blood thinners, and certain antidepressants. High doses of vitamin B12 can increase the risk of these interactions, which can lead to serious side effects.\n3. Kidney problems: Vitamin B12 is excreted by the kidneys, and excessive consumption can put a strain on the kidneys, particularly in individuals with pre-existing kidney problems. This can lead to kidney damage and other complications.\n4. Masking of deficiencies: Excessive vitamin B12 consumption can mask the symptoms of deficiencies in other B vitamins, such as vitamin B6 and folate. This can lead to an inadequate diagnosis and treatment of these deficiencies, which can have serious health consequences.\n5. Increased risk of cardiovascular disease: Some studies have suggested that high doses of vitamin B12 may increase the risk of cardiovascular disease, particularly in individuals with pre-existing cardiovascular conditions.\n6. Increased risk of cancer: Some studies have suggested that high doses of vitamin B12 may increase the risk of certain types of cancer, particularly colorectal cancer.\n7. Gastrointestinal problems: Excessive vitamin B12 consumption can cause gastrointestinal problems, including diarrhe",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin B12 plays a crucial role in the production of red blood cells and the maintenance of the nervous system.",
      "Taking more than 1000 mcg of Vitamin B12 per day can lead to toxicity in some individuals.",
      "Vitamin B12 can interact with certain medications, including metformin, blood thinners, and certain antidepressants.",
      "Excessive consumption of Vitamin B12 can strain the kidneys and potentially lead to kidney damage.",
      "Excessive Vitamin B12 consumption can mask the symptoms of deficiencies in other B vitamins, such as vitamin B6 and folate."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Vitamin B12 is water-soluble, and the body can flush out excess amounts, so it is generally not considered toxic, even at high levels.",
      "true",
      "false, [corrected fact]: While excessive consumption of some vitamins could potentially strain the kidneys, vitamin B12 is generally not implicated in this risk as it is water soluble and can be readily excreted in urine.",
      "false, [corrected fact]: Excessive Vitamin B12 consumption does not mask the symptoms of other B vitamins deficiencies, instead it can mask a deficiency in Vitamin B9 (Folic Acid)."
    ]
  },
  {
    "id": 4516,
    "user_query": "how do you achieve a good omega 3 to omega 6 fatty acid ratio ?",
    "llama-2-7b-chat-hf_response": "Here are some tips to help you achieve a good omega-3 to omega-6 fatty acid ratio:\n1. Eat more omega-3 rich foods: Focus on consuming more foods that are high in omega-3 fatty acids, such as fatty fish (salmon, sardines, mackerel), flaxseeds, chia seeds, walnuts, and hemp seeds.\n2. Limit omega-6 rich foods: Reduce your intake of foods that are high in omega-6 fatty acids, such as vegetable oils (corn, soybean, canola), nuts (peanuts, cashews, almonds), and seeds (sunflower, pumpkin, sesame).\n3. Choose the right cooking methods: When cooking, choose methods that don't damage the omega-3 fatty acids, such as grilling, roasting, or sauting. Avoid deep-frying or cooking at high temperatures, as this can destroy the delicate molecular structure of omega-3 fatty acids.\n4. Consider supplements: If you're having trouble getting enough omega-3 fatty acids from your diet, consider taking a supplement. Look for a supplement that contains both EPA and DHA, the two most important types of omega-3 fatty acids.\n5. Be mindful of processed foods: Many processed foods, such as packaged snacks and frozen meals, are high in omega-6 fatty acids and low in omega-3 fatty acids. Try to limit your consumption of these foods and instead choose whole, unprocessed foods.\n6. Eat fermented foods: Fermented foods, such as sauerkraut, kimchi, and miso, contain omega-3 fatty acids and can help promote a healthy balance between omega-3 and omega-6 fatty acids.\n7. Consider your individual needs: Your individual needs for omega-3 and omega-6 fatty acids may vary depending on your age, health status, and other factors. Consult with a healthcare professional or registered dietitian to",
    "llama-2-7b-chat-hf_fact": [
      "Foods high in omega-3 fatty acids include fatty fish, flaxseeds, chia seeds, walnuts, and hemp seeds.",
      "Foods high in omega-6 fatty acids include vegetable oils, certain nuts, and some seeds.",
      "Cooking methods such as grilling, roasting, and sauting do not damage the molecular structure of omega-3 fatty acids.",
      "Many processed foods are high in omega-6 fatty acids and low in omega-3 fatty acids.",
      "Fermented foods, such as sauerkraut, kimchi, and miso, contain omega-3 fatty acids."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: High-heat cooking methods such as grilling, roasting, and sauting can damage the molecular structure of omega-3 fatty acids.",
      "true",
      "false, [corrected fact]: Fermented foods, such as sauerkraut, kimchi, and miso, generally do not contain significant amounts of omega-3 fatty acids."
    ]
  },
  {
    "id": 4518,
    "user_query": "how long to avoid fish before conception ?",
    "llama-2-7b-chat-hf_response": "Avoid consuming raw or undercooked fish and shellfish for at least 3 months before conception to minimize the risk of mercury exposure. Mercury is a toxic substance that can affect fetal brain development and increase the risk of birth defects. It is found in some fish and shellfish, particularly those that are high in the food chain, such as shark, swordfish, king mackerel, and tilefish.\nIt is important to note that not all fish and shellfish contain high levels of mercury, and some can be safely consumed in moderation. The FDA and EPA recommend the following guidelines for consuming fish and shellfish during preconception and pregnancy:\n* Avoid eating shark, swordfish, king mackerel, and tilefish, as they contain high levels of mercury.\n* Limit consumption of albacore (white) tuna to no more than 6 ounces (170 grams) per week.\n* Eat up to 12 ounces (340 grams) of light canned tuna and up to 6 ounces (170 grams) of cooked salmon per week.\n* Avoid eating raw or undercooked fish and shellfish, as they may contain harmful bacteria or parasites.\nIt is also important to note that some fish and shellfish may contain other toxins, such as polychlorinated biphenyls (PCBs) and dioxins, which can also affect fetal brain development and increase the risk of birth defects.\nIn summary, to minimize the risk of mercury exposure during preconception and pregnancy, it is recommended to avoid consuming raw or undercooked fish and shellfish for at least 3 months before conception, and to limit consumption of high-mercury fish and shellfish during pregnancy.",
    "llama-2-7b-chat-hf_fact": [
      "Mercury is a toxic substance that can affect fetal brain development and increase the risk of birth defects.",
      "Certain fish and shellfish like shark, swordfish, king mackerel, and tilefish can contain high levels of mercury.",
      "The FDA and EPA recommend avoiding eating shark, swordfish, king mackerel, and tilefish during preconception and pregnancy because of their high mercury content.",
      "The FDA and EPA advise limiting consumption of albacore (white) tuna to no more than 6 ounces (170 grams) per week during preconception and pregnancy.",
      "Some fish and shellfish may contain other toxins, such as polychlorinated biphenyls (PCBs) and dioxins, which can also affect fetal brain development and increase the risk of birth defects."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4522,
    "user_query": "are canned beans as healthy as home cooked ?",
    "llama-2-7b-chat-hf_response": "Canned beans are a convenient and affordable way to get your daily dose of protein and fiber, but are they as healthy as home-cooked beans? Here are some pros and cons to consider:\nPros of canned beans:\n1. Convenience: Canned beans are quick and easy to prepare, making them a great option for busy days or meal prep.\n2. Cost-effective: Canned beans are generally cheaper than buying fresh or home-cooked beans, making them a budget-friendly option.\n3. Consistency: Canned beans have a consistent texture and flavor, which can be appealing to some people.\nCons of canned beans:\n1. Salt content: Canned beans are often high in sodium, which can be a concern for people with high blood pressure or other health conditions.\n2. Preservatives: Canned beans may contain preservatives like BPA, which has been linked to health problems in some studies.\n3. Nutrient content: While canned beans are a good source of protein and fiber, they may be lower in some nutrients compared to home-cooked beans.\nPros of home-cooked beans:\n1. Customization: When you cook beans at home, you can control the amount of salt and seasonings you use, making them a healthier option.\n2. Nutrient content: Home-cooked beans tend to be higher in fiber and other nutrients compared to canned beans.\n3. Freshness: Home-cooked beans are fresher and have a better texture than canned beans.\nCons of home-cooked beans:\n1. Time-consuming: Cooking beans from scratch can take time and effort, especially if you're making a large batch.\n2. Messy: Cooking beans at home can be messy, especially if you're working with dry beans.\n3. Limited options: When you cook beans at home, you're limited to the types of beans you have on hand and the seasonings you use.\nIn conclusion, while canned beans are convenient and affordable, home-cooked beans offer more nutrients and",
    "llama-2-7b-chat-hf_fact": [
      "Canned beans are known to be high in sodium.",
      "Canned beans may contain preservatives like BPA.",
      "Home-cooked beans tend to be higher in fiber and other nutrients compared to canned beans.",
      "Cooking beans from scratch can be time-consuming.",
      "Canned beans are generally cheaper than fresh or home-cooked beans."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Canned beans are generally cheaper than fresh beans, but the cost of home-cooked beans can depend on various factors and may not always be more expensive."
    ]
  },
  {
    "id": 4525,
    "user_query": "does animal protein cause osteoporosis ?",
    "llama-2-7b-chat-hf_response": "Animal protein, particularly from red meat, has been linked to an increased risk of osteoporosis. There are several reasons why this may be the case:\n1. Acidic environment: Animal protein can create an acidic environment in the body, which can lead to the breakdown of bone tissue.\n2. Hormones: Animal protein can stimulate the production of hormones such as insulin-like growth factor-1 (IGF-1), which can promote bone resorption and contribute to osteoporosis.\n3. Mineral imbalance: Animal protein can lead to an imbalance of minerals such as calcium and phosphorus in the body, which can negatively impact bone health.\n4. Chronic inflammation: Consuming high amounts of animal protein can lead to chronic inflammation in the body, which can contribute to bone loss and osteoporosis.\nIt's important to note that not all animal protein is created equal, and some types of protein may be more beneficial for bone health than others. For example, plant-based protein sources such as beans, lentils, and tofu may be more beneficial than animal-based protein sources due to their higher content of nutrients such as calcium, magnesium, and potassium, which are important for bone health.\nIt's also worth noting that the relationship between animal protein and osteoporosis is complex and may be influenced by a variety of factors, including the amount and type of protein consumed, as well as other lifestyle factors such as physical activity and overall diet quality.\nIn summary, while animal protein can contribute to osteoporosis, it's not the only factor and a balanced diet that includes a variety of protein sources, as well as other nutrients important for bone health, can help to mitigate this risk.",
    "llama-2-7b-chat-hf_fact": [
      "Animal protein, especially from red meat, is linked to an increased risk of osteoporosis.",
      "Consuming animal protein can create an acidic environment in the body, leading to the breakdown of bone tissue.",
      "Insulin-like growth factor-1 (IGF-1), stimulated by animal protein, can promote bone resorption and contribute to osteoporosis.",
      "Animal protein can disrupt the balance of minerals like calcium and phosphorus in the body, negatively affecting bone health.",
      "High amounts of animal protein can lead to chronic inflammation in the body, which contributes to bone loss and osteoporosis."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4540,
    "user_query": "which parts of the mediterranean diet extended life ?",
    "llama-2-7b-chat-hf_response": "The Mediterranean diet has been associated with a number of health benefits, including a reduced risk of chronic diseases such as heart disease, stroke, and cancer. Some of the specific components of the Mediterranean diet that have been linked to a longer lifespan include:\n1. High consumption of fruits, vegetables, and legumes: These foods are rich in vitamins, minerals, and antioxidants, which can help protect against cell damage and reduce the risk of chronic diseases.\n2. Moderate consumption of dairy products: Dairy products, such as cheese and yogurt, are a good source of protein and calcium, which are important for maintaining muscle mass and bone density.\n3. High consumption of nuts and seeds: Nuts and seeds, such as almonds, walnuts, and pumpkin seeds, are rich in healthy fats, protein, and fiber, which can help lower cholesterol levels and improve digestive health.\n4. Moderate consumption of red wine: Red wine contains antioxidants and polyphenols, which may help protect against heart disease and certain types of cancer.\n5. High consumption of olive oil: Olive oil is rich in healthy fats, such as monounsaturated fats, which can help lower cholesterol levels and improve heart health.\n6. Low consumption of red meat: Red meat, such as beef, pork, and lamb, has been linked to an increased risk of chronic diseases, such as heart disease and certain types of cancer.\n7. High consumption of fish and seafood: Fish and seafood, such as salmon, tuna, and shrimp, are rich in protein, omega-3 fatty acids, and other nutrients that can help protect against chronic diseases.\n8. Low consumption of processed meats: Processed meats, such as hot dogs and sausages, have been linked to an increased risk of chronic diseases, such as heart disease and certain types of cancer.\n9. High consumption of whole grains: Whole grains, such as brown rice, quinoa, and whole wheat bread, are rich in fiber, vit",
    "llama-2-7b-chat-hf_fact": [
      "The Mediterranean diet is associated with reduced risk of chronic diseases like heart disease, stroke, and cancer.",
      "Certain components of the Mediterranean diet like high consumption of fruits, vegetables, and legumes are linked to extended lifespan due to their richness in vitamins, minerals, and antioxidants.",
      "Dairy products, consumed moderately in the Mediterranean diet, are a good source of protein and calcium important for maintaining muscle mass and bone density.",
      "The Mediterranean diet includes high consumption of nuts and seeds rich in healthy fats, protein, and fiber which contribute to lowering cholesterol levels and improving digestive health.",
      "High consumption of olive oil in the Mediterranean diet provides monounsaturated fats which help lower cholesterol levels and improve heart health."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4541,
    "user_query": "predimed : does eating nuts prevent strokes ?",
    "llama-2-7b-chat-hf_response": "Nuts are a nutritious snack that can provide a range of health benefits, including reducing the risk of stroke. According to a study published in the Journal of the American Heart Association, eating nuts regularly can help lower the risk of stroke by up to 25%.\nThe study analyzed data from over 100,000 adults in the United States and found that those who ate nuts at least five times a week had a lower risk of stroke compared to those who did not eat nuts. The researchers believe that the antioxidants, vitamins, and minerals in nuts may help protect against stroke by reducing inflammation and improving blood vessel function.\nOther studies have also found a link between nut consumption and reduced stroke risk. For example, a study published in the American Journal of Clinical Nutrition found that eating a handful of nuts per day was associated with a lower risk of cardiovascular disease, including stroke, in a cohort of over 100,000 adults in the United Kingdom.\nWhile the exact mechanism by which nuts may help prevent stroke is not fully understood, it is thought that the antioxidants and other nutrients in nuts may help reduce inflammation and improve blood vessel function. Additionally, nuts are a good source of healthy fats, which can help lower cholesterol levels and reduce the risk of cardiovascular disease.\nOverall, the evidence suggests that eating nuts may be an important part of a healthy diet and may help reduce the risk of stroke. However, it is important to note that nuts are high in calories, so it is important to eat them in moderation as part of a balanced diet.",
    "llama-2-7b-chat-hf_fact": [
      "Nuts contain antioxidants, vitamins, and minerals that may help protect against stroke by reducing inflammation and improving blood vessel function.",
      "A study published in the Journal of the American Heart Association found that regular intake of nuts can reduce the risk of stroke by up to 25%.",
      "The aforementioned study analyzed data from over 100,000 adults in the United States.",
      "Another study published in the American Journal of Clinical Nutrition found that eating a handful of nuts per day was associated with a lower risk of cardiovascular disease, including stroke, in a cohort of over 100,000 adults in the United Kingdom.",
      "While nuts may help in reducing the risk of stroke, they are high in calories, hence should be consumed in moderation as part of a balanced diet."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4548,
    "user_query": "why do vegan women have 5x fewer twins ?",
    "llama-2-7b-chat-hf_response": "Research has shown that vegan women are less likely to have twins than non-vegan women. According to a study published in the journal Fertility and Sterility, vegan women are 5 times less likely to have twins than non-vegan women.\nThere are several reasons why this might be the case:\n1. Hormone levels: Vegan women tend to have lower levels of hormones such as estrogen and progesterone, which are important for fertility and twinning. These hormones play a role in regulating ovulation and the thickness of the uterine lining, which can affect the likelihood of twinning.\n2. Nutrient deficiencies: A vegan diet can be low in certain nutrients that are important for fertility and twinning, such as vitamin D, calcium, and omega-3 fatty acids. These nutrients are important for the health of the reproductive system and the development of the embryo.\n3. Weight: Vegan women tend to have a lower body mass index (BMI) than non-vegan women, which can affect the likelihood of twinning. Twinning is more common in women who are overweight or obese, as there is more space for the embryos to implant in the uterus.\n4. Lifestyle factors: Vegan women may be more likely to engage in lifestyle factors that can affect fertility and twinning, such as smoking, excessive alcohol consumption, and stress. These factors can all impact the likelihood of twinning.\nIt's important to note that these are general trends and that many vegan women will still have twins. However, if you are a vegan woman trying to conceive, it's important to be aware of these factors and to make sure you are getting enough of the nutrients that are important for fertility and twinning. Consulting with a healthcare provider or a registered dietitian can help ensure that you are getting the nutrients you need.",
    "llama-2-7b-chat-hf_fact": [
      "According to a study in the journal Fertility and Sterility, vegan women are 5 times less likely to have twins than non-vegan women.",
      "Vegan women usually have lower levels of hormones such as estrogen and progesterone which can affect fertility and the likelihood of twinning.",
      "Vegan diets can be deficient in nutrients essential for fertility and twinning, such as vitamin D, calcium, and omega-3 fatty acids.",
      "Vegan women generally have a lower body mass index (BMI) than non-vegan women, which can influence the likelihood of twins.",
      "Lifestyle factors such as smoking, excessive alcohol consumption, and stress can impact the likelihood of twinning."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4554,
    "user_query": "is there too much aluminum in tea ?",
    "llama-2-7b-chat-hf_response": "Aluminum is a common contaminant in tea, particularly in black tea. According to the World Health Organization (WHO), the acceptable daily intake of aluminum is 500 micrograms (mcg) per day. However, some studies have suggested that long-term exposure to low levels of aluminum in tea may still pose a health risk, particularly for people with pre-existing kidney disease.",
    "llama-2-7b-chat-hf_fact": [
      "Aluminum is a common contaminant in tea, especially black tea.",
      "The World Health Organization (WHO) has set the acceptable daily intake of aluminum at 500 micrograms per day.",
      "Long-term exposure to low levels of aluminum in tea could pose health risks.",
      "People with pre-existing kidney disease could particularly be at risk from long-term exposure to aluminum in tea."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: The World Health Organization (WHO) has set the acceptable daily intake of aluminum at 2 milligrams per kilogram of body weight per day.",
      "true",
      "true"
    ]
  },
  {
    "id": 4555,
    "user_query": "does meditation affect cellular aging ?",
    "llama-2-7b-chat-hf_response": "Meditation has been shown to have a positive impact on cellular aging by reducing oxidative stress, improving telomere length, and activating cellular pathways that promote longevity. Here are some key findings from recent studies:\n1. Reduces oxidative stress: Meditation has been shown to reduce oxidative stress, which is a major contributor to cellular aging. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify these harmful compounds. Meditation has been shown to reduce ROS levels and improve antioxidant defenses, which can help slow down cellular aging.\n2. Improves telomere length: Telomeres are the protective caps on the ends of chromosomes that shorten with each cell division. Shorter telomeres have been linked to an increased risk of age-related diseases and shorter lifespan. Meditation has been shown to increase telomere length, which can help slow down cellular aging.\n3. Activates cellular pathways that promote longevity: Meditation has been shown to activate cellular pathways that promote longevity, such as the AMP-activated protein kinase (AMPK) pathway. AMPK is a master regulator of cellular energy metabolism and is activated during meditation. Activation of AMPK has been shown to promote cellular longevity and reduce the risk of age-related diseases.\n4. Increases NAD+ levels: NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that plays a critical role in energy metabolism and mitochondrial function. NAD+ levels decline with age, which can lead to a decline in mitochondrial function and an increase in cellular aging. Meditation has been shown to increase NAD+ levels, which can help improve mitochondrial function and slow down cellular aging.\n5. Reduces inflammation: Chronic inflammation is a major contributor to cellular aging. Meditation has been shown to reduce inflammation by reducing the production of pro-inflammatory cytokines and increasing the production of anti-infl",
    "llama-2-7b-chat-hf_fact": [
      "Oxidative stress is a major contributor to cellular aging and is defined as an imbalance between the production of reactive oxygen species and the body's ability to detoxify these compounds.",
      "Telomeres are the protective caps on the ends of chromosomes that shorten with each cell division, linked to an increased risk of age-related diseases and a shorter lifespan.",
      "The AMP-activated protein kinase (AMPK) pathway, a master regulator of cellular energy metabolism, has been shown to promote cellular longevity and reduce the risk of age-related diseases when activated.",
      "NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that plays a critical role in energy metabolism and mitochondrial function, which can lead to a decline in mitochondrial function and an increase in cellular aging when NAD+ levels decline with age.",
      "Chronic inflammation, which can contribute to cellular aging, is characterized by the overproduction of pro-inflammatory cytokines."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that plays a critical role in energy metabolism and mitochondrial function, which can lead to a decline in mitochondrial function and an increase in cellular aging when NAD+ levels decline with age.",
      "true"
    ]
  },
  {
    "id": 4556,
    "user_query": "is gluten sensitivity real ?",
    "llama-2-7b-chat-hf_response": "Gluten sensitivity, also known as non-celiac gluten sensitivity (NCGS), is a condition in which individuals experience symptoms after consuming gluten, a protein found in wheat, barley, and rye. While the exact cause of gluten sensitivity is not fully understood, research suggests that it is a real condition that affects a significant number of people. Here are some reasons why gluten sensitivity is real:\n1. Increased prevalence: The prevalence of gluten sensitivity has increased significantly over the past decade, with some studies suggesting that it affects up to 15% of the population.\n2. Symptoms: Individuals with gluten sensitivity often experience a range of symptoms, including abdominal pain, bloating, diarrhea, fatigue, and brain fog. These symptoms are similar to those experienced by people with celiac disease, an autoimmune disorder that causes an adverse reaction to gluten.\n3. Immune system response: Research has shown that individuals with gluten sensitivity have an immune system response to gluten, similar to that seen in people with celiac disease. This suggests that gluten sensitivity is an immune-mediated disorder, rather than a psychological or fictional condition.\n4. Genetic markers: Studies have identified genetic markers associated with gluten sensitivity, which suggests that there may be a genetic component to the condition.\n5. Neurological symptoms: Some individuals with gluten sensitivity experience neurological symptoms, such as headaches, migraines, and cognitive impairment. These symptoms are similar to those experienced by people with celiac disease and other autoimmune disorders.\n6. Improved symptoms on gluten-free diet: Many individuals with gluten sensitivity report improved symptoms after adopting a gluten-free diet. This suggests that gluten sensitivity is a real condition that can cause adverse reactions to gluten.\n7. Mechanistic studies: Mechanistic studies have shown that gluten can cause inflammation and damage to the gut lining, which can lead to the release of toxic substances into the bloodstream. This can cause a range of symptoms, including abdominal pain, fatigue, and brain fog.\n8. Clinical",
    "llama-2-7b-chat-hf_fact": [
      "Gluten sensitivity is a condition in which people experience symptoms after consuming gluten, a protein found in wheat, barley, and rye.",
      "Studies show that the prevalence of gluten sensitivity has increased significantly over the past decade.",
      "Gluten sensitivity often results in a range of symptoms including abdominal pain, bloating, diarrhea, fatigue, and brain fog.",
      "Research has found that individuals with gluten sensitivity have an immune response to gluten, suggesting that the condition is an immune-mediated disorder.",
      "There are genetic markers associated with gluten sensitivity, indicating a potential genetic component to the condition."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4562,
    "user_query": "fruits , veggies , and longevity : how many minutes per mouthful ?",
    "llama-2-7b-chat-hf_response": "Fruits, vegetables, and longevity: How many minutes per mouthful?\nEating a diet rich in fruits and vegetables has been shown to have numerous health benefits, including reducing the risk of chronic diseases such as heart disease, diabetes, and certain types of cancer. In fact, the World Health Organization recommends that adults consume at least 400g (5 portions) of fruits and vegetables per day. But how many minutes per mouthful do we need to consume to reap these benefits?\nTo answer this question, researchers from the University of Otago in New Zealand analyzed data from over 300,000 adults across 18 countries. They found that the amount of time spent chewing each mouthful of fruits and vegetables was associated with a lower risk of death from any cause. Specifically, they found that for every additional minute spent chewing each mouthful of fruits and vegetables, there was a 10% reduction in the risk of death from any cause.\nFor example, if an individual consumed a mouthful of fruits or vegetables in 30 seconds, they would have a 10% lower risk of death compared to someone who consumed the same amount in 15 seconds. Similarly, if they consumed a mouthful in 60 seconds, they would have a 20% lower risk of death compared to someone who consumed the same amount in 30 seconds.\nThe researchers also found that the association between chewing time and mortality risk was strongest for fruits and vegetables that are high in fiber and antioxidants, such as berries, leafy greens, and cruciferous vegetables. This suggests that the longer chewing time may allow for better digestion and absorption of these beneficial compounds.\nOverall, these findings suggest that taking the time to chew each mouthful of fruits and vegetables slowly and thoroughly may have important health benefits. So, the next time you're eating a piece of fruit or a handful of vegetables, take a moment to savor the taste and texture, and enjoy the potential health benefits that come with it.\nIn conclusion, the amount of time spent chewing each mouthful of fruits and vegetables is associated with a lower risk of death from any cause.",
    "llama-2-7b-chat-hf_fact": [
      "The World Health Organization recommends that adults consume at least 400g (5 portions) of fruits and vegetables per day.",
      "Researchers from the University of Otago in New Zealand analyzed data from over 300,000 adults across 18 countries.",
      "The researchers found that the amount of time spent chewing each mouthful of fruits and vegetables was associated with a lower risk of death from any cause.",
      "For every additional minute spent chewing each mouthful of fruits and vegetables, there was a 10% reduction in the risk of death from any cause.",
      "The association between chewing time and mortality risk was strongest for fruits and vegetables that are high in fiber and antioxidants, such as berries, leafy greens, and cruciferous vegetables."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4571,
    "user_query": "should we take a multivitamin ?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4576,
    "user_query": "canned beans or cooked beans ?",
    "llama-2-7b-chat-hf_response": "Canned beans and cooked beans are both convenient and nutritious options for adding protein to your diet. Here are some key differences to help you decide which one is best for you:\nCanned Beans:\n* Canned beans are already cooked and can be eaten straight out of the can.\n* They are quick and easy to prepare, making them a great option for busy days.\n* Canned beans are often lower in fiber and higher in sodium than cooked beans.\n* They may contain added salt or preservatives, which can be a concern for some people.\nCooked Beans:\n* Cooked beans are already prepared and can be stored in the fridge or freezer for later use.\n* They are higher in fiber and lower in sodium than canned beans.\n* Cooked beans can be seasoned with herbs and spices to add flavor.\n* They may require more preparation time than canned beans, as they need to be cooked before they can be eaten.\nUltimately, the choice between canned and cooked beans comes down to personal preference and your dietary needs. If you're looking for a quick and easy protein source, canned beans may be the way to go. However, if you're looking for a higher fiber and lower sodium option, cooked beans may be the better choice.",
    "llama-2-7b-chat-hf_fact": [
      "Canned beans are pre-cooked and can be eaten straight out of the can.",
      "Canned beans are often lower in fiber and higher in sodium than cooked beans.",
      "Cooked beans can be stored in the fridge or freezer for later use.",
      "Cooked beans are usually higher in fiber and lower in sodium than canned beans.",
      "Cooked beans require to be cooked before they can be eaten."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Cooked beans do not need to be cooked again before being eaten."
    ]
  },
  {
    "id": 4577,
    "user_query": "how many poppy seeds are too many ?",
    "llama-2-7b-chat-hf_response": "Poppy seeds are a popular spice used in baking and cooking, but consuming too many can be harmful. Here are some guidelines on how many poppy seeds are too many:",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4584,
    "user_query": "which fruit fights cancer better ?",
    "llama-2-7b-chat-hf_response": "Which fruit fights cancer better?\nFruits are a rich source of vitamins, minerals, and antioxidants that have been shown to have anti-cancer properties. While all fruits have some anti-cancer properties, some have been found to be more effective than others in fighting cancer. Here are some of the top fruits that have been shown to have anti-cancer properties:\n1. Berries: Berries such as blueberries, raspberries, and strawberries are packed with antioxidants and phytochemicals that have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n2. Citrus fruits: Citrus fruits like oranges, lemons, and grapefruits are rich in vitamin C and flavonoids, which have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n3. Apples: Apples are a good source of quercetin, a flavonoid that has been shown to have anti-cancer properties. Quercetin can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n4. Pineapples: Pineapples are rich in an enzyme called bromelain, which has been shown to have anti-cancer properties. Bromelain can help reduce inflammation and inhibit the growth of cancer cells.\n5. Pomegranates: Pomegranates are a rich source of antioxidants and phytochemicals that have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n6. Acai berries: Acai berries are a rich source of antioxidants and phytochemicals that have been shown to have anti-cancer properties. These compounds can help protect cells from damage, reduce inflammation, and inhibit the growth of cancer cells.\n7. Goji berries: Goji berries are a rich source of antioxid",
    "llama-2-7b-chat-hf_fact": [
      "Berries such as blueberries, raspberries, and strawberries contain antioxidants and phytochemicals with anti-cancer properties.",
      "Citrus fruits like oranges, lemons, and grapefruits are rich in vitamin C and flavonoids that have anti-cancer properties.",
      "Apples are a good source of quercetin, a flavonoid that has been shown to have anti-cancer properties.",
      "Pineapples are rich in an enzyme called bromelain, which has been shown to have anti-cancer properties.",
      "Pomegranates and Acai berries are rich sources of antioxidants and phytochemicals that have been shown to have anti-cancer properties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4590,
    "user_query": "can gargling prevent the common cold ?",
    "llama-2-7b-chat-hf_response": "Gargling with salt water has been suggested as a way to help prevent the common cold, but there is limited scientific evidence to support this claim. Here are some reasons why gargling may not be effective in preventing the common cold:\n1. The common cold is caused by viruses: The common cold is caused by viruses, such as rhinoviruses, coronaviruses, and adenoviruses. These viruses are highly contagious and can easily spread through the air when an infected person talks, coughs, or sneezes. Gargling with salt water may not be able to kill or remove these viruses from the throat and nasal passages.\n2. Gargling may not reach the nasal passages: The nasal passages are the primary entry point for the common cold virus. Gargling with salt water may not be able to reach the nasal passages, where the virus enters the body.\n3. Gargling may not be able to remove the virus: Even if gargling with salt water can reach the throat and nasal passages, it may not be able to remove the virus from the body. The common cold virus can hide in the nasal passages and throat, and gargling may not be able to dislodge it.\n4. Gargling may cause irritation: Gargling with salt water can cause irritation to the throat and nasal passages. This irritation can lead to inflammation and swelling, which can make the body more susceptible to infection.\n5. There are other ways to prevent the common cold: While gargling with salt water may not be effective in preventing the common cold, there are other ways to reduce the risk of getting sick. These include:\n* Washing your hands frequently with soap and water\n* Avoiding close contact with people who are sick\n* Avoiding touching your face, especially your eyes, nose, and mouth\n* Keeping surfaces clean and disinfected\n* Getting enough sleep and managing stress\n* Staying hydrated by drinking plenty of fluids\nIn conclusion, while gargling with salt water may have some benefits for the throat and nasal passages, it is unlikely to be effective in preventing the common cold. There are other ways to",
    "llama-2-7b-chat-hf_fact": [
      "The common cold is caused by viruses, such as rhinoviruses, coronaviruses, and adenoviruses.",
      "These viruses can be spread through the air when an infected person talks, coughs, or sneezes.",
      "The nasal passages are the primary entry point for the common cold virus.",
      "Gargling with salt water can cause irritation to the throat and nasal passages.",
      "Washing hands frequently with soap and water, avoiding close contact with sick people, keeping surfaces clean and disinfected, getting adequate sleep, managing stress, and staying hydrated are other ways to reduce the risk of getting sick."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Gargling with salt water can help soothe the throat and reduce irritation in the throat and nasal passages.",
      "true"
    ]
  },
  {
    "id": 4591,
    "user_query": "are cats or dogs more protective for children 's health ?",
    "llama-2-7b-chat-hf_response": "Cats and dogs are both popular pets that can provide companionship and affection to children. However, when it comes to protecting children's health, both cats and dogs can play a role, but in different ways.\nCats are generally considered to be more protective of children's health than dogs. Here are some reasons why:\n1. Allergy protection: Cats produce fewer allergens than dogs, making them a better choice for children with allergies. According to a study published in the Journal of Allergy and Clinical Immunology, children who grow up in households with cats are less likely to develop allergies than those who grow up in households with dogs.\n2. Lower risk of infection: Cats are less likely to carry harmful bacteria and viruses than dogs, which can reduce the risk of infection for children. For example, cats are less likely to carry MRSA (methicillin-resistant Staphylococcus aureus), a bacteria that can cause serious infections in humans.\n3. Emotional support: Cats are known for their calming presence and can provide emotional support to children, which can help reduce stress and anxiety. This can be especially important for children who may be experiencing stress or anxiety due to bullying, academic pressure, or other issues.\n4. Lower risk of injury: Cats are generally smaller and more agile than dogs, which means they are less likely to accidentally knock over or step on a child. Additionally, cats are less likely to bite or attack children, which can reduce the risk of injury.\nHowever, it's important to note that both cats and dogs can provide health benefits for children, and the right pet for your family will depend on your family's lifestyle, preferences, and needs. Here are some factors to consider:\n1. Time commitment: If you have a busy schedule, a low-maintenance pet like a cat may be a better choice. Cats are generally easier to care for than dogs and require less attention and exercise.\n2. Allergy concerns: If someone in your household has allergies, you may want to consider a pet that is hypoallergenic, such as a cat.\n3. Space constraints: If you live in a small apartment or have limited space",
    "llama-2-7b-chat-hf_fact": [
      "Cats produce fewer allergens than dogs, according to a study published in the Journal of Allergy and Clinical Immunology.",
      "Children who grow up in households with cats are less likely to develop allergies than those who grow up in households with dogs.",
      "Cats are less likely to carry harmful bacteria and viruses than dogs, which can reduce the risk of infection for children.",
      "Cats are less likely to carry MRSA (methicillin-resistant Staphylococcus aureus), a bacteria that can cause serious infections in humans.",
      "Cats are generally smaller and more agile than dogs, reducing the risk of accidental injury to children."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4613,
    "user_query": "better than green tea ?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4614,
    "user_query": "fast food : do you want fries with that lipitor ?",
    "llama-2-7b-chat-hf_response": "",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4628,
    "user_query": "are dates good for you ?",
    "llama-2-7b-chat-hf_response": "Dates are a nutritious fruit that provides several health benefits when consumed as part of a balanced diet. Here are some of the key benefits of dates:\n1. Rich in Fiber: Dates are a good source of dietary fiber, which can help promote digestive health and prevent constipation.\n2. Natural Energy Boost: Dates are a good source of natural sugars like glucose, fructose, and sucrose, which can provide a quick energy boost when consumed.\n3. Good Source of Antioxidants: Dates are rich in antioxidants like vitamin C, vitamin E, and beta-carotene, which can help protect the body against free radicals and oxidative stress.\n4. Supports Bone Health: Dates are a good source of several minerals like calcium, magnesium, and potassium, which are essential for bone health.\n5. May Help Manage Blood Sugar: Dates have been shown to have a beneficial effect on blood sugar levels in people with type 2 diabetes.\n6. Supports Brain Health: Dates contain antioxidants and other nutrients that may help support brain health and reduce the risk of age-related cognitive decline.\n7. May Help Lower Cholesterol: The fiber and potassium in dates may help lower cholesterol levels and reduce the risk of heart disease.\n8. Supports Healthy Gut Bacteria: Dates contain prebiotic fiber that can help feed the good bacteria in the gut, promoting a healthy gut microbiome.\n9. May Help Reduce Inflammation: Dates contain anti-inflammatory compounds that may help reduce inflammation in the body and reduce the risk of chronic diseases.\n10. Supports Eye Health: Dates are a good source of vitamin A, which is essential for healthy vision and can help reduce the risk of age-related macular degeneration.\nOverall, dates are a nutritious fruit that can provide several health benefits when consumed as part of a balanced diet. They are a good source of fiber, antioxidants, minerals, and",
    "llama-2-7b-chat-hf_fact": [
      "Dates are a source of dietary fiber, which can help promote digestive health and prevent constipation.",
      "Dates consist of natural sugars like glucose, fructose, and sucrose, and can provide an energy boost.",
      "Dates contain antioxidants like vitamin C, vitamin E, and beta-carotene.",
      "Several minerals like calcium, magnesium, and potassium found in dates are essential for bone health.",
      "Dates contain prebiotic fiber that promotes a healthy gut microbiome."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: Dates contain antioxidants like flavonoids, carotenoids, and phenolic acid, not vitamin C, vitamin E, or beta-carotene.",
      "true",
      "true"
    ]
  },
  {
    "id": 4629,
    "user_query": "are chili peppers good for you ?",
    "llama-2-7b-chat-hf_response": "Chili peppers are a nutritious and versatile ingredient that can provide numerous health benefits when consumed as part of a balanced diet. Here are some of the potential health benefits of chili peppers:\n1. Pain relief: Chili peppers contain a compound called capsaicin, which has been shown to have analgesic and anti-inflammatory properties. This means that chili peppers can help to relieve pain and reduce inflammation.\n2. Improved heart health: Chili peppers are a good source of potassium, which can help to lower blood pressure and reduce the risk of heart disease. They also contain antioxidants and other nutrients that can help to protect the heart and cardiovascular system.\n3. Anti-cancer properties: Chili peppers contain a variety of antioxidants and other compounds that have been shown to have anti-cancer properties. For example, capsaicin has been shown to inhibit the growth of cancer cells and induce apoptosis (cell death).\n4. Improved digestion: Chili peppers contain fiber and other nutrients that can help to promote digestive health and improve bowel function. They may also help to reduce symptoms of irritable bowel syndrome (IBS) and other digestive disorders.\n5. Boosted immune system: Chili peppers contain a variety of nutrients and compounds that can help to support the immune system. For example, capsaicin has been shown to stimulate the production of white blood cells, which are important for fighting off infections.\n6. Anti-diabetic properties: Chili peppers have been shown to have anti-diabetic properties, including the ability to improve insulin sensitivity and reduce blood sugar levels.\n7. Anti-bacterial properties: Chili peppers contain compounds that have been shown to have anti-bacterial properties, which can help to protect against infections and promote wound healing.\n8. Anti-viral properties: Chili peppers have been shown to have anti-viral properties, which can help to protect against viral infections such as the common cold and flu.\n9. Anti-inflammatory properties: Chili pe",
    "llama-2-7b-chat-hf_fact": [
      "Chili peppers contain a compound called capsaicin, which has analgesic and anti-inflammatory properties.",
      "Capsaicin in chili peppers can stimulate the production of white blood cells, which are important for fighting off infections.",
      "Chili peppers are a good source of potassium, which can lower blood pressure and reduce the risk of heart disease.",
      "Chili peppers contain nutrients and compounds that can improve digestion and bowel function.",
      "Some compounds in chili peppers have been shown to have anti-viral and anti-bacterial properties."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false, [corrected fact]: Capsaicin does not stimulate production of white blood cells. It can help in reducing inflammation and pain.",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4636,
    "user_query": "can cholesterol be too low ?",
    "llama-2-7b-chat-hf_response": "Can cholesterol be too low? Yes, it is possible for cholesterol levels to be too low, a condition known as hypolipidemia or low cholesterol. While cholesterol is important for various bodily functions, very low levels of cholesterol can have negative effects on health.\nCauses of low cholesterol:\n1. Genetics: Some people may have a genetic predisposition to low cholesterol levels.\n2. Malabsorption: Certain medical conditions, such as celiac disease or pancreatic insufficiency, can lead to malabsorption of fats and cholesterol, resulting in low levels.\n3. Medications: Certain medications, such as cholestyramine, can lower cholesterol levels by binding to bile acids in the digestive tract and preventing their reabsorption into the bloodstream.\n4. Diet: A very low-fat diet can lead to low cholesterol levels.\n5. Other medical conditions: Certain medical conditions, such as hypothyroidism or liver disease, can also contribute to low cholesterol levels.\nEffects of low cholesterol:\n1. Increased risk of infection: Low cholesterol levels can impair the immune system's ability to fight off infections.\n2. Fatigue and weakness: Hypolipidemia can cause fatigue, weakness, and muscle weakness.\n3. Nervous system problems: Low cholesterol levels can affect the nervous system, leading to numbness, tingling, and weakness in the hands and feet.\n4. Mood changes: Hypolipidemia can cause mood changes, such as depression, anxiety, and irritability.\n5. Reproductive problems: In women, low cholesterol levels can lead to irregular menstrual cycles and infertility.\nTreversing low cholesterol:\n1. Dietary changes: Increasing fat and cholesterol intake can help raise low cholesterol levels.\n2. Medications: In some cases, medications such as cholestyramine or other cholesterol-lowering drugs may",
    "llama-2-7b-chat-hf_fact": [
      "It is possible for cholesterol levels to be excessively low, a condition known as hypolipidemia.",
      "Certain diseases, such as celiac disease or pancreatic insufficiency, can result in malabsorption of fats and cholesterol, leading to low levels.",
      "Cholestyramine, a medication, can lower cholesterol levels by binding to bile acids in the digestive tract and preventing their reabsorption into the bloodstream.",
      "A very low-fat diet can lead to low cholesterol level.",
      "Hypolipidemia can cause fatigue, weakness, and muscle weakness."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Hypolipidemia does not typically cause symptoms in itself. The problems associated with it, if any, are generally due to the underlying cause of the low blood lipid levels."
    ]
  },
  {
    "id": 4643,
    "user_query": "toxins in cooked potatoes ?",
    "llama-2-7b-chat-hf_response": "Potatoes are a nutritious and versatile food, but they can also contain toxins that can cause health problems if consumed in excess. Here are some of the toxins found in cooked potatoes:\n1. Solanine: Solanine is a glycoalkaloid toxin found in potatoes, particularly in green or sprouted potatoes. It can cause nausea, vomiting, diarrhea, and abdominal cramps if consumed in large amounts.\n2. Chaconine: Chaconine is another glycoalkaloid toxin found in potatoes, particularly in the skin and eyes of the potato. It can cause similar symptoms to solanine, including nausea, vomiting, and abdominal cramps.\n3. Lectins: Lectins are proteins found in many plant-based foods, including potatoes. While they are generally considered safe in small amounts, consuming large amounts of cooked potatoes can lead to digestive problems and inflammation.\n4. Acrylamide: Acrylamide is a potential carcinogen that forms when potatoes are cooked at high temperatures, particularly when they are fried or roasted. It can increase the risk of cancer if consumed in large amounts.\n5. Hydrogen cyanide: Hydrogen cyanide is a toxin found in small amounts in potatoes, particularly in the skin and eyes. It can cause headaches, dizziness, and nausea if consumed in large amounts.\nIt's important to note that the toxins found in cooked potatoes are generally not present in raw potatoes, and cooking potatoes can actually reduce the levels of these toxins. However, it's still important to consume potatoes in moderation and to cook them properly to reduce the risk of toxicity.",
    "llama-2-7b-chat-hf_fact": [
      "Solanine, a glycoalkaloid toxin, can be present in potatoes, particularly in green or sprouted ones.",
      "Symptoms from large amounts of consumed solanine include nausea, vomiting, diarrhea, and abdominal cramps.",
      "Chaconine, another glycoalkaloid toxin, can be found in potatoes, particularly in the skin and eyes.",
      "When potatoes are cooked at high temperatures, acrylamide, a potential carcinogen, forms.",
      "Hydrogen cyanide is a toxin found in small amounts in potatoes, particularly in the skin and eyes."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Hydrogen cyanide is not found in potatoes. It's typically found in certain fruit seeds, such as apricots, cherries, peaches, and apples."
    ]
  },
  {
    "id": 4660,
    "user_query": "is chlorella good for you ?",
    "llama-2-7b-chat-hf_response": "Chlorella is a type of algae that has been used for centuries in traditional medicine. It is rich in nutrients, including protein, vitamins, and minerals, and has been shown to have a range of potential health benefits. Here are some of the ways that chlorella may be good for you:\n1. Boosts immune system: Chlorella contains beta-glucans, which are known to stimulate the immune system and increase its ability to fight off infection.\n2. Detoxifies the body: Chlorella has been shown to bind to heavy metals and other toxins in the body, helping to remove them and promote detoxification.\n3. Supports digestive health: Chlorella contains fiber and other nutrients that can help support digestive health and promote regular bowel movements.\n4. May help lower cholesterol: Some studies have suggested that chlorella may help lower cholesterol levels by binding to bile acids and removing them from the body.\n5. May help manage blood sugar: Chlorella has been shown to improve insulin sensitivity and may help manage blood sugar levels in people with type 2 diabetes.\n6. May help reduce inflammation: Chlorella contains anti-inflammatory compounds that may help reduce inflammation in the body.\n7. May help improve cognitive function: Chlorella contains chlorella growth factor (CGF), which has been shown to improve cognitive function and memory in some studies.\n8. May help support skin health: Chlorella contains antioxidants and other nutrients that may help protect the skin from damage and promote healthy aging.\n9. May help support eye health: Chlorella contains lutein and zeaxanthin, which are antioxidants that may help protect the eyes from damage and reduce the risk of age-related macular degeneration.\n10. May help support bone health: Chlorella contains calcium and other minerals that are important for bone health, and may help reduce the risk of osteoporosis.\nIt is important to note that while chlorella may have a range of potential health benefits, more research is needed to confirm the effectiveness of chlorella for many of these uses. Additionally, chlorella",
    "llama-2-7b-chat-hf_fact": [
      "Chlorella is a type of algae used in traditional medicine.",
      "Chlorella is rich in protein, vitamins, and minerals.",
      "Chlorella contains beta-glucans, which may stimulate the immune system.",
      "Chlorella has been shown to potentially improve insulin sensitivity and help manage blood sugar levels in people with type 2 diabetes.",
      "Chlorella contains antioxidants and other nutrients that may support skin health."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4677,
    "user_query": "is msg bad for you ?",
    "llama-2-7b-chat-hf_response": "MSG (monosodium glutamate) is a flavor enhancer commonly used in many food products, including soups, sauces, and processed meats. While some people may be sensitive to MSG and experience adverse effects, the scientific consensus is that MSG is generally safe for most people in small amounts.\nThe U.S. Food and Drug Administration (FDA) has classified MSG as generally recognized as safe (GRAS) for use in food, and the European Food Safety Authority (EFSA) has also concluded that MSG is safe for human consumption.\nHowever, some studies have suggested that MSG may cause adverse effects in some individuals, including:\n1. Headaches and migraines: Some people may experience headaches or migraines after consuming foods that contain MSG.\n2. Digestive problems: Some people may experience nausea, vomiting, or diarrhea after consuming MSG.\n3. Allergic reactions: Some people may be allergic to MSG and experience symptoms such as hives, itching, or difficulty breathing.\n4. Neurological effects: Some studies have suggested that MSG may cause neurological effects, such as numbness or tingling in the face, neck, or other areas of the body.\nIt is important to note that these adverse effects are generally mild and temporary, and they do not occur in everyone who consumes MSG. If you experience any adverse effects after consuming MSG, you should speak with a healthcare professional.\nIn summary, while MSG is generally safe for most people in small amounts, some people may be sensitive to it and experience adverse effects. If you have concerns about MSG or any other food additive, it is always a good idea to speak with a healthcare professional or registered dietitian for personalized advice.",
    "llama-2-7b-chat-hf_fact": [
      "MSG (monosodium glutamate) is commonly used as a flavor enhancer in various food products including soups, sauces, and processed meats.",
      "The U.S. Food and Drug Administration (FDA) has classified MSG as generally recognized as safe (GRAS) for use in food.",
      "The European Food Safety Authority (EFSA) also concludes that MSG is safe for human consumption.",
      "Some studies suggest that MSG may cause adverse effects in some individuals, such as headaches, migraines, digestive problems, allergic reactions and neurological effects.",
      "If any adverse effects are experienced after consuming MSG, it is advised to speak with a healthcare professional."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4693,
    "user_query": "are organic foods safer ?",
    "llama-2-7b-chat-hf_response": "Organic foods are grown and processed using farming practices that avoid the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge. These practices aim to promote ecological balance and conserve biodiversity. While organic foods may have some potential health benefits, there is limited scientific evidence to support the claim that they are safer than conventionally grown foods.\nSome of the potential health benefits of organic foods include:\n1. Lower pesticide exposure: Organic foods are less likely to contain residues of pesticides, which have been linked to a range of health problems including cancer, hormone disruption, and neurological damage.\n2. Higher antioxidant levels: Organic foods may contain higher levels of antioxidants, such as vitamins C and E, and polyphenols, which can help protect against oxidative stress and inflammation.\n3. Better nutrient levels: Organic foods may have higher levels of certain nutrients, such as vitamins C and E, and minerals like zinc and iron, compared to conventionally grown foods.\n4. Lower risk of foodborne illness: Organic foods are less likely to be contaminated with harmful bacteria, such as E. coli and Salmonella, which can cause foodborne illness.\nHowever, it's important to note that the scientific evidence for these potential health benefits is mixed, and more research is needed to fully understand the differences between organic and conventionally grown foods. Additionally, organic foods may be more expensive and less widely available than conventionally grown foods, which can make it difficult for some people to incorporate them into their diets.\nIn summary, while organic foods may have some potential health benefits, there is limited scientific evidence to support the claim that they are safer than conventionally grown foods. It's important to consider the potential risks and benefits of organic foods, as well as their availability and cost, when making dietary choices.",
    "llama-2-7b-chat-hf_fact": [
      "Organic foods are grown and processed using farming practices that avoid the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge.",
      "Organic foods can potentially have lower pesticide exposure, higher antioxidant levels, better nutrient levels, and a lower risk of foodborne illness.",
      "The scientific evidence about the potential health benefits of organic foods is mixed and more research is needed.",
      "Organic foods may be more expensive and less widely available compared to conventionally grown foods.",
      "Despite the potential benefits, there is limited scientific evidence to support the claim that organic foods are safer than conventionally grown foods."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4696,
    "user_query": "do vegetarians get enough protein ?",
    "llama-2-7b-chat-hf_response": "do vegetarians get enough protein?\nAs a vegetarian, it's important to make sure you're getting enough protein in your diet. Protein is an essential nutrient that helps build and repair muscles, organs, and tissues in the body. Here are some tips for getting enough protein as a vegetarian:\n1. Eat a variety of plant-based protein sources: Include a variety of plant-based protein sources in your diet, such as beans, lentils, tofu, tempeh, seitan, nuts, and seeds.\n2. Combine plant-based protein sources: Combine different plant-based protein sources to create complete proteins, which are proteins that contain all the essential amino acids your body needs. Examples of complete proteins include beans and rice, lentils and whole grains, and tofu and whole grains.\n3. Incorporate protein-rich grains: Incorporate protein-rich grains like quinoa, farro, and bulgur into your diet. These grains are complete proteins, meaning they contain all the essential amino acids your body needs.\n4. Try plant-based protein powders: Plant-based protein powders like pea protein, hemp protein, and rice protein can be a convenient way to boost your protein intake, especially after a workout.\n5. Consult with a registered dietitian: If you're concerned about getting enough protein as a vegetarian, consult with a registered dietitian who can help you create a personalized meal plan that meets your protein needs.",
    "llama-2-7b-chat-hf_fact": [
      "Protein is an essential nutrient that helps build and repair muscles, organs, and tissues in the body.",
      "Plant-based protein sources include beans, lentils, tofu, tempeh, seitan, nuts, and seeds.",
      "Combining different plant-based protein sources can create complete proteins, which contain all the essential amino acids the body needs.",
      "Quinoa, farro, and bulgur are protein-rich grains that are considered complete proteins.",
      "Plant-based protein powders, such as pea protein, hemp protein, and rice protein, can be used to increase protein intake."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Quinoa is a protein-rich grain that is considered a complete protein. Farro and bulgur are not considered complete proteins.",
      "true"
    ]
  },
  {
    "id": 4708,
    "user_query": "is dragon fruit good for you ?",
    "llama-2-7b-chat-hf_response": "Dragon fruit, also known as pitaya, is a nutritious fruit that offers several health benefits due to its richness in vitamins, minerals, and antioxidants. Here are some of the potential health benefits of dragon fruit:\n1. Rich in Vitamins and Minerals: Dragon fruit is a good source of vitamins C and B, as well as minerals like potassium, magnesium, and iron.\n2. Antioxidant Properties: Dragon fruit contains a variety of antioxidants, including flavonoids, carotenoids, and polyphenols, which can help protect the body against free radicals and oxidative stress.\n3. Supports Digestive Health: Dragon fruit is high in dietary fiber, which can help promote digestive health and prevent constipation.\n4. May Help Lower Blood Pressure: The potassium content in dragon fruit can help lower blood pressure by counteracting the effects of sodium in the body.\n5. May Help Reduce Inflammation: Dragon fruit contains anti-inflammatory compounds that may help reduce inflammation in the body, which can reduce the risk of chronic diseases.\n6. Supports Eye Health: Dragon fruit is a good source of vitamin A, which is essential for maintaining healthy vision and preventing age-related macular degeneration.\n7. May Help Boost Immune System: Dragon fruit contains vitamin C, which can help boost the immune system and protect against infections.\n8. May Help Reduce Cancer Risk: The antioxidants and other nutrients in dragon fruit may help reduce the risk of certain types of cancer, such as colon and breast cancer.\n9. Supports Skin Health: Dragon fruit is rich in antioxidants and vitamins that can help protect the skin against sun damage and promote collagen production, which can improve skin elasticity and reduce the appearance of fine lines and wrinkles.\n10. May Help Manage Blood Sugar: The fiber and antioxidants in dragon fruit may help manage blood sugar levels and reduce the risk of developing type 2 diabetes.\nOverall, dragon fruit is",
    "llama-2-7b-chat-hf_fact": [
      "Dragon fruit, also known as pitaya, is rich in vitamins, minerals, and antioxidants.",
      "Dragon fruit contains vitamins C and B, and minerals like potassium, magnesium, and iron.",
      "Dragon fruit is high in dietary fiber, which can help promote digestive health.",
      "The potassium content in dragon fruit can potentially help to lower blood pressure.",
      "Dragon fruit contains vitamin A, which is essential for maintaining healthy vision."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Dragon fruit does not contain vitamin A, but it does contain vitamin C, which can help support healthy vision."
    ]
  },
  {
    "id": 4713,
    "user_query": "is coconut milk good for you ?",
    "llama-2-7b-chat-hf_response": "Coconut milk is a popular plant-based milk alternative that is rich in nutrients and has several potential health benefits. Here are some of the reasons why coconut milk is good for you:\n1. Rich in Medium-Chain Triglycerides (MCTs): Coconut milk contains medium-chain triglycerides (MCTs), which are metabolized differently than other fats. MCTs are easily absorbed and can be used as a quick source of energy.\n2. High in Healthy Fats: Coconut milk is high in healthy fats, including medium-chain triglycerides (MCTs) and lauric acid. These fats have been shown to have anti-inflammatory and antimicrobial properties.\n3. Good Source of Protein: Coconut milk is a good source of protein, with approximately 5 grams of protein per cup. This makes it a good option for vegetarians and vegans looking to boost their protein intake.\n4. Low in Calories: Coconut milk is low in calories, with approximately 50 calories per cup. This makes it a good option for those looking to lose weight or maintain weight loss.\n5. Supports Digestive Health: Coconut milk contains prebiotic fiber, which can help support digestive health by promoting the growth of beneficial gut bacteria.\n6. May Help Lower Cholesterol: Coconut milk contains a type of fiber called beta-glucan, which has been shown to help lower cholesterol levels.\n7. Supports Bone Health: Coconut milk is a good source of several minerals, including calcium, magnesium, and potassium, which are important for bone health.\n8. May Help Manage Blood Sugar: Coconut milk contains a type of fiber called inulin, which has been shown to help manage blood sugar levels.\n9. Supports Immune System: Coconut milk contains lauric acid, which has been shown to have antimicrobial and anti-inflammatory properties, supporting the immune system.\n10. May Help Reduce Inflammation: Coconut milk contains anti-inflammat",
    "llama-2-7b-chat-hf_fact": [
      "Coconut milk is a plant-based milk alternative that is rich in nutrients.",
      "Coconut milk contains medium-chain triglycerides (MCTs) and lauric acid.",
      "One cup of coconut milk provides approximately 5 grams of protein.",
      "Coconut milk is low in calories, containing about 50 calories per cup.",
      "Coconut milk can support bone health as it is a good source of several minerals, including calcium, magnesium, and potassium."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: One cup of coconut milk provides approximately 5 ounces of protein.",
      "false, [corrected fact]: Coconut milk is relatively high in calories, with one cup containing approximately 550 calories.",
      "true"
    ]
  },
  {
    "id": 4717,
    "user_query": "what do you think of dr. jenkins ' take on paleolithic diets ?",
    "llama-2-7b-chat-hf_response": "Dr. Jenkins has written extensively on the topic of paleolithic diets, and his views are well-respected in the field of nutrition. Here are some key points he has made about paleolithic diets:\n1. The paleolithic diet is based on the idea that the human body is genetically adapted to eat foods that were available to our ancestors during the Paleolithic era, which spanned from about 2.5 million years ago to around 10,000 years ago.\n2. Dr. Jenkins argues that the modern diet, which includes foods such as grains, dairy products, and processed foods, is not well-suited to the human body and can lead to chronic diseases such as obesity, diabetes, and heart disease.\n3. In contrast, the paleolithic diet consists of foods that were available to our ancestors during the Paleolithic era, including meats, fish, fruits, vegetables, nuts, and seeds.\n4. Dr. Jenkins believes that the paleolithic diet is a more natural and sustainable way of eating, as it is based on the foods that our bodies are genetically adapted to digest and process.\n5. He also notes that the paleolithic diet is high in nutrients and fiber, and low in calories, which can help with weight loss and overall health.\n6. However, Dr. Jenkins also acknowledges that the paleolithic diet may not be suitable for everyone, and that it is important to consult with a healthcare professional before making any significant changes to your diet.\nOverall, Dr. Jenkins' views on paleolithic diets are that they are a more natural and sustainable way of eating, based on the foods that our bodies are genetically adapted to digest and process. However, he also acknowledges that the diet may not be suitable for everyone, and that it is important to consult with a healthcare professional before making any significant changes to your diet.",
    "llama-2-7b-chat-hf_fact": [
      "Dr. Jenkins has written extensively on the topic of paleolithic diets.",
      "The paleolithic diet is based on the foods that were available to our ancestors during the Paleolithic era, which was about 2.5 million years ago to around 10,000 years ago.",
      "The paleolithic diet includes meats, fish, fruits, vegetables, nuts, and seeds.",
      "Dr. Jenkins argues that a modern diet, includes grains, dairy products, and processed foods, leads to chronic diseases such as obesity, diabetes, and heart disease.",
      "Before making any significant changes to your diet, it is important to consult with a healthcare professional."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4721,
    "user_query": "are krill oil supplements better than fish oil capsules ?",
    "llama-2-7b-chat-hf_response": "Krill oil supplements have gained popularity in recent years due to their potential health benefits, but are they better than fish oil capsules? Here are some key differences to consider:\n1. Source: Krill oil is derived from tiny crustaceans that are found in Antarctic waters, while fish oil is typically obtained from fatty fish such as salmon, mackerel, and sardines.\n2. Fatty Acid Composition: Krill oil contains a higher percentage of the omega-3 fatty acid EPA (eicosapentaenoic acid) than fish oil, with a typical ratio of 1:1 EPA to DHA (docosahexaenoic acid). Fish oil, on the other hand, tends to have a higher DHA content.\n3. Antioxidant Content: Krill oil is rich in antioxidants such as astaxanthin, which has been shown to have anti-inflammatory properties and protect against oxidative stress. Fish oil supplements may also contain antioxidants, but the levels can vary depending on the source and processing methods.\n4. Sustainability: Krill oil is generally considered to be more sustainable than fish oil, as it is derived from a renewable source that is not overfished. Fish oil, on the other hand, can have a larger environmental impact due to the need to catch and process large quantities of fish.\n5. Taste and Smell: Krill oil has a milder taste and smell than fish oil, which can be a benefit for those who find the taste and smell of fish oil unpleasant.\n6. Absorption Rate: Some studies suggest that krill oil may be better absorbed by the body than fish oil, as it contains phospholipids that help to facilitate the absorption of omega-3s. However, more research is needed to confirm this.\nIn conclusion, while both krill oil and fish oil supplements have potential health benefits, the choice between the two depends on individual preferences and needs. Krill oil may be a better option for those looking for a more sustainable and better-absorbed source of omega-3s, while fish oil may be a better choice for those who prefer the taste and smell of fish",
    "llama-2-7b-chat-hf_fact": [
      "Krill oil is derived from tiny crustaceans that are found in Antarctic waters.",
      "Fish oil is typically obtained from fatty fish such as salmon, mackerel, and sardines.",
      "Antioxidants such as astaxanthin found in krill oil have been shown to have anti-inflammatory properties and protect against oxidative stress.",
      "Krill oil is generally thought to be more sustainable than fish oil, as it comes from a renewable source that is not overfished.",
      "Some studies suggest that krill oil may be better absorbed by the body than fish oil due to the presence of phospholipids."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4729,
    "user_query": "are organic foods safer ?",
    "llama-2-7b-chat-hf_response": "Organic foods are grown and processed using farming practices that avoid the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge. These practices aim to promote ecological balance and conserve biodiversity. While organic foods may offer some potential health benefits, there is limited scientific evidence to support the claim that they are safer than conventionally grown foods.\nSome of the potential health benefits of organic foods include:\n1. Lower pesticide exposure: Organic foods are less likely to contain residues of pesticides, which have been linked to a range of health problems including cancer, hormone disruption, and neurological damage.\n2. Higher antioxidant levels: Organic foods tend to have higher levels of antioxidants, which can help protect cells from damage and reduce the risk of chronic diseases such as heart disease, cancer, and neurodegenerative disorders.\n3. Better nutrient levels: Organic foods may have higher levels of certain nutrients, such as vitamins C and E, and minerals like zinc and iron, compared to conventionally grown foods.\n4. Lower risk of foodborne illness: Organic foods are less likely to be contaminated with harmful bacteria, such as E. coli and Salmonella, which can cause foodborne illness.\nHowever, it's important to note that the scientific evidence supporting the safety of organic foods is mixed. Some studies have found no significant differences in the safety of organic and conventionally grown foods, while others have suggested that organic foods may be safer.\nFor example, a 2012 review of 247 studies published in the British Journal of Nutrition found that organic foods were no more likely to be contaminated with pesticides or heavy metals than conventionally grown foods. However, a 2014 study published in the Journal of Agricultural and Food Chemistry found that organic produce contained higher levels of certain antioxidants and lower levels of pesticide residues than conventionally grown produce.\nOverall, while organic foods may offer some potential health benefits, the scientific evidence",
    "llama-2-7b-chat-hf_fact": [
      "Organic foods are grown and processed using farming practices that avoid the use of synthetic fertilizers, pesticides, genetically modified organisms (GMOs), irradiation, and sewage sludge.",
      "Organic foods may contain higher levels of antioxidants compared to conventionally grown foods.",
      "Organic foods may have higher levels of certain nutrients, such as vitamins C and E, and minerals like zinc and iron, compared to conventionally grown foods.",
      "Organic foods are less likely to be contaminated with harmful bacteria, such as E. coli and Salmonella.",
      "A 2014 study published in the Journal of Agricultural and Food Chemistry found that organic produce had higher levels of certain antioxidants and lower levels of pesticide residues than conventionally grown produce."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: Organic foods are not necessarily less likely to be contaminated with harmful bacteria. Foodborne illnesses can be present in all types of foods, regardless of whether or not they are organically grown.",
      "true"
    ]
  },
  {
    "id": 4732,
    "user_query": "do vegetarians get enough protein ?",
    "llama-2-7b-chat-hf_response": "There is a common misconception that vegetarians do not get enough protein in their diet. However, with proper planning, vegetarians can easily meet their protein needs. Here are some high protein foods that are suitable for a vegetarian diet:\n1. Legumes: Legumes are a great source of protein and include beans, lentils, chickpeas, and peas. They are also rich in fiber, vitamins, and minerals.\n2. Nuts and seeds: Nuts and seeds, such as almonds, cashews, pumpkin seeds, and chia seeds, are high in protein and healthy fats.\n3. Whole grains: Whole grains, such as quinoa, brown rice, and whole wheat, contain protein as well as other important nutrients like fiber and B vitamins.\n4. Soy products: Soy products, such as tofu, tempeh, and edamame, are high in protein and can be used in a variety of dishes.\n5. Dairy alternatives: Many dairy alternatives, such as soy milk and almond milk, are fortified with protein.\n6. Meat alternatives: Meat alternatives, such as seitan and veggie burgers, can be high in protein and are often made from plant-based protein sources like soy, wheat gluten, or lentils.\n7. Vegetables: While not as high in protein as other foods, vegetables like broccoli, spinach, and kale do contain some protein, and can add up to a significant amount when consumed in large quantities.\n8. Tofu and tempeh: Tofu and tempeh are both high in protein and can be used in a variety of dishes.\n9. Seitan: Seitan is a meat substitute made from wheat gluten and is high in protein.\n10. Veggie burgers: Many veggie burgers are made with protein-rich ingredients like beans, lentils, and soy.\nIt is important to note that vegetarians do not need to consume all of their protein in one meal, but rather can spread it out throughout the day. It is also important to consume a variety of protein sources to ensure that you are getting",
    "llama-2-7b-chat-hf_fact": [
      "Legumes, including beans, lentils, chickpeas, and peas, are a source of protein beneficial for vegetarians.",
      "Nuts and seeds, such as almonds, cashews, pumpkin seeds, and chia seeds, contain high amounts of protein.",
      "Soy products, like tofu, tempeh, and edamame, are rich in protein and suitable for a vegetarian diet.",
      "Several dairy alternatives, including soy milk and almond milk, can be fortified with protein.",
      "Seitan, a meat substitute made from wheat gluten, has a high protein content."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4743,
    "user_query": "is dragon fruit good for you ?",
    "llama-2-7b-chat-hf_response": "Dragon fruit, also known as pitaya, is a nutritious fruit that offers several health benefits due to its richness in vitamins, minerals, and antioxidants. Here are some of the potential health benefits of dragon fruit:\n1. Rich in Vitamins and Minerals: Dragon fruit is a good source of vitamins C and B, as well as minerals like potassium, magnesium, and iron.\n2. Antioxidant Properties: Dragon fruit contains a variety of antioxidants, including flavonoids, carotenoids, and polyphenols, which can help protect the body against free radicals and oxidative stress.\n3. Supports Digestive Health: Dragon fruit is high in dietary fiber, which can help promote digestive health and prevent constipation.\n4. May Help Lower Blood Pressure: The potassium content in dragon fruit can help lower blood pressure by counteracting the effects of sodium in the body.\n5. May Help Reduce Inflammation: Dragon fruit contains anti-inflammatory compounds that may help reduce inflammation in the body, which can reduce the risk of chronic diseases.\n6. Supports Eye Health: Dragon fruit is a good source of vitamin A, which is essential for maintaining healthy vision and preventing age-related macular degeneration.\n7. May Help Boost Immune System: Dragon fruit contains vitamin C, which can help boost the immune system and protect against infections.\n8. May Help Reduce Cancer Risk: The antioxidants and other nutrients in dragon fruit may help reduce the risk of certain types of cancer, such as colon and breast cancer.\n9. Supports Skin Health: Dragon fruit is rich in antioxidants and vitamins that can help protect the skin against sun damage and promote collagen production, which can improve skin elasticity and reduce the appearance of fine lines and wrinkles.\n10. May Help Manage Blood Sugar: The fiber and antioxidants in dragon fruit may help manage blood sugar levels and reduce the risk of developing type 2 diabetes.\nOverall, dragon fruit is",
    "llama-2-7b-chat-hf_fact": [
      "Dragon fruit, also known as pitaya, is a nutritious fruit rich in vitamins, minerals, and antioxidants.",
      "The fruit is a source of vitamins C and B, as well as minerals such as potassium, magnesium, and iron.",
      "Dragon fruit contains a variety of antioxidants, including flavonoids, carotenoids, and polyphenols.",
      "The potassium content in dragon fruit can potentially assist in lowering blood pressure.",
      "The antioxidants and other nutrients in dragon fruit may help in reducing the risk of certain types of cancer."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4746,
    "user_query": "is coconut milk good for you ?",
    "llama-2-7b-chat-hf_response": "Coconut milk is a popular plant-based milk alternative that has gained popularity in recent years due to its potential health benefits. Here are some of the potential benefits of coconut milk:\n1. Rich in Medium-Chain Triglycerides (MCTs): Coconut milk contains medium-chain triglycerides (MCTs), which are metabolized differently than other fats. MCTs are easily absorbed and can be used as a quick source of energy.\n2. High in Healthy Fats: Coconut milk is high in healthy fats, including medium-chain triglycerides (MCTs) and lauric acid. These fats can help support heart health and may also have anti-inflammatory effects.\n3. Good Source of Protein: Coconut milk is a good source of protein, with approximately 5 grams of protein per cup. This can be especially beneficial for vegetarians and vegans who may struggle to get enough protein in their diet.\n4. May Support Digestive Health: Coconut milk contains prebiotic fiber, which can help support the growth of beneficial gut bacteria. This can help promote a healthy gut microbiome and may also have anti-inflammatory effects.\n5. May Help with Weight Management: Coconut milk is low in calories and high in fiber, which can help support weight management. It can also help reduce hunger and increase feelings of fullness, making it a good addition to a weight loss diet.\n6. May Support Immune Function: Coconut milk contains lauric acid, which has been shown to have antimicrobial and anti-inflammatory effects. This may help support immune function and reduce the risk of illness.\n7. May Help with Skin Health: Coconut milk contains lauric acid, which has been shown to have moisturizing and anti-inflammatory effects. This may help improve skin health and reduce the risk of skin conditions such as acne and eczema.\n8. May Support Bone Health: Coconut milk is a good source of several minerals, including calcium, magnesium, and potassium. These minerals are important for bone health and may",
    "llama-2-7b-chat-hf_fact": [
      "Coconut milk is a plant-based milk alternative.",
      "Coconut milk contains medium-chain triglycerides (MCTs) which can be used as a quick source of energy.",
      "There are approximately 5 grams of protein per cup in coconut milk.",
      "Coconut milk also contains prebiotic fiber that can support the growth of beneficial gut bacteria.",
      "Coconut milk is a source of several minerals, including calcium, magnesium, and potassium."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false, [corrected fact]: There are approximately 0.5 grams of protein per cup in coconut milk.",
      "false, [corrected fact]: Coconut milk does not contain prebiotic fiber that can support the growth of beneficial gut bacteria.",
      "true"
    ]
  },
  {
    "id": 4748,
    "user_query": "can we fight the blues with greens ?",
    "llama-2-7b-chat-hf_response": "A study published in the Journal of Affective Disorders suggests that spending time in nature can help alleviate symptoms of depression. The researchers found that people who spent time in green spaces had lower levels of cortisol (a hormone associated with stress) and higher levels of serotonin (a neurotransmitter associated with mood regulation) compared to those who spent time in urban areas.\nAnother study published in the Journal of Environmental Psychology found that people who lived in areas with more green spaces reported feeling more positive emotions and fewer negative emotions compared to those who lived in areas with less green spaces.\nSo, it seems that spending time in nature can have a positive impact on our mental health. But why might this be the case? Here are a few theories:\n1. Exposure to natural environments can help reduce stress and anxiety by promoting relaxation and reducing cortisol levels.\n2. Being in nature can help improve mood by increasing exposure to sunlight, which is important for regulating circadian rhythms and mood.\n3. Spending time in nature can help improve cognitive functioning by reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) and improving memory and creativity.\n4. Being in nature can help improve social connections by providing opportunities for social interaction and community building.\n5. Exposure to natural environments can help reduce symptoms of depression by providing a sense of awe and wonder, which can help improve mood and reduce symptoms of depression.\nOverall, these studies suggest that spending time in nature can have a positive impact on our mental health by reducing stress and anxiety, improving mood, cognitive functioning, and social connections. So, next time you're feeling down, try taking a walk in a nearby park or forest  it might just help improve your mood!",
    "llama-2-7b-chat-hf_fact": [
      "The Journal of Affective Disorders published a study suggesting that spending time in nature can help alleviate symptoms of depression.",
      "People who spent time in green spaces had lower levels of cortisol and higher levels of serotonin compared to those who spent time in urban areas, according to the study published in Journal of Affective Disorders.",
      "The Journal of Environmental Psychology published a study indicating that people who lived in areas with more green spaces reported feeling more positive emotions and fewer negative emotions compared to those who lived in areas with less green spaces.",
      "Exposure to natural environments can help reduce stress and anxiety by promoting relaxation and reducing cortisol levels.",
      "Spending time in nature can improve cognitive functioning by reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) and improving memory and creativity."
    ],
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4759,
    "user_query": "should probiotics be taken before , during , or after meals ?",
    "llama-2-7b-chat-hf_response": "Probiotics are live microorganisms that can provide health benefits when consumed in adequate amounts. The timing of when to take probiotics is important, as it can affect how well they are absorbed and utilized by the body. Here are some general guidelines on when to take probiotics:\nBefore meals:\n1. Better absorption: Taking probiotics before meals can improve their absorption and utilization by the body. Food can interfere with the absorption of probiotics, so taking them before meals can help minimize this effect.\n2. Reduced gas and bloating: Some people may experience gas and bloating after taking probiotics, especially if they are taken on an empty stomach. Taking probiotics before meals can help reduce these symptoms.\nDuring meals:\n1. Increased bioavailability: Studies have shown that taking probiotics during meals can increase their bioavailability and utilization by the body. This is because the food can help protect the probiotics from stomach acid and improve their passage through the digestive system.\n2. Improved gut health: Taking probiotics during meals can help support the growth of beneficial gut bacteria and improve overall gut health.\nAfter meals:\n1. Reduced acidity: Taking probiotics after meals can help reduce the acidity of the stomach, which can improve their absorption and utilization.\n2. Enhanced immune function: Taking probiotics after meals can help enhance immune function by promoting the growth of beneficial bacteria in the gut.\nIt's important to note that these are general guidelines and the best timing for taking probiotics may vary depending on the individual and their specific health needs. Some probiotics may be better absorbed before or after meals, while others may be more effective when taken at a specific time of day. It's always a good idea to consult with a healthcare professional or registered dietitian for personalized advice on when to take probiotics.",
    "llama-2-7b-chat-hf_fact": [
      "Probiotics are live microorganisms that can provide health benefits when consumed in adequate amounts.",
      "The timing of when to take probiotics can affect how well they are absorbed and utilized by the body.",
      "Taking probiotics before meals can improve their absorption and utilization by the body.",
      "Studies have shown that taking probiotics during meals can increase their bioavailability.",
      "Taking probiotics after meals can help enhance immune function by promoting the growth of beneficial bacteria in the gut."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4764,
    "user_query": "are avocados bad for you ?",
    "llama-2-7b-chat-hf_response": "Avocados are a nutritious fruit that are high in healthy fats, fiber, and various vitamins and minerals. However, like any other food, they can have some negative effects on health if consumed in excess. Here are some reasons why avocados may be bad for you:\n1. High in calories: Avocados are high in calories, with a single medium-sized avocado containing around 320 calories. If you consume too many avocados, you may end up consuming more calories than you need, which can lead to weight gain.\n2. Rich in fat: Avocados are high in healthy fats, but they are also high in monounsaturated fats, which can be problematic for people with high cholesterol or heart disease. While the fats in avocados are generally considered healthy, consuming too much of them can lead to an excessive intake of calories and fat.\n3. May cause digestive issues: Some people may experience digestive issues, such as bloating, gas, or stomach discomfort, after consuming avocados. This is often due to the high fiber content, which can be difficult for some people to digest.\n4. May interact with medications: Avocados contain a compound called persin, which can interact with certain medications, such as blood thinners, and cause adverse effects. If you are taking any medications, it is important to consult with your doctor before consuming avocados.\n5. May cause an allergic reaction: Some people may be allergic to avocados, which can cause symptoms such as hives, itching, and difficulty breathing. If you experience any of these symptoms after consuming avocados, seek medical attention immediately.\nIn conclusion, while avocados are generally considered a healthy food, consuming them in excess or experiencing an allergy can have negative effects on health. It is important to consume avocados in moderation and be aware of any potential interactions with medications or allergies.",
    "llama-2-7b-chat-hf_fact": [
      "Avocados are high in healthy fats, fiber, and various vitamins and minerals.",
      "A single medium-sized avocado contains around 320 calories.",
      "Avocados are high in monounsaturated fats.",
      "Avocados contain a compound called persin, which can interact with certain medications, such as blood thinners.",
      "Some people may be allergic to avocados, causing symptoms such as hives, itching, and difficulty breathing."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false, [corrected fact]: While avocados do contain a compound called persin, it is not known to interact with medications. Persin can be toxic to some animals, but not humans.",
      "true"
    ]
  },
  {
    "id": 4776,
    "user_query": "in making water alkaline , how much baking soda is too much ?",
    "llama-2-7b-chat-hf_response": "Answer: Baking soda (sodium bicarbonate) is commonly used to raise the pH of water and make it more alkaline. However, it's important to use the right amount of baking soda to avoid over-alkalizing the water, which can have negative health effects.\nThe recommended amount of baking soda to add to water for alkalization is typically around 1/4 teaspoon per 8 ounces of water. This can help raise the pH of the water to a more alkaline level, typically between 8 and 9.5.\nHowever, it's important to note that excessive consumption of baking soda can lead to an over-alkalization of the body, which can cause a range of negative health effects, including:\n1. Kidney damage: Excessive consumption of baking soda can put a strain on the kidneys, which can lead to kidney damage over time.\n2. Nutrient deficiencies: An over-alkalization of the body can lead to a decrease in the absorption of essential minerals, such as calcium, magnesium, and potassium.\n3. Weakened immune system: An over-alkalization of the body can weaken the immune system, making it more susceptible to illness and infection.\n4. Digestive problems: Excessive consumption of baking soda can lead to digestive problems, such as bloating, gas, and stomach cramps.\nTo avoid these negative health effects, it's important to use the right amount of baking soda when making alkaline water. Here are some general guidelines to follow:\n1. Start with a small amount: If you're new to using baking soda in your water, start with a small amount, such as 1/8 teaspoon per 8 ounces of water.\n2. Monitor the pH level: Use a pH test strip to monitor the pH level of your alkaline water. Aim for a pH level between 8 and 9.5.\n3. Gradually increase the amount: If you want to increase the alkalinity of your water, you can gradually increase the amount of baking soda you use,",
    "llama-2-7b-chat-hf_fact": [
      "Baking soda (sodium bicarbonate) is used to raise the pH of water and make it more alkaline.",
      "The recommended amount of baking soda to add to water for alkalization is around 1/4 teaspoon per 8 ounces of water.",
      "Over-consumption of baking soda can lead to an over-alkalization of the body that can cause negative health effects.",
      "High consumption of baking soda may cause kidney damage, nutrient deficiencies, immune system weakening, and digestive problems.",
      "The desired pH level of alkaline water is typically between 8 and 9.5."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4779,
    "user_query": "isn 't regular cocoa powder healthier than alkali-processed \" dutched \" cocoa ?",
    "llama-2-7b-chat-hf_response": "Yes, regular cocoa powder is generally considered to be healthier than alkali-processed \"Dutch-processed\" cocoa powder. Here's why:\n1. Alkali processing: Dutch-processed cocoa powder is made by treating cocoa beans with an alkalizing agent, such as sodium hydroxide, to neutralize their natural acidity. This process can strip away some of the natural flavonoids and other nutrients found in cocoa beans.\n2. Flavonoids: Flavonoids are a type of antioxidant found in cocoa beans that have been shown to have numerous health benefits, including improving heart health, reducing inflammation, and boosting cognitive function. Dutch-processed cocoa powder may contain lower levels of flavonoids than regular cocoa powder due to the alkali processing.\n3. Mineral content: Cocoa beans are a good source of minerals such as iron, magnesium, and zinc. Dutch-processed cocoa powder may have lower levels of these minerals than regular cocoa powder due to the alkali processing.\n4. Taste and aroma: Dutch-processed cocoa powder has a milder flavor and aroma than regular cocoa powder, which some people prefer. However, others may find that it lacks the rich, deep flavor of regular cocoa powder.\nIn summary, while Dutch-processed cocoa powder is still a good source of antioxidants and other nutrients, regular cocoa powder is generally considered to be healthier due to its higher levels of flavonoids and minerals, as well as its more intense flavor and aroma.",
    "llama-2-7b-chat-hf_fact": [
      "Dutch-processed cocoa powder is made by treating cocoa beans with an alkalizing agent, such as sodium hydroxide.",
      "The process of making Dutch-processed cocoa can strip away some of the natural flavonoids and other nutrients found in cocoa beans.",
      "Cocoa beans are a good source of minerals such as iron, magnesium, and zinc.",
      "Dutch-processed cocoa powder may contain lower levels of flavonoids and minerals than regular cocoa powder due to the alkali processing.",
      "Dutch-processed cocoa powder has a milder flavor and aroma compared to regular cocoa powder."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4787,
    "user_query": "should probiotics be taken before , during , or after meals ?",
    "llama-2-7b-chat-hf_response": "Probiotics are live microorganisms that can provide health benefits when consumed in adequate amounts. The timing of when to take probiotics is important, as it can affect how well they are absorbed and utilized by the body. Here are some general guidelines on when to take probiotics:\nBefore meals:\n1. Better absorption: Taking probiotics before meals can improve their absorption and utilization by the body. Food can interfere with the absorption of probiotics, so taking them before meals can help minimize this effect.\n2. Reduced gas and bloating: Some people may experience gas and bloating after taking probiotics, especially if they are taken on an empty stomach. Taking probiotics before meals can help reduce these symptoms.\nDuring meals:\n1. Increased bioavailability: Taking probiotics during meals can increase their bioavailability, as the food can help protect the probiotics from stomach acid and digestive enzymes.\n2. Improved colonization: Probiotics can colonize the gut more effectively when taken during meals, as the food can provide a source of nutrients for the probiotics to grow and multiply.\nAfter meals:\n1. Reduced acidity: Taking probiotics after meals can help reduce the acidity of the stomach, which can make it easier for the probiotics to survive and colonize the gut.\n2. Enhanced immune response: Taking probiotics after meals can enhance the immune response, as the probiotics can help stimulate the immune system and promote the growth of beneficial bacteria in the gut.\nIt's important to note that these are general guidelines, and the best timing for taking probiotics may vary depending on the individual and the specific probiotic strain being used. Some probiotics may be more sensitive to stomach acid and may be better taken before or after meals, while others may be more resistant and can be taken at any time. It's always a good idea to consult with a healthcare professional or a registered dietitian for personalized advice on when to take probiotics.",
    "llama-2-7b-chat-hf_fact": [
      "Probiotics are live microorganisms that provide health benefits when consumed adequately.",
      "The timing of probiotic intake can influence how well they are absorbed and utilized in the body.",
      "Probiotics can help reduce gas and bloating when taken before meals.",
      "The efficacy of probiotics can improve if taken during meals as food can protect them from stomach acid.",
      "Taking probiotics after meals can reduce the stomach's acidity, thus enhancing their survival and colonization in the gut."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Taking probiotics before or during meals can reduce the stomach's acidity, thus enhancing their survival and colonization in the gut. There is no specific evidence to suggest that taking them after meals would lower stomach acidity."
    ]
  },
  {
    "id": 4792,
    "user_query": "are avocados bad for you ?",
    "llama-2-7b-chat-hf_response": "Avocados are a nutritious fruit that are high in healthy fats, fiber, and various vitamins and minerals. However, like any other food, they can have some negative effects on health if consumed in excess. Here are some reasons why avocados may be bad for you:\n1. High in calories: Avocados are high in calories, with a single medium-sized avocado containing around 320 calories. If you consume too many avocados, you may end up consuming more calories than you need, which can lead to weight gain.\n2. Rich in fat: Avocados are high in healthy fats, but they are also high in calories. If you consume too many avocados, you may end up consuming more fat than you need, which can lead to weight gain and other health problems.\n3. May cause digestive issues: Some people may experience digestive issues, such as bloating, gas, and stomach discomfort, after consuming avocados. This is because avocados are high in fiber, which can be difficult for some people to digest.\n4. May interact with medications: Avocados contain a compound called persin, which can interact with certain medications, such as blood thinners, and cause adverse effects.\n5. May cause an allergic reaction: Some people may be allergic to avocados, which can cause an allergic reaction when consumed. Symptoms of an allergic reaction to avocados may include hives, itching, swelling, and difficulty breathing.\n6. May have a negative impact on blood sugar: Avocados are high in healthy fats and fiber, but they are also high in carbohydrates. If you have diabetes or are trying to manage your blood sugar levels, consuming too many avocados may cause a spike in blood sugar levels.\n7. May interact with other medications: Avocados contain a compound called carotenoids, which can interact with certain medications, such as blood thinners, and cause adverse effects.\n8. May cause a nutrient imbalance: Consuming too many avocados can lead to an imbalance of certain nutrients in the body,",
    "llama-2-7b-chat-hf_fact": [
      "Avocados are a nutritious fruit that are high in healthy fats, fiber, and various vitamins and minerals.",
      "A single medium-sized avocado contains around 320 calories.",
      "Overconsumption of avocados can lead to weight gain due to their high caloric and fat content.",
      "Some people may experience digestive issues, such as bloating, gas, and stomach discomfort, after consuming avocados.",
      "Avocados contain a compound called persin, which can interact with certain medications, such as blood thinners."
    ],
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false, [corrected fact]: Avocados contain a compound called persin, but it is harmless to humans and does not interact with medications. Persin can be harmful to certain animals."
    ]
  }
]